Citrus Sinensis ID: 003059
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 852 | 2.2.26 [Sep-21-2011] | |||||||
| Q9XID3 | 829 | G-type lectin S-receptor- | yes | no | 0.909 | 0.934 | 0.636 | 0.0 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.879 | 0.858 | 0.370 | 1e-130 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.829 | 0.853 | 0.374 | 1e-122 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.802 | 0.858 | 0.361 | 1e-102 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.367 | 0.381 | 0.541 | 1e-100 | |
| P17801 | 817 | Putative receptor protein | N/A | no | 0.868 | 0.905 | 0.330 | 5e-96 | |
| Q39202 | 832 | G-type lectin S-receptor- | no | no | 0.892 | 0.913 | 0.313 | 7e-93 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.799 | 0.780 | 0.318 | 3e-86 | |
| P93756 | 764 | G-type lectin S-receptor- | no | no | 0.820 | 0.914 | 0.293 | 5e-84 | |
| O64771 | 809 | G-type lectin S-receptor- | no | no | 0.856 | 0.902 | 0.293 | 2e-73 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1009 bits (2610), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 509/800 (63%), Positives = 618/800 (77%), Gaps = 25/800 (3%)
Query: 29 SFADISLGSSLSASNLNQSWPSPNSTFSLSFIQR-SPNSFIPAITYSGGVPIWTAGSTPV 87
SF+ I LGS + AS NQ+WPSPNSTFS+SF+ SPNSF+ A++++G VPIW+AG+ V
Sbjct: 23 SFSTIPLGSVIYASGSNQNWPSPNSTFSVSFVPSPSPNSFLAAVSFAGSVPIWSAGT--V 80
Query: 88 DSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLNVTSASLDDSGNLVLLKNGGVSAWSSFD 147
DS +LH+SG+LRL +GSG +WDS T RL VTS S++D+G +LL N V WSSFD
Sbjct: 81 DSRGSLRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNRSVPVWSSFD 140
Query: 148 NPTDTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWNDSVVYFNQGLNSAINSTVNSNL 207
NPTDTIV SQNFT+ K LRSG YSF L +SGNL+L+WN S +Y+N GLNS+ +S +
Sbjct: 141 NPTDTIVQSQNFTAGKILRSGLYSFQLERSGNLTLRWNTSAIYWNHGLNSSFSSNL---- 196
Query: 208 TSPILRLQPVGILSISDVSLNSAAIIAYSSDYAEGSDILRFLSLGSDGNLRIFSSA-RGS 266
+SP L LQ G++SI + +L A I YS DY + S+ RFL L DGNLRI+SSA R S
Sbjct: 197 SSPRLSLQTNGVVSIFESNLLGGAEIVYSGDYGD-SNTFRFLKLDDDGNLRIYSSASRNS 255
Query: 267 GTKTRRWAAVADQCEVFGYCGNMGICGYNGYNDSSSDPLCECPSQNFEFIDQNDRRKGCR 326
G W+AV DQC V+GYCGN GIC YN N P+C CPS+NF+F+D NDRRKGC+
Sbjct: 256 GPVNAHWSAV-DQCLVYGYCGNFGICSYNDTN-----PICSCPSRNFDFVDVNDRRKGCK 309
Query: 327 RKVEIDSCPGSATMLELPHTKFLTFQPELSSQVFFVGISACRLNCLVTGSCVASTSLSDG 386
RKVE+ C G+ TML+L HT+ T++ + +S+ FF G S CR NCL + C+AS S+SDG
Sbjct: 310 RKVELSDCSGNTTMLDLVHTRLFTYEDDPNSESFFAGSSPCRANCLSSVLCLASVSMSDG 369
Query: 387 TGLCYLKTP-DFVSGFQNPALPSTSYVKVCGPVLPNPSGSLQAEEKSKSWRLKAWIVVVA 445
+G C+ K P F +G+Q P++PSTSYVKVCGPV+ N + + S ++ WIV VA
Sbjct: 370 SGNCWQKHPGSFFTGYQWPSVPSTSYVKVCGPVVANTLERATKGDDNNS-KVHLWIVAVA 428
Query: 446 VLATLMVLVVLEGGLWYWCCRNSPKFVSLSAQYALLEYASGAPVQFSYKELQRSTKGFKD 505
V+A L+ LV +E GLW+ CCR +P+F +LS+ Y LLEYASGAPVQF+YKELQR TK FK+
Sbjct: 429 VIAGLLGLVAVEIGLWWCCCRKNPRFGTLSSHYTLLEYASGAPVQFTYKELQRCTKSFKE 488
Query: 506 KLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSE 565
KLGAGGFG VYRGVL NRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRL+GF S+
Sbjct: 489 KLGAGGFGTVYRGVLTNRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLIGFCSQ 548
Query: 566 GKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVH 625
G+HRLLVYEFM+NGSLDNFLF + S K L W+ RFNIALGTA+GITYLHEECRDCIVH
Sbjct: 549 GRHRLLVYEFMRNGSLDNFLFTTD--SAKFLTWEYRFNIALGTAKGITYLHEECRDCIVH 606
Query: 626 CDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSK 685
CDIKPENIL+D+N+ AKVSDFGLAKL+NPKD+R+ ++SVRGTRGYLAPEWLANLPITSK
Sbjct: 607 CDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRY-NMSSVRGTRGYLAPEWLANLPITSK 665
Query: 686 SDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA-GEDVDI 744
SDVYSYGMVLLE+VSG+RNF+VS++TN KKFS+WAYEEFEKGN K I+D L+ + VD+
Sbjct: 666 SDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIWAYEEFEKGNTKAILDTRLSEDQTVDM 725
Query: 745 EQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPPAPKALTEGSVGGTSVNMSS 804
EQVMR ++ SFWCIQEQP QRP MGKVVQMLEGITEI+ P PK ++E S G S+
Sbjct: 726 EQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEIKNPLCPKTISEVSFSGNSM---- 781
Query: 805 STSALSTFAASAPAPSSSSS 824
STS S F AS P SSS S
Sbjct: 782 STSHASMFVASGPTRSSSFS 801
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 468 bits (1203), Expect = e-130, Method: Compositional matrix adjust.
Identities = 303/818 (37%), Positives = 463/818 (56%), Gaps = 69/818 (8%)
Query: 26 FISSFA---DISLGSSLSASNLNQSWPSPNSTFSLSFIQRSP-NSFIPAITYSG--GVP- 78
F+ S A I LGS L AS N++W S N TF++ F + P + F+ +I ++ G P
Sbjct: 20 FLVSLATEPHIGLGSKLKASEPNRAWVSANGTFAIGFTRFKPTDRFLLSIWFAQLPGDPT 79
Query: 79 -IWTAG-STPVDSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLNVTSASLDDSGNLVLLK 136
+W+ ++PV A +L ++G L ++S ++W SNT V SA + +SGN +LL
Sbjct: 80 IVWSPNRNSPVTKEAVLELEATGNL-VLSDQNTVVWTSNTSNHGVESAVMSESGNFLLLG 138
Query: 137 N---GGVSAWSSFDNPTDTIVPSQNFTSDKTL-------RSGYYSFTLLK---SGNLSLK 183
G + W SF P+DT++P+Q T L R G+YS +L+ S +L L
Sbjct: 139 TEVTAGPTIWQSFSQPSDTLLPNQPLTVSLELTSNPSPSRHGHYSLKMLQQHTSLSLGLT 198
Query: 184 WNDSVVYFNQGLNSAINSTVN-SNLTSPILR-LQPVGILSISDVSLNSAAIIAYSS---- 237
+N + + N + S + SN+T + L G I + A+ Y +
Sbjct: 199 YN---INLDPHANYSYWSGPDISNVTGDVTAVLDDTGSFKIVYGESSIGAVYVYKNPVDD 255
Query: 238 --DYAEGSD-------ILRFLSLGSDGNLRIF---SSARGSGTKTRRWAAVADQCEVFGY 285
+Y S+ +LR L L ++GNLR++ + GS WAAV++ C++ G
Sbjct: 256 NRNYNNSSNLGLTKNPVLRRLVLENNGNLRLYRWDNDMNGSSQWVPEWAAVSNPCDIAGI 315
Query: 286 CGNMGICGYNGYNDSSSDPLCECPSQNFEFIDQNDRRKGCRRKVEIDSCP------GSAT 339
CGN G+C + ++ C C + + DQ + + + C GS
Sbjct: 316 CGN-GVCNLDRTKKNAD---CLCLPGSVKLPDQENAKLCSDNSSLVQECESNINRNGSFK 371
Query: 340 MLELPHTKFLTFQPELSSQVFFV-GISACRLNCLVTGSCVAST-SLSDGTGLCY-LKTPD 396
+ + T + + + + + + C CL CVAS L D C+ LK+ +
Sbjct: 372 ISTVQETNYYFSERSVIENISDISNVRKCGEMCLSDCKCVASVYGLDDEKPYCWILKSLN 431
Query: 397 FVSGFQNPALPSTSYVKVCGPVLPNPSGSLQAEEKSKSWRLKAWIVVVAVLATLMVLVVL 456
F GF++P ST +VK + + + KS L+ ++V+ ++ ++VLV L
Sbjct: 432 F-GGFRDPG--STLFVKTRANESYPSNSNNNDSKSRKSHGLRQKVLVIPIVVGMLVLVAL 488
Query: 457 EGGLWYWCCRNSPKFVSLSAQYALLEYASGAPVQFSYKELQRSTKGFKDKLGAGGFGAVY 516
G L Y+ + + + +A+ +L+ +PV F+Y++LQ T F LG+GGFG VY
Sbjct: 489 LGMLLYYNL-DRKRTLKRAAKNSLI--LCDSPVSFTYRDLQNCTNNFSQLLGSGGFGTVY 545
Query: 517 RGVLANRTVVAVKQLE-GIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575
+G +A T+VAVK+L+ + GE++F EV TI S HH+NLVRL G+ SE HRLLVYE+
Sbjct: 546 KGTVAGETLVAVKRLDRALSHGEREFITEVNTIGSMHHMNLVRLCGYCSEDSHRLLVYEY 605
Query: 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL 635
M NGSLD ++F++E+ + LL+W++RF IA+ TA+GI Y HE+CR+ I+HCDIKPENILL
Sbjct: 606 MINGSLDKWIFSSEQ-TANLLDWRTRFEIAVATAQGIAYFHEQCRNRIIHCDIKPENILL 664
Query: 636 DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVL 695
D+N+ KVSDFGLAK++ ++H H +T +RGTRGYLAPEW++N PIT K+DVYSYGM+L
Sbjct: 665 DDNFCPKVSDFGLAKMMG-REHSH-VVTMIRGTRGYLAPEWVSNRPITVKADVYSYGMLL 722
Query: 696 LEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSF 755
LEIV GRRN ++S + + WAY+E G VDK L G + E+V++A++V+F
Sbjct: 723 LEIVGGRRNLDMSYDAEDFFYPGWAYKELTNGTSLKAVDKRLQGV-AEEEEVVKALKVAF 781
Query: 756 WCIQEQPSQRPMMGKVVQMLEGIT-EIEKPPAPKALTE 792
WCIQ++ S RP MG+VV++LEG + EI PP P+ + E
Sbjct: 782 WCIQDEVSMRPSMGEVVKLLEGTSDEINLPPMPQTILE 819
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 441 bits (1133), Expect = e-122, Method: Compositional matrix adjust.
Identities = 294/786 (37%), Positives = 422/786 (53%), Gaps = 79/786 (10%)
Query: 45 NQSWPSPNSTFSLSFIQR-SPNSFIPAITYS--GGVPIWTAGSTPVDS---SAFFQLHSS 98
+Q+ S + T+ + F + S ++F + Y +W A S S+ F++ S+
Sbjct: 35 DQTIVSSDGTYEMGFFKPGSSSNFYIGMWYKQLSQTILWVANRDKAVSDKNSSVFKI-SN 93
Query: 99 GTLRLISGSGAI-IWDS---NTQRLNVTSASLDDSGNLVLLKNGGVSA-----WSSFDNP 149
G L L+ G+ +W + +T ++ A L D GNLVL + GG S W SFD+P
Sbjct: 94 GNLILLDGNYQTPVWSTGLNSTSSVSALEAVLQDDGNLVL-RTGGSSLSANVLWQSFDHP 152
Query: 150 TDTIVP------------SQNFTSDKTLRS---GYYSFTLLKSGNLSLKWNDSVVYFNQG 194
DT +P SQ TS K+L G +S L +S + WN S Y++ G
Sbjct: 153 GDTWLPGVKIRLDKRTGKSQRLTSWKSLEDPSPGLFSLELDESTAYKILWNGSNEYWSSG 212
Query: 195 LNSAINSTVNSNLTSPILRLQPVGILSISDVSLNSAAIIAYSSDYAEGSDILRFLSLGSD 254
+ + +S P +RL I + S S + + YS ++ RF+ +
Sbjct: 213 PWNPQSRIFDS---VPEMRLNY--IYNFSFFSNTTDSYFTYS--IYNQLNVSRFV-MDVS 264
Query: 255 GNLRIFSSARGSGTKTRRWAAVADQCEVFGYCGNMGICGYNGYNDSSSDPLCECPSQNFE 314
G ++ F+ G+ W+ QC+V+ YCG+ GIC S+P C CP Q F
Sbjct: 265 GQIKQFTWLEGNKAWNLFWSQPRQQCQVYRYCGSFGICS------DKSEPFCRCP-QGFR 317
Query: 315 FIDQND-----RRKGCRRKVEIDSCPGSAT-MLELPHTKFLTFQPELSSQVFFVGISACR 368
+ Q D GC RK E+ G LP+ K L+ + SAC+
Sbjct: 318 PMSQKDWDLKDYSAGCVRKTELQCSRGDINQFFRLPNMKLADNSEVLTRTSLSICASACQ 377
Query: 369 LNCLVTGSCVASTSLSDGTGLCYLKTPDFVSGFQNPALPSTS---YVKVCGPVLPNPSGS 425
+C SC A + +G+ C + + D ++ Q S Y+++ +PN S
Sbjct: 378 GDC----SCKA-YAYDEGSSKCLVWSKDVLNLQQLEDENSEGNIFYLRLAASDVPNVGAS 432
Query: 426 LQAEEKSKSWRLKAWIVVVAVLATLMVLVVLEGGLWYWCCRNSPKFVSLSAQYALLEYAS 485
++ K ++ AVL +L G + + E
Sbjct: 433 GKSNNKG--------LIFGAVLGSL-------GVIVLVLLVVILILRYRRRKRMRGEKGD 477
Query: 486 GAPVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEV 545
G FSY+ELQ +TK F DKLG GGFG+V++G L + + +AVK+LEGI QGEKQFR EV
Sbjct: 478 GTLSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRTEV 537
Query: 546 ATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIA 605
TI + H+NLVRL GF SEG +LLVY++M NGSLD+ LF N+ +L W+ RF IA
Sbjct: 538 VTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIA 597
Query: 606 LGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSV 665
LGTARG+ YLH+ECRDCI+HCDIKPENILLD + KV+DFGLAKL+ +D R LT++
Sbjct: 598 LGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVG-RDF-SRVLTTM 655
Query: 666 RGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFE 725
RGTRGYLAPEW++ + IT+K+DVYSYGM+L E+VSGRRN E S+ + F WA
Sbjct: 656 RGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAATILT 715
Query: 726 K-GNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKP 784
K G+++ +VD L G+ VDIE+V RA +V+ WCIQ++ S RP M +VVQ+LEG+ E+ P
Sbjct: 716 KDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPP 775
Query: 785 PAPKAL 790
P P+++
Sbjct: 776 PFPRSI 781
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 375 bits (962), Expect = e-102, Method: Compositional matrix adjust.
Identities = 283/783 (36%), Positives = 401/783 (51%), Gaps = 99/783 (12%)
Query: 79 IWTAGST-PVDS--SAFFQLHSSGTLRLISGSGAIIWDSNTQRLNVTSASLDDSGNLVLL 135
+W A PV S+ +L S+G L + + ++W ++ ++ T ++GNL+L+
Sbjct: 69 VWVANRIRPVSDPDSSTLELTSTGYLIVSNLRDGVVWQTDNKQPG-TDFRFSETGNLILI 127
Query: 136 KNGGVSAWSSFDNPTDTIVPSQNFTSDKTLRS---------GYYSFTLLKSGN-LSLKWN 185
+ G W SFDNPTDT +P N T + S G+YS L S N L +
Sbjct: 128 NDDGSPVWQSFDNPTDTWLPGMNVTGLTAMTSWRSLFDPSPGFYSLRLSPSFNEFQLVYK 187
Query: 186 DSVVYFNQGLNSAINSTVNSNLTSPILRLQPVGILSISDVSLNSAAI--IAYSSDYAEGS 243
+ Y++ G N T + + P + + + + +A+ I D
Sbjct: 188 GTTPYWSTG-----NWTGEAFVGVPEMTIPYIYRFHFVNPYTPTASFWYIVPPLDSVSEP 242
Query: 244 DILRFLSLGSDGNLRIFSSARGSGTKTRRWAAVADQCEVFGYCGNMGICGYNGYNDSSSD 303
+ RF+ +G++G L+ ++ + + W D C V+ CG +G C SS+
Sbjct: 243 RLTRFM-VGANGQLKQYTWDPQTQSWNMFWLQPEDPCRVYNLCGQLGFC--------SSE 293
Query: 304 PL--CEC----PSQNFEFIDQNDRRKGCRRKVEIDSCPGSATMLELPHTKFLTFQPELSS 357
L C C +N +D GCRR+ DS S T + L + ++
Sbjct: 294 LLKPCACIRGFRPRNDAAWRSDDYSDGCRRE-NGDSGEKSDTFEAVGD---LRYDGDVKM 349
Query: 358 QVFFVGISACRLNCLVTGSCVASTSLSDGTGLC--YLKTPDFVSGFQNPALPSTSYVKVC 415
V S+C CL SCV + + LC L++P+ + + S S + +C
Sbjct: 350 SRLQVSKSSCAKTCLGNSSCVGFYH-KEKSNLCKILLESPNNLKNSKGNI--SKSIIILC 406
Query: 416 GPVLPNPSGSLQAEEKSKSWRLKAWIVVVAVLATLMVLVVLEGGLWYWCCRNSPKFVSLS 475
V GS+ V+ L ++L+ ++ F L+
Sbjct: 407 SVV-----GSIS--------------VLGFTLLVPLILLKRSRKRKKTRKQDEDGFAVLN 447
Query: 476 AQYALLEYASGAPVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI 534
+ FS+KELQ +T GF DK+G GGFGAV++G L + T VAVK+LE
Sbjct: 448 LKV------------FSFKELQSATNGFSDKVGHGGFGAVFKGTLPGSSTFVAVKRLERP 495
Query: 535 EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGK 594
GE +FR EV TI + H+NLVRL GF SE HRLLVY++M GSL ++L S K
Sbjct: 496 GSGESEFRAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYL---SRTSPK 552
Query: 595 LLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654
LL+W++RF IALGTA+GI YLHE CRDCI+HCDIKPENILLD +YNAKVSDFGLAKL+
Sbjct: 553 LLSWETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLG- 611
Query: 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRK 714
+D R L ++RGT GY+APEW++ LPIT+K+DVYS+GM LLE++ GRRN V+ +T +
Sbjct: 612 RDF-SRVLATMRGTWGYVAPEWISGLPITTKADVYSFGMTLLELIGGRRNVIVNSDTLGE 670
Query: 715 K--------FSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP 766
K F WA E +GNV +VD L GE + E+V R V+ WCIQ+ RP
Sbjct: 671 KETEPEKWFFPPWAAREIIQGNVDSVVDSRLNGE-YNTEEVTRMATVAIWCIQDNEEIRP 729
Query: 767 MMGKVVQMLEGITEIEKPPAPK---ALTEGS----VGGTSVNMSSSTSALSTFAASAPAP 819
MG VV+MLEG+ E+ PP PK AL G V GTS + S L+T S+P
Sbjct: 730 AMGTVVKMLEGVVEVTVPPPPKLIQALVSGDSYRGVSGTSCSEGHGCSDLNT-GLSSPGS 788
Query: 820 SSS 822
SS
Sbjct: 789 RSS 791
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 365 bits (938), Expect = e-100, Method: Compositional matrix adjust.
Identities = 171/316 (54%), Positives = 231/316 (73%), Gaps = 3/316 (0%)
Query: 475 SAQYALLEYASGAPVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGI 534
S + LE SG P++F+YK+LQ +T F KLG GGFG+VY G L + + +AVK+LEGI
Sbjct: 467 SEEDNFLENLSGMPIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGI 526
Query: 535 EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGK 594
QG+K+FR EV+ I S HHL+LVRL GF +EG HRLL YEF+ GSL+ ++F ++G
Sbjct: 527 GQGKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGD-V 585
Query: 595 LLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654
LL+W +RFNIALGTA+G+ YLHE+C IVHCDIKPENILLD+N+NAKVSDFGLAKL+
Sbjct: 586 LLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMT- 644
Query: 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRK 714
++ H T++RGTRGYLAPEW+ N I+ KSDVYSYGMVLLE++ GR+N++ S+ + +
Sbjct: 645 REQSH-VFTTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKC 703
Query: 715 KFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774
F +A+++ E+G + IVD + DV E+V RA++ + WCIQE RP M KVVQM
Sbjct: 704 HFPSFAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQM 763
Query: 775 LEGITEIEKPPAPKAL 790
LEG+ + +PP+ +
Sbjct: 764 LEGVFPVVQPPSSSTM 779
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 353 bits (905), Expect = 5e-96, Method: Compositional matrix adjust.
Identities = 274/830 (33%), Positives = 411/830 (49%), Gaps = 90/830 (10%)
Query: 14 LLLLLSLSVSLNFI--------SSFADISLGSSLSASNLNQS-WPSPNSTFSLSFIQRSP 64
L LLS + L+F SS + LGSSL + S S + TFS F +
Sbjct: 5 LAALLSTACILSFFIALFPRAASSRDILPLGSSLVVESYESSTLQSSDGTFSSGFYEVYT 64
Query: 65 NSFIPAITYS--------GGVPIWTAG-STPVDSS-AFFQLHSSGTLRLISGSGAIIWDS 114
++F ++ YS +W+A PV + + L G + L GA +W +
Sbjct: 65 HAFTFSVWYSKTEAAAANNKTIVWSANPDRPVHARRSALTLQKDGNMVLTDYDGAAVWRA 124
Query: 115 NTQRLN-VTSASLDDSGNLVLLKNGGVSAWSSFDNPTDTIVPSQNFTSDKTL------RS 167
+ V A L D+GNLV+ +GG + W SFD+PTDT +P+Q T+ L RS
Sbjct: 125 DGNNFTGVQRARLLDTGNLVIEDSGGNTVWQSFDSPTDTFLPTQLITAATRLVPTTQSRS 184
Query: 168 -GYYSFTLLKSGNLSLKWND---SVVYFNQGLNSAINSTVNSNLTSPILRLQPVGILSIS 223
G Y F LSL ++ S +Y+ + N ++ + L G+L+ S
Sbjct: 185 PGNYIFRFSDLSVLSLIYHVPQVSDIYWPDPDQNLYQDGRNQYNSTRLGMLTDSGVLASS 244
Query: 224 DVSLNSAAIIAYSSDYAEGSDILRFLSLGSDGNLRIFSSARGSGTKTRRWAAVADQCEVF 283
D + + A++A SD G + R L+L DGNLR++S G+ + A+ C +
Sbjct: 245 DFA-DGQALVA--SDVGPG--VKRRLTLDPDGNLRLYSMNDSDGSWSVSMVAMTQPCNIH 299
Query: 284 GYCGNMGICGYNGYNDSSSDPLCECPSQNFEFIDQNDRRKGCRRKVEIDSC----PGSAT 339
G CG GIC Y S P C CP + + + +GC V +C S
Sbjct: 300 GLCGPNGICHY------SPTPTCSCPP-GYATRNPGNWTEGCMAIVNT-TCDRYDKRSMR 351
Query: 340 MLELPHTKFLTFQPELSSQVFFVGISACRLNCLVTGSCVASTSLSDGTGLCYLKTPDFVS 399
+ LP+T F + + V + CR C+ +C +GTG CY K F S
Sbjct: 352 FVRLPNTDFWGSDQQ---HLLSVSLRTCRDICISDCTC-KGFQYQEGTGSCYPKAYLF-S 406
Query: 400 GFQNPA-------LPSTSYVKVCGPVLPNPS------GSLQAEEKSKSWRL--------- 437
G P L + V V ++P L + +KS R
Sbjct: 407 GRTYPTSDVRTIYLKLPTGVSVSNALIPRSDVFDSVPRRLDCDRMNKSIREPFPDVHKTG 466
Query: 438 ---KAWIVVVAVLATLMVL-VVLEGGLWYWCCRNSPKFVSLSAQYALLEYASGAPVQFSY 493
W +A V+ V W++ + + L A + + ++SY
Sbjct: 467 GGESKWFYFYGFIAAFFVVEVSFISFAWFFVLKRELRPSELWASEKGYKAMTSNFRRYSY 526
Query: 494 KELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHH 553
+EL ++T+ FK +LG G G VY+GVL + VAVK+LE + QG++ F+ E++ I +H
Sbjct: 527 RELVKATRKFKVELGRGESGTVYKGVLEDDRHVAVKKLENVRQGKEVFQAELSVIGRINH 586
Query: 554 LNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGIT 613
+NLVR+ GF SEG HRLLV E+++NGSL N LF+ EG LL+W+ RFNIALG A+G+
Sbjct: 587 MNLVRIWGFCSEGSHRLLVSEYVENGSLANILFS--EGGNILLDWEGRFNIALGVAKGLA 644
Query: 614 YLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLA 673
YLH EC + ++HCD+KPENILLD+ + K++DFGL KL+N + + ++ VRGT GY+A
Sbjct: 645 YLHHECLEWVIHCDVKPENILLDQAFEPKITDFGLVKLLN-RGGSTQNVSHVRGTLGYIA 703
Query: 674 PEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETN------RKKFSLWA--YEEFE 725
PEW+++LPIT+K DVYSYG+VLLE+++G R E+ T+ RK + + E E
Sbjct: 704 PEWVSSLPITAKVDVYSYGVVLLELLTGTRVSELVGGTDEVHSMLRKLVRMLSAKLEGEE 763
Query: 726 KGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQML 775
+ + G +D L V+ Q I+++ C++E S+RP M VQ L
Sbjct: 764 QSWIDGYLDSKL-NRPVNYVQARTLIKLAVSCLEEDRSKRPTMEHAVQTL 812
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 342 bits (877), Expect = 7e-93, Method: Compositional matrix adjust.
Identities = 260/830 (31%), Positives = 405/830 (48%), Gaps = 70/830 (8%)
Query: 5 SCSSSSLSLLLLLLSLSVSLNFISSFADISLGSSLSASNLNQ---SWPSPNSTFSLSFIQ 61
SCS L L+L L + V I + + +G SL+AS Q SW SP+ F+ F +
Sbjct: 5 SCSIIHLVLILQLQTFFVFSQNIRN-GSVPVGESLTASESQQISSSWRSPSGDFAFGFRK 63
Query: 62 RSPNS-FIPAITY---SGGVPIWTAGSTPVDSSAFFQLHSSGTLRLISGSGAIIWDSNTQ 117
PN F +I + S +W A + + + + + L + G +I D Q
Sbjct: 64 IQPNDGFTLSIWFDKISDKTIVWHAQAVNTTTGL---VPNGSKVTLTADGGLVIADPRGQ 120
Query: 118 RL-------NVTSASLDDSGNLVLLKNGGVSA----WSSFDNPTDTIVPSQNFT------ 160
L +V+ D GN VL ++G + WSSF+NPTDT++P+QN
Sbjct: 121 ELWRALSGGSVSRGRFTDDGNFVLFRDGSEDSDEVLWSSFENPTDTLLPNQNIEVGRNLS 180
Query: 161 ---SDKTLRSGYYSFTLLKSGNLSLKWNDSVVYFNQGLNSAINSTVNSNLTSPILRLQPV 217
++ + + G +S L GNL L ++ + S + ++ +P ++L
Sbjct: 181 SRRTETSFKKGRFSLRLEDDGNLQLHSLNAETASESDIYSQYYESNTNDPNNPGIQLVFN 240
Query: 218 GILSISDVSLNSAAIIAYSSDYAEGSDILRFLSLGSDGNLRIFSSARGSGTKTRRWAAVA 277
I + N++ + D ++S G + I AR
Sbjct: 241 QSGEIYVLQRNNSRFVVKDRDPDFSIAAPFYISTGFLLSTIIPKEARRIVGGCLLGLCRD 300
Query: 278 DQCEVFGYCGNMGICGYNGYND--SSSDPLCECPSQNFEFIDQNDRRKGCRRKVEIDSC- 334
+ C GNM CGYN ++ P CECP + F D ++ C E+ +C
Sbjct: 301 NMCSPDDALGNMA-CGYNNICSLGNNKRPKCECP-ERFVLKDPSNEYGDCLPDFEMQTCR 358
Query: 335 PGSATM-LELPHTKFLTFQP------ELSSQVFFVGISACRLNCLVTGSCVASTSLSDGT 387
P + T ++ +F+T + + S + C+ +CL C A ++
Sbjct: 359 PENQTANSDVNLYEFITLEKTNWPFGDYESYANY-DEERCKASCLSDCLCAAVIFGTNRD 417
Query: 388 GLCYLKTPDFVSGFQNPALPSTSYVKVCGPVLPNPSGSLQAEEKSKSWRLKAWIVVVAVL 447
C+ K G ++P S +++KV N S + +++ +L I+ +VL
Sbjct: 418 LKCWKKKFPLSHGERSPRGDSDTFIKV-----RNRSIADVPVTGNRAKKLDWLIIACSVL 472
Query: 448 ATLMVLVVLEGGLWYWCCRNSPKFVSLSAQYALLEYASGAPVQ-----FSYKELQRSTKG 502
V+ + Y + S + A+ A+ + F+Y EL +T+
Sbjct: 473 LGTSAFVIFDTSCSYRKTKKSKNMMKNQARDIGRTTATTTANELNLRVFTYGELAEATRD 532
Query: 503 FKDKLGAGGFGAVYRGVL----ANRTVVAVKQLEGIE-QGEKQFRMEVATISSTHHLNLV 557
F ++LG G FG VY+G L + VAVK+L+ ++ EK+F+ EV I HH NLV
Sbjct: 533 FTEELGRGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEKEFKNEVKVIGQIHHKNLV 592
Query: 558 RLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHE 617
RL+GF +EG+ +++VYEF+ G+L NFLF S W+ R NIA+ ARGI YLHE
Sbjct: 593 RLIGFCNEGQSQMIVYEFLPQGTLANFLFRRPRPS-----WEDRKNIAVAIARGILYLHE 647
Query: 618 ECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWL 677
EC + I+HCDIKP+NILLDE Y ++SDFGLAKL+ ++ TLT++RGT+GY+APEW
Sbjct: 648 ECSEQIIHCDIKPQNILLDEYYTPRISDFGLAKLL--LMNQTYTLTNIRGTKGYVAPEWF 705
Query: 678 ANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSL 737
N PITSK DVYSYG++LLEIV ++ V E N + WAY+ F +G ++ + +
Sbjct: 706 RNSPITSKVDVYSYGVMLLEIVCCKK--AVDLEDNVILIN-WAYDCFRQGRLEDLTEDDS 762
Query: 738 AGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPPAP 787
+ D+E V R ++++ WCIQE+ RP M V QMLEG+ ++ PP P
Sbjct: 763 EAMN-DMETVERYVKIAIWCIQEEHGMRPNMRNVTQMLEGVIQVFDPPNP 811
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 320 bits (820), Expect = 3e-86, Method: Compositional matrix adjust.
Identities = 247/776 (31%), Positives = 375/776 (48%), Gaps = 95/776 (12%)
Query: 67 FIPAITYSGGVPIWTAG-STPVDSSAFFQLHSSGTLRLISGSGAI-IWDSNTQRLNVTSA 124
+ + G IW++ +PV SS L G + G I +W + V S
Sbjct: 74 YFSVVHVDSGSTIWSSNRDSPVSSSGTMNLTPQGISVIEDGKSQIPVWSTPVLASPVKSL 133
Query: 125 SLDDSGNLVLLKNGGVSAWSSFDNPTDTIVPSQN-----FTSDKTLRS----GYYSFTLL 175
L D+GNL+LL + VS W SFD PTD+IV Q F S RS G Y F +
Sbjct: 134 RLTDAGNLLLLDHLNVSLWESFDFPTDSIVLGQRLKLGMFLSGSVSRSDFSTGDYKFLVG 193
Query: 176 KSGNLSLKWNDSVVYFNQGLNSAINSTVNSNLTSPILRLQPVGILSISDVSLNSAAIIAY 235
+S L ++W + L I + V+SN L + G+ ++ + ++
Sbjct: 194 ESDGL-MQWRGQNYW---KLRMHIRANVDSNFPVEYLTVTTSGLALMA----RNGTVVVV 245
Query: 236 SSDYAEGSDILRFLSLGSDGNLRIFSSARGSGTK-TRRWAAVADQCEVFGYCGNMGICGY 294
SD R + S G F +R SG ++ D C++ CG +G+C
Sbjct: 246 RVALPPSSD-FRVAKMDSSGK---FIVSRFSGKNLVTEFSGPMDSCQIPFVCGKLGLCNL 301
Query: 295 NGYNDSSSDPLCECPSQNFEFIDQNDRRKG-CRRKVEIDSCPGSATMLELPHTKF----L 349
+ +++ S C CP + + D KG C + S P S + + +
Sbjct: 302 DNASENQS---CSCPDEM-----RMDAGKGVCVPVSQSLSLPVSCEARNISYLELGLGVS 353
Query: 350 TFQPELSSQV-----FFVGISACRLNCLVTGSCVASTSLSDGTGLCYLKTPDFVSGFQNP 404
F + V C NC G +TS S CYL F S
Sbjct: 354 YFSTHFTDPVEHGLPLLACHDICSKNCSCLGVFYENTSRS-----CYLVKDSFGSLSLVK 408
Query: 405 ALPSTS----YVKV-CGPVLPNPSGSLQAEEKSKSWRLKAWIVVVAVLATLMVLVVLEGG 459
P YVK+ P G+ ++ I +V + + L++ G
Sbjct: 409 NSPENHDLIGYVKLSIRKTNAQPPGN-----NNRGGSSFPVIALVLLPCSGFFLLIALGL 463
Query: 460 LWYWCC---RNS---PKFVSLSAQYALLEYAS----GAPVQFSYKELQRSTKGFKDKLGA 509
LW+ C R S K V+ + + S G P +F ++EL+++T+ FK ++G+
Sbjct: 464 LWWRRCAVMRYSSIREKQVTRPGSFESGDLGSFHIPGLPQKFEFEELEQATENFKMQIGS 523
Query: 510 GGFGAVYRGVLANRTVVAVKQL--EGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK 567
GGFG+VY+G L + T++AVK++ G+ G ++F E+A I + H NLV+L GF + G+
Sbjct: 524 GGFGSVYKGTLPDETLIAVKKITNHGL-HGRQEFCTEIAIIGNIRHTNLVKLRGFCARGR 582
Query: 568 HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCD 627
LLVYE+M +GSL+ LF+ G+G +L WQ RF+IALGTARG+ YLH C I+HCD
Sbjct: 583 QLLLVYEYMNHGSLEKTLFS---GNGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCD 639
Query: 628 IKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSD 687
+KPENILL +++ K+SDFGL+KL+N ++ T++RGTRGYLAPEW+ N I+ K+D
Sbjct: 640 VKPENILLHDHFQPKISDFGLSKLLNQEE--SSLFTTMRGTRGYLAPEWITNAAISEKAD 697
Query: 688 VYSYGMVLLEIVSGRRNF-------EVSQETNRKK------------FSLWAYEEFEKGN 728
VYSYGMVLLE+VSGR+N V+++ N+ F L+A + E+G
Sbjct: 698 VYSYGMVLLELVSGRKNCSFRSRSNSVTEDNNQNHSSTTTTSTGLVYFPLYALDMHEQGR 757
Query: 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKP 784
+ D L G V ++ + ++++ C+ E+P+ RP M VV M EG + P
Sbjct: 758 YMELADPRLEGR-VTSQEAEKLVRIALCCVHEEPALRPTMAAVVGMFEGSIPLGNP 812
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93756|SD31_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD3-1 OS=Arabidopsis thaliana GN=SD31 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 313 bits (801), Expect = 5e-84, Method: Compositional matrix adjust.
Identities = 234/796 (29%), Positives = 363/796 (45%), Gaps = 97/796 (12%)
Query: 24 LNFISSFADISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIW-TA 82
L F ++I LGS L N W S N F+L F P + + IW +
Sbjct: 17 LAFQIVVSEIQLGSKLVVGE-NTLWVSNNGDFALGFFNP------PGLLNRFSIGIWFNS 69
Query: 83 GSTPVD----------------SSAFFQLHSSGTLRLI-SGSGAIIWDSNTQRLNVTSAS 125
S P D +S++F+L +G L L S G +W+S T R +V+SA
Sbjct: 70 NSIPYDQRKVVWVAGAGVVVSDNSSYFELTRNGELVLFDSLLGVPVWNSKTNRFSVSSAL 129
Query: 126 LDDSGNLVLLKNGGVSAWSSFDNPTDTIVPSQNFTSDKTL-------RSGYYSFTLLKSG 178
L D GNLVLLK+ W SF PTDT++P+Q F + + L RS YYS L SG
Sbjct: 130 LRDDGNLVLLKDREEIVWQSFGTPTDTLLPNQKFPAFEMLRAASENSRSSYYSLHLEDSG 189
Query: 179 NLSLKWNDSVVYFNQGLNSAINSTVNSNLTSPILRLQPVGILSISDVSLNSAAIIAYSSD 238
L L+W ++ +++ G N+ + L G L + D L + D
Sbjct: 190 RLELRWESNITFWSSGNEVVKKKKKKKNIGAV---LTSEGALFLEDQDLMRPVWSVFGED 246
Query: 239 YAEGSDILRFLSLGSDGNLRIFSSARGSGTKTRRWAAVADQCEVFGYCGNMGICGYN--G 296
+ + RFL L DGNLR++S S W AV +QC VF CG+ +C +N G
Sbjct: 247 HNDTVK-FRFLRLDRDGNLRMYSWNEDSRIWKPVWQAVENQCRVFATCGSQ-VCSFNSSG 304
Query: 297 YNDSSSDPLCECPSQNFEFIDQNDRRKGCRRKVEIDSCPGSATMLELPHTKFLTFQPELS 356
Y + C CP F+ +D + C + C M++ + + P
Sbjct: 305 YTE------CNCPFN--AFVSVSDPK--CLVPYQKPGCKSGFNMVKFKNLELYGIYPAND 354
Query: 357 SQVFFVGISACRLNCLVTGSCVASTSLSDGTGLCYLKTPDFVSGFQNPALPSTSYVKVC- 415
S + + C+ CL +C A T +DG C +K ++SG+ +P+L S SYVK C
Sbjct: 355 SVISQISSQRCKKLCLENSACTAVTYTNDGEPQCRMKLTRYISGYSDPSLSSISYVKTCL 414
Query: 416 GPVLPNPSGSLQAE--EKSKSWRLKAWIVVVAVLATLMVLVVLEGGLWYWCCRNSPKFVS 473
P+ +P+ + +KS + +V A TL++ + + G+ + R K
Sbjct: 415 DPIAVDPNNVSKESPVTVTKSHSICIPCLVGATSTTLVLFLGFQLGIVVYIYRRKKKLAK 474
Query: 474 LSAQYALLEYASGAPVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEG 533
A+ + FS E++ T F + +G +++GV+ +VAVK++E
Sbjct: 475 KKAERFSKATNPKGVMIFSVDEIKAMTDNFDNNIGP----QIFKGVMPENELVAVKEVEA 530
Query: 534 IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSG 593
E++FR + I + HH NL L G+ E R LVYE+ KNGS+ + + +
Sbjct: 531 TLTEERKFRSSASKIGTMHHKNLANLEGYCCELGRRFLVYEYAKNGSILDHIV--DPLRS 588
Query: 594 KLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653
K L W+ R + L A+ + YLH ECR+ + H ++ NILL E+ AK++++G
Sbjct: 589 KKLTWRIRTDTCLSVAKALCYLHMECREFVSHGNLNCGNILLGEDLEAKLTEYGF----- 643
Query: 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNR 713
G A + DV +G +L +++GR E
Sbjct: 644 ----------------GLCA----------ADKDVEDFGKTVLALITGRYEPE------- 670
Query: 714 KKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773
S W Y E+ G + +VDK L G D+E++ R +++SFWC+Q RP MG+VV+
Sbjct: 671 GVVSEWVYREWIGGRKETVVDKGLEG-CFDVEELERVLRISFWCVQTDERLRPSMGEVVK 729
Query: 774 MLEGITEIEKPPAPKA 789
+LEG ++ PP P A
Sbjct: 730 VLEGTLSVDPPPPPFA 745
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64771|Y1148_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61480 OS=Arabidopsis thaliana GN=At1g61480 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 278 bits (710), Expect = 2e-73, Method: Compositional matrix adjust.
Identities = 239/815 (29%), Positives = 395/815 (48%), Gaps = 85/815 (10%)
Query: 12 SLLLLLLSLSVSLNFISSFADISLGSSLSASNLNQSWPSPNSTFSLSFI--QRSPNSFIP 69
SLLL+ + LS S I+ + +S+G +LS+SN + L F S N ++
Sbjct: 11 SLLLITIFLSFSYAGITRESPLSIGKTLSSSN---------GVYELGFFSFNNSQNQYV- 60
Query: 70 AITYSGGVP---IWTAG-STPV-DSSAFFQLHSSGTLRLISGSGAIIWD-SNTQRLNVTS 123
I + G +P +W A PV DS+A + S+G+L L + + +++W T N +
Sbjct: 61 GIWFKGIIPRVVVWVANREKPVTDSAANLTISSNGSLLLFNENHSVVWSIGETFASNGSR 120
Query: 124 ASLDDSGNLVLLKNG-GVSAWSSFDNPTDTIVPSQNF-----TSDKTLRSGYYSFTLLKS 177
A L D+GNLV++ N G + W SF++ DT++P N T +K + + + S T
Sbjct: 121 AELTDNGNLVVIDNNSGRTLWESFEHFGDTMLPFSNLMYNLATGEKRVLTSWKSHTDPSP 180
Query: 178 GNLSLKWNDSVVYFNQGLNSAINSTVNSNLTSPILRLQPVGILSISDV-----SLNSAAI 232
G+ +++ V + + + P + + GI + D SL
Sbjct: 181 GDFTVQITPQV----PSQACTMRGSKTYWRSGPWAKTRFTGIPVMDDTYTSPFSLQQDTN 236
Query: 233 IAYSSDYAEGSDILRFLSLGSDGNLRIFSSARGSGTKTRRWAAVADQCEVFGYCGNMGIC 292
+ S Y E + L ++ + S+G+L+IF + A + C+++G+CG GIC
Sbjct: 237 GSGSFTYFERNFKLSYIMITSEGSLKIFQ--HNGMDWELNFEAPENSCDIYGFCGPFGIC 294
Query: 293 GYNGYNDSSSDPLCEC----PSQNFEFIDQNDRRKGCRRKVEIDSCPGSA---TMLELPH 345
S P C+C ++ E + + GC R E+ C G+ T+ H
Sbjct: 295 VM------SVPPKCKCFKGFVPKSIEEWKRGNWTDGCVRHTEL-HCQGNTNGKTVNGFYH 347
Query: 346 TKFLTFQPELSSQVFFVGISACRLNCLVTGSCVASTSLSDGTGLCYLKTPDFVSGFQNPA 405
+ P+ FV C CL SC+A + +G G C + D + Q A
Sbjct: 348 VANIK-PPDFYEFASFVDAEGCYQICLHNCSCLAFAYI-NGIG-CLMWNQDLMDAVQFSA 404
Query: 406 LPSTSYVKVCGPVLPNPSGSLQAEEKSKSWRLKAWIVVVAVLATLMVLVVLEGGLWYWCC 465
+++ S L +++K ++VA + +L + V+L + +
Sbjct: 405 GGEILSIRLA-------SSELGGNKRNK--------IIVASIVSLSLFVILAFAAFCFLR 449
Query: 466 RN-----SPKFVSLSAQYAL---LEYASGAPVQF-SYKELQRSTKGFK--DKLGAGGFGA 514
S K ++++ A LE + ++F +Q +T F +KLG GGFG+
Sbjct: 450 YKVKHTVSAKISKIASKEAWNNDLEPQDVSGLKFFEMNTIQTATDNFSLSNKLGQGGFGS 509
Query: 515 VYRGVLANRTVVAVKQLEGIE-QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573
VY+G L + +AVK+L QG+++F E+ IS H NLVR++G EG+ RLLVY
Sbjct: 510 VYKGKLQDGKEIAVKRLSSSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEERLLVY 569
Query: 574 EFMKNGSLDNFLFANEEGSGKL-LNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPEN 632
EF+ N SLD FLF + + +L ++W RFNI G ARG+ YLH + ++H D+K N
Sbjct: 570 EFLLNKSLDTFLFDSRK---RLEIDWPKRFNIIEGIARGLHYLHRDSCLRVIHRDLKVSN 626
Query: 633 ILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYG 692
ILLDE N K+SDFGLA++ +++ T V GT GY+APE+ + KSD+YS+G
Sbjct: 627 ILLDEKMNPKISDFGLARMYQGTEYQDNT-RRVAGTLGYMAPEYAWTGMFSEKSDIYSFG 685
Query: 693 MVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQ 752
++LLEI++G + S K +A+E + + ++DK +A +E V R +Q
Sbjct: 686 VILLEIITGEKISRFSYGRQGKTLLAYAWESWCESGGIDLLDKDVADSCHPLE-VERCVQ 744
Query: 753 VSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPPAP 787
+ C+Q QP+ RP +++ ML +++ P P
Sbjct: 745 IGLLCVQHQPADRPNTMELLSMLTTTSDLTSPKQP 779
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 852 | ||||||
| 296088674 | 927 | unnamed protein product [Vitis vinifera] | 0.943 | 0.867 | 0.740 | 0.0 | |
| 225460468 | 849 | PREDICTED: G-type lectin S-receptor-like | 0.943 | 0.946 | 0.740 | 0.0 | |
| 147815186 | 846 | hypothetical protein VITISV_009161 [Viti | 0.919 | 0.925 | 0.742 | 0.0 | |
| 224146440 | 840 | predicted protein [Populus trichocarpa] | 0.976 | 0.990 | 0.706 | 0.0 | |
| 224146438 | 834 | predicted protein [Populus trichocarpa] | 0.946 | 0.966 | 0.726 | 0.0 | |
| 255553819 | 851 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.946 | 0.947 | 0.667 | 0.0 | |
| 225460466 | 838 | PREDICTED: G-type lectin S-receptor-like | 0.931 | 0.947 | 0.687 | 0.0 | |
| 224145207 | 839 | predicted protein [Populus trichocarpa] | 0.942 | 0.957 | 0.667 | 0.0 | |
| 356502317 | 836 | PREDICTED: G-type lectin S-receptor-like | 0.944 | 0.962 | 0.669 | 0.0 | |
| 356574579 | 830 | PREDICTED: G-type lectin S-receptor-like | 0.899 | 0.922 | 0.653 | 0.0 |
| >gi|296088674|emb|CBI38124.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1226 bits (3172), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 608/821 (74%), Positives = 693/821 (84%), Gaps = 17/821 (2%)
Query: 29 SFADISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGS---T 85
S ADI LG+S++AS+LNQ+W SPNSTFSL FI +P SF AITY GGVPIW AG
Sbjct: 21 SSADIPLGASITASDLNQTWNSPNSTFSLGFIAATPTSFYAAITY-GGVPIWRAGGAYPV 79
Query: 86 PVDSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLNVTSASLDDSGNLVLLKNGGVSAWSS 145
VD F+ +SG L L+S +G ++W+S T V+SA+L DSGNLVL NG VS WS+
Sbjct: 80 AVDFGGSFRFLTSGNLHLVSSNGTVLWESGTAGRGVSSATLSDSGNLVL-TNGTVSVWST 138
Query: 146 FDNPTDTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWNDSVVYFNQGLNSAINSTVNS 205
F+NPTDTIVP+QNFT+ +LRSG YSF+L KSGNL+L WN S++Y+++GLNS TV+
Sbjct: 139 FENPTDTIVPTQNFTTSNSLRSGLYSFSLTKSGNLTLTWNSSILYWSKGLNS----TVDK 194
Query: 206 NLTSPILRLQPVGILSISDVSLNSAAIIAYSSDYAEGSDILRFLSLGSDGNLRIFSSARG 265
NLTSP L LQ +GILS+SD++L+++ ++AYSSDYAEGSD+LRF+ L SDGNLRI+SS G
Sbjct: 195 NLTSPSLGLQSIGILSLSDLTLSTSVVLAYSSDYAEGSDLLRFVRLDSDGNLRIYSSDSG 254
Query: 266 SGTKTRRWAAVADQCEVFGYCGNMGICGYNGYNDSSSDPLCECPSQNFEFIDQNDRRKGC 325
SG RWAAV DQCEVFGYCGN+GIC YN S P+C CPS+NFE +D D KGC
Sbjct: 255 SGISNVRWAAVEDQCEVFGYCGNLGICSYN-----DSTPVCGCPSENFELVDPKDSTKGC 309
Query: 326 RRKVEIDSCPGSATMLELPHTKFLTFQPELSSQVFFVGISACRLNCLVTGSCVASTSLSD 385
+RK EI++CPG TMLEL H KFLT+ ELSSQVFFVGISACRLNCLV GSC+ASTSLSD
Sbjct: 310 KRKEEIENCPGDLTMLELQHAKFLTYSSELSSQVFFVGISACRLNCLVGGSCIASTSLSD 369
Query: 386 GTGLCYLKTPDFVSGFQNPALPSTSYVKVCGPVLPNPSGSLQAEEKSKSWRLKAWIVVVA 445
GTGLCYLK P FVSG+Q+PALPSTSYVKVCGPV+PNPS ++ + W+L AWIV V
Sbjct: 370 GTGLCYLKVPGFVSGYQSPALPSTSYVKVCGPVVPNPSAFSHGDDGA--WKLHAWIVAVV 427
Query: 446 VLATLMVLVVLEGGLWYWCCRNSPKFVSLSAQYALLEYASGAPVQFSYKELQRSTKGFKD 505
VL TL LV+LEGGLW+WCC+NSPKF LSAQYALLEYASGAPVQFSYKELQRSTKGFK+
Sbjct: 428 VLGTLAALVLLEGGLWWWCCKNSPKFGGLSAQYALLEYASGAPVQFSYKELQRSTKGFKE 487
Query: 506 KLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSE 565
KLGAGGFGAVYRG+LANRT+VAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRL+GF SE
Sbjct: 488 KLGAGGFGAVYRGILANRTIVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLIGFCSE 547
Query: 566 GKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVH 625
G+HRLLVYEFMKNGSLD LF E SG+LLNW++RF+IALGTARGITYLHEECRDCIVH
Sbjct: 548 GRHRLLVYEFMKNGSLDTCLFPTEGHSGRLLNWENRFSIALGTARGITYLHEECRDCIVH 607
Query: 626 CDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSK 685
CDIKPENILLDENYNAKVSDFGLAKLINPKDHR+RTLTSVRGTRGYLAPEWLANLPITSK
Sbjct: 608 CDIKPENILLDENYNAKVSDFGLAKLINPKDHRYRTLTSVRGTRGYLAPEWLANLPITSK 667
Query: 686 SDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIE 745
SDVYSYGMVLLEIVSG+RNFEVS ETNRKKFSLWAYEEFEKGN++GIVDK L + VD+E
Sbjct: 668 SDVYSYGMVLLEIVSGKRNFEVSAETNRKKFSLWAYEEFEKGNMEGIVDKRLGDQGVDME 727
Query: 746 QVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPPAPKALTEGSVGGTSVNMSSS 805
Q RAIQVSFWCIQEQPSQRPMMGKVVQMLEG+TEIE+PPAPKA E S GGTS+N+SS+
Sbjct: 728 QAKRAIQVSFWCIQEQPSQRPMMGKVVQMLEGVTEIERPPAPKAAMEVSAGGTSINVSSN 787
Query: 806 TSALSTFAASAPAPSSSSSTH-TGVSALASDRNIERASSSL 845
SALSTFAASAPAPSSSSS G S++ RN+E++SSS+
Sbjct: 788 VSALSTFAASAPAPSSSSSMQNAGFSSIVLGRNVEKSSSSV 828
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225460468|ref|XP_002267635.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1225 bits (3169), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 608/821 (74%), Positives = 693/821 (84%), Gaps = 17/821 (2%)
Query: 29 SFADISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGS---T 85
S ADI LG+S++AS+LNQ+W SPNSTFSL FI +P SF AITY GGVPIW AG
Sbjct: 21 SSADIPLGASITASDLNQTWNSPNSTFSLGFIAATPTSFYAAITY-GGVPIWRAGGAYPV 79
Query: 86 PVDSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLNVTSASLDDSGNLVLLKNGGVSAWSS 145
VD F+ +SG L L+S +G ++W+S T V+SA+L DSGNLVL NG VS WS+
Sbjct: 80 AVDFGGSFRFLTSGNLHLVSSNGTVLWESGTAGRGVSSATLSDSGNLVL-TNGTVSVWST 138
Query: 146 FDNPTDTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWNDSVVYFNQGLNSAINSTVNS 205
F+NPTDTIVP+QNFT+ +LRSG YSF+L KSGNL+L WN S++Y+++GLNS TV+
Sbjct: 139 FENPTDTIVPTQNFTTSNSLRSGLYSFSLTKSGNLTLTWNSSILYWSKGLNS----TVDK 194
Query: 206 NLTSPILRLQPVGILSISDVSLNSAAIIAYSSDYAEGSDILRFLSLGSDGNLRIFSSARG 265
NLTSP L LQ +GILS+SD++L+++ ++AYSSDYAEGSD+LRF+ L SDGNLRI+SS G
Sbjct: 195 NLTSPSLGLQSIGILSLSDLTLSTSVVLAYSSDYAEGSDLLRFVRLDSDGNLRIYSSDSG 254
Query: 266 SGTKTRRWAAVADQCEVFGYCGNMGICGYNGYNDSSSDPLCECPSQNFEFIDQNDRRKGC 325
SG RWAAV DQCEVFGYCGN+GIC YN S P+C CPS+NFE +D D KGC
Sbjct: 255 SGISNVRWAAVEDQCEVFGYCGNLGICSYN-----DSTPVCGCPSENFELVDPKDSTKGC 309
Query: 326 RRKVEIDSCPGSATMLELPHTKFLTFQPELSSQVFFVGISACRLNCLVTGSCVASTSLSD 385
+RK EI++CPG TMLEL H KFLT+ ELSSQVFFVGISACRLNCLV GSC+ASTSLSD
Sbjct: 310 KRKEEIENCPGDLTMLELQHAKFLTYSSELSSQVFFVGISACRLNCLVGGSCIASTSLSD 369
Query: 386 GTGLCYLKTPDFVSGFQNPALPSTSYVKVCGPVLPNPSGSLQAEEKSKSWRLKAWIVVVA 445
GTGLCYLK P FVSG+Q+PALPSTSYVKVCGPV+PNPS ++ + W+L AWIV V
Sbjct: 370 GTGLCYLKVPGFVSGYQSPALPSTSYVKVCGPVVPNPSAFSHGDDGA--WKLHAWIVAVV 427
Query: 446 VLATLMVLVVLEGGLWYWCCRNSPKFVSLSAQYALLEYASGAPVQFSYKELQRSTKGFKD 505
VL TL LV+LEGGLW+WCC+NSPKF LSAQYALLEYASGAPVQFSYKELQRSTKGFK+
Sbjct: 428 VLGTLAALVLLEGGLWWWCCKNSPKFGGLSAQYALLEYASGAPVQFSYKELQRSTKGFKE 487
Query: 506 KLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSE 565
KLGAGGFGAVYRG+LANRT+VAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRL+GF SE
Sbjct: 488 KLGAGGFGAVYRGILANRTIVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLIGFCSE 547
Query: 566 GKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVH 625
G+HRLLVYEFMKNGSLD LF E SG+LLNW++RF+IALGTARGITYLHEECRDCIVH
Sbjct: 548 GRHRLLVYEFMKNGSLDTCLFPTEGHSGRLLNWENRFSIALGTARGITYLHEECRDCIVH 607
Query: 626 CDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSK 685
CDIKPENILLDENYNAKVSDFGLAKLINPKDHR+RTLTSVRGTRGYLAPEWLANLPITSK
Sbjct: 608 CDIKPENILLDENYNAKVSDFGLAKLINPKDHRYRTLTSVRGTRGYLAPEWLANLPITSK 667
Query: 686 SDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIE 745
SDVYSYGMVLLEIVSG+RNFEVS ETNRKKFSLWAYEEFEKGN++GIVDK L + VD+E
Sbjct: 668 SDVYSYGMVLLEIVSGKRNFEVSAETNRKKFSLWAYEEFEKGNMEGIVDKRLGDQGVDME 727
Query: 746 QVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPPAPKALTEGSVGGTSVNMSSS 805
Q RAIQVSFWCIQEQPSQRPMMGKVVQMLEG+TEIE+PPAPKA E S GGTS+N+SS+
Sbjct: 728 QAKRAIQVSFWCIQEQPSQRPMMGKVVQMLEGVTEIERPPAPKAAMEVSAGGTSINVSSN 787
Query: 806 TSALSTFAASAPAPSSSSSTH-TGVSALASDRNIERASSSL 845
SALSTFAASAPAPSSSSS G S++ RN+E++SSS+
Sbjct: 788 VSALSTFAASAPAPSSSSSMQNAGFSSIVLGRNVEKSSSSV 828
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147815186|emb|CAN67775.1| hypothetical protein VITISV_009161 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1196 bits (3093), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 594/800 (74%), Positives = 673/800 (84%), Gaps = 17/800 (2%)
Query: 50 SPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGS---TPVDSSAFFQLHSSGTLRLISG 106
SPNSTFSL FI +P SF AITY GGVPIW AG VD F+ +SG L L+S
Sbjct: 39 SPNSTFSLGFIAATPTSFYAAITY-GGVPIWRAGGAYPVAVDFGGSFRFLTSGNLHLVSS 97
Query: 107 SGAIIWDSNTQRLNVTSASLDDSGNLVLLKNGGVSAWSSFDNPTDTIVPSQNFTSDKTLR 166
+G ++W+S T V+SA+L DSGNL L NG VS WS+F+NPTDTIVP+QNFT+ +LR
Sbjct: 98 NGTVLWESGTAGRGVSSATLSDSGNLXL-XNGTVSVWSTFENPTDTIVPTQNFTTSNSLR 156
Query: 167 SGYYSFTLLKSGNLSLKWNDSVVYFNQGLNSAINSTVNSNLTSPILRLQPVGILSISDVS 226
SG YSF+L KSGNL+L WN S++Y+++GLNS TV+ NLTSP L LQ +GILS+SD++
Sbjct: 157 SGLYSFSLTKSGNLTLTWNSSILYWSKGLNS----TVDKNLTSPSLGLQSIGILSLSDLT 212
Query: 227 LNSAAIIAYSSDYAEGSDILRFLSLGSDGNLRIFSSARGSGTKTRRWAAVADQCEVFGYC 286
L+++ ++AYSSDYAEGSD+LRF+ L SDGNLRI+SS GSG RWAAV DQCEVFGYC
Sbjct: 213 LSTSVVLAYSSDYAEGSDLLRFVRLDSDGNLRIYSSDSGSGISNVRWAAVEDQCEVFGYC 272
Query: 287 GNMGICGYNGYNDSSSDPLCECPSQNFEFIDQNDRRKGCRRKVEIDSCPGSATMLELPHT 346
GN+GIC YN S P+C CPS+NFE +D D KGC+RK EI++CPG TMLEL H
Sbjct: 273 GNLGICSYN-----DSTPVCGCPSENFELVDPKDSTKGCKRKEEIENCPGDLTMLELQHA 327
Query: 347 KFLTFQPELSSQVFFVGISACRLNCLVTGSCVASTSLSDGTGLCYLKTPDFVSGFQNPAL 406
KFLT+ ELSSQVFFVGISACRLNCLV GSC+ASTSLSDGTGLCYLK P FVSG+Q+PAL
Sbjct: 328 KFLTYSSELSSQVFFVGISACRLNCLVGGSCIASTSLSDGTGLCYLKVPGFVSGYQSPAL 387
Query: 407 PSTSYVKVCGPVLPNPSGSLQAEEKSKSWRLKAWIVVVAVLATLMVLVVLEGGLWYWCCR 466
PSTSYVKVCGPV+PNPS ++ + W+L AWIV V VL TL LV+LEGGLW+WCC+
Sbjct: 388 PSTSYVKVCGPVVPNPSAFSHGDDGA--WKLHAWIVAVVVLGTLAALVLLEGGLWWWCCK 445
Query: 467 NSPKFVSLSAQYALLEYASGAPVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVV 526
NSPKF LSAQYALLEYASGAPVQFSYKELQRSTKGFK+KLGAGGFGAVYRG+LANRT+V
Sbjct: 446 NSPKFGGLSAQYALLEYASGAPVQFSYKELQRSTKGFKEKLGAGGFGAVYRGILANRTIV 505
Query: 527 AVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLF 586
AVKQLEGIEQGEKQFRMEVATISSTHHLNLVRL+GF SEG+HRLLVYEFMKNGSLD LF
Sbjct: 506 AVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLIGFCSEGRHRLLVYEFMKNGSLDTCLF 565
Query: 587 ANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDF 646
E SG+LLNW++RF+IALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDF
Sbjct: 566 PTEGHSGRLLNWENRFSIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDF 625
Query: 647 GLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFE 706
GLAKLINPKDHR+RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSG+RNFE
Sbjct: 626 GLAKLINPKDHRYRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGKRNFE 685
Query: 707 VSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP 766
VS ETNRKKFSLWAYEEFEKGN++GIVDK L + VD+EQ RAIQVSFWCIQEQPSQRP
Sbjct: 686 VSAETNRKKFSLWAYEEFEKGNMEGIVDKRLGDQGVDMEQAKRAIQVSFWCIQEQPSQRP 745
Query: 767 MMGKVVQMLEGITEIEKPPAPKALTEGSVGGTSVNMSSSTSALSTFAASAPAPSSSSSTH 826
MMGKVVQMLEG+TEIE+PPAPKA E S GGTS+N+SS+ SALSTFAASAPAPSSSSS
Sbjct: 746 MMGKVVQMLEGVTEIERPPAPKAAMEVSAGGTSINVSSNVSALSTFAASAPAPSSSSSMQ 805
Query: 827 -TGVSALASDRNIERASSSL 845
G S+ RN+E++SSS+
Sbjct: 806 NAGFSSFVLGRNVEKSSSSV 825
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224146440|ref|XP_002326008.1| predicted protein [Populus trichocarpa] gi|222862883|gb|EEF00390.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1167 bits (3018), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 599/848 (70%), Positives = 696/848 (82%), Gaps = 16/848 (1%)
Query: 8 SSSLSLLLLLLSLSVSLNFISSFADISLGSSLSASNLNQSWPSPNSTFSLSFIQRS-PNS 66
+ +L LLL + + +S I LG++LSASN N++W SPN++F + F Q +S
Sbjct: 3 TQNLPFYLLLFFCTTA----TSQTTIQLGATLSASNPNKTWSSPNNSFYIGFSQVGFSSS 58
Query: 67 FIPAITYSGGVPIWTAG--STPVDSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLNVTSA 124
+ I Y+GGVPIWTAG +T VDS FQ SSG LRL++GSGAI+WDSNT RL VT+A
Sbjct: 59 YTLTINYNGGVPIWTAGNAATTVDSKGSFQFLSSGNLRLLNGSGAIVWDSNTARLGVTTA 118
Query: 125 SLDDSGNLVLLKNGGVSAWSSFDNPTDTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKW 184
SLDD GNLVL KNG WSSFDNPTDTIVP+Q FT ++ LRSG YSF L +GNL+L+W
Sbjct: 119 SLDDFGNLVL-KNGTFFVWSSFDNPTDTIVPNQTFTVNQVLRSGSYSFRFLSTGNLTLRW 177
Query: 185 NDSVVYFNQGLNSAINSTVNSNLTSPILRLQPVGILSISDVSLNSAA-IIAYSSDYAEGS 243
ND++VY+N+GLNS+ ++NLTSP L LQP GIL+I DV+ S + I+AYS+DYAEGS
Sbjct: 178 NDNIVYWNKGLNSS----ADANLTSPALGLQPNGILTIFDVAFTSGSYIVAYSNDYAEGS 233
Query: 244 DILRFLSLGSDGNLRIFSSARGSGTKTRRWAAVADQCEVFGYCGNMGICGYNGYNDSSSD 303
LRFL L DGN R++S+ GSGT T W+A+ DQCE+FGYCGNMGIC YN + S S
Sbjct: 234 TRLRFLRLEKDGNFRMYSTDIGSGTATMVWSALTDQCEIFGYCGNMGICSYNELSSSLS- 292
Query: 304 PLCECPSQNFEFIDQNDRRKGCRRKVEIDSCPGSATMLELPHTKFLTFQPELSSQVFFVG 363
P C CPS+NFE +D ND R+GC+RKVEI+SC GSATML L + KFLT+ PE SQVFFVG
Sbjct: 293 PTCGCPSENFEPVDVNDSRQGCKRKVEIESCVGSATMLVLDNVKFLTYLPETVSQVFFVG 352
Query: 364 ISACRLNCLVTGSCVASTSLSDGTGLCYLKTPDFVSGFQNPALPSTSYVKVCGPVLPNPS 423
ISACRLNCL SC+ASTSLSDGTGLCYLK F+SG+QNPALPSTSYVK+CGP PNP
Sbjct: 353 ISACRLNCLSQSSCIASTSLSDGTGLCYLKNQGFISGYQNPALPSTSYVKICGPARPNPP 412
Query: 424 GSLQAEEKSKSWRLKAWIVVVAVLATLMVLVVLEGGLWYWCCRNSPKFVSLSAQYALLEY 483
+Q KSKS RL+ W+V+V V+ TL+ L+ +EGGLW+WCCRNSPKF SLSAQYALLEY
Sbjct: 413 PGVQIAGKSKSSRLRVWVVLVVVVITLLGLIAVEGGLWWWCCRNSPKFGSLSAQYALLEY 472
Query: 484 ASGAPVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRM 543
ASGAPVQFSYKELQ STK FK+KLGAGGFGAVY+GVL NRTVVAVKQLEGIEQGEKQFRM
Sbjct: 473 ASGAPVQFSYKELQHSTKEFKEKLGAGGFGAVYKGVLDNRTVVAVKQLEGIEQGEKQFRM 532
Query: 544 EVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFN 603
EVATISSTHHLNL+RL+GF SEG+HRLLVY+FMKNGSLDNFLF +EE G+LLNW+ RFN
Sbjct: 533 EVATISSTHHLNLIRLIGFCSEGRHRLLVYDFMKNGSLDNFLFTSEEQPGRLLNWEQRFN 592
Query: 604 IALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLT 663
IALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP+DHR+RTL
Sbjct: 593 IALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPEDHRYRTLV 652
Query: 664 SVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEE 723
SVRGTRGYLAPEW+ANLPITSKSD+YSYGMVLLEIVSGRRN+EVS ETNRKKFS+WA EE
Sbjct: 653 SVRGTRGYLAPEWIANLPITSKSDIYSYGMVLLEIVSGRRNYEVSSETNRKKFSVWACEE 712
Query: 724 FEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEK 783
FEKG+V I+D+ L +D+D++QV RAIQVSFWCIQEQPSQRP MGKVVQMLEGI+EIE+
Sbjct: 713 FEKGDVNAILDQRLTHQDLDLDQVTRAIQVSFWCIQEQPSQRPTMGKVVQMLEGISEIER 772
Query: 784 PPAPKALTEGSVGGTSVNMSSSTSALSTFAASAPAPSSSSSTHT-GVSALASDRNIERAS 842
PPAPK +T GS GG++V++SS+ S LSTF APA SSSSS T G+S LAS RNIER +
Sbjct: 773 PPAPKTITGGSFGGSNVSVSSNVSTLSTFEVLAPALSSSSSYQTIGISPLASARNIER-T 831
Query: 843 SSLLRSSS 850
SSLL S S
Sbjct: 832 SSLLHSDS 839
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224146438|ref|XP_002326007.1| predicted protein [Populus trichocarpa] gi|222862882|gb|EEF00389.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1163 bits (3008), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 595/819 (72%), Positives = 679/819 (82%), Gaps = 13/819 (1%)
Query: 33 ISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIP-AITYSGGVPIWTAG--STPVDS 89
I G++LSA+N Q+W SPN+TF + F Q +S+ I Y+GGVPIWTAG +T VDS
Sbjct: 23 IQPGTTLSAANPGQTWSSPNNTFYVGFSQVDSSSYYTLTINYNGGVPIWTAGNATTTVDS 82
Query: 90 SAFFQLHSSGTLRLISGSGAIIWDSNTQRLNVTSASLDDSGNLVLLKNGGVSAWSSFDNP 149
FQ SG LRL++GSGA++WDSNT RL VT+ASLDD GNLVL KNG + WSSFDNP
Sbjct: 83 KGSFQFLPSGNLRLLNGSGAVVWDSNTARLGVTTASLDDFGNLVL-KNGTSTVWSSFDNP 141
Query: 150 TDTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWNDSVVYFNQGLNSAINSTVNSNLTS 209
TDTIVP+QNF+ ++ LRS Y F L +GNL+L+WND ++Y+NQGLNS+++ NLTS
Sbjct: 142 TDTIVPNQNFSVNQVLRSESYHFRFLSNGNLTLRWNDFILYWNQGLNSSLDV----NLTS 197
Query: 210 PILRLQPVGILSISDVSLNSAA-IIAYSSDYAEGSDILRFLSLGSDGNLRIFSSARGSGT 268
P L LQ G+L+I DV+ S + +A S+DY EG LRFL LG DGN R++S+A G+GT
Sbjct: 198 PTLGLQRTGVLTIFDVAFPSGSYTVASSNDYDEGGTRLRFLRLGKDGNFRMYSTAIGTGT 257
Query: 269 KTRRWAAVADQCEVFGYCGNMGICGYNGYNDSSSDPLCECPSQNFEFIDQNDRRKGCRRK 328
T W+A+ DQCEVFGYCGNMGIC YN +SSS P C CPS+NFE +D ND R+GC+RK
Sbjct: 258 ITMVWSALTDQCEVFGYCGNMGICRYN---ESSSSPNCGCPSENFEPVDVNDSRQGCKRK 314
Query: 329 VEIDSCPGSATMLELPHTKFLTFQPELSSQVFFVGISACRLNCLVTGSCVASTSLSDGTG 388
VEI+SC G+ATML L + KFLT+QPE SQVF GISACRLNCL SC+ASTSLSDGTG
Sbjct: 315 VEIESCVGNATMLVLDNAKFLTYQPETLSQVFSNGISACRLNCLSQSSCIASTSLSDGTG 374
Query: 389 LCYLKTPDFVSGFQNPALPSTSYVKVCGPVLPNPSGSLQAEEKSKSWRLKAWIVVVAVLA 448
+CYLK DF+SG+QNP LPSTSYVKVCG PNP LQ EKSKS L+ W+V+V V+
Sbjct: 375 MCYLKNSDFISGYQNPVLPSTSYVKVCGQAQPNPPPGLQIAEKSKSSSLRVWVVLVVVVI 434
Query: 449 TLMVLVVLEGGLWYWCCRNSPKFVSLSAQYALLEYASGAPVQFSYKELQRSTKGFKDKLG 508
TL+ L+ +EGGLW+WCCRNSPKF SLSAQYALLEYASGAPVQFSYKELQRSTK FK+KLG
Sbjct: 435 TLLGLIAVEGGLWWWCCRNSPKFGSLSAQYALLEYASGAPVQFSYKELQRSTKQFKEKLG 494
Query: 509 AGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKH 568
AGGFGAVY+GVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRL+GF SEG+H
Sbjct: 495 AGGFGAVYKGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLIGFCSEGRH 554
Query: 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDI 628
RLLVYEFMKNGSLDNFLF EE G+LLNW+ RFNIALGTARGITYLHEECRDCIVHCDI
Sbjct: 555 RLLVYEFMKNGSLDNFLFTTEEQPGRLLNWEQRFNIALGTARGITYLHEECRDCIVHCDI 614
Query: 629 KPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDV 688
KPENILLDENYNAKVSDFGLAKLI+P+DHR+RTLTSVRGTRGYLAPEWLANLPITSKSD+
Sbjct: 615 KPENILLDENYNAKVSDFGLAKLISPRDHRYRTLTSVRGTRGYLAPEWLANLPITSKSDI 674
Query: 689 YSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVM 748
Y YGMVLLEIVSGRRNFEVS ET+RKKFS WAYEEFEK NV I+D+ L +DVD++QV
Sbjct: 675 YGYGMVLLEIVSGRRNFEVSAETDRKKFSAWAYEEFEKSNVTAILDQRLTDQDVDMQQVT 734
Query: 749 RAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPPAPKALTEGSVGGTSVNMSSSTSA 808
RAIQVSFWCIQ+QPSQRP MGKVVQMLEGI+EIE PPAPKA+TEGS+ GTS+ SS+ SA
Sbjct: 735 RAIQVSFWCIQDQPSQRPKMGKVVQMLEGISEIENPPAPKAITEGSIPGTSILSSSNVSA 794
Query: 809 LSTFAASAPAPSSSSSTHT-GVSALASDRNIERASSSLL 846
LSTFA SAP PSSSSS T GVS LAS RNIERASSSLL
Sbjct: 795 LSTFAPSAPTPSSSSSYQTLGVSPLASGRNIERASSSLL 833
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255553819|ref|XP_002517950.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223542932|gb|EEF44468.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1113 bits (2880), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 553/828 (66%), Positives = 661/828 (79%), Gaps = 22/828 (2%)
Query: 33 ISLGSSLSASNLNQSWPSPNSTFSLSFI----QRSPNSFIPAITYSGGVPIWTAGSTPVD 88
I+ GS L ASN QSW S N TFSL FI Q SP SF+ AI+YSGGVPIW+AG+TPVD
Sbjct: 28 ITPGSILFASNTGQSWTSDNETFSLGFIPLNPQTSPPSFLAAISYSGGVPIWSAGTTPVD 87
Query: 89 SSAFFQLHSSGTLRLISGSGAIIWDSNTQRLNVTSASLDDSGNLVLLKNGGVSAWSSFDN 148
SA S+GTLRL++GSG I+WDSNT++L V+SASL+++GNLVL +NG + WSSFDN
Sbjct: 88 VSASLHFLSTGTLRLLNGSGHILWDSNTEKLGVSSASLEENGNLVL-RNGNAAVWSSFDN 146
Query: 149 PTDTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWNDSVVYFNQGLNSAINSTVNSNLT 208
P DTIVP+QNFT K L SG YSF+LL GN++L+WN+S+ Y+++GLNS+ NS N++LT
Sbjct: 147 PVDTIVPTQNFTVGKVLLSGVYSFSLLSFGNITLRWNNSITYWSEGLNSSFNSG-NTSLT 205
Query: 209 SPILRLQPVGILSISDVSLNS-AAIIAYSSDYAEGSDILRFLSLGSDGNLRIFSSARGSG 267
SP L LQ VG LS+ D +L + A++ YS DYAEG D+LRFL L +DGNLRI+SS RGSG
Sbjct: 206 SPSLGLQTVGTLSLFDQTLPAVGAVMVYSDDYAEGGDVLRFLKLDNDGNLRIYSSERGSG 265
Query: 268 TKTRRWAAVADQCEVFGYCGNMGICGYNGYNDSSSDPLCECPSQNFEFIDQNDRRKGCRR 327
T+T RWAAV DQC V+GYCG+MGIC YN ++ PLC CPSQNF+ +D ND RKGC+R
Sbjct: 266 TQTVRWAAVEDQCRVYGYCGDMGICSYN-----ATGPLCGCPSQNFDLVDPNDSRKGCKR 320
Query: 328 KVEIDSCPGSATMLELPHTKFLTFQPE------LSSQVFFVGISACRLNCLVTG-SCVAS 380
K+E++ CPG+ TML+L HT LT+ P+ S+VFFV +SACRLNCL SC S
Sbjct: 321 KMELEDCPGNLTMLDLEHTLLLTYPPQSIFAGGEESEVFFVAVSACRLNCLRDATSCEGS 380
Query: 381 TSLSDGTGLCYLKTPDFVSGFQNPALPSTSYVKVCGPVLPNPSGSLQAEEKSKSWRLKAW 440
T LSDG+G CYLK P F++G+ NPALPSTS++KVC PV+PNP SLQ ++ W+++ W
Sbjct: 381 TLLSDGSGQCYLKRPGFLTGYWNPALPSTSHIKVCPPVIPNPLPSLQVSGENYGWKVQGW 440
Query: 441 IVVVAVLATLMVLVVLEGGLWYWCCRNSPKFVSLSAQYALLEYASGAPVQFSYKELQRST 500
++V +A ++ LV LE GLW+WCCRNS K SAQYALLEYASGAPVQF YK+LQ +T
Sbjct: 441 ALIVEGVAIVLGLVSLEVGLWFWCCRNSSKSGGQSAQYALLEYASGAPVQFWYKDLQSAT 500
Query: 501 KGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLV 560
KGFK+KLG GGFG+VY+GVL N VVAVKQLEGIEQGEKQFRMEV TISSTHHLNLVRL+
Sbjct: 501 KGFKEKLGTGGFGSVYKGVLVNGMVVAVKQLEGIEQGEKQFRMEVGTISSTHHLNLVRLI 560
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGS-GKLLNWQSRFNIALGTARGITYLHEEC 619
GF SEG+HRLLVYEFMKNGSLD FLF + GK LNW+ RFNIALGTA+ ITYLHEEC
Sbjct: 561 GFCSEGRHRLLVYEFMKNGSLDQFLFNTDNNQMGKPLNWEQRFNIALGTAKAITYLHEEC 620
Query: 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN 679
RDCIVHCDIKPENILLDENY AKVSDFGLAKLI+ K+HR++TL S+RGTRGYLAPEW+AN
Sbjct: 621 RDCIVHCDIKPENILLDENYTAKVSDFGLAKLIHSKEHRYKTLASIRGTRGYLAPEWIAN 680
Query: 680 LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAG 739
LPITSKSD+YSYGMVLLEIVSGRRNFEVS ETN KKFS+WAYE+FE GNV+GIVD+ LA
Sbjct: 681 LPITSKSDIYSYGMVLLEIVSGRRNFEVSAETNMKKFSVWAYEKFEIGNVEGIVDRRLAD 740
Query: 740 EDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPPAPKALTEGSVGGTS 799
++VD+EQV RAIQVSFWCIQEQPSQRP MGK+VQMLEGI EI++PPA A EGS TS
Sbjct: 741 QEVDMEQVKRAIQVSFWCIQEQPSQRPRMGKIVQMLEGIAEIDRPPAIVANPEGSSSETS 800
Query: 800 VNMSSSTSALSTFAASAPAPSSSSSTHTG-VSALASDRNIERASSSLL 846
+ +SS+ S++S AASAP P SSS+ S ASD+N E+ASSSLL
Sbjct: 801 LCLSSNISSVSQ-AASAPDPPSSSAFQAERFSTFASDKNSEKASSSLL 847
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225460466|ref|XP_002267316.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1111 bits (2873), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 562/817 (68%), Positives = 655/817 (80%), Gaps = 23/817 (2%)
Query: 32 DISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGS---TPVD 88
DI G++L AS+LN +W SPNSTFSL FI +P SF AIT +PIW AG T VD
Sbjct: 22 DIRPGATLHASHLNDTWTSPNSTFSLRFIAATPTSFSAAIT-CAHIPIWRAGGASPTVVD 80
Query: 89 SSAFFQLHSSGTLRLISGSGAIIWDSNTQRLNVTSASLDDSGNLVLLKNGGVSAWSSFDN 148
S Q +SG LRL++GSG I+W+S T V+ A LDDSGNLVL +NG +S WS+F+N
Sbjct: 81 SGGSLQFLTSGNLRLVNGSGTILWESGTAGHGVSHAVLDDSGNLVL-RNGTISVWSTFEN 139
Query: 149 PTDTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWNDSVVYFNQGLNSAINSTVNSNLT 208
PTDTIVPSQ FTS TLR+G +SF+L KSGNL+L+WN+S+VY+NQGLNS +V+SNLT
Sbjct: 140 PTDTIVPSQIFTSSNTLRAGSFSFSLTKSGNLTLRWNNSIVYWNQGLNS----SVSSNLT 195
Query: 209 SPILRLQPVGILSISDVSLNSAAIIAYSSDYAEGSDILRFLSLGSDGNLRIFSSARGSGT 268
SP +Q +GIL++SD +L+++ ++AYSSDYAEGSD+LRF+ L SDGNLRI+S RGS
Sbjct: 196 SPSFGIQSLGILTLSDPTLSASVVMAYSSDYAEGSDMLRFVRLDSDGNLRIYSFDRGSRI 255
Query: 269 KTRRWAAVADQCEVFGYCGNMGICGYNGYNDSSSDPLCECPSQNFEFIDQNDRRKGCRRK 328
T RWAAV DQCEVFGYCG++GIC Y+ S P+C CPS+NFE +D D KGC+RK
Sbjct: 256 STVRWAAVKDQCEVFGYCGDLGICSYH-----DSSPVCSCPSENFELVDPKDSTKGCKRK 310
Query: 329 VEIDSCPGSATMLELPHTKFLTFQPELSSQVFFVGISACRLNCLVTGSCVASTSLSDGTG 388
EI++C G TMLEL H KFLT+ PE SQVFFVGI ACRLNCL+ G+CVASTSLSDGTG
Sbjct: 311 EEIENCAGVVTMLELQHAKFLTYPPESPSQVFFVGILACRLNCLMGGACVASTSLSDGTG 370
Query: 389 LCYLKTPDFVSGFQNPALPSTSYVKVCGPVLPNPSGSLQAEEKSKSWRLKAWIVVVAVLA 448
CY+K P FVSG+Q+P LPSTSY+KVCGPV PNPS SL + + S +L WIV V+
Sbjct: 371 SCYMKVPGFVSGYQSPTLPSTSYIKVCGPVSPNPSASLNGGDDT-SCKLHMWIVAAVVVG 429
Query: 449 TLMVLVVLEGGLWYWCC-RNSPKFVSLSAQYALLEYASGAPVQFSYKELQRSTKGFKDKL 507
TL+ LV+L+ GLW+WCC RNSPKF S +ALLEYASGAPV+FSYK+L+ STKGFK+KL
Sbjct: 430 TLLGLVLLQVGLWWWCCCRNSPKFWGSSVPHALLEYASGAPVRFSYKDLRYSTKGFKEKL 489
Query: 508 GAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK 567
GAGGFGAVYRGVLANRT+VAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRL+GF SEG+
Sbjct: 490 GAGGFGAVYRGVLANRTIVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLIGFCSEGR 549
Query: 568 HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCD 627
HRLLVYEFMKNGSLD FLF SG+LLNW+SRF+IALGTARGITYLHEECRDCIVHCD
Sbjct: 550 HRLLVYEFMKNGSLDIFLFPTGGHSGRLLNWESRFSIALGTARGITYLHEECRDCIVHCD 609
Query: 628 IKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSD 687
IKPENILLDENY+AKVSDFGLAKLIN KDHR+RTLTSVRGTRGYLAPEWLANLPITSKSD
Sbjct: 610 IKPENILLDENYSAKVSDFGLAKLINLKDHRYRTLTSVRGTRGYLAPEWLANLPITSKSD 669
Query: 688 VYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQV 747
VY YGMVLLE+VSGRRNFEVS E+N KKFS+WAYEEFEKGN++GIVDK L +V++EQ
Sbjct: 670 VYGYGMVLLEMVSGRRNFEVSAESNGKKFSVWAYEEFEKGNMEGIVDKRLVDREVNMEQA 729
Query: 748 MRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPPAPKALTEGSVGGTSVNMSSSTS 807
RA++VSFWCIQEQPSQRP MGKVVQMLEGI EIEKPPAPKA TE G +S N+SS
Sbjct: 730 KRAVEVSFWCIQEQPSQRPTMGKVVQMLEGIIEIEKPPAPKAGTEECTGESSRNVSSKVV 789
Query: 808 ALSTFAASAPAPSSSSSTHTGVSALASDRNIERASSS 844
A+ P SSS TG S+ S R +E++S S
Sbjct: 790 AV-------PPSSSSLLEKTGCSSFVSGRTVEKSSLS 819
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224145207|ref|XP_002325564.1| predicted protein [Populus trichocarpa] gi|222862439|gb|EEE99945.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1076 bits (2782), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 554/830 (66%), Positives = 645/830 (77%), Gaps = 27/830 (3%)
Query: 29 SFADISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWT------- 81
S A I GSSL ASN +++W SPN+TF L F Q S+ +I+Y+ GV IWT
Sbjct: 21 STATIPPGSSLYASNTSRTWSSPNNTFFLGFTQVG-TSYTVSISYAAGVAIWTTDSVVSG 79
Query: 82 -AGSTPVDSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLNVTSASLDDSGNLVLLKNGGV 140
A + VDS FQ +G LRL++GSGA +W SNT +L VTSASLDD+GNLVL N
Sbjct: 80 TASAAVVDSGGVFQFLRNGNLRLVNGSGATVWTSNTAKLGVTSASLDDTGNLVLAANT-F 138
Query: 141 SAWSSFDNPTDTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWNDSVVYFNQGLNSAIN 200
+ WSSF+NPTDT+VPSQN T ++TLRSG +SF LL +GN++L WNDSVVY+NQGL+S
Sbjct: 139 AVWSSFENPTDTLVPSQNLTVNQTLRSGVHSFRLLSNGNITLTWNDSVVYWNQGLSSL-- 196
Query: 201 STVNSNLTSPILRLQPVGILSISDVSLNSAAIIAYSSDYAEGSDILRFLSLGSDGNLRIF 260
N+TSP LRLQP GIL++SD SL + +A+ +DY EG+D++RFL SDGNLR++
Sbjct: 197 --SALNVTSPTLRLQPNGILTLSDASLRRSENVAFGNDYGEGADVMRFLRF-SDGNLRMY 253
Query: 261 SSARGSGTKTRRWAAVADQCEVFGYCGNMGICGYNGYNDSSSDPLCECPSQNFEFIDQND 320
S GT T WA +ADQC+V+GYCGNMGIC YN +S+S P+C+CPS NFE +D ND
Sbjct: 254 SG----GTTTMTWAVLADQCQVYGYCGNMGICSYN---ESNSSPICKCPSLNFEAVDVND 306
Query: 321 RRKGCRRKVEIDSCPGSATMLELPHTKFLTFQPELSSQVFFVGISACRLNCLVTGSCVAS 380
RRKGC+RKVE++ C G+ TMLEL TKF TFQ + Q+ +GI+ACR+NCL + SC AS
Sbjct: 307 RRKGCKRKVEVEDCVGNVTMLELKQTKFFTFQAQ---QIVSIGITACRVNCLSSTSCFAS 363
Query: 381 TSLSDGTGLCYLK-TPDFVSGFQNPALPSTSYVKVCGPVLPNPSGSLQAEEKSKSWRLKA 439
TS SD CYLK +PDFVSG+Q P L STSYVKVCG V PNPS Q+ K W+L+
Sbjct: 364 TSFSDTNVWCYLKNSPDFVSGYQGPVLLSTSYVKVCGTVQPNPSPLQQSGGDKKCWKLRV 423
Query: 440 WIVVVAVLATLMVLVVLEGGLWYWCCRNSPKFVSLSAQYALLEYASGAPVQFSYKELQRS 499
W+V V+ T++V+ L G W++CC+ SPKF + AQY LLEYASGAPVQFSYK+L R
Sbjct: 424 WVVGFVVVVTILVMAALAGLFWWFCCKTSPKFGGVWAQYTLLEYASGAPVQFSYKDLHRW 483
Query: 500 TKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRL 559
TK FKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRL
Sbjct: 484 TKRFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRL 543
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
+GF SEG+HRLLVYEFMKNGSLD+FLF E+ S KLLNW++RFNIALGTARGITYLHEEC
Sbjct: 544 IGFCSEGRHRLLVYEFMKNGSLDHFLFRTEDQSEKLLNWKNRFNIALGTARGITYLHEEC 603
Query: 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN 679
RDCIVHCDIKPENILLDEN+NAKVSDFGLAKLI+ KD R+R+LTS+RGTRGYLAPEWLAN
Sbjct: 604 RDCIVHCDIKPENILLDENFNAKVSDFGLAKLISTKDQRYRSLTSIRGTRGYLAPEWLAN 663
Query: 680 LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAG 739
LPITSKSDVYSYGMVLLEIVSGRRNFEVS E N KKFS WAY EFEKGNV IVDK LA
Sbjct: 664 LPITSKSDVYSYGMVLLEIVSGRRNFEVSAEINEKKFSEWAYGEFEKGNVAAIVDKRLAD 723
Query: 740 EDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPPAPKALTEGSVGGTS 799
+ VD+EQVMRA+QVSFWC QE PSQRP MGKVVQMLEGI EI PPAPKALTEGS GTS
Sbjct: 724 QGVDMEQVMRAVQVSFWCFQEHPSQRPTMGKVVQMLEGIIEIAMPPAPKALTEGSSCGTS 783
Query: 800 VNMSSSTSALSTFAASAPAPSSSSSTHT-GVSALASDRNIERASSSLLRS 848
++S A ST+ ASAP PSSSSS T G+S S+R E+ SSS L S
Sbjct: 784 TSLSGKDGAHSTYEASAPPPSSSSSFQTAGISPFISERITEKQSSSFLGS 833
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356502317|ref|XP_003519966.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1060 bits (2741), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 554/827 (66%), Positives = 653/827 (78%), Gaps = 22/827 (2%)
Query: 33 ISLGSSLSASNLNQSWPSPNSTFSLSFIQ----RSPNSFIPAITYSGGVPI-WTAGS-TP 86
I GS+L+AS+ NQ+W SP+ TFSL FI +P SFI AI +SGG P+ W+AG+
Sbjct: 23 IDPGSTLAASSSNQTWSSPSGTFSLRFISVQPPTTPPSFIAAIVFSGGAPVVWSAGNGAA 82
Query: 87 VDSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLNVTSASLDDSGNLVLLKNGGVSAWSSF 146
VDS+ Q SG LRL +GSGA +WD+ T +SA+L+DSGNLV+ + G S WSSF
Sbjct: 83 VDSAGSLQFLRSGHLRLFNGSGATVWDTGTA--GASSATLEDSGNLVISNSTG-SLWSSF 139
Query: 147 DNPTDTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWNDSVVYFNQGLNSAINSTVNSN 206
D+PTDT+VPSQNFT K L S YSF L GNL+LKWN+S+VY+ QGLNS +VN +
Sbjct: 140 DHPTDTLVPSQNFTVGKVLNSESYSFGLSSIGNLTLKWNNSIVYWTQGLNS----SVNVS 195
Query: 207 LTSPILRLQPVGILSISDVSLNSAAIIAYSSDYAEG-SDILRFLSLGSDGNLRIFSSARG 265
L SP L L +G+L +SD +L+ + +AYSSDYAEG SD++R L L SDGNLRI+S+A+G
Sbjct: 196 LDSPSLGLLSIGLLQLSDANLSPSIDVAYSSDYAEGNSDVMRVLKLDSDGNLRIYSTAKG 255
Query: 266 SGTKTRRWAAVADQCEVFGYCGNMGICGYNGYNDSSSDPLCECPSQNFEFIDQNDRRKGC 325
SG T RWAAV DQCEV+ YCGN G+C YN S P+C CPS+NFE +D ND RKGC
Sbjct: 256 SGVATARWAAVLDQCEVYAYCGNYGVCSYN-----DSTPVCGCPSENFEMVDPNDSRKGC 310
Query: 326 RRKVEIDSCPGSATMLELPHTKFLTFQPELSSQVFFVGISACRLNCLV-TGSCVASTSLS 384
RRK ++SC GSATML L H L++ PE +SQ FF GISACR NCL + +C ASTSLS
Sbjct: 311 RRKASLNSCQGSATMLTLDHAVILSYPPEAASQSFFSGISACRGNCLSGSRACFASTSLS 370
Query: 385 DGTGLCYLKTPDFVSGFQNPALPSTSYVKVCGPVLPNPSGSLQAEEKSKSWRLKAWIVVV 444
DGTG C +++ DFVS + NP+LPSTSYVKVC P+ PNP S+ + +S R+ AW+VVV
Sbjct: 371 DGTGQCVMRSEDFVSAYHNPSLPSTSYVKVCPPLEPNPPPSMGGVREKRS-RVPAWVVVV 429
Query: 445 AVLATLMVLVVLEGGLWYWCCRNSPKFVSLSAQYALLEYASGAPVQFSYKELQRSTKGFK 504
VL TL+ L+ LEGGLW WCCRNS +F LSA YALLEYASGAPVQFS+KELQ++TKGFK
Sbjct: 430 VVLGTLLGLIALEGGLWMWCCRNSTRFGGLSAHYALLEYASGAPVQFSHKELQQATKGFK 489
Query: 505 DKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSS 564
+KLGAGGFG VYRG L N+TV+AVKQLEGIEQGEKQFRMEVATISSTHHLNLVRL+GF S
Sbjct: 490 EKLGAGGFGTVYRGTLVNKTVIAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLIGFCS 549
Query: 565 EGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIV 624
EG+HRLLVYEFMKNGSLDNFLF E SG LNW+ R+NIALGTARGITYLHEECRDCIV
Sbjct: 550 EGRHRLLVYEFMKNGSLDNFLFLTELHSGNFLNWEYRYNIALGTARGITYLHEECRDCIV 609
Query: 625 HCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITS 684
HCDIKPENILLDENY AKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITS
Sbjct: 610 HCDIKPENILLDENYVAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITS 669
Query: 685 KSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDI 744
KSDVYSYGMVLLEIVSGRRNF+VS++TNRKKFS+WAYEEFEKGN+ GI+DK LA ++V++
Sbjct: 670 KSDVYSYGMVLLEIVSGRRNFDVSEDTNRKKFSIWAYEEFEKGNISGILDKRLAEQEVEM 729
Query: 745 EQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPPAPKALTEGSVGGTSVNMSS 804
EQV RAIQ SFWCIQEQPSQRP M +V+QMLEG+TE+E+PPAPK++ EG+V GTS SS
Sbjct: 730 EQVRRAIQASFWCIQEQPSQRPTMSRVLQMLEGVTELERPPAPKSVMEGAVSGTSTYFSS 789
Query: 805 STSALSTFAASAPAP-SSSSSTHTGVSALASDRNIERASSSLLRSSS 850
+ SA ST S P SSSS + VS RN E+A+SSLL+S +
Sbjct: 790 NASAFSTVGVSPAGPSSSSSFQTSVVSTFTLGRNPEKATSSLLQSDT 836
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574579|ref|XP_003555423.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1060 bits (2740), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 515/788 (65%), Positives = 624/788 (79%), Gaps = 22/788 (2%)
Query: 11 LSLLL-LLLSLSVSLNFISSFADISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIP 69
LSL L +L L V L+F + IS G++L ASN QSW SPN TFSL F+ P +F P
Sbjct: 17 LSLWLQWILKLQVDLHFPFNKNTISPGTTLYASNTTQSWSSPNDTFSLHFLPLHPPTFPP 76
Query: 70 ----AITYSGGVP-IWTAGS-TPVDSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLNVTS 123
A+ +SGG P +W+AG+ VDS+A FQ +G L L++GSG+ +WDS T + V+S
Sbjct: 77 SFTAAVVHSGGAPAVWSAGNGAAVDSAASFQFLPAGNLVLVNGSGSTVWDSGTSNMGVSS 136
Query: 124 ASLDDSGNLVLLKNGGVSAWSSFDNPTDTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLK 183
A+L D+GNLVL N S WSSFDNPTDTIV QNFT LRSG +SF++L SGNL+LK
Sbjct: 137 ATLHDNGNLVL-SNATSSVWSSFDNPTDTIVSFQNFTVGMVLRSGSFSFSVLSSGNLTLK 195
Query: 184 WNDSVVYFNQGLNSAINSTVNSNLTSPILRLQPVGILSISDVSLNSAAIIAYSSDYAEGS 243
W+DSV Y++QGLN +++ NL+SP+L ++P G+L + +L++ ++AYSSDY EGS
Sbjct: 196 WSDSVPYWDQGLNFSMSVM---NLSSPVLGVEPKGVLQLFYPNLSAPVVVAYSSDYGEGS 252
Query: 244 DILRFLSLGSDGNLRIFSSARGSGTKTRRWAAVADQCEVFGYCGNMGICGYNGYNDSSSD 303
D+LR L L DGNLR++SS RGSGT + W AV DQCEVFGYCG+ G+C YN DSSS
Sbjct: 253 DVLRVLKLDGDGNLRVYSSKRGSGTVSSTWVAVEDQCEVFGYCGHNGVCSYN---DSSSS 309
Query: 304 PLCECPSQNFEFIDQNDRRKGCRRKVEIDSCPGSATMLELPHTKFLTFQPE--LSSQVFF 361
P+C CPSQNFE ++ +D RKGCRRKV ++ C G ML+L H +FLT+ P+ ++ +VFF
Sbjct: 310 PICGCPSQNFEMVNPSDSRKGCRRKVRLEDCVGKVAMLQLDHAQFLTYPPQFLINPEVFF 369
Query: 362 VGISACRLNCLVTGSCVASTSLSDGTGLCYLKTPDFVSGFQNPALPSTSYVKVCGPVLPN 421
+GISAC NCL + SC ASTSLSDG+GLCY+KT +F+SG+QNPALPSTSY+KVCGPV PN
Sbjct: 370 IGISACSGNCLASNSCFASTSLSDGSGLCYIKTSNFISGYQNPALPSTSYIKVCGPVAPN 429
Query: 422 PSGSLQAEEKSKSWRLKAWIVVVAVLATLMVLVVLEGGLWYWCCRNSPKFVSLSAQYALL 481
+ SL+ + WRL W+ +V VL+TL+ +V +GGLW WCCRN +F +AQY LL
Sbjct: 430 LAPSLE----NAHWRLHGWVALV-VLSTLLCFLVFQGGLWLWCCRNRQRFGGFAAQYTLL 484
Query: 482 EYASGAPVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQF 541
EYASGAPV FSYKELQRSTKGFK+KLG GGFGAVY+G L N+TVVAVKQLEGIEQGEKQF
Sbjct: 485 EYASGAPVHFSYKELQRSTKGFKEKLGDGGFGAVYKGTLFNQTVVAVKQLEGIEQGEKQF 544
Query: 542 RMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEG-SGKLLNWQS 600
RMEV+TISSTHHLNLVRL+GF SEG+HRLLVYEFMKNGSLDNFLF +EE SGKLLNW
Sbjct: 545 RMEVSTISSTHHLNLVRLIGFCSEGQHRLLVYEFMKNGSLDNFLFVDEEQQSGKLLNWGY 604
Query: 601 RFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHR 660
RFNIALG A+G+TYLHEECR+CIVHCD+KPENILLDENYNAKVSDFGLAKL+ P D RHR
Sbjct: 605 RFNIALGAAKGLTYLHEECRNCIVHCDVKPENILLDENYNAKVSDFGLAKLLRPVDCRHR 664
Query: 661 TLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA 720
TLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVS+ET R+KFS+WA
Sbjct: 665 TLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSEETRRRKFSVWA 724
Query: 721 YEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780
YEEFEKGN+ G++D+ L +++++EQV R + FWCIQEQPS RP M KVVQMLEG+ +
Sbjct: 725 YEEFEKGNIMGVIDRRLVNQEINLEQVKRVLMACFWCIQEQPSHRPTMSKVVQMLEGVID 784
Query: 781 IEKPPAPK 788
IE+PPAPK
Sbjct: 785 IERPPAPK 792
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 852 | ||||||
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.854 | 0.878 | 0.630 | 6.6e-255 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.360 | 0.370 | 0.567 | 2.3e-116 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.360 | 0.373 | 0.548 | 5.7e-107 | |
| TAIR|locus:2054326 | 764 | AT2G41890 [Arabidopsis thalian | 0.690 | 0.769 | 0.300 | 8.2e-85 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.343 | 0.336 | 0.416 | 7.4e-82 | |
| TAIR|locus:2200923 | 802 | AT1G61550 [Arabidopsis thalian | 0.597 | 0.634 | 0.318 | 1.6e-75 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.341 | 0.359 | 0.397 | 2.4e-75 | |
| TAIR|locus:2147635 | 452 | AT5G20050 [Arabidopsis thalian | 0.362 | 0.683 | 0.453 | 6.7e-72 | |
| TAIR|locus:2197744 | 807 | AT1G61420 [Arabidopsis thalian | 0.341 | 0.360 | 0.387 | 9.4e-72 | |
| TAIR|locus:2197714 | 792 | AT1G61440 [Arabidopsis thalian | 0.342 | 0.368 | 0.392 | 1e-71 |
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2454 (868.9 bits), Expect = 6.6e-255, P = 6.6e-255
Identities = 472/749 (63%), Positives = 573/749 (76%)
Query: 48 WPSPNSTFSLSFIQR-SPNSFIPAITYSGGVPIWTAGSTPVDSSAFFQLHSSGTLRLISG 106
WPSPNSTFS+SF+ SPNSF+ A++++G VPIW+AG+ VDS +LH+SG+LRL +G
Sbjct: 42 WPSPNSTFSVSFVPSPSPNSFLAAVSFAGSVPIWSAGT--VDSRGSLRLHTSGSLRLTNG 99
Query: 107 SGAIIWDSNTQRLNVTSASLDDSGNLVLLKNGGVSAWSSFDNPTDTIVPSQNFTSDKTLR 166
SG +WDS T RL VTS S++D+G +LL N V WSSFDNPTDTIV SQNFT+ K LR
Sbjct: 100 SGTTVWDSKTDRLGVTSGSIEDTGEFILLNNRSVPVWSSFDNPTDTIVQSQNFTAGKILR 159
Query: 167 SGYYSFTLLKSGNLSLKWNDSVVYFNQGLNSAINSTVNSNLTSPILRLQPVGILSISDVS 226
SG YSF L +SGNL+L+WN S +Y+N GLNS+ +S NL+SP L LQ G++SI + +
Sbjct: 160 SGLYSFQLERSGNLTLRWNTSAIYWNHGLNSSFSS----NLSSPRLSLQTNGVVSIFESN 215
Query: 227 LNXXXXXXXXXXXXEGSDILRFLSLGSDGNLRIFSSA-RGSGTKTRRWAAVADQCEVFGY 285
L + S+ RFL L DGNLRI+SSA R SG W+AV DQC V+GY
Sbjct: 216 LLGGAEIVYSGDYGD-SNTFRFLKLDDDGNLRIYSSASRNSGPVNAHWSAV-DQCLVYGY 273
Query: 286 CGNMGICGYNGYNDSSSDPLCECPSQNFEFIDQNDRRKGCRRKVEIDSCPGSATMLELPH 345
CGN GIC YN N P+C CPS+NF+F+D NDRRKGC+RKVE+ C G+ TML+L H
Sbjct: 274 CGNFGICSYNDTN-----PICSCPSRNFDFVDVNDRRKGCKRKVELSDCSGNTTMLDLVH 328
Query: 346 TKFLTFQPELSSQVFFVGISACRLNCLVTGSCVASTSLSDGTGLCYLKTP-DFVSGFQNP 404
T+ T++ + +S+ FF G S CR NCL + C+AS S+SDG+G C+ K P F +G+Q P
Sbjct: 329 TRLFTYEDDPNSESFFAGSSPCRANCLSSVLCLASVSMSDGSGNCWQKHPGSFFTGYQWP 388
Query: 405 ALPSTSYVKVCGPVLPNPSGSLQAEEKSKSWRLKAWIXXXXXXXXXXXXXXXEGGLWYWC 464
++PSTSYVKVCGPV+ N + + S ++ WI E GLW+ C
Sbjct: 389 SVPSTSYVKVCGPVVANTLERATKGDDNNS-KVHLWIVAVAVIAGLLGLVAVEIGLWWCC 447
Query: 465 CRNSPKFVSLSAQYALLEYASGAPVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLANRT 524
CR +P+F +LS+ Y LLEYASGAPVQF+YKELQR TK FK+KLGAGGFG VYRGVL NRT
Sbjct: 448 CRKNPRFGTLSSHYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRT 507
Query: 525 VVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNF 584
VVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRL+GF S+G+HRLLVYEFM+NGSLDNF
Sbjct: 508 VVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNF 567
Query: 585 LFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVS 644
LF + S K L W+ RFNIALGTA+GITYLHEECRDCIVHCDIKPENIL+D+N+ AKVS
Sbjct: 568 LFTTD--SAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVS 625
Query: 645 DFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRN 704
DFGLAKL+NPKD+R+ ++SVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLE+VSG+RN
Sbjct: 626 DFGLAKLLNPKDNRYN-MSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRN 684
Query: 705 FEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGED-VDIEQVMRAIQVSFWCIQEQPS 763
F+VS++TN KKFS+WAYEEFEKGN K I+D L+ + VD+EQVMR ++ SFWCIQEQP
Sbjct: 685 FDVSEKTNHKKFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPL 744
Query: 764 QRPMMGKVVQMLEGITEIEKPPAPKALTE 792
QRP MGKVVQMLEGITEI+ P PK ++E
Sbjct: 745 QRPTMGKVVQMLEGITEIKNPLCPKTISE 773
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 926 (331.0 bits), Expect = 2.3e-116, Sum P(2) = 2.3e-116
Identities = 176/310 (56%), Positives = 229/310 (73%)
Query: 482 EYASGAPVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQF 541
E G FSY+ELQ +TK F DKLG GGFG+V++G L + + +AVK+LEGI QGEKQF
Sbjct: 474 EKGDGTLSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQF 533
Query: 542 RMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSR 601
R EV TI + H+NLVRL GF SEG +LLVY++M NGSLD+ LF N+ +L W+ R
Sbjct: 534 RTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLR 593
Query: 602 FNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRT 661
F IALGTARG+ YLH+ECRDCI+HCDIKPENILLD + KV+DFGLAKL+ +D R
Sbjct: 594 FQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVG-RDFS-RV 651
Query: 662 LTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAY 721
LT++RGTRGYLAPEW++ + IT+K+DVYSYGM+L E+VSGRRN E S+ + F WA
Sbjct: 652 LTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAA 711
Query: 722 EEFEK-GNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780
K G+++ +VD L G+ VDIE+V RA +V+ WCIQ++ S RP M +VVQ+LEG+ E
Sbjct: 712 TILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLE 771
Query: 781 IEKPPAPKAL 790
+ PP P+++
Sbjct: 772 VNPPPFPRSI 781
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 904 (323.3 bits), Expect = 5.7e-107, Sum P(2) = 5.7e-107
Identities = 170/310 (54%), Positives = 229/310 (73%)
Query: 481 LEYASGAPVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQ 540
LE SG P++F+YK+LQ +T F KLG GGFG+VY G L + + +AVK+LEGI QG+K+
Sbjct: 473 LENLSGMPIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIGQGKKE 532
Query: 541 FRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQS 600
FR EV+ I S HHL+LVRL GF +EG HRLL YEF+ GSL+ ++F ++G LL+W +
Sbjct: 533 FRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGD-VLLDWDT 591
Query: 601 RFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHR 660
RFNIALGTA+G+ YLHE+C IVHCDIKPENILLD+N+NAKVSDFGLAKL+ ++ H
Sbjct: 592 RFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMT-REQSH- 649
Query: 661 TLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA 720
T++RGTRGYLAPEW+ N I+ KSDVYSYGMVLLE++ GR+N++ S+ + + F +A
Sbjct: 650 VFTTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCHFPSFA 709
Query: 721 YEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780
+++ E+G + IVD + DV E+V RA++ + WCIQE RP M KVVQMLEG+
Sbjct: 710 FKKMEEGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFP 769
Query: 781 IEKPPAPKAL 790
+ +PP+ +
Sbjct: 770 VVQPPSSSTM 779
|
|
| TAIR|locus:2054326 AT2G41890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 690 (248.0 bits), Expect = 8.2e-85, Sum P(2) = 8.2e-85
Identities = 190/633 (30%), Positives = 293/633 (46%)
Query: 48 WPSPNSTFSLSFIQRSP--NSFIPAITY-SGGVP------IWTAGSTPV--DSSAFFQLH 96
W S N F+L F N F I + S +P +W AG+ V D+S++F+L
Sbjct: 40 WVSNNGDFALGFFNPPGLLNRFSIGIWFNSNSIPYDQRKVVWVAGAGVVVSDNSSYFELT 99
Query: 97 SSGTLRLISGS-GAIIWDSNTQRLNVTSASLDDSGNLVLLKNGGVSAWSSFDNPTDTIVP 155
+G L L G +W+S T R +V+SA L D GNLVLLK+ W SF PTDT++P
Sbjct: 100 RNGELVLFDSLLGVPVWNSKTNRFSVSSALLRDDGNLVLLKDREEIVWQSFGTPTDTLLP 159
Query: 156 SQNFTSDKTLR-------SGYYSFTLLKSGNLSLKWNDSVVYFNQGLNSAINSTVNSNLT 208
+Q F + + LR S YYS L SG L L+W ++ +++ G N +
Sbjct: 160 NQKFPAFEMLRAASENSRSSYYSLHLEDSGRLELRWESNITFWSSG-NEVVKKKKKKKNI 218
Query: 209 SPILRLQPVGILSISDVSLNXXXXXXXXXXXXEGSDILRFLSLGSDGNLRIFSSARGSGT 268
+L + G L + D L + RFL L DGNLR++S S
Sbjct: 219 GAVLTSE--GALFLEDQDLMRPVWSVFGEDHNDTVKF-RFLRLDRDGNLRMYSWNEDSRI 275
Query: 269 KTRRWAAVADQCEVFGYCGNMGICGYNGYNDSSSDPLCECPSQNFEFIDQNDRRKGCRRK 328
W AV +QC VF CG+ +C +N SS C CP F+ +D + C
Sbjct: 276 WKPVWQAVENQCRVFATCGSQ-VCSFN----SSGYTECNCPFN--AFVSVSDPK--CLVP 326
Query: 329 VEIDSCPGSATMLELPHTKFLTFQPELSSQVFFVGISACRLNCLVTGSCVASTSLSDGTG 388
+ C M++ + + P S + + C+ CL +C A T +DG
Sbjct: 327 YQKPGCKSGFNMVKFKNLELYGIYPANDSVISQISSQRCKKLCLENSACTAVTYTNDGEP 386
Query: 389 LCYLKTPDFVSGFQNPALPSTSYVKVC-GPVLPNPSG-SLQAEEK-SKSWRLKAWIXXXX 445
C +K ++SG+ +P+L S SYVK C P+ +P+ S ++ +KS +
Sbjct: 387 QCRMKLTRYISGYSDPSLSSISYVKTCLDPIAVDPNNVSKESPVTVTKSHSICIPCLVGA 446
Query: 446 XXXXXXXXXXXEGGLWYWCCRNSPKFVSLSAQ-YALLEYASGAPVQFSYKELQRSTKGFK 504
+ G+ + R K A+ ++ G + FS E++ T F
Sbjct: 447 TSTTLVLFLGFQLGIVVYIYRRKKKLAKKKAERFSKATNPKGVMI-FSVDEIKAMTDNFD 505
Query: 505 DKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSS 564
+ +G +++GV+ +VAVK++E E++FR + I + HH NL L G+
Sbjct: 506 NNIGP----QIFKGVMPENELVAVKEVEATLTEERKFRSSASKIGTMHHKNLANLEGYCC 561
Query: 565 EGKHRLLVYEFMKNGS-LDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCI 623
E R LVYE+ KNGS LD+ + + K L W+ R + L A+ + YLH ECR+ +
Sbjct: 562 ELGRRFLVYEYAKNGSILDHIV---DPLRSKKLTWRIRTDTCLSVAKALCYLHMECREFV 618
Query: 624 VHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656
H ++ NILL E+ AK++++G KD
Sbjct: 619 SHGNLNCGNILLGEDLEAKLTEYGFGLCAADKD 651
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 645 (232.1 bits), Expect = 7.4e-82, Sum P(2) = 7.4e-82
Identities = 133/319 (41%), Positives = 199/319 (62%)
Query: 486 GAPVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQL--EGIEQGEKQFRM 543
G P +F ++EL+++T+ FK ++G+GGFG+VY+G L + T++AVK++ G+ G ++F
Sbjct: 500 GLPQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKITNHGLH-GRQEFCT 558
Query: 544 EVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFN 603
E+A I + H NLV+L GF + G+ LLVYE+M +GSL+ LF+ G+G +L WQ RF+
Sbjct: 559 EIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFS---GNGPVLEWQERFD 615
Query: 604 IALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLT 663
IALGTARG+ YLH C I+HCD+KPENILL +++ K+SDFGL+KL+N ++ T
Sbjct: 616 IALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESS--LFT 673
Query: 664 SVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEE 723
++RGTRGYLAPEW+ N I+ K+DVYSYGMVLLE+VSGR+N +N
Sbjct: 674 TMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCSFRSRSNSVTEDNNQNHS 733
Query: 724 FEKGNVKGIV-------DKSLAGEDVDI-----------EQVMRAIQVSFWCIQEQPSQR 765
G+V D G +++ ++ + ++++ C+ E+P+ R
Sbjct: 734 STTTTSTGLVYFPLYALDMHEQGRYMELADPRLEGRVTSQEAEKLVRIALCCVHEEPALR 793
Query: 766 PMMGKVVQMLEGITEIEKP 784
P M VV M EG + P
Sbjct: 794 PTMAAVVGMFEGSIPLGNP 812
|
|
| TAIR|locus:2200923 AT1G61550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 614 (221.2 bits), Expect = 1.6e-75, Sum P(2) = 1.6e-75
Identities = 177/555 (31%), Positives = 270/555 (48%)
Query: 249 LSLGSDGNLRIFSSARGSGTK-TRRWAAVADQCEVFGYCGNMGICGYNGYNDSSSDPLCE 307
L L S+G+L++ +GT A+ C+ +G CG G+C S P C+
Sbjct: 248 LVLTSEGSLKV---THHNGTDWVLNIDVPANTCDFYGVCGPFGLCVM------SIPPKCK 298
Query: 308 CPSQNF--EFIDQNDRRK---GCRRKVEIDSCPGSAT--MLELPHTKFLTFQPELSSQVF 360
C + F +F ++ R GC R+ E+ C G++T + + H P+ V
Sbjct: 299 C-FKGFVPQFSEEWKRGNWTGGCVRRTEL-LCQGNSTGRHVNVFHPVANIKPPDFYEFVS 356
Query: 361 FVGISACRLNCLVTGSCVASTSLSDGTGLCYLKTPDFVSGFQNPALPSTSYVKVCGPVLP 420
C +CL SC+A ++ G G C + N L V G +L
Sbjct: 357 SGSAEECYQSCLHNCSCLAFAYIN-GIG-CLI---------WNQELMDVMQFSVGGELL- 404
Query: 421 NPSGSLQAEEKSKSWRLKAWIXXXXXXXXXXXXXXXEGGLWYWCCRNSPKFVSLSAQYAL 480
S L + E + R K I G W + +++ +S Q A
Sbjct: 405 --SIRLASSEMGGNQRKKTIIASIVSISLFVTLASAAFGFWRYRLKHNAIVSKVSLQGAW 462
Query: 481 LEYASGAPVQ----FSYKELQRSTKGFK--DKLGAGGFGAVYRGVLANRTVVAVKQLEGI 534
V F K ++ +T F +KLG GGFG VY+G L + +AVK+L
Sbjct: 463 RNDLKSEDVSGLYFFEMKTIEIATNNFSLVNKLGQGGFGPVYKGKLQDGKEIAVKRLSSS 522
Query: 535 E-QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSG 593
QG+++F E+ IS H+NLVR++G EG+ RLLVYEFM N SLD F+F + +
Sbjct: 523 SGQGKEEFMNEILLISKLQHINLVRILGCCIEGEERLLVYEFMVNKSLDTFIFDSRKRVE 582
Query: 594 KLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653
++W RF+I G ARG+ YLH + R I+H D+K NILLD+ N K+SDFGLA++
Sbjct: 583 --IDWPKRFSIIQGIARGLLYLHRDSRLRIIHRDVKVSNILLDDKMNPKISDFGLARMYE 640
Query: 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNR 713
++ T V GT GY++PE+ + KSD YS+G++LLE++SG + S + R
Sbjct: 641 GTKYQDNTRRIV-GTLGYMSPEYAWTGVFSEKSDTYSFGVLLLEVISGEKISRFSYDKER 699
Query: 714 KKFSLWAYEEF-EKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVV 772
K +A+E + E G V G +DK A + +V R +Q+ C+Q QP+ RP +++
Sbjct: 700 KNLLAYAWESWCENGGV-GFLDKD-ATDSCHPSEVGRCVQIGLLCVQHQPADRPNTLELL 757
Query: 773 QMLEGITEIEKPPAP 787
ML +++ P P
Sbjct: 758 SMLTTTSDLPLPKEP 772
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 547 (197.6 bits), Expect = 2.4e-75, Sum P(2) = 2.4e-75
Identities = 120/302 (39%), Positives = 180/302 (59%)
Query: 491 FSYKELQRSTKGFK--DKLGAGGFGAVYRGVLANRTVVAVKQLEGIE-QGEKQFRMEVAT 547
F +Q +T F +KLG GGFG+VY+G L + +AVK+L QG+++F E+
Sbjct: 484 FEMNTIQTATDNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNEIVL 543
Query: 548 ISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKL-LNWQSRFNIAL 606
IS H NLVR++G EG+ RLLVYEF+ N SLD FLF + + +L ++W RFNI
Sbjct: 544 ISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLDTFLFDSRK---RLEIDWPKRFNIIE 600
Query: 607 GTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVR 666
G ARG+ YLH + ++H D+K NILLDE N K+SDFGLA++ +++ T V
Sbjct: 601 GIARGLHYLHRDSCLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNT-RRVA 659
Query: 667 GTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEF-E 725
GT GY+APE+ + KSD+YS+G++LLEI++G + S K +A+E + E
Sbjct: 660 GTLGYMAPEYAWTGMFSEKSDIYSFGVILLEIITGEKISRFSYGRQGKTLLAYAWESWCE 719
Query: 726 KGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPP 785
G + ++DK +A +E V R +Q+ C+Q QP+ RP +++ ML +++ P
Sbjct: 720 SGGID-LLDKDVADSCHPLE-VERCVQIGLLCVQHQPADRPNTMELLSMLTTTSDLTSPK 777
Query: 786 AP 787
P
Sbjct: 778 QP 779
|
|
| TAIR|locus:2147635 AT5G20050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 727 (261.0 bits), Expect = 6.7e-72, P = 6.7e-72
Identities = 148/326 (45%), Positives = 217/326 (66%)
Query: 474 LSAQYALLEYASGAPVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEG 533
L +Y+ L +G P +F ++L+ +T GF+ +G GG G+V++GVL + + VAVK++EG
Sbjct: 76 LRIEYSFLRKVAGVPTKFKLEDLEEATDGFRSLIGKGGSGSVFKGVLKDGSQVAVKRIEG 135
Query: 534 IEQGEKQFRMEVATISSTHHLNLVRLVGFSSE---GKHRLLVYEFMKNGSLDNFLFANEE 590
E+GE++FR EVA I+S H NLVRL G+SS + R LVY+++ N SLD ++F +
Sbjct: 136 EEKGEREFRSEVAAIASVQHKNLVRLYGYSSSTSANRPRFLVYDYIVNSSLDIWIFPDRG 195
Query: 591 GSGK----LLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDF 646
G+ L+W+ R+ +A+ A+ + YLH +CR I+H D+KPENILLDEN+ A V+DF
Sbjct: 196 NRGRSGGGCLSWEQRYQVAIDVAKALAYLHHDCRSKILHLDVKPENILLDENFRAVVTDF 255
Query: 647 GLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNF- 705
GL+KLI +D R LT +RGTRGYLAPEWL I+ KSDVYSYG+VLLE++ GRR+
Sbjct: 256 GLSKLI-ARDES-RVLTDIRGTRGYLAPEWLLEHGISEKSDVYSYGIVLLEMIGGRRSIS 313
Query: 706 --EVSQETNRKKFSLW---AYEEFEKGNVKGIVDKSLAG-EDVDIEQVMRAIQVSFWCIQ 759
EV +ET +KK + ++ + + IVD+ L +VD E+VM+ + V+ WCIQ
Sbjct: 314 RVEV-KETKKKKLEYFPRIVNQKMRERKIMEIVDQRLIEVNEVDEEEVMKLVCVALWCIQ 372
Query: 760 EQPSQRPMMGKVVQMLEGITEIEKPP 785
E+ +RP M V++MLEG + +PP
Sbjct: 373 EKSKKRPDMTMVIEMLEGRVPVNEPP 398
|
|
| TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 534 (193.0 bits), Expect = 9.4e-72, Sum P(2) = 9.4e-72
Identities = 117/302 (38%), Positives = 178/302 (58%)
Query: 491 FSYKELQRSTKGFK--DKLGAGGFGAVYRGVLANRTVVAVKQLEGIE-QGEKQFRMEVAT 547
F +Q +T F +KLG GGFG VY+G L + +AVK+L QG+++F E+
Sbjct: 482 FDMHTIQTATNNFSISNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNEIVL 541
Query: 548 ISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKL-LNWQSRFNIAL 606
IS H NLVR++G EG+ +LL+YEFM N SLD FLF + + +L ++W R +I
Sbjct: 542 ISKLQHKNLVRILGCCIEGEEKLLIYEFMLNNSLDTFLFDSRK---RLEIDWPKRLDIIQ 598
Query: 607 GTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVR 666
G ARGI YLH + ++H D+K NILLDE N K+SDFGLA++ +++ T V
Sbjct: 599 GIARGIHYLHRDSHLKVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVV- 657
Query: 667 GTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEF-E 725
GT GY+APE+ + KSD+YS+G+++LEI+SG + S K +A+E + +
Sbjct: 658 GTLGYMAPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGKEEKTLIAYAWESWCD 717
Query: 726 KGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPP 785
G + ++DK +A +E V R +Q+ C+Q QP+ RP +++ ML +++ P
Sbjct: 718 TGGID-LLDKDVADSCRPLE-VERCVQIGLLCVQHQPADRPNTLELLSMLTTTSDLPPPE 775
Query: 786 AP 787
P
Sbjct: 776 QP 777
|
|
| TAIR|locus:2197714 AT1G61440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 540 (195.1 bits), Expect = 1.0e-71, Sum P(2) = 1.0e-71
Identities = 118/301 (39%), Positives = 178/301 (59%)
Query: 491 FSYKELQRSTKGFK--DKLGAGGFGAVYRGVLANRTVVAVKQLEGI-EQGEKQFRMEVAT 547
F +Q +T F +KLG GGFG+VY+G L + +AVK+L EQG+++F E+
Sbjct: 466 FEMNTIQTATSNFSLSNKLGHGGFGSVYKGKLQDGREIAVKRLSSSSEQGKQEFMNEIVL 525
Query: 548 ISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKL-LNWQSRFNIAL 606
IS H NLVR++G EGK +LL+YEFMKN SLD F+F + + +L L+W RF+I
Sbjct: 526 ISKLQHRNLVRVLGCCVEGKEKLLIYEFMKNKSLDTFVFGSRK---RLELDWPKRFDIIQ 582
Query: 607 GTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVR 666
G RG+ YLH + R ++H D+K NILLDE N K+SDFGLA+L ++ +T V
Sbjct: 583 GIVRGLLYLHRDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARLFQGSQYQDKTRRVV- 641
Query: 667 GTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEK 726
GT GY++PE+ + KSD+YS+G++LLEI+SG + S K + +E + +
Sbjct: 642 GTLGYMSPEYAWTGVFSEKSDIYSFGVLLLEIISGEKISRFSYGEEGKALLAYVWECWCE 701
Query: 727 GNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPPA 786
++D++L E V R +Q+ C+Q QP+ RP +++ ML +++ P
Sbjct: 702 TRGVNLLDQALDDSSHPAE-VGRCVQIGLLCVQHQPADRPNTLELLSMLTTTSDLPLPKQ 760
Query: 787 P 787
P
Sbjct: 761 P 761
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9XID3 | Y1343_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6362 | 0.9096 | 0.9348 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00001735001 | SubName- Full=Chromosome chr18 scaffold_121, whole genome shotgun sequence; (849 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 852 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-49 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-48 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-46 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-44 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-34 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-34 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-31 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-27 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-27 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-26 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-26 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-25 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-25 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-24 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-22 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-19 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-19 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-17 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 3e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-12 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 2e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-11 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 2e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-06 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 8e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-04 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 4e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-04 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 5e-04 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 5e-04 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 6e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 8e-04 | |
| TIGR03895 | 602 | TIGR03895, protease_PatA, cyanobactin maturation p | 0.001 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 0.002 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.003 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 1e-49
Identities = 73/205 (35%), Positives = 105/205 (51%), Gaps = 16/205 (7%)
Query: 503 FKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEG---IEQGEKQFRMEVATISSTHHLNLVR 558
KLG+G FG VY+ +VAVK L+ + ++ R E+ + H N+VR
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 559 LVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618
L+ + H LV E+ + G L ++L L+ IAL RG+ YLH
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYLSRG-----GPLSEDEAKKIALQILRGLEYLHSN 117
Query: 619 CRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLA 678
I+H D+KPENILLDEN K++DFGLAK + LT+ GT Y+APE L
Sbjct: 118 G---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS---LTTFVGTPWYMAPEVLL 171
Query: 679 -NLPITSKSDVYSYGMVLLEIVSGR 702
K DV+S G++L E+++G+
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 5e-49
Identities = 69/197 (35%), Positives = 99/197 (50%), Gaps = 15/197 (7%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVKQL--EGIEQGEKQFRMEVATISSTHHLNLVRLVGFS 563
LG GGFG VY VA+K + E ++ E+ + +H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 564 SEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCI 623
+ H LV E+ + GSL + L NE L+ I L G+ YLH I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK----LSEDEILRILLQILEGLEYLHSN---GI 113
Query: 624 VHCDIKPENILLDE-NYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPE-WLANLP 681
+H D+KPENILLD N K++DFGL+KL+ L ++ GT Y+APE L
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK---SLLKTIVGTPAYMAPEVLLGKGY 170
Query: 682 ITSKSDVYSYGMVLLEI 698
+ KSD++S G++L E+
Sbjct: 171 YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 1e-48
Identities = 88/293 (30%), Positives = 133/293 (45%), Gaps = 57/293 (19%)
Query: 503 FKDKLGAGGFGAVYRGVL-----ANRTVVAVKQL-EGIEQGEKQ-FRMEVATISSTHHLN 555
KLG G FG VY+G L T VAVK L EG + E++ F E + + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 556 LVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYL 615
+VRL+G ++G+ +V E+M G L +FL + E L + +AL A+G+ YL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEYL 118
Query: 616 HEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH---RHRTLTSVRGTRGYL 672
++ + H D+ N L+ EN K+SDFGL++ I D+ R ++ ++
Sbjct: 119 ES--KNFV-HRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WM 171
Query: 673 APEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEVSQETNRKKFSLWAYEEFE 725
APE L + TSKSDV+S+G++L EI + G N EV E E
Sbjct: 172 APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV-------------LELLE 218
Query: 726 KGNVKGIVDKSLA---GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQML 775
G L ++ ++M C P RP ++V+ L
Sbjct: 219 DGYR-------LPRPENCPDELYELMLQ------CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 9e-47
Identities = 86/290 (29%), Positives = 130/290 (44%), Gaps = 51/290 (17%)
Query: 503 FKDKLGAGGFGAVYRGVL-----ANRTVVAVKQL--EGIEQGEKQFRMEVATISSTHHLN 555
KLG G FG VY+G L VAVK L + EQ ++F E + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 556 LVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYL 615
+V+L+G +E + ++V E+M G L ++L N K L+ + AL ARG+ YL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYL 119
Query: 616 HEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRG---YL 672
+ +H D+ N L+ EN K+SDFGL++ + D V+G + ++
Sbjct: 120 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD-----YYKVKGGKLPIRWM 171
Query: 673 APEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEVSQETNRKKFSLWAYEEFE 725
APE L TSKSDV+S+G++L EI + G N EV E +
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEV-------------LEYLK 218
Query: 726 KGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQML 775
KG ++ ++M C E P RP ++V++L
Sbjct: 219 KGYRLPKPPNCPP----ELYKLML------QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 1e-46
Identities = 66/203 (32%), Positives = 105/203 (51%), Gaps = 15/203 (7%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQL--EGIEQGEKQFRMEVATISSTHHLNLVRL 559
+KLG G FG VY +VA+K + + I++ ++ E+ + H N+VRL
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
+ LV E+ + G L + L G+L ++RF + YLH +
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLLKKR----GRLSEDEARF-YLRQILSALEYLHSKG 117
Query: 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN 679
IVH D+KPENILLDE+ + K++DFGLA+ ++P LT+ GT Y+APE L
Sbjct: 118 ---IVHRDLKPENILLDEDGHVKLADFGLARQLDP----GEKLTTFVGTPEYMAPEVLLG 170
Query: 680 LPITSKSDVYSYGMVLLEIVSGR 702
D++S G++L E+++G+
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 2e-46
Identities = 84/290 (28%), Positives = 127/290 (43%), Gaps = 52/290 (17%)
Query: 503 FKDKLGAGGFGAVYRGVL-----ANRTVVAVKQL--EGIEQGEKQFRMEVATISSTHHLN 555
KLG G FG VY+G L + VAVK L + EQ ++F E + H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 556 LVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYL 615
+V+L+G +E + +V E+M+ G L ++L N L+ + AL ARG+ YL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP----KLSLSDLLSFALQIARGMEYL 118
Query: 616 HEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRG---YL 672
+ +H D+ N L+ EN K+SDFGL++ + D RG + ++
Sbjct: 119 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD-----YYRKRGGKLPIRWM 170
Query: 673 APEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEVSQETNRKKFSLWAYEEFE 725
APE L TSKSDV+S+G++L EI + G N EV E +
Sbjct: 171 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV-------------LEYLK 217
Query: 726 KGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQML 775
G ++ +M C E P RP ++V++L
Sbjct: 218 NGYRLPQPPNCPP----ELYDLML------QCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 1e-44
Identities = 84/295 (28%), Positives = 131/295 (44%), Gaps = 56/295 (18%)
Query: 505 DKLGAGGFGAVYRGVL----ANRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVR 558
KLG G FG VY+G L T VAVK L+ E+ K F E + H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 559 LVGFSSEGKHRLLVYEFMKNGSLDNFL----FANEEGSGKLLNWQSRFNIALGTARGITY 614
L+G +E + LV E+M+ G L ++L L+ + + A+ A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH---RHRTLTSVRGTRGY 671
L + VH D+ N L+ E+ K+SDFGL++ + D+ + +R +
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 672 LAPEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEVSQ---ETNRKKFSLWAY 721
+APE L + TSKSDV+S+G++L EI + G N EV + + R +
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCP 233
Query: 722 EEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776
+E + ++M C Q P RP ++V+ LE
Sbjct: 234 DE--------------------LYELML------SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 506 KLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQ---FRMEVATISSTHHLNLVRLVG 561
LG G FG+VY + ++AVK +E E++ E+ +SS H N+VR G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 562 F--SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTA---RGITYLH 616
E + E++ GSL + L + GKL I T G+ YLH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLL----KKFGKL----PEPVIRKYTRQILEGLAYLH 118
Query: 617 EECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEW 676
IVH DIK NIL+D + K++DFG AK + + T SVRGT ++APE
Sbjct: 119 SNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT-GSVRGTPYWMAPEV 174
Query: 677 LANLPITSKSDVYSYGMVLLEIVSGRR 703
+ +D++S G ++E+ +G+
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 503 FKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGF 562
+G G FG V G + V AVK L+ + F E + +++ H NLV+L+G
Sbjct: 10 LGATIGKGEFGDVMLGDYRGQKV-AVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 563 SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC 622
+G +V E+M GSL ++L + ++ + AL G+ YL E+
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGR---AVITLAQQLGFALDVCEGMEYLEEK---N 122
Query: 623 IVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPI 682
VH D+ N+L+ E+ AKVSDFGLAK + + S + + APE L
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS------QGQDSGKLPVKWTAPEALREKKF 176
Query: 683 TSKSDVYSYGMVLLEIVS-GR 702
++KSDV+S+G++L EI S GR
Sbjct: 177 STKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 78/226 (34%), Positives = 111/226 (49%), Gaps = 15/226 (6%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHL 554
E+ R + + KLGAG FG V+ G T VAVK L+ + F E + H
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHD 61
Query: 555 NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
LV+L SE + +V E+M GSL +FL + G GK L ++A A G+ Y
Sbjct: 62 KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFL---KSGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAP 674
L E +H D+ NIL+ EN K++DFGLA+LI +D + + + AP
Sbjct: 119 L-ESRN--YIHRDLAARNILVGENLVCKIADFGLARLI--EDDEYTAREGAKFPIKWTAP 173
Query: 675 EWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEVSQETNR 713
E T KSDV+S+G++L EIV+ G N EV ++ R
Sbjct: 174 EAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 76/229 (33%), Positives = 115/229 (50%), Gaps = 21/229 (9%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHL 554
E+ R++ KLGAG FG V+ G+ N T VAVK L+ K F E + H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61
Query: 555 NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
L++L + + +V E MK GSL +L + G+G+ L ++A A G+ Y
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYL---QGGAGRALKLPQLIDMAAQVASGMAY 118
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR---GY 671
L E ++ I H D+ N+L+ EN KV+DFGLA++I + R G + +
Sbjct: 119 L--EAQNYI-HRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE-----GAKFPIKW 170
Query: 672 LAPEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEVSQETNR 713
APE + KSDV+S+G++L EIV+ G N EV Q+ ++
Sbjct: 171 TAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ 219
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 5e-29
Identities = 74/213 (34%), Positives = 108/213 (50%), Gaps = 19/213 (8%)
Query: 506 KLGAGGFGAVYRGVLANRTVVAVKQL----EGIEQGEKQFRMEVATISS-THHLNLVRLV 560
KLG G FG VY +R +VA+K L E + ++F E+ ++S H N+V+L
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620
F + LV E++ GSL++ L + G L+ I + YLH +
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLL--KKIGRKGPLSESEALFILAQILSALEYLHSKG- 121
Query: 621 DCIVHCDIKPENILLDENYN-AKVSDFGLAKLINPKD---HRHRTLTSVRGTRGYLAPEW 676
I+H DIKPENILLD + K+ DFGLAKL+ ++ GT GY+APE
Sbjct: 122 --IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 677 LANL---PITSKSDVYSYGMVLLEIVSGRRNFE 706
L L +S SD++S G+ L E+++G FE
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFE 212
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 73/230 (31%), Positives = 115/230 (50%), Gaps = 23/230 (10%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEG-IEQGEKQFRMEVATISSTHH 553
E R + KLG+G FG V+ G+ NR VA+K L+ ++ F+ EV + H
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRH 61
Query: 554 LNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGIT 613
+L+ L S G+ ++ E M+ GSL FL + E G++L S ++A A G+
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPE---GQVLPVASLIDMACQVAEGMA 118
Query: 614 YLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH---RHRTLTSVRGTRG 670
YL E+ +H D+ NIL+ E+ KV+DFGLA+LI K+ + T
Sbjct: 119 YLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWT-- 171
Query: 671 YLAPEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEVSQETNR 713
APE ++ ++KSDV+S+G++L E+ + G N EV +
Sbjct: 172 --APEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA 219
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 68/204 (33%), Positives = 103/204 (50%), Gaps = 22/204 (10%)
Query: 507 LGAGGFGAVYRGVLA----NRTVVAVKQLEGIEQGEKQ---FRMEVATISSTHHLNLVRL 559
+G G FG V RG L VA+K L+ +KQ F E + + H N++RL
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS-DKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
G ++ + +++ E+M+NGSLD FL N+ + G A G+ YL E
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLRENDGK----FTVGQLVGMLRGIASGMKYLSEM- 125
Query: 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTL---TSVRGTRGYLAPEW 676
VH D+ NIL++ N KVSDFGL++ + + + T +R T APE
Sbjct: 126 --NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEA 179
Query: 677 LANLPITSKSDVYSYGMVLLEIVS 700
+A TS SDV+S+G+V+ E++S
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 23/208 (11%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQ--LEGIEQGE-KQFRMEVATISSTHHLNLVR 558
D +G G FG VY+G+ L VA+KQ LE I++ K E+ + + H N+V+
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 559 LVGFSSEGKHRLLVYEFMKNGSLDNFLFA----NEEGSGKLLNWQSRFNIALGTARGITY 614
+G ++ E+ +NGSL + E + + + G A Y
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYV-----YQVLQGLA----Y 114
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAP 674
LHE+ ++H DIK NIL ++ K++DFG+A +N SV GT ++AP
Sbjct: 115 LHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK---DDASVVGTPYWMAP 168
Query: 675 EWLANLPITSKSDVYSYGMVLLEIVSGR 702
E + ++ SD++S G ++E+++G
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 504 KDKLGAGGFGAVYRG-VLANRTVVAVKQLEGIEQGEKQ---FRMEVATISSTHHLNLVRL 559
+K+G GGFG VY+ VA+K ++ +E EK+ E+ + H N+V+
Sbjct: 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIK-LESKEKKEKIIN-EIQILKKCKHPNIVKY 62
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
G + +V EF GSL + L + + + L + +G+ YLH
Sbjct: 63 YGSYLKKDELWIVMEFCSGGSLKDLL----KSTNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN 679
I+H DIK NILL + K+ DFGL+ ++ R+ + GT ++APE +
Sbjct: 119 ---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV----GTPYWMAPEVING 171
Query: 680 LPITSKSDVYSYGMVLLEIVSGR 702
P K+D++S G+ +E+ G+
Sbjct: 172 KPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 82/311 (26%), Positives = 128/311 (41%), Gaps = 65/311 (20%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQLEGIEQGEK--QFRMEVA 546
EL R +LG G FG VY G+ T VA+K + + +F E +
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEAS 61
Query: 547 TISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFA----NEEGSG-------KL 595
+ + ++VRL+G S G+ L+V E M G L ++L + E G K
Sbjct: 62 VMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121
Query: 596 LNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655
+ A A G+ YL + VH D+ N ++ E+ K+ DFG+ + I
Sbjct: 122 IQM------AAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYET 172
Query: 656 DHRHRT---LTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNF 705
D+ + L VR ++APE L + T+KSDV+S+G+VL E+ + G N
Sbjct: 173 DYYRKGGKGLLPVR----WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE 228
Query: 706 EVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQR 765
EV +F G +D + ++MR C Q P R
Sbjct: 229 EVL--------------KFVIDG--GHLDLP-ENCPDKLLELMRM------CWQYNPKMR 265
Query: 766 PMMGKVVQMLE 776
P ++V L+
Sbjct: 266 PTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-27
Identities = 82/291 (28%), Positives = 134/291 (46%), Gaps = 41/291 (14%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRT-VVAVKQLEGIEQGEKQFRMEVATISSTHH 553
E++R+ K KLG G +G VY GV + VAVK L+ ++F E A + H
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 61
Query: 554 LNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGIT 613
NLV+L+G + ++ EFM G+L ++L + +N +A + +
Sbjct: 62 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR---QEVNAVVLLYMATQISSAME 118
Query: 614 YLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR---G 670
YL E ++ I H D+ N L+ EN+ KV+DFGL++L+ T T+ G +
Sbjct: 119 YL--EKKNFI-HRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAGAKFPIK 170
Query: 671 YLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730
+ APE LA + KSDV+++G++L EI + + + Y + V
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT---------------YGMSPYPGIDLSQVY 215
Query: 731 GIVDKSL-----AGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776
+++K G + ++MRA C Q PS RP ++ Q E
Sbjct: 216 ELLEKGYRMERPEGCPPKVYELMRA------CWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 75/279 (26%), Positives = 122/279 (43%), Gaps = 52/279 (18%)
Query: 504 KDKLGAGGFGAVYRGV-LANRTVVAVKQ--LEGIEQGEKQFRM-EVATISSTHHLNLVRL 559
++G G FG VY ++ + +K+ L + + E++ + EV + +H N+++
Sbjct: 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKL------LNWQSRF-NIALGTARGI 612
E +V E+ G L + ++ GK L+W F + L +
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKI-KKQKKEGKPFPEEQILDW---FVQLCLA----L 116
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK-LINPKDHRHRTLTSVRGTRGY 671
YLH + I+H DIKP+NI L N K+ DFG++K L + D +V GT Y
Sbjct: 117 KYLHSR-K--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL----AKTVVGTPYY 169
Query: 672 LAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731
L+PE N P KSD++S G VL E+ + + FE N+
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKH-------------------PFEGENLLE 210
Query: 732 IVDKSLAGEDVDIE----QVMRAIQVSFWCIQEQPSQRP 766
+ K L G+ I +R + VS +Q+ P +RP
Sbjct: 211 LALKILKGQYPPIPSQYSSELRNL-VS-SLLQKDPEERP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 69/214 (32%), Positives = 102/214 (47%), Gaps = 24/214 (11%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGE----KQFRMEVATISSTHHLNLVRL 559
+K+G G FG VY V L ++AVK++ I+ + K+ E+ + H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIR-IQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 560 VGFSSEGKHRLLVYEFMK---NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLH 616
G HR VY FM+ G+L+ L E G + + + L G+ YLH
Sbjct: 65 YGVEV---HREKVYIFMEYCSGGTLEELL---EHGRILDEHVIRVYTLQL--LEGLAYLH 116
Query: 617 EECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI-NPKDHRHRTLTSVRGTRGYLAPE 675
IVH DIKP NI LD N K+ DFG A + N + S+ GT Y+APE
Sbjct: 117 SHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173
Query: 676 WLANLPITSK---SDVYSYGMVLLEIVSGRRNFE 706
+ +D++S G V+LE+ +G+R +
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 25/219 (11%)
Query: 506 KLGAGGFGAVYRGVLAN-----RTVVAVKQL--EGIEQGEKQFRMEVATISSTHHLNLVR 558
+LG G FG V VAVK L G EQ F E+ + + H N+V+
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 559 LVGFSSE--GKHRLLVYEFMKNGSLDNFL--FANEEGSGKLLNWQSRFNIALGTARGITY 614
G + G+ L+ E++ +GSL ++L ++ +LL F + +G+ Y
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLL----LF--SSQICKGMDY 124
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGT--RGYL 672
L + I H D+ NIL++ K+SDFGLAK++ P+D + + + Y
Sbjct: 125 LGS--QRYI-HRDLAARNILVESEDLVKISDFGLAKVL-PEDKDYYYVKEPGESPIFWY- 179
Query: 673 APEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQE 710
APE L +S SDV+S+G+ L E+ + G + E
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAE 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 83/279 (29%), Positives = 138/279 (49%), Gaps = 35/279 (12%)
Query: 507 LGAGGFGAVYRGVLA----NRTVVAVKQLEG--IEQGEKQFRMEVATISSTHHLNLVRLV 560
+GAG FG V+RG+L VA+K L+ E+ + F E + + H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620
G ++ K +++ E+M+NG+LD +L + G+ ++Q + G A G+ YL +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYL---RDHDGEFSSYQ-LVGMLRGIAAGMKYLSDM-- 126
Query: 621 DCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRG--YLAPEWLA 678
VH D+ NIL++ N KVSDFGL++++ +D T T+ G + APE +A
Sbjct: 127 -NYVHRDLAARNILVNSNLECKVSDFGLSRVL--EDDPEGTYTTSGGKIPIRWTAPEAIA 183
Query: 679 NLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSL 737
TS SDV+S+G+V+ E++S G R + W E +K I D
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSFGERPY-------------WDMSNHEV--MKAINDGFR 228
Query: 738 AGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776
+D + Q+ C Q+ ++RP +V +L+
Sbjct: 229 LPAPMDCPSAVY--QLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 74/209 (35%), Positives = 111/209 (53%), Gaps = 18/209 (8%)
Query: 507 LGAGGFGAVYRGVLA----NRTVVAVKQLEG--IEQGEKQFRMEVATISSTHHLNLVRLV 560
+GAG FG V RG L VA+K L+ E+ + F E + + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620
G ++ + +++ EFM+NG+LD+FL N+ G+ Q + G A G+ YL E
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQND---GQFTVIQ-LVGMLRGIAAGMKYLSEM-- 125
Query: 621 DCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR---GYLAPEWL 677
VH D+ NIL++ N KVSDFGL++ + D T TS G + + APE +
Sbjct: 126 -NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE-DDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 678 ANLPITSKSDVYSYGMVLLEIVS-GRRNF 705
A TS SDV+SYG+V+ E++S G R +
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERPY 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 69/242 (28%), Positives = 113/242 (46%), Gaps = 34/242 (14%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQLEGI--EQGEKQFRMEVA 546
+QR T K +LG G FG V+ G + + +VAVK L+ K F E
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAE 60
Query: 547 TISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFL--------FANEEGSGKL-LN 597
+++ H N+V+ G +EG ++V+E+M++G L+ FL F S L
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 598 WQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657
IA+ A G+ YL + VH D+ N L+ + K+ DFG+++ + D+
Sbjct: 121 LSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY 177
Query: 658 RH---RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEV 707
T+ +R ++ PE + T++SDV+S+G+VL EI + G N EV
Sbjct: 178 YRVGGHTMLPIR----WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV 233
Query: 708 SQ 709
+
Sbjct: 234 IE 235
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 66/215 (30%), Positives = 110/215 (51%), Gaps = 31/215 (14%)
Query: 507 LGAGGFGAVYRGVLA--NRTV---VAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRL 559
LG+G FG VY+GV V VA+K L + K+ E ++S H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEE--GSGKLLNWQSRFNIALGTARGITYLHE 617
+G L+ + M G L +++ +++ GS LLNW + A+G++YL E
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYL-E 126
Query: 618 ECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRG-----YL 672
E R +VH D+ N+L+ + K++DFGLAKL++ + G ++
Sbjct: 127 EKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE------KEYHAEGGKVPIKWM 178
Query: 673 APEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFE 706
A E + + T KSDV+SYG+ + E+++ G + +E
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 76/229 (33%), Positives = 114/229 (49%), Gaps = 22/229 (9%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHL 554
E+ R T KLGAG FG V+ G T VA+K L+ + F E + H
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHP 61
Query: 555 NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
LVRL ++ + ++ E+M+NGSL +FL E G L ++A A G+ +
Sbjct: 62 RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAF 117
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR---GY 671
+ E ++ I H D++ NIL+ E K++DFGLA+LI ++ T+ G + +
Sbjct: 118 I--ERKNYI-HRDLRAANILVSETLCCKIADFGLARLIEDNEY-----TAREGAKFPIKW 169
Query: 672 LAPEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEVSQETNR 713
APE + T KSDV+S+G++L EIV+ G N EV Q R
Sbjct: 170 TAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER 218
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 84/295 (28%), Positives = 136/295 (46%), Gaps = 47/295 (15%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVL---ANR---TVVAVKQLEGIEQGEKQ--FRMEVA 546
E+ S F ++LG G FG VY+G L R T VA+K L+ + + Q FR E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60
Query: 547 TISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFL----------FANEEGSGKLL 596
+S H N+V L+G ++ + +++E++ +G L FL + + + K
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 597 NWQSRF-NIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655
S F +IA+ A G+ YL VH D+ N L+ E K+SDFGL++ I
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177
Query: 656 DH---RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETN 712
D+ + ++L VR ++ PE + T++SD++S+G+VL EI S
Sbjct: 178 DYYRVQSKSLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEIFS------------ 221
Query: 713 RKKFSLWAYEEFEKGNV-KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP 766
+ L Y F V + I + L D + A+ + W E P++RP
Sbjct: 222 ---YGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECW--NEIPARRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 62/234 (26%), Positives = 102/234 (43%), Gaps = 37/234 (15%)
Query: 503 FKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI----EQGEKQFRMEVATISS-THHLNL 556
F +G G F V A+K L+ E+ K ++E ++ H +
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 557 VRLVG-FSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
++L F E L V E+ NG L ++ + GS L+ + A + Y
Sbjct: 65 IKLYYTFQDEEN--LYFVLEYAPNGELLQYI--RKYGS---LDEKCTRFYAAEILLALEY 117
Query: 615 LHEECRDC-IVHCDIKPENILLDENYNAKVSDFGLAKLINPKD----------------- 656
LH I+H D+KPENILLD++ + K++DFG AK+++P
Sbjct: 118 LH----SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQE 710
R S GT Y++PE L P SD+++ G ++ ++++G+ F S E
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 69/201 (34%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 507 LGAGGFGAVYRGVL---ANRTV-VAVKQL--EGIEQGEKQFRMEVATISSTHHLNLVRLV 560
LG G FG+V +GV + + V VAVK L E I G+K+F E + ++ H +VRL+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGS-GKLLNWQSRFNIALGTARGITYLHEEC 619
G +G+ +LV E G L +L E L A A G+ YL E
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYL-ESK 114
Query: 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN 679
VH D+ N+LL + AK+SDFG+++ + +R T+ R + APE +
Sbjct: 115 H--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 680 LPITSKSDVYSYGMVLLEIVS 700
+SKSDV+SYG+ L E S
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-25
Identities = 91/285 (31%), Positives = 141/285 (49%), Gaps = 39/285 (13%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHL 554
LQ+ T G + +G G FGAV +G + V AVK ++ + + F E A ++ HH
Sbjct: 4 NLQKLTLG--EIIGEGEFGAVLQGEYTGQKV-AVKNIK-CDVTAQAFLEETAVMTKLHHK 59
Query: 555 NLVRLVG-FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGK-LLNWQSRFNIALGTARGI 612
NLVRL+G G + +V E M G+L NFL G+ L++ +L A G+
Sbjct: 60 NLVRLLGVILHNGLY--IVMELMSKGNLVNFL----RTRGRALVSVIQLLQFSLDVAEGM 113
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYL 672
YL + +VH D+ NIL+ E+ AKVSDFGLA+ + + + + +
Sbjct: 114 EYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLAR-VGS-----MGVDNSKLPVKWT 164
Query: 673 APEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731
APE L + +SKSDV+SYG++L E+ S GR + K SL +E ++ KG
Sbjct: 165 APEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY--------PKMSL---KEVKECVEKG 213
Query: 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776
+ G D+ +M + C + +P +RP K+ + LE
Sbjct: 214 YRMEPPEGCPADVYVLMTS------CWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 69/208 (33%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 507 LGAGGFGAVYRGV--LANRTVVAVKQLEG----IEQGEKQFRMEVATISSTHHLNLVRLV 560
LG G FG V V + A+K L+ + + E +S +H +V+L
Sbjct: 1 LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 561 -GFSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIA-LGTARGITYLHE 617
F +E K L LV E+ G L + L ++EG + ++RF A + A + YLH
Sbjct: 60 YAFQTEEK--LYLVLEYAPGGELFSHL--SKEG--RFSEERARFYAAEIVLA--LEYLHS 111
Query: 618 ECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWL 677
I++ D+KPENILLD + + K++DFGLAK + RT T GT YLAPE L
Sbjct: 112 LG---IIYRDLKPENILLDADGHIKLTDFGLAKEL--SSEGSRTNTFC-GTPEYLAPEVL 165
Query: 678 ANLPITSKSDVYSYGMVLLEIVSGRRNF 705
D +S G++L E+++G+ F
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKPPF 193
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 80/277 (28%), Positives = 133/277 (48%), Gaps = 31/277 (11%)
Query: 507 LGAGGFGAVYRGVL---ANRTV-VAVKQLEG--IEQGEKQFRMEVATISSTHHLNLVRLV 560
+GAG FG V G L R + VA+K L+ E+ + F E + + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620
G ++ K ++V E+M+NGSLD FL ++ G+ Q + G A G+ YL +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHD---GQFTVIQ-LVGMLRGIASGMKYLSDM-- 125
Query: 621 DCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL 680
VH D+ NIL++ N KVSDFGL++++ T + + APE +A
Sbjct: 126 -GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 681 PITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAG 739
TS SDV+SYG+V+ E++S G R + +E + +K I +
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERPY---------------WEMSNQDVIKAIEEGYRLP 229
Query: 740 EDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776
+D + + + W Q+ ++RP ++V +L+
Sbjct: 230 APMDCPAALHQLMLDCW--QKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 81/226 (35%), Positives = 106/226 (46%), Gaps = 34/226 (15%)
Query: 507 LGAGGFGAVYRGVLANRTV------VAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVR 558
LG G FG VY G+ R VAVK L EQ E F ME +S +H N+VR
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 559 LVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGK--LLNWQSRFNIALGTARGITYLH 616
L+G S E R ++ E M G L +FL N + L + A A+G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL- 132
Query: 617 EECRDCIVHCDIKPENILLD---ENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLA 673
EE +H DI N LL AK++DFG+A+ I +R +G R L
Sbjct: 133 EENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDI------YRASYYRKGGRAMLP 184
Query: 674 PEWL---ANLP--ITSKSDVYSYGMVLLEIVS-------GRRNFEV 707
+W+ A L TSK+DV+S+G++L EI S GR N EV
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 65/219 (29%), Positives = 96/219 (43%), Gaps = 28/219 (12%)
Query: 506 KLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGE--KQFRMEVATISSTHHLNLVRLVG- 561
+LG G G+V + L + A+K + + KQ E+ S +V+ G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 562 FSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFN------IALGTARGITY 614
F E + + E+ + GSLD+ K+ R IA +G++Y
Sbjct: 68 FLDESSSSIGIAMEYCEGGSLDSIY-------KKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA-KLINPKDHRHRTLTSVRGTRGYLA 673
LH I+H DIKP NILL K+ DFG++ +L+N T T GT Y+A
Sbjct: 121 LHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA---GTFT---GTSFYMA 171
Query: 674 PEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETN 712
PE + P + SDV+S G+ LLE+ R F E
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP 210
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 67/206 (32%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 505 DKLGAGGFGAVYRGVLANRTVVAVK--QLEGIEQGEKQFRMEVATISSTHHLNLVRLVGF 562
+K+G G FG VY+GVL T VAVK + +++F E + H N+V+L+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 563 SSEGKHRLLVYEFMKNGSLDNFLFANEEG--SGKLLNWQSRFNIALGTARGITYLHEECR 620
+ + +V E + GSL FL + KLL ++L A G+ YL E +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLL------QMSLDAAAGMEYL--ESK 112
Query: 621 DCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRG-----YLAPE 675
+CI H D+ N L+ EN K+SDFG+++ + +V + APE
Sbjct: 113 NCI-HRDLAARNCLVGENNVLKISDFGMSR------EEEGGIYTVSDGLKQIPIKWTAPE 165
Query: 676 WLANLPITSKSDVYSYGMVLLEIVSG 701
L TS+SDV+SYG++L E S
Sbjct: 166 ALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 22/221 (9%)
Query: 503 FKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGF 562
F +LG+G FG V+ G + VA+K + E F E + H NLV+L G
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 563 SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC 622
++ + +V E+M NG L N+L + L + ++ + YL +
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLRERKG----KLGTEWLLDMCSDVCEAMEYLE---SNG 120
Query: 623 IVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR---GYLAPEWLAN 679
+H D+ N L+ E+ KVSDFGLA+ + + TS +GT+ + PE
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-----TSSQGTKFPVKWAPPEVFDY 175
Query: 680 LPITSKSDVYSYGMVLLEIVS-------GRRNFEVSQETNR 713
+SKSDV+S+G+++ E+ S N EV + +
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 72/280 (25%), Positives = 124/280 (44%), Gaps = 36/280 (12%)
Query: 502 GFK--DKLGAGGFGAVYR-GVLANRTVVAVKQ--LEGIEQGEKQFRM-EVATISSTHHLN 555
FK KLG G +G+VY+ L++ A+K+ L + Q E++ + E+ ++S +H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 556 LVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYL 615
++ +G +V E+ G L + + + KL+ Q + I + RG+ L
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAI-SKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 616 HEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPE 675
HE+ I+H D+K NILL N K+ D G++K++ + + GT Y+APE
Sbjct: 120 HEQK---ILHRDLKSANILLVANDLVKIGDLGISKVL-----KKNMAKTQIGTPHYMAPE 171
Query: 676 WLANLPITSKSDVYSYGMVLLEIVSGRRNFEVS--QETNRKKFSLWAYEEFEKGNVKGIV 733
P + KSD++S G +L E+ + FE Q+ K G
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR-------------GKY 218
Query: 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773
D++ +R +Q +P RP K++
Sbjct: 219 PPIPPIYSQDLQNFIR------SMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 85/300 (28%), Positives = 136/300 (45%), Gaps = 55/300 (18%)
Query: 507 LGAGGFGAVYR----GVLANR--TVVAVKQL--EGIEQGEKQFRMEVATISSTHHLNLVR 558
+G G FG V++ G+L T+VAVK L E + F+ E A ++ H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 559 LVGFSSEGKHRLLVYEFMKNGSLDNFLFAN----------------EEGSGKL-LNWQSR 601
L+G + GK L++E+M G L+ FL + G L L+ +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 602 FNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRT 661
IA A G+ YL E VH D+ N L+ EN K++DFGL++ I D+ +
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 662 LTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWA 720
R ++ PE + T++SDV++YG+VL EI S G + + + + A
Sbjct: 190 ENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY----------YGM-A 237
Query: 721 YEE----FEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776
+EE GNV D +++ +MR C + PS RP + ++L+
Sbjct: 238 HEEVIYYVRDGNVLSCPD----NCPLELYNLMRL------CWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-23
Identities = 72/226 (31%), Positives = 114/226 (50%), Gaps = 15/226 (6%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHL 554
E+ R + KLGAG FG V+ G N T VAVK L+ + F E + + H
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD 61
Query: 555 NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
LVRL ++ + ++ E+M GSL +FL ++EG LL F+ + A G+ Y
Sbjct: 62 KLVRLYAVVTKEEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQI--AEGMAY 118
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAP 674
+ R +H D++ N+L+ E+ K++DFGLA++I +D+ + + + AP
Sbjct: 119 IE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAP 173
Query: 675 EWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEVSQETNR 713
E + T KSDV+S+G++L EIV+ G N +V R
Sbjct: 174 EAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-23
Identities = 73/280 (26%), Positives = 125/280 (44%), Gaps = 39/280 (13%)
Query: 503 FKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGF 562
++G+G FG V+ G + VA+K + E+ F E + H LV+L G
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 563 SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC 622
+E LV+EFM++G L ++L A + ++ + L G+ YL
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLES---SN 120
Query: 623 IVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPI 682
++H D+ N L+ EN KVSDFG+ + + D ++ + T + + +PE +
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFV--LDDQYTSSTGTKFPVKWSSPEVFSFSKY 178
Query: 683 TSKSDVYSYGMVLLEIVS-------GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735
+SKSDV+S+G+++ E+ S R N EV + N F L+
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-AGFRLY--------------KP 223
Query: 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQML 775
LA + V ++M+ C +E+P RP ++ L
Sbjct: 224 RLASQSV--YELMQ------HCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 6e-23
Identities = 75/226 (33%), Positives = 111/226 (49%), Gaps = 16/226 (7%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHL 554
E+ R + KLG G FG V+ G T VA+K L+ + F E + H
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHD 61
Query: 555 NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
LV L SE + +V EFM GSL +FL +EG GK L ++A A G+ Y
Sbjct: 62 KLVPLYAVVSE-EPIYIVTEFMGKGSLLDFL---KEGDGKYLKLPQLVDMAAQIADGMAY 117
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAP 674
+ R +H D++ NIL+ +N K++DFGLA+LI +D+ + + + AP
Sbjct: 118 IE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAP 172
Query: 675 EWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEVSQETNR 713
E T KSDV+S+G++L E+V+ G N EV ++ R
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER 218
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 7e-23
Identities = 72/226 (31%), Positives = 112/226 (49%), Gaps = 16/226 (7%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHL 554
E+ R + KLG G FG V+ G T VAVK L+ + F E + H
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHD 61
Query: 555 NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
LV+L SE + +V E+M GSL +FL ++G G+ L + ++A A G+ Y
Sbjct: 62 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL---KDGEGRALKLPNLVDMAAQVAAGMAY 117
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAP 674
+ R +H D++ NIL+ + K++DFGLA+LI +D+ + + + AP
Sbjct: 118 IE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAP 172
Query: 675 EWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEVSQETNR 713
E T KSDV+S+G++L E+V+ G N EV ++ R
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 218
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 505 DKLGAGGFGAVYRGVLANRT--VVAVK--QLEGIEQGEKQFRMEVATISSTHHLNLVRLV 560
LG G G VY+ T + A+K ++G E+ KQ E+ T+ S +V+
Sbjct: 7 KVLGQGSSGVVYKVRHK-PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCY 65
Query: 561 G-FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTA---RGITYLH 616
G F EG+ + V E+M GSL + L K+ +A +G+ YLH
Sbjct: 66 GAFYKEGEISI-VLEYMDGGSLADLL-------KKVGKIPEPV-LAYIARQILKGLDYLH 116
Query: 617 EECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEW 676
+ I+H DIKP N+L++ K++DFG++K++ + T GT Y++PE
Sbjct: 117 TKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV---GTVTYMSPER 171
Query: 677 LANLPITSKSDVYSYGMVLLEIVSGR 702
+ + +D++S G+ LLE G+
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 71/209 (33%), Positives = 108/209 (51%), Gaps = 30/209 (14%)
Query: 505 DKLGAGGFGAVYRGVLANRT--VVAVK--QLEGIEQGEKQFRMEVATISSTHHLNLVRLV 560
+LGAG G V + VL T ++AVK +LE E +KQ E+ + + +V
Sbjct: 7 GELGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 561 G-FSSEGKHRLLVYEFMKNGSLDNFL-----FANEEGSGKLLNWQSRFNIALGTARGITY 614
G F + G + + E+M GSLD L E GK IA+ +G+TY
Sbjct: 66 GAFYNNGDISICM-EYMDGGSLDKILKEVQGRIPERILGK---------IAVAVLKGLTY 115
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA-KLINPKDHRHRTLTSVRGTRGYLA 673
LHE+ + I+H D+KP NIL++ K+ DFG++ +L+N T V GT Y+A
Sbjct: 116 LHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL-----AKTFV-GTSSYMA 167
Query: 674 PEWLANLPITSKSDVYSYGMVLLEIVSGR 702
PE + + KSD++S G+ L+E+ +GR
Sbjct: 168 PERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 1e-22
Identities = 84/295 (28%), Positives = 140/295 (47%), Gaps = 47/295 (15%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVL-----ANRTVVAVKQLEGIEQGEK--QFRMEVAT 547
EL S F ++LG FG +Y+G L + +VA+K L+ I ++ +F+ E +
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 548 ISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLF-----------ANEEGSGK-L 595
++ HH N+V L+G ++ + +++E++ G L FL ++E+G+ K
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 596 LNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655
L+ +IA+ A G+ YL VH D+ NIL+ E + K+SD GL++ I
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 656 DH---RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETN 712
D+ + ++L +R ++ PE + +S SD++S+G+VL EI S
Sbjct: 178 DYYRVQPKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS------------ 221
Query: 713 RKKFSLWAYEEFEKGNVKGIVDK-SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP 766
F L Y F V +V K L D M ++ W QE PS+RP
Sbjct: 222 ---FGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECW--QEGPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-22
Identities = 66/228 (28%), Positives = 109/228 (47%), Gaps = 33/228 (14%)
Query: 496 LQRSTKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQL-EGIEQGEKQFRMEVATI 548
++R K +LG G FG V+ N + +VAVK L E E + F+ E +
Sbjct: 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 61
Query: 549 SSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFAN-------EEGSGKL---LNW 598
+ H ++VR G +EG+ L+V+E+M++G L+ FL ++ G L
Sbjct: 62 TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121
Query: 599 QSRFNIALGTARGITY---LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655
IA A G+ Y LH VH D+ N L+ + K+ DFG+++ I
Sbjct: 122 GQMLAIASQIASGMVYLASLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 175
Query: 656 DHRH---RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS 700
D+ RT+ +R ++ PE + T++SD++S+G+VL EI +
Sbjct: 176 DYYRVGGRTMLPIR----WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 13/211 (6%)
Query: 504 KDKLGAGGFGAVYRGVL-ANRTVVAVKQ--LEGIEQGEKQFRM-EVATISSTHHLNLVRL 559
+K+G G FG V++ V A++ V A+KQ L + + E++ + E ++ ++R
Sbjct: 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRY 64
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
+ +V E+ +NG L L G+ L + + G+ +LH +
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN 679
I+H DIK N+ LD N K+ D G+AKL++ + T+ GT YL+PE +
Sbjct: 122 ---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV---GTPYYLSPELCED 175
Query: 680 LPITSKSDVYSYGMVLLEIVSGRRNFEVSQE 710
P KSDV++ G+VL E +G+ F+ + +
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQ 206
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 5e-22
Identities = 70/209 (33%), Positives = 103/209 (49%), Gaps = 9/209 (4%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHL 554
E+ R + + KLG G FG V+ G T VA+K L+ + F E + H
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 61
Query: 555 NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
LV+L SE + +V E+M GSL +FL GK L ++A A G+ Y
Sbjct: 62 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAY 117
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAP 674
+ R VH D++ NIL+ EN KV+DFGLA+LI +D+ + + + AP
Sbjct: 118 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 172
Query: 675 EWLANLPITSKSDVYSYGMVLLEIVSGRR 703
E T KSDV+S+G++L E+ + R
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 69/206 (33%), Positives = 105/206 (50%), Gaps = 23/206 (11%)
Query: 507 LGAGGFGAVYRGVL----ANRTVVAVKQLEGIEQGEK--QFRMEVATISSTHHLNLVRLV 560
+G G FG VY G L + AVK L I E+ QF E + H N++ L+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 561 GFS--SEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618
G SEG L+V +MK+G L NF+ +E + + + L A+G+ YL +
Sbjct: 63 GICLPSEGS-PLVVLPYMKHGDLRNFI-RSETHNPTV---KDLIGFGLQVAKGMEYLASK 117
Query: 619 CRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD----HRHRTLTSVRGTRGYLAP 674
VH D+ N +LDE++ KV+DFGLA+ I K+ H H T + ++A
Sbjct: 118 K---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH---TGAKLPVKWMAL 171
Query: 675 EWLANLPITSKSDVYSYGMVLLEIVS 700
E L T+KSDV+S+G++L E+++
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 8e-22
Identities = 65/231 (28%), Positives = 104/231 (45%), Gaps = 34/231 (14%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVL------ANRTVVAVKQLEG--IEQGEKQFRMEVA 546
EL R LG G FG V + + VAVK L+ E+ E+
Sbjct: 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEME 67
Query: 547 TISST-HHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFAN---EEGSGKLLNWQSRF 602
+ H N++ L+G ++ +V E+ +G+L +FL A E +
Sbjct: 68 MMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE 127
Query: 603 NI--------ALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654
+ A ARG+ +L + CI H D+ N+L+ E++ K++DFGLA+ I+
Sbjct: 128 TLTQKDLVSFAYQVARGMEFL--ASKKCI-HRDLAARNVLVTEDHVMKIADFGLARDIHH 184
Query: 655 KDHRHRTLTSVRGTRGYL-----APEWLANLPITSKSDVYSYGMVLLEIVS 700
D+ +T T G L APE L + T +SDV+S+G++L EI +
Sbjct: 185 IDYYRKT------TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 506 KLGAGGFGAVYRG-VLANRTVVAVKQLEGIEQGE---KQFRMEVATISSTHHLNLVRLV- 560
+G G +G V + A +VA+K+ + E E K EV + H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSG----KLLNWQSRFNIALGTARGITYLH 616
F +G+ LV+E+++ L+ L A+ G + WQ + I Y H
Sbjct: 68 AFRRKGRL-YLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQ--------LLQAIAYCH 117
Query: 617 EECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEW 676
I+H DIKPENIL+ E+ K+ DFG A+ + + LT TR Y APE
Sbjct: 118 ---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP--LTDYVATRWYRAPEL 172
Query: 677 LANLPITSKS-DVYSYGMVLLEIVSGR 702
L K DV++ G ++ E++ G
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 67/224 (29%), Positives = 108/224 (48%), Gaps = 25/224 (11%)
Query: 507 LGAGGFGAVYRGVL-ANRTV---VAVK--QLEGIEQGE-KQFRMEVATISSTHHLNLVRL 559
LG G FG+V G L + VAVK +L+ E ++F E A + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 560 VGFSSEGKHR------LLVYEFMKNGSLDNFLFANE-EGSGKLLNWQSRFNIALGTARGI 612
+G E +++ FMK+G L +FL + G + L Q+ + A G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYL 672
YL R+ I H D+ N +L E+ V+DFGL+K I D+ + + + ++
Sbjct: 127 EYLSN--RNFI-HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-WI 182
Query: 673 APEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEVSQ 709
A E LA+ TSKSDV+++G+ + EI + G N E+
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD 226
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 9e-21
Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 29/209 (13%)
Query: 503 FKDKLGAGGFGAVYRGVLANRTV----VAVKQLEGIEQGEKQFRMEVATISSTHHLNLVR 558
+K+G G G VY+ A VA+K++ +Q ++ E+ + H N+V
Sbjct: 23 NLEKIGEGASGEVYK---ATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVD 79
Query: 559 LVGFSSEGKHRLLVYEFMKNGSL-----DNFLFANEEGSGKLLNWQSRFNIALGTARGIT 613
G +V E+M GSL NF+ NE Q + + +G+
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEP--------QIAY-VCREVLQGLE 130
Query: 614 YLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL-AKLINPKDHRHRTLTSVRGTRGYL 672
YLH ++ I H DIK +NILL ++ + K++DFG A+L K R+ SV GT ++
Sbjct: 131 YLHS--QNVI-HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN----SVVGTPYWM 183
Query: 673 APEWLANLPITSKSDVYSYGMVLLEIVSG 701
APE + K D++S G++ +E+ G
Sbjct: 184 APEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 77/278 (27%), Positives = 126/278 (45%), Gaps = 48/278 (17%)
Query: 496 LQRSTKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQL-EGIEQGEKQFRMEVATI 548
++R K +LG G FG V+ N + +VAVK L + + K F E +
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61
Query: 549 SSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFAN-------EEGSGKLLNWQSR 601
++ H ++V+ G EG ++V+E+MK+G L+ FL A+ EG+ QS+
Sbjct: 62 TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121
Query: 602 -FNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRH- 659
+IA A G+ YL + VH D+ N L+ EN K+ DFG+++ + D+
Sbjct: 122 MLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 178
Query: 660 --RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRR------NFEV--- 707
T+ +R ++ PE + T++SDV+S G+VL EI + G++ N EV
Sbjct: 179 GGHTMLPIR----WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234
Query: 708 -------------SQETNRKKFSLWAYEEFEKGNVKGI 732
+E W E + N+K I
Sbjct: 235 ITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEI 272
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 55/202 (27%), Positives = 105/202 (51%), Gaps = 14/202 (6%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVG 561
+KLG G +G+VY+ + VVA+K + +E+ ++ E++ + +V+ G
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQEIIKEISILKQCDSPYIVKYYG 65
Query: 562 FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD 621
+ +V E+ GS+ + + + + K L + I T +G+ YLH +
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSDIM----KITNKTLTEEEIAAILYQTLKGLEYLH---SN 118
Query: 622 CIVHCDIKPENILLDENYNAKVSDFGLA-KLINPKDHRHRTLTSVRGTRGYLAPEWLANL 680
+H DIK NILL+E AK++DFG++ +L + R+ +V GT ++APE + +
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN----TVIGTPFWMAPEVIQEI 174
Query: 681 PITSKSDVYSYGMVLLEIVSGR 702
+K+D++S G+ +E+ G+
Sbjct: 175 GYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 6e-20
Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGE------KQFRMEVATISSTHHLNLVRL 559
LG+G FG+VY G+ L + AVK++ + G+ KQ E+A +S H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTAR---GITYLH 616
+G E + + E + GSL L + G I L T + G+ YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPV----IRLYTRQILLGLEYLH 119
Query: 617 EECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEW 676
+ VH DIK NIL+D N K++DFG+AK + S +G+ ++APE
Sbjct: 120 DRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV----EFSFAKSFKGSPYWMAPEV 172
Query: 677 LANL-PITSKSDVYSYGMVLLEIVSGR 702
+A +D++S G +LE+ +G+
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 8e-20
Identities = 72/286 (25%), Positives = 122/286 (42%), Gaps = 39/286 (13%)
Query: 505 DKLGAGGFGAVY--RGVLANRTVVAVKQL--------EGIEQGEKQFRMEVATIS----S 550
+ LG+G FG VY R + ++A+K++ + + +K V+ ++
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 551 THHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTAR 610
H N+VR E +V + ++ L F + + + + +NI +
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 611 GITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRG 670
+ YLH+E R IVH D+ P NI+L E+ ++DFGLAK P+ LTSV GT
Sbjct: 125 ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK----LTSVVGTIL 178
Query: 671 YLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQE-TNRKKFSLWAYEEFEKGNV 729
Y PE + N P K+DV+++G +L ++ + + F + + K YE
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP---- 234
Query: 730 KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQML 775
E + E V I C+ RP + +V M+
Sbjct: 235 ----------EGMYSEDVTDVIT---SCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 1e-19
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 26/209 (12%)
Query: 504 KDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQF-----RMEVATISSTHHLNLV 557
+KLG G +G VY+ +VA+K++ ++ E+ R E++ + H N+V
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIR-LDNEEEGIPSTALR-EISLLKELKHPNIV 61
Query: 558 RLVGFSSEGKHRLLVYEFMKN---GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
+L+ + LV+E+ LD K + +Q RG+ Y
Sbjct: 62 KLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQ--------LLRGLAY 113
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAP 674
H I+H D+KP+NIL++ + K++DFGLA+ RT T T Y AP
Sbjct: 114 CH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL---RTYTHEVVTLWYRAP 167
Query: 675 EWLANLPITSKS-DVYSYGMVLLEIVSGR 702
E L S + D++S G + E+++G+
Sbjct: 168 EILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 68/213 (31%), Positives = 115/213 (53%), Gaps = 18/213 (8%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHL 554
E+ R + + KLGAG FG V+ T VAVK ++ + F E + + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 61
Query: 555 NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSG----KLLNWQSRFNIALGTAR 610
LV+L ++ + ++ EFM GSL +FL ++EGS KL+++ ++ A
Sbjct: 62 KLVKLHAVVTK-EPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQI------AE 113
Query: 611 GITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRG 670
G+ ++ E R+ I H D++ NIL+ + K++DFGLA++I +D+ + +
Sbjct: 114 GMAFI--EQRNYI-HRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIK 168
Query: 671 YLAPEWLANLPITSKSDVYSYGMVLLEIVS-GR 702
+ APE + T KSDV+S+G++L+EIV+ GR
Sbjct: 169 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 87/323 (26%), Positives = 145/323 (44%), Gaps = 52/323 (16%)
Query: 493 YKELQRSTKGFKDKLGAGGFGAVYRGVLAN---RTVVAVKQLE--GIEQGEKQFRMEVAT 547
Y L+ + F+D +G G FG V + + R A+K+++ + + F E+
Sbjct: 1 YPVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60
Query: 548 ISST-HHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFL-----------FANEEGSGKL 595
+ HH N++ L+G + L E+ +G+L +FL FA +
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120
Query: 596 LNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655
L+ Q + A ARG+ YL ++ +H D+ NIL+ ENY AK++DFGL++
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----- 172
Query: 656 DHRHRTLTSVRGTRGYLAPEWLA----NLPI-TSKSDVYSYGMVLLEIVS-GRRNFEVSQ 709
V+ T G L W+A N + T+ SDV+SYG++L EIVS G +
Sbjct: 173 ----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY---- 224
Query: 710 ETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMG 769
+ E +EK ++K L +D ++ +MR C +E+P +RP
Sbjct: 225 ------CGMTCAELYEKLPQGYRLEKPLNCDD-EVYDLMRQ------CWREKPYERPSFA 271
Query: 770 KVVQMLEGITEIEKPPAPKALTE 792
+++ L + E K L E
Sbjct: 272 QILVSLNRMLEERKTYVNTTLYE 294
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 67/226 (29%), Positives = 115/226 (50%), Gaps = 33/226 (14%)
Query: 491 FSYKELQRSTKGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGI--EQGEKQFRMEV-A 546
F+ ++L+ ++G G FG V + + T++AVK++ E+ +K+ M++
Sbjct: 1 FTAEDLKD-----LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDV 55
Query: 547 TISSTHHLNLVRLVG--FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNI 604
+ S+ +V+ G F EG + E M + SLD F E ++ + I
Sbjct: 56 VMRSSDCPYIVKFYGALFR-EGDC-WICMELM-DISLDKFYKYVYEVLKSVIPEEILGKI 112
Query: 605 ALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA-KLINPKDHRHRTLT 663
A+ T + + YL EE + I+H D+KP NILLD N N K+ DFG++ +L++ ++
Sbjct: 113 AVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD-------SIA 163
Query: 664 SVR--GTRGYLAPEWLANLPITS-----KSDVYSYGMVLLEIVSGR 702
R G R Y+APE + P +SDV+S G+ L E+ +G+
Sbjct: 164 KTRDAGCRPYMAPERID--PSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 75/231 (32%), Positives = 108/231 (46%), Gaps = 19/231 (8%)
Query: 482 EYASGAPVQFSYK---ELQRSTKGFKDKLGAGGFGAVYR----GVLANRTV--VAVKQL- 531
EY P Q Y E R+ F LGAG FG V G+ + V VAVK L
Sbjct: 15 EYVYIDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK 74
Query: 532 EGIEQGEKQFRMEVATISST--HHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANE 589
E++ M I S +H N+V L+G + G L++ E+ G L NFL
Sbjct: 75 PTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR 134
Query: 590 EGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649
E L + + + A+G+ +L ++CI H D+ N+LL K+ DFGLA
Sbjct: 135 E---SFLTLEDLLSFSYQVAKGMAFL--ASKNCI-HRDLAARNVLLTHGKIVKICDFGLA 188
Query: 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS 700
+ I D + + R ++APE + N T +SDV+SYG++L EI S
Sbjct: 189 RDIM-NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 7e-19
Identities = 66/219 (30%), Positives = 114/219 (52%), Gaps = 34/219 (15%)
Query: 507 LGAGGFGAVYRGVLANR-TVVAVKQLE---GIEQGEKQFRM-------EVATISSTHHLN 555
+G+G FG+VY G+ A+ ++AVKQ+E + + R E+A + H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 556 LVRLVGFSSEGKHRLLVYEFMKNGS----LDNFLFANEEGSGKLLNWQSRFNIALGTARG 611
+V+ +G S + H + E++ GS L+N+ A EE + N +G
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVR--------NFVRQILKG 118
Query: 612 ITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK-----LINPKDHRHRTLTSVR 666
+ YLH R I+H DIK NIL+D K+SDFG++K ++ K + R S++
Sbjct: 119 LNYLHN--RG-IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGAR--PSLQ 173
Query: 667 GTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNF 705
G+ ++APE + T K+D++S G +++E+++G+ F
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 7e-19
Identities = 72/229 (31%), Positives = 113/229 (49%), Gaps = 33/229 (14%)
Query: 507 LGAGGFGAVYRGVLAN-------RTVVAVKQLE--GIEQGEKQFRMEVATISSTHHLNLV 557
LG+G FG VY G + VAVK L +Q +K+F E +S+ +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 558 RLVGFSSEGKHRLLVYEFMKNGSLDNFLFAN--EEGSGKLLNWQSRFNIALGTARGITYL 615
+L+G + + ++ E M+ G L ++L E LL + +I L A+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 616 HEECRDCIVHCDIKPENILLDE-NYNA----KVSDFGLAKLINPKDH---RHRTLTSVRG 667
E+ +H D+ N L+ E Y+A K+ DFGLA+ I D+ L VR
Sbjct: 123 -EQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 668 TRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEVSQ 709
++APE L + T++SDV+S+G+++ EI++ N EV Q
Sbjct: 179 ---WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQ 224
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 505 DKLGAGGFGAVY--RGVLANRTVVAVKQLEGIEQGEKQFRM---EVATISSTHHLNLVRL 559
K+G G +G VY R L +VA+K+++ + E + E+ + +H N+++L
Sbjct: 5 GKIGEGTYGVVYKARDKLTGE-IVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKL 63
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
+ LV+EFM L + + + L + +G+ + H
Sbjct: 64 LDVFRHKGDLYLVFEFMDT-DLYKLI----KDRQRGLPESLIKSYLYQLLQGLAFCH--- 115
Query: 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN 679
I+H D+KPEN+L++ K++DFGLA+ R T TR Y APE L
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSP---VRPYTHYVVTRWYRAPELLLG 172
Query: 680 LPI-TSKSDVYSYGMVLLEIVSGR 702
++ D++S G + E++S R
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 8e-19
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 18/209 (8%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVK--QLEGIEQGEKQFRMEVATISSTHHLNLVRL 559
+ +G G VY + L N VA+K LE + + R EV +S +H N+V+
Sbjct: 5 LIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY 64
Query: 560 VGFSSEGKHRLLVYEFMKNGS-LDNFLFANEEGSGKLLNWQSRFNIAL---GTARGITYL 615
G LV ++ GS LD + G IA +G+ YL
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG------LDEAIIATVLKEVLKGLEYL 118
Query: 616 HEECRDCIVHCDIKPENILLDENYNAKVSDFGL-AKLINPKDHRHRTLTSVRGTRGYLAP 674
H + +H DIK NILL E+ + K++DFG+ A L + D + + GT ++AP
Sbjct: 119 H---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
Query: 675 EWLANLP-ITSKSDVYSYGMVLLEIVSGR 702
E + + K+D++S+G+ +E+ +G
Sbjct: 176 EVMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 8e-19
Identities = 66/220 (30%), Positives = 104/220 (47%), Gaps = 34/220 (15%)
Query: 503 FKDKLGAGGFGAVYRGVL---ANRTVVAVKQLE--GIEQGEKQFRMEVATISST-HHLNL 556
F+D +G G FG V R ++ + A+K L+ E + F E+ + HH N+
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 557 VRLVGFSSEGKHRLLVYEFMKNGSLDNFL-----------FANEEGSGKLLNWQSRFNIA 605
+ L+G + + E+ G+L +FL FA E G+ L Q A
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 606 LGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSV 665
A G+ YL E+ +H D+ N+L+ EN +K++DFGL++ V
Sbjct: 126 SDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR---------GEEVYV 173
Query: 666 RGTRGYLAPEWLA----NLPI-TSKSDVYSYGMVLLEIVS 700
+ T G L W+A N + T+KSDV+S+G++L EIVS
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 9e-19
Identities = 63/226 (27%), Positives = 111/226 (49%), Gaps = 28/226 (12%)
Query: 496 LQRSTKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQLEGIE-QGEKQFRMEVATI 548
++R K +LG G FG V+ N + +VAVK L+ K F+ E +
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELL 61
Query: 549 SSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSR------- 601
++ H ++V+ G +G ++V+E+MK+G L+ FL A+ + L++ Q R
Sbjct: 62 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121
Query: 602 ----FNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657
+IA A G+ YL + VH D+ N L+ N K+ DFG+++ + D+
Sbjct: 122 LSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178
Query: 658 RH---RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS 700
T+ +R ++ PE + T++SDV+S+G++L EI +
Sbjct: 179 YRVGGHTMLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 9e-19
Identities = 84/297 (28%), Positives = 126/297 (42%), Gaps = 56/297 (18%)
Query: 507 LGAGGFGAVYRGVLANR----TVVAVKQLEG-------IEQGEKQFRMEVATISSTHHLN 555
LG G FG+V L + VAVK L+ IE+ F E A + H N
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEE----FLREAACMKEFDHPN 62
Query: 556 LVRLVGFS--SEGKHRL----LVYEFMKNGSLDNFLFANEEGSGKL-LNWQSRFNIALGT 608
+++L+G S S K RL ++ FMK+G L FL + G L Q+ +
Sbjct: 63 VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122
Query: 609 ARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGT 668
A G+ YL + +H D+ N +L+EN V+DFGL+K I D+ + S
Sbjct: 123 ASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179
Query: 669 RGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEVSQETNRKKFSLWAY 721
+ +LA E LA+ T+ SDV+++G+ + EI++ G N E+ Y
Sbjct: 180 K-WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI-------------Y 225
Query: 722 EEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778
KGN L D+ ++M C +P RP + LE I
Sbjct: 226 NYLIKGNRLKQPPDCLE----DVYELMCQ------CWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 65/209 (31%), Positives = 96/209 (45%), Gaps = 17/209 (8%)
Query: 507 LGAGGFGAVY--RGVLANRTVV--AVKQLEGIEQG-EKQFRMEVATISSTHHLNLVRLVG 561
LG GGFG V + NRT VK+ +E G ++ E + +H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 562 FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD 621
+ K+ ++ E+ G L L G + +RF IA YLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDR----GLFDEYTARFYIA-CVVLAFEYLHNRG-- 113
Query: 622 CIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLP 681
I++ D+KPEN+LLD N K+ DFG AK + +T T GT Y+APE + N
Sbjct: 114 -IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS---GQKTWTFC-GTPEYVAPEIILNKG 168
Query: 682 ITSKSDVYSYGMVLLEIVSGRRNFEVSQE 710
D +S G++L E+++GR F E
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPPFGEDDE 197
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 80/301 (26%), Positives = 133/301 (44%), Gaps = 45/301 (14%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQL-EGIEQGEK-QFRMEVA 546
E+ R +LG G FG VY G + T VAVK + E E+ +F E +
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 547 TIS--STHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFA----NEEGSGKLL-NWQ 599
+ + HH+ VRL+G S+G+ L+V E M +G L ++L + E G+ Q
Sbjct: 62 VMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 119
Query: 600 SRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRH 659
+A A G+ YL+ + VH D+ N ++ ++ K+ DFG+ + I D+
Sbjct: 120 EMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR 176
Query: 660 RT---LTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKF 716
+ L VR +APE L + T+ SD++S+G+VL EI S
Sbjct: 177 KGGKGLLPVRW----MAPESLKDGVFTTSSDMWSFGVVLWEITS---------------L 217
Query: 717 SLWAYEEFEKGNV-KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQML 775
+ Y+ V K ++D + + + + + W Q P RP ++V +L
Sbjct: 218 AEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCW--QFNPKMRPTFLEIVNLL 275
Query: 776 E 776
+
Sbjct: 276 K 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 11/196 (5%)
Query: 507 LGAGGFGAVYRGVLANRTVVAVKQL-EGIEQGEK-QFRMEVATISSTHHLNLVRLVGFSS 564
LG G FG V++G L ++T VAVK E + Q K +F E + H N+V+L+G +
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 565 EGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIV 624
+ + +V E + G +FL ++ L + AL A G+ YL E ++CI
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDE----LKTKQLVKFALDAAAGMAYL--ESKNCI- 115
Query: 625 HCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITS 684
H D+ N L+ EN K+SDFG+++ + + L + + APE L +S
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSS 173
Query: 685 KSDVYSYGMVLLEIVS 700
+SDV+SYG++L E S
Sbjct: 174 ESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 23/210 (10%)
Query: 503 FKDKLGAGGFGAV----YRGVLANRT--VVAVKQLE-GIEQGEKQFRMEVATISSTHHLN 555
F +LG G FG+V Y L + T VVAVK+L+ + + F E+ + S H N
Sbjct: 8 FIQQLGKGNFGSVELCRY-DPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDN 66
Query: 556 LVRLVGFS-SEGKHRL-LVYEFMKNGSLDNFLFANEE--GSGKLLNWQSRFNIALGTARG 611
+V+ G S G+ L LV E++ GSL ++L + E KLL + S+ +G
Sbjct: 67 IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI------CKG 120
Query: 612 ITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSV-RGTRG 670
+ YL + VH D+ NIL++ K+ DFGL K++ P+D + +
Sbjct: 121 MEYLGS--KRY-VHRDLATRNILVESENRVKIGDFGLTKVL-PQDKEYYKVREPGESPIF 176
Query: 671 YLAPEWLANLPITSKSDVYSYGMVLLEIVS 700
+ APE L + SDV+S+G+VL E+ +
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 5e-18
Identities = 68/269 (25%), Positives = 116/269 (43%), Gaps = 35/269 (13%)
Query: 503 FKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGF 562
F +LG G FG V G + VA+K ++ E +F E + H LV+L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67
Query: 563 SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC 622
++ + +V E+M NG L N+L GK + G+ YL +
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYL----REHGKRFQPSQLLEMCKDVCEGMAYLESK---Q 120
Query: 623 IVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR---GYLAPEWLAN 679
+H D+ N L+D+ KVSDFGL++ + ++ TS G++ + PE L
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-----TSSVGSKFPVRWSPPEVLLY 175
Query: 680 LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAG 739
+SKSDV+++G+++ E+ +SL +E+ N V+K G
Sbjct: 176 SKFSSKSDVWAFGVLMWEV-----------------YSL-GKMPYERFNNSETVEKVSQG 217
Query: 740 EDVDIEQVM--RAIQVSFWCIQEQPSQRP 766
+ + + + + C E+ +RP
Sbjct: 218 LRLYRPHLASEKVYAIMYSCWHEKAEERP 246
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 73/274 (26%), Positives = 124/274 (45%), Gaps = 27/274 (9%)
Query: 503 FKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGF 562
F +LG+G FG V+ G + VA+K + E+ F E + H LV+L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 563 SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC 622
++ K +V EFM+NG L N+L + GK L+ ++ G+ YL R+
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYL---RQRQGK-LSKDMLLSMCQDVCEGMEYLE---RNS 120
Query: 623 IVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPI 682
+H D+ N L+ KVSDFG+ + + D + + + + + PE
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYV--LDDEYTSSSGAKFPVKWSPPEVFNFSKY 178
Query: 683 TSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGED 741
+SKSDV+S+G+++ E+ + G+ FE KK + E +G + LA
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMPFE-------KKSNYEVVEMISRGF--RLYRPKLAS-- 227
Query: 742 VDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQML 775
M +V + C E+P RP ++++ +
Sbjct: 228 ------MTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 7e-18
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 34/211 (16%)
Query: 506 KLGAGGFGAVYRGV-LANRTVVAVKQL--------EGIEQGEKQFRMEVATISSTHHLNL 556
+LG G FG+VY +VA+K++ E + E + ++ H N+
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKL-----NEHPNI 60
Query: 557 VRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLH 616
V+L E V+E+M G+L + + GK + +I +G+ ++H
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIH 116
Query: 617 EECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEW 676
+ H D+KPEN+L+ K++DFGLA+ I + T TR Y APE
Sbjct: 117 ---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP----PYTDYVSTRWYRAPEI 169
Query: 677 LA-----NLPITSKSDVYSYGMVLLEIVSGR 702
L + P+ D+++ G ++ E+ + R
Sbjct: 170 LLRSTSYSSPV----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 7e-18
Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 38/223 (17%)
Query: 505 DKLGAGGFGAVYRGVLANRT--VVAVKQLEGIEQGEKQFRM---EVATISSTHHLNLVRL 559
+ +G G FG V + V ++ K+++ EK+ + EV + H N+VR
Sbjct: 6 ETIGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY 64
Query: 560 VG-FSSEGKHRL-LVYEFMKNGSLDNFL--------FANEEGSGKLLNWQSRFNIALGTA 609
L +V E+ + G L + + EE W+ + L
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEE-----FIWRILTQLLLA-- 117
Query: 610 RGITYLHEEC------RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLT 663
L+E C + ++H D+KP NI LD N N K+ DFGLAK++ T
Sbjct: 118 -----LYE-CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG--HDSSFAKT 169
Query: 664 SVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFE 706
V GT Y++PE L ++ KSD++S G ++ E+ + F
Sbjct: 170 YV-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-17
Identities = 67/224 (29%), Positives = 104/224 (46%), Gaps = 37/224 (16%)
Query: 507 LGAGGFGAVYRGV------LANRTVVAVKQL-EGIEQGE-KQFRMEVATISSTHHLNLVR 558
LG G FG V + A T VAVK L E E + E + +H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 559 LVGFSSEGKHRLLVYEFMKNGSLDNFLFANEE------GSGKLLNWQSRFN--------- 603
L G S+ LL+ E+ K GSL +FL + + GS N N
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 604 ----IALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD--- 656
A +RG+ YL E +VH D+ N+L+ E K+SDFGL++ + +D
Sbjct: 128 DLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS 700
R + V+ ++A E L + T++SDV+S+G++L EIV+
Sbjct: 185 KRSKGRIPVK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 500 TKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLE----GIEQGEKQFRM---EVATISSTH 552
TKG + LG G +G VY G+ ++AVKQ+E + EK++ EV + S
Sbjct: 3 TKG--EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 553 HLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGI 612
H+N+V+ +G + + EF+ GS+ + L N G + L G+
Sbjct: 61 HVNIVQYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQIL---DGV 115
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK---LINPKDHRHRTLTSVRGTR 669
YLH +C+VH DIK N++L N K+ DFG A+ + L S+ GT
Sbjct: 116 AYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP 172
Query: 670 GYLAPEWLANLPITSKSDVYSYGMVLLEIVSGR 702
++APE + KSD++S G + E+ +G+
Sbjct: 173 YWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 507 LGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEK--QFRMEVATISSTHHLNLVRLV-GFS 563
LG G FG VY+ + A ++ IE E+ F +E+ +S H N+V L +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 564 SEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCI 623
E K +L+ EF G+LD+ + E G L Q R+ + + +LH +
Sbjct: 73 YENKLWILI-EFCDGGALDSIMLELERG---LTEPQIRY-VCRQMLEALNFLHSHK---V 124
Query: 624 VHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLA----- 678
+H D+K NILL + + K++DFG++ + T GT ++APE +A
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI---GTPYWMAPEVVACETFK 181
Query: 679 NLPITSKSDVYSYGMVLLEIVSGR 702
+ P K+D++S G+ L+E+
Sbjct: 182 DNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 76/290 (26%), Positives = 118/290 (40%), Gaps = 54/290 (18%)
Query: 505 DKLGAGGFGAVYRGV---LANRTV-VAVKQLEGIEQGEKQ--FRMEVATISSTHHLNLVR 558
KLG G FG V RG + + VAVK L+ + + F E A + S H NL+R
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 559 LVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGS---GKLLNWQSRFNIALGTARGITYL 615
L G ++V E GSL + L + G L ++ A+ A G+ YL
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDY------AVQIANGMRYL 113
Query: 616 HEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK-LINPKDHRHRTLTSVRGTRGYLAP 674
E + I H D+ NILL + K+ DFGL + L +DH + ++ + AP
Sbjct: 114 --ESKRFI-HRDLAARNILLASDDKVKIGDFGLMRALPQNEDH-YVMEEHLKVPFAWCAP 169
Query: 675 EWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEVSQETNRKKFSLWAYEEFEKG 727
E L + SDV+ +G+ L E+ + G ++ ++ +++ E E+
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE------GERLER- 222
Query: 728 NVKGIVDKSLAGEDV--DIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQML 775
E DI VM C P+ RP + + L
Sbjct: 223 -----------PEACPQDIYNVMLQ------CWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 3e-17
Identities = 37/85 (43%), Positives = 46/85 (54%), Gaps = 3/85 (3%)
Query: 78 PIWTAGST-PV-DSSAFFQLHSSGTLRLISGSGAIIWDSNTQRL-NVTSASLDDSGNLVL 134
+W A P+ DSS L S G L L G+G ++W SNT + A L D GNLVL
Sbjct: 4 VVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGNLVL 63
Query: 135 LKNGGVSAWSSFDNPTDTIVPSQNF 159
N G W SFD+PTDT++P Q
Sbjct: 64 YDNSGKVLWQSFDHPTDTLLPGQKD 88
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 39/214 (18%)
Query: 503 FKDKLGAGGFGAV----YRG--------VLANRTVVAVKQLEGIEQGEKQFRMEVATISS 550
F LG G FG V ++G +L+ +V +KQ+E + EK+ + S
Sbjct: 5 FIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLN-EKR------ILQS 57
Query: 551 THHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRF---NIALG 607
H LV L G + + LV E++ G L F++ SG+ +RF + L
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL----FSHLRKSGRFPEPVARFYAAQVVLA 113
Query: 608 TARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRG 667
+ YLH IV+ D+KPEN+LLD + K++DFG AK + RT T G
Sbjct: 114 ----LEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLC-G 160
Query: 668 TRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSG 701
T YLAPE + + D ++ G+++ E+++G
Sbjct: 161 TPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 36/104 (34%), Positives = 52/104 (50%), Gaps = 7/104 (6%)
Query: 611 GITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRG 670
+ YLH + I+H DIKP+NILLDE + ++DF +A + TS GT G
Sbjct: 112 ALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKV----TPDTLTTSTSGTPG 164
Query: 671 YLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRK 714
Y+APE L + D +S G+ E + G+R + T R
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD 208
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 6e-17
Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 34/218 (15%)
Query: 505 DKLGAGGFGAVYRGVLAN---RTVVAVKQLE--GIEQGEKQFRMEVATISST-HHLNLVR 558
D +G G FG V + + R A+K+++ + + F E+ + HH N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 559 LVGFSSEGKHRLLVYEFMKNGSLDNFL-----------FANEEGSGKLLNWQSRFNIALG 607
L+G + L E+ +G+L +FL FA + L+ Q + A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 608 TARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRG 667
ARG+ YL ++ +H D+ NIL+ ENY AK++DFGL++ V+
Sbjct: 121 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---------GQEVYVKK 168
Query: 668 TRGYLAPEWLA----NLPI-TSKSDVYSYGMVLLEIVS 700
T G L W+A N + T+ SDV+SYG++L EIVS
Sbjct: 169 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 6e-17
Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 506 KLGAGGFGAVYRGVLANRTV---VAVKQLEGIEQGEKQFRMEVATISS-THHLN---LVR 558
+LG+G FG V +GV R VA+K L+ + EK R E+ + H L+ +VR
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLK--NENEKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 559 LVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618
++G E + +LV E G L+ FL ++ + + + + G+ YL +
Sbjct: 60 MIGVC-EAEALMLVMEMASGGPLNKFLSGKKDE----ITVSNVVELMHQVSMGMKYLEGK 114
Query: 619 CRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLA 678
VH D+ N+LL + AK+SDFGL+K + D ++ ++ + + APE +
Sbjct: 115 N---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171
Query: 679 NLPITSKSDVYSYGMVLLEIVS 700
+S+SDV+SYG+ + E S
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 6e-17
Identities = 57/206 (27%), Positives = 107/206 (51%), Gaps = 17/206 (8%)
Query: 507 LGAGGFGAVY--RGVLANRTVVAVKQL--EGIEQGEKQ-FRMEVATISSTHHLNLVRLVG 561
+G G FG V+ R A++ +V +KQ+ E + + E+ + E + H N++
Sbjct: 8 VGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 562 FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD 621
E K ++V E+ G+L ++ ++ LL+ + + + + ++H +
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYI---QKRCNSLLDEDTILHFFVQILLALHHVHTKL-- 121
Query: 622 CIVHCDIKPENILLDENYNA-KVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL 680
I+H D+K +NILLD++ K+ DFG++K+++ K + +V GT Y++PE
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY----TVVGTPCYISPELCEGK 176
Query: 681 PITSKSDVYSYGMVLLEIVSGRRNFE 706
P KSD+++ G VL E+ S +R FE
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 37/218 (16%)
Query: 507 LGAGGFGAVYRGVLANR-TVVAVKQLE----GIEQGE-------KQFRMEVATISSTHHL 554
+G G +G VY + ++AVKQ+E + + K R E+ T+ HL
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 555 NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIAL------GT 608
N+V+ +GF + ++ + E++ GS+ G L RF L
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSI-----------GSCLRTYGRFEEQLVRFFTEQV 117
Query: 609 ARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD-HRHRTLTSVRG 667
G+ YLH + I+H D+K +N+L+D + K+SDFG++K D + + S++G
Sbjct: 118 LEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDNDQNMSMQG 172
Query: 668 TRGYLAPEWLAN--LPITSKSDVYSYGMVLLEIVSGRR 703
+ ++APE + + ++K D++S G V+LE+ +GRR
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 6e-17
Identities = 66/220 (30%), Positives = 104/220 (47%), Gaps = 20/220 (9%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLA----NRTVVAVKQLEGIEQGEKQ--FRMEVATI 548
EL + + LG G FG + RG L VA+ L +++ F E T+
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 549 SSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGT 608
H N+VRL G + G ++V E+M NG+LD+FL +E G+L+ Q + G
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHE---GQLVAGQ-LMGMLPGL 116
Query: 609 ARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGT 668
A G+ YL E VH + +L++ + K+S F +D T++ G
Sbjct: 117 ASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRL----QEDKSEAIYTTMSGK 169
Query: 669 RGYL--APEWLANLPITSKSDVYSYGMVLLEIVS-GRRNF 705
L APE + +S SDV+S+G+V+ E++S G R +
Sbjct: 170 SPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPY 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-17
Identities = 66/202 (32%), Positives = 99/202 (49%), Gaps = 24/202 (11%)
Query: 507 LGAGGFGAV----YRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGF 562
+G G FG V YRG VAVK ++ + + F E + ++ H NLV+L+G
Sbjct: 14 IGKGEFGDVMLGDYRG-----NKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 563 SSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD 621
E K L +V E+M GSL ++L + +L +L + YL +
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEA---N 121
Query: 622 CIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLP 681
VH D+ N+L+ E+ AKVSDFGL K + T + + + APE L
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS------TQDTGKLPVKWTAPEALREKK 175
Query: 682 ITSKSDVYSYGMVLLEIVS-GR 702
++KSDV+S+G++L EI S GR
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 507 LGAGGFGAVYRGVLANRTV---VAVKQLE---GIEQGEKQFRMEVATISSTHHLNLVRLV 560
LG G FG+V G L VAVK ++ + F E + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 561 GFSSEGKHR------LLVYEFMKNGSLDNFLFANEEGSGKL-LNWQSRFNIALGTARGIT 613
G + +++ FMK+G L +FL + G L Q A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 614 YLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLA 673
YL + +H D+ N +L+EN N V+DFGL+K I D+ + + + ++A
Sbjct: 127 YLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK-WIA 182
Query: 674 PEWLANLPITSKSDVYSYGMVLLEIVS 700
E LA+ T+KSDV+S+G+ + EI +
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 9e-17
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 34/210 (16%)
Query: 506 KLGAGGFGAVYRGVLANRT---VVAVKQLEGIEQGE----KQFRM-EVATISSTHHLNLV 557
K+G G +G V++ NR +VA+K+ +E + K+ + E+ + H NLV
Sbjct: 8 KIGEGSYGVVFK--CRNRETGQIVAIKKF--VESEDDPVIKKIALREIRMLKQLKHPNLV 63
Query: 558 RLVGFSSEGKHRL-LVYEFMKNGSLDNFLFAN----EEGSGKLLNWQSRFNIALGTARGI 612
L+ K +L LV+E+ + ++ N L N E K + WQ T + +
Sbjct: 64 NLIEVFRR-KRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQ--------TLQAV 113
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYL 672
+ H+ +CI H D+KPENIL+ + K+ DFG A+++ + T TR Y
Sbjct: 114 NFCHKH--NCI-HRDVKPENILITKQGQIKLCDFGFARILTGPGDDY---TDYVATRWYR 167
Query: 673 APEWL-ANLPITSKSDVYSYGMVLLEIVSG 701
APE L + DV++ G V E+++G
Sbjct: 168 APELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 17/215 (7%)
Query: 507 LGAGGFGAVYR-GVLANRTVVAVKQLEG----IEQGEKQFRMEVATISSTHHLNLVRLVG 561
LG GGFG V V A + A K+L+ +GE+ E + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 562 FSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620
++ E K L LV M G L ++ G ++ F A G+ +LH+
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIY--NVGEPGFPEARAIFYAA-QIICGLEHLHQRR- 115
Query: 621 DCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL 680
IV+ D+KPEN+LLD++ N ++SD GLA + + + GT GY+APE L
Sbjct: 116 --IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG----KKIKGRAGTPGYMAPEVLQGE 169
Query: 681 PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKK 715
D ++ G L E+++GR F +E K+
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 61/219 (27%), Positives = 108/219 (49%), Gaps = 17/219 (7%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQL-EGIEQGEK-QFRMEVA 546
E+ R +LG G FG VY G+ T VA+K + E E+ +F E +
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 547 TISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFA---NEEGSGKLL--NWQSR 601
+ + ++VRL+G S+G+ L++ E M G L ++L + E + + +
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 602 FNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRT 661
+A A G+ YL+ + VH D+ N ++ E++ K+ DFG+ + I D+ +
Sbjct: 122 IQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 662 LTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS 700
+ R +++PE L + T+ SDV+S+G+VL EI +
Sbjct: 179 GKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 57/204 (27%), Positives = 103/204 (50%), Gaps = 22/204 (10%)
Query: 507 LGAGGFGAVYRGVL-----ANRTVVAVKQLEGIEQGEKQFRM---EVATISSTHHLNLVR 558
LG+G FG V++G+ + + VA+K ++ G + F+ + + S H +VR
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD-RSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 559 LVGFSSEGKHRLLVYEFMKNGSLDNFLFANEE--GSGKLLNWQSRFNIALGTARGITYLH 616
L+G G LV + GSL + + + + +LLNW + A+G+ YL
Sbjct: 74 LLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYLE 126
Query: 617 EECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEW 676
E +VH ++ NILL + +++DFG+A L+ P D ++ + + ++A E
Sbjct: 127 EHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY-FYSEHKTPIKWMALES 182
Query: 677 LANLPITSKSDVYSYGMVLLEIVS 700
+ T +SDV+SYG+ + E++S
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 506 KLGAGGFGAVYRGVLANRT---VVAVKQ-LEGIEQGE-KQFRM-EVATISSTHHLNLVRL 559
+G G +G V + ++ +VA+K+ LE + K+ M E+ + H NLV L
Sbjct: 8 LVGEGSYGMVMK--CKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
+ K LV+EF+ + LD+ L G + + F I RGI + H
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQIL----RGIEFCH--- 117
Query: 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN-PKDHRHRTLTSVRGTRGYLAPEWLA 678
I+H DIKPENIL+ ++ K+ DFG A+ + P + T TR Y APE L
Sbjct: 118 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE----VYTDYVATRWYRAPELLV 173
Query: 679 NLPITSKS-DVYSYGMVLLEIVSG 701
++ D+++ G ++ E+++G
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 65/236 (27%), Positives = 108/236 (45%), Gaps = 39/236 (16%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVY-----------------RGVLANRTVVAVKQL--EGIE 535
E R F +KLG G FG V+ +VAVK L + +
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60
Query: 536 QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSG-- 593
+ F EV +S N+ RL+G + ++ E+M+NG L+ FL + +
Sbjct: 61 NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 594 ----KLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649
K L++ + +A A G+ YL E + VH D+ N L+ +NY K++DFG++
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYL--ESLN-FVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLANLPI-----TSKSDVYSYGMVLLEIVS 700
+ + D+ V+G R L W+A + T+KSDV+++G+ L EI++
Sbjct: 178 RNLYSSDY-----YRVQG-RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 70/212 (33%), Positives = 104/212 (49%), Gaps = 21/212 (9%)
Query: 507 LGAGGFGAVYRGVLANRT--VVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLV 560
LG GGFG V V T + A K+L+ + GEK +E + + +V L
Sbjct: 1 LGKGGFGEVC-AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL- 58
Query: 561 GFSSEGK-HRLLVYEFMKNGSLDNFLF-ANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618
++ E K H LV M G L ++ E G L + + + GI +LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG----LEMERVIHYSAQITCGILHLHSM 114
Query: 619 CRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLA 678
IV+ D+KPEN+LLD+ N ++SD GLA + KD +T+T GT GY+APE L
Sbjct: 115 D---IVYRDMKPENVLLDDQGNCRLSDLGLA--VELKD--GKTITQRAGTNGYMAPEILK 167
Query: 679 NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQE 710
P + D ++ G + E+V+GR F+ +E
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 53/198 (26%), Positives = 103/198 (52%), Gaps = 14/198 (7%)
Query: 506 KLGAGGFGAV-YRGVLANRTVVAVKQLEGIEQGEKQFRM-EVATISSTHHLNLVRLVGFS 563
K+G G G V V ++ +VAVK+++ +Q ++ EV + H N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 564 SEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCI 623
G +V EF++ G+L + + + +N + + L + ++ LH + +
Sbjct: 87 LVGDELWVVMEFLEGGALTDIV------THTRMNEEQIAAVCLAVLKALSVLHAQG---V 137
Query: 624 VHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPIT 683
+H DIK ++ILL + K+SDFG ++ + R ++L GT ++APE ++ LP
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV---GTPYWMAPELISRLPYG 194
Query: 684 SKSDVYSYGMVLLEIVSG 701
+ D++S G++++E+V G
Sbjct: 195 PEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 20/203 (9%)
Query: 507 LGAGGFGAVYRGVLA--NRTV---VAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRL 559
LG+G FG VY+G+ TV VA+K L + +F E ++S H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEE--GSGKLLNWQSRFNIALGTARGITYLHE 617
+G +L V + M +G L +++ +++ GS LLNW + A+G+ YL E
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYL-E 126
Query: 618 ECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWL 677
E R +VH D+ N+L+ + K++DFGLA+L+ D + + ++A E +
Sbjct: 127 ERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLE-GDEKEYNADGGKMPIKWMALECI 183
Query: 678 ANLPITSKSDVYSYGMVLLEIVS 700
T +SDV+SYG+ + E+++
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 26/224 (11%)
Query: 491 FSYKELQRSTKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQLEGI--EQGEKQFR 542
F LQ T LG G FG V+ T+V VK L+ E + +FR
Sbjct: 2 FPRSNLQEITT-----LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR 56
Query: 543 MEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKL----LNW 598
E+ H N+VRL+G E + ++ E+ G L FL A + KL L+
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 599 QSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD-H 657
+ + + A G+ +L VH D+ N L+ KVS L+K + + +
Sbjct: 117 KQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173
Query: 658 RHR-TLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS 700
+ R L +R +LAPE + ++KSDV+S+G+++ E+ +
Sbjct: 174 KLRNALIPLR----WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 23/204 (11%)
Query: 505 DKLGAGGFGAVYRGVLANRT--VVAVK--QLEGIEQGEKQFRMEVATISSTHHLNLVRLV 560
+++G G FG V++G+ NRT VVA+K LE E + + E+ +S + +
Sbjct: 10 ERIGKGSFGEVFKGI-DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIAL---GTARGITYLHE 617
G +G ++ E++ GS + L A F IA +G+ YLH
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLRAGP---------FDEFQIATMLKEILKGLDYLHS 119
Query: 618 ECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWL 677
E + +H DIK N+LL E + K++DFG+A + + T GT ++APE +
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV---GTPFWMAPEVI 173
Query: 678 ANLPITSKSDVYSYGMVLLEIVSG 701
SK+D++S G+ +E+ G
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 55/199 (27%), Positives = 102/199 (51%), Gaps = 19/199 (9%)
Query: 506 KLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGE--KQFRMEVATISSTHHLNLVRLVGF 562
++G+G +G VY+ +A +VA+K ++ +E G+ + + E++ + H N+V G
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIK-LEPGDDFEIIQQEISMLKECRHPNIVAYFG- 67
Query: 563 SSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD 621
S + +L +V E+ GSL + + G L Q + + T +G+ YLHE +
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIY---QVTRGPLSELQIAY-VCRETLKGLAYLHETGK- 122
Query: 622 CIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLA--- 678
+H DIK NILL E+ + K++DFG++ + + ++ GT ++APE A
Sbjct: 123 --IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI---GTPYWMAPEVAAVER 177
Query: 679 NLPITSKSDVYSYGMVLLE 697
K D+++ G+ +E
Sbjct: 178 KGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 7e-16
Identities = 76/300 (25%), Positives = 135/300 (45%), Gaps = 59/300 (19%)
Query: 498 RSTKGFKDK-LGAGGFGAVYRGVLAN-----RTVVAVKQLEGIE--QGEKQFRMEVATIS 549
+ T+ K K LG+G FG VY+G+ + VA+K+L + K+ E ++
Sbjct: 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 64
Query: 550 STHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEE--GSGKLLNWQSRFNIALG 607
S + ++ RL+G +L + + M G L +++ +++ GS LLNW +
Sbjct: 65 SVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 117
Query: 608 TARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRG 667
A+G+ YL E +VH D+ N+L+ + K++DFGLAKL+ + +
Sbjct: 118 IAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEY------HA 168
Query: 668 TRGYLAPEWLANLPI-----TSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYE 722
G + +W+A I T +SDV+SYG+ + E+++ F Y+
Sbjct: 169 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT---------------FGSKPYD 213
Query: 723 EFEKGNVKGIVDKSLAGEDV------DIEQVMRAIQVSFWCI--QEQPSQRPMMGKVVQM 774
+ I++K GE + I+ M I V W I +P R ++ + +M
Sbjct: 214 GIPASEISSILEK---GERLPQPPICTIDVYM--IMVKCWMIDADSRPKFRELIIEFSKM 268
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 8e-16
Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 43/227 (18%)
Query: 505 DKLGAGGFGAVYRGVLANRT--VVAVKQLEGIEQGEKQF-----RMEVATISSTHHLNLV 557
++G G +G VY+ +T +VA+K++ +E ++ F R E+ + H N+V
Sbjct: 5 AQIGEGTYGQVYKA-RNKKTGELVALKKIR-MENEKEGFPITAIR-EIKLLQKLRHPNIV 61
Query: 558 RL--VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFN------IALGTA 609
RL + S +V+E+M D+ L +G L + + +F
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYM-----DHDL------TGLLDSPEVKFTESQIKCYMKQLL 110
Query: 610 RGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR 669
G+ YLH + I+H DIK NIL++ + K++DFGLA+ T+ T
Sbjct: 111 EGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTK--RNSADYTNRVITL 165
Query: 670 GYLAPEWLANLPITS---KSDVYSYGMVLLEIVSGRRNF----EVSQ 709
Y PE L L T + D++S G +L E+ G+ F E+ Q
Sbjct: 166 WYRPPELL--LGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 9e-16
Identities = 65/216 (30%), Positives = 96/216 (44%), Gaps = 33/216 (15%)
Query: 507 LGAGGFGAVYR------GVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLV 560
LGAG G+V + G + + VV + KQ E+ + +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHI---GAKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 561 G-FSSEGKHRLLVYEFMKNGSLDNFLFA----NEEGSGKLLNWQSRFNIALGTARGITYL 615
G F +E + + EFM GSLD E GK IA+ G+TYL
Sbjct: 70 GAFLNEN-NICMCMEFMDCGSLDRIYKKGGPIPVEILGK---------IAVAVVEGLTYL 119
Query: 616 HEECRDCIVHCDIKPENILLDENYNAKVSDFGLA-KLINPKDHRHRTLTSVRGTRGYLAP 674
+ R I+H DIKP NIL++ K+ DFG++ +LIN + GT Y++P
Sbjct: 120 YNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN------SIADTFVGTSTYMSP 171
Query: 675 EWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQE 710
E + T KSDV+S G+ ++E+ G+ F S
Sbjct: 172 ERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 506 KLGAGGFGAVYR-GVLANRTVVAVKQL------EGIEQGEKQFRMEVATISSTHHLNLVR 558
++G G G V++ VA+K++ GI Q E+ + + H +V+
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP---NQALREIKALQACQHPYVVK 63
Query: 559 LVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618
L+ G +LV E+M L L +EE +S + L +G+ Y+H
Sbjct: 64 LLDVFPHGSGFVLVMEYMP-SDLSEVL-RDEERPLPEAQVKSYMRMLL---KGVAYMHAN 118
Query: 619 CRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLA 678
I+H D+KP N+L+ + K++DFGLA+L + ++ R + TR Y APE L
Sbjct: 119 G---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE--PRLYSHQVATRWYRAPELLY 173
Query: 679 NLP-ITSKSDVYSYGMVLLEIVSGR 702
D+++ G + E+++G
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 74/282 (26%), Positives = 119/282 (42%), Gaps = 43/282 (15%)
Query: 505 DKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGE--KQFRMEVATISSTHHLNLVRLVG 561
+++G G FG V+ G L A+ T VAVK + +F E + H N+VRL+G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 562 FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD 621
++ + +V E ++ G FL G L + + A G+ YL +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFL----RTEGPRLKVKELIQMVENAAAGMEYLESKH-- 114
Query: 622 CIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR----GYLAPEWL 677
CI H D+ N L+ E K+SDFG+++ + S G + + APE L
Sbjct: 115 CI-HRDLAARNCLVTEKNVLKISDFGMSR-----EEEDGVYASTGGMKQIPVKWTAPEAL 168
Query: 678 ANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA--YEEFEKGNVKGIVDK 735
+S+SDV+S+G++L E FSL A Y + +++
Sbjct: 169 NYGRYSSESDVWSFGILLWE-----------------AFSLGAVPYANLSNQQTREAIEQ 211
Query: 736 S--LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQML 775
L ++ + V R ++ C + P QRP V Q L
Sbjct: 212 GVRLPCPELCPDAVYRLMER---CWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 506 KLGAGGFGAVYRGVLANRT---VVAVKQLEGIEQGEK---QFRMEVATISSTHHLNLVRL 559
+LG+G FG V +G+ + VAVK L+ + E + + +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
+G E + +LV E + G L+ FL N+ + K + + + G+ YL E
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNIT-----ELVHQVSMGMKYLEE-- 113
Query: 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN 679
VH D+ N+LL + AK+SDFGL+K + ++ ++ T + + APE +
Sbjct: 114 -TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 680 LPITSKSDVYSYGMVLLEIVS 700
+SKSDV+S+G+++ E S
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 48/177 (27%), Positives = 96/177 (54%), Gaps = 13/177 (7%)
Query: 526 VAVKQLEGIEQGEKQFRM-EVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNF 584
VAVK+++ +Q ++ EV + HH N+V + G +V EF++ G+L +
Sbjct: 50 VAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDI 109
Query: 585 LFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVS 644
+ + +N + + L R ++YLH + ++H DIK ++ILL + K+S
Sbjct: 110 V------THTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLS 160
Query: 645 DFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSG 701
DFG ++ + + ++L GT ++APE ++ LP ++ D++S G++++E++ G
Sbjct: 161 DFGFCAQVSKEVPKRKSLV---GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 48/183 (26%), Positives = 94/183 (51%), Gaps = 25/183 (13%)
Query: 526 VAVKQLEGIEQGEKQFRM-EVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNF 584
VAVK+++ +Q ++ EV + H N+V + G +V EF++ G+L +
Sbjct: 47 VAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDI 106
Query: 585 LFANEEGSGKLLNWQSRFN------IALGTARGITYLHEECRDCIVHCDIKPENILLDEN 638
+ +R N + L + +++LH + ++H DIK ++ILL +
Sbjct: 107 VT------------HTRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSD 151
Query: 639 YNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEI 698
K+SDFG ++ + R ++L GT ++APE ++ LP ++ D++S G++++E+
Sbjct: 152 GRVKLSDFGFCAQVSKEVPRRKSLV---GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 208
Query: 699 VSG 701
V G
Sbjct: 209 VDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 70/246 (28%), Positives = 111/246 (45%), Gaps = 52/246 (21%)
Query: 507 LGAGGFGAVYRG------------VLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHL 554
+G G FG V+ V+A V+ +KQ + + EK+ EV+ H
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHV-HNEKRVLKEVS------HP 61
Query: 555 NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
++RL + + ++ E++ G L ++L SG+ N F A + Y
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN----SGRFSNSTGLF-YASEIVCALEY 116
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAP 674
LH + IV+ D+KPENILLD+ + K++DFG AK + R RT T + GT YLAP
Sbjct: 117 LHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL-----RDRTWT-LCGTPEYLAP 167
Query: 675 EWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734
E + + D ++ G+++ E++ G Y F N GI +
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVG-------------------YPPFFDDNPFGIYE 208
Query: 735 KSLAGE 740
K LAG+
Sbjct: 209 KILAGK 214
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 68/244 (27%), Positives = 100/244 (40%), Gaps = 49/244 (20%)
Query: 486 GAPVQFSYKELQRSTKGFKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQ---- 540
G Y+ L KLG G FG VY+ + VVA+K++ + EK
Sbjct: 3 GCSKLRDYEILG--------KLGEGTFGEVYKARQIKTGRVVALKKI--LMHNEKDGFPI 52
Query: 541 --FRMEVATISSTHHLNLVRLVGFS---SEGKHRL-----LVYEFMK---NGSLDNFLFA 587
R E+ + H N+V L+ + + R +V +M +G L+N
Sbjct: 53 TALR-EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK 111
Query: 588 NEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFG 647
E K L GI YLHE + I+H DIK NIL+D K++DFG
Sbjct: 112 LTESQIK--------CYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFG 160
Query: 648 LAKLI--NPKDHRH------RTLTSVRGTRGYLAPEWLANLP-ITSKSDVYSYGMVLLEI 698
LA+ P + + R T++ TR Y PE L T+ D++ G V E+
Sbjct: 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEM 220
Query: 699 VSGR 702
+ R
Sbjct: 221 FTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 507 LGAGGFGAVYRGVLANR-TVVAVKQLEGIEQGEKQFRMEVATI-------SSTHHLNLVR 558
LG G FG VY + +AVKQ+ + + + EV + + H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVP-FDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 559 LVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618
G + + + E+M GS+ + L A G L +R G+ YLH
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAY----GALTETVTR-KYTRQILEGVEYLH-- 121
Query: 619 CRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLA 678
+ IVH DIK NIL D N K+ DFG +K + + SV GT +++PE ++
Sbjct: 122 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 679 NLPITSKSDVYSYGMVLLEIVS 700
K+DV+S G ++E+++
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 507 LGAGGFGAV--YRGVLANR---TVVAVKQL--EGIEQGEKQFRMEVATISSTHHLNLVRL 559
LG G FG V Y AN +VAVK L E +Q ++ E+ + + +H N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 560 VGFSSE--GKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHE 617
G SE GK L+ E++ GSL ++L ++ +LL + A G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLF------AQQICEGMAYLHS 125
Query: 618 ECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWL 677
+ +H D+ N+LLD + K+ DFGLAK + +R + A E L
Sbjct: 126 QH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182
Query: 678 ANLPITSKSDVYSYGMVLLEIVS 700
+ SDV+S+G+ L E+++
Sbjct: 183 KENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 3e-15
Identities = 56/178 (31%), Positives = 88/178 (49%), Gaps = 26/178 (14%)
Query: 539 KQFRMEVATISSTHHLNLVRLVGFSSEGKHRLL-VYEFMKNGSLDNFLFANE-----EGS 592
+FR E A + +H N+V L+ L V+E++ +L L A + +
Sbjct: 23 ARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL-AADGALPAGET 81
Query: 593 GKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL---DENYNAKVSDFGLA 649
G+L+ Q +A +GI VH D+KP+NI++ +AKV DFG+
Sbjct: 82 GRLML-QVLDALACAHNQGI-----------VHRDLKPQNIMVSQTGVRPHAKVLDFGIG 129
Query: 650 KLI-NPKDHRHRTLT---SVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRR 703
L+ +D TLT V GT Y APE L P+T SD+Y++G++ LE ++G+R
Sbjct: 130 TLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 62/235 (26%), Positives = 104/235 (44%), Gaps = 38/235 (16%)
Query: 495 ELQRSTKGFKDKLGAGGFGAV----------YRGVLANR-----TVVAVKQL--EGIEQG 537
E R K+KLG G FG V + G A +VAVK L + +
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA 60
Query: 538 EKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSG---- 593
F E+ +S + N++RL+G ++ E+M+NG L+ FL E S
Sbjct: 61 RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHA 120
Query: 594 ---KLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650
++ + +A+ A G+ YL VH D+ N L+ +Y K++DFG+++
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANLPI-----TSKSDVYSYGMVLLEIVS 700
+ D+ ++G R L W+A I T+ SDV+++G+ L E+ +
Sbjct: 178 NLYSGDYYR-----IQG-RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-15
Identities = 80/351 (22%), Positives = 157/351 (44%), Gaps = 30/351 (8%)
Query: 431 KSKSWRLKAWIVVVAVLATLMVLVVLEGGLWYWCCRNSPKFVSLSAQ---YALLEYASGA 487
K+ SW W + L +VL ++ G + RN+ + + + + L + S
Sbjct: 624 KTPSW----WFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKV 679
Query: 488 PVQFSYKELQRSTKGFKDKLGAGGFGAVYRG-VLANRTVVAVKQLEGIEQGEKQFRMEVA 546
+ ++ S K ++ + G GA Y+G + N VK++ + E+A
Sbjct: 680 SKSITINDILSSLKE-ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS---SEIA 735
Query: 547 TISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIAL 606
+ H N+V+L+G K L++E+++ +L L + L+W+ R IA+
Sbjct: 736 DMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL--------RNLSWERRRKIAI 787
Query: 607 GTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVR 666
G A+ + +LH C +V ++ PE I++D + L L+ T T
Sbjct: 788 GIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC-------TDTKCF 839
Query: 667 GTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEK 726
+ Y+APE IT KSD+Y +G++L+E+++G+ + + WA +
Sbjct: 840 ISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVE-WARYCYSD 898
Query: 727 GNVKGIVDKSLAGE-DVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776
++ +D S+ G+ V+ +++ + ++ C P+ RP V++ LE
Sbjct: 899 CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 5e-15
Identities = 70/255 (27%), Positives = 117/255 (45%), Gaps = 38/255 (14%)
Query: 469 PKFVSLSAQYALLEYASGAPVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLANRT--VV 526
P S S+ + S S EL+R +++G+G G VY+ V+ T +
Sbjct: 49 PPSSSSSSSSSSSASGSAPSAAKSLSELERV-----NRIGSGAGGTVYK-VIHRPTGRLY 102
Query: 527 AVKQLEGIEQGE--KQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNF 584
A+K + G + +Q E+ + +H N+V+ ++ EFM GSL+
Sbjct: 103 ALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT 162
Query: 585 LFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVS 644
A+E Q ++A GI YLH R IVH DIKP N+L++ N K++
Sbjct: 163 HIADE---------QFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIA 210
Query: 645 DFGLAKLINPKDHRHRTL---TSVRGTRGYLAPEWLANLPITS------KSDVYSYGMVL 695
DFG+++++ +T+ S GT Y++PE + N + D++S G+ +
Sbjct: 211 DFGVSRILA------QTMDPCNSSVGTIAYMSPERI-NTDLNHGAYDGYAGDIWSLGVSI 263
Query: 696 LEIVSGRRNFEVSQE 710
LE GR F V ++
Sbjct: 264 LEFYLGRFPFGVGRQ 278
|
Length = 353 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 65/276 (23%), Positives = 116/276 (42%), Gaps = 36/276 (13%)
Query: 507 LGAGGFG--AVYRGVLANRTVVAVKQLEGIEQGEKQFRM---EVATISSTHHLNLVRLVG 561
LG G FG +YR + VV K++ EK+ R E+ +S H N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVV-WKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 562 FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD 621
+ L+ E+ G+L + + G+L + ++Y+H+
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKI---VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 622 CIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLP 681
I+H DIK NI L + K+ DFG++K++ + T V GT Y++PE +
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET---VVGTPYYMSPELCQGVK 177
Query: 682 ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGED 741
KSD+++ G VL E+++ +R F+ + N +V K + G
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFDAT-------------------NPLNLVVKIVQGNY 218
Query: 742 VDIEQVMRA--IQVSFWCIQEQPSQRPMMGKVVQML 775
+ V + I + +Q+ P +RP +V+
Sbjct: 219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQ-FRMEVATISSTHHLNLVRLVGFSS 564
LG G +G VY L+ + +A+K++ + Q E+A S H N+V+ +G S
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 565 EGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTAR---GITYLHEECRD 621
E + E + GSL L G L + + I T + G+ YLH+
Sbjct: 76 ENGFFKIFMEQVPGGSLSALL---RSKWGPLKDNEQ--TIIFYTKQILEGLKYLHDN--- 127
Query: 622 CIVHCDIKPENILLDENYNA--KVSDFGLAKL---INPKDHRHRTLTSVRGTRGYLAPEW 676
IVH DIK +N+L++ Y+ K+SDFG +K INP + GT Y+APE
Sbjct: 128 QIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINP------CTETFTGTLQYMAPEV 180
Query: 677 LANLP--ITSKSDVYSYGMVLLEIVSGRRNF 705
+ P + +D++S G ++E+ +G+ F
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 5e-15
Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 505 DKLGAGGFGAVYRGVLANRT--VVAVK--QLEGIEQGEKQFRMEVATISSTHHLNLVRLV 560
+++G G FG VY+G+ NRT VVA+K LE E + + E+ +S + R
Sbjct: 10 ERIGKGSFGEVYKGI-DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620
G +G ++ E++ GS + L L I +G+ YLH E +
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLKPGP------LEETYIATILREILKGLDYLHSERK 122
Query: 621 DCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL 680
+H DIK N+LL E + K++DFG+A + + T GT ++APE +
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV---GTPFWMAPEVIKQS 176
Query: 681 PITSKSDVYSYGMVLLEIVSG 701
K+D++S G+ +E+ G
Sbjct: 177 AYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 506 KLGAGGFGAVYRGVLANRT--VVAVKQLEGIEQGEKQ---FRMEVATISSTHHLNLVRLV 560
+G G FG VY+ + RT VVA+K ++ +E+ E + + E+ +S + +
Sbjct: 8 CIGKGSFGEVYKAI-DKRTNQVVAIKVID-LEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620
G +G ++ E+ GS + L GKL F I G+ YLHEE +
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAF-ILREVLLGLEYLHEEGK 119
Query: 621 DCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL 680
+H DIK NILL E + K++DFG++ + + T GT ++APE +
Sbjct: 120 ---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV---GTPFWMAPEVIKQS 173
Query: 681 PITSKSDVYSYGMVLLEIVSG 701
K+D++S G+ +E+ G
Sbjct: 174 GYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 7e-15
Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 43/215 (20%)
Query: 504 KDKLGAGGFGAV----YRG--------VLANRTVVAVKQLEGIEQGEKQFRMEVATISST 551
+ LG G FG V ++G L R ++ +KQ++ + Q EK ME+ +
Sbjct: 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQ-EKSILMEL-----S 76
Query: 552 HHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARG 611
H + + F E + L+ EF+ G L F + +G+ N ++F A
Sbjct: 77 HPFIVNMMCSFQDENRVYFLL-EFVVGGEL----FTHLRKAGRFPNDVAKFYHA-ELVLA 130
Query: 612 ITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGY 671
YLH + I++ D+KPEN+LLD + KV+DFG AK + RT T + GT Y
Sbjct: 131 FEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKV-----PDRTFT-LCGTPEY 181
Query: 672 LAPEWLANLPITSKS-----DVYSYGMVLLEIVSG 701
LAPE I SK D ++ G++L E ++G
Sbjct: 182 LAPE-----VIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 48/220 (21%)
Query: 507 LGAGGFGAVYRGVLANRT----VVAVKQLEGIEQGEKQFRM-------EVATISSTHHLN 555
+ G +G V+ LA + + A+K I++ + + E +S
Sbjct: 1 ISKGAYGRVF---LAKKKSTGDIYAIKV---IKKADMIRKNQVDQVLTERDILSQAQSPY 54
Query: 556 LVRLVGFSSEGKHRL-LVYEFMKNGS----LDNFLFANEEGSGKLLNWQSRFNIALGTAR 610
+V+L +S +GK L LV E++ G L+N +E+ +R IA
Sbjct: 55 VVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDED--------VARIYIA-EIVL 104
Query: 611 GITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK---------LINPKDHRHRT 661
+ YLH + I+H D+KP+NIL+D N + K++DFGL+K L + + R
Sbjct: 105 ALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161
Query: 662 LTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSG 701
+ GT Y+APE + + D +S G +L E + G
Sbjct: 162 V----GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 9e-15
Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 30/218 (13%)
Query: 507 LGAGGFGAVYR----GVLANR----TVVAVKQLEGIEQGEKQF-----RMEVATISSTHH 553
LG G FG V R G+ +R VAVK L+ +K ME+ + H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKD-NATDKDLADLISEMELMKLIGKHK 78
Query: 554 LNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANE-----------EGSGKLLNWQSRF 602
N++ L+G ++ ++ E+ G+L FL A + + L+++
Sbjct: 79 -NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 603 NIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTL 662
+ A ARG+ YL E R CI H D+ N+L+ E+ K++DFGLA+ ++ D+ +T
Sbjct: 138 SCAYQVARGMEYL--ESRRCI-HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT- 193
Query: 663 TSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS 700
++ R ++APE L + T +SDV+S+G+++ EI +
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 69/233 (29%), Positives = 113/233 (48%), Gaps = 36/233 (15%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLA----------NR-TVVAVKQLEGIEQGEKQF-- 541
E+ R LG G FG V V+A NR T VAVK L+ + EK
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKS-DATEKDLSD 69
Query: 542 ---RMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFAN---------- 588
ME+ + H N++ L+G ++ ++ E+ G+L +L A
Sbjct: 70 LISEMEMMKMIGKHK-NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYN 128
Query: 589 -EEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFG 647
+ + L+++ + A ARG+ YL + CI H D+ N+L+ E+ K++DFG
Sbjct: 129 PTQVPEEQLSFKDLVSCAYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFG 185
Query: 648 LAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS 700
LA+ I+ D+ +T T+ R ++APE L + T +SDV+S+G++L EI +
Sbjct: 186 LARDIHHIDYYKKT-TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 505 DKLGAGGFGAVYRGVLANRT--VVAVK--QLEGIEQGEKQFRMEVATISSTHHLNLVRLV 560
+K+G G FG V++G+ NRT VVA+K LE E + + E+ +S + +
Sbjct: 10 EKIGKGSFGEVFKGI-DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620
G + ++ E++ GS + L E G L+ I +G+ YLH E +
Sbjct: 69 GSYLKDTKLWIIMEYLGGGSALDLL---EPGP---LDETQIATILREILKGLDYLHSEKK 122
Query: 621 DCIVHCDIKPENILLDENYNAKVSDFGLA-KLINPKDHRHRTLTSVRGTRGYLAPEWLAN 679
+H DIK N+LL E+ K++DFG+A +L + + R+ + GT ++APE +
Sbjct: 123 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV----GTPFWMAPEVIKQ 175
Query: 680 LPITSKSDVYSYGMVLLEIVSG 701
SK+D++S G+ +E+ G
Sbjct: 176 SAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 32/214 (14%)
Query: 507 LGAGGFGAVY-----RGVLANRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVR 558
LG G FG V+ G A + A+K L+ + + +ME ++ +H +V+
Sbjct: 4 LGQGSFGKVFLVRKITGPDAG-QLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 559 L-VGFSSEGKHRLLVYEFMKNGSL-----DNFLFANEEGSGKLLNWQSRFNIALGTARGI 612
L F +EGK L+ +F++ G L +F E+ +F +A A +
Sbjct: 63 LHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEED---------VKFYLA-ELALAL 111
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYL 672
+LH I++ D+KPENILLDE + K++DFGL+K DH + S GT Y+
Sbjct: 112 DHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAY-SFCGTVEYM 165
Query: 673 APEWLANLPITSKSDVYSYGMVLLEIVSGRRNFE 706
APE + T +D +S+G+++ E+++G F+
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 43/224 (19%)
Query: 498 RSTKGFKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQ-------FRMEVATIS 549
R KG KLG G + VY+ +VA+K+++ E+ E + R E+ +
Sbjct: 1 RYEKG--KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQ 57
Query: 550 STHHLNLVRLVGFSSEGKHRLLVYEFM--------KNGSLDNFLFANEEGSGKLLNWQSR 601
H N++ L+ + LV+EFM K+ S+ A+ +
Sbjct: 58 ELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIV-LTPADIK----------- 105
Query: 602 FNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI-NPKDHRHR 660
+ L T RG+ YLH + I+H D+KP N+L+ + K++DFGLA+ +P +R
Sbjct: 106 -SYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP----NR 157
Query: 661 TLTSVRGTRGYLAPEWL--ANLPITSKSDVYSYGMVLLEIVSGR 702
+T TR Y APE L A D++S G + E++
Sbjct: 158 KMTHQVVTRWYRAPELLFGARH-YGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 507 LGAGGFGAVY--RGVLANRTVVAVKQLE-----GIEQGE--KQFRMEVATISSTHHLNLV 557
LG G F + Y R V T++AVKQ+ EQ E + R E+ ++ +H +++
Sbjct: 8 LGTGAFSSCYQARDVKTG-TLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 558 RLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHE 617
R++G + E H L E+M GS+ + L ++ N RG++YLHE
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII-----NYTEQLLRGLSYLHE 121
Query: 618 ECRDCIVHCDIKPENILLDEN-YNAKVSDFGLAKLINPKDHRHRTLT-SVRGTRGYLAPE 675
+ I+H D+K N+L+D +++DFG A + K + GT ++APE
Sbjct: 122 ---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 676 WLANLPITSKSDVYSYGMVLLEIVSGR 702
L DV+S G V++E+ + +
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 60/220 (27%), Positives = 105/220 (47%), Gaps = 31/220 (14%)
Query: 506 KLGAGGFGAVYRGVLANRT-----VVAVKQLEGIEQGEKQ-FRMEVATISSTHHLNLVRL 559
K+G G FG ++ ++ V+ + + E++ R EVA +S+ H N+V+
Sbjct: 7 KIGEGSFGKAI--LVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 560 VGFSSEGKHRLLVYEFMKNGSL-------DNFLFANEEGSGKLLNWQSRFNIALGTARGI 612
E + +V ++ + G L LF ++ +L+W + +AL
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQ----ILDWFVQICLAL------ 114
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYL 672
++H+ I+H DIK +NI L ++ K+ DFG+A+++N RT GT YL
Sbjct: 115 KHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI---GTPYYL 168
Query: 673 APEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETN 712
+PE N P +KSD+++ G VL E+ + + FE N
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 28/213 (13%)
Query: 506 KLGAGGFGAVYRG---VLANRTVVAVKQLEGIEQGEKQF-RMEVATISSTHHLNLVRLVG 561
K+G G FG +Y + V+ L + EK+ + EV ++ H N+V
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 562 FSSEGKHRLLVYEFMKNGSL-------DNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
E +V E+ G L LF+ ++ +L+W I+LG + +
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ----ILSW--FVQISLG----LKH 116
Query: 615 LHEECRDCIVHCDIKPENILLDEN-YNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLA 673
+H+ I+H DIK +NI L +N AK+ DFG+A+ +N T GT YL+
Sbjct: 117 IHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV---GTPYYLS 170
Query: 674 PEWLANLPITSKSDVYSYGMVLLEIVSGRRNFE 706
PE N P +K+D++S G VL E+ + + FE
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 39/212 (18%)
Query: 510 GGFGAVYRG------------VLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLV 557
G FG+VY VL ++A Q+ + + E+ M +
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNV-KAERAIMM-----IQGESPYVA 60
Query: 558 RLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKL-LNWQSRFNIALGTARGITYLH 616
+L + LV E++ G + + + G L +W ++ G+ LH
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLI----KTLGGLPEDWAKQY--IAEVVLGVEDLH 114
Query: 617 EECRDCIVHCDIKPENILLDENYNAKVSDFGLAK--LINPKDHRHRTLTSVRGTRGYLAP 674
+ I+H DIKPEN+L+D+ + K++DFGL++ L N K GT YLAP
Sbjct: 115 Q---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK---------FVGTPDYLAP 162
Query: 675 EWLANLPITSKSDVYSYGMVLLEIVSGRRNFE 706
E + + SD +S G V+ E + G F
Sbjct: 163 ETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 24/205 (11%)
Query: 503 FKDKLGAGGFGAVYRG-VLANRTVVAVK--QLEGIEQGEKQFRMEVATISSTHHLNLVRL 559
+++ LG G G VY+ L R ++AVK L+ + +KQ E+ + ++
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 560 VG-FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618
G F E + + EFM GSLD + E G+ IA+ +G+TYL
Sbjct: 65 YGAFFVENRISICT-EFMDGGSLDVYRKIPEHVLGR---------IAVAVVKGLTYLWSL 114
Query: 619 CRDCIVHCDIKPENILLDENYNAKVSDFGLA-KLINPKDHRHRTLTSVRGTRGYLAPEWL 677
I+H D+KP N+L++ K+ DFG++ +L+N + GT Y+APE +
Sbjct: 115 K---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN------SIAKTYVGTNAYMAPERI 165
Query: 678 ANLPITSKSDVYSYGMVLLEIVSGR 702
+ SDV+S G+ +E+ GR
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 30/208 (14%)
Query: 507 LGAGGFGAVYRGVLAN-----RTVVAVKQLE--GIEQGEKQFRMEVATISSTHHLNLVRL 559
LG+G FG VY+G+ + VA+K L + K+ E ++ + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEE--GSGKLLNWQSRFNIALGTARGITYLHE 617
+G +L V + M G L +++ N++ GS LLNW + A+G++YL E
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYL-E 126
Query: 618 ECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWL 677
E R +VH D+ N+L+ + K++DFGLA+L++ + T G + +W+
Sbjct: 127 EVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE------TEYHADGGKVPIKWM 178
Query: 678 ANLPI-----TSKSDVYSYGMVLLEIVS 700
A I T +SDV+SYG+ + E+++
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 7e-14
Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 506 KLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFS-- 563
+LGAG G V + ++ ++L +E + + H N +VGF
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 564 --SEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD 621
S+G+ + + E M GSLD L + ++L +++ RG+ YL E+ +
Sbjct: 72 FYSDGEISICM-EHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYLREKHQ- 124
Query: 622 CIVHCDIKPENILLDENYNAKVSDFGLA-KLINPKDHRHRTLTSVRGTRGYLAPEWLANL 680
I+H D+KP NIL++ K+ DFG++ +LI+ S GTR Y++PE L
Sbjct: 125 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID------SMANSFVGTRSYMSPERLQGT 177
Query: 681 PITSKSDVYSYGMVLLEIVSGR 702
+ +SD++S G+ L+E+ GR
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 54/199 (27%), Positives = 100/199 (50%), Gaps = 16/199 (8%)
Query: 506 KLGAGGFGAV--YRGVLANRTVVAVKQLEGIEQGEKQFRM-EVATISSTHHLNLVRLVGF 562
K+G G G V R + R V AVK ++ +Q ++ EV + H N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQV-AVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 563 SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC 622
G+ ++ EF++ G+L + + S LN + + + + YLH +
Sbjct: 87 YLVGEELWVLMEFLQGGALTDIV------SQTRLNEEQIATVCESVLQALCYLHSQG--- 137
Query: 623 IVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPI 682
++H DIK ++ILL + K+SDFG I+ + ++L GT ++APE ++ P
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV---GTPYWMAPEVISRTPY 194
Query: 683 TSKSDVYSYGMVLLEIVSG 701
++ D++S G++++E+V G
Sbjct: 195 GTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 7e-14
Identities = 64/244 (26%), Positives = 107/244 (43%), Gaps = 47/244 (19%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLAN-----------------RTVVAVKQL--EGIE 535
+ R FK+KLG G FG V+ + N +VAVK L + +
Sbjct: 1 KFPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK 60
Query: 536 QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFAN------- 588
F EV +S N++RL+G + ++ E+M+NG L+ FL ++
Sbjct: 61 NARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEE 120
Query: 589 -------EEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNA 641
+++ S ++AL A G+ YL VH D+ N L+ EN
Sbjct: 121 NGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTI 177
Query: 642 KVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPI-----TSKSDVYSYGMVLL 696
K++DFG+++ + D+ ++G R L W+A I T+ SDV+++G+ L
Sbjct: 178 KIADFGMSRNLYAGDYYR-----IQG-RAVLPIRWMAWECILMGKFTTASDVWAFGVTLW 231
Query: 697 EIVS 700
EI+
Sbjct: 232 EILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 7e-14
Identities = 88/345 (25%), Positives = 146/345 (42%), Gaps = 46/345 (13%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYR----GVLANR----TVVAVKQL--EGIEQGEKQFRME 544
EL R+ LG G FG V G+ ++ VAVK L + ++ E
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67
Query: 545 VATISST-HHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEE-------GSGKLL 596
+ + H N++ L+G ++ ++ E+ G+L +L A + KL
Sbjct: 68 MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127
Query: 597 NWQSRF----NIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652
Q F + A ARG+ YL + CI H D+ N+L+ E+ K++DFGLA+ +
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYLASQ--KCI-HRDLAARNVLVTEDNVMKIADFGLARDV 184
Query: 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETN 712
+ D+ +T T+ R ++APE L + T +SDV+S+G++L EI +
Sbjct: 185 HNIDYYKKT-TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT----------LG 233
Query: 713 RKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVV 772
+ EE K +G A ++ +MR C PSQRP ++V
Sbjct: 234 GSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRE------CWHAVPSQRPTFKQLV 287
Query: 773 QMLEGITEIEKPPAPKALT----EGSVGGTSVNMSSSTSALSTFA 813
+ L+ + + L+ + S G S S+ S FA
Sbjct: 288 EDLDRVLTVTSTDEYLDLSVPFEQYSPGCPDSPSSCSSGDDSVFA 332
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 64/274 (23%), Positives = 121/274 (44%), Gaps = 28/274 (10%)
Query: 506 KLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRM----EVATISSTHHLNLVRLV 560
K+G G F VY+ + L + VVA+K+++ E + + R E+ + H N+++ +
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620
E +V E G L + + + +L+ ++ + + + ++H + R
Sbjct: 69 ASFIENNELNIVLELADAGDLSR-MIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK-R 126
Query: 621 DCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL 680
I+H DIKP N+ + K+ D GL + + K +L GT Y++PE +
Sbjct: 127 --IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYYMSPERIHEN 181
Query: 681 PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA-YEEFEKGNVKGIVDKSLAG 739
KSD++S G +L E+ + + F K +L++ ++ EK D
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGD------KMNLYSLCKKIEKC------DYPPLP 229
Query: 740 EDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773
D E++ + CI P +RP + V+Q
Sbjct: 230 ADHYSEELRDLVSR---CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 7e-14
Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 19/202 (9%)
Query: 506 KLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFS-- 563
+LGAG G V++ ++ ++L +E + + H N +VGF
Sbjct: 12 ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 564 --SEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD 621
S+G+ + + E M GSLD L + +G++ Q +++ +G+TYL E+ +
Sbjct: 72 FYSDGEISICM-EHMDGGSLDQVL----KKAGRIPE-QILGKVSIAVIKGLTYLREKHK- 124
Query: 622 CIVHCDIKPENILLDENYNAKVSDFGLA-KLINPKDHRHRTLTSVRGTRGYLAPEWLANL 680
I+H D+KP NIL++ K+ DFG++ +LI+ S GTR Y++PE L
Sbjct: 125 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID------SMANSFVGTRSYMSPERLQGT 177
Query: 681 PITSKSDVYSYGMVLLEIVSGR 702
+ +SD++S G+ L+E+ GR
Sbjct: 178 HYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 8e-14
Identities = 69/209 (33%), Positives = 102/209 (48%), Gaps = 35/209 (16%)
Query: 507 LGAGGFGAVYRGVLANRT--VVAVK--QLEGIEQGEKQFRMEVATISSTHHLNLVRLVG- 561
LGAG G V + VL + ++A K LE Q E+ + H N +VG
Sbjct: 9 LGAGNGGVVTK-VLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVL---HECNSPYIVGF 64
Query: 562 ---FSSEGKHRLLVYEFMKNGSLDNFLFAN----EEGSGKLLNWQSRFNIALGTARGITY 614
F S+G+ + + E M GSLD L E GK I++ RG+TY
Sbjct: 65 YGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPENILGK---------ISIAVLRGLTY 114
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA-KLINPKDHRHRTLTSVRGTRGYLA 673
L E+ + I+H D+KP NIL++ K+ DFG++ +LI+ S GTR Y++
Sbjct: 115 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID------SMANSFVGTRSYMS 166
Query: 674 PEWLANLPITSKSDVYSYGMVLLEIVSGR 702
PE L T +SD++S G+ L+E+ GR
Sbjct: 167 PERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 1e-13
Identities = 38/95 (40%), Positives = 59/95 (62%), Gaps = 6/95 (6%)
Query: 610 RGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRH-RTLTSVRGT 668
RG+ Y+H ++H D+KP N+LL+ N + K+ DFGLA++ +P +H H LT T
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADP-EHDHTGFLTEYVAT 172
Query: 669 RGYLAPEWLANLPITSKS-DVYSYGMVLLEIVSGR 702
R Y APE + N +K+ D++S G +L E++S R
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 68/223 (30%), Positives = 104/223 (46%), Gaps = 38/223 (17%)
Query: 507 LGAGGFGAVYR-GVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLV--RLV--- 560
LG GGFG V V A + A K+LE ++ K+ + E ++ L V R V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLE--KKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 561 GFSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
++ E K L LV M G L ++ E R + Y E C
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEA-------------GFEEGRAVFYAAEIC 112
Query: 620 -------RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYL 672
++ IV+ D+KPENILLD++ + ++SD GLA + P+ +T+ GT GY+
Sbjct: 113 CGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEG---QTIKGRVGTVGYM 168
Query: 673 APEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKK 715
APE + N T D ++ G +L E+++G+ F+ RKK
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ-----QRKK 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 16/206 (7%)
Query: 505 DKLGAGGFGAVYRG---VLANRTVVAVKQLEGIEQGEKQ--FRMEVATISSTHHLNLVRL 559
D++G G FG V G ++ V VK+L ++Q F EV +H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
+G E LLV EF G L N+L +N ++ +A A G+ +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEW--- 676
+ +H D+ N L + + K+ D+GLA P+D+ R +LAPE
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR-WLAPELVEI 176
Query: 677 ----LANLPITSKSDVYSYGMVLLEI 698
L T KS+++S G+ + E+
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 23/225 (10%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRT------VVAVKQLEGIEQG--EKQFRMEVA 546
E+ ST F ++LG FG VY+G L VA+K L+ +G ++F+ E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 547 TISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSG-----------KL 595
S H N+V L+G ++ + +++ + + L FL S
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 596 LNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655
L +I A G+ +L +VH D+ N+L+ + N K+SD GL + +
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS 700
D+ S+ R +++PE + + SD++SYG+VL E+ S
Sbjct: 178 DYYKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 542 RMEVATISSTHHLNLVRLV-GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQS 600
R E ++ H N+V F ++G H +V E+ G L + + GKL +
Sbjct: 46 RKEAVLLAKMKHPNIVAFKESFEADG-HLYIVMEYCDGGDL---MQKIKLQRGKLFPEDT 101
Query: 601 RFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI-NPKDHRH 659
+ G+ ++HE+ ++H DIK +NI L +N K+ DFG A+L+ +P +
Sbjct: 102 ILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY-- 156
Query: 660 RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETN 712
T V GT Y+ PE N+P +KSD++S G +L E+ + + F+ + N
Sbjct: 157 -ACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 17/216 (7%)
Query: 497 QRSTKGFKDKLGAGGFGAVYRGVLANRTV-----VAVKQLEGIEQGEKQFRM---EVATI 548
R D L G FG ++ G+L + V VK ++ E Q + E +
Sbjct: 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLL 62
Query: 549 SSTHHLNLVRLVGFSSEGKHRLLV-YEFMKNGSLDNFLFA---NEEGSGKLLNWQSRFNI 604
H N++ ++ E V Y +M G+L FL E + + L+ Q ++
Sbjct: 63 YGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHM 122
Query: 605 ALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTS 664
A+ A G++YLH + ++H DI N ++DE K++D L++ + P D+
Sbjct: 123 AIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE 179
Query: 665 VRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS 700
R + ++A E L N +S SDV+S+G++L E+++
Sbjct: 180 NRPVK-WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 30/230 (13%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYR----GVLANR----TVVAVKQLEGIEQGEKQF----- 541
E R LG G FG V G+ ++ VAVK L+ + EK
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVS 69
Query: 542 RMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANE-----------E 590
ME+ + H N++ L+G ++ ++ E+ G+L +L A
Sbjct: 70 EMEMMKMIGKHK-NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128
Query: 591 GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650
+ + ++ + ARG+ YL + CI H D+ N+L+ EN K++DFGLA+
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYLASQ--KCI-HRDLAARNVLVTENNVMKIADFGLAR 185
Query: 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS 700
+N D+ +T T+ R ++APE L + T +SDV+S+G+++ EI +
Sbjct: 186 DVNNIDYYKKT-TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLAN----RTVVAVKQLEGIEQGEK--QFRMEVATI 548
E+QR +G G FG VY+GV + + VAVK + +F E +
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61
Query: 549 SSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEG--SGKLLNWQSRFNIAL 606
H ++V+L+G +E +V E G L ++L N+ L+ + + + AL
Sbjct: 62 RQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTAL 120
Query: 607 GTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVR 666
YL E + VH DI N+L+ K+ DFGL++ + D + + +
Sbjct: 121 ------AYL--ESKRF-VHRDIAARNVLVSSPDCVKLGDFGLSRYLE--DESYYKASKGK 169
Query: 667 GTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS 700
++APE + TS SDV+ +G+ + EI+
Sbjct: 170 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 3e-13
Identities = 52/199 (26%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRM-EVATISSTHHLNLVRLVGF 562
+K+G G G VY + +A VA+KQ+ +Q +K+ + E+ + + N+V +
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 563 SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC 622
G +V E++ GSL + + G++ + + + +LH +
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALDFLHS---NQ 135
Query: 623 IVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPI 682
++H DIK +NILL + + K++DFG I P+ + T+ GT ++APE +
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAY 192
Query: 683 TSKSDVYSYGMVLLEIVSG 701
K D++S G++ +E+V G
Sbjct: 193 GPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 53/199 (26%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRM-EVATISSTHHLNLVRLVGF 562
+K+G G G VY + +A VA+KQ+ +Q +K+ + E+ + H N+V +
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 563 SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC 622
G +V E++ GSL + + G++ + + + +LH +
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLHS---NQ 135
Query: 623 IVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPI 682
++H DIK +NILL + + K++DFG I P+ + T+ GT ++APE +
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAY 192
Query: 683 TSKSDVYSYGMVLLEIVSG 701
K D++S G++ +E+V G
Sbjct: 193 GPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 69/217 (31%), Positives = 94/217 (43%), Gaps = 31/217 (14%)
Query: 507 LGAGGFGAVYR-GVLANRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVG 561
LG GGFG V V A + A K+LE +GE E + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 562 FSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC- 619
++ E K L LV M G L F N G R I Y E C
Sbjct: 67 YAYETKDALCLVLTIMNGGDL-KFHIYNMGNPG------------FDEQRAIFYAAELCC 113
Query: 620 ------RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLA 673
R+ IV+ D+KPENILLD+ + ++SD GLA I P+ R GT GY+A
Sbjct: 114 GLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRV---GTVGYMA 169
Query: 674 PEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQE 710
PE + N T D + G ++ E++ G+ F +E
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 29/206 (14%)
Query: 506 KLGAGGFGAVYR------GVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRL 559
+LG G FG VY+ G LA V+ K E +E + +E+ +++ +H +V+L
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED----YMVEIEILATCNHPYIVKL 74
Query: 560 VG-FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618
+G F +GK +++ EF G++D + + G L Q + I + YLH
Sbjct: 75 LGAFYWDGKLWIMI-EFCPGGAVDAIMLELDRG---LTEPQIQV-ICRQMLEALQYLHSM 129
Query: 619 CRDCIVHCDIKPENILLDENYNAKVSDFGL-AKLINPKDHRHRTLTSVRGTRGYLAP--- 674
I+H D+K N+LL + + K++DFG+ AK N K + R S GT ++AP
Sbjct: 130 K---IIHRDLKAGNVLLTLDGDIKLADFGVSAK--NVKTLQRR--DSFIGTPYWMAPEVV 182
Query: 675 --EWLANLPITSKSDVYSYGMVLLEI 698
E + + P K+D++S G+ L+E+
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 4e-13
Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 49/221 (22%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVKQLEGIEQ----GEKQFRMEVATISSTHHLNLVRL-- 559
+G+G +G V V VA+K++ + ++ R E+ + H N++ L
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGLLD 66
Query: 560 --VGFSSEGKHRL-LVYEFM---------KNGSLDN-----FLFANEEGSGKLLNWQSRF 602
S E + + +V E M L + FL+ ++L
Sbjct: 67 ILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLY-------QIL------ 113
Query: 603 NIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTL 662
RG+ YLH ++H D+KP NIL++ N + K+ DFGLA+ ++P + L
Sbjct: 114 -------RGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163
Query: 663 TSVRGTRGYLAPEWLANLPITSKS-DVYSYGMVLLEIVSGR 702
T TR Y APE L + +K+ D++S G + E+++ +
Sbjct: 164 TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 69/250 (27%), Positives = 104/250 (41%), Gaps = 59/250 (23%)
Query: 507 LGAGGFGAVYRGVLANRT----VVAVKQL---EGIEQGEKQ-FRMEVATISSTHHLNLVR 558
+G G FG V+ L V A+K L + I++ + R E ++ +V+
Sbjct: 9 IGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVK 65
Query: 559 LVGFSSEGKHRL-LVYEFMKNGSLDNFL-----FANEEGSGKLLNWQSRFNIALGTARGI 612
L +S + + L LV E+M G L N L F E +RF IA +
Sbjct: 66 LY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET---------ARFYIAELVL-AL 114
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN------------------- 653
+H + +H DIKP+NIL+D + + K++DFGL K +N
Sbjct: 115 DSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 654 -------PKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNF- 705
R S GT Y+APE L P + D +S G++L E++ G F
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231
Query: 706 -EVSQETNRK 714
+ QET K
Sbjct: 232 SDTLQETYNK 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATISS-THHLNLVRLVGF-- 562
+G G +G VY+G + + A+K ++ E E++ ++E+ + +HH N+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83
Query: 563 --SSEGK--HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618
S G LV EF GS+ + L N +G+ +W + I RG+ +LH
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAY--ICREILRGLAHLHAH 140
Query: 619 CRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLA 678
++H DIK +N+LL EN K+ DFG++ ++ R T GT ++APE +A
Sbjct: 141 K---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI---GTPYWMAPEVIA 194
Query: 679 -----NLPITSKSDVYSYGMVLLEIVSG 701
+ +SD++S G+ +E+ G
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 5e-13
Identities = 35/97 (36%), Positives = 60/97 (61%), Gaps = 8/97 (8%)
Query: 610 RGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI--NPKDHRHRTLTSVRG 667
RG+ Y+H ++H D+KP N+L++E+ ++ DFG+A+ + +P +H+ +T
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK-YFMTEYVA 173
Query: 668 TRGYLAPEWLANLP-ITSKSDVYSYGMVLLEIVSGRR 703
TR Y APE L +LP T+ D++S G + E++ GRR
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 5e-13
Identities = 38/100 (38%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 610 RGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR 669
RG+ YLH I+H DIKP N+L++ N K+ DFGLA++ P + +H T V T+
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV--TQ 168
Query: 670 GYLAPEWLANLP-ITSKSDVYSYGMVLLEIVSGRRNFEVS 708
Y APE L TS D++S G + E++ R F+
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ 208
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 61/220 (27%), Positives = 107/220 (48%), Gaps = 44/220 (20%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQLEGI--EQGEKQFRMEV-ATISSTHHLNLVRLV 560
++LG G +G V + + T++AVK++ Q +K+ M++ ++ S V
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 561 G-FSSEGKHRLLVYEFMK--NGSLDNF--------LFANEEGSGKLLNWQSRFNIALGTA 609
G EG V+ M+ + SLD F L E+ GK IA+
Sbjct: 67 GALFREGD----VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGK---------IAVSIV 113
Query: 610 RGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA-KLINPKDHRHRTLTSVRGT 668
+ + YLH + ++H D+KP N+L++ N K+ DFG++ L+ D +T+ + G
Sbjct: 114 KALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTIDA--GC 166
Query: 669 RGYLAPEWLANLPITS------KSDVYSYGMVLLEIVSGR 702
+ Y+APE + P + KSDV+S G+ ++E+ +GR
Sbjct: 167 KPYMAPERIN--PELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 6e-13
Identities = 70/223 (31%), Positives = 106/223 (47%), Gaps = 46/223 (20%)
Query: 503 FKDKLGAGGFGAVYRGVLANRT--VVAVKQLEGIEQGEKQFR---MEVATISSTHHLNLV 557
D+LG G +G+VY+ VL T +A+K++ +E E +F ME+ + +V
Sbjct: 5 VLDELGKGNYGSVYK-VLHRPTGVTMAMKEIR-LELDESKFNQIIMELDILHKAVSPYIV 62
Query: 558 RLVG-FSSEGKHRLLVY---EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGIT 613
G F EG VY E+M GSLD L+A + + R I +G+
Sbjct: 63 DFYGAFFIEGA----VYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRR-ITYAVVKGLK 116
Query: 614 YLHEECRDCIVHCDIKPENILLDENYNAKVSDFG--------LAKLINPKDHRHRTLTSV 665
+L EE I+H D+KP N+L++ N K+ DFG LAK T++
Sbjct: 117 FLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK------------TNI 162
Query: 666 RGTRGYLAPEWL------ANLPITSKSDVYSYGMVLLEIVSGR 702
G + Y+APE + N T +SDV+S G+ +LE+ GR
Sbjct: 163 -GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 7e-13
Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 26/211 (12%)
Query: 507 LGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISS-THHLNLVRLVGFSS 564
+G G +G VY+ +VA+K ++ IE E++ + E + ++H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFI 73
Query: 565 EGKHRL------LVYEFMKNGSLDNFLFANEEGSGKLL--NWQSRFNIALGTARGITYLH 616
+ LV E GS+ + L GK L W + I T RG+ YLH
Sbjct: 74 KKNPPGNDDQLWLVMELCGGGSVTD-LVKGLRKKGKRLKEEWIAY--ILRETLRGLAYLH 130
Query: 617 EECRDCIVHCDIKPENILLDENYNAKVSDFGL-AKLINPKDHRHRTLTSVRGTRGYLAPE 675
E + ++H DIK +NILL +N K+ DFG+ A+L + R T + GT ++APE
Sbjct: 131 E---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST---LGRRNTFI-GTPYWMAPE 183
Query: 676 WLA-----NLPITSKSDVYSYGMVLLEIVSG 701
+A + ++SDV+S G+ +E+ G
Sbjct: 184 VIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 505 DKLGAGGFGAVYRGVLANRT---VVAVKQ--LEGIEQG--EKQFRMEVATISSTHHLNLV 557
+K+G G +G VY+G N+ +VA+K+ LE E+G R E++ + H N+V
Sbjct: 6 EKIGEGTYGVVYKGR--NKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHPNIV 62
Query: 558 RLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHE 617
L + L++EF+ S+D + + G+ ++ + + +GI + H
Sbjct: 63 CLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH- 118
Query: 618 ECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN-PKDHRHRTLTSVRGTRGYLAPEW 676
++H D+KP+N+L+D K++DFGLA+ P R T T Y APE
Sbjct: 119 --SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV----RVYTHEVVTLWYRAPEV 172
Query: 677 LANLPITSKS-DVYSYGMVLLEIVSGRRNFEVSQE 710
L P S D++S G + E+ + + F E
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 9e-13
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 35/210 (16%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVKQL--EGIEQGEKQFRM-EVAT---ISSTHHLNLVRL 559
+G G +G VY+ L VA+K++ E+G + E+A + S H N+VRL
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 560 --VGFSSEGKHRL---LVYEFMKNGSLDNFLFANEEGSG------KLLNWQSRFNIALGT 608
V L LV+E + L +L + G K L Q
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVDQ-DLATYL-SKCPKPGLPPETIKDLMRQ--------L 116
Query: 609 ARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGT 668
RG+ +LH IVH D+KP+NIL+ + K++DFGLA++ + LTSV T
Sbjct: 117 LRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYS----FEMALTSVVVT 169
Query: 669 RGYLAPEWLANLPITSKSDVYSYGMVLLEI 698
Y APE L + D++S G + E+
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 1e-12
Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATISS-THHLNLVRLVG-FS 563
+G G +G VY+G + + A+K ++ E++ + E+ + +HH N+ G F
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 564 SEGKHRL-----LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618
+ + LV EF GS+ + L N +G+ W + I RG+++LH+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH 130
Query: 619 CRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLA 678
++H DIK +N+LL EN K+ DFG++ ++ R T GT ++APE +A
Sbjct: 131 K---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI---GTPYWMAPEVIA 184
Query: 679 -----NLPITSKSDVYSYGMVLLEIVSG 701
+ KSD++S G+ +E+ G
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 77/261 (29%), Positives = 106/261 (40%), Gaps = 71/261 (27%)
Query: 507 LGAGGFGAVYRGVL------ANRTVVAVKQL-EGIEQGEKQFRMEVATI--SSTHHLNLV 557
LG G FG V ++ VAVK L EG E + M I +HLN+V
Sbjct: 15 LGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVV 74
Query: 558 RLVGFSSEGKHRLLV-YEFMKNGSLDNFLFANEEG------------------------- 591
L+G ++ L+V EF K G+L NFL A E
Sbjct: 75 NLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVD 134
Query: 592 ----SGKLLNWQSRFNIALG----------------------------TARGITYLHEEC 619
+G+ SRF + ARG+ +L
Sbjct: 135 RRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL--AS 192
Query: 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN 679
R CI H D+ NILL EN K+ DFGLA+ I KD + S R ++APE + +
Sbjct: 193 RKCI-HRDLAARNILLSENNVVKICDFGLARDIY-KDPDYVRKGSARLPLKWMAPESIFD 250
Query: 680 LPITSKSDVYSYGMVLLEIVS 700
T++SDV+S+G++L EI S
Sbjct: 251 KVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 25/217 (11%)
Query: 497 QRSTKGFKDKLGAGGFGAVY------RGVLANRT--VVAVKQLEGIEQGEKQ---FRMEV 545
+R K +D LG G FG V G + T VAVK L+ E G + E+
Sbjct: 3 KRFLKRIRD-LGEGHFGKVELCRYDPEG---DNTGEQVAVKSLKP-ESGGNHIADLKKEI 57
Query: 546 ATISSTHHLNLVRLVGFSSEGKHR--LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFN 603
+ + +H N+V+ G +E L+ EF+ +GSL +L N+ +N + +
Sbjct: 58 EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK----INLKQQLK 113
Query: 604 IALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLT 663
A+ +G+ YL VH D+ N+L++ + K+ DFGL K I +
Sbjct: 114 YAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 170
Query: 664 SVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS 700
+ + APE L SDV+S+G+ L E+++
Sbjct: 171 DLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 28/213 (13%)
Query: 505 DKLGAGGFGAVYRGV--LANRTVVAVK-QLEGIEQGEKQFRM-EVATISSTHHLNLVRLV 560
+K+G G +G VY+ + N T+ K +LE ++G + E++ + H N+VRL
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFL-----FANEEGSGKLLNWQSRFNIALGTARGITYL 615
K LV+E++ + L + FA K +Q RGI Y
Sbjct: 68 DVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQ--------ILRGIAYC 118
Query: 616 HEECRDCIVHCDIKPENILLDENYNA-KVSDFGLAKLIN-PKDHRHRTLTSVRGTRGYLA 673
H R ++H D+KP+N+L+D NA K++DFGLA+ P RT T T Y A
Sbjct: 119 HSH-R--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV----RTFTHEVVTLWYRA 171
Query: 674 PE-WLANLPITSKSDVYSYGMVLLEIVSGRRNF 705
PE L + ++ D++S G + E+V+ + F
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLF 204
|
Length = 294 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 2e-12
Identities = 32/80 (40%), Positives = 38/80 (47%), Gaps = 2/80 (2%)
Query: 72 TYSGGVPIWTAGS-TPVDSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLN-VTSASLDDS 129
S +W A P SS L S G L + GSG ++W SNT R+N L D
Sbjct: 37 KGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDD 96
Query: 130 GNLVLLKNGGVSAWSSFDNP 149
GNLVL + G W SFD P
Sbjct: 97 GNLVLYDSDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 27/205 (13%)
Query: 506 KLGAGGFGAVYR------GVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRL 559
+LG G FG VY+ GVLA V+ K E +E + +E+ ++S H N+V+L
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELED----YMVEIDILASCDHPNIVKL 67
Query: 560 V-GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618
+ F E +L+ EF G++D + E L Q R + T + YLHE
Sbjct: 68 LDAFYYENNLWILI-EFCAGGAVDAVMLELER---PLTEPQIRV-VCKQTLEALNYLHE- 121
Query: 619 CRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWL- 677
+ I+H D+K NIL + + K++DFG++ N + + R S GT ++APE +
Sbjct: 122 --NKIIHRDLKAGNILFTLDGDIKLADFGVSAK-NTRTIQRR--DSFIGTPYWMAPEVVM 176
Query: 678 ----ANLPITSKSDVYSYGMVLLEI 698
+ P K+DV+S G+ L+E+
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 63/221 (28%), Positives = 110/221 (49%), Gaps = 27/221 (12%)
Query: 492 SYKELQRSTKGFKDKLGAGGFGAVYRGVLANRT---VVAVKQLE-GIEQGEKQFRM-EVA 546
++K+L+ KLG G + VY+G NRT +VA+K++ E+G + E++
Sbjct: 1 NFKQLE--------KLGEGTYATVYKG--RNRTTGEIVALKEIHLDAEEGTPSTAIREIS 50
Query: 547 TISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIAL 606
+ H N+VRL +LV+E+M L ++ + N F L
Sbjct: 51 LMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQL 109
Query: 607 GTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN-PKDHRHRTLTSV 665
+GI + HE + ++H D+KP+N+L+++ K++DFGLA+ P + T ++
Sbjct: 110 --LKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN----TFSNE 160
Query: 666 RGTRGYLAPEWLANLPITSKS-DVYSYGMVLLEIVSGRRNF 705
T Y AP+ L S S D++S G ++ E+++GR F
Sbjct: 161 VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF 201
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 505 DKLGAGGFGAVYRG-VLANRTVVAVKQ--LEGIEQGEKQFRMEVATISSTHHLNLVRLVG 561
DKLG G + VY+G +VA+K+ LE E EV+ + H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 562 FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD 621
K LV+E++ + L +L + G +N + RG+ Y H R
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYL----DDCGNSINMHNVKLFLFQLLRGLNYCH---RR 123
Query: 622 CIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPE-WLANL 680
++H D+KP+N+L++E K++DFGLA+ K +T ++ T Y P+ L +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYRPPDILLGST 180
Query: 681 PITSKSDVYSYGMVLLEIVSGRRNF 705
+++ D++ G + E+ +GR F
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 68/216 (31%), Positives = 96/216 (44%), Gaps = 19/216 (8%)
Query: 507 LGAGGFGAVYR-GVLANRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVG 561
LG GGFG V V A + A K+LE +GE E + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66
Query: 562 FSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620
++ E K L LV M G L F N G + A G+ LH E
Sbjct: 67 YAYETKDALCLVLTIMNGGDL-KFHIYNMGNPG--FEEERALFYAAEILCGLEDLHREN- 122
Query: 621 DCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH-RHRTLTSVRGTRGYLAPEWLAN 679
V+ D+KPENILLD+ + ++SD GLA I + R R GT GY+APE L N
Sbjct: 123 --TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV-----GTVGYMAPEVLNN 175
Query: 680 LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKK 715
T D + G ++ E++ G+ F +E +++
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 5e-12
Identities = 63/236 (26%), Positives = 107/236 (45%), Gaps = 39/236 (16%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVY----------------RGVLANRTV-VAVKQL--EGIE 535
E R FK+KLG G FG V+ V N+ V VAVK L + +
Sbjct: 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60
Query: 536 QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANE------ 589
F E+ +S N++RL+ ++ E+M+NG L+ FL +E
Sbjct: 61 NARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAE 120
Query: 590 EGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649
+ +++ + +A A G+ YL VH D+ N L+ +NY K++DFG++
Sbjct: 121 KADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLANLPI-----TSKSDVYSYGMVLLEIVS 700
+ + D+ ++G R L W++ I T+ SDV+++G+ L EI++
Sbjct: 178 RNLYSGDYYR-----IQG-RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 50/199 (25%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRM-EVATISSTHHLNLVRLVGF 562
+K+G G G VY + +A VA++Q+ +Q +K+ + E+ + + N+V +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 563 SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC 622
G +V E++ GSL + + G++ + + + +LH +
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLHS---NQ 136
Query: 623 IVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPI 682
++H DIK +NILL + + K++DFG I P+ + T+ GT ++APE +
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAY 193
Query: 683 TSKSDVYSYGMVLLEIVSG 701
K D++S G++ +E++ G
Sbjct: 194 GPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 33/209 (15%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVK--QLEGIEQGEKQFRMEVATISSTHHL---NLVRLV 560
+G G +GAVYRG + VVA+K L+ + + EVA +S N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFN--IALGTARGITYLHEE 618
G +G ++ E+ + GS+ + A G + ++ I + Y+H
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKA-----GPI---AEKYISVIIREVLVALKYIH-- 118
Query: 619 CRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLA 678
+ ++H DIK NIL+ N K+ DFG+A L+N + T GT P W+A
Sbjct: 119 -KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV---GT-----PYWMA 169
Query: 679 NLPIT------SKSDVYSYGMVLLEIVSG 701
IT +K+D++S G+ + E+ +G
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-12
Identities = 71/225 (31%), Positives = 103/225 (45%), Gaps = 32/225 (14%)
Query: 492 SYKELQRSTK------GFKDKLGAGGFGAVYRGVLANRTV--VAVKQLEG---IEQGE-K 539
S KE +R K F LG G FG V N VA+K+ E I+Q +
Sbjct: 17 STKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVD 76
Query: 540 QFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQ 599
E ++ +H V L G + + LV EF+ G FL N+
Sbjct: 77 HVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK---------- 126
Query: 600 SRFNIALGT--ARGITYLHEECRDC-IVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656
RF +G A I + E + IV+ D+KPEN+LLD++ K++DFG AK++ D
Sbjct: 127 -RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---D 182
Query: 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSG 701
R TL GT Y+APE L N+ +D ++ G+ + EI+ G
Sbjct: 183 TRTYTLC---GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 68/209 (32%), Positives = 94/209 (44%), Gaps = 27/209 (12%)
Query: 501 KGFKD--KLGAGGFGAVY--RGVLANRTVVAVKQL--EGIEQGEK--QFRMEVATISSTH 552
K F D ++G G FGAVY R V VVA+K++ G + EK EV +
Sbjct: 15 KLFTDLREIGHGSFGAVYFARDVR-TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 553 HLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGI 612
H N + G LV E+ GS + L E K L I G +G+
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYCL-GSASDIL----EVHKKPLQEVEIAAICHGALQGL 128
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYL 672
YLH R +H DIK NILL E K++DFG A L++P + S GT ++
Sbjct: 129 AYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-------SFVGTPYWM 178
Query: 673 APEWLANL---PITSKSDVYSYGMVLLEI 698
APE + + K DV+S G+ +E+
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 67/216 (31%), Positives = 99/216 (45%), Gaps = 29/216 (13%)
Query: 507 LGAGGFGAVYR-GVLANRTVVAVKQL----------EGIEQGEKQFRMEVATISSTHHLN 555
LG GGFG V V A + A K+L E + EKQ +V +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR------- 60
Query: 556 LVRLVGFSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
V + ++ E K L LV M G L ++ G+ ++ F A T G+
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--NMGNPGFDEERAVFYAAEITC-GLED 117
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAP 674
LH R+ IV+ D+KPENILLD+ + ++SD GLA I + T+ GT GY+AP
Sbjct: 118 LH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE----TIRGRVGTVGYMAP 170
Query: 675 EWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQE 710
E + N T D + G ++ E++ G+ F +E
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 9e-12
Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 507 LGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVA------TISSTHHLNLVRLV 560
+G G FG V + + R + L+ I + R EV T+ + + + +
Sbjct: 1 IGKGSFGKVMQ--VRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58
Query: 561 GFSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIA-LGTARGITYLHEE 618
FS + +L LV F+ G L F + + G+ ++RF A L A + LH+
Sbjct: 59 KFSFQSPEKLYLVLAFINGGEL----FHHLQREGRFDLSRARFYTAELLCA--LENLHKF 112
Query: 619 CRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLA 678
+++ D+KPENILLD + + DFGL KL D + T GT YLAPE L
Sbjct: 113 N---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC---GTPEYLAPELLL 166
Query: 679 NLPITSKSDVYSYGMVLLEIVSG 701
T D ++ G++L E+++G
Sbjct: 167 GHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 31/210 (14%)
Query: 507 LGAGGFGAVYRG-VLANRTVVAVKQLEGIEQGEKQFR--MEVATISSTHHL-NLVRLVGF 562
+G+G G VY+ V+AVKQ+ E+ R M++ + +H +V+ G+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82
Query: 563 SSEGKHRLLVYEFMKNGSLDNFL-----FANEEGSGKLLNWQSRFNIALGTARGITYLHE 617
+ E M LD L E+ GK + + + + YL E
Sbjct: 83 FITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGK---------MTVAIVKALHYLKE 132
Query: 618 ECRDCIVHCDIKPENILLDENYNAKVSDFGLA-KLINPKDHRHRTLTSVRGTRGYLAPEW 676
+ ++H D+KP NILLD + N K+ DFG++ +L++ K T G Y+APE
Sbjct: 133 K--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK-----TRSAGCAAYMAPER 185
Query: 677 LANLPITSK----SDVYSYGMVLLEIVSGR 702
+ K +DV+S G+ L+E+ +G+
Sbjct: 186 IDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 25/204 (12%)
Query: 506 KLGAGGFGAVYRGVLANRT----VVAVKQL--EGIEQGEK--QFRMEVATISSTHHLNLV 557
++G GG+G V+ LA + +VA+K++ + + + E +++T LV
Sbjct: 8 QVGQGGYGQVF---LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLV 64
Query: 558 RLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHE 617
+L+ + ++ L E++ G L G L +RF +A + LHE
Sbjct: 65 KLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFE-AVDALHE 119
Query: 618 ECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWL 677
+H D+KPEN L+D + + K++DFGL+K I + SV G+ Y+APE L
Sbjct: 120 LG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN------SVVGSPDYMAPEVL 170
Query: 678 ANLPITSKSDVYSYGMVLLEIVSG 701
D +S G +L E + G
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 1e-11
Identities = 61/208 (29%), Positives = 106/208 (50%), Gaps = 22/208 (10%)
Query: 506 KLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQ----GEKQFRMEVATISS-THHLNLVRL 559
KLG G +G V++ + + VVA+K++ + ++ FR E+ + H N+V+L
Sbjct: 14 KLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKL 72
Query: 560 --VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHE 617
V + K LV+E+M+ L + AN L + R+ I + + Y+H
Sbjct: 73 LNVIKAENDKDIYLVFEYMET-DLHAVIRAN-----ILEDVHKRY-IMYQLLKALKYIHS 125
Query: 618 ECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN--PKDHRHRTLTSVRGTRGYLAPE 675
++H D+KP NILL+ + K++DFGLA+ ++ ++ + LT TR Y APE
Sbjct: 126 GN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPE 182
Query: 676 WLANLPITSKS-DVYSYGMVLLEIVSGR 702
L +K D++S G +L E++ G+
Sbjct: 183 ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-11
Identities = 38/108 (35%), Positives = 45/108 (41%), Gaps = 4/108 (3%)
Query: 45 NQSWPSPNSTFSLSFIQRSPNSFIPAITY--SGGVPIWTAGST-PVDSSAFFQLHSSGTL 101
Q+ S NS F L F + I Y S +W A PV S L S G L
Sbjct: 7 GQTLVSGNSLFELGFFTLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNL 66
Query: 102 RLISGSGAIIWDSNTQRLN-VTSASLDDSGNLVLLKNGGVSAWSSFDN 148
L G G ++W SNT N L D GNLV+ + G W SFD
Sbjct: 67 VLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 14/215 (6%)
Query: 507 LGAGGFGAVYRGVL-ANRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVG 561
LG GGFG V + A + A K+L +G + +E ++ H +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 562 FSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620
++ + K L LV M G L ++ +E + ++ F A G+ +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTA-QIISGLEHLHQRR- 117
Query: 621 DCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL 680
I++ D+KPEN+LLD + N ++SD GLA + KD + +T GT G++APE L
Sbjct: 118 --IIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKT-KGYAGTPGFMAPELLQGE 172
Query: 681 PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKK 715
D ++ G+ L E+++ R F E K
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 505 DKLGAGGFGAVYRG-VLANRTVVAVKQ--LEGIEQGEKQFRMEVATISSTHHLNLVRLVG 561
DKLG G + V++G +VA+K+ LE E EV+ + + H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 562 FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD 621
+ LV+E++ + L +L + G L++ + RG++Y H+
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYL----DNCGNLMSMHNVKIFMFQLLRGLSYCHKRK-- 123
Query: 622 CIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPE-WLANL 680
I+H D+KP+N+L++E K++DFGLA+ K +T ++ T Y P+ L +
Sbjct: 124 -ILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGST 179
Query: 681 PITSKSDVYSYGMVLLEIVSGRRNF 705
++ D++ G +L E+ +GR F
Sbjct: 180 EYSTPIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 49/199 (24%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRM-EVATISSTHHLNLVRLVGF 562
+K+G G G V+ + +A VA+KQ+ +Q +K+ + E+ + + N+V +
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 563 SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC 622
G +V E++ GSL + + + ++ + + + +LH +
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVV------TETCMDEAQIAAVCRECLQALEFLHA---NQ 135
Query: 623 IVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPI 682
++H DIK +N+LL + + K++DFG I P+ + T+ GT ++APE +
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAY 192
Query: 683 TSKSDVYSYGMVLLEIVSG 701
K D++S G++ +E+V G
Sbjct: 193 GPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 505 DKLGAGGFGAVYRG-VLANRTVVAVKQ--LEGIEQGEKQFRMEVATISSTHHLNLVRLVG 561
+KLG G + V++G +VA+K+ LE E EV+ + H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 562 FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD 621
K LV+E+ LD L + G +++ + RG+ Y H R
Sbjct: 72 IVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RR 123
Query: 622 CIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPE-WLANL 680
++H D+KP+N+L++E K++DFGLA+ K +T ++ T Y P+ L +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSS 180
Query: 681 PITSKSDVYSYGMVLLEIVSGRRNF 705
+++ D++ G + E+ SGR F
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 42/225 (18%)
Query: 498 RSTKGFK--DKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQ------FRMEVATI 548
RS F+ +++G G +G VYR + +VA+K++ ++ E+ R E+ +
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR-MDN-ERDGIPISSLR-EITLL 60
Query: 549 SSTHHLNLVRLVGFSSEGKHR---LLVYEFMKNGSLDNFLFANEEGSGKLL-NWQSRFN- 603
+ H N+V L GKH LV E+ E+ LL N + F+
Sbjct: 61 LNLRHPNIVELKEVVV-GKHLDSIFLVMEYC------------EQDLASLLDNMPTPFSE 107
Query: 604 -----IALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658
+ L RG+ YLHE I+H D+K N+LL + K++DFGLA+
Sbjct: 108 SQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK- 163
Query: 659 HRTLTSVRGTRGYLAPEWL-ANLPITSKSDVYSYGMVLLEIVSGR 702
T V T Y APE L T+ D+++ G +L E+++ +
Sbjct: 164 PMTPKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 68/219 (31%), Positives = 105/219 (47%), Gaps = 33/219 (15%)
Query: 507 LGAGGFGAVYRGVLANRT----VVAVKQL--EGIEQGEKQFRMEVATISSTHHLNLVR-- 558
LG G FG V LA + AVK L + I Q + +E T++ L L
Sbjct: 3 LGKGSFGKVL---LAELKGTDELYAVKVLKKDVILQDDD---VE-CTMTEKRVLALAGKH 55
Query: 559 --LVGFSS--EGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGIT 613
L S + K RL V E++ G L +F + SG+ ++RF A G+
Sbjct: 56 PFLTQLHSCFQTKDRLFFVMEYVNGGDL---MFHIQR-SGRFDEPRARF-YAAEIVLGLQ 110
Query: 614 YLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL-INPKDHRHRTLTSVRGTRGYL 672
+LHE R I++ D+K +N+LLD + K++DFG+ K I T ++ GT Y+
Sbjct: 111 FLHE--RG-IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFCGTPDYI 163
Query: 673 APEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQET 711
APE L+ P D ++ G++L E+++G+ FE E
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED 202
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 52/164 (31%), Positives = 79/164 (48%), Gaps = 12/164 (7%)
Query: 544 EVATISSTHHLNLVRLVGFSSEGKHRLL--VYEFMKNGSLDNFLFANEEGSGKLLNWQSR 601
E +S H N+V S EG+ LL V F + G L + L +E GKLL
Sbjct: 49 EAQLLSQLKHPNIV-AYRESWEGEDGLLYIVMGFCEGGDLYHKL---KEQKGKLLPENQV 104
Query: 602 FNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRT 661
+ A + YLHE+ I+H D+K +N+ L KV D G+A+++ + T
Sbjct: 105 VEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST 161
Query: 662 LTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNF 705
L GT Y++PE +N P KSDV++ G + E+ + + F
Sbjct: 162 LI---GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAF 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 69/221 (31%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 507 LGAGGFGAVYRGVLANR----TVVAVK--QLEGIEQGEKQFRMEVATISSTHH--LNLVR 558
+G G FG V LA AVK Q + I + + E I + + L V+
Sbjct: 3 IGKGSFGKVL---LAKHKADGKFYAVKVLQKKAILK-----KKEQKHIMAERNVLLKNVK 54
Query: 559 ---LVG--FSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGI 612
LVG +S + +L V +++ G L F E S ++RF A A +
Sbjct: 55 HPFLVGLHYSFQTADKLYFVLDYVNGGEL--FFHLQRERS--FPEPRARF-YAAEIASAL 109
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL-INPKDHRHRTLTSVRGTRGY 671
YLH I++ D+KPENILLD + ++DFGL K I T ++ GT Y
Sbjct: 110 GYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK----TTSTFCGTPEY 162
Query: 672 LAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETN 712
LAPE L P D + G VL E++ G F S++T
Sbjct: 163 LAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRDTA 202
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 6e-11
Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 27/212 (12%)
Query: 505 DKLGAGGFGAVYRGVLANRT---VVAVKQL------EGIEQGEKQFRMEVATISSTHHLN 555
+K+G G +G VY+ N+ VVA+K++ EG+ + E++ + +H N
Sbjct: 6 EKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPN 60
Query: 556 LVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYL 615
+V+L+ LV+EF+ + L F+ A+ SG L + L +G+ +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASP-LSGIPLPLIKSYLFQL--LQGLAFC 116
Query: 616 HEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN-PKDHRHRTLTSVRGTRGYLAP 674
H R ++H D+KP+N+L++ K++DFGLA+ P RT T T Y AP
Sbjct: 117 HSH-R--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV----RTYTHEVVTLWYRAP 169
Query: 675 EWLANLPITSKS-DVYSYGMVLLEIVSGRRNF 705
E L S + D++S G + E+V+ R F
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 35/97 (36%), Positives = 54/97 (55%), Gaps = 10/97 (10%)
Query: 610 RGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR 669
RG+ Y+H +VH D+KP NIL++EN + K+ DFGLA+ +D + +T TR
Sbjct: 119 RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR---IQDPQ---MTGYVSTR 169
Query: 670 GYLAPE-WLANLPITSKSDVYSYGMVLLEIVSGRRNF 705
Y APE L + D++S G + E++ G+ F
Sbjct: 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 62/201 (30%), Positives = 90/201 (44%), Gaps = 23/201 (11%)
Query: 506 KLGAGGFGAVYRGVLANRT-VVAVKQLE--GIEQGEK--QFRMEVATISSTHHLNLVRLV 560
++G G FGAVY ++ VVAVK++ G + EK EV + H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620
G + LV E+ GS + L E K L I G +G+ YLH
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLL----EVHKKPLQEVEIAAITHGALQGLAYLHSHN- 141
Query: 621 DCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL 680
++H DIK NILL E K++DFG A +P + S GT ++APE + +
Sbjct: 142 --MIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN-------SFVGTPYWMAPEVILAM 192
Query: 681 ---PITSKSDVYSYGMVLLEI 698
K DV+S G+ +E+
Sbjct: 193 DEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 8e-11
Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 30/208 (14%)
Query: 505 DKLGAGGFGAVYRG-VLANRTVVAVKQL----EGIEQGEKQFRMEVATISSTHHLNLVRL 559
K+G G F V + A+K + + +EQ R A + H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRL 63
Query: 560 VGFSSEGKH-RL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHE 617
+ + K RL LV+E M D L+ +G + L + + + + ++H
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH- 117
Query: 618 ECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWL 677
R+ I H DIKPENIL+ + K++DFG + I + T TR Y APE L
Sbjct: 118 --RNGIFHRDIKPENILIK-DDILKLADFGSCRGI----YSKPPYTEYISTRWYRAPECL 170
Query: 678 ANLPITS-----KSDVYSYGMVLLEIVS 700
+T K D+++ G V EI+S
Sbjct: 171 ----LTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 9e-11
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 33/212 (15%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQ--LEGIEQG--EKQFRMEVATISSTHHLNLVRL 559
+K+G G +G VY+ +VA+K+ LE ++G R E++ + +H N+VRL
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELNHPNIVRL 63
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
+ LV+EF LD L K ++ S L +YL++
Sbjct: 64 LDVVHSENKLYLVFEF-----LDLDL-------KKYMD--SSPLTGLDPPLIKSYLYQLL 109
Query: 620 RD---C----IVHCDIKPENILLDENYNAKVSDFGLAKLIN-PKDHRHRTLTSVRGTRGY 671
+ C ++H D+KP+N+L+D K++DFGLA+ P RT T T Y
Sbjct: 110 QGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV----RTYTHEVVTLWY 165
Query: 672 LAPEWLANLPITSKS-DVYSYGMVLLEIVSGR 702
APE L S D++S G + E+V+ R
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 35/215 (16%)
Query: 507 LGAGGFGAVYRGVLANR-----------TVVAVKQLEGIEQGEKQFRMEVATISSTHHLN 555
LG G F +Y+GVL + V +K L + F + +S H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 556 LVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYL 615
LV+L G ++ ++V E++K G LD FL + E + L+W + ++A A + YL
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPLDVFL--HREKNNVSLHW--KLDVAKQLASALHYL 117
Query: 616 HEECRDCIVHCDIKPENILL-----DENYN--AKVSDFGLAKLINPKDHRHRTLTSVRGT 668
++ +VH ++ +NIL+ +E Y K+SD G+ + ++ R +
Sbjct: 118 EDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP----- 169
Query: 669 RGYLAPEWLANLP--ITSKSDVYSYGMVLLEIVSG 701
++APE + N +T +D +S+G LLEI S
Sbjct: 170 --WIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-10
Identities = 55/226 (24%), Positives = 100/226 (44%), Gaps = 35/226 (15%)
Query: 495 ELQRSTKGFKDK------LGAGGFGAVYRGVLA-NRTVVAVKQL----EGIEQGEKQFRM 543
EL ++ D+ +G+G +G V VA+K+L + ++ +R
Sbjct: 5 ELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR- 63
Query: 544 EVATISSTHHLNLVRLVGFSSEGKHR------LLVYEFMKNGSLDNFLFANEEGSGKLLN 597
E+ + H N++ L+ + LV M L+N + KL +
Sbjct: 64 ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIV-----KCQKLSD 117
Query: 598 WQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657
+F + RG+ Y+H I+H D+KP NI ++E+ K+ DFGLA+ + +
Sbjct: 118 DHIQF-LVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-- 171
Query: 658 RHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGR 702
+T TR Y APE + N + D++S G ++ E+++G+
Sbjct: 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 69/276 (25%), Positives = 124/276 (44%), Gaps = 30/276 (10%)
Query: 506 KLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRM----EVATISSTHHLNLVRLV 560
K+G G F VYR L +R VA+K+++ E + + R E+ + +H N+++ +
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL 68
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFL--FANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618
E +V E G L + F ++ +L+ ++ + + + ++H
Sbjct: 69 DSFIEDNELNIVLELADAGDLSQMIKYFKKQK---RLIPERTVWKYFVQLCSAVEHMHSR 125
Query: 619 CRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLA 678
++H DIKP N+ + K+ D GL + + K +L GT Y++PE +
Sbjct: 126 R---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYYMSPERIH 179
Query: 679 NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738
KSD++S G +L E+ + + F + N FSL ++ E+ + L
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNL--FSLC--QKIEQCDY-----PPLP 229
Query: 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774
E + +R + VS CI P QRP +G V Q+
Sbjct: 230 TEHY--SEKLREL-VSM-CIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 507 LGAGGFGAVYRGVLANR-TVVAVKQLE---GIEQGEKQ---FRMEVATISSTHHLNLVRL 559
LG G FG VY A+ +AVKQ+ ++ K+ E+ + + H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 560 VGFSSEGKHRLL--VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHE 617
G + + + L E+M GS+ + L A + + +R +G++YLH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR-----QILQGVSYLHS 124
Query: 618 ECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWL 677
+ IVH DIK NIL D N K+ DFG +K I + SV GT +++PE +
Sbjct: 125 ---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 678 ANLPITSKSDVYSYGMVLLEIVS 700
+ K+DV+S ++E+++
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 69/217 (31%), Positives = 104/217 (47%), Gaps = 30/217 (13%)
Query: 507 LGAGGFGAVYRGVLANR----TVVAVKQLEG---IEQGEKQFRMEVATI--SSTHHLNLV 557
+G G FG V +LA R + AVK L+ +++ E+ M + + H LV
Sbjct: 3 IGKGSFGKV---LLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 558 RLVGFSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLH 616
L +S + +L V +++ G L F + + L ++RF A A I YLH
Sbjct: 60 GL-HYSFQTAEKLYFVLDYVNGGEL----FFHLQRERCFLEPRARF-YAAEVASAIGYLH 113
Query: 617 EECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL-INPKDHRHRTLTSVRGTRGYLAPE 675
I++ D+KPENILLD + ++DFGL K + P++ T ++ GT YLAPE
Sbjct: 114 SLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE----TTSTFCGTPEYLAPE 166
Query: 676 WLANLPITSKSDVYSYGMVLLEIVSGRRNF---EVSQ 709
L P D + G VL E++ G F +VSQ
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 59/224 (26%), Positives = 104/224 (46%), Gaps = 56/224 (25%)
Query: 505 DKLGAGGFGAVYRGVLANR---TVVAVK--QLEGIEQGEKQFRM-EVATISSTHHLNLVR 558
+K+G G +G V++ NR +VA+K +L+ ++G + E+ + H N+VR
Sbjct: 6 EKIGEGTYGTVFKAK--NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVR 63
Query: 559 LVGFSSEGKHRLLVYEF----MK------NGSLD-----NFLFANEEGSGKLLNWQSRFN 603
L K LV+E+ +K NG +D +F+F +LL
Sbjct: 64 LYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMF-------QLL------- 109
Query: 604 IALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL--INPKDHRHRT 661
+G+ + H ++H D+KP+N+L+++N K++DFGLA+ I + +
Sbjct: 110 ------KGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEV 160
Query: 662 LTSVRGTRGYLAPEWL--ANLPITSKSDVYSYGMVLLEIVSGRR 703
+ T Y P+ L A L TS D++S G + E+ + R
Sbjct: 161 V-----TLWYRPPDVLFGAKLYSTS-IDMWSAGCIFAELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 507 LGAGGFGAVYRGVLANR-TVVAVKQL----EGIEQGEK--QFRMEVATISSTHHLNLVRL 559
LG G FG VY A+ +AVKQ+ E E ++ E+ + + H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 560 VGFSSEGKHRLL--VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHE 617
G + R L E M GS+ + L + + + +R G++YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR-----QILEGVSYLHS 124
Query: 618 ECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWL 677
+ IVH DIK NIL D N K+ DFG +K + + SV GT +++PE +
Sbjct: 125 ---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 678 ANLPITSKSDVYSYGMVLLEIVSGR 702
+ K+D++S G ++E+++ +
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 46/203 (22%), Positives = 92/203 (45%), Gaps = 26/203 (12%)
Query: 515 VYRGVLANRTVVAVKQLEGIEQGEK----QFRMEVATISSTHHLNLVRLVGFSSEGKHRL 570
+Y+G+ N+ V+ ++ + +G K E+ + N++++ GF + L
Sbjct: 36 IYKGIFNNKEVI-IRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 571 ----LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHC 626
L+ E+ G L L K L+++++ ++A+ +G+ L++ +
Sbjct: 95 PRLSLILEYCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYK 147
Query: 627 DIKPENILLDENYNAKVSDFGLAK-LINPKDHRHRTLTSVRGTRGYLAPEWLANL--PIT 683
++ + L+ ENY K+ GL K L +P + Y + + L ++ T
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-------YFSYKMLNDIFSEYT 200
Query: 684 SKSDVYSYGMVLLEIVSGRRNFE 706
K D+YS G+VL EI +G+ FE
Sbjct: 201 IKDDIYSLGVVLWEIFTGKIPFE 223
|
Length = 283 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 71/223 (31%), Positives = 106/223 (47%), Gaps = 32/223 (14%)
Query: 507 LGAGGFGAVYRGVLANRT--VVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVR------ 558
+G G FG VY+ V T + A+K L E K+ EVA ++ LVR
Sbjct: 1 IGKGTFGQVYQ-VRKKDTRRIYAMKVLSKKEIVAKK---EVAHTIGERNI-LVRTLLDES 55
Query: 559 --LVG--FSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGIT 613
+VG FS + L LV ++M G L F + + G+ +++F IA +
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGEL----FWHLQKEGRFSEDRAKFYIA-ELVLALE 110
Query: 614 YLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLA 673
+LH+ IV+ D+KPENILLD + + DFGL+K ++T + GT YLA
Sbjct: 111 HLHK---YDIVYRDLKPENILLDATGHIALCDFGLSK---ANLTDNKTTNTFCGTTEYLA 164
Query: 674 PE-WLANLPITSKSDVYSYGMVLLEIVSGRRNF--EVSQETNR 713
PE L T D +S G+++ E+ G F E +Q+ R
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYR 207
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 29/224 (12%)
Query: 507 LGAGGFGAVYRGVLANRTV-VAVKQL----EGIEQGEKQFRMEVATISSTHHLNLVRLVG 561
+G+G +G+V + VAVK+L + I ++ +R E+ + H N++ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83
Query: 562 FSSEGKHR------LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYL 615
+ + LV M L+N + KL + +F I RG+ Y+
Sbjct: 84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLI-YQILRGLKYI 136
Query: 616 HEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPE 675
H I+H D+KP N+ ++E+ K+ DFGLA+ H +T TR Y APE
Sbjct: 137 HSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMTGYVATRWYRAPE 187
Query: 676 WLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSL 718
+ N + D++S G ++ E+++GR F + ++ K L
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 231
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 63/209 (30%), Positives = 93/209 (44%), Gaps = 27/209 (12%)
Query: 501 KGFKD--KLGAGGFGAVY--RGVLANRTVVAVKQLE--GIEQGEK--QFRMEVATISSTH 552
K F D ++G G FGAVY R V + VVA+K++ G + EK EV +
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSE-VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 553 HLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGI 612
H N ++ G LV E+ GS + L E K L + G +G+
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLL----EVHKKPLQEVEIAAVTHGALQGL 128
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYL 672
YLH ++H D+K NILL E K+ DFG A ++ P + GT ++
Sbjct: 129 AYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-------XFVGTPYWM 178
Query: 673 APEWLANL---PITSKSDVYSYGMVLLEI 698
APE + + K DV+S G+ +E+
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 16/212 (7%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVKQL---EGIEQGEKQFRMEVATISSTHHLNLVRLV-G 561
+G G +G V + + +VA+K+ E E+ ++ E+ + + N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 562 FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD 621
F GK LV+E+++ L+ E +G + L + I + H ++
Sbjct: 69 FRRRGK-LYLVFEYVEKNMLE---LLEEMPNGVPPEKVRSYIYQL--IKAIHWCH---KN 119
Query: 622 CIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLP 681
IVH DIKPEN+L+ N K+ DFG A+ N + + T TR Y +PE L P
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFAR--NLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 682 ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNR 713
D++S G +L E+ G+ F E ++
Sbjct: 178 YGKAVDMWSVGCILGELSDGQPLFPGESEIDQ 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 8e-10
Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 19/214 (8%)
Query: 504 KDKLGAGGFGAVYRGVLANRTVVA---VKQLEGIEQGE------KQFRMEVATISSTHHL 554
+ +LG G FG VY ++ ++ VA +K L+ I GE Q E +S H
Sbjct: 5 QQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 555 NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
+V+ E ++ E+ + LD + +GK L+ + G+ Y
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLD-CKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAP 674
+H+ I+H D+K +NI L N K+ DFG+++L+ T T GT Y++P
Sbjct: 122 MHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFT---GTPYYMSP 174
Query: 675 EWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVS 708
E L + SKSD++S G +L E+ FE
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 9e-10
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 507 LGAGGFGAVYRGVLANR-TVVAVKQLEG----IEQGEKQFRMEVATIS--STHHLNLVRL 559
+G GGFG VY A+ + A+K L+ ++QGE E +S ST +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 560 VGFSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618
+ ++ +L + + M G L L + G + RF A G+ ++H
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQH----GVFSEAEMRF-YAAEIILGLEHMHNR 116
Query: 619 CRDCIVHCDIKPENILLDENYNAKVSDFGLA-KLINPKDHRHRTLTSVRGTRGYLAPEWL 677
+V+ D+KP NILLDE+ + ++SD GLA K H SV GT GY+APE L
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH-----ASV-GTHGYMAPEVL 167
Query: 678 AN-LPITSKSDVYSYGMVLLEIVSGRRNFE 706
+ S +D +S G +L +++ G F
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 47/242 (19%)
Query: 489 VQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLANRT--VVAVKQLEGIEQGE---KQFRM 543
V Y++L+ ++G+G +G V L RT VA+K+L Q E K+
Sbjct: 13 VPDRYRDLK--------QVGSGAYGTVCSA-LDRRTGAKVAIKKLYRPFQSELFAKRAYR 63
Query: 544 EVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNF----LFANEEGS--GKLLN 597
E+ + H N++ L+ F + SLD F L G+ GKL+
Sbjct: 64 ELRLLKHMKHENVIGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMK 111
Query: 598 WQ----SRFN-IALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652
+ R + +G+ Y+H I+H D+KP N+ ++E+ K+ DFGLA+
Sbjct: 112 HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-- 166
Query: 653 NPKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQET 711
+T TR Y APE + N + T D++S G ++ E+++G+ F+
Sbjct: 167 ----QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL 222
Query: 712 NR 713
++
Sbjct: 223 DQ 224
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 27/209 (12%)
Query: 501 KGFKD--KLGAGGFGAVY--RGVLANRTVVAVKQLE--GIEQGEK--QFRMEVATISSTH 552
K F D ++G G FGAVY R V N VVA+K++ G + EK EV +
Sbjct: 25 KLFTDLREIGHGSFGAVYFARDVRTNE-VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK 83
Query: 553 HLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGI 612
H N + G LV E+ GS + L E K L I G +G+
Sbjct: 84 HPNSIEYKGCYLREHTAWLVMEYCL-GSASDLL----EVHKKPLQEVEIAAITHGALQGL 138
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYL 672
YLH ++H DIK NILL E K++DFG A + +P + S GT ++
Sbjct: 139 AYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPAN-------SFVGTPYWM 188
Query: 673 APEWLANL---PITSKSDVYSYGMVLLEI 698
APE + + K DV+S G+ +E+
Sbjct: 189 APEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 31/99 (31%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 610 RGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP-KDHRHRTLTSVRGT 668
G+ Y+H ++H D+KP N+L++ + K+ DFGLA+ + +T T
Sbjct: 116 CGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 669 RGYLAPE-WLANLPITSKSDVYSYGMVLLEIVSGRRNFE 706
R Y APE L+ T DV+S G +L E++ + F+
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFK 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 38/92 (41%), Positives = 54/92 (58%), Gaps = 4/92 (4%)
Query: 609 ARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGT 668
ARG+ +L R CI H D+ NILL EN K+ DFGLA+ I KD + R
Sbjct: 183 ARGMEFL--ASRKCI-HRDLAARNILLSENNVVKICDFGLARDIY-KDPDYVRKGDARLP 238
Query: 669 RGYLAPEWLANLPITSKSDVYSYGMVLLEIVS 700
++APE + + T++SDV+S+G++L EI S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 490 QFSYKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGE--KQFRMEVAT 547
Q Y+ +QR +G+G +G VY+ + +A ++ +E G+ + E+
Sbjct: 8 QHDYELIQR--------VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFM 59
Query: 548 ISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALG 607
+ H N+V G + + E+ GSL + +G L Q + +
Sbjct: 60 VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV----TGPLSELQIAY-VCRE 114
Query: 608 TARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRG 667
T +G+ YLH + + +H DIK NILL +N + K++DFG+A I + ++ G
Sbjct: 115 TLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI---G 168
Query: 668 TRGYLAPEWLA---NLPITSKSDVYSYGMVLLEI 698
T ++APE A N D+++ G+ +E+
Sbjct: 169 TPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 507 LGAGGFGAVY--RGVLANRTVVAVKQL----EGIEQGEK--QFRMEVATISSTHHLNLVR 558
LG G FG VY V R + A KQ+ E E ++ E+ + + H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGREL-AAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 559 LVG-FSSEGKHRLLVY-EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLH 616
G + L ++ E+M GS+ + L A G L +R G++YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA----YGALTESVTR-KYTRQILEGMSYLH 123
Query: 617 EECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEW 676
+ IVH DIK NIL D N K+ DFG +K + + SV GT +++PE
Sbjct: 124 S---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 677 LANLPITSKSDVYSYGMVLLEIVSGR 702
++ K+DV+S G ++E+++ +
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 34/89 (38%), Positives = 49/89 (55%), Gaps = 7/89 (7%)
Query: 610 RGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR 669
RG+ +LH +CIVH D+KPENIL+ K++DFGLA++ + LT V T
Sbjct: 119 RGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIYS----CQMALTPVVVTL 171
Query: 670 GYLAPEWLANLPITSKSDVYSYGMVLLEI 698
Y APE L + D++S G + E+
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-09
Identities = 48/171 (28%), Positives = 78/171 (45%), Gaps = 36/171 (21%)
Query: 623 IVHCDIKPENILLDENYNAKVSDFGLAKLINP--KDHRHRTLTSVRGTRGYLAPEWLANL 680
++H DIK NILL N K+ DFG +K+ D RT GT Y+APE
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC---GTPYYVAPEIWRRK 220
Query: 681 PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGE 740
P + K+D++S G++L E+++ +R F+ N++ ++ K+LAG
Sbjct: 221 PYSKKADMFSLGVLLYELLTLKR-------------------PFDGENMEEVMHKTLAGR 261
Query: 741 ----DVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM------LEGITEI 781
I M+ I + + P +RP K++ M + G+ EI
Sbjct: 262 YDPLPPSISPEMQEIVTAL--LSSDPKRRPSSSKLLNMPICKLFISGLLEI 310
|
Length = 496 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 505 DKLGAGGFGAVYRGVLANR---TVVAVKQLEGIEQGEKQFRMEVATISS-THHLNLVRLV 560
+ +G G +G VY+ + N+ ++ AVK L+ I +++ E + S +H N+V+
Sbjct: 28 ETIGKGTYGKVYK--VTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFY 85
Query: 561 GFSSEGKHRL-----LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYL 615
G + + LV E GS+ L G+ L+ I G G+ +L
Sbjct: 86 GMFYKADKLVGGQLWLVLELCNGGSVTE-LVKGLLICGQRLDEAMISYILYGALLGLQHL 144
Query: 616 HEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPE 675
H + I+H D+K NILL K+ DFG++ + R R TSV GT ++APE
Sbjct: 145 HN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST--RLRRNTSV-GTPFWMAPE 198
Query: 676 WLA-----NLPITSKSDVYSYGMVLLEIVSG 701
+A + ++ DV+S G+ +E+ G
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 8/95 (8%)
Query: 610 RGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR 669
RG+ Y+H ++H D+KP N+LL+ N + K+ DFGLA+ + K +T TR
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEK---GDFMTEYVVTR 172
Query: 670 GYLAPEWLANLP-ITSKSDVYSYGMVLLEIVSGRR 703
Y APE L N T+ DV+S G + E++ GR+
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 507 LGAGGFGAVYRGVLANR-TVVAVKQLEG----IEQGEKQFRMEVATIS--STHHLNLVRL 559
+G GGFG VY A+ + A+K L+ ++QGE E +S ST +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 560 VGFSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618
+ ++ +L + + M G L L + S K + RF A G+ ++H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEK----EMRF-YATEIILGLEHMHNR 116
Query: 619 CRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLA 678
+V+ D+KP NILLDE+ + ++SD GLA D + + GT GY+APE L
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYMAPEVLQ 168
Query: 679 N-LPITSKSDVYSYGMVLLEIVSGRRNF 705
S +D +S G +L +++ G F
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 31/217 (14%)
Query: 507 LGAGGFGAVYRGVLANRT----VVAVKQLEG---IEQGEKQFRM---EVATISSTHHLNL 556
LG G FG V +LA V A+K L+ ++ + M + +++ H L
Sbjct: 3 LGKGSFGKV---MLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPF-L 58
Query: 557 VRLVGFSS-EGKHRLL-VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
L + K RL V E++ G L +F + S K +SRF A T + +
Sbjct: 59 TAL--HCCFQTKDRLFFVMEYVNGGDL---MFQIQR-SRKFDEPRSRFYAAEVTL-ALMF 111
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL-INPKDHRHRTLTSVRGTRGYLA 673
LH R +++ D+K +NILLD + K++DFG+ K I T T+ GT Y+A
Sbjct: 112 LH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG----VTTTTFCGTPDYIA 164
Query: 674 PEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQE 710
PE L L D ++ G+++ E+++G+ FE E
Sbjct: 165 PEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 69/257 (26%), Positives = 107/257 (41%), Gaps = 64/257 (24%)
Query: 507 LGAGGFGAVYRGVLANRT--VVAVKQLEGIEQGEKQ----FRMEVATISSTHHLNLVRLV 560
+G G FG V R V T + A+K+L E EK+ R E ++ + +V+L
Sbjct: 9 IGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67
Query: 561 GFSSEGKHRL-LVYEFMKNGSLDNFL-----FANEEGSGKLLNWQSRFNIALGTARGITY 614
+S + ++ L L+ E++ G + L F EE +RF IA T I
Sbjct: 68 -YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE---------TRFYIA-ETILAIDS 116
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK------------------------ 650
+H+ +H DIKP+N+LLD + K+SDFGL
Sbjct: 117 IHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173
Query: 651 -LINPKDHRHRTLT----------SVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIV 699
+ P + + T S GT Y+APE + D +S G+++ E++
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
Query: 700 SGRRNF--EVSQETNRK 714
G F + QET RK
Sbjct: 234 VGYPPFCSDNPQETYRK 250
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 48/207 (23%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 506 KLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRM----EVATISSTHHLNLVRLV 560
K+G G F VYR L + VA+K+++ + + + R E+ + +H N+++
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFL--FANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618
E +V E G L + F ++ +L+ ++ + + + ++H
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQK---RLIPEKTVWKYFVQLCSALEHMHSR 125
Query: 619 CRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLA 678
++H DIKP N+ + K+ D GL + + K +L GT Y++PE +
Sbjct: 126 R---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYYMSPERIH 179
Query: 679 NLPITSKSDVYSYGMVLLEIVSGRRNF 705
KSD++S G +L E+ + + F
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 5e-09
Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 36/216 (16%)
Query: 507 LGAGGFGAVY--RGVLANRTVVAVKQL---EGIEQGEKQFRMEVATISSTHHLN---LVR 558
+G G FG V R +++ V A+K L E I++ + F E I + H N +V+
Sbjct: 51 IGRGAFGEVQLVRHK-SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA--HANSEWIVQ 107
Query: 559 LVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNI-----ALGTARGIT 613
L + K+ +V E+M G L N L +N + K W +RF AL +
Sbjct: 108 LHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEK---W-ARFYTAEVVLALDAIHSMG 162
Query: 614 YLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLA 673
++H D+KP+N+LLD++ + K++DFG ++ + R T+V GT Y++
Sbjct: 163 FIHR---------DVKPDNMLLDKSGHLKLADFGTCMKMD-ANGMVRCDTAV-GTPDYIS 211
Query: 674 PEWLANLPITS----KSDVYSYGMVLLEIVSGRRNF 705
PE L + + D +S G+ L E++ G F
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 506 KLGAGGFGAVYRGVL---ANRTVVAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRLV 560
++G G FG V G + V VK+L Q + +F E S H NL++ +
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620
G +E LLV EF G L +L + + + + +A A G+ +LH +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---K 118
Query: 621 DCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH---RHRTLTSVRGTRGYLAPEWL 677
+ +H D+ N LL + K+ D+GL+ +D+ + +R ++APE +
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR----WIAPELV 174
Query: 678 ----ANLPI---TSKSDVYSYGMVLLEI 698
NL + T +S+V+S G+ + E+
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-09
Identities = 69/249 (27%), Positives = 104/249 (41%), Gaps = 51/249 (20%)
Query: 507 LGAGGFGAVYRGVLANRT--VVAVKQLEGIEQGEKQ----FRMEVATISSTHHLNLVRLV 560
+G G FG V R V T V A+K L + EK+ R E + L +V++
Sbjct: 9 IGRGAFGEV-RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67
Query: 561 GFSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
+S + K L L+ EF+ G + L + L +++F IA T I +H+
Sbjct: 68 -YSFQDKLNLYLIMEFLPGGDMMTLLMKKD----TLTEEETQFYIA-ETVLAIDSIHQLG 121
Query: 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN---------------PKDHRHRTLTS 664
+H DIKP+N+LLD + K+SDFGL + P D + + S
Sbjct: 122 ---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 665 VR-----------------GTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNF-- 705
R GT Y+APE D +S G+++ E++ G F
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238
Query: 706 EVSQETNRK 714
E QET +K
Sbjct: 239 ETPQETYKK 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 61/227 (26%), Positives = 108/227 (47%), Gaps = 37/227 (16%)
Query: 505 DKLGAGGFGAVYRGVLANRT--VVAVKQLEGIEQGEKQFRM----EVATISSTHHLNLVR 558
++G G +G VY+ T +VA+K++ ++ ++ F + E+ + +H N+V
Sbjct: 13 GQIGEGTYGQVYKAR-DKDTGELVALKKVR-LDNEKEGFPITAIREIKILRQLNHRNIVN 70
Query: 559 L----------VGFSSEGKHRLLVYEFMKN---GSLDNFLFA-NEEGSGKLLNWQSRFNI 604
L + F + LV+E+M + G L++ L +E+ + +S
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED------HIKSFMKQ 124
Query: 605 ALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTS 664
L G+ Y H++ +H DIK NILL+ K++DFGLA+L N ++ R T
Sbjct: 125 LL---EGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 665 VRGTRGYLAPEWLANLPITSKS-DVYSYGMVLLEIVSGRRNFEVSQE 710
+ T Y PE L + DV+S G +L E+ + + F+ +QE
Sbjct: 179 I--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 507 LGAGGFGAVYRGVLANRTVVAVKQLEGIEQ--GEKQFRMEVATISSTHHLNLVRLVGFSS 564
LG G FG V+ + +L+G Q K + +V + +V S
Sbjct: 3 LGKGSFGKVF-----------LAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 51
Query: 565 EGKHRLLVYEFMKNGSLDNFLFANE--EGSGKLLNWQS--RFNIALGT------ARGITY 614
+H L + + + +N F E G + + QS +F++ T G+ +
Sbjct: 52 AWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQF 111
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAP 674
LH + IV+ D+K +NILLD + + K++DFG+ K D + T GT Y+AP
Sbjct: 112 LHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC---GTPDYIAP 165
Query: 675 EWLANLPITSKSDVYSYGMVLLEIVSGRRNF 705
E L + D +S+G++L E++ G+ F
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 6e-09
Identities = 47/172 (27%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 506 KLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEK--QFRMEVATISSTHHLNLVRLVGFS 563
++G+G +G VY+ N +A ++ +E GE + E+ + H N+V G
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 564 SEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCI 623
+ EF GSL + +G L Q + ++ T +G+ YLH + +
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYHV----TGPLSESQIAY-VSRETLQGLYYLHSKGK--- 127
Query: 624 VHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPE 675
+H DIK NILL +N + K++DFG++ I + ++ GT ++APE
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI---GTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-09
Identities = 53/190 (27%), Positives = 78/190 (41%), Gaps = 24/190 (12%)
Query: 521 ANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGS 580
R V VK + G + ++ + + TIS H ++ L+ V M
Sbjct: 117 EQRKKVIVKAVTGGKTPGREIDI-LKTIS---HRAIINLIHAYRWKS---TVCMVMPKYK 169
Query: 581 LDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYN 640
D F + + G L + I + YLH I+H D+K ENI LDE N
Sbjct: 170 CDLFTYVDRSGP---LPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPEN 223
Query: 641 AKVSDFGLA-KLI----NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVL 695
A + DFG A KL P+ + GT +PE LA P +K+D++S G+VL
Sbjct: 224 AVLGDFGAACKLDAHPDTPQCY------GWSGTLETNSPELLALDPYCAKTDIWSAGLVL 277
Query: 696 LEIVSGRRNF 705
E+
Sbjct: 278 FEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 7e-09
Identities = 32/103 (31%), Positives = 58/103 (56%), Gaps = 8/103 (7%)
Query: 609 ARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL-INPKDHRHRTLTSVRG 667
A G+ +LH + I++ D+K +N++LD + K++DFG+ K I T + G
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFCG 163
Query: 668 TRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQE 710
T Y+APE +A P D +++G++L E+++G+ F+ E
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 206
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 7e-09
Identities = 56/218 (25%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 498 RSTKGFK--DKLGAGGFGAVYRGVLANRT--VVAVKQLEGIEQGEKQFRM----EVATIS 549
RS ++ +++ G +G VYR +T +VA+K+L+ +E+ ++ F + E+ +
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRA-RDKKTGEIVALKKLK-MEKEKEGFPITSLREINILL 59
Query: 550 STHHLNLVRL--VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQS-RFNIAL 606
H N+V + V S +V E++++ L + + E L QS + L
Sbjct: 60 KLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLM---ETMKQPFL--QSEVKCLML 113
Query: 607 GTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI-NPKDHRHRTLTSV 665
G+ +LH+ + I+H D+K N+LL+ K+ DFGLA+ +P + T +
Sbjct: 114 QLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL----KPYTQL 166
Query: 666 RGTRGYLAPEWLANLPI-TSKSDVYSYGMVLLEIVSGR 702
T Y APE L ++ D++S G + E+++ +
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 67/235 (28%), Positives = 105/235 (44%), Gaps = 57/235 (24%)
Query: 507 LGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEV---ATI--------------- 548
LG GG+G V++ V+++ G + G K F M+V ATI
Sbjct: 4 LGKGGYGKVFQ----------VRKVTGADTG-KIFAMKVLKKATIVRNQKDTAHTKAERN 52
Query: 549 --SSTHHLNLVRLV-GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLN-----WQS 600
+ H +V L+ F + GK L+ E++ G L F + E G + + S
Sbjct: 53 ILEAVKHPFIVDLIYAFQTGGK-LYLILEYLSGGEL----FMHLEREGIFMEDTACFYLS 107
Query: 601 RFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHR 660
++AL +LH++ I++ D+KPENILLD + K++DFGL K +
Sbjct: 108 EISLALE------HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158
Query: 661 TLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKK 715
T GT Y+APE L D +S G ++ ++++G F NRKK
Sbjct: 159 TFC---GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE---NRKK 207
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 47/153 (30%), Positives = 81/153 (52%), Gaps = 16/153 (10%)
Query: 559 LVGFSS--EGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYL 615
LVG S + RL LV E++ G L +F + + KL +RF A + +L
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MF-HMQRQRKLPEEHARF-YAAEICIALNFL 112
Query: 616 HEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL-INPKDHRHRTLTSVRGTRGYLAP 674
HE I++ D+K +N+LLD + + K++D+G+ K + P D T ++ GT Y+AP
Sbjct: 113 HERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD----TTSTFCGTPNYIAP 165
Query: 675 EWLANLPITSKSDVYSYGMVLLEIVSGRRNFEV 707
E L D ++ G+++ E+++GR F++
Sbjct: 166 EILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-09
Identities = 74/253 (29%), Positives = 106/253 (41%), Gaps = 59/253 (23%)
Query: 507 LGAGGFGAVYRGVLANRT--VVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVG--- 561
+G G FG V R V T + A+K L + EK+ +VA I + + LV G
Sbjct: 9 IGRGAFGEV-RLVQKKDTGHIYAMKILRKADMLEKE---QVAHIRAERDI-LVEADGAWV 63
Query: 562 ----FSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLH 616
+S + K L L+ EF+ G + L + L ++F IA T I +H
Sbjct: 64 VKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD----TLSEEATQFYIA-ETVLAIDAIH 118
Query: 617 EECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR---HRTLT---------- 663
+ +H DIKP+N+LLD + K+SDFGL + K HR +R LT
Sbjct: 119 QLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK-KAHRTEFYRNLTHNPPSDFSFQ 174
Query: 664 --------------------SVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRR 703
S GT Y+APE D +S G+++ E++ G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 704 NF--EVSQETNRK 714
F E QET RK
Sbjct: 235 PFCSETPQETYRK 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 25/216 (11%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQ--LEGIEQG--EKQFRMEVATISS-THHLNLVR 558
+K+G G +G VY+ +VA+K+ LE E+G R E++ + + + +VR
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSESIYIVR 65
Query: 559 LVGF----SSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGIT 613
L+ GK L LV+E++ + L F+ +N G G+ L ++ + +G+
Sbjct: 66 LLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 614 YLHEECRDCIVHCDIKPENILLDENYNA-KVSDFGLAK--LINPKDHRHRTLTSVRGTRG 670
+ H+ ++H D+KP+N+L+D+ K++D GL + I K + H + T
Sbjct: 125 HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-----TLW 176
Query: 671 YLAPE-WLANLPITSKSDVYSYGMVLLEIVSGRRNF 705
Y APE L + ++ D++S G + E+ + F
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 68/206 (33%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 507 LGAGGFGAVYRGVLANRTV----VAVKQLEG---IEQGEKQFRMEVATI--SSTHHLNLV 557
+G G FG V +LA R + AVK L+ + + E++ M + + H LV
Sbjct: 3 IGKGSFGKV---LLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 558 RLVGFSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLH 616
L +S + +L V +F+ G L F E S ++RF A A + YLH
Sbjct: 60 GL-HYSFQTTEKLYFVLDFVNGGEL--FFHLQRERS--FPEPRARFYAA-EIASALGYLH 113
Query: 617 EECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL-INPKDHRHRTLTSVRGTRGYLAPE 675
IV+ D+KPENILLD + ++DFGL K I D T T+ GT YLAPE
Sbjct: 114 SIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD----TTTTFCGTPEYLAPE 166
Query: 676 WLANLPITSKSDVYSYGMVLLEIVSG 701
+ P + D + G VL E++ G
Sbjct: 167 VIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 54/175 (30%), Positives = 80/175 (45%), Gaps = 35/175 (20%)
Query: 609 ARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGT 668
A+G+ +L R CI H D+ NILL EN K+ DFGLA+ I KD + R
Sbjct: 189 AKGMEFL--ASRKCI-HRDLAARNILLSENNVVKICDFGLARDIY-KDPDYVRKGDARLP 244
Query: 669 RGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAY------- 721
++APE + + T +SDV+S+G++L EI FSL A
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI-----------------FSLGASPYPGVKI 287
Query: 722 -EEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQML 775
EEF + +G ++ ++ Q M C +PSQRP ++V+ L
Sbjct: 288 DEEFCRRLKEGTRMRAPDYTTPEMYQTM------LDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 44/143 (30%), Positives = 75/143 (52%), Gaps = 11/143 (7%)
Query: 568 HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCD 627
H V EF+ G L +F ++ G+ +++ F A G+ +LH + I++ D
Sbjct: 70 HLFFVMEFLNGGDL---MFHIQD-KGRFDLYRATF-YAAEIVCGLQFLHSKG---IIYRD 121
Query: 628 IKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSD 687
+K +N++LD + + K++DFG+ K D+R T GT Y+APE L L T D
Sbjct: 122 LKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC---GTPDYIAPEILQGLKYTFSVD 178
Query: 688 VYSYGMVLLEIVSGRRNFEVSQE 710
+S+G++L E++ G+ F E
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGDDE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 19/168 (11%)
Query: 609 ARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGT 668
A+G+++L ++CI H D+ NILL K+ DFGLA+ I D + + R
Sbjct: 224 AKGMSFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIR-NDSNYVVKGNARLP 279
Query: 669 RGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN 728
++APE + N T +SDV+SYG++L EI S + + K F K
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK---------FYKMI 330
Query: 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776
+G S ++ +M++ C P +RP ++VQ++E
Sbjct: 331 KEGYRMLSPECAPSEMYDIMKS------CWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 65/234 (27%), Positives = 101/234 (43%), Gaps = 48/234 (20%)
Query: 507 LGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEV---ATI----SSTHH------ 553
LG G +G V+ V+++ G + G K + M+V ATI + H
Sbjct: 8 LGTGAYGKVF----------LVRKVGGHDAG-KLYAMKVLKKATIVQKAKTAEHTRTERQ 56
Query: 554 -LNLVR----LV----GFSSEGK-HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFN 603
L VR LV F ++ K H L+ +++ G L L+ E + R
Sbjct: 57 VLEAVRRCPFLVTLHYAFQTDTKLH--LILDYVNGGELFTHLYQRE----HFTESEVRVY 110
Query: 604 IALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLT 663
IA + +LH+ I++ DIK ENILLD + ++DFGL+K + R
Sbjct: 111 IA-EIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA-EEEERA-Y 164
Query: 664 SVRGTRGYLAPEWLANLPI--TSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKK 715
S GT Y+APE + D +S G++ E+++G F V E N +
Sbjct: 165 SFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 38/120 (31%), Positives = 66/120 (55%), Gaps = 11/120 (9%)
Query: 593 GKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652
GK Q+ F A + G+ +LH R I++ D+K +N++LD + K++DFG+ K
Sbjct: 96 GKFKEPQAVF-YAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-- 149
Query: 653 NPKDHRHRTLTSVR--GTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQE 710
+H +T+ GT Y+APE +A P D ++YG++L E+++G+ F+ E
Sbjct: 150 ---EHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 206
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 64/203 (31%), Positives = 93/203 (45%), Gaps = 21/203 (10%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVKQLEG---IEQGEKQFRMEVATI--SSTHHLNLVRLV 560
+G G FG V A AVK L+ +++ E++ M + + H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61
Query: 561 GFSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
FS + +L V +++ G L F + + L ++RF A A + YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARF-YAAEIASALGYLHSLN 116
Query: 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKL-INPKDHRHRTLTSVRGTRGYLAPEWLA 678
IV+ D+KPENILLD + ++DFGL K I T ++ GT YLAPE L
Sbjct: 117 ---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG----TTSTFCGTPEYLAPEVLH 169
Query: 679 NLPITSKSDVYSYGMVLLEIVSG 701
P D + G VL E++ G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 505 DKLGAGGFGAVYRG-VLANRTVVAVKQLEGIEQGEKQFRM--EVATISSTHHLNLVRLVG 561
+KLG G + VY+G N +VA+K + E+ F E + + H N+V L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 562 FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD 621
+ LV+E++ D + ++ G F L RG++Y+H+
Sbjct: 71 IIHTKETLTLVFEYVHT---DLCQYMDKHPGGLHPENVKLFLFQL--LRGLSYIHQRY-- 123
Query: 622 CIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPE-WLANL 680
I+H D+KP+N+L+ + K++DFGLA+ + H T ++ T Y P+ L +
Sbjct: 124 -ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH---TYSNEVVTLWYRPPDVLLGST 179
Query: 681 PITSKSDVYSYGMVLLEIVSGRRNF 705
++ D++ G + +E++ G F
Sbjct: 180 EYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 40/138 (28%), Positives = 72/138 (52%), Gaps = 11/138 (7%)
Query: 568 HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCD 627
H V E++ G L +F + SG+ ++RF A G+ +LH + I++ D
Sbjct: 70 HLFFVMEYLNGGDL---MFHIQS-SGRFDEARARF-YAAEIICGLQFLH---KKGIIYRD 121
Query: 628 IKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSD 687
+K +N+LLD++ + K++DFG+ K + ++ GT Y+APE L D
Sbjct: 122 LKLDNVLLDKDGHIKIADFGMCKE---NMNGEGKASTFCGTPDYIAPEILKGQKYNESVD 178
Query: 688 VYSYGMVLLEIVSGRRNF 705
+S+G++L E++ G+ F
Sbjct: 179 WWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 63/222 (28%), Positives = 99/222 (44%), Gaps = 30/222 (13%)
Query: 544 EVATISSTHHLNLVRLVGFSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRF 602
E + +T H L L +S + RL V E+ G L F + E ++RF
Sbjct: 45 ESRVLQNTRHPFLTAL-KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV--FSEDRARF 99
Query: 603 NIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRH-RT 661
A + YLH D +V+ D+K EN++LD++ + K++DFGL K + T
Sbjct: 100 YGA-EIVSALGYLHS--CD-VVYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGAT 151
Query: 662 LTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAY 721
+ + GT YLAPE L + D + G+V+ E++ GR F +Q+ K F L
Sbjct: 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHE-KLFELILM 209
Query: 722 EEFE---------KGNVKGIVDKS----LAGEDVDIEQVMRA 750
EE K + G++ K L G D +++M
Sbjct: 210 EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 3e-08
Identities = 55/246 (22%), Positives = 98/246 (39%), Gaps = 41/246 (16%)
Query: 506 KLGAGGFGAVYRGVLANRT---VVAVKQLEGIEQGEKQFRM----EVATISSTHHLNLVR 558
+G G +G VY+ N A+K+ +G ++ E+A + H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 559 LVG--FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFN---IALGTAR--- 610
LV K L++++ E +++ + + I +
Sbjct: 67 LVEVFLEHADKSVYLLFDYA------------EHDLWQIIKFHRQAKRVSIPPSMVKSLL 114
Query: 611 -----GITYLHEECRDCIVHCDIKPENILL----DENYNAKVSDFGLAKLINPKDHRHRT 661
G+ YLH + ++H D+KP NIL+ E K+ D GLA+L N
Sbjct: 115 WQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171
Query: 662 LTSVRGTRGYLAPE-WLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA 720
L V T Y APE L T D+++ G + E+++ F+ + KK + +
Sbjct: 172 LDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKI-KKSNPFQ 230
Query: 721 YEEFEK 726
++ E+
Sbjct: 231 RDQLER 236
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 28/211 (13%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGE---KQFRMEVATISSTHHLNLVRLVG- 561
+G+G +G+V + VA+K+L Q E K+ E+ + H N++ L+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 562 FSSEGKHR-----LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLH 616
F+S LV +M+ E + L +Q G+ Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQ--------MLCGLKYIH 134
Query: 617 EECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEW 676
I+H D+KP N+ ++E+ K+ DFGLA+ H +T TR Y APE
Sbjct: 135 SAG---IIHRDLKPGNLAVNEDCELKILDFGLAR------HADAEMTGYVVTRWYRAPEV 185
Query: 677 LAN-LPITSKSDVYSYGMVLLEIVSGRRNFE 706
+ N + D++S G ++ E+++G+ F+
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 505 DKLGAGGFGAVYRGVL--ANRTVVAVKQLEGIEQGEKQFRMEVATISS-THHLNLVRLVG 561
+ +G G +G V++ VL N + AVK L+ I +++ E + + + H N+V+ G
Sbjct: 24 ETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYG 82
Query: 562 F-----SSEGKHRLLVYEFMKNGSLDN----FLFANEEGSGKLLNWQSRFNIALGTARGI 612
G LV E GS+ + FL E ++ + I G+
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-----ILHEALMGL 137
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL-AKLINPKDHRHRTLTSVRGTRGY 671
+LH + +H D+K NILL K+ DFG+ A+L + R R TSV GT +
Sbjct: 138 QHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST---RLRRNTSV-GTPFW 190
Query: 672 LAPEWLA-----NLPITSKSDVYSYGMVLLEIVSG 701
+APE +A + ++ DV+S G+ +E+ G
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 54/218 (24%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKL--LNWQSRFNIALGTARGITYLHEE 618
GFSS+G + + + S + +EE + L+ + A+G+ +L
Sbjct: 172 GFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL--A 229
Query: 619 CRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLA 678
++CI H D+ N+LL + AK+ DFGLA+ I D + + R ++APE +
Sbjct: 230 SKNCI-HRDVAARNVLLTDGRVAKICDFGLARDIM-NDSNYVVKGNARLPVKWMAPESIF 287
Query: 679 NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738
+ T +SDV+SYG++L EI S ++ N K + + ++G D +
Sbjct: 288 DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM-----VKRGYQMSRPDFAP- 341
Query: 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776
+I +M+ C +P++RP ++ Q+++
Sbjct: 342 ---PEIYSIMKM------CWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 52/215 (24%), Positives = 98/215 (45%), Gaps = 32/215 (14%)
Query: 505 DKLGAGGFGAVYRGVL--------ANRTVVAVKQLEGIEQGEKQFRMEVATI-SSTHHLN 555
+ LG G F +++G+ ++T V +K L+ + + E A++ S H +
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 556 LVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYL 615
LV G G ++V E++K GSLD +L N L+N + +A A + +L
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKN----KNLINISWKLEVAKQLAWALHFL 116
Query: 616 HEECRDCIVHCDIKPENILLDENYNA--------KVSDFGLAKLINPKDHRHRTLTSVRG 667
++ + H ++ +N+LL + K+SD G++ + PK+ +
Sbjct: 117 EDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP---- 169
Query: 668 TRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSG 701
++ PE + N ++ +D +S+G L EI SG
Sbjct: 170 ---WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 36/226 (15%)
Query: 507 LGAGGFGAVYRGVLAN-RTVVAVKQLEGIE-QGEKQFRMEVATISSTHHLNLVRLVGFSS 564
LG G G V+ V ++ VAVK++ + Q K E+ I H N+V++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 565 EGKHRL--------------LVYEFMKNGSLDNFLFANE--EGSGKLLNWQSRFNIALGT 608
L +V E+M+ L N L E +L +Q
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQ--------L 123
Query: 609 ARGITYLHEECRDCIVHCDIKPENILLD-ENYNAKVSDFGLAKLINPKDHRHRT-LTSVR 666
RG+ Y+H ++H D+KP N+ ++ E+ K+ DFGLA++++P + H+ L+
Sbjct: 124 LRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDP-HYSHKGYLSEGL 179
Query: 667 GTRGYLAPEWLANLP--ITSKSDVYSYGMVLLEIVSGRRNFEVSQE 710
T+ Y +P L + P T D+++ G + E+++G+ F + E
Sbjct: 180 VTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE 224
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 40/113 (35%), Positives = 61/113 (53%), Gaps = 7/113 (6%)
Query: 611 GITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRG 670
+ YLH E +V+ D+K EN++LD++ + K++DFGL K KD T+ + GT
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKD--GATMKTFCGTPE 161
Query: 671 YLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEE 723
YLAPE L + D + G+V+ E++ GR F + + K F L EE
Sbjct: 162 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF--YNQDHEKLFELILMEE 212
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 8/89 (8%)
Query: 624 VHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPIT 683
VH DIKPEN+L+D + K++DFG A + + L GT Y+APE L +
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV--GTPDYIAPEVLTTMNGD 181
Query: 684 SKS------DVYSYGMVLLEIVSGRRNFE 706
K D +S G++ E++ GR F
Sbjct: 182 GKGTYGVECDWWSLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 6e-08
Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 41/217 (18%)
Query: 507 LGAGGFGAVYRGVLAN-RTVVAVKQL----EGIEQGEKQFRMEVATISSTHHLNLVRLVG 561
+G+G +G+V R VAVK+L + + + +R E+ + H N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLLD 81
Query: 562 FSSEGKHRLLVYEFMKNGSLDNF----LFANEEGSG--------KLLNWQSRFNIALGTA 609
F S++NF L N G+ KL + +F I
Sbjct: 82 V------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLI-YQLL 128
Query: 610 RGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR 669
RG+ Y+H I+H D+KP N+ ++E+ ++ DFGLA+ + + +T TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE------MTGYVATR 179
Query: 670 GYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNF 705
Y APE + N + D++S G ++ E++ G+ F
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 7e-08
Identities = 47/153 (30%), Positives = 81/153 (52%), Gaps = 16/153 (10%)
Query: 559 LVGFSS--EGKHRLL-VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYL 615
LVG S + + RL V E++ G L +F + + KL +RF A + + YL
Sbjct: 58 LVGLHSCFQTESRLFFVIEYVNGGDL---MF-HMQRQRKLPEEHARFYSA-EISLALNYL 112
Query: 616 HEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL-INPKDHRHRTLTSVRGTRGYLAP 674
HE I++ D+K +N+LLD + K++D+G+ K + P D T ++ GT Y+AP
Sbjct: 113 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSTFCGTPNYIAP 165
Query: 675 EWLANLPITSKSDVYSYGMVLLEIVSGRRNFEV 707
E L D ++ G+++ E+++GR F++
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 63/235 (26%), Positives = 103/235 (43%), Gaps = 57/235 (24%)
Query: 492 SYKELQRSTKGFKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGE----KQFRMEVA 546
+YK+L DKLG G + VY+G +VA+K++ +E E R E +
Sbjct: 6 TYKKL--------DKLGEGSYATVYKGRSKLTGQLVALKEIR-LEHEEGAPFTAIR-EAS 55
Query: 547 TISSTHHLNLVRLVGFSSEGKHRLLVYEFMK-----------NG-SLDN---FLFANEEG 591
+ H N+V L K LV+E++ G S+ N FLF
Sbjct: 56 LLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLF----- 110
Query: 592 SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651
+LL RG+ Y H + ++H D+KP+N+L+ E K++DFGLA+
Sbjct: 111 --QLL-------------RGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR- 151
Query: 652 INPKDHRHRTLTSVRGTRGYLAPE-WLANLPITSKSDVYSYGMVLLEIVSGRRNF 705
K +T ++ T Y P+ L + ++ D++ G + E+ +GR F
Sbjct: 152 --AKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 9e-08
Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 544 EVATISSTHHLNLVRLVGFSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRF 602
E + +T H L L +S + K RL V E++ G L F + E ++RF
Sbjct: 45 ESRVLKNTRHPFLTSL-KYSFQTKDRLCFVMEYVNGGEL--FFHLSRERV--FSEDRTRF 99
Query: 603 NIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTL 662
A + YLH IV+ D+K EN++LD++ + K++DFGL K T+
Sbjct: 100 YGA-EIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATM 152
Query: 663 TSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYE 722
+ GT YLAPE L + D + G+V+ E++ GR F + + K F L E
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF--YNQDHEKLFELILME 210
Query: 723 EFE---------KGNVKGIV----DKSLAGEDVDIEQVMR 749
+ + K + G++ +K L G D +++MR
Sbjct: 211 DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 59/235 (25%), Positives = 94/235 (40%), Gaps = 45/235 (19%)
Query: 506 KLGAGGFGAVYRGVLANRTVV----AVKQLE--GIEQGEKQFRM--EVATISSTHHLNLV 557
LG G G V+ L A+K L+ + + K R+ E +++ H L
Sbjct: 8 LLGKGDVGRVF---LVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 558 RLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQS-RFNIALGTARGITYLH 616
L + LV ++ G L L + GK L+ + RF A + YLH
Sbjct: 65 TLYASFQTETYLCLVMDYCPGGELFRLL---QRQPGKCLSEEVARFYAAEVLL-ALEYLH 120
Query: 617 EECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH--------------RHRTL 662
IV+ D+KPENILL E+ + +SDF L+K + + +
Sbjct: 121 LLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 663 T------------SVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNF 705
+ S GT Y+APE ++ S D ++ G++L E++ G F
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF 232
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 17/218 (7%)
Query: 506 KLGAGGFGAVYRGVLAN---RTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRL--V 560
K+G G +G VY+ + A+KQ+EG R E+A + H N++ L V
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR-EIALLRELKHPNVIALQKV 66
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRF---NIALGTARGITYLHE 617
S + L++++ ++ F + K R ++ GI YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 618 ECRDCIVHCDIKPENILL----DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLA 673
+ ++H D+KP NIL+ E K++D G A+L N L V T Y A
Sbjct: 127 ---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 674 PEWLANLPITSKS-DVYSYGMVLLEIVSGRRNFEVSQE 710
PE L +K+ D+++ G + E+++ F QE
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 11/93 (11%)
Query: 610 RGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK--LINPKDHRHRTLTSVRG 667
G+ YLH + I+H D+K ENI +++ + D G A+ ++ P + G
Sbjct: 168 EGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL------GLAG 218
Query: 668 TRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS 700
T APE LA SK+D++S G+VL E+++
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 34/102 (33%), Positives = 59/102 (57%), Gaps = 6/102 (5%)
Query: 609 ARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGT 668
A G+ +LH + I++ D+K +N++LD + K++DFG+ K N D T + GT
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE-NMWDGV--TTKTFCGT 164
Query: 669 RGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQE 710
Y+APE +A P D +++G++L E+++G+ FE E
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 206
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 41/112 (36%), Positives = 60/112 (53%), Gaps = 8/112 (7%)
Query: 612 ITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGY 671
+ YLH RD +V+ DIK EN++LD++ + K++DFGL K +T GT Y
Sbjct: 108 LEYLHS--RD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---GTPEY 161
Query: 672 LAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEE 723
LAPE L + D + G+V+ E++ GR F +Q+ R F L EE
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHER-LFELILMEE 211
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 507 LGAGGFGAVYRGVL-ANRTVVAVKQLEG---IEQGEKQFRMEVATISST--HHLNLVRLV 560
LG G FG V L + + AVK L+ ++ + + M I S +H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620
V EF+ G L +F ++ S + ++RF A T+ + +LH++
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDL---MFHIQK-SRRFDEARARFYAAEITS-ALMFLHDKG- 116
Query: 621 DCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL 680
I++ D+K +N+LLD + K++DFG+ K +T ++ GT Y+APE L +
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAPEILQEM 171
Query: 681 PITSKSDVYSYGMVLLEIVSGRRNFEVSQE 710
D ++ G++L E++ G FE E
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 60/249 (24%), Positives = 96/249 (38%), Gaps = 60/249 (24%)
Query: 503 FKDK-LGAGGFGAVYRGV-LANRTVVAVKQLEGIE--QGEKQFRM-------------EV 545
K LG G +G V + +VA+K+++ IE + R E+
Sbjct: 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71
Query: 546 ATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFN-- 603
++ H N++ LV EG LV + M L K+++ + R
Sbjct: 72 KIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLK-----------KVVDRKIRLTES 119
Query: 604 ----IALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA---------- 649
I L G+ LH + +H D+ P NI ++ K++DFGLA
Sbjct: 120 QVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176
Query: 650 ---KLINPKDHRHRTLTSVRGTRGYLAPEWL--ANLPITSKSDVYSYGMVLLEIVSGRRN 704
K + R +TS T Y APE L A D++S G + E+++G+
Sbjct: 177 TLSKDETMQ--RREEMTSKVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGKPL 233
Query: 705 F----EVSQ 709
F E+ Q
Sbjct: 234 FPGENEIDQ 242
|
Length = 335 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 505 DKLGAGGFGAVYRGV------LANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVR 558
+KLG G + VY+G+ L V+++K EG+ + E + + H N+V
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR---EASLLKGLKHANIVL 67
Query: 559 LVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618
L + V+E+M L ++ + G L + R RG+ Y+H
Sbjct: 68 LHDIIHTKETLTFVFEYMHT-DLAQYM---IQHPGGLHPYNVRL-FMFQLLRGLAYIH-- 120
Query: 619 CRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPE-WL 677
I+H D+KP+N+L+ K++DFGLA+ K +T +S T Y P+ L
Sbjct: 121 -GQHILHRDLKPQNLLISYLGELKLADFGLAR---AKSIPSQTYSSEVVTLWYRPPDVLL 176
Query: 678 ANLPITSKSDVYSYGMVLLEIVSGRRNF 705
+S D++ G + +E++ G+ F
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 33/226 (14%)
Query: 506 KLGAGGFGAVYRGVLAN---RTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRL--V 560
K+G G +G VY+ + A+KQ+EG R E+A + H N++ L V
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR-EIALLRELKHPNVISLQKV 66
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLF-----ANEE------GSGKLLNWQSRFNIALGTA 609
S + L++++ ++ F AN++ G K L +Q
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ--------IL 118
Query: 610 RGITYLHEECRDCIVHCDIKPENILL----DENYNAKVSDFGLAKLINPKDHRHRTLTSV 665
GI YLH + ++H D+KP NIL+ E K++D G A+L N L V
Sbjct: 119 DGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 666 RGTRGYLAPEWLANLPITSKS-DVYSYGMVLLEIVSGRRNFEVSQE 710
T Y APE L +K+ D+++ G + E+++ F QE
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 34/93 (36%), Positives = 45/93 (48%), Gaps = 5/93 (5%)
Query: 610 RGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR 669
R I YLHE + I+H DIK ENI ++ + + DFG A P D GT
Sbjct: 193 RAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACF--PVDINANKYYGWAGTI 247
Query: 670 GYLAPEWLANLPITSKSDVYSYGMVLLEIVSGR 702
APE LA P D++S G+VL E+ +
Sbjct: 248 ATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-07
Identities = 31/128 (24%), Positives = 62/128 (48%), Gaps = 24/128 (18%)
Query: 611 GITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL------------INPKDHR 658
I Y+H + ++H D+KP+NILL + D+G A ++ ++
Sbjct: 125 TIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 659 HRTLT---SVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKK 715
+ ++T + GT Y+APE L +P + +D+Y+ G++L ++++ + RKK
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR------RKK 235
Query: 716 FSLWAYEE 723
+Y +
Sbjct: 236 GRKISYRD 243
|
Length = 932 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 49/161 (30%), Positives = 83/161 (51%), Gaps = 22/161 (13%)
Query: 559 LVGFSS--EGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRF---NIALGTARGI 612
LVG S + + RL V EF+ G L +F + KL +RF I+L +
Sbjct: 58 LVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQR-QRKLPEEHARFYSAEISLA----L 109
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL-INPKDHRHRTLTSVRGTRGY 671
+LHE I++ D+K +N+LLD + K++D+G+ K I P D T ++ GT Y
Sbjct: 110 NFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFCGTPNY 162
Query: 672 LAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETN 712
+APE L D ++ G+++ E+++GR F++ ++
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 4e-07
Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 7/92 (7%)
Query: 611 GITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRG 670
GI +LH I+H D+KP NI++ + K+ DFGLA+ +T TR
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPYVVTRY 182
Query: 671 YLAPEWLANLPITSKSDVYSYGMVLLEIVSGR 702
Y APE + + D++S G ++ E++ G
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 42/146 (28%), Positives = 62/146 (42%), Gaps = 44/146 (30%)
Query: 600 SRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL---------AK 650
+RF IA T I +H + +H DIKP+NIL+D + + K++DFGL +K
Sbjct: 103 ARFYIAELTC-AIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158
Query: 651 LINPKDH------------------RHRTLT-------------SVRGTRGYLAPEWLAN 679
DH R + L S+ GT Y+APE L
Sbjct: 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR 218
Query: 680 LPITSKSDVYSYGMVLLEIVSGRRNF 705
T D +S G++L E++ G+ F
Sbjct: 219 TGYTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 6e-07
Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 20/147 (13%)
Query: 567 KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHC 626
+H +V E+++ G L + G L +R A T + YLH IVH
Sbjct: 74 RHLCMVMEYVEGGDCATLL----KNIGALPVDMARMYFA-ETVLALEYLHNYG---IVHR 125
Query: 627 DIKPENILLDENYNAKVSDFGLAK--LIN----------PKDHRHRTLTSVRGTRGYLAP 674
D+KP+N+L+ + K++DFGL+K L++ KD R V GT Y+AP
Sbjct: 126 DLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAP 185
Query: 675 EWLANLPITSKSDVYSYGMVLLEIVSG 701
E + D ++ G++L E + G
Sbjct: 186 EVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 58/222 (26%), Positives = 107/222 (48%), Gaps = 26/222 (11%)
Query: 506 KLGAGGFGAVY--RGVLANRTVVAVKQLEGIEQGEKQFRM----EVATI---SSTHHLNL 556
++G G +G V+ R + VA+K++ ++ GE+ + EVA + + H N+
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 557 VRL-----VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARG 611
VRL V + LV+E + + L +L ++ + ++ ++ RG
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL---DKVPEPGVPTETIKDMMFQLLRG 122
Query: 612 ITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGY 671
+ +LH +VH D+KP+NIL+ + K++DFGLA++ + + LTSV T Y
Sbjct: 123 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ----MALTSVVVTLWY 175
Query: 672 LAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNR 713
APE L + D++S G + E+ + F S + ++
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 507 LGAGGFGAV-YRGVLANRTVVAVKQL---EGIEQGEKQFRMEVATISSTHHLNLVRLVGF 562
+G G FG V + R V A+K L E I++ + F E I + + V + +
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 563 S-SEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD 621
+ + ++ +V E+M G L N L +N + K W +RF TA + L
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEK---W-ARFY----TAEVVLALDAIHSM 161
Query: 622 CIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLP 681
+H D+KP+N+LLD++ + K++DFG +N K+ R T+V GT Y++PE L +
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTAV-GTPDYISPEVLKSQG 219
Query: 682 ----ITSKSDVYSYGMVLLEIVSGRRNF 705
+ D +S G+ L E++ G F
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 5/98 (5%)
Query: 610 RGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR 669
R + Y+H + H D+KP+NIL + + K+ DFGLA++ T TR
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 670 GYLAPEWLANL--PITSKSDVYSYGMVLLEIVSGRRNF 705
Y APE + T D++S G + E+++G+ F
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 611 GITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVR-GTR 669
G+ YLHE + IV+ D+K +N+LLD K++DFGL K + TS GT
Sbjct: 113 GLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRTSTFCGTP 165
Query: 670 GYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNF 705
+LAPE L T D + G+++ E++ G F
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 7/96 (7%)
Query: 611 GITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRG 670
GI +LH I+H D+KP NI++ + K+ DFGLA+ + +T TR
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACT----NFMMTPYVVTRY 187
Query: 671 YLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFE 706
Y APE + + D++S G ++ E+V G F+
Sbjct: 188 YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-06
Identities = 58/234 (24%), Positives = 106/234 (45%), Gaps = 52/234 (22%)
Query: 495 ELQRS-TKGFK--DKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATISS 550
++ RS K +K + +G G FG VY + + VA+K+ + Q + E+ + +
Sbjct: 59 DINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKK---VLQDPQYKNRELLIMKN 115
Query: 551 THHLNLVRL---------------------VGFSSEGKHRLLVYEFMKNGSLDNFLFANE 589
+H+N++ L + F + H+ + + N +L FL
Sbjct: 116 LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV--- 172
Query: 590 EGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDEN-YNAKVSDFGL 648
KL ++Q R + Y+H + I H D+KP+N+L+D N + K+ DFG
Sbjct: 173 ----KLYSYQ--------LCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGS 217
Query: 649 AKLINPKDHRHRTLTSVRGTRGYLAPE-WLANLPITSKSDVYSYGMVLLEIVSG 701
AK + R+++ + +R Y APE L T+ D++S G ++ E++ G
Sbjct: 218 AKNLLAG---QRSVSYI-CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 3/91 (3%)
Query: 623 IVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPI 682
IV+ DIK ENILLD + ++DFGL+K + + RT S GT Y+APE +
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTY-SFCGTIEYMAPEIIRGKGG 183
Query: 683 TSKS-DVYSYGMVLLEIVSGRRNFEVSQETN 712
K+ D +S G+++ E+++G F + E N
Sbjct: 184 HGKAVDWWSLGILIFELLTGASPFTLEGERN 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 62/231 (26%), Positives = 101/231 (43%), Gaps = 48/231 (20%)
Query: 507 LGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEV---ATI----SSTHHLNLVRL 559
LG G +G V+ V+++ G + G K + M+V ATI +T H R
Sbjct: 8 LGTGAYGKVF----------LVRKVSGHDSG-KLYAMKVLKKATIVQKAKTTEHTRTERQ 56
Query: 560 V---------------GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNI 604
V F ++ K L++ +++ G L L E + I
Sbjct: 57 VLEHIRQSPFLVTLHYAFQTDTKLHLIL-DYINGGELFTHLSQRERFK------EQEVQI 109
Query: 605 ALG-TARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLT 663
G + +LH + I++ DIK ENILLD N + ++DFGL+K + +D R
Sbjct: 110 YSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH-EDEVERAY- 164
Query: 664 SVRGTRGYLAPEWLA--NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETN 712
S GT Y+AP+ + + D +S G+++ E+++G F V E N
Sbjct: 165 SFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 21/207 (10%)
Query: 506 KLGAGGFGAV-----YRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLV 560
++G G FG V Y R VV + + + +F + H N+++ +
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEE--GSGKLLNWQSRFNIALGTARGITYLHEE 618
G E LLV+E+ + G L ++L + + +LL Q +A A G+T++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMH-- 116
Query: 619 CRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEW-- 676
+ +H D+ N L + KV D+G+ +D+ R +LAPE
Sbjct: 117 -KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR-WLAPELVG 174
Query: 677 -----LANLPITSKSDVYSYGMVLLEI 698
L T S+V++ G+ L E+
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 3e-06
Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 38/231 (16%)
Query: 506 KLGAGGFGAVYRGVLANRT----VVAVKQLEGIEQGEK-QFRMEVATISSTHHLNLVRLV 560
K+G G FG V+ V RT G+++ EK Q +EV + H N+VR +
Sbjct: 20 KIGNGRFGEVFL-VKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYI 78
Query: 561 G-FSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618
F ++ +L ++ EF G L + + GK+ + +I + Y H
Sbjct: 79 DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKI-EEHAIVDITRQLLHALAYCHN- 136
Query: 619 CRDC-----IVHCDIKPENILLD-------------ENYN----AKVSDFGLAKLINPKD 656
+D ++H D+KP+NI L N N AK+ DFGL+K I +
Sbjct: 137 LKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES 196
Query: 657 HRHRTLTSVRGTRGYLAPEWLANLPIT--SKSDVYSYGMVLLEIVSGRRNF 705
H S GT Y +PE L + + KSD+++ G ++ E+ SG+ F
Sbjct: 197 MAH----SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 6e-06
Identities = 41/165 (24%), Positives = 74/165 (44%), Gaps = 21/165 (12%)
Query: 552 HHL-----NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIAL 606
H L N ++L + K +L+ +++K+G L + L GKL + + I
Sbjct: 62 HQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVK-KIIR 116
Query: 607 GTARGITYLHEECRDCIVHCDIKPENILLDEN-YNAKVSDFGLAKLINPKDHRHRTLTSV 665
+ LH + I+H DIK EN+L D + D+GL K+I T +
Sbjct: 117 QLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG-------TPSCY 166
Query: 666 RGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQE 710
GT Y +PE + D ++ G++ E+++G+ F+ ++
Sbjct: 167 DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211
|
Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 58/231 (25%), Positives = 104/231 (45%), Gaps = 29/231 (12%)
Query: 493 YKELQRSTKGFKDK---------LGAGGFGAV-YRGVLANRTVVAVKQL---EGIEQGEK 539
Y+++ R + + K +G G FG V +++ V A+K L E I++ +
Sbjct: 28 YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS 87
Query: 540 QFRMEVATISS-THHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNW 598
F E I + + +V+L + K+ +V E+M G L N L +N + K W
Sbjct: 88 AFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEK---W 143
Query: 599 QSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658
+ TA + L ++H D+KP+N+LLD++ + K++DFG ++
Sbjct: 144 AKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198
Query: 659 HRTLTSVRGTRGYLAPEWLANLP----ITSKSDVYSYGMVLLEIVSGRRNF 705
+ GT Y++PE L + + D +S G+ L E++ G F
Sbjct: 199 R--CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 4/92 (4%)
Query: 609 ARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGT 668
ARG+ +L ++C VH D+ N+LL + K+ DFGLA+ I D + + S
Sbjct: 247 ARGMEFL--ASKNC-VHRDLAARNVLLAQGKIVKICDFGLARDIM-HDSNYVSKGSTFLP 302
Query: 669 RGYLAPEWLANLPITSKSDVYSYGMVLLEIVS 700
++APE + + T+ SDV+SYG++L EI S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 8e-06
Identities = 51/195 (26%), Positives = 86/195 (44%), Gaps = 41/195 (21%)
Query: 506 KLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRM----EVATISSTHHLNLVRLV 560
K+G G FG V++ + +VA+K++ +E ++ F + E+ + H N+V L+
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVL-MENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 561 --------GFSSEGKHRLLVYEFMKN---GSLDNFLFANEEGSGK-----LLNWQSRFNI 604
++ LV+EF ++ G L N K LLN
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN------- 130
Query: 605 ALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK--LINPKDHRHRTL 662
G+ Y+H R+ I+H D+K NIL+ ++ K++DFGLA+ ++ +R
Sbjct: 131 ------GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 663 TSVRGTRGYLAPEWL 677
V T Y PE L
Sbjct: 182 NRVV-TLWYRPPELL 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 8e-06
Identities = 23/66 (34%), Positives = 33/66 (50%), Gaps = 6/66 (9%)
Query: 243 SDILRFLSLGSDGNLRIFSSARGSGTKTRRWAAVADQCEVFGYCGNMGICGYNGYNDSSS 302
+ I L+L S+G+L F+ S W+A DQC+V+G CG G C D ++
Sbjct: 43 NSIYSRLTLSSEGSLERFTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYC------DVNT 96
Query: 303 DPLCEC 308
P C C
Sbjct: 97 SPKCNC 102
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 7/92 (7%)
Query: 611 GITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRG 670
GI +LH I+H D+KP NI++ + K+ DFGLA+ +T TR
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPYVVTRY 190
Query: 671 YLAPEWLANLPITSKSDVYSYGMVLLEIVSGR 702
Y APE + + D++S G ++ E++ G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 36/127 (28%), Positives = 64/127 (50%), Gaps = 12/127 (9%)
Query: 582 DNFLFANEEGSGK--------LLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENI 633
D +L + E + + L++ + A G+ +L ++C VH D+ N+
Sbjct: 214 DQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL--ASKNC-VHRDLAARNV 270
Query: 634 LLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGM 693
L+ E K+ DFGLA+ I +D + + S ++APE + N T+ SDV+S+G+
Sbjct: 271 LICEGKLVKICDFGLARDIM-RDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGI 329
Query: 694 VLLEIVS 700
+L EI +
Sbjct: 330 LLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-05
Identities = 29/89 (32%), Positives = 45/89 (50%), Gaps = 7/89 (7%)
Query: 611 GITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRG 670
GI +LH I+H D+KP NI++ + K+ DFGLA+ +T TR
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPYVVTRY 183
Query: 671 YLAPEWLANLPITSKSDVYSYGMVLLEIV 699
Y APE + + D++S G ++ E+V
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 43/151 (28%), Positives = 66/151 (43%), Gaps = 12/151 (7%)
Query: 567 KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSR-----------FNIALGTARGITYL 615
H +V F S D L E GSG LN Q + + + L + + L
Sbjct: 123 DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLAL 182
Query: 616 HEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPE 675
E ++H D+K NI L K+ DFG +K + +S GT YLAPE
Sbjct: 183 DEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD-VASSFCGTPYYLAPE 241
Query: 676 WLANLPITSKSDVYSYGMVLLEIVSGRRNFE 706
+ K+D++S G++L E+++ R F+
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHRPFK 272
|
Length = 478 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 34/109 (31%), Positives = 50/109 (45%), Gaps = 15/109 (13%)
Query: 612 ITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI-----NPKDHRHRTLTSVR 666
I Y+H + I+H DIK EN+L++ + + DFG A P + +
Sbjct: 273 IDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY------GIA 323
Query: 667 GTRGYLAPEWLANLPITSKSDVYSYGMVLLEI-VSGRRNFEVSQETNRK 714
GT APE LA P T D++S G+V+ E V F S+ R+
Sbjct: 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERR 372
|
Length = 461 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 14/143 (9%)
Query: 568 HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCD 627
+ LV ++ G L L E+ +L +RF IA + +H + VH D
Sbjct: 75 YLYLVMDYYVGGDLLTLLSKFED---RLPEDMARFYIA----EMVLAIHSIHQLHYVHRD 127
Query: 628 IKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL-----PI 682
IKP+N+LLD N + +++DFG +N +D ++ +V GT Y++PE L +
Sbjct: 128 IKPDNVLLDMNGHIRLADFGSCLKMN-QDGTVQSSVAV-GTPDYISPEILQAMEDGMGKY 185
Query: 683 TSKSDVYSYGMVLLEIVSGRRNF 705
+ D +S G+ + E++ G F
Sbjct: 186 GPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 22/54 (40%), Positives = 35/54 (64%), Gaps = 2/54 (3%)
Query: 624 VHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWL 677
VH DIKP+N+LLD+N + +++DFG + D ++ +V GT Y++PE L
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLA-DGTVQSNVAV-GTPDYISPEIL 175
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 52/218 (23%), Positives = 88/218 (40%), Gaps = 39/218 (17%)
Query: 507 LGAGGFGAVYR------GVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTH-------- 552
+G GGFG VY + N+ V ++ LE + ME ++ +
Sbjct: 20 IGCGGFGCVYETQCASDHCINNQAVAKIENLE-----NETIVMETLVYNNIYDIDKIALW 74
Query: 553 -------HLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRF--N 603
HL + + G S K + Y F+ L+ + +E ++ + N
Sbjct: 75 KNIHNIDHLGIPKYYGCGS-FKRCRMYYRFIL---LEKLVENTKEIFKRIKCKNKKLIKN 130
Query: 604 IALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK--LINPK--DHRH 659
I + Y+HE I H DIKPENI++D N + D+G+A +I+ K ++
Sbjct: 131 IMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSK 187
Query: 660 RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLE 697
RGT Y + +T + D+ S G +L+
Sbjct: 188 EQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 35/126 (27%), Positives = 51/126 (40%), Gaps = 44/126 (34%)
Query: 624 VHCDIKPENILLDENYNAKVSDFGL---------AKLINPKDH----------------- 657
+H DIKP+NIL+D + + K++DFGL +K DH
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 658 -----------------RHRTLT-SVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIV 699
R L S+ GT Y+APE L T D +S G++L E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 700 SGRRNF 705
G+ F
Sbjct: 243 VGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 35/130 (26%), Positives = 59/130 (45%), Gaps = 27/130 (20%)
Query: 595 LLNW---QSRFN------IALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSD 645
LL+W F+ I T + Y H E ++H D+KPENIL++ + V D
Sbjct: 218 LLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETS--DTVVD 273
Query: 646 FGLAKLINPK-------------DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYG 692
+ + P D RH + T++ TR Y +PE + L +D++S G
Sbjct: 274 PVTNRALPPDPCRVRICDLGGCCDERH-SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMG 332
Query: 693 MVLLEIVSGR 702
++ E+ +G+
Sbjct: 333 CIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 41/137 (29%), Positives = 56/137 (40%), Gaps = 46/137 (33%)
Query: 624 VHCDIKPENILLDENYNAKVSDFGLA-------------KLI------NPKDHRHR---- 660
+H DIKP+NIL+D + K+SDFGL+ KL+ N D+R+
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182
Query: 661 --TLT-------------------SVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIV 699
LT S GT Y+APE + D +S G ++ E +
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECL 242
Query: 700 SGRRNF--EVSQETNRK 714
G F E S ET RK
Sbjct: 243 IGWPPFCSENSHETYRK 259
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 59/250 (23%), Positives = 96/250 (38%), Gaps = 35/250 (14%)
Query: 500 TKGFKDKLGAGGFGAVYRGVLANRTVVAVKQ--LEGIEQGE-KQFRMEVATISSTHHLNL 556
K F+D + + T+VAVK+ L+ + + K + E+ T H N+
Sbjct: 7 GKCFED----LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 557 VRLVGFSSEGKHRLLVYEFMKNGSLDNFLFAN-EEGSGKLLNWQSRFNIAL---GTARGI 612
+ V +V M GS ++ L + EG +L IA +
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA-------IAFILKDVLNAL 114
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTL----TSVRGT 668
Y+H + I H +K +ILL + +S + + R R + S
Sbjct: 115 DYIHSK--GFI-HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171
Query: 669 RGYLAPEWL-ANLP-ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEK 726
+L+PE L NL KSD+YS G+ E+ +G F+ T E +
Sbjct: 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT-------QMLLEKVR 224
Query: 727 GNVKGIVDKS 736
G V ++DKS
Sbjct: 225 GTVPCLLDKS 234
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 4e-04
Identities = 29/113 (25%), Positives = 40/113 (35%), Gaps = 24/113 (21%)
Query: 74 SGGVPIWTAGSTPVDSSAFFQLHSSGTLRL----ISGSGAIIWDSNTQRLNVTSA--SLD 127
S G + ++GS FF+L S ++W +N + +S +L
Sbjct: 5 SSGQTLVSSGSL--FELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQ 62
Query: 128 DSGNLVLLKNGGVSAWSSFDNPTDTIVPSQNFTSDKTLRSGYYSFTLLKSGNL 180
GNLV+ G WSS N T G Y LL GNL
Sbjct: 63 SDGNLVIYDGSGTVVWSS------------NTTRVN----GNYVLVLLDDGNL 99
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 35/135 (25%), Positives = 61/135 (45%), Gaps = 16/135 (11%)
Query: 567 KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHC 626
K+ +Y FM + + D + L Q+R I + Y+H++ ++H
Sbjct: 244 KYDFDLYSFMYDEAFD--------WKDRPLLKQTR-AIMKQLLCAVEYIHDKK---LIHR 291
Query: 627 DIKPENILLDENYNAKVSDFGLAKLI-NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSK 685
DIK ENI L+ + + DFG A ++ GT +PE LA
Sbjct: 292 DIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWV---GTVATNSPEILAGDGYCEI 348
Query: 686 SDVYSYGMVLLEIVS 700
+D++S G++LL+++S
Sbjct: 349 TDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 45/148 (30%), Positives = 70/148 (47%), Gaps = 18/148 (12%)
Query: 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE--CRDCI----- 623
L Y F +L +L + G LL S+F L YL E D +
Sbjct: 66 LHYAFQDENNL--YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY 123
Query: 624 VHCDIKPENILLDENYNAKVSDFG-LAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLP- 681
VH DIKP+NIL+D N + +++DFG KL+ +D ++ +V GT Y++PE L +
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLM--EDGTVQSSVAV-GTPDYISPEILQAMED 180
Query: 682 ----ITSKSDVYSYGMVLLEIVSGRRNF 705
+ D +S G+ + E++ G F
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 5e-04
Identities = 18/76 (23%), Positives = 33/76 (43%), Gaps = 1/76 (1%)
Query: 74 SGGVPIWTAGSTPVDSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLNVTSASLDDSGNLV 133
G +W++ ++ S L G L L SG ++W S + T GN+V
Sbjct: 34 GNGRVVWSSNTSGKGSGCVAVLQDDGNLVLYDNSGKVLWQSFDHPTD-TLLPGQKDGNVV 92
Query: 134 LLKNGGVSAWSSFDNP 149
+ + +++W S +P
Sbjct: 93 IGGSRRLTSWKSNTDP 108
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 5e-04
Identities = 21/85 (24%), Positives = 38/85 (44%), Gaps = 8/85 (9%)
Query: 333 SCPGSATM---LELPHTKFLTFQPELSSQVFFVGISACRLNCLVTGSCVASTSLSDGTGL 389
+C G + L+LP K P+ +S + + + CR CL SC A + ++G+G
Sbjct: 4 NCGGDGSTDGFLKLPDVKL----PDNASAITAISLEECREACLSNCSCTA-YAYNNGSGG 58
Query: 390 CYLKTPDFVSGFQNPALPSTSYVKV 414
C L + + T Y+++
Sbjct: 59 CLLWNGLLNNLRSLSSGGGTLYLRL 83
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 6e-04
Identities = 27/94 (28%), Positives = 35/94 (37%), Gaps = 21/94 (22%)
Query: 92 FFQLHSSGTLRLI---SGSGAIIWDSNTQRL--NVTSASLDDSGNLVLLKNGGVSAWSSF 146
FF L LI S S ++W +N + + +L GNLVL G WSS
Sbjct: 21 FFTLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSS- 79
Query: 147 DNPTDTIVPSQNFTSDKTLRSGYYSFTLLKSGNL 180
+ T +G Y LL GNL
Sbjct: 80 ---------------NTTGANGNYVLVLLDDGNL 98
|
Length = 114 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 37/110 (33%), Positives = 46/110 (41%), Gaps = 12/110 (10%)
Query: 488 PVQFSYK---ELQRSTKGFKDKLGAGGFGAVYR------GVLANRTVVAVKQLEG-IEQG 537
P Q Y E R F LGAG FG V G N VAVK L+
Sbjct: 24 PTQLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD 83
Query: 538 EKQFRMEVATISS--THHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFL 585
E++ M I S H N+V L+G + G L++ E+ G L NFL
Sbjct: 84 EREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 31/151 (20%), Positives = 55/151 (36%), Gaps = 16/151 (10%)
Query: 506 KLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATIS--STHHLNLVRLVGFS 563
L G VY + V +K E+G EVA + + L + +++
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYV-LKINPSREKGA-DREREVAILQLLARKGLPVPKVLASG 62
Query: 564 SEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCI 623
L+ E+++ +LD +E + L A + LH+ +
Sbjct: 63 ESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQL------------AELLAKLHQLPLLVL 110
Query: 624 VHCDIKPENILLDENYNAKVSDFGLAKLINP 654
H D+ P NIL+D+ + D+ A P
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|234383 TIGR03895, protease_PatA, cyanobactin maturation protease, PatA/PatG family | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 33/124 (26%), Positives = 50/124 (40%), Gaps = 10/124 (8%)
Query: 738 AGEDVDIEQVMRAI-QVSFWCIQEQPSQ--RPMMGKV-----VQMLEGITEIEKPP--AP 787
GE D + V A+ + C E + R + G++ +Q+L G T E
Sbjct: 181 QGETPDPQAVRTALLNSAIPCDPEDDEECERCLAGRLNIPGAIQLLTGETMSEGLVTSEQ 240
Query: 788 KALTEGSVGGTSVNMSSSTSALSTFAASAPAPSSSSSTHTGVSALASDRNIERASSSLLR 847
+ E S G + SSTS + A+ PAP S G A + IE ++ L
Sbjct: 241 DGVEEASGCGVQGTIESSTSVIPPGRAAEPAPVSIPVAAPGEGATPAAAQIELSAGVLPN 300
Query: 848 SSSP 851
+ SP
Sbjct: 301 AISP 304
|
This model describes a protease domain associated with the maturation of various members of the cyanobactin family of ribosomally produced, heavily modified bioactive metabolites. Members include the PatA protein and C-terminal domain of the PatG protein of Prochloron didemni, TenA and a region of TenG from Nostoc spongiaeforme var. tenue, etc. Length = 602 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 35/126 (27%), Positives = 52/126 (41%), Gaps = 44/126 (34%)
Query: 624 VHCDIKPENILLDENYNAKVSDFGLAK--------------------LINPKD------- 656
+H DIKP+NIL+D + + K++DFGL + P D
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 657 ----HRHRTLT-------------SVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIV 699
R +TL S+ GT Y+APE L T D +S G++L E++
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 700 SGRRNF 705
G+ F
Sbjct: 243 VGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 26/85 (30%), Positives = 45/85 (52%), Gaps = 16/85 (18%)
Query: 571 LVYEFMKNGSLDNFL----FANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHC 626
LV E++ G + + L + +EE + I+ A + YLH R I+H
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEE--------MAVKYIS-EVALALDYLH---RHGIIHR 128
Query: 627 DIKPENILLDENYNAKVSDFGLAKL 651
D+KP+N+L+ + K++DFGL+K+
Sbjct: 129 DLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 37.3 bits (87), Expect = 0.002
Identities = 19/71 (26%), Positives = 28/71 (39%), Gaps = 9/71 (12%)
Query: 334 CPGSATMLELPHTKFLTFQPELSSQVFFVGISA--CRLNCLVTGSCVA--STSLSDGTGL 389
C G L LP+ K P+ ++ + I C CL SC A + G+G
Sbjct: 1 CGGGDGFLRLPNMKL----PDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRGGSG- 55
Query: 390 CYLKTPDFVSG 400
C + T + V
Sbjct: 56 CLIWTGELVDM 66
|
Length = 66 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 36/110 (32%), Positives = 52/110 (47%), Gaps = 12/110 (10%)
Query: 488 PVQFSYK---ELQRSTKGFKDKLGAGGFGAVYR----GVLANRTV--VAVKQLE-GIEQG 537
P Q Y E R+ F LGAG FG V G+ + VAVK L+
Sbjct: 21 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLT 80
Query: 538 EKQFRM-EVATISST-HHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFL 585
E++ M E+ +S +H+N+V L+G + G L++ E+ G L NFL
Sbjct: 81 EREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 852 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.91 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.7 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.69 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.63 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.63 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.54 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.46 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.41 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.33 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.27 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.17 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.16 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.13 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.11 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.06 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.03 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.0 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.99 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.92 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.89 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.71 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.71 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.7 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.7 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.68 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.58 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.45 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.37 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.35 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.34 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.33 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.19 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.17 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.16 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.03 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.02 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.0 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.99 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.9 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.85 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.82 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.73 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.71 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.71 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.69 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.54 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.42 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.38 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.33 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.29 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.26 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.19 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.03 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.99 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.96 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.8 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.64 | |
| PLN02236 | 344 | choline kinase | 96.57 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.51 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.45 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.02 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.0 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.87 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.85 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.81 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.71 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.55 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-55 Score=475.31 Aligned_cols=289 Identities=45% Similarity=0.786 Sum_probs=256.3
Q ss_pred CCcccCHHHHHHhccccc--ccccccccceEEEEEECCCcEEEEEEecCcccc-hHHHHHHHHHhhcccccceeeeeeee
Q 003059 487 APVQFSYKELQRSTKGFK--DKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQG-EKQFRMEVATISSTHHLNLVRLVGFS 563 (852)
Q Consensus 487 ~~~~~~~~el~~~~~~~~--~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-~~~f~~E~~~l~~l~h~niv~l~g~~ 563 (852)
....|++.||..+|.+|. +.||+|+||.||+|.+.+++.||||++...... .++|.+|++++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 466799999999999998 589999999999999999999999999855444 67799999999999999999999999
Q ss_pred ccCc-eeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceE
Q 003059 564 SEGK-HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAK 642 (852)
Q Consensus 564 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 642 (852)
.+.+ +++||||||++|+|+++|+..... +|+|.+|++||.++|+||+|||+.+.+.||||||||+|||||+++++|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 9999 599999999999999999875432 789999999999999999999999888999999999999999999999
Q ss_pred EeecccccccCCCCCcceeeeee-cCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHH
Q 003059 643 VSDFGLAKLINPKDHRHRTLTSV-RGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAY 721 (852)
Q Consensus 643 l~DFGla~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 721 (852)
|+|||+|+..... ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+.........+..|+.
T Consensus 218 lsDFGLa~~~~~~---~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 218 LSDFGLAKLGPEG---DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred ccCccCcccCCcc---ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 9999999765431 1111222 89999999999999999999999999999999999999998766555666999999
Q ss_pred HHHhhCCcccccccccCCCCCCH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 722 EEFEKGNVKGIVDKSLAGEDVDI-EQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 722 ~~~~~~~~~~~~d~~l~~~~~~~-~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
..+.++.+.+++|+.+.....+. +++.++++++++|++.+|.+||+|.||+++|+.+...
T Consensus 295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 99999999999999987434444 7899999999999999999999999999999766543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=397.80 Aligned_cols=254 Identities=35% Similarity=0.516 Sum_probs=209.3
Q ss_pred ccccccccccceEEEEEECCCcEEEEEEecCcccc---hHHHHHHHHHhhcccccceeeeeeeeccCc-eeeEEEeecCC
Q 003059 503 FKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQG---EKQFRMEVATISSTHHLNLVRLVGFSSEGK-HRLLVYEFMKN 578 (852)
Q Consensus 503 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~e~~~~ 578 (852)
+.+.||+|+||+||+|.+++...||||++...... .++|.+|+.+|.+++|||||+|+|+|.+.. ..+||||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 44569999999999999988777999999844322 558999999999999999999999999988 79999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCC-cccCCCCCCceEeCCCC-ceEEeecccccccCCCC
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC-IVHCDIKPENILLDENY-NAKVSDFGLAKLINPKD 656 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 656 (852)
|+|.++|+.. ....+++..+++|+.|||+||.|||+ .+ ||||||||+||||+.++ ++||+|||+++......
T Consensus 125 GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 125 GSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999864 24579999999999999999999999 55 99999999999999997 99999999998765321
Q ss_pred CcceeeeeecCCCCCCChhhhh--cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLA--NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
...+...||..|||||++. ...++.|+||||||++||||+||+.||....... .+......+. .
T Consensus 199 ---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~------~~~~v~~~~~-----R 264 (362)
T KOG0192|consen 199 ---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ------VASAVVVGGL-----R 264 (362)
T ss_pred ---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcCC-----C
Confidence 2334478999999999999 6699999999999999999999999998654311 0111111111 1
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
+ ..+.+....+..++.+||+.||..||++.+|+..|+.+...
T Consensus 265 p-----~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 265 P-----PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred C-----CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 1 11222445677788889999999999999999999987653
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=390.76 Aligned_cols=263 Identities=30% Similarity=0.444 Sum_probs=220.1
Q ss_pred HHHHHhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 494 KELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 494 ~el~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
.++.+...++.++||+|.||.||.|.+++...||+|.++......+.|.+|+++|++|+|+|||+++|+|..++.+||||
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 35566667788899999999999999999889999999977777889999999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
|||+.|+|.+||... .+..+...+.+.++.|||+||+||++ +++|||||.++||||+++..+||+|||||+...
T Consensus 281 E~m~~GsLl~yLr~~---~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTR---EGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred EecccCcHHHHhhhc---CCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccC
Confidence 999999999999752 35678899999999999999999999 899999999999999999999999999999544
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcccc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI 732 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (852)
.+ .........-++.|.|||.+....++.|||||||||+||||+| |+.||......+ +.+.+.++.
T Consensus 355 d~--~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-------v~~~le~Gy---- 421 (468)
T KOG0197|consen 355 DD--EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-------VLELLERGY---- 421 (468)
T ss_pred CC--ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-------HHHHHhccC----
Confidence 32 2223334456789999999999999999999999999999999 899987553221 222222221
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
++ +.+......+.+++..||+.+|++|||++.+...|+.+...
T Consensus 422 ---Rl---p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 422 ---RL---PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred ---cC---CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 11 22333445666788889999999999999999999887653
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=360.22 Aligned_cols=198 Identities=27% Similarity=0.486 Sum_probs=176.5
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
.|.+.++||+|.|++||+|+++ ++.+||||.+... ....+.+..|+++|+.++|||||+|++++...+..||||||
T Consensus 11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEy 90 (429)
T KOG0595|consen 11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEY 90 (429)
T ss_pred cceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEe
Confidence 4566778999999999999964 5789999999743 33445678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCC------CceEEeecccc
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDEN------YNAKVSDFGLA 649 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~------~~~kl~DFGla 649 (852)
|.+|+|.+||+... .+++.....++.|||.||++||+ ++||||||||+||||+.. -.+||+|||+|
T Consensus 91 C~gGDLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 91 CNGGDLSDYIRRRG-----RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred CCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999997654 58999999999999999999999 899999999999999764 46899999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccc
Q 003059 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQ 709 (852)
Q Consensus 650 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~ 709 (852)
+.+.+. .......|++-|||||+++..+|+.|+|+||+|++|||+++|+.||+...
T Consensus 163 R~L~~~----~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 163 RFLQPG----SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hhCCch----hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 998643 23456789999999999999999999999999999999999999998554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=356.58 Aligned_cols=255 Identities=28% Similarity=0.409 Sum_probs=206.8
Q ss_pred ccCHHHHHHhcccccccccccccceEEEEEEC-CCcEEEEEEec--CcccchHHHHHHHHHhhcccccceeeeeeeeccC
Q 003059 490 QFSYKELQRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLE--GIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEG 566 (852)
Q Consensus 490 ~~~~~el~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~--~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~ 566 (852)
..+..||++ .+.||+|..|+|||+.++ +++.+|+|.+. ......+++.+|++++++.+|||||.++|.|...
T Consensus 75 ~i~~~dle~-----~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 75 GISLSDLER-----LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred ccCHHHhhh-----hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 355556554 467999999999999975 57889999995 3445568899999999999999999999999998
Q ss_pred c-eeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEee
Q 003059 567 K-HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSD 645 (852)
Q Consensus 567 ~-~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 645 (852)
+ ...|+||||.+|||++++... ..+++...-+|+.++++||.|||++ ++||||||||+||||+..|++||+|
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicD 222 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICD 222 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecc
Confidence 8 599999999999999999643 3488999999999999999999964 7899999999999999999999999
Q ss_pred cccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHh
Q 003059 646 FGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFE 725 (852)
Q Consensus 646 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 725 (852)
||.++.+.. .......||..|||||.+.+..|+.++||||||++++|+.+|+.||..........+..
T Consensus 223 FGVS~~lvn-----S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~L------- 290 (364)
T KOG0581|consen 223 FGVSGILVN-----SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFEL------- 290 (364)
T ss_pred ccccHHhhh-----hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHH-------
Confidence 999987643 24567889999999999999999999999999999999999999997642211111110
Q ss_pred hCCcccccccccCCCCCCH-HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 726 KGNVKGIVDKSLAGEDVDI-EQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~-~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+..+++..-. ..+. ....++..++-.|+++||.+||++.|+++
T Consensus 291 ---l~~Iv~~ppP--~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 291 ---LCAIVDEPPP--RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred ---HHHHhcCCCC--CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1112221111 1111 24456778888899999999999999986
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=397.80 Aligned_cols=267 Identities=30% Similarity=0.462 Sum_probs=220.8
Q ss_pred HHHHHHhcccccccccccccceEEEEEEC------CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeec
Q 003059 493 YKELQRSTKGFKDKLGAGGFGAVYRGVLA------NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSS 564 (852)
Q Consensus 493 ~~el~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~ 564 (852)
..++.+....+.++||+|+||.||+|+.. +...||||.++.. .+..++|++|+++++.++|||||+|+|.|.
T Consensus 480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 44666677778899999999999999843 3568999999843 336789999999999999999999999999
Q ss_pred cCceeeEEEeecCCCCHHHHhhhcccC-----C----ccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEe
Q 003059 565 EGKHRLLVYEFMKNGSLDNFLFANEEG-----S----GKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL 635 (852)
Q Consensus 565 ~~~~~~lV~e~~~~gsL~~~l~~~~~~-----~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl 635 (852)
+++..+||+|||..|+|.+||...... . ..+|+..+.+.||.|||.||+||-+ +.+|||||..+|+||
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLV 636 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhcee
Confidence 999999999999999999999754331 1 2349999999999999999999998 889999999999999
Q ss_pred CCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccch
Q 003059 636 DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRK 714 (852)
Q Consensus 636 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~ 714 (852)
.++..+||+||||+|.....++.. ...+..-+++|||||.+..++||.+||||||||+|||+++ |+.||.....++
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk-~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-- 713 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYK-VRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-- 713 (774)
T ss_pred ccceEEEecccccchhhhhhhhhc-ccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH--
Confidence 999999999999999876554432 2223445789999999999999999999999999999998 999997554321
Q ss_pred hhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 715 KFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
+.+.+..+.+. +.+.....++..|++.||+.+|++||+++||-.+|+...+
T Consensus 714 -----VIe~i~~g~lL----------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 714 -----VIECIRAGQLL----------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred -----HHHHHHcCCcc----------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 33334444331 2333445577888999999999999999999999987654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=370.81 Aligned_cols=246 Identities=27% Similarity=0.378 Sum_probs=208.8
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecC----cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEG----IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~----~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
.+|...+.||+|||+.||+++. ..|..||+|++.+ .....+...+||++.+.|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5677788999999999999997 8899999999974 3445677899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
|+|++++|..++.. .+++++.+++.+..||+.||.|||+ ++|||||||..|+||++++++||+|||||..+.
T Consensus 98 ELC~~~sL~el~Kr-----rk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR-----RKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EecCCccHHHHHHh-----cCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeec
Confidence 99999999999863 4579999999999999999999999 899999999999999999999999999999886
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
.++. ......||+.|+|||++.....+..+||||+|||||-||.|++||+...-. ..+..+...
T Consensus 170 ~~~E---rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk-------ety~~Ik~~------ 233 (592)
T KOG0575|consen 170 YDGE---RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK-------ETYNKIKLN------ 233 (592)
T ss_pred Cccc---ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH-------HHHHHHHhc------
Confidence 5432 234678999999999999999999999999999999999999999854311 112222211
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
....+......+.+++..+|+.||.+||++.+|+.
T Consensus 234 -----~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 234 -----EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -----CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11222233345677888899999999999999984
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=382.43 Aligned_cols=262 Identities=31% Similarity=0.479 Sum_probs=220.4
Q ss_pred HHHHhcccccccccccccceEEEEEECC----CcEEEEEEec--CcccchHHHHHHHHHhhcccccceeeeeeeeccCce
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLAN----RTVVAVKQLE--GIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKH 568 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~--~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 568 (852)
||..+...+.+.||.|.||.|++|.++- ...||||.++ ..+....+|..|+.||.++.||||++|.|+.+..+.
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 5666666777899999999999999742 4579999999 345567889999999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.+||.|||+||+|+.||..+. ..+++-+...++++||.||+||.+ .++|||||.++||||+.+..+|++|||+
T Consensus 705 vMIiTEyMENGsLDsFLR~~D----GqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQND----GQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcC----CceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccc
Confidence 999999999999999997654 248899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhC
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKG 727 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (852)
+|.+..+...........-+++|.|||.+...+++.++||||||+||||.++ |.+||-.....+ +...++++
T Consensus 778 SRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-------VIkaIe~g 850 (996)
T KOG0196|consen 778 SRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VIKAIEQG 850 (996)
T ss_pred eeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-------HHHHHHhc
Confidence 9988665433333334445789999999999999999999999999999997 999985433211 11111111
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 728 NVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 728 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
-+| +.+++....+.+|+++||++|-.+||++.+|+..|+++..
T Consensus 851 -------yRL---PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 851 -------YRL---PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred -------cCC---CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 122 5677778889999999999999999999999999998753
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=353.56 Aligned_cols=255 Identities=27% Similarity=0.353 Sum_probs=203.8
Q ss_pred HHHHhcccccccccccccceEEEEEE-CCCcEEEEEEecCcc--------cchHHHHHHHHHhhcccccceeeeeeeecc
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE--------QGEKQFRMEVATISSTHHLNLVRLVGFSSE 565 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~ 565 (852)
+..+..|-+.+.||+|+||.|-+|.. ++++.||||+++... ......++|+++|++|+|||||++++++.+
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 33556777889999999999999985 568999999997321 122345799999999999999999999999
Q ss_pred CceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCC---CceE
Q 003059 566 GKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDEN---YNAK 642 (852)
Q Consensus 566 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~k 642 (852)
.+..||||||++||.|.+++..+. .+.+..-..+++|++.|+.|||+ .||+||||||+|||+..+ ..+|
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llK 319 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLK 319 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEE
Confidence 999999999999999999997654 36777778899999999999999 899999999999999765 7899
Q ss_pred EeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCC--CC-CCccchhhhHHHHHHHhCCccccccccccchhhHHH
Q 003059 643 VSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLP--IT-SKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLW 719 (852)
Q Consensus 643 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s-~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 719 (852)
|+|||+|+.... ...+....||+.|.|||++.... +. .+.|+||+||+||-+++|.+||........
T Consensus 320 ItDFGlAK~~g~----~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s------ 389 (475)
T KOG0615|consen 320 ITDFGLAKVSGE----GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS------ 389 (475)
T ss_pred ecccchhhcccc----ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc------
Confidence 999999998753 34667789999999999997654 33 488999999999999999999975432210
Q ss_pred HHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 720 AYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 720 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
..+.+..++.... ...-.+-.++.++++-++|..||++||++.|+++.
T Consensus 390 l~eQI~~G~y~f~-------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 390 LKEQILKGRYAFG-------PLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred HHHHHhcCccccc-------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1122222221110 01122344678899999999999999999999863
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=338.57 Aligned_cols=257 Identities=24% Similarity=0.362 Sum_probs=206.1
Q ss_pred hcccccccccccccceEEEEE-ECCCcEEEEEEec---CcccchHHHHHHHHHhhcccccceeeeee-eeccCce-eeEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGV-LANRTVVAVKQLE---GIEQGEKQFRMEVATISSTHHLNLVRLVG-FSSEGKH-RLLV 572 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~---~~~~~~~~f~~E~~~l~~l~h~niv~l~g-~~~~~~~-~~lV 572 (852)
+.|.+.++||+|.||+|||+. +.++..||.|.++ .+....++...|+.+|++|+|||||++++ -+.++.+ .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 446677899999999999998 6789999999987 23345577899999999999999999999 4555555 8999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCC-CcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD-CIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
|||+..|+|...+..... .++.++++.+++++.|++.||.++|...++ -|+||||||.||+|+.+|.+||+|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999965443 467899999999999999999999986543 389999999999999999999999999999
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
+.... ......+|||.||+||.++...|+.|+||||+||++|||+.-+.||.+.. +. -....+..++..
T Consensus 178 l~s~~---tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~-~L~~KI~qgd~~- 246 (375)
T KOG0591|consen 178 LSSKT---TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LL-SLCKKIEQGDYP- 246 (375)
T ss_pred hcchh---HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HH-HHHHHHHcCCCC-
Confidence 86532 22345789999999999999999999999999999999999999997542 11 112223333211
Q ss_pred ccccccCCCCCC-HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003059 732 IVDKSLAGEDVD-IEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776 (852)
Q Consensus 732 ~~d~~l~~~~~~-~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~ 776 (852)
+.+ ......+.+++..|+..||+.||+.-.+++.+.
T Consensus 247 ---------~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 247 ---------PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ---------CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 122 334456777888899999999999655554443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=344.08 Aligned_cols=271 Identities=28% Similarity=0.417 Sum_probs=200.7
Q ss_pred ccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhh--cccccceeeeeeeeccCc----eeeEEEe
Q 003059 501 KGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATIS--STHHLNLVRLVGFSSEGK----HRLLVYE 574 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~--~l~h~niv~l~g~~~~~~----~~~lV~e 574 (852)
..+.+.||+|+||.||||.+.+ +.||||++. .+..+.|++|-+|.+ .++|+||+++++.-.... +++||+|
T Consensus 212 l~l~eli~~Grfg~V~KaqL~~-~~VAVKifp--~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLDN-RLVAVKIFP--EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhhHHHhhcCccceeehhhccC-ceeEEEecC--HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 4467899999999999999966 789999998 334456777666655 578999999999876555 8999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhcccc------CCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC------RDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
|.++|||.+||.. ..++|....+|+..+++||+|||++. +++|+|||||++||||.+|+.+.|+|||+
T Consensus 289 fh~kGsL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 289 FHPKGSLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eccCCcHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 9999999999964 45999999999999999999999875 45799999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcCC-CC-----CCccchhhhHHHHHHHhCCcccc-ccccccchhhHHH--
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANLP-IT-----SKSDVYSYGMVLLEIVSGRRNFE-VSQETNRKKFSLW-- 719 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~ksDv~s~Gvvl~elltG~~p~~-~~~~~~~~~l~~~-- 719 (852)
|..+.+..... .....+||.+|||||++.+.. +. .+.||||+|.|||||++.-.-++ ...++....+...
T Consensus 363 Al~~~p~~~~~-d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 363 ALRLEPGKPQG-DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eEEecCCCCCc-chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 99887654333 333478999999999997652 22 46899999999999998553332 1111111110000
Q ss_pred ---HHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 720 ---AYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 720 ---~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
..+.+.+-.+.+...+.+......-..+..+.+.+..||+.||+.|-|+.=|.+++.++...
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 00111111111112222222222224556678888999999999999999999999887643
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=355.12 Aligned_cols=265 Identities=26% Similarity=0.427 Sum_probs=207.1
Q ss_pred CHHHHHHhcccccccccccccceEEEEEECCCcEEEEEEecC---cccchHHHHHHHHHhhcccccceeeeeeeeccCce
Q 003059 492 SYKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEG---IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKH 568 (852)
Q Consensus 492 ~~~el~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 568 (852)
.+.||......+.++||+|.||+||+|.+.+ .||||+++. ..+..+.|++|+.++++-+|.||+-+.|||.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 4456666666778899999999999999865 399999983 33456789999999999999999999999999888
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.||..+|+|.+|..+|+..+ ..++..+.++||+|||+|+.|||. ++|||||||..||+|.+++.+||+||||
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred -eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccc
Confidence 99999999999999997653 458888999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhc---CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHh
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLAN---LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFE 725 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 725 (852)
+..-..- ..........|...|||||+++. .+|++.+||||||+|+|||++|..||.....+..-. ...
T Consensus 535 atvk~~w-~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif-------mVG 606 (678)
T KOG0193|consen 535 ATVKTRW-SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF-------MVG 606 (678)
T ss_pred eeeeeee-ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE-------Eec
Confidence 9754321 11122233457888999999974 478999999999999999999999998432211100 001
Q ss_pred hCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 726 KGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
.+. +.+.+. .........+.+|+..||..++++||.+.+|+..|+.+..
T Consensus 607 rG~----l~pd~s--~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 607 RGY----LMPDLS--KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ccc----cCccch--hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 110 011110 0111223345566777999999999999999998887764
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=375.97 Aligned_cols=269 Identities=30% Similarity=0.440 Sum_probs=217.6
Q ss_pred HHHHHHhcccccccccccccceEEEEEECC--C----cEEEEEEecC--cccchHHHHHHHHHhhcccccceeeeeeeec
Q 003059 493 YKELQRSTKGFKDKLGAGGFGAVYRGVLAN--R----TVVAVKQLEG--IEQGEKQFRMEVATISSTHHLNLVRLVGFSS 564 (852)
Q Consensus 493 ~~el~~~~~~~~~~lG~G~fg~Vy~~~~~~--~----~~vavK~l~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~ 564 (852)
+.++......+.+.||+|+||.||+|.+.+ + ..||||.++. ..+...+|.+|..+|+.++|||||+++|+|.
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL 765 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence 445566677788899999999999999643 3 3499999984 4667789999999999999999999999999
Q ss_pred cCceeeEEEeecCCCCHHHHhhhccc--CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceE
Q 003059 565 EGKHRLLVYEFMKNGSLDNFLFANEE--GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAK 642 (852)
Q Consensus 565 ~~~~~~lV~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 642 (852)
+....+|++|||++|+|..||...+. .....|+....+.++.|||+|+.|||+ +++|||||.++|+||++...+|
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VK 842 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVK 842 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEE
Confidence 99999999999999999999976532 124578999999999999999999999 8899999999999999999999
Q ss_pred EeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHH
Q 003059 643 VSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAY 721 (852)
Q Consensus 643 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 721 (852)
|+|||||+.+...++.. ......-..+|||||.+..+.++.|+|||||||+||||+| |..||......+ +.
T Consensus 843 IaDFGlArDiy~~~yyr-~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~-------v~ 914 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYR-KHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-------VL 914 (1025)
T ss_pred EcccchhHhhhhchhee-ccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH-------HH
Confidence 99999999665443322 1122345678999999999999999999999999999999 889997543211 11
Q ss_pred HHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCC
Q 003059 722 EEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIE 782 (852)
Q Consensus 722 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~ 782 (852)
..+.++- +| +.+......+.+++..||+.+|++||++..|++.+..+....
T Consensus 915 ~~~~~gg-------RL---~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 915 LDVLEGG-------RL---DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred HHHHhCC-------cc---CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 1111111 22 233444556778999999999999999999999888776443
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=330.77 Aligned_cols=280 Identities=22% Similarity=0.323 Sum_probs=215.1
Q ss_pred CcccCHHHHHHhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCc
Q 003059 488 PVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK 567 (852)
Q Consensus 488 ~~~~~~~el~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~ 567 (852)
..++-...-...+..+.+.||+|.||.||+|.++++ .||||++...++....-+.|+.....|+|+||+.+++.-..+.
T Consensus 200 GlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wrGe-~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 200 GLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWRGE-DVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred CchhHhHHhhhheeEEEEEecCccccceeeccccCC-ceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 344444555566778899999999999999999765 5999999855443333344444455679999999999865443
Q ss_pred ----eeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccc-----cCCCcccCCCCCCceEeCCC
Q 003059 568 ----HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE-----CRDCIVHCDIKPENILLDEN 638 (852)
Q Consensus 568 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivH~Dlkp~NILl~~~ 638 (852)
+.+||.+|.++|||.|||.. ..++.+..++++..+|.||+|||.+ .++.|.|||||++||||..+
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn 352 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 352 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence 78999999999999999953 4689999999999999999999975 35779999999999999999
Q ss_pred CceEEeecccccccCCCC-CcceeeeeecCCCCCCChhhhhcCC------CCCCccchhhhHHHHHHHh-----C-----
Q 003059 639 YNAKVSDFGLAKLINPKD-HRHRTLTSVRGTRGYLAPEWLANLP------ITSKSDVYSYGMVLLEIVS-----G----- 701 (852)
Q Consensus 639 ~~~kl~DFGla~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~------~s~ksDv~s~Gvvl~ellt-----G----- 701 (852)
+.+.|+|+|||....... ......+..+||.+|||||++...- .-..+||||||.|+||+.. |
T Consensus 353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 999999999998765542 2223344577999999999985431 2247899999999999985 2
Q ss_pred CccccccccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 702 RRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 702 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
+.||....+.+.. .+.+.+-...+.+.+.++....+.+.+..+.+++..||..+|..|-|+-.|.+.|.++.+
T Consensus 433 ~~Pyyd~Vp~DPs------~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 433 QLPYYDVVPSDPS------FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred cCCcccCCCCCCC------HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 3566544332221 223333333444555566556677889999999999999999999999999999888764
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=336.42 Aligned_cols=254 Identities=28% Similarity=0.400 Sum_probs=198.2
Q ss_pred cccccccccccccceEEEEEECC-CcEEEEEEecCc-ccchHHHHHHHHHhhcccccceeeeeeeeccCc--eeeEEEee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK--HRLLVYEF 575 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV~e~ 575 (852)
.+...+.||+|.||+||++...+ +...|||.+... ....+.+++|+.+|.+++|||||+.+|...... .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 34556789999999999999654 889999998743 122566899999999999999999999855544 68999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC-CCceEEeecccccccCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE-NYNAKVSDFGLAKLINP 654 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~ 654 (852)
+++|+|.+++.... + .|++..+.++++||++||+|||+ ++||||||||+||||+. ++.+||+|||+++....
T Consensus 98 ~~~GsL~~~~~~~g---~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 98 APGGSLSDLIKRYG---G-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred cCCCcHHHHHHHcC---C-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999996543 2 59999999999999999999998 89999999999999999 79999999999987764
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
............||+.|||||++..+ ...+++|||||||++.||+||+.||..... ...+..........
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~-----~~~~~~~ig~~~~~---- 241 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE-----EAEALLLIGREDSL---- 241 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc-----hHHHHHHHhccCCC----
Confidence 22222334457899999999999953 344699999999999999999999975310 01111111111111
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQML 775 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L 775 (852)
+. .+..-.....+++..|+..+|++|||+.++++..
T Consensus 242 -P~-----ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 242 -PE-----IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred -CC-----CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 11 1112233566778889999999999999998754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=331.02 Aligned_cols=240 Identities=25% Similarity=0.325 Sum_probs=195.5
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
..+.+.+.||+|+||.||.++. +.++.+|+|.+++.. ...+...+|..+|.+++||.||+++-.|.+.+..|||+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 3456678999999999999985 458899999997432 34566789999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+.||.|..+|.+.. .+++..+.-++.+|+.||.|||+ ++||||||||+|||||++|+++|+|||+++...
T Consensus 105 d~~~GGeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREG-----RFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred eccCCccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 9999999999996543 48888888899999999999999 899999999999999999999999999999654
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
... .......||+.|||||++.+..++..+|.||+|+++|||++|.+||...+... ..+.+..++
T Consensus 177 ~~~---~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~-------~~~~I~~~k----- 241 (357)
T KOG0598|consen 177 KDG---DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK-------MYDKILKGK----- 241 (357)
T ss_pred cCC---CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH-------HHHHHhcCc-----
Confidence 322 23344789999999999999999999999999999999999999997654211 112222222
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCC
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP 766 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RP 766 (852)
+. ..+.--...+.+++...+..||++|-
T Consensus 242 ---~~--~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 ---LP--LPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---CC--CCCccCCHHHHHHHHHHhccCHHHhc
Confidence 10 11111223556777789999999995
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=352.35 Aligned_cols=265 Identities=28% Similarity=0.413 Sum_probs=203.9
Q ss_pred HHHhcccccccccccccceEEEEEE------CCCcEEEEEEecCc--ccchHHHHHHHHHhhcc-cccceeeeeeeeccC
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVL------ANRTVVAVKQLEGI--EQGEKQFRMEVATISST-HHLNLVRLVGFSSEG 566 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~ 566 (852)
+....+.+.++||+|+||.||+|.. ..++.||||++... ....+.+.+|+.++.++ +||||++++++|...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 3445678889999999999999974 23467999998743 23345789999999999 899999999988764
Q ss_pred -ceeeEEEeecCCCCHHHHhhhcccC------------------------------------------------------
Q 003059 567 -KHRLLVYEFMKNGSLDNFLFANEEG------------------------------------------------------ 591 (852)
Q Consensus 567 -~~~~lV~e~~~~gsL~~~l~~~~~~------------------------------------------------------ 591 (852)
...++||||+++|+|.+++......
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4689999999999999999653210
Q ss_pred ---CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcceeeeeecCC
Q 003059 592 ---SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGT 668 (852)
Q Consensus 592 ---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt 668 (852)
....+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++........ .......++
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~ 239 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGSARLP 239 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcch-hcccCCCCC
Confidence 02358888999999999999999998 89999999999999999999999999999865432111 111233467
Q ss_pred CCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHH
Q 003059 669 RGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQV 747 (852)
Q Consensus 669 ~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 747 (852)
..|+|||.+.+..++.++||||||+++|||++ |+.||....... . .......+... . .+....
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~----~~~~~~~~~~~-----~-----~~~~~~ 303 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--E----FCQRLKDGTRM-----R-----APENAT 303 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--H----HHHHHhcCCCC-----C-----CCCCCC
Confidence 88999999999999999999999999999997 999997543211 0 11111111110 0 011122
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 748 MRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 748 ~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
..+.+++.+|++.||.+||++.+|++.|+.+..
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 356788999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=329.73 Aligned_cols=258 Identities=24% Similarity=0.355 Sum_probs=204.3
Q ss_pred HhcccccccccccccceEEEEE-ECCCcEEEEEEec--CcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGV-LANRTVVAVKQLE--GIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~--~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
...|++.+.||.|..++||+|. .+.+..||||++. +.....+.+.+|+..|+.++||||++.+..|..+...|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 3468889999999999999998 4567899999997 333446789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
||.+||+.+.+...-. ..+++..+..|++++++||.|||. +|.||||||+.||||+.+|.+||+|||..-.+..
T Consensus 105 fMa~GS~ldIik~~~~---~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP---DGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhcCCcHHHHHHHHcc---ccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999976543 338899999999999999999999 8999999999999999999999999998765544
Q ss_pred CCCcceee-eeecCCCCCCChhhhhc--CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 655 KDHRHRTL-TSVRGTRGYLAPEWLAN--LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 655 ~~~~~~~~-~~~~gt~~y~aPE~~~~--~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
........ ....||+.|||||+++. ..|+.|+||||||++..||.+|..||....+... ....+ .+....
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv------Ll~tL-qn~pp~ 251 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV------LLLTL-QNDPPT 251 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH------HHHHh-cCCCCC
Confidence 33333333 66789999999999643 4689999999999999999999999975543211 00111 111110
Q ss_pred ccccccCCCCCCHHH----HHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 732 IVDKSLAGEDVDIEQ----VMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~----~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.. .. ..+.++ -..+.+++..|++.||.+|||++++++
T Consensus 252 ~~---t~--~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 252 LL---TS--GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cc---cc--cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00 00 111121 124667777899999999999999875
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=352.58 Aligned_cols=266 Identities=28% Similarity=0.417 Sum_probs=210.6
Q ss_pred HHHHHHhcccccccccccccceEEEEEECC--C---cEEEEEEecC----cccchHHHHHHHHHhhcccccceeeeeeee
Q 003059 493 YKELQRSTKGFKDKLGAGGFGAVYRGVLAN--R---TVVAVKQLEG----IEQGEKQFRMEVATISSTHHLNLVRLVGFS 563 (852)
Q Consensus 493 ~~el~~~~~~~~~~lG~G~fg~Vy~~~~~~--~---~~vavK~l~~----~~~~~~~f~~E~~~l~~l~h~niv~l~g~~ 563 (852)
-.||......+.++||+|+||.||+|.+.. + ..||||..+. ......+|.+|++++++++|||||+++|++
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 356777777788999999999999999643 2 2389999884 244567899999999999999999999999
Q ss_pred ccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEE
Q 003059 564 SEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKV 643 (852)
Q Consensus 564 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 643 (852)
......|||||+|+||+|++||.+... .++..++++++.++|.||+|||+ +++|||||.++|+|++.++.+||
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKI 303 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKI 303 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEe
Confidence 999999999999999999999976532 58999999999999999999999 89999999999999999999999
Q ss_pred eecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHH
Q 003059 644 SDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYE 722 (852)
Q Consensus 644 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 722 (852)
+|||+++.-.. .........-+.+|+|||.+....++.++|||||||++||+.+ |..||....... +..
T Consensus 304 SDFGLs~~~~~---~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~-------v~~ 373 (474)
T KOG0194|consen 304 SDFGLSRAGSQ---YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE-------VKA 373 (474)
T ss_pred CccccccCCcc---eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH-------HHH
Confidence 99999875431 1111112246789999999999999999999999999999999 889997654321 111
Q ss_pred HHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCCCC
Q 003059 723 EFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKP 784 (852)
Q Consensus 723 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~~~ 784 (852)
.+.... -+. ..+......+..++..|+..+|++||+|.+|.+.|+.+.....+
T Consensus 374 kI~~~~------~r~---~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 374 KIVKNG------YRM---PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred HHHhcC------ccC---CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 110100 011 11112233444555689999999999999999999988765444
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.74 Aligned_cols=249 Identities=25% Similarity=0.373 Sum_probs=202.0
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCc----ccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEEE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI----EQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 573 (852)
.+.|.+.||+|.|++|++|+. ..++.+|||++.+. +...+-...|-++|.+| .||.|++|+--|.+....|+|+
T Consensus 74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvL 153 (604)
T KOG0592|consen 74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVL 153 (604)
T ss_pred hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEE
Confidence 456789999999999999994 56899999999743 23344567788889999 8999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+++|+|.++|.+.. .+++.....++.+|+.||+|||. +|||||||||+|||||++|++||+|||.|+.+.
T Consensus 154 e~A~nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 154 EYAPNGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EecCCCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 9999999999997654 48888888999999999999999 999999999999999999999999999999885
Q ss_pred CCCCc----------ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHH
Q 003059 654 PKDHR----------HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEE 723 (852)
Q Consensus 654 ~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 723 (852)
+.... .......+||..|.+||++.....++.+|+|+|||+||+|+.|++||....+- +. ...
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney----li---Fqk 298 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY----LI---FQK 298 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH----HH---HHH
Confidence 42111 11124588999999999999999999999999999999999999999865431 11 111
Q ss_pred HhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 724 FEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 724 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
+. . ++- .++..-.+.+.+|+...|..||.+|++.++|.+.
T Consensus 299 I~-----~-l~y-----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 299 IQ-----A-LDY-----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HH-----H-hcc-----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11 0 011 1122222456677778899999999999998863
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=338.65 Aligned_cols=269 Identities=25% Similarity=0.348 Sum_probs=216.7
Q ss_pred HHHHHHhcccccccccccccceEEEEEECCCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceee
Q 003059 493 YKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRL 570 (852)
Q Consensus 493 ~~el~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 570 (852)
+.|+.+....|.++||+|-||.|.+....+...||||+++.. .....+|.+|+++|.+++||||++|+|+|..++.++
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 457777778889999999999999999998899999999843 344578999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+|+|||++|+|..||.++... .+.-..-.+|+.||+.||+||.+ .++|||||.++|+|+|.++++||+|||+++
T Consensus 612 mI~EYmEnGDLnqFl~aheap---t~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELP---TAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCc---ccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCccccc
Confidence 999999999999999876432 24555667899999999999998 899999999999999999999999999999
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh--CCccccccccccchhhHHHHHHHHhhCC
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS--GRRNFEVSQETNRKKFSLWAYEEFEKGN 728 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (852)
-+...+.. +.....+-+++|||+|.+..++++.++|||+||+++||+++ ...||....++. .++.....+....
T Consensus 686 ~lysg~yy-~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~ 761 (807)
T KOG1094|consen 686 NLYSGDYY-RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQG 761 (807)
T ss_pred ccccCCce-eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCC
Confidence 77655433 33445667899999999999999999999999999999864 788886543321 1111111111111
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
....+ ..+.-....+.+++++||..+-++||+++++...|.+.
T Consensus 762 ~~~~l-------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 RQVVL-------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cceec-------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11111 12223344667999999999999999999999988754
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=333.68 Aligned_cols=264 Identities=24% Similarity=0.319 Sum_probs=207.0
Q ss_pred hcccccccccccccceEEEEE-ECCCcEEEEEEecCcccchHH--HHHHHHHhhccc-ccceeeeeeeeccCc-eeeEEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQ--FRMEVATISSTH-HLNLVRLVGFSSEGK-HRLLVY 573 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~--f~~E~~~l~~l~-h~niv~l~g~~~~~~-~~~lV~ 573 (852)
.+|...++||.|.||.||+|+ ...+..||||+++..-...++ -.+|++.|++|. |||||+|.+.+.+.+ ..++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 467788999999999999998 566888999999844333333 368999999998 999999999999988 999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
|||+ .+|.+++..+ ++.+++..+..|+.||++||+|+|. +|+.|||+||+|||+.....+||+|||+||...
T Consensus 90 E~Md-~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 90 EFMD-CNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred Hhhh-hhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence 9994 5899988654 5689999999999999999999998 999999999999999999999999999999885
Q ss_pred CCCCcceeeeeecCCCCCCChhhhh-cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHH-----HHhh-
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLA-NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYE-----EFEK- 726 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~-----~~~~- 726 (852)
.. ...+..+.|.-|.|||++. ..-|+.+.|||++|||++||.+-++.|.+..+.++-.-+..+.. .+.+
T Consensus 162 Sk----pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 162 SK----PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred cC----CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 43 3346677899999999875 66899999999999999999999999987765443322111110 0001
Q ss_pred CCcccccccccCCC-CCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 727 GNVKGIVDKSLAGE-DVDI-----EQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 727 ~~~~~~~d~~l~~~-~~~~-----~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
..+...+.-.+... ..+. ....++++++.+|+..||.+|||+.|.++.
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00111111111110 1111 244578899999999999999999999874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=333.43 Aligned_cols=263 Identities=22% Similarity=0.285 Sum_probs=201.1
Q ss_pred cccccccccccccceEEEEE-ECCCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccC--ceeeEEE
Q 003059 500 TKGFKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEG--KHRLLVY 573 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~ 573 (852)
.|.-.++||+|.||.||||+ ..+++.||+|++.... .......+||.+|++|.||||++|.+...+. +..|||+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 34446789999999999999 5679999999997322 2234557999999999999999999988776 6899999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
|||++ +|.-++... +-.++..++..+++|++.||+|+|. ++|+|||||.+|||||.+|.+||+|||||+++.
T Consensus 198 eYMdh-DL~GLl~~p----~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSSP----GVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred ecccc-hhhhhhcCC----CcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeecc
Confidence 99976 787777432 3458999999999999999999999 999999999999999999999999999999886
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcc--
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVK-- 730 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-- 730 (852)
.... ...+..+-|.-|.|||.+.+. .|+...|+||.||||.||+.|++.|.+..+.++...+....-...+....
T Consensus 270 ~~~~--~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 270 PSGS--APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred CCCC--cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 6332 335677789999999999876 79999999999999999999999998876544433222211111111111
Q ss_pred -----cccccccCCCCCCHHH-----HHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 731 -----GIVDKSLAGEDVDIEQ-----VMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 731 -----~~~d~~l~~~~~~~~~-----~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..+.+.-.- .....+ ....++|+..+|..||.+|.|+.++++
T Consensus 348 kLP~~~~~kp~~~y-~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLPHATIFKPQQPY-KRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCcccccCCCCcc-cchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111111000 001111 123567777889999999999999885
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=337.51 Aligned_cols=238 Identities=29% Similarity=0.478 Sum_probs=195.5
Q ss_pred ccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCCHHHH
Q 003059 505 DKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNF 584 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 584 (852)
+=||.|+.|.||+|.+++. .||||+++.. -+.+|+-|++|+|+||+.|.|+|.....++||||||+.|-|...
T Consensus 130 eWlGSGaQGAVF~Grl~ne-tVAVKKV~el------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLHNE-TVAVKKVREL------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hhhccCcccceeeeeccCc-eehhHHHhhh------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 3499999999999999764 5999988732 24578889999999999999999999999999999999999999
Q ss_pred hhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcceeeee
Q 003059 585 LFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTS 664 (852)
Q Consensus 585 l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 664 (852)
|.. +..+.-.....|..+||.||.|||. +.|||||||.-||||..+..+||+|||-++..... .+.-.
T Consensus 203 Lka-----~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~----STkMS 270 (904)
T KOG4721|consen 203 LKA-----GRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK----STKMS 270 (904)
T ss_pred Hhc-----cCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh----hhhhh
Confidence 964 4457778888999999999999999 88999999999999999999999999999876432 34445
Q ss_pred ecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCCCCCCH
Q 003059 665 VRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDI 744 (852)
Q Consensus 665 ~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 744 (852)
+.||..|||||++++.+.++|+|||||||||||||||..||..-+... +.| + +-...|. -+.+.
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIw-------G----VGsNsL~-LpvPs 334 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIW-------G----VGSNSLH-LPVPS 334 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEE-------e----ccCCccc-ccCcc
Confidence 789999999999999999999999999999999999999997432110 001 0 0011111 13444
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003059 745 EQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEG 777 (852)
Q Consensus 745 ~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~ 777 (852)
+....+.-++.+||+..|.+||++.+|+..|+-
T Consensus 335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 445556667778999999999999999988753
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=337.75 Aligned_cols=266 Identities=26% Similarity=0.351 Sum_probs=202.3
Q ss_pred HhcccccccccccccceEEEEEECC-----------------CcEEEEEEecCc--ccchHHHHHHHHHhhcccccceee
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLAN-----------------RTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVR 558 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~ 558 (852)
+..+.+.++||+|+||.||++.+++ +..||+|.+... .....+|.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4567788999999999999998532 336999998743 334567999999999999999999
Q ss_pred eeeeeccCceeeEEEeecCCCCHHHHhhhccc--------------CCccccchhHHHHHHHhhHhhhhhhccccCCCcc
Q 003059 559 LVGFSSEGKHRLLVYEFMKNGSLDNFLFANEE--------------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIV 624 (852)
Q Consensus 559 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv 624 (852)
+++++.+.+..++||||+++++|.+++..... .....+++..+++++.||+.||+|||+ .+|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCcc
Confidence 99999999999999999999999999864321 112357889999999999999999998 8999
Q ss_pred cCCCCCCceEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh--CC
Q 003059 625 HCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS--GR 702 (852)
Q Consensus 625 H~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt--G~ 702 (852)
||||||+|||+++++.+||+|||+++.+..... ........++..|+|||.+....++.++||||||+++|||++ +.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCce-eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 999999999999999999999999986643221 112223445788999999998899999999999999999987 55
Q ss_pred ccccccccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003059 703 RNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEG 777 (852)
Q Consensus 703 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~ 777 (852)
.||...... .........+.... ..... ..+......+.+++.+||+.+|++||++.+|.+.|++
T Consensus 240 ~p~~~~~~~---~~~~~~~~~~~~~~-~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 240 QPYGELTDE---QVIENAGEFFRDQG-RQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCcCCHH---HHHHHHHHHhhhcc-ccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 677543221 11111111111110 00000 0011122457788999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=313.47 Aligned_cols=259 Identities=21% Similarity=0.302 Sum_probs=201.1
Q ss_pred ccccccccccceEEEEEEC-CCcEEEEEEecCcccc---hHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 503 FKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQG---EKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 503 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
-.-++|+|+||+|||.+.+ .|+.||||++...++. .+--.+|+++|++++|+|+|.++.+|...+..+||+||++.
T Consensus 6 ~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh 85 (396)
T KOG0593|consen 6 KLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH 85 (396)
T ss_pred hhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch
Confidence 3457999999999999965 4899999999744332 34457999999999999999999999999999999999987
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
.-|.+ |... ...++.+.+.+++.|++.|+.|+|+ +++|||||||+||||..++.+||+|||+|+.+....
T Consensus 86 TvL~e-Le~~----p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg-- 155 (396)
T KOG0593|consen 86 TVLHE-LERY----PNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG-- 155 (396)
T ss_pred HHHHH-HHhc----cCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCc--
Confidence 55544 4332 2347888999999999999999999 899999999999999999999999999999887322
Q ss_pred ceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHH--------hhC-C
Q 003059 659 HRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEF--------EKG-N 728 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~--------~~~-~ 728 (852)
...+..+-|.-|.|||.+.+ .+|+...|||++||++.||++|.+.|.+..+.+..+++......+ ... .
T Consensus 156 -d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 156 -DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred -chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 22345667899999999987 689999999999999999999999998887766655544332211 111 1
Q ss_pred cccccccccCCCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 729 VKGIVDKSLAGEDVDI-----EQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 729 ~~~~~d~~l~~~~~~~-----~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
...+.-+.... .-+. ....-+++++..|++.||.+|++-++++.
T Consensus 235 F~Gv~lP~~~~-~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHGVRLPEPEH-PEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeeecCCCCC-ccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111111111 1111 11224778999999999999999998874
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=337.93 Aligned_cols=246 Identities=23% Similarity=0.351 Sum_probs=202.0
Q ss_pred ccccccccccccceEEEEE-ECCCcEEEEEEecCcccch-HHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 501 KGFKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGE-KQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~-~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
|.-.++||+|+.|.||.+. ...++.||||++....+.. +-+.+|+.+|+..+|+|||++++.+..+++.|+|||||++
T Consensus 275 y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~g 354 (550)
T KOG0578|consen 275 YTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEG 354 (550)
T ss_pred hcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCC
Confidence 3345689999999999998 4568889999999655544 4568999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
|+|.+.+.. ..+++.++..|++++++||+|||. ++|+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 355 gsLTDvVt~------~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 355 GSLTDVVTK------TRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred Cchhhhhhc------ccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 999998843 348999999999999999999999 8999999999999999999999999999987764322
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccC
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (852)
.....+||+.|||||++....|++|.||||||++++||+.|.+||-........+ .+.... .+.+
T Consensus 425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly-------LIa~ng-----~P~l- 489 (550)
T KOG0578|consen 425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------LIATNG-----TPKL- 489 (550)
T ss_pred --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHH-------HHhhcC-----CCCc-
Confidence 4456789999999999999999999999999999999999999996432211111 111111 1111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 739 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.........+.++..+||+.|+++||++.|+++
T Consensus 490 --k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 490 --KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred --CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 112222345667888899999999999999986
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=332.77 Aligned_cols=258 Identities=19% Similarity=0.315 Sum_probs=201.6
Q ss_pred cccCHHHHHHhcccccccccccccceEEEEEECCCcEEEEEEecCcccc----hHHHHHHHHHhhcccccceeeeeeeec
Q 003059 489 VQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQG----EKQFRMEVATISSTHHLNLVRLVGFSS 564 (852)
Q Consensus 489 ~~~~~~el~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~----~~~f~~E~~~l~~l~h~niv~l~g~~~ 564 (852)
..++..+|...+ ...||+|+++.||+|.+ +++.||||++...... .+.|.+|+.+|.+++||||++++|++.
T Consensus 13 ~~i~~~~i~~~~---~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~ 88 (283)
T PHA02988 13 KCIESDDIDKYT---SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFII 88 (283)
T ss_pred eecCHHHcCCCC---CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEE
Confidence 344555553322 14699999999999998 5778999999754333 366789999999999999999999987
Q ss_pred c----CceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCc
Q 003059 565 E----GKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYN 640 (852)
Q Consensus 565 ~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 640 (852)
+ ....++||||+++|+|.+++... ..+++...++++.|++.||.|||+. .+++||||||+|||+++++.
T Consensus 89 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~ 161 (283)
T PHA02988 89 DIVDDLPRLSLILEYCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYK 161 (283)
T ss_pred ecccCCCceEEEEEeCCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCc
Confidence 6 45789999999999999999643 3588999999999999999999972 37889999999999999999
Q ss_pred eEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhc--CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHH
Q 003059 641 AKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN--LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSL 718 (852)
Q Consensus 641 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~ 718 (852)
+||+|||+++.+.... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... +
T Consensus 162 ~kl~dfg~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~-- 230 (283)
T PHA02988 162 LKIICHGLEKILSSPP------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---I-- 230 (283)
T ss_pred EEEcccchHhhhcccc------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---H--
Confidence 9999999998654321 23457889999999976 689999999999999999999999997543211 0
Q ss_pred HHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 719 WAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 719 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
.......... . ..+......+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 231 --~~~i~~~~~~----~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 231 --YDLIINKNNS----L-----KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred --HHHHHhcCCC----C-----CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1111111100 0 111122345678888999999999999999999998764
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=346.69 Aligned_cols=263 Identities=28% Similarity=0.418 Sum_probs=203.6
Q ss_pred HHHhcccccccccccccceEEEEEE------CCCcEEEEEEecCc--ccchHHHHHHHHHhhcc-cccceeeeeeeeccC
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVL------ANRTVVAVKQLEGI--EQGEKQFRMEVATISST-HHLNLVRLVGFSSEG 566 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~ 566 (852)
+....+.+.++||+|+||.||+|+. ..+..||||+++.. ....+.+.+|+.++..+ +||||++++++|.++
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3445677889999999999999973 23568999999733 23345788999999999 899999999999999
Q ss_pred ceeeEEEeecCCCCHHHHhhhccc--------------------------------------------------------
Q 003059 567 KHRLLVYEFMKNGSLDNFLFANEE-------------------------------------------------------- 590 (852)
Q Consensus 567 ~~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 590 (852)
+..++||||+++|+|.+++.....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 999999999999999999964321
Q ss_pred --------------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 591 --------------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 591 --------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
.....+++..+++++.||++||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 011257899999999999999999998 899999999999999999999999999998664322
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
.. .......++..|+|||.+.+..++.++||||||+++|||++ |..||....... .+ ...+..+.. .
T Consensus 269 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~----~~~~~~~~~-----~ 336 (375)
T cd05104 269 NY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KF----YKMIKEGYR-----M 336 (375)
T ss_pred cc-cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HH----HHHHHhCcc-----C
Confidence 11 11122345678999999999999999999999999999998 888986432211 11 111111110 0
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
.. +......+.+++.+|++.||++||++.+|++.|++.
T Consensus 337 ~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 LS-----PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CC-----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 00 001123567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=338.66 Aligned_cols=262 Identities=28% Similarity=0.394 Sum_probs=218.0
Q ss_pred CHHHHHHhcccccccccccccceEEEEEECC-CcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceee
Q 003059 492 SYKELQRSTKGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRL 570 (852)
Q Consensus 492 ~~~el~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 570 (852)
.-.|+++......++||.|.||.||.|+|+. .-.||||.++.+....++|..|+.+|+.++|||+|+|+|+|+.+...|
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 4457778888889999999999999999865 567999999988888999999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
||.|||.+|+|.+||.... +..++--..+.++.||+.||+||.. +++|||||.++|+|+.++..+||+||||++
T Consensus 340 IiTEfM~yGNLLdYLRecn---r~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECN---RSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred EEEecccCccHHHHHHHhc---hhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhh
Confidence 9999999999999997654 3346666778999999999999998 899999999999999999999999999999
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCc
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
++..+.+. ......-.+.|.|||.+....++.|+|||+|||+||||.| |-.||.+.+.. .++..++.+-.
T Consensus 414 lMtgDTYT--AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-------qVY~LLEkgyR 484 (1157)
T KOG4278|consen 414 LMTGDTYT--AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYGLLEKGYR 484 (1157)
T ss_pred hhcCCcee--cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-------HHHHHHhcccc
Confidence 98764322 2223345788999999999999999999999999999998 88888654321 13333333321
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 730 KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
.+ -+.-....+.++++.||+.+|.+||+++|+-+.+|.+
T Consensus 485 M~----------~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 485 MD----------GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred cc----------CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 11 1222334567778889999999999999999988865
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=382.90 Aligned_cols=270 Identities=24% Similarity=0.486 Sum_probs=217.6
Q ss_pred ccCHHHHHHhcccccccccccccceEEEEEE-CCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCce
Q 003059 490 QFSYKELQRSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKH 568 (852)
Q Consensus 490 ~~~~~el~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 568 (852)
.++++++... +...+.||+|+||.||+|.. .++..||||+++.... ....|++++++++|||||+++|+|.+.+.
T Consensus 682 ~~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l~HpnIv~~~~~~~~~~~ 757 (968)
T PLN00113 682 SITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKLQHPNIVKLIGLCRSEKG 757 (968)
T ss_pred hhhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence 3556666543 44556899999999999996 5788999999874332 22456889999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.++||||+++|+|.+++. .++|..+.+|+.||++||+|||..+.++|+||||||+||+++.++.+++. ||.
T Consensus 758 ~~lv~Ey~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~ 828 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL 828 (968)
T ss_pred CEEEEeCCCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecc
Confidence 999999999999999994 28899999999999999999997655899999999999999999988876 665
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN 728 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (852)
....... ....++..|+|||++.+..++.|+|||||||++|||+||+.||+.... .......|+........
T Consensus 829 ~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~ 900 (968)
T PLN00113 829 PGLLCTD-------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCH 900 (968)
T ss_pred ccccccC-------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccc
Confidence 5433211 123578999999999999999999999999999999999999964332 23345566655554555
Q ss_pred cccccccccCCC-CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 729 VKGIVDKSLAGE-DVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 729 ~~~~~d~~l~~~-~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
....+++.+... ..+.++..++.+++.+|++.+|++||+|+||++.|+++..
T Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred hhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 556666665432 3456777888999999999999999999999999988754
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=328.74 Aligned_cols=257 Identities=26% Similarity=0.381 Sum_probs=202.8
Q ss_pred HHHhcccccccccccccceEEEEEEC----CCcEEEEEEecCcc--cchHHHHHHHHHhhcccccceeeeeeeeccCcee
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLA----NRTVVAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHR 569 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 569 (852)
|....+.+.+.||+|+||.||+|.+. .+..||+|+++... .....|.+|+.++.+++||||+++++++..++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 34456788899999999999999853 35689999988432 3346789999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+|||++.++.+|++|||.+
T Consensus 82 ~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~ 154 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRL 154 (266)
T ss_pred EEEEEeCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccc
Confidence 9999999999999999643 2358899999999999999999998 89999999999999999999999999987
Q ss_pred cccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCC
Q 003059 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGN 728 (852)
Q Consensus 650 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (852)
....... ........++..|+|||.+.+..++.++||||||+++||+++ |+.||....... ......++.
T Consensus 155 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~ 225 (266)
T cd05064 155 QEDKSEA--IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-------VIKAVEDGF 225 (266)
T ss_pred ccccccc--hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCC
Confidence 6532211 111112335678999999999999999999999999999875 999996543211 111111111
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
.. +.+......+.+++..||+.+|.+||++.+|.+.|+++
T Consensus 226 ~~----------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 RL----------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CC----------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00 11112234567888899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=325.97 Aligned_cols=259 Identities=29% Similarity=0.445 Sum_probs=209.4
Q ss_pred HHHHhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
|+....+.+.++||+|+||.||+|...+++.||+|.++......+++.+|+.++++++|+||+++++++...+..++|||
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 34556788889999999999999998788889999998665667789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++++|.+++.... ...+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 82 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 82 LMKYGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred cccCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 999999999996432 3468999999999999999999998 8999999999999999999999999999987642
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
... ........+..|+|||.+.+..++.++||||||+++|||++ |+.||....... ..........
T Consensus 156 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~---- 222 (261)
T cd05068 156 DIY--EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-------VLQQVDQGYR---- 222 (261)
T ss_pred Ccc--cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC----
Confidence 211 11111223457999999999999999999999999999999 999996432111 1111111100
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
+ +.+......+.+++.+|++.+|.+||++.++++.|+++
T Consensus 223 ---~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 ---M---PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ---C---CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0 11112235678889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=325.53 Aligned_cols=257 Identities=27% Similarity=0.424 Sum_probs=207.6
Q ss_pred HHhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
....+.+.++||+|+||.||+|...++..||+|.+.......+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 34567788999999999999999888888999998865556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|.+++.... ...+++..++.++.|+++||+|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 84 AKGSLLDFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 9999999996532 3458889999999999999999998 899999999999999999999999999998764321
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
........++..|+|||.+....++.++||||||+++|||++ |+.||....... ......... ..+
T Consensus 158 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~----~~~ 224 (261)
T cd05072 158 --YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-------VMSALQRGY----RMP 224 (261)
T ss_pred --eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCC----CCC
Confidence 111122345678999999998899999999999999999998 999996432211 111111110 001
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
. .......+.+++.+|++.+|++||++.++.+.|+.+
T Consensus 225 ~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 225 R------MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred C------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1 111224567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=343.88 Aligned_cols=264 Identities=28% Similarity=0.407 Sum_probs=203.3
Q ss_pred HHHhcccccccccccccceEEEEEEC------CCcEEEEEEecCcc--cchHHHHHHHHHhhcc-cccceeeeeeeeccC
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLA------NRTVVAVKQLEGIE--QGEKQFRMEVATISST-HHLNLVRLVGFSSEG 566 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~ 566 (852)
+....+.+.+.||+|+||.||+++.. +...||||++.... .....+.+|+++++.+ +|+||++++++|.+.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 34456778899999999999998742 23579999997432 2345688999999999 899999999999999
Q ss_pred ceeeEEEeecCCCCHHHHhhhccc--------------------------------------------------------
Q 003059 567 KHRLLVYEFMKNGSLDNFLFANEE-------------------------------------------------------- 590 (852)
Q Consensus 567 ~~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 590 (852)
+..++||||+++|+|.+++.....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999999864321
Q ss_pred ---------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCccee
Q 003059 591 ---------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRT 661 (852)
Q Consensus 591 ---------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 661 (852)
.....+++..+++++.||++||+|||+ ++|+||||||+|||+++++.+||+|||+++....... ...
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~-~~~ 270 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-YVV 270 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-eee
Confidence 012357889999999999999999998 8999999999999999999999999999986543211 111
Q ss_pred eeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcccccccccCCC
Q 003059 662 LTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGE 740 (852)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (852)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||....... . .......+ . .....
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~----~~~~~~~~-~----~~~~~-- 337 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K----FYKMVKRG-Y----QMSRP-- 337 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H----HHHHHHcc-c----CccCC--
Confidence 122345678999999999999999999999999999997 999997543211 0 00111111 0 00000
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 741 DVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 741 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
......+.+++.+|++.||++||++.+|+++|+++.
T Consensus 338 ---~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 ---DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 011245678888999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=330.29 Aligned_cols=244 Identities=28% Similarity=0.419 Sum_probs=202.9
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCcccch---HHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGE---KQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
.|.+.+.||+|.||.||||+.+ +.+.||+|.+.+....+ +.+.+|++++++++|||||.++++|+...+.++|.||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 3556788999999999999854 57889999997544443 4578999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+.+ +|..+|..+. .++++.+..|+.++..||.|||+ .+|+|||+||+||||+.++.+|++|||+|+.+..
T Consensus 83 a~g-~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 83 AVG-DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred hhh-hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 977 9999997654 48999999999999999999999 8999999999999999999999999999998764
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
.....+.+.||+-|||||...+.+|+..+|+||+||++||+.+|++||....- ...+ + .++..
T Consensus 153 --~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si------~~Lv-~--------~I~~d 215 (808)
T KOG0597|consen 153 --NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI------TQLV-K--------SILKD 215 (808)
T ss_pred --CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH------HHHH-H--------HHhcC
Confidence 34566788999999999999999999999999999999999999999963211 0000 0 11111
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.. ..+.+....++.++.-.+++||..|-+-.+++.
T Consensus 216 ~v---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 216 PV---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CC---CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 00 223344456677777899999999999988774
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=322.95 Aligned_cols=251 Identities=26% Similarity=0.431 Sum_probs=203.0
Q ss_pred cccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCC
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNG 579 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 579 (852)
.+.+.++||+|+||.||++.+.++..+|+|.+.......++|.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 84 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENG 84 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCC
Confidence 46677899999999999999888888999998866666778999999999999999999999999999999999999999
Q ss_pred CHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcc
Q 003059 580 SLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRH 659 (852)
Q Consensus 580 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 659 (852)
+|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.......
T Consensus 85 ~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-- 155 (256)
T cd05114 85 CLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-- 155 (256)
T ss_pred cHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCce--
Confidence 9999986432 248899999999999999999998 8999999999999999999999999999886532211
Q ss_pred eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcccccccccC
Q 003059 660 RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738 (852)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (852)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... . ......+.. ...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~----~~~i~~~~~--~~~---- 222 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---V----VEMISRGFR--LYR---- 222 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHCCCC--CCC----
Confidence 11122335668999999998899999999999999999999 899996443211 0 111111110 000
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003059 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776 (852)
Q Consensus 739 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~ 776 (852)
+......+.+++.+|++.+|.+||++.++++.|.
T Consensus 223 ----~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 223 ----PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112245788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.37 Aligned_cols=249 Identities=26% Similarity=0.315 Sum_probs=197.1
Q ss_pred ccccccccccccceEEEEEE-CCCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 501 KGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
|...+.||+|+||.||++.. .+++.||+|.+.... .....+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 45668899999999999985 568899999986322 2334678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+++|+|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++......
T Consensus 82 ~~~g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 82 MNGGDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred cCCCcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999998885432 2358899999999999999999998 89999999999999999999999999999865321
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
.......|+..|+|||.+.+..++.++|||||||++|||++|+.||.......... ........ .
T Consensus 156 ----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~---~~~~~~~~--------~ 220 (285)
T cd05631 156 ----ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE---EVDRRVKE--------D 220 (285)
T ss_pred ----CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH---HHHHHhhc--------c
Confidence 12234568999999999999999999999999999999999999997543211100 00000100 0
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPM-----MGKVVQ 773 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt-----~~ev~~ 773 (852)
.. ..+......+.+++.+||+.||.+||+ ++++++
T Consensus 221 ~~---~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 QE---EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cc---cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 00 111112235677888999999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=327.78 Aligned_cols=258 Identities=29% Similarity=0.464 Sum_probs=204.6
Q ss_pred cccccccccccccceEEEEEECC------CcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLL 571 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 571 (852)
.+.+.+.||+|+||.||+|.... ...|++|.+... .....+|.+|++++.+++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 56678899999999999998643 257999998733 2334678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhhcccCC-----------ccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCc
Q 003059 572 VYEFMKNGSLDNFLFANEEGS-----------GKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYN 640 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 640 (852)
+|||+++++|.+++....... ...+++..++.++.|++.||+|||+ .+++||||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence 999999999999997543211 1468899999999999999999999 89999999999999999999
Q ss_pred eEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHH
Q 003059 641 AKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLW 719 (852)
Q Consensus 641 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 719 (852)
+||+|||+++.....+. ........++..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 163 ~~L~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05048 163 VKISDFGLSRDIYSADY-YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE------- 234 (283)
T ss_pred EEECCCcceeecccccc-ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 99999999986543221 112233456788999999998899999999999999999998 999997543211
Q ss_pred HHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 720 AYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 720 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
....+..+... ..+......+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus 235 ~~~~i~~~~~~----------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 235 VIEMIRSRQLL----------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHHcCCcC----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 11111111111 11122335677888999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=299.28 Aligned_cols=264 Identities=21% Similarity=0.306 Sum_probs=203.2
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCcccc---hHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQG---EKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
+|.-.++||+|.||.||+|.. ..++.||||+++..... .....+|++.|+.++|+||+.++++|.+.+..-||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 455567899999999999994 56899999999833222 35678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
|+. +|+..+... ...++-..+..++.++++||+|||. +.|+||||||.|+|++++|.+||+|||+++.+...
T Consensus 83 m~t-dLe~vIkd~----~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 83 MPT-DLEVVIKDK----NIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ccc-cHHHHhccc----ccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 954 898888543 4578899999999999999999999 89999999999999999999999999999988754
Q ss_pred CCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC---ccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN---VKG 731 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~ 731 (852)
.. .....+-|.-|.|||.+.+. .|+...||||.||++.||+-|.+-|.+..+.++...+..+.....+.. +..
T Consensus 155 ~~---~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 155 NR---IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred Cc---ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence 32 22333678899999998765 689999999999999999999988877665544333222211111111 111
Q ss_pred ccccc----cCC---CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 732 IVDKS----LAG---EDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 732 ~~d~~----l~~---~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
+.|-. ... ...-......+++++..++..||.+|.++.|++++
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11100 000 00111223455888999999999999999998864
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.66 Aligned_cols=256 Identities=29% Similarity=0.428 Sum_probs=205.3
Q ss_pred HhcccccccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
...+.+.++||+|+||.||+|... .++.|++|.+........++.+|++++.+++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 345667889999999999999965 4788999998866656678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|.+++.... ...+++..++.++.|++++|+|||+ .+++||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~~~L~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 85 TYGNLLDYLRECN---RQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred CCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 9999999996432 3458999999999999999999998 899999999999999999999999999998764321
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
. ........+..|+|||.+.+..++.++||||||+++|||++ |..||....... ......... ..
T Consensus 159 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~-----~~ 224 (263)
T cd05052 159 Y--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKGY-----RM 224 (263)
T ss_pred e--eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCC-----CC
Confidence 1 11112234568999999999999999999999999999998 999986432211 111111110 00
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
..+......+.+++.+|++.+|.+||++.+++++|+.+
T Consensus 225 -----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 -----ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 01111224577788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=334.09 Aligned_cols=248 Identities=27% Similarity=0.392 Sum_probs=202.0
Q ss_pred HHHhcccccccccccccceEEEEEE-CCCcEEEEEEecCc-----c-cchHHHHHHHHHhhccc-ccceeeeeeeeccCc
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI-----E-QGEKQFRMEVATISSTH-HLNLVRLVGFSSEGK 567 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~-~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~ 567 (852)
.....|.+.+.||+|.||.|++|.. ..++.||+|.+... . ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3455778889999999999999974 56799999976532 1 23456778999999999 999999999999999
Q ss_pred eeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCC-CceEEeec
Q 003059 568 HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDEN-YNAKVSDF 646 (852)
Q Consensus 568 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DF 646 (852)
..++||||+.+|+|.+++... ..+.+.....++.|++.|++|||+ ++|+||||||+|||+|.+ +++||+||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~-----g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK-----GRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecc
Confidence 999999999999999999653 347789999999999999999999 899999999999999999 99999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCChhhhhcCC-CC-CCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHH
Q 003059 647 GLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLP-IT-SKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEF 724 (852)
Q Consensus 647 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 724 (852)
|++..... .........|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+...... ....+
T Consensus 166 G~s~~~~~---~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-------l~~ki 235 (370)
T KOG0583|consen 166 GLSAISPG---EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-------LYRKI 235 (370)
T ss_pred ccccccCC---CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-------HHHHH
Confidence 99998741 123445678999999999999877 76 78999999999999999999998632110 11111
Q ss_pred hhCCcccccccccCCCCCCHHH-HHHHHHHHHhccccCCCCCCCHHHHH
Q 003059 725 EKGNVKGIVDKSLAGEDVDIEQ-VMRAIQVSFWCIQEQPSQRPMMGKVV 772 (852)
Q Consensus 725 ~~~~~~~~~d~~l~~~~~~~~~-~~~~~~l~~~cl~~dp~~RPt~~ev~ 772 (852)
..+. . ..+..- ...+..++.+|+..+|.+|+++.+|+
T Consensus 236 ~~~~--------~---~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 236 RKGE--------F---KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred hcCC--------c---cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1111 0 011111 45677888999999999999999999
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=339.43 Aligned_cols=265 Identities=26% Similarity=0.385 Sum_probs=205.2
Q ss_pred HHHHhcccccccccccccceEEEEEECC------CcEEEEEEecCc--ccchHHHHHHHHHhhccc-ccceeeeeeeecc
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQLEGI--EQGEKQFRMEVATISSTH-HLNLVRLVGFSSE 565 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~ 565 (852)
+.....+.+.++||+|+||.||+|+... ...||||++... ....+.|.+|+++++++. ||||++++++|.+
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 3345567778999999999999998532 346999999733 223467899999999996 9999999999999
Q ss_pred CceeeEEEeecCCCCHHHHhhhcccC------------------------------------------------------
Q 003059 566 GKHRLLVYEFMKNGSLDNFLFANEEG------------------------------------------------------ 591 (852)
Q Consensus 566 ~~~~~lV~e~~~~gsL~~~l~~~~~~------------------------------------------------------ 591 (852)
....+|||||+++|+|.++|......
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 99999999999999999998753210
Q ss_pred -------------------------------------CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceE
Q 003059 592 -------------------------------------SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENIL 634 (852)
Q Consensus 592 -------------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIL 634 (852)
....+++..++.++.||++||+|||+ .+|+||||||+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEE
Confidence 11347888899999999999999998 89999999999999
Q ss_pred eCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccc
Q 003059 635 LDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNR 713 (852)
Q Consensus 635 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~ 713 (852)
+++++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 999999999999999865432111 11223346788999999999999999999999999999997 9999864321110
Q ss_pred hhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 714 KKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 714 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
.......+. .. ..+......+.+++.+||+.+|++||++.+|+++|+.+.
T Consensus 349 ------~~~~~~~~~-------~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 ------FYNKIKSGY-------RM---AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ------HHHHHhcCC-------CC---CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 111111110 00 111122346778899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=316.47 Aligned_cols=247 Identities=24% Similarity=0.400 Sum_probs=206.7
Q ss_pred HhcccccccccccccceEEEEEE-CCCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
+-+|.|.+.||+|.||.|-++.. ..|+.||||.+++.. +..-.+.+|++||..|+||||+.++.+|...+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 44677889999999999999985 679999999997432 3334578999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||..+|.|.+|+... ..|++.+..++++||..|+.|+|. ++++|||||.+|||||.++++||+|||++.++
T Consensus 132 MEYaS~GeLYDYiSer-----~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 132 MEYASGGELYDYISER-----GSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEecCCccHHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhh
Confidence 9999999999999654 359999999999999999999998 89999999999999999999999999999987
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCCC-CCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPIT-SKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
... .....+.|.+-|.+||++.+.+|. +..|-|||||+||-|+.|..||++.+.. . ....+..+
T Consensus 204 ~~~----kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~----lvrQIs~G---- 268 (668)
T KOG0611|consen 204 ADK----KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---R----LVRQISRG---- 268 (668)
T ss_pred ccc----cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---H----HHHHhhcc----
Confidence 542 344668899999999999999884 7899999999999999999999865321 1 11122222
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQML 775 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L 775 (852)
.-..++..-...-++.|++..+|++|.|+.+|...-
T Consensus 269 --------aYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 269 --------AYREPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred --------cccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 122233334566788999999999999999998743
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=325.79 Aligned_cols=249 Identities=35% Similarity=0.547 Sum_probs=192.5
Q ss_pred ccccccccccceEEEEEEC-----CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 503 FKDKLGAGGFGAVYRGVLA-----NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 503 ~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
+.+.||.|.||.||+|.+. .+..|+||.++.. ....++|.+|++.+++++||||++++|++.+.+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999976 2578999999643 23468899999999999999999999999988889999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+++|+|.++|.... ...+++..++.|+.||++||.|||+ .+++|+||+++|||+++++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp -TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccc---ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 99999999997652 3458999999999999999999998 78999999999999999999999999999876322
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
.. ............|+|||.+....++.++||||||+++|||++ |+.||....... ....+.++....
T Consensus 157 ~~-~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-------~~~~~~~~~~~~--- 225 (259)
T PF07714_consen 157 SK-YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-------IIEKLKQGQRLP--- 225 (259)
T ss_dssp SS-EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-------HHHHHHTTEETT---
T ss_pred cc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------ccccccccccce---
Confidence 11 122223446778999999999999999999999999999999 788886442211 111222221111
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQML 775 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L 775 (852)
.+......+.+++..||+.+|++||++.+|++.|
T Consensus 226 -------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 -------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1111233466788899999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=329.71 Aligned_cols=240 Identities=24% Similarity=0.267 Sum_probs=193.2
Q ss_pred ccccccccceEEEEEE-CCCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCC
Q 003059 505 DKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNG 579 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 579 (852)
+.||+|+||.||++.. .+++.||+|++... ......+..|++++++++||||+++++++..++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986 46889999998732 223356788999999999999999999999999999999999999
Q ss_pred CHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcc
Q 003059 580 SLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRH 659 (852)
Q Consensus 580 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 659 (852)
+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... .
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~---~ 149 (323)
T cd05571 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD---G 149 (323)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC---C
Confidence 999998643 358899999999999999999998 89999999999999999999999999998753221 1
Q ss_pred eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCC
Q 003059 660 RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAG 739 (852)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (852)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ..........
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------~~~~~~~~~~---------- 212 (323)
T cd05571 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEEI---------- 212 (323)
T ss_pred CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH-------HHHHHHcCCC----------
Confidence 12234569999999999999999999999999999999999999996432211 0111111100
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003059 740 EDVDIEQVMRAIQVSFWCIQEQPSQRP-----MMGKVVQ 773 (852)
Q Consensus 740 ~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~ev~~ 773 (852)
..+......+.+++.+|++.||++|| ++.++++
T Consensus 213 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 213 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred -CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 11111233567888899999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=318.83 Aligned_cols=252 Identities=25% Similarity=0.404 Sum_probs=203.3
Q ss_pred hcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
..+.+.+.||+|+||.||+|...++..+|+|.+.......++|.+|+.++.+++||||+++++++.+....++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 35677889999999999999987777899999886555567899999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
++|.+++.... ..+++..++.++.||+.||+|||+ ++++|+||||+||++++++.+||+|||+++.......
T Consensus 84 ~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~- 155 (256)
T cd05113 84 GCLLNYLREHG----KRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY- 155 (256)
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCce-
Confidence 99999996432 258999999999999999999998 8999999999999999999999999999886543211
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccccccc
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSL 737 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (852)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+...
T Consensus 156 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~------- 220 (256)
T cd05113 156 -TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-------TVEKVSQGLRL------- 220 (256)
T ss_pred -eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHhcCCCC-------
Confidence 11122335678999999998889999999999999999998 999986433211 01111111100
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003059 738 AGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776 (852)
Q Consensus 738 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~ 776 (852)
..+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 221 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 ---YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 001112356778899999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=332.37 Aligned_cols=245 Identities=25% Similarity=0.384 Sum_probs=203.1
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
-|.+.+.||.|+-|.|-+|+. ..|+.+|||++.+. ......+++|+.+|+.+.||||+++++++.++.+.|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 456778999999999999984 57999999999743 2234568999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++|-|.++|..+. .+.+.+..+++.||+.|+.|+|. .+|+||||||+|+|||.++++||+|||+|.+-.+
T Consensus 93 yv~gGELFdylv~kG-----~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKG-----PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred ecCCchhHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 999999999997543 58899999999999999999999 8999999999999999999999999999987533
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCC-CCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPIT-SKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
.....+.+|.+.|.|||++++.+|. .++||||.|||||.||||+.||+..+ ... ...++..|..
T Consensus 165 ----gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---ir~----LLlKV~~G~f---- 229 (786)
T KOG0588|consen 165 ----GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---IRV----LLLKVQRGVF---- 229 (786)
T ss_pred ----CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---HHH----HHHHHHcCcc----
Confidence 3455678899999999999999985 68999999999999999999998322 111 1122222211
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
..+-.-..++.+++.++++.||++|-|++||++.
T Consensus 230 -------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 -------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1122223356678888999999999999999873
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=318.27 Aligned_cols=257 Identities=30% Similarity=0.461 Sum_probs=207.8
Q ss_pred HHHHhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
+|...++++.++||+|+||.||+|...+++.||+|.+........+|.+|+.++++++|+||+++++++. .+..++|||
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 4566788899999999999999999888899999999866666778999999999999999999999874 457899999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++++|.+++.... +..+++..++.++.|++.||+|||+ .+++||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 81 YMENGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred cCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 999999999986432 3468899999999999999999998 8999999999999999999999999999986643
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
... .......++..|+|||.+....++.++||||||+++|||++ |+.||....... . ...+......
T Consensus 155 ~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~----~~~~~~~~~~--- 222 (260)
T cd05067 155 NEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---V----IQNLERGYRM--- 222 (260)
T ss_pred CCc--ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---H----HHHHHcCCCC---
Confidence 211 11122345678999999998899999999999999999999 999997443211 0 1111111000
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEG 777 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~ 777 (852)
+.+......+.+++.+|++.+|++||+++++++.|+.
T Consensus 223 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 -------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0011112357888999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=338.77 Aligned_cols=263 Identities=23% Similarity=0.291 Sum_probs=210.5
Q ss_pred cccccccccccccceEEEEEECCC-cEEEEEEec-CcccchHHHHHHHHHhhccc-ccceeeeeee-ecc------Ccee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLANR-TVVAVKQLE-GIEQGEKQFRMEVATISSTH-HLNLVRLVGF-SSE------GKHR 569 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~l~-~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~-~~~------~~~~ 569 (852)
+.++.+.|-+|||+.||.+....+ ..+|+|++- ..+...+.+.+||++|++|+ |+|||.+++. ... .-+.
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 455678899999999999998766 899999886 55666788999999999997 9999999993 221 2378
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
+|+||||++|+|-+++..+.. ..|++.++++|+.|+++|+++||.. +.+|||||||-+||||+.+++.||||||.+
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 999999999999999976553 2399999999999999999999974 467999999999999999999999999998
Q ss_pred cccCCCCCcceee------eeecCCCCCCChhhh---hcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHH
Q 003059 650 KLINPKDHRHRTL------TSVRGTRGYLAPEWL---ANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA 720 (852)
Q Consensus 650 ~~~~~~~~~~~~~------~~~~gt~~y~aPE~~---~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 720 (852)
............. -...-|+-|+|||.+ .+..+++|+|||+|||+||-|+....||+....
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---------- 263 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---------- 263 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence 6432211110000 112368999999977 578999999999999999999999999975421
Q ss_pred HHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCCCCCC
Q 003059 721 YEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPPA 786 (852)
Q Consensus 721 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~~~~~ 786 (852)
..+++....- +.......++..||..||+.||.+||++.+|+..+-+++..+.+-.
T Consensus 264 ---------laIlng~Y~~-P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~ 319 (738)
T KOG1989|consen 264 ---------LAILNGNYSF-PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIP 319 (738)
T ss_pred ---------eeEEeccccC-CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcc
Confidence 2233333222 3335677888899999999999999999999999988876554443
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=318.18 Aligned_cols=256 Identities=30% Similarity=0.437 Sum_probs=205.7
Q ss_pred HHhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
....|.+.++||+|+||.||+|.+.+...||+|++.......++|.+|++++.+++|+||+++++++.+ ...++||||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 345688899999999999999998777789999998655566789999999999999999999998754 5689999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|.+++.... ...+++..+..++.|+++||+|||+ .+++||||||+||++++++.+||+|||.++.+....
T Consensus 83 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 83 SKGSLLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCcHHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 9999999996432 3457899999999999999999998 899999999999999999999999999998664322
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
. .......++..|+|||...+..++.++||||||+++|||++ |+.||....... ......... ..
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-------~~~~~~~~~-----~~ 222 (262)
T cd05071 157 Y--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGY-----RM 222 (262)
T ss_pred c--ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-------HHHHHhcCC-----CC
Confidence 1 11122346678999999998899999999999999999999 888886432110 111111110 00
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
....+....+.+++.+|++.+|++||++.++.+.|+..
T Consensus 223 -----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 -----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -----CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11223345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=316.53 Aligned_cols=255 Identities=29% Similarity=0.452 Sum_probs=204.3
Q ss_pred HHhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
....+.+.++||+|+||.||++...++..+|+|.+.......+.|.+|+.++++++|+|++++++++. ....++||||+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 34467788999999999999999888888999999865556678999999999999999999999885 45689999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|.+++.... ...+++..++.++.|++.||+|||+ ++++||||||+||++++++.++|+|||++..+....
T Consensus 83 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 83 SKGSLLDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 9999999996432 3458899999999999999999998 899999999999999999999999999998764321
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
. .......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ......... ..
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~-----~~ 222 (260)
T cd05070 157 Y--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-------VLEQVERGY-----RM 222 (260)
T ss_pred c--ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC-----CC
Confidence 1 11122335678999999998899999999999999999999 899996432111 111111110 00
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEG 777 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~ 777 (852)
+.+......+.+++.+|++.+|.+||++.++.+.|++
T Consensus 223 -----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 -----PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -----CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111223467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=318.45 Aligned_cols=255 Identities=30% Similarity=0.460 Sum_probs=203.2
Q ss_pred hcccccccccccccceEEEEEECC----CcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLAN----RTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
..+.+.+.||+|+||.||+|.+.. ...||||.+... .....+|.+|+.++.+++|+||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 456778899999999999998742 457999998743 23346789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++..
T Consensus 84 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 84 TEYMENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEcCCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 99999999999996432 258899999999999999999998 89999999999999999999999999999877
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
..... ........++..|+|||.+.+..++.++||||||+++|||++ |..||....... ..........
T Consensus 157 ~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~-- 226 (266)
T cd05033 157 EDSEA-TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-------VIKAVEDGYR-- 226 (266)
T ss_pred ccccc-ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCC--
Confidence 52111 111222345678999999999999999999999999999998 999986432111 1111111100
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
. +.+......+.+++.+|++.+|++||++.+|++.|+++
T Consensus 227 --~------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 --L------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --C------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 11112234577899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=297.58 Aligned_cols=265 Identities=24% Similarity=0.308 Sum_probs=209.7
Q ss_pred HhcccccccccccccceEEEEE-ECCCcEEEEEEecCc-ccchHHHHHHHHHhhcccccceeeeeeeeccCc-----eee
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK-----HRL 570 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~ 570 (852)
..+|++.++||+|||..||.++ ..+++.+|+|++... .++.+..++|++..++++||||+++++++..+. ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4578899999999999999998 677889999999843 466778899999999999999999999876543 589
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
|+++|...|+|.+.+..... .+..+++.+.+.|+.+|++||++||+.. ..++||||||.|||+.+.+.++|.|||.+.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEeehhccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 99999999999999965433 4668999999999999999999999843 359999999999999999999999999987
Q ss_pred ccCCCC------CcceeeeeecCCCCCCChhhhh---cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHH
Q 003059 651 LINPKD------HRHRTLTSVRGTRGYLAPEWLA---NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAY 721 (852)
Q Consensus 651 ~~~~~~------~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 721 (852)
...-.- .....-....-|..|.|||.+. +..+++++|||||||+||+|+.|..||+..-.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~----------- 246 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ----------- 246 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----------
Confidence 653210 0011112345688999999885 45688999999999999999999999974321
Q ss_pred HHHhhCCcc-cccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 722 EEFEKGNVK-GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 722 ~~~~~~~~~-~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
..+.+. .+....+.- +.+....+.+.+++.+|++.||.+||+..+++..++.+.
T Consensus 247 ---~GgSlaLAv~n~q~s~-P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 ---QGGSLALAVQNAQISI-PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---cCCeEEEeeecccccc-CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111111 122222221 222225677889999999999999999999999987653
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=317.22 Aligned_cols=250 Identities=26% Similarity=0.416 Sum_probs=201.4
Q ss_pred cccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCC
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNG 579 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 579 (852)
.+.+.+.||+|+||.||++...++..+|+|.+........+|.+|++++++++|+||+++++++.+.+..++||||++++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 45677899999999999999887778999998755555678899999999999999999999999999999999999999
Q ss_pred CHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcc
Q 003059 580 SLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRH 659 (852)
Q Consensus 580 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 659 (852)
+|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.......
T Consensus 85 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-- 155 (256)
T cd05059 85 CLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-- 155 (256)
T ss_pred CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccc--
Confidence 9999996432 258899999999999999999998 8999999999999999999999999999986532111
Q ss_pred eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcccccccccC
Q 003059 660 RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738 (852)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (852)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ........ ...
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~-----~~~--- 220 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-------VVESVSAG-----YRL--- 220 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-------HHHHHHcC-----CcC---
Confidence 11111223457999999999999999999999999999999 899996443211 01111111 000
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003059 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQML 775 (852)
Q Consensus 739 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L 775 (852)
..+......+.+++.+|++.+|++||++.+|++.|
T Consensus 221 --~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 --YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 01111234677899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=330.76 Aligned_cols=243 Identities=25% Similarity=0.291 Sum_probs=196.4
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
..|.+.+.||+|+||.||++... +++.||+|.+.... ...+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 35677889999999999999975 57899999987322 23456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++...
T Consensus 98 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 98 EFVVGGELFTHLRKA-----GRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred cCCCCChHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 999999999999643 347888889999999999999999 899999999999999999999999999998664
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
.. .....|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .......++...
T Consensus 170 ~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~~~~--- 233 (329)
T PTZ00263 170 DR------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-------RIYEKILAGRLK--- 233 (329)
T ss_pred CC------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-------HHHHHHhcCCcC---
Confidence 32 12356899999999999999999999999999999999999999643211 011122221110
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPM-----MGKVVQ 773 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt-----~~ev~~ 773 (852)
+ +......+.+++.+||+.||.+||+ ++++++
T Consensus 234 ---~-----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 234 ---F-----PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ---C-----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0 0011234668889999999999997 566653
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=321.93 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=205.2
Q ss_pred HhcccccccccccccceEEEEEECC------CcEEEEEEecCccc--chHHHHHHHHHhhcccccceeeeeeeeccCcee
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQLEGIEQ--GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHR 569 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 569 (852)
..++.+.+.||+|+||.||+|...+ ++.||||.+..... ..+.|.+|++++.+++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4567788999999999999998633 47899999974332 357899999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhhccc---------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCc
Q 003059 570 LLVYEFMKNGSLDNFLFANEE---------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYN 640 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 640 (852)
++||||+++++|.+++..... .....+++..+..++.|++.||+|||+ ++++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 999999999999999975431 223458899999999999999999998 89999999999999999999
Q ss_pred eEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHH
Q 003059 641 AKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLW 719 (852)
Q Consensus 641 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 719 (852)
+||+|||+++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .
T Consensus 161 ~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~--- 233 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---V--- 233 (280)
T ss_pred EEECCcccceecccCcce-ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---H---
Confidence 999999999765332111 11122345778999999999999999999999999999998 999986443211 1
Q ss_pred HHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003059 720 AYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEG 777 (852)
Q Consensus 720 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~ 777 (852)
......+.... .+......+.+++.+||+.||.+||++.||++.|++
T Consensus 234 -~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 234 -IECITQGRLLQ----------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -HHHHHcCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11111111110 111123456788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=321.66 Aligned_cols=246 Identities=24% Similarity=0.386 Sum_probs=199.9
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEec--CcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLE--GIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~--~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
.|+-.+.||+|.||.||||.. ..++.||+|++. ..+...+++++|+.+|..++++||.+.+|.+..+...+++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 344457899999999999996 458899999997 34455678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
.+|++.+.|.. +..+++..+.-|++++..||.|||. .+.+|||||+.|||+..+|.+||+|||.+-.+....
T Consensus 94 ~gGsv~~lL~~-----~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 94 GGGSVLDLLKS-----GNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred cCcchhhhhcc-----CCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99999999953 3344677777789999999999999 789999999999999999999999999998775432
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
. .....+||+.|||||++....|+.|+||||||++.+||++|.+|+....+. ++.-++.+.
T Consensus 166 ~---rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------rvlflIpk~ 226 (467)
T KOG0201|consen 166 K---RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM----------------RVLFLIPKS 226 (467)
T ss_pred h---ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------eEEEeccCC
Confidence 2 226688999999999999889999999999999999999999999754432 122222221
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
-.. ..+......+.+++..|++.||+.||++.++++
T Consensus 227 ~PP-~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 227 APP-RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCC-ccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 111 111122234556667799999999999998874
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=318.76 Aligned_cols=254 Identities=29% Similarity=0.485 Sum_probs=206.6
Q ss_pred hcccccccccccccceEEEEEECCCcEEEEEEecCccc-chHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQ-GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
..|.+.++||.|+||.||+|...+++.+++|.+..... ...++..|+.+++.++|+||+++++++.+....++||||++
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME 85 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence 45677889999999999999988889999999985443 56789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
+++|.+++.... +..+++..++.++.||+.||+|||+ ++|+|+||||+||++++++.+||+|||++........
T Consensus 86 ~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 86 KGSLLAFLRSPE---GQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 999999996532 3468999999999999999999998 8999999999999999999999999999986643211
Q ss_pred cceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 658 RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
......++..|+|||.+....++.++||||||++++||++ |+.||....... . ......+..
T Consensus 160 ---~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~----~~~~~~~~~------- 222 (261)
T cd05148 160 ---LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---V----YDQITAGYR------- 222 (261)
T ss_pred ---cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---H----HHHHHhCCc-------
Confidence 1123345678999999998899999999999999999998 899996443111 1 111111100
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
. +.+......+.+++.+|++.+|.+||++.++++.|+.+
T Consensus 223 ~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 M---PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred C---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0 11122234577889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=328.13 Aligned_cols=240 Identities=23% Similarity=0.264 Sum_probs=191.0
Q ss_pred ccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCCH
Q 003059 507 LGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSL 581 (852)
Q Consensus 507 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 581 (852)
||+|+||.||++... +++.||+|++... ......+..|++++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999965 5788999998632 23345678899999999999999999999999999999999999999
Q ss_pred HHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCccee
Q 003059 582 DNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRT 661 (852)
Q Consensus 582 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 661 (852)
.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~ 149 (312)
T cd05585 81 FHHLQRE-----GRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD---DK 149 (312)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC---Cc
Confidence 9999643 248899999999999999999998 899999999999999999999999999998643221 12
Q ss_pred eeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCCCC
Q 003059 662 LTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGED 741 (852)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 741 (852)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... . ......... . .
T Consensus 150 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~-~~~~~~~~~--------~---~ 211 (312)
T cd05585 150 TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------E-MYRKILQEP--------L---R 211 (312)
T ss_pred cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------H-HHHHHHcCC--------C---C
Confidence 23456899999999999999999999999999999999999999743221 0 111111110 0 0
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003059 742 VDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQML 775 (852)
Q Consensus 742 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L 775 (852)
.+......+.+++.+|++.||.+||++..+.+.|
T Consensus 212 ~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 212 FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 1111223566788899999999998754444444
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=326.54 Aligned_cols=242 Identities=23% Similarity=0.300 Sum_probs=196.1
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.|.+.++||+|+||.||++... +++.||+|++.... ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 3567789999999999999965 58899999986322 234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++++|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 82 YVPGGELFSYLRNS-----GRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred CCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999643 348889999999999999999998 8999999999999999999999999999986543
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
. .....|++.|+|||.+.+..++.++|||||||++|||++|+.||....... .......+..
T Consensus 154 ~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~----- 215 (291)
T cd05612 154 R------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-------IYEKILAGKL----- 215 (291)
T ss_pred C------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCc-----
Confidence 1 123468999999999999999999999999999999999999997543211 1111111111
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPM-----MGKVVQ 773 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt-----~~ev~~ 773 (852)
..+......+.+++.+|++.||.+||+ +.++++
T Consensus 216 ------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 216 ------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred ------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 011111235678888999999999995 777664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=325.40 Aligned_cols=259 Identities=25% Similarity=0.410 Sum_probs=212.9
Q ss_pred HHHHhcccccccccccccceEEEEEECC-----CcEEEEEEecC--cccchHHHHHHHHHhhcccccceeeeeeeeccCc
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLAN-----RTVVAVKQLEG--IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK 567 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~ 567 (852)
||.++...+.++||.|-||.||+|++.+ .-.||||..+. .....+.|..|..+|++++||||++|+|+|.+.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 5666777788899999999999999532 23689998873 345578899999999999999999999999875
Q ss_pred eeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecc
Q 003059 568 HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFG 647 (852)
Q Consensus 568 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 647 (852)
..+||||.++-|.|..||..+. ..|+......++.||+.+|+|||+ +++|||||..+|||+....-+||+|||
T Consensus 464 P~WivmEL~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred ceeEEEecccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccc
Confidence 6799999999999999997653 358888899999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhh
Q 003059 648 LAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEK 726 (852)
Q Consensus 648 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (852)
++|.+....... .....-++.|||||.+...+++.++|||.|||.+||++. |..||.+-...
T Consensus 537 LSR~~ed~~yYk--aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs--------------- 599 (974)
T KOG4257|consen 537 LSRYLEDDAYYK--ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS--------------- 599 (974)
T ss_pred hhhhccccchhh--ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc---------------
Confidence 999987654432 334556889999999999999999999999999999987 99999754221
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 727 GNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
++...++..-+ -+.++.....+..++.+||..+|.+||.+.++...|+.+..
T Consensus 600 -DVI~~iEnGeR-lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 600 -DVIGHIENGER-LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -ceEEEecCCCC-CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 11111211111 13445556677788999999999999999999998887654
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=327.48 Aligned_cols=200 Identities=27% Similarity=0.363 Sum_probs=173.1
Q ss_pred HHhcccccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
....|.+.++||+|+||.||++... ++..+|+|.+... .....++.+|++++++++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 3456677889999999999999975 5788999988743 233467999999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+++++|.+++... ..+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++...
T Consensus 83 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 83 EHMDGGSLDQVLKEA-----KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 999999999999643 3488899999999999999999972 469999999999999999999999999987653
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCcccccc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVS 708 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~ 708 (852)
.. ......|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 156 DS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred cc-----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 21 123346899999999999999999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=326.55 Aligned_cols=240 Identities=24% Similarity=0.336 Sum_probs=191.5
Q ss_pred ccccccccceEEEEEE----CCCcEEEEEEecCc-----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 505 DKLGAGGFGAVYRGVL----ANRTVVAVKQLEGI-----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~-----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
++||+|+||.||++.. ..++.||+|.++.. ......+..|++++++++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 35788999998732 12335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+++++|.+++... ..+.+..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLERE-----GIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 9999999998543 347788888999999999999998 89999999999999999999999999998754321
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
. .......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... .......+.
T Consensus 154 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-------~~~~~~~~~------- 216 (323)
T cd05584 154 G---TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-------TIDKILKGK------- 216 (323)
T ss_pred C---CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC-------
Confidence 1 12233568999999999999889999999999999999999999997543211 111111111
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP-----MMGKVVQ 773 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~ev~~ 773 (852)
. ..+......+.+++.+|++.+|++|| ++.++++
T Consensus 217 -~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 217 -L---NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -C---CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 0 01111123567888999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=321.36 Aligned_cols=258 Identities=29% Similarity=0.457 Sum_probs=201.6
Q ss_pred hcccccccccccccceEEEEEE-----CCCcEEEEEEecCcc--cchHHHHHHHHHhhcccccceeeeeeeeccCceeeE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-----ANRTVVAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLL 571 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 571 (852)
..+.+.++||+|+||.||+|.. ..+..|++|.+.... ....++.+|++++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4567788999999999999984 245789999997332 234678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhhccc------------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC
Q 003059 572 VYEFMKNGSLDNFLFANEE------------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY 639 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~ 639 (852)
||||+++++|.+++..... .....+++..++.++.|++.||+|||+ ++++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 9999999999999964321 012358899999999999999999998 8999999999999999999
Q ss_pred ceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHH
Q 003059 640 NAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSL 718 (852)
Q Consensus 640 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~ 718 (852)
.+||+|||+++....... ........++..|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 162 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~------ 234 (283)
T cd05090 162 HVKISDLGLSREIYSADY-YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE------ 234 (283)
T ss_pred cEEeccccccccccCCcc-eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH------
Confidence 999999999986543221 111223345678999999998899999999999999999998 999986432110
Q ss_pred HHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003059 719 WAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEG 777 (852)
Q Consensus 719 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~ 777 (852)
............ .+......+.+++.+|++.+|++||++.+|.+.|..
T Consensus 235 -~~~~~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 -VIEMVRKRQLLP----------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHHcCCcCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111111110 111122456778889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=320.88 Aligned_cols=267 Identities=23% Similarity=0.306 Sum_probs=200.1
Q ss_pred cccccccccccceEEEEEE-----CCCcEEEEEEecCcc--cchHHHHHHHHHhhcccccceeeeeeeeccC--ceeeEE
Q 003059 502 GFKDKLGAGGFGAVYRGVL-----ANRTVVAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRLVGFSSEG--KHRLLV 572 (852)
Q Consensus 502 ~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV 572 (852)
.+.+.||+|+||.||++.. .+++.||+|.+.... .....|.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6778999999999988653 357789999987432 3456788999999999999999999988653 467899
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++++|.+++.. ..+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++..
T Consensus 87 ~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 87 MEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred ecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 999999999999953 248999999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI 732 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (852)
..............++..|+|||.+....++.++||||||+++|||++|..||......... .............+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh-hhcccccccchhhhhhh
Confidence 43222111112234566799999999889999999999999999999999998643221000 00000000000011111
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
++..... +.+......+.+++.+|++.+|.+||++++|+++|+.+.
T Consensus 237 ~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LERGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1111110 111222346778899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=326.92 Aligned_cols=249 Identities=22% Similarity=0.257 Sum_probs=193.4
Q ss_pred ccccccccccccceEEEEEE----CCCcEEEEEEecCc-----ccchHHHHHHHHHhhcc-cccceeeeeeeeccCceee
Q 003059 501 KGFKDKLGAGGFGAVYRGVL----ANRTVVAVKQLEGI-----EQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRL 570 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~-----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 570 (852)
|.+.++||+|+||.||++.. ..++.||+|++... ....+.+..|++++.++ +|+||+++++++.+++..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 56778999999999999985 35789999998632 12335678899999999 5999999999999999999
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 82 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 82 LILDYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999643 348899999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCc
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
....... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.......... ........
T Consensus 154 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~~~~~~~~--- 225 (332)
T cd05614 154 EFLSEEK--ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS---EVSRRILK--- 225 (332)
T ss_pred cccccCC--CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH---HHHHHHhc---
Confidence 6533211 122345699999999999865 47889999999999999999999997543221111 01111111
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003059 730 KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP-----MMGKVVQ 773 (852)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~ev~~ 773 (852)
.++.+ +......+.+++.+|++.||++|| +++++++
T Consensus 226 ---~~~~~-----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 ---CDPPF-----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ---CCCCC-----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 01111 111223456788899999999999 5666664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=327.67 Aligned_cols=258 Identities=23% Similarity=0.388 Sum_probs=200.8
Q ss_pred HHhcccccccccccccceEEEEEEC-CCc----EEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCcee
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLA-NRT----VVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHR 569 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 569 (852)
....+...+.||+|+||.||+|++. ++. .||+|.++.. ....+++..|+.+++.++||||++++|+|... ..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 3456777889999999999999853 333 4899998733 33456789999999999999999999999875 57
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
++|+||+++|+|.+++... ...+++..++.++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||++
T Consensus 84 ~~v~e~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a 156 (316)
T cd05108 84 QLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLA 156 (316)
T ss_pred eeeeecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEcccccc
Confidence 7999999999999999653 2358889999999999999999998 89999999999999999999999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCC
Q 003059 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGN 728 (852)
Q Consensus 650 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (852)
+........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||+...... + ......+.
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~----~~~~~~~~ 228 (316)
T cd05108 157 KLLGADEKE-YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I----SSILEKGE 228 (316)
T ss_pred ccccCCCcc-eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHhCCC
Confidence 876532211 11122334678999999999999999999999999999998 999997532211 0 01111110
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
.+ +.+......+.+++.+|++.+|.+||++.++++.|..+..
T Consensus 229 -------~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 229 -------RL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred -------CC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 00 0011122356788899999999999999999999887743
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=330.11 Aligned_cols=251 Identities=23% Similarity=0.295 Sum_probs=199.6
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.|.+.++||+|+||.||+|... +++.||+|++... ......+..|++++.+++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 3667889999999999999975 4789999999732 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~g~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 82 YVPGGDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred CCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999543 348889999999999999999998 8999999999999999999999999999986532
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ...+... ...+.
T Consensus 154 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-------~~~i~~~--~~~~~ 218 (333)
T cd05600 154 ------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-------WENLKYW--KETLQ 218 (333)
T ss_pred ------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-------HHHHHhc--ccccc
Confidence 22345689999999999999999999999999999999999999975432111 0111100 00111
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
..... .........+.+++.+|++.+|.+||++.++++.
T Consensus 219 ~~~~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 219 RPVYD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00000 0001123456678888999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=327.86 Aligned_cols=264 Identities=20% Similarity=0.308 Sum_probs=193.6
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccC-----ceeeE
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEG-----KHRLL 571 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 571 (852)
|.+.++||+|+||.||+|... +++.||||++... .....++.+|++++++++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 567889999999999999964 5889999998732 23345688999999999999999999987543 35799
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
||||+. ++|.+++... ..+++..+..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 82 v~e~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 82 VFELME-SDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEecCC-CCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 999995 6899888533 348899999999999999999999 8999999999999999999999999999986
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhc--CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHH--------HHH
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLAN--LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSL--------WAY 721 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~--------~~~ 721 (852)
...............|++.|+|||++.+ ..++.++|||||||++|||++|+.||............. ...
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 5332222122234568999999999876 678999999999999999999999996543211100000 000
Q ss_pred HHHhhCCcccccccccCCCCCCHH-----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 722 EEFEKGNVKGIVDKSLAGEDVDIE-----QVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 722 ~~~~~~~~~~~~d~~l~~~~~~~~-----~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..+........+............ ....+.+++.+|++.||++||++.|+++
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000001111111110000011111 1134578899999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=322.67 Aligned_cols=271 Identities=24% Similarity=0.326 Sum_probs=197.8
Q ss_pred cccccccccccccceEEEEEEC-----CCcEEEEEEecCc-ccchHHHHHHHHHhhcccccceeeeeeeecc--CceeeE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-----NRTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLVGFSSE--GKHRLL 571 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l 571 (852)
.+.+.+.||+|+||.||++... +++.|++|++... ....+.|.+|++++.+++||||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 4567789999999999999742 4778999998743 3345678999999999999999999998754 346899
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
||||+++++|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.
T Consensus 85 v~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 85 VMEYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEecCCCCHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccc
Confidence 99999999999999543 2358999999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
...............++..|+|||.+.+..++.++||||||+++|||++|..++......-................+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 64322211111112234569999999988999999999999999999998877543221100000000000000000000
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
.+..... .+.+......+.+++.+|++.+|++|||+.+|++.|+.+
T Consensus 238 ~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 LLKNNGR-LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHhcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1110000 011112234577889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.59 Aligned_cols=255 Identities=29% Similarity=0.431 Sum_probs=203.8
Q ss_pred HHhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
....+.+.++||+|+||.||++...++..+++|.+.......+.+.+|+.++++++|+|++++++++. .+..++||||+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 34567788999999999999999877778999998765556678999999999999999999999875 45689999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|.+++.... ...+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||+++......
T Consensus 83 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 83 GKGSLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 9999999996532 3458899999999999999999998 899999999999999999999999999998664321
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
. .......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ......... ..
T Consensus 157 ~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~-----~~ 222 (260)
T cd05069 157 Y--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-------VLEQVERGY-----RM 222 (260)
T ss_pred c--cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC-----CC
Confidence 1 11122345678999999998899999999999999999999 899996432211 011111110 00
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEG 777 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~ 777 (852)
..+......+.+++.+|++.+|.+||++++|++.|++
T Consensus 223 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 -----PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111223457788899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=314.88 Aligned_cols=246 Identities=26% Similarity=0.406 Sum_probs=193.8
Q ss_pred cccccccceEEEEEE---CCCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCC
Q 003059 506 KLGAGGFGAVYRGVL---ANRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNG 579 (852)
Q Consensus 506 ~lG~G~fg~Vy~~~~---~~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 579 (852)
+||+|+||.||+|.+ .++..+|+|+++... ...+++..|+.++++++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 699999999999975 356889999987332 23467899999999999999999999885 45678999999999
Q ss_pred CHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcc
Q 003059 580 SLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRH 659 (852)
Q Consensus 580 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 659 (852)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.+.......
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 81 PLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 999999533 358899999999999999999998 899999999999999999999999999998765432211
Q ss_pred eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcccccccccC
Q 003059 660 RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738 (852)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (852)
.......++..|+|||.+....++.++||||||+++|||++ |+.||...... .. ......+...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~----~~~i~~~~~~-------- 217 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EV----TQMIESGERM-------- 217 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHCCCCC--------
Confidence 11122334678999999988889999999999999999998 99999754321 11 1111111110
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003059 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEG 777 (852)
Q Consensus 739 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~ 777 (852)
..+......+.+++.+|++.||++||++.+|++.|++
T Consensus 218 --~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 218 --ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred --CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1111123456788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=328.38 Aligned_cols=237 Identities=24% Similarity=0.315 Sum_probs=190.2
Q ss_pred ccccccccceEEEEEE----CCCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 505 DKLGAGGFGAVYRGVL----ANRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
+.||+|+||.||++.. .+++.||+|++.... .....+..|++++.+++||||+++++++.+++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 357899999997432 233557789999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
+++|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 152 (318)
T cd05582 82 GGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE- 152 (318)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-
Confidence 99999998543 348899999999999999999998 899999999999999999999999999988653321
Q ss_pred cceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccccc
Q 003059 658 RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSL 737 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (852)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ..........
T Consensus 153 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-------~~~~i~~~~~-------- 215 (318)
T cd05582 153 --KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE-------TMTMILKAKL-------- 215 (318)
T ss_pred --CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH-------HHHHHHcCCC--------
Confidence 12234568999999999998889999999999999999999999997543211 1111111110
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 003059 738 AGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGK 770 (852)
Q Consensus 738 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~e 770 (852)
..+......+.+++.+|++.||++||++.+
T Consensus 216 ---~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 ---GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 011111234567888899999999999666
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=318.95 Aligned_cols=260 Identities=24% Similarity=0.388 Sum_probs=201.7
Q ss_pred HHhcccccccccccccceEEEEEEC------CCcEEEEEEecCcc--cchHHHHHHHHHhhcccccceeeeeeeeccCce
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLA------NRTVVAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKH 568 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 568 (852)
....+.+.++||+|+||.||+|... .+..||+|++.... ....+|.+|+.+++.++|+||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4456778899999999999999753 24679999986322 234578899999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHhhhcccC-----CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEE
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEG-----SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKV 643 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 643 (852)
.++||||+++++|.+++...... ....+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 99999999999999999653211 12356888999999999999999998 89999999999999999999999
Q ss_pred eecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHH
Q 003059 644 SDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYE 722 (852)
Q Consensus 644 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 722 (852)
+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||....... . ..
T Consensus 161 ~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~----~~ 232 (277)
T cd05062 161 GDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---V----LR 232 (277)
T ss_pred CCCCCccccCCccee-ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HH
Confidence 999998765432111 11112345778999999999999999999999999999999 788886443211 0 11
Q ss_pred HHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003059 723 EFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEG 777 (852)
Q Consensus 723 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~ 777 (852)
......... .+......+.+++.+|++.+|++||++.|+++.|++
T Consensus 233 ~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 233 FVMEGGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHcCCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111111111 011122357788999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=325.34 Aligned_cols=241 Identities=23% Similarity=0.263 Sum_probs=193.0
Q ss_pred ccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCC
Q 003059 505 DKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNG 579 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 579 (852)
+.||+|+||.||++... +++.||+|++... ......+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 5889999999732 233457788999999999999999999999999999999999999
Q ss_pred CHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcc
Q 003059 580 SLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRH 659 (852)
Q Consensus 580 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 659 (852)
+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..... .
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~---~ 149 (328)
T cd05593 81 ELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD---A 149 (328)
T ss_pred CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCc---c
Confidence 999988543 358899999999999999999998 89999999999999999999999999998754221 1
Q ss_pred eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCC
Q 003059 660 RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAG 739 (852)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (852)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ........ .
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~-------~~~~~~~~------~---- 212 (328)
T cd05593 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELILMED------I---- 212 (328)
T ss_pred cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH-------HHHhccCC------c----
Confidence 122345689999999999999999999999999999999999999964322110 00110000 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003059 740 EDVDIEQVMRAIQVSFWCIQEQPSQRP-----MMGKVVQM 774 (852)
Q Consensus 740 ~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~ev~~~ 774 (852)
..+......+.+++.+|++.||.+|| ++.++++.
T Consensus 213 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 213 -KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 11111223567788899999999997 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=320.21 Aligned_cols=258 Identities=25% Similarity=0.384 Sum_probs=202.2
Q ss_pred hcccccccccccccceEEEEEECC------CcEEEEEEecCccc--chHHHHHHHHHhhcccccceeeeeeeeccCceee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQLEGIEQ--GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRL 570 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 570 (852)
..+.+.++||+|+||.||+|...+ ++.||+|++..... ..+.|..|+.++.+++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 456677899999999999998632 47899999974332 2466889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhhccc-----------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC
Q 003059 571 LVYEFMKNGSLDNFLFANEE-----------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY 639 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~ 639 (852)
+++||+++++|.+++..... .....+++..++.++.|++.||+|||+ ++|+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCC
Confidence 99999999999999853211 112458888999999999999999998 8999999999999999999
Q ss_pred ceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHH
Q 003059 640 NAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSL 718 (852)
Q Consensus 640 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~ 718 (852)
.+||+|||+++....... ........+++.|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------ 234 (283)
T cd05091 162 NVKISDLGLFREVYAADY-YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------ 234 (283)
T ss_pred ceEecccccccccccchh-eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH------
Confidence 999999999886643221 112233446789999999998899999999999999999998 888886432211
Q ss_pred HHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003059 719 WAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEG 777 (852)
Q Consensus 719 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~ 777 (852)
........... ..+......+.+++..|++.+|.+||++++|++.|+.
T Consensus 235 -~~~~i~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 -VIEMIRNRQVL----------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HHHHHHcCCcC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11122222111 1111223446788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.32 Aligned_cols=256 Identities=29% Similarity=0.464 Sum_probs=201.7
Q ss_pred hcccccccccccccceEEEEEECC-C---cEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLAN-R---TVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
..++..+.||+|+||.||+|.... + ..+++|.+... ....+++..|++++.+++|+||+++++++.+.+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 345667899999999999999642 2 37999988743 23356789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++...
T Consensus 85 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 85 TEYMENGALDKYLRDH----DGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999998543 2358999999999999999999998 89999999999999999999999999999866
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
...............+..|+|||.+....++.++||||||+++|||++ |+.||....... .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-------~~~~i~~~~--- 227 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-------VMKAINDGF--- 227 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHHhcCC---
Confidence 432222111112223567999999998889999999999999999998 999996432211 111111110
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
.. +........+.+++.+|++.+|.+||++.+|++.|+++
T Consensus 228 -~~------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 -RL------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -CC------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 11112234577899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=313.27 Aligned_cols=248 Identities=25% Similarity=0.396 Sum_probs=194.0
Q ss_pred cccccccceEEEEEEC---CCcEEEEEEecCcc--cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCC
Q 003059 506 KLGAGGFGAVYRGVLA---NRTVVAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGS 580 (852)
Q Consensus 506 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 580 (852)
.||+|+||.||+|.+. .+..||+|++.... ...++|.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999864 34569999987432 23467899999999999999999999885 457899999999999
Q ss_pred HHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcce
Q 003059 581 LDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHR 660 (852)
Q Consensus 581 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 660 (852)
|.+++... ...+++..+++++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++..........
T Consensus 81 L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 81 LNKFLSGK----KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 99998543 2358899999999999999999998 8999999999999999999999999999986543322211
Q ss_pred eeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcccccccccCC
Q 003059 661 TLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAG 739 (852)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (852)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~--------- 217 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQGKRL--------- 217 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCCC---------
Confidence 1222234678999999998889999999999999999996 999997543211 11111111100
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 740 EDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 740 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
..+......+.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 218 -~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 -DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11122234566788999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=329.26 Aligned_cols=263 Identities=28% Similarity=0.429 Sum_probs=202.8
Q ss_pred HhcccccccccccccceEEEEEEC------CCcEEEEEEecCc--ccchHHHHHHHHHhhcc-cccceeeeeeeecc-Cc
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA------NRTVVAVKQLEGI--EQGEKQFRMEVATISST-HHLNLVRLVGFSSE-GK 567 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~-~~ 567 (852)
..+|.+.+.||+|+||.||+|... .++.||+|++... ....+.+..|++++.++ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 456788899999999999999742 2468999998743 22345678899999999 89999999998764 45
Q ss_pred eeeEEEeecCCCCHHHHhhhcccC--------------------------------------------------------
Q 003059 568 HRLLVYEFMKNGSLDNFLFANEEG-------------------------------------------------------- 591 (852)
Q Consensus 568 ~~~lV~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 591 (852)
..+++|||+++++|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 788999999999999998643210
Q ss_pred CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCC
Q 003059 592 SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGY 671 (852)
Q Consensus 592 ~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y 671 (852)
....++|..+.+++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.+...... .......++..|
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~-~~~~~~~~~~~y 241 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARLPLKW 241 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch-hhccCCCCCccc
Confidence 01368999999999999999999998 89999999999999999999999999999876432111 112234467789
Q ss_pred CChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHH
Q 003059 672 LAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRA 750 (852)
Q Consensus 672 ~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 750 (852)
+|||++.+..++.++|||||||++|||++ |+.||......+ .+ ......+... ..+......+
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~----~~~~~~~~~~----------~~~~~~~~~~ 305 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EF----CRRLKEGTRM----------RAPEYATPEI 305 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HH----HHHHhccCCC----------CCCccCCHHH
Confidence 99999999999999999999999999998 999996532211 10 1111111100 0111223467
Q ss_pred HHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 751 IQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 751 ~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
.+++.+|++.+|++||++.||++.|+.+..
T Consensus 306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 306 YSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 888999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=321.54 Aligned_cols=263 Identities=21% Similarity=0.272 Sum_probs=197.6
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
.|.+.+.||+|+||.||+++.. +++.||+|++... ....+.+.+|++++.+++|+||+++++++.+.+..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 4667889999999999999975 5788999998743 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
++++.+..+... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 82 VEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred CCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 998877655421 2358889999999999999999998 89999999999999999999999999999876432
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHH--------HHHH-hh
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA--------YEEF-EK 726 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~-~~ 726 (852)
.. .......|+..|+|||.+.+..++.++|||||||++|||++|+.||......+........ .... ..
T Consensus 154 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 154 SN--ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred cc--ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence 11 1223456899999999999989999999999999999999999999754322111000000 0000 00
Q ss_pred CCcccccccccCCCCCCH------HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 727 GNVKGIVDKSLAGEDVDI------EQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~------~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
........+.... .... .....+.+++.+|++.||++||+++++++
T Consensus 232 ~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 232 PRFHGLRFPAVNH-PQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred chhcccccCcccC-cccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000000 0000 01235788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.68 Aligned_cols=261 Identities=26% Similarity=0.436 Sum_probs=205.9
Q ss_pred hcccccccccccccceEEEEEEC------CCcEEEEEEecCcc-cchHHHHHHHHHhhcccccceeeeeeeeccCceeeE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA------NRTVVAVKQLEGIE-QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLL 571 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 571 (852)
..+.+.+.||+|+||.||++... ++..+++|.+.... ...+.+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 44667789999999999999742 34568999987433 334679999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhhccc-----------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCc
Q 003059 572 VYEFMKNGSLDNFLFANEE-----------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYN 640 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 640 (852)
||||+++++|.+++..... .....+++..++.++.||+.||+|||+ ++|+||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 9999999999999965431 122358999999999999999999998 89999999999999999999
Q ss_pred eEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHH
Q 003059 641 AKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLW 719 (852)
Q Consensus 641 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 719 (852)
+||+|||++........ ........++..|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 162 ~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------- 233 (291)
T cd05094 162 VKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------- 233 (291)
T ss_pred EEECCCCcccccCCCce-eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------
Confidence 99999999976543211 111223446788999999999999999999999999999999 999986433211
Q ss_pred HHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 720 AYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 720 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
.......+..... .......+.+++.+|++.+|.+||++.+|+++|+.+.+
T Consensus 234 ~~~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 234 VIECITQGRVLER----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHHhCCCCCCC----------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1111111111110 11123457789999999999999999999999998855
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=320.97 Aligned_cols=263 Identities=22% Similarity=0.326 Sum_probs=195.4
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
.|.+.++||+|+||.||+|... +++.||+|.+... ......+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 4677889999999999999865 5789999998732 233456789999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++ +|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 86 ~~-~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 86 DS-DLKQYLDNC----GNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred Cc-CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 75 899988543 2357888999999999999999998 899999999999999999999999999997653221
Q ss_pred CcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHH-----HHHhh----
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAY-----EEFEK---- 726 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~-----~~~~~---- 726 (852)
.......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+......... ..+..
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 158 ---KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred ---ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 12233457899999999865 568999999999999999999999997543221111000000 00000
Q ss_pred CCcccccccccCCCCC---CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 727 GNVKGIVDKSLAGEDV---DIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 727 ~~~~~~~d~~l~~~~~---~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
........+....... .......+.+++.+|++.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000001010000000 0011235678899999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=324.89 Aligned_cols=201 Identities=27% Similarity=0.374 Sum_probs=173.7
Q ss_pred HHHhcccccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
|....|.+.++||+|+||.||++... ++..+|+|.+... .....++.+|++++++++|+||+++++++.++++.++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 44567788899999999999999975 5778999988743 23346789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++++|.+++... ..+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++...
T Consensus 82 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 82 MEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (333)
T ss_pred EecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence 9999999999999643 3478889999999999999999972 47999999999999999999999999998765
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCcccccc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVS 708 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~ 708 (852)
... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 155 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 155 IDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hhh-----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 321 122346899999999999989999999999999999999999999744
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=313.21 Aligned_cols=257 Identities=32% Similarity=0.463 Sum_probs=208.5
Q ss_pred HHHhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
+....+.+.++||+|+||.||++..++++.|+||.+.......+++.+|+.++++++|+||+++++++......++||||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 44567788899999999999999988888899999986666678899999999999999999999999998999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+++++|.+++.... ...+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++.+...
T Consensus 83 ~~~~~L~~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 83 MSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred cCCCCHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 99999999996532 3458999999999999999999998 89999999999999999999999999999866431
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
.. ........+..|+|||.+.+..++.++||||||++++||++ |+.||....... .......+ ..
T Consensus 157 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~~~~~~~-----~~ 222 (261)
T cd05034 157 EY--TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-------VLEQVERG-----YR 222 (261)
T ss_pred hh--hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC-----CC
Confidence 11 11122334678999999998899999999999999999999 999996432211 11111111 00
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEG 777 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~ 777 (852)
. ..+......+.+++.+|++.+|++||+++++++.|+.
T Consensus 223 ~-----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 M-----PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred C-----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0 0111113457788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=314.13 Aligned_cols=257 Identities=23% Similarity=0.302 Sum_probs=200.4
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCccc---------------chHHHHHHHHHhhcccccceeeeeeee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQ---------------GEKQFRMEVATISSTHHLNLVRLVGFS 563 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---------------~~~~f~~E~~~l~~l~h~niv~l~g~~ 563 (852)
.|.+.+.||+|.||.|-+|.. .+++.||||++.+.+. ..++..+||.+|++++|||||+|+.+.
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 567778999999999999995 4689999999964321 125788999999999999999999998
Q ss_pred cc--CceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCce
Q 003059 564 SE--GKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNA 641 (852)
Q Consensus 564 ~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 641 (852)
.+ .+..|||+|||..|.+...- .....|+..+.+++++++..||+|||. .+||||||||+|+||+++|++
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred cCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcE
Confidence 65 55899999999988765422 112239999999999999999999999 899999999999999999999
Q ss_pred EEeecccccccCCCC--CcceeeeeecCCCCCCChhhhhcCC----CCCCccchhhhHHHHHHHhCCccccccccccchh
Q 003059 642 KVSDFGLAKLINPKD--HRHRTLTSVRGTRGYLAPEWLANLP----ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKK 715 (852)
Q Consensus 642 kl~DFGla~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~ 715 (852)
||+|||.+..+.... ..........||+.|+|||...++. .+.+.||||+||+||-|+.|+.||-....
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~----- 324 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE----- 324 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH-----
Confidence 999999998763221 1122234478999999999987632 35688999999999999999999964321
Q ss_pred hHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 716 FSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 716 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
...+. .++...+.- +...+.-+.+-+++.++|++||+.|.+..+|.....-...
T Consensus 325 --~~l~~--------KIvn~pL~f-P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 325 --LELFD--------KIVNDPLEF-PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred --HHHHH--------HHhcCcccC-CCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 11111 223333322 2233456677889999999999999999999887765544
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=323.28 Aligned_cols=240 Identities=25% Similarity=0.279 Sum_probs=191.9
Q ss_pred ccccccccceEEEEEE-CCCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCC
Q 003059 505 DKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNG 579 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 579 (852)
+.||+|+||.||++.. .+++.||+|.+... ......+..|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999986 45889999998732 223456778999999999999999999999999999999999999
Q ss_pred CHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcc
Q 003059 580 SLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRH 659 (852)
Q Consensus 580 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 659 (852)
+|..++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--- 149 (323)
T cd05595 81 ELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--- 149 (323)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC---
Confidence 999988543 358899999999999999999998 899999999999999999999999999987532211
Q ss_pred eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCC
Q 003059 660 RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAG 739 (852)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (852)
.......|++.|+|||.+.+..++.++|||||||++|||++|+.||....... .......... .+
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-------~~~~~~~~~~------~~-- 214 (323)
T cd05595 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEI------RF-- 214 (323)
T ss_pred CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCC------CC--
Confidence 12234568999999999999999999999999999999999999996443211 0111111100 01
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003059 740 EDVDIEQVMRAIQVSFWCIQEQPSQRP-----MMGKVVQ 773 (852)
Q Consensus 740 ~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~ev~~ 773 (852)
+......+.+++.+|++.||++|| ++.++++
T Consensus 215 ---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 215 ---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred ---CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 111223566788889999999998 7887765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.33 Aligned_cols=259 Identities=26% Similarity=0.399 Sum_probs=202.0
Q ss_pred ccccccccccccceEEEEEEC------CCcEEEEEEecCcc--cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA------NRTVVAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
+.+.+.||+|+||.||+|+.. ....+++|.+.... ....++.+|+.+++.++||||+++++.+.+.+..++|
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 456788999999999999853 23578898887432 2346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhccc-------------------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCce
Q 003059 573 YEFMKNGSLDNFLFANEE-------------------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENI 633 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI 633 (852)
+||+++++|.+++..... .....+++..++.++.|++.||+|||+ .+|+||||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheE
Confidence 999999999999864321 112458899999999999999999998 8999999999999
Q ss_pred EeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCcccccccccc
Q 003059 634 LLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETN 712 (852)
Q Consensus 634 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~ 712 (852)
|+++++.+||+|||+++......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYV-KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchh-cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999998654322211 1122345678999999988899999999999999999998 999996443211
Q ss_pred chhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 713 RKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 713 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
+ ....... . .. ..+......+.+++.+|++.+|++||++.++++.|+++..
T Consensus 238 ---~----~~~~~~~-~----~~-----~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 ---L----FNLLKTG-Y----RM-----ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ---H----HHHHhCC-C----CC-----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1 1111111 0 00 1111123467788999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=332.13 Aligned_cols=266 Identities=25% Similarity=0.388 Sum_probs=205.5
Q ss_pred HHHHHhcccccccccccccceEEEEEEC------CCcEEEEEEecCcc--cchHHHHHHHHHhhccc-ccceeeeeeeec
Q 003059 494 KELQRSTKGFKDKLGAGGFGAVYRGVLA------NRTVVAVKQLEGIE--QGEKQFRMEVATISSTH-HLNLVRLVGFSS 564 (852)
Q Consensus 494 ~el~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~f~~E~~~l~~l~-h~niv~l~g~~~ 564 (852)
.++....+.+.++||+|+||.||+|.+. .+..||+|+++... ...+.+.+|++++.++. ||||++++++|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3555566777899999999999999864 24679999998432 22356889999999997 999999999999
Q ss_pred cCceeeEEEeecCCCCHHHHhhhccc------------------------------------------------------
Q 003059 565 EGKHRLLVYEFMKNGSLDNFLFANEE------------------------------------------------------ 590 (852)
Q Consensus 565 ~~~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------------ 590 (852)
..+..++||||+++|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999975421
Q ss_pred ---------------------------------------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCC
Q 003059 591 ---------------------------------------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPE 631 (852)
Q Consensus 591 ---------------------------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~ 631 (852)
.....+++..++.++.||+.||+|||+ .+++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcc
Confidence 012357788899999999999999998 89999999999
Q ss_pred ceEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCcccccccc
Q 003059 632 NILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQE 710 (852)
Q Consensus 632 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~ 710 (852)
|||+++++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred eEEEeCCCEEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999865322111 11122346788999999998899999999999999999998 8899864321
Q ss_pred ccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 711 TNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 711 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
... .......+.. + ..+......+.+++..||+.+|.+||++.+|++.|+++.
T Consensus 348 ~~~------~~~~~~~~~~-------~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NEQ------FYNAIKRGYR-------M---AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hHH------HHHHHHcCCC-------C---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 110 1111111100 0 011112345678888999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.39 Aligned_cols=263 Identities=27% Similarity=0.411 Sum_probs=206.0
Q ss_pred HHHhcccccccccccccceEEEEEEC------CCcEEEEEEecCc--ccchHHHHHHHHHhhcc-cccceeeeeeeeccC
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLA------NRTVVAVKQLEGI--EQGEKQFRMEVATISST-HHLNLVRLVGFSSEG 566 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~ 566 (852)
+....+.+.+.||+|+||.||++... +...+|+|.+... .....++.+|++++.++ +|+||+++++++.++
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34456677889999999999999863 2367999998743 23345688999999999 899999999999999
Q ss_pred ceeeEEEeecCCCCHHHHhhhccc-----------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEe
Q 003059 567 KHRLLVYEFMKNGSLDNFLFANEE-----------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL 635 (852)
Q Consensus 567 ~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl 635 (852)
+..++||||+++|+|.+++..... .....+++..+++++.|++.||+|||+ .+|+||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEE
Confidence 999999999999999999964321 234568999999999999999999998 899999999999999
Q ss_pred CCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccch
Q 003059 636 DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRK 714 (852)
Q Consensus 636 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~ 714 (852)
++++.+||+|||+++.+...... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-- 242 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYY-RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-- 242 (293)
T ss_pred cCCCeEEeCccccccccccccce-eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--
Confidence 99999999999999876432211 11122335678999999998899999999999999999998 999986433211
Q ss_pred hhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 715 KFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
.......+... ..+......+.+++.+|++.+|++||++.++++.|+.+.
T Consensus 243 -----~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 -----LFKLLKEGYRM----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -----HHHHHHcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111111100 111222346778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=318.54 Aligned_cols=249 Identities=22% Similarity=0.284 Sum_probs=195.3
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCccc----chHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQ----GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
+.+...||+|+||.||+++.+ .|..+|+|++++... ..+..+.|-.+|....+|+||+|+-.|.+.++.||||||
T Consensus 143 Fe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEy 222 (550)
T KOG0605|consen 143 FELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEY 222 (550)
T ss_pred chhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEe
Confidence 344578999999999999954 589999999985432 335577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC-
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP- 654 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~- 654 (852)
++||++..+|... ..|+......++.+++-|+.-||+ .|+|||||||+|+|||..|++||+||||+.-+..
T Consensus 223 lPGGD~mTLL~~~-----~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 223 LPGGDMMTLLMRK-----DTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred cCCccHHHHHHhc-----CcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 9999999999654 358999999999999999999999 9999999999999999999999999999853311
Q ss_pred --------------------CCCcc-----------------------eeeeeecCCCCCCChhhhhcCCCCCCccchhh
Q 003059 655 --------------------KDHRH-----------------------RTLTSVRGTRGYLAPEWLANLPITSKSDVYSY 691 (852)
Q Consensus 655 --------------------~~~~~-----------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~ 691 (852)
..+.. ......+|||.|||||++.+..|+..+|.|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 00000 00113469999999999999999999999999
Q ss_pred hHHHHHHHhCCccccccccccc-hhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCC---
Q 003059 692 GMVLLEIVSGRRNFEVSQETNR-KKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPM--- 767 (852)
Q Consensus 692 Gvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt--- 767 (852)
|||+||||.|-+||........ ..+..|... +.. +...+...++.++|.+|+. ||++|--
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~--------------l~f-P~~~~~s~eA~DLI~rll~-d~~~RLG~~G 438 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRET--------------LKF-PEEVDLSDEAKDLITRLLC-DPENRLGSKG 438 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh--------------ccC-CCcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence 9999999999999986654321 122222110 100 1112222566788888888 9999975
Q ss_pred HHHHHH
Q 003059 768 MGKVVQ 773 (852)
Q Consensus 768 ~~ev~~ 773 (852)
++||.+
T Consensus 439 ~~EIK~ 444 (550)
T KOG0605|consen 439 AEEIKK 444 (550)
T ss_pred HHHHhc
Confidence 555543
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=317.17 Aligned_cols=255 Identities=24% Similarity=0.355 Sum_probs=197.3
Q ss_pred cccccccccccccceEEEEEEC-CCc----EEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRT----VVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
.+.+.+.||+|+||.||+|.+. +++ .+++|.+... .....++..|+..++++.||||+++++++.. ...++|
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence 4556788999999999999863 333 4778887632 2234577888989999999999999998864 567899
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
+||+++|+|.+++... ...+++..++.++.||+.||+|||+ ++++||||||+|||+++++.+||+|||+++..
T Consensus 87 ~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 87 TQLSPLGSLLDHVRQH----RDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEeCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999643 2358999999999999999999998 88999999999999999999999999999866
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
.... .........++..|+|||.+.+..++.++||||||+++|||++ |+.||....... . ...+..+...
T Consensus 160 ~~~~-~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~----~~~~~~~~~~- 230 (279)
T cd05111 160 YPDD-KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---V----PDLLEKGERL- 230 (279)
T ss_pred cCCC-cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHCCCcC-
Confidence 4322 1122233457788999999999999999999999999999998 999996542211 0 1111111100
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
..+. . ....+.+++.+|+..+|.+||++.|+++.|+.+..
T Consensus 231 -~~~~----~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 231 -AQPQ----I----CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred -CCCC----C----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0010 1 12345677889999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=318.11 Aligned_cols=249 Identities=23% Similarity=0.378 Sum_probs=206.9
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCce-eeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKH-RLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~-~~lV~e 574 (852)
.|.+.+++|+|+||.++..+. .+++.+++|.+.... ...+...+|+.++++++|||||.+.+.+.+++. .+|||+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 466778999999999998874 356789999987333 233456899999999999999999999999888 999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|++||+|.+.|.... +..++++.+.+++.||+.|+.|||+ ..|+|||||++||++..+..+||+|||+|+.+.+
T Consensus 85 Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred ecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 999999999997654 5678999999999999999999997 8899999999999999999999999999999876
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
.. .......||+.||.||.+.+.+|..|+|||||||++|||++-+++|+..+... + . .........
T Consensus 159 ~~---~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---L---i-----~ki~~~~~~ 224 (426)
T KOG0589|consen 159 ED---SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---L---I-----LKINRGLYS 224 (426)
T ss_pred ch---hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---H---H-----HHHhhccCC
Confidence 43 23456789999999999999999999999999999999999999997654221 0 0 001111111
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
+.+......+..++..|++.+|+.||++.+++.+
T Consensus 225 ------Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 ------PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ------CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 3444455667778888999999999999999865
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=312.36 Aligned_cols=257 Identities=26% Similarity=0.444 Sum_probs=206.8
Q ss_pred HHHHhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
++..+++.+.++||+|+||.||++.+.++..+++|.+.......+.|.+|++++++++|+||+++++++.+ ...++|||
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 45567888899999999999999998788889999988655556789999999999999999999999887 78899999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++++|.+++.... ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 81 FMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred eCCCCcHHHHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 999999999996532 3458899999999999999999998 8999999999999999999999999999976543
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
... .......++..|+|||.+....++.++||||||+++||+++ |+.||....... + ......+...
T Consensus 155 ~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~----~~~~~~~~~~--- 222 (260)
T cd05073 155 NEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---V----IRALERGYRM--- 222 (260)
T ss_pred CCc--ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---H----HHHHhCCCCC---
Confidence 211 11122345678999999998889999999999999999999 999996432211 0 1111111100
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEG 777 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~ 777 (852)
+........+.+++.+|++.+|++||++.++.+.|+.
T Consensus 223 -------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 -------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111223457788899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=311.40 Aligned_cols=249 Identities=29% Similarity=0.424 Sum_probs=196.8
Q ss_pred ccccccccceEEEEEECC----CcEEEEEEecCccc--chHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 505 DKLGAGGFGAVYRGVLAN----RTVVAVKQLEGIEQ--GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
++||+|+||.||+|.+.. +..+|+|.+..... ..+++..|+++++++.|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998532 26899999884443 5678999999999999999999999876 4568999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
++|.+++.... .+++..+..++.|++.+|+|||+ .+++||||||+|||++.++.+||+|||+++.+......
T Consensus 80 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 80 GPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 99999996432 58899999999999999999998 88999999999999999999999999999876443222
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccccccc
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSL 737 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (852)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.. ........
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~----~~~~~~~~------- 217 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIA----MLESGERL------- 217 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHH----HHHcCCcC-------
Confidence 111222334568999999999999999999999999999998 99999654321 1111 11111100
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 738 AGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 738 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
..+......+.+++.+|++.+|.+||++.+|++.|+++.
T Consensus 218 ---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 ---PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 011112245678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=324.38 Aligned_cols=236 Identities=25% Similarity=0.309 Sum_probs=185.3
Q ss_pred ccccccccceEEEEEEC-CCcEEEEEEecCcc----cchHHHHHHHH-HhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 505 DKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE----QGEKQFRMEVA-TISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~f~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
+.||+|+||.||+++.. +++.||+|++.... ....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999974 57889999986321 22344555554 57889999999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
++|..++... ..++...+..++.||++||+|||+ .+|+||||||+||||+.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 150 (321)
T cd05603 81 GELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-- 150 (321)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--
Confidence 9999888542 347788888999999999999998 899999999999999999999999999987532211
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccC
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (852)
.......|++.|+|||.+.+..++.++|||||||++|||++|+.||....... ........ .+
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i~~~--------~~- 213 (321)
T cd05603 151 -ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-------MYDNILHK--------PL- 213 (321)
T ss_pred -CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH-------HHHHHhcC--------CC-
Confidence 12234568999999999999999999999999999999999999996543110 11111111 11
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 003059 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMG 769 (852)
Q Consensus 739 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ 769 (852)
..+......+.+++.+|++.+|.+||+..
T Consensus 214 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 --QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11112234567889999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=311.45 Aligned_cols=247 Identities=27% Similarity=0.390 Sum_probs=194.8
Q ss_pred ccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCCH
Q 003059 505 DKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSL 581 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 581 (852)
++||+|+||.||+|... +++.||+|.+... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999964 6888999987632 33456789999999999999999999999999999999999999999
Q ss_pred HHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCccee
Q 003059 582 DNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRT 661 (852)
Q Consensus 582 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 661 (852)
.+++... ...+++..++.++.|+++||+|||+ .+++||||||+|||++.++.+||+|||+++........ ..
T Consensus 81 ~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~ 152 (252)
T cd05084 81 LTFLRTE----GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA-ST 152 (252)
T ss_pred HHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCccccccccc-cc
Confidence 9998532 2358899999999999999999998 89999999999999999999999999998764321110 00
Q ss_pred eeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcccccccccCCC
Q 003059 662 LTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGE 740 (852)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 740 (852)
......+..|+|||.+.+..++.++||||||+++|||++ |..||....... ........ ...
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~---------~~~- 215 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQG---------VRL- 215 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcC---------CCC-
Confidence 111123457999999999899999999999999999998 888886432211 01111110 000
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003059 741 DVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776 (852)
Q Consensus 741 ~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~ 776 (852)
..+......+.+++.+|++.+|++||++.+|.++|+
T Consensus 216 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 216 PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 111122346778899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=319.41 Aligned_cols=262 Identities=27% Similarity=0.442 Sum_probs=205.8
Q ss_pred HhcccccccccccccceEEEEEEC------CCcEEEEEEecCc-ccchHHHHHHHHHhhcccccceeeeeeeeccCceee
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA------NRTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRL 570 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 570 (852)
+..+.+.+.||+|+||.||++... ++..+|+|.+... ......+.+|++++.+++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 345667789999999999999842 3456899988743 334567999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhhccc--------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceE
Q 003059 571 LVYEFMKNGSLDNFLFANEE--------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAK 642 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 642 (852)
+||||+++++|.+++..... .....+++..++.++.|++.||+|||+ ++++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 99999999999999964421 122358999999999999999999998 8999999999999999999999
Q ss_pred EeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHH
Q 003059 643 VSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAY 721 (852)
Q Consensus 643 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 721 (852)
|+|||+++....... ........++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ..
T Consensus 161 l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~ 232 (288)
T cd05093 161 IGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VI 232 (288)
T ss_pred eccCCccccccCCce-eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HH
Confidence 999999986543211 111222335778999999999899999999999999999998 899986443211 11
Q ss_pred HHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 722 EEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 722 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
.....+.... ... . ....+.+++.+|++.+|.+||++.+|.+.|+.+..
T Consensus 233 ~~i~~~~~~~-----~~~-~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 233 ECITQGRVLQ-----RPR-T----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHHHcCCcCC-----CCC-C----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1111111111 000 1 12357889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=328.35 Aligned_cols=246 Identities=26% Similarity=0.313 Sum_probs=197.8
Q ss_pred HHhcccccccccccccceEEEEEECC--CcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceee
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLAN--RTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRL 570 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 570 (852)
....|.+.++||+|+||.||+|...+ +..||+|++... ....+.+.+|++++..++||||+++++++.+++..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34457788999999999999998543 368999998632 233456889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 108 lv~Ey~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~ 179 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRN-----KRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAK 179 (340)
T ss_pred EEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCe
Confidence 999999999999999643 348899999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcc
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (852)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+..
T Consensus 180 ~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~i~~~~~- 245 (340)
T PTZ00426 180 VVDTR------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIYQKILEGII- 245 (340)
T ss_pred ecCCC------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHHHHHhcCCC-
Confidence 65421 23456899999999999989999999999999999999999999754321 11111111111
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003059 731 GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP-----MMGKVVQM 774 (852)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~ev~~~ 774 (852)
.+ +......+.+++.+|++.||++|+ +++++++.
T Consensus 246 -----~~-----p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 -----YF-----PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----CC-----CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 00 111123456788899999999995 78887753
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=341.23 Aligned_cols=252 Identities=18% Similarity=0.217 Sum_probs=199.0
Q ss_pred cccccccccccccceEEEEEEC-C-CcEEEEEEecCc-ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-N-RTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
.|.+.+.||+|+||.||+|... + ++.|++|.+... ......+..|+.++++++||||+++++++..++..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3778899999999999999853 3 567888876533 333456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++|+|.++|..... ....+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.+....
T Consensus 148 ~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 148 SGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 99999999864322 23468889999999999999999998 899999999999999999999999999998764321
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+... +
T Consensus 224 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~-------~~~~~~~~~~~----~- 290 (478)
T PTZ00267 224 S-LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE-------IMQQVLYGKYD----P- 290 (478)
T ss_pred c-cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC----C-
Confidence 1 112234569999999999999999999999999999999999999996432210 01111111111 0
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.+......+.+++.+|++.+|++||++.++++
T Consensus 291 -----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 -----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -----CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11112235678888999999999999998864
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=330.01 Aligned_cols=244 Identities=25% Similarity=0.387 Sum_probs=188.7
Q ss_pred cccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 502 GFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 502 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
.+.++||+|+||.||+++.. +++.||||++... ......+.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 156 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG 156 (353)
T ss_pred hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence 34678999999999999964 5789999998633 23346789999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
++|.... .+.+..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.+....
T Consensus 157 ~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-- 222 (353)
T PLN00034 157 GSLEGTH---------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-- 222 (353)
T ss_pred Ccccccc---------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--
Confidence 9986532 24567788899999999999998 899999999999999999999999999998764321
Q ss_pred ceeeeeecCCCCCCChhhhhc-----CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 659 HRTLTSVRGTRGYLAPEWLAN-----LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
.......|+..|+|||.+.. ...+.++|||||||++|||++|+.||......+...+ .. ......
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~-~~~~~~----- 292 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL---MC-AICMSQ----- 292 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH---HH-HHhccC-----
Confidence 11233568999999998743 2345689999999999999999999973322111110 00 000000
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.. .........+.+++.+||+.||++||++.||++.
T Consensus 293 ~~-----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 PP-----EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CC-----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 1111223457788899999999999999999874
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=313.28 Aligned_cols=259 Identities=22% Similarity=0.343 Sum_probs=204.5
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.|.+.++||+|+||.||+|+. .+++.||||.+... ......+.+|++++++++||||+++++++.+.+..++|+|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 466788999999999999995 46889999987532 2334568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++++|.+++..... ....++...+..++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 83 LADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998854322 23457889999999999999999998 8999999999999999999999999999887643
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
.. .......++..|+|||.+.+..++.++||||||+++|||++|+.||....... ..+. ....... .
T Consensus 159 ~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~-~~~~~~~-----~ 225 (267)
T cd08228 159 KT---TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLC-QKIEQCD-----Y 225 (267)
T ss_pred hh---HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHH-HHHhcCC-----C
Confidence 21 11123458889999999998889999999999999999999999985432110 0111 1111100 0
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
+. .........+.+++.+||+.+|.+||++.+|++.|++++
T Consensus 226 ~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 226 PP----LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CC----CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 10 111123356778899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=323.15 Aligned_cols=243 Identities=25% Similarity=0.311 Sum_probs=189.8
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHh---hcccccceeeeeeeeccCceeeEE
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATI---SSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l---~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
|.+.+.||+|+||.||++... +++.||||+++.. ....+.+..|+.++ ++++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 356789999999999999864 5789999999732 22234566666554 567899999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++++|..++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999999988842 358999999999999999999998 89999999999999999999999999998753
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI 732 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (852)
.... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+.....
T Consensus 152 ~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-------~~~~i~~~~~--- 218 (324)
T cd05589 152 MGFG---DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-------VFDSIVNDEV--- 218 (324)
T ss_pred CCCC---CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC---
Confidence 2211 12234568999999999999999999999999999999999999997543211 0111111110
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPM-----MGKVVQ 773 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt-----~~ev~~ 773 (852)
. .+......+.+++.+|++.||.+||+ +.++++
T Consensus 219 ---~-----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 ---R-----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---C-----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0 11111234678889999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=315.49 Aligned_cols=266 Identities=26% Similarity=0.367 Sum_probs=203.4
Q ss_pred HhcccccccccccccceEEEEEECC-----------------CcEEEEEEecCc--ccchHHHHHHHHHhhcccccceee
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLAN-----------------RTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVR 558 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~ 558 (852)
...+.+.++||+|+||.||++...+ +..||+|.+... ....+++.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3467788999999999999988542 246899998743 234567899999999999999999
Q ss_pred eeeeeccCceeeEEEeecCCCCHHHHhhhcccC------CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCc
Q 003059 559 LVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEG------SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPEN 632 (852)
Q Consensus 559 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 632 (852)
+++++..++..++||||+++++|.+++...... ....+++..++.++.|++.||+|||+ .+|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 999999999999999999999999999764421 12368999999999999999999998 899999999999
Q ss_pred eEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh--CCcccccccc
Q 003059 633 ILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS--GRRNFEVSQE 710 (852)
Q Consensus 633 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt--G~~p~~~~~~ 710 (852)
|++++++.++|+|||+++....... ........++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDY-YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcc-eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999999986543221 112223446778999999998899999999999999999998 6677754321
Q ss_pred ccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003059 711 TNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEG 777 (852)
Q Consensus 711 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~ 777 (852)
. .........+........ . ..+......+.+++.+|++.+|.+||++.+|++.|++
T Consensus 240 ~---~~~~~~~~~~~~~~~~~~----~---~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 Q---QVIENAGHFFRDDGRQIY----L---PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred H---HHHHHHHhcccccccccc----C---CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1 111111111110000000 0 1111122467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=328.98 Aligned_cols=194 Identities=24% Similarity=0.314 Sum_probs=167.3
Q ss_pred HHhcccccccccccccceEEEEEE-CCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
....|.+.++||+|+||.||++.. ..++.||+|... ...+.+|++++++++||||+++++++..+...++|+|+
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 345688889999999999999996 457889999754 23578899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+. ++|.+++... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 165 ~~-~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 165 YK-TDLYCYLAAK-----RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred CC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 95 7888888543 347899999999999999999998 89999999999999999999999999999754321
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCcccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFE 706 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~ 706 (852)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||-
T Consensus 236 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 236 --NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred --cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 1112234579999999999999999999999999999999999998864
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=323.05 Aligned_cols=241 Identities=26% Similarity=0.292 Sum_probs=186.5
Q ss_pred ccccccccceEEEEEEC-CCcEEEEEEecCcc----cchHHHHHHHH-HhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 505 DKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE----QGEKQFRMEVA-TISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~f~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
+.||+|+||.||++... +++.||+|++.... ....++..|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 56789999987322 22234444444 56788999999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
++|.+++... ..+....+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-- 150 (325)
T cd05602 81 GELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-- 150 (325)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--
Confidence 9999999643 246778888899999999999998 899999999999999999999999999997543211
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccC
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (852)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ......... ..
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i~~~~--------~~ 214 (325)
T cd05602 151 -GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-------MYDNILNKP--------LQ 214 (325)
T ss_pred -CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-------HHHHHHhCC--------cC
Confidence 12234569999999999999999999999999999999999999997433211 011111111 00
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 739 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
........+.+++.+|++.+|.+||++.+.+..
T Consensus 215 ---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 215 ---LKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred ---CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 011122356678888999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=315.52 Aligned_cols=268 Identities=24% Similarity=0.346 Sum_probs=201.7
Q ss_pred HHHhcccccccccccccceEEEEEECC---------------CcEEEEEEecCc--ccchHHHHHHHHHhhcccccceee
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLAN---------------RTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVR 558 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~~---------------~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~ 558 (852)
+.+..+.+.++||+|+||.||++...+ ...||+|.+... ......|.+|++++.+++|+||++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 345578888999999999999987532 235899998742 233467899999999999999999
Q ss_pred eeeeeccCceeeEEEeecCCCCHHHHhhhcccC-------CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCC
Q 003059 559 LVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEG-------SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPE 631 (852)
Q Consensus 559 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~ 631 (852)
+++++...+..++||||+++++|.+++...... ....+++..++.++.|++.||+|||+ .+++||||||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~ 158 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATR 158 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChh
Confidence 999999999999999999999999999643211 11347889999999999999999998 89999999999
Q ss_pred ceEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh--CCccccccc
Q 003059 632 NILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS--GRRNFEVSQ 709 (852)
Q Consensus 632 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt--G~~p~~~~~ 709 (852)
||++++++.+||+|||+++....... ........++..|+|||.+.+..++.++||||||++++||++ |..||....
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcc-eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 99999999999999999986543211 111222345678999999998899999999999999999998 566776433
Q ss_pred cccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003059 710 ETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEG 777 (852)
Q Consensus 710 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~ 777 (852)
... ............. ...... .+......+.+++.+|++.+|++||++.+|++.|++
T Consensus 238 ~~~---~~~~~~~~~~~~~-~~~~~~------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 238 DEQ---VIENTGEFFRNQG-RQIYLS------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred hHH---HHHHHHHhhhhcc-ccccCC------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 211 1111111111000 000000 011112467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=322.58 Aligned_cols=267 Identities=26% Similarity=0.399 Sum_probs=207.6
Q ss_pred HHHHhcccccccccccccceEEEEEECC--------CcEEEEEEecCc--ccchHHHHHHHHHhhcc-cccceeeeeeee
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLAN--------RTVVAVKQLEGI--EQGEKQFRMEVATISST-HHLNLVRLVGFS 563 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~--~~~~~~f~~E~~~l~~l-~h~niv~l~g~~ 563 (852)
++...++.+.+.||+|+||.||++...+ ...||+|.+... ....+++.+|++++.++ +|+||++++++|
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 5556678889999999999999997421 236899988743 23456789999999999 899999999999
Q ss_pred ccCceeeEEEeecCCCCHHHHhhhccc-----------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCc
Q 003059 564 SEGKHRLLVYEFMKNGSLDNFLFANEE-----------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPEN 632 (852)
Q Consensus 564 ~~~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 632 (852)
.+.+..++||||+++|+|.+++..... .....+++..++.++.|++.||+|||+ ++|+||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccce
Confidence 999999999999999999999975421 123468899999999999999999998 899999999999
Q ss_pred eEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccc
Q 003059 633 ILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQET 711 (852)
Q Consensus 633 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~ 711 (852)
||+++++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred EEEcCCCcEEECCcccceeccccccc-ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999865432111 11122334567999999999999999999999999999998 88888643221
Q ss_pred cchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCC
Q 003059 712 NRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIE 782 (852)
Q Consensus 712 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~ 782 (852)
. ........... ..+......+.+++.+|++.+|.+||++.++++.|+++....
T Consensus 244 ~-------~~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 244 E-------LFKLLKEGHRM----------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred H-------HHHHHHcCCCC----------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 1 01111111100 111122345778899999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=332.82 Aligned_cols=250 Identities=26% Similarity=0.427 Sum_probs=205.2
Q ss_pred cccccccccceEEEEEE-CC----CcEEEEEEecC--cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 504 KDKLGAGGFGAVYRGVL-AN----RTVVAVKQLEG--IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~-~~----~~~vavK~l~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
.++||.|+||+||||.+ .. +.+||+|++.. ..+...++.+|+.+|.+++||||++|+|+|.... ..||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 46899999999999985 33 35799999873 3445688999999999999999999999998876 88999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
+.|+|.+|+..+ +..+--+..+.|..|||+||.|||+ ++++||||.++||||..-..+||.|||+++.+.+++
T Consensus 780 P~G~LlDyvr~h----r~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 780 PLGCLLDYVREH----RDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred ccchHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 999999999764 3458888899999999999999998 899999999999999999999999999999987654
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
.. .......-.+.|||-|.++...++.++|||||||++||++| |..|++....++..+ .++.+ ++
T Consensus 853 ~e-y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d-------lle~g------eR 918 (1177)
T KOG1025|consen 853 KE-YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD-------LLEKG------ER 918 (1177)
T ss_pred cc-ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH-------HHhcc------cc
Confidence 32 33334455788999999999999999999999999999998 999998654332211 11111 11
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
| .-++-....+..++..||..|+..||+++++...+.+..
T Consensus 919 -L---sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 919 -L---SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred -C---CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 2 223344556777888999999999999999998887653
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=313.21 Aligned_cols=256 Identities=30% Similarity=0.468 Sum_probs=201.5
Q ss_pred hcccccccccccccceEEEEEEC----CCcEEEEEEecCcc--cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA----NRTVVAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
..+.+.+.||+|+||.||+|... .+..+|+|.++... ...+.|.+|+.++.+++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45677889999999999999863 23479999987432 3346789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.++|+|||+++.+
T Consensus 84 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 84 TEYMENGSLDAFLRKH----DGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 9999999999999643 2358899999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
..............++..|+|||.+.+..++.++||||||+++||+++ |+.||......+ . .....++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~----~~~~~~~~--- 226 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---V----IKAIEEGY--- 226 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---H----HHHHhCCC---
Confidence 543221111122234568999999998899999999999999999886 999996443211 0 11111110
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
. . +.+......+.+++.+|++.+|.+||+|.++++.|+++
T Consensus 227 --~--~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 --R--L---PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --c--C---CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 0 11111234567888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=329.54 Aligned_cols=201 Identities=23% Similarity=0.293 Sum_probs=170.2
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.|.+.++||+|+||.||++.. .+++.||||++... ....+.+++|++++.+++||||+++++++.+....|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 356678999999999999985 46889999998632 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 82 FLPGGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999643 347888899999999999999998 8999999999999999999999999999964321
Q ss_pred CCCc------------c--------------------------------eeeeeecCCCCCCChhhhhcCCCCCCccchh
Q 003059 655 KDHR------------H--------------------------------RTLTSVRGTRGYLAPEWLANLPITSKSDVYS 690 (852)
Q Consensus 655 ~~~~------------~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s 690 (852)
.... . .......||+.|+|||.+.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 1000 0 0001245899999999999999999999999
Q ss_pred hhHHHHHHHhCCcccccc
Q 003059 691 YGMVLLEIVSGRRNFEVS 708 (852)
Q Consensus 691 ~Gvvl~elltG~~p~~~~ 708 (852)
|||++|||++|+.||...
T Consensus 234 lGvil~elltG~~Pf~~~ 251 (377)
T cd05629 234 LGAIMFECLIGWPPFCSE 251 (377)
T ss_pred cchhhhhhhcCCCCCCCC
Confidence 999999999999999654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=314.34 Aligned_cols=260 Identities=23% Similarity=0.309 Sum_probs=191.6
Q ss_pred cccccccccccccceEEEEEEC--CCcEEEEEEecCcc---cchHHHHHHHHHhhcc---cccceeeeeeeec-----cC
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA--NRTVVAVKQLEGIE---QGEKQFRMEVATISST---HHLNLVRLVGFSS-----EG 566 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l---~h~niv~l~g~~~-----~~ 566 (852)
+|.+.++||+|+||.||+|... +++.||+|++.... .....+.+|+++++.+ +||||++++++|. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 4677889999999999999863 46889999887322 2234566777777665 6999999999885 34
Q ss_pred ceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeec
Q 003059 567 KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDF 646 (852)
Q Consensus 567 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 646 (852)
...++||||++ ++|.+++.... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccc
Confidence 56899999996 69999986432 3358899999999999999999998 89999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhh
Q 003059 647 GLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEK 726 (852)
Q Consensus 647 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (852)
|+++..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+.. .. .......
T Consensus 155 g~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~--~~-i~~~~~~ 227 (290)
T cd07862 155 GLARIYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL--GK-ILDVIGL 227 (290)
T ss_pred cceEeccCC----cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH--HH-HHHHhCC
Confidence 999865432 1223456899999999999889999999999999999999999999765332111 00 0000000
Q ss_pred ---CCcc---cccccccC-CCCCCHH-----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 727 ---GNVK---GIVDKSLA-GEDVDIE-----QVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 727 ---~~~~---~~~d~~l~-~~~~~~~-----~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.... .+....+. ....+.+ ....+.+++.+|++.||++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 00000000 0011111 1234568999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=287.76 Aligned_cols=245 Identities=27% Similarity=0.335 Sum_probs=202.7
Q ss_pred ccccccccccccceEEEEEE-CCCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 501 KGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
.++.+.||+|-||.||.|.. .++-.||+|++.+. .+.+.++.+|+++-..|+||||++++++|.+....||++||
T Consensus 24 feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEy 103 (281)
T KOG0580|consen 24 FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEY 103 (281)
T ss_pred ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEe
Confidence 45678899999999999995 45778999998743 34457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
.++|+|...|.... ...++......++.|+|.||.|+|. +++|||||||+|+|++..+..||+|||-+....
T Consensus 104 a~~gel~k~L~~~~---~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 104 APRGELYKDLQEGR---MKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred cCCchHHHHHHhcc---cccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 99999999997433 4457888888999999999999999 899999999999999999999999999887543
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
........||..|++||...+...+...|+|++|++.||++.|.+||+..... ..+..+.+- ++.+
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-------etYkrI~k~---~~~~- 241 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-------ETYKRIRKV---DLKF- 241 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-------HHHHHHHHc---cccC-
Confidence 22345678999999999999999999999999999999999999999855421 122222221 1111
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
+..-...+.+++.+|+..+|.+|.+..||++.
T Consensus 242 -------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 242 -------PSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -------CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 12223456788999999999999999998864
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=314.67 Aligned_cols=257 Identities=31% Similarity=0.421 Sum_probs=199.1
Q ss_pred hcccccccccccccceEEEEEECC------CcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRL 570 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 570 (852)
..+.+.+.||+|+||.||+|.+.+ +..|++|.+... ......|..|+.++++++|+||+++++++.+....+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 345667899999999999999753 567899988633 233467899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhhcccC--CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC---ceEEee
Q 003059 571 LVYEFMKNGSLDNFLFANEEG--SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY---NAKVSD 645 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~D 645 (852)
+||||+++++|.+++...... ....+++..++.++.||+.||+|||+ ++++||||||+|||++.++ .+||+|
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEecc
Confidence 999999999999999754321 22368999999999999999999998 8899999999999998755 599999
Q ss_pred cccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHH
Q 003059 646 FGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEF 724 (852)
Q Consensus 646 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 724 (852)
||+++........ ........+..|+|||++.+..++.++|||||||++|||++ |+.||....... . ....
T Consensus 163 fg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~----~~~~ 234 (277)
T cd05036 163 FGMARDIYRASYY-RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---V----MEFV 234 (277)
T ss_pred CccccccCCccce-ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHH
Confidence 9999876332111 11112223568999999999999999999999999999997 999997543211 1 0111
Q ss_pred hhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003059 725 EKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776 (852)
Q Consensus 725 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~ 776 (852)
...... ..+......+.+++.+|++.+|++||++.+|++.|+
T Consensus 235 ~~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111000 111112245778899999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=315.24 Aligned_cols=250 Identities=25% Similarity=0.306 Sum_probs=197.4
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
+|+..++||+|+||.||++... +++.||+|.+.... .....+.+|+.++++++|+||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3566788999999999999864 58899999987322 223557889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++++|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 999999999886432 2458999999999999999999998 8999999999999999999999999999986532
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
.. ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......... ........
T Consensus 155 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~--------- 218 (285)
T cd05605 155 GE----TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVK--------- 218 (285)
T ss_pred CC----ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhh---------
Confidence 21 122346899999999999889999999999999999999999999754321110 00000010
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP-----MMGKVVQ 773 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~ev~~ 773 (852)
.... ..+......+.+++..|++.||.+|| +++++++
T Consensus 219 ~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 219 EDQE--EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred hccc--ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 0000 11112234567888999999999999 7778765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=320.53 Aligned_cols=247 Identities=20% Similarity=0.308 Sum_probs=192.8
Q ss_pred ccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEEEeecCC
Q 003059 505 DKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
+.||+|+||.||++... +++.||+|+++.. ....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999864 5789999999742 22335678899999888 799999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-- 150 (329)
T cd05588 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-- 150 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC--
Confidence 9999988543 358999999999999999999998 899999999999999999999999999987532211
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCcccccccccc--chhhHHHHHHHHhhCCcccccccc
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETN--RKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||+...... ......+...........
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 223 (329)
T cd05588 151 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------ 223 (329)
T ss_pred -CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------
Confidence 12234568999999999999999999999999999999999999997432211 111112222222221110
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCC------HHHHHH
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPM------MGKVVQ 773 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt------~~ev~~ 773 (852)
+ +......+.+++.+|++.||.+||+ +.++++
T Consensus 224 ~-----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 I-----PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred C-----CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1 1111235677888999999999997 556653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=313.70 Aligned_cols=246 Identities=24% Similarity=0.334 Sum_probs=192.6
Q ss_pred ccccccceEEEEEEC-CCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCCH
Q 003059 507 LGAGGFGAVYRGVLA-NRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSL 581 (852)
Q Consensus 507 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 581 (852)
||+|+||.||++... +++.||+|.+.... ...+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999864 57899999986322 2235678899999999999999999999999999999999999999
Q ss_pred HHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCccee
Q 003059 582 DNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRT 661 (852)
Q Consensus 582 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 661 (852)
..++..... ....+++..++.++.||+.||+|||+ ++|+||||||+||++++++.+||+|||++..+..... .
T Consensus 81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~---~ 153 (280)
T cd05608 81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS---K 153 (280)
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc---c
Confidence 988854322 24468999999999999999999998 8999999999999999999999999999976543221 1
Q ss_pred eeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCCCC
Q 003059 662 LTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGED 741 (852)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 741 (852)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||......... ..... .+..... .
T Consensus 154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-------~~~~~----~~~~~~~---~ 219 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-------KELKQ----RILNDSV---T 219 (280)
T ss_pred ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-------HHHHH----hhcccCC---C
Confidence 23356899999999999999999999999999999999999999754321110 00000 0111111 1
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003059 742 VDIEQVMRAIQVSFWCIQEQPSQRP-----MMGKVVQ 773 (852)
Q Consensus 742 ~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~ev~~ 773 (852)
.+......+.+++.+|++.||++|| +++++++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 1112234567888899999999999 5666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=326.24 Aligned_cols=201 Identities=23% Similarity=0.312 Sum_probs=170.3
Q ss_pred ccccccccccccceEEEEEE-CCCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 501 KGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
+.+.++||+|+||.||+|.. .+++.||+|++... ......+.+|++++.+++|+||+++++++.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 55678999999999999986 45789999999742 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++.+...
T Consensus 83 ~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 83 IPGGDMMSLLIRM-----EVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred CCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999643 347888889999999999999998 89999999999999999999999999998643210
Q ss_pred CCc--------------------------------------------ceeeeeecCCCCCCChhhhhcCCCCCCccchhh
Q 003059 656 DHR--------------------------------------------HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSY 691 (852)
Q Consensus 656 ~~~--------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~ 691 (852)
... ........||+.|+|||.+.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 000 000123469999999999999899999999999
Q ss_pred hHHHHHHHhCCccccccc
Q 003059 692 GMVLLEIVSGRRNFEVSQ 709 (852)
Q Consensus 692 Gvvl~elltG~~p~~~~~ 709 (852)
||++|||++|+.||....
T Consensus 235 G~il~elltG~~Pf~~~~ 252 (381)
T cd05626 235 GVILFEMLVGQPPFLAPT 252 (381)
T ss_pred hhHHHHHHhCCCCCcCCC
Confidence 999999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=319.80 Aligned_cols=262 Identities=21% Similarity=0.293 Sum_probs=194.2
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCcc--cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
..|.+.++||+|+||.||+|... +++.||+|++.... .....+.+|+.++++++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 35677889999999999999975 57899999987332 2335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
++ ++|.+++... ...++...+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 85 ~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 85 VH-TDLCQYMDKH----PGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CC-cCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 95 6888887543 2347888899999999999999998 89999999999999999999999999998754321
Q ss_pred CCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC---c--
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN---V-- 729 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~-- 729 (852)
. .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||........ .+ ........... .
T Consensus 157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~-~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 157 S---HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD-QL-ERIFLVLGTPNEDTWPG 231 (303)
T ss_pred C---ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HH-HHHHHHhCCCChhhccc
Confidence 1 12233557899999999865 4578899999999999999999999975432111 00 00000000000 0
Q ss_pred ----ccccccccC-CCCCCHH-------HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 730 ----KGIVDKSLA-GEDVDIE-------QVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 730 ----~~~~d~~l~-~~~~~~~-------~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
......... ..+.... ....+.+++..|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000000 0001111 1134668888999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=319.51 Aligned_cols=260 Identities=28% Similarity=0.439 Sum_probs=200.7
Q ss_pred hcccccccccccccceEEEEEEC-CCc--EEEEEEecC--cccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRT--VVAVKQLEG--IEQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~--~vavK~l~~--~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 572 (852)
..+.+.+.||+|+||.||+|... ++. .+++|.+.. ......++.+|++++.++ +|+||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 34567789999999999999964 343 467777763 233456788999999999 899999999999999999999
Q ss_pred EeecCCCCHHHHhhhccc-----------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCce
Q 003059 573 YEFMKNGSLDNFLFANEE-----------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNA 641 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 641 (852)
|||+++++|.+++..... .....+++..++.++.|++.||+|||+ ++++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence 999999999999975432 112368899999999999999999998 899999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHH
Q 003059 642 KVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWA 720 (852)
Q Consensus 642 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 720 (852)
||+|||+++..... .......++..|+|||.+.+..++.++||||||+++|||+| |..||....... .
T Consensus 164 kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~ 232 (303)
T cd05088 164 KIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------L 232 (303)
T ss_pred EeCccccCcccchh----hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-------H
Confidence 99999998643211 01111234667999999988889999999999999999998 999996432211 0
Q ss_pred HHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCC
Q 003059 721 YEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIE 782 (852)
Q Consensus 721 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~ 782 (852)
........ .. ..+......+.+++.+|++.+|++||++.++++.|+.+.+..
T Consensus 233 ~~~~~~~~-------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 233 YEKLPQGY-------RL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred HHHHhcCC-------cC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11111110 00 001111235678899999999999999999999998775443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=310.64 Aligned_cols=255 Identities=25% Similarity=0.327 Sum_probs=190.8
Q ss_pred ccccccccceEEEEEECC---CcEEEEEEecCcc--cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCC
Q 003059 505 DKLGAGGFGAVYRGVLAN---RTVVAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNG 579 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 579 (852)
+.||+|+||.||+|...+ +..+++|.++... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998643 3579999887433 33457889999999999999999999999999999999999999
Q ss_pred CHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcc
Q 003059 580 SLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRH 659 (852)
Q Consensus 580 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 659 (852)
+|.+++..........+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~-~ 156 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-Y 156 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcce-e
Confidence 99999975443233456788888999999999999998 8999999999999999999999999999875432211 1
Q ss_pred eeeeeecCCCCCCChhhhhcC-------CCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 660 RTLTSVRGTRGYLAPEWLANL-------PITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~-------~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
.......++..|+|||++.+. .++.++||||||+++|||++ |+.||......... . .........
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---~----~~~~~~~~~ 229 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---T----YTVREQQLK 229 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---H----HHhhcccCC
Confidence 111234567889999998642 35789999999999999996 99999654322110 0 001111111
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~ 776 (852)
..++.+.. .....+.+++..|+ .+|++||++.+|++.|+
T Consensus 230 ~~~~~~~~-----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKL-----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCC-----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11222111 11123455667788 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=313.59 Aligned_cols=261 Identities=26% Similarity=0.395 Sum_probs=205.1
Q ss_pred HHHhcccccccccccccceEEEEEECC------CcEEEEEEecCcc--cchHHHHHHHHHhhcccccceeeeeeeeccCc
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRLVGFSSEGK 567 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~ 567 (852)
|....+.+.+.||+|+||.||+|...+ +..|++|.+.... .....+.+|+.++..++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 445567778899999999999998642 3689999987432 33457889999999999999999999999999
Q ss_pred eeeEEEeecCCCCHHHHhhhcccC-----CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceE
Q 003059 568 HRLLVYEFMKNGSLDNFLFANEEG-----SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAK 642 (852)
Q Consensus 568 ~~~lV~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 642 (852)
..++||||+++++|.+++...... ....+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEE
Confidence 999999999999999999654321 12357899999999999999999998 8999999999999999999999
Q ss_pred EeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHH
Q 003059 643 VSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAY 721 (852)
Q Consensus 643 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 721 (852)
|+|||+++.+...... .......++..|+|||.+....++.++||||||+++|||++ |+.||....... + .
T Consensus 160 l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~----~ 231 (277)
T cd05032 160 IGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---V----L 231 (277)
T ss_pred ECCcccchhhccCccc-ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---H----H
Confidence 9999999866432211 11223346788999999998899999999999999999998 999986433211 1 1
Q ss_pred HHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003059 722 EEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEG 777 (852)
Q Consensus 722 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~ 777 (852)
.....+.... .+......+.+++.+|++.+|++||++.++++.|++
T Consensus 232 ~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 232 KFVIDGGHLD----------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHHhcCCCCC----------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111111111 111123467789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=322.76 Aligned_cols=200 Identities=25% Similarity=0.336 Sum_probs=171.5
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
+.+.++||+|+||.||++... +++.||+|++... ......+..|+.++.+++|+||+++++.+.+....++||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 556789999999999999864 5789999999742 22335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+++|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.+...
T Consensus 83 ~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 83 LPGGDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred CCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999643 358899999999999999999998 89999999999999999999999999999765321
Q ss_pred CCc--------------------------------ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCc
Q 003059 656 DHR--------------------------------HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRR 703 (852)
Q Consensus 656 ~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~ 703 (852)
... ........||+.|+|||.+.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 000123469999999999999999999999999999999999999
Q ss_pred ccccc
Q 003059 704 NFEVS 708 (852)
Q Consensus 704 p~~~~ 708 (852)
||...
T Consensus 235 Pf~~~ 239 (363)
T cd05628 235 PFCSE 239 (363)
T ss_pred CCCCC
Confidence 99754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=321.48 Aligned_cols=236 Identities=26% Similarity=0.309 Sum_probs=185.8
Q ss_pred ccccccccceEEEEEEC-CCcEEEEEEecCcc----cchHHHHHHHH-HhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 505 DKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE----QGEKQFRMEVA-TISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~f~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
+.||+|+||.||+|... +++.||+|++.... ....++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999974 68899999987321 22334555554 56789999999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--- 149 (323)
T cd05575 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--- 149 (323)
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC---
Confidence 9999998543 358888999999999999999998 89999999999999999999999999998754221
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccC
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (852)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ......... ..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~--------~~ 214 (323)
T cd05575 150 SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-------MYDNILNKP--------LR 214 (323)
T ss_pred CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH-------HHHHHHcCC--------CC
Confidence 112234568999999999999999999999999999999999999997542211 111111111 10
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 003059 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMG 769 (852)
Q Consensus 739 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ 769 (852)
........+.+++.+|++.||.+||++.
T Consensus 215 ---~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 215 ---LKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 0111134567888899999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=307.59 Aligned_cols=246 Identities=28% Similarity=0.398 Sum_probs=196.3
Q ss_pred ccccccccceEEEEEECCCcEEEEEEecCcc--cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCCHH
Q 003059 505 DKLGAGGFGAVYRGVLANRTVVAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLD 582 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 582 (852)
+.||+|+||.||+|...+++.+|+|.+.... .....|.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 4699999999999998888999999987432 23456889999999999999999999999999999999999999999
Q ss_pred HHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcceee
Q 003059 583 NFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTL 662 (852)
Q Consensus 583 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 662 (852)
+++... ...+++..++.++.|++.+|.|||+ ++++||||||+||++++++.+||+|||++........ ...
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~ 151 (250)
T cd05085 81 SFLRKK----KDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY--SSS 151 (250)
T ss_pred HHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccc--ccC
Confidence 998543 2347899999999999999999998 8999999999999999999999999999875432111 111
Q ss_pred eeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcccccccccCCCC
Q 003059 663 TSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGED 741 (852)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 741 (852)
....++..|+|||++.+..++.++||||||+++|||++ |..||....... .......+... .
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~~~~~----------~ 214 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKGYRM----------S 214 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCCCC----------C
Confidence 12234667999999998899999999999999999998 999996432211 11111111100 0
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003059 742 VDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776 (852)
Q Consensus 742 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~ 776 (852)
.+......+.+++.+|++.+|++||++.++++.|.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 215 CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 11112346778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=311.54 Aligned_cols=255 Identities=25% Similarity=0.363 Sum_probs=188.5
Q ss_pred ccccccccceEEEEEECC---CcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCC
Q 003059 505 DKLGAGGFGAVYRGVLAN---RTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNG 579 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 579 (852)
++||+|+||.||+|...+ ...+++|.+... ......|.+|+++++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 356888887633 233457889999999999999999999999999999999999999
Q ss_pred CHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcc
Q 003059 580 SLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRH 659 (852)
Q Consensus 580 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 659 (852)
+|.+++...........++...+.++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~- 156 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY- 156 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhe-
Confidence 99999976543333446788889999999999999998 89999999999999999999999999998754322111
Q ss_pred eeeeeecCCCCCCChhhhhc-------CCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 660 RTLTSVRGTRGYLAPEWLAN-------LPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
.......++..|+|||++.. ..++.++||||||+++|||++ |..||......+ ............
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~~~~~~~~ 229 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-------VLKQVVREQDIK 229 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHHhhccCcc
Confidence 11122345678999998753 356789999999999999999 788886442211 011111111111
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~ 776 (852)
+..+.+. ......+.+++..|+ .||++||++++|++.|.
T Consensus 230 ~~~~~~~-----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQLD-----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCccc-----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1122111 112233445566677 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=311.71 Aligned_cols=256 Identities=28% Similarity=0.413 Sum_probs=197.0
Q ss_pred cccccccccccceEEEEEECCC---cEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccC------cee
Q 003059 502 GFKDKLGAGGFGAVYRGVLANR---TVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEG------KHR 569 (852)
Q Consensus 502 ~~~~~lG~G~fg~Vy~~~~~~~---~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 569 (852)
.+.++||+|+||.||+|.+.+. ..||+|.++.. ....+.+..|++++++++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 3568899999999999997543 25899988743 23356788999999999999999999987532 256
Q ss_pred eEEEeecCCCCHHHHhhhccc-CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEE-GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
++||||+++|+|.+++..... .....+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999998854321 223458999999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhC
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKG 727 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (852)
++.+..... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... . .......+
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~----~~~~~~~~ 230 (272)
T cd05075 159 SKKIYNGDY-YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---E----IYDYLRQG 230 (272)
T ss_pred ccccCcccc-eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H----HHHHHHcC
Confidence 987643221 111122345678999999999999999999999999999999 88998643221 1 11112221
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 728 NVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 728 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
... ..+......+.+++.+|++.+|++||++.+|++.|+++
T Consensus 231 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 110 01111233567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=316.56 Aligned_cols=263 Identities=24% Similarity=0.332 Sum_probs=201.2
Q ss_pred hcccccccccccccceEEEEEE-----CCCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccC--cee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-----ANRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEG--KHR 569 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~ 569 (852)
..+.+.++||+|+||.||++.+ .++..||+|.+... ......+.+|++++++++|+||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4556678899999999999974 34778999998733 23346789999999999999999999998775 578
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN----KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred EEEEEccCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccc
Confidence 9999999999999998543 2358999999999999999999998 89999999999999999999999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccc--------cchhhHHHHH
Q 003059 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQET--------NRKKFSLWAY 721 (852)
Q Consensus 650 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~--------~~~~l~~~~~ 721 (852)
+.+..............++..|+|||.+.+..++.++||||||+++|||++++.|....... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 87654322212223345677899999999889999999999999999999988765322110 0000000011
Q ss_pred HHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 722 EEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 722 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
.....+.. . +........+.+++.+|++.+|++||++.++++.|+++
T Consensus 237 ~~~~~~~~-------~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGKR-------L---PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCcc-------C---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111110 0 11112235688899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=320.65 Aligned_cols=243 Identities=27% Similarity=0.400 Sum_probs=196.3
Q ss_pred cccccccceEEEEEECC-CcEEEEEEec-CcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCCHHH
Q 003059 506 KLGAGGFGAVYRGVLAN-RTVVAVKQLE-GIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDN 583 (852)
Q Consensus 506 ~lG~G~fg~Vy~~~~~~-~~~vavK~l~-~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 583 (852)
+||+|.||+||-|++.+ ...+|||.+. ......+-+..|+.+-++++|.|||+.+|.|.++++.-|.||.+|||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 59999999999999654 6679999987 444445667889999999999999999999999999999999999999999
Q ss_pred HhhhcccCCcccc--chhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeC-CCCceEEeecccccccCCCCCcce
Q 003059 584 FLFANEEGSGKLL--NWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD-ENYNAKVSDFGLAKLINPKDHRHR 660 (852)
Q Consensus 584 ~l~~~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~ 660 (852)
+|...-. ++ .+.++--+.+||++||.|||+ ..|||||||-.||||+ -.|.+||+|||-++.+..- ..
T Consensus 662 LLrskWG----PlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi---nP 731 (1226)
T KOG4279|consen 662 LLRSKWG----PLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI---NP 731 (1226)
T ss_pred HHHhccC----CCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccC---Cc
Confidence 9965432 34 566677788999999999999 8899999999999996 5799999999999876532 23
Q ss_pred eeeeecCCCCCCChhhhhcC--CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccC
Q 003059 661 TLTSVRGTRGYLAPEWLANL--PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738 (852)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (852)
......||.-|||||++..+ .|+..+|||||||++.||.||++||-.........+ . ..+...
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF--------k----VGmyKv--- 796 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF--------K----VGMYKV--- 796 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh--------h----hcceec---
Confidence 44567799999999999765 488999999999999999999999964432211110 0 011111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 739 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..+.+.+-..++..++++|+.+||.+||++.++++
T Consensus 797 HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 797 HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 12445566677889999999999999999999885
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=314.14 Aligned_cols=263 Identities=26% Similarity=0.403 Sum_probs=206.2
Q ss_pred HHhcccccccccccccceEEEEEECC-----CcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeecc-Cce
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLAN-----RTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSE-GKH 568 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~ 568 (852)
...++.+.+.||+|+||.||+|...+ +..|++|++... ......+.+|+.++++++|+||+++++++.+ +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45567788999999999999999765 688999998743 2335668899999999999999999998776 568
Q ss_pred eeEEEeecCCCCHHHHhhhcccC---CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEee
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEG---SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSD 645 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 645 (852)
.++++||+++++|.+++...... ....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999999654221 12568999999999999999999998 8999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHH
Q 003059 646 FGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEF 724 (852)
Q Consensus 646 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 724 (852)
||+++.+...+.. .......++..|+|||.+.+..++.++||||||+++||+++ |+.||...... .+. ...
T Consensus 161 ~g~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~----~~~ 232 (280)
T cd05043 161 NALSRDLFPMDYH-CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMA----AYL 232 (280)
T ss_pred CCCcccccCCceE-EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHH----HHH
Confidence 9999876443211 11122346778999999998899999999999999999999 99999643221 111 111
Q ss_pred hhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 725 EKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 725 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
..+. .+. ........+.+++.+|++.+|++||++.+|++.|+.+.+
T Consensus 233 ~~~~-------~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 233 KDGY-------RLA---QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HcCC-------CCC---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1110 000 011112356789999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=310.45 Aligned_cols=256 Identities=29% Similarity=0.457 Sum_probs=199.6
Q ss_pred cccccccccccceEEEEEECC----CcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCce------
Q 003059 502 GFKDKLGAGGFGAVYRGVLAN----RTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKH------ 568 (852)
Q Consensus 502 ~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~------ 568 (852)
.+.+.||+|+||.||+|.+.. +..||+|+++... .....+.+|++.++.++|+||+++++++.+...
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 467889999999999998642 3679999987432 234578999999999999999999998876554
Q ss_pred eeEEEeecCCCCHHHHhhhcccC-CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEG-SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFG 647 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 647 (852)
.++|+||+++++|..++...... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCcc
Confidence 79999999999999998654321 23468999999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhh
Q 003059 648 LAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEK 726 (852)
Q Consensus 648 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (852)
+++.+...... ........+..|+|||.+.+..++.++||||||+++|||++ |..||...... .+ ......
T Consensus 159 ~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~----~~~~~~ 230 (273)
T cd05035 159 LSKKIYSGDYY-RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EI----YDYLRH 230 (273)
T ss_pred ceeeccccccc-cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHc
Confidence 99876432211 11112335678999999998899999999999999999999 88998643221 11 111111
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 727 GNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
+... ..+......+.+++.+|++.||.+||++.+|++.|+++
T Consensus 231 ~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRL----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCC----------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 11112334678889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=307.92 Aligned_cols=249 Identities=26% Similarity=0.385 Sum_probs=197.6
Q ss_pred ccccccccceEEEEEECC--C--cEEEEEEecCcc--cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 505 DKLGAGGFGAVYRGVLAN--R--TVVAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~--~--~~vavK~l~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
++||+|++|.||+|.+.+ + ..||+|.+.... ...+.+..|+.++++++|+||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 469999999999998643 2 368999998433 345689999999999999999999999988 899999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
++|.+++..... ..+++..++.++.|+++||+|||+ ++++|+||||+||+++.++.+||+|||+++.+......
T Consensus 80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 999999965431 468999999999999999999998 89999999999999999999999999999876543222
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccccccc
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSL 737 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (852)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ . ...... .. ...
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~----~~~~~~-~~-----~~~ 220 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---I----LKKIDK-EG-----ERL 220 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHh-cC-----CcC
Confidence 112223457789999999999999999999999999999999 999996432211 0 001110 00 000
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003059 738 AGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776 (852)
Q Consensus 738 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~ 776 (852)
..+......+.+++.+|++.+|++||++.+|++.|.
T Consensus 221 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ---ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011112345778899999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=321.44 Aligned_cols=242 Identities=24% Similarity=0.269 Sum_probs=192.2
Q ss_pred ccccccccceEEEEEE-CCCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCC
Q 003059 505 DKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNG 579 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 579 (852)
+.||+|+||.||++.. .+++.||+|.+... .....++..|++++..++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 46889999998732 223456788999999999999999999999999999999999999
Q ss_pred CHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcc
Q 003059 580 SLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRH 659 (852)
Q Consensus 580 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 659 (852)
+|..++... ..+++..+..++.||+.||+|||+. .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--- 150 (325)
T cd05594 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--- 150 (325)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC---
Confidence 999988543 3588999999999999999999962 589999999999999999999999999987543211
Q ss_pred eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCC
Q 003059 660 RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAG 739 (852)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (852)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ........ ..+
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~-------~~~i~~~~------~~~-- 215 (325)
T cd05594 151 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELILMEE------IRF-- 215 (325)
T ss_pred cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH-------HHHHhcCC------CCC--
Confidence 122345699999999999999999999999999999999999999965432110 01111000 001
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003059 740 EDVDIEQVMRAIQVSFWCIQEQPSQRP-----MMGKVVQM 774 (852)
Q Consensus 740 ~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~ev~~~ 774 (852)
+......+.+++.+|++.||++|+ ++.++++.
T Consensus 216 ---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 ---PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ---CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 111123466788899999999996 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=319.62 Aligned_cols=266 Identities=27% Similarity=0.395 Sum_probs=206.1
Q ss_pred HHHHhcccccccccccccceEEEEEEC--------CCcEEEEEEecCc--ccchHHHHHHHHHhhcc-cccceeeeeeee
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLA--------NRTVVAVKQLEGI--EQGEKQFRMEVATISST-HHLNLVRLVGFS 563 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l-~h~niv~l~g~~ 563 (852)
++....|.+.++||+|+||.||++... ....+|+|.+... .....++..|++++.++ +|+||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 445567888999999999999999752 2346999998743 23345788899999999 799999999999
Q ss_pred ccCceeeEEEeecCCCCHHHHhhhcccC-----------CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCc
Q 003059 564 SEGKHRLLVYEFMKNGSLDNFLFANEEG-----------SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPEN 632 (852)
Q Consensus 564 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 632 (852)
.+.+..++||||+++++|.+++...... ....+++..+++++.|++.||+|||+ .+++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHh
Confidence 9999999999999999999999754321 12358999999999999999999998 899999999999
Q ss_pred eEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccc
Q 003059 633 ILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQET 711 (852)
Q Consensus 633 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~ 711 (852)
||++.++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchh-hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 99999999999999998765422111 11112234568999999999899999999999999999998 88888643221
Q ss_pred cchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 712 NRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 712 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
. ........... ..+......+.+++.+|++.+|.+||++.+|++.|+++...
T Consensus 250 ~-------~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 250 E-------LFKLLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred H-------HHHHHHcCCCC----------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1 11111111100 11112234666788999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=317.23 Aligned_cols=261 Identities=28% Similarity=0.417 Sum_probs=201.4
Q ss_pred cccccccccccccceEEEEEECC-C--cEEEEEEecC--cccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEEE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLAN-R--TVVAVKQLEG--IEQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~-~--~~vavK~l~~--~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 573 (852)
.+.+.+.||+|+||.||+|...+ + ..+++|.++. .....+.|.+|++++.++ +||||+++++++.+.+..++|+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 45677899999999999998754 3 3478888873 233456789999999999 7999999999999999999999
Q ss_pred eecCCCCHHHHhhhccc-----------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceE
Q 003059 574 EFMKNGSLDNFLFANEE-----------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAK 642 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 642 (852)
||+++++|.+++..... .....+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+|
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEE
Confidence 99999999999965321 112358899999999999999999998 8999999999999999999999
Q ss_pred EeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHH
Q 003059 643 VSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAY 721 (852)
Q Consensus 643 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 721 (852)
|+|||++...... ........+..|+|||.+.+..++.++|||||||++|||++ |+.||....... ..
T Consensus 160 l~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-------~~ 228 (297)
T cd05089 160 IADFGLSRGEEVY----VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-------LY 228 (297)
T ss_pred ECCcCCCccccce----eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HH
Confidence 9999998643210 01111223567999999998899999999999999999997 999996443211 11
Q ss_pred HHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCCCC
Q 003059 722 EEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKP 784 (852)
Q Consensus 722 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~~~ 784 (852)
.....+. .. ..+......+.+++.+|++.+|.+||++.+|++.|+.+.....+
T Consensus 229 ~~~~~~~-----~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 229 EKLPQGY-----RM-----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred HHHhcCC-----CC-----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 1111110 00 01111223567889999999999999999999999887765433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=328.03 Aligned_cols=252 Identities=25% Similarity=0.328 Sum_probs=199.2
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.|.+.++||+|+||.||++... +++.||+|++... ......+..|++++..++|+||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 4667889999999999999965 5889999998732 2344678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++++|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 82 ~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 82 YMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred CCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999999654 358899999999999999999999 8999999999999999999999999999986643
Q ss_pred CC--------------------------CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCcccccc
Q 003059 655 KD--------------------------HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVS 708 (852)
Q Consensus 655 ~~--------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~ 708 (852)
.. ..........||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 22 0001223456899999999999999999999999999999999999999754
Q ss_pred ccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 003059 709 QETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPM-MGKVVQM 774 (852)
Q Consensus 709 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt-~~ev~~~ 774 (852)
.... ....+... ..... +. ........+.+++.+|++ +|.+||+ +.++++.
T Consensus 234 ~~~~-------~~~~i~~~-~~~~~---~p---~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQE-------TYNKIINW-KESLR---FP---PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHH-------HHHHHhcc-CCccc---CC---CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 3211 11111110 00000 00 000123456677788997 9999999 9999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=321.12 Aligned_cols=240 Identities=24% Similarity=0.325 Sum_probs=190.5
Q ss_pred ccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEEEeecCC
Q 003059 505 DKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
++||+|+||.||+|+.. +++.||+|++... ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 4789999998742 23345677888888866 799999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
++|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-- 150 (321)
T cd05591 81 GDLMFQIQRS-----RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-- 150 (321)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCC--
Confidence 9999988543 348889999999999999999998 899999999999999999999999999987543211
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccC
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (852)
.......|++.|+|||++.+..++.++||||||+++|||++|+.||....... .......... .
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-------~~~~i~~~~~---~----- 214 (321)
T cd05591 151 -VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-------LFESILHDDV---L----- 214 (321)
T ss_pred -ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC---C-----
Confidence 12234568999999999999999999999999999999999999997543211 1111111110 0
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCC-------CHHHHHH
Q 003059 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRP-------MMGKVVQ 773 (852)
Q Consensus 739 ~~~~~~~~~~~~~~l~~~cl~~dp~~RP-------t~~ev~~ 773 (852)
.+......+.+++..|++.||++|| ++.++++
T Consensus 215 ---~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 215 ---YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred ---CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 0111123567788899999999999 6777664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=315.82 Aligned_cols=239 Identities=22% Similarity=0.314 Sum_probs=187.2
Q ss_pred ccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhc-ccccceeeeeeeeccCceeeEEEeecCC
Q 003059 505 DKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISS-THHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
+.||+|+||.||+|... +++.||+|.++.. ....+.+..|..++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 4778999998742 2233455667777664 4899999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
|+|..++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-- 150 (316)
T cd05592 81 GDLMFHIQSS-----GRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-- 150 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--
Confidence 9999988543 248888999999999999999999 899999999999999999999999999997643221
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccC
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (852)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+... .+
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~------~~--- 213 (316)
T cd05592 151 -GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-------LFDSILND------RP--- 213 (316)
T ss_pred -CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcC------CC---
Confidence 22234568999999999999999999999999999999999999997543211 11111110 00
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 003059 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMG-KVV 772 (852)
Q Consensus 739 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~-ev~ 772 (852)
..+......+.+++.+|++.+|.+||++. +++
T Consensus 214 --~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 214 --HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred --CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 01111223456788899999999999975 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=308.34 Aligned_cols=251 Identities=26% Similarity=0.456 Sum_probs=202.1
Q ss_pred cccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCC
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNG 579 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 579 (852)
.+.+.+.||+|+||.||++.+.+++.+++|.+........+|.+|++++++++|||++++++++......++||||++++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG 84 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence 46677899999999999999877788999998866666678999999999999999999999999999999999999999
Q ss_pred CHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcc
Q 003059 580 SLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRH 659 (852)
Q Consensus 580 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 659 (852)
+|.+++... ...++++.+..++.|++.+|+|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 155 (256)
T cd05112 85 CLSDYLRAQ----RGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-- 155 (256)
T ss_pred cHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcc--
Confidence 999998643 2347899999999999999999998 8899999999999999999999999999876533211
Q ss_pred eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcccccccccC
Q 003059 660 RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738 (852)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (852)
.......++.+|+|||.+.+..++.++||||||+++|||++ |+.||....... ......++. ....+.
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~--~~~~~~-- 224 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-------VVETINAGF--RLYKPR-- 224 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-------HHHHHhCCC--CCCCCC--
Confidence 11112234678999999998899999999999999999998 999986433211 011111110 001111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003059 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776 (852)
Q Consensus 739 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~ 776 (852)
.....+.+++.+|++.+|++||++.+|++.|.
T Consensus 225 ------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 ------LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ------CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 11246788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=307.10 Aligned_cols=258 Identities=21% Similarity=0.359 Sum_probs=206.2
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.|.+.+.||+|+||.||+|... +++.|++|.++.. ....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 5677889999999999999976 7889999988621 2235678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++++|.+++..... ....+++..++.++.+++.||+|||+ .+|+||||||+||+++.++.++|+|||+++.+..
T Consensus 83 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 83 LADAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred cCCCCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999865322 24458899999999999999999998 8999999999999999999999999999886543
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... .... ......+...
T Consensus 159 ~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~-~~~~~~~~~~---- 226 (267)
T cd08224 159 KTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSL-CKKIEKCDYP---- 226 (267)
T ss_pred CCc---ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHH-HhhhhcCCCC----
Confidence 211 122345888999999999889999999999999999999999998643211 1000 1111111100
Q ss_pred cccCCCCCCH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 735 KSLAGEDVDI-EQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 735 ~~l~~~~~~~-~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
+.+. .....+.+++.+|++.+|.+||++.+|+++|+++.
T Consensus 227 ------~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 227 ------PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ------CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1111 22345678899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=313.45 Aligned_cols=258 Identities=27% Similarity=0.419 Sum_probs=200.9
Q ss_pred hcccccccccccccceEEEEEEC------CCcEEEEEEecC-cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA------NRTVVAVKQLEG-IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLL 571 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 571 (852)
..+.+.++||+|+||.||++... ++..+++|.+.. .......|.+|++++++++|+||+++++++.++...++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45567789999999999999742 356789998873 33445679999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhhccc----------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCce
Q 003059 572 VYEFMKNGSLDNFLFANEE----------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNA 641 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 641 (852)
||||+++++|.+++..... .....+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 9999999999999965421 112358899999999999999999998 899999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHH
Q 003059 642 KVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWA 720 (852)
Q Consensus 642 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 720 (852)
||+|||+++....... ........+++.|+|||.+.+..++.++|||||||++|||++ |+.||........
T Consensus 162 kL~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------- 233 (280)
T cd05092 162 KIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA------- 233 (280)
T ss_pred EECCCCceeEcCCCce-eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-------
Confidence 9999999976543211 111122335678999999999999999999999999999998 9999864332111
Q ss_pred HHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003059 721 YEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEG 777 (852)
Q Consensus 721 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~ 777 (852)
......+... ..+......+.+++.+||+.||.+||++.+|++.|++
T Consensus 234 ~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 234 IECITQGREL----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHHcCccC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 0111111100 0001112346788899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=314.18 Aligned_cols=271 Identities=22% Similarity=0.343 Sum_probs=204.0
Q ss_pred hcccccccccccccceEEEEEEC-----CCcEEEEEEecCccc--chHHHHHHHHHhhcccccceeeeeeeecc--Ccee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-----NRTVVAVKQLEGIEQ--GEKQFRMEVATISSTHHLNLVRLVGFSSE--GKHR 569 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~ 569 (852)
..+.+.++||+|+||.||++.+. .+..+|||.+..... ..++|.+|++++++++|+||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35567789999999999999854 367899999985544 36789999999999999999999999877 5688
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 99999999999999996442 258999999999999999999998 89999999999999999999999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCc
Q 003059 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 650 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
.................++..|+|||.+.+..++.++||||||++++||++|+.|+............. .........+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 235 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRL 235 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHH
Confidence 876532221111112345667999999998899999999999999999999999986432211000000 0000000000
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 730 KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
.+.+...... ..+......+.+++.+|++.+|++||++.||+++|+.+
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLKEGERL-PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHcCCcC-CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0011111100 11111225677899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.91 Aligned_cols=266 Identities=23% Similarity=0.333 Sum_probs=201.0
Q ss_pred HhcccccccccccccceEEEEEEC-----------------CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceee
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-----------------NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVR 558 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-----------------~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~ 558 (852)
+..+.+.++||+|+||.||++... +...||+|++... .....+|.+|++++.+++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 345778899999999999998532 2346899998743 234567999999999999999999
Q ss_pred eeeeeccCceeeEEEeecCCCCHHHHhhhcccC------CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCc
Q 003059 559 LVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEG------SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPEN 632 (852)
Q Consensus 559 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 632 (852)
+++++.+.+..++||||+++++|.+++...... ....+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhe
Confidence 999999999999999999999999999754321 12357888999999999999999998 899999999999
Q ss_pred eEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh--CCcccccccc
Q 003059 633 ILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS--GRRNFEVSQE 710 (852)
Q Consensus 633 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt--G~~p~~~~~~ 710 (852)
||+++++.++|+|||+++.+...... .......++..|+|||...+..++.++|||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcce-eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 99999999999999999865432111 11122334678999999988899999999999999999998 6788854322
Q ss_pred ccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003059 711 TNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEG 777 (852)
Q Consensus 711 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~ 777 (852)
.. ............ ......+. +......+.+++.+|++.||.+||++.+|++.|++
T Consensus 240 ~~---~~~~~~~~~~~~-~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 EQ---VIENTGEFFRDQ-GRQVYLPK------PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH---HHHHHHHHHhhc-cccccCCC------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 111011111110 00011010 11122467788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=310.53 Aligned_cols=251 Identities=28% Similarity=0.445 Sum_probs=195.1
Q ss_pred ccccccccceEEEEEECC-Cc--EEEEEEecCc--ccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEEEeecCC
Q 003059 505 DKLGAGGFGAVYRGVLAN-RT--VVAVKQLEGI--EQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~~--~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
+.||+|+||.||+|.+.+ +. .+++|.+... ....+.+..|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 469999999999999754 33 4788888732 33456788999999999 899999999999999999999999999
Q ss_pred CCHHHHhhhccc-----------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecc
Q 003059 579 GSLDNFLFANEE-----------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFG 647 (852)
Q Consensus 579 gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 647 (852)
++|.+++..... .....+++..++.++.|++.||+|||+ ++++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 999999965431 112358899999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhh
Q 003059 648 LAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEK 726 (852)
Q Consensus 648 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (852)
+++..... ........+..|+|||++....++.++||||||+++|||++ |+.||....... .......
T Consensus 158 l~~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~~~~~~~ 226 (270)
T cd05047 158 LSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKLPQ 226 (270)
T ss_pred Cccccchh----hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-------HHHHHhC
Confidence 98632210 01111234567999999988899999999999999999997 999996432211 0111111
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 727 GNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
+. .. ..+......+.+++.+|++.+|.+||++.++++.|+++.
T Consensus 227 ~~-------~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 GY-------RL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CC-------CC---CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 10 00 011112235678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=290.66 Aligned_cols=196 Identities=27% Similarity=0.358 Sum_probs=174.6
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
+++.+.||.|.||.|.+++.+ ++..+|+|+++... ...+...+|..+|+.+.||.++++++.+.+.+..||||||
T Consensus 46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmey 125 (355)
T KOG0616|consen 46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEY 125 (355)
T ss_pred hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEec
Confidence 345678999999999999954 58899999998432 2234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
.+||.|..+|.+.+ .++...++-++.||+.||+|||+ ..|++|||||+|||||.+|.+||.|||+|+.+..
T Consensus 126 v~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 126 VPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred cCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 99999999997543 48889999999999999999999 8999999999999999999999999999997643
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCcccccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQE 710 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~ 710 (852)
..-...||+.|+|||.++...+...+|-|+|||++|||+.|.+||...+.
T Consensus 197 -----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 197 -----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred -----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 24567899999999999999999999999999999999999999976543
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=314.19 Aligned_cols=263 Identities=27% Similarity=0.390 Sum_probs=203.4
Q ss_pred HHHhcccccccccccccceEEEEEEC------CCcEEEEEEecCcc--cchHHHHHHHHHhhcccccceeeeeeeeccCc
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLA------NRTVVAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRLVGFSSEGK 567 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~ 567 (852)
+...+|.+.++||+|+||.||+|... .+..||+|.+.... .....+.+|+.++++++|+||+++++++.+..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34557788899999999999999753 24579999887333 23346788999999999999999999999999
Q ss_pred eeeEEEeecCCCCHHHHhhhcccC-----CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceE
Q 003059 568 HRLLVYEFMKNGSLDNFLFANEEG-----SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAK 642 (852)
Q Consensus 568 ~~~lV~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 642 (852)
..++||||+++|+|.+++...... ....+++..+.+++.|++.||.|||+ ++|+||||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEE
Confidence 999999999999999999653211 12456778889999999999999998 8999999999999999999999
Q ss_pred EeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHH
Q 003059 643 VSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAY 721 (852)
Q Consensus 643 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 721 (852)
|+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....++ . .
T Consensus 160 L~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~----~ 231 (288)
T cd05061 160 IGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---V----L 231 (288)
T ss_pred ECcCCccccccccccc-cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H----H
Confidence 9999999865432211 11122335678999999999999999999999999999998 788886433211 0 0
Q ss_pred HHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 722 EEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 722 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
.....+... ..+......+.+++.+|++.+|++||++.++++.|++..
T Consensus 232 ~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 232 KFVMDGGYL----------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHHcCCCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 111111100 011111246788899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=319.40 Aligned_cols=242 Identities=20% Similarity=0.304 Sum_probs=188.8
Q ss_pred ccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEEEeecCC
Q 003059 505 DKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
+.||+|+||.||++... +++.||+|.++.. ......+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 5788999998742 22334577888888776 899999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
|+|..++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-- 150 (329)
T cd05618 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-- 150 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--
Confidence 9999888543 358899999999999999999998 899999999999999999999999999987542211
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCcccccccccc--chhhHHHHHHHHhhCCcccccccc
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETN--RKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
.......||..|+|||++.+..++.++||||||+++|||++|+.||....... ......+..........
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------- 222 (329)
T cd05618 151 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------- 222 (329)
T ss_pred -CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-------
Confidence 12234568999999999999999999999999999999999999996432111 11111222222211111
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMM 768 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~ 768 (852)
..+......+.+++.+|++.||++||+.
T Consensus 223 ----~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 ----RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ----CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1111223456688889999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=337.17 Aligned_cols=255 Identities=21% Similarity=0.287 Sum_probs=200.0
Q ss_pred HhcccccccccccccceEEEEEE-CCCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCc------
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK------ 567 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------ 567 (852)
...|.+.+.||+|+||.||++.. .+++.||||++... ......+++|+..+..++|+||++++..+....
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 34788889999999999999985 56889999998633 233456889999999999999999988765332
Q ss_pred --eeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEee
Q 003059 568 --HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSD 645 (852)
Q Consensus 568 --~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 645 (852)
..++||||+++|+|.++|..... ....+++..+..++.|++.||+|||+ ++|+||||||+||||+.++.+||+|
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEe
Confidence 36899999999999999965432 24568899999999999999999998 8999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHh
Q 003059 646 FGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFE 725 (852)
Q Consensus 646 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 725 (852)
||+++.+..... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||...... . ......
T Consensus 187 FGls~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~-~~~~~~ 258 (496)
T PTZ00283 187 FGFSKMYAATVS-DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------E-VMHKTL 258 (496)
T ss_pred cccCeecccccc-ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------H-HHHHHh
Confidence 999987643211 11223456999999999999999999999999999999999999999743211 1 111111
Q ss_pred hCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 726 KGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.+.. ++ .+......+.+++.+||+.+|.+||++.++++.
T Consensus 259 ~~~~----~~------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGRY----DP------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCCC----CC------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111 11 111123456788889999999999999999763
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=309.26 Aligned_cols=258 Identities=21% Similarity=0.325 Sum_probs=204.2
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.|.+.+.||+|+||.||++.. .+++.++||.+... .....++.+|+.+++.++|+||+++++++.+++..++|||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 456678899999999999995 57889999987632 2234578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++++|.+++..... ....+++..++.++.||++||+|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 83 LADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999864322 24568999999999999999999998 8999999999999999999999999999886643
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
.. .......++..|+|||++.+..++.++||||||+++|||++|..||......... . ..... ....
T Consensus 159 ~~---~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~----~-~~~~~-----~~~~ 225 (267)
T cd08229 159 KT---TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS----L-CKKIE-----QCDY 225 (267)
T ss_pred CC---cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHH----H-hhhhh-----cCCC
Confidence 21 1122345888999999999989999999999999999999999999643221000 0 00111 1111
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
+.+. .......+.+++.+|++.+|.+||||.+|++.++++
T Consensus 226 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 226 PPLP----SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCC----cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1111 112334577888899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=307.15 Aligned_cols=250 Identities=30% Similarity=0.442 Sum_probs=203.2
Q ss_pred hcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
..+.+.+.||.|+||.||++... ++.|++|.+.......+++.+|+.++.+++|+||+++++++.+....++||||+++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 35667889999999999999875 67799999986555667899999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
++|.+++.... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 85 GSLVDYLRSRG---RAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred CcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence 99999996443 2358999999999999999999998 899999999999999999999999999998653211
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccccccc
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSL 737 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (852)
.....+..|+|||.+....++.++||||||+++|||++ |+.||....... .......+...
T Consensus 157 ----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~------- 218 (256)
T cd05039 157 ----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVEKGYRM------- 218 (256)
T ss_pred ----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCCC-------
Confidence 12334668999999998899999999999999999997 999986442211 11111111000
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 738 AGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 738 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
..+......+.+++.+|++.+|++||++.+++++|+.+
T Consensus 219 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 ---EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ---CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 01111234677889999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=311.97 Aligned_cols=258 Identities=23% Similarity=0.375 Sum_probs=199.8
Q ss_pred HhcccccccccccccceEEEEEE-CCCc----EEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceee
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVL-ANRT----VVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRL 570 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~----~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 570 (852)
...+.+.++||+|+||.||+|.+ .++. .||+|++... .....++.+|+.++..++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 34566778999999999999985 3343 4899998732 3345678899999999999999999999875 4578
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+++||+++|+|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++
T Consensus 85 l~~~~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN----KDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred EEEEcCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCcee
Confidence 999999999999999643 2358899999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCc
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
.+...... .......++..|+|||.+.+..++.++||||||+++|||++ |..||+...... +. ..+..+..
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~~ 229 (279)
T cd05109 158 LLDIDETE-YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IP----DLLEKGER 229 (279)
T ss_pred ecccccce-eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHCCCc
Confidence 76432111 11122334678999999998899999999999999999998 999986432211 11 11111110
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 730 KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
. +.+......+.+++..|++.||++||++.++++.|+.+...
T Consensus 230 ~----------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 230 L----------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred C----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 0 11111234567888999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=320.87 Aligned_cols=250 Identities=21% Similarity=0.227 Sum_probs=195.7
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.|.+.++||+|+||.||++... +++.||+|+++... ...+.+..|+.+++.++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 3567889999999999999864 58899999997432 244668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++|+|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+..
T Consensus 82 ~~~~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 82 YQPGGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 99999999999654 2358899999999999999999999 8999999999999999999999999999987643
Q ss_pred CCCcceeeeeecCCCCCCChhhhh------cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLA------NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN 728 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (852)
... .......||+.|+|||.+. ...++.++|||||||++|||++|+.||....... ....+...
T Consensus 155 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~- 224 (330)
T cd05601 155 NKM--VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-------TYNNIMNF- 224 (330)
T ss_pred CCc--eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-------HHHHHHcC-
Confidence 221 1223356899999999986 4567899999999999999999999996443211 11111111
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
...+. . +........+.+++..|++ +|.+||++.++++
T Consensus 225 -~~~~~--~---~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 225 -QRFLK--F---PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred -CCccC--C---CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00000 0 1111122345567777887 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=317.54 Aligned_cols=266 Identities=26% Similarity=0.399 Sum_probs=207.2
Q ss_pred HHHHhcccccccccccccceEEEEEEC--------CCcEEEEEEecCc--ccchHHHHHHHHHhhcc-cccceeeeeeee
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLA--------NRTVVAVKQLEGI--EQGEKQFRMEVATISST-HHLNLVRLVGFS 563 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l-~h~niv~l~g~~ 563 (852)
++....+.+.+.||+|+||.||++... ++..||+|.+... ....+++.+|+.++..+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 345566778899999999999999741 2357999988743 33456789999999999 899999999999
Q ss_pred ccCceeeEEEeecCCCCHHHHhhhcccC-----------CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCc
Q 003059 564 SEGKHRLLVYEFMKNGSLDNFLFANEEG-----------SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPEN 632 (852)
Q Consensus 564 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 632 (852)
......++||||+++++|.+++...... ....+++..++.++.||++||.|||+ ++++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccce
Confidence 9999999999999999999999754321 12458899999999999999999998 899999999999
Q ss_pred eEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccc
Q 003059 633 ILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQET 711 (852)
Q Consensus 633 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~ 711 (852)
||+++++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred EEEcCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 99999999999999999876432211 11122345678999999998899999999999999999998 78888643211
Q ss_pred cchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 712 NRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 712 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
. ........... ..+......+.+++.+|++.+|.+||++.+|++.|+++...
T Consensus 247 ~-------~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 247 E-------LFKLLKEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred H-------HHHHHHcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1 11111111100 11112234567788999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=319.47 Aligned_cols=240 Identities=26% Similarity=0.297 Sum_probs=187.7
Q ss_pred ccccccccceEEEEEE-CCCcEEEEEEecCc----ccchHHHHHHHH-HhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 505 DKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI----EQGEKQFRMEVA-TISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~f~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
+.||+|+||.||++.. .+++.||+|++... .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999985 46889999998632 223345555655 46779999999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
|+|..++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--- 149 (325)
T cd05604 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--- 149 (325)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC---
Confidence 9999888543 358899999999999999999998 89999999999999999999999999998753221
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccC
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (852)
........|++.|+|||.+.+..++.++|||||||++|||++|+.||....... ......... +.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-------~~~~~~~~~--------~~ 214 (325)
T cd05604 150 SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-------MYDNILHKP--------LV 214 (325)
T ss_pred CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-------HHHHHHcCC--------cc
Confidence 112234568999999999999999999999999999999999999997542110 111111111 10
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 739 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
........+.+++.+|++.+|.+||++.+.++
T Consensus 215 ---~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 215 ---LRPGASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred ---CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 01112235667888899999999999864443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=319.99 Aligned_cols=236 Identities=24% Similarity=0.317 Sum_probs=188.4
Q ss_pred ccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEEEeecCC
Q 003059 505 DKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
+.||+|+||.||++... +++.||+|++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 5789999998732 23345677888888876 699999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~i~~~-----~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-- 150 (320)
T cd05590 81 GDLMFHIQKS-----RRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-- 150 (320)
T ss_pred chHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--
Confidence 9999988643 348899999999999999999998 899999999999999999999999999987543211
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccC
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (852)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ..........
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~~--------- 213 (320)
T cd05590 151 -KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEV--------- 213 (320)
T ss_pred -CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCC---------
Confidence 12234568999999999999999999999999999999999999997543211 1111111110
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 003059 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMG 769 (852)
Q Consensus 739 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ 769 (852)
..+......+.+++.+|++.||++||++.
T Consensus 214 --~~~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 214 --VYPTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred --CCCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 00111123567788899999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=322.45 Aligned_cols=248 Identities=24% Similarity=0.352 Sum_probs=206.1
Q ss_pred ccccccccccccceEEEEEECC--C--cEEEEEEecCccc--chHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 501 KGFKDKLGAGGFGAVYRGVLAN--R--TVVAVKQLEGIEQ--GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~~--~--~~vavK~l~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
..+.|+||+|.||.|++|.|.. | -.||||.+..... ...+|.+|+.+|.+|+|+|+++|+|+..+ ...+||+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 3456899999999999999753 3 3689999984433 56889999999999999999999999888 78899999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
.++.|||.+.|++. ....+.......++.|||.||.||.. +++|||||.++|+||-....+||+||||.+.+..
T Consensus 191 LaplGSLldrLrka---~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKA---KKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hcccchHHHHHhhc---cccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 99999999999763 34568888899999999999999998 8999999999999999999999999999999887
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
.++.........-...|+|||.++...++.++|||+|||++|||+| |..||.+..... +.+.+
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----------------IL~~i 328 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----------------ILKNI 328 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----------------HHHhc
Confidence 6655433344556788999999999999999999999999999998 788997543221 11122
Q ss_pred c--cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 734 D--KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 734 d--~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
| .+| +.+....+++.+++..||..+|++||++..|++.
T Consensus 329 D~~erL---pRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 329 DAGERL---PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred cccccC---CCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 2 112 3344566788899999999999999999999743
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=341.38 Aligned_cols=265 Identities=22% Similarity=0.310 Sum_probs=200.0
Q ss_pred CHHHHHHhcccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeecc--
Q 003059 492 SYKELQRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSE-- 565 (852)
Q Consensus 492 ~~~el~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-- 565 (852)
...++....|.+.++||+|+||.||++... .+..||+|.+... ......|..|+.++.+++|||||++++++.+
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 334556667889999999999999999964 4678999988732 2334678899999999999999999998754
Q ss_pred CceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhcccc----CCCcccCCCCCCceEeCC----
Q 003059 566 GKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC----RDCIVHCDIKPENILLDE---- 637 (852)
Q Consensus 566 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----~~~ivH~Dlkp~NILl~~---- 637 (852)
....||||||+++++|.++|..... ....+++..++.|+.||+.||.|||+.. ..+||||||||+||||+.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 4578999999999999999965322 1346899999999999999999999732 145999999999999964
Q ss_pred -------------CCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhc--CCCCCCccchhhhHHHHHHHhCC
Q 003059 638 -------------NYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN--LPITSKSDVYSYGMVLLEIVSGR 702 (852)
Q Consensus 638 -------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~s~Gvvl~elltG~ 702 (852)
...+||+|||+++.+.... ......||+.|+|||++.+ ..++.++|||||||+||||++|+
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccc----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 3348999999998664321 1234568999999999864 45889999999999999999999
Q ss_pred ccccccccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcC
Q 003059 703 RNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ--MLEGI 778 (852)
Q Consensus 703 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~--~L~~~ 778 (852)
.||....... . ....+... +.+.. ......+.+++..||+.+|.+||++.++++ .+..+
T Consensus 241 ~PF~~~~~~~-----q-li~~lk~~-------p~lpi----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 241 TPFHKANNFS-----Q-LISELKRG-------PDLPI----KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCCCcCCcHH-----H-HHHHHhcC-------CCCCc----CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 9996432111 1 11111111 01100 011245678889999999999999999983 44433
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=319.07 Aligned_cols=239 Identities=22% Similarity=0.302 Sum_probs=190.0
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhccccc-ceeeeeeeeccCceeeEEEe
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHL-NLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~-niv~l~g~~~~~~~~~lV~e 574 (852)
|.+.+.||+|+||.||+|... +++.||||++... ....+.+..|++++..++|+ +|+++++++.+.+..++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 567789999999999999965 4678999998732 23445678899999999765 68889999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 82 YVNGGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred CCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999998543 247889999999999999999998 8999999999999999999999999999875322
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... .........
T Consensus 154 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-------~~~~i~~~~------ 217 (324)
T cd05587 154 G---GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-------LFQSIMEHN------ 217 (324)
T ss_pred C---CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCC------
Confidence 1 122344679999999999999999999999999999999999999997543211 011111111
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMM 768 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~ 768 (852)
. ..+......+.+++.+|++.||.+|++.
T Consensus 218 ~-----~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 V-----SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred C-----CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0 0111122356788889999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=316.65 Aligned_cols=243 Identities=21% Similarity=0.282 Sum_probs=190.3
Q ss_pred ccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEEEeecCC
Q 003059 505 DKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
+.||+|+||.||++... +++.||+|+++.. ....+.+..|+.++.++ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 5788999999743 22345678899998888 699999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
|+|..++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 150 (327)
T cd05617 81 GDLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-- 150 (327)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--
Confidence 9999988543 358999999999999999999999 899999999999999999999999999987532211
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccC
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (852)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.............+......... .
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~- 220 (327)
T cd05617 151 -DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--------I- 220 (327)
T ss_pred -CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC--------C-
Confidence 122345689999999999999999999999999999999999999965432221111122222221111 0
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 003059 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMG 769 (852)
Q Consensus 739 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ 769 (852)
..+......+.+++.+|++.||.+|+++.
T Consensus 221 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 221 --RIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred --CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 01111123456788889999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=310.12 Aligned_cols=256 Identities=31% Similarity=0.479 Sum_probs=200.5
Q ss_pred hcccccccccccccceEEEEEECC-C---cEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLAN-R---TVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
..+.+.+.||+|+||.||+|.... + ..|+||.+... .....+|..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 356788999999999999999643 2 36999998743 33456899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++++|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++..
T Consensus 84 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 84 TEFMENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EecCCCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 9999999999998643 2358899999999999999999998 89999999999999999999999999998865
Q ss_pred CCCCCcceeeeeec--CCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCc
Q 003059 653 NPKDHRHRTLTSVR--GTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 653 ~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
.............. .+..|+|||.+.+..++.++||||||+++|||++ |..||...... ... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~----~~i~~~-- 227 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVI----NAIEQD-- 227 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHH----HHHHcC--
Confidence 43222111111111 2457999999999999999999999999999886 99999643321 111 111110
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 730 KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
. .+ +.+.+....+.+++.+|++.+|.+||++.+|++.|+++
T Consensus 228 ---~--~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 ---Y--RL---PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---C--cC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00 11112234567888999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=308.75 Aligned_cols=246 Identities=27% Similarity=0.352 Sum_probs=191.8
Q ss_pred ccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCCH
Q 003059 507 LGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSL 581 (852)
Q Consensus 507 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 581 (852)
||+|+||.||++... +++.+|+|.+... ......+..|++++.+++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999864 5889999998632 12234566799999999999999999999999999999999999999
Q ss_pred HHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCccee
Q 003059 582 DNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRT 661 (852)
Q Consensus 582 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 661 (852)
.+++.... ...+++..+..++.||+.||+|||+ .+|+||||||+||++++++.++|+|||++...... ..
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~----~~ 150 (277)
T cd05607 81 KYHIYNVG---ERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG----KT 150 (277)
T ss_pred HHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC----ce
Confidence 99885432 3458899999999999999999998 89999999999999999999999999998865432 12
Q ss_pred eeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCCCC
Q 003059 662 LTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGED 741 (852)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 741 (852)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||......... ... ...... ..+... .
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~-~~~~~~----~~~~~~--~-- 219 (277)
T cd05607 151 ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EEL-KRRTLE----DEVKFE--H-- 219 (277)
T ss_pred eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHH-HHHhhc----cccccc--c--
Confidence 23356899999999999989999999999999999999999999643221110 000 011111 001000 0
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003059 742 VDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQML 775 (852)
Q Consensus 742 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L 775 (852)
......+.+++..|++.||++||+++|+++.+
T Consensus 220 --~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 220 --QNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred --ccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 01123467888889999999999998766433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.08 Aligned_cols=249 Identities=29% Similarity=0.398 Sum_probs=197.2
Q ss_pred hcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeec-cCceeeEEEeecC
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSS-EGKHRLLVYEFMK 577 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lV~e~~~ 577 (852)
..+.+.+.||+|+||.||++... +..|++|.+.... ..+.|.+|+.++++++|+|++++++++. +++..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 35677889999999999999875 5668999887433 3567899999999999999999999754 5567899999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
+++|.+++.... ...+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 84 KGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 999999986532 3358899999999999999999998 899999999999999999999999999987643211
Q ss_pred cceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 658 RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
....++..|+|||++.+..++.++||||||+++|||++ |+.||...... .+ ......+.. .
T Consensus 157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~----~~~~~~~~~-----~- 218 (256)
T cd05082 157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DV----VPRVEKGYK-----M- 218 (256)
T ss_pred -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHhcCCC-----C-
Confidence 12234567999999999899999999999999999998 99998643211 01 111111100 0
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
.........+.+++.+|++.+|++||++.++++.|+++
T Consensus 219 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 ----DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 01111234567888999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=312.95 Aligned_cols=258 Identities=28% Similarity=0.424 Sum_probs=201.6
Q ss_pred hcccccccccccccceEEEEEEC------CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA------NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRL 570 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 570 (852)
..+.+.++||+|+||.||++... ++..||+|++... .....+|.+|+.++++++||||+++++++.++...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 45667789999999999999863 4678999998743 234567999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhhccc-----------------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCce
Q 003059 571 LVYEFMKNGSLDNFLFANEE-----------------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENI 633 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI 633 (852)
+||||+++++|.+++..... .....+++..++.++.|++.||+|||+ .+++||||||+||
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~ni 161 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNC 161 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhhe
Confidence 99999999999999964321 112357889999999999999999998 8999999999999
Q ss_pred EeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCcccccccccc
Q 003059 634 LLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETN 712 (852)
Q Consensus 634 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~ 712 (852)
++++++.+||+|||+++.+...... ........+..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYY-KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred EecCCCceEECccccceecccCccc-cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999998765432111 11112234667999999998999999999999999999998 888885432211
Q ss_pred chhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003059 713 RKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEG 777 (852)
Q Consensus 713 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~ 777 (852)
.......+.... .+......+.+++.+|++.+|.+||++.||++.|++
T Consensus 241 -------~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 -------VIYYVRDGNVLS----------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -------HHHHHhcCCCCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111112221110 011123467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=322.86 Aligned_cols=264 Identities=28% Similarity=0.415 Sum_probs=201.3
Q ss_pred HHhcccccccccccccceEEEEEE------CCCcEEEEEEecCc--ccchHHHHHHHHHhhcc-cccceeeeeeeecc-C
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVL------ANRTVVAVKQLEGI--EQGEKQFRMEVATISST-HHLNLVRLVGFSSE-G 566 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~-~ 566 (852)
...++.+.+.||+|+||.||+|.. .+++.||||+++.. ......+.+|++++.++ +|+||+++++++.. +
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 345788899999999999999973 34678999999743 22345688999999999 78999999998765 4
Q ss_pred ceeeEEEeecCCCCHHHHhhhcccC-------------------------------------------------------
Q 003059 567 KHRLLVYEFMKNGSLDNFLFANEEG------------------------------------------------------- 591 (852)
Q Consensus 567 ~~~~lV~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 591 (852)
...++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 5678999999999999998643210
Q ss_pred -------CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcceeeee
Q 003059 592 -------SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTS 664 (852)
Q Consensus 592 -------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 664 (852)
....+++..+..++.||++||+|||+ ++|+||||||+|||+++++.+||+|||+++........ .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~ 240 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGD 240 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcch-hhcCC
Confidence 01347888999999999999999998 89999999999999999999999999999865332111 11122
Q ss_pred ecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcccccccccCCCCCC
Q 003059 665 VRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVD 743 (852)
Q Consensus 665 ~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 743 (852)
..++..|+|||.+.+..++.++||||||+++|||++ |..||....... . .......+.... ... .
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~----~~~~~~~~~~~~-----~~~-~-- 306 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--E----FCRRLKEGTRMR-----APD-Y-- 306 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--H----HHHHHhccCCCC-----CCC-C--
Confidence 345678999999999899999999999999999997 999986432211 0 111111111100 000 1
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 744 IEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 744 ~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
....+.+++.+|++.+|++||++.+|++.|+.+..
T Consensus 307 --~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 307 --TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred --CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 12356788899999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=304.29 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=200.8
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
|.+.+.||+|+||.||++... +++.|++|.+... .....++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 456788999999999999964 5788999998632 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|.+++.... ...+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 82 ENGDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999997542 3468899999999999999999998 899999999999999999999999999998764322
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
. ......++..|+|||++.+..++.++||||||+++|||++|+.||....... .......+...
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~------ 219 (256)
T cd08529 156 N---FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA-------LILKIIRGVFP------ 219 (256)
T ss_pred c---hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCC------
Confidence 1 1223457889999999999999999999999999999999999997543210 11111111110
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
..+......+.+++.+|++.+|++||++.++++.
T Consensus 220 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 ----PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ----CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1111223467889999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.71 Aligned_cols=259 Identities=28% Similarity=0.415 Sum_probs=202.5
Q ss_pred HHhcccccccccccccceEEEEEEC------CCcEEEEEEecCcc--cchHHHHHHHHHhhcc-cccceeeeeeeeccCc
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLA------NRTVVAVKQLEGIE--QGEKQFRMEVATISST-HHLNLVRLVGFSSEGK 567 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~ 567 (852)
....+.+.+.||+|+||.||++... .+..||+|+++... ...+.+.+|+++++++ +|+||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3445777889999999999999741 24579999987432 2345789999999999 7999999999999999
Q ss_pred eeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecc
Q 003059 568 HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFG 647 (852)
Q Consensus 568 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 647 (852)
..++||||+++++|.+++.... ...+++.++..++.|++.||+|||+ .+|+|+||||+|||++.++.+||+|||
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCc
Confidence 9999999999999999996432 2348999999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhh
Q 003059 648 LAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEK 726 (852)
Q Consensus 648 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (852)
+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .+ ......
T Consensus 187 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~----~~~~~~ 259 (302)
T cd05055 187 LARDIMNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KF----YKLIKE 259 (302)
T ss_pred ccccccCCCce-eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HH----HHHHHc
Confidence 99866432211 11122345778999999999999999999999999999998 999986433211 00 111111
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 727 GNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
+. .. ..+......+.+++.+|++.+|++||++.+|++.|+++
T Consensus 260 ~~-----~~-----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 260 GY-----RM-----AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CC-----cC-----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 10 00 00111124577889999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=298.12 Aligned_cols=267 Identities=23% Similarity=0.294 Sum_probs=200.0
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCccc---chHHHHHHHHHhhcccccc-eeeeeeeeccCc------e
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQ---GEKQFRMEVATISSTHHLN-LVRLVGFSSEGK------H 568 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~f~~E~~~l~~l~h~n-iv~l~g~~~~~~------~ 568 (852)
.+...++||+|.||+||+|+. .+|+.||+|++.-..+ .-..-.+|+.++++++|+| ||+|++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 344467899999999999994 5688999999973322 2345689999999999999 999999998777 7
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.++|+||+ .-+|..|+....... ..++-..+..+..||++||+|||+ ++|+||||||+||||+++|.+||+|||+
T Consensus 92 l~lvfe~~-d~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 92 LYLVFEFL-DRDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred EEEEEEee-cccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccch
Confidence 89999999 559999996554321 346668899999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhC
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG 727 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (852)
|+...-. ....+..++|.-|.|||++.+. .|+...||||+||++.||++++..|.+..+.++...+........+.
T Consensus 167 Ara~~ip---~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 167 ARAFSIP---MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred HHHhcCC---cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence 9976522 2234566788889999999877 79999999999999999999999998765533222221111111111
Q ss_pred Cccc---ccccc--cCCC--CCCHHH-----HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 728 NVKG---IVDKS--LAGE--DVDIEQ-----VMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 728 ~~~~---~~d~~--l~~~--~~~~~~-----~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.... +.+-. .... +.+... .....+++.+|++.+|.+|.+++.+++.
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111 11111 1000 001100 1357788999999999999999998875
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=315.26 Aligned_cols=263 Identities=25% Similarity=0.391 Sum_probs=203.9
Q ss_pred HHhcccccccccccccceEEEEEEC--------CCcEEEEEEecCcc--cchHHHHHHHHHhhcc-cccceeeeeeeecc
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLA--------NRTVVAVKQLEGIE--QGEKQFRMEVATISST-HHLNLVRLVGFSSE 565 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~--~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~ 565 (852)
....+.+.++||+|+||.||++... ....+|+|.+.... ....++..|++++.++ +||||+++++++.+
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3456677899999999999999742 24578999887432 3346788999999999 69999999999999
Q ss_pred CceeeEEEeecCCCCHHHHhhhccc-----------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceE
Q 003059 566 GKHRLLVYEFMKNGSLDNFLFANEE-----------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENIL 634 (852)
Q Consensus 566 ~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIL 634 (852)
++..++||||+++|+|.+++..... .....+++..+++++.||+.||.|||+ ++++||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEE
Confidence 9999999999999999999965421 123468999999999999999999998 89999999999999
Q ss_pred eCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccc
Q 003059 635 LDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNR 713 (852)
Q Consensus 635 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~ 713 (852)
+++++.+||+|||+++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~- 244 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYK-KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE- 244 (314)
T ss_pred EcCCCcEEEcccccccccccccccc-ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence 9999999999999998664321111 1112234567999999999899999999999999999999 889986432211
Q ss_pred hhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 714 KKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 714 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
.......+... ..+......+.+++.+|++.+|++||++.++++.|+++..
T Consensus 245 ------~~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 245 ------LFKLLREGHRM----------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred ------HHHHHHcCCCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11111111110 1111122356688899999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=324.95 Aligned_cols=251 Identities=20% Similarity=0.270 Sum_probs=192.4
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.|.+.+.||+|+||.||++... +++.||||++... ......+.+|+.++..++|+||+++++++.++...++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 3566789999999999999964 5789999999742 2233567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 82 YLPGGDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCcHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999643 348899999999999999999998 8999999999999999999999999999876532
Q ss_pred CCCcc-----------------------------------eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHH
Q 003059 655 KDHRH-----------------------------------RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIV 699 (852)
Q Consensus 655 ~~~~~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ell 699 (852)
..... .......||+.|+|||++....++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 11000 0011235899999999999999999999999999999999
Q ss_pred hCCccccccccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCC---HHHHHH
Q 003059 700 SGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPM---MGKVVQ 773 (852)
Q Consensus 700 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt---~~ev~~ 773 (852)
+|+.||....... .......... .+ .... .......+.+++.+|+. +|.+|++ +.++++
T Consensus 234 ~G~~Pf~~~~~~~-------~~~~i~~~~~-~~---~~~~---~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDNPQE-------TYRKIINWKE-TL---QFPD---EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCCHHH-------HHHHHHcCCC-cc---CCCC---CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999997543211 0111111000 00 0000 00112234556666776 8999998 777765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=316.57 Aligned_cols=240 Identities=24% Similarity=0.328 Sum_probs=189.5
Q ss_pred ccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhc-ccccceeeeeeeeccCceeeEEEeecCC
Q 003059 505 DKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISS-THHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
+.||+|+||.||+|... +++.||||+++.. ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 4788999998743 2334556678888876 4899999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 150 (316)
T cd05619 81 GDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-- 150 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--
Confidence 9999998542 348889999999999999999998 899999999999999999999999999987532211
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccC
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (852)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......... +..
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-------~~~~i~~~~------~~~- 215 (316)
T cd05619 151 -AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE-------LFQSIRMDN------PCY- 215 (316)
T ss_pred -CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCC------CCC-
Confidence 12234568999999999999999999999999999999999999997543211 111111110 111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 003059 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMG-KVVQ 773 (852)
Q Consensus 739 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~-ev~~ 773 (852)
+......+.+++.+|++.||.+||++. ++.+
T Consensus 216 ----~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 ----PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ----CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 111223466888899999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=318.23 Aligned_cols=239 Identities=23% Similarity=0.305 Sum_probs=189.8
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEEEe
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e 574 (852)
+.+.+.||+|+||.||+|... +++.||+|.+... ......+..|..++..+ +|++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 456789999999999999865 4678999998742 22234567788888776 68999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 82 ~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 82 YVNGGDLMYQIQQV-----GRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred CCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999988543 348889999999999999999998 8999999999999999999999999999975432
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
.. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+.....
T Consensus 154 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-------~~~~i~~~~~----- 218 (323)
T cd05616 154 DG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-------LFQSIMEHNV----- 218 (323)
T ss_pred CC---CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC-----
Confidence 11 12234568999999999999999999999999999999999999997543211 1111111110
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMM 768 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~ 768 (852)
..+......+.+++.+|++.+|.+|++.
T Consensus 219 ------~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 ------AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ------CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1111223456788899999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.90 Aligned_cols=240 Identities=24% Similarity=0.309 Sum_probs=191.3
Q ss_pred ccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEEEeecCC
Q 003059 505 DKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
+.||+|+||.||++... +++.||+|.+... ......+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 4788999998732 23345677888888877 799999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
++|..++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 150 (318)
T cd05570 81 GDLMFHIQRS-----GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-- 150 (318)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--
Confidence 9999988543 248899999999999999999998 899999999999999999999999999987532211
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccC
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (852)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||....... ..........
T Consensus 151 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-------~~~~i~~~~~--------- 213 (318)
T cd05570 151 -VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-------LFQSILEDEV--------- 213 (318)
T ss_pred -CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCC---------
Confidence 12233568999999999999999999999999999999999999997443211 1111111110
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 003059 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMM-----GKVVQ 773 (852)
Q Consensus 739 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~-----~ev~~ 773 (852)
..+......+.+++.+|++.||.+||++ .++++
T Consensus 214 --~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 214 --RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred --CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 0111122356788899999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=306.41 Aligned_cols=239 Identities=23% Similarity=0.396 Sum_probs=186.7
Q ss_pred ccccccccceEEEEEECC-------------CcEEEEEEecCcc-cchHHHHHHHHHhhcccccceeeeeeeeccCceee
Q 003059 505 DKLGAGGFGAVYRGVLAN-------------RTVVAVKQLEGIE-QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRL 570 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~-------------~~~vavK~l~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 570 (852)
+.||+|+||.||+|++.. ...|++|.+.... .....|..|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 469999999999998532 2358889887433 33457888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCc-------eEE
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYN-------AKV 643 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~-------~kl 643 (852)
+||||+++++|+.++... ...+++..++.++.||++||+|||+ ++|+||||||+|||++.++. +|+
T Consensus 81 lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK----SDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEecccCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 999999999999988543 2358899999999999999999998 89999999999999987664 899
Q ss_pred eecccccccCCCCCcceeeeeecCCCCCCChhhhh-cCCCCCCccchhhhHHHHHHH-hCCccccccccccchhhHHHHH
Q 003059 644 SDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLA-NLPITSKSDVYSYGMVLLEIV-SGRRNFEVSQETNRKKFSLWAY 721 (852)
Q Consensus 644 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDv~s~Gvvl~ell-tG~~p~~~~~~~~~~~l~~~~~ 721 (852)
+|||++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|+.||........
T Consensus 154 ~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------- 218 (262)
T cd05077 154 SDPGIPITVLSR-------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------- 218 (262)
T ss_pred CCCCCCccccCc-------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--------
Confidence 999998754321 2245788899999887 467899999999999999998 58888764321110
Q ss_pred HHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003059 722 EEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776 (852)
Q Consensus 722 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~ 776 (852)
........ ... .. ....+.+++.+||+.||.+||++.+|++.|+
T Consensus 219 ~~~~~~~~------~~~--~~---~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 219 ERFYEGQC------MLV--TP---SCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHHHhcCc------cCC--CC---ChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 01111100 000 11 1235678889999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=324.47 Aligned_cols=252 Identities=21% Similarity=0.271 Sum_probs=196.1
Q ss_pred HhcccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
...|.+.++||+|+||.||++... +++.||+|.+... ....+.+..|+.+++.++||||+++++++.++...++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 346777889999999999999864 5789999998632 22345578899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++|+|.+++.. ..++...+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 122 ~Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 122 MEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 999999999999853 237778888899999999999998 89999999999999999999999999999865
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcC----CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANL----PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN 728 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (852)
..... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||....... ....+....
T Consensus 193 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~ 263 (370)
T cd05596 193 DANGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------TYSKIMDHK 263 (370)
T ss_pred cCCCc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-------HHHHHHcCC
Confidence 43211 112345699999999998653 47899999999999999999999997543210 111111110
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 003059 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQ--RPMMGKVVQM 774 (852)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~--RPt~~ev~~~ 774 (852)
. .+ .. +........+.+++..|++.+|.+ ||++.++++.
T Consensus 264 ~-~~---~~---~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 264 N-SL---TF---PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred C-cC---CC---CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0 00 00 111112345667888899999988 9999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=303.25 Aligned_cols=251 Identities=33% Similarity=0.476 Sum_probs=202.0
Q ss_pred ccccccccceEEEEEECC----CcEEEEEEecCcccc--hHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 505 DKLGAGGFGAVYRGVLAN----RTVVAVKQLEGIEQG--EKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~--~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
+.||+|+||.||++.... +..|++|.+...... .+++.+|++.+.+++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999654 788999999854433 57899999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcccC----CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 579 GSLDNFLFANEEG----SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 579 gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
++|.+++...... ....+++..+..++.|++.||+|||+ ++++||||||+||++++++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999654211 13568999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
... ........++..|+|||.+....++.++||||||++++||++ |..||....... .......+..
T Consensus 158 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~---- 225 (262)
T cd00192 158 DDY-YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRKGYR---- 225 (262)
T ss_pred ccc-cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC----
Confidence 321 122234557889999999998899999999999999999999 699997552211 1111111100
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~ 776 (852)
. ..+......+.+++.+|++.+|.+||++.++++.|+
T Consensus 226 ---~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ---L---PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---C---CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0 111112346778899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=316.84 Aligned_cols=239 Identities=23% Similarity=0.314 Sum_probs=188.6
Q ss_pred ccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEEEeecCC
Q 003059 505 DKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
+.||+|+||.||++... +++.||+|.++.. ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999975 5788999998742 23345567788887754 899999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
|+|.+++... ..+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 149 (316)
T cd05620 81 GDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--- 149 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccC---
Confidence 9999998543 347888999999999999999998 89999999999999999999999999998743211
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccC
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (852)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ........ .+.+.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-------~~~~~~~~------~~~~~ 216 (316)
T cd05620 150 DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-------LFESIRVD------TPHYP 216 (316)
T ss_pred CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhC------CCCCC
Confidence 122344668999999999999999999999999999999999999996443210 11111111 01111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 003059 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMG-KVV 772 (852)
Q Consensus 739 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~-ev~ 772 (852)
......+.+++.+|++.||.+||++. ++.
T Consensus 217 -----~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 -----RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -----CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11123566788899999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=324.88 Aligned_cols=202 Identities=23% Similarity=0.312 Sum_probs=170.9
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.|.+.++||+|+||.||++... +++.||||.+... ......+.+|++++.+++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 3667889999999999999964 5789999998632 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++|+|.+++... ..++...+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+..
T Consensus 82 ~~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 82 YIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999643 347888888999999999999998 8999999999999999999999999999753321
Q ss_pred CCC----------------------------------------cceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHH
Q 003059 655 KDH----------------------------------------RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMV 694 (852)
Q Consensus 655 ~~~----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvv 694 (852)
... .........||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 000 0000113469999999999999999999999999999
Q ss_pred HHHHHhCCccccccc
Q 003059 695 LLEIVSGRRNFEVSQ 709 (852)
Q Consensus 695 l~elltG~~p~~~~~ 709 (852)
+|||++|+.||....
T Consensus 234 lyell~G~~Pf~~~~ 248 (376)
T cd05598 234 LYEMLVGQPPFLADT 248 (376)
T ss_pred eeehhhCCCCCCCCC
Confidence 999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=322.40 Aligned_cols=252 Identities=21% Similarity=0.271 Sum_probs=192.8
Q ss_pred HhcccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
...|.+.++||+|+||.||++... +++.+|+|.+... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 356778889999999999999975 4788999998632 22345678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++|+|.+++... .+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++..
T Consensus 122 ~Ey~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 122 MEYMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 9999999999998532 37888899999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCC----CCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLP----ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN 728 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (852)
.... ........||+.|+|||.+.+.. ++.++|||||||++|||++|+.||....... ....+....
T Consensus 193 ~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-------~~~~i~~~~ 263 (370)
T cd05621 193 DETG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-------TYSKIMDHK 263 (370)
T ss_pred ccCC--ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCC
Confidence 4321 11223456999999999997643 7889999999999999999999997443211 011111110
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 003059 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQ--RPMMGKVVQM 774 (852)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~--RPt~~ev~~~ 774 (852)
. .+.- +........+.+++..|++.++.+ ||++.++++.
T Consensus 264 ~------~~~~-p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 264 N------SLNF-PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred c------ccCC-CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0 0000 111112234456666777755543 8899998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=306.49 Aligned_cols=254 Identities=22% Similarity=0.283 Sum_probs=197.6
Q ss_pred HhcccccccccccccceEEEEEE-CCCcEEEEEEecCc-ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
...|.+.++||+|+||.||+|+. .+++.||+|++... ......+++|+.++.+++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 34577788999999999999996 56788999998733 33445688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||+++.+...
T Consensus 88 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 88 CGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred CCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 9999999998533 347899999999999999999998 89999999999999999999999999999865321
Q ss_pred CCcceeeeeecCCCCCCChhhhh---cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLA---NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI 732 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (852)
. .......++..|+|||.+. ...++.++||||||+++|||++|+.||.......... .... ...
T Consensus 160 ~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~---~~~ 226 (267)
T cd06646 160 I---AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSK---SNF 226 (267)
T ss_pred c---cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeec---CCC
Confidence 1 1112345788999999884 3457889999999999999999999985332111000 0000 000
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQML 775 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L 775 (852)
..+... ........+.+++.+|++.+|++||++++|++.|
T Consensus 227 ~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 QPPKLK---DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCc---cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 001110 0111234677889999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=307.33 Aligned_cols=248 Identities=24% Similarity=0.350 Sum_probs=194.5
Q ss_pred ccccccccccccceEEEEEE-CCCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 501 KGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
+.+.+.||+|+||.||+|.. .+++.||+|.+... .....++.+|++++.+++||||+++++++...+..++||||++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 45678899999999999985 46788999998633 2334678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
+++|..+. .+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.+||+|||++......
T Consensus 83 ~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 83 GGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 99997653 36778888999999999999998 89999999999999999999999999999865332
Q ss_pred cceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccccc
Q 003059 658 RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSL 737 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (852)
......++..|+|||.+.+..++.++||||||+++|||++|+.||.............-........ ..+.+
T Consensus 149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 220 (279)
T cd06619 149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-----DPPVL 220 (279)
T ss_pred ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-----CCCCC
Confidence 1223468899999999999999999999999999999999999996533221111000000111100 01111
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 738 AGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 738 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.. ......+.+++.+|++.+|++||+++++++.
T Consensus 221 ~~----~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 PV----GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CC----CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11 1122356788889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=309.94 Aligned_cols=247 Identities=21% Similarity=0.340 Sum_probs=198.3
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecC-cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEG-IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
+|.+.++||+|+||.||+|.. .+++.|++|.+.. .....+.+.+|+.+++.++|+||+++++.+..+.+.++||||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 566778999999999999985 4578999999873 33345678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
+++|.+++.. ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 101 ~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 101 GGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 9999999842 247889999999999999999998 8999999999999999999999999999886543211
Q ss_pred cceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccccc
Q 003059 658 RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSL 737 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (852)
......+++.|+|||.+.+..++.++|||||||++|||++|+.||........ + ....... .+.+
T Consensus 172 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~----~~~~~~~------~~~~ 236 (296)
T cd06654 172 ---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--L----YLIATNG------TPEL 236 (296)
T ss_pred ---ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--H----HHHhcCC------CCCC
Confidence 12234588899999999988899999999999999999999999965432111 0 0000000 0011
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 738 AGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 738 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..+......+.+++.+|++.+|++||++.+|++
T Consensus 237 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 ---QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ---CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 111122245678889999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=289.43 Aligned_cols=259 Identities=20% Similarity=0.266 Sum_probs=195.2
Q ss_pred cccccccccceEEEEEE-CCCcEEEEEEecCcccch---HHHHHHHHHhhcccccceeeeeeeec--cCceeeEEEeecC
Q 003059 504 KDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGE---KQFRMEVATISSTHHLNLVRLVGFSS--EGKHRLLVYEFMK 577 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~---~~f~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lV~e~~~ 577 (852)
.++|++|.||.||+|+. ++++.||+|+++.....+ -.-.+||.+|.+++|||||.+-.+.. +-+..|||||||+
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 46899999999999995 468899999998444222 23578999999999999999988754 4457999999997
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
. +|..++... .+++...++.-+..|+++||+|||. ..|+|||||++|+|+...|.+||+|||+||.+...
T Consensus 161 h-DLksl~d~m----~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-- 230 (419)
T KOG0663|consen 161 H-DLKSLMETM----KQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-- 230 (419)
T ss_pred h-hHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCC--
Confidence 6 888888543 3568888999999999999999999 89999999999999999999999999999988643
Q ss_pred cceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccc-
Q 003059 658 RHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK- 735 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~- 735 (852)
....+..+-|.-|.|||.+.+. .|+...|+||+|||+.||+++++.|.+..+.++.+.+........+......-..
T Consensus 231 -~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 231 -LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred -cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 3445667789999999999875 6899999999999999999999999877655443332221111111111110000
Q ss_pred -----ccCCC-------CCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 736 -----SLAGE-------DVDIE-QVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 736 -----~l~~~-------~~~~~-~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..... .+... -.+...++.-..+..||++|-|+.+.++
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 00000 00000 1134456677788999999999998775
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=339.55 Aligned_cols=263 Identities=20% Similarity=0.284 Sum_probs=200.9
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.|.+.++||+|+||.||+|... .++.||+|++... ....++|.+|++++++++||||+++++++.+++..++|||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 4677889999999999999965 4889999998732 2234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhccc------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 575 FMKNGSLDNFLFANEE------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
|+++++|.+++..... .....+++..+++++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCc
Confidence 9999999999864211 112346778889999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCCc---------------ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccc
Q 003059 649 AKLINPKDHR---------------HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNR 713 (852)
Q Consensus 649 a~~~~~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~ 713 (852)
++........ ........||+.|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 9876221100 0011224699999999999999999999999999999999999999975322110
Q ss_pred hhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcCcc
Q 003059 714 KKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP-MMGKVVQMLEGITE 780 (852)
Q Consensus 714 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-t~~ev~~~L~~~~~ 780 (852)
.... .. .++.-. ....+....+.+++.+|++.||++|| +++++.+.|+....
T Consensus 240 ------~~~~----~i---~~P~~~--~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 240 ------SYRD----VI---LSPIEV--APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred ------hhhh----hc---cChhhc--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0000 00 000000 00011123466788899999999995 56777777776543
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=305.80 Aligned_cols=251 Identities=31% Similarity=0.470 Sum_probs=198.3
Q ss_pred ccccccccccccceEEEEEECC-CcEEEEEEecCcccchHH---HHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 501 KGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGIEQGEKQ---FRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~---f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
|++.+.||+|+||+||++.... ++.+|+|.+......... ...|+.++.+++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4677899999999999999765 568999999855443332 345999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|.+++.. ...+++..++.++.|+++||++||+ .+|+|+||||+||++++++.++|+|||.+....
T Consensus 81 ~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--- 149 (260)
T PF00069_consen 81 PGGSLQDYLQK-----NKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--- 149 (260)
T ss_dssp TTEBHHHHHHH-----HSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEEST---
T ss_pred ccccccccccc-----ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc---
Confidence 99999999962 3458999999999999999999999 899999999999999999999999999997641
Q ss_pred CcceeeeeecCCCCCCChhhhh-cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLA-NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
..........++..|+|||++. +..++.++||||||+++|+|++|+.||......+..... .......... .
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~----~~~~~~~~~~---~ 222 (260)
T PF00069_consen 150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEII----EKILKRPLPS---S 222 (260)
T ss_dssp STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHH----HHHHHTHHHH---H
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhh----hhcccccccc---c
Confidence 1222344566899999999998 888999999999999999999999999865211111111 0000000000 0
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.. ........+.+++.+|++.||++||++.++++
T Consensus 223 -~~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 223 -SQ---QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -TT---SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -cc---ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00001257788889999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=307.73 Aligned_cols=238 Identities=24% Similarity=0.361 Sum_probs=184.9
Q ss_pred cccccccceEEEEEECC-------------------------CcEEEEEEecCc-ccchHHHHHHHHHhhcccccceeee
Q 003059 506 KLGAGGFGAVYRGVLAN-------------------------RTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRL 559 (852)
Q Consensus 506 ~lG~G~fg~Vy~~~~~~-------------------------~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h~niv~l 559 (852)
+||+|+||.||+|.+.. ...|++|++... .....+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 135889988733 2334578889999999999999999
Q ss_pred eeeeccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC
Q 003059 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY 639 (852)
Q Consensus 560 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~ 639 (852)
+++|.+....++||||+++|+|+.++... ...+++..++.++.||++||+|||+ ++|+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE----KGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccC
Confidence 99999999999999999999999998543 2357889999999999999999998 8999999999999997644
Q ss_pred -------ceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHH-hCCcccccccc
Q 003059 640 -------NAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIV-SGRRNFEVSQE 710 (852)
Q Consensus 640 -------~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~ell-tG~~p~~~~~~ 710 (852)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.....
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred cccCccceeeecCCccccccccc-------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 3799999988643221 12346788999998875 56899999999999999995 79999865432
Q ss_pred ccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003059 711 TNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776 (852)
Q Consensus 711 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~ 776 (852)
..... ..... ..+.. . ....+.+++.+||+.+|++||++.+|++.|+
T Consensus 228 ~~~~~-------~~~~~-------~~~~~-~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 228 SEKER-------FYEKK-------HRLPE-P----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHH-------HHHhc-------cCCCC-C----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11100 00000 00111 1 1135678899999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=312.51 Aligned_cols=201 Identities=26% Similarity=0.366 Sum_probs=162.9
Q ss_pred cccccccccceEEEEEEC---CCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeecc--CceeeEEEeecCC
Q 003059 504 KDKLGAGGFGAVYRGVLA---NRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSE--GKHRLLVYEFMKN 578 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~~~~ 578 (852)
.++||+|+||.||+|... +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 358999999999999864 45789999987433 23457889999999999999999998854 457899999985
Q ss_pred CCHHHHhhhccc----CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEe----CCCCceEEeeccccc
Q 003059 579 GSLDNFLFANEE----GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL----DENYNAKVSDFGLAK 650 (852)
Q Consensus 579 gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~DFGla~ 650 (852)
++|.+++..... .....+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 588888753221 112358899999999999999999998 899999999999999 466889999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccc
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQ 709 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~ 709 (852)
................+|+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 764322222223345689999999999774 58999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=303.85 Aligned_cols=249 Identities=24% Similarity=0.364 Sum_probs=195.2
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhcc-cccceeeeeeeeccC------ceeeE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISST-HHLNLVRLVGFSSEG------KHRLL 571 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~------~~~~l 571 (852)
.|.+.+.||+|+||.||+|... .++.||+|.+........++..|+.++.++ +|+||+++++++... ...++
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 86 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 86 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence 4566788999999999999864 578899999986666667889999999998 799999999998653 46899
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
||||+++++|.+++.... ...+++..+..++.|++.||+|||+ ++|+|+||||+||++++++.+||+|||+++.
T Consensus 87 v~e~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 87 VMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEcCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 999999999999986432 3458899999999999999999998 8999999999999999999999999999986
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhh-----cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhh
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLA-----NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEK 726 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (852)
..... .......|+..|+|||++. ...++.++|||||||++|||++|+.||........ ......
T Consensus 161 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-------~~~~~~ 230 (272)
T cd06637 161 LDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-------LFLIPR 230 (272)
T ss_pred ccccc---ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-------HHHHhc
Confidence 54321 1223356889999999986 34578899999999999999999999964321110 001111
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 727 GNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.. ...+.. ......+.+++.+|++.+|.+||++.+|++
T Consensus 231 ~~-----~~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 NP-----APRLKS----KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CC-----CCCCCC----CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 10 111111 111235678889999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=324.24 Aligned_cols=201 Identities=23% Similarity=0.323 Sum_probs=170.1
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.+.+.++||+|+||.||+|.. .+++.||+|++.... .....+.+|++++++++|+||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 355678999999999999986 457889999987432 234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 82 YIPGGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 99999999998643 247888889999999999999998 8999999999999999999999999999764321
Q ss_pred CCC--------------------------------------------cceeeeeecCCCCCCChhhhhcCCCCCCccchh
Q 003059 655 KDH--------------------------------------------RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYS 690 (852)
Q Consensus 655 ~~~--------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s 690 (852)
... .........||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 000 000011246899999999999999999999999
Q ss_pred hhHHHHHHHhCCcccccc
Q 003059 691 YGMVLLEIVSGRRNFEVS 708 (852)
Q Consensus 691 ~Gvvl~elltG~~p~~~~ 708 (852)
|||++|||++|+.||...
T Consensus 234 lGvil~elltG~~Pf~~~ 251 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred chHHHHHHHhCCCCCCCC
Confidence 999999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=308.32 Aligned_cols=249 Identities=25% Similarity=0.323 Sum_probs=194.6
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
+...+.||+|+||.||++... +++.||+|.+.... .....+.+|++++.+++|+||+.+++.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 445678999999999999864 58899999986432 2234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+++++|.+++.... ...+++..+..++.|++.||.|||+ ++|+||||||+||++++++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 82 MNGGDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred ccCccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999999886432 2358999999999999999999998 89999999999999999999999999998765321
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
. ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......... .......... ..
T Consensus 156 ~----~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~---~~~~~~~~~~--~~--- 223 (285)
T cd05632 156 E----SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE---EVDRRVLETE--EV--- 223 (285)
T ss_pred C----cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhhhccc--cc---
Confidence 1 1233468999999999999999999999999999999999999997543211100 0011111100 00
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPM-----MGKVVQ 773 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt-----~~ev~~ 773 (852)
........+.+++..|++.||++||+ +.++++
T Consensus 224 ------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 224 ------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 01111234567888899999999999 556654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=314.79 Aligned_cols=262 Identities=21% Similarity=0.324 Sum_probs=194.9
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
.+|.+.++||+|+||.||+|... +++.||+|.++.. ......+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 35677889999999999999865 5778999998732 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+++ +|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 86 LDK-DLKQYMDDC----GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred CCC-CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 975 888887543 3357889999999999999999998 89999999999999999999999999999764322
Q ss_pred CCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHH--------HHHHhh
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA--------YEEFEK 726 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~ 726 (852)
. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+........ +.....
T Consensus 158 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 158 T---KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred c---cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence 1 11223457899999999865 46889999999999999999999999755332211111000 000000
Q ss_pred CCcccccccccCCC-C-----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 727 GNVKGIVDKSLAGE-D-----VDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 727 ~~~~~~~d~~l~~~-~-----~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
. ....+...... . ........+.+++.+|++.||.+|||+.|+++
T Consensus 235 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 235 N--DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred h--hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0 00000000000 0 00011234568899999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=300.76 Aligned_cols=248 Identities=24% Similarity=0.363 Sum_probs=200.8
Q ss_pred cccccccccccccceEEEEEECC-CcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
.|.+.++||+|+||.||+|...+ ++.+++|.+..... .+++.+|++++++++|+||+++++++.+....++++||+++
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 46677899999999999999765 78899999875433 67899999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
++|.+++... ...+++..+..++.|+++||.|||+ .+++||||+|+||++++++.+||+|||++........
T Consensus 83 ~~L~~~l~~~----~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 83 GSVSDIMKIT----NKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 9999998543 3468999999999999999999998 8999999999999999999999999999987643211
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccC
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (852)
......++..|+|||.+.+..++.++||||||+++|||++|+.||......... ... .....+.+
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~~~-----~~~~~~~~- 219 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------FMI-----PNKPPPTL- 219 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------hhh-----ccCCCCCC-
Confidence 223345788999999999999999999999999999999999999754321100 000 00000111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 739 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..+......+.+++.+|++.+|.+||++.+|++
T Consensus 220 --~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 --SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred --CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 111122245778889999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=307.68 Aligned_cols=249 Identities=25% Similarity=0.325 Sum_probs=195.1
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
+...+.||+|+||.||++... +++.||+|.+.... .....+..|+.++++++|+|++++++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 455678999999999999864 57899999986322 2234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+++++|.+++.... ...+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++......
T Consensus 82 ~~g~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 82 MNGGDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred cCCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999999985432 2358899999999999999999998 89999999999999999999999999998765322
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
. ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......... ....... ....
T Consensus 156 ~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~----~~~~~~~----~~~~- 222 (285)
T cd05630 156 Q----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE----EVERLVK----EVQE- 222 (285)
T ss_pred c----cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH----HHHhhhh----hhhh-
Confidence 1 1123468999999999999999999999999999999999999997542211000 0000000 0000
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPM-----MGKVVQ 773 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt-----~~ev~~ 773 (852)
... ......+.+++..|++.||++||+ +.|+++
T Consensus 223 ~~~-----~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 EYS-----EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hcC-----ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 000 111234567888899999999999 778775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=303.77 Aligned_cols=251 Identities=23% Similarity=0.303 Sum_probs=197.2
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCcc------cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE------QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
.+...+.||+|++|.||++.. .+++.|++|.+.... ...+.+.+|++++.+++||||+++++++.++...++|
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 356678999999999999986 458899999886322 1235688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
+||+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||+++..
T Consensus 83 ~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 83 MEYMPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEECCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999998643 347888999999999999999998 89999999999999999999999999999765
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI 732 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (852)
..............++..|+|||.+.+..++.++||||||+++|||++|+.||........ .. .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~-~~~~~~~--- 224 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA------IF-KIATQPT--- 224 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH------HH-HHhccCC---
Confidence 4322111111234577899999999999999999999999999999999999964322110 00 0000000
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.. ..+......+.+++.+|++.+|.+||++.++++.
T Consensus 225 -~~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 -NP-----QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CC-----CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00 1111223356778889999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=303.97 Aligned_cols=251 Identities=29% Similarity=0.429 Sum_probs=191.3
Q ss_pred ccccccccceEEEEEEC----CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeec-cCceeeEEEeecC
Q 003059 505 DKLGAGGFGAVYRGVLA----NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSS-EGKHRLLVYEFMK 577 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lV~e~~~ 577 (852)
+.||+|+||.||+|.+. +...||+|++... ....+.+..|+.+++.++||||+++++++. .++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46999999999999853 2457999998632 233567889999999999999999999775 4557899999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
+++|.+++.... ..+++..++.++.|+++||+|||+ .+++||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 81 HGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 999999996432 236778889999999999999998 8999999999999999999999999999986543211
Q ss_pred cc-eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhC-CccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 658 RH-RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSG-RRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 658 ~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
.. .......++..|+|||.+.+..++.++||||||+++|||++| ..||...... ... .....+.
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~----~~~~~~~------- 219 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DIT----VYLLQGR------- 219 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HHHhcCC-------
Confidence 11 111233457789999999988999999999999999999995 5566532211 111 1111110
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
.. ..+......+.+++..|++.+|++||++.+|++.|+++.
T Consensus 220 ~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 220 RL---LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CC---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 00 001111235778899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=313.83 Aligned_cols=208 Identities=27% Similarity=0.408 Sum_probs=179.8
Q ss_pred cCHHHHHHhcccccccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhccc-cc-----ceeeeeeee
Q 003059 491 FSYKELQRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISSTH-HL-----NLVRLVGFS 563 (852)
Q Consensus 491 ~~~~el~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~-h~-----niv~l~g~~ 563 (852)
+-..|....+|.+.+.||+|.||.|.|+... .++.||||++++...-..+-..|+.+|..|+ |. |+|+++++|
T Consensus 178 ~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 178 LVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred EEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 3344555558889999999999999999964 5899999999988888888899999999997 44 899999999
Q ss_pred ccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCC--Cce
Q 003059 564 SEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDEN--YNA 641 (852)
Q Consensus 564 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~--~~~ 641 (852)
...++.|||+|.+ ..+|.++|..+.. ..++...+..|+.||+.||.+||+ .+|||+||||+||||.+. ..+
T Consensus 258 ~fr~HlciVfELL-~~NLYellK~n~f---~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~v 330 (586)
T KOG0667|consen 258 YFRNHLCIVFELL-STNLYELLKNNKF---RGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRI 330 (586)
T ss_pred ccccceeeeehhh-hhhHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCce
Confidence 9999999999999 5699999976653 459999999999999999999998 899999999999999653 469
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccc
Q 003059 642 KVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQET 711 (852)
Q Consensus 642 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~ 711 (852)
||+|||.+...... .-....+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.+..+.
T Consensus 331 KVIDFGSSc~~~q~------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 331 KVIDFGSSCFESQR------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred eEEecccccccCCc------ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 99999999875432 11445678899999999999999999999999999999999888766543
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=313.12 Aligned_cols=200 Identities=24% Similarity=0.280 Sum_probs=170.6
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.|.+.++||+|+||.||++... +++.||+|.+... ......+..|+.++..++|+||+++++++.+.+..|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 4667889999999999999965 5788999998632 2233457889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 82 y~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 82 YYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred CCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999643 2357888999999999999999998 8999999999999999999999999999986643
Q ss_pred CCCcceeeeeecCCCCCCChhhhhc-----CCCCCCccchhhhHHHHHHHhCCcccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLAN-----LPITSKSDVYSYGMVLLEIVSGRRNFEVS 708 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~s~Gvvl~elltG~~p~~~~ 708 (852)
... .......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 155 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 155 DGT--VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CCc--eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 211 12233569999999999875 46788999999999999999999999643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=302.32 Aligned_cols=248 Identities=23% Similarity=0.335 Sum_probs=199.0
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecC--cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEG--IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
|.+.++||+|+||.||++... +++.+++|.++. .....+.+..|+.++++++|+||+++++.+.+++..++||||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 456789999999999999864 578899998863 23345678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
+++|.+++.... ...++...++.++.|++.||.|||+ .+|+|+||||+||++++++.++|+|||+++......
T Consensus 82 ~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 154 (255)
T cd08219 82 GGDLMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG- 154 (255)
T ss_pred CCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence 999999885432 3457889999999999999999998 899999999999999999999999999997664321
Q ss_pred cceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccccc
Q 003059 658 RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSL 737 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (852)
.......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... .......+...
T Consensus 155 --~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~------- 218 (255)
T cd08219 155 --AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN-------LILKVCQGSYK------- 218 (255)
T ss_pred --cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH-------HHHHHhcCCCC-------
Confidence 11233568899999999999899999999999999999999999997432110 01111111111
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 738 AGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 738 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
..+......+.+++.+||+.||++||++.+|+..
T Consensus 219 ---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 ---PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1111122356788899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=304.98 Aligned_cols=252 Identities=29% Similarity=0.461 Sum_probs=196.6
Q ss_pred ccccccccceEEEEEECC-------CcEEEEEEecCcc--cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 505 DKLGAGGFGAVYRGVLAN-------RTVVAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
+.||+|+||.||+|+..+ ++.+++|.+.... ....++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 2579999886432 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccC--CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC-----ceEEeeccc
Q 003059 576 MKNGSLDNFLFANEEG--SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY-----NAKVSDFGL 648 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-----~~kl~DFGl 648 (852)
+++++|.+++...... ....+++..++.++.|++.||+|||+ .+++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999753221 23457899999999999999999998 8899999999999999887 899999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhC
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKG 727 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (852)
++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... . ......+
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~----~~~~~~~ 229 (269)
T cd05044 158 ARDIYKSDYY-RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---V----LQHVTAG 229 (269)
T ss_pred cccccccccc-ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---H----HHHHhcC
Confidence 9765432111 11122345678999999999999999999999999999998 999986432211 0 0011111
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003059 728 NVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEG 777 (852)
Q Consensus 728 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~ 777 (852)
. .. ..+......+.+++.+|++.+|.+||++.+|++.|++
T Consensus 230 ~-------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 G-------RL---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred C-------cc---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 00 1111123456788999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=298.18 Aligned_cols=265 Identities=24% Similarity=0.309 Sum_probs=193.5
Q ss_pred cccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCc-----eeeEEEeecC
Q 003059 504 KDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK-----HRLLVYEFMK 577 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lV~e~~~ 577 (852)
.+.+|.|.||.||+|++. .+..||||+.-.... .--+|+++|+++.|||||+|+-+|.... ...+||||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP 105 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP 105 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence 568999999999999965 468999999864333 1246899999999999999998875432 3469999997
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCC-CceEEeecccccccCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDEN-YNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFGla~~~~~~~ 656 (852)
. +|.+++..... .+..++.-.+.-+..||.+||+|||+ .+|+||||||+|+|+|.+ |.+||+|||.|+.+...+
T Consensus 106 ~-tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 106 E-TLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred H-HHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 6 89888864221 23446666777899999999999999 899999999999999976 999999999999887654
Q ss_pred CcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHH-----HHHHhhCCcc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA-----YEEFEKGNVK 730 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~-----~~~~~~~~~~ 730 (852)
.. ....-+.-|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.+....++...+.-+ .+.+...+..
T Consensus 181 pn----iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 181 PN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred Cc----eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence 33 233457789999998765 7999999999999999999999999875443332222111 1111111111
Q ss_pred --cccccccCCCC----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcCcc
Q 003059 731 --GIVDKSLAGED----VDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ--MLEGITE 780 (852)
Q Consensus 731 --~~~d~~l~~~~----~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~--~L~~~~~ 780 (852)
+.-.+.+.... .......+.++++.++++.+|.+|.++.|++. .++++++
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 11112221111 11222346778899999999999999999884 4555543
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=306.61 Aligned_cols=259 Identities=25% Similarity=0.375 Sum_probs=202.0
Q ss_pred HHHhcccccccccccccceEEEEEECC----CcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCcee
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLAN----RTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHR 569 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 569 (852)
+.+.++.+.++||+|+||.||+|...+ ...|++|..... ....+.+.+|+.++++++|+||+++++++.+ ...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 344567788999999999999998643 346899988743 3345679999999999999999999998875 467
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++
T Consensus 82 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 82 WIVMELAPLGELRSYLQVN----KYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred EEEEEcCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCcee
Confidence 8999999999999999643 2358999999999999999999998 89999999999999999999999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCC
Q 003059 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGN 728 (852)
Q Consensus 650 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (852)
+....... .......++..|+|||.+....++.++||||||+++|||++ |+.||........ ......+.
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-------~~~~~~~~ 225 (270)
T cd05056 155 RYLEDESY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-------IGRIENGE 225 (270)
T ss_pred eecccccc--eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHHcCC
Confidence 86643211 11122234568999999988889999999999999999996 9999965432110 01111111
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
.. ..+......+.+++.+|+..+|.+||++.++++.|+++...
T Consensus 226 ~~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 226 RL----------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred cC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00 01111223577788999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=294.53 Aligned_cols=260 Identities=22% Similarity=0.319 Sum_probs=199.8
Q ss_pred cccccccccceEEEEEE-CCCcEEEEEEecC---cccchHHHHHHHHHhhcccccceeeeeeeecc-----CceeeEEEe
Q 003059 504 KDKLGAGGFGAVYRGVL-ANRTVVAVKQLEG---IEQGEKQFRMEVATISSTHHLNLVRLVGFSSE-----GKHRLLVYE 574 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~lV~e 574 (852)
.+.||+|+||.|..+.. .+++.||||++.. .....++-.+|+++|+.++|+||+.+++.+.. -+..|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 57799999999999985 4689999999872 33445677899999999999999999998765 347899999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
+| .-+|...|.. ++.|+.....-++.||++||+|+|+ -+|+||||||+|+|++.+...||+|||+|+....
T Consensus 107 lM-etDL~~iik~-----~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 107 LM-ETDLHQIIKS-----QQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred HH-hhHHHHHHHc-----CccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeeccc
Confidence 99 6688888853 3348889999999999999999999 7899999999999999999999999999998865
Q ss_pred CCCcceeeeeecCCCCCCChhhhh-cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHH--------HHHHh
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLA-NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA--------YEEFE 725 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~ 725 (852)
. .....++..+-|.-|.|||.+. ...|+...||||.||++.||++|++.|.+.+..++-.+.... ...+.
T Consensus 178 ~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 178 F-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred c-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 4 3344557778899999999875 558999999999999999999999999876543322222111 11111
Q ss_pred hCCcccccccccCCCCCCHHHH-----HHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 726 KGNVKGIVDKSLAGEDVDIEQV-----MRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~~~-----~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.......+...-.....+...+ ..++++..+++..||.+|+|++|.++
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1111121111111112222221 35678888999999999999999885
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=314.52 Aligned_cols=240 Identities=23% Similarity=0.323 Sum_probs=190.0
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhccc-ccceeeeeeeeccCceeeEEEe
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTH-HLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e 574 (852)
+++.+.||+|+||.||++... +++.||+|++... ....+.+..|..++..+. |++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 567789999999999999864 5889999998732 223456778888888875 5778889999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 82 y~~~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 82 YVNGGDLMYHIQQV-----GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred CCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999998543 348899999999999999999998 8999999999999999999999999999875432
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..........
T Consensus 154 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-------~~~~i~~~~~----- 218 (323)
T cd05615 154 DG---VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE-------LFQSIMEHNV----- 218 (323)
T ss_pred CC---ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC-----
Confidence 11 11233558999999999999999999999999999999999999997543211 1111111111
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMG 769 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ 769 (852)
..+......+.+++.+|++.+|.+|++..
T Consensus 219 ------~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 219 ------SYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred ------CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 01111223567888999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=303.18 Aligned_cols=238 Identities=25% Similarity=0.415 Sum_probs=189.6
Q ss_pred ccccccccceEEEEEECCCc-----------EEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 505 DKLGAGGFGAVYRGVLANRT-----------VVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
+.||+|+||.||+|...+.. .|++|.+.........|.+|+.++++++|+||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46999999999999975432 57888877444447789999999999999999999999988 7889999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC-------ceEEeec
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY-------NAKVSDF 646 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-------~~kl~DF 646 (852)
||+++++|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++ .+||+||
T Consensus 80 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 80 EYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999996542 258899999999999999999998 8999999999999999888 7999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCChhhhhcC--CCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHH
Q 003059 647 GLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL--PITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEE 723 (852)
Q Consensus 647 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 723 (852)
|++..... .....++..|+|||.+.+. .++.++||||||+++|||++ |..||.......... .
T Consensus 153 g~a~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-------~ 218 (259)
T cd05037 153 GIPITVLS-------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-------F 218 (259)
T ss_pred Cccccccc-------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-------H
Confidence 99986532 1223467789999999876 78999999999999999999 577775442111100 0
Q ss_pred HhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003059 724 FEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776 (852)
Q Consensus 724 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~ 776 (852)
.... ..+. ......+.+++.+|++.+|.+||++.+|++.|+
T Consensus 219 ~~~~-------~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 YQDQ-------HRLP-----MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HhcC-------CCCC-----CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 0010 011156778899999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=315.99 Aligned_cols=195 Identities=27% Similarity=0.353 Sum_probs=165.3
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCc------e
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK------H 568 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~ 568 (852)
..|.+.+.||+|+||.||++... .++.||+|++... ......+.+|+.+++.++||||+++++++.... .
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 46778899999999999999864 5889999998632 234567889999999999999999999886443 5
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 101 ~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 101 VYLVMELMDA-NLCQVIH-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred eEEEEeCCCc-CHHHHHh-------ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCC
Confidence 7999999965 5666663 237788899999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCcccccc
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVS 708 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~ 708 (852)
++..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 170 a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 170 ARTACTN----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred ccccccC----ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 9764321 1223356899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=313.06 Aligned_cols=239 Identities=26% Similarity=0.287 Sum_probs=182.8
Q ss_pred ccccccceEEEEEEC-CCcEEEEEEecCcc----cchHHHHHHHHHhhcc---cccceeeeeeeeccCceeeEEEeecCC
Q 003059 507 LGAGGFGAVYRGVLA-NRTVVAVKQLEGIE----QGEKQFRMEVATISST---HHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 507 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l---~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
||+|+||.||+|... +++.||||++.... .....+..|..++.+. +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999864 58899999986321 1223445566666655 699999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
|+|.+++... ..+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-- 150 (330)
T cd05586 81 GELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-- 150 (330)
T ss_pred ChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--
Confidence 9999988543 348899999999999999999998 899999999999999999999999999987543211
Q ss_pred ceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccccc
Q 003059 659 HRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSL 737 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (852)
.......||..|+|||.+.+. .++.++|||||||++|||++|+.||....... .......+.. .+
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~------~~ 216 (330)
T cd05586 151 -KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-------MYRNIAFGKV------RF 216 (330)
T ss_pred -CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-------HHHHHHcCCC------CC
Confidence 122345689999999998765 47999999999999999999999996533210 1111111111 11
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCC----HHHHHH
Q 003059 738 AGEDVDIEQVMRAIQVSFWCIQEQPSQRPM----MGKVVQ 773 (852)
Q Consensus 738 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt----~~ev~~ 773 (852)
.... ....+.+++.+|++.||.+||+ +.++++
T Consensus 217 ~~~~----~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 217 PKNV----LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCcc----CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1101 1234567888899999999984 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=306.42 Aligned_cols=257 Identities=26% Similarity=0.400 Sum_probs=201.0
Q ss_pred HhcccccccccccccceEEEEEECC-C----cEEEEEEecCcc--cchHHHHHHHHHhhcccccceeeeeeeeccCceee
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLAN-R----TVVAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRL 570 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~----~~vavK~l~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 570 (852)
...+.+.+.||+|+||.||+|...+ + ..+|+|.+.... ....++.+|++++++++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3456778899999999999998643 2 368999887443 344678899999999999999999999987 7889
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+||||+++|+|.+++... ...+++..++.++.||+.||+|||+ .+++||||||+|||+++++.+||+|||+++
T Consensus 85 ~v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH----KDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred EEEecCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 999999999999999643 2348999999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCc
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
........ .......++..|+|||.+....++.++||||||+++|||++ |+.||+.....+ + ......+..
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~----~~~~~~~~~ 229 (279)
T cd05057 158 LLDVDEKE-YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---I----PDLLEKGER 229 (279)
T ss_pred cccCcccc-eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---H----HHHHhCCCC
Confidence 76532211 11112224568999999988899999999999999999998 999997543211 1 111111100
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 730 KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
. ..+......+.+++.+|+..+|.+||++.++++.|+.+..
T Consensus 230 -------~---~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 -------L---PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred -------C---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 1111122356678889999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=321.52 Aligned_cols=192 Identities=24% Similarity=0.267 Sum_probs=164.8
Q ss_pred cccccccccccccceEEEEEECC-CcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
.|.+.++||+|+||.||++.... ++.||||... ...+.+|++++++++|+|||++++++..++..++|||++ .
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~ 243 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-R 243 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-C
Confidence 56677899999999999999754 7789999643 234678999999999999999999999999999999999 4
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
++|.+++... ...+++..++.|+.||++||.|||+ ++|+||||||+||||+.++.+||+|||+++.......
T Consensus 244 ~~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~- 315 (461)
T PHA03211 244 SDLYTYLGAR----LRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS- 315 (461)
T ss_pred CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccc-
Confidence 7898888543 2368999999999999999999998 8999999999999999999999999999987643211
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccc
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNF 705 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~ 705 (852)
........||..|+|||++.+..++.++|||||||+||||++|..++
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 11122456999999999999999999999999999999999988654
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=309.36 Aligned_cols=262 Identities=23% Similarity=0.282 Sum_probs=196.2
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
+.+.++||+|+||.||++... ++..+++|.+... .....++.+|++++.+++||||+++++++.+++..++||||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 566789999999999999864 5778899988633 2234568899999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
+++|.+++... ..+++..+..++.|+++||.|||+. .+++||||||+|||+++++.+||+|||++......
T Consensus 83 ~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 83 GGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 99999999643 3478899999999999999999972 47999999999999999999999999998755321
Q ss_pred cceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC---------
Q 003059 658 RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN--------- 728 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--------- 728 (852)
......++..|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 12234688999999999888899999999999999999999999864332111000000000000000
Q ss_pred --------cccccccccCCC---CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 729 --------VKGIVDKSLAGE---DVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 729 --------~~~~~d~~l~~~---~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
..+..+...... .........+.+++.+|++.+|++||++.+|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000 0000112347789999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=301.75 Aligned_cols=250 Identities=25% Similarity=0.372 Sum_probs=196.9
Q ss_pred ccccccccccccceEEEEEECCCcEEEEEEecCcc-------cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 501 KGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIE-------QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
|...+.||+|+||.||+|...+++.+|+|.+.... .....+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 45678899999999999998888999999886321 12356889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+++++|.+++... ..+++..+..++.|++.+|+|||+ .+|+|+||+|+||++++++.++|+|||++....
T Consensus 82 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 82 EFVPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred ecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 999999999999543 247889999999999999999998 889999999999999999999999999987653
Q ss_pred CCCC---cceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcc
Q 003059 654 PKDH---RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730 (852)
Q Consensus 654 ~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (852)
.... .........++..|+|||.+.+..++.++||||||+++|||++|+.||........ .. .... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-----~~--~~~~--~~ 224 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-----MF--YIGA--HR 224 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-----HH--Hhhh--cc
Confidence 2111 11112334588999999999998999999999999999999999999964321110 00 0000 00
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 731 GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.. .+. .+......+.+++.+|++.+|.+||++.++++
T Consensus 225 ~~-~~~-----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 GL-MPR-----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CC-CCC-----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 011 11122345678889999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=307.35 Aligned_cols=200 Identities=25% Similarity=0.288 Sum_probs=169.7
Q ss_pred cccccccccccccceEEEEEECC-CcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.|.+.++||+|+||.||++.... ++.+|+|.+... ......+..|+.++..++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 45677899999999999999754 678999998632 2223458889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++|+|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 82 y~~~g~L~~~l~~~----~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 82 YYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred ccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999643 2358888999999999999999998 8999999999999999999999999999876533
Q ss_pred CCCcceeeeeecCCCCCCChhhhh-----cCCCCCCccchhhhHHHHHHHhCCcccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLA-----NLPITSKSDVYSYGMVLLEIVSGRRNFEVS 708 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG~~p~~~~ 708 (852)
.. ........||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 155 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 155 DG--TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred CC--cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 21 11223356999999999986 346789999999999999999999999743
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=305.76 Aligned_cols=257 Identities=25% Similarity=0.297 Sum_probs=201.3
Q ss_pred HhcccccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
...+++.++||+|+||.||++... +++.||+|.+... ....+++.+|++++..++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 345677789999999999999964 5788999987632 3345788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++++|.+++... ..+++..+..++.+++.+|.|||+. ++++||||||+||++++++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 84 FMDCGSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred cCCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 99999999988542 3588999999999999999999962 5799999999999999999999999999875422
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccch-----hhHHHHHHHHhhCCc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRK-----KFSLWAYEEFEKGNV 729 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~-----~l~~~~~~~~~~~~~ 729 (852)
. ......|+..|+|||.+.+..++.++|||||||++|||++|+.||......... .+..+.
T Consensus 157 ~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--------- 222 (284)
T cd06620 157 S-----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL--------- 222 (284)
T ss_pred h-----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH---------
Confidence 1 112346899999999998889999999999999999999999999754332110 011111
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003059 730 KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776 (852)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~ 776 (852)
..++...... ....+....+.+++.+|++.||.+||++.||++...
T Consensus 223 ~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 223 QQIVQEPPPR-LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred HHHhhccCCC-CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0111100000 011112345778889999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.35 Aligned_cols=247 Identities=28% Similarity=0.413 Sum_probs=196.2
Q ss_pred ccccccccceEEEEEECCCcEEEEEEecCccc--chHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCCHH
Q 003059 505 DKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQ--GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLD 582 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 582 (852)
++||+|+||.||++...+++.|++|.+..... ....+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 47999999999999987789999998874332 4567899999999999999999999999999999999999999999
Q ss_pred HHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcceee
Q 003059 583 NFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTL 662 (852)
Q Consensus 583 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 662 (852)
+++... ...+++..++.++.+++.+|+|||+ .+++||||||+|||++.++.+||+|||+++........ ...
T Consensus 81 ~~l~~~----~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~ 152 (251)
T cd05041 81 TFLRKK----KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT-VSD 152 (251)
T ss_pred HHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcce-ecc
Confidence 999543 2357889999999999999999998 89999999999999999999999999999865421110 000
Q ss_pred eeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcccccccccCCCC
Q 003059 663 TSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGED 741 (852)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 741 (852)
.....+..|+|||.+.+..++.++||||||+++|||++ |..||........ ........ .. .
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~-------~~~~~~~~-------~~---~ 215 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT-------RERIESGY-------RM---P 215 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH-------HHHHhcCC-------CC---C
Confidence 11223567999999998899999999999999999999 8888864432110 01111100 00 1
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003059 742 VDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776 (852)
Q Consensus 742 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~ 776 (852)
.+......+.+++.+|++.+|.+||++.||++.|+
T Consensus 216 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 11122346778899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=319.42 Aligned_cols=262 Identities=22% Similarity=0.311 Sum_probs=193.3
Q ss_pred cccccccccccceEEEEEE-CCCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCc-----eeeEE
Q 003059 502 GFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK-----HRLLV 572 (852)
Q Consensus 502 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lV 572 (852)
.+.++||+|+||.||++.. .+++.||+|++... ....+++.+|+++++.++|+||+++++++.... ..++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 4567899999999999996 46889999998642 223467889999999999999999999998776 78999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
+||+. ++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 83 ~e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 83 TELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred eeccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 99996 578887743 2358899999999999999999998 89999999999999999999999999999865
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHH-----HHHHhh
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA-----YEEFEK 726 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~-----~~~~~~ 726 (852)
..... .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||............... ...+..
T Consensus 154 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 154 EPDES--KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred ccCcc--ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 43211 122334578899999999874 4789999999999999999999999755322111100000 000000
Q ss_pred --CCcccccccccCCC-------CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 727 --GNVKGIVDKSLAGE-------DVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 727 --~~~~~~~d~~l~~~-------~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
......+....... ....+....+.+++.+|++.||++||++.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000000000 0001113456789999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=307.96 Aligned_cols=200 Identities=24% Similarity=0.277 Sum_probs=170.1
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.|.+.+.||+|+||.||++... +++.||+|.+... ....+.+.+|+.++..++|+||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 4667889999999999999964 5789999998632 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++|+|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++..+..
T Consensus 82 ~~~g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 82 YYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred cCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999542 2358888999999999999999998 8999999999999999999999999999876543
Q ss_pred CCCcceeeeeecCCCCCCChhhhhc-----CCCCCCccchhhhHHHHHHHhCCcccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLAN-----LPITSKSDVYSYGMVLLEIVSGRRNFEVS 708 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~s~Gvvl~elltG~~p~~~~ 708 (852)
... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 155 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 155 DGT--VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CCC--ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 211 11223468999999999873 45788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=316.50 Aligned_cols=238 Identities=24% Similarity=0.323 Sum_probs=195.5
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEEE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 573 (852)
..+|.++||+|.||.|+++.++ +++.+|||.+++. ....+..+.|..++... +||.|++++.+|...++.|.||
T Consensus 369 ~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvm 448 (694)
T KOG0694|consen 369 DFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVM 448 (694)
T ss_pred ceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEE
Confidence 4567789999999999999975 4789999999853 33445667788887766 5999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+.||++..+.+ ...+++..+.-++..|+.||.|||+ ++|||||||.+|||||.+|.+||+|||+++...
T Consensus 449 ey~~Ggdm~~~~~------~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 449 EYVAGGDLMHHIH------TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EecCCCcEEEEEe------cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccC
Confidence 9999999444332 3458899999999999999999999 999999999999999999999999999999654
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
. .........||+.|||||++.+..|+...|-|||||+|||||.|+.||.+.++++ ++
T Consensus 520 ~---~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-------------------~F 577 (694)
T KOG0694|consen 520 G---QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-------------------VF 577 (694)
T ss_pred C---CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-------------------HH
Confidence 2 2235567899999999999999999999999999999999999999998654321 11
Q ss_pred ccccCC-CCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 003059 734 DKSLAG-EDVDIEQVMRAIQVSFWCIQEQPSQRPMM 768 (852)
Q Consensus 734 d~~l~~-~~~~~~~~~~~~~l~~~cl~~dp~~RPt~ 768 (852)
|..+.. ...+..-..+.+.++.+.+..+|++|--+
T Consensus 578 dsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 578 DSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 211111 12344445677888899999999999866
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=330.65 Aligned_cols=262 Identities=16% Similarity=0.262 Sum_probs=190.2
Q ss_pred HhcccccccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhccccc------ceeeeeeeeccC-cee
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISSTHHL------NLVRLVGFSSEG-KHR 569 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~------niv~l~g~~~~~-~~~ 569 (852)
...|.+.++||+|+||.||+|... .++.||||+++.......++..|++++..++|. +++++++++... .+.
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 356778889999999999999864 578899999975444455667777777776554 588899988654 578
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC----------
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY---------- 639 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~---------- 639 (852)
++|||++ +++|.+++... ..+++..+..|+.||+.||+|||++ .+||||||||+|||++.++
T Consensus 208 ~iv~~~~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred EEEEecc-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccc
Confidence 9999988 77899888643 3588999999999999999999962 4899999999999998765
Q ss_pred ------ceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccc
Q 003059 640 ------NAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNR 713 (852)
Q Consensus 640 ------~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~ 713 (852)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||+.....+.
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERH------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred cCCCCceEEECCCCccccCcc------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 499999998764321 22346789999999999999999999999999999999999999976543211
Q ss_pred hhhHHHHH----HHHhh----CCcccccc------ccc---------CCC-CCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 003059 714 KKFSLWAY----EEFEK----GNVKGIVD------KSL---------AGE-DVDIEQVMRAIQVSFWCIQEQPSQRPMMG 769 (852)
Q Consensus 714 ~~l~~~~~----~~~~~----~~~~~~~d------~~l---------~~~-~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ 769 (852)
..+..... ..+.. .....+.+ +.. ... .........+++++.+||+.||++||+++
T Consensus 354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence 11110000 00000 00000000 000 000 00001123567899999999999999999
Q ss_pred HHHH
Q 003059 770 KVVQ 773 (852)
Q Consensus 770 ev~~ 773 (852)
|+++
T Consensus 434 e~L~ 437 (467)
T PTZ00284 434 QMTT 437 (467)
T ss_pred HHhc
Confidence 9986
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=318.29 Aligned_cols=267 Identities=21% Similarity=0.209 Sum_probs=198.7
Q ss_pred HHHHHhcccccccccccccceEEEEEEC---CCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceee
Q 003059 494 KELQRSTKGFKDKLGAGGFGAVYRGVLA---NRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRL 570 (852)
Q Consensus 494 ~el~~~~~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 570 (852)
..+....|.+.++||+|+||.||++... .++.|++|.+... ..+.+|++++++++||||+++++++......+
T Consensus 87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 3444567888999999999999999753 3578999988643 34578999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+|||++. ++|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 163 lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAAC 233 (392)
T ss_pred EEehhcC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCcccc
Confidence 9999995 688888832 3458999999999999999999998 899999999999999999999999999997
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcc
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (852)
........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||..................+......
T Consensus 234 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~ 312 (392)
T PHA03207 234 KLDAHPDT-PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE 312 (392)
T ss_pred ccCccccc-ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc
Confidence 65432211 12234569999999999999999999999999999999999999996543322111111111111000000
Q ss_pred -------cc------cccccCCCCCCH------HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 731 -------GI------VDKSLAGEDVDI------EQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 731 -------~~------~d~~l~~~~~~~------~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.+ ............ .....+.+++.+|++.||++||++.|++..
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 313 FPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 000000000000 012345678889999999999999999865
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=304.71 Aligned_cols=249 Identities=23% Similarity=0.322 Sum_probs=194.9
Q ss_pred ccccccccccccceEEEEEECC-CcEEEEEEecC-cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 501 KGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEG-IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
|++.++||+|+||.||+|.... +..+++|.+.. .....+.+.+|+++++.++|+||+++++++..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 4556789999999999999754 67889998873 334456788999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
++|..++... ...+++..+..++.|+++||.|||+ .+++||||||+|||++.++.+||+|||++.......
T Consensus 87 ~~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-- 157 (282)
T cd06643 87 GAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 157 (282)
T ss_pred CcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc--
Confidence 9999988542 2358999999999999999999999 899999999999999999999999999987653211
Q ss_pred ceeeeeecCCCCCCChhhhh-----cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 659 HRTLTSVRGTRGYLAPEWLA-----NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
.......++..|+|||.+. +..++.++|||||||++|||++|+.||....... . .........
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~-----~~~~~~~~~---- 225 (282)
T cd06643 158 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--V-----LLKIAKSEP---- 225 (282)
T ss_pred -cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--H-----HHHHhhcCC----
Confidence 1223356889999999984 4567889999999999999999999986432110 0 001111100
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
+.+. .+......+.+++.+|++.+|.+||++.++++.
T Consensus 226 -~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 226 -PTLA---QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -CCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0110 011112456788899999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=311.01 Aligned_cols=200 Identities=20% Similarity=0.214 Sum_probs=164.9
Q ss_pred cccccccc--ccceEEEEEE-CCCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 503 FKDKLGAG--GFGAVYRGVL-ANRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 503 ~~~~lG~G--~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
+.++||+| +|++||++.. .+++.||+|++.... ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 6889999986 468899999997432 23456778999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++|+|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.++++||+.........
T Consensus 82 ~~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 82 AYGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 9999999996432 2348899999999999999999998 899999999999999999999999998765432111
Q ss_pred Ccce----eeeeecCCCCCCChhhhhc--CCCCCCccchhhhHHHHHHHhCCcccccc
Q 003059 657 HRHR----TLTSVRGTRGYLAPEWLAN--LPITSKSDVYSYGMVLLEIVSGRRNFEVS 708 (852)
Q Consensus 657 ~~~~----~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~s~Gvvl~elltG~~p~~~~ 708 (852)
.... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 1100 0112346778999999976 46889999999999999999999999743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=302.17 Aligned_cols=245 Identities=26% Similarity=0.394 Sum_probs=190.9
Q ss_pred cccccccccceEEEEEEC-CCcEEEEEEecCc-ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCCH
Q 003059 504 KDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSL 581 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 581 (852)
...||+|+||.||+|... +++.|++|.+... ....+.+.+|++++++++|+||+++++++..++..++|+||+++++|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 357999999999999954 5778999988743 33456789999999999999999999999999999999999999999
Q ss_pred HHHhhhcccCCcccc--chhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC-CCceEEeecccccccCCCCCc
Q 003059 582 DNFLFANEEGSGKLL--NWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE-NYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 582 ~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~ 658 (852)
.+++.... ..+ ++..+..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||++........
T Consensus 93 ~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~- 164 (268)
T cd06624 93 SALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP- 164 (268)
T ss_pred HHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-
Confidence 99996432 123 778888999999999999998 89999999999999986 67999999999876543211
Q ss_pred ceeeeeecCCCCCCChhhhhcCC--CCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLP--ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
......++..|+|||.+.... ++.++||||||+++|||++|+.||......... .+..... . ..+
T Consensus 165 --~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~~~------~-~~~- 231 (268)
T cd06624 165 --CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVGMF------K-IHP- 231 (268)
T ss_pred --ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhhhh------c-cCC-
Confidence 122345789999999987643 788999999999999999999999643221110 0000000 0 001
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..+......+.+++.+|++.+|.+||++.+|++
T Consensus 232 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 232 ----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 111122345678889999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.77 Aligned_cols=248 Identities=21% Similarity=0.319 Sum_probs=198.7
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecC-cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEG-IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
..|.+.++||+|+||.||++.. .+++.||+|.+.. .....+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 4677788999999999999996 5688999999873 3334566889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|.+++.. ..+++..+..++.|++.+|.|||+ .+++||||||+|||++.++.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 99 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred CCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 99999999843 347888999999999999999998 899999999999999999999999999998654322
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
. ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.......... . .... -.+.
T Consensus 170 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~-~~~~-----~~~~ 234 (297)
T cd06656 170 S---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------L-IATN-----GTPE 234 (297)
T ss_pred c---CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------e-eccC-----CCCC
Confidence 1 1223457889999999999899999999999999999999999996543211100 0 0000 0000
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+ ..+......+.+++.+|++.+|++||++.+|++
T Consensus 235 ~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 L---QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred C---CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 011112234567888999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=326.11 Aligned_cols=266 Identities=20% Similarity=0.286 Sum_probs=191.4
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeecc--------Ccee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSE--------GKHR 569 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--------~~~~ 569 (852)
..|.+.++||+|+||.||+|... .++.||||++.... ....+|+.++++++|+||+++++++.. ....
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 45778899999999999999964 57899999886432 234579999999999999999987632 1246
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC-ceEEeeccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY-NAKVSDFGL 648 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGl 648 (852)
++||||+++ +|.+++..... ....+++..+..++.||+.||+|||+ ++|+||||||+||||+.++ .+||+|||+
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEecCCc-cHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 799999975 77777753221 24568899999999999999999998 8999999999999999665 799999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhC
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG 727 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (852)
++.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+. +.... ..+...
T Consensus 218 a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~-~~~~~p 290 (440)
T PTZ00036 218 AKNLLAGQ----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRII-QVLGTP 290 (440)
T ss_pred chhccCCC----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHH-HHhCCC
Confidence 98764321 12234679999999998764 689999999999999999999999975432211 11100 000000
Q ss_pred ----------CcccccccccCCC----CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcCc
Q 003059 728 ----------NVKGIVDKSLAGE----DVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ--MLEGIT 779 (852)
Q Consensus 728 ----------~~~~~~d~~l~~~----~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~--~L~~~~ 779 (852)
....+.-+..... ..+......+.+++.+||+.||.+||++.|+++ .++.+.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 0000000000000 001111246778999999999999999999984 444443
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=298.35 Aligned_cols=254 Identities=22% Similarity=0.314 Sum_probs=186.9
Q ss_pred ccccccccceEEEEEECCC---cEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCC
Q 003059 505 DKLGAGGFGAVYRGVLANR---TVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNG 579 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~~---~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 579 (852)
++||+|+||.||+|...++ ..+++|.+... ....+.|.+|+.+++.++||||+++++.|.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975433 34667766532 234568999999999999999999999999999999999999999
Q ss_pred CHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcc
Q 003059 580 SLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRH 659 (852)
Q Consensus 580 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 659 (852)
+|.+++..... ....+.+..+..++.||++||+|||+ .+++||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~-~~ 155 (268)
T cd05086 81 DLKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED-YI 155 (268)
T ss_pred cHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcch-hh
Confidence 99999975432 13346677788999999999999998 889999999999999999999999999986432211 11
Q ss_pred eeeeeecCCCCCCChhhhhc-------CCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 660 RTLTSVRGTRGYLAPEWLAN-------LPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
.......++..|+|||++.. ..++.++||||||+++|||++ |..||....... .......+....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~~~~~~~~ 228 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-------VLNHVIKDQQVK 228 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHhhcccc
Confidence 11223457889999998753 245789999999999999997 567875432211 111111122222
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~ 776 (852)
+.++.+.. . ....+.+++..|+ .+|++||++++|++.|.
T Consensus 229 ~~~~~~~~-~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQLEL-P----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCccCC-C----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 33333321 1 1234455667788 57999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=304.27 Aligned_cols=246 Identities=23% Similarity=0.350 Sum_probs=197.0
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
.|...+.||+|+||.||+|... +++.||+|.+... ....+.+.+|++++++++|+||+++++++..+...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3445678999999999999864 5788999988732 234467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|.+++.. ..+++..+..++.|+++||.|||+ ++++|+||+|+||++++++.++|+|||++..+....
T Consensus 85 ~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 85 GGGSALDLLKP------GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 99999998842 358899999999999999999998 899999999999999999999999999997654321
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||......... ...... ..+.
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~-----~~~~ 220 (277)
T cd06642 156 ---IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL-------FLIPKN-----SPPT 220 (277)
T ss_pred ---hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH-------hhhhcC-----CCCC
Confidence 1112345788999999999989999999999999999999999998643221100 000100 0111
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
+ .......+.+++.+|++.+|.+||++.+|++.
T Consensus 221 ~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 L-----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred C-----CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1 11223457788899999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=304.91 Aligned_cols=239 Identities=24% Similarity=0.417 Sum_probs=187.0
Q ss_pred ccccccccceEEEEEECC--------CcEEEEEEecCc-ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 505 DKLGAGGFGAVYRGVLAN--------RTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
+.||+|+||.||+|.... ..+|++|.+... ....+.+..|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999998532 235888887633 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCc--------eEEeecc
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYN--------AKVSDFG 647 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~--------~kl~DFG 647 (852)
+++|+|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++. ++++|||
T Consensus 81 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 81 VKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred CCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 99999999996442 358899999999999999999998 89999999999999987765 5999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCC-ccccccccccchhhHHHHHHHHh
Q 003059 648 LAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGR-RNFEVSQETNRKKFSLWAYEEFE 725 (852)
Q Consensus 648 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~ 725 (852)
++...... ....++..|+|||++.+. .++.++||||||+++|||++|. .|+......... ...
T Consensus 154 ~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~--------~~~ 218 (258)
T cd05078 154 ISITVLPK-------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL--------QFY 218 (258)
T ss_pred cccccCCc-------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH--------HHH
Confidence 88754321 224578899999999864 5789999999999999999995 555432221100 000
Q ss_pred hCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003059 726 KGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776 (852)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~ 776 (852)
... . ..+......+.+++.+|++.+|++||++++|++.|+
T Consensus 219 ~~~------~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 219 EDR------H-----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred Hcc------c-----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 0 111112245678899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=307.84 Aligned_cols=199 Identities=26% Similarity=0.377 Sum_probs=161.7
Q ss_pred ccccccccceEEEEEECC---CcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeec--cCceeeEEEeecCCC
Q 003059 505 DKLGAGGFGAVYRGVLAN---RTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSS--EGKHRLLVYEFMKNG 579 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lV~e~~~~g 579 (852)
.+||+|+||.||+|...+ +..||+|.+.... ....+.+|++++++++||||+++++++. .+...++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 579999999999999643 4789999987433 2346788999999999999999999884 35678999999864
Q ss_pred CHHHHhhhccc----CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEe----CCCCceEEeecccccc
Q 003059 580 SLDNFLFANEE----GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL----DENYNAKVSDFGLAKL 651 (852)
Q Consensus 580 sL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~DFGla~~ 651 (852)
+|.+++..... .....+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 78777753211 122358899999999999999999998 899999999999999 5678999999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCcccccc
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVS 708 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~ 708 (852)
...............+|..|+|||.+.+. .++.++|||||||++|||+||+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 65432222223345689999999998764 5789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=314.27 Aligned_cols=196 Identities=25% Similarity=0.341 Sum_probs=165.9
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccC------ce
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEG------KH 568 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~ 568 (852)
..|.+.+.||+|+||.||++... .++.||||++... ......+.+|+.+++.++||||+++++++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 46777889999999999999864 5788999998742 23345678899999999999999999987543 35
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.++||||+++ +|.+++. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred EEEEEeCCCC-CHHHHHH-------hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 7999999965 7777773 237888899999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccc
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQ 709 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~ 709 (852)
++..... .......+|..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 173 a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 173 ARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred ccccCCC----CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 9865321 12233568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=299.79 Aligned_cols=257 Identities=25% Similarity=0.373 Sum_probs=199.8
Q ss_pred hcccccccccccccceEEEEEEC------CCcEEEEEEecCccc--chHHHHHHHHHhhcccccceeeeeeeeccCceee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA------NRTVVAVKQLEGIEQ--GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRL 570 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 570 (852)
..+...++||+|+||.||+|... +.+.|++|.+..... ..+++.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 34556678999999999999853 346799998874333 3467999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhhcccCC----ccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeec
Q 003059 571 LVYEFMKNGSLDNFLFANEEGS----GKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDF 646 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 646 (852)
+||||+++++|.+++....... ...+++..+..++.|++.+|+|||+ .+|+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999996543211 1258999999999999999999998 88999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHh
Q 003059 647 GLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFE 725 (852)
Q Consensus 647 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 725 (852)
|+++....... .......++..|+|||.+.+...+.++||||||+++|||++ |..||....... . .....
T Consensus 162 ~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~----~~~~~ 232 (275)
T cd05046 162 SLSKDVYNSEY--YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---V----LNRLQ 232 (275)
T ss_pred ccccccCcccc--cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---H----HHHHH
Confidence 99875432111 11223345678999999998889999999999999999999 788885432211 0 11111
Q ss_pred hCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003059 726 KGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776 (852)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~ 776 (852)
.+..... ........+.+++.+|++.+|.+||++.++++.|+
T Consensus 233 ~~~~~~~---------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 AGKLELP---------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cCCcCCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111100 01112236778899999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=318.24 Aligned_cols=253 Identities=20% Similarity=0.258 Sum_probs=193.1
Q ss_pred HHHhcccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceee
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRL 570 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 570 (852)
+....|.+.+.||+|+||.||++... +++.+|+|.+... ....+.+.+|+.+++.++||||+++++.+.+++..+
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34457778899999999999999965 5788999998632 223455788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+||||+++|+|.+++.. ..++...+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 120 lv~Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 99999999999999853 237788888999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhcCC----CCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhh
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANLP----ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEK 726 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (852)
...... ........||+.|+|||++.... ++.++|||||||++|||++|+.||....... ....+..
T Consensus 191 ~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~ 261 (371)
T cd05622 191 KMNKEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------TYSKIMN 261 (371)
T ss_pred EcCcCC--cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-------HHHHHHc
Confidence 764321 11223456999999999997543 7899999999999999999999997543210 1111111
Q ss_pred CC-cccccccccCCCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 003059 727 GN-VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQ--RPMMGKVVQM 774 (852)
Q Consensus 727 ~~-~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~--RPt~~ev~~~ 774 (852)
.. .... +........+.+++..|++.++.+ ||++.+|++.
T Consensus 262 ~~~~~~~--------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 262 HKNSLTF--------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCCcccC--------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 10 0000 011112334556777788744433 7788888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=299.85 Aligned_cols=253 Identities=26% Similarity=0.402 Sum_probs=197.8
Q ss_pred ccccccccccccceEEEEEECC--CcEEEEEEecCc-----------ccchHHHHHHHHHhhc-ccccceeeeeeeeccC
Q 003059 501 KGFKDKLGAGGFGAVYRGVLAN--RTVVAVKQLEGI-----------EQGEKQFRMEVATISS-THHLNLVRLVGFSSEG 566 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~-----------~~~~~~f~~E~~~l~~-l~h~niv~l~g~~~~~ 566 (852)
|.+.+.||+|+||.||+|.... ++.+|+|.+... .....++..|+.++.+ ++|+||+++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 4567889999999999999755 678999987521 1123456778888765 7999999999999999
Q ss_pred ceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeec
Q 003059 567 KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDF 646 (852)
Q Consensus 567 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 646 (852)
+..++||||+++++|.+++..... ....+++..+++++.|++.+|.|||+. .+++|+||||+||+++.++.+||+||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999998854221 234688999999999999999999952 57999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhh
Q 003059 647 GLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEK 726 (852)
Q Consensus 647 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (852)
|++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||....... . .....+
T Consensus 159 g~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~------~-~~~~~~ 227 (269)
T cd08528 159 GLAKQKQPES----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS------L-ATKIVE 227 (269)
T ss_pred cceeeccccc----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH------H-HHHHhh
Confidence 9998764322 2234568899999999999889999999999999999999999996432211 0 011111
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003059 727 GNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776 (852)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~ 776 (852)
...... . .......+.+++.+|++.||++||++.||.++++
T Consensus 228 ~~~~~~----~-----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 AVYEPL----P-----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ccCCcC----C-----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111100 0 0011245678888999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=306.22 Aligned_cols=247 Identities=20% Similarity=0.321 Sum_probs=198.3
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecC-cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEG-IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
+|.+.++||.|+||.||+|.. .+++.|++|.+.. .....+.+.+|+++++.++|+||+++++++...+..++|+||++
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 466778999999999999985 5688999999873 33345678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
+++|.+++.. ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 100 ~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 100 GGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 9999998842 248899999999999999999999 8999999999999999999999999999886543221
Q ss_pred cceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccccc
Q 003059 658 RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSL 737 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (852)
......++..|+|||.+.+..++.++|||||||++|||++|+.||......... ........ +.+
T Consensus 171 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~-------~~~~~~~~-----~~~ 235 (296)
T cd06655 171 ---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------YLIATNGT-----PEL 235 (296)
T ss_pred ---cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhcCC-----ccc
Confidence 122345888999999999888999999999999999999999999754321110 00110000 001
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 738 AGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 738 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
. .+......+.+++.+|+..+|.+||++.+|++
T Consensus 236 ~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 Q---NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred C---CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0 01111234667888999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=299.11 Aligned_cols=247 Identities=32% Similarity=0.454 Sum_probs=195.9
Q ss_pred hcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
..+.+.+.||+|+||.||++.. .++.||+|.+.... ..+.+.+|+.++.+++|||++++++++.+. ..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 3567788999999999999975 56679999987432 346789999999999999999999998765 47999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
++|.+++.... ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 83 GNLVNFLRTRG---RALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred CCHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 99999996542 3358899999999999999999998 89999999999999999999999999998754321
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccccccc
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSL 737 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (852)
......+..|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+.. .
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~---~---- 216 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKGYR---M---- 216 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhCCCC---C----
Confidence 112234567999999998899999999999999999998 999986443211 0111111100 0
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003059 738 AGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEG 777 (852)
Q Consensus 738 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~ 777 (852)
..+......+.+++.+|++.+|++||++++|++.|++
T Consensus 217 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 ---EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ---CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0111123456788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=314.00 Aligned_cols=191 Identities=23% Similarity=0.307 Sum_probs=162.9
Q ss_pred HhcccccccccccccceEEEEEECC-CcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
...|.+.+.||+|+||.||+|.... ++.||+|..... ....|+.++++++|+||+++++++.+....++|+||+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 3457788999999999999999754 678999975422 2356999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
.++|.+++... ...+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 140 -~~~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 140 -SSDLYTYLTKR----SRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred -CCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 46888888543 3468999999999999999999998 89999999999999999999999999999754321
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNF 705 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~ 705 (852)
.......||..|+|||.+.+..++.++|||||||++|||+++..++
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223456899999999999999999999999999999999865544
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.79 Aligned_cols=259 Identities=24% Similarity=0.312 Sum_probs=189.8
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCcc---cchHHHHHHHHHhhcc---cccceeeeeeeecc-----Cce
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---QGEKQFRMEVATISST---HHLNLVRLVGFSSE-----GKH 568 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l---~h~niv~l~g~~~~-----~~~ 568 (852)
|.+.+.||+|+||.||+|... +++.||+|.+.... .....+.+|++++.++ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 566789999999999999865 58899999987322 2234566777777665 69999999998764 346
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.++||||++ ++|.+++.... ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred EEEEEcccc-cCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCc
Confidence 799999997 48988885432 2358899999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhC-
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG- 727 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~- 727 (852)
++...... ......++..|+|||.+.+..++.++|||||||++|||++|+.||......+. +... .......
T Consensus 155 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~~-~~~~~~~~ 227 (288)
T cd07863 155 ARIYSCQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKI-FDLIGLPP 227 (288)
T ss_pred cccccCcc----cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHHH-HHHhCCCC
Confidence 98664321 12234578999999999999999999999999999999999999965432111 0000 0000000
Q ss_pred --Cccc---ccccccCC-CCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 728 --NVKG---IVDKSLAG-EDVD-----IEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 728 --~~~~---~~d~~l~~-~~~~-----~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.... ........ .... .+....+.+++.+|++.||++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 00000000 0000 112235678999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=302.25 Aligned_cols=254 Identities=22% Similarity=0.314 Sum_probs=195.7
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhcc-cccceeeeeeeec-----cCceeeE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISST-HHLNLVRLVGFSS-----EGKHRLL 571 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~-----~~~~~~l 571 (852)
.+|.+.+.||+|+||.||++... .++.+++|.+........++.+|+.++.++ +|+||+++++++. .++..++
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 97 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL 97 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence 35667789999999999999864 578899998875544556788999999999 6999999999874 4457899
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
||||+++++|.+++..... ....+++..+..++.|+++||.|||+ .+++||||||+||++++++.+||+|||+++.
T Consensus 98 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 173 (286)
T cd06638 98 VLELCNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ 173 (286)
T ss_pred EEeecCCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceee
Confidence 9999999999998864322 23468899999999999999999998 8999999999999999999999999999986
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhc-----CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhh
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLAN-----LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEK 726 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (852)
+..... ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||....... .+ .....
T Consensus 174 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~-----~~~~~ 243 (286)
T cd06638 174 LTSTRL---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--AL-----FKIPR 243 (286)
T ss_pred cccCCC---ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HH-----hhccc
Confidence 543211 1223468999999998853 457889999999999999999999986432110 00 00000
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 727 GNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
. ..+.+.. +......+.+++.+|++.+|++||++.||++.
T Consensus 244 ~-----~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 244 N-----PPPTLHQ---PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred c-----CCCcccC---CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 0011100 01112357788999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=307.98 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=196.8
Q ss_pred cccccccccccccceEEEEEEC-CCc----EEEEEEecCcc--cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRT----VVAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
.+...+.||+|+||.||+|.+. ++. .||+|.+.... ....++.+|+.++++++||||+++++++... ..+++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v 86 (303)
T cd05110 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLV 86 (303)
T ss_pred hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceee
Confidence 3455678999999999999853 333 57889887432 2234688999999999999999999998754 56799
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
+||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++..
T Consensus 87 ~e~~~~g~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 87 TQLMPHGCLLDYVHEH----KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred ehhcCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccc
Confidence 9999999999998643 2357889999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
...... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .. .....+.
T Consensus 160 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~--- 228 (303)
T cd05110 160 EGDEKE-YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IP----DLLEKGE--- 228 (303)
T ss_pred cCcccc-cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHCCC---
Confidence 432111 11122345678999999999999999999999999999997 899986432111 11 1111110
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
.. +.+......+.+++..|+..+|++||++.++++.|+.+.+.
T Consensus 229 ----~~---~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 229 ----RL---PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ----CC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00 00111224567888999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=303.24 Aligned_cols=250 Identities=22% Similarity=0.332 Sum_probs=195.9
Q ss_pred hcccccccccccccceEEEEEECC-CcEEEEEEecCc-ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
..|++.++||.|+||.||+|.... ++.|++|.+... ....+.+..|+++++.++|+||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 356678899999999999999754 788999998743 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|..++... ...+++..+..++.|++.+|+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 92 ~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~- 163 (292)
T cd06644 92 PGGAVDAIMLEL----DRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT- 163 (292)
T ss_pred CCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccc-
Confidence 999999887543 2358899999999999999999998 89999999999999999999999999998754321
Q ss_pred CcceeeeeecCCCCCCChhhhh-----cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLA-----NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
........++..|+|||.+. ...++.++|||||||++|||++|+.||....... .........
T Consensus 164 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~--- 231 (292)
T cd06644 164 --LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-------VLLKIAKSE--- 231 (292)
T ss_pred --ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-------HHHHHhcCC---
Confidence 11123456888999999884 3456889999999999999999999986432110 011111110
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.+.. ..+......+.+++.+|++.+|++||++.+|++
T Consensus 232 --~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 232 --PPTL---SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred --CccC---CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0111 111122335678889999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=313.25 Aligned_cols=261 Identities=21% Similarity=0.280 Sum_probs=192.5
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccC------ce
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEG------KH 568 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~ 568 (852)
..|.+.+.||+|+||.||++... .++.||||++... ......+.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 96 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD 96 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence 46777889999999999999864 5788999998743 22345678899999999999999999987543 35
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.++||||+++ +|.+++. ..+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 97 ~~lv~e~~~~-~l~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 97 VYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred eEEEhhhhcc-cHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcc
Confidence 7999999965 6777663 237888899999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHH---------H
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSL---------W 719 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~---------~ 719 (852)
++..... .......+|..|+|||.+.+..++.++|||||||++|||++|+.||............. .
T Consensus 166 ~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 166 ARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred cccCCCc----cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9865321 12233568999999999999999999999999999999999999997543211100000 0
Q ss_pred H------HHHHhh--CCccccc-ccccCCC------CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 720 A------YEEFEK--GNVKGIV-DKSLAGE------DVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 720 ~------~~~~~~--~~~~~~~-d~~l~~~------~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
. ...+.+ .....+. .+..... .........+.+++.+|++.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0 000000 0000000 0000000 0011123456789999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=301.61 Aligned_cols=250 Identities=22% Similarity=0.318 Sum_probs=197.3
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc-ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
.|.+.++||.|+||.||++... ++..+++|.+... ....+.|..|++++++++|+||+++++++.++...++||||++
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence 4667789999999999999974 5789999998733 3345678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
+++|.+++... ...+++..+..++.|++.+|.|||+ .+|+|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (280)
T cd06611 86 GGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL- 157 (280)
T ss_pred CCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence 99999998543 2358999999999999999999998 899999999999999999999999999987653221
Q ss_pred cceeeeeecCCCCCCChhhhh-----cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccc
Q 003059 658 RHRTLTSVRGTRGYLAPEWLA-----NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI 732 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (852)
.......++..|+|||.+. ...++.++||||||+++|||++|+.||....... . .........
T Consensus 158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~-----~~~~~~~~~--- 225 (280)
T cd06611 158 --QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--V-----LLKILKSEP--- 225 (280)
T ss_pred --cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--H-----HHHHhcCCC---
Confidence 1223456899999999985 3457789999999999999999999997542211 0 011111110
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
+.+. .+......+.+++..|++.+|.+||++.+|++.
T Consensus 226 --~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 --PTLD---QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred --CCcC---CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1110 011112356678889999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=298.40 Aligned_cols=248 Identities=25% Similarity=0.376 Sum_probs=195.9
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCccc----------chHHHHHHHHHhhcccccceeeeeeeeccCcee
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQ----------GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHR 569 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 569 (852)
+.+.+.||+|+||.||+|... +++.+|+|.+..... ..+.+++|++++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 556788999999999999864 578899998863211 124688999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||++
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred EEEEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999543 347888999999999999999998 89999999999999999999999999999
Q ss_pred cccCCCCCcc---eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhh
Q 003059 650 KLINPKDHRH---RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEK 726 (852)
Q Consensus 650 ~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (852)
+......... .......++..|+|||.+.+..++.++||||||+++|||++|+.||....... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~ 226 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-------AIFKIGE 226 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-------HHHHHhc
Confidence 8765321111 11122457889999999998899999999999999999999999997532210 0001111
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 727 GNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
...+. .+......+.+++.+|++.+|.+||++.+|++
T Consensus 227 -----~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 -----NASPE-----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -----cCCCc-----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11111 11122345677888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=281.71 Aligned_cols=249 Identities=24% Similarity=0.363 Sum_probs=198.2
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecC---cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEG---IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
..|.+.+.||+|.|+.||+... ..|+.+|+|++.. ...+.+++++|+.+-+.|+||||++|++.+.+....|||+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 3566778999999999999874 5688888888762 23366788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeC---CCCceEEeecccccc
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD---ENYNAKVSDFGLAKL 651 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~DFGla~~ 651 (852)
+|.|++|..-|.++ ...++..+-+.++||+++|.|+|. ++|||||+||.|+||. ..--+||+|||+|..
T Consensus 91 ~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred cccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 99999997777543 357788888999999999999999 8999999999999995 345589999999998
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
+.. ........||++|||||+++..+++..+|||+-||+||-||.|..||-..... ..++.+..+...-
T Consensus 163 l~~----g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-------rlye~I~~g~yd~ 231 (355)
T KOG0033|consen 163 VND----GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYEQIKAGAYDY 231 (355)
T ss_pred eCC----ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-------HHHHHHhccccCC
Confidence 862 22345678999999999999999999999999999999999999999753211 1233333322110
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
-.+.+. ...+...+++.+|+..||.+|.|+.|.++
T Consensus 232 -~~~~w~------~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 232 -PSPEWD------TVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred -CCcccC------cCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 001111 11234556788899999999999988775
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=299.33 Aligned_cols=250 Identities=22% Similarity=0.298 Sum_probs=195.0
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCc-ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
.|.+.++||+|+||.||+|.. .+++.||+|.++.. ......+.+|+.++..++||||+++++.+...+..++||||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 556678899999999999986 45888999998743 2334567889999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
+++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++......
T Consensus 90 ~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd06645 90 GGSLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-- 159 (267)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--
Confidence 99999998543 348899999999999999999998 89999999999999999999999999998765421
Q ss_pred cceeeeeecCCCCCCChhhhh---cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 658 RHRTLTSVRGTRGYLAPEWLA---NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
........|+..|+|||.+. ...++.++|||||||++|||++|+.||......... ....... ...
T Consensus 160 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~-------~~~~~~~---~~~ 228 (267)
T cd06645 160 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-------FLMTKSN---FQP 228 (267)
T ss_pred -ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH-------HhhhccC---CCC
Confidence 11223456899999999974 456889999999999999999999998543221100 0000000 001
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+.... .......+.+++.+|++.+|++||++.+|++
T Consensus 229 ~~~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 229 PKLKD---KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred Ccccc---cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 11100 0011234678889999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.74 Aligned_cols=264 Identities=22% Similarity=0.294 Sum_probs=193.6
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
|.+.++||+|+||.||+|+.. +++.||+|++... ......+.+|+.++.+++||||+++++++.+++..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 456788999999999999964 5889999998632 223467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
+ ++|.+++..... ...+++..+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||++.......
T Consensus 82 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 82 S-MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred C-CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 7 689888854322 3568999999999999999999998 899999999999999999999999999997653221
Q ss_pred CcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHH-----HHHhh----
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAY-----EEFEK---- 726 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~-----~~~~~---- 726 (852)
.......+++.|+|||.+.+. .++.++||||||+++|||++|+.||................ ..+..
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 156 ---RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred ---ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence 112234568899999988754 57889999999999999999999997543211100000000 00000
Q ss_pred CCcccccccccCCC--CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 727 GNVKGIVDKSLAGE--DVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 727 ~~~~~~~d~~l~~~--~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
......+....... ........++.+++.+|++.||.+||++.+|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000000 000001234568899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=298.18 Aligned_cols=246 Identities=23% Similarity=0.349 Sum_probs=198.6
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
.|...++||.|+||.||+|... .+..||+|.+... ......+.+|+++++++.|+||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 3455678999999999999965 5788999988733 334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|.+++.. ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 85 GGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 99999999842 247888899999999999999998 899999999999999999999999999997664322
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
. ......++..|+|||.+.+..++.++||||||+++|||++|+.||......... ....... .+
T Consensus 156 ~---~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~~-----~~- 219 (277)
T cd06640 156 I---KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-------FLIPKNN-----PP- 219 (277)
T ss_pred c---ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-------hhhhcCC-----CC-
Confidence 1 122345788999999999889999999999999999999999999643221100 0000000 01
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.........+.+++.+|++.+|++||++.++++.
T Consensus 220 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 ----TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ----CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1222344567789999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=299.79 Aligned_cols=246 Identities=24% Similarity=0.360 Sum_probs=198.3
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
.|.+.+.||.|+||.||+|... +++.|++|.+... ......+.+|+++++.++|+||+++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 3556788999999999999965 5789999998733 334467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|.+++... .+++..+..++.|++.+|.|||+ .+++||||+|+||++++++.++|+|||+++.+....
T Consensus 82 ~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 82 GGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred CCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999998532 68999999999999999999998 889999999999999999999999999998765421
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||....... ........ ..+.
T Consensus 153 ---~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-------~~~~~~~~-----~~~~ 217 (274)
T cd06609 153 ---SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-------VLFLIPKN-----NPPS 217 (274)
T ss_pred ---cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-------HHHHhhhc-----CCCC
Confidence 12233457889999999999899999999999999999999999996443110 00011111 1111
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+.. . .....+.+++.+|+..+|++||+++++++
T Consensus 218 ~~~-~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 218 LEG-N---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred Ccc-c---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111 0 02235677888999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=296.04 Aligned_cols=247 Identities=23% Similarity=0.345 Sum_probs=197.1
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeecc-CceeeEEEee
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSE-GKHRLLVYEF 575 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~e~ 575 (852)
|.+.+.||+|++|.||++... +++.|++|++... ....+.+..|++++++++|+|++++++.+.. ....++||||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 567889999999999999964 4778999998632 2334568899999999999999999998764 4467999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+++++|.+++.... ...+++.+++.++.|++.+|+|||+ .+++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 82 CEGGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred cCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999996432 3458999999999999999999998 89999999999999999999999999999876432
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
. .......+++.|+|||.+.+..++.++||||||++++||++|+.||...... .... ....+...
T Consensus 156 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~-~~~~~~~~----- 220 (257)
T cd08223 156 C---DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVY-RIIEGKLP----- 220 (257)
T ss_pred C---CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHH-HHHhcCCC-----
Confidence 1 1223455889999999999999999999999999999999999999743211 1111 11111110
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..+......+.+++.+|++.+|++||++.++++
T Consensus 221 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 -----PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -----CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111223346778899999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=313.73 Aligned_cols=201 Identities=24% Similarity=0.334 Sum_probs=171.3
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
+++.+.||+|+||.||++... +++.||+|++... ......+..|+.++.+++|+||+++++.+.+++..++||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 556789999999999999865 5789999998732 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+++|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||||+.++.+||+|||+++.+...
T Consensus 83 ~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 83 LPGGDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred CCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999643 348899999999999999999998 89999999999999999999999999998754321
Q ss_pred CCc--------------------------------ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCc
Q 003059 656 DHR--------------------------------HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRR 703 (852)
Q Consensus 656 ~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~ 703 (852)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 000 000113468999999999999999999999999999999999999
Q ss_pred cccccc
Q 003059 704 NFEVSQ 709 (852)
Q Consensus 704 p~~~~~ 709 (852)
||....
T Consensus 235 Pf~~~~ 240 (360)
T cd05627 235 PFCSET 240 (360)
T ss_pred CCCCCC
Confidence 997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=295.32 Aligned_cols=248 Identities=23% Similarity=0.353 Sum_probs=199.8
Q ss_pred ccccccccccccceEEEEEE-CCCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 501 KGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
|.+.+.||.|+||.||.+.. .+++.+++|.+... .....++.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 56778999999999999885 45788999988632 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|.+++.... ...+++..+..++.|++++|+|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 82 NGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred CCCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999999996442 3458899999999999999999998 789999999999999999999999999998764322
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
. ......++..|+|||.+.+..++.++||||||+++|||++|+.||+...... .......+....
T Consensus 156 ~---~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-------~~~~~~~~~~~~----- 220 (256)
T cd08221 156 S---MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-------LVVKIVQGNYTP----- 220 (256)
T ss_pred c---cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCCC-----
Confidence 1 2234568899999999998889999999999999999999999996532211 011111111111
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
........+.+++.+|++.+|.+||++.++++.
T Consensus 221 -----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 -----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -----CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 111123456788889999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=306.14 Aligned_cols=261 Identities=23% Similarity=0.320 Sum_probs=194.3
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
..|.+.++||+|+||.||+|... +++.||+|.+... ......+.+|+.++++++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 35677889999999999999865 5788999998732 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
++ ++|.+++... ...+++..+..++.||++||+|||+ .+|+|+||||+|||+++++.+||+|||++......
T Consensus 86 ~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 86 LD-KDLKQYLDDC----GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred cc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 97 5899888543 2357889999999999999999998 89999999999999999999999999999764321
Q ss_pred CCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHh---hCCccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFE---KGNVKG 731 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~ 731 (852)
. .......+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+... ....... ......
T Consensus 158 ~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~ 231 (301)
T cd07873 158 T---KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH---FIFRILGTPTEETWPG 231 (301)
T ss_pred C---CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCChhhchh
Confidence 1 112234568899999998754 57889999999999999999999997543221110 0000000 000000
Q ss_pred ccc------cccCCC-C-----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 732 IVD------KSLAGE-D-----VDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 732 ~~d------~~l~~~-~-----~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
++. ...... . ........+.+++.+|++.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 232 ILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 000000 0 00011224568899999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=301.86 Aligned_cols=252 Identities=22% Similarity=0.326 Sum_probs=195.6
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCcccchHHHHHHHHHhhcc-cccceeeeeeeeccC-----ceeeEE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVATISST-HHLNLVRLVGFSSEG-----KHRLLV 572 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~-----~~~~lV 572 (852)
.|.+.+.||+|+||.||++.. .+++.+|+|.+........++.+|+.++.++ +|||++++++++... +..++|
T Consensus 23 ~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv 102 (291)
T cd06639 23 TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV 102 (291)
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence 456678999999999999996 4688999999875555556788999999998 899999999998653 368999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++++|.+++..... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++..
T Consensus 103 ~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~ 178 (291)
T cd06639 103 LELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178 (291)
T ss_pred EEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence 999999999998864321 24468899999999999999999998 89999999999999999999999999998865
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcC-----CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhC
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANL-----PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG 727 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (852)
..... ......++..|+|||.+... .++.++|||||||++|||++|+.||....... .+ ......
T Consensus 179 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--~~-----~~~~~~ 248 (291)
T cd06639 179 TSTRL---RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--TL-----FKIPRN 248 (291)
T ss_pred ccccc---cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--HH-----HHHhcC
Confidence 43211 11234578899999998644 36889999999999999999999996432211 00 111111
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 728 NVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 728 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
....+. .+.+....+.+++.+|++.+|++||++.++++
T Consensus 249 ~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 249 PPPTLL--------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCCCC--------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111 11122345778899999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=297.40 Aligned_cols=248 Identities=24% Similarity=0.330 Sum_probs=188.5
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCcc------cchHHHHHHHHHhhcccccceeeeeeeecc--CceeeE
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE------QGEKQFRMEVATISSTHHLNLVRLVGFSSE--GKHRLL 571 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l 571 (852)
|...+.||+|+||.||++... .++.|++|++.... .....+.+|+.++++++|+||+++++++.+ +...++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 455688999999999999864 58899999886321 123468889999999999999999998865 357789
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
++||+++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 84 FMEYMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 99999999999999543 247889999999999999999998 8999999999999999999999999999986
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
+..............++..|+|||.+.+..++.++||||||+++|||++|+.||....... . .. .... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-----~-~~-~~~~----~ 224 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-----A-IF-KIAT----Q 224 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-----H-HH-HHhc----C
Confidence 5432111112223458889999999999899999999999999999999999996432110 0 00 0000 0
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
...+.+ +. .....++.++.|+..+|++||+++||++
T Consensus 225 ~~~~~~-----~~-~~~~~~~~li~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 225 PTNPQL-----PS-HISEHARDFLGCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCCC-----ch-hcCHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 001111 11 1112223334688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=303.78 Aligned_cols=251 Identities=27% Similarity=0.358 Sum_probs=206.8
Q ss_pred HHhcccccccccccccceEEEEEECC-CcEEEEEEecCccc----chHHHHHHHHHhhccc-ccceeeeeeeeccCceee
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGIEQ----GEKQFRMEVATISSTH-HLNLVRLVGFSSEGKHRL 570 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~ 570 (852)
....|.+.+.||+|.||.||+++.+. ++.+|+|.+.+... ....+.+|+.+|+++. |||||.+.+.+.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 44567888999999999999999765 89999999974332 3468999999999998 999999999999999999
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC----CCceEEeec
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE----NYNAKVSDF 646 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~----~~~~kl~DF 646 (852)
+|||++.||.|.+.+... .+++.....++.||+.+++|||+ .+|+||||||+|+|+.. ++.+|++||
T Consensus 113 lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 999999999999999654 28999999999999999999999 89999999999999953 357999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhh
Q 003059 647 GLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEK 726 (852)
Q Consensus 647 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (852)
|++..... ........||+.|+|||++....++...||||+||++|.|++|..||......... ..+..
T Consensus 184 Gla~~~~~----~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~-------~~i~~ 252 (382)
T KOG0032|consen 184 GLAKFIKP----GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF-------LAILR 252 (382)
T ss_pred CCceEccC----CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH-------HHHHc
Confidence 99998754 34567789999999999999999999999999999999999999999865432211 12222
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 727 GNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
++. +.-++.. ......+-+++..++..||.+|+++.++++.
T Consensus 253 ~~~-~f~~~~w------~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 253 GDF-DFTSEPW------DDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCC-CCCCCCc------cccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 222 1111111 1123455677888999999999999999984
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=296.09 Aligned_cols=247 Identities=23% Similarity=0.348 Sum_probs=198.3
Q ss_pred ccccccccccccceEEEEEE-CCCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 501 KGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
|.+.++||+|+||.||++.. .+++.|++|++... ....+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 56778999999999999985 45789999998632 233467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|.+++.... ...+++..++.++.|++.||+|||+ .+++|+||+|+|||++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 82 EGGDLYKKINAQR---GVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999886432 2357889999999999999999998 899999999999999999999999999998654321
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
. ......++..|+|||.+.+..++.++||||||++++||++|+.||...... ... .....+...
T Consensus 156 ~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~-~~~~~~~~~------ 219 (256)
T cd08218 156 E---LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLV-LKIIRGSYP------ 219 (256)
T ss_pred h---hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHH-HHHhcCCCC------
Confidence 1 112345788999999999989999999999999999999999999643211 111 111111110
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..+......+.+++.+|++.+|.+||++.+|++
T Consensus 220 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 ----PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ----CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111122345778889999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=294.13 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=200.1
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc-ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
..|.+.+.||+|+||.||++... +++.+++|.+... ....+.+.+|++++++++||||+++++++.++...+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 35677889999999999999864 5778999998733 335578899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|.+++... ...++...+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 83 GGGSLQDIYQVT----RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 999999998643 2358899999999999999999998 899999999999999999999999999987654321
Q ss_pred CcceeeeeecCCCCCCChhhhhcC---CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANL---PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
.......++..|+|||.+.+. .++.++||||||+++|||++|+.||......... ....... ..
T Consensus 156 ---~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~-------~~~~~~~---~~ 222 (262)
T cd06613 156 ---AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL-------FLISKSN---FP 222 (262)
T ss_pred ---hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhcc---CC
Confidence 112234578899999999877 8899999999999999999999999654321110 0011100 00
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
...+ .........+.+++.+|++.+|.+||++.+|+.
T Consensus 223 ~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 223 PPKL---KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred Cccc---cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0111 112223456788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=295.65 Aligned_cols=248 Identities=22% Similarity=0.278 Sum_probs=190.9
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCcc------cchHHHHHHHHHhhcccccceeeeeeeeccC--ceeeE
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE------QGEKQFRMEVATISSTHHLNLVRLVGFSSEG--KHRLL 571 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 571 (852)
+.+.+.||+|+||.||+|... +++.|++|.+.... ...+.+.+|+.++.+++|+||+++++++.+. ...++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 556789999999999999964 48899999875221 1235678899999999999999999988763 46789
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
||||+++++|.+++... ..+++..+++++.|++.+|+|||+ .+++|+||||+||+++.++.++|+|||+++.
T Consensus 84 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 84 FMEHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 99999999999998533 247888899999999999999998 8899999999999999999999999999986
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
...............++..|+|||.+.+..++.++||||||+++|||++|+.||....... . .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~-----~~~~~~~---- 224 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA--A-----IFKIATQ---- 224 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH--H-----HHHHhcC----
Confidence 5432211112233458889999999998889999999999999999999999996432110 0 0011000
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
...+ ..+......+.+++.+|+. +|++||++++|++
T Consensus 225 ~~~~-----~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 225 PTNP-----VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCCC-----CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0011 1222333455667777874 8999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=293.85 Aligned_cols=249 Identities=31% Similarity=0.503 Sum_probs=198.3
Q ss_pred cccccccccccceEEEEEECC-----CcEEEEEEecCccc--chHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 502 GFKDKLGAGGFGAVYRGVLAN-----RTVVAVKQLEGIEQ--GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 502 ~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.+.+.||.|+||.||++...+ +..||+|.+..... ..+.+..|+.++.+++|+||+++++++.+.+..++|||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 356789999999999999754 37899999974443 46789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++++|.+++..... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||+++....
T Consensus 82 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 82 YMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred ccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999964321 128999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
...... ....++..|+|||.+.+..++.++||||||++++||++ |+.||...... .. ..........
T Consensus 156 ~~~~~~--~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~----~~~~~~~~~~--- 223 (258)
T smart00219 156 DDYYKK--KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EV----LEYLKKGYRL--- 223 (258)
T ss_pred cccccc--ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHhcCCCC---
Confidence 322111 12336789999999988889999999999999999998 78888643211 10 1111111110
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQML 775 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L 775 (852)
.........+.+++.+|++.+|++||++.++++.|
T Consensus 224 -------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 -------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 01111234577788999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=299.56 Aligned_cols=262 Identities=23% Similarity=0.329 Sum_probs=196.4
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
.|.+.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++++++|+||+++++++......++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 4667789999999999999975 58899999886322 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
++++.|..++.. ...+++..++.++.|++.+|+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~~l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 82 CDHTVLNELEKN-----PRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred cCccHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999988887643 2348999999999999999999999 89999999999999999999999999999876542
Q ss_pred CCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHH--------HHHhh
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAY--------EEFEK 726 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~ 726 (852)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+......-.. ..+..
T Consensus 154 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 154 GD---DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST 230 (286)
T ss_pred cc---cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccc
Confidence 21 1123457788999999876 467899999999999999999999997543221111000000 00000
Q ss_pred CC-cccccccccCCCCCCHH-----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 727 GN-VKGIVDKSLAGEDVDIE-----QVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 727 ~~-~~~~~d~~l~~~~~~~~-----~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.. ......+.... ..+.+ ....+.+++.+|++.+|++||++.|+++
T Consensus 231 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 231 NQFFKGLSIPEPET-REPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccCCCccc-ccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 00000000000 11111 1245778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=297.91 Aligned_cols=256 Identities=29% Similarity=0.432 Sum_probs=196.6
Q ss_pred cccccccccccceEEEEEEC----CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCc------e
Q 003059 502 GFKDKLGAGGFGAVYRGVLA----NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK------H 568 (852)
Q Consensus 502 ~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~ 568 (852)
.+.+.||+|+||.||+|.+. .++.||||++... ....+++.+|++++++++||||+++++++.... .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 45678999999999999853 3578999998743 234567889999999999999999999876532 3
Q ss_pred eeEEEeecCCCCHHHHhhhccc-CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEE-GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFG 647 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 647 (852)
.++++||+++|+|.+++..... .....+++...+.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECccc
Confidence 4789999999999998864321 122357889999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhh
Q 003059 648 LAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEK 726 (852)
Q Consensus 648 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (852)
+++....... ........++..|++||.+....++.++||||||+++|||++ |+.||....... + ......
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~----~~~~~~ 230 (273)
T cd05074 159 LSKKIYSGDY-YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---I----YNYLIK 230 (273)
T ss_pred ccccccCCcc-eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---H----HHHHHc
Confidence 9986543211 111122335678999999998899999999999999999999 888886432211 1 111111
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 727 GNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
... + ..+......+.+++.+|++.+|.+||++.++++.|+++
T Consensus 231 ~~~-------~---~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNR-------L---KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCc-------C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 110 0 01112234678899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=291.68 Aligned_cols=257 Identities=26% Similarity=0.316 Sum_probs=205.2
Q ss_pred cccccccccccccceEEEEEECC-CcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
..++.++||.|.-|+||++.+++ +...|+|++.+. .....+.+.|-+||+.+.||-++.|++.+..++..|||||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 34456789999999999999876 588999999743 3334567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
||+||+|..+++++. ++.++...+.-++.+++-||+|||. .|||+|||||+||||.++|++.|+||.|+.....
T Consensus 158 yCpGGdL~~LrqkQp---~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQP---GKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred cCCCccHHHHHhhCC---CCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 999999999886543 6679999999999999999999999 8999999999999999999999999998753310
Q ss_pred C--------------------------------CCc---------------------ceeeeeecCCCCCCChhhhhcCC
Q 003059 655 K--------------------------------DHR---------------------HRTLTSVRGTRGYLAPEWLANLP 681 (852)
Q Consensus 655 ~--------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~ 681 (852)
. ... .......+||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 000 00112357999999999999999
Q ss_pred CCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccC
Q 003059 682 ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQ 761 (852)
Q Consensus 682 ~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~d 761 (852)
.+.++|.|+|||++||||.|..||.+..... .+..++-+.+.- +..++....+.++|...|.+|
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~---------------Tl~NIv~~~l~F-p~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE---------------TLRNIVGQPLKF-PEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchh---------------hHHHHhcCCCcC-CCCCcchhHHHHHHHHHhccC
Confidence 9999999999999999999999998765432 122233333322 122244456778899999999
Q ss_pred CCCCCC----HHHHHH--HHhcC
Q 003059 762 PSQRPM----MGKVVQ--MLEGI 778 (852)
Q Consensus 762 p~~RPt----~~ev~~--~L~~~ 778 (852)
|.+|-. ++||.+ .++++
T Consensus 376 P~kRlg~~rGA~eIK~HpFF~gV 398 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKRHPFFEGV 398 (459)
T ss_pred hhhhhccccchHHhhcCccccCC
Confidence 999988 777775 34444
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=303.58 Aligned_cols=238 Identities=28% Similarity=0.359 Sum_probs=194.4
Q ss_pred ccccccccceEEEEEE-CCCcEEEEEEecC-ccc---chHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCC
Q 003059 505 DKLGAGGFGAVYRGVL-ANRTVVAVKQLEG-IEQ---GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNG 579 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~-~~~---~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 579 (852)
+.||.|.||.||-+.. .+...||||++.- .++ .-.++..|+..|.+++|||++.+-|+|..+...||||||| -|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence 4699999999999995 5678999999973 222 2357889999999999999999999999999999999999 56
Q ss_pred CHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcc
Q 003059 580 SLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRH 659 (852)
Q Consensus 580 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 659 (852)
|-.|+|.-. .+++....+..|..+.+.||+|||+ ++.||||||+.||||.+.|.+||+|||.|..+.+
T Consensus 111 SAsDlleVh----kKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----- 178 (948)
T KOG0577|consen 111 SASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----- 178 (948)
T ss_pred cHHHHHHHH----hccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc-----
Confidence 888888543 5678899999999999999999999 8999999999999999999999999999987754
Q ss_pred eeeeeecCCCCCCChhhhh---cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 660 RTLTSVRGTRGYLAPEWLA---NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
...++||+.|||||++. .+.|+-|+||||||++..||...++|+-..+..... -.+..+ -.+.
T Consensus 179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL-------YHIAQN-----esPt 244 (948)
T KOG0577|consen 179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-------YHIAQN-----ESPT 244 (948)
T ss_pred --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH-------HHHHhc-----CCCC
Confidence 34678999999999985 568999999999999999999999997544321111 111111 1112
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+. ..+....+..++-.|++.-|.+|||.++++.
T Consensus 245 Lq----s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 245 LQ----SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CC----CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 21 3355566778888899999999999887664
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=300.65 Aligned_cols=251 Identities=24% Similarity=0.380 Sum_probs=196.5
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
.+++.+.||+|+||.||++... .++.||+|.+... .....++.+|++++++++|+||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 3567789999999999999975 6889999988732 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|..++.... ....+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||++..+...
T Consensus 82 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 82 DAGSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred CCCCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 9999999986432 133689999999999999999999962 58999999999999999999999999998765321
Q ss_pred CcceeeeeecCCCCCCChhhhhcCC------CCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLP------ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~------~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (852)
......++..|+|||.+.+.. ++.++|||||||++|||++|+.||........ . ........+..
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~--~~~~~~~~~~~- 227 (286)
T cd06622 157 ----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI--F--AQLSAIVDGDP- 227 (286)
T ss_pred ----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH--H--HHHHHHhhcCC-
Confidence 112345788999999986543 47899999999999999999999964321110 0 00011111110
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 731 GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+ ..+......+.+++.+|++.+|.+||++.++++
T Consensus 228 ----~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 ----P-----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ----C-----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 0 112223455678889999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=294.33 Aligned_cols=251 Identities=26% Similarity=0.434 Sum_probs=197.8
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCccc---chHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQ---GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
|...+.||+|+||.||+|... +++.|++|.+..... ..+++..|++++++++|+||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 566789999999999999864 678999999874433 4578899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|.+++... ..+++..+..++.|+++||.|||+ .+|+|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 82 SGGTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999998542 347889999999999999999998 899999999999999999999999999998765432
Q ss_pred Cccee-eeeecCCCCCCChhhhhcCC---CCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccc
Q 003059 657 HRHRT-LTSVRGTRGYLAPEWLANLP---ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI 732 (852)
Q Consensus 657 ~~~~~-~~~~~gt~~y~aPE~~~~~~---~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (852)
..... .....++..|+|||.+.+.. .+.++||||||+++|||++|+.||....... .. ... ...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~--~~---~~~-~~~~----- 222 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF--QI---MFH-VGAG----- 222 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH--HH---HHH-HhcC-----
Confidence 22111 22345788999999998766 8899999999999999999999996432110 00 000 0000
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..+.+. ........+.+++.+|++.+|.+||++.+++.
T Consensus 223 ~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 HKPPIP---DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCC---cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 011111 11111345568889999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=291.58 Aligned_cols=245 Identities=27% Similarity=0.390 Sum_probs=196.0
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCcc------cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE------QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
|...+.||+|+||.||+|... +++.|++|.+.... ...+.+.+|+.++++++|+||+++++++..+...++|+
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 455678999999999999976 68899999886322 23467899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+++++|.+++... ..+++..+..++.|+++||+|||+ .+++|+||+|+||+++.++.+||+|||++....
T Consensus 82 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 82 ELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999543 247899999999999999999998 899999999999999999999999999988654
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcCC-CCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANLP-ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI 732 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (852)
... ......++..|+|||.+.... ++.++|+||||+++|||++|+.||....... . ...........
T Consensus 154 ~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~----~~~~~~~~~~~-- 221 (258)
T cd06632 154 EFS----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--A----VFKIGRSKELP-- 221 (258)
T ss_pred ccc----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--H----HHHHHhcccCC--
Confidence 322 223455888999999997766 8999999999999999999999996543110 0 00000000010
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..+......+.+++.+|++.+|.+||++.++++
T Consensus 222 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 --------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 111112345667888999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=295.78 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=198.1
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhcc-cccceeeeeeeeccCc------eee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISST-HHLNLVRLVGFSSEGK------HRL 570 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~------~~~ 570 (852)
..|.+.+.||+|+||.||+|... +++.+++|.+.......+++.+|+.+++++ +|+||+++++++.+.. ..+
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence 45677889999999999999975 578899999986666667899999999999 7999999999986544 589
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+||||+++++|.+++..... ....+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.+||+|||++.
T Consensus 86 lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 99999999999999864321 23468899999999999999999998 899999999999999999999999999987
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhc-----CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHh
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLAN-----LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFE 725 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 725 (852)
...... .......++..|+|||.+.. ..++.++||||||++++||++|+.||....... . .....
T Consensus 162 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~-----~~~~~ 231 (275)
T cd06608 162 QLDSTL---GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--A-----LFKIP 231 (275)
T ss_pred ecccch---hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--H-----HHHhh
Confidence 653211 11233458889999998753 346789999999999999999999996432110 0 01111
Q ss_pred hCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 726 KGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
... .+.+ ..+......+.+++.+|+..||++||++.+|++
T Consensus 232 ~~~-----~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RNP-----PPTL---KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ccC-----CCCC---CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 110 1111 111223456778999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=297.80 Aligned_cols=250 Identities=23% Similarity=0.359 Sum_probs=194.7
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCcccchHHHHHHHHHhhcc-cccceeeeeeeecc------Cceee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVATISST-HHLNLVRLVGFSSE------GKHRL 570 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~------~~~~~ 570 (852)
..|.+.+.||+|+||.||+|.. .+++.+|+|.+........++..|+.++.++ +|+||+++++++.. ....+
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 4566778999999999999996 4578899999876555567789999999998 69999999999853 45789
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+||||+++|+|.+++.... ...+++..+..++.||++||+|||+ .+|+|+||||+||++++++.++|+|||++.
T Consensus 96 iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred EEEEeCCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 9999999999999986432 3357888889999999999999998 899999999999999999999999999987
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhh-----cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHh
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLA-----NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFE 725 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 725 (852)
...... .......|+..|+|||.+. ...++.++||||||+++|||++|+.||......... ....
T Consensus 170 ~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-------~~~~ 239 (282)
T cd06636 170 QLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-------FLIP 239 (282)
T ss_pred hhhccc---cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-------hhHh
Confidence 653211 1122355888999999885 346788999999999999999999999643211100 0000
Q ss_pred hCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 726 KGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
. .....+. .......+.+++.+||+.||.+||++.||++
T Consensus 240 ~-----~~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 240 R-----NPPPKLK----SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred h-----CCCCCCc----ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 0011111 0112245778899999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=293.11 Aligned_cols=257 Identities=23% Similarity=0.356 Sum_probs=200.9
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
.|.+.+.||.|+||.||+|.. .++..+++|++... ....+.+.+|+++++.++|+||+++++.+...+..++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 466788999999999999995 45788999998632 234578899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|.+++..... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++..+....
T Consensus 82 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 82 SGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred CCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999965322 2458899999999999999999998 899999999999999999999999999998765432
Q ss_pred Ccc-eeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 657 HRH-RTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 657 ~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
... .......++..|+|||.+... .++.++||||||+++|||++|+.||....... .+ ...... ..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~-----~~~~~~-----~~ 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VL-----MLTLQN-----DP 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hH-----HHHhcC-----CC
Confidence 221 122334588999999999877 78999999999999999999999997543211 00 000110 01
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..+............+.+++..|++.||++||++.+|++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111110000122345678888999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=302.33 Aligned_cols=243 Identities=22% Similarity=0.337 Sum_probs=193.8
Q ss_pred ccccccccceEEEEEEC-CCcEEEEEEecC-cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCCHH
Q 003059 505 DKLGAGGFGAVYRGVLA-NRTVVAVKQLEG-IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLD 582 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 582 (852)
.+||+|+||.||++... +++.|++|.+.. .....+.+.+|+.++..++||||+++++++..++..++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 47999999999999864 688999999863 3344567889999999999999999999999999999999999999999
Q ss_pred HHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcceee
Q 003059 583 NFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTL 662 (852)
Q Consensus 583 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 662 (852)
.++.. ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....... ...
T Consensus 107 ~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~---~~~ 174 (297)
T cd06659 107 DIVSQ------TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV---PKR 174 (297)
T ss_pred HHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc---ccc
Confidence 98742 348899999999999999999998 899999999999999999999999999987654321 112
Q ss_pred eeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCCCCC
Q 003059 663 TSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDV 742 (852)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 742 (852)
....++..|+|||.+.+..++.++||||||+++|||++|+.||........ + ..+.... ......
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~-----~~~~~~~-----~~~~~~--- 239 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--M-----KRLRDSP-----PPKLKN--- 239 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H-----HHHhccC-----CCCccc---
Confidence 335688999999999998999999999999999999999999964322110 0 1111110 000000
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 743 DIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 743 ~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.......+.+++.+|++.+|++||++.+|++.
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00112346678889999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=294.37 Aligned_cols=258 Identities=25% Similarity=0.317 Sum_probs=198.0
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCcc--cchHHHHHHHHHhhcccccceeeeeeeecc--CceeeEEEee
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRLVGFSSE--GKHRLLVYEF 575 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~ 575 (852)
+.+.++||.|++|.||++... +++.+|+|.+.... ....++.+|++++++++||||+++++++.+ .+..++||||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 456789999999999999974 57889999987432 345678999999999999999999998865 3478999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+++++|.+++..... ....++...+..++.||+.||+|||+ .+++|+||+|+||++++++.++|+|||++......
T Consensus 83 ~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 83 CEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred cCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 999999998754322 24458889999999999999999998 89999999999999999999999999998765321
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
. .....++..|+|||.+.+..++.++||||||+++|||++|+.||+........... . ...........+.+.
T Consensus 159 ~-----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~ 231 (287)
T cd06621 159 L-----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIE-L-LSYIVNMPNPELKDE 231 (287)
T ss_pred c-----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHH-H-HHHHhcCCchhhccC
Confidence 1 12345788999999999999999999999999999999999999755321111111 0 011111111111100
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
. .........+.+++.+|++.+|.+||++.||++
T Consensus 232 -~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 -P---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -C---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0 001122356789999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=293.95 Aligned_cols=253 Identities=23% Similarity=0.377 Sum_probs=199.1
Q ss_pred ccccccccccccceEEEEEE-CCCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeecc--CceeeEEEe
Q 003059 501 KGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSE--GKHRLLVYE 574 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e 574 (852)
|.+.+.||.|+||.||++.. .+++.+++|.+... ....+++..|++++++++|+||+++++++.. +...+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 55678899999999999985 45788999998632 2334568899999999999999999997753 456799999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhcccc--CCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC--RDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|+++++|.+++..... ....+++..++.++.||+.||+|||... ..+++|+||||+||++++++.+||+|||++...
T Consensus 82 ~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 82 YCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999965322 2456899999999999999999999321 278999999999999999999999999999876
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI 732 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (852)
..... ......++..|+|||.+....++.++||||||+++++|++|+.||...... . .......+..
T Consensus 161 ~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~----~~~~~~~~~~--- 227 (265)
T cd08217 161 GHDSS---FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---Q----LASKIKEGKF--- 227 (265)
T ss_pred cCCcc---cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---H----HHHHHhcCCC---
Confidence 54321 123346899999999999888999999999999999999999999754311 1 1111111111
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
+ ..+......+.+++.+|++.+|.+||++.+|++.
T Consensus 228 --~-----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 --R-----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --C-----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 1222233567788999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=299.94 Aligned_cols=260 Identities=20% Similarity=0.288 Sum_probs=191.9
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
|.+.+.||+|+||.||+|... +++.|++|++... ......+.+|++++++++|+||+++++++.+....++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 566788999999999999964 5888999998632 222356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
+ ++|.+++... ...+++..++.++.||++||.|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 82 D-QDLKKYFDSC----NGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred C-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 6 5888877532 2358999999999999999999998 899999999999999999999999999998654321
Q ss_pred CcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhC------Cc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG------NV 729 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------~~ 729 (852)
.......++..|+|||.+.+. .++.++||||||+++|||++|..|+....... ..+. ......... ..
T Consensus 154 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 154 ---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLK-RIFRLLGTPTEESWPGV 228 (284)
T ss_pred ---CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-HHHH-HHHHHhCCCChHHhHHh
Confidence 112234578899999998765 46899999999999999999998864322111 1100 000000000 00
Q ss_pred cccccc----ccCC----CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 730 KGIVDK----SLAG----EDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 730 ~~~~d~----~l~~----~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
....+. .... ..........+.+++.+|++.||.+|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000 0000 0000112245678899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=302.14 Aligned_cols=244 Identities=24% Similarity=0.360 Sum_probs=193.6
Q ss_pred cccccccccceEEEEEEC-CCcEEEEEEecC-cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCCH
Q 003059 504 KDKLGAGGFGAVYRGVLA-NRTVVAVKQLEG-IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSL 581 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 581 (852)
...||+|+||.||++... ++..||||.+.. .....+.+.+|+.++.+++|+||+++++.+..++..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 357999999999999864 578899999873 333456788999999999999999999999999999999999999999
Q ss_pred HHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCccee
Q 003059 582 DNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRT 661 (852)
Q Consensus 582 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 661 (852)
.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+||++++++.++|+|||++....... ..
T Consensus 107 ~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~---~~ 174 (292)
T cd06658 107 TDIVTH------TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV---PK 174 (292)
T ss_pred HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc---cc
Confidence 998842 247899999999999999999998 899999999999999999999999999987653321 11
Q ss_pred eeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCCCC
Q 003059 662 LTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGED 741 (852)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 741 (852)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||........ ..... ..+...+..
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-------~~~~~-----~~~~~~~~~-- 240 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-------MRRIR-----DNLPPRVKD-- 240 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHH-----hcCCCcccc--
Confidence 2335688999999999988999999999999999999999999974332110 00111 111111111
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 742 VDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 742 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.......+..++.+|++.+|.+||+++++++.
T Consensus 241 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 -SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00112245567788999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=299.98 Aligned_cols=259 Identities=22% Similarity=0.300 Sum_probs=195.8
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCccc------chHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQ------GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
|.+.+.||+|+||.||+|... +++.|++|.+..... ....+..|++++++++|+||+++++++.+....++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 556788999999999999964 588999999974322 2345778999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+ +++|.+++.... ..+++..+..++.||++||.|||+ .+|+|+||||+||+++.++.+||+|||+++...
T Consensus 82 e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 82 EFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred ccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 999 999999995432 358999999999999999999998 899999999999999999999999999998764
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhh------
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEK------ 726 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~------ 726 (852)
.... ......++..|+|||.+.+ ..++.++||||||++++||++|..+|......+.. .. .......
T Consensus 154 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~ 227 (298)
T cd07841 154 SPNR---KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL--GK-IFEALGTPTEENW 227 (298)
T ss_pred CCCc---cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH--HH-HHHHcCCCchhhh
Confidence 3211 1222346778999998865 46789999999999999999998888654322110 00 0000000
Q ss_pred ---CCcccccccccCCCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 727 ---GNVKGIVDKSLAGEDVD-----IEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 727 ---~~~~~~~d~~l~~~~~~-----~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.......... .....+ ......+.+++.+|++.+|++||++.||++.
T Consensus 228 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 228 PGVTSLPDYVEFK-PFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhccccccccccc-ccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000 000111 1123467789999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=299.32 Aligned_cols=261 Identities=21% Similarity=0.339 Sum_probs=192.9
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCcc--cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
.|.+.+.||+|+||.||+|... +++.||+|.+.... .....+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence 4667789999999999999965 57899999986322 22345778999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++ +|.+++.... ..+++.....++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~-~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 86 DT-DLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 75 9999886432 357899999999999999999998 899999999999999999999999999987543211
Q ss_pred CcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC---c---
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN---V--- 729 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~--- 729 (852)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... + ......+.... .
T Consensus 158 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 158 ---KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ-L-HKIFRVLGTPTEETWPGV 232 (291)
T ss_pred ---ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH-H-HHHHHhcCCCChhhhhhh
Confidence 11122346788999999875 45889999999999999999999999654311110 0 00000000000 0
Q ss_pred ---ccccc--------cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 730 ---KGIVD--------KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 730 ---~~~~d--------~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..... ..+............+.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 000000001111245678899999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=300.61 Aligned_cols=262 Identities=24% Similarity=0.342 Sum_probs=195.4
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
+|.+.++||+|+||.||++... +++.||+|++.... ...+.+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 4667789999999999999975 47899999886322 2345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+++++|..+.... ..+++..++.++.||+++|+|||+ .+++|+||+|+||++++++.++|+|||++......
T Consensus 82 ~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 82 VDHTVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred CCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999998876432 248999999999999999999998 89999999999999999999999999999876432
Q ss_pred CCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHH--------HHHHhh
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA--------YEEFEK 726 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~ 726 (852)
. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||............... ......
T Consensus 154 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 154 G---EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK 230 (286)
T ss_pred c---cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhcc
Confidence 2 12223457889999999875 45788999999999999999999999643321100000000 000000
Q ss_pred CCc-ccccccccCCCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 727 GNV-KGIVDKSLAGEDVD-----IEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 727 ~~~-~~~~d~~l~~~~~~-----~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
... .....+.... ..+ ......+.+++.+|++.+|++||++.+|++
T Consensus 231 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 231 NPLFAGMRLPEVKE-IEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred chHhhccccccccC-cchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000 0000000000 000 012345788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=286.23 Aligned_cols=246 Identities=23% Similarity=0.336 Sum_probs=203.8
Q ss_pred ccccccccccccceEEEEEE-CCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCC
Q 003059 501 KGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNG 579 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 579 (852)
+.+.++||+|.||.|||+.. ..|+.+|+|.+.. +...+++..|+.++++.+.+++|+++|.+......++|||||--|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 34567999999999999985 4589999999873 345678999999999999999999999999999999999999999
Q ss_pred CHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcc
Q 003059 580 SLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRH 659 (852)
Q Consensus 580 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 659 (852)
|+.+.+..+ +++|++.++..+++..++||+|||. ..-||||||+.||||+-+|.+||+|||.|-.+.. .-
T Consensus 114 SiSDI~R~R----~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD---TM 183 (502)
T KOG0574|consen 114 SISDIMRAR----RKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD---TM 183 (502)
T ss_pred cHHHHHHHh----cCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhh---hH
Confidence 999999654 5689999999999999999999998 6779999999999999999999999999976542 22
Q ss_pred eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccccc-C
Q 003059 660 RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSL-A 738 (852)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l-~ 738 (852)
.....+.||+.|||||++..-.|..++||||||++..||..|++||....+.. ..-++...- .
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR----------------AIFMIPT~PPP 247 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR----------------AIFMIPTKPPP 247 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc----------------eeEeccCCCCC
Confidence 23356789999999999999999999999999999999999999996433211 111111111 1
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 739 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
....+.+....+-+++..|+-..|++|-|+.++++
T Consensus 248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 11234455567889999999999999999888765
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=302.00 Aligned_cols=252 Identities=25% Similarity=0.264 Sum_probs=197.0
Q ss_pred cccccccccccccceEEEEEECC-CcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.|.+.+.||+|+||.||++...+ ++.||+|.+.... ...+.+..|++++.+++|+||+++++.+.++...++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 35667889999999999999754 8899999987432 234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++++|.+++.... ...+++..+..++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 82 YCPGGELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred ecCCCCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999986432 3468899999999999999999998 8999999999999999999999999999875532
Q ss_pred CCCcc--------------------------eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCcccccc
Q 003059 655 KDHRH--------------------------RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVS 708 (852)
Q Consensus 655 ~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~ 708 (852)
..... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 11100 0111245788999999999989999999999999999999999999754
Q ss_pred ccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCC----HHHHHH
Q 003059 709 QETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPM----MGKVVQ 773 (852)
Q Consensus 709 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt----~~ev~~ 773 (852)
.... . .... ......- .........+.+++.+|++.+|++||+ ++++++
T Consensus 236 ~~~~--~-----~~~~--------~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRDE--T-----FSNI--------LKKEVTF-PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chHH--H-----HHHH--------hcCCccC-CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 3211 0 0111 1111100 111113456778889999999999999 555544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=295.69 Aligned_cols=246 Identities=23% Similarity=0.361 Sum_probs=197.2
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
.+.+.++||+|+||.||+|... ++..||+|.+... ....+.+.+|+.++.+++|+||+++++++.++...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4556788999999999999864 5789999987632 234467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|.+++.. ..+++..+..++.|++.+|.|||+ .+++|+||||+||+++.++.++|+|||++..+....
T Consensus 85 ~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 85 GGGSALDLLEP------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 99999999842 348899999999999999999998 899999999999999999999999999987654321
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
. ......++..|+|||.+.+..++.++||||||+++|||++|..||....... .......... +.
T Consensus 156 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~-----~~ 220 (277)
T cd06641 156 I---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-------VLFLIPKNNP-----PT 220 (277)
T ss_pred h---hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-------HHHHHhcCCC-----CC
Confidence 1 1123457889999999998889999999999999999999999996432110 0011111110 11
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
........+.+++.+|++.+|.+||++.++++.
T Consensus 221 -----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 -----LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -----CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111223456778899999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=276.36 Aligned_cols=247 Identities=26% Similarity=0.399 Sum_probs=194.2
Q ss_pred ccccccccccccceEEEEEE-CCCcEEEEEEecCcc---cc------hHHHHHHHHHhhcc-cccceeeeeeeeccCcee
Q 003059 501 KGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE---QG------EKQFRMEVATISST-HHLNLVRLVGFSSEGKHR 569 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~------~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 569 (852)
|.-.+.||+|..++|-+... .++...|+|++.... .+ .+.-..|+.+|+++ .||+|+++.+++......
T Consensus 19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~ 98 (411)
T KOG0599|consen 19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV 98 (411)
T ss_pred cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence 34457899999999988874 567889999886221 11 13345799999988 699999999999999999
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
++|+|.|+.|.|.|||.. .-.++++...+|++|+.+|++|||. ++||||||||+|||+|++.++||+|||++
T Consensus 99 FlVFdl~prGELFDyLts-----~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 99 FLVFDLMPRGELFDYLTS-----KVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred hhhhhhcccchHHHHhhh-----heeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEecccee
Confidence 999999999999999954 3458999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCChhhhhcC------CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHH
Q 003059 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLANL------PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEE 723 (852)
Q Consensus 650 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 723 (852)
..+.+.. ......||++|+|||.+... .|+...|+|+.||+||-|+.|.+||-.... ......
T Consensus 171 ~~l~~Ge----kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-------mlMLR~ 239 (411)
T KOG0599|consen 171 CQLEPGE----KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-------MLMLRM 239 (411)
T ss_pred eccCCch----hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-------HHHHHH
Confidence 9886543 34567899999999998543 478899999999999999999999953210 111222
Q ss_pred HhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 724 FEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 724 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+.+++.. .-.+.+. +.....-+++.+|++.||.+|-|.+|+++
T Consensus 240 ImeGkyq-F~speWa------dis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 240 IMEGKYQ-FRSPEWA------DISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHhcccc-cCCcchh------hccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 2222211 1111111 11234557888899999999999999885
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=292.48 Aligned_cols=252 Identities=24% Similarity=0.399 Sum_probs=196.8
Q ss_pred ccccccccccccceEEEEEE-CCCcEEEEEEecCcc-------cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 501 KGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE-------QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
|...+.||+|+||.||++.. .+++.||+|.+.... ...+++..|++++++++|+||+++++++.+.+..++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 44567899999999999985 568899999986322 1246788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC-ceEEeecccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY-NAKVSDFGLAKL 651 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~~ 651 (852)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++ .+||+|||++..
T Consensus 82 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 82 VEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EeccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999998543 357899999999999999999998 8999999999999998776 599999999976
Q ss_pred cCCCCCcc-eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcc
Q 003059 652 INPKDHRH-RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730 (852)
Q Consensus 652 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (852)
........ .......++..|+|||.+.+..++.++||||||++++||++|+.||........... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~---- 226 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKIASA---- 226 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHHHhcc----
Confidence 64321111 112234578899999999888899999999999999999999999964332111110 0000000
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 731 GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
...+ ..+......+.+++.+|++.+|.+||++.++++
T Consensus 227 -~~~~-----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 -TTAP-----SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -CCCC-----CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0000 122233356778999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=293.88 Aligned_cols=245 Identities=23% Similarity=0.354 Sum_probs=195.3
Q ss_pred ccccccccccccceEEEEEE-CCCcEEEEEEecC--cccchHHHHHHHHHhhccc---ccceeeeeeeeccCceeeEEEe
Q 003059 501 KGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEG--IEQGEKQFRMEVATISSTH---HLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~--~~~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~e 574 (852)
|.+.+.||+|+||.||+|.. .+++.|++|.+.. .....+++.+|++++++++ |||++++++++.++...++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 45567899999999999996 5688999999863 2334567889999999987 9999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++++|.+++.. ..+++..++.++.|++.+|.|||+ .+|+|+||+|+||++++++.++|+|||++..+..
T Consensus 83 ~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 83 YAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred cCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 9999999999843 258899999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
.. .......|+..|+|||.+.+. .++.++||||||+++|||++|+.||........ . .. .....
T Consensus 154 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~-~~-----~~~~~ 218 (277)
T cd06917 154 NS---SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------M-ML-----IPKSK 218 (277)
T ss_pred Cc---cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------h-hc-----cccCC
Confidence 32 112334688899999998754 568999999999999999999999974422110 0 00 00111
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.+.+... .....+.+++.+|++.||++||++.++++
T Consensus 219 ~~~~~~~----~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 219 PPRLEDN----GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCcc----cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1111110 12345678889999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=311.21 Aligned_cols=257 Identities=22% Similarity=0.317 Sum_probs=190.6
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccC------ce
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEG------KH 568 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~ 568 (852)
..|.+.+.||+|+||.||++.. .+++.||||++.... ...+.+.+|++++++++|+||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 3566778999999999999986 457889999987432 2345677899999999999999999987543 35
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.++++|++ +++|.+++. ...+++..+..++.||+.||.|||+ .+|+||||||+|||+++++.+||+|||+
T Consensus 95 ~~~~~~~~-~~~l~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 95 VYLVTNLM-GADLNNIVK------CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred EEEEeecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCcc
Confidence 78999998 789988774 2348899999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHH------
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAY------ 721 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~------ 721 (852)
++..... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||........ +.....
T Consensus 165 ~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~ 236 (343)
T cd07878 165 ARQADDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKRIMEVVGTPS 236 (343)
T ss_pred ceecCCC------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCC
Confidence 9865321 223468999999999876 5689999999999999999999999965432110 000000
Q ss_pred ----HHHhhCCcccccccccCCCC-CCHH-----HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 722 ----EEFEKGNVKGIVDKSLAGED-VDIE-----QVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 722 ----~~~~~~~~~~~~d~~l~~~~-~~~~-----~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
...........+. .+...+ .... ....+.+++.+|++.||.+||++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 237 PEVLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000 000000 0000 01235788999999999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=291.54 Aligned_cols=246 Identities=24% Similarity=0.381 Sum_probs=196.3
Q ss_pred ccccccccccccceEEEEEE-CCCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 501 KGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
|.+.+.||+|+||.||++.. .+++.+++|.+... ......+.+|++++++++|+||+++++.+..++..++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 56678999999999999986 45788999998633 233567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCC-CceEEeecccccccCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDEN-YNAKVSDFGLAKLINPK 655 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFGla~~~~~~ 655 (852)
++++|.+++.... ...+++..+..++.|++++|+|||+ .+++|+||||+||+++++ +.+||+|||++......
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 82 PGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999996532 3458899999999999999999998 899999999999999865 46899999999876432
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
. ......++..|+|||.+.+..++.++||||||+++|||++|+.||+...... . .. .........
T Consensus 156 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~---~~-~~~~~~~~~---- 220 (256)
T cd08220 156 S----KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---L---VL-KIMSGTFAP---- 220 (256)
T ss_pred c----cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---H---HH-HHHhcCCCC----
Confidence 1 1123457889999999998889999999999999999999999996543211 1 11 111111111
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.+......+.+++.+|++.+|.+||++.++++
T Consensus 221 ------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 221 ------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 01112335678889999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=298.75 Aligned_cols=264 Identities=23% Similarity=0.307 Sum_probs=197.4
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
.|.+.++||+|+||.||+|... +++.|++|.++.. ....+.+.+|++++++++|+||+++++++.+++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 4677889999999999999975 4788999988732 23346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
++++.+..++.. ...+++..+..++.||+.||+|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 82 ~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 82 VERTLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred CCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 998777665532 2348899999999999999999998 89999999999999999999999999999876543
Q ss_pred CCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHH--------HHh-
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYE--------EFE- 725 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~--------~~~- 725 (852)
.. .......++..|+|||++.+. .++.++||||||+++|||++|+.||......+.......... .+.
T Consensus 154 ~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 154 PA--SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred cc--ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence 21 122335578899999999888 889999999999999999999999975432211100000000 000
Q ss_pred hCCccc--ccccccC---CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 726 KGNVKG--IVDKSLA---GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 726 ~~~~~~--~~d~~l~---~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
...... ..+.... ....+......+.+++.+|++.+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000 0000000 00001111356788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=298.11 Aligned_cols=206 Identities=24% Similarity=0.342 Sum_probs=169.9
Q ss_pred ccccccccccccceEEEEEEC---CCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccC--ceeeE
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA---NRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEG--KHRLL 571 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 571 (852)
|.+.++||+|+||.||+|... +++.||+|.+.... .....+.+|+.++.+++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 566788999999999999964 47899999998532 2345678899999999999999999999888 78999
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC----CCceEEeecc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE----NYNAKVSDFG 647 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~----~~~~kl~DFG 647 (852)
||||+++ +|.+++..........++...+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 67777754333233468899999999999999999998 89999999999999999 9999999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCcccccccc
Q 003059 648 LAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQE 710 (852)
Q Consensus 648 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~ 710 (852)
+++................++..|+|||.+.+. .++.++||||||++++||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 998764332211222335678899999988764 578999999999999999999999975543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=296.73 Aligned_cols=249 Identities=21% Similarity=0.327 Sum_probs=198.5
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecC-cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEG-IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
.+|.+.+.||+|+||.||++.. .+++.|++|.+.. .....+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 4667788999999999999985 4578899999863 3334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|.+++.. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 99 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 99999999853 247888999999999999999998 899999999999999999999999999987654322
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.......... ...... .+.
T Consensus 170 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-------~~~~~~-----~~~ 234 (293)
T cd06647 170 S---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------LIATNG-----TPE 234 (293)
T ss_pred c---ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-------ehhcCC-----CCC
Confidence 1 1223458889999999988889999999999999999999999997543211100 000000 000
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
. .........+.+++.+|++.+|++||++.+++..
T Consensus 235 ~---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 L---QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred C---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 1111122356678899999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=299.53 Aligned_cols=254 Identities=21% Similarity=0.237 Sum_probs=195.8
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
|.+.+.||+|+||.||++... .++.|++|.+.... ...+.+.+|+++++.++||||+++++.+.++++.++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 556789999999999999965 46789999887332 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 83 VEGGDCATLLKNI-----GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred CCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999543 348899999999999999999998 89999999999999999999999999998742110
Q ss_pred C------------CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHH
Q 003059 656 D------------HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEE 723 (852)
Q Consensus 656 ~------------~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 723 (852)
. ..........++..|+|||.+....++.++||||||+++|||++|+.||....... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-------~~~~ 227 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-------LFGQ 227 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHH
Confidence 0 00001112457889999999988889999999999999999999999996432110 0111
Q ss_pred HhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003059 724 FEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEG 777 (852)
Q Consensus 724 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~ 777 (852)
..... ...+... ......+.+++.+|++.+|++||+..++.+.|+.
T Consensus 228 ~~~~~---~~~~~~~-----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VISDD---IEWPEGD-----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHhcc---cCCCCcc-----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11111 0001100 0122346788899999999999998777777654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=295.62 Aligned_cols=249 Identities=23% Similarity=0.366 Sum_probs=190.1
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCcc--cchHHHHHHHHH-hhcccccceeeeeeeeccCceeeEEEeec
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE--QGEKQFRMEVAT-ISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~f~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
+.+.+.||+|+||.||++... +++.||+|+++... ....++..|+.+ ++.++||||+++++++..++..++||||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 556788999999999999965 58899999987432 234456667665 56678999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCC-CcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD-CIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+ ++|.+++..... ....+++..++.++.||+.||+|||+ + +++||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~-~~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 83 D-TSLDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred c-ccHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 6 689888864322 23568999999999999999999998 5 8999999999999999999999999999865321
Q ss_pred CCcceeeeeecCCCCCCChhhhhc----CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLAN----LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
.......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||....... ..+ ......
T Consensus 158 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~-----~~~~~~---- 223 (283)
T cd06617 158 ----VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQL-----KQVVEE---- 223 (283)
T ss_pred ----cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHH-----HHHHhc----
Confidence 11123457889999998865 456889999999999999999999996432110 000 000111
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..+.+.. ......+.+++.+|++.+|.+||++.+|++
T Consensus 224 -~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 -PSPQLPA----EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -CCCCCCc----cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111111 011245678889999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=304.52 Aligned_cols=244 Identities=23% Similarity=0.361 Sum_probs=193.6
Q ss_pred cccccccccccceEEEEEEC-CCcEEEEEEec-----CcccchHHHHHHHHHhhcccccceeeeeeeeccCc--eeeEEE
Q 003059 502 GFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLE-----GIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK--HRLLVY 573 (852)
Q Consensus 502 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~-----~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV~ 573 (852)
.|.++||+|+|-+||||.+. .|..||--.++ ......++|..|+.+|+.|+|+||++++.++.+.. ...+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45679999999999999864 36666633222 33344578999999999999999999999887655 478999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC-CCceEEeeccccccc
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE-NYNAKVSDFGLAKLI 652 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGla~~~ 652 (852)
|.|..|+|..|+.+.++ ++.+.+.+|++||++||.|||.+. ++|||||||-.||+|+. .|.+||+|+|||..+
T Consensus 123 EL~TSGtLr~Y~kk~~~-----vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR-----VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred ecccCCcHHHHHHHhcc-----CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 99999999999976554 778899999999999999999976 68999999999999974 699999999999987
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI 732 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (852)
+.. ......|||.|||||.+. ..|++..||||||+.++||+|+..||..-... .-.+.+...|....-
T Consensus 197 r~s-----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~------AQIYKKV~SGiKP~s 264 (632)
T KOG0584|consen 197 RKS-----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP------AQIYKKVTSGIKPAA 264 (632)
T ss_pred hcc-----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH------HHHHHHHHcCCCHHH
Confidence 542 234478999999999988 78999999999999999999999999633221 123444444433332
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+.+-- -..+.++|..|+.. ..+||++.|+++
T Consensus 265 l~kV~---------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 265 LSKVK---------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred hhccC---------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 22211 12456778889999 999999999985
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=291.95 Aligned_cols=246 Identities=24% Similarity=0.370 Sum_probs=207.0
Q ss_pred hcccccccccccccceEEEEE-ECCCcEEEEEEecCccc---chHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 499 STKGFKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQ---GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~---~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.-|.+.+.||+|.|..|-+++ .-.|..||||++.+.+. ....+..|+.-|+.++|||||+|+.+.......|||.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 356777899999999999997 35788999999985543 34578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEe-CCCCceEEeecccccccC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL-DENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl-~~~~~~kl~DFGla~~~~ 653 (852)
.=.+|+|.+||.++.. .+.+....+++.||+.|+.|+|+ ..+|||||||+||.+ ..-|-+||.|||++..+.
T Consensus 98 LGD~GDl~DyImKHe~----Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE----GLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred ecCCchHHHHHHhhhc----cccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 9999999999987754 48889999999999999999999 789999999999886 567899999999998876
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcCCCC-CCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPIT-SKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI 732 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (852)
+. ...+...|...|-|||++.+..|+ ++.||||||||||-|++|+.||+..++.+. +.-+
T Consensus 171 PG----~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmI 231 (864)
T KOG4717|consen 171 PG----KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMI 231 (864)
T ss_pred Cc----chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhh
Confidence 54 345667899999999999999887 688999999999999999999986544321 1122
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+|-.. ..+.....++.++|..|+..||++|.+.+||+.
T Consensus 232 mDCKY---tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 232 MDCKY---TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hcccc---cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 22211 344455667889999999999999999999985
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=296.67 Aligned_cols=263 Identities=21% Similarity=0.277 Sum_probs=191.3
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
.|.+.+.||+|+||.||+|... +++.|++|++... ......+.+|+.++++++|+||+++++++.+++..++||||+
T Consensus 6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07870 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM 85 (291)
T ss_pred eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence 4667789999999999999864 5788999998733 223346789999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
. ++|.+++... ...+.+..+..++.|++.||+|||+ .+|+|+||||+|||++.++++||+|||+++......
T Consensus 86 ~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 86 H-TDLAQYMIQH----PGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred c-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 5 6787777433 2347788888999999999999998 899999999999999999999999999997643221
Q ss_pred CcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHH---------HHh-
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYE---------EFE- 725 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~---------~~~- 725 (852)
. ......++..|+|||.+.+. .++.++||||||+++|||++|+.||+............|... ...
T Consensus 158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 158 Q---TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred C---CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 1 11233468899999998754 578899999999999999999999975432211110000000 000
Q ss_pred -hCCccccccc----ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 726 -KGNVKGIVDK----SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 726 -~~~~~~~~d~----~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.......... .+............+.+++.+|++.||.+|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000 00000000011245667889999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=294.32 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=199.8
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
.+.+.+.||+|+||.||+|... +++.+++|.+.......+.+.+|++++++++|+||+++++++......++|+||+++
T Consensus 20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 99 (286)
T cd06614 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG 99 (286)
T ss_pred cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCC
Confidence 3455678999999999999976 578899999985444567889999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
++|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 100 ~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 100 GSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred CcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 99999996532 368999999999999999999998 8999999999999999999999999999876543211
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccC
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (852)
......++..|+|||.+.+..++.++||||||+++|||++|+.||........ . .......... .
T Consensus 172 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~------~-~~~~~~~~~~-----~- 236 (286)
T cd06614 172 --KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA------L-FLITTKGIPP-----L- 236 (286)
T ss_pred --hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH------H-HHHHhcCCCC-----C-
Confidence 11233478899999999988899999999999999999999999864322110 0 0111111100 0
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 739 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.........+.+++.+|++.+|.+||++.+|++
T Consensus 237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 237 --KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred --cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 001112245678899999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=291.24 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=194.1
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCcc---c--------chHHHHHHHHHhhcccccceeeeeeeeccCce
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---Q--------GEKQFRMEVATISSTHHLNLVRLVGFSSEGKH 568 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~--------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 568 (852)
|...+.||+|+||.||+|... +++.||+|.++... . ..+.+..|++++.+++|+||+++++++...+.
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 445678999999999999854 58899999875211 0 12457889999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||+ .+++||||+|+||+++.++.++|+|||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred eEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccc
Confidence 99999999999999999643 358889999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcCC--CCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhh
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANLP--ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEK 726 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (852)
++....... ........++..|+|||.+.... ++.++||||||+++|||++|+.||....... . .. ....
T Consensus 155 ~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~-~~-~~~~ 226 (272)
T cd06629 155 SKKSDDIYD-NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-----A-MF-KLGN 226 (272)
T ss_pred ccccccccc-ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-----H-HH-Hhhc
Confidence 986543211 11223355889999999987654 7899999999999999999999996332110 0 00 0011
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 727 GNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
......+... ...+....+.+++..|++.+|.+||++.+|++.
T Consensus 227 ~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 227 KRSAPPIPPD-----VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cccCCcCCcc-----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111111111 111123466778889999999999999998863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=320.02 Aligned_cols=203 Identities=21% Similarity=0.261 Sum_probs=160.4
Q ss_pred HHhcccccccccccccceEEEEEECC--CcEEE------------------EEEecCcccchHHHHHHHHHhhcccccce
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLAN--RTVVA------------------VKQLEGIEQGEKQFRMEVATISSTHHLNL 556 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~va------------------vK~l~~~~~~~~~f~~E~~~l~~l~h~ni 556 (852)
....|.+.++||+|+||.||++.++. +..++ .|.+........++++|+++|.+++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 34578889999999999999987532 11111 12222222334568899999999999999
Q ss_pred eeeeeeeccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeC
Q 003059 557 VRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD 636 (852)
Q Consensus 557 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~ 636 (852)
+++++++.+.+..|+|+|++ .++|.+++..................++.||+.||+|||+ ++||||||||+||||+
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEC
Confidence 99999999999999999998 4578787754332212233456677899999999999998 8999999999999999
Q ss_pred CCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccc
Q 003059 637 ENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNF 705 (852)
Q Consensus 637 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~ 705 (852)
.++.+||+|||+++.+.... ........||..|+|||.+.+..++.++|||||||++|||++|..++
T Consensus 302 ~~~~vkL~DFGla~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKER--EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCEEEEeCCCceecCccc--ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999998764321 11223356899999999999999999999999999999999988543
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=296.92 Aligned_cols=261 Identities=21% Similarity=0.309 Sum_probs=197.9
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
|.+.+.||+|+||.||+|... +++.|++|++.... .....+.+|+.++++++|+||+++++++..+...++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 567789999999999999964 68899999987432 33467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
+++|.+++.... ..+++..++.++.||+++|+|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 82 -~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 82 -PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred -CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 999999986432 458999999999999999999998 899999999999999999999999999998765432
Q ss_pred CcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhC--------
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG-------- 727 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-------- 727 (852)
. .......++..|+|||.+.+. .++.++||||||++++||++|+.+|........ ...........
T Consensus 154 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07832 154 P--RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGL 228 (286)
T ss_pred C--CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhc
Confidence 1 122345688999999998654 468999999999999999999888864332111 01111100000
Q ss_pred ----CcccccccccCCCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 728 ----NVKGIVDKSLAGED---VDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 728 ----~~~~~~d~~l~~~~---~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
....+..+...... ...+....+.+++.+|++.+|.+||+++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000000 000122567889999999999999999998763
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=294.09 Aligned_cols=243 Identities=23% Similarity=0.360 Sum_probs=194.4
Q ss_pred cccccccccceEEEEEE-CCCcEEEEEEecCc-ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCCH
Q 003059 504 KDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSL 581 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 581 (852)
.+.||+|++|.||++.. .+++.+++|++... ....+.+.+|+.++++++|+||+++++++...++.++|+||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 46899999999999985 46788999988632 33456688999999999999999999999999999999999999999
Q ss_pred HHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCccee
Q 003059 582 DNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRT 661 (852)
Q Consensus 582 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 661 (852)
.+++.. ..+++..+..++.|++.+|+|||+ .+++||||+|+||+++.++.++|+|||++....... ..
T Consensus 104 ~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~---~~ 171 (285)
T cd06648 104 TDIVTH------TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV---PR 171 (285)
T ss_pred HHHHHh------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCC---cc
Confidence 999853 248899999999999999999998 899999999999999999999999999887654321 11
Q ss_pred eeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCCCC
Q 003059 662 LTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGED 741 (852)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 741 (852)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ......... .+.+..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~-------~~~~~~~~~-----~~~~~~-- 237 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ-------AMKRIRDNL-----PPKLKN-- 237 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH-------HHHHHHhcC-----CCCCcc--
Confidence 223458899999999998889999999999999999999999986432110 011111110 111110
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 742 VDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 742 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.......+.+++.+|++.+|++||++.++++
T Consensus 238 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 -LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1112246778899999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=290.05 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=197.8
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
+.+.+.||+|+||.||++... +++.+++|.+... .....++.+|++++++++||||+++++.+...+..++|+||++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 456678999999999999975 5788999998743 3445678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
+++|.+++.... ..++...+..++.|++++|+|||+. .+++|+||||+||++++++.++|+|||.+........
T Consensus 83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 83 GGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 999999996432 4688889999999999999999972 5899999999999999999999999999876532111
Q ss_pred cceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccccc
Q 003059 658 RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSL 737 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (852)
....++..|+|||.+.+..++.++||||||+++|||++|+.||......... .... ........ .+.+
T Consensus 157 -----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~-~~~~~~~~-----~~~~ 224 (265)
T cd06605 157 -----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFEL-LQYIVNEP-----PPRL 224 (265)
T ss_pred -----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHH-HHHHhcCC-----CCCC
Confidence 1156888999999999999999999999999999999999999644221111 1111 11111110 0111
Q ss_pred CCCCCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 738 AGEDVDIE-QVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 738 ~~~~~~~~-~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+.. ....+.+++..|+..+|++||++.+++.
T Consensus 225 -----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 225 -----PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -----ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 111 2345678889999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=321.83 Aligned_cols=266 Identities=27% Similarity=0.377 Sum_probs=208.9
Q ss_pred HHHHHhcccccccccccccceEEEEEEC--------CCcEEEEEEecCc--ccchHHHHHHHHHhhcc-cccceeeeeee
Q 003059 494 KELQRSTKGFKDKLGAGGFGAVYRGVLA--------NRTVVAVKQLEGI--EQGEKQFRMEVATISST-HHLNLVRLVGF 562 (852)
Q Consensus 494 ~el~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l-~h~niv~l~g~ 562 (852)
.|+......+.+.||+|.||.|++|... ....||||+++.. ....+.+..|+++|+.+ +|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 3444444456679999999999999843 1457999999833 34567899999999998 69999999999
Q ss_pred eccCceeeEEEeecCCCCHHHHhhhcc---------cCCc--cccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCC
Q 003059 563 SSEGKHRLLVYEFMKNGSLDNFLFANE---------EGSG--KLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPE 631 (852)
Q Consensus 563 ~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~ 631 (852)
|.+++..++|+||++.|+|.+||...+ .... ..|.....+.++.|||.|++||++ .++|||||.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhh
Confidence 999999999999999999999998766 1111 248999999999999999999999 88999999999
Q ss_pred ceEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCcccccccc
Q 003059 632 NILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQE 710 (852)
Q Consensus 632 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~ 710 (852)
||||.++..+||+|||+++.....+..........-...|||||.+....++.|+|||||||+||||+| |..||.....
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 999999999999999999976553332211111113567999999999999999999999999999998 8889864210
Q ss_pred ccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 711 TNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 711 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
. .. ..+.+.++... ..+.....++.+++..||+.+|++||++.++++.|+..
T Consensus 528 ~--~~----l~~~l~~G~r~----------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 528 T--EE----LLEFLKEGNRM----------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred H--HH----HHHHHhcCCCC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 0 01 12233333222 12223345667888899999999999999999999884
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=285.06 Aligned_cols=247 Identities=25% Similarity=0.405 Sum_probs=199.8
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCccc-chHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQ-GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
|...+.||+|++|.||++... +++.+++|++..... ..+++.+|++.+++++|+|++++++++......++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 455678999999999999975 678899999985433 567899999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
++|.+++.... ..+++..+..++.|++.+|+|||+ .+++||||+|+||++++++.++|+|||.+........
T Consensus 82 ~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 82 GSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999986432 468999999999999999999998 8999999999999999999999999999987654321
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccC
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (852)
.....++..|+|||.+.....+.++||||||++++||++|+.||........ . .......... +
T Consensus 154 ---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~-~~~~~~~~~~-----~- 217 (253)
T cd05122 154 ---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA------L-FKIATNGPPG-----L- 217 (253)
T ss_pred ---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH------H-HHHHhcCCCC-----c-
Confidence 2345688899999999988899999999999999999999999964321100 0 0011010111 1
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 739 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.........+.+++.+|++.||.+||++.++++
T Consensus 218 --~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 218 --RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred --CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111345778889999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=295.25 Aligned_cols=252 Identities=25% Similarity=0.369 Sum_probs=196.7
Q ss_pred HhcccccccccccccceEEEEEECCCcEEEEEEec---CcccchHHHHHHHHHhhccc-ccceeeeeeeeccCceeeEEE
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLE---GIEQGEKQFRMEVATISSTH-HLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~---~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~ 573 (852)
...|...++||+||.+.||++...+.+.+|+|++. .+.+...-|.+|++.|.+|+ |.+||+|++|-..++..||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 34566678999999999999998888889999876 34455677999999999995 999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||= ..+|...|.+.. .....| .+..+..|++.++.++|+ ++|||.||||.|+|+- .|.+||+|||+|..+.
T Consensus 440 E~G-d~DL~kiL~k~~---~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKK---SIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred ecc-cccHHHHHHhcc---CCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 986 569999996543 233445 667789999999999999 8999999999999985 4689999999999887
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcC-----------CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHH
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANL-----------PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYE 722 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 722 (852)
.+. .........||+.||+||.+... ++++++||||+||+||+|+-|+.||.... ..|+
T Consensus 511 ~DT-TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------n~~a-- 580 (677)
T KOG0596|consen 511 PDT-TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------NQIA-- 580 (677)
T ss_pred ccc-cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------HHHH--
Confidence 643 22334557899999999998533 26689999999999999999999996321 1111
Q ss_pred HHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 723 EFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 723 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
++..+.++.-.-+......-..+++++..||..||++||+..++++
T Consensus 581 -----Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 -----KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -----HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 2233444422111111111122889999999999999999999986
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=293.86 Aligned_cols=261 Identities=22% Similarity=0.333 Sum_probs=195.1
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
|.+.++||.|++|.||+|+.. +++.||+|.+... ....+.+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 456789999999999999975 5889999998733 2334667889999999999999999999999999999999998
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
+ +|.+++..... ...+++..+..++.|+++||+|||+ .+++||||||+||++++++.++|+|||+++......
T Consensus 82 ~-~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~- 154 (284)
T cd07836 82 K-DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV- 154 (284)
T ss_pred c-cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-
Confidence 5 89888864332 3468999999999999999999998 899999999999999999999999999997653211
Q ss_pred cceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHH--------HHHHhhCC
Q 003059 658 RHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA--------YEEFEKGN 728 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~~ 728 (852)
.......++..|++||.+.+. .++.++||||||+++|||++|+.||......+........ +..+. .
T Consensus 155 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 230 (284)
T cd07836 155 --NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS--Q 230 (284)
T ss_pred --cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh--c
Confidence 112234568899999998664 5688999999999999999999999755432111100000 00000 0
Q ss_pred cccccccccCC-CCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 729 VKGIVDKSLAG-EDVD-----IEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 729 ~~~~~d~~l~~-~~~~-----~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..... ..... .... ......+.+++.+|++.||.+||++.+|++
T Consensus 231 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 231 LPEYK-PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred Cchhc-ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 00000 0000 111235678899999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=289.55 Aligned_cols=248 Identities=23% Similarity=0.361 Sum_probs=196.9
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
|.+.+.||+|+||.||++... ++..+|+|.+... ....+.+.+|++++++++|+||+++++.+.+....++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 456788999999999999965 4788999998632 234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC-ceEEeecccccccCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY-NAKVSDFGLAKLINPK 655 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~~ 655 (852)
++++|.+++.... ...+++..+..++.|+++||.|||+ .+++|+||||+||++++++ .+||+|||.+......
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 82 DGGDLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999996432 3357899999999999999999998 8999999999999999885 4699999999876432
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
.. ......|+..|+|||.+.+..++.++||||||++++||++|+.||...... ..... ..... +.+
T Consensus 156 ~~---~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~~----~~~ 221 (257)
T cd08225 156 ME---LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLK-ICQGY----FAP 221 (257)
T ss_pred cc---cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHH-Hhccc----CCC
Confidence 21 122345888999999998888999999999999999999999999643211 11111 11111 111
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
........+.+++.+|++.+|++||++.+|++.
T Consensus 222 ------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 ------ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ------CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111122357788899999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=291.05 Aligned_cols=245 Identities=24% Similarity=0.299 Sum_probs=197.8
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
|.+.+.||.|+||.||++... ++..|++|.+.... ...+.+.+|++++++++||||+++++++.++...++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 566789999999999999975 58889999987322 3457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+++++|.+++... ..+++..+..++.|++++|.|||+ .+++|+||+|+||++++++.++|+|||++......
T Consensus 82 ~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 82 LLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999543 358899999999999999999998 89999999999999999999999999999876442
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
. ......++..|+|||.+....++.++|+||||+++|+|++|+.||.......... ....... .. .
T Consensus 154 ~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~--~~----~ 219 (258)
T cd05578 154 T----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ----IRAKQET--AD----V 219 (258)
T ss_pred c----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHH----HHHHhcc--cc----c
Confidence 2 2233558889999999998889999999999999999999999997554321111 1111100 00 0
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCH--HHHH
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMM--GKVV 772 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~--~ev~ 772 (852)
..+......+.+++.+|++.+|.+||++ +|++
T Consensus 220 -----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 -----LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -----cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1112223567788899999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=294.99 Aligned_cols=241 Identities=26% Similarity=0.301 Sum_probs=194.8
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.|.+.+.||+|+||.||++... +++.+|+|.+.... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 3567789999999999999965 57899999986322 234668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++++|.+++... ..++...+..++.|++.||+|||+ .+++|+||+|+|||++.++.+||+|||+++....
T Consensus 82 ~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 82 YVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred cCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999643 358899999999999999999998 8999999999999999999999999999987643
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
. .....+++.|+|||.+.+...+.++||||||+++|||++|+.||...... ........+..
T Consensus 154 ~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~----- 215 (290)
T cd05580 154 R------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-------QIYEKILEGKV----- 215 (290)
T ss_pred C------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCc-----
Confidence 2 22345889999999998888999999999999999999999999644311 01111111110
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHH
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP-----MMGKVV 772 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~ev~ 772 (852)
.+ +......+.+++.+|++.+|.+|| ++++++
T Consensus 216 -~~-----~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 216 -RF-----PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred -cC-----CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 01 111134566788899999999998 555555
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=296.26 Aligned_cols=263 Identities=19% Similarity=0.214 Sum_probs=183.6
Q ss_pred HHHHhcccccccccccccceEEEEEECCC----cEEEEEEecCcccc---h---------HHHHHHHHHhhcccccceee
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANR----TVVAVKQLEGIEQG---E---------KQFRMEVATISSTHHLNLVR 558 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~~---~---------~~f~~E~~~l~~l~h~niv~ 558 (852)
++....|.+.++||+|+||.||+|...+. ..+++|........ + .....+...+..+.|+|+++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 44556788899999999999999996543 45666654321111 0 11223344566778999999
Q ss_pred eeeeeccCc----eeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceE
Q 003059 559 LVGFSSEGK----HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENIL 634 (852)
Q Consensus 559 l~g~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIL 634 (852)
+++++.... ..++++|++. .++.+.+... ...++..+..++.|+++||+|||+ .+|+||||||+|||
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nil 158 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIM 158 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEE
Confidence 999765443 4578888774 3666665322 224677889999999999999998 89999999999999
Q ss_pred eCCCCceEEeecccccccCCCCCcc----eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCcccccccc
Q 003059 635 LDENYNAKVSDFGLAKLINPKDHRH----RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQE 710 (852)
Q Consensus 635 l~~~~~~kl~DFGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~ 710 (852)
++.++.++|+|||+++.+....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999998764321111 111234699999999999999999999999999999999999999975532
Q ss_pred ccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003059 711 TNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776 (852)
Q Consensus 711 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~ 776 (852)
... +.......+. ..+....+.- ... ...+.+++..|++.+|++||++.++++.|+
T Consensus 239 ~~~--~~~~~~~~~~----~~~~~~~~~~-~~~---~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 239 NGN--LIHAAKCDFI----KRLHEGKIKI-KNA---NKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred chH--HHHHhHHHHH----HHhhhhhhcc-CCC---CHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 111 1111110000 0111111000 111 244667778899999999999999998773
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=286.39 Aligned_cols=250 Identities=25% Similarity=0.353 Sum_probs=201.5
Q ss_pred ccccccccccccceEEEEEECC-CcEEEEEEecCcc--cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 501 KGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
+.+.+.||+|++|.||+++... ++.|++|++.... ....++.+|+..+.+++|+||+++++++...+..++||||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 4567899999999999999764 8899999987443 346789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
+++|.+++... ..++...++.++.|++++|+|||+. .+++||||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 83 GGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 99999999643 4588999999999999999999973 5899999999999999999999999999987643222
Q ss_pred cceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccccc
Q 003059 658 RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSL 737 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (852)
. .....++..|+|||.+.+..++.++||||||+++|||++|+.||..........+. ........ +
T Consensus 156 ~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~----~~~~~~~~-----~-- 221 (264)
T cd06623 156 Q---CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM----QAICDGPP-----P-- 221 (264)
T ss_pred c---ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH----HHHhcCCC-----C--
Confidence 1 12345788999999999989999999999999999999999999755421111111 11111100 1
Q ss_pred CCCCCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 738 AGEDVDIE-QVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 738 ~~~~~~~~-~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
..+.. ....+.+++.+|++.+|.+||++.++++.
T Consensus 222 ---~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 ---SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ---CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11111 33567788888999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=295.65 Aligned_cols=264 Identities=20% Similarity=0.282 Sum_probs=192.5
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCcc---cchHHHHHHHHHhhccc-ccceeeeeeeeccCce-----e
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---QGEKQFRMEVATISSTH-HLNLVRLVGFSSEGKH-----R 569 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~-----~ 569 (852)
.|.+.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.++++++ |+||+++++++..... .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 3566788999999999999965 58899999886332 23357888999999995 6999999999877665 8
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC-CCceEEeeccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE-NYNAKVSDFGL 648 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGl 648 (852)
++||||+++ +|.+++..........+++..++.++.||+.||.|||+ ++|+||||||+||+++. ++.+||+|||+
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeeccc
Confidence 999999985 89998865443334568999999999999999999998 89999999999999998 89999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhC
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG 727 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (852)
++...... .......+++.|+|||++.+ ..++.++||||||+++|||++|..||......... .. ........
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~-~~~~~~~~ 231 (295)
T cd07837 158 GRAFSIPV---KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LH-IFKLLGTP 231 (295)
T ss_pred ceecCCCc---cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HH-HHHHhCCC
Confidence 87653211 11122346788999998865 45789999999999999999999999754321110 00 00000000
Q ss_pred Ccc---cc---ccc--ccCCCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 728 NVK---GI---VDK--SLAGEDVD-----IEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 728 ~~~---~~---~d~--~l~~~~~~-----~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
... .. .+. ........ ......+.+++.+|++.+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 00 000 00000000 112245678899999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-33 Score=304.24 Aligned_cols=202 Identities=30% Similarity=0.461 Sum_probs=173.6
Q ss_pred ccccccccccccceEEEEE-ECCCcEEEEEEecC--cccchHHHHHHHHHhhcccccceeeeeeeeccC------ceeeE
Q 003059 501 KGFKDKLGAGGFGAVYRGV-LANRTVVAVKQLEG--IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEG------KHRLL 571 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~~~l 571 (852)
+...+.||+|+||.||+|+ -..|+.||||.++. .....+...+|+++|++++|+|||+++++-.+. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3446789999999999999 56799999999984 334456778999999999999999999975543 46789
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeC--CCCc--eEEeecc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD--ENYN--AKVSDFG 647 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~--~~~~--~kl~DFG 647 (852)
|||||.+|||+..|....+ ...|++.+.+.++.+++.||.|||+ ++|+||||||.||++- ++|+ -||+|||
T Consensus 95 vmEyC~gGsL~~~L~~PEN--~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPEN--AYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEeecCCCcHHHHhcCccc--ccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 9999999999999976543 4569999999999999999999998 8999999999999984 3343 6999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccc
Q 003059 648 LAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQET 711 (852)
Q Consensus 648 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~ 711 (852)
.|+.+..+ .......||..|++||.+.. +.++..+|.|||||++||.+||..||......
T Consensus 170 ~Arel~d~----s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 170 AARELDDN----SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccccCCCC----CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 99988543 36778899999999999985 88999999999999999999999999765444
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=293.99 Aligned_cols=253 Identities=26% Similarity=0.375 Sum_probs=190.0
Q ss_pred ccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhccc-ccceeeeeeeeccCceeeEEEeecCC
Q 003059 503 FKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTH-HLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 503 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
+.++||+|+||.||++... +++.||+|.+... ......+.+|+.++.++. |+||+++++++..++..+++|||++
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~- 86 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD- 86 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-
Confidence 4568999999999999964 5789999998733 234567889999999996 9999999999999999999999985
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
++|.++...........+++..+..++.|++.||+|||+. .+++||||||+||+++.++.+||+|||+++......
T Consensus 87 ~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 162 (288)
T cd06616 87 ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI-- 162 (288)
T ss_pred CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC--
Confidence 4665543211111234689999999999999999999972 489999999999999999999999999997654321
Q ss_pred ceeeeeecCCCCCCChhhhhcC---CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 659 HRTLTSVRGTRGYLAPEWLANL---PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||..... ... .......+. .+
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~-~~~~~~~~~-----~~ 229 (288)
T cd06616 163 --AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFD-QLTQVVKGD-----PP 229 (288)
T ss_pred --ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHH-HHhhhcCCC-----CC
Confidence 11233578899999999766 689999999999999999999999964321 000 000000000 11
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.+.. .........+.+++.+|++.+|.+||++.+|++.
T Consensus 230 ~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 ILSN-SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCC-cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 1111233467788999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=290.87 Aligned_cols=241 Identities=25% Similarity=0.302 Sum_probs=184.5
Q ss_pred cccccccceEEEEEEC-CCcEEEEEEecCcc----cchHHHHHHHHHhh---cccccceeeeeeeeccCceeeEEEeecC
Q 003059 506 KLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE----QGEKQFRMEVATIS---STHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 506 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~f~~E~~~l~---~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
.||+|+||.||++... +++.+|+|.+.... .....+..|..++. ..+|+||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 57899999886322 22233445544433 3479999999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
+++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~- 151 (279)
T cd05633 81 GGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (279)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-
Confidence 99999998643 348999999999999999999998 899999999999999999999999999987553211
Q ss_pred cceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 658 RHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
.....|+..|+|||.+.. ..++.++|||||||+++||++|+.||..........+.. .. ......
T Consensus 152 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~------~~~~~~ 217 (279)
T cd05633 152 ----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MT------LTVNVE 217 (279)
T ss_pred ----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH----Hh------hcCCcC
Confidence 122458999999999864 568999999999999999999999997543222111100 00 000111
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRP-----MMGKVVQM 774 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~ev~~~ 774 (852)
.+......+.+++..|++.||.+|| +++++++.
T Consensus 218 -----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 -----LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -----CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1112234567888899999999999 58888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=293.37 Aligned_cols=260 Identities=22% Similarity=0.294 Sum_probs=192.2
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
|+..+.||.|+||.||+|+.. +++.|+||++.... .....+.+|++++++++||||+++++++.+++..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 455678999999999999864 57899999887322 23357889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
. ++|..++.... ...+++..+..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||++.......
T Consensus 82 ~-~~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 82 H-QDLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred c-cCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 5 68999885432 3458999999999999999999998 899999999999999999999999999987654321
Q ss_pred CcceeeeeecCCCCCCChhhhhcCC-CCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC-------
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLP-ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN------- 728 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------- 728 (852)
.......++..|+|||.+.+.. ++.++||||||+++|||+||+.||........ +... ........
T Consensus 155 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~ 228 (284)
T cd07860 155 ---RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRI-FRTLGTPDEVVWPGV 228 (284)
T ss_pred ---cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHH-HHHhCCCChhhhhhh
Confidence 1122334678899999887654 58899999999999999999999965432111 0000 00000000
Q ss_pred -----cccccccccCCC--CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 729 -----VKGIVDKSLAGE--DVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 729 -----~~~~~d~~l~~~--~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
....+....... .........+.+++.+|++.||.+||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 229 TSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000 000001134568899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-33 Score=304.51 Aligned_cols=268 Identities=23% Similarity=0.319 Sum_probs=195.7
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecC--cccchHHHHHHHHHhhcccccceeeeeeeeccC-----ceee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEG--IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEG-----KHRL 570 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~ 570 (852)
..|.+.++||+|+||.||+|.. .+++.||+|.+.. .......+..|+.++++++|+||+++++++... ...+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 3567788999999999999985 4588999999863 223446688899999999999999999986544 3579
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+|+||+++ +|.+++. ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 85 lv~e~~~~-~l~~~~~------~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 85 IVQELMET-DLYKLIK------TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEehhccc-CHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECccccee
Confidence 99999964 8887773 2358899999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhC--
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG-- 727 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-- 727 (852)
................++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ .......+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~ 231 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQ 231 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCH
Confidence 76433222222233568899999998765 4688999999999999999999999965322110 00000000000
Q ss_pred -Cccccccc-------ccC-CCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcCc
Q 003059 728 -NVKGIVDK-------SLA-GEDVDI-----EQVMRAIQVSFWCIQEQPSQRPMMGKVVQM--LEGIT 779 (852)
Q Consensus 728 -~~~~~~d~-------~l~-~~~~~~-----~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~--L~~~~ 779 (852)
....+.+. ... ....+. .....+.+++.+|++.+|++||++.++++. ++...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00000000 000 001111 112457789999999999999999999875 54443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=290.08 Aligned_cols=246 Identities=23% Similarity=0.340 Sum_probs=194.7
Q ss_pred ccccccceEEEEEECC-CcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCCH
Q 003059 507 LGAGGFGAVYRGVLAN-RTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSL 581 (852)
Q Consensus 507 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 581 (852)
||.|+||.||++.... ++.+++|.+.... ...+.+.+|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999764 8899999987432 3456788999999999999999999999999999999999999999
Q ss_pred HHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc---
Q 003059 582 DNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR--- 658 (852)
Q Consensus 582 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~--- 658 (852)
.+++... ..+++..+..++.|+++||+|||+ .+++|+||+|+||++++++.++|+|||++.........
T Consensus 81 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLENV-----GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 9999643 258999999999999999999998 89999999999999999999999999998765332110
Q ss_pred --ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 659 --HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 659 --~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
........++..|+|||.+.....+.++||||||++++||++|+.||....... .......+...
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~------ 219 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-------IFQNILNGKIE------ 219 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCcC------
Confidence 112233557889999999988889999999999999999999999996443211 01111111100
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~ 776 (852)
. +........+.+++.+|++.+|.+||++.++.+.|+
T Consensus 220 ~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 W---PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred C---CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0 000011346678889999999999999977776664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=286.87 Aligned_cols=241 Identities=26% Similarity=0.343 Sum_probs=192.4
Q ss_pred ccccccceEEEEEECC-CcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCCH
Q 003059 507 LGAGGFGAVYRGVLAN-RTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSL 581 (852)
Q Consensus 507 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 581 (852)
||.|+||.||+++... ++.+++|.+.... ...+.+.+|++++++++|+||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 7999999999999754 7889999986322 3446789999999999999999999999999999999999999999
Q ss_pred HHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCccee
Q 003059 582 DNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRT 661 (852)
Q Consensus 582 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 661 (852)
.+++... ..+++..+..++.||+.||+|||+ .+++|+||+|+||+++.++.++|+|||+++...... .
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----~ 148 (262)
T cd05572 81 WTILRDR-----GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----K 148 (262)
T ss_pred HHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----c
Confidence 9999643 248899999999999999999998 899999999999999999999999999998764321 1
Q ss_pred eeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCCCC
Q 003059 662 LTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGED 741 (852)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 741 (852)
.....++..|++||.+.+..++.++|+||||+++|||++|..||......... . ......+. ... .
T Consensus 149 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~-~~~~~~~~------~~~---~ 214 (262)
T cd05572 149 TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME----I-YNDILKGN------GKL---E 214 (262)
T ss_pred cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH----H-HHHHhccC------CCC---C
Confidence 22345788999999998888999999999999999999999999755421110 0 01111000 000 1
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003059 742 VDIEQVMRAIQVSFWCIQEQPSQRPM-----MGKVVQ 773 (852)
Q Consensus 742 ~~~~~~~~~~~l~~~cl~~dp~~RPt-----~~ev~~ 773 (852)
.+......+.+++..|++.+|.+||+ ++|+++
T Consensus 215 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 215 FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 11112456788899999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=294.12 Aligned_cols=245 Identities=26% Similarity=0.338 Sum_probs=193.1
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.|.+.++||+|+||.||+|... +++.|++|.+... ....+++.+|+++++.++||||+++++++.+.+..++|||
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 4667789999999999999964 5889999988632 1233568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|++ |+|.+++... ...+++..+..++.|++.||.|||+ .+|+||||+|+||++++++.+||+|||++.....
T Consensus 96 ~~~-g~l~~~~~~~----~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 96 YCL-GSASDILEVH----KKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred hhC-CCHHHHHHHc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 996 5777777432 2358999999999999999999998 8999999999999999999999999999876543
Q ss_pred CCCcceeeeeecCCCCCCChhhhh---cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLA---NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
. ....++..|+|||.+. ...++.++||||||+++|||++|+.||........ .. .......
T Consensus 168 ~-------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~-~~~~~~~-- 231 (307)
T cd06607 168 A-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LY-HIAQNDS-- 231 (307)
T ss_pred C-------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HH-HHhcCCC--
Confidence 2 1245788999999874 45688999999999999999999999864432110 00 0010000
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQML 775 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L 775 (852)
+. .........+.+++.+||+.+|++||++.+|+...
T Consensus 232 ---~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 232 ---PT----LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred ---CC----CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 00 01112334678889999999999999999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=289.28 Aligned_cols=243 Identities=26% Similarity=0.359 Sum_probs=190.2
Q ss_pred ccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCCH
Q 003059 507 LGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSL 581 (852)
Q Consensus 507 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 581 (852)
||+|+||+||++... +++.+++|.+... ......+..|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 799999999999854 5889999998632 22345677899999999999999999999999999999999999999
Q ss_pred HHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCccee
Q 003059 582 DNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRT 661 (852)
Q Consensus 582 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 661 (852)
.+++.... ...+++..++.++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++...... ..
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~----~~ 150 (277)
T cd05577 81 KYHIYNVG---EPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG----KK 150 (277)
T ss_pred HHHHHHcC---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccC----Cc
Confidence 99996543 2358899999999999999999998 89999999999999999999999999998765431 11
Q ss_pred eeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCCCC
Q 003059 662 LTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGED 741 (852)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 741 (852)
.....++..|+|||.+.+..++.++||||||++++||++|+.||......... ..+....... .. .
T Consensus 151 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~----~~---~ 216 (277)
T cd05577 151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK-------EELKRRTLEM----AV---E 216 (277)
T ss_pred cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH-------HHHHhccccc----cc---c
Confidence 22345788999999998888999999999999999999999999754331110 0111110000 00 1
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003059 742 VDIEQVMRAIQVSFWCIQEQPSQRP-----MMGKVVQ 773 (852)
Q Consensus 742 ~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~ev~~ 773 (852)
.+......+.+++.+|++.+|.+|| ++.++++
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 217 YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 1111233567888999999999999 5555553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=292.16 Aligned_cols=262 Identities=19% Similarity=0.240 Sum_probs=193.3
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccC--ceeeEEE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEG--KHRLLVY 573 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~ 573 (852)
.|.+.+.||+|+||.||+|... +++.+++|.++... .....+.+|+.++.+++||||+++++++... ...++||
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 4566789999999999999975 57889999987332 2234567899999999999999999998776 8999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||++ ++|.+++.... ..+++..++.++.||+.||+|||+ .+++|+||||+||++++++.+||+|||+++...
T Consensus 86 e~~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 86 EYVE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred hhcC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 9997 59999885432 358999999999999999999998 899999999999999999999999999998664
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhH-H-------HHHHHH
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFS-L-------WAYEEF 724 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~-~-------~~~~~~ 724 (852)
... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||............ . ..+..+
T Consensus 158 ~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 158 SPL---KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred CCc---cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence 321 112334578899999998764 4689999999999999999999999754322110000 0 000000
Q ss_pred hh------CCcccccccccCCCCCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 725 EK------GNVKGIVDKSLAGEDVDIE-QVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 725 ~~------~~~~~~~d~~l~~~~~~~~-~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.. ..........+.. ..+.. ....+.+++..|++.+|++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRK-KFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hccchhcccccccccchhhhc-cccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 0000000000000 01111 1344667888999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=292.44 Aligned_cols=259 Identities=22% Similarity=0.276 Sum_probs=193.0
Q ss_pred cccccccccccceEEEEEEC-CCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 502 GFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 502 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
.+.++||.|++|.||+|... +++.|++|++.... .....+.+|++++++++|+|++++++++.+++..++||||++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 45678999999999999864 68899999987332 233568899999999999999999999999999999999995
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
++|.+++.... ...+++..++.++.|+++||+|||+ ++++||||+|+||+++.++.++|+|||+++......
T Consensus 82 -~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~- 153 (283)
T cd07835 82 -LDLKKYMDSSP---LTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV- 153 (283)
T ss_pred -cCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-
Confidence 68999986433 2358999999999999999999998 899999999999999999999999999997653221
Q ss_pred cceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhC---------
Q 003059 658 RHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG--------- 727 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--------- 727 (852)
.......++..|+|||.+.+. .++.++||||||+++|||++|+.||........ +.... ......
T Consensus 154 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~ 228 (283)
T cd07835 154 --RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIF-RTLGTPDEDVWPGVT 228 (283)
T ss_pred --cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-HHhCCCChHHhhhhh
Confidence 111223468899999988654 578999999999999999999999975432111 00000 000000
Q ss_pred CcccccccccCCCCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 728 NVKGIVDKSLAGEDV-----DIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 728 ~~~~~~d~~l~~~~~-----~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.+.+........... .......+.+++.+|++.+|.+||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 229 SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000000000 0111245778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=290.74 Aligned_cols=257 Identities=23% Similarity=0.261 Sum_probs=190.2
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhccc-ccceeeeeeeeccC--ceeeEEEe
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTH-HLNLVRLVGFSSEG--KHRLLVYE 574 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lV~e 574 (852)
|.+.++||+|+||.||+|... +++.||+|++... .........|+.++.++. |+||+++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 356788999999999999964 5788999998743 222334557888898885 99999999999887 89999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|++ ++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++. +.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKGR----KRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 996 5888887543 2358999999999999999999998 89999999999999999 9999999999987643
Q ss_pred CCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHH-----------
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYE----------- 722 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~----------- 722 (852)
... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||......+. ......
T Consensus 152 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~ 224 (282)
T cd07831 152 KPP----YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLK 224 (282)
T ss_pred CCC----cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHH
Confidence 211 122457889999997654 5678999999999999999999999975432111 111110
Q ss_pred HHhhCCcccccccccCCC---CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 723 EFEKGNVKGIVDKSLAGE---DVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 723 ~~~~~~~~~~~d~~l~~~---~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
............+..... .........+.+++.+|++.+|++||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 225 KFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred hhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000000000000 000122456789999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=293.74 Aligned_cols=266 Identities=19% Similarity=0.227 Sum_probs=190.6
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCc--------
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGK-------- 567 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-------- 567 (852)
.|.+.++||+|+||.||++... +++.||||.+.... .....+.+|++++++++||||+++++++...+
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 4777889999999999999964 58899999886322 22345678999999999999999999886544
Q ss_pred eeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecc
Q 003059 568 HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFG 647 (852)
Q Consensus 568 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 647 (852)
..++||||+. ++|.+++... ...+++..++.++.||+.||+|||+ ++++|+||||+||+++.++.+||+|||
T Consensus 93 ~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 93 SFYLVFEFCE-HDLAGLLSNK----NVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred eEEEEEcCCC-cCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCC
Confidence 4599999996 4888877432 2358999999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCCc-ceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHh
Q 003059 648 LAKLINPKDHR-HRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFE 725 (852)
Q Consensus 648 la~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 725 (852)
++......... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||....................
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99866432211 1122334578899999988765 478899999999999999999999975432211111110000000
Q ss_pred -----hCCccccccc-ccCCCC--------CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 726 -----KGNVKGIVDK-SLAGED--------VDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 726 -----~~~~~~~~d~-~l~~~~--------~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
........+. ...... ........+.+++.+|++.||.+||+++++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000000000 000000 00001234568999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=281.27 Aligned_cols=249 Identities=27% Similarity=0.379 Sum_probs=200.3
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccC--ceeeEEEe
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEG--KHRLLVYE 574 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e 574 (852)
|...+.||+|++|.||+|... +++.|++|.+.... ...+.+.+|++++++++|+||+++++.+.+. ...++|+|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 345678999999999999976 68899999987443 4467889999999999999999999999988 89999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++++|.+++.... .+++..+..++.|++++|+|||+ .+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 82 YVSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred ecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999996432 68999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
.... .......++..|+|||.+.....+.++||||||+++++|++|+.||....... .... ..... ...
T Consensus 154 ~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~-~~~~~---~~~- 222 (260)
T cd06606 154 IETG-EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-----AALY-KIGSS---GEP- 222 (260)
T ss_pred cccc-ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHH-hcccc---CCC-
Confidence 3221 01233558889999999998889999999999999999999999997544110 0000 00000 000
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
. ..+......+.+++.+|++.+|.+||++.++++
T Consensus 223 ~-----~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 P-----EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred c-----CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 0 111122456778889999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=292.74 Aligned_cols=260 Identities=22% Similarity=0.285 Sum_probs=191.1
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
.|.+.++||+|++|.||+|... +++.|++|++.... ...+.+.+|++++++++|+||+++++++.+....++||||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY 82 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence 4667789999999999999965 57899999986332 2345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC-CCceEEeecccccccCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE-NYNAKVSDFGLAKLINP 654 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~ 654 (852)
++ ++|.+++.... ...+++..+..++.||+.||+|||+ ++++||||+|+||+++. ++.+||+|||++.....
T Consensus 83 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 83 LD-LDLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred cc-ccHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 95 58888774332 2335788888999999999999998 89999999999999985 56799999999976532
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
.. .......+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+... . ...... .......
T Consensus 156 ~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~--~-~~~~~~-~~~~~~~ 228 (294)
T PLN00009 156 PV---RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF--K-IFRILG-TPNEETW 228 (294)
T ss_pred Cc---cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-HHHHhC-CCChhhc
Confidence 11 111234567899999998764 57899999999999999999999997543221110 0 000000 0000000
Q ss_pred -------c--cccCC-CCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 734 -------D--KSLAG-EDV-----DIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 734 -------d--~~l~~-~~~-----~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+ ..... ... .......+.+++.+|++.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00000 000 0111234678899999999999999999985
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=291.99 Aligned_cols=248 Identities=25% Similarity=0.324 Sum_probs=193.7
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
+...+.||+|+||.||+++.. ++..||+|.+.... ....++.+|++++++++|+|++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 445678999999999999964 57899999986321 2235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
++ |+|.+++... ...+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 107 CL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 96 5787777532 3358999999999999999999998 89999999999999999999999999998754321
Q ss_pred CCcceeeeeecCCCCCCChhhhh---cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLA---NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI 732 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (852)
....++..|+|||.+. ...++.++||||||+++|||++|+.||........ .........
T Consensus 179 -------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-------~~~~~~~~~--- 241 (317)
T cd06635 179 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------LYHIAQNES--- 241 (317)
T ss_pred -------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-------HHHHHhccC---
Confidence 2345788999999974 45688999999999999999999999864321110 001111100
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
+. .........+.+++.+|++.+|.+||++.+|++.+....
T Consensus 242 --~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 242 --PT----LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred --CC----CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 00 111122335678889999999999999999998665443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-32 Score=284.56 Aligned_cols=248 Identities=25% Similarity=0.361 Sum_probs=200.4
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
|.+.++||+|+||.||++... +++.+++|.+... .....++.+|++++++++|+||+++++++.+....++||||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 556789999999999999854 5788999998742 233456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|.+++..... ....+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||+++.....
T Consensus 82 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 82 PFGDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred CCCCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999865322 23568999999999999999999998 89999999999999999999999999999876542
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||....... + ..........
T Consensus 157 ----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~----~~~~~~~~~~------ 219 (256)
T cd08530 157 ----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---L----RYKVQRGKYP------ 219 (256)
T ss_pred ----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H----HHHHhcCCCC------
Confidence 1122457889999999999999999999999999999999999997543211 0 0111111111
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
..+......+.+++.+|++.+|++||++.++++.
T Consensus 220 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 ----PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ----CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1122334567889999999999999999999763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=297.24 Aligned_cols=262 Identities=21% Similarity=0.262 Sum_probs=193.4
Q ss_pred HhcccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccC------c
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEG------K 567 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~ 567 (852)
...|...+.||+|+||.||++... +++.||+|.+... .....++.+|++++++++|+||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 356777889999999999999964 6889999998632 22345677899999999999999999987643 3
Q ss_pred eeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecc
Q 003059 568 HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFG 647 (852)
Q Consensus 568 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 647 (852)
..++||||+. ++|.+++.. .++...+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred cEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCc
Confidence 5799999995 588887732 27888899999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhh---------HH
Q 003059 648 LAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKF---------SL 718 (852)
Q Consensus 648 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l---------~~ 718 (852)
+++...... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+....... ..
T Consensus 164 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 239 (353)
T cd07850 164 LARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE 239 (353)
T ss_pred cceeCCCCC----CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 998654321 12234578899999999999999999999999999999999999965432110000 00
Q ss_pred H-------HHHHHhhC------CcccccccccCC---CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 719 W-------AYEEFEKG------NVKGIVDKSLAG---EDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 719 ~-------~~~~~~~~------~~~~~~d~~l~~---~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
+ ........ ....+....+.. ..........+.+++.+|++.||.+||++.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00000000 000000000000 00011224456789999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=290.67 Aligned_cols=260 Identities=23% Similarity=0.275 Sum_probs=194.5
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccC--ceeeEEEe
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEG--KHRLLVYE 574 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e 574 (852)
|.+.++||+|+||.||+|+.. +++.+++|++... ......+.+|++++++++|+|++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 345688999999999999975 4789999999844 23345688999999999999999999999888 89999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++ +|.+++... ...+++..++.++.||++||+|||+ .+++|+||||+||++++++.+||+|||++.....
T Consensus 81 ~~~~-~l~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 81 YMDH-DLTGLLDSP----EVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred cccc-cHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 9975 898888543 2368999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhC------
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG------ 727 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------ 727 (852)
... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... .........
T Consensus 153 ~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~ 227 (287)
T cd07840 153 RNS--ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE---KIFELCGSPTDENWP 227 (287)
T ss_pred CCc--ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCchhhcc
Confidence 321 12233456788999998765 467899999999999999999999997544221110 000000000
Q ss_pred Ccccc-cccccCCC-C--------CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 728 NVKGI-VDKSLAGE-D--------VDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 728 ~~~~~-~d~~l~~~-~--------~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
....+ ........ . ........+.+++.+|++.+|.+||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000 00000000 0 00001346788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=284.44 Aligned_cols=249 Identities=24% Similarity=0.280 Sum_probs=191.7
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc------ccchHHHHHHHHHhhcccccceeeeeeeeccC--ceee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI------EQGEKQFRMEVATISSTHHLNLVRLVGFSSEG--KHRL 570 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~------~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~ 570 (852)
.|.+.+.||+|+||.||+|... ++..|++|.+... ......+++|++++++++|+||+++++++.+. ...+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 3567789999999999999964 5889999987521 22335788999999999999999999998654 4688
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+|+||+++++|.+++... ..+++....+++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++
T Consensus 83 ~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEeCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 999999999999998543 247888899999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcc
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (852)
................++..|+|||.+.+..++.++||||||++++||++|+.||....... . ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~-----~~~~~~~~~~ 227 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--A-----IFKIATQPTK 227 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--H-----HHHHHcCCCC
Confidence 65432111112233458899999999998889999999999999999999999996432110 0 0011000000
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 731 GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+ ..+......+.+++.+|++ +|.+||+..+++.
T Consensus 228 ----~-----~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 228 ----P-----MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ----C-----CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1 1122223456777888998 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=294.95 Aligned_cols=266 Identities=24% Similarity=0.360 Sum_probs=194.7
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecC---cccchHHHHHHHHHhhcc-cccceeeeeeeeccC--ceeeE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEG---IEQGEKQFRMEVATISST-HHLNLVRLVGFSSEG--KHRLL 571 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~---~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~--~~~~l 571 (852)
..|.+.+.||+|+||.||+|... +++.+++|++.. .......+.+|+.++.++ +|+||+++++++... ...++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 45667789999999999999975 578899998853 223345677899999999 999999999988653 46899
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
||||++ ++|..++... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 87 v~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 87 VFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred Eecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 999997 5998888432 57889999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCCc--ceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHH--------
Q 003059 652 INPKDHR--HRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA-------- 720 (852)
Q Consensus 652 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~-------- 720 (852)
....... ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 6433211 112234568899999998754 46789999999999999999999999654322111000000
Q ss_pred HHHHhhCCcccccccccCCCCCCHH-----HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 721 YEEFEKGNVKGIVDKSLAGEDVDIE-----QVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 721 ~~~~~~~~~~~~~d~~l~~~~~~~~-----~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
...+.......+++........... ....+.+++.+|++.+|.+||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000011111111000011111 23457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=293.61 Aligned_cols=260 Identities=21% Similarity=0.268 Sum_probs=189.9
Q ss_pred cccccc--ccceEEEEEE-CCCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 505 DKLGAG--GFGAVYRGVL-ANRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 505 ~~lG~G--~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
+.||+| +||+||++.. ..++.||+|.+.... ...+.+++|+.+++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457777 8999999996 468999999987332 2346788999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
++|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 84 GSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 99999986542 2348889999999999999999998 89999999999999999999999999866443221111
Q ss_pred cee----eeeecCCCCCCChhhhhcC--CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHH-----------
Q 003059 659 HRT----LTSVRGTRGYLAPEWLANL--PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAY----------- 721 (852)
Q Consensus 659 ~~~----~~~~~gt~~y~aPE~~~~~--~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~----------- 721 (852)
... .....++..|+|||++.+. .++.++||||||+++|||++|+.||........ ......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccc
Confidence 100 0112345679999999764 478999999999999999999999975422110 000000
Q ss_pred -----HH-------Hhh----CCc-----ccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 722 -----EE-------FEK----GNV-----KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 722 -----~~-------~~~----~~~-----~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.. ... ... ..+.+..+.. .........+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRT-PSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccc-hhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00 000 000 0000111111 112233456789999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=287.79 Aligned_cols=262 Identities=25% Similarity=0.324 Sum_probs=194.7
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCccc--chHHHHHHHHHhhccc-ccceeeeeeeeccCceeeEEEeec
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQ--GEKQFRMEVATISSTH-HLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
|.+.+.||+|+||.||+|+.. +++.|++|++..... ......+|+..+.+++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 356788999999999999975 478899999874332 2334567999999999 999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
+++|.+++.... ...+++..+..++.|++.+|.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 81 -EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred -CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 889999886543 3468999999999999999999998 899999999999999999999999999998654321
Q ss_pred CcceeeeeecCCCCCCChhhhh-cCCCCCCccchhhhHHHHHHHhCCccccccccccchhh----------HHHHHHHHh
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLA-NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKF----------SLWAYEEFE 725 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l----------~~~~~~~~~ 725 (852)
......++..|+|||.+. ...++.++||||||++++||++|+.||......+...- ..|......
T Consensus 154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 154 ----PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred ----CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 112345788999999875 44678999999999999999999999965532211100 000000000
Q ss_pred hCCcccccccccCCC--CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 726 KGNVKGIVDKSLAGE--DVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 726 ~~~~~~~~d~~l~~~--~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.......+....... .........+.+++.+|++.+|++||++.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 001110000000000 000011356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=290.06 Aligned_cols=242 Identities=23% Similarity=0.356 Sum_probs=192.5
Q ss_pred ccccccccceEEEEEE-CCCcEEEEEEecC-cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCCHH
Q 003059 505 DKLGAGGFGAVYRGVL-ANRTVVAVKQLEG-IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLD 582 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 582 (852)
.+||+|+||.||++.. .+++.||+|++.. .......+.+|+.++++++|+||+++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999986 4688999999863 3334567889999999999999999999999999999999999999999
Q ss_pred HHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcceee
Q 003059 583 NFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTL 662 (852)
Q Consensus 583 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 662 (852)
+++.. ..+++..+..++.|++.+|+|||+ .+++||||+|+||++++++.++|+|||++....... ...
T Consensus 106 ~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~---~~~ 173 (292)
T cd06657 106 DIVTH------TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV---PRR 173 (292)
T ss_pred HHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccc---ccc
Confidence 98742 247889999999999999999998 899999999999999999999999999987654321 112
Q ss_pred eeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCCCCC
Q 003059 663 TSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDV 742 (852)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 742 (852)
....++..|+|||.+.+..++.++||||||+++|||++|+.||........ ...... .....+..
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-------~~~~~~-----~~~~~~~~--- 238 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-------MKMIRD-----NLPPKLKN--- 238 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHh-----hCCcccCC---
Confidence 334588999999999888899999999999999999999999864322110 001110 01111100
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 743 DIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 743 ~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.......+.+++.+|++.+|.+||++.++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 0011224567788899999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-32 Score=289.23 Aligned_cols=258 Identities=22% Similarity=0.296 Sum_probs=196.2
Q ss_pred cccccccccccceEEEEEEC-CCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 502 GFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 502 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
.+.+.||+|++|.||++... +++.+++|++.... .....+..|++++++++|+||+++++++..+...++|+||++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 45678999999999999864 68889999987432 235678899999999999999999999999999999999997
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
+ +|.+++... ...+++..+..++.|+++||.|||+ .+|+|+||||+||++++++.+||+|||.+.......
T Consensus 82 ~-~l~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 82 T-DLYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred C-CHHHHHHhh----cccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 5 888888543 2368999999999999999999998 899999999999999999999999999998765432
Q ss_pred cceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC---ccccc
Q 003059 658 RHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN---VKGIV 733 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~ 733 (852)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+.... ......... .....
T Consensus 153 --~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 227 (283)
T cd05118 153 --RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK---IFRTLGTPDPEVWPKFT 227 (283)
T ss_pred --ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCchHhcccch
Confidence 122234578889999999876 789999999999999999999999965432211100 000000000 00000
Q ss_pred c------cccC-CCCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 734 D------KSLA-GEDV-----DIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 734 d------~~l~-~~~~-----~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+ .... .... .......+.+++..|++.||.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 0000 0011 1122356789999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=270.25 Aligned_cols=245 Identities=22% Similarity=0.373 Sum_probs=188.2
Q ss_pred cccccccccceEEEEEECC-CcEEEEEEecCc--ccchHHHHHHHHHhhccc-ccceeeeeeeeccCceeeEEEeecCCC
Q 003059 504 KDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGI--EQGEKQFRMEVATISSTH-HLNLVRLVGFSSEGKHRLLVYEFMKNG 579 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~g 579 (852)
...||.|..|.|++...+. +..+|||.+... .+..+++...+.++.+-+ .|+||+.+|||..+...++.||.|. .
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-T 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-H
Confidence 4569999999999999654 888999999843 344567788888876664 9999999999999999999999983 3
Q ss_pred CHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcc
Q 003059 580 SLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRH 659 (852)
Q Consensus 580 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 659 (852)
-++.+|..- ..++++...=++...+.+||.||.+ +++|||||+||+|||+|+.|++||+|||++-.+-. .
T Consensus 176 C~ekLlkri----k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd----S 245 (391)
T KOG0983|consen 176 CAEKLLKRI----KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD----S 245 (391)
T ss_pred HHHHHHHHh----cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeec----c
Confidence 455655432 3458888888999999999999998 48999999999999999999999999999976532 1
Q ss_pred eeeeeecCCCCCCChhhhh---cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 660 RTLTSVRGTRGYLAPEWLA---NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
...+...|.+.|||||.+. ...|+.++||||||++|+||.||+.||.....+-+ +...+.. -..+.
T Consensus 246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe------~ltkvln-----~ePP~ 314 (391)
T KOG0983|consen 246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE------VLTKVLN-----EEPPL 314 (391)
T ss_pred cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH------HHHHHHh-----cCCCC
Confidence 2334567999999999985 34688899999999999999999999986433211 1111111 11133
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
|.+.. .-...++++...|++.|+.+||.+.++++
T Consensus 315 L~~~~---gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 315 LPGHM---GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCccc---CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 33211 02235667777799999999999998875
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-33 Score=276.45 Aligned_cols=262 Identities=25% Similarity=0.353 Sum_probs=196.6
Q ss_pred cccCHHHHHHhcccccccccccccceEEEEEE-CCCcEEEEEEecC--cccchHHHHHHHHHhhc-ccccceeeeeeeec
Q 003059 489 VQFSYKELQRSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEG--IEQGEKQFRMEVATISS-THHLNLVRLVGFSS 564 (852)
Q Consensus 489 ~~~~~~el~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~--~~~~~~~f~~E~~~l~~-l~h~niv~l~g~~~ 564 (852)
..|+-+.|+.. ..||.|+||+|+|-.. +.++..|||++.. .....+++..|.+...+ -+.||||+++|.+.
T Consensus 59 ~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F 133 (361)
T KOG1006|consen 59 HTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF 133 (361)
T ss_pred cccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence 34554444432 4699999999999885 4689999999983 34556788889887655 47999999999999
Q ss_pred cCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEe
Q 003059 565 EGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVS 644 (852)
Q Consensus 565 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 644 (852)
.++..++.||.| .-||+.+-..-.......++++..-+|......||.||.++ ..|||||+||+|||||..|.+||+
T Consensus 134 ~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLC 210 (361)
T KOG1006|consen 134 SEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLC 210 (361)
T ss_pred cCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeee
Confidence 999999999999 56887765432222344688888888999999999999985 679999999999999999999999
Q ss_pred ecccccccCCCCCcceeeeeecCCCCCCChhhhhc--CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHH
Q 003059 645 DFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN--LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYE 722 (852)
Q Consensus 645 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 722 (852)
|||++-.+.. ....+...|...|||||.+.. ..++.++||||||++|+|+.||+.||+.... +.....
T Consensus 211 DFGIcGqLv~----SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s------vfeql~ 280 (361)
T KOG1006|consen 211 DFGICGQLVD----SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS------VFEQLC 280 (361)
T ss_pred cccchHhHHH----HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH------HHHHHH
Confidence 9999976532 122244568899999999853 3588999999999999999999999975432 111112
Q ss_pred HHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 723 EFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 723 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
....+....+. ......+....++.++-.|+.+|..+||.+.++.+
T Consensus 281 ~Vv~gdpp~l~-----~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 281 QVVIGDPPILL-----FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HHHcCCCCeec-----CcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 22222222211 11222334556777888899999999999998875
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=289.44 Aligned_cols=262 Identities=23% Similarity=0.288 Sum_probs=193.1
Q ss_pred HHHhcccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCc----
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK---- 567 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~---- 567 (852)
.....|.+.++||+|+||.||+|... +++.|++|+++.. ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34456777889999999999999975 4788999998732 223356788999999999999999999887654
Q ss_pred ------eeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCce
Q 003059 568 ------HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNA 641 (852)
Q Consensus 568 ------~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 641 (852)
..++|+||+++ +|..++... ...+++..+..++.||+.||+|||+ .+|+|+||||+||++++++.+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcE
Confidence 78999999976 777776432 2358999999999999999999998 899999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHH
Q 003059 642 KVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA 720 (852)
Q Consensus 642 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 720 (852)
||+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ +...
T Consensus 156 kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~--~~~~- 230 (302)
T cd07864 156 KLADFGLARLYNSEES--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ--LELI- 230 (302)
T ss_pred EeCcccccccccCCcc--cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHH-
Confidence 9999999987644321 11122345778999998865 3578999999999999999999999975432111 1000
Q ss_pred HHHHhhCCccc----c--------ccc------ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 721 YEEFEKGNVKG----I--------VDK------SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 721 ~~~~~~~~~~~----~--------~d~------~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.... ...... + .+. .+.. ... .....+.+++.+|++.+|.+||++.+|++
T Consensus 231 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 231 SRLC-GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFS-FIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHh-CCCChhhcccccccccccccccccccccchhh-hcC-CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 000000 0 000 0000 000 01235678899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=291.20 Aligned_cols=250 Identities=22% Similarity=0.362 Sum_probs=190.1
Q ss_pred cccccccccccccceEEEEEECC-CcEEEEEEecCcc--cchHHHHHHHHHhhccc-ccceeeeeeeeccCceeeEEEee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGIE--QGEKQFRMEVATISSTH-HLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
.+.+.++||+|+||.||+|...+ ++.||||+++... ....++..|+.++.+.. |+||+++++++.+....++||||
T Consensus 16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 95 (296)
T cd06618 16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL 95 (296)
T ss_pred hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeec
Confidence 45677899999999999999865 8899999997432 23455677887776665 99999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
++ ++|.+++... ...+++..+..++.||+.||+|||+. .+|+||||+|+||++++++.+||+|||++..+...
T Consensus 96 ~~-~~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 96 MS-TCLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred cC-cCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 85 4777776432 23689999999999999999999962 48999999999999999999999999998765322
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCC----CCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLP----ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
. ......++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... . ..........
T Consensus 169 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~-----~~~~~~~~~~-- 236 (296)
T cd06618 169 K----AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-E-----VLTKILQEEP-- 236 (296)
T ss_pred C----cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-H-----HHHHHhcCCC--
Confidence 1 112234778999999987654 7889999999999999999999996432110 0 0111111110
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
+.+. ........+.+++.+|++.||.+||++.++++.
T Consensus 237 ---~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 ---PSLP---PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ---CCCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0110 000123457788899999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=288.11 Aligned_cols=253 Identities=22% Similarity=0.249 Sum_probs=195.4
Q ss_pred ccccccccccccceEEEEEE----CCCcEEEEEEecCc-----ccchHHHHHHHHHhhcc-cccceeeeeeeeccCceee
Q 003059 501 KGFKDKLGAGGFGAVYRGVL----ANRTVVAVKQLEGI-----EQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRL 570 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~-----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 570 (852)
|.+.+.||+|+||.||+++. .+++.||||.+... ....+.+..|++++.++ +|+||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 45678899999999999984 35678999998632 12335688999999999 5999999999999999999
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+||||+++++|.+++... ..+++..+..++.|++++|.|||+ .+++||||||+||+++.++.++|+|||+++
T Consensus 82 lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 82 LILDYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999998542 348889999999999999999998 899999999999999999999999999988
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhcCC--CCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANLP--ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN 728 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (852)
.+..... .......++..|+|||.+.+.. .+.++||||||+++|||++|+.||......... ..... ....
T Consensus 154 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~-~~~~-- 226 (288)
T cd05583 154 EFLAEEE--ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEISR-RILK-- 226 (288)
T ss_pred ccccccc--cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHHHH-HHHc--
Confidence 6543211 1112345788999999987765 788999999999999999999999643211110 01110 0000
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003059 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEG 777 (852)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~ 777 (852)
. .. ..+......+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 227 --~--~~-----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 227 --S--KP-----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --c--CC-----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0 00 0111112345678889999999999999999887764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=292.58 Aligned_cols=262 Identities=22% Similarity=0.299 Sum_probs=191.7
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccC--ceeeEEE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEG--KHRLLVY 573 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~ 573 (852)
.|.+.++||+|+||.||+|... +++.||+|.+.... .....+.+|+.++.+++|+||+++++++.+. +..++||
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 4667789999999999999974 58899999987322 1233567899999999999999999998654 5689999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+. ++|.+++... ...+++..+..++.||++||+|||+ .+++||||||+||++++++.+||+|||+++...
T Consensus 88 e~~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 88 EYCE-QDLASLLDNM----PTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred ecCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9996 4888888543 2458999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHH--------HHHHH
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLW--------AYEEF 724 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~--------~~~~~ 724 (852)
... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............- .+...
T Consensus 160 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 160 LPA---KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred Ccc---CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 321 11222345788999999875 4578999999999999999999999975432211100000 00000
Q ss_pred hhCCcccccccccCCCCC-CH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 725 EKGNVKGIVDKSLAGEDV-DI-----EQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 725 ~~~~~~~~~d~~l~~~~~-~~-----~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
........+ .+..... .. .....+.+++.+|++.||++||++.++++.
T Consensus 237 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 237 SDLPLVGKF--TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hcccccccc--cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000 0000000 00 013345688999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=293.68 Aligned_cols=248 Identities=21% Similarity=0.365 Sum_probs=196.1
Q ss_pred ccccccccccccceEEEEEECC-CcEEEEEEec-CcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 501 KGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLE-GIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~-~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
+++.-.||.|+||.||+++.++ +-..|.|.+. ......++|.-||+||+...||+||+|++.|..++..+|+.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 4455679999999999999665 4445677777 5556668899999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
|-.+..+..- ++.|...++.-+++|++.||.|||+ .+|||||||+.|||+.-+|.++|+|||.+-.... .
T Consensus 114 GAVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~---t 183 (1187)
T KOG0579|consen 114 GAVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS---T 183 (1187)
T ss_pred chHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh---H
Confidence 9999887543 4579999999999999999999999 8999999999999999999999999998754321 1
Q ss_pred ceeeeeecCCCCCCChhhhh-----cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 659 HRTLTSVRGTRGYLAPEWLA-----NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
......+.||+.|||||+.. ..+|+.++||||||++|.||..+.+|-..... ..+.-.+.......++
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-------MRVllKiaKSePPTLl 256 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSEPPTLL 256 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-------HHHHHHHhhcCCCccc
Confidence 12234577999999999874 56899999999999999999999998643221 1111111111111111
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
-+......+-++..+|+..||..||+++++++
T Consensus 257 --------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 --------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred --------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 12233456778888899999999999999875
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=293.24 Aligned_cols=267 Identities=21% Similarity=0.324 Sum_probs=195.1
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeecc----Cceee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSE----GKHRL 570 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~----~~~~~ 570 (852)
..|.+.+.||+|+||.||+|... +++.|++|++... ......+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 35667789999999999999964 5889999998743 2334667889999999999999999998753 35789
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+||||+. ++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++
T Consensus 85 lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEehhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccce
Confidence 9999995 6898888532 348999999999999999999998 899999999999999999999999999997
Q ss_pred ccCCCCCc-ceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHH--------H
Q 003059 651 LINPKDHR-HRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLW--------A 720 (852)
Q Consensus 651 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~--------~ 720 (852)
........ ........++..|+|||.+.. ..++.++||||||+++|||++|+.||.............. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 65432211 111234568889999999865 4688999999999999999999999965432111000000 0
Q ss_pred HHHHhhCCcccccccccCCCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 721 YEEFEKGNVKGIVDKSLAGEDVDI-----EQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 721 ~~~~~~~~~~~~~d~~l~~~~~~~-----~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
........+....+..-.....+. .....+.+++.+|++.+|.+||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000011111111000001111 123567889999999999999999998863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=289.36 Aligned_cols=256 Identities=20% Similarity=0.225 Sum_probs=188.9
Q ss_pred cccccccccceEEEEEECCCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCC
Q 003059 504 KDKLGAGGFGAVYRGVLANRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGS 580 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 580 (852)
.+.+|.|+++.||++.. +++.||||++... ....+.+..|++++++++|+||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455566666666554 6788999998743 3345679999999999999999999999999999999999999999
Q ss_pred HHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc--
Q 003059 581 LDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR-- 658 (852)
Q Consensus 581 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-- 658 (852)
|.+++.... ...+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||.+.........
T Consensus 86 l~~~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 86 CEDLLKTHF---PEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred HHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 999996542 2347888899999999999999998 89999999999999999999999999988755322111
Q ss_pred --ceeeeeecCCCCCCChhhhhcC--CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc-
Q 003059 659 --HRTLTSVRGTRGYLAPEWLANL--PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV- 733 (852)
Q Consensus 659 --~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~- 733 (852)
........++..|+|||.+... .++.++||||||+++|||++|+.||....... .+. ... .+.....+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~----~~~-~~~~~~~~~ 232 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLL----EKV-RGTVPCLLD 232 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH----HHH-hccCccccc
Confidence 1111234577889999998763 57899999999999999999999997532211 000 000 00000000
Q ss_pred -------------------ccccC---CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 734 -------------------DKSLA---GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 734 -------------------d~~l~---~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+.... ...........+.+++.+||+.||++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00000 00111122346778999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=278.46 Aligned_cols=245 Identities=24% Similarity=0.391 Sum_probs=198.1
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
|.+.+.||+|++|.||+++.. +++.|++|.+.... ...+.+.+|++++.+++|+|++++++++.+.+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 556789999999999999865 57889999997543 34567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|.+++... ..+++..+..++.|++.+|.|||+ .+|+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 82 ENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 999999998543 358999999999999999999998 899999999999999999999999999998765432
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
.. .....++..|+|||.+.+...+.++|||+||++++||++|+.||...... ...+. ...... .
T Consensus 154 ~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----~~~~~---~~~~~~-----~- 217 (254)
T cd06627 154 KD---DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----AALFR---IVQDDH-----P- 217 (254)
T ss_pred cc---ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----HHHHH---HhccCC-----C-
Confidence 21 23345788999999998888899999999999999999999999643211 00011 110000 0
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..+......+.+++.+|++.+|++||++.+++.
T Consensus 218 ----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 ----PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ----CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111112345678889999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=280.01 Aligned_cols=243 Identities=22% Similarity=0.276 Sum_probs=187.1
Q ss_pred ccccccccceEEEEEEC-CCcEEEEEEecCcc----cchHHHHHHHHHh-hcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 505 DKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE----QGEKQFRMEVATI-SSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~f~~E~~~l-~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
+.||+|+||.||+|... +++.||+|.+.... .....+..|..++ ...+|+|++++++++.+++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999864 57899999987432 1223344555444 455899999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 82 GDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 9999999543 348889999999999999999998 8999999999999999999999999999875432
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccC
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (852)
.....++..|+|||.+.+..++.++||||||+++|||++|..||....... ........... ...
T Consensus 150 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~--~~~--- 214 (260)
T cd05611 150 ---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-------VFDNILSRRIN--WPE--- 214 (260)
T ss_pred ---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhcccC--CCC---
Confidence 123457889999999988889999999999999999999999996443211 11111111110 000
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003059 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776 (852)
Q Consensus 739 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~ 776 (852)
.........+.+++.+|++.+|++||++.++.+.|+
T Consensus 215 --~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 215 --EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred --cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 011112345778899999999999998876666553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-33 Score=322.00 Aligned_cols=245 Identities=29% Similarity=0.424 Sum_probs=192.5
Q ss_pred cccccccccceEEEEE-ECCCcEEEEEEec---CcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCC
Q 003059 504 KDKLGAGGFGAVYRGV-LANRTVVAVKQLE---GIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNG 579 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~---~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 579 (852)
..+||.|.||.||.+. .++|...|+|-+. ..........+|+.++..++|||+|+.+|+-.+++..+|.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 4589999999999999 5668888999876 22344567789999999999999999999999999999999999999
Q ss_pred CHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC-Cc
Q 003059 580 SLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD-HR 658 (852)
Q Consensus 580 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~-~~ 658 (852)
+|.+.+... ..+++.....+..|++.|++|||+ ++||||||||.||+|+.+|.+|++|||.|..+.... ..
T Consensus 1320 sLa~ll~~g-----ri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1320 SLASLLEHG-----RIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred cHHHHHHhc-----chhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 999999543 335555666788999999999999 899999999999999999999999999999876542 12
Q ss_pred ceeeeeecCCCCCCChhhhhcCC---CCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHH-HhhCCcccccc
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLP---ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEE-FEKGNVKGIVD 734 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~d 734 (852)
........||+.|||||++.+.. -..+.||||+|||++||+||++||...+. .|+..- ...+...
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V~~gh~P---- 1460 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHVAAGHKP---- 1460 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHHhccCCC----
Confidence 22234567999999999997543 45689999999999999999999974432 222211 1111111
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..+..-...-.+++.+|++.||++|.++.|+++
T Consensus 1461 ------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1461 ------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 111222234567888999999999988877665
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=285.82 Aligned_cols=249 Identities=22% Similarity=0.256 Sum_probs=191.2
Q ss_pred ccccccccccccceEEEEEE----CCCcEEEEEEecCcc-----cchHHHHHHHHHhhcc-cccceeeeeeeeccCceee
Q 003059 501 KGFKDKLGAGGFGAVYRGVL----ANRTVVAVKQLEGIE-----QGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRL 570 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 570 (852)
|.+.+.||+|+||.||++.. .+++.||+|++.... ...+.+.+|++++.++ +|+||+++++++..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 45678999999999999985 367889999987321 2346678899999999 5999999999999999999
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+||||+++++|.+++... ..+++..+..++.|+++||.|||+ .+++||||||+|||+++++.+||+|||+++
T Consensus 82 lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 82 LILDYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999643 347888899999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhcC--CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANL--PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN 728 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (852)
....... .......|+..|+|||.+... .++.++||||||+++|||++|+.||........ ...........
T Consensus 154 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~-- 227 (290)
T cd05613 154 EFHEDEV--ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS-- 227 (290)
T ss_pred ecccccc--cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhcc--
Confidence 6543211 122235588999999998753 467899999999999999999999964322111 11111110000
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003059 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP-----MMGKVVQ 773 (852)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~ev~~ 773 (852)
.+ +.+......+.+++.+|++.+|++|| +..+++.
T Consensus 228 -----~~-----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 -----EP-----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -----CC-----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 00 11111223566888899999999997 5566554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=291.57 Aligned_cols=264 Identities=21% Similarity=0.348 Sum_probs=190.4
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccC------cee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEG------KHR 569 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 569 (852)
.|...+.||+|+||.||+|.. .+++.||+|++... ......+.+|+.++++++|+||+++++++... ...
T Consensus 16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 95 (342)
T cd07879 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF 95 (342)
T ss_pred ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence 345567899999999999996 46889999998632 22345688999999999999999999988654 356
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
++|+||+.. +|..++ ...+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++
T Consensus 96 ~lv~e~~~~-~l~~~~-------~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 96 YLVMPYMQT-DLQKIM-------GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred EEEeccccc-CHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 999999964 777665 2348889999999999999999998 89999999999999999999999999998
Q ss_pred cccCCCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHH--------
Q 003059 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA-------- 720 (852)
Q Consensus 650 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~-------- 720 (852)
+..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...............
T Consensus 165 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 165 RHADAE------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred cCCCCC------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 765321 123356788999999876 46889999999999999999999999754321100000000
Q ss_pred HHHHhhCCccccccc--ccCCCCCC---HHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcCcc
Q 003059 721 YEEFEKGNVKGIVDK--SLAGEDVD---IEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ--MLEGITE 780 (852)
Q Consensus 721 ~~~~~~~~~~~~~d~--~l~~~~~~---~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~--~L~~~~~ 780 (852)
............+.. ........ ......+.+++.+|++.||++||++.++++ .++..+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000000000000000 00000000 011234678999999999999999999984 4666554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=279.51 Aligned_cols=249 Identities=25% Similarity=0.373 Sum_probs=200.6
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
|.+.+.||+|+||.||++... ++..+++|++.... ...+++..|++++++++|+|++++++.+..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 456788999999999999965 57889999987432 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|.+++..... ....+++..+..++.+++.||.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 82 DGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred CCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999965431 23568999999999999999999998 799999999999999999999999999998764422
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
.......+++.|+|||.+....++.++||||||+++++|++|+.||....... ............
T Consensus 158 ---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~----- 222 (258)
T cd08215 158 ---DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-------LALKILKGQYPP----- 222 (258)
T ss_pred ---ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH-------HHHHHhcCCCCC-----
Confidence 12233467889999999998899999999999999999999999996443110 011111111111
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.+......+.+++.+|+..+|.+||++.++++
T Consensus 223 -----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 -----IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11122245678888999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=283.29 Aligned_cols=240 Identities=24% Similarity=0.291 Sum_probs=184.2
Q ss_pred cccccccceEEEEEE-CCCcEEEEEEecCcc----cchHHHHHHHHH---hhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 506 KLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE----QGEKQFRMEVAT---ISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 506 ~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~f~~E~~~---l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
.||+|+||.||++.. .+++.||+|.+.... .....+..|..+ ++...||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999986 457899999886322 222234444433 444579999999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
+++|.+++... ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~- 151 (278)
T cd05606 81 GGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (278)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-
Confidence 99999988532 358999999999999999999998 899999999999999999999999999987653221
Q ss_pred cceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 658 RHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
.....|+..|+|||.+.+. .++.++||||||+++|||++|+.||........... ..... .....
T Consensus 152 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~------~~~~~ 217 (278)
T cd05606 152 ----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTL------TMAVE 217 (278)
T ss_pred ----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhh------ccCCC
Confidence 1234689999999999754 689999999999999999999999975432211110 00000 00111
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRP-----MMGKVVQ 773 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~ev~~ 773 (852)
+. ......+.+++.+|+..+|.+|| ++.++++
T Consensus 218 ~~-----~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 LP-----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CC-----CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 11 11134677788899999999999 8889875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=284.57 Aligned_cols=259 Identities=24% Similarity=0.301 Sum_probs=191.5
Q ss_pred ccccccccccccceEEEEEECC-CcEEEEEEecCccc---chHHHHHHHHHhhcc---cccceeeeeeeeccCce-----
Q 003059 501 KGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGIEQ---GEKQFRMEVATISST---HHLNLVRLVGFSSEGKH----- 568 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~f~~E~~~l~~l---~h~niv~l~g~~~~~~~----- 568 (852)
|.+.+.||+|+||.||+|+... ++.||+|++..... ....+.+|+.++.++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 3456789999999999999764 88999999973222 234566788777655 59999999999988776
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.+++|||++ ++|.+++.... ...+++..+..++.|+++||+|||+ .+++|+||+|+||++++++.+||+|||+
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~---~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP---KPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCc
Confidence 999999996 48999886432 2358999999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN 728 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (852)
+....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||......+ .+... ........
T Consensus 154 ~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~-~~~~~~~~ 226 (287)
T cd07838 154 ARIYSFEM----ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKI-FDVIGLPS 226 (287)
T ss_pred ceeccCCc----ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHH-HHHcCCCC
Confidence 98764321 1122347889999999999999999999999999999999999987543221 11111 01000000
Q ss_pred c----------ccccccccCCC--CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 729 V----------KGIVDKSLAGE--DVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 729 ~----------~~~~d~~l~~~--~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
. ........... ....+....+.+++.+|++.||.+||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 00000000000 001122355678899999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=295.38 Aligned_cols=271 Identities=22% Similarity=0.331 Sum_probs=201.1
Q ss_pred ccccccccccccceEEEEEECC-CcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCc-----eeeE
Q 003059 501 KGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK-----HRLL 571 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~l 571 (852)
|.+.++||+|+||.||++.... ++.|++|++... ....+.+.+|+++++.++|+||+++++++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 5677899999999999999754 889999998743 334567899999999999999999999988775 7899
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
||||++ ++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.++|+|||++..
T Consensus 82 v~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 82 VTELME-TDLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred Eecchh-hhHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 999997 5888888532 268999999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHH-----HH--
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAY-----EE-- 723 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~-----~~-- 723 (852)
...............++..|+|||.+.+. .++.++||||||+++|+|++|+.||................ ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 65432111223344578899999999887 88999999999999999999999997654321110000000 00
Q ss_pred -HhhCCcccccccccCCCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcCcc
Q 003059 724 -FEKGNVKGIVDKSLAGEDVDI-----EQVMRAIQVSFWCIQEQPSQRPMMGKVVQM--LEGITE 780 (852)
Q Consensus 724 -~~~~~~~~~~d~~l~~~~~~~-----~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~--L~~~~~ 780 (852)
.........+...-.....+. .....+.+++.+||+.+|.+||++.++++. ++++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000000001100000001111 112456788999999999999999999973 555543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=295.17 Aligned_cols=267 Identities=22% Similarity=0.290 Sum_probs=194.6
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccC-----ceee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEG-----KHRL 570 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~ 570 (852)
.|.+.+.||+|+||.||++.. .+++.||||.+... ......+..|+.++..++|+||+++++++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 466678999999999999985 45889999998732 23345677899999999999999999987654 3579
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+||||+. ++|.+++... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++
T Consensus 86 lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 86 IVYELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEeCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 9999995 6898888532 358899999999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHH--------H
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA--------Y 721 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~ 721 (852)
...... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||............... .
T Consensus 157 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 157 TTSEKG---DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred ccCCCc---ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 664321 11233457889999998865 46889999999999999999999999754321110000000 0
Q ss_pred HHHhhCCcccccccccCCCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcC
Q 003059 722 EEFEKGNVKGIVDKSLAGEDVD-----IEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM--LEGI 778 (852)
Q Consensus 722 ~~~~~~~~~~~~d~~l~~~~~~-----~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~--L~~~ 778 (852)
...........+.......... ......+.+++.+|++.+|++||+++++++. ++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000000000000000000000 1123456789999999999999999999865 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=291.88 Aligned_cols=246 Identities=25% Similarity=0.359 Sum_probs=197.4
Q ss_pred HHhcccccccccccccceEEEEEE-CCCcEEEEEEecCccc---chHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQ---GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
...-|.+...||+|.|+.|..|+. ..+..||+|.+.+... ..+.+.+|+++|..++|||||+++.+.......|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 334566778999999999999985 4588999999985432 234588999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+.+|.+.+||.++.+ ........++.|+.++++|||+ +.|||||||++||||+.+.++||+|||++..+
T Consensus 134 ~eya~~ge~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred EEeccCchhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceee
Confidence 999999999999987654 4447778899999999999999 89999999999999999999999999999887
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCC-CCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPI-TSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
.. ........|++.|.|||++.+.++ ++++|+||+|++||-|+.|..||++..- ++
T Consensus 206 ~~----~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-------------------k~ 262 (596)
T KOG0586|consen 206 DY----GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-------------------KE 262 (596)
T ss_pred cc----cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-------------------cc
Confidence 53 334566789999999999998876 5899999999999999999999985431 11
Q ss_pred ccccccCCC-CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 732 IVDKSLAGE-DVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 732 ~~d~~l~~~-~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+-++.+.+. ..+.--...+-+++.+.+..+|.+|+++.+|.+
T Consensus 263 Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 263 LRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 111111110 111111223445666678888999988888765
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=280.39 Aligned_cols=249 Identities=24% Similarity=0.303 Sum_probs=192.2
Q ss_pred cccccccccccccceEEEEEECC-CcEEEEEEecC------cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEG------IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~------~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
+|.+.++||+|+||.||++.... +..+++|.++. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 36678899999999999998643 34455555542 122334577899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++++|.+++..... ....+++..++.++.|+++||.|||+ .+++|+||||+||++++ +.+||+|||+++..
T Consensus 81 ~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeec
Confidence 999999999999864322 24568999999999999999999998 89999999999999975 56999999998776
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI 732 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (852)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ... .....+.
T Consensus 156 ~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~-~~~~~~~---- 221 (260)
T cd08222 156 MGSCD---LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL------SVV-LRIVEGP---- 221 (260)
T ss_pred CCCcc---cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHH-HHHHcCC----
Confidence 43221 122345788999999998888999999999999999999999999633210 000 1111110
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.+ ..+......+.+++.+|++.+|++||++.++++
T Consensus 222 -~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 -TP-----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -CC-----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 01 112223346778899999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=286.19 Aligned_cols=247 Identities=25% Similarity=0.320 Sum_probs=191.8
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
.++...+.||+|+||.||+|+.. ++..+++|.+... .....++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34555678999999999999964 5788999988632 223456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+. |+|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 95 e~~~-~~l~~~~~~~----~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 95 EYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EccC-CCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 9996 6888777432 2347899999999999999999998 899999999999999999999999999987654
Q ss_pred CCCCcceeeeeecCCCCCCChhhhh---cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLA---NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (852)
.. ....++..|+|||.+. ...++.++||||||+++|||++|+.||........ . ........
T Consensus 167 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~-~~~~~~~~- 231 (308)
T cd06634 167 PA-------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------L-YHIAQNES- 231 (308)
T ss_pred Cc-------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH------H-HHHhhcCC-
Confidence 32 2245788999999985 34678899999999999999999999864321110 0 01111100
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003059 731 GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776 (852)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~ 776 (852)
+.. ........+.+++.+|++.+|++||++.+|++...
T Consensus 232 ----~~~----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 232 ----PAL----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ----CCc----CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 000 11122345678889999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=285.09 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=197.9
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhccc-ccceeeeeeeeccCceeeEEE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTH-HLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~ 573 (852)
.|.+.+.||+|+||.||++... +++.|++|.+... ....+.+..|++++.+++ |+||+++++++.+.+..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 3567789999999999999965 6889999998742 233467889999999998 999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+++++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 82 EYAPNGELLQYIRKY-----GSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999643 259999999999999999999998 899999999999999999999999999998664
Q ss_pred CCCCc-----------------ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhh
Q 003059 654 PKDHR-----------------HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKF 716 (852)
Q Consensus 654 ~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l 716 (852)
..... ........++..|+|||.+....++.++||||||++++|+++|+.||.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---- 229 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---- 229 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH----
Confidence 32210 011223457889999999998889999999999999999999999997543110
Q ss_pred HHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCH----HHHHH
Q 003059 717 SLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMM----GKVVQ 773 (852)
Q Consensus 717 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~----~ev~~ 773 (852)
........ .. ..+......+.+++.+|++.+|.+||++ +++++
T Consensus 230 ---~~~~~~~~------~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 ---TFQKILKL------EY-----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ---HHHHHHhc------CC-----CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00111100 00 1111223457788999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=282.04 Aligned_cols=195 Identities=30% Similarity=0.389 Sum_probs=174.1
Q ss_pred cccccccccceEEEEEEC-CCcEEEEEEec----CcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 504 KDKLGAGGFGAVYRGVLA-NRTVVAVKQLE----GIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~----~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
-++||+||||.||-...+ .|+.+|.|++. +...++..-.+|-.+|.+++.+.||.+--.+...+..++|+..|.|
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 468999999999998854 58899999886 3455667788999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
|+|.-+|.... ...++++.++-++.+|+.||++||. .+||+|||||+|||||++|+++|+|+|+|..+...
T Consensus 270 GDLkfHiyn~g---~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g--- 340 (591)
T KOG0986|consen 270 GDLKFHIYNHG---NPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG--- 340 (591)
T ss_pred CceeEEeeccC---CCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCC---
Confidence 99999997554 3568999999999999999999998 89999999999999999999999999999987643
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCcccccc
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVS 708 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~ 708 (852)
......+||.+|||||++.+..|+...|-|||||+||||+.|+.||...
T Consensus 341 -~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 341 -KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred -CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 2334558999999999999999999999999999999999999999743
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=287.00 Aligned_cols=267 Identities=24% Similarity=0.299 Sum_probs=191.2
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccC--------
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEG-------- 566 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-------- 566 (852)
..|.+.++||+|+||.||+|... +++.+++|++.... .....+.+|++++++++|+||+++++++.+.
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 45677889999999999999964 57889999886322 2234678899999999999999999987543
Q ss_pred ceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeec
Q 003059 567 KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDF 646 (852)
Q Consensus 567 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 646 (852)
...++|+||+.+ +|...+... ...+++..+..++.|+++||+|||+ .+|+|+||||+||++++++.+||+||
T Consensus 88 ~~~~lv~~~~~~-~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 88 GSVYMVTPYMDH-DLSGLLENP----SVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred ceEEEEEecCCc-CHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcC
Confidence 346999999964 677766532 3358999999999999999999998 89999999999999999999999999
Q ss_pred ccccccCCCCCc--------ceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhH
Q 003059 647 GLAKLINPKDHR--------HRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFS 717 (852)
Q Consensus 647 Gla~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~ 717 (852)
|+++........ ........+++.|+|||.+.+. .++.++||||||+++|||++|+.||............
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999865432211 1112234568889999988654 5789999999999999999999999754332211110
Q ss_pred HHHHHHHhh------CCcccccc-cccCCCCCCHH-----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 718 LWAYEEFEK------GNVKGIVD-KSLAGEDVDIE-----QVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 718 ~~~~~~~~~------~~~~~~~d-~~l~~~~~~~~-----~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
......... ..+....+ ......+...+ ....+.+++.+|++.+|.+||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000000000 00000000 00000011111 1145778999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=290.95 Aligned_cols=259 Identities=24% Similarity=0.283 Sum_probs=190.8
Q ss_pred ccccccccccceEEEEEEC-CCcEEEEEEecCcccc---------------hHHHHHHHHHhhcccccceeeeeeeeccC
Q 003059 503 FKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQG---------------EKQFRMEVATISSTHHLNLVRLVGFSSEG 566 (852)
Q Consensus 503 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---------------~~~f~~E~~~l~~l~h~niv~l~g~~~~~ 566 (852)
+.+.||.|+||.||+|... +++.||||.+...... ...+.+|++++.+++|+||+++++++..+
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 3467999999999999964 5889999988633221 12477899999999999999999999999
Q ss_pred ceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeec
Q 003059 567 KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDF 646 (852)
Q Consensus 567 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 646 (852)
+..++||||+. ++|.+++... ..+++.....++.|++.||+|||+ .+++|+||||+||+++.++.+||+||
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCc
Confidence 99999999996 6899988532 348899999999999999999998 89999999999999999999999999
Q ss_pred ccccccCCCCC-----------cceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccch
Q 003059 647 GLAKLINPKDH-----------RHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRK 714 (852)
Q Consensus 647 Gla~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~ 714 (852)
|+++....... .........++..|+|||.+.+. .++.++||||||+++|||++|+.||......+.
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~- 242 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ- 242 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 99986541110 01111223467889999998764 468999999999999999999999975543211
Q ss_pred hhHHHHHHHHhhCCcc---cc-----cccccCCCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 715 KFSLWAYEEFEKGNVK---GI-----VDKSLAGEDVDI-----EQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 715 ~l~~~~~~~~~~~~~~---~~-----~d~~l~~~~~~~-----~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.............. .. ..+.....+... .....+.+++.+|++.+|++||++.+++.
T Consensus 243 --~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 243 --LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred --HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11111111100000 00 000000000000 11245678999999999999999999986
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=289.34 Aligned_cols=264 Identities=23% Similarity=0.298 Sum_probs=189.6
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc-ccchHHHHHHHHHhhcccccceeeeeeeeccC----------
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLVGFSSEG---------- 566 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~---------- 566 (852)
.+|.+.+.||.|+||.||+|... +++.|++|.+... ....+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 46777889999999999999964 5789999998733 34456788999999999999999999876543
Q ss_pred ----ceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeC-CCCce
Q 003059 567 ----KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD-ENYNA 641 (852)
Q Consensus 567 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~ 641 (852)
...++||||++ ++|.+++.. ..+++..+..++.||++||.|||+ .+|+||||||+||+++ +++.+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceE
Confidence 35789999997 589888742 248899999999999999999998 8999999999999997 45678
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHH
Q 003059 642 KVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA 720 (852)
Q Consensus 642 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 720 (852)
||+|||+++.+..............++..|+|||.+.. ..++.++|||||||++|||++|+.||...............
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999865432111111123457889999998754 56788999999999999999999999654321110000000
Q ss_pred --------HHHHhhCCcccccccccCCCCCCHH-----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 721 --------YEEFEKGNVKGIVDKSLAGEDVDIE-----QVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 721 --------~~~~~~~~~~~~~d~~l~~~~~~~~-----~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
....... ..............+.. ....+.+++..|++.||++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNV-IPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhh-hhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000 00000000000011111 1245678999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=277.95 Aligned_cols=240 Identities=20% Similarity=0.267 Sum_probs=182.5
Q ss_pred cccccc--ccccccceEEEEEE-CCCcEEEEEEecCcccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEEEeec
Q 003059 501 KGFKDK--LGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 501 ~~~~~~--lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
+.+.+. ||+|+||.||++.. .+++.+++|.+....... .|+.....+ +|+||+++++++...+..++||||+
T Consensus 16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~ 91 (267)
T PHA03390 16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYI 91 (267)
T ss_pred hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcC
Confidence 344444 59999999999985 457889999887432221 122222222 7999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC-ceEEeecccccccCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY-NAKVSDFGLAKLINPK 655 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~~ 655 (852)
++++|.+++... ..+++..+..++.||++||.|||+ .+++||||||+||+++.++ .++|+|||+++.....
T Consensus 92 ~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 92 KDGDLFDLLKKE-----GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 999999999543 268999999999999999999998 8899999999999999998 9999999998765421
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
....++..|+|||++.+..++.++||||||+++|||++|+.||....... .....+.... ..
T Consensus 164 -------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~----------~~ 225 (267)
T PHA03390 164 -------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ----------QK 225 (267)
T ss_pred -------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh----------cc
Confidence 12357899999999999999999999999999999999999997443221 1111111100 01
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPM-MGKVVQ 773 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt-~~ev~~ 773 (852)
.. .........+.+++.+|++.+|.+||+ ++++++
T Consensus 226 ~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 KL---PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cC---CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 011122345677888999999999996 588764
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=269.86 Aligned_cols=205 Identities=27% Similarity=0.387 Sum_probs=171.8
Q ss_pred cccccccccccccceEEEEEEC---C--CcEEEEEEecCcccc---hHHHHHHHHHhhcccccceeeeeeeecc-Cceee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA---N--RTVVAVKQLEGIEQG---EKQFRMEVATISSTHHLNLVRLVGFSSE-GKHRL 570 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~---~--~~~vavK~l~~~~~~---~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~~ 570 (852)
.|+...+||+|.||.||+|+-. + ...+|+|+++..... .....+|+.+++.++||||+.|..++.+ +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 4566778999999999999632 2 237999999854322 2456789999999999999999998876 78999
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCC----CceEEeec
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDEN----YNAKVSDF 646 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~----~~~kl~DF 646 (852)
|++||.+. +|...|+-+.....+.++-..+..|+-||+.|+.|||+ +-|+||||||.||||..+ |.+||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999976 88888876666566789999999999999999999999 889999999999999776 99999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCcccccc
Q 003059 647 GLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVS 708 (852)
Q Consensus 647 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~ 708 (852)
|++|.+...-........++-|+-|.|||.+.+. .|+++.|||+.||++.||+|-++.|...
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 9999986543322334456778999999999876 6899999999999999999988888654
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=280.79 Aligned_cols=260 Identities=25% Similarity=0.309 Sum_probs=195.2
Q ss_pred cccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 502 GFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 502 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
.+.++||+|+||.||+|+.. +++.+++|.+... ....+.+..|++++++++|+||+++++++.+.+..++||||++
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 45678999999999999965 4889999998843 3334678899999999999999999999999999999999997
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
++|.+++.... ..+++..+..++.|++.+|+|||+ .+|+||||+|+||++++++.+||+|||+++.......
T Consensus 82 -~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 82 -MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred -cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 59999996432 358999999999999999999999 8999999999999999999999999999987643211
Q ss_pred cceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchh-hH-------HHHHHHHhhCC
Q 003059 658 RHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKK-FS-------LWAYEEFEKGN 728 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~-l~-------~~~~~~~~~~~ 728 (852)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||.......... .. ...+.......
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 154 ---TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred ---ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 12233457789999998776 88999999999999999999999996543211100 00 00000000000
Q ss_pred -cccccccccCCCCC---CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 729 -VKGIVDKSLAGEDV---DIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 729 -~~~~~d~~l~~~~~---~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
....... ...... .......+.+++..|++.+|++||++.+|+.
T Consensus 231 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 231 DYKPTFPK-FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccc-cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000 000000 0011346788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=306.95 Aligned_cols=245 Identities=27% Similarity=0.408 Sum_probs=183.7
Q ss_pred ccccccccceEEEEEE-CCCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeec-----------------
Q 003059 505 DKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSS----------------- 564 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~----------------- 564 (852)
+.||+||||.|||++. -||+.+|||++... ......+.+|++.|++|+|||||+++..+.
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 4799999999999994 47899999999843 444567889999999999999999862100
Q ss_pred ------------------------------------------------------------------------c-------
Q 003059 565 ------------------------------------------------------------------------E------- 565 (852)
Q Consensus 565 ------------------------------------------------------------------------~------- 565 (852)
+
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence 0
Q ss_pred ---------------C--------ceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCC
Q 003059 566 ---------------G--------KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC 622 (852)
Q Consensus 566 ---------------~--------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 622 (852)
+ ...||=||||+...|++++..+.... .-...++++++|++||+|+|+ .+
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEGLaYIH~---~g 717 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEGLAYIHD---QG 717 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHHHHHHHh---Cc
Confidence 0 13478899999988888886543211 356678999999999999999 88
Q ss_pred cccCCCCCCceEeCCCCceEEeecccccccC----C-----------CCCcceeeeeecCCCCCCChhhhhcC---CCCC
Q 003059 623 IVHCDIKPENILLDENYNAKVSDFGLAKLIN----P-----------KDHRHRTLTSVRGTRGYLAPEWLANL---PITS 684 (852)
Q Consensus 623 ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~----~-----------~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ 684 (852)
||||||||.||+||++..+||+|||+|.... . ........+...||.-|+|||.+.+. .|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999998721 0 01112234567899999999999765 4999
Q ss_pred CccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCC-CCCCHHHHHHHHHHHHhccccCCC
Q 003059 685 KSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAG-EDVDIEQVMRAIQVSFWCIQEQPS 763 (852)
Q Consensus 685 ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~~~~~l~~~cl~~dp~ 763 (852)
|+|+|||||||+||+. ||...-+. .-....++ +..++. ..+..++...-.+++.|+++.||.
T Consensus 798 KiDmYSLGIVlFEM~y---PF~TsMER------a~iL~~LR--------~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~ 860 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGTSMER------ASILTNLR--------KGSIPEPADFFDPEHPEEASLIRWLLSHDPS 860 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCchHHH------HHHHHhcc--------cCCCCCCcccccccchHHHHHHHHHhcCCCc
Confidence 9999999999999995 45432110 00111122 222221 122344555667899999999999
Q ss_pred CCCCHHHHHH
Q 003059 764 QRPMMGKVVQ 773 (852)
Q Consensus 764 ~RPt~~ev~~ 773 (852)
+|||+.|+++
T Consensus 861 kRPtA~eLL~ 870 (1351)
T KOG1035|consen 861 KRPTATELLN 870 (1351)
T ss_pred cCCCHHHHhh
Confidence 9999999875
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=284.89 Aligned_cols=259 Identities=24% Similarity=0.304 Sum_probs=191.1
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeecc-CceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSE-GKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~e 574 (852)
.|.+.+.||+|+||.||++... +++.||+|++... ....+.+..|++++.+++||||+++++++.. ....++|+|
T Consensus 11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e 90 (328)
T cd07856 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE 90 (328)
T ss_pred ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence 4666789999999999999854 6889999988532 2334678899999999999999999998865 567899999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+ +++|.+++.. ..+++.....++.|+++||+|||+ .+|+||||+|+|||+++++.+||+|||++.....
T Consensus 91 ~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 91 LL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred hh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 98 5689888742 247788888999999999999998 8999999999999999999999999999875432
Q ss_pred CCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhh-HHH-------HHHHHh
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKF-SLW-------AYEEFE 725 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l-~~~-------~~~~~~ 725 (852)
. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........... ... ......
T Consensus 161 ~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 161 Q------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred C------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 1 122356788999998765 5689999999999999999999999965432111000 000 000000
Q ss_pred hCCcccccccccCCCCCCHH-----HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 726 KGNVKGIVDKSLAGEDVDIE-----QVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~-----~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.....+.+.........+.. ....+.+++.+|++.+|++||++.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00011111111011111111 12467788999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=286.49 Aligned_cols=264 Identities=21% Similarity=0.275 Sum_probs=188.7
Q ss_pred ccccccccccccceEEEEEECC---CcEEEEEEecCc---ccchHHHHHHHHHhhcc-cccceeeeeeeecc----Ccee
Q 003059 501 KGFKDKLGAGGFGAVYRGVLAN---RTVVAVKQLEGI---EQGEKQFRMEVATISST-HHLNLVRLVGFSSE----GKHR 569 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~----~~~~ 569 (852)
|.+.+.||+|+||.||++.... +..||+|++... ....+.+.+|++++.++ +|+||+++++.+.. ....
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 5567889999999999999643 678999998732 22346788899999999 59999999987543 2457
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
++++||+. ++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||++
T Consensus 82 ~~~~e~~~-~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 82 YLYEELME-ADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEeccc-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 88899885 689988853 3358899999999999999999998 89999999999999999999999999999
Q ss_pred cccCCCCCc-ceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHH--------H
Q 003059 650 KLINPKDHR-HRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSL--------W 719 (852)
Q Consensus 650 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~--------~ 719 (852)
+.+...... ........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||............. .
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 865432211 111233568999999998865 468999999999999999999999997543211000000 0
Q ss_pred HHHHHhhCCcccccccccCCCCCCHH-----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 720 AYEEFEKGNVKGIVDKSLAGEDVDIE-----QVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 720 ~~~~~~~~~~~~~~d~~l~~~~~~~~-----~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
....+............-........ ....+.+++.+|++.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000000000000000111 1245778999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=286.64 Aligned_cols=264 Identities=22% Similarity=0.311 Sum_probs=193.1
Q ss_pred HhcccccccccccccceEEEEEE-CCCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCc------
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK------ 567 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------ 567 (852)
..+|.+.+.||+|+||.||++.. .+++.||||++... ......+.+|++++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 34567788999999999999985 46889999998632 223456889999999999999999999887543
Q ss_pred eeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecc
Q 003059 568 HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFG 647 (852)
Q Consensus 568 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 647 (852)
..++||||+ +++|.+++.. ..+++..++.++.||++||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999999 7799888742 358899999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHH------
Q 003059 648 LAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA------ 720 (852)
Q Consensus 648 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~------ 720 (852)
++...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||........ +....
T Consensus 164 ~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~ 235 (343)
T cd07880 164 LARQTDSE------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ--LMEIMKVTGTP 235 (343)
T ss_pred cccccccC------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCC
Confidence 99865321 123457889999999876 4588999999999999999999999975432110 00000
Q ss_pred ----HHHHhhCCcccccccccCCCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcCc
Q 003059 721 ----YEEFEKGNVKGIVDKSLAGEDVDI-----EQVMRAIQVSFWCIQEQPSQRPMMGKVVQ--MLEGIT 779 (852)
Q Consensus 721 ----~~~~~~~~~~~~~d~~l~~~~~~~-----~~~~~~~~l~~~cl~~dp~~RPt~~ev~~--~L~~~~ 779 (852)
...+.................... .....+.+++.+|++.||.+||++.++++ .++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 000000000000000000000000 11224678999999999999999999983 444443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=282.62 Aligned_cols=242 Identities=27% Similarity=0.376 Sum_probs=188.1
Q ss_pred cccccccccccceEEEEEEC-CCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 502 GFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 502 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
...++||+|+||.||+|+.. +++.|++|.+.... .....+.+|++++++++|+|++++++++.+....++||||+
T Consensus 24 ~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 103 (313)
T cd06633 24 VGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC 103 (313)
T ss_pred hcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecC
Confidence 33567999999999999864 57889999986322 22356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
. ++|.+++... ...+++..+..++.||+.+|.|||+ .+++|+||+|+||++++++.+||+|||++.....
T Consensus 104 ~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 104 L-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred C-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 5 5787777532 2358999999999999999999998 8999999999999999999999999999864322
Q ss_pred CcceeeeeecCCCCCCChhhhh---cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLA---NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
.....|+..|+|||.+. ...++.++||||||+++|||++|..||........ ... ......
T Consensus 174 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~~-~~~~~~---- 237 (313)
T cd06633 174 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYH-IAQNDS---- 237 (313)
T ss_pred -----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHH-HHhcCC----
Confidence 12345788999999984 45688899999999999999999999865432110 000 011111
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
+... .......+.+++.+|++.+|.+||++.++++.
T Consensus 238 -~~~~----~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 -PTLQ----SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CCCC----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1110 01112346678889999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=275.03 Aligned_cols=262 Identities=23% Similarity=0.318 Sum_probs=205.3
Q ss_pred HHHhcccccccccccccceEEEEEEC------CCcEEEEEEecC--cccchHHHHHHHHHhhcccccceeeeeeeecc-C
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLA------NRTVVAVKQLEG--IEQGEKQFRMEVATISSTHHLNLVRLVGFSSE-G 566 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~ 566 (852)
+.+.+.++...+-+|.||.||+|.++ +.+.|.||.++. .......+..|...+..+.|||+..+.+++.+ .
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 34555666778999999999999754 345688888773 33345678899999999999999999998765 5
Q ss_pred ceeeEEEeecCCCCHHHHhhhc---ccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEE
Q 003059 567 KHRLLVYEFMKNGSLDNFLFAN---EEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKV 643 (852)
Q Consensus 567 ~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 643 (852)
...+.+|.++.-|+|..||... .....+.++..+...++.|++.|++|||. +++||.||.++|++||+..++||
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEe
Confidence 5789999999999999999732 12234567778888999999999999998 89999999999999999999999
Q ss_pred eecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHH
Q 003059 644 SDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYE 722 (852)
Q Consensus 644 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 722 (852)
+|-.++|.+.+.++. ....+...+..||+||.+.+..|+..+|||||||+||||+| |+.|+...++.+ +..
T Consensus 438 tDsaLSRDLFP~DYh-cLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-------m~~ 509 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYH-CLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-------MEH 509 (563)
T ss_pred ccchhccccCccccc-ccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-------HHH
Confidence 999999988776543 22333445778999999999999999999999999999998 899986443321 111
Q ss_pred HHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 723 EFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 723 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
.+.++ .++.+ +.....++..++.-||..+|++||+++|++..|.+.
T Consensus 510 ylkdG-------yRlaQ---P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 510 YLKDG-------YRLAQ---PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred HHhcc-------ceecC---CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 12222 12222 223344566777889999999999999999998753
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=264.89 Aligned_cols=259 Identities=23% Similarity=0.341 Sum_probs=197.0
Q ss_pred HHHHHHhcccccccccccccceEEEEE-ECCCcEEEEEEecCc-ccchHHHHHHHHHhhccc-ccceeeeeeeeccCcee
Q 003059 493 YKELQRSTKGFKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGI-EQGEKQFRMEVATISSTH-HLNLVRLVGFSSEGKHR 569 (852)
Q Consensus 493 ~~el~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~ 569 (852)
+.|+.+-| .+.||+|+++.|--++ +.++.++|||++.+. .....+..+|++++...+ |+||++|++||.++...
T Consensus 75 F~d~YkLt---~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 75 FEDMYKLT---SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHHHHHhH---HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence 45555555 3679999999999887 678999999999854 344577889999999885 99999999999999999
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCc---eEEeec
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYN---AKVSDF 646 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~DF 646 (852)
|||||-|.||+|..+|.++ +.+++.++.++.++|+.||.+||. ++|.||||||+|||-.+... +||+||
T Consensus 152 YLVfEKm~GGplLshI~~~-----~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKR-----KHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred EEEEecccCchHHHHHHHh-----hhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeecc
Confidence 9999999999999999754 348899999999999999999999 99999999999999865443 799999
Q ss_pred ccccccCCCCCc----ceeeeeecCCCCCCChhhhh-----cCCCCCCccchhhhHHHHHHHhCCccccccccccch---
Q 003059 647 GLAKLINPKDHR----HRTLTSVRGTRGYLAPEWLA-----NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRK--- 714 (852)
Q Consensus 647 Gla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~--- 714 (852)
.+..-.....+. ........|...|||||+.. ...|+.+.|.||||||||-||+|.+||.+...++-.
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 988654322221 12233467889999999873 346889999999999999999999999766443211
Q ss_pred -----hhHHHHHHHHhhCCcccccccccCCCCCCHHHH----HHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 715 -----KFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQV----MRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 715 -----~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~----~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.......+.+.++.. .++.+++ ...-+++...+..++.+|-++.++++
T Consensus 304 Ge~Cr~CQ~~LFesIQEGkY-----------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGKY-----------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCccHHHHHHHHHHHhccCC-----------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111112222222221 2233222 22345556677789999999988886
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=273.03 Aligned_cols=235 Identities=28% Similarity=0.337 Sum_probs=189.9
Q ss_pred ccccccceEEEEEEC-CCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCCH
Q 003059 507 LGAGGFGAVYRGVLA-NRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSL 581 (852)
Q Consensus 507 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 581 (852)
||+|+||.||++... +++.+++|.+.... .....+..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999975 47889999987432 2345789999999999999999999999999999999999999999
Q ss_pred HHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCccee
Q 003059 582 DNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRT 661 (852)
Q Consensus 582 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 661 (852)
.+++... ..+++..+..++.|+++||.|||+ .+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~ 149 (250)
T cd05123 81 FSHLSKE-----GRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG---SR 149 (250)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC---Cc
Confidence 9999643 248899999999999999999998 899999999999999999999999999998764321 12
Q ss_pred eeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCCCC
Q 003059 662 LTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGED 741 (852)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 741 (852)
.....++..|+|||.+.+...+.++|+||||+++|||++|+.||...... .. ...... ..+ .
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~----~~~~~~--------~~~---~ 211 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EI----YEKILK--------DPL---R 211 (250)
T ss_pred ccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HH----HHHHhc--------CCC---C
Confidence 23455788999999999888999999999999999999999999644321 10 111111 000 1
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 003059 742 VDIEQVMRAIQVSFWCIQEQPSQRPMMGK 770 (852)
Q Consensus 742 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~e 770 (852)
.+......+.+++.+|+..||++||++.+
T Consensus 212 ~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 212 FPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11111345678889999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=288.80 Aligned_cols=260 Identities=22% Similarity=0.315 Sum_probs=188.8
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccC------ce
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEG------KH 568 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~ 568 (852)
.+|.+.+.||+|+||.||++.. .+++.||+|++.... ...+.+.+|+.++.+++|+||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 3455678899999999999985 468899999987432 2345678899999999999999999987543 34
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+
T Consensus 97 ~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~ 166 (345)
T cd07877 97 VYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL 166 (345)
T ss_pred EEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEecccc
Confidence 67888887 7899888742 348899999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhh-HH-------H
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKF-SL-------W 719 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l-~~-------~ 719 (852)
++.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........... .. .
T Consensus 167 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T cd07877 167 ARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 240 (345)
T ss_pred cccccc------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 876432 1123457889999999876 5688999999999999999999999964432111000 00 0
Q ss_pred HHHHHhhCCcccccc--cccCCCCCC---HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 720 AYEEFEKGNVKGIVD--KSLAGEDVD---IEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 720 ~~~~~~~~~~~~~~d--~~l~~~~~~---~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
....+........+. +........ ......+.+++.+|++.||.+||++.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000000000000 000000000 0112356788999999999999999998854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=307.38 Aligned_cols=143 Identities=25% Similarity=0.389 Sum_probs=127.6
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.|.+.++||+|+||.||+|... .++.||||++.... ....++..|+.++..++|+||+++++++......+||||
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE 84 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME 84 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence 4667889999999999999975 58899999987432 223678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
|+++++|.+++... ..+++..++.++.||+.||+|||. .+|+||||||+||||+.++.+||+|||+++
T Consensus 85 y~~g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 85 YLIGGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999543 247888899999999999999998 799999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=285.77 Aligned_cols=258 Identities=22% Similarity=0.325 Sum_probs=191.3
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCce------e
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKH------R 569 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~------~ 569 (852)
.|.+.+.||+|+||.||+|... +++.||+|++... ......+.+|+.++++++|+||+++++++...+. .
T Consensus 16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07851 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV 95 (343)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence 4666789999999999999975 5788999998632 2234567789999999999999999998776554 8
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||++
T Consensus 96 ~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 96 YLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred EEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 9999998 6799998852 358999999999999999999998 89999999999999999999999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhH-HH-------H
Q 003059 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFS-LW-------A 720 (852)
Q Consensus 650 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~-~~-------~ 720 (852)
...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||............ .. .
T Consensus 166 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 166 RHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccccc------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 865321 223457888999999865 36789999999999999999999999654321110000 00 0
Q ss_pred HHHHhhCCcccccccccCCCCCCHH-----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 721 YEEFEKGNVKGIVDKSLAGEDVDIE-----QVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 721 ~~~~~~~~~~~~~d~~l~~~~~~~~-----~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
...+........+............ ....+.+++.+|++.+|++||++.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000000000000000000000111 1346788999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=268.52 Aligned_cols=268 Identities=24% Similarity=0.336 Sum_probs=201.8
Q ss_pred CCcccCHHHHHHhcccccccccccccceEEEEE-ECCCcEEEEEEecCccc--------chHHHHHHHHHhhccccccee
Q 003059 487 APVQFSYKELQRSTKGFKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQ--------GEKQFRMEVATISSTHHLNLV 557 (852)
Q Consensus 487 ~~~~~~~~el~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~--------~~~~f~~E~~~l~~l~h~niv 557 (852)
...+|.-.-+...+|-+.+.||+|||+.|||+. +...+.||||+-...+. -.+...+|..|-+.|.||.||
T Consensus 451 dnSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIV 530 (775)
T KOG1151|consen 451 DNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIV 530 (775)
T ss_pred chhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceee
Confidence 344566566666777778899999999999998 45678999998752211 123456799999999999999
Q ss_pred eeeeeec-cCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeC
Q 003059 558 RLVGFSS-EGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD 636 (852)
Q Consensus 558 ~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~ 636 (852)
++++++. +.+..|-|.|||+|.+|+-||..+ +.+++.++..|+.||+.||.||.+. +.+|||-||||.||||-
T Consensus 531 KlYDyfslDtdsFCTVLEYceGNDLDFYLKQh-----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv 604 (775)
T KOG1151|consen 531 KLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQH-----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLV 604 (775)
T ss_pred eeeeeeeeccccceeeeeecCCCchhHHHHhh-----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEe
Confidence 9999986 456789999999999999999654 4589999999999999999999975 47899999999999995
Q ss_pred ---CCCceEEeecccccccCCCCCcce----eeeeecCCCCCCChhhhhcC----CCCCCccchhhhHHHHHHHhCCccc
Q 003059 637 ---ENYNAKVSDFGLAKLINPKDHRHR----TLTSVRGTRGYLAPEWLANL----PITSKSDVYSYGMVLLEIVSGRRNF 705 (852)
Q Consensus 637 ---~~~~~kl~DFGla~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~----~~s~ksDv~s~Gvvl~elltG~~p~ 705 (852)
.-|.+||.|||+++.+..+.+... ......||.-|++||.+--+ +++.|.||||.||++|..+-|+.||
T Consensus 605 ~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPF 684 (775)
T KOG1151|consen 605 NGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPF 684 (775)
T ss_pred cCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCC
Confidence 458899999999999876544321 22346799999999988533 5788999999999999999999999
Q ss_pred cccccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 003059 706 EVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVV 772 (852)
Q Consensus 706 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~ 772 (852)
....... ..+.++.+.....-.+ +..+....+.-.++.+|++..-++|....++.
T Consensus 685 GhnqsQQ---------dILqeNTIlkAtEVqF---P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 685 GHNQSQQ---------DILQENTILKATEVQF---PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred CCchhHH---------HHHhhhchhcceeccC---CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 7543211 1122222222222111 11222223456788999999999997766553
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=271.64 Aligned_cols=272 Identities=21% Similarity=0.292 Sum_probs=208.6
Q ss_pred cccCHHHHHHhcccccccccccccceEEEEEECC-CcEEEEEEecCcccchHHHHHHHHHhhccc-cc-----ceeeeee
Q 003059 489 VQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGIEQGEKQFRMEVATISSTH-HL-----NLVRLVG 561 (852)
Q Consensus 489 ~~~~~~el~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~f~~E~~~l~~l~-h~-----niv~l~g 561 (852)
..|...+....+|.+...+|+|.||.|-+...+. +..||||+++....-.+.-+-|+++|.++. +. -+|.+.+
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 3466778888899999999999999999998644 689999999977776777788999999994 22 3888889
Q ss_pred eeccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeC-----
Q 003059 562 FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD----- 636 (852)
Q Consensus 562 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~----- 636 (852)
++...++.+||+|.+ |-|+.++|..+. -.+++...+..|+.|++++++|||+ .+++|-||||+|||+-
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceE
Confidence 999999999999998 779999996543 4568889999999999999999999 8999999999999983
Q ss_pred ---------------CCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhC
Q 003059 637 ---------------ENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSG 701 (852)
Q Consensus 637 ---------------~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG 701 (852)
.+..+||+|||.|..-.. .....+.|..|.|||++.+..++.++||||+||||+||.+|
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e------~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG 305 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE------HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG 305 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceecc------CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence 234589999999986533 12556789999999999999999999999999999999999
Q ss_pred CccccccccccchhhHHHH--------H------HHHhhCCc-----------cccccccc---CCCCCCHHHHHHHHHH
Q 003059 702 RRNFEVSQETNRKKFSLWA--------Y------EEFEKGNV-----------KGIVDKSL---AGEDVDIEQVMRAIQV 753 (852)
Q Consensus 702 ~~p~~~~~~~~~~~l~~~~--------~------~~~~~~~~-----------~~~~d~~l---~~~~~~~~~~~~~~~l 753 (852)
...|...+..+....-... . ..+..+.+ ....+... .......++..++.++
T Consensus 306 ~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDL 385 (415)
T KOG0671|consen 306 ETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDL 385 (415)
T ss_pred ceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHH
Confidence 9999765522211100000 0 00001100 00000000 0001223455678999
Q ss_pred HHhccccCCCCCCCHHHHHH
Q 003059 754 SFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 754 ~~~cl~~dp~~RPt~~ev~~ 773 (852)
+..++..||.+|+|+.|++.
T Consensus 386 l~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 386 LRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHccCccccccHHHHhc
Confidence 99999999999999999875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=265.87 Aligned_cols=221 Identities=20% Similarity=0.169 Sum_probs=175.1
Q ss_pred cccceEEEEEE-CCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCCHHHHhhhc
Q 003059 510 GGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFAN 588 (852)
Q Consensus 510 G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~ 588 (852)
|.||.||++.. .+++.+|+|++.... .+..|...+....||||+++++++.+....++||||+++++|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 88999999996 457889999987432 3345555566667999999999999999999999999999999998643
Q ss_pred ccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcceeeeeecCC
Q 003059 589 EEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGT 668 (852)
Q Consensus 589 ~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt 668 (852)
..+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.++|+|||.+..+... .....++
T Consensus 80 -----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~------~~~~~~~ 145 (237)
T cd05576 80 -----LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS------CDGEAVE 145 (237)
T ss_pred -----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc------cccCCcC
Confidence 248899999999999999999998 89999999999999999999999999988755331 1223456
Q ss_pred CCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHH
Q 003059 669 RGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVM 748 (852)
Q Consensus 669 ~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 748 (852)
..|+|||.+.+..++.++||||+|+++|||++|+.|+....... . ..... ..+.....
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~-----~~~~~-----~~~~~~~~ 203 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------N-----THTTL-----NIPEWVSE 203 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------c-----ccccc-----CCcccCCH
Confidence 78999999988889999999999999999999998875321100 0 00000 01111224
Q ss_pred HHHHHHHhccccCCCCCCCHHH
Q 003059 749 RAIQVSFWCIQEQPSQRPMMGK 770 (852)
Q Consensus 749 ~~~~l~~~cl~~dp~~RPt~~e 770 (852)
.+.+++.+|++.||.+||++.+
T Consensus 204 ~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 204 EARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHHHHHccCCHHHhcCCCc
Confidence 5677889999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=273.31 Aligned_cols=194 Identities=34% Similarity=0.495 Sum_probs=169.1
Q ss_pred cccccccccceEEEEEE-CCCcEEEEEEecC---cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCC
Q 003059 504 KDKLGAGGFGAVYRGVL-ANRTVVAVKQLEG---IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNG 579 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 579 (852)
.|.||.|.||+||-|+. ++|+.||||++.+ ....+.++++|+.||.+++||.||.+--.|+..+..++|||.+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 46899999999999995 5699999999874 3455688999999999999999999999999999999999999 66
Q ss_pred CHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCC---CceEEeecccccccCCCC
Q 003059 580 SLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDEN---YNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 580 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~DFGla~~~~~~~ 656 (852)
++.+.|...+ ...|+...-.-++.||+.||.|||. ++|+|+||||+||||... -++||+|||+|+.+.+..
T Consensus 648 DMLEMILSsE---kgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 648 DMLEMILSSE---KGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred hHHHHHHHhh---cccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 7766665443 3358888878889999999999998 899999999999999643 569999999999987643
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCcccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVS 708 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~ 708 (852)
-...++||+.|+|||+++.+.|...-|+||.||++|--|+|..||...
T Consensus 722 ----FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 722 ----FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred ----hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 235678999999999999999999999999999999999999999643
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=260.40 Aligned_cols=198 Identities=27% Similarity=0.305 Sum_probs=171.4
Q ss_pred ccccccccccccceEEEEEE-CCCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 501 KGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
..|.+.||+|.||.|.+++- ..++.+|+|++++.. .....-..|-.+|+..+||.+..|--.|...++.|.||||
T Consensus 170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey 249 (516)
T KOG0690|consen 170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY 249 (516)
T ss_pred hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence 44678999999999999984 568999999998432 2223346788999999999999998889999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
..||.|.-+|.. .+.+++....-+...|..||.|||+ ++||.||||.+|.|||.+|++||+|||+++.--
T Consensus 250 anGGeLf~HLsr-----er~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-- 319 (516)
T KOG0690|consen 250 ANGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-- 319 (516)
T ss_pred ccCceEeeehhh-----hhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc--
Confidence 999999988854 3457777777889999999999999 899999999999999999999999999998532
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQ 709 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~ 709 (852)
.....+....||+.|+|||++....|....|-|.+|||+|||++|+.||...+
T Consensus 320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d 372 (516)
T KOG0690|consen 320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD 372 (516)
T ss_pred -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence 22345677899999999999999999999999999999999999999997554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=281.82 Aligned_cols=238 Identities=24% Similarity=0.289 Sum_probs=189.8
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCcccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEEEeecC
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
.|.+...+|.|+|+.|-++.. ..++..+||++... ..+-.+|+.++.+. +||||+++.+.+.++.+.|+|||.+.
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 466677899999999999885 45788999999854 23345677666555 79999999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEe-CCCCceEEeecccccccCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL-DENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl-~~~~~~kl~DFGla~~~~~~~ 656 (852)
++-|.+.+..... .. ..+..|+.+|+.++.|||+ +++|||||||+|||+ ++.++++|+|||.++...+.
T Consensus 400 g~ell~ri~~~~~-----~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 400 GGELLRRIRSKPE-----FC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred ccHHHHHHHhcch-----hH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9988887764332 22 6777899999999999999 899999999999999 69999999999999987653
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
....+-|..|.|||++....+++++|+||||++||+||+|+.||...... ......+..+
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~--------- 529 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMP--------- 529 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCC---------
Confidence 23345678999999999999999999999999999999999999765432 0011111111
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.+.......+.+++.+||+.||.+||+|.++...
T Consensus 530 ----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 530 ----KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ----ccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1222233456677888999999999999998754
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=282.74 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=205.7
Q ss_pred hcccccccccccccceEEEEE-ECCCcEEEEEEecCcccchHHHHHHHHHhhcc-cccceeeeeeeec-----cCceeeE
Q 003059 499 STKGFKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATISST-HHLNLVRLVGFSS-----EGKHRLL 571 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~-----~~~~~~l 571 (852)
.++.|.+.||.|.+|.||+++ .++++.+|+|++.......++++.|.++++.. .|||++.++|++. .++++||
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 356778999999999999998 56789999999998888889999999999888 6999999999875 3569999
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
|||||.+||.-|++.... +..+.|..+.-|++.++.||.+||. ..++|||||-.|||+..++.+||.|||++..
T Consensus 99 VMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred EeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 999999999999997654 6679999999999999999999998 8899999999999999999999999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhcC-----CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhh
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLANL-----PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEK 726 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (852)
+... ........||+.|||||++... .|+.++|+||||++..||.-|.+|+....+... .-.
T Consensus 173 ldsT---~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra-------LF~--- 239 (953)
T KOG0587|consen 173 LDST---VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA-------LFL--- 239 (953)
T ss_pred eecc---cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-------hcc---
Confidence 6432 1223456799999999999654 477899999999999999999999875433110 000
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 727 GNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+.....+.+ ..+.....++.+++..|+..|.++||++.++++
T Consensus 240 --IpRNPPPkL---krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 240 --IPRNPPPKL---KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --CCCCCCccc---cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 000111111 123456678899999999999999999988764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=259.19 Aligned_cols=237 Identities=27% Similarity=0.399 Sum_probs=190.1
Q ss_pred ccceEEEEEECC-CcEEEEEEecCccc-c-hHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCCHHHHhhh
Q 003059 511 GFGAVYRGVLAN-RTVVAVKQLEGIEQ-G-EKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFA 587 (852)
Q Consensus 511 ~fg~Vy~~~~~~-~~~vavK~l~~~~~-~-~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 587 (852)
+||.||+|+..+ ++.+++|++..... . .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999764 88999999974332 2 57899999999999999999999999999999999999999999999864
Q ss_pred cccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcceeeeeecC
Q 003059 588 NEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRG 667 (852)
Q Consensus 588 ~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~g 667 (852)
.. .+++..++.++.+++++|.|||+ .+++|+||+|+||++++++.++|+|||.+....... ......+
T Consensus 81 ~~-----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~ 148 (244)
T smart00220 81 RG-----RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVG 148 (244)
T ss_pred cc-----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccC
Confidence 32 28899999999999999999999 799999999999999999999999999998765422 2234557
Q ss_pred CCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHH
Q 003059 668 TRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQV 747 (852)
Q Consensus 668 t~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 747 (852)
+..|++||.+....++.++|||+||++++||++|..||...... .. ............ . .......
T Consensus 149 ~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~----~~~~~~~~~~~~----~----~~~~~~~ 214 (244)
T smart00220 149 TPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LE----LFKKIGKPKPPF----P----PPEWKIS 214 (244)
T ss_pred CcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HH----HHHHHhccCCCC----c----cccccCC
Confidence 88999999999888999999999999999999999999653111 11 011111110000 0 0000023
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 748 MRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 748 ~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..+.+++.+|+..+|++||++.++++
T Consensus 215 ~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 215 PEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHHccCCchhccCHHHHhh
Confidence 46778999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=230.31 Aligned_cols=207 Identities=25% Similarity=0.386 Sum_probs=169.7
Q ss_pred ccccccccccceEEEEEE-CCCcEEEEEEecCccc--c-hHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 503 FKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQ--G-EKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 503 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~-~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
-.|+||+|.||+||||+. +.++.||+|+++-.+. + -....+|+-+++.++|.|||++++....++..-+|+||| .
T Consensus 6 kmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-d 84 (292)
T KOG0662|consen 6 KMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-D 84 (292)
T ss_pred HHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-h
Confidence 357899999999999995 4578899999873322 2 255789999999999999999999999999999999999 5
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
.+|..|...- ...++.+....++.|+++||.++|+ +++.|||+||+|.||+.+|+.||+|||+++.+.-.
T Consensus 85 qdlkkyfdsl----ng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgip--- 154 (292)
T KOG0662|consen 85 QDLKKYFDSL----NGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--- 154 (292)
T ss_pred HHHHHHHHhc----CCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCc---
Confidence 5788877432 3458888999999999999999999 89999999999999999999999999999977531
Q ss_pred ceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHH
Q 003059 659 HRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWA 720 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 720 (852)
.+.....+-|.-|.+|+++.+. -|+...|+||-||++.|+.. |++.|.+.+-.++...+.|.
T Consensus 155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~ 218 (292)
T KOG0662|consen 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218 (292)
T ss_pred eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHH
Confidence 2333445678899999999876 47889999999999999986 77777766544444333333
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=278.42 Aligned_cols=204 Identities=22% Similarity=0.263 Sum_probs=152.5
Q ss_pred HhcccccccccccccceEEEEEE-----------------CCCcEEEEEEecCccc-chH--------------HHHHHH
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVL-----------------ANRTVVAVKQLEGIEQ-GEK--------------QFRMEV 545 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~-----------------~~~~~vavK~l~~~~~-~~~--------------~f~~E~ 545 (852)
...+.+.++||+|+||.||+|.+ .+++.||||++....+ ..+ .+..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 34566778999999999999964 2356799999874322 122 234477
Q ss_pred HHhhcccccce-----eeeeeeecc--------CceeeEEEeecCCCCHHHHhhhcccC-------------------Cc
Q 003059 546 ATISSTHHLNL-----VRLVGFSSE--------GKHRLLVYEFMKNGSLDNFLFANEEG-------------------SG 593 (852)
Q Consensus 546 ~~l~~l~h~ni-----v~l~g~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~~-------------------~~ 593 (852)
.++.+++|.++ ++++++|.. .+..+|||||+++++|.++|+..... ..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777776654 677887753 35789999999999999999743210 11
Q ss_pred cccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCC
Q 003059 594 KLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLA 673 (852)
Q Consensus 594 ~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~a 673 (852)
..++|..+..++.|++++|.|||+ .+|+||||||+|||++.++.+||+|||+++.+..... .......+++.|+|
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~--~~~~~g~~tp~Y~a 378 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN--FNPLYGMLDPRYSP 378 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc--cCccccCCCcceeC
Confidence 245778899999999999999998 8899999999999999999999999999976543211 11112335789999
Q ss_pred hhhhhcCCC----------------------CCCccchhhhHHHHHHHhCCc-ccc
Q 003059 674 PEWLANLPI----------------------TSKSDVYSYGMVLLEIVSGRR-NFE 706 (852)
Q Consensus 674 PE~~~~~~~----------------------s~ksDv~s~Gvvl~elltG~~-p~~ 706 (852)
||.+..... ..+.||||+||+++||++|.. |+.
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 998754321 134799999999999999885 664
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-30 Score=262.08 Aligned_cols=205 Identities=24% Similarity=0.341 Sum_probs=173.1
Q ss_pred HHHHhcccccccccccccceEEEEEECC-CcEEEEEEecCcc----cchHHHHHHHHHhhcc-cccceeeeeeeeccCce
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGIE----QGEKQFRMEVATISST-HHLNLVRLVGFSSEGKH 568 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~ 568 (852)
.|..+..+|...||+|.||.|-++.-++ .+.+|||++++.. ...+--..|-.+|+.. +-|.++.++.++..-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 4556677899999999999999998654 5679999998432 2223335677777776 57789999999999999
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.|.||||+.||+|--++.+-.+ +.+..+.-+|.+||-||-+||+ ++||.||||..|||||.+|++||+|||+
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~Gk-----FKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGm 496 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGK-----FKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGM 496 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcc-----cCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccc
Confidence 9999999999999888865433 5566677789999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCcccccccc
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQE 710 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~ 710 (852)
++.-- ....+.....||+.|+|||++...+|+...|.|||||+||||+.|++||++.++
T Consensus 497 cKEni---~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 497 CKENI---FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred ccccc---cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 98532 222445678899999999999999999999999999999999999999987654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=280.99 Aligned_cols=244 Identities=27% Similarity=0.365 Sum_probs=186.5
Q ss_pred ccccccccce-EEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEEEeecCCCCHH
Q 003059 505 DKLGAGGFGA-VYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLVYEFMKNGSLD 582 (852)
Q Consensus 505 ~~lG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 582 (852)
+.+|.|.-|+ ||+|... ++.||||++-. ...+...+|+..|+.- +|||||++++.-.+....||..|.| ..+|+
T Consensus 515 eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~--e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~ 590 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYE-GREVAVKRLLE--EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQ 590 (903)
T ss_pred HHcccCCCCcEEEEEeeC-CceehHHHHhh--HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHH
Confidence 5799999887 6999984 56899999862 2233457899999877 6999999999999999999999999 56999
Q ss_pred HHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC-----CCceEEeecccccccCCCCC
Q 003059 583 NFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE-----NYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 583 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~DFGla~~~~~~~~ 657 (852)
+++..... ......--..+.+..|+++||++||+ .+||||||||+||||+. ..+++|+|||+++.+..+..
T Consensus 591 dlie~~~~-d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 591 DLIESSGL-DVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred HHHhcccc-chhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 99976411 11111113446788999999999999 89999999999999975 35799999999999877655
Q ss_pred cceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhC-CccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 658 RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSG-RRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
.........||-+|+|||.+....-+..+||||||||+|+.++| ..||...-..+. .+..+.. . +..
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~---------NIl~~~~-~-L~~- 734 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA---------NILTGNY-T-LVH- 734 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh---------hhhcCcc-c-eee-
Confidence 55556677899999999999999888999999999999999996 899974422110 0000000 0 000
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+ ....+. .+.+++.++++.+|..||++.+|+.
T Consensus 735 L---~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 L---EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred e---ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0 011111 6778899999999999999999974
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=284.95 Aligned_cols=258 Identities=19% Similarity=0.198 Sum_probs=166.0
Q ss_pred hcccccccccccccceEEEEEECC-----CcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeee------eccCc
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLAN-----RTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGF------SSEGK 567 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~------~~~~~ 567 (852)
..|.+.++||+|+||.||+|++.+ +..||||++......+ .+..| .+....+.++..++.. +.++.
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-IWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-HHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 456677899999999999999754 5889999886322211 11111 1122222233222221 24567
Q ss_pred eeeEEEeecCCCCHHHHhhhcccC---------------CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCc
Q 003059 568 HRLLVYEFMKNGSLDNFLFANEEG---------------SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPEN 632 (852)
Q Consensus 568 ~~~lV~e~~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 632 (852)
..+|||||+++++|.+++...... .........+..++.||+.||+|||+ ++|+||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHH
Confidence 899999999999999998643210 00112234456799999999999998 899999999999
Q ss_pred eEeCC-CCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcC----------------------CCCCCccch
Q 003059 633 ILLDE-NYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL----------------------PITSKSDVY 689 (852)
Q Consensus 633 ILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~ksDv~ 689 (852)
||+++ ++.+||+|||+++.+.... ........+++.|+|||.+... .++.++|||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~--~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGI--NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred EEEeCCCCcEEEEeCCCcccccccc--ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 99986 6899999999998664321 1223446789999999966422 234567999
Q ss_pred hhhHHHHHHHhCCcccccccccc-------chhhHHHHHHHHhhCCcccccccccCCC---CCC--HHHHHHHHHHHHhc
Q 003059 690 SYGMVLLEIVSGRRNFEVSQETN-------RKKFSLWAYEEFEKGNVKGIVDKSLAGE---DVD--IEQVMRAIQVSFWC 757 (852)
Q Consensus 690 s~Gvvl~elltG~~p~~~~~~~~-------~~~l~~~~~~~~~~~~~~~~~d~~l~~~---~~~--~~~~~~~~~l~~~c 757 (852)
||||+||||+++..+++.....- ...+..|. ..+.+..... .+. ........+++.+|
T Consensus 364 SlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m 433 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWR----------KLVEPRASPDLRRGFEVLDLDGGAGWELLKSM 433 (566)
T ss_pred HHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHH----------HhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence 99999999999877654221000 00011111 0011100000 000 00112344788999
Q ss_pred cccCCCCCCCHHHHHHH
Q 003059 758 IQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 758 l~~dp~~RPt~~ev~~~ 774 (852)
++.||++|||+.++++.
T Consensus 434 L~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 434 MRFKGRQRISAKAALAH 450 (566)
T ss_pred ccCCcccCCCHHHHhCC
Confidence 99999999999999863
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=290.08 Aligned_cols=201 Identities=24% Similarity=0.286 Sum_probs=174.6
Q ss_pred HHhcccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeE
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLL 571 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 571 (852)
.+..+.+.+.||+|+||.|..++++ .++.+|+|++.+. ......|..|-.+|.--..+-|+.++-.|.+..+.|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 3455667789999999999999975 4789999999853 2334678889999998899999999999999999999
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
|||||+||+|-.+|.+.. .++...+.-++..|.-||.-||+ .|+|||||||+|||||..|++||+|||.+-.
T Consensus 153 VMdY~pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLK 224 (1317)
T ss_pred EEecccCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHh
Confidence 999999999999995442 48888888899999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhh----c-CCCCCCccchhhhHHHHHHHhCCccccc
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLA----N-LPITSKSDVYSYGMVLLEIVSGRRNFEV 707 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~ksDv~s~Gvvl~elltG~~p~~~ 707 (852)
+..+ ........+|||.|++||+++ + +.|++.+|-||+||++|||+.|..||..
T Consensus 225 m~~d--G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 225 MDAD--GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred cCCC--CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 7653 333445678999999999995 3 5789999999999999999999999963
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=237.04 Aligned_cols=197 Identities=26% Similarity=0.390 Sum_probs=162.9
Q ss_pred cccccccccceEEEEEE-CCCcEEEEEEecC--cccchHHHHHHHHHhhc-ccccceeeeeeeeccCceeeEEEeecCCC
Q 003059 504 KDKLGAGGFGAVYRGVL-ANRTVVAVKQLEG--IEQGEKQFRMEVATISS-THHLNLVRLVGFSSEGKHRLLVYEFMKNG 579 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~--~~~~~~~f~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lV~e~~~~g 579 (852)
.+.||+|++|.|-+-++ .+|+..|+|++.. ..+..++..+|+.+..+ ..+|.+|.++|.....+..++.||.| .-
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~t 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DT 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hh
Confidence 45799999999988774 5789999999983 34455677888888655 47999999999999999999999999 55
Q ss_pred CHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcc
Q 003059 580 SLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRH 659 (852)
Q Consensus 580 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 659 (852)
||+.|-.+-. ..+..+++.-.=+|+..+.+||.|||++ ..+||||+||+||||+.+|++|++|||++-.+...
T Consensus 130 Sldkfy~~v~-~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS---- 202 (282)
T KOG0984|consen 130 SLDKFYRKVL-KKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS---- 202 (282)
T ss_pred hHHHHHHHHH-hcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhh----
Confidence 8887764322 2355688888889999999999999994 68999999999999999999999999999876431
Q ss_pred eeeeeecCCCCCCChhhhhc----CCCCCCccchhhhHHHHHHHhCCcccccc
Q 003059 660 RTLTSVRGTRGYLAPEWLAN----LPITSKSDVYSYGMVLLEIVSGRRNFEVS 708 (852)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~----~~~s~ksDv~s~Gvvl~elltG~~p~~~~ 708 (852)
...+...|...|||||.+.. ..|+-|+||||||+++.||.+++.||+..
T Consensus 203 iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 203 IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 11122458889999998853 36889999999999999999999999754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=258.57 Aligned_cols=155 Identities=25% Similarity=0.359 Sum_probs=133.8
Q ss_pred hhHhhhhhhccCCCcccCHHHHHH-hcccccccccccccceEEEEEE-CCCcEEEEEEecCcccchHHHHHHHHHhhccc
Q 003059 475 SAQYALLEYASGAPVQFSYKELQR-STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVATISSTH 552 (852)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~el~~-~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~ 552 (852)
..++...++..++.+.+...|... ++|-+.++||.|.|++||++.+ .+.+.||+|+.+....-.+.-..||++|++++
T Consensus 53 ~eqE~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~ 132 (590)
T KOG1290|consen 53 EEQEDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVR 132 (590)
T ss_pred ccccChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHH
Confidence 345566678889999999999998 9999999999999999999985 56789999999977666677889999999884
Q ss_pred -----cc---ceeeeeeeecc----CceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccC
Q 003059 553 -----HL---NLVRLVGFSSE----GKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620 (852)
Q Consensus 553 -----h~---niv~l~g~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ 620 (852)
|+ .||+|+++|.. +.+.+||+|++ |-+|..+|.... .+-++...+.+|++||+.||.|||.+|
T Consensus 133 ~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~---YrGlpl~~VK~I~~qvL~GLdYLH~ec- 207 (590)
T KOG1290|consen 133 EGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSN---YRGLPLSCVKEICRQVLTGLDYLHREC- 207 (590)
T ss_pred hcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhC---CCCCcHHHHHHHHHHHHHHHHHHHHhc-
Confidence 32 69999999875 45999999999 778999986554 345889999999999999999999974
Q ss_pred CCcccCCCCCCceEe
Q 003059 621 DCIVHCDIKPENILL 635 (852)
Q Consensus 621 ~~ivH~Dlkp~NILl 635 (852)
+|||-||||+||||
T Consensus 208 -gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 208 -GIIHTDLKPENVLL 221 (590)
T ss_pred -CccccCCCcceeee
Confidence 79999999999999
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=245.35 Aligned_cols=243 Identities=23% Similarity=0.264 Sum_probs=187.5
Q ss_pred ccccccccceEEEEEE-CCCcEEEEEEecCcccchHHHHHHHHHhhcc-cccceeeeeeeecc----CceeeEEEeecCC
Q 003059 505 DKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVATISST-HHLNLVRLVGFSSE----GKHRLLVYEFMKN 578 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~lV~e~~~~ 578 (852)
++||-|-.|.|-.... ..++..|+|++..... .++|+++--+. .|||||.+++++.. ....++|||.|+|
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K----ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meG 143 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK----ARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEG 143 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcCHH----HHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccc
Confidence 5799999999999885 4578899999875433 46677765444 69999999998754 4577899999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeC---CCCceEEeecccccccCCC
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD---ENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~DFGla~~~~~~ 655 (852)
|.|...+..+. ...++++++-.|..||+.|+.|||+ .+|.||||||+|+|.. .|-.+||+|||+|+....
T Consensus 144 GeLfsriq~~g---~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~- 216 (400)
T KOG0604|consen 144 GELFSRIQDRG---DQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE- 216 (400)
T ss_pred hHHHHHHHHcc---cccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccCC-
Confidence 99999996554 4568999999999999999999999 8999999999999995 456799999999997543
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
........-|+.|.|||++...+|+...|+||+||++|-||+|.+||......... --....+..
T Consensus 217 ---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais---pgMk~rI~~--------- 281 (400)
T KOG0604|consen 217 ---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKRRIRT--------- 281 (400)
T ss_pred ---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC---hhHHhHhhc---------
Confidence 23445567899999999999999999999999999999999999999654321100 000011111
Q ss_pred ccCCCCCCHHH----HHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003059 736 SLAGEDVDIEQ----VMRAIQVSFWCIQEQPSQRPMMGKVVQML 775 (852)
Q Consensus 736 ~l~~~~~~~~~----~~~~~~l~~~cl~~dp~~RPt~~ev~~~L 775 (852)
....++.++ .+..-+++...+..+|.+|-|+.++...-
T Consensus 282 --gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 282 --GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred --cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 011222222 23455677788999999999999998643
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-29 Score=245.81 Aligned_cols=267 Identities=19% Similarity=0.264 Sum_probs=190.7
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEec--Ccccc-hHHHHHHHHHhhcccccceeeeeeeecc--------Cc
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLE--GIEQG-EKQFRMEVATISSTHHLNLVRLVGFSSE--------GK 567 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~--~~~~~-~~~f~~E~~~l~~l~h~niv~l~g~~~~--------~~ 567 (852)
+|.-..+||+|.||.||+|... .++.||+|++- ..+.+ -..-.+|+++|..++|+|++.++..|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3334468999999999999854 47778888653 22222 2345789999999999999999998864 33
Q ss_pred eeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecc
Q 003059 568 HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFG 647 (852)
Q Consensus 568 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 647 (852)
..||||++|+. +|.-+|... ...++..++.++..++..||.|+|. ..|+|||+||.|+||+.++.+||+|||
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~----~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNR----KVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCc----cccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccc
Confidence 57999999976 788777432 3458888999999999999999998 789999999999999999999999999
Q ss_pred cccccCCCCC-cceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHH-
Q 003059 648 LAKLINPKDH-RHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEF- 724 (852)
Q Consensus 648 la~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~- 724 (852)
+++.+...+. .....++.+-|..|.+||.+.+. .++++.|||+-||++.||.||.+-+..........++......+
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 9987653222 12223456678999999998765 78999999999999999999999887654333222222111100
Q ss_pred -------hhCCccccc--ccccCCCC-CCHHHHH------HHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 725 -------EKGNVKGIV--DKSLAGED-VDIEQVM------RAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 725 -------~~~~~~~~~--d~~l~~~~-~~~~~~~------~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.+-.+-..+ .+.-.+.. .-.+.+. ..++++..++..||.+|+++.+++..
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 000000000 00000000 0011111 46677788999999999999998753
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=261.33 Aligned_cols=209 Identities=25% Similarity=0.354 Sum_probs=171.2
Q ss_pred HHHHhcccccccccccccceEEEEEE-CCCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCcee
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHR 569 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 569 (852)
...+..+...+.||-|+||.|.++.. +....+|+|.+++.+ ......+.|-.||+....+-||+|+-.|.+++.+
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 33333344456799999999999984 456789999987432 2334577899999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
|+||||++||++-.+|.+.. .+.+..+.-++.++..|+++.|. .|+|||||||+|||||.+|++||.||||+
T Consensus 705 YFVMdYIPGGDmMSLLIrmg-----IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLC 776 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRMG-----IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLC 776 (1034)
T ss_pred EEEEeccCCccHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeecccc
Confidence 99999999999999986543 47777888889999999999998 89999999999999999999999999998
Q ss_pred cccC---------CCCC------------------------------cceeeeeecCCCCCCChhhhhcCCCCCCccchh
Q 003059 650 KLIN---------PKDH------------------------------RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYS 690 (852)
Q Consensus 650 ~~~~---------~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s 690 (852)
.-++ ..++ .....-..+||+.|+|||++....++.-+|.||
T Consensus 777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws 856 (1034)
T KOG0608|consen 777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWS 856 (1034)
T ss_pred ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhH
Confidence 6442 1100 000111246999999999999999999999999
Q ss_pred hhHHHHHHHhCCccccccccc
Q 003059 691 YGMVLLEIVSGRRNFEVSQET 711 (852)
Q Consensus 691 ~Gvvl~elltG~~p~~~~~~~ 711 (852)
.|||||||+.|+.||-.....
T Consensus 857 ~gvil~em~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 857 VGVILYEMLVGQPPFLADTPG 877 (1034)
T ss_pred hhHHHHHHhhCCCCccCCCCC
Confidence 999999999999999765443
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=260.48 Aligned_cols=242 Identities=23% Similarity=0.289 Sum_probs=193.9
Q ss_pred cccccccccceEEEEEECCCc-EEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 504 KDKLGAGGFGAVYRGVLANRT-VVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~~~~~-~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
...||-||||.|=++..+... ..|+|.+++. ....+....|-.+|...+.|.||+++--|.+.++.|++||-|-|
T Consensus 425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 356999999999999876644 3788877632 23345567899999999999999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
|.|...|..+. .++..+..-++..+.+|++|||. ++||+|||||+|.+||.+|-+||.|||+|+.+..
T Consensus 505 GElWTiLrdRg-----~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~---- 572 (732)
T KOG0614|consen 505 GELWTILRDRG-----SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS---- 572 (732)
T ss_pred chhhhhhhhcC-----CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhcc----
Confidence 99999996543 36777777889999999999998 9999999999999999999999999999998854
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccC
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (852)
........||+.|.|||++.+...+..+|.|+||++++|||+|++||...++...-.++.-..+.+
T Consensus 573 g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i-------------- 638 (732)
T KOG0614|consen 573 GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI-------------- 638 (732)
T ss_pred CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh--------------
Confidence 234567899999999999999999999999999999999999999998766543222211111111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003059 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPM-----MGKVVQ 773 (852)
Q Consensus 739 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt-----~~ev~~ 773 (852)
.++..-.....+++.+.+..+|.+|-- ..+|.+
T Consensus 639 --~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 639 --EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred --hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 223333445667777778889999975 455554
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-28 Score=242.18 Aligned_cols=261 Identities=23% Similarity=0.325 Sum_probs=190.6
Q ss_pred cccccccccceEEEEEE-CCCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccC-----ceeeEEEe
Q 003059 504 KDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEG-----KHRLLVYE 574 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lV~e 574 (852)
.+-||-|+||.||..++ ++++.|++|++...- ...+.+.+|+++|.-.+|.|++..+++..-. .+.|+|.|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 35699999999999986 578999999987433 3457788999999999999999988865432 26788899
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
.| ..+|.+.|. +...|+-..+.-+.+||++||+|||+ .+|.||||||.|.|++.|...||+|||+++....
T Consensus 138 Lm-QSDLHKIIV-----SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 138 LM-QSDLHKIIV-----SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HH-Hhhhhheec-----cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccch
Confidence 88 447777664 34568888888899999999999999 7999999999999999999999999999997655
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHH--------HHHHh
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA--------YEEFE 725 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~ 725 (852)
+ ....++..+-|..|.|||.+++. .|+...||||.||++.||+..+..|....+.....++... .+..-
T Consensus 209 d--~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 209 R--DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred h--hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 3 23345556678899999999876 6899999999999999999999888765544333222111 00001
Q ss_pred hCCcccccccccCCCC--------CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003059 726 KGNVKGIVDKSLAGED--------VDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQML 775 (852)
Q Consensus 726 ~~~~~~~~d~~l~~~~--------~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L 775 (852)
++....++........ .+...-.+.+.+...++..||..|.+.++.+..+
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1111112211111100 0111222344566668899999999888877644
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=232.14 Aligned_cols=209 Identities=34% Similarity=0.558 Sum_probs=181.9
Q ss_pred ccccccceEEEEEECC-CcEEEEEEecCccc--chHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCCHHH
Q 003059 507 LGAGGFGAVYRGVLAN-RTVVAVKQLEGIEQ--GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDN 583 (852)
Q Consensus 507 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 583 (852)
||+|.+|.||++...+ ++.+++|++..... ..+.+.+|++.+++++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 88899999985444 35789999999999999999999999999999999999999999999
Q ss_pred HhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC-CCceEEeecccccccCCCCCcceee
Q 003059 584 FLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE-NYNAKVSDFGLAKLINPKDHRHRTL 662 (852)
Q Consensus 584 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~ 662 (852)
++.... ..+++..+..++.+++++|++||+ .+++|+||+|.||+++. ++.++|+|||.+........ ..
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~ 150 (215)
T cd00180 81 LLKENE----GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LL 150 (215)
T ss_pred HHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hh
Confidence 985432 358899999999999999999999 79999999999999999 89999999999987644221 12
Q ss_pred eeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCCCC
Q 003059 663 TSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGED 741 (852)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 741 (852)
....+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 334578889999999887 888999999999999998
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 742 VDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 742 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
..+.+++..|++.+|.+||++.++++.
T Consensus 188 ------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 356678888999999999999998864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=236.81 Aligned_cols=244 Identities=20% Similarity=0.287 Sum_probs=187.0
Q ss_pred ccccccccccccceEEEEEEC-CCcEEEEEEecC----cccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEEEe
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEG----IEQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~----~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e 574 (852)
+++...||+|.|..|..+.+. ..+.+|+|++++ ..+..+-.+.|-.+..+. +||.+|.++.+|..+...+.|.|
T Consensus 252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvie 331 (593)
T KOG0695|consen 252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIE 331 (593)
T ss_pred ceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEE
Confidence 455678999999999999864 577899998873 233334456676666655 79999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++|+|--++... +.|+++.+.-+...|.-||.|||+ ++||.||||..|||||..|++||.|+|+++.--.
T Consensus 332 yv~ggdlmfhmqrq-----rklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 332 YVNGGDLMFHMQRQ-----RKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EecCcceeeehhhh-----hcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 99999997777543 348888888899999999999999 9999999999999999999999999999986433
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccc-hhhHHHHHHHHhhCCccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNR-KKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~ 733 (852)
.. .......||+.|+|||.+++..|....|.|+|||+++||+.|+.||+.-...+. .+..++....+.
T Consensus 404 ~g---d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil-------- 472 (593)
T KOG0695|consen 404 PG---DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL-------- 472 (593)
T ss_pred CC---cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh--------
Confidence 22 234568899999999999999999999999999999999999999985432221 112222222221
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCC
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP 766 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RP 766 (852)
.+.++ .+..-..+...+...-+++||.+|.
T Consensus 473 ekqir---iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 473 EKQIR---IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred hhccc---ccceeehhhHHHHHHhhcCCcHHhc
Confidence 12111 1111122344556668889999884
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=252.69 Aligned_cols=193 Identities=25% Similarity=0.318 Sum_probs=165.5
Q ss_pred ccccccccccccceEEEEEECC-CcEEEEEEecCcccchH---------HHHHHHHHhhccc---ccceeeeeeeeccCc
Q 003059 501 KGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGIEQGEK---------QFRMEVATISSTH---HLNLVRLVGFSSEGK 567 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~---------~f~~E~~~l~~l~---h~niv~l~g~~~~~~ 567 (852)
|...+.+|+|+||.|+.++++. ...|+||++.+.+.-.+ ..-.|++||+.++ |+||++++++|++++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 4456789999999999999654 66789998875432222 2446999999997 999999999999999
Q ss_pred eeeEEEeec-CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeec
Q 003059 568 HRLLVYEFM-KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDF 646 (852)
Q Consensus 568 ~~~lV~e~~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 646 (852)
++||+||-. ++-+|.++|..+ +.+++.+...|++||+.|+++||+ .+|||||||-+||.++.+|-+||+||
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~k-----p~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEFK-----PRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred eeEEEecCCCCCcchhhhhhcc-----CccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeec
Confidence 999999987 677999999543 458899999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCChhhhhcCCC-CCCccchhhhHHHHHHHhCCcccc
Q 003059 647 GLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPI-TSKSDVYSYGMVLLEIVSGRRNFE 706 (852)
Q Consensus 647 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~s~Gvvl~elltG~~p~~ 706 (852)
|.+...... .....+||..|.|||++.+.+| ...-|||++|++||-++-...||.
T Consensus 715 gsaa~~ksg-----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSG-----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCC-----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999876432 3456789999999999999887 456899999999999999888874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=226.63 Aligned_cols=251 Identities=19% Similarity=0.319 Sum_probs=188.7
Q ss_pred cccccccccccccceEEEEEECC-CcEEEEEEecCcccchHHHHHHHHHhhcc-cccceeeeeee-eccCceeeEEEeec
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGIEQGEKQFRMEVATISST-HHLNLVRLVGF-SSEGKHRLLVYEFM 576 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~-~~~~~~~~lV~e~~ 576 (852)
.|++.+.||+|.||.+-++..+. ++.+++|.+.......++|.+|...--.| .|.||+.-++. |...+.++.++||+
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~a 104 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFA 104 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccC
Confidence 56778899999999999999765 67899999998888889999999875555 69999988774 66777889999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeC--CCCceEEeecccccccCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD--ENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kl~DFGla~~~~~ 654 (852)
|.|+|..-+.. ..+.+....+++.|+++||.|+|+ +++||||||.+||||- +..++||+|||+.+....
T Consensus 105 P~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 105 PRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred ccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999987743 336777788999999999999999 8999999999999993 445899999999885432
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcC-----CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANL-----PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
.......+..|.+||..... ...+.+|||.||++++.++||..||+.....+. ..|.+..+..+..
T Consensus 176 ------tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~---~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 176 ------TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK---PYWEWEQWLKRKN 246 (378)
T ss_pred ------eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc---hHHHHHHHhcccC
Confidence 22233356679999987533 356789999999999999999999984333222 2344555554443
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003059 730 KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQML 775 (852)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L 775 (852)
..+.+.- . .+. .++.++..+-+..++++|-...++.++-
T Consensus 247 ~~~P~~F-~--~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 247 PALPKKF-N--PFS----EKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred ccCchhh-c--ccC----HHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 3222211 1 122 2344555667889999996555555443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.3e-27 Score=247.01 Aligned_cols=213 Identities=25% Similarity=0.281 Sum_probs=184.5
Q ss_pred CCCcccCHHHHHHhcccccccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhccc------ccceee
Q 003059 486 GAPVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISSTH------HLNLVR 558 (852)
Q Consensus 486 ~~~~~~~~~el~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~------h~niv~ 558 (852)
+++.++.+.|+...+|.+.-..|+|-|++|.+|... -+..||||++...+...+.=+.|+++|.+|+ .-|+++
T Consensus 419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 456778899999999999999999999999999864 3679999999988777788889999999996 338999
Q ss_pred eeeeeccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCC
Q 003059 559 LVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDEN 638 (852)
Q Consensus 559 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~ 638 (852)
|+-.|.+.+++|||+|-+ ..+|.+.|.+... .-.|....+..++.|+.-||..|.. .+|+|.||||.|||+++.
T Consensus 499 l~r~F~hknHLClVFE~L-slNLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNES 572 (752)
T ss_pred HHHHhhhcceeEEEehhh-hchHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccC
Confidence 999999999999999988 6699999977654 4458888999999999999999998 899999999999999875
Q ss_pred -CceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccc
Q 003059 639 -YNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQ 709 (852)
Q Consensus 639 -~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~ 709 (852)
..+||||||.|......+- +...-...|.|||++.+.+|+...|+||.||+||||.||+..|.+..
T Consensus 573 k~iLKLCDfGSA~~~~enei-----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENEI-----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred cceeeeccCccccccccccc-----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 5579999999987654322 22334567999999999999999999999999999999999987653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=228.55 Aligned_cols=197 Identities=33% Similarity=0.467 Sum_probs=170.4
Q ss_pred cccccccccccceEEEEEECC-CcEEEEEEecCccc--chHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 502 GFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGIEQ--GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 502 ~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
.+.+.||.|++|.||++...+ ++.+++|.+..... ..+.+.+|++.+.+++|+|++++++++......++++||+++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 456789999999999999865 78899999984433 467889999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
++|.+++..... .+++..+..++.+++.+|.+||+ .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-- 152 (225)
T smart00221 82 GDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-- 152 (225)
T ss_pred CCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc--
Confidence 999999864321 17889999999999999999998 799999999999999999999999999998765432
Q ss_pred ceeeeeecCCCCCCChhhh-hcCCCCCCccchhhhHHHHHHHhCCccccc
Q 003059 659 HRTLTSVRGTRGYLAPEWL-ANLPITSKSDVYSYGMVLLEIVSGRRNFEV 707 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~-~~~~~s~ksDv~s~Gvvl~elltG~~p~~~ 707 (852)
........++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 0122345577889999998 666788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=212.80 Aligned_cols=257 Identities=18% Similarity=0.310 Sum_probs=185.6
Q ss_pred hcccccccccccccceEEEEE-ECCCcEEEEEEecCcccchHHHHHHHHHhhccc-ccceeeeeeeeccC--ceeeEEEe
Q 003059 499 STKGFKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATISSTH-HLNLVRLVGFSSEG--KHRLLVYE 574 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lV~e 574 (852)
..|.+.+++|+|.++.||.|. ..++..++||+++..+ .+.+.+|+++|..|. ||||++|++...+. ....||+|
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 356667899999999999998 5667889999998443 467899999999997 99999999988764 46789999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC-CCceEEeecccccccC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE-NYNAKVSDFGLAKLIN 653 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGla~~~~ 653 (852)
|+.+.+...+- +.|+-..+.-.+.++++||.|+|+ .||.|||+||.|++||. .-..+|+|+|+|....
T Consensus 116 ~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 116 YVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 99998876654 236667778899999999999999 89999999999999985 4569999999999887
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHH----H----H
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYE----E----F 724 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~----~----~ 724 (852)
+.... .-.+.+..|--||.+-. ..++..-|+|||||+|.+|+..+.||-...+ +...++..+.. + +
T Consensus 185 p~~eY----nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 185 PGKEY----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred CCcee----eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHHHhChHHHHHHH
Confidence 64322 22334566888998865 4578889999999999999999999853321 22222222210 0 0
Q ss_pred ------hhCCcccccccccCCC---CC-C-HH--HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 725 ------EKGNVKGIVDKSLAGE---DV-D-IE--QVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 725 ------~~~~~~~~~d~~l~~~---~~-~-~~--~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
......+++....+.. .. + .. ...++++++-..+..|-.+|||++|...
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0111111111110000 00 0 00 0135667777788999999999998764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-25 Score=242.58 Aligned_cols=249 Identities=20% Similarity=0.267 Sum_probs=192.7
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEec-CcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLE-GIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~-~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
.|.+..++|.|.+|.|||++. ..+...|+|+++ ......+-.++|+-+++..+|+|||.++|.+......++.||||.
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycg 95 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCG 95 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecC
Confidence 466678999999999999995 568889999998 444555667889999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
+|+|++.-+.. .++++.++..+.+...+||+|||. .+=+|||||-.|||+.+.|.+|++|||.+-.+..
T Consensus 96 ggslQdiy~~T-----gplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqita--- 164 (829)
T KOG0576|consen 96 GGSLQDIYHVT-----GPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--- 164 (829)
T ss_pred CCcccceeeec-----ccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhh---
Confidence 99999977644 358888888999999999999999 7789999999999999999999999999876542
Q ss_pred cceeeeeecCCCCCCChhhh---hcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 658 RHRTLTSVRGTRGYLAPEWL---ANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~---~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
.........||+.|||||+. +.+.|..++|||+.|+...|+-.-+.|.-...... +.... .+..++
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-------~l~Lm----TkS~~q 233 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-------ALFLM----TKSGFQ 233 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-------HHHHh----hccCCC
Confidence 22233557799999999987 45678999999999999999988777743211110 00000 111122
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVV 772 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~ 772 (852)
+.-. .........+-+++..|+..+|++||+++.++
T Consensus 234 pp~l--kDk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 234 PPTL--KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CCcc--cCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 1111 11122334455667779999999999987654
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-24 Score=193.75 Aligned_cols=110 Identities=37% Similarity=0.583 Sum_probs=97.5
Q ss_pred CccccCCCCCccccCCCceEEEEEecCCCC-eeEEEEEeC--CeeEEeeCC-CCCCCCceEEEeeCccEEEEcCCCceEe
Q 003059 37 SSLSASNLNQSWPSPNSTFSLSFIQRSPNS-FIPAITYSG--GVPIWTAGS-TPVDSSAFFQLHSSGTLRLISGSGAIIW 112 (852)
Q Consensus 37 ~~l~~~~~~~~l~S~~g~f~lgf~~~~~~~-~~~~i~~~~--~~~vW~an~-~p~~~~~~l~~~~~g~l~l~~~~~~~vW 112 (852)
+.|..++ +|+|++|.|++|||...... ++.+|||.. .++||+||+ .|....+.|.|+.||||+|+|.+|.+||
T Consensus 2 ~~l~~~~---~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW 78 (116)
T cd00028 2 NPLSSGQ---TLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVW 78 (116)
T ss_pred cCcCCCC---EEEeCCCcEEEecccCCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEE
Confidence 3566666 89999999999999998776 999999944 489999998 5667788999999999999999999999
Q ss_pred eccCCC-CceeEEEEcCCccEEEecCCCccccccCCCC
Q 003059 113 DSNTQR-LNVTSASLDDSGNLVLLKNGGVSAWSSFDNP 149 (852)
Q Consensus 113 st~~~~-~~~~~~~l~d~GNlvl~~~~~~~lWQSFD~P 149 (852)
+|++.+ ....+|+|+|||||||++.++.++|||||||
T Consensus 79 ~S~~~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P 116 (116)
T cd00028 79 SSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116 (116)
T ss_pred EecccCCCCceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence 999876 4556899999999999999999999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.4e-25 Score=220.95 Aligned_cols=252 Identities=21% Similarity=0.278 Sum_probs=181.3
Q ss_pred cccccccceEEEEEE-CCCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCc------eeeEEEee
Q 003059 506 KLGAGGFGAVYRGVL-ANRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK------HRLLVYEF 575 (852)
Q Consensus 506 ~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~~~lV~e~ 575 (852)
-+|.|.- .|-.+.+ -.+++||+|++... ....+.-.+|...+..++|+||++++.+++-.. ..|+|||+
T Consensus 24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 4666665 3444432 23678999987632 233456788999999999999999999987543 67999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
| ..+|...+. ..++-+.+..|..|++.|++|||+ .+|+||||||+||++..+..+||.|||+++.....
T Consensus 103 m-~~nl~~vi~-------~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 103 M-DANLCQVIL-------MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred h-hhHHHHHHH-------HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccCcc
Confidence 9 568888885 237778888999999999999999 89999999999999999999999999999865432
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhh----------------HHH
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKF----------------SLW 719 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l----------------~~~ 719 (852)
-.++....|.-|.|||++.+..+.+.+||||.||++.||++|+.-|.+....+.-.. ...
T Consensus 172 ----~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 172 ----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred ----cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 345567789999999999998899999999999999999999998875432221100 000
Q ss_pred HHH------HHhhCCccccc-ccccCCC-CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 720 AYE------EFEKGNVKGIV-DKSLAGE-DVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 720 ~~~------~~~~~~~~~~~-d~~l~~~-~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+.. +...-...+.+ |...... ..+.-....+.+++.++|-.+|++|-+.+++++
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 000 00000001111 1111100 011112234567888999999999999999986
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-24 Score=266.48 Aligned_cols=198 Identities=17% Similarity=0.232 Sum_probs=140.1
Q ss_pred hcccc-cceeeeeeee-------ccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccC
Q 003059 549 SSTHH-LNLVRLVGFS-------SEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620 (852)
Q Consensus 549 ~~l~h-~niv~l~g~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ 620 (852)
+.++| +||++++++| .+.+..++++||+ +++|.++|... ...+++.+++.++.||++||+|||+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~--- 98 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHS--- 98 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHh---
Confidence 35566 6888899987 3334678889988 66999999532 3458999999999999999999998
Q ss_pred CCcccCCCCCCceEeCC-------------------CCceEEeecccccccCCCCCc-------------ceeeeeecCC
Q 003059 621 DCIVHCDIKPENILLDE-------------------NYNAKVSDFGLAKLINPKDHR-------------HRTLTSVRGT 668 (852)
Q Consensus 621 ~~ivH~Dlkp~NILl~~-------------------~~~~kl~DFGla~~~~~~~~~-------------~~~~~~~~gt 668 (852)
++|+||||||+||||+. ++.+||+|||+++........ ........||
T Consensus 99 ~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 99 QGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred CCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 89999999999999965 445566666666532110000 0001123578
Q ss_pred CCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHH
Q 003059 669 RGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVM 748 (852)
Q Consensus 669 ~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 748 (852)
+.|||||++.+..++.++|||||||+||||++|..|+..... . ...+... .+.+. ......
T Consensus 179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~-----~~~~~~~----~~~~~------~~~~~~ 239 (793)
T PLN00181 179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----T-----MSSLRHR----VLPPQ------ILLNWP 239 (793)
T ss_pred cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----H-----HHHHHHh----hcChh------hhhcCH
Confidence 889999999999999999999999999999999888652210 0 0011100 01110 011223
Q ss_pred HHHHHHHhccccCCCCCCCHHHHHH
Q 003059 749 RAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 749 ~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
....++.+||+.+|.+||+|.||++
T Consensus 240 ~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 240 KEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHHHhCCCChhhCcChHHHhh
Confidence 4557788899999999999999975
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=220.70 Aligned_cols=196 Identities=26% Similarity=0.371 Sum_probs=161.6
Q ss_pred ccccccccccccceEEEEEEC----CCcEEEEEEecCcccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEEEee
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA----NRTVVAVKQLEGIEQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
+...++||+|.|++||++++. ..+.||+|.+.... .-..+.+|++.|..+ .+.||+++.+++..++...+|+||
T Consensus 38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~ 116 (418)
T KOG1167|consen 38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPY 116 (418)
T ss_pred hhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecc
Confidence 445689999999999999853 46789999987332 234688999999998 599999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC-CCceEEeecccccccCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE-NYNAKVSDFGLAKLINP 654 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~ 654 (852)
++.....+++. .++...+...+..+..||+++|. .|||||||||+|+|.+. .++-.|.|||+|.....
T Consensus 117 ~~H~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 117 FEHDRFRDLYR--------SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred cCccCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 99999999884 26688888999999999999999 89999999999999975 57789999999972110
Q ss_pred C-----------------------------------------CCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhh
Q 003059 655 K-----------------------------------------DHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYG 692 (852)
Q Consensus 655 ~-----------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~G 692 (852)
. +..........||++|.|||++.. ...++++||||-|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 0 001111223569999999999864 4678999999999
Q ss_pred HHHHHHHhCCcccccc
Q 003059 693 MVLLEIVSGRRNFEVS 708 (852)
Q Consensus 693 vvl~elltG~~p~~~~ 708 (852)
|+++-+++++.||-..
T Consensus 266 VI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKA 281 (418)
T ss_pred ceeehhhccccccccC
Confidence 9999999999998544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.5e-23 Score=206.18 Aligned_cols=270 Identities=20% Similarity=0.279 Sum_probs=205.2
Q ss_pred cccccccccccccceEEEEE-ECCCcEEEEEEecCcccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEEEeecC
Q 003059 500 TKGFKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
.|.+.++||+|.||.++.|+ +-++++||||.-. .+....++..|....+.| ..++|..++-|..++.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP-rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP-RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecc-ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 46778999999999999998 6678999999654 334456788888888877 5889999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC-----CCceEEeeccccccc
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE-----NYNAKVSDFGLAKLI 652 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~DFGla~~~ 652 (852)
|.||+|+..- .++.++.+++..||.|++.-++|+|+ +.+|.|||||+|+||.. ...+.|+|||+|+.+
T Consensus 107 GPSLEDLFD~----CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 107 GPSLEDLFDL----CGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred CcCHHHHHHH----hcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8899998742 35679999999999999999999999 88999999999999964 345899999999987
Q ss_pred CCCCCcce----eeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC
Q 003059 653 NPKDHRHR----TLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN 728 (852)
Q Consensus 653 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (852)
........ ......||.+||+-..+.+.+.+.+.|+-|||-|+++.|-|..||.+....... ..++++.+.+
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK----~kYeKIGe~K 255 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK----EKYEKIGETK 255 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH----HHHHHhcccc
Confidence 65332221 223456999999999999999999999999999999999999999865433221 1334444443
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCCCCCCCC
Q 003059 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPPAPK 788 (852)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~~~~~~~ 788 (852)
-.--++.+..+ -++++...++.+ -..+..+-|+.+-+...+..+.+....-...
T Consensus 256 r~T~i~~Lc~g---~P~efa~Yl~yv---R~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg 309 (449)
T KOG1165|consen 256 RSTPIEVLCEG---FPEEFATYLRYV---RRLDFFETPDYDYLRKLFDDVLDRLGETDDG 309 (449)
T ss_pred ccCCHHHHHhc---CHHHHHHHHHHH---HhcCcccCCCHHHHHHHHHHHHHhcCCcccc
Confidence 33334444433 233444444443 3457888899988887776665544333333
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.5e-23 Score=186.11 Aligned_cols=109 Identities=34% Similarity=0.530 Sum_probs=95.9
Q ss_pred CccccCCCCCccccCCCceEEEEEecCCCCeeEEEEEeC--CeeEEeeCC-CCCCCCceEEEeeCccEEEEcCCCceEee
Q 003059 37 SSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSG--GVPIWTAGS-TPVDSSAFFQLHSSGTLRLISGSGAIIWD 113 (852)
Q Consensus 37 ~~l~~~~~~~~l~S~~g~f~lgf~~~~~~~~~~~i~~~~--~~~vW~an~-~p~~~~~~l~~~~~g~l~l~~~~~~~vWs 113 (852)
+.|..++ .|+|++|.|++|||......++.+|||.. .++||+||+ .|+..++.|.|..||||+|+|.+|.+||+
T Consensus 2 ~~l~~~~---~l~s~~~~f~~G~~~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~ 78 (114)
T smart00108 2 NTLSSGQ---TLVSGNSLFELGFFTLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWS 78 (114)
T ss_pred cccCCCC---EEecCCCcEeeeccccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEE
Confidence 3466666 89999999999999998778999999954 489999998 57666689999999999999999999999
Q ss_pred ccCC-CCceeEEEEcCCccEEEecCCCccccccCCC
Q 003059 114 SNTQ-RLNVTSASLDDSGNLVLLKNGGVSAWSSFDN 148 (852)
Q Consensus 114 t~~~-~~~~~~~~l~d~GNlvl~~~~~~~lWQSFD~ 148 (852)
|++. +....+++|+|+|||||++..+.++||||||
T Consensus 79 S~t~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~ 114 (114)
T smart00108 79 SNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114 (114)
T ss_pred ecccCCCCceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence 9987 4455689999999999999999999999997
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.2e-22 Score=214.79 Aligned_cols=263 Identities=22% Similarity=0.311 Sum_probs=194.9
Q ss_pred cccccccccccccceEEEEEECCC--cEEEEEEecCcc-cchHHHHHHHHHhhcccc----cceeeeeeee-ccCceeeE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLANR--TVVAVKQLEGIE-QGEKQFRMEVATISSTHH----LNLVRLVGFS-SEGKHRLL 571 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~~--~~vavK~l~~~~-~~~~~f~~E~~~l~~l~h----~niv~l~g~~-~~~~~~~l 571 (852)
.|.+.++||+|+||.||++..... ..+|+|...... .....+..|+.++..+.+ +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 677889999999999999996553 478888776432 222378889999988873 5899999988 57889999
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCC-----CceEEeec
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDEN-----YNAKVSDF 646 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-----~~~kl~DF 646 (852)
||+.+ |.+|.++..... ...++..+.++|+.|++.+|++||+ .+++||||||.|+++... ..+.|.||
T Consensus 99 VM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 99998 889999775443 4568999999999999999999999 899999999999999865 46999999
Q ss_pred cccc--ccCCCCCc----cee-eeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHH
Q 003059 647 GLAK--LINPKDHR----HRT-LTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLW 719 (852)
Q Consensus 647 Gla~--~~~~~~~~----~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 719 (852)
|+++ .+...... .+. ....+||.+|++++.+.+.+.+++.|+||++.++.|++.|..||.........
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~----- 246 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK----- 246 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH-----
Confidence 9998 33221111 111 23466999999999999999999999999999999999999999655432211
Q ss_pred HHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCC
Q 003059 720 AYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIE 782 (852)
Q Consensus 720 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~ 782 (852)
..+........... .....+.+...+... +-..+..++|....+...|+......
T Consensus 247 --~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~---~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 247 --SKFEKDPRKLLTDR---FGDLKPEEFAKILEY---IDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred --HHHHHHhhhhcccc---ccCCChHHHHHHHHH---hhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11111111111111 112233344333333 44579999999999999987765544
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-22 Score=202.31 Aligned_cols=166 Identities=22% Similarity=0.310 Sum_probs=124.2
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
|+|.+++... +..+++..++.|+.||++||+|||+ .+ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--- 62 (176)
T smart00750 1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPE--- 62 (176)
T ss_pred CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeeccc---
Confidence 6899999643 3459999999999999999999998 33 999999999999999 9999865432
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccC
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (852)
...|++.|+|||++.+..++.++|||||||++|||++|+.||....... ..+... ... .. +...
T Consensus 63 -----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~-----~~~----~~-~~~~ 126 (176)
T smart00750 63 -----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEIL-----LNG----MP-ADDP 126 (176)
T ss_pred -----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHH-----HHH----hc-cCCc
Confidence 1258899999999999999999999999999999999999996432211 111110 000 00 0000
Q ss_pred CCCCCHHHH---HHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 739 GEDVDIEQV---MRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 739 ~~~~~~~~~---~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
......... ..+.+++.+|++.+|.+||++.++++.+..+
T Consensus 127 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 127 RDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred cccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 001112222 2588999999999999999999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.9e-23 Score=198.07 Aligned_cols=265 Identities=20% Similarity=0.283 Sum_probs=205.5
Q ss_pred HHHHhcccccccccccccceEEEEE-ECCCcEEEEEEecCcccchHHHHHHHHHhhcccc-cceeeeeeeeccCceeeEE
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATISSTHH-LNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV 572 (852)
.|....|.+.++||.|.||.+|.|. +.+|.+||||.-. ......++..|..+...|+| ..|..+.-|..++.+-.||
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es-~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLES-SKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeec-ccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 3455678899999999999999998 6789999999765 33445678889999999975 4677788888899999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC---CCceEEeecccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE---NYNAKVSDFGLA 649 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFGla 649 (852)
||.+ |.||++++.-. .+.++..+++-++.|++.-++|+|. +++|||||||+|+|..- ...+.|+|||++
T Consensus 90 MdLL-GPsLEdLfnfC----~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFC----SRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred eecc-CccHHHHHHHH----hhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccch
Confidence 9999 88999988533 3458889999999999999999998 89999999999999964 356899999999
Q ss_pred cccCCCCCcc----eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHh
Q 003059 650 KLINPKDHRH----RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFE 725 (852)
Q Consensus 650 ~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 725 (852)
+.+....... +...+..||.+|.+-..+.+.+.+.+.|+-|+|.+|....-|..||++....... -.++.+.
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~----QKyEkI~ 237 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK----QKYEKIS 237 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH----HHHHHHH
Confidence 8765422211 1223466999999999999999999999999999999999999999876433222 2344555
Q ss_pred hCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 726 KGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
+.++.-.+.....+. +. ++...+.-|-..-.++-|+..-+.+.+.-+
T Consensus 238 EkK~s~~ie~LC~G~--P~----EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 238 EKKMSTPIEVLCKGF--PA----EFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred HhhcCCCHHHHhCCC--cH----HHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 555555555555542 22 223334458888889999988877776544
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-23 Score=189.68 Aligned_cols=89 Identities=36% Similarity=0.645 Sum_probs=66.4
Q ss_pred CCeeEEeeCC-CCC-C--CCceEEEeeCccEEEEcCCCceEeec-cCCCCc--eeEEEEcCCccEEEecCCCccccccCC
Q 003059 75 GGVPIWTAGS-TPV-D--SSAFFQLHSSGTLRLISGSGAIIWDS-NTQRLN--VTSASLDDSGNLVLLKNGGVSAWSSFD 147 (852)
Q Consensus 75 ~~~~vW~an~-~p~-~--~~~~l~~~~~g~l~l~~~~~~~vWst-~~~~~~--~~~~~l~d~GNlvl~~~~~~~lWQSFD 147 (852)
++|+||+||| .|+ + ....|.|+.||||+|+|.++..||++ ++.+.+ ...|+|+|+|||||+|..+.++|||||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~ 80 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFD 80 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTT
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecC
Confidence 3689999998 577 3 35899999999999999999999999 555443 678999999999999999999999999
Q ss_pred CCCCcccCCCccccCc
Q 003059 148 NPTDTIVPSQNFTSDK 163 (852)
Q Consensus 148 ~PTDtlLpg~kl~~~~ 163 (852)
|||||+||+|+|+.+.
T Consensus 81 ~ptdt~L~~q~l~~~~ 96 (114)
T PF01453_consen 81 YPTDTLLPGQKLGDGN 96 (114)
T ss_dssp SSS-EEEEEET--TSE
T ss_pred CCccEEEeccCcccCC
Confidence 9999999999998653
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.8e-22 Score=216.99 Aligned_cols=174 Identities=21% Similarity=0.199 Sum_probs=132.9
Q ss_pred HHhcccccccccccccceEEEEEEC--CCcEEEEEEecCc------ccchHHHHHHHHHhhcccccceee-eeeeeccCc
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLA--NRTVVAVKQLEGI------EQGEKQFRMEVATISSTHHLNLVR-LVGFSSEGK 567 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~------~~~~~~f~~E~~~l~~l~h~niv~-l~g~~~~~~ 567 (852)
....|.+.+.||+|+||.||+|... +++.||||++... ......|.+|+++|.+++|+|+++ ++++ +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 3456788899999999999999864 5777899987522 123456899999999999999985 4432 4
Q ss_pred eeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCC-CCCceEeCCCCceEEeec
Q 003059 568 HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDI-KPENILLDENYNAKVSDF 646 (852)
Q Consensus 568 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl-kp~NILl~~~~~~kl~DF 646 (852)
..+|||||+++++|.. +. . .. ...++.+++++|.|||+ ++|+|||| ||+|||++.++++||+||
T Consensus 92 ~~~LVmE~~~G~~L~~-~~--~---~~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-AR--P---HG------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred CcEEEEEccCCCCHHH-hC--c---cc------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 5799999999999963 21 0 00 14678899999999999 89999999 999999999999999999
Q ss_pred ccccccCCCCCcce-----eeeeecCCCCCCChhhhhcCC------CCCCccch
Q 003059 647 GLAKLINPKDHRHR-----TLTSVRGTRGYLAPEWLANLP------ITSKSDVY 689 (852)
Q Consensus 647 Gla~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~------~s~ksDv~ 689 (852)
|+++.+........ ......+++.|+|||.+...+ .+...|-|
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 99997765432222 113566888999999885332 33446766
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.5e-23 Score=201.47 Aligned_cols=250 Identities=20% Similarity=0.343 Sum_probs=187.2
Q ss_pred hcccccccccccccceEEEEEECCCcEEEEEEec---CcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLE---GIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~---~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
...++.-+|.+...|..|+|++.++. +++|++. ......++|..|.-.|+.+.||||+.++|.|....+..+|..|
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 34456678999999999999997765 5567765 2334457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEe--ecccccccC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVS--DFGLAKLIN 653 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~--DFGla~~~~ 653 (852)
|+.|||...|+... +-..+..+..+++.+||+|++|||+-. +-|.---|.+..|+||++.+++|+ |--++.
T Consensus 269 mp~gslynvlhe~t---~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf--- 341 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF--- 341 (448)
T ss_pred ccchHHHHHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee---
Confidence 99999999997543 456788899999999999999999854 335555799999999999998885 221111
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcCCCC---CCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPIT---SKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s---~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (852)
......-.+.||+||.++..+-+ ..+|+|||.+++|||.|...||......+-... + .++
T Consensus 342 -------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk-------i---ale 404 (448)
T KOG0195|consen 342 -------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK-------I---ALE 404 (448)
T ss_pred -------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh-------h---hhc
Confidence 11122346789999999877544 478999999999999999999975543221110 0 011
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 731 GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
. +.. ..++-....+.+++.-|+..||.+||.+..|+-.||++.
T Consensus 405 g-lrv-----~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 405 G-LRV-----HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred c-ccc-----cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1 111 112222234455555699999999999999999998764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.3e-19 Score=193.39 Aligned_cols=262 Identities=28% Similarity=0.364 Sum_probs=194.6
Q ss_pred ccccccccccccceEEEEEECCCcEEEEEEecCccc----chHHHHHHHHHhhccccc-ceeeeeeeeccCceeeEEEee
Q 003059 501 KGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQ----GEKQFRMEVATISSTHHL-NLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~----~~~~f~~E~~~l~~l~h~-niv~l~g~~~~~~~~~lV~e~ 575 (852)
+.+.+.||.|+|+.||++... ..+++|.+..... ....|.+|+.++..+.|+ +++++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 456678999999999999987 7789999873322 367899999999999988 799999999777778999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC-ceEEeecccccccCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY-NAKVSDFGLAKLINP 654 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~ 654 (852)
+.+++|.+++...... ..+.......+..|++.++.|+|+ .+++|||+||+||+++..+ .+++.|||+++.+..
T Consensus 80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 9999999777533211 358888999999999999999998 7899999999999999998 799999999986554
Q ss_pred CCCcce---eeeeecCCCCCCChhhhhc---CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC
Q 003059 655 KDHRHR---TLTSVRGTRGYLAPEWLAN---LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN 728 (852)
Q Consensus 655 ~~~~~~---~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (852)
...... ......|+..|+|||.+.+ .......|+|++|++++++++|..||...... ..............
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~ 231 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELP 231 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcC
Confidence 322221 3456779999999999987 57889999999999999999999997654321 00001111111111
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.. ........ .........+.+++..|+..+|..|.++.+....
T Consensus 232 ~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TP-SLASPLSP-SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred Cc-ccccccCc-cccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 00000000 0001122456677778899999999999887653
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.5e-20 Score=167.66 Aligned_cols=110 Identities=30% Similarity=0.530 Sum_probs=83.1
Q ss_pred eccCcccccccccccccccceeeeccCcceeeeeccCCcceEEEeecccCCCcceEEEEEEccCCcEEEEEccCCCCcce
Q 003059 191 FNQGLNSAINSTVNSNLTSPILRLQPVGILSISDVSLNSAAIIAYSSDYAEGSDILRFLSLGSDGNLRIFSSARGSGTKT 270 (852)
Q Consensus 191 w~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~dG~l~~~~w~~~~~~w~ 270 (852)
||+|+|+|.. +++.+++.....+.+.+..++... ++++. ..+.+.++|++||++|++++|.|.+..+.|.
T Consensus 1 wrsG~WnG~~-------f~g~p~~~~~~~~~~~fv~~~~e~--~~t~~-~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~ 70 (110)
T PF00954_consen 1 WRSGPWNGQR-------FSGIPEMSSNSLYNYSFVSNNEEV--YYTYS-LSNSSVLSRLVLDSDGQLQRYIWNESTQSWS 70 (110)
T ss_pred CCccccCCeE-------ECCcccccccceeEEEEEECCCeE--EEEEe-cCCCceEEEEEEeeeeEEEEEEEecCCCcEE
Confidence 8999998873 344455554433333333333322 23222 2245689999999999999999999999999
Q ss_pred eeehhhhccccCCcCcCCCccccCCCCCCCCCCCCccCCCCCceeec
Q 003059 271 RRWAAVADQCEVFGYCGNMGICGYNGYNDSSSDPLCECPSQNFEFID 317 (852)
Q Consensus 271 ~~~~~p~~~C~~~~~CG~~g~C~~~~~~~~~~~~~C~C~~~gf~~~~ 317 (852)
..|.+|.|+||+|+.||+||+|+. +..|.|+|++ ||+|++
T Consensus 71 ~~~~~p~d~Cd~y~~CG~~g~C~~------~~~~~C~Cl~-GF~P~n 110 (110)
T PF00954_consen 71 VFWSAPKDQCDVYGFCGPNGICNS------NNSPKCSCLP-GFEPKN 110 (110)
T ss_pred EEEEecccCCCCccccCCccEeCC------CCCCceECCC-CcCCCc
Confidence 999999999999999999999965 3678999999 999864
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.5e-20 Score=184.98 Aligned_cols=174 Identities=11% Similarity=0.086 Sum_probs=135.4
Q ss_pred HHHHHHhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHH----------HHHHHHHhhcccccceeeeeee
Q 003059 493 YKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQ----------FRMEVATISSTHHLNLVRLVGF 562 (852)
Q Consensus 493 ~~el~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~----------f~~E~~~l~~l~h~niv~l~g~ 562 (852)
.+++...+|+..+.||.|+||.||.... ++..+|+|.+.......+. +++|+..+.+++|++|..+.++
T Consensus 25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 3567788899999999999999999765 5667999999733222222 6899999999999999999888
Q ss_pred eccC--------ceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceE
Q 003059 563 SSEG--------KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENIL 634 (852)
Q Consensus 563 ~~~~--------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIL 634 (852)
+... +..+|||||++|.+|.++.. ++. ....+++.+|..+|+ .+++|||+||+||+
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nil 167 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFI 167 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEE
Confidence 5532 35799999999999988741 221 245699999999998 89999999999999
Q ss_pred eCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHH
Q 003059 635 LDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIV 699 (852)
Q Consensus 635 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ell 699 (852)
+++++ ++|+|||..+....... ...+.....+..++|+|+||+++.-+.
T Consensus 168 i~~~g-i~liDfg~~~~~~e~~a---------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 168 VSKNG-LRIIDLSGKRCTAQRKA---------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EeCCC-EEEEECCCcccccchhh---------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 99988 99999998875532111 011344455678999999999988665
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.5e-20 Score=215.99 Aligned_cols=252 Identities=21% Similarity=0.265 Sum_probs=183.0
Q ss_pred cccccccccceEEEEEEC-CCcEEEEEEecC---cccch----HHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 504 KDKLGAGGFGAVYRGVLA-NRTVVAVKQLEG---IEQGE----KQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~---~~~~~----~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
.+.+|.|++|.|+..... .....+.|.... ....+ ..+..|+.+-..++|+|++..+..+.+....+-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 467999999988877632 222233332210 11111 2255677778889999999999988888777777999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+++ +|..++... ..+....+..++.|+..|++|+|+ .+|.|||||++|+++..++.+||+|||.+..+.-.
T Consensus 403 ~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 403 CPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred ccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 999 999999643 247778888999999999999999 89999999999999999999999999999876543
Q ss_pred CC-cceeeeeecCCCCCCChhhhhcCCCCCC-ccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 656 DH-RHRTLTSVRGTRGYLAPEWLANLPITSK-SDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 656 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~k-sDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
.. .........|...|+|||.+.+.+|.++ .||||.|+++..|++|+.||......+.... . . ....-.
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-~------~--~~~~~~ 544 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-T------N--NYSDQR 544 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-h------h--cccccc
Confidence 22 1234456789999999999999999875 7999999999999999999976654433210 0 0 000000
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
...............+...++.++++.+|.+|-++++|++
T Consensus 545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000000111122234567888999999999999999985
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-19 Score=180.17 Aligned_cols=138 Identities=17% Similarity=0.151 Sum_probs=107.3
Q ss_pred cccccccccceEEEEEECCCcEEEEEEecCccc---c-------hHHH-----------------HHHHHHhhcccccce
Q 003059 504 KDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQ---G-------EKQF-----------------RMEVATISSTHHLNL 556 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---~-------~~~f-----------------~~E~~~l~~l~h~ni 556 (852)
.+.||+|+||.||+|...+|+.||||+++.... . ...| ..|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 367999999999999988899999999973311 1 1122 349999999988776
Q ss_pred eeeeeeeccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhh-ccccCCCcccCCCCCCceEe
Q 003059 557 VRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYL-HEECRDCIVHCDIKPENILL 635 (852)
Q Consensus 557 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~Dlkp~NILl 635 (852)
.....+.. ...+|||||++++++...+.. ...++.....+++.|++.+|.|| |+ .+|+||||||+|||+
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEE
Confidence 44333222 223899999998877654322 23578889999999999999999 56 789999999999999
Q ss_pred CCCCceEEeeccccccc
Q 003059 636 DENYNAKVSDFGLAKLI 652 (852)
Q Consensus 636 ~~~~~~kl~DFGla~~~ 652 (852)
+ ++.++|+|||++...
T Consensus 152 ~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 152 H-DGKLYIIDVSQSVEH 167 (190)
T ss_pred E-CCcEEEEEccccccC
Confidence 8 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7e-20 Score=210.45 Aligned_cols=252 Identities=23% Similarity=0.289 Sum_probs=183.3
Q ss_pred cccccccccccccceEEEEEECCCcEEEEEEecCc--ccchHHHHHHHHH--hhcccccceeeeeeeeccCceeeEEEee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGI--EQGEKQFRMEVAT--ISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~f~~E~~~--l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
.+.+.+.||.+.|=.|.+++.+.|. |+||++-+. ....+.|+++++- ...++|||++++.-.-...+.-|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4556789999999999999998887 889988632 2334445444333 4566999999998887778888999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
..+ +|.|.|. .++.|..-+..-|+-|++.||..+|. .+|+|||||.+||||..-+-+.|+||...+...-.
T Consensus 103 vkh-nLyDRlS-----TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 103 VKH-NLYDRLS-----TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred Hhh-hhhhhhc-----cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCC
Confidence 855 8888873 34567777888899999999999998 89999999999999999999999999988754433
Q ss_pred CCcceeeeee----cCCCCCCChhhhhc----------CC-CCCCccchhhhHHHHHHHh-CCccccccccccchhhHHH
Q 003059 656 DHRHRTLTSV----RGTRGYLAPEWLAN----------LP-ITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLW 719 (852)
Q Consensus 656 ~~~~~~~~~~----~gt~~y~aPE~~~~----------~~-~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 719 (852)
++......-. +.-..|+|||.+-. .. .+++-||||+||++.||++ |++||+.++--
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~-------- 245 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLL-------- 245 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHH--------
Confidence 3333333332 23346999998743 12 6788999999999999987 79999755311
Q ss_pred HHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 720 AYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 720 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
+++..........+. .+.. ..+..+++.|++.||.+|-++++.++.-.++
T Consensus 246 aYr~~~~~~~e~~Le-~Ied--------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 246 AYRSGNADDPEQLLE-KIED--------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred hHhccCccCHHHHHH-hCcC--------ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 111110000111111 1110 1355678889999999999999999875554
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.4e-19 Score=194.27 Aligned_cols=218 Identities=24% Similarity=0.417 Sum_probs=163.3
Q ss_pred hhcccccceeeeeeeeccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCc-ccC
Q 003059 548 ISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCI-VHC 626 (852)
Q Consensus 548 l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i-vH~ 626 (852)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+... ...++|.-...++++|+.||+|||. ..| .|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAYLHN---SPIGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHHHhc---Ccceeee
Confidence 45789999999999999999999999999999999999753 3458899999999999999999998 333 999
Q ss_pred CCCCCceEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcC-------CCCCCccchhhhHHHHHHH
Q 003059 627 DIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL-------PITSKSDVYSYGMVLLEIV 699 (852)
Q Consensus 627 Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~ksDv~s~Gvvl~ell 699 (852)
.++++|+++|....+||+|||+....... ..........-..-|.|||.++.. ..+.+.||||||++++|++
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~-~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEET-AEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred eeccccceeeeeEEEEechhhhccccccc-ccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 99999999999999999999998876431 011111122234569999999764 1467899999999999999
Q ss_pred hCCccccccccccch-hhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 700 SGRRNFEVSQETNRK-KFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 700 tG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
+.+.||+........ .+... +.+ .....+.+.+.. .. +....++.++..||..+|.+||++++|...++.+
T Consensus 153 ~r~~~~~~~~~~~~~~eii~~----~~~-~~~~~~rP~i~~--~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDPDEIILR----VKK-GGSNPFRPSIEL--LN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred hccCccccccccCChHHHHHH----HHh-cCCCCcCcchhh--hh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 999999865332221 11111 111 111122222211 01 2233688899999999999999999999998877
Q ss_pred ccC
Q 003059 779 TEI 781 (852)
Q Consensus 779 ~~~ 781 (852)
...
T Consensus 225 ~~~ 227 (484)
T KOG1023|consen 225 NKG 227 (484)
T ss_pred ccc
Confidence 553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=172.24 Aligned_cols=183 Identities=18% Similarity=0.133 Sum_probs=139.4
Q ss_pred cccccccccceEEEEEECCCcEEEEEEecCcccch-----HHHHHHHHHhhccc-ccceeeeeeeeccCceeeEEEeecC
Q 003059 504 KDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGE-----KQFRMEVATISSTH-HLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-----~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
...|++|+||+||.+.. ++.+++.+.+.....-. ..|.+|+++|.+++ |+++++++++ ...+++|||++
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 46799999999997655 66778888887444322 25889999999995 5889999886 34699999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCC-CCCceEeCCCCceEEeecccccccCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDI-KPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl-kp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
|.+|...+.. ....++.|++++|+++|+ .+|+|||| ||+|||++.++.++|+|||++....+..
T Consensus 82 G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 82 GAAMYQRPPR------------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred CccHHhhhhh------------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 9998654310 113477899999999998 89999999 7999999999999999999998655432
Q ss_pred Cc-----ceee-----eeecCCCCCCChhhhhcC-CCC-CCccchhhhHHHHHHHhCCcccc
Q 003059 657 HR-----HRTL-----TSVRGTRGYLAPEWLANL-PIT-SKSDVYSYGMVLLEIVSGRRNFE 706 (852)
Q Consensus 657 ~~-----~~~~-----~~~~gt~~y~aPE~~~~~-~~s-~ksDv~s~Gvvl~elltG~~p~~ 706 (852)
.. .... -....++.|++|+..... ..+ .+.+.++.|.-+|.++|++.+.-
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 10 0000 012368889999876533 333 56688899999999999998764
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=173.10 Aligned_cols=140 Identities=16% Similarity=0.112 Sum_probs=109.5
Q ss_pred cccccccccceEEEEEECCCcEEEEEEecCcccc---------------------------hHHHHHHHHHhhcccccce
Q 003059 504 KDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQG---------------------------EKQFRMEVATISSTHHLNL 556 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---------------------------~~~f~~E~~~l~~l~h~ni 556 (852)
...||+|+||.||+|...+|+.||||++...... ...++.|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3579999999999999878999999998743210 1123578999999999987
Q ss_pred eeeeeeeccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeC
Q 003059 557 VRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD 636 (852)
Q Consensus 557 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~ 636 (852)
.....+... ..+|||||++++++...... ...++......++.|++.+|.++|+. .+|+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE
Confidence 544433332 24899999998865443221 12467788899999999999999973 5899999999999999
Q ss_pred CCCceEEeecccccccC
Q 003059 637 ENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 637 ~~~~~kl~DFGla~~~~ 653 (852)
++.++|+|||++..+.
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 8999999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.6e-18 Score=175.51 Aligned_cols=232 Identities=22% Similarity=0.292 Sum_probs=148.8
Q ss_pred ccccccccccccceEEEEEECC-CcEEEEEEecC----cccchHHHHHHHHHhhccc----------ccceeeeeeeec-
Q 003059 501 KGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEG----IEQGEKQFRMEVATISSTH----------HLNLVRLVGFSS- 564 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~----~~~~~~~f~~E~~~l~~l~----------h~niv~l~g~~~- 564 (852)
....+.||.|+++.||.+++.. ++.+|||.+.. .....+++++|...+..+. |-.++.-++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 3345689999999999999755 88999998862 2234466777776665533 223333222211
Q ss_pred --------cC---c-----eeeEEEeecCCCCHHHHhh---hcccCCccccchhHHHHHHHhhHhhhhhhccccCCCccc
Q 003059 565 --------EG---K-----HRLLVYEFMKNGSLDNFLF---ANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVH 625 (852)
Q Consensus 565 --------~~---~-----~~~lV~e~~~~gsL~~~l~---~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH 625 (852)
.. . ..+++|+-+ .++|.+++. ..... ...+....++.+..|+++.+++||. .+++|
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVH 168 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLHS---YGLVH 168 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHhh---cceEe
Confidence 11 1 336788877 668888764 22221 3456667778888999999999999 89999
Q ss_pred CCCCCCceEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhc--------CCCCCCccchhhhHHHHH
Q 003059 626 CDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN--------LPITSKSDVYSYGMVLLE 697 (852)
Q Consensus 626 ~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDv~s~Gvvl~e 697 (852)
+||||+|++++.+|.++|+||+....... .......+..|.+||.... ..++.+.|.|+||+++|.
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~------~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT------RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTE------EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCc------eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 99999999999999999999988765421 1111345678999997744 257889999999999999
Q ss_pred HHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCC
Q 003059 698 IVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQR 765 (852)
Q Consensus 698 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~R 765 (852)
|.+|+.||+....+..... .+..+. +-.+.+..++...++.+|++|
T Consensus 243 lWC~~lPf~~~~~~~~~~~-------------------~f~~C~---~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW-------------------DFSRCR---DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG-------------------GGTTSS------HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc-------------------cchhcC---CcCHHHHHHHHHHccCCcccC
Confidence 9999999986643322110 222333 333344556777899999887
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.3e-17 Score=163.01 Aligned_cols=133 Identities=19% Similarity=0.208 Sum_probs=102.3
Q ss_pred cccccccccceEEEEEECCCcEEEEEEecC-cccchHHHHHHHHHhhcc-----cccceeeeeeeeccCc---eee-EEE
Q 003059 504 KDKLGAGGFGAVYRGVLANRTVVAVKQLEG-IEQGEKQFRMEVATISST-----HHLNLVRLVGFSSEGK---HRL-LVY 573 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~-~~~~~~~f~~E~~~l~~l-----~h~niv~l~g~~~~~~---~~~-lV~ 573 (852)
.+.||+|+||.||. .-.+.. .+||++.. .....+++.+|+.++..+ .||||++++|++.++. ..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 35799999999996 323333 46888763 233557799999999999 5799999999998763 433 789
Q ss_pred ee--cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhh-hhhccccCCCcccCCCCCCceEeCC----CCceEEeec
Q 003059 574 EF--MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGI-TYLHEECRDCIVHCDIKPENILLDE----NYNAKVSDF 646 (852)
Q Consensus 574 e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~ivH~Dlkp~NILl~~----~~~~kl~DF 646 (852)
|| +++++|.+++... .+++. ..++.+++.++ +|||+ .+|+||||||+|||++. +.+++|+||
T Consensus 85 e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred cCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 99 6689999999432 24444 35677888777 99999 89999999999999974 347999995
Q ss_pred ccc
Q 003059 647 GLA 649 (852)
Q Consensus 647 Gla 649 (852)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.4e-17 Score=181.83 Aligned_cols=185 Identities=25% Similarity=0.289 Sum_probs=151.3
Q ss_pred cccccccceEEEEE----ECCCcEEEEEEecCcccc---hHHHHHHHHHhhccc-ccceeeeeeeeccCceeeEEEeecC
Q 003059 506 KLGAGGFGAVYRGV----LANRTVVAVKQLEGIEQG---EKQFRMEVATISSTH-HLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 506 ~lG~G~fg~Vy~~~----~~~~~~vavK~l~~~~~~---~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
.+|+|.||.|++.. .+.+..+|+|.+.+.... ......|..++...+ ||.+|++.-.+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999998765 334677888877632211 114556788888887 9999999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
+|.|...+... ..............++-+++++|+ .+|+|||+|++||+++.+|.+|+.|||+.+..-...
T Consensus 81 gg~lft~l~~~-----~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~- 151 (612)
T KOG0603|consen 81 GGDLFTRLSKE-----VMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK- 151 (612)
T ss_pred cchhhhccccC-----CchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhh-
Confidence 99998877433 235555666677888999999999 899999999999999999999999999998754321
Q ss_pred cceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccc
Q 003059 658 RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEV 707 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~ 707 (852)
...||..|||||++. ......|-||||++++||+||..||..
T Consensus 152 ------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 152 ------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 117899999999998 567889999999999999999999974
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.6e-17 Score=190.71 Aligned_cols=198 Identities=20% Similarity=0.256 Sum_probs=159.2
Q ss_pred HHHHhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhccc---ccceeeeeeeeccCceeeE
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTH---HLNLVRLVGFSSEGKHRLL 571 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~~~~~l 571 (852)
++....+.+.+.||+|+||.||+|...+++.||+|.-+... ..+|---.+++.||+ -+-|..+...+.-.+.-+|
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~--~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPN--PWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCC--ceeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 45555667778999999999999998889999999876322 123333334455555 2334445555556778899
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeC-------CCCceEEe
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD-------ENYNAKVS 644 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~-------~~~~~kl~ 644 (852)
|+||.+.|+|.+++. ..+..+|.....++.|+++.+++||. .+|||+||||+|+||. +..-++|+
T Consensus 772 v~ey~~~Gtlld~~N-----~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN-----TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeccccccHHHhhc-----cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEE
Confidence 999999999999996 34568999999999999999999999 8999999999999994 34458999
Q ss_pred ecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCc
Q 003059 645 DFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRR 703 (852)
Q Consensus 645 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~ 703 (852)
|||-+..+....+. ......++|-.+-.+|...+.+++...|.|.|+.+++-||.|+.
T Consensus 844 DfG~siDm~lfp~~-~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEcCCC-cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999776543232 45667889999999999999999999999999999999999975
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.5e-16 Score=163.10 Aligned_cols=133 Identities=18% Similarity=0.280 Sum_probs=111.9
Q ss_pred ccccccccceEEEEEECCCcEEEEEEecCccc---------chHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 505 DKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQ---------GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
+.||+|++|.||+|.. .+..+++|+...... ....+.+|++++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 556688897652211 124578899999999999988877777777888999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
+++++|.+++... .+ .+..++.+++.+|.++|+ .+++|||++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988432 11 778899999999999998 8999999999999999 78999999998875
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.8e-16 Score=164.26 Aligned_cols=140 Identities=15% Similarity=0.158 Sum_probs=109.3
Q ss_pred ccccccccccccceEEEEE--ECCCcEEEEEEecCccc-------------------------chHHHHHHHHHhhcccc
Q 003059 501 KGFKDKLGAGGFGAVYRGV--LANRTVVAVKQLEGIEQ-------------------------GEKQFRMEVATISSTHH 553 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~--~~~~~~vavK~l~~~~~-------------------------~~~~f~~E~~~l~~l~h 553 (852)
+.+.+.||+|+||.||+|. ..+++.||+|.+..... ....++.|+.++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 5567899999999999998 56789999999873211 01235689999999976
Q ss_pred c--ceeeeeeeeccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCC-cccCCCCC
Q 003059 554 L--NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC-IVHCDIKP 630 (852)
Q Consensus 554 ~--niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivH~Dlkp 630 (852)
. .+.+++++ ...++||||+++.+|..++... ..+.......++.||+.+|.+||+ .+ |+||||||
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp 177 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSE 177 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCCh
Confidence 3 34445543 2358999999998887654221 234555678899999999999999 78 99999999
Q ss_pred CceEeCCCCceEEeecccccccC
Q 003059 631 ENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 631 ~NILl~~~~~~kl~DFGla~~~~ 653 (852)
+||+++ +++++|+|||.+....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccC
Confidence 999999 8899999999988553
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.6e-16 Score=157.65 Aligned_cols=135 Identities=16% Similarity=0.178 Sum_probs=108.0
Q ss_pred ccccccccccccceEEEEEECCCcEEEEEEecCccc-----------------------chHHHHHHHHHhhccccc--c
Q 003059 501 KGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQ-----------------------GEKQFRMEVATISSTHHL--N 555 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-----------------------~~~~f~~E~~~l~~l~h~--n 555 (852)
+.+.+.||+|+||.||++...+++.||||++..... ....+..|+.++..+.|+ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 666789999999999999988899999998753211 112356788899999887 4
Q ss_pred eeeeeeeeccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEe
Q 003059 556 LVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL 635 (852)
Q Consensus 556 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl 635 (852)
+...++. ...++||||+++++|...... .....++.+++.++.++|+ .+|+||||||+||++
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill 158 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILV 158 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEE
Confidence 4555543 345899999999998765420 2345788999999999999 899999999999999
Q ss_pred CCCCceEEeecccccccC
Q 003059 636 DENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 636 ~~~~~~kl~DFGla~~~~ 653 (852)
++++.++|+|||++....
T Consensus 159 ~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 159 DDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cCCCcEEEEECCccccCC
Confidence 999999999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=7.5e-16 Score=179.78 Aligned_cols=134 Identities=19% Similarity=0.267 Sum_probs=110.1
Q ss_pred cccccccccccceEEEEEECCCcEEEEEEecCc-c-------cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 502 GFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGI-E-------QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 502 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~-~-------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
...+.||+|+||.||+|.+.+...++.+++... . ...+.+.+|++++.+++|++++....++......++||
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred CccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 346789999999999998766554333333211 1 12356889999999999999998888887777889999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
||+++++|.+++. ....++.+++++|.|||+ .+++||||||+|||+ +++.++|+|||+++..
T Consensus 416 E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 416 EYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999999883 346789999999999999 899999999999999 6789999999999854
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.63 E-value=8.8e-16 Score=155.78 Aligned_cols=129 Identities=19% Similarity=0.293 Sum_probs=105.3
Q ss_pred cccccccceEEEEEECCCcEEEEEEecCcc--c-------chHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 506 KLGAGGFGAVYRGVLANRTVVAVKQLEGIE--Q-------GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 506 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~-------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
.||+|+||.||+|.+ ++..|++|...... . ...++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999986 45678999865211 1 1255778999999999887665555556666789999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
++++|.+++.... . .++.+++.+|.+||+ .+++|||++|.||+++ ++.+++.|||++..
T Consensus 80 ~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN------D------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH------H------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999874321 0 789999999999998 8999999999999999 89999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.3e-15 Score=158.03 Aligned_cols=200 Identities=23% Similarity=0.308 Sum_probs=134.4
Q ss_pred ccccceeeeeeeecc---------------------------CceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHH
Q 003059 551 THHLNLVRLVGFSSE---------------------------GKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFN 603 (852)
Q Consensus 551 l~h~niv~l~g~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~ 603 (852)
-+|||||++.++|.+ ....|+||...+ .+|.+|+..+. .+.....-
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~------~s~r~~~~ 345 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH------RSYRTGRV 345 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC------CchHHHHH
Confidence 478999888876532 346789999884 59999997443 55666777
Q ss_pred HHHhhHhhhhhhccccCCCcccCCCCCCceEe--CCCC--ceEEeecccccccCCCC---CcceeeeeecCCCCCCChhh
Q 003059 604 IALGTARGITYLHEECRDCIVHCDIKPENILL--DENY--NAKVSDFGLAKLINPKD---HRHRTLTSVRGTRGYLAPEW 676 (852)
Q Consensus 604 i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl--~~~~--~~kl~DFGla~~~~~~~---~~~~~~~~~~gt~~y~aPE~ 676 (852)
|+.|+++|+.|||. ++|.|||+|++|||| |+|+ ...|+|||.+-.-.... ......-..-|...-||||+
T Consensus 346 ~laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi 422 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI 422 (598)
T ss_pred HHHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence 89999999999998 899999999999998 4443 46889999874321100 11111122346778999999
Q ss_pred hhcCC------CCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHH
Q 003059 677 LANLP------ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRA 750 (852)
Q Consensus 677 ~~~~~------~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 750 (852)
....+ --.|+|.|+.|.+.||+++...||....+. ...... +.+..+.. +. ......+
T Consensus 423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~-----Yqe~qLPa-----lp-----~~vpp~~ 486 (598)
T KOG4158|consen 423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRT-----YQESQLPA-----LP-----SRVPPVA 486 (598)
T ss_pred hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhh-----hhhhhCCC-----Cc-----ccCChHH
Confidence 86443 125899999999999999999999752211 001000 11111111 11 1111234
Q ss_pred HHHHHhccccCCCCCCCHHHHHHHHh
Q 003059 751 IQVSFWCIQEQPSQRPMMGKVVQMLE 776 (852)
Q Consensus 751 ~~l~~~cl~~dp~~RPt~~ev~~~L~ 776 (852)
.+++...++.||.+|++..-....|.
T Consensus 487 rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 487 RQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHHHhcCCccccCCccHHHhHHH
Confidence 56677789999999999876665553
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2e-16 Score=171.44 Aligned_cols=176 Identities=20% Similarity=0.359 Sum_probs=129.9
Q ss_pred eeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecc
Q 003059 568 HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFG 647 (852)
Q Consensus 568 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 647 (852)
+.|+.|++|.-.+|.+||.+... ....++...++++.|++.+++| ++.+|+|+||.||+...+..+||.|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence 57899999999999999975543 4567888999999999999999 479999999999999999999999999
Q ss_pred cccccCCCC---CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHH
Q 003059 648 LAKLINPKD---HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEE 723 (852)
Q Consensus 648 la~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 723 (852)
+........ ......+...||..||+||.+.+..|+.|+|||+||++|+||+. =..+++.. -+...
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------~t~~d 471 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------ATLTD 471 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------Hhhhh
Confidence 998765432 11223456779999999999999999999999999999999997 33333211 01111
Q ss_pred HhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 003059 724 FEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKV 771 (852)
Q Consensus 724 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev 771 (852)
++++.+. +.. ......-..+..+++.+.|.+||++.++
T Consensus 472 ~r~g~ip----~~~------~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 472 IRDGIIP----PEF------LQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hhcCCCC----hHH------hhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 2222111 111 1111123456778999999999944443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.8e-14 Score=138.64 Aligned_cols=135 Identities=21% Similarity=0.195 Sum_probs=114.7
Q ss_pred cccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccc--cceeeeeeeeccCceeeEEEeecCCCCH
Q 003059 504 KDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHH--LNLVRLVGFSSEGKHRLLVYEFMKNGSL 581 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~e~~~~gsL 581 (852)
.+.||+|.++.||++...+ ..+++|....... ...+..|+..+..++| .++++++++....+..+++|||++++.+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 3679999999999999865 6799999875433 5679999999999987 5899999998888899999999988776
Q ss_pred HHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 582 DNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 582 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
..+ +......++.+++++|++||.....+++|+|++|+||++++.+.+++.|||.++..
T Consensus 81 ~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 81 DEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 543 45566778999999999999855457999999999999999999999999988743
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.3e-14 Score=145.57 Aligned_cols=137 Identities=20% Similarity=0.198 Sum_probs=97.3
Q ss_pred cccccccccceEEEEEECCCcEEEEEEecCcccch---HH----------------------HHHHHHHhhcccccc--e
Q 003059 504 KDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGE---KQ----------------------FRMEVATISSTHHLN--L 556 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~---~~----------------------f~~E~~~l~~l~h~n--i 556 (852)
.+.||+|+||.||+|...+++.||||++....... .. ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998888999999886432111 11 134555555554432 3
Q ss_pred eeeeeeeccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeC
Q 003059 557 VRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD 636 (852)
Q Consensus 557 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~ 636 (852)
.+.+++ ...++||||++++.+......... .. .....++.+++.++.++|.+ .+|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE
Confidence 444443 245899999999544321111100 11 56678999999999999973 6899999999999999
Q ss_pred CCCceEEeecccccccC
Q 003059 637 ENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 637 ~~~~~kl~DFGla~~~~ 653 (852)
++.++|+|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 9999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.2e-13 Score=143.54 Aligned_cols=133 Identities=17% Similarity=0.154 Sum_probs=103.2
Q ss_pred cccc-ccccceEEEEEECCCcEEEEEEecCc--------------ccchHHHHHHHHHhhcccccce--eeeeeeeccCc
Q 003059 505 DKLG-AGGFGAVYRGVLANRTVVAVKQLEGI--------------EQGEKQFRMEVATISSTHHLNL--VRLVGFSSEGK 567 (852)
Q Consensus 505 ~~lG-~G~fg~Vy~~~~~~~~~vavK~l~~~--------------~~~~~~f~~E~~~l~~l~h~ni--v~l~g~~~~~~ 567 (852)
..|| .||.|+||++... +..++||++... ......+.+|++++.+++|++| ++.+++...+.
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8999999999875 556888877421 1223567889999999998875 67777644322
Q ss_pred ----eeeEEEeecCC-CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceE
Q 003059 568 ----HRLLVYEFMKN-GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAK 642 (852)
Q Consensus 568 ----~~~lV~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 642 (852)
..++||||+++ .+|.+++... .++.. .+.+|+.+|.+||+ .+|+||||||.|||++.++.++
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEE
Confidence 23599999997 6999887431 23332 36789999999999 8999999999999999999999
Q ss_pred Eeecccccc
Q 003059 643 VSDFGLAKL 651 (852)
Q Consensus 643 l~DFGla~~ 651 (852)
|+|||.++.
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.4e-14 Score=166.37 Aligned_cols=254 Identities=24% Similarity=0.318 Sum_probs=182.4
Q ss_pred cccccccccccccceEEEEEEC--CCcEEEEEEecCcccch---HHHHHHHHHhhccc-ccceeeeeeeeccCceeeEEE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA--NRTVVAVKQLEGIEQGE---KQFRMEVATISSTH-HLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~~~---~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~ 573 (852)
.+.+.+.||+|.|+.|-..... ....+|+|.+....... .....|..+=..+. |.|++.+++...+.+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4566777999999999888753 34456777665333222 23334676666665 999999999999999999999
Q ss_pred eecCCCCHHHHhh-hcccCCccccchhHHHHHHHhhHhhhhhhc-cccCCCcccCCCCCCceEeCCCC-ceEEeeccccc
Q 003059 574 EFMKNGSLDNFLF-ANEEGSGKLLNWQSRFNIALGTARGITYLH-EECRDCIVHCDIKPENILLDENY-NAKVSDFGLAK 650 (852)
Q Consensus 574 e~~~~gsL~~~l~-~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~ 650 (852)
||..++++.+.+. .. ....+....-....|+..++.|+| + .++.|+||||+|.+++..+ ..+++|||+|.
T Consensus 101 ~~s~g~~~f~~i~~~~----~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPD----STGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred CcccccccccccccCC----ccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhc
Confidence 9999999988873 22 113444556678899999999999 6 8899999999999999999 99999999999
Q ss_pred ccCCCCCcceeeeeecC-CCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC
Q 003059 651 LINPKDHRHRTLTSVRG-TRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN 728 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (852)
.+..............| ++.|+|||...+. -..+..|+||.|+++.-+++|..|++.......... .| .+..
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~-~~-----~~~~ 247 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS-SW-----KSNK 247 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce-ee-----cccc
Confidence 87763344455556678 9999999999874 446789999999999999999999987654432211 11 1110
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
...... .-..-.....++...++..+|..|.+.+++..
T Consensus 248 --~~~~~~-----~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 --GRFTQL-----PWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --cccccC-----ccccCChhhhhcccccccCCchhccccccccc
Confidence 000000 00001123344555577789999988777653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=9.7e-14 Score=160.64 Aligned_cols=164 Identities=26% Similarity=0.309 Sum_probs=114.2
Q ss_pred ccccccccccceEEEEEECC-CcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCCH
Q 003059 503 FKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSL 581 (852)
Q Consensus 503 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 581 (852)
-.+.|-.|++|.||...++. .+..|+|+-+... +.+- ++.....|.+| |+-
T Consensus 87 ~IklisngAygavylvrh~~trqrfa~kiNkq~l-----ilRn--ilt~a~npfvv---------------------gDc 138 (1205)
T KOG0606|consen 87 TIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-----ILRN--ILTFAGNPFVV---------------------GDC 138 (1205)
T ss_pred eeEeeccCCCCceeeeeccccccchhhcccccch-----hhhc--cccccCCccee---------------------chh
Confidence 35679999999999998654 5567774322111 0000 22222233222 333
Q ss_pred HHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC------
Q 003059 582 DNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK------ 655 (852)
Q Consensus 582 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~------ 655 (852)
.+.+..- ..++. +++.+++|||. .+|+|||+||+|.||..-|++|+.|||+.+.....
T Consensus 139 ~tllk~~-----g~lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 139 ATLLKNI-----GPLPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred hhhcccC-----CCCcc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 3333211 12322 23788999999 89999999999999999999999999998753210
Q ss_pred ------CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCcccccccc
Q 003059 656 ------DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQE 710 (852)
Q Consensus 656 ------~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~ 710 (852)
+...-....+.||+.|+|||++....|...+|.|++|+++||.+-|..||.....
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp 263 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 263 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH
Confidence 0111112346799999999999999999999999999999999999999986644
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.4e-13 Score=110.08 Aligned_cols=64 Identities=30% Similarity=0.518 Sum_probs=53.5
Q ss_pred CCCCCceeecccccccCCcccccccccccChhhHHhhhccCCcEEEEEecc-CCccceEeccCCCcc
Q 003059 334 CPGSATMLELPHTKFLTFQPELSSQVFFVGISACRLNCLVTGSCVASTSLS-DGTGLCYLKTPDFVS 399 (852)
Q Consensus 334 C~~~~~f~~l~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~-~~~~~C~~~~~~~~~ 399 (852)
|+.+++|++|+++++|++.... ...++++++|++.||+||||+||+|.. .++++|++|.++|.|
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~--~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d 65 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAI--VDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVD 65 (66)
T ss_pred CcCCCEEEEECCeeCCCCccee--eecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeec
Confidence 4567899999999999986543 235689999999999999999999973 266899999998875
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.33 E-value=5.3e-12 Score=142.56 Aligned_cols=139 Identities=25% Similarity=0.256 Sum_probs=99.6
Q ss_pred ccccccccceEEEEEECCCcEEEEEEecCcccc-----------------------------------------hHHHHH
Q 003059 505 DKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQG-----------------------------------------EKQFRM 543 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-----------------------------------------~~~f~~ 543 (852)
+.||.|++|.||+|++.+|+.||||+.+..... +-+|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 359999999999999999999999998632100 012455
Q ss_pred HHHHhhccc----ccceeeeeeeec-cCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHh-hhhhhcc
Q 003059 544 EVATISSTH----HLNLVRLVGFSS-EGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTAR-GITYLHE 617 (852)
Q Consensus 544 E~~~l~~l~----h~niv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-~L~yLH~ 617 (852)
|+..+.+++ |.+-+.+-..+. .....+|||||++|++|.+++..... .. .+.+++..++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHHHh
Confidence 666555553 333333333332 24467999999999999887643211 11 23456666666 4677887
Q ss_pred ccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 618 ECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 618 ~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
.+++|+|+||.||+++++++++|.|||++..+.
T Consensus 276 ---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 ---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 899999999999999999999999999998664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.8e-12 Score=128.47 Aligned_cols=156 Identities=23% Similarity=0.331 Sum_probs=118.4
Q ss_pred HHHhhcccccceeeeeeeeccCc-----eeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhcccc
Q 003059 545 VATISSTHHLNLVRLVGFSSEGK-----HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619 (852)
Q Consensus 545 ~~~l~~l~h~niv~l~g~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~ 619 (852)
...|-.+-|.|||+++.|+.+.+ +..++.|||..|+|..+|.+..+ ....+......+++.||..||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~-~~~a~~~~~wkkw~tqIlsal~yLhs~- 195 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK-NQKALFQKAWKKWCTQILSALSYLHSC- 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH-hhhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence 33455667999999999976543 57899999999999999976554 355677778889999999999999985
Q ss_pred CCCcccCCCCCCceEeCCCCceEEeecccccccCCCC--CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHH
Q 003059 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD--HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLE 697 (852)
Q Consensus 620 ~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~e 697 (852)
.+.|+|+++.-+.|++..++-+|+.--.-. ...... ..........+-++|.|||+=.....+..+|||+||+..+|
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 478999999999999999998888532111 111000 00011122346789999998777778889999999999999
Q ss_pred HHhCCc
Q 003059 698 IVSGRR 703 (852)
Q Consensus 698 lltG~~ 703 (852)
|.-+..
T Consensus 275 mailEi 280 (458)
T KOG1266|consen 275 MAILEI 280 (458)
T ss_pred HHHhee
Confidence 988764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.6e-11 Score=119.48 Aligned_cols=130 Identities=20% Similarity=0.139 Sum_probs=97.2
Q ss_pred ccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhccccccee-eeeeeeccCceeeEEEeecCCCCHHH
Q 003059 505 DKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLV-RLVGFSSEGKHRLLVYEFMKNGSLDN 583 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~e~~~~gsL~~ 583 (852)
+.|+.|.++.||++... ++.+++|...........++.|++++..+.+.+++ +++.+.. ...++||||+++.++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccc
Confidence 56899999999999875 56799998764433345678899999998766554 4555433 34589999999988754
Q ss_pred HhhhcccCCccccchhHHHHHHHhhHhhhhhhcccc--CCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 584 FLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC--RDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 584 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
.. . ....++.+++++|+.||... +..++|+|++|.||+++ ++.++++||+.+..
T Consensus 81 ~~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 ED----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 20 0 11245678999999999832 22369999999999999 67899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.8e-11 Score=132.63 Aligned_cols=253 Identities=23% Similarity=0.245 Sum_probs=176.0
Q ss_pred HHHHhcccccccccc--cccceEEEEEE---CCCcEEEEEEecC---cccchHHHHHHHHHhhcc-cccceeeeeeeecc
Q 003059 495 ELQRSTKGFKDKLGA--GGFGAVYRGVL---ANRTVVAVKQLEG---IEQGEKQFRMEVATISST-HHLNLVRLVGFSSE 565 (852)
Q Consensus 495 el~~~~~~~~~~lG~--G~fg~Vy~~~~---~~~~~vavK~l~~---~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~ 565 (852)
+....+..+.+.+|. |.+|.||.+.. .+...+|+|+-+. .......=.+|+..-+++ .|+|.++....+..
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence 445556677889999 99999999986 3467788887441 122223335677776777 49999998888999
Q ss_pred CceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHh----hhhhhccccCCCcccCCCCCCceEeCCC-Cc
Q 003059 566 GKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTAR----GITYLHEECRDCIVHCDIKPENILLDEN-YN 640 (852)
Q Consensus 566 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~ivH~Dlkp~NILl~~~-~~ 640 (852)
++..++-.|++ +.+|..+.+.... .++....+....+..+ ||.++|. ..++|-|+||.||++..+ ..
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred CCcceeeeccc-cchhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCC---Ccccccccchhheecccccce
Confidence 99999999998 5788888865433 3444555556666666 9999999 899999999999999998 88
Q ss_pred eEEeecccccccCCCCCcceee--eeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHH
Q 003059 641 AKVSDFGLAKLINPKDHRHRTL--TSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSL 718 (852)
Q Consensus 641 ~kl~DFGla~~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~ 718 (852)
.++.|||+...+.......... ....|...|++||...+ .++..+|||++|.++.|..++..+.... +...
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g------~~~~ 334 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVG------KNSS 334 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCC------CCCC
Confidence 9999999999887654222221 22357888999998765 5688999999999999999987654321 0001
Q ss_pred HHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 719 WAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 719 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
| ..++... +-+..+.+ ...++..+...+++.+|..|++.+.+..
T Consensus 335 W--~~~r~~~---ip~e~~~~------~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 335 W--SQLRQGY---IPLEFCEG------GSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred c--ccccccc---CchhhhcC------cchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1 1111111 11111111 0112222566689999999998776653
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.4e-11 Score=103.57 Aligned_cols=77 Identities=25% Similarity=0.397 Sum_probs=62.3
Q ss_pred CCCCC---CceeecccccccCCcccccccccccChhhHHhhhccCCcEEEEEeccCCccceEeccCCCccCCcCCCCCCc
Q 003059 333 SCPGS---ATMLELPHTKFLTFQPELSSQVFFVGISACRLNCLVTGSCVASTSLSDGTGLCYLKTPDFVSGFQNPALPST 409 (852)
Q Consensus 333 ~C~~~---~~f~~l~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~C~~~~~~~~~~~~~~~~~~~ 409 (852)
.|... ++|++++++++|+.... . ..+++++|++.|++||+|+||+|. +++++|++|..++.+++.......+
T Consensus 4 ~C~~~~~~~~f~~~~~~~~~~~~~~---~-~~~s~~~C~~~Cl~nCsC~a~~~~-~~~~~C~~~~~~~~~~~~~~~~~~~ 78 (84)
T cd01098 4 NCGGDGSTDGFLKLPDVKLPDNASA---I-TAISLEECREACLSNCSCTAYAYN-NGSGGCLLWNGLLNNLRSLSSGGGT 78 (84)
T ss_pred ccCCCCCCCEEEEeCCeeCCCchhh---h-ccCCHHHHHHHHhcCCCcceeeec-CCCCeEEEEeceecceEeecCCCcE
Confidence 57544 68999999999987543 2 667999999999999999999997 4467999999998877654444578
Q ss_pred cceec
Q 003059 410 SYVKV 414 (852)
Q Consensus 410 ~~~kv 414 (852)
+|+|+
T Consensus 79 ~yiKv 83 (84)
T cd01098 79 LYLRL 83 (84)
T ss_pred EEEEe
Confidence 89987
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.1e-11 Score=135.37 Aligned_cols=140 Identities=20% Similarity=0.174 Sum_probs=92.8
Q ss_pred ccccccccceEEEEEECC-CcEEEEEEecCcccc-----------------------------------------hHHHH
Q 003059 505 DKLGAGGFGAVYRGVLAN-RTVVAVKQLEGIEQG-----------------------------------------EKQFR 542 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~-----------------------------------------~~~f~ 542 (852)
+-||.|++|.||+|++++ |+.||||+.+..... +-+|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 469999999999999987 999999998632100 01244
Q ss_pred HHHHHhhccc----ccceeeeeeeecc-CceeeEEEeecCCCCHHHHhhhcccC-CccccchhHHHHHHHhhHhhhhhhc
Q 003059 543 MEVATISSTH----HLNLVRLVGFSSE-GKHRLLVYEFMKNGSLDNFLFANEEG-SGKLLNWQSRFNIALGTARGITYLH 616 (852)
Q Consensus 543 ~E~~~l~~l~----h~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH 616 (852)
+|+..+.+++ +.+.+.+-..+.+ ....+|||||++|+.|.++-.-...+ ..+.+.......++.|+.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------- 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------- 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence 5555555543 4444444443333 45678999999999998753211110 111233333333344443
Q ss_pred cccCCCcccCCCCCCceEeCCCC----ceEEeecccccccCC
Q 003059 617 EECRDCIVHCDIKPENILLDENY----NAKVSDFGLAKLINP 654 (852)
Q Consensus 617 ~~~~~~ivH~Dlkp~NILl~~~~----~~kl~DFGla~~~~~ 654 (852)
. .+++|+|+||.||+++.++ ++++.|||++..+.+
T Consensus 278 ~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 2 6899999999999999988 999999999987643
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=6.3e-11 Score=99.03 Aligned_cols=71 Identities=17% Similarity=0.090 Sum_probs=59.8
Q ss_pred CCCCCceeecccccccCCcccccccccccChhhHHhhhcc---CCcEEEEEeccCCccceEeccCCC-ccCCcCCCCCCc
Q 003059 334 CPGSATMLELPHTKFLTFQPELSSQVFFVGISACRLNCLV---TGSCVASTSLSDGTGLCYLKTPDF-VSGFQNPALPST 409 (852)
Q Consensus 334 C~~~~~f~~l~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~---nCsC~a~~~~~~~~~~C~~~~~~~-~~~~~~~~~~~~ 409 (852)
|..++.|+++.++++|++.. ++++||+++|++ ||||+||+|... +.+|++|.+++ .+.+.....+.+
T Consensus 5 ~~~~g~fl~~~~~klpd~~~--------~s~~eC~~~Cl~~~~nCsC~Aya~~~~-~~gC~~W~~~l~~d~~~~~~~g~~ 75 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA--------NTADECANRCEKNGLPFSCKAFVFAKA-RKQCLWFPFNSMSGVRKEFSHGFD 75 (80)
T ss_pred eecCCeEEEeecccCCcccc--------cCHHHHHHHHhcCCCCCCceeeeccCC-CCCeEEecCcchhhHHhccCCCce
Confidence 55677899999999987643 689999999999 999999999643 35899999999 888877767788
Q ss_pred ccee
Q 003059 410 SYVK 413 (852)
Q Consensus 410 ~~~k 413 (852)
+|+|
T Consensus 76 Ly~r 79 (80)
T cd00129 76 LYEN 79 (80)
T ss_pred eEeE
Confidence 9987
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.06 E-value=6.5e-10 Score=114.57 Aligned_cols=141 Identities=18% Similarity=0.193 Sum_probs=108.7
Q ss_pred ccccccccceEEEEEECCCcEEEEEEecCccc--chHHHHHHHHHhhcccc--cceeeeeeeeccCc---eeeEEEeecC
Q 003059 505 DKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQ--GEKQFRMEVATISSTHH--LNLVRLVGFSSEGK---HRLLVYEFMK 577 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~f~~E~~~l~~l~h--~niv~l~g~~~~~~---~~~lV~e~~~ 577 (852)
+.|+.|..+.||++...+++.+++|....... ...++..|++++..+++ .++.+++.+..+.. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999987767899998764332 45678999999999976 44677888776643 6789999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhcccc--------------------------------------
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC-------------------------------------- 619 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------------------------------------- 619 (852)
+.++.+.+.. ..++...+..++.++++.|.+||+..
T Consensus 84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9888765421 23566667777778888888777421
Q ss_pred ---------------CCCcccCCCCCCceEeCC--CCceEEeecccccc
Q 003059 620 ---------------RDCIVHCDIKPENILLDE--NYNAKVSDFGLAKL 651 (852)
Q Consensus 620 ---------------~~~ivH~Dlkp~NILl~~--~~~~kl~DFGla~~ 651 (852)
+..++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.4e-09 Score=120.08 Aligned_cols=166 Identities=16% Similarity=0.191 Sum_probs=123.2
Q ss_pred ECCCcEEEEEEecCccc-chHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCCHHHHhhhcccCCccccch
Q 003059 520 LANRTVVAVKQLEGIEQ-GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNW 598 (852)
Q Consensus 520 ~~~~~~vavK~l~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~ 598 (852)
..++.+|.|...+.... ......+.++.|+.++||||+++++...+.+..|||+|.+. -|..++.. +..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--------l~~ 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--------LGK 103 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------hHH
Confidence 45677888888773332 23456788899999999999999999999999999999873 46666632 224
Q ss_pred hHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhh
Q 003059 599 QSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLA 678 (852)
Q Consensus 599 ~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 678 (852)
....-.+.||+.||.|||+. .+++|++|..+-|+|++.|+.||++|.++........ .......-..|..|+.+.
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---~~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---PAKSLYLIESFDDPEEID 178 (690)
T ss_pred HHHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---ccccchhhhcccChhhcC
Confidence 44555788999999999974 6799999999999999999999999998865432111 111112223466676543
Q ss_pred cCCCCCCccchhhhHHHHHHHhCC
Q 003059 679 NLPITSKSDVYSYGMVLLEIVSGR 702 (852)
Q Consensus 679 ~~~~s~ksDv~s~Gvvl~elltG~ 702 (852)
... -..|.|.||++++|++.|.
T Consensus 179 ~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 179 PSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred ccc--cchhhhhHHHHHHHHhCcc
Confidence 222 3469999999999999993
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.9e-09 Score=105.77 Aligned_cols=136 Identities=18% Similarity=0.152 Sum_probs=97.5
Q ss_pred ccccccccceEEEEEECC-------CcEEEEEEecCcc-----------------------cchHHHH----HHHHHhhc
Q 003059 505 DKLGAGGFGAVYRGVLAN-------RTVVAVKQLEGIE-----------------------QGEKQFR----MEVATISS 550 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~-----------------------~~~~~f~----~E~~~l~~ 550 (852)
-.||.|--+.||.|...+ +..+|||+.+... ...+.+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 368999999999998543 4789999774210 0012233 79999988
Q ss_pred ccc--cceeeeeeeeccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhh-ccccCCCcccCC
Q 003059 551 THH--LNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYL-HEECRDCIVHCD 627 (852)
Q Consensus 551 l~h--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~D 627 (852)
+.. -++.+++++ ...+|||||+.+..+..-..+ ...++......+..+++.+|..| |+ .+|||+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCC
Confidence 853 466677765 467899999976544221111 11244455667889999999999 76 7999999
Q ss_pred CCCCceEeCCCCceEEeecccccccC
Q 003059 628 IKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 628 lkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
|++.|||++ ++.+.|+|||.+....
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999997 4689999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.99 E-value=6.3e-10 Score=123.83 Aligned_cols=245 Identities=22% Similarity=0.237 Sum_probs=167.4
Q ss_pred cccccccccccccceEEEEEE--CCCcEEEEEEecCcccc-hHH--HHHHHHHhhcc-cccceeeeeeeeccCceeeEEE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL--ANRTVVAVKQLEGIEQG-EKQ--FRMEVATISST-HHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~-~~~--f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 573 (852)
+..+..+||.|.|+.|++... .++..+++|.+...... ..+ -..|+.+...+ .|.++++....+....+.|+=-
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~ 345 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPL 345 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCch
Confidence 345567899999999999874 35778999987633221 111 24566666555 5888999888888888888999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCC-CceEEeeccccccc
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDEN-YNAKVSDFGLAKLI 652 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFGla~~~ 652 (852)
||++++++...+. ....++...++++..|++.++.++|+ +.++|+|+||+||++..+ +..++.|||.+..+
T Consensus 346 e~~~~~s~~l~~~-----~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 346 EFCEGGSSSLRSV-----TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred hhhcCcchhhhhH-----HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccccccc
Confidence 9999999887762 13347778889999999999999998 899999999999999886 88899999998642
Q ss_pred CCCCCcceeeeeecCCCCC-CChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 653 NPKDHRHRTLTSVRGTRGY-LAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
.- ........+..| .+++......+-.+.|+++||..+.|.+++..--..... |. .+..
T Consensus 418 ~~-----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~~-------~i~~ 477 (524)
T KOG0601|consen 418 AF-----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------SL-------TIRS 477 (524)
T ss_pred ce-----ecccccccccccccchhhccccccccccccccccccccccccCcccCccccc--------ce-------eeec
Confidence 11 011111223334 356666677888999999999999999998753221100 00 0111
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
-.-+.+.+ ...+. ..++...+..++..||.+.++....+-.
T Consensus 478 ~~~p~~~~---~~~~~---q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 478 GDTPNLPG---LKLQL---QVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ccccCCCc---hHHhh---hhhhhhhcCCccccchhhhhhcccchhh
Confidence 11111111 11222 2333347889999999988876655433
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=7.2e-09 Score=99.19 Aligned_cols=130 Identities=21% Similarity=0.278 Sum_probs=99.6
Q ss_pred ccccccccceEEEEEECCCcEEEEEEec-Ccc--------cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 505 DKLGAGGFGAVYRGVLANRTVVAVKQLE-GIE--------QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~-~~~--------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
..+.+|+-+.+|.+.+.+.. +++|.-. +.- -....-.+|+.++.+++--.|.--.=+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999775544 5555432 211 1123456899999998766665555566677788899999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
.++..|.+++... +..++..+-.-+.-||. .+|+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999988532 24577888888889998 8999999999999998775 99999999974
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.1e-08 Score=97.23 Aligned_cols=143 Identities=19% Similarity=0.262 Sum_probs=103.3
Q ss_pred cccccccccceEEEEEECCCcEEEEEEecCc--------ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 504 KDKLGAGGFGAVYRGVLANRTVVAVKQLEGI--------EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--------~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
.+.|-+|+-+.|+++.+.+.+.+.-+++.+. .-..++.++|+..|.+++--.|.--.-++.+...-.|+|||
T Consensus 12 l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred ceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 4578899999999998866553433344321 12345678899999988766655555556666677899999
Q ss_pred cCC-CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCc---eEEeecccccc
Q 003059 576 MKN-GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYN---AKVSDFGLAKL 651 (852)
Q Consensus 576 ~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~DFGla~~ 651 (852)
+++ .++.+++...... ...-.....++..|-+.+.-||. ..|||+||..+||+|..++. +.++|||++..
T Consensus 92 ~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred ccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 976 4888888654321 12222336788999999999998 89999999999999965543 58999999875
Q ss_pred c
Q 003059 652 I 652 (852)
Q Consensus 652 ~ 652 (852)
-
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 3
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.71 E-value=4.1e-08 Score=89.54 Aligned_cols=86 Identities=27% Similarity=0.447 Sum_probs=67.3
Q ss_pred EEEeeCccEEEEcCC-CceEeeccCCCC--ceeEEEEcCCccEEEecCCCccccccCCCCCCcccCCCccccCccccccc
Q 003059 93 FQLHSSGTLRLISGS-GAIIWDSNTQRL--NVTSASLDDSGNLVLLKNGGVSAWSSFDNPTDTIVPSQNFTSDKTLRSGY 169 (852)
Q Consensus 93 l~~~~~g~l~l~~~~-~~~vWst~~~~~--~~~~~~l~d~GNlvl~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~l~sG~ 169 (852)
+.+..|||+|+++.. +.+||++++... ....+.|+++|||||++.++..+|+|=..+ ..|.
T Consensus 24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~t~~----------------~~~~ 87 (114)
T smart00108 24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNTTG----------------ANGN 87 (114)
T ss_pred cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEecccC----------------CCCc
Confidence 344578999999765 589999997543 225789999999999999899999982210 1367
Q ss_pred eEEEeecCCceeeeecCceeeeccC
Q 003059 170 YSFTLLKSGNLSLKWNDSVVYFNQG 194 (852)
Q Consensus 170 ~sl~~~~~g~~~~~~~~~~~yw~~g 194 (852)
+.+.++.+|+++++-....+.|.+.
T Consensus 88 ~~~~L~ddGnlvl~~~~~~~~W~Sf 112 (114)
T smart00108 88 YVLVLLDDGNLVIYDSDGNFLWQSF 112 (114)
T ss_pred eEEEEeCCCCEEEECCCCCEEeCCC
Confidence 8899999999999876667889773
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.71 E-value=7.1e-08 Score=95.61 Aligned_cols=125 Identities=21% Similarity=0.224 Sum_probs=83.1
Q ss_pred eEEEEEECCCcEEEEEEecCcc--------------c-------------chHHHHHHHHHhhccccc--ceeeeeeeec
Q 003059 514 AVYRGVLANRTVVAVKQLEGIE--------------Q-------------GEKQFRMEVATISSTHHL--NLVRLVGFSS 564 (852)
Q Consensus 514 ~Vy~~~~~~~~~vavK~l~~~~--------------~-------------~~~~f~~E~~~l~~l~h~--niv~l~g~~~ 564 (852)
.||.|...++..+|||...... . .....++|.+.|.++..- ++.+++++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899999899999999875210 0 012356899999999765 566777553
Q ss_pred cCceeeEEEeecC--CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhh-hccccCCCcccCCCCCCceEeCCCCce
Q 003059 565 EGKHRLLVYEFMK--NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY-LHEECRDCIVHCDIKPENILLDENYNA 641 (852)
Q Consensus 565 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~y-LH~~~~~~ivH~Dlkp~NILl~~~~~~ 641 (852)
..+|||||++ +..+..+... .++......++.+++..+.. +|. .+|+|+||.+.|||++++ .+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-------~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-------DLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-------GGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-------cccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eE
Confidence 4479999998 5555443321 12234556677888886655 466 799999999999999988 99
Q ss_pred EEeecccccccC
Q 003059 642 KVSDFGLAKLIN 653 (852)
Q Consensus 642 kl~DFGla~~~~ 653 (852)
.|+|||.+....
T Consensus 146 ~iIDf~qav~~~ 157 (188)
T PF01163_consen 146 YIIDFGQAVDSS 157 (188)
T ss_dssp EE--GTTEEETT
T ss_pred EEEecCcceecC
Confidence 999999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.6e-07 Score=102.41 Aligned_cols=170 Identities=16% Similarity=0.234 Sum_probs=130.7
Q ss_pred cceEEEEE-ECCCcEEEEEEecCccc-chHHHHHHHHHhhcccccceeeeeeeec----cCceeeEEEeecCC-CCHHHH
Q 003059 512 FGAVYRGV-LANRTVVAVKQLEGIEQ-GEKQFRMEVATISSTHHLNLVRLVGFSS----EGKHRLLVYEFMKN-GSLDNF 584 (852)
Q Consensus 512 fg~Vy~~~-~~~~~~vavK~l~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~----~~~~~~lV~e~~~~-gsL~~~ 584 (852)
-.+.||+. ..+|..|++|+++.... .......-++.++++.|+|||++..++. .+...++||+|.|+ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35779988 45788999999963322 2223455678899999999999999876 34578999999975 578777
Q ss_pred hhhcccC----------CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 585 LFANEEG----------SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 585 l~~~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
-+..... .+..++++..+.++.|+..||.++|+ .|+.-+-|.+++||++.+.+++|+..|+...+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 7654332 23457788999999999999999999 7888899999999999999999999998877654
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCcc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRN 704 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p 704 (852)
+.. |.+. --.+-|.=.||.+++.|.||...
T Consensus 446 d~~-----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT-----------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC-----------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 320 1111 12357888999999999999654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=6.7e-09 Score=121.32 Aligned_cols=242 Identities=20% Similarity=0.231 Sum_probs=151.5
Q ss_pred ccccccccceEEEEEECC-CcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCC
Q 003059 505 DKLGAGGFGAVYRGVLAN-RTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNG 579 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 579 (852)
+-+-+|.++.++.+.-.. +...+.|..... ....+....+-.++-..+||-++...--+.-....+||++|+.++
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 357778888887665322 211222222111 111111222222222334555555554455677889999999999
Q ss_pred CHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC-----
Q 003059 580 SLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP----- 654 (852)
Q Consensus 580 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~----- 654 (852)
+|...|+... .++.+.....+..+..+++|||. ..++|+|++|.|+|+..++..+++|||.......
T Consensus 890 ~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 890 DLPSKLHNSG-----CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred CchhhhhcCC-----CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 9999886543 34444445567778889999998 5689999999999999999999999984432210
Q ss_pred ----------------C---C----CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccc
Q 003059 655 ----------------K---D----HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQET 711 (852)
Q Consensus 655 ----------------~---~----~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~ 711 (852)
. . +..+......+|+.|.+||...+......+|.|++|++++|.++|..||......
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 0 0 0001122356899999999999999999999999999999999999999765432
Q ss_pred cchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 003059 712 NRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMG 769 (852)
Q Consensus 712 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ 769 (852)
.. ...++...+.....+.+....+.+++...+..+|.+|-.+.
T Consensus 1042 ~~---------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1042 QI---------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hh---------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 11 11122111111112222333344455556677888886654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.5e-07 Score=98.92 Aligned_cols=132 Identities=17% Similarity=0.096 Sum_probs=95.8
Q ss_pred ceEEEEEECCCcEEEEEEecCccc------------chHHHHHHHHHhhcccccc--eeeeeeeecc-----CceeeEEE
Q 003059 513 GAVYRGVLANRTVVAVKQLEGIEQ------------GEKQFRMEVATISSTHHLN--LVRLVGFSSE-----GKHRLLVY 573 (852)
Q Consensus 513 g~Vy~~~~~~~~~vavK~l~~~~~------------~~~~f~~E~~~l~~l~h~n--iv~l~g~~~~-----~~~~~lV~ 573 (852)
..|++..+ +|+.+.||+...... ....+.+|...+.++...+ .+.++++... ...-+||+
T Consensus 36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 44667666 556799997753221 1124788999988885443 3445555543 23578999
Q ss_pred eecCCC-CHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC-------CCceEEee
Q 003059 574 EFMKNG-SLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE-------NYNAKVSD 645 (852)
Q Consensus 574 e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-------~~~~kl~D 645 (852)
|++++- +|.+++.... ....+...+..++.+++..+.-||+ .+|+|+|++++|||++. +..+.|+|
T Consensus 115 e~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID 188 (268)
T PRK15123 115 EDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKLSVID 188 (268)
T ss_pred eeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence 999886 8999884321 1234456677899999999999999 89999999999999975 57899999
Q ss_pred cccccc
Q 003059 646 FGLAKL 651 (852)
Q Consensus 646 FGla~~ 651 (852)
|+.++.
T Consensus 189 l~r~~~ 194 (268)
T PRK15123 189 LHRAQI 194 (268)
T ss_pred CCcccc
Confidence 998863
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.68 E-value=5.7e-08 Score=88.90 Aligned_cols=84 Identities=30% Similarity=0.488 Sum_probs=67.1
Q ss_pred Eee-CccEEEEcCC-CceEeeccCCCC--ceeEEEEcCCccEEEecCCCccccccCCCCCCcccCCCccccCccccccce
Q 003059 95 LHS-SGTLRLISGS-GAIIWDSNTQRL--NVTSASLDDSGNLVLLKNGGVSAWSSFDNPTDTIVPSQNFTSDKTLRSGYY 170 (852)
Q Consensus 95 ~~~-~g~l~l~~~~-~~~vWst~~~~~--~~~~~~l~d~GNlvl~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~l~sG~~ 170 (852)
+.. +|+||+++.. +.+||++|+... ....+.|+++|||||+|.++.++|||-... ..+.+
T Consensus 26 ~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~~----------------~~~~~ 89 (116)
T cd00028 26 MQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTTR----------------VNGNY 89 (116)
T ss_pred CCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEecccC----------------CCCce
Confidence 444 8999999764 589999997642 345789999999999999999999984321 13678
Q ss_pred EEEeecCCceeeeecCceeeeccC
Q 003059 171 SFTLLKSGNLSLKWNDSVVYFNQG 194 (852)
Q Consensus 171 sl~~~~~g~~~~~~~~~~~yw~~g 194 (852)
.+.++.+|+++++-....+.|.+.
T Consensus 90 ~~~L~ddGnlvl~~~~~~~~W~Sf 113 (116)
T cd00028 90 VLVLLDDGNLVLYDSDGNFLWQSF 113 (116)
T ss_pred EEEEeCCCCEEEECCCCCEEEcCC
Confidence 899999999999876677889875
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.7e-06 Score=92.12 Aligned_cols=262 Identities=15% Similarity=0.168 Sum_probs=154.7
Q ss_pred ccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcc-cccceeeeeee------eccCc-eeeEEEe
Q 003059 503 FKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISST-HHLNLVRLVGF------SSEGK-HRLLVYE 574 (852)
Q Consensus 503 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~------~~~~~-~~~lV~e 574 (852)
....||+|+-+.+|-.---.+ .| .|+.....-..+. +.++.|... .||-+-.-+.+ .-+++ ..-++|.
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d-~V-AKIYh~Pppa~~a--qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRD-QV-AKIYHAPPPAAQA--QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CCccccCCccceeeecchhhc-hh-heeecCCCchHHH--HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 456799999999996432111 23 3655532221111 122223333 45543331222 11222 2456677
Q ss_pred ecCCC-CHHHHhh-hcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 575 FMKNG-SLDNFLF-ANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 575 ~~~~g-sL~~~l~-~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
.+++. -+.+++. ..++.+-....|.-.++.++.+|.+.+.||+ .|.+-+|+.++|+|+.+++.+.|.|-......
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec
Confidence 66554 2233332 1233345678899999999999999999999 89999999999999999999999985543332
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhh-----cCCCCCCccchhhhHHHHHHHhC-Cccccccccccc--hhhHHHHHHHH
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLA-----NLPITSKSDVYSYGMVLLEIVSG-RRNFEVSQETNR--KKFSLWAYEEF 724 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG-~~p~~~~~~~~~--~~l~~~~~~~~ 724 (852)
.........+|...|.+||.-. +..-+...|.|.||+++++||.| +.||.+...... ..+. ..+
T Consensus 168 ----~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E----~~I 239 (637)
T COG4248 168 ----ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE----TDI 239 (637)
T ss_pred ----cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch----hhh
Confidence 2334455677899999999754 44567889999999999999986 999975422110 0000 011
Q ss_pred hhCCcccccccccCCC----CCCHHHH-HHHHHHHHhcccc--CCCCCCCHHHHHHHHhcCc
Q 003059 725 EKGNVKGIVDKSLAGE----DVDIEQV-MRAIQVSFWCIQE--QPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 725 ~~~~~~~~~d~~l~~~----~~~~~~~-~~~~~l~~~cl~~--dp~~RPt~~ev~~~L~~~~ 779 (852)
..+.....-+....-. ..+.+.+ ..+-.+..+|+.. .+.-||+++..+..|..+.
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 1111111111111000 1122211 1233445567754 3568999999988887654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=7.6e-07 Score=90.55 Aligned_cols=135 Identities=20% Similarity=0.181 Sum_probs=95.1
Q ss_pred ccccccccccccceEEEEEECCCcEEEEEEecCcc-----------------------cchHHHHHHHHHhhccccc--c
Q 003059 501 KGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIE-----------------------QGEKQFRMEVATISSTHHL--N 555 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-----------------------~~~~~f~~E~~~l~~l~h~--n 555 (852)
+.+.++||-|--+.||.|....+.++|||.-+... ......++|.+.|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678999999999999999999999999643110 0012356789999988655 6
Q ss_pred eeeeeeeeccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEe
Q 003059 556 LVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL 635 (852)
Q Consensus 556 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl 635 (852)
|.+.+++ +...+||||.++--|...- ++.+..-.++..|++-+..+-. .||||+|+.+-||++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV 235 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILV 235 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEE
Confidence 7776654 3458999999886654322 1222233344444443333333 789999999999999
Q ss_pred CCCCceEEeeccccccc
Q 003059 636 DENYNAKVSDFGLAKLI 652 (852)
Q Consensus 636 ~~~~~~kl~DFGla~~~ 652 (852)
+++|.+.++||--+...
T Consensus 236 ~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 236 TEDGDIVVIDWPQAVPI 252 (304)
T ss_pred ecCCCEEEEeCcccccC
Confidence 99999999999876644
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.37 E-value=2.4e-06 Score=77.59 Aligned_cols=98 Identities=24% Similarity=0.451 Sum_probs=68.2
Q ss_pred ccccCCCceEEEEEecCCCCeeEEEEEeCCeeEEeeC-CC-CCCCCceEEEeeCccEEEEcCCCceEeeccCCCCceeEE
Q 003059 47 SWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAG-ST-PVDSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLNVTSA 124 (852)
Q Consensus 47 ~l~S~~g~f~lgf~~~~~~~~~~~i~~~~~~~vW~an-~~-p~~~~~~l~~~~~g~l~l~~~~~~~vWst~~~~~~~~~~ 124 (852)
++.+.+|.+.|-|...++ |.|....++++|.++ .. .....+.+.|.++|||||+|..+.+||++.... ..+.+
T Consensus 13 p~~~~s~~~~L~l~~dGn----Lvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~p-tdt~L 87 (114)
T PF01453_consen 13 PLTSSSGNYTLILQSDGN----LVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFDYP-TDTLL 87 (114)
T ss_dssp EEEECETTEEEEEETTSE----EEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTTSS-S-EEE
T ss_pred ccccccccccceECCCCe----EEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecCCC-ccEEE
Confidence 555555899999976655 555545568899994 32 222678999999999999999999999995432 34556
Q ss_pred EEcC--CccEEEecCCCccccccCCCCC
Q 003059 125 SLDD--SGNLVLLKNGGVSAWSSFDNPT 150 (852)
Q Consensus 125 ~l~d--~GNlvl~~~~~~~lWQSFD~PT 150 (852)
..++ +||++ ......+.|.|=+.|+
T Consensus 88 ~~q~l~~~~~~-~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 88 PGQKLGDGNVT-GKNDSLTSWSSNTDPS 114 (114)
T ss_dssp EEET--TSEEE-EESTSSEEEESS----
T ss_pred eccCcccCCCc-cccceEEeECCCCCCC
Confidence 6666 89998 7767788899987774
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.1e-06 Score=87.25 Aligned_cols=107 Identities=22% Similarity=0.285 Sum_probs=84.1
Q ss_pred chHHHHHHHHHhhccccc--ceeeeeeeeccCc----eeeEEEeecCC-CCHHHHhhhcccCCccccchhHHHHHHHhhH
Q 003059 537 GEKQFRMEVATISSTHHL--NLVRLVGFSSEGK----HRLLVYEFMKN-GSLDNFLFANEEGSGKLLNWQSRFNIALGTA 609 (852)
Q Consensus 537 ~~~~f~~E~~~l~~l~h~--niv~l~g~~~~~~----~~~lV~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia 609 (852)
......+|...+.+++.. .+.+.+++..... ..+||+|++++ .+|.+++..... ++......++.+++
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-----~~~~~~~~ll~~l~ 128 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-----LDPSQRRELLRALA 128 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-----cchhhHHHHHHHHH
Confidence 345678888888877533 4556667665432 45899999987 489998854221 55566788999999
Q ss_pred hhhhhhccccCCCcccCCCCCCceEeCCCC---ceEEeecccccc
Q 003059 610 RGITYLHEECRDCIVHCDIKPENILLDENY---NAKVSDFGLAKL 651 (852)
Q Consensus 610 ~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~DFGla~~ 651 (852)
+.++-||+ .+|+|+|+++.|||++.+. .+.|+||+-++.
T Consensus 129 ~~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 129 RLIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999 8999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.34 E-value=6.5e-06 Score=82.10 Aligned_cols=137 Identities=18% Similarity=0.116 Sum_probs=103.4
Q ss_pred ccccccceEEEEEECCCcEEEEEEecC----c---ccchHHHHHHHHHhhccccc--ceeeeeeeecc-----CceeeEE
Q 003059 507 LGAGGFGAVYRGVLANRTVVAVKQLEG----I---EQGEKQFRMEVATISSTHHL--NLVRLVGFSSE-----GKHRLLV 572 (852)
Q Consensus 507 lG~G~fg~Vy~~~~~~~~~vavK~l~~----~---~~~~~~f~~E~~~l~~l~h~--niv~l~g~~~~-----~~~~~lV 572 (852)
-|+||-+-|++-.+.+. .+-+|+-++ . ..+...|.+|+..|.++... .+.+++ ++.. .-.-+||
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 57799999999877655 588887651 1 34678899999999988633 344444 3321 1245899
Q ss_pred EeecCC-CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCc--eEEeecccc
Q 003059 573 YEFMKN-GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYN--AKVSDFGLA 649 (852)
Q Consensus 573 ~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~kl~DFGla 649 (852)
+|-+++ .+|.+++.... ..+.+...+..++.+++..++-||+ .++.|+|+.+.|||++.++. ++++||.-.
T Consensus 104 Te~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 997753 68988884322 2245677788999999999999999 89999999999999986667 999999876
Q ss_pred cc
Q 003059 650 KL 651 (852)
Q Consensus 650 ~~ 651 (852)
+.
T Consensus 178 r~ 179 (216)
T PRK09902 178 RR 179 (216)
T ss_pred ch
Confidence 53
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.3e-06 Score=99.54 Aligned_cols=141 Identities=23% Similarity=0.275 Sum_probs=91.2
Q ss_pred ccccccccceEEEEEECCCcEEEEEEecCcccc-----------------------------------------hHHHHH
Q 003059 505 DKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQG-----------------------------------------EKQFRM 543 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-----------------------------------------~~~f~~ 543 (852)
+-|+.+.-|.||+|++++|+.||||+.+..... +-++..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 358999999999999999999999988632110 012344
Q ss_pred HHHHhhccc----ccceeeeeeeec-cCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccc
Q 003059 544 EVATISSTH----HLNLVRLVGFSS-EGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618 (852)
Q Consensus 544 E~~~l~~l~----h~niv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~ 618 (852)
|+..+.+++ +..-+.+=..+. -.+...|+|||++|-.+.+....... ..+ +..++..++++ |+-+-
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~----g~d---~k~ia~~~~~~--f~~q~ 281 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA----GID---RKELAELLVRA--FLRQL 281 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc----CCC---HHHHHHHHHHH--HHHHH
Confidence 555544442 222333333333 35678999999999999888533221 122 12222222221 11111
Q ss_pred cCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 619 CRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 619 ~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
...+++|.|.+|.||+++.++++.+.|||+...+.+
T Consensus 282 ~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 282 LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 115899999999999999999999999999887654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.19 E-value=6.9e-07 Score=101.20 Aligned_cols=101 Identities=27% Similarity=0.427 Sum_probs=77.7
Q ss_pred HHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC------cceeeeeecCCCCCCChhhhh
Q 003059 605 ALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH------RHRTLTSVRGTRGYLAPEWLA 678 (852)
Q Consensus 605 ~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~ 678 (852)
+.+++.||.|+|.. ..+||++|.|++|.++.++..||+.|+.+........ .............|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 45566999999984 6799999999999999999999999998865543111 111111123456799999999
Q ss_pred cCCCCCCccchhhhHHHHHHH-hCCccccc
Q 003059 679 NLPITSKSDVYSYGMVLLEIV-SGRRNFEV 707 (852)
Q Consensus 679 ~~~~s~ksDv~s~Gvvl~ell-tG~~p~~~ 707 (852)
....+.++|+||+|+++|-+. .|+.-+..
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a 212 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAA 212 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhc
Confidence 988899999999999999999 45554443
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.17 E-value=4e-06 Score=70.57 Aligned_cols=61 Identities=25% Similarity=0.389 Sum_probs=47.8
Q ss_pred CCceeecccccccCCcccccccccccChhhHHhhhcc-CCcEEEEEeccCCccceEecc-CCCccCC
Q 003059 337 SATMLELPHTKFLTFQPELSSQVFFVGISACRLNCLV-TGSCVASTSLSDGTGLCYLKT-PDFVSGF 401 (852)
Q Consensus 337 ~~~f~~l~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~-nCsC~a~~~~~~~~~~C~~~~-~~~~~~~ 401 (852)
...|+.++++.+++.... .....++++|++.|++ +|+|.||.|.. +++.|++|. ..+.+..
T Consensus 3 ~~~f~~~~~~~l~~~~~~---~~~~~s~~~C~~~C~~~~~~C~s~~y~~-~~~~C~l~~~~~~~~~~ 65 (78)
T smart00473 3 DDCFVRLPNTKLPGFSRI---VISVASLEECASKCLNSNCSCRSFTYNN-GTKGCLLWSESSLGDAR 65 (78)
T ss_pred CceeEEecCccCCCCcce---eEcCCCHHHHHHHhCCCCCceEEEEEcC-CCCEEEEeeCCccccce
Confidence 346899999999865443 2345799999999999 99999999975 567999999 5555444
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.4e-05 Score=82.31 Aligned_cols=141 Identities=13% Similarity=0.155 Sum_probs=85.0
Q ss_pred ccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccc--eeeeeeeeccCceeeEEEeecCCCC-H
Q 003059 505 DKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLN--LVRLVGFSSEGKHRLLVYEFMKNGS-L 581 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lV~e~~~~gs-L 581 (852)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+++++....+...+|||+++|.. +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 46899999999984 23456778776422 3455788999998886443 4677888877778889999998863 2
Q ss_pred HHHh---------------------hhcccCCccccc--hhHHHHHHH-------hhHh-hhhhhcc-ccCCCcccCCCC
Q 003059 582 DNFL---------------------FANEEGSGKLLN--WQSRFNIAL-------GTAR-GITYLHE-ECRDCIVHCDIK 629 (852)
Q Consensus 582 ~~~l---------------------~~~~~~~~~~l~--~~~~~~i~~-------~ia~-~L~yLH~-~~~~~ivH~Dlk 629 (852)
...+ +.-. .....+. +....+.+. .+.+ ...+|.. .....++|+|+.
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~-~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTK-CDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCC-CCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 1111 1100 0000111 000000000 0000 1111111 123457899999
Q ss_pred CCceEeCCCCceEEeecccccc
Q 003059 630 PENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 630 p~NILl~~~~~~kl~DFGla~~ 651 (852)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999997753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.03 E-value=3.5e-05 Score=80.74 Aligned_cols=142 Identities=14% Similarity=0.079 Sum_probs=86.3
Q ss_pred cccccc-ceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhccc-ccceeeeeeeeccCceeeEEEeecCCCCHHHH
Q 003059 507 LGAGGF-GAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTH-HLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNF 584 (852)
Q Consensus 507 lG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 584 (852)
|-.|.. ..||+....+ ..+.||+..... ..++.+|++++..+. +--+.+++++....+..++|||+++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGKN-PGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCCC-CcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 444555 7889987654 678888876443 445778999888874 44566778887777778999999999887644
Q ss_pred hh----------------h--cccCCccccc--hhHHHHH-----------------------HHhhHhhhhhhc-cccC
Q 003059 585 LF----------------A--NEEGSGKLLN--WQSRFNI-----------------------ALGTARGITYLH-EECR 620 (852)
Q Consensus 585 l~----------------~--~~~~~~~~l~--~~~~~~i-----------------------~~~ia~~L~yLH-~~~~ 620 (852)
.. . .......... ...++.. ..++.+.|.... ....
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 21 0 0000000111 0011100 011111111100 1112
Q ss_pred CCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 621 DCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 621 ~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
..++|+|+.|.|||++++..+.|+||+.+..
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 5689999999999999988789999997753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.02 E-value=3.7e-05 Score=77.03 Aligned_cols=140 Identities=12% Similarity=0.122 Sum_probs=90.5
Q ss_pred HHHHHhcccccccccccccceEEEEEECCCcEEEEEEecCcc-cchHH---------HHHHHHHhhccccccee---eee
Q 003059 494 KELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIE-QGEKQ---------FRMEVATISSTHHLNLV---RLV 560 (852)
Q Consensus 494 ~el~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~---------f~~E~~~l~~l~h~niv---~l~ 560 (852)
+++....+...+.+-......|.+-..++ +.+++|...... ..++. ..+++..+.+++...+. .++
T Consensus 26 ~~i~~~~~~~~kv~k~~~r~~ValIei~~-~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 26 EKILDNNYKIIKVFKNTKRNYVALIEIDG-KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHHHhCCceEEEeecCCCccEEEEEEECC-cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 34555566666777777777777776654 568888776322 12222 23445545555433222 222
Q ss_pred eee-----ccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEe
Q 003059 561 GFS-----SEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL 635 (852)
Q Consensus 561 g~~-----~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl 635 (852)
... .-....+|||||++|..|.++.. ++. .++..+.+++.-||+ .|+.|+|.+|.|+++
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv 168 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLV 168 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEE
Confidence 222 22335579999999988766541 221 245677788999999 899999999999999
Q ss_pred CCCCceEEeecccccc
Q 003059 636 DENYNAKVSDFGLAKL 651 (852)
Q Consensus 636 ~~~~~~kl~DFGla~~ 651 (852)
.+++ +++.||+..+.
T Consensus 169 ~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 169 SNNG-IRIIDTQGKRM 183 (229)
T ss_pred ECCc-EEEEECccccc
Confidence 9655 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.00 E-value=2.6e-06 Score=95.29 Aligned_cols=184 Identities=18% Similarity=0.133 Sum_probs=132.9
Q ss_pred ccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccc-eeeeeeeeccCceeeEEEeecCCC-C
Q 003059 503 FKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLN-LVRLVGFSSEGKHRLLVYEFMKNG-S 580 (852)
Q Consensus 503 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~e~~~~g-s 580 (852)
+.+.+++|+++.+||.+--..+...++.+... ....-++++|.+++||| .+..++-+..+...+++++++..+ +
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 44678899999999876433333344444422 44567899999999999 777777777788899999999776 2
Q ss_pred HHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcce
Q 003059 581 LDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHR 660 (852)
Q Consensus 581 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 660 (852)
-..-.. .....+...+...+.+.-+++|+|||+ ..=+|+| ||+..+ +..|..||+....+.+..
T Consensus 322 ~~~~~~----~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---- 385 (829)
T KOG0576|consen 322 SALEMT----VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---- 385 (829)
T ss_pred ccccCC----hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc----
Confidence 211110 011123334445566777889999998 3348898 777665 678999999988765432
Q ss_pred eeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCcccc
Q 003059 661 TLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFE 706 (852)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~ 706 (852)
..+...+++.++|||+.....+..+.|+|++++-..++--|..|-.
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 3445678999999999999999999999999998888877776653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.99 E-value=3.5e-05 Score=79.84 Aligned_cols=145 Identities=19% Similarity=0.253 Sum_probs=86.1
Q ss_pred ccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccc--eeeeeeeecc---CceeeEEEeecCCC
Q 003059 505 DKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLN--LVRLVGFSSE---GKHRLLVYEFMKNG 579 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~g~~~~---~~~~~lV~e~~~~g 579 (852)
+.|+.|..+.||+....+ +.+++|..... .....+..|+.++..+.... +.+++.++.. ....+++|+++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 468999999999999887 57999987755 55667888999988885443 5566664432 33578999999999
Q ss_pred CHHH----------------Hhh---hcccCCccccchh--------HHHHH------------HHhhHh-hhhhhcc--
Q 003059 580 SLDN----------------FLF---ANEEGSGKLLNWQ--------SRFNI------------ALGTAR-GITYLHE-- 617 (852)
Q Consensus 580 sL~~----------------~l~---~~~~~~~~~l~~~--------~~~~i------------~~~ia~-~L~yLH~-- 617 (852)
.+.. .+. ...........+. ..... ...+.+ .+..+++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 8877 111 1100000001111 00000 111222 2333332
Q ss_pred --ccCCCcccCCCCCCceEeC-CCCceEEeecccccc
Q 003059 618 --ECRDCIVHCDIKPENILLD-ENYNAKVSDFGLAKL 651 (852)
Q Consensus 618 --~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFGla~~ 651 (852)
.....++|+|+.|.|||++ +++.+.|.||+.+..
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1346799999999999999 666678999987753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.90 E-value=4.1e-05 Score=86.96 Aligned_cols=141 Identities=21% Similarity=0.248 Sum_probs=90.6
Q ss_pred ccccccccceEEEEEECCCcEEEEEEecCcccc--------------------------------------hHHHHHHHH
Q 003059 505 DKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQG--------------------------------------EKQFRMEVA 546 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--------------------------------------~~~f~~E~~ 546 (852)
+-|+.-..|.||+|++++|+.||||+-+..-.. +-+|..|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 459999999999999999999999987632111 113555665
Q ss_pred Hhhcc----cccce---eeeeeeec-cCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccc
Q 003059 547 TISST----HHLNL---VRLVGFSS-EGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618 (852)
Q Consensus 547 ~l~~l----~h~ni---v~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~ 618 (852)
...+. +|-++ |.+=.++. -...+.|+||||+|..+.+.-.-... .++-.. ++..+.++ |++.-
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~----gi~~~~---i~~~l~~~--~~~qI 317 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR----GISPHD---ILNKLVEA--YLEQI 317 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc----CCCHHH---HHHHHHHH--HHHHH
Confidence 54433 35551 22223332 24578999999999988776432221 233332 33333222 22222
Q ss_pred cCCCcccCCCCCCceEeCC----CCceEEeecccccccCC
Q 003059 619 CRDCIVHCDIKPENILLDE----NYNAKVSDFGLAKLINP 654 (852)
Q Consensus 619 ~~~~ivH~Dlkp~NILl~~----~~~~kl~DFGla~~~~~ 654 (852)
...|++|+|-+|.||+++. ++++.+-|||+...+..
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 2267999999999999983 67899999999886643
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.85 E-value=2.9e-05 Score=77.33 Aligned_cols=105 Identities=19% Similarity=0.216 Sum_probs=82.2
Q ss_pred HHHHHHhhcccc-cceeeeeeeeccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccC
Q 003059 542 RMEVATISSTHH-LNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620 (852)
Q Consensus 542 ~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ 620 (852)
..|..++..+++ +++.+++|+|-+ ++|.||...+++...-. .-..-...+|..|.+||.++++.+.+|++...
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~--~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYR--PLSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccc--ccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 357888888876 599999999954 78999998775532100 00001236899999999999999999998655
Q ss_pred CCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 621 DCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 621 ~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
..+.-.|++++|+-+++++++|+.|...+...
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 56888999999999999999999999877654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00012 Score=90.25 Aligned_cols=78 Identities=9% Similarity=0.193 Sum_probs=58.2
Q ss_pred cccccccccceEEEEEECCC---cEEEEEEecCcc--cchHHHHHHHHHhhccc-ccce--eeeeeeeccC---ceeeEE
Q 003059 504 KDKLGAGGFGAVYRGVLANR---TVVAVKQLEGIE--QGEKQFRMEVATISSTH-HLNL--VRLVGFSSEG---KHRLLV 572 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~~~~---~~vavK~l~~~~--~~~~~f~~E~~~l~~l~-h~ni--v~l~g~~~~~---~~~~lV 572 (852)
.++|+.|.+..+|+....++ ..+++|+..... .....+.+|+++++.+. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 35789999999999887654 357777765322 23457889999999985 6654 7888888764 467899
Q ss_pred EeecCCCCH
Q 003059 573 YEFMKNGSL 581 (852)
Q Consensus 573 ~e~~~~gsL 581 (852)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999988653
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00024 Score=76.54 Aligned_cols=76 Identities=9% Similarity=0.046 Sum_probs=57.3
Q ss_pred cccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccc---cceeeeeeeecc---CceeeEEEeecC
Q 003059 504 KDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHH---LNLVRLVGFSSE---GKHRLLVYEFMK 577 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h---~niv~l~g~~~~---~~~~~lV~e~~~ 577 (852)
.+.||.|..+.||+....+++ +.+|..+. ......|..|.+.|+.+.. ..+.+++++|.. .+..+||||+++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGN-PMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eeecCCccceeEEEEEcCCCC-EEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 356999999999998776664 66676442 2234588999999988853 368888888754 367899999999
Q ss_pred CCCH
Q 003059 578 NGSL 581 (852)
Q Consensus 578 ~gsL 581 (852)
++++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8765
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00018 Score=72.82 Aligned_cols=136 Identities=20% Similarity=0.229 Sum_probs=87.4
Q ss_pred cccccccceEEEEEECCCcEEEEEEecCcccc----------hHH---------------HHHHHHHhhccc--ccceee
Q 003059 506 KLGAGGFGAVYRGVLANRTVVAVKQLEGIEQG----------EKQ---------------FRMEVATISSTH--HLNLVR 558 (852)
Q Consensus 506 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~----------~~~---------------f~~E~~~l~~l~--h~niv~ 558 (852)
.|..|--+.||+|.-.++..+|||+....... ... ..+|+..|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 57888888999999888999999998632211 111 134666666653 334444
Q ss_pred eeeeeccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCC
Q 003059 559 LVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDEN 638 (852)
Q Consensus 559 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~ 638 (852)
-+++. .-.|||||+....+.. .......+.......+..++++.+.-|-.. .++||+||..=|||+. +
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pA-----P~LkDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPA-----PRLKDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-D 202 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCC-----CCcccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-C
Confidence 44443 3479999995431100 000111122224555666666666666542 5799999999999999 8
Q ss_pred CceEEeecccccccC
Q 003059 639 YNAKVSDFGLAKLIN 653 (852)
Q Consensus 639 ~~~kl~DFGla~~~~ 653 (852)
+.+.|+||+-+....
T Consensus 203 ~~p~iID~~QaV~~~ 217 (268)
T COG1718 203 GEPYIIDVSQAVTID 217 (268)
T ss_pred CeEEEEECccccccC
Confidence 899999999887653
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00015 Score=75.37 Aligned_cols=73 Identities=16% Similarity=0.212 Sum_probs=46.4
Q ss_pred ccccccccc-eEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhccccc---ceeeeeeeeccC---ceeeEEEeecC
Q 003059 505 DKLGAGGFG-AVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHL---NLVRLVGFSSEG---KHRLLVYEFMK 577 (852)
Q Consensus 505 ~~lG~G~fg-~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~---niv~l~g~~~~~---~~~~lV~e~~~ 577 (852)
+.|+.|+.. .||+. + ..+++|..+. .....++..|++++..+... -+.++++..... ...++|||+++
T Consensus 3 ~~~~~gG~~n~vy~~---~-~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL---G-DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc---C-CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 457777776 48875 2 2466776553 33455789999999877532 344455544332 24589999999
Q ss_pred CCCHH
Q 003059 578 NGSLD 582 (852)
Q Consensus 578 ~gsL~ 582 (852)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 97764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.0002 Score=74.43 Aligned_cols=73 Identities=14% Similarity=0.093 Sum_probs=48.8
Q ss_pred ccccccccceEEEEEECC--CcEEEEEEecCcccchHHHHHHHHHhhcccccc-eeeeeeeeccCceeeEEEeecCCCCH
Q 003059 505 DKLGAGGFGAVYRGVLAN--RTVVAVKQLEGIEQGEKQFRMEVATISSTHHLN-LVRLVGFSSEGKHRLLVYEFMKNGSL 581 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~e~~~~gsL 581 (852)
+.|..|-...+|+....+ +..+++|..........+.++|+.++..+...+ ..++++.+. ..+||||++|.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 457788888999998764 567888977633222233457888888885433 344554433 2489999998776
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00096 Score=66.81 Aligned_cols=130 Identities=21% Similarity=0.263 Sum_probs=89.9
Q ss_pred ccccccccceEEEEEECCCcEEEEEEecCcc-----------------cchHHHHHHHHHhhccc------ccceeeeee
Q 003059 505 DKLGAGGFGAVYRGVLANRTVVAVKQLEGIE-----------------QGEKQFRMEVATISSTH------HLNLVRLVG 561 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-----------------~~~~~f~~E~~~l~~l~------h~niv~l~g 561 (852)
..||+|+.-.||. +++.....||+..... ...+++.+|+.....+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 4699999999996 4555567888876433 23466777877766665 889999999
Q ss_pred eeccCceeeEEEeecCC------CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEe
Q 003059 562 FSSEGKHRLLVYEFMKN------GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL 635 (852)
Q Consensus 562 ~~~~~~~~~lV~e~~~~------gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl 635 (852)
+...+...-+|+|...+ .+|.+++... .++. ...+.+.+.. .||-+ ..|+.+|++|+||++
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~------~~~~-~~~~~L~~f~---~~l~~---~~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG------GLTE-ELRQALDEFK---RYLLD---HHIVIRDLNPHNIVV 151 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcC------CccH-HHHHHHHHHH---HHHHH---cCCeecCCCcccEEE
Confidence 99999888999998643 3678888432 2443 3333334333 44444 569999999999999
Q ss_pred CCCC----ceEEee-cccc
Q 003059 636 DENY----NAKVSD-FGLA 649 (852)
Q Consensus 636 ~~~~----~~kl~D-FGla 649 (852)
.... .+.|+| ||-.
T Consensus 152 ~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred EecCCCceEEEEEeCCCCc
Confidence 5322 466666 5543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00072 Score=64.84 Aligned_cols=128 Identities=16% Similarity=0.223 Sum_probs=85.3
Q ss_pred ccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceee-eeeeeccCceeeEEEeecCCCCH
Q 003059 503 FKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVR-LVGFSSEGKHRLLVYEFMKNGSL 581 (852)
Q Consensus 503 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~-l~g~~~~~~~~~lV~e~~~~gsL 581 (852)
..+.|++|.+|.||++.+.++ .+|+|.-.. +.....++.|+++|..++-.++.+ ++.|..+ .+.|||..|..|
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~-ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGG-EVALKVRRR-DSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEEeeccCc-eEEEEEecC-CcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcch
Confidence 346799999999999999776 577776552 344567899999999988766654 3433322 345999988888
Q ss_pred HHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCC-CCceEeCCCCceEEeecccccc
Q 003059 582 DNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIK-PENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 582 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk-p~NILl~~~~~~kl~DFGla~~ 651 (852)
.+.-... +-++ +..+++.---|.. .+|-|+.|. |...+|-.++.+.|+||.-|+.
T Consensus 100 ~~~~~~~--------~rk~----l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIGG--------DRKH----LLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcc--------cHHH----HHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 7755211 1122 2333333222332 678888875 5555555556999999998874
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00067 Score=71.60 Aligned_cols=139 Identities=14% Similarity=0.106 Sum_probs=78.9
Q ss_pred cccccccceEEEEEECCCcEEEEEEecCcccch-HHHHHHHHHhhcccccce-eeeeeeeccCceeeEEEeecCCCCHHH
Q 003059 506 KLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGE-KQFRMEVATISSTHHLNL-VRLVGFSSEGKHRLLVYEFMKNGSLDN 583 (852)
Q Consensus 506 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~~~gsL~~ 583 (852)
.+..|-...+|+... ++..+++|......... -+..+|.++++.+....+ .++++.+. ..+||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 356677889998874 45568888765322211 246788888888864433 34444432 368999999876542
Q ss_pred H-----------------hhhcccCCccccchhHH-HHHHHhh---------Hhhhhhhcc-----ccCCCcccCCCCCC
Q 003059 584 F-----------------LFANEEGSGKLLNWQSR-FNIALGT---------ARGITYLHE-----ECRDCIVHCDIKPE 631 (852)
Q Consensus 584 ~-----------------l~~~~~~~~~~l~~~~~-~~i~~~i---------a~~L~yLH~-----~~~~~ivH~Dlkp~ 631 (852)
- |+... .....++...+ .+...++ ...+..+.. ..+..++|+|+.|.
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~-~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQP-RFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 1 11111 11112222111 1111111 111111111 11346899999999
Q ss_pred ceEeCCCCceEEeecccccc
Q 003059 632 NILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 632 NILl~~~~~~kl~DFGla~~ 651 (852)
||++++++ ++|+||..+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999877 78999997764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0016 Score=72.23 Aligned_cols=74 Identities=16% Similarity=0.168 Sum_probs=53.7
Q ss_pred ccccccccceEEEEEECCC-cEEEEEEecC------c--ccchHHHHHHHHHhhccc---ccceeeeeeeeccCceeeEE
Q 003059 505 DKLGAGGFGAVYRGVLANR-TVVAVKQLEG------I--EQGEKQFRMEVATISSTH---HLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~------~--~~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV 572 (852)
+.||.|.+..||++...++ +.|+||.-.. . ....+++..|.+.|..+. ..++.+++.+.. +..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence 5699999999999998876 4899997431 1 223456777888887753 345777877743 567899
Q ss_pred EeecCCCC
Q 003059 573 YEFMKNGS 580 (852)
Q Consensus 573 ~e~~~~gs 580 (852)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.00083 Score=72.77 Aligned_cols=143 Identities=20% Similarity=0.157 Sum_probs=84.6
Q ss_pred ccccccccceEEEEEECC-------CcEEEEEEecCcccchHHHHHHHHHhhcccccce-eeeeeeeccCceeeEEEeec
Q 003059 505 DKLGAGGFGAVYRGVLAN-------RTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNL-VRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~ 576 (852)
+.|..|-...+|+....+ ++.+++|+.........+...|.+++..+....+ .++++++.. .+|+||+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 346667777899988655 4778899876543344456788888887753333 355555542 3589999
Q ss_pred CCCCHHHHh-----------------hhcccCC------ccccchhHHHHH--------------------------HHh
Q 003059 577 KNGSLDNFL-----------------FANEEGS------GKLLNWQSRFNI--------------------------ALG 607 (852)
Q Consensus 577 ~~gsL~~~l-----------------~~~~~~~------~~~l~~~~~~~i--------------------------~~~ 607 (852)
+|..+.... +...... ....-|.....+ ...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 887764321 1111000 001111111111 112
Q ss_pred hHhhhhhhcc------ccCCCcccCCCCCCceEeCCC----CceEEeecccccc
Q 003059 608 TARGITYLHE------ECRDCIVHCDIKPENILLDEN----YNAKVSDFGLAKL 651 (852)
Q Consensus 608 ia~~L~yLH~------~~~~~ivH~Dlkp~NILl~~~----~~~kl~DFGla~~ 651 (852)
+...+..|.. ..+..++|+|+.+.|||++++ +.++|+||..+..
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 2222333321 134679999999999999985 8899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0017 Score=64.54 Aligned_cols=124 Identities=23% Similarity=0.310 Sum_probs=89.1
Q ss_pred hccccccccccccc-ceEEEEEECCCcEEEEEEecC-----c-------c----------cchHHHHHHHHHhhccc---
Q 003059 499 STKGFKDKLGAGGF-GAVYRGVLANRTVVAVKQLEG-----I-------E----------QGEKQFRMEVATISSTH--- 552 (852)
Q Consensus 499 ~~~~~~~~lG~G~f-g~Vy~~~~~~~~~vavK~l~~-----~-------~----------~~~~~f~~E~~~l~~l~--- 552 (852)
+...|.+.||.|.- |.|||+.+.+ +.+|+|.+.. . . .-..-|..|....++|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g-~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDG-RIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECC-eEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67788999999999 9999999855 5899999321 0 0 01134788999888885
Q ss_pred ccce--eeeeeeeccC------------------ceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhh
Q 003059 553 HLNL--VRLVGFSSEG------------------KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGI 612 (852)
Q Consensus 553 h~ni--v~l~g~~~~~------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L 612 (852)
+.++ |+.+||..-. ..+.||.||.+... .+. .+-+.+|.+-|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~----~~~~~~~~~dl 177 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQ----IRDIPQMLRDL 177 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccc----hhHHHHHHHHH
Confidence 4455 8999986211 13457888875532 111 23356777888
Q ss_pred hhhccccCCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 613 ~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
..+|. .+|+-+|+++.|.. .-||+|||.+
T Consensus 178 ~~~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 178 KILHK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHH---CCeeeccCcccccc-----CCEEEecccC
Confidence 88998 89999999999986 5689999854
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.00046 Score=57.22 Aligned_cols=53 Identities=21% Similarity=0.367 Sum_probs=40.6
Q ss_pred eeecccccccCCcccccccccccChhhHHhhhccCCcEEEEEeccCCccceEeccCC
Q 003059 340 MLELPHTKFLTFQPELSSQVFFVGISACRLNCLVTGSCVASTSLSDGTGLCYLKTPD 396 (852)
Q Consensus 340 f~~l~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~C~~~~~~ 396 (852)
|..+++++++..+... ....+.++|++.|+.||+|.||.|. .+.+.|+++...
T Consensus 6 ~~~~~~~~~~g~d~~~---~~~~s~~~Cq~~C~~~~~C~afT~~-~~~~~C~lk~~~ 58 (73)
T cd01100 6 FRQGSNVDFRGGDLST---VFASSAEQCQAACTADPGCLAFTYN-TKSKKCFLKSSE 58 (73)
T ss_pred ccccCCCccccCCcce---eecCCHHHHHHHcCCCCCceEEEEE-CCCCeEEcccCC
Confidence 4445677777766542 2356899999999999999999997 345789998864
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0036 Score=67.54 Aligned_cols=143 Identities=15% Similarity=0.159 Sum_probs=86.0
Q ss_pred ccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccc--eeeeeee------eccCceeeEEEeec
Q 003059 505 DKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLN--LVRLVGF------SSEGKHRLLVYEFM 576 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~g~------~~~~~~~~lV~e~~ 576 (852)
+.|..|....+|+....++ .+++|+... ....+...|++++..+++.+ +.+++.. ....+..++|++|+
T Consensus 20 ~~i~~G~~n~~y~v~~~~~-~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 20 EGISAGIENTNYFVTTDSG-RYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred ecccCccccceEEEEeCCC-cEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 4577888889999876555 588888764 33456777888888775433 4444432 12344668999999
Q ss_pred CCCCHHH----Hh----------hhcccC------CccccchhHHHH----------HHHhhHhhhhhhcc----ccCCC
Q 003059 577 KNGSLDN----FL----------FANEEG------SGKLLNWQSRFN----------IALGTARGITYLHE----ECRDC 622 (852)
Q Consensus 577 ~~gsL~~----~l----------~~~~~~------~~~~l~~~~~~~----------i~~~ia~~L~yLH~----~~~~~ 622 (852)
+|..+.. .+ +..... ......|..... ....+...+.++.+ ..+.+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 9877532 01 110000 001122222110 11112233344432 22357
Q ss_pred cccCCCCCCceEeCCCCceEEeeccccc
Q 003059 623 IVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 623 ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
++|+|+.|.|||++++..+.|.||+.+.
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhc
Confidence 9999999999999998778999998775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0051 Score=67.21 Aligned_cols=143 Identities=11% Similarity=0.137 Sum_probs=78.5
Q ss_pred ccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccc--eeeeee------eeccCceeeEEEeec
Q 003059 505 DKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLN--LVRLVG------FSSEGKHRLLVYEFM 576 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~g------~~~~~~~~~lV~e~~ 576 (852)
+.|..|....+|+....++ .+++|+.+ ....+....|+.++..|...+ +.+++. +....+..++++||+
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 4577788789999887666 47888876 222334444555555553222 333332 122345678999999
Q ss_pred CCCCHHH-----------Hh---hhcccC------Cccccch-hHHHH------------HHHh-hHhhhhhhcc----c
Q 003059 577 KNGSLDN-----------FL---FANEEG------SGKLLNW-QSRFN------------IALG-TARGITYLHE----E 618 (852)
Q Consensus 577 ~~gsL~~-----------~l---~~~~~~------~~~~l~~-~~~~~------------i~~~-ia~~L~yLH~----~ 618 (852)
+|..+.. .| +..... ....+.| ..... ...+ +...++.+.. .
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 9875421 11 111100 0011112 11111 1111 1112222221 1
Q ss_pred cCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 619 CRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 619 ~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
.+.+++|+|+++.|||++.+....|+||+.+.
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 34689999999999999977666899999775
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0028 Score=67.51 Aligned_cols=73 Identities=18% Similarity=0.331 Sum_probs=49.4
Q ss_pred cccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhccc---ccceeeeeeeeccCceeeEEEeecCCC
Q 003059 504 KDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTH---HLNLVRLVGFSSEGKHRLLVYEFMKNG 579 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~e~~~~g 579 (852)
.+.|+.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+.+++++....+..+||+||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 3568989999999987 567789999876 444567899999888884 446788899888777889999999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.013 Score=63.65 Aligned_cols=144 Identities=15% Similarity=0.192 Sum_probs=82.6
Q ss_pred ccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccc--eeeeeeee------ccCceeeEEEeec
Q 003059 505 DKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLN--LVRLVGFS------SEGKHRLLVYEFM 576 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~g~~------~~~~~~~lV~e~~ 576 (852)
+.++.|-...+|+....+++ +++|+.... ...++...|++++..|.... +.+++... ...+..++|+||+
T Consensus 28 ~~~~~G~~n~~y~v~t~~~~-~vLK~~~~~-~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i 105 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVGR-YILTLYEKR-VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL 105 (307)
T ss_pred cccCCccccceEEEEeCCCc-EEEEEecCC-CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence 45777777899998766554 667876532 12345566777776664322 34444321 2245678999999
Q ss_pred CCCCHHH-----------H---hhhcccCC--c-----cccchhHHHH------------HHHhhHhhhhhhcc----cc
Q 003059 577 KNGSLDN-----------F---LFANEEGS--G-----KLLNWQSRFN------------IALGTARGITYLHE----EC 619 (852)
Q Consensus 577 ~~gsL~~-----------~---l~~~~~~~--~-----~~l~~~~~~~------------i~~~ia~~L~yLH~----~~ 619 (852)
+|..+.. . ++.....- . ..-.|..... ....+.+.++++.. ..
T Consensus 106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~ 185 (307)
T TIGR00938 106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL 185 (307)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 8865421 0 11111100 0 0112221110 01112334444432 23
Q ss_pred CCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 620 ~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+.+++|+|+++.||++++++...|.||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 4789999999999999998877899999775
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.0011 Score=69.26 Aligned_cols=134 Identities=14% Similarity=0.160 Sum_probs=88.1
Q ss_pred ccccccccccccceEEEEEECCCcEEEEEEecCc-------c----------cc------hHHHHHHHHHhhcccc--cc
Q 003059 501 KGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGI-------E----------QG------EKQFRMEVATISSTHH--LN 555 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~-------~----------~~------~~~f~~E~~~l~~l~h--~n 555 (852)
+.+.++||-|--+.||.+...+|++.++|.-.-. . .. .-...+|...|+.|.. --
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 4567899999999999999999999998853210 0 00 0123467777877753 23
Q ss_pred eeeeeeeeccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEe
Q 003059 556 LVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL 635 (852)
Q Consensus 556 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl 635 (852)
+.+.++++ ..++|||++.+-.|...-+ ..+..+++. .+..-+.-|.. +|+||+|..-=||+|
T Consensus 174 VPkpiD~~----RH~Vvmelv~g~Pl~~v~~--------v~d~~~ly~---~lm~~Iv~la~---~GlIHgDFNEFNimv 235 (465)
T KOG2268|consen 174 VPKPIDHN----RHCVVMELVDGYPLRQVRH--------VEDPPTLYD---DLMGLIVRLAN---HGLIHGDFNEFNIMV 235 (465)
T ss_pred CCCccccc----ceeeHHHhhcccceeeeee--------cCChHHHHH---HHHHHHHHHHH---cCceecccchheeEE
Confidence 44555443 4589999998876654321 122222222 22222233333 899999999999999
Q ss_pred CCCCceEEeeccccccc
Q 003059 636 DENYNAKVSDFGLAKLI 652 (852)
Q Consensus 636 ~~~~~~kl~DFGla~~~ 652 (852)
++++.++++||--....
T Consensus 236 ~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMVST 252 (465)
T ss_pred ecCCCEEEeechHhhcc
Confidence 99999999999765443
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.0096 Score=65.60 Aligned_cols=142 Identities=20% Similarity=0.190 Sum_probs=82.3
Q ss_pred cccccccceEEEEEECC-----CcEEEEEEecCcccchHHHHHHHHHhhccccccee-eeeeeeccCceeeEEEeecCCC
Q 003059 506 KLGAGGFGAVYRGVLAN-----RTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLV-RLVGFSSEGKHRLLVYEFMKNG 579 (852)
Q Consensus 506 ~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~e~~~~g 579 (852)
.|-.|-.-.+|+....+ ++.|++|.........-+...|..++..+...++. ++++.+..+ .|+||+++.
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~ 118 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR 118 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence 45557778899987532 35788887764332222347788888888654444 556665433 589999887
Q ss_pred CHHHH-----------------hhhccc-CCccccchhHHHHHHHhhH-----------------hhhhh----hcc-cc
Q 003059 580 SLDNF-----------------LFANEE-GSGKLLNWQSRFNIALGTA-----------------RGITY----LHE-EC 619 (852)
Q Consensus 580 sL~~~-----------------l~~~~~-~~~~~l~~~~~~~i~~~ia-----------------~~L~y----LH~-~~ 619 (852)
+|..- +|.... .......|....++..++. ..+.. +.. ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 76421 111110 1111222333333332211 11111 121 12
Q ss_pred CCCcccCCCCCCceEeCC-CCceEEeecccccc
Q 003059 620 RDCIVHCDIKPENILLDE-NYNAKVSDFGLAKL 651 (852)
Q Consensus 620 ~~~ivH~Dlkp~NILl~~-~~~~kl~DFGla~~ 651 (852)
+..++|+|+++.|||+++ ++.++|+||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 356899999999999986 47899999988764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.0096 Score=72.13 Aligned_cols=196 Identities=18% Similarity=0.168 Sum_probs=128.9
Q ss_pred HHHHHHHhhcccccceeeeeeeeccCcee----eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhc
Q 003059 541 FRMEVATISSTHHLNLVRLVGFSSEGKHR----LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLH 616 (852)
Q Consensus 541 f~~E~~~l~~l~h~niv~l~g~~~~~~~~----~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH 616 (852)
.+.|.+.+.++.|+|++.++.|-.++... .+..|++..-++...+.. ...++....+.+..++.+||+|+|
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-----v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-----VGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-----ccccCHHHHHHHHHHHhhhHHHHH
Confidence 45677788899999999999987654322 345667777777777642 335778888889999999999999
Q ss_pred cccCCCcccCCCCCC---ceEeCCCCceEEe--ecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCC--Cccch
Q 003059 617 EECRDCIVHCDIKPE---NILLDENYNAKVS--DFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITS--KSDVY 689 (852)
Q Consensus 617 ~~~~~~ivH~Dlkp~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--ksDv~ 689 (852)
+ ....|.-+..+ +...+.++...++ ||+..+.+..... .....-+..+.++|......+.. ..|+|
T Consensus 304 ~---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~----~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 304 S---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK----SFSDLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred H---hccceeEEecccccccccCccceeecchhhhcccccCCCccc----chhhcCccccccccccccccchhhhhhHHH
Confidence 8 34455444444 4445566667776 8888776543221 11122345677888776655544 47999
Q ss_pred hhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 003059 690 SYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMG 769 (852)
Q Consensus 690 s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ 769 (852)
.+|..+..+..|..+-.... ....+++... .. ........|+..++++|+...
T Consensus 377 ~lgll~~~~~~~~~i~~~~~------------------~~~~~l~~~~-----~~----~~~d~~~~~~~~~~~~Rl~~~ 429 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDISEKSA------------------VPVSLLDVLS-----TS----ELLDALPKCLDEDSEERLSAL 429 (1351)
T ss_pred HHHHHHhhhhhcCccccccc------------------chhhhhcccc-----ch----hhhhhhhhhcchhhhhccchh
Confidence 99999999998876532111 0011111110 00 234455569999999999999
Q ss_pred HHHHHH
Q 003059 770 KVVQML 775 (852)
Q Consensus 770 ev~~~L 775 (852)
+++...
T Consensus 430 ~ll~~~ 435 (1351)
T KOG1035|consen 430 ELLTHP 435 (1351)
T ss_pred hhhhch
Confidence 988654
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.012 Score=62.57 Aligned_cols=32 Identities=34% Similarity=0.548 Sum_probs=26.5
Q ss_pred CCcccCCCCCCceEeCCCCc-eEEeeccccccc
Q 003059 621 DCIVHCDIKPENILLDENYN-AKVSDFGLAKLI 652 (852)
Q Consensus 621 ~~ivH~Dlkp~NILl~~~~~-~kl~DFGla~~~ 652 (852)
..++|+|+++.|||++++++ .-|.||+.+..-
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 45899999999999997555 569999988753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.0027 Score=78.21 Aligned_cols=161 Identities=16% Similarity=0.077 Sum_probs=116.2
Q ss_pred HHHHHHhhcccccceeeeeeeec--cCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhcccc
Q 003059 542 RMEVATISSTHHLNLVRLVGFSS--EGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619 (852)
Q Consensus 542 ~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~ 619 (852)
..|...++...|+++.....-.. +..+.+.+++|+..|.+...|.+... ....++..-+...-.+...+..-.|...
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~e-e~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLE-ESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccc-cCCcchhchHHHHHHHHHhccchhhhcc
Confidence 34445556678998877665443 34577899999999999999876543 2334444444333334355555555432
Q ss_pred --CCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHH
Q 003059 620 --RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLE 697 (852)
Q Consensus 620 --~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~e 697 (852)
..-.+|+++|+-|.+|..+.++|+.++|+.+...+. ........+++-|+.|+......++.|+|+|..++.+|+
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~---~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV---LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCch---HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 234799999999999999999999999999943321 122334567788999999999999999999999999999
Q ss_pred HHhCCcccc
Q 003059 698 IVSGRRNFE 706 (852)
Q Consensus 698 lltG~~p~~ 706 (852)
+--|..+|.
T Consensus 1433 rs~~n~~fi 1441 (2724)
T KOG1826|consen 1433 RSDGNAYFI 1441 (2724)
T ss_pred HhcccHHHH
Confidence 988887763
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.039 Score=59.30 Aligned_cols=140 Identities=20% Similarity=0.286 Sum_probs=78.8
Q ss_pred ceEEEEEECCCcEEEEEEec---CcccchHHHHHHHHHhhcccc--cceeeeeeeeccCc--eeeEEEeecCCCCHHHH-
Q 003059 513 GAVYRGVLANRTVVAVKQLE---GIEQGEKQFRMEVATISSTHH--LNLVRLVGFSSEGK--HRLLVYEFMKNGSLDNF- 584 (852)
Q Consensus 513 g~Vy~~~~~~~~~vavK~l~---~~~~~~~~f~~E~~~l~~l~h--~niv~l~g~~~~~~--~~~lV~e~~~~gsL~~~- 584 (852)
-.+|..... +++.+++ .. ..........+|..+|+.+.- .-+...+++|.++. ..+.||+|++|..+...
T Consensus 39 n~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~ 116 (321)
T COG3173 39 NDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSAL 116 (321)
T ss_pred cceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcC
Confidence 344544433 6667777 33 222333455677778777642 34455677787766 77999999988432211
Q ss_pred -----------------hhh---cc----c--------CCccccchhHHHHHHH--------hhHhhhhhhccc-----c
Q 003059 585 -----------------LFA---NE----E--------GSGKLLNWQSRFNIAL--------GTARGITYLHEE-----C 619 (852)
Q Consensus 585 -----------------l~~---~~----~--------~~~~~l~~~~~~~i~~--------~ia~~L~yLH~~-----~ 619 (852)
|.. -. . ..++.-.|...++.++ ....-..+|++. .
T Consensus 117 ~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~ 196 (321)
T COG3173 117 PPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAG 196 (321)
T ss_pred CcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCC
Confidence 110 00 0 0011112222221111 111222333321 2
Q ss_pred CCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 620 ~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
+..++|+|+++.||+++.+..+-|.||+++..-.+
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred CceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 35699999999999999999999999999986544
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.061 Score=58.42 Aligned_cols=141 Identities=16% Similarity=0.240 Sum_probs=84.8
Q ss_pred ccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccce---ee---eeee--eccC--ceeeEEEeec
Q 003059 507 LGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNL---VR---LVGF--SSEG--KHRLLVYEFM 576 (852)
Q Consensus 507 lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~ni---v~---l~g~--~~~~--~~~~lV~e~~ 576 (852)
|.+ .-..+|+....+++. ++|..+.. ....+...|++.+..+.-..| ++ +-|- ..-. .+.+-|++|+
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l 110 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL 110 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence 444 456789998888876 88888765 666777778888776642221 12 1121 1223 3788999999
Q ss_pred CCCCHHH-H--------------hhhc-------ccCCccccchhH-------------HHHHHHhhHhhhhhhccc---
Q 003059 577 KNGSLDN-F--------------LFAN-------EEGSGKLLNWQS-------------RFNIALGTARGITYLHEE--- 618 (852)
Q Consensus 577 ~~gsL~~-~--------------l~~~-------~~~~~~~l~~~~-------------~~~i~~~ia~~L~yLH~~--- 618 (852)
+|..+.. . |+.. .........|.. ......++...+..+++.
T Consensus 111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~ 190 (331)
T COG2334 111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA 190 (331)
T ss_pred CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence 9988872 1 1110 011112344441 001223333344444332
Q ss_pred -cCCC---cccCCCCCCceEeCCCCc-eEEeeccccc
Q 003059 619 -CRDC---IVHCDIKPENILLDENYN-AKVSDFGLAK 650 (852)
Q Consensus 619 -~~~~---ivH~Dlkp~NILl~~~~~-~kl~DFGla~ 650 (852)
.+.. +||+|+.|.||+++.+.. +.+.||+-+.
T Consensus 191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1223 999999999999999885 8999999775
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.015 Score=59.23 Aligned_cols=125 Identities=19% Similarity=0.181 Sum_probs=62.4
Q ss_pred CcEEEEEEecCcccchHHHHHHHHHhhcccccce-eeeeeeeccCceeeEEEeecCCCCHHHH-------h---------
Q 003059 523 RTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNL-VRLVGFSSEGKHRLLVYEFMKNGSLDNF-------L--------- 585 (852)
Q Consensus 523 ~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~~~gsL~~~-------l--------- 585 (852)
.+.|+||+........-....|..+++.+...++ .++++++.++ +|+||+++..|..- +
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~ 77 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLAK 77 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHHH
Confidence 3568888877555555667789999988865544 4566655443 57799877665221 1
Q ss_pred -hhccc--CCccccchhHHHHH----------------------HHhhHhhhhhhcc-----ccCCCcccCCCCCCceEe
Q 003059 586 -FANEE--GSGKLLNWQSRFNI----------------------ALGTARGITYLHE-----ECRDCIVHCDIKPENILL 635 (852)
Q Consensus 586 -~~~~~--~~~~~l~~~~~~~i----------------------~~~ia~~L~yLH~-----~~~~~ivH~Dlkp~NILl 635 (852)
|.... .....--|....++ ...+..-+..+.+ ..+..+.|.|+.+.|||+
T Consensus 78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~ 157 (211)
T PF01633_consen 78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI 157 (211)
T ss_dssp HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence 11000 01111112222222 0111111111111 112468999999999999
Q ss_pred -CCCCceEEeecccccc
Q 003059 636 -DENYNAKVSDFGLAKL 651 (852)
Q Consensus 636 -~~~~~~kl~DFGla~~ 651 (852)
+.++.++|+||..+..
T Consensus 158 ~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 158 NNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp TSSSSCEEE--GTT-EE
T ss_pred ccCCCeEEEecHHHHhh
Confidence 8899999999987753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.04 Score=59.85 Aligned_cols=32 Identities=25% Similarity=0.390 Sum_probs=28.8
Q ss_pred CCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 620 ~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
+.+++|+|+.+.|||+++++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 46899999999999999999999999987764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.067 Score=58.08 Aligned_cols=30 Identities=30% Similarity=0.349 Sum_probs=26.1
Q ss_pred CCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 620 ~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+.+++|+|+++.||+++. +.+.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 367999999999999988 678999998665
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.051 Score=59.55 Aligned_cols=143 Identities=14% Similarity=0.179 Sum_probs=80.8
Q ss_pred ccccccccceEEEEEECC----CcEEEEEEecCcccchHHHHHHHHHhhccccccee-eeeeeeccCceeeEEEeecCCC
Q 003059 505 DKLGAGGFGAVYRGVLAN----RTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLV-RLVGFSSEGKHRLLVYEFMKNG 579 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~e~~~~g 579 (852)
+.|..|-.-.+|+....+ +..|++|+........-+..+|..++..+..-++- ++++++.. + +|.+|+++.
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g~ 95 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINAR 95 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcCC
Confidence 345557777889887543 23788888764332223346788888888655553 56666532 2 589999776
Q ss_pred CHHHH-------h----------hhcccC-CccccchhHHHHHHHhhH-------------------------hhhhhhc
Q 003059 580 SLDNF-------L----------FANEEG-SGKLLNWQSRFNIALGTA-------------------------RGITYLH 616 (852)
Q Consensus 580 sL~~~-------l----------~~~~~~-~~~~l~~~~~~~i~~~ia-------------------------~~L~yLH 616 (852)
.|..- + |..... ...+--|..+.++..++. ..+..+.
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 65221 1 111100 111222333333322221 1111111
Q ss_pred -c-ccCCCcccCCCCCCceEeCC-CCceEEeecccccc
Q 003059 617 -E-ECRDCIVHCDIKPENILLDE-NYNAKVSDFGLAKL 651 (852)
Q Consensus 617 -~-~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGla~~ 651 (852)
. ..+.-+.|.|+.+.|||+++ ++.++++||..+-.
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 11234799999999999975 57899999998764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 852 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-59 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-58 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-41 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-41 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-41 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-39 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-38 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-24 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-22 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-22 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-21 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-21 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-21 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-21 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-20 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-18 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-18 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-18 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-17 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-15 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-09 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-07 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-07 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 5e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-07 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 7e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 9e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 9e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 6e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 6e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 7e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 9e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 427 bits (1099), Expect = e-144
Identities = 136/319 (42%), Positives = 191/319 (59%), Gaps = 11/319 (3%)
Query: 471 FVSLSAQYALLEYASGAPVQFSYKELQRSTKGF--KDKLGAGGFGAVYRGVLANRTVVAV 528
F + A+ E G +FS +ELQ ++ F K+ LG GGFG VY+G LA+ T+VAV
Sbjct: 1 FFDVPAEE-DPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAV 59
Query: 529 KQL-EGIEQG-EKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLF 586
K+L E QG E QF+ EV IS H NL+RL GF RLLVY +M NGS+ + L
Sbjct: 60 KRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR 119
Query: 587 ANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDF 646
E L +W R IALG+ARG+ YLH+ C I+H D+K NILLDE + A V DF
Sbjct: 120 ERPESQPPL-DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 178
Query: 647 GLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFE 706
GLAKL+ H T T+VRGT G++APE+L+ + K+DV+ YG++LLE+++G+R F+
Sbjct: 179 GLAKLM-DYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236
Query: 707 VSQETNRKKFSL--WAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQ 764
+++ N L W ++ ++ +VD L + E+V + IQV+ C Q P +
Sbjct: 237 LARLANDDDVMLLDWVKGLLKEKKLEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPME 295
Query: 765 RPMMGKVVQMLEGITEIEK 783
RP M +VV+MLEG E+
Sbjct: 296 RPKMSEVVRMLEGDGLAER 314
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 376 bits (969), Expect = e-125
Identities = 118/315 (37%), Positives = 168/315 (53%), Gaps = 30/315 (9%)
Query: 481 LEYASGAPVQFSYKELQRSTKGFKD--------KLGAGGFGAVYRGVLANRTVVAVKQLE 532
LE + FS+ EL+ T F + K+G GGFG VY+G + N T VAVK+L
Sbjct: 5 LEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLA 63
Query: 533 -----GIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFA 587
E+ ++QF E+ ++ H NLV L+GFSS+G LVY +M NGSL + L
Sbjct: 64 AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS- 122
Query: 588 NEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFG 647
L+W R IA G A GI +LHE + +H DIK NILLDE + AK+SDFG
Sbjct: 123 -CLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFG 178
Query: 648 LAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEV 707
LA+ T + + GT Y+APE L IT KSD+YS+G+VLLEI++G
Sbjct: 179 LARASEKFAQTVMT-SRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAV-- 234
Query: 708 SQETNRKKFSL--WAYEEF-EKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQ 764
+ +R+ L E E+ ++ +DK + D D V V+ C+ E+ ++
Sbjct: 235 --DEHREPQLLLDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNK 290
Query: 765 RPMMGKVVQMLEGIT 779
RP + KV Q+L+ +T
Sbjct: 291 RPDIKKVQQLLQEMT 305
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 368 bits (946), Expect = e-121
Identities = 103/298 (34%), Positives = 160/298 (53%), Gaps = 9/298 (3%)
Query: 490 QFSYKELQRSTKGFKDK--LGAGGFGAVYRGVLANRTVVAVKQL-EGIEQGEKQFRMEVA 546
+ +L+ +T F K +G G FG VY+GVL + VA+K+ QG ++F E+
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 547 TISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIAL 606
T+S H +LV L+GF E +L+Y++M+NG+L L+ + ++W+ R I +
Sbjct: 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY-GSDLPTMSMSWEQRLEICI 146
Query: 607 GTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVR 666
G ARG+ YLH I+H D+K NILLDEN+ K++DFG++K D H + T V+
Sbjct: 147 GAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS-TVVK 202
Query: 667 GTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEK 726
GT GY+ PE+ +T KSDVYS+G+VL E++ R S + WA E
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262
Query: 727 GNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKP 784
G ++ IVD +LA + E + + + C+ RP MG V+ LE +++
Sbjct: 263 GQLEQIVDPNLAD-KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 245 bits (626), Expect = 2e-74
Identities = 75/317 (23%), Positives = 123/317 (38%), Gaps = 31/317 (9%)
Query: 489 VQFSYKELQRSTKGFK--DKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVA 546
V + L + + + G FG V++ L N V AVK ++ Q EV
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYV-AVKIFPIQDKQSWQNEYEVY 70
Query: 547 TISSTHHLNLVRLVGFSSEGKH----RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRF 602
++ H N+++ +G G L+ F + GSL +FL AN +++W
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNELC 124
Query: 603 NIALGTARGITYLHEE-------CRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655
+IA ARG+ YLHE+ + I H DIK +N+LL N A ++DFGLA
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA- 183
Query: 656 DHRHRTLTSVRGTRGYLAPEWL-----ANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQE 710
GTR Y+APE L + D+Y+ G+VL E+ S + +
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
Query: 711 TNRKKFSLWAYEEFEKGNVKGIVDKSLA----GEDVDIEQVMRAI-QVSFWCIQEQPSQR 765
F + +++ +V + M + + C R
Sbjct: 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 766 PMMGKVVQMLEGITEIE 782
G V + + + +
Sbjct: 304 LSAGCVGERITQMQRLT 320
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 3e-65
Identities = 79/304 (25%), Positives = 134/304 (44%), Gaps = 44/304 (14%)
Query: 493 YKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTH 552
YKE++ ++ +G G FG V + + V A+KQ+E E K F +E+ +S +
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKAKWRAKDV-AIKQIES-ESERKAFIVELRQLSRVN 59
Query: 553 HLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGI 612
H N+V+L G LV E+ + GSL N L + + L ++G+
Sbjct: 60 HPNIVKLYGACL--NPVCLVMEYAEGGSLYNVL--HGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYN-AKVSDFGLAKLINPKDHRHRTLTSVRGTRGY 671
YLH ++H D+KP N+LL K+ DFG A I +T+ +G+ +
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI------QTHMTNNKGSAAW 169
Query: 672 LAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731
+APE + K DV+S+G++L E+++ R+ F+ + A+ +
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD--------EIGGPAFR------IMW 215
Query: 732 IVDKSL-----AGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPPA 786
V IE +M C + PSQRP M ++V+++ + P A
Sbjct: 216 AVHNGTRPPLIKNLPKPIESLMTR------CWSKDPSQRPSMEEIVKIMTHL-MRYFPGA 268
Query: 787 PKAL 790
+ L
Sbjct: 269 DEPL 272
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 8e-65
Identities = 79/302 (26%), Positives = 137/302 (45%), Gaps = 43/302 (14%)
Query: 493 YKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQL---EGIEQGEKQFRMEVATIS 549
+ +L K+K+GAG FG V+R + VAVK L + + +F EVA +
Sbjct: 36 WCDLN-----IKEKIGAGSFGTVHRAEWHG-SDVAVKILMEQDFHAERVNEFLREVAIMK 89
Query: 550 STHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTA 609
H N+V +G ++ + +V E++ GSL L + + + L+ + R ++A A
Sbjct: 90 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG--AREQLDERRRLSMAYDVA 147
Query: 610 RGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR 669
+G+ YLH IVH ++K N+L+D+ Y KV DFGL++L K + S GT
Sbjct: 148 KGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL---KASTFLSSKSAAGTP 203
Query: 670 GYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNV 729
++APE L + P KSDVYS+G++L E+ + ++ + V
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ----------------PWGNLNPAQV 247
Query: 730 -KGIVDKSL-----AGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEK 783
+ K + + ++ C +P +RP ++ +L + +
Sbjct: 248 VAAVGFKCKRLEIPRNLNPQVAAIIEG------CWTNEPWKRPSFATIMDLLRPLIKSAV 301
Query: 784 PP 785
PP
Sbjct: 302 PP 303
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-59
Identities = 81/305 (26%), Positives = 123/305 (40%), Gaps = 58/305 (19%)
Query: 493 YKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQL-----EGIEQGEKQFRMEVAT 547
+ EL ++ +G GGFG VYR VAVK E I Q + R E
Sbjct: 6 FAELT-----LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 548 ISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALG 607
+ H N++ L G + + LV EF + G L+ L SGK + N A+
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL------SGKRIPPDILVNWAVQ 113
Query: 608 TARGITYLHEECRDCIVHCDIKPENILLDE--------NYNAKVSDFGLAKLINPKDHRH 659
ARG+ YLH+E I+H D+K NIL+ + N K++DFGLA+ +
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-----R 168
Query: 660 RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLW 719
T S G ++APE + + SDV+SYG++L E+++G
Sbjct: 169 TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV---------------- 212
Query: 720 AYEEFEKGNV-KGIVDKSL-----AGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773
+ + V G+ L + ++M C P RP ++
Sbjct: 213 PFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMED------CWNPDPHSRPSFTNILD 266
Query: 774 MLEGI 778
L I
Sbjct: 267 QLTTI 271
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-59
Identities = 70/345 (20%), Positives = 119/345 (34%), Gaps = 59/345 (17%)
Query: 489 VQFSYKELQRSTKGFK--DKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRME-- 544
++ + E K + +G G +GAVY+G L R V AVK + F E
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPV-AVKVFS--FANRQNFINEKN 57
Query: 545 VATISSTHHLNLVRLVGFSSEG-----KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQ 599
+ + H N+ R + LLV E+ NGSL +L + +W
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT------SDWV 111
Query: 600 SRFNIALGTARGITYLHEE------CRDCIVHCDIKPENILLDENYNAKVSDFGLAKL-- 651
S +A RG+ YLH E + I H D+ N+L+ + +SDFGL+
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 652 ---INPKDHRHRTLTSVRGTRGYLAPEWLANL-------PITSKSDVYSYGMVLLEIVSG 701
+ S GT Y+APE L + D+Y+ G++ EI
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
Query: 702 RRNFEVSQETNRKK--FSLWAYEEFEKGNVKGIVD------------KSLAGEDVDIEQV 747
+ + + F +++ +V K + +++
Sbjct: 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291
Query: 748 MRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI---TEIEKPPAPKA 789
+ C + R + + + E K +P A
Sbjct: 292 IED------CWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTA 330
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 3e-59
Identities = 69/321 (21%), Positives = 123/321 (38%), Gaps = 58/321 (18%)
Query: 494 KELQRSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI-EQGEKQFRMEVATISST 551
+ + S + LG G FG + V+ +K+L E+ ++ F EV +
Sbjct: 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64
Query: 552 HHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARG 611
H N+++ +G + K + E++K G+L + + + W R + A A G
Sbjct: 65 EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ----YPWSQRVSFAKDIASG 120
Query: 612 ITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI-----------NPKDHRHR 660
+ YLH I+H D+ N L+ EN N V+DFGLA+L+ + K +
Sbjct: 121 MAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 661 TLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA 720
+V G ++APE + K DV+S+G+VL EI+ A
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN----------------A 221
Query: 721 YEEFEKGNVKGIVDKSLAGEDVDIEQVMRA----------IQVSFWCIQEQPSQRPMMGK 770
++ + +++ + ++ C P +RP K
Sbjct: 222 DPDYLPRTMDFG---------LNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVK 272
Query: 771 VVQMLEGI---TEIEKPPAPK 788
+ LE + P P+
Sbjct: 273 LEHWLETLRMHLAGHLPLGPQ 293
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 6e-59
Identities = 74/310 (23%), Positives = 127/310 (40%), Gaps = 64/310 (20%)
Query: 493 YKELQRSTKGFKDKLGAGGFGAVYRGVLANR-TVVAVKQLEGIEQGE--------KQFRM 543
E++ ++ ++G GGFG V++G L +VVA+K L + ++F+
Sbjct: 18 DNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 544 EVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFN 603
EV +S+ +H N+V+L G +V EF+ G L + L + W +
Sbjct: 73 EVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRL----LDKAHPIKWSVKLR 126
Query: 604 IALGTARGITYLHEECRDCIVHCDIKPENILLDE-----NYNAKVSDFGLAKLINPKDHR 658
+ L A GI Y+ IVH D++ NI L AKV+DFGL++
Sbjct: 127 LMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ------S 179
Query: 659 HRTLTSVRGTRGYLAPEWLA--NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKF 716
+++ + G ++APE + T K+D YS+ M+L I++G
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG------------- 226
Query: 717 SLWAYEEFEKGNVKGIVDKSLAGE--------DVDIEQVMRAIQVSFWCIQEQPSQRPMM 768
++E+ G +K I G + V+ C P +RP
Sbjct: 227 ---PFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIEL------CWSGDPKKRPHF 277
Query: 769 GKVVQMLEGI 778
+V+ L +
Sbjct: 278 SYIVKELSEL 287
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 5e-58
Identities = 74/282 (26%), Positives = 138/282 (48%), Gaps = 29/282 (10%)
Query: 503 FKDKLGAGGFGAVYRGVLANRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRL 559
++G+G FG VY+G VAVK L Q + F+ EV + T H+N++
Sbjct: 28 VGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
+G+S+ +V ++ + SL + L A+E + +IA TARG+ YLH +
Sbjct: 86 MGYSTAP-QLAIVTQWCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN 679
I+H D+K NI L E+ K+ DFGLA + + + G+ ++APE +
Sbjct: 141 ---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS-RWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 680 ---LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736
P + +SDVY++G+VL E+++G+ + NR + E +G++ + K
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYS--NINNRDQ----IIEMVGRGSLSPDLSKV 250
Query: 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778
+ ++++M C++++ +RP +++ +E +
Sbjct: 251 RSNCPKRMKRLMAE------CLKKKRDERPSFPRILAEIEEL 286
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 7e-57
Identities = 58/302 (19%), Positives = 115/302 (38%), Gaps = 54/302 (17%)
Query: 493 YKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQL---EGIEQGEKQFRMEVATIS 549
+K+L F KL G +++G + VK L + + + F E +
Sbjct: 9 FKQLN-----FLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLR 62
Query: 550 STHHLNLVRLVGFSSE--GKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALG 607
H N++ ++G H L+ +M GSL N L EG+ +++ AL
Sbjct: 63 IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL---HEGTNFVVDQSQAVKFALD 119
Query: 608 TARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRG 667
ARG+ +LH I + ++++DE+ A++S +
Sbjct: 120 MARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVK--------FSFQSPGRMY 170
Query: 668 TRGYLAPEWLANLP---ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEF 724
++APE L P +D++S+ ++L E+V+ + +
Sbjct: 171 APAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV----------------PFADL 214
Query: 725 EKGNV-KGIVDKSL-----AGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778
+ + + L G + ++M+ C+ E P++RP +V +LE +
Sbjct: 215 SNMEIGMKVALEGLRPTIPPGISPHVSKLMKI------CMNEDPAKRPKFDMIVPILEKM 268
Query: 779 TE 780
+
Sbjct: 269 QD 270
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 4e-56
Identities = 64/313 (20%), Positives = 116/313 (37%), Gaps = 57/313 (18%)
Query: 493 YKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQL---EGIEQGEKQFRMEVATIS 549
+++L+ + +G G FG VY G VA++ + E K F+ EV
Sbjct: 32 FEQLE-----IGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYR 84
Query: 550 STHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTA 609
T H N+V +G H ++ K +L + + + +L+ IA
Sbjct: 85 QTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV----RDAKIVLDVNKTRQIAQEIV 140
Query: 610 RGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI--NPKDHRHRTLTSVRG 667
+G+ YLH + I+H D+K +N+ D ++DFGL + R L G
Sbjct: 141 KGMGYLHAK---GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNG 196
Query: 668 TRGYLAPE---------WLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSL 718
+LAPE LP + SDV++ G + E+ +
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE---------------- 240
Query: 719 WAYEEFEKGNVKGIVDKSL------AGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVV 772
W ++ + + + G +I ++ C + +RP K++
Sbjct: 241 WPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLF------CWAFEQEERPTFTKLM 294
Query: 773 QMLEGITEIEKPP 785
MLE + + +
Sbjct: 295 DMLEKLPKRNRRL 307
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 5e-53
Identities = 62/300 (20%), Positives = 117/300 (39%), Gaps = 31/300 (10%)
Query: 503 FKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGF 562
++G G +G V+ G V AVK E+ E+ H N++ +
Sbjct: 41 MVKQIGKGRYGEVWMGKWRGEKV-AVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 563 SSEGKHR----LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618
+G L+ ++ +NGSL ++L L+ +S +A + G+ +LH E
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYL------KSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 619 -----CRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP-KDHRHRTLTSVRGTRGYL 672
+ I H D+K +NIL+ +N ++D GLA + + GT+ Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 673 APEWLA------NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEK 726
PE L + +D+YS+G++L E+ + + +E L + +
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 727 GNVKGIVDKSL------AGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780
+ + K L + + M + C P+ R +V + L ++E
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE--CWAHNPASRLTALRVKKTLAKMSE 331
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 1e-51
Identities = 64/326 (19%), Positives = 120/326 (36%), Gaps = 74/326 (22%)
Query: 494 KELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRME--VATISST 551
+++ + +G G +G V+RG V AVK + EK + E +
Sbjct: 8 RDIT-----LLECVGKGRYGEVWRGSWQGENV-AVKIFS--SRDEKSWFRETELYNTVML 59
Query: 552 HHLNLVRLVGFSSEGKHR----LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALG 607
H N++ + +H L+ + + GSL ++L L+ S I L
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT------LDTVSCLRIVLS 113
Query: 608 TARGITYLHEE-----CRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP-KDHRHRT 661
A G+ +LH E + I H D+K +NIL+ +N ++D GLA + + +
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 662 LTSVRGTRGYLAPEWLANLPITS------KSDVYSYGMVLLEIVSGRRNFEVSQETNRKK 715
GT+ Y+APE L + D++++G+VL E+ + + ++
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP-- 231
Query: 716 FSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQV--------SFW----------- 756
+ + + D E + + + V + W
Sbjct: 232 ----PFYD-------------VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK 274
Query: 757 ----CIQEQPSQRPMMGKVVQMLEGI 778
C + PS R ++ + L I
Sbjct: 275 LMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 7e-51
Identities = 60/305 (19%), Positives = 118/305 (38%), Gaps = 41/305 (13%)
Query: 503 FKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVG- 561
++ +G G FG V+RG V AVK E+ E+ H N++ +
Sbjct: 46 LQESIGKGRFGEVWRGKWRGEEV-AVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 562 ---FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618
+ LV ++ ++GSL ++L + + +AL TA G+ +LH E
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT------VTVEGMIKLALSTASGLAHLHME 158
Query: 619 -----CRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP-KDHRHRTLTSVRGTRGYL 672
+ I H D+K +NIL+ +N ++D GLA + D GT+ Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 673 APE------WLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEK 726
APE + + ++D+Y+ G+V EI + ++ + + +
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY-QLPYYDLVPSDPSV 277
Query: 727 GNVKGIV---------DKSLAGEDVD--IEQVMRAIQVSFWCIQEQPSQRPMMGKVVQML 775
++ +V + + ++MR C + R ++ + L
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR------ECWYANGAARLTALRIKKTL 331
Query: 776 EGITE 780
+++
Sbjct: 332 SQLSQ 336
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-45
Identities = 76/302 (25%), Positives = 124/302 (41%), Gaps = 47/302 (15%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQL-EGI-EQGEKQFRMEVATISST 551
L +++G G FG V+ G L A+ T+VAVK E + + +F E +
Sbjct: 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY 169
Query: 552 HHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARG 611
H N+VRL+G ++ + +V E ++ G FL G L ++ + A G
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE----GARLRVKTLLQMVGDAAAG 225
Query: 612 ITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTS---VRGT 668
+ YL + C +H D+ N L+ E K+SDFG+++ + V+ T
Sbjct: 226 MEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT 282
Query: 669 RGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEVSQETNRKKFSLWAY 721
APE L +S+SDV+S+G++L E S N +
Sbjct: 283 ----APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT-------------R 325
Query: 722 EEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781
E EKG G + D + ++M C +P QRP + Q L+ I +
Sbjct: 326 EFVEKG---GRLPCPELCPD-AVFRLME------QCWAYEPGQRPSFSTIYQELQSIRKR 375
Query: 782 EK 783
+
Sbjct: 376 HR 377
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-43
Identities = 84/308 (27%), Positives = 131/308 (42%), Gaps = 45/308 (14%)
Query: 487 APVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVA 546
+ E+ R + + KLG G FG V+ G T VA+K L+ + F E
Sbjct: 172 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQ 231
Query: 547 TISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIAL 606
+ H LV+L SE + +V E+M GSL +FL GK L ++A
Sbjct: 232 VMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAA 287
Query: 607 GTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTS-- 664
A G+ Y+ E + + H D++ NIL+ EN KV+DFGLA+LI ++ R
Sbjct: 288 QIASGMAYV--ERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 665 VRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEVSQETNRKKFS 717
++ T APE T KSDV+S+G++L E+ + G N EV
Sbjct: 345 IKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---------- 390
Query: 718 LWAYEEFEKGNVKGIVDK-SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776
++ E+G + E + +M C +++P +RP + LE
Sbjct: 391 ---LDQVERG---YRMPCPPECPESLH--DLMC------QCWRKEPEERPTFEYLQAFLE 436
Query: 777 GITEIEKP 784
+P
Sbjct: 437 DYFTSTEP 444
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-42
Identities = 81/300 (27%), Positives = 136/300 (45%), Gaps = 51/300 (17%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTV-VAVKQLEGIEQGEKQFRMEVATISSTHH 553
E++R+ K KLG G +G VY GV ++ VAVK L+ ++F E A + H
Sbjct: 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 275
Query: 554 LNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGIT 613
NLV+L+G + ++ EFM G+L ++L + ++ +A + +
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAME 332
Query: 614 YLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTS--VRGTRGY 671
YL + ++ I H ++ N L+ EN+ KV+DFGL++L+ + ++ T
Sbjct: 333 YLEK--KNFI-HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT--- 386
Query: 672 LAPEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEVSQETNRKKFSLWAYEEF 724
APE LA + KSDV+++G++L EI + G +V YE
Sbjct: 387 -APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------------YELL 432
Query: 725 EKGNV----KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780
EK +G +K + ++MRA C Q PS RP ++ Q E + +
Sbjct: 433 EKDYRMERPEGCPEK--------VYELMRA------CWQWNPSDRPSFAEIHQAFETMFQ 478
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 77/300 (25%), Positives = 127/300 (42%), Gaps = 47/300 (15%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHL 554
EL+R +LG+G FG V G + VAVK ++ E +F E T+ H
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHP 63
Query: 555 NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
LV+ G S+ +V E++ NG L N+L ++ GK L + G+ +
Sbjct: 64 KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH----GKGLEPSQLLEMCYDVCEGMAF 119
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTS--VRGTRGYL 672
L E I H D+ N L+D + KVSDFG+ + + + T V+ +
Sbjct: 120 L--ESHQFI-HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS---- 172
Query: 673 APEWLANLPITSKSDVYSYGMVLLEIVS-GRR------NFEVSQETNRKKFSLWAYEEFE 725
APE +SKSDV+++G+++ E+ S G+ N EV +
Sbjct: 173 APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV-------------VLKVS 219
Query: 726 KGNVKGIVDKSLAGED--VDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEK 783
+G + + I Q+M + C E P +RP +++ +E + E +K
Sbjct: 220 QG---HRLYRP---HLASDTIYQIMYS------CWHELPEKRPTFQQLLSSIEPLREKDK 267
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 7e-42
Identities = 66/222 (29%), Positives = 101/222 (45%), Gaps = 20/222 (9%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHL 554
+ S F ++G+G FG V+ G N+ VA+K + E+ F E + H
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHP 63
Query: 555 NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
LV+L G E LV EFM++G L ++L L ++ + L G+ Y
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG----LFAAETLLGMCLDVCEGMAY 119
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTS--VRGTRGYL 672
L E I H D+ N L+ EN KVSDFG+ + + + T T V+
Sbjct: 120 L--EEACVI-HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA---- 172
Query: 673 APEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEV 707
+PE + +SKSDV+S+G+++ E+ S R N EV
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 214
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-41
Identities = 84/300 (28%), Positives = 130/300 (43%), Gaps = 45/300 (15%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHL 554
E+ R + + KLG G FG V+ G T VA+K L+ + F E + H
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 322
Query: 555 NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
LV+L SE + +V E+M GSL +FL GK L ++A A G+ Y
Sbjct: 323 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAY 378
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTS--VRGTRGYL 672
+ E + + H D++ NIL+ EN KV+DFGLA+LI ++ R ++ T
Sbjct: 379 V--ERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT---- 431
Query: 673 APEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEVSQETNRKKFSLWAYEEFE 725
APE T KSDV+S+G++L E+ + G N EV ++ E
Sbjct: 432 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-------------LDQVE 478
Query: 726 KGNVKGIVDK-SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKP 784
+G + E + +M C +++P +RP + LE +P
Sbjct: 479 RG---YRMPCPPECPESLH--DLMC------QCWRKEPEERPTFEYLQAFLEDYFTSTEP 527
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-41
Identities = 70/229 (30%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 488 PVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVAT 547
P + E+ R + + KLGAG FG V+ T VAVK ++ + F E
Sbjct: 177 PWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANV 236
Query: 548 ISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALG 607
+ + H LV+L ++ + ++ EFM GSL +FL ++E G + +
Sbjct: 237 MKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQ 292
Query: 608 TARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTS--V 665
A G+ ++ E R+ I H D++ NIL+ + K++DFGLA++I ++ R +
Sbjct: 293 IAEGMAFI--EQRNYI-HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI 349
Query: 666 RGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRR------NFEV 707
+ T APE + T KSDV+S+G++L+EIV+ GR N EV
Sbjct: 350 KWT----APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV 394
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-41
Identities = 87/326 (26%), Positives = 122/326 (37%), Gaps = 68/326 (20%)
Query: 494 KELQRSTKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQL-EGIEQGEKQ-FRMEV 545
KE+ R LG G FG VY G ++ VAVK L E + ++ F ME
Sbjct: 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 84
Query: 546 ATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFAN--EEGSGKLLNWQSRFN 603
IS +H N+VR +G S + R ++ E M G L +FL L +
Sbjct: 85 LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 604 IALGTARGITYLHEECRDCIVHCDIKPENILLD---ENYNAKVSDFGLAKLINPKDHRHR 660
+A A G YL E I H DI N LL AK+ DFG+A+ I +R
Sbjct: 145 VARDIACGCQYL--EENHFI-HRDIAARNCLLTCPGPGRVAKIGDFGMARDI------YR 195
Query: 661 TLTSVRGTRGYL-----APEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEVS 708
+G L PE TSK+D +S+G++L EI S + N EV
Sbjct: 196 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV- 254
Query: 709 QETNRKKFSLWAYEEFEKGNV----KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQ 764
E G K + ++M C Q QP
Sbjct: 255 ------------LEFVTSGGRMDPPKNCPG--------PVYRIMTQ------CWQHQPED 288
Query: 765 RPMMGKVVQMLEGIT---EIEKPPAP 787
RP +++ +E T ++ P
Sbjct: 289 RPNFAIILERIEYCTQDPDVINTALP 314
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 7e-41
Identities = 74/222 (33%), Positives = 112/222 (50%), Gaps = 20/222 (9%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHL 554
E+ R T ++LGAG FG V+ G T VAVK L+ F E + H
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 555 NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
LVRL ++ + ++ E+M+NGSL +FL G L ++A A G+ +
Sbjct: 69 RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAF 124
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTS--VRGTRGYL 672
+ E R+ I H D++ NIL+ + + K++DFGLA+LI ++ R ++ T
Sbjct: 125 I--EERNYI-HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT---- 177
Query: 673 APEWLANLPITSKSDVYSYGMVLLEIVS-GRR------NFEV 707
APE + T KSDV+S+G++L EIV+ GR N EV
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 9e-41
Identities = 85/317 (26%), Positives = 137/317 (43%), Gaps = 54/317 (17%)
Query: 488 PVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLAN---RTVVAVKQL-EGIEQGEKQ-FR 542
P Y L + F+D +G G FG V + + R A+K++ E + + + F
Sbjct: 14 PDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 73
Query: 543 MEVATISS-THHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFL-----------FANEE 590
E+ + HH N++ L+G + L E+ +G+L +FL FA
Sbjct: 74 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133
Query: 591 GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650
+ L+ Q + A ARG+ YL + I H D+ NIL+ ENY AK++DFGL++
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYL--SQKQFI-HRDLAARNILVGENYVAKIADFGLSR 190
Query: 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-------GRR 703
+ VR A E L T+ SDV+SYG++L EIVS G
Sbjct: 191 GQEVYVKKTMGRLPVRWM----AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246
Query: 704 NFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPS 763
E+ YE+ +G ++K D ++ +MR C +E+P
Sbjct: 247 CAEL-------------YEKLPQGYR---LEKP-LNCDDEVYDLMRQ------CWREKPY 283
Query: 764 QRPMMGKVVQMLEGITE 780
+RP +++ L + E
Sbjct: 284 ERPSFAQILVSLNRMLE 300
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 66/297 (22%), Positives = 120/297 (40%), Gaps = 43/297 (14%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHL 554
E+ F +LG G FG V G + VA+K ++ E +F E + + H
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE 79
Query: 555 NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
LV+L G ++ + ++ E+M NG L N+L Q + + Y
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH--RHRTLTSVRGTRGYL 672
L E + + H D+ N L+++ KVSDFGL++ + ++ + VR +
Sbjct: 136 L--ESKQFL-HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS---- 188
Query: 673 APEWLANLPITSKSDVYSYGMVLLEIVS-GRR------NFEVSQETNRKKFSLWAYEEFE 725
PE L +SKSD++++G+++ EI S G+ N E E
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-------------AEHIA 235
Query: 726 KGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIE 782
+G + + + +M + C E+ +RP ++ + + + E
Sbjct: 236 QG---LRLYRP-HLASEKVYTIMYS------CWHEKADERPTFKILLSNILDVMDEE 282
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 74/324 (22%), Positives = 131/324 (40%), Gaps = 68/324 (20%)
Query: 494 KELQRSTKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQL-EGIEQGEKQFRMEVA 546
+ ++R K +LG G FG V+ N + +VAVK L + K F+ E
Sbjct: 10 QHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAE 69
Query: 547 TISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFL-----------FANEEGSGKL 595
+++ H ++V+ G +G ++V+E+MK+G L+ FL +
Sbjct: 70 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 596 LNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655
L +IA A G+ YL + + H D+ N L+ N K+ DFG+++ +
Sbjct: 130 LGLSQMLHIASQIASGMVYL--ASQHFV-HRDLATRNCLVGANLLVKIGDFGMSRDVYST 186
Query: 656 DH---RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNF 705
D+ T+ +R PE + T++SDV+S+G++L EI + N
Sbjct: 187 DYYRVGGHTMLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 242
Query: 706 EVSQETNRKKFSLWAYEEFEKGNV----KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQ 761
EV E +G V + ++ VM C Q +
Sbjct: 243 EV-------------IECITQGRVLERPRVCPK--------EVYDVMLG------CWQRE 275
Query: 762 PSQRPMMGKVVQMLEGITEIEKPP 785
P QR + ++ ++L + + P
Sbjct: 276 PQQRLNIKEIYKILHAL--GKATP 297
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-40
Identities = 87/359 (24%), Positives = 137/359 (38%), Gaps = 70/359 (19%)
Query: 459 GLWYWCCRNSPKF---VSLSAQYALLEYASGAPVQFSYK---ELQRSTKGFKDKLGAGGF 512
G+ Y + PK+ + Y Y P Q Y E R+ F LGAG F
Sbjct: 1 GVDY-KYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAF 59
Query: 513 GAVYRGVL------ANRTVVAVKQL-EGIEQGEKQ-FRMEVATISS-THHLNLVRLVGFS 563
G V VAVK L EK+ E+ +S H N+V L+G
Sbjct: 60 GKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119
Query: 564 SEGKHRLLVYEFMKNGSLDNFL---------FANEEGSGKLLNWQSRFNIALGTARGITY 614
+ G L++ E+ G L NFL + + + + + A+G+ +
Sbjct: 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAF 179
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYL-- 672
L ++CI H D+ N+LL + AK+ DFGLA+ I + L
Sbjct: 180 L--ASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDI------MNDSNYIVKGNARLPV 230
Query: 673 ---APEWLANLPITSKSDVYSYGMVLLEIVS-GRR-------NFEVSQETNRKKFSLWAY 721
APE + + T +SDV+SYG++L EI S G N + Y
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF-------------Y 277
Query: 722 EEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780
+ + G + + A +I +M+A C +P+ RP ++ L+ +
Sbjct: 278 KLVKDG---YQMAQP-AFAPKNIYSIMQA------CWALEPTHRPTFQQICSFLQEQAQ 326
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-40
Identities = 81/328 (24%), Positives = 136/328 (41%), Gaps = 65/328 (19%)
Query: 482 EYASGAPVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQL-EGI 534
+Y S A V ++R K +LG G FG V+ N + +VAVK L E
Sbjct: 28 QYFSDACV----HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS 83
Query: 535 EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFL--------- 585
E + F+ E ++ H ++VR G +EG+ L+V+E+M++G L+ FL
Sbjct: 84 ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKL 143
Query: 586 -FANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVS 644
E+ + L +A A G+ YL VH D+ N L+ + K+
Sbjct: 144 LAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIG 200
Query: 645 DFGLAKLINPKDH---RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS- 700
DFG+++ I D+ RT+ +R PE + T++SDV+S+G+VL EI +
Sbjct: 201 DFGMSRDIYSTDYYRVGGRTMLPIRWM----PPESILYRKFTTESDVWSFGVVLWEIFTY 256
Query: 701 ------GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGED--VDIEQVMRAIQ 752
N E + +G +++ ++ +MR
Sbjct: 257 GKQPWYQLSNTEA-------------IDCITQG---RELERP---RACPPEVYAIMRG-- 295
Query: 753 VSFWCIQEQPSQRPMMGKVVQMLEGITE 780
C Q +P QR + V L+ + +
Sbjct: 296 ----CWQREPQQRHSIKDVHARLQALAQ 319
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-40
Identities = 69/326 (21%), Positives = 132/326 (40%), Gaps = 50/326 (15%)
Query: 494 KELQRSTKGFKDKLGAGGFGAVYRGVL-----ANRTVVAVKQL-EGIEQGEKQFRMEVAT 547
+ + +LG G FG+V +VAVKQL ++ F+ E+
Sbjct: 18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 77
Query: 548 ISSTHHLNLVRLVGFSSEGKHR--LLVYEFMKNGSLDNFLFANEE--GSGKLLNWQSRFN 603
+ + H +V+ G S + LV E++ +G L +FL + + +LL +
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY----- 132
Query: 604 IALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLT 663
+ +G+ YL R VH D+ NIL++ + K++DFGLAKL+ +
Sbjct: 133 -SSQICKGMEYL-GSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE 188
Query: 664 S----VRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSL 718
+ APE L++ + +SDV+S+G+VL E+ + ++ S +
Sbjct: 189 PGQSPIFWY----APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC--SPSAEFLRMMG 242
Query: 719 WAYEEFEKGNVKGIVDKSLAGE--------DVDIEQVMRAIQVSFWCIQEQPSQRPMMGK 770
+ + ++++ G+ ++ ++M+ C P RP
Sbjct: 243 CERDVPALSRLLELLEE---GQRLPAPPACPAEVHELMKL------CWAPSPQDRPSFSA 293
Query: 771 VVQMLEGI---TEIEKPPAPKALTEG 793
+ L+ + + + A A EG
Sbjct: 294 LGPQLDMLWSGSRGCETHAFTAHPEG 319
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-40
Identities = 75/353 (21%), Positives = 131/353 (37%), Gaps = 62/353 (17%)
Query: 488 PVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVL-----ANRTVVAVKQL--EGIEQGEKQ 540
++ + + + LG+G FG V++GV + + V +K + + Q +
Sbjct: 2 AMKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA 61
Query: 541 FRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEE--GSGKLLNW 598
+ I S H ++VRL+G LV +++ GSL + + + G LLNW
Sbjct: 62 VTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW 120
Query: 599 QSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD-- 656
+ A+G+ YL EE +VH ++ N+LL +V+DFG+A L+ P D
Sbjct: 121 ------GVQIAKGMYYL-EEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171
Query: 657 -HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRK 714
T ++ A E + T +SDV+SYG+ + E+++ G
Sbjct: 172 LLYSEAKTPIKWM----ALESIHFGKYTHQSDVWSYGVTVWELMTFGAE----------- 216
Query: 715 KFSLWAYEEFEKGNVKGIVDKSLAGE--------DVDIEQVMRAIQVSFWCIQEQPSQRP 766
Y V +++K GE +D+ VM C + RP
Sbjct: 217 -----PYAGLRLAEVPDLLEK---GERLAQPQICTIDVYMVMVK------CWMIDENIRP 262
Query: 767 MMGKVVQMLEGITEIEKPPAPKALTEGSVGGTSVNMSSSTSALSTFAASAPAP 819
++ + PP + S G + P
Sbjct: 263 TFKELANEFTRM--ARDPPRYLVIKRESGPGIAPGPEPHGLTNKKLEEVELEP 313
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 5e-40
Identities = 91/354 (25%), Positives = 127/354 (35%), Gaps = 71/354 (20%)
Query: 466 RNSPKFVSLSAQYALLEYASGAPVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLAN--- 522
R S + Y S KE+ R LG G FG VY G ++
Sbjct: 41 RTSTIMTDYNPNYCFAGKTSSIS---DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPN 97
Query: 523 ---RTVVAVKQL-EGIEQGEKQ-FRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577
VAVK L E + ++ F ME IS +H N+VR +G S + R ++ E M
Sbjct: 98 DPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMA 157
Query: 578 NGSLDNFLFAN--EEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL 635
G L +FL L ++A A G YL E I H DI N LL
Sbjct: 158 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL--EENHFI-HRDIAARNCLL 214
Query: 636 D---ENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYL-----APEWLANLPITSKSD 687
AK+ DFG+A+ I +R +G L PE TSK+D
Sbjct: 215 TCPGPGRVAKIGDFGMARDI------YRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTD 268
Query: 688 VYSYGMVLLEIVS-------GRRNFEVSQETNRKKFSLWAYEEFEKGNV----KGIVDKS 736
+S+G++L EI S + N EV E G K
Sbjct: 269 TWSFGVLLWEIFSLGYMPYPSKSNQEV-------------LEFVTSGGRMDPPKNCPG-- 313
Query: 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT---EIEKPPAP 787
+ ++M C Q QP RP +++ +E T ++ P
Sbjct: 314 ------PVYRIMTQ------CWQHQPEDRPNFAIILERIEYCTQDPDVINTALP 355
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 5e-40
Identities = 80/302 (26%), Positives = 118/302 (39%), Gaps = 55/302 (18%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQL-EGIEQGEKQFRMEVATISSTHH 553
L +G G FG V G V AVK + + F E + ++ H
Sbjct: 189 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDAT--AQAFLAEASVMTQLRH 245
Query: 554 LNLVRLVGFSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGI 612
NLV+L+G E K L +V E+M GSL ++L + +L +L +
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAM 302
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYL 672
YL E + + H D+ N+L+ E+ AKVSDFGL K + + V+ T
Sbjct: 303 EYL--EGNNFV-HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK--LPVKWT---- 353
Query: 673 APEWLANLPITSKSDVYSYGMVLLEIVS-GRR------NFEVSQETNRKKFSLWAYEEFE 725
APE L ++KSDV+S+G++L EI S GR +V E
Sbjct: 354 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------------VPRVE 400
Query: 726 KGNV----KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781
KG G + VM+ C + RP ++ + LE I
Sbjct: 401 KGYKMDAPDGCPP--------AVYDVMKN------CWHLDAATRPTFLQLREQLEHIRTH 446
Query: 782 EK 783
E
Sbjct: 447 EL 448
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 7e-40
Identities = 84/325 (25%), Positives = 134/325 (41%), Gaps = 58/325 (17%)
Query: 482 EYASGAPVQF-SYKELQRSTKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQL-EG 533
EY S A V E+ R +LG G FG VY GV T VA+K + E
Sbjct: 7 EYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA 66
Query: 534 IEQGEKQ-FRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFAN---- 588
E+ F E + + + ++VRL+G S+G+ L++ E M G L ++L +
Sbjct: 67 ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAM 126
Query: 589 -EEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFG 647
+ +A A G+ YL VH D+ N ++ E++ K+ DFG
Sbjct: 127 ANNPVLAPPSLSKMIQMAGEIADGMAYL--NANKF-VHRDLAARNCMVAEDFTVKIGDFG 183
Query: 648 LAKLINPKDHRHRTLTSVRGTRGYL-----APEWLANLPITSKSDVYSYGMVLLEIVS-- 700
+ + I D +G +G L +PE L + T+ SDV+S+G+VL EI +
Sbjct: 184 MTRDIYETD------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 237
Query: 701 -----GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSF 755
G N +V +G G++DK D + ++MR
Sbjct: 238 EQPYQGLSNEQV-------------LRFVMEG---GLLDKPDNCPD-MLFELMRM----- 275
Query: 756 WCIQEQPSQRPMMGKVVQMLEGITE 780
C Q P RP +++ ++ E
Sbjct: 276 -CWQYNPKMRPSFLEIISSIKEEME 299
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-40
Identities = 64/240 (26%), Positives = 114/240 (47%), Gaps = 33/240 (13%)
Query: 487 APVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLA-----NRTVVAVKQL-EGIEQGEKQ 540
AP Q + L+ + LG+G FG VY+G+ + VA+K+L E +
Sbjct: 3 APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK 62
Query: 541 -FRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEE--GSGKLLN 597
E ++S + ++ RL+G L+ + M G L +++ +++ GS LLN
Sbjct: 63 EILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 598 WQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD- 656
W + A+G+ YL E+ R +VH D+ N+L+ + K++DFGLAKL+ ++
Sbjct: 122 W------CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 657 --HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEV 707
H ++ A E + + T +SDV+SYG+ + E+++ G E+
Sbjct: 173 EYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 68/309 (22%), Positives = 119/309 (38%), Gaps = 46/309 (14%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVL-----ANRTVVAVKQL-EGIEQGEKQFRMEVATI 548
+ + F +LG G FG+V VVAVK+L E+ + F E+ +
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 549 SSTHHLNLVRLVGFSSEGKHR--LLVYEFMKNGSLDNFLFANEE--GSGKLLNWQSRFNI 604
S H N+V+ G R L+ E++ GSL ++L ++E KLL +
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY------ 119
Query: 605 ALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTS 664
+G+ YL + I H D+ NIL++ K+ DFGL K++ P+D +
Sbjct: 120 TSQICKGMEYLGT--KRYI-HRDLATRNILVENENRVKIGDFGLTKVL-PQDKEFFKVKE 175
Query: 665 -----VRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLW 719
+ APE L + SDV+S+G+VL E+ + + +
Sbjct: 176 PGESPIFWY----APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231
Query: 720 AYEEFEKGNVKGIVDKSLAGE--------DVDIEQVMRAIQVSFWCIQEQPSQRPMMGKV 771
+ ++ ++ +I +M C +QRP +
Sbjct: 232 KQGQMIVFHLIELLKN---NGRLPRPDGCPDEIYMIMTE------CWNNNVNQRPSFRDL 282
Query: 772 VQMLEGITE 780
++ I +
Sbjct: 283 ALRVDQIRD 291
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 85/301 (28%), Positives = 138/301 (45%), Gaps = 53/301 (17%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTV-VAVKQL-EGIEQGEKQFRMEVATISSTH 552
E++R+ K KLG G +G VY GV ++ VAVK L E + E+ F E A +
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIK 67
Query: 553 HLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGI 612
H NLV+L+G + ++ EFM G+L ++L E + + ++ +A + +
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAM 124
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTS--VRGTRG 670
YL E ++ I H D+ N L+ EN+ KV+DFGL++L+ + ++ T
Sbjct: 125 EYL--EKKNFI-HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT-- 179
Query: 671 YLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRR------NFEVSQETNRKKFSLWAYEE 723
APE LA + KSDV+++G++L EI + G +V YE
Sbjct: 180 --APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------------YEL 224
Query: 724 FEKGNV----KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779
EK +G + + ++MRA C Q PS RP ++ Q E +
Sbjct: 225 LEKDYRMERPEGCPE--------KVYELMRA------CWQWNPSDRPSFAEIHQAFETMF 270
Query: 780 E 780
+
Sbjct: 271 Q 271
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 75/316 (23%), Positives = 120/316 (37%), Gaps = 65/316 (20%)
Query: 493 YKELQRSTKGFKDKLGAGGFGAVYRGVLANR------TVVAVKQL-EGIEQGEKQ-FRME 544
KE+ S F ++LG FG VY+G L VA+K L + E ++ FR E
Sbjct: 3 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62
Query: 545 VATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFL-----------FANEEGSG 593
+ H N+V L+G ++ + +++ + +G L FL ++
Sbjct: 63 AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 594 KLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653
L ++ A G+ YL VH D+ N+L+ + N K+SD GL + +
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYL--SSHHV-VHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 654 PKDH---RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-------GRR 703
D+ +L +R APE + + SD++SYG+VL E+ S G
Sbjct: 180 AADYYKLLGNSLLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 235
Query: 704 NFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGED---VDIEQVMRAIQVSFWCIQE 760
N +V E V L D + +M C E
Sbjct: 236 NQDV-------------VEMIRNRQV-------LPCPDDCPAWVYALMIE------CWNE 269
Query: 761 QPSQRPMMGKVVQMLE 776
PS+RP + L
Sbjct: 270 FPSRRPRFKDIHSRLR 285
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 67/309 (21%), Positives = 118/309 (38%), Gaps = 50/309 (16%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLA-----NRTVVAVKQL--EGIEQGEKQFRMEVAT 547
++ LG G FG V VAVK L E + E+
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI 76
Query: 548 ISSTHHLNLVRLVGFSSEGKHR--LLVYEFMKNGSLDNFLFANEE--GSGKLLNWQSRFN 603
+ + +H N+V+ G +E L+ EF+ +GSL +L N+ + L +
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY----- 131
Query: 604 IALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLT 663
A+ +G+ YL R + H D+ N+L++ + K+ DFGL K I D + T+
Sbjct: 132 -AVQICKGMDYLGS--RQYV-HRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVK 186
Query: 664 S-----VRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFS 717
V APE L SDV+S+G+ L E+++ + +
Sbjct: 187 DDRDSPVFWY----APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP 242
Query: 718 LWAYEEFEKGNVKGIVDKSLAGE--------DVDIEQVMRAIQVSFWCIQEQPSQRPMMG 769
+ + + + + G+ ++ Q+MR C + QPS R
Sbjct: 243 --THGQMTVTRLVNTLKE---GKRLPCPPNCPDEVYQLMRK------CWEFQPSNRTSFQ 291
Query: 770 KVVQMLEGI 778
+++ E +
Sbjct: 292 NLIEGFEAL 300
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 71/239 (29%), Positives = 115/239 (48%), Gaps = 32/239 (13%)
Query: 488 PVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVL----ANRTVVAVKQL-EG-IEQGEKQF 541
+ +E++ S + +G+G G V G L VA+K L G E+ + F
Sbjct: 38 AGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF 97
Query: 542 RMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEE--GSGKLLNWQ 599
E + + H N++RL G + G+ ++V E+M+NGSLD FL ++ +L+
Sbjct: 98 LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM- 156
Query: 600 SRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRH 659
G G+ YL + VH D+ N+L+D N KVSDFGL++++
Sbjct: 157 -----LRGVGAGMRYL-SDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA 208
Query: 660 RTLTS----VRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRR------NFEV 707
T T +R T APE +A +S SDV+S+G+V+ E+++ G R N +V
Sbjct: 209 YTTTGGKIPIRWT----APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV 263
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-39
Identities = 78/309 (25%), Positives = 127/309 (41%), Gaps = 53/309 (17%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANR----TVVAVKQL--EGIEQGEKQ-FRMEVAT 547
+ R+ LG G FG+V G L VAVK + + Q E + F E A
Sbjct: 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAAC 89
Query: 548 ISSTHHLNLVRLVGFSSEGK-----HRLLVYEFMKNGSLDNFLFAN-EEGSGKLLNWQSR 601
+ H N++RL+G E +++ FMK G L +L + E K + Q+
Sbjct: 90 MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL 149
Query: 602 FNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH---R 658
+ A G+ YL R+ + H D+ N +L ++ V+DFGL+K I D+
Sbjct: 150 LKFMVDIALGMEYL--SNRNFL-HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG 206
Query: 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEVSQET 711
V+ A E LA+ TSKSDV+++G+ + EI + G +N E+
Sbjct: 207 RIAKMPVKWI----AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---- 258
Query: 712 NRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKV 771
Y+ G + + D ++ ++M + C + P RP +
Sbjct: 259 ---------YDYLLHG---HRLKQPEDCLD-ELYEIMYS------CWRTDPLDRPTFSVL 299
Query: 772 VQMLEGITE 780
LE + E
Sbjct: 300 RLQLEKLLE 308
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-39
Identities = 68/309 (22%), Positives = 120/309 (38%), Gaps = 46/309 (14%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVL-----ANRTVVAVKQL-EGIEQGEKQFRMEVATI 548
+ + F +LG G FG+V VVAVK+L E+ + F E+ +
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96
Query: 549 SSTHHLNLVRLVGFSSEGKHR--LLVYEFMKNGSLDNFLFANEE--GSGKLLNWQSRFNI 604
S H N+V+ G R L+ E++ GSL ++L ++E KLL +
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY------ 150
Query: 605 ALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTS 664
+G+ YL + I H D+ NIL++ K+ DFGL K++ P+D + +
Sbjct: 151 TSQICKGMEYLGT--KRYI-HRDLATRNILVENENRVKIGDFGLTKVL-PQDKEYYKVKE 206
Query: 665 -----VRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLW 719
+ APE L + SDV+S+G+VL E+ + + +
Sbjct: 207 PGESPIFWY----APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 262
Query: 720 AYEEFEKGNVKGIVDKSLAGE--------DVDIEQVMRAIQVSFWCIQEQPSQRPMMGKV 771
+ ++ ++ +I +M C +QRP +
Sbjct: 263 KQGQMIVFHLIELLKN---NGRLPRPDGCPDEIYMIMTE------CWNNNVNQRPSFRDL 313
Query: 772 VQMLEGITE 780
++ I +
Sbjct: 314 ALRVDQIRD 322
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-39
Identities = 77/341 (22%), Positives = 133/341 (39%), Gaps = 69/341 (20%)
Query: 482 EYASGAPVQFSYK---ELQRSTKGFKDKLGAGGFGAVYRGVL--------ANRTVVAVKQ 530
A + + E R LG G FG V VAVK
Sbjct: 15 MLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM 74
Query: 531 L-EGIEQGEKQ-FRMEVATISS-THHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFL-- 585
L + + + E+ + H N++ L+G ++ ++ E+ G+L +L
Sbjct: 75 LKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 134
Query: 586 ---------FANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD 636
+ + + ++ + ARG+ YL + CI H D+ N+L+
Sbjct: 135 RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVT 191
Query: 637 ENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYL-----APEWLANLPITSKSDVYSY 691
EN K++DFGLA+ IN D+ + T G L APE L + T +SDV+S+
Sbjct: 192 ENNVMKIADFGLARDINNIDY------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 245
Query: 692 GMVLLEIVS-------GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDI 744
G+++ EI + G E+ ++ ++G+ +DK A ++
Sbjct: 246 GVLMWEIFTLGGSPYPGIPVEEL-------------FKLLKEGHR---MDKP-ANCTNEL 288
Query: 745 EQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPP 785
+MR C PSQRP ++V+ L+ I +
Sbjct: 289 YMMMRD------CWHAVPSQRPTFKQLVEDLDRILTLTTNE 323
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 5e-39
Identities = 65/310 (20%), Positives = 116/310 (37%), Gaps = 66/310 (21%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVL--------ANRTVVAVKQL-EGIEQGEKQFRMEV 545
+++ F + LG G F +++GV + T V +K L + + F
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAA 63
Query: 546 ATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIA 605
+ +S H +LV G G +LV EF+K GSLD +L N +N + +A
Sbjct: 64 SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN----KNCINILWKLEVA 119
Query: 606 LGTARGITYLHEECRDCIVHCDIKPENILLD--------ENYNAKVSDFGLAKLINPKDH 657
A + +L EE ++H ++ +NILL K+SD G++ + PKD
Sbjct: 120 KQLAAAMHFL-EENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI 176
Query: 658 RHRTLTSVRGTRGYLAPEWLANLPI-TSKSDVYSYGMVLLEIVS-------GRRNFEVSQ 709
+ PE + N +D +S+G L EI S +
Sbjct: 177 ---LQERIPWV----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-- 227
Query: 710 ETNRKKFSLWAYEEFEKGNVKGIVDKSL-AGEDVDIEQVMRAIQVSFWCIQEQPSQRPMM 768
+ +E + L A + ++ ++ C+ +P RP
Sbjct: 228 -----------LQFYEDRHQ-------LPAPKAAELANLINN------CMDYEPDHRPSF 263
Query: 769 GKVVQMLEGI 778
+++ L +
Sbjct: 264 RAIIRDLNSL 273
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 5e-39
Identities = 71/328 (21%), Positives = 131/328 (39%), Gaps = 71/328 (21%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQL-EGIEQGEKQ-FRMEVA 546
E R LG G FG V + + T VAVK L E E + E
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 547 TISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFL-------------------FA 587
+ +H ++++L G S+ LL+ E+ K GSL FL +
Sbjct: 79 VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 588 NEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFG 647
+ + L + A ++G+ YL + H D+ NIL+ E K+SDFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL--AEMKLV-HRDLAARNILVAEGRKMKISDFG 195
Query: 648 LAKLINPKDHRHRTLTSVRGTRGYL-----APEWLANLPITSKSDVYSYGMVLLEIVS-- 700
L++ + + + V+ ++G + A E L + T++SDV+S+G++L EIV+
Sbjct: 196 LSRDV------YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249
Query: 701 -----GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSF 755
G + + + G+ +++ ++ ++M
Sbjct: 250 GNPYPGIPPERL-------------FNLLKTGHR---MERP-DNCSEEMYRLMLQ----- 287
Query: 756 WCIQEQPSQRPMMGKVVQMLEGITEIEK 783
C +++P +RP+ + + LE + +
Sbjct: 288 -CWKQEPDKRPVFADISKDLEKMMVKRR 314
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 8e-39
Identities = 80/301 (26%), Positives = 121/301 (40%), Gaps = 51/301 (16%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQL-EGIEQGEKQFRMEVATISSTHH 553
L +G G FG V G V AVK + + F E + ++ H
Sbjct: 17 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDAT--AQAFLAEASVMTQLRH 73
Query: 554 LNLVRLVGFSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGI 612
NLV+L+G E K L +V E+M GSL ++L + +L +L +
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAM 130
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYL 672
YL E + + H D+ N+L+ E+ AKVSDFGL K + + V+ T
Sbjct: 131 EYL--EGNNFV-HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK--LPVKWT---- 181
Query: 673 APEWLANLPITSKSDVYSYGMVLLEIVS-GRR------NFEVSQETNRKKFSLWAYEEFE 725
APE L ++KSDV+S+G++L EI S GR +V E
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------------VPRVE 228
Query: 726 KGNVKGIVDKSLAGED--VDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEK 783
KG +D + + +VM+ C + RP ++ + LE I E
Sbjct: 229 KG---YKMDAP---DGCPPAVYEVMK------NCWHLDAAMRPSFLQLREQLEHIKTHEL 276
Query: 784 P 784
Sbjct: 277 H 277
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 75/308 (24%), Positives = 118/308 (38%), Gaps = 54/308 (17%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANR----TVVAVKQL-EGI--EQGEKQFRMEVAT 547
+ LG G FG+V L VAVK L I ++F E A
Sbjct: 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAAC 78
Query: 548 ISSTHHLNLVRLVGFSSEG------KHRLLVYEFMKNGSLDNFLFAN-EEGSGKLLNWQS 600
+ H ++ +LVG S +++ FMK+G L FL A+ + L Q+
Sbjct: 79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT 138
Query: 601 RFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH--- 657
+ A G+ YL R+ I H D+ N +L E+ V+DFGL++ I D+
Sbjct: 139 LVRFMVDIACGMEYL--SSRNFI-HRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ 195
Query: 658 RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEVSQE 710
+ V+ A E LA+ T SDV+++G+ + EI++ G N E+
Sbjct: 196 GCASKLPVKWL----ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI--- 248
Query: 711 TNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGK 770
Y G + + + ++ +M C P QRP
Sbjct: 249 ----------YNYLIGG---NRLKQPPECME-EVYDLMYQ------CWSADPKQRPSFTC 288
Query: 771 VVQMLEGI 778
+ LE I
Sbjct: 289 LRMELENI 296
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 72/316 (22%), Positives = 129/316 (40%), Gaps = 48/316 (15%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLAN-----RTVVAVKQL--EGIEQGEKQFRMEVAT 547
+ LG G FG V +VAVK L + Q ++ E+
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI 86
Query: 548 ISSTHHLNLVRLVGFSSEGKHR--LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIA 605
+ + +H ++++ G + LV E++ GSL ++L + G +LL + A
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF------A 140
Query: 606 LGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSV 665
G+ YLH + I H D+ N+LLD + K+ DFGLAK + P+ H + +
Sbjct: 141 QQICEGMAYLHA--QHYI-HRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVR-- 194
Query: 666 RGTRGYL-----APEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLW 719
G APE L SDV+S+G+ L E+++ + S T +
Sbjct: 195 --EDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ--SPPTKFLELIGI 250
Query: 720 AYEEFEKGNVKGIVDKSLAGE--------DVDIEQVMRAIQVSFWCIQEQPSQRPMMGKV 771
A + + ++++ GE ++ +M+ C + + S RP +
Sbjct: 251 AQGQMTVLRLTELLER---GERLPRPDKCPAEVYHLMKN------CWETEASFRPTFENL 301
Query: 772 VQMLEGITEIEKPPAP 787
+ +L+ + E + AP
Sbjct: 302 IPILKTVHEKYQGQAP 317
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 62/242 (25%), Positives = 91/242 (37%), Gaps = 35/242 (14%)
Query: 487 APVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVL----ANRTVVAVKQL-EGIEQGEKQ- 540
P+Q + +KLG G FG V RG VAVK L + +
Sbjct: 6 GPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM 65
Query: 541 --FRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEE--GSGKLL 596
F EV + S H NL+RL G +V E GSL + L ++ G L
Sbjct: 66 DDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS 124
Query: 597 NWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656
+ A+ A G+ YL E R +H D+ N+LL K+ DFGL + + D
Sbjct: 125 RY------AVQVAEGMGYL-ESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175
Query: 657 H----RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNF 705
+ APE L + SD + +G+ L E+ + G
Sbjct: 176 DHYVMQEHRKVPFAWC----APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 231
Query: 706 EV 707
++
Sbjct: 232 QI 233
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-38
Identities = 58/230 (25%), Positives = 97/230 (42%), Gaps = 31/230 (13%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLAN----RTVVAVKQL-EG-IEQGEKQFRMEVATI 548
+ R LG G FG VY GV N + VAVK + +++F E +
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 67
Query: 549 SSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEE--GSGKLLNWQSRFNIAL 606
+ H ++V+L+G E + ++ E G L ++L N+ L+ + +L
Sbjct: 68 KNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY------SL 120
Query: 607 GTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD--HRHRTLTS 664
+ + YL E VH DI NIL+ K+ DFGL++ I +D T
Sbjct: 121 QICKAMAYL-ESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP 177
Query: 665 VRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEV 707
++ +PE + T+ SDV+ + + + EI+S N +V
Sbjct: 178 IKWM----SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV 223
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 6e-38
Identities = 76/236 (32%), Positives = 116/236 (49%), Gaps = 37/236 (15%)
Query: 494 KELQRSTKGFKDKLGAGGFGAVYRGVLANRTV-----VAVKQL-EG-IEQGEKQFRMEVA 546
E+ S + +GAG FG VY+G+L + VA+K L G E+ F E
Sbjct: 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAG 98
Query: 547 TISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEE--GSGKLLNWQSRFNI 604
+ H N++RL G S+ K +++ E+M+NG+LD FL + +L+
Sbjct: 99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM------ 152
Query: 605 ALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTS 664
G A G+ YL VH D+ NIL++ N KVSDFGL++++ +D T T+
Sbjct: 153 LRGIAAGMKYL-ANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEATYTT 207
Query: 665 VRG------TRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRR------NFEV 707
G T APE ++ TS SDV+S+G+V+ E+++ G R N EV
Sbjct: 208 SGGKIPIRWT----APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 259
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-38
Identities = 78/318 (24%), Positives = 129/318 (40%), Gaps = 66/318 (20%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVL--------ANRTVVAVKQL-EGIEQGEKQ-FRME 544
EL R LG G FG V T VAVK L + + E
Sbjct: 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124
Query: 545 VATISS-THHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFL-----------FANEEGS 592
+ + H N++ L+G ++ ++ E+ G+L +L +
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 593 GKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652
+ L+ + + A ARG+ YL + CI H D+ N+L+ E+ K++DFGLA+ I
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDI 241
Query: 653 NPKDHRHRTLTSVRGTRGYL-----APEWLANLPITSKSDVYSYGMVLLEIVS------- 700
+ D + T G L APE L + T +SDV+S+G++L EI +
Sbjct: 242 HHID------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295
Query: 701 GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQE 760
G E+ ++ ++G +DK + ++ +MR C
Sbjct: 296 GVPVEEL-------------FKLLKEG---HRMDKP-SNCTNELYMMMRD------CWHA 332
Query: 761 QPSQRPMMGKVVQMLEGI 778
PSQRP ++V+ L+ I
Sbjct: 333 VPSQRPTFKQLVEDLDRI 350
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 9e-38
Identities = 76/318 (23%), Positives = 129/318 (40%), Gaps = 66/318 (20%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVL--------ANRTVVAVKQL-EGIEQGEKQ-FRME 544
E R LG G FG V VAVK L + + + E
Sbjct: 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136
Query: 545 VATISS-THHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFL-----------FANEEGS 592
+ + H N++ L+G ++ ++ E+ G+L +L +
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 593 GKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652
+ + ++ + ARG+ YL + CI H D+ N+L+ EN K++DFGLA+ I
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDI 253
Query: 653 NPKDHRHRTLTSVRGTRGYL-----APEWLANLPITSKSDVYSYGMVLLEIVS------- 700
N D+ + T G L APE L + T +SDV+S+G+++ EI +
Sbjct: 254 NNIDY------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 307
Query: 701 GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQE 760
G E+ ++ ++G+ +DK A ++ +MR C
Sbjct: 308 GIPVEEL-------------FKLLKEGHR---MDKP-ANCTNELYMMMRD------CWHA 344
Query: 761 QPSQRPMMGKVVQMLEGI 778
PSQRP ++V+ L+ I
Sbjct: 345 VPSQRPTFKQLVEDLDRI 362
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 82/333 (24%), Positives = 130/333 (39%), Gaps = 66/333 (19%)
Query: 482 EYASGAPVQFSYK---ELQRSTKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQL- 531
Y P Q Y E R+ F LGAG FG V VAVK L
Sbjct: 3 NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 62
Query: 532 EGIEQGEKQ-FRMEVATISS-THHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFL---- 585
E++ E+ +S +H+N+V L+G + G L++ E+ G L NFL
Sbjct: 63 PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 122
Query: 586 ---------FANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD 636
A E L+ + + + A+G+ +L ++CI H D+ NILL
Sbjct: 123 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCI-HRDLAARNILLT 179
Query: 637 ENYNAKVSDFGLAKLINPKDH---RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGM 693
K+ DFGLA+ I + + V+ APE + N T +SDV+SYG+
Sbjct: 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWM----APESIFNCVYTFESDVWSYGI 235
Query: 694 VLLEIVS-GR-------RNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIE 745
L E+ S G + + Y+ ++G + ++
Sbjct: 236 FLWELFSLGSSPYPGMPVDSKF-------------YKMIKEG---FRMLSP-EHAPAEMY 278
Query: 746 QVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778
+M+ C P +RP ++VQ++E
Sbjct: 279 DIMKT------CWDADPLKRPTFKQIVQLIEKQ 305
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-37
Identities = 75/231 (32%), Positives = 111/231 (48%), Gaps = 28/231 (12%)
Query: 494 KELQRSTKGFKDKLGAGGFGAVYRGVL----ANRTVVAVKQL--EGIEQGEKQFRMEVAT 547
KEL + +GAG FG V G L VA+K L E+ + F E +
Sbjct: 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 548 ISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALG 607
+ H N++RL G ++ K ++V E+M+NGSLD+FL ++ + Q + G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQ-LVGMLRG 155
Query: 608 TARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH----RHRTLT 663
A G+ YL + VH D+ NIL++ N KVSDFGL +++
Sbjct: 156 IASGMKYL-SDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212
Query: 664 SVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRR------NFEV 707
+R T +PE +A TS SDV+SYG+VL E++S G R N +V
Sbjct: 213 PIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-37
Identities = 79/342 (23%), Positives = 123/342 (35%), Gaps = 75/342 (21%)
Query: 482 EYASGAPVQFSYK---ELQRSTKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQL- 531
EY ++ Y E R F LG+G FG V VAVK L
Sbjct: 25 EYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK 84
Query: 532 EGIEQGEKQ-FRMEVATISS-THHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFL---- 585
E + E++ E+ ++ H N+V L+G + L++E+ G L N+L
Sbjct: 85 EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 144
Query: 586 --------------FANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPE 631
EE +L ++ A A+G+ +L E + C+ H D+
Sbjct: 145 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL--EFKSCV-HRDLAAR 201
Query: 632 NILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYL-----APEWLANLPITSKS 686
N+L+ K+ DFGLA+ I + V L APE L T KS
Sbjct: 202 NVLVTHGKVVKICDFGLARDIMSDSNY------VVRGNARLPVKWMAPESLFEGIYTIKS 255
Query: 687 DVYSYGMVLLEIVS-GR-------RNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738
DV+SYG++L EI S G + Y+ + G +D+
Sbjct: 256 DVWSYGILLWEIFSLGVNPYPGIPVDANF-------------YKLIQNGFK---MDQP-F 298
Query: 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780
+I +M++ C +RP + L
Sbjct: 299 YATEEIYIIMQS------CWAFDSRKRPSFPNLTSFLGCQLA 334
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 72/302 (23%), Positives = 123/302 (40%), Gaps = 55/302 (18%)
Query: 497 QRSTKGFKDKLGAGGFGAVYRGVLA----NRTVVAVKQL-EGIEQGEKQ-FRMEVATISS 550
+R +G G FG VY G NR A+K L E + + F E +
Sbjct: 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78
Query: 551 THHLNLVRLVGFSSEGK-HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTA 609
+H N++ L+G + ++ +M +G L F+ + + + L A
Sbjct: 79 LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI----RSPQRNPTVKDLISFGLQVA 134
Query: 610 RGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR 669
RG+ YL + + H D+ N +LDE++ KV+DFGLA+ I +++ SV+ R
Sbjct: 135 RGMEYL--AEQKFV-HRDLAARNCMLDESFTVKVADFGLARDILDREY-----YSVQQHR 186
Query: 670 GYL------APEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEVSQETNRKKF 716
A E L T+KSDV+S+G++L E+++ F++
Sbjct: 187 HARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL--------- 237
Query: 717 SLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776
+G + + D + QVM+ C + P+ RP +V +E
Sbjct: 238 ----THFLAQG---RRLPQPEYCPD-SLYQVMQQ------CWEADPAVRPTFRVLVGEVE 283
Query: 777 GI 778
I
Sbjct: 284 QI 285
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 64/240 (26%), Positives = 116/240 (48%), Gaps = 33/240 (13%)
Query: 487 APVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLA-----NRTVVAVKQL-EGIEQGEKQ 540
AP Q + L+ + LG+G FG VY+G+ + VA+K+L E +
Sbjct: 3 APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK 62
Query: 541 -FRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEE--GSGKLLN 597
E ++S + ++ RL+G L+ + M G L +++ +++ GS LLN
Sbjct: 63 EILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 598 WQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657
W + A+G+ YL E+ R +VH D+ N+L+ + K++DFGLAKL+ ++
Sbjct: 122 W------CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 658 RHRTLTSVRGTR---GYLAPEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEV 707
+ G + ++A E + + T +SDV+SYG+ + E+++ G E+
Sbjct: 173 EYHA----EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 79/328 (24%), Positives = 127/328 (38%), Gaps = 77/328 (23%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQL-EGIEQGEKQ-FRMEVA 546
E R+ + +G G FG V++ T+VAVK L E + F+ E A
Sbjct: 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 547 TISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFL-------------------FA 587
++ + N+V+L+G + GK L++E+M G L+ FL
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 588 NEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFG 647
L+ + IA A G+ YL R VH D+ N L+ EN K++DFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYL--SERKF-VHRDLATRNCLVGENMVVKIADFG 219
Query: 648 LAKLINPKDHRHRTLTSVRGTRGYL-----APEWLANLPITSKSDVYSYGMVLLEIVS-- 700
L++ I D + PE + T++SDV++YG+VL EI S
Sbjct: 220 LSRNIYSAD------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 273
Query: 701 -----GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSL---AGEDVDIEQVMRAIQ 752
G + EV GN+ L +++ +MR
Sbjct: 274 LQPYYGMAHEEV-------------IYYVRDGNI-------LACPENCPLELYNLMRL-- 311
Query: 753 VSFWCIQEQPSQRPMMGKVVQMLEGITE 780
C + P+ RP + ++L+ + E
Sbjct: 312 ----CWSKLPADRPSFCSIHRILQRMCE 335
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 74/307 (24%), Positives = 117/307 (38%), Gaps = 59/307 (19%)
Query: 494 KELQRSTKGFKDKLGAGGFGAVYRGVLANR----TVVAVKQLEGI--EQGEKQFRMEVAT 547
F + +G G FG VY G L + AVK L I QF E
Sbjct: 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 79
Query: 548 ISSTHHLNLVRLVGFSSEGKH-RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIAL 606
+ H N++ L+G + L+V +MK+G L NF+ + L
Sbjct: 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGL 135
Query: 607 GTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVR 666
A+G+ YL + VH D+ N +LDE + KV+DFGLA+ + K++ SV
Sbjct: 136 QVAKGMKYLAS--KKF-VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY-----YSVH 187
Query: 667 GTRGYL------APEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEVSQETNR 713
G A E L T+KSDV+S+G++L E+++ F++
Sbjct: 188 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI------ 241
Query: 714 KKFSLWAYEEFEKGNVKGIVDKSLAGED--VDIEQVMRAIQVSFWCIQEQPSQRPMMGKV 771
+G + + E + +VM C + RP ++
Sbjct: 242 -------TVYLLQG---RRLLQP---EYCPDPLYEVMLK------CWHPKAEMRPSFSEL 282
Query: 772 VQMLEGI 778
V + I
Sbjct: 283 VSRISAI 289
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 504 KDKLGAGGFGAVYRGVL---ANRTVVAVKQL-EGIEQGEKQ-FRMEVATISSTHHLNLVR 558
+LG G FG+V +GV + VA+K L +G E+ + + E + + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 559 LVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618
L+G +LV E G L FL G + + + + + G+ YL EE
Sbjct: 75 LIGVCQAEAL-MLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKYL-EE 128
Query: 619 CRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH----RHRTLTSVRGTRGYLAP 674
VH D+ N+LL + AK+SDFGL+K + D R ++ AP
Sbjct: 129 KN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----AP 182
Query: 675 EWLANLPITSKSDVYSYGMVLLEIVS-GRR------NFEV 707
E + +S+SDV+SYG+ + E +S G++ EV
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV 222
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 83/320 (25%), Positives = 122/320 (38%), Gaps = 66/320 (20%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQL-EGIEQGEKQ-FRMEVA 546
E R LG G FG V VAVK L EG E + E+
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 547 TISS-THHLNLVRLVGFSS-EGKHRLLVYEFMKNGSLDNFL-----------FANEEGSG 593
+ HHLN+V L+G + G +++ EF K G+L +L A E+
Sbjct: 83 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 594 KLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653
L + + A+G+ +L R CI H D+ NILL E K+ DFGLA+ I
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 654 PKDHRHRTLTSVRGTRGYL-----APEWLANLPITSKSDVYSYGMVLLEIVS-GR----- 702
VR L APE + + T +SDV+S+G++L EI S G
Sbjct: 200 KDPDY------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253
Query: 703 --RNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQE 760
+ E ++G + ++ Q M C
Sbjct: 254 VKIDEEF-------------CRRLKEGTR---MRAP-DYTTPEMYQTMLD------CWHG 290
Query: 761 QPSQRPMMGKVVQMLEGITE 780
+PSQRP ++V+ L + +
Sbjct: 291 EPSQRPTFSELVEHLGNLLQ 310
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 57/230 (24%), Positives = 98/230 (42%), Gaps = 31/230 (13%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLAN----RTVVAVKQL-EG-IEQGEKQFRMEVATI 548
E+QR +G G FG V++G+ + VA+K + ++F E T+
Sbjct: 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 70
Query: 549 SSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEE--GSGKLLNWQSRFNIAL 606
H ++V+L+G +E ++ E G L +FL + L+ + A
Sbjct: 71 RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILY------AY 123
Query: 607 GTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD--HRHRTLTS 664
+ + YL E R VH DI N+L+ N K+ DFGL++ + +
Sbjct: 124 QLSTALAYL-ESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 180
Query: 665 VRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEV 707
++ APE + TS SDV+ +G+ + EI+ G +N +V
Sbjct: 181 IKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 226
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-36
Identities = 73/306 (23%), Positives = 116/306 (37%), Gaps = 55/306 (17%)
Query: 493 YKELQRSTKGFKDKLGAGGFGAVYRGVLANR----TVVAVKQLEGI--EQGEKQFRMEVA 546
F + +G G FG VY G L + AVK L I QF E
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 142
Query: 547 TISSTHHLNLVRLVGFSSEGKH-RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIA 605
+ H N++ L+G + L+V +MK+G L NF+ +
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFG 198
Query: 606 LGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSV 665
L A+G+ +L + VH D+ N +LDE + KV+DFGLA+ + K+ SV
Sbjct: 199 LQVAKGMKFLAS--KKF-VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF-----DSV 250
Query: 666 RGTRGYL------APEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEVSQETN 712
G A E L T+KSDV+S+G++L E+++ F++
Sbjct: 251 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----- 305
Query: 713 RKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVV 772
+G + + D + +VM C + RP ++V
Sbjct: 306 --------TVYLLQG---RRLLQPEYCPD-PLYEVMLK------CWHPKAEMRPSFSELV 347
Query: 773 QMLEGI 778
+ I
Sbjct: 348 SRISAI 353
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 63/239 (26%), Positives = 104/239 (43%), Gaps = 33/239 (13%)
Query: 488 PVQFSYKELQRSTKGFKDK-LGAGGFGAVYRGVLANR---TVVAVKQL-EGI--EQGEKQ 540
++ L R +DK LG+G FG V +G + VAVK L + +
Sbjct: 5 EIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 64
Query: 541 FRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEE-GSGKLLNWQ 599
E + + +VR++G +LV E + G L+ +L N ++
Sbjct: 65 LLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIEL- 122
Query: 600 SRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRH 659
+ G+ YL EE VH D+ N+LL + AK+SDFGL+K + ++ +
Sbjct: 123 -----VHQVSMGMKYL-EESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 174
Query: 660 RTLTS----VRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRR------NFEV 707
+ T V+ APE + +SKSDV+S+G+++ E S G++ EV
Sbjct: 175 KAQTHGKWPVKWY----APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 229
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-35
Identities = 59/238 (24%), Positives = 99/238 (41%), Gaps = 32/238 (13%)
Query: 487 APVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLANR----TVVAVKQL-EGIEQGEKQ- 540
P Y E+QR +G G FG V++G+ + VA+K ++
Sbjct: 379 MPSTRDY-EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK 437
Query: 541 FRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEE--GSGKLLNW 598
F E T+ H ++V+L+G +E ++ E G L +FL + L+ +
Sbjct: 438 FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILY 496
Query: 599 QSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD-- 656
A + + YL E R VH DI N+L+ N K+ DFGL++ +
Sbjct: 497 ------AYQLSTALAYL-ESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 547
Query: 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-------GRRNFEV 707
+ ++ APE + TS SDV+ +G+ + EI+ G +N +V
Sbjct: 548 KASKGKLPIKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 601
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-34
Identities = 63/264 (23%), Positives = 107/264 (40%), Gaps = 31/264 (11%)
Query: 463 WCCRNSPKFVSLSAQYALLEYASGAPVQF---SYKELQRSTKGFKDKLGAGGFGAVYRGV 519
+ K + ++ E P + + + +LG G FG+V +GV
Sbjct: 297 ARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGV 356
Query: 520 LANR---TVVAVKQL--EGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574
R VA+K L + ++ E + + +VRL+G + +LV E
Sbjct: 357 YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 415
Query: 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENIL 634
G L FL + + + + + G+ YL EE VH ++ N+L
Sbjct: 416 MAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYL-EEKN--FVHRNLAARNVL 468
Query: 635 LDENYNAKVSDFGLAKLINPKDH----RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYS 690
L + AK+SDFGL+K + D R ++ APE + +S+SDV+S
Sbjct: 469 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECINFRKFSSRSDVWS 524
Query: 691 YGMVLLEIVS-GRR------NFEV 707
YG+ + E +S G++ EV
Sbjct: 525 YGVTMWEALSYGQKPYKKMKGPEV 548
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 4e-34
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 20/216 (9%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVK-----QLEGIEQGEKQFRMEVATISSTHHLNLVRLV 560
LG GGF + + V A K L Q ++ ME++ S H ++V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ-REKMSMEISIHRSLAHQHVVGFH 81
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620
GF + +V E + SL L ++R+ G YLH R
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRR----KALTEPEARY-YLRQIVLGCQYLH---R 133
Query: 621 DCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL 680
+ ++H D+K N+ L+E+ K+ DFGLA + R + L GT Y+APE L+
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKK 190
Query: 681 PITSKSDVYSYGMVLLEIVSGRRNFEVS--QETNRK 714
+ + DV+S G ++ ++ G+ FE S +ET +
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR 226
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-34
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 20/216 (9%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVK-----QLEGIEQGEKQFRMEVATISSTHHLNLVRLV 560
LG GGF + + V A K L Q ++ ME++ S H ++V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ-REKMSMEISIHRSLAHQHVVGFH 107
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620
GF + +V E + SL L ++R+ G YLH R
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRR----KALTEPEARY-YLRQIVLGCQYLH---R 159
Query: 621 DCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL 680
+ ++H D+K N+ L+E+ K+ DFGLA + R + L GT Y+APE L+
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKK 216
Query: 681 PITSKSDVYSYGMVLLEIVSGRRNFEVS--QETNRK 714
+ + DV+S G ++ ++ G+ FE S +ET +
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR 252
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 62/273 (22%), Positives = 116/273 (42%), Gaps = 36/273 (13%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEK---QFRMEVATISSTHHLNLVR 558
F ++G G F VY+G+ VA +L+ + + +F+ E + H N+VR
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 559 LVGF---SSEGKHRLLVY-EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
+ +GK +++ E M +G+L +L K++ + + +G+ +
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQF 144
Query: 615 LHEECRDCIVHCDIKPENILLD-ENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLA 673
LH I+H D+K +NI + + K+ D GLA L + +V GT ++A
Sbjct: 145 LHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-----AVIGTPEFMA 198
Query: 674 PEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733
PE DVY++GM +LE+ + + S+ N + + +
Sbjct: 199 PEMYEE-KYDESVDVYAFGMCMLEMATSEYPY--SECQNAAQI-------YRRVTSG--- 245
Query: 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP 766
K + + V I +V I+ CI++ +R
Sbjct: 246 VKPASFDKVAIPEVKEIIE---GCIRQNKDERY 275
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVKQL--EGIEQG--EKQFRMEVATISSTHHLNLVRLVG 561
LG G F VYR + VA+K + + + + ++ + EV H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 562 FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD 621
+ + + LV E NG ++ +L ++R + G+ YLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNR---VKPFSENEARHFMH-QIITGMLYLH---SH 131
Query: 622 CIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLP 681
I+H D+ N+LL N N K++DFGLA + +H TL GT Y++PE
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTPNYISPEIATRSA 188
Query: 682 ITSKSDVYSYGMVLLEIVSGRRNFE 706
+SDV+S G + ++ GR F+
Sbjct: 189 HGLESDVWSLGCMFYTLLIGRPPFD 213
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-33
Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVKQL--EGIEQG--EKQFRMEVATISSTHHLNLVRLVG 561
LG G FG VY ++ ++A+K L +E+ E Q R EV S H N++RL G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 562 FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD 621
+ + L+ E+ G++ L + K ++ I A ++Y H
Sbjct: 77 YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITE-LANALSYCH---SK 128
Query: 622 CIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLP 681
++H DIKPEN+LL K++DFG + R L GT YL PE +
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTDLC---GTLDYLPPEMIEGRM 183
Query: 682 ITSKSDVYSYGMVLLEIVSGRRNFE 706
K D++S G++ E + G+ FE
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFE 208
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 17/220 (7%)
Query: 488 PVQFSYKELQRSTKGFKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVA 546
PV + Y+E + ++G G FG V+R AVK++ +E + E+
Sbjct: 48 PVDYEYREEVHWMTH-QPRVGRGSFGEVHRMKDKQTGFQCAVKKVR-LEVFRVE---ELV 102
Query: 547 TISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIAL 606
+ +V L G EG + E ++ GSL + + G L ++
Sbjct: 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRAL-YYLG 157
Query: 607 GTARGITYLHEECRDCIVHCDIKPENILLDEN-YNAKVSDFGLAKLINPKDHRHRTLT-- 663
G+ YLH I+H D+K +N+LL + A + DFG A + P LT
Sbjct: 158 QALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214
Query: 664 SVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRR 703
+ GT ++APE + P +K D++S ++L +++G
Sbjct: 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 67/211 (31%), Positives = 96/211 (45%), Gaps = 23/211 (10%)
Query: 505 DKLGAGGFGAVYRGV--LANRTVVAVK----QLEGIEQGEKQFRMEVATISSTHHLNLVR 558
DKLG GG VY + N V A+K E+ K+F EV S H N+V
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKV-AIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 559 LVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618
++ E LV E+++ +L ++ G L+ + N GI + H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGP---LSVDTAINFTNQILDGIKHAH-- 128
Query: 619 CRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLT---SVRGTRGYLAPE 675
IVH DIKP+NIL+D N K+ DFG+AK ++ +LT V GT Y +PE
Sbjct: 129 -DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-----ETSLTQTNHVLGTVQYFSPE 182
Query: 676 WLANLPITSKSDVYSYGMVLLEIVSGRRNFE 706
+D+YS G+VL E++ G F
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEPPFN 213
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 16/225 (7%)
Query: 484 ASGAPVQFSYKELQRSTKGFKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGE-KQF 541
+++ Y E + LG G +G VY G L+N+ +A+K++ + +
Sbjct: 10 CESDLLEYDY-EYDENGDR--VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPL 66
Query: 542 RMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSR 601
E+A H N+V+ +G SE + E + GSL L ++ G K
Sbjct: 67 HEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIG 125
Query: 602 FNIALGTARGITYLHEECRDCIVHCDIKPENILLD-ENYNAKVSDFGLAKLINPKDHRHR 660
G+ YLH+ IVH DIK +N+L++ + K+SDFG +K + +
Sbjct: 126 -FYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA---GINP 178
Query: 661 TLTSVRGTRGYLAPEWLANLPI--TSKSDVYSYGMVLLEIVSGRR 703
+ GT Y+APE + P +D++S G ++E+ +G+
Sbjct: 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 60/291 (20%), Positives = 102/291 (35%), Gaps = 32/291 (10%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLE--GIEQGEKQFRMEVATISSTHHLNLVRL 559
D LG G V+RG + A+K + E + +H N+V+L
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 560 VGF--SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHE 617
+ +H++L+ EF GSL L E + L + G+ +L E
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 618 ECRDCIVHCDIKPENILL----DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLA 673
IVH +IKP NI+ D K++DFG A+ + + S+ GT YL
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ----FVSLYGTEEYLH 183
Query: 674 PEWLANLPI--------TSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFE 725
P+ + + D++S G+ +G F + R K E
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK------EVMY 237
Query: 726 KGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776
K + + + + + C + Q + + +LE
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILE 288
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-31
Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 19/208 (9%)
Query: 503 FKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVAT-ISSTHHLNLVRLVG 561
KD LG G G + + + VAVK++ + + EV S H N++R
Sbjct: 28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRI--LPECFSFADREVQLLRESDEHPNVIRYFC 85
Query: 562 FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD 621
+ + + + E +L ++ E+ L + + T G+ +LH
Sbjct: 86 TEKDRQFQYIAIELC-AATLQEYV---EQKDFAHLGLEPI-TLLQQTTSGLAHLHSLN-- 138
Query: 622 CIVHCDIKPENILLDE-----NYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEW 676
IVH D+KP NIL+ A +SDFGL K + H + V GT G++APE
Sbjct: 139 -IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 677 L---ANLPITSKSDVYSYGMVLLEIVSG 701
L T D++S G V ++S
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVKQL--EGIEQG--EKQFRMEVATISSTHHLNLVRLVG 561
LG G FG VY N+ ++A+K L +E+ E Q R E+ S H N++R+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 562 FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD 621
+ + K L+ EF G L + + G+ +S + A + Y H
Sbjct: 82 YFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEE-LADALHYCH---ER 133
Query: 622 CIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLP 681
++H DIKPEN+L+ K++DFG + R RT+ GT YL PE +
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRTMC---GTLDYLPPEMIEGKT 188
Query: 682 ITSKSDVYSYGMVLLEIVSGRRNFE 706
K D++ G++ E + G F+
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPPFD 213
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-31
Identities = 46/273 (16%), Positives = 82/273 (30%), Gaps = 27/273 (9%)
Query: 503 FKDKLGAGGFGAVYRGV------LANRTVVAVKQLEGIEQGEKQ-FRMEVATISSTHHLN 555
LG G F VY N+ +K + E + + +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 556 LVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYL 615
++ +LV E G+L N + + K++ + A+ I +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188
Query: 616 HEECRDCIVHCDIKPENILL-----------DENYNAKVSDFGLAKLIN--PKDHRHRTL 662
H+ I+H DIKP+N +L D + + D G + + PK
Sbjct: 189 HDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT---IF 242
Query: 663 TSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYE 722
T+ T G+ E L+N P + D + + ++ G V E K
Sbjct: 243 TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK-VKNEGGECKPEGLFRR 301
Query: 723 EFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSF 755
L D + ++
Sbjct: 302 LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 49/218 (22%), Positives = 90/218 (41%), Gaps = 29/218 (13%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQ--LEGIEQGEKQFRMEVATISSTHHLNLVRLVG 561
LG GGFG V+ + A+K+ L E ++ EV ++ H +VR
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 562 F---------SSEGKHRLLVY---EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTA 609
++ +Y + + +L +++ N + + +I L A
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM--NGRCTIEERERSVCLHIFLQIA 128
Query: 610 RGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTL------- 662
+ +LH + ++H D+KP NI + KV DFGL ++ + L
Sbjct: 129 EAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 663 --TSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEI 698
T GT+ Y++PE + + K D++S G++L E+
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 25/215 (11%)
Query: 505 DKLGAGGFGAVYRGV--LANRTVVAVK----QLEGIEQGEKQFRMEVATISSTHHLNLVR 558
+ LG GG V+ +R V AVK L +FR E ++ +H +V
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDV-AVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 559 L--VGFSSEGKHRL--LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
+ G + L +V E++ +L + + + EG + + + + + +
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGP---MTPKRAIEVIADACQALNF 131
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLT---SVRGTRGY 671
H ++ I+H D+KP NI++ KV DFG+A+ I + ++T +V GT Y
Sbjct: 132 SH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN---SVTQTAAVIGTAQY 185
Query: 672 LAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFE 706
L+PE + ++SDVYS G VL E+++G F
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 505 DKLGAGGFGAVYRGVLANRTVVAVKQ--LEGIEQGE-KQFRMEVATIS--STHHLNLVRL 559
++G+GG V++ + + + A+K LE + +R E+A ++ H ++RL
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
+ ++ +V E N L+++L + W+ + + +H+
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKK----KSIDPWERKS-YWKNMLEAVHTIHQHG 147
Query: 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN 679
IVH D+KP N L+ + K+ DFG+A + P D S GT Y+ PE + +
Sbjct: 148 ---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQP-DTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 680 LP-----------ITSKSDVYSYGMVLLEIVSGR 702
+ I+ KSDV+S G +L + G+
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 46/217 (21%), Positives = 95/217 (43%), Gaps = 30/217 (13%)
Query: 506 KLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSS 564
+G+GGFG V++ + +K+ ++ ++ EV ++ H+N+V G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNNEKAEREVKALAKLDHVNIVHYNGCWD 74
Query: 565 EGKHRL----------------LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGT 608
+ + EF G+L+ ++ E+ G+ L+ +
Sbjct: 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI---EKRRGEKLDKVLALELFEQI 131
Query: 609 ARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGT 668
+G+ Y+H + +++ D+KP NI L + K+ DFGL + R T +GT
Sbjct: 132 TKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR----TRSKGT 184
Query: 669 RGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNF 705
Y++PE +++ + D+Y+ G++L E++
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-31
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 505 DKLGAGGFGAVYRGVLANRTVVAVKQ--LEGIEQGE-KQFRMEVATIS--STHHLNLVRL 559
++G+GG V++ + + + A+K LE + +R E+A ++ H ++RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
+ ++ +V E N L+++L + W+ + + +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKK----KSIDPWERKS-YWKNMLEAVHTIHQHG 128
Query: 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN 679
IVH D+KP N L+ + K+ DFG+A + P D S GT Y+ PE + +
Sbjct: 129 ---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQP-DTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 680 LP-----------ITSKSDVYSYGMVLLEIVSGR 702
+ I+ KSDV+S G +L + G+
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 53/203 (26%), Positives = 78/203 (38%), Gaps = 18/203 (8%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEK---QFRMEVATISS-THHLNLVRL 559
+LG G +G V++ + + AVK+ +G K + EV + H VRL
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
EG L E SL E G L + T + +LH
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHC----EAWGASLPEAQVWGYLRDTLLALAHLHS-- 175
Query: 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN 679
+ +VH D+KP NI L K+ DFGL + G Y+APE L
Sbjct: 176 QG-LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE----VQEGDPRYMAPELLQG 230
Query: 680 LPITSKSDVYSYGMVLLEIVSGR 702
+ +DV+S G+ +LE+
Sbjct: 231 -SYGTAADVFSLGLTILEVACNM 252
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 57/230 (24%), Positives = 96/230 (41%), Gaps = 43/230 (18%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVG 561
LG G FG V + + A+K++ E+ EV ++S +H +VR
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYA 69
Query: 562 FSSEGKHRL-------------LVYEFMKNGSLDNFL-----FANEEGSGKLLNWQSRFN 603
E ++ + + E+ +NG+L + + + +L Q
Sbjct: 70 AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF-RQ---- 124
Query: 604 IALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRT-- 661
I ++Y+H + I+H D+KP NI +DE+ N K+ DFGLAK ++ +
Sbjct: 125 ILEA----LSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 662 ---------LTSVRGTRGYLAPEWLANLPI-TSKSDVYSYGMVLLEIVSG 701
LTS GT Y+A E L K D+YS G++ E++
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 64/342 (18%), Positives = 127/342 (37%), Gaps = 43/342 (12%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQ--LEGIEQGEKQF-RMEVATISSTHHLNLVRLV 560
K+G G FG + +K+ + + E++ R EVA +++ H N+V+
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620
E +V ++ + G L + G L + + + ++H+
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRI---NAQKGVLFQEDQILDWFVQICLALKHVHDRK- 145
Query: 621 DCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL 680
I+H DIK +NI L ++ ++ DFG+A+++N R GT YL+PE N
Sbjct: 146 --ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI---GTPYYLSPEICENK 200
Query: 681 PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGE 740
P +KSD+++ G VL E+ + + FE G++K +V K ++G
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKH-------------------AFEAGSMKNLVLKIISGS 241
Query: 741 DVDIEQVM--RAIQVSFWCIQEQPSQRP---------MMGKVVQMLEGITEIEKPPAPKA 789
+ + + P RP + K ++ I + K
Sbjct: 242 FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKT 301
Query: 790 LTEGSVGGTSVNMSSSTSALSTFAASAPAPSSSSSTHTGVSA 831
++ +S + + ++ ++
Sbjct: 302 FSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAY 343
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 3e-30
Identities = 54/230 (23%), Positives = 87/230 (37%), Gaps = 26/230 (11%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLE--GIEQGEKQFRMEVATISSTHHLNLVRL 559
D LG G V+RG + A+K + E + +H N+V+L
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 560 VGF--SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHE 617
+ +H++L+ EF GSL L E + L + G+ +L E
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 618 ECRDCIVHCDIKPENILL----DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLA 673
IVH +IKP NI+ D K++DFG A+ + + S+ GT YL
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ----FVSLYGTEEYLH 183
Query: 674 PEWLANLPI--------TSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKK 715
P+ + + D++S G+ +G F + R K
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 49/209 (23%), Positives = 90/209 (43%), Gaps = 12/209 (5%)
Query: 506 KLGAGGFGAVYRGV-LANRTVVAVKQ--LEGIEQGEKQF-RMEVATISSTHHLNLVRLVG 561
+G G +G + ++ ++ K+ + + EKQ EV + H N+VR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 562 -FSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
L +V E+ + G L + + + + L+ + + + H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 620 RDC--IVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWL 677
++H D+KP N+ LD N K+ DFGLA+++N +T GT Y++PE +
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV---GTPYYMSPEQM 188
Query: 678 ANLPITSKSDVYSYGMVLLEIVSGRRNFE 706
+ KSD++S G +L E+ + F
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPFT 217
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 69/318 (21%), Positives = 112/318 (35%), Gaps = 72/318 (22%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLV 560
F KLG GGF V L + A+K++ +Q ++ + E +H N++RLV
Sbjct: 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 561 GFSSE----GKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLH 616
+ L+ F K G+L N + ++ L Q + LG RG+ +H
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL-WLLLGICRGLEAIH 151
Query: 617 EECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSV------RGTRG 670
+ H D+KP NILL + + D G R ++ R T
Sbjct: 152 AKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 671 YLAPEWL---ANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG 727
Y APE ++ I ++DV+S G VL ++ G ++
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD--------------------- 247
Query: 728 NVKGIVDKSLAGEDVDIEQVMRAIQVSF-----------------WCIQEQPSQRPMMGK 770
+ V A+Q + P QRP +
Sbjct: 248 -----------MVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPL 296
Query: 771 VVQMLEGITEIEKPPAPK 788
++ LE + +PPAP
Sbjct: 297 LLSQLEAL----QPPAPG 310
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-29
Identities = 49/214 (22%), Positives = 93/214 (43%), Gaps = 27/214 (12%)
Query: 505 DKLGAGGFGAVYRGVLANRTVVAVKQ--LEGIEQGE-KQFRMEVATISSTHHLNL--VRL 559
++G+GG V++ + + + A+K LE + +R E+A ++ + +RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
+ ++ +V E N L+++L + W+ + + +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKK----KSIDPWERKS-YWKNMLEAVHTIHQHG 175
Query: 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN 679
IVH D+KP N L+ + K+ DFG+A + P D S G Y+ PE + +
Sbjct: 176 ---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQP-DTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 680 LP-----------ITSKSDVYSYGMVLLEIVSGR 702
+ I+ KSDV+S G +L + G+
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 67/302 (22%), Positives = 116/302 (38%), Gaps = 63/302 (20%)
Query: 505 DKLGAGGFGAVYRGVL-ANRTVVAVKQ--LEGIEQGEKQFRMEVATISSTHHLNLVRLVG 561
+LGAG G V++ + V+A K LE Q E+ + + +V G
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 562 -FSSEGKHRLLVY---EFMKNGSLDNFLFANEEGSGKLLNWQSRFN------IALGTARG 611
F S+G+ + E M GSLD ++L R +++ +G
Sbjct: 99 AFYSDGE----ISICMEHMDGGSLD-----------QVLKKAGRIPEQILGKVSIAVIKG 143
Query: 612 ITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA-KLINPKDHRHRTLTSVRGTRG 670
+TYL E+ + I+H D+KP NIL++ K+ DFG++ +LI+ + + V GTR
Sbjct: 144 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-----SFV-GTRS 195
Query: 671 YLAPEWLANLPITSKSDVYSYGMVLLEIVSGR---------RNFEVSQETNRKKFSLWAY 721
Y++PE L + +SD++S G+ L+E+ GR + +
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255
Query: 722 EEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQ---------------VSF--WCIQEQPSQ 764
G E + + F C+ + P++
Sbjct: 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 315
Query: 765 RP 766
R
Sbjct: 316 RA 317
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-29
Identities = 71/290 (24%), Positives = 107/290 (36%), Gaps = 46/290 (15%)
Query: 503 FKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVAT-ISSTHHLNLVRLVG 561
+ LG G G V VAVK++ ME+ S H N++R
Sbjct: 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRML--IDFCDIALMEIKLLTESDDHPNVIRYYC 76
Query: 562 FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSR--FNIALGTARGITYLHEEC 619
+ + + E N +L + + + L + ++ A G+ +LH
Sbjct: 77 SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 135
Query: 620 RDCIVHCDIKPENILLD-------------ENYNAKVSDFGLAKLINPKDHRHRT-LTSV 665
I+H D+KP+NIL+ EN +SDFGL K ++ RT L +
Sbjct: 136 ---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 666 RGTRGYLAPEWL-------ANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFS 717
GT G+ APE L +T D++S G V I+S G+ F
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIR 252
Query: 718 LWAYEEFEKGNVKGIVDKSLAGEDVD-IEQVMRAIQVSFWCIQEQPSQRP 766
F +K + D+SL E D I Q I P +RP
Sbjct: 253 ----GIFSLDEMKCLHDRSLIAEATDLISQ----------MIDHDPLKRP 288
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 55/270 (20%), Positives = 105/270 (38%), Gaps = 32/270 (11%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQ--LEGIEQGE--KQFRMEVATISSTHHLNLVRL 559
K+G G F VYR L + VA+K+ + + + E+ + +H N+++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
E +V E G L + ++ +L+ ++ + + + ++H
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSRR 156
Query: 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN 679
++H DIKP N+ + K+ D GL + + K +L GT Y++PE +
Sbjct: 157 ---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYYMSPERIHE 210
Query: 680 LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAG 739
KSD++S G +L E+ + + F +K N+ + K
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSPF-----------------YGDKMNLYSLCKKIEQC 253
Query: 740 EDVDIEQVM---RAIQVSFWCIQEQPSQRP 766
+ + Q+ CI P +RP
Sbjct: 254 DYPPLPSDHYSEELRQLVNMCINPDPEKRP 283
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-29
Identities = 60/214 (28%), Positives = 91/214 (42%), Gaps = 23/214 (10%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLE---GIEQGEKQFRMEVATISSTHHLNLVR 558
K++LG GGFG V R + VA+KQ + E+ E+ + +H N+V
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL-EIQIMKKLNHPNVVS 76
Query: 559 LV------GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGI 612
+ LL E+ + G L +L N+ + L + + +
Sbjct: 77 AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL--NQFENCCGLKEGPIRTLLSDISSAL 134
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNA---KVSDFGLAKLINPKDHRHRTLTSVRGTR 669
YLHE I+H D+KPENI+L K+ D G AK ++ + T GT
Sbjct: 135 RYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL----CTEFVGTL 187
Query: 670 GYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRR 703
YLAPE L T D +S+G + E ++G R
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 49/236 (20%), Positives = 93/236 (39%), Gaps = 39/236 (16%)
Query: 506 KLGAGGFGAVYRGVLANRT--VVAVKQLE------------------GIEQGEKQFRMEV 545
L G F + L + A+K+ E I+ F+ E+
Sbjct: 38 TLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 546 ATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFA----NEEGSGKLLNWQSR 601
I+ + + G + ++YE+M+N S+ F ++ + + +
Sbjct: 95 QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 602 FNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRT 661
I +Y+H I H D+KP NIL+D+N K+SDFG ++ + D + +
Sbjct: 155 C-IIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYM--VDKKIKG 209
Query: 662 LTSVRGTRGYLAPEWLANLPITS--KSDVYSYGMVLLEIVSGRRNFEVSQETNRKK 715
RGT ++ PE+ +N + K D++S G+ L + F + + +
Sbjct: 210 S---RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS--LKISLVE 260
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 62/239 (25%), Positives = 108/239 (45%), Gaps = 30/239 (12%)
Query: 477 QYALLEYASGAPVQFSYKELQRSTKGFKDKLGAGGFGAVYRGV-LANRTVVAVKQ--LEG 533
L+ + F+ ++L+ ++G G +G+V + V + ++AVK+
Sbjct: 5 SSGKLKISPEQHWDFTAEDLKD-----LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV 59
Query: 534 IEQGEKQFRMEVATI-SSTHHLNLVRLVG-FSSEGKHRLLVY---EFMKNGSLDNFLFAN 588
E+ +KQ M++ + S+ +V+ G EG + E M + S D F
Sbjct: 60 DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD----CWICMELM-STSFDKFYKYV 114
Query: 589 EEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648
++ + I L T + + +L E + I+H DIKP NILLD + N K+ DFG+
Sbjct: 115 YSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGI 172
Query: 649 -AKLINPKDHRHRTLTSVRGTRGYLAPE----WLANLPITSKSDVYSYGMVLLEIVSGR 702
+L++ G R Y+APE + +SDV+S G+ L E+ +GR
Sbjct: 173 SGQLVDSIAKT----RDA-GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 7e-29
Identities = 29/320 (9%), Positives = 68/320 (21%), Gaps = 55/320 (17%)
Query: 483 YASGAPVQFSYKELQRSTK-GFKDKLGAGGFGAVYRGV-LANRTVVAVK----QLEGIEQ 536
+ A Q K + L G V+ + A+K E
Sbjct: 45 WPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRS 104
Query: 537 GEKQFRMEVATISSTHHLNLVRLVGF--------------------------SSEGKHRL 570
++ + + + L
Sbjct: 105 ELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYL 164
Query: 571 LVYEFMKNGSLDNF--LFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDI 628
L+ L+ + + R L + +VH
Sbjct: 165 LLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHF 220
Query: 629 KPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWL--ANLPITSKS 686
P+N+ + + + D + + Y E+L + T
Sbjct: 221 TPDNLFIMPDGRLMLGDVSALWKVG------TRGPASSVPVTYAPREFLNASTATFTHAL 274
Query: 687 DVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQ 746
+ + G+ + + F + + + + ++ L +
Sbjct: 275 NAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLP------DF 328
Query: 747 VMRAIQVSFWCIQEQPSQRP 766
V I + +R
Sbjct: 329 VKTLIG---RFLNFDRRRRL 345
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 7e-29
Identities = 49/211 (23%), Positives = 78/211 (36%), Gaps = 23/211 (10%)
Query: 505 DKLGAGGFGAVYRG--VLANRTVVAVK----QLEGIEQGEKQFRMEVATISSTHHLNLVR 558
+G GG G VY + R V A+K L + + E T ++V
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIV-ALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 559 LVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618
+ F + + L L +G L I + H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAML--RRQGP---LAPPRAVAIVRQIGSALDAAH-- 151
Query: 619 CRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLT---SVRGTRGYLAPE 675
H D+KPENIL+ + A + DFG+A + LT + GT Y+APE
Sbjct: 152 -AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE-----KLTQLGNTVGTLYYMAPE 205
Query: 676 WLANLPITSKSDVYSYGMVLLEIVSGRRNFE 706
+ T ++D+Y+ VL E ++G ++
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPPYQ 236
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 2e-28
Identities = 42/338 (12%), Positives = 89/338 (26%), Gaps = 81/338 (23%)
Query: 483 YASGAPVQFSYKELQRS-TKGFKDKLGAGGFGAVYRGV-LANRTVVAVKQL--------- 531
+ +G P + + +R T LG A V
Sbjct: 56 WNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN 115
Query: 532 --------------------EGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEG--KHR 569
+ + +F + ++R+ + R
Sbjct: 116 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 175
Query: 570 LLVYEFMK--NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCD 627
+Y M+ + L ++ L +R + L R + LH +VH
Sbjct: 176 FFLYPRMQSNLQTFGEVLLSHSSTHKS-LVHHARLQLTLQVIRLLASLHHY---GLVHTY 231
Query: 628 IKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLA--------- 678
++P +I+LD+ ++ F +RG+ PE A
Sbjct: 232 LRPVDIVLDQRGGVFLTGFEHLVRDG-------ARVVSSVSRGFEPPELEARRATISYHR 284
Query: 679 --NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736
+T D ++ G+V+ I K G +
Sbjct: 285 DRRTLMTFSFDAWALGLVIYWIWCADL-------------------PITKDAALGGSEWI 325
Query: 737 LAGEDVDI-EQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773
+I + V ++ ++ R + + ++
Sbjct: 326 FRSCK-NIPQPVRALLE---GFLRYPKEDRLLPLQAME 359
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 71/328 (21%), Positives = 116/328 (35%), Gaps = 49/328 (14%)
Query: 506 KLGAGGFGAVYRGV-LANRTVVAVKQLEGI-EQGEKQFRMEVATISS-THHLNLVRLVGF 562
L GGF VY + + A+K+L E+ + EV + + H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 563 SSEGKHR-------LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYL 615
+S GK L+ + G L FL E G L I T R + ++
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFL-KKMESRGPLSCDTVL-KIFYQTCRAVQHM 152
Query: 616 HEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSV---------R 666
H + I+H D+K EN+LL K+ DFG A I+ +
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 667 GTRGYLAPE---WLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEE 723
T Y PE +N PI K D+++ G +L + + FE + + +
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE---DGAKLRIV------ 262
Query: 724 FEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEK 783
G + + ++R +Q P +R + +VV L+ I
Sbjct: 263 --NGKYSIPPHDT---QYTVFHSLIR------AMLQVNPEERLSIAEVVHQLQEIAAARN 311
Query: 784 PPAPKALTEGSVGGTSVNMSSSTSALST 811
+TE N ++ LS
Sbjct: 312 VNPKSPITELL----EQNGGYGSATLSR 335
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-28
Identities = 49/249 (19%), Positives = 88/249 (35%), Gaps = 43/249 (17%)
Query: 505 DKLGAGGFGAVYRG---VLANRTVVAVKQL--EGIEQGEKQFRMEVATISSTHHLNLVRL 559
+ GG G +Y + R V +K L G + + E ++ H ++V++
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPV-VLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 560 VGFSSEGKHRL-----LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
F +V E++ SL G+ L L ++Y
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-------GQKLPVAEAIAYLLEILPALSY 197
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLT---SVRGTRGY 671
LH +V+ D+KPENI+L E K+ D G + + GT G+
Sbjct: 198 LH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAV----------SRINSFGYLYGTPGF 243
Query: 672 LAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNF--EVSQETNRKKFSLWAYEEFEKGNV 729
APE + P T +D+Y+ G L + L Y+ + +
Sbjct: 244 QAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGR--- 299
Query: 730 KGIVDKSLA 738
++ +++
Sbjct: 300 --LLRRAID 306
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 50/217 (23%), Positives = 93/217 (42%), Gaps = 38/217 (17%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQ--LEGIEQGEKQFRMEVATI-SSTHHLNLVRLV 560
+LG G +G V + + + ++AVK+ Q +K+ M++ + V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 561 G-FSSEGKHRLLVY---EFMKNGSLDNFLFANEEGSGKLLNWQSRFN------IALGTAR 610
G EG V+ E M + SLD F ++++ IA+ +
Sbjct: 73 GALFREGD----VWICMELM-DTSLDKFY-------KQVIDKGQTIPEDILGKIAVSIVK 120
Query: 611 GITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL-AKLINPKDHRHRTLTSVRGTR 669
+ +LH + ++H D+KP N+L++ K+ DFG+ L++ G +
Sbjct: 121 ALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD----IDA-GCK 173
Query: 670 GYLAPE----WLANLPITSKSDVYSYGMVLLEIVSGR 702
Y+APE L + KSD++S G+ ++E+ R
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 55/288 (19%), Positives = 102/288 (35%), Gaps = 58/288 (20%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEK---QFRMEVATISS-THHLNLVRL 559
+K+G+G FG+V++ V + + A+K+ + G EV + H ++VR
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
+E H L+ E+ GSL + + N + + ++ L RG+ Y+H
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK-DLLLQVGRGLRYIHSMS 135
Query: 620 RDCIVHCDIKPENILLDEN-------------------YNAKVSDFGLAKLINPKDHRHR 660
+VH DIKP NI + K+ D G I+
Sbjct: 136 ---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS------- 185
Query: 661 TLTSVRGTRGYLAPE-WLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLW 719
+ G +LA E N K+D+++ + ++ +
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--------- 236
Query: 720 AYEEFEKGNVKGIVDK-SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP 766
+ E +G + I S ++ ++ I P +RP
Sbjct: 237 -WHEIRQGRLPRIPQVLSQEFTEL-LKV----------MIHPDPERRP 272
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVKQL--EGIEQGEKQFRMEVATISSTHHLNLVRLVGFS 563
LG G +G V V VAVK + + + + E+ +H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 564 SEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSR--FN--IALGTARGITYLHEEC 619
EG + L E+ G L + + + + ++ F+ +A G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMA-----GVVYLH--- 122
Query: 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN 679
I H DIKPEN+LLDE N K+SDFGLA + + GT Y+APE L
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKR 181
Query: 680 LPIT-SKSDVYSYGMVLLEIVSGRRNFE 706
DV+S G+VL +++G ++
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 26/214 (12%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVK-----QLEGIEQGEKQFRMEVATISSTHHLNLVRL- 559
LG G +G V + AVK +L I GE + E+ + H N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 560 -VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSR--FN--IALGTARGITY 614
V ++ E + +V E+ G + + + + Q+ F I G+ Y
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--ML-DSVPEKRFPVCQAHGYFCQLID-----GLEY 124
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAP 674
LH IVH DIKP N+LL K+S G+A+ ++P T + +G+ + P
Sbjct: 125 LH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD-TCRTSQGSPAFQPP 180
Query: 675 EWLANLPI--TSKSDVYSYGMVLLEIVSGRRNFE 706
E L K D++S G+ L I +G FE
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVKQL--EGIEQGEKQFRMEVATISSTHHLNLVRLVGFS 563
LG G +G V V VAVK + + + + E+ +H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 564 SEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSR--FN--IALGTARGITYLHEEC 619
EG + L E+ G L + + + + ++ F+ +A G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMA-----GVVYLH--- 122
Query: 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN 679
I H DIKPEN+LLDE N K+SDFGLA + + GT Y+APE L
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKR 181
Query: 680 LPIT-SKSDVYSYGMVLLEIVSGRRNFE 706
DV+S G+VL +++G ++
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 47/360 (13%), Positives = 92/360 (25%), Gaps = 79/360 (21%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGE----KQFRMEVATISST---------- 551
LG A V E+ KQ + EV +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 552 ------------HHLNLVRLVGFSSEGKHRLLVYEFMK----NGSLDNFL--FANEEGSG 593
+++ + + ++ F +L F + +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 594 KLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653
K L +R + L R + LH +VH ++P +I+LD+ ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 654 PKDHRHRTLTSVRGTRGYLAPEWLA----------NLPITSKSDVYSYGMVLLEIVSGRR 703
RG+ PE A +T D ++ G+ + I
Sbjct: 263 -------ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 704 NFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDI-EQVMRAIQVSFWCIQEQP 762
G + +I + V ++ ++
Sbjct: 316 -------------------PNTDDAALGGSEWIFR-SCKNIPQPVRALLE---GFLRYPK 352
Query: 763 SQRPMMGKVVQ--MLEGITEIEKPPAPKALTEGSVGGTSVNMSSSTSALSTFAASAPAPS 820
R + + ++ E + P T+G S TS A+ +
Sbjct: 353 EDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEAGAAEAVTA 412
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 59/226 (26%), Positives = 93/226 (41%), Gaps = 42/226 (18%)
Query: 497 QRSTKGFKDK------LGAGGFGAVYRGV-LANRTVVAVK----------QLEGIEQGEK 539
ST GF + LG G V R + AVK E +++ +
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 540 QFRMEVATISS-THHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANE---EGSGKL 595
EV + + H N+++L LV++ MK G L ++L E +
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK 128
Query: 596 LNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655
+ I LH+ IVH D+KPENILLD++ N K++DFG + ++P
Sbjct: 129 IMRA--------LLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177
Query: 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKS------DVYSYGMVL 695
+ L V GT YLAPE + + D++S G+++
Sbjct: 178 E----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-25
Identities = 58/229 (25%), Positives = 92/229 (40%), Gaps = 37/229 (16%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLE----GIEQGEKQFRMEVATISSTHHLNLV 557
+ LG G FG V AVK + + ++ EV + H N++
Sbjct: 30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 89
Query: 558 RLVGFSSEGKHRLLVYEFMKNGSL-------DNFLFANEEGSGKLLNWQSRFNIALGTAR 610
+L F + + LV E G L F +E + +++ +
Sbjct: 90 KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF---SEVDAARIIR-----QVL----S 137
Query: 611 GITYLHEECRDCIVHCDIKPENILL---DENYNAKVSDFGLAKLINPKDHRHRTLTSVRG 667
GITY+H+ IVH D+KPEN+LL ++ N ++ DFGL+ + G
Sbjct: 138 GITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK----KMKDKIG 190
Query: 668 TRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKF 716
T Y+APE L K DV+S G++L ++SG F +
Sbjct: 191 TAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPF--NGANEYDIL 236
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 34/225 (15%)
Query: 490 QFSYKELQRSTKGFKD------KLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQ-F 541
++ + ++ D +LG+G FG V+R V A V K + +K
Sbjct: 36 KYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV 95
Query: 542 RMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSL------DNFLFANEEGSGKL 595
+ E++ ++ HH L+ L + +L+ EF+ G L +++ +E
Sbjct: 96 KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKM-SEAEVINY 154
Query: 596 LNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL--DENYNAKVSDFGLAKLIN 653
+ Q G+ ++HE IVH DIKPENI+ + + K+ DFGLA +N
Sbjct: 155 MR-Q--------ACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202
Query: 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEI 698
P + + T + APE + P+ +D+++ G VL +
Sbjct: 203 PDE----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIG-VLGYV 242
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 50/198 (25%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 506 KLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRM-EVATISSTHHLNLVRLVGFS 563
K+G G G VY + +A VA++Q+ +Q +K+ + E+ + + N+V +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 564 SEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCI 623
G +V E++ GSL + + + Q + + + +LH +
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAA-VCRECLQALEFLHSNQ---V 137
Query: 624 VHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPIT 683
+H DIK +NILL + + K++DFG I P+ + T+ GT ++APE +
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAYG 194
Query: 684 SKSDVYSYGMVLLEIVSG 701
K D++S G++ +E++ G
Sbjct: 195 PKVDIWSLGIMAIEMIEG 212
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 51/247 (20%), Positives = 88/247 (35%), Gaps = 44/247 (17%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQL------EGIEQGEKQFRMEVATISSTHHLN 555
K +G G +G V + R + A+K + + + ++ + EV + HH N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 556 LVRLVGFSSEGKHRLLVYEFMKNGSL-----------------DNFLFANEEGSGKLLNW 598
+ RL + ++ LV E G L D
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 599 QSRFNIALGTARGITYLHEECRDC---------------IVHCDIKPENILL--DENYNA 641
+ + + + I H DIKPEN L ++++
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEI 209
Query: 642 KVSDFGLAKLINPKDHRHR-TLTSVRGTRGYLAPEWL--ANLPITSKSDVYSYGMVLLEI 698
K+ DFGL+K ++ +T+ GT ++APE L N K D +S G++L +
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 699 VSGRRNF 705
+ G F
Sbjct: 270 LMGAVPF 276
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 34/217 (15%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLE--GIEQGEKQ-FRMEVATISSTHHLNLVR 558
KLG+G +G V A+K + + EVA + H N+++
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100
Query: 559 LVGFSSEGKHRLLVYEFMKNGSL-------DNFLFANEEGSGKLLNWQSRFNIALGTARG 611
L F + ++ LV E K G L F NE + ++ + G
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHRMKF---NEVDAAVIIK-----QVL----SG 148
Query: 612 ITYLHEECRDCIVHCDIKPENILL---DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGT 668
+TYLH+ IVH D+KPEN+LL +++ K+ DFGL+ + + + GT
Sbjct: 149 VTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK----KMKERLGT 201
Query: 669 RGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNF 705
Y+APE L K DV+S G++L +++G F
Sbjct: 202 AYYIAPEVL-RKKYDEKCDVWSIGVILFILLAGYPPF 237
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 63/228 (27%), Positives = 97/228 (42%), Gaps = 45/228 (19%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQL--------------EGIEQGEKQFRMEVAT 547
KLG+G +G V + A+K + + IE+ ++ E++
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 548 ISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSL-------DNFLFANEEGSGKLLNWQS 600
+ S H N+++L + K+ LV EF + G L F +E + ++
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF---DECDAANIM---- 152
Query: 601 RFNIALGTARGITYLHEECRDCIVHCDIKPENILL---DENYNAKVSDFGLAKLINPKDH 657
I GI YLH+ IVH DIKPENILL + N K+ DFGL+ +
Sbjct: 153 -KQIL----SGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY- 203
Query: 658 RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNF 705
L GT Y+APE L K DV+S G+++ ++ G F
Sbjct: 204 ---KLRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPPF 247
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 40/217 (18%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQ--LEGIEQGEKQFRMEVATI-SSTHHLNLVRLV 560
++G+G G V++ V+AVKQ G ++ K+ M++ + S +V+
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90
Query: 561 G-FSSEGKHRLLVY---EFMKNGSLDNFLFA-----NEEGSGKLLNWQSRFNIALGTARG 611
G F + V+ E M + E GK + + +
Sbjct: 91 GTFITNTD----VFIAMELM-GTCAEKLKKRMQGPIPERILGK---------MTVAIVKA 136
Query: 612 ITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL-AKLINPKDHRHRTLTSVRGTRG 670
+ YL E+ ++H D+KP NILLDE K+ DFG+ +L++ K S G
Sbjct: 137 LYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD----RSA-GCAA 189
Query: 671 YLAPE-----WLANLPITSKSDVYSYGMVLLEIVSGR 702
Y+APE ++DV+S G+ L+E+ +G+
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 50/199 (25%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQ-FRMEVATISSTHHLNLVRLVGF 562
K+G G G V + VAVK ++ +Q ++ EV + H N+V +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 563 SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC 622
G+ ++ EF++ G+L + + +L Q + + + YLH +
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIV-----SQVRLNEEQIAT-VCEAVLQALAYLHAQG--- 161
Query: 623 IVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPI 682
++H DIK ++ILL + K+SDFG I+ + ++L GT ++APE ++
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV---GTPYWMAPEVISRSLY 218
Query: 683 TSKSDVYSYGMVLLEIVSG 701
++ D++S G++++E+V G
Sbjct: 219 ATEVDIWSLGIMVIEMVDG 237
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 49/222 (22%), Positives = 87/222 (39%), Gaps = 38/222 (17%)
Query: 496 LQRSTKGFKDK-------LGAGGFGAVYRGV-LANRTVVAVKQLE---GIEQGEKQFRME 544
+S + F + LG G F V + + + A K L+ + + E
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHE 78
Query: 545 VATISS-THHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFN 603
+A + ++ L +L+ E+ G + + +
Sbjct: 79 IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEM---------VS 129
Query: 604 --IALGTAR----GITYLHEECRDCIVHCDIKPENILL---DENYNAKVSDFGLAKLINP 654
+ + G+ YLH+ IVH D+KP+NILL + K+ DFG+++ I
Sbjct: 130 ENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186
Query: 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLL 696
L + GT YLAPE L PIT+ +D+++ G ++
Sbjct: 187 AC----ELREIMGTPEYLAPEILNYDPITTATDMWNIG-IIA 223
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 41/209 (19%), Positives = 83/209 (39%), Gaps = 35/209 (16%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVG 561
+ LG G FG V+R V +++ K ++ + + E++ ++ H N++ L
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 562 FSSEGKHRLLVYEFMKNGSL------DNFLFANEEGSGKLLNWQSRFNIALGTAR----G 611
+ ++++EF+ + F E +
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAFELNERE--------------IVSYVHQVCEA 114
Query: 612 ITYLHEECRDCIVHCDIKPENILL--DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR 669
+ +LH I H DI+PENI+ + K+ +FG A+ + P D +
Sbjct: 115 LQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAP 167
Query: 670 GYLAPEWLANLPITSKSDVYSYGMVLLEI 698
Y APE + +++ +D++S G L+ +
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLG-TLVYV 195
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 26/202 (12%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLE-GIEQGEKQFRMEVATISSTHHLNLVRLV 560
F + LG+G F V+ + A+K ++ + E+A + H N+V L
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFA----NEEGSGKLLNWQSRFNIALGTARGITYLH 616
H LV + + G L + + E+ + ++ + + YLH
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ-----QVL----SAVKYLH 123
Query: 617 EECRDCIVHCDIKPENILL---DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLA 673
E IVH D+KPEN+L +EN ++DFGL+K+ +++ GT GY+A
Sbjct: 124 ENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-----IMSTACGTPGYVA 175
Query: 674 PEWLANLPITSKSDVYSYGMVL 695
PE LA P + D +S G++
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVIT 197
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 65/236 (27%), Positives = 105/236 (44%), Gaps = 33/236 (13%)
Query: 484 ASGAPVQFSYKELQRSTKGFKD-----KLGAGGFGAVYRGVLA----NRTVVAVKQL--E 532
+Q + Q K +D LG G F V LA A+K L
Sbjct: 10 PGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVV---LARELATSREYAIKILEKR 66
Query: 533 GIEQGEKQF---RMEVATISSTHHLNLVRLVG-FSSEGKHRL-LVYEFMKNGSLDNFLFA 587
I + E + E +S H V+L F + +L + KNG L
Sbjct: 67 HIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLYFGLSYAKNGEL----LK 119
Query: 588 NEEGSGKLLNWQSRFNIA-LGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDF 646
G +RF A + +A + YLH + I+H D+KPENILL+E+ + +++DF
Sbjct: 120 YIRKIGSFDETCTRFYTAEIVSA--LEYLHG--KG-IIHRDLKPENILLNEDMHIQITDF 174
Query: 647 GLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGR 702
G AK+++P+ + R + V GT Y++PE L SD+++ G ++ ++V+G
Sbjct: 175 GTAKVLSPESKQARANSFV-GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-24
Identities = 54/211 (25%), Positives = 87/211 (41%), Gaps = 31/211 (14%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVK-----QLEGIEQGE--KQFRMEVATISSTHHL 554
++LG+G F V + + A K Q +G ++ EV+ + H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 555 NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANE---EGSGKLLNWQSRFNIALGTARG 611
N++ L +L+ E + G L +FL E E Q G
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ--------ILDG 127
Query: 612 ITYLHEECRDCIVHCDIKPENILL----DENYNAKVSDFGLAKLINPKDHRHRTLTSVRG 667
+ YLH + I H D+KPENI+L + K+ DFGLA I ++ G
Sbjct: 128 VNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EFKNIFG 180
Query: 668 TRGYLAPEWLANLPITSKSDVYSYGMVLLEI 698
T ++APE + P+ ++D++S G V+ I
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIG-VITYI 210
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 54/211 (25%), Positives = 87/211 (41%), Gaps = 31/211 (14%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVK-----QLEGIEQGE--KQFRMEVATISSTHHL 554
++LG+G F V + + A K Q +G ++ EV+ + H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 555 NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANE---EGSGKLLNWQSRFNIALGTARG 611
N++ L +L+ E + G L +FL E E Q G
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ--------ILDG 127
Query: 612 ITYLHEECRDCIVHCDIKPENILL----DENYNAKVSDFGLAKLINPKDHRHRTLTSVRG 667
+ YLH + I H D+KPENI+L + K+ DFGLA I ++ G
Sbjct: 128 VNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EFKNIFG 180
Query: 668 TRGYLAPEWLANLPITSKSDVYSYGMVLLEI 698
T ++APE + P+ ++D++S G V+ I
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIG-VITYI 210
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-24
Identities = 57/247 (23%), Positives = 100/247 (40%), Gaps = 36/247 (14%)
Query: 468 SPKFVSLSAQYALLEYASGAPVQFSYKELQRSTKGFKDK--------LGAGGFGAVYRGV 519
V AL P F ++ + LG G FG V++
Sbjct: 50 ERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCE 109
Query: 520 -LANRTVVAVKQLEGIEQGEKQ-FRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577
A +A K ++ +K+ + E++ ++ H NL++L +LV E++
Sbjct: 110 ETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169
Query: 578 NGSL------DNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPE 631
G L +++ E + + Q GI ++H+ I+H D+KPE
Sbjct: 170 GGELFDRIIDESYNL-TELDTILFMK-Q--------ICEGIRHMHQMY---ILHLDLKPE 216
Query: 632 NILL--DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVY 689
NIL + K+ DFGLA+ P++ L GT +LAPE + ++ +D++
Sbjct: 217 NILCVNRDAKQIKIIDFGLARRYKPRE----KLKVNFGTPEFLAPEVVNYDFVSFPTDMW 272
Query: 690 SYGMVLL 696
S G V+
Sbjct: 273 SVG-VIA 278
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 57/228 (25%), Positives = 90/228 (39%), Gaps = 36/228 (15%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLE---GIEQGEKQFRMEVATISSTHHLNLVR 558
LG G FG V + + AVK + + EV + H N+++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 559 LVGFSSEGKHRLLVYEFMKNGSL-------DNFLFANEEGSGKLLNWQSRFNIALGTARG 611
L + +V E G L F +E + +++ + G
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKRF---SEHDAARII-----KQVF----SG 133
Query: 612 ITYLHEECRDCIVHCDIKPENILL---DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGT 668
ITY+H+ IVH D+KPENILL +++ + K+ DFGL+ + GT
Sbjct: 134 ITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT----KMKDRIGT 186
Query: 669 RGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKF 716
Y+APE L K DV+S G++L ++SG F +
Sbjct: 187 AYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF--YGKNEYDIL 231
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 54/211 (25%), Positives = 87/211 (41%), Gaps = 31/211 (14%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVK-----QLEGIEQGE--KQFRMEVATISSTHHL 554
++LG+G F V + A K +L +G ++ EV + H
Sbjct: 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68
Query: 555 NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANE---EGSGKLLNWQSRFNIALGTARG 611
N++ L +L+ E + G L +FL E E Q G
Sbjct: 69 NIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQ--------ILDG 120
Query: 612 ITYLHEECRDCIVHCDIKPENILL----DENYNAKVSDFGLAKLINPKDHRHRTLTSVRG 667
+ YLH + I H D+KPENI+L N K+ DFG+A I + ++ G
Sbjct: 121 VHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN----EFKNIFG 173
Query: 668 TRGYLAPEWLANLPITSKSDVYSYGMVLLEI 698
T ++APE + P+ ++D++S G V+ I
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIG-VITYI 203
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 52/199 (26%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFS 563
+KLG G +G+VY+ + +VA+KQ+ +E ++ E++ + ++V+ G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVP-VESDLQEIIKEISIMQQCDSPHVVKYYGSY 93
Query: 564 SEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCI 623
+ +V E+ GS+ + + + L + I T +G+ YLH
Sbjct: 94 FKNTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIAT-ILQSTLKGLEYLHFMR---K 146
Query: 624 VHCDIKPENILLDENYNAKVSDFGL-AKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPI 682
+H DIK NILL+ +AK++DFG+ +L + R+ T + GT ++APE + +
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN---TVI-GTPFWMAPEVIQEIGY 202
Query: 683 TSKSDVYSYGMVLLEIVSG 701
+D++S G+ +E+ G
Sbjct: 203 NCVADIWSLGITAIEMAEG 221
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 55/227 (24%), Positives = 90/227 (39%), Gaps = 30/227 (13%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVKQLE---------GIEQGEKQFRMEVATISSTHHLNL 556
LG+G FG V+ V V VK ++ + + +E+A +S H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 557 VRLVGFSSEGKHRLLVYEFMKNGS-LDNFLFAN---EEGSGKLLNWQSRFNIALGTARGI 612
++++ LV E +G L F+ + +E + Q +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ--------LVSAV 143
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYL 672
YL I+H DIK ENI++ E++ K+ DFG A + + T GT Y
Sbjct: 144 GYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY---TFC-GTIEYC 196
Query: 673 APEWLANLP-ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSL 718
APE L P + +++S G+ L +V F +ET
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHP 243
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 56/206 (27%), Positives = 85/206 (41%), Gaps = 31/206 (15%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVK-----QLEGIEQGEKQFRMEVATISSTHHLNL 556
K++LG G F V R V A K +L + ++ E H N+
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF--QKLEREARICRKLQHPNI 67
Query: 557 VRLVGFSSEGKHRLLVYEFMKNGSLDNFLFA----NEEGSGKLLNWQSRFNIALGTARGI 612
VRL E LV++ + G L + A +E + + I I
Sbjct: 68 VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-----QIL----ESI 118
Query: 613 TYLHEECRDCIVHCDIKPENILL---DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR 669
Y H IVH ++KPEN+LL + K++DFGLA +N + GT
Sbjct: 119 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----AWHGFAGTP 171
Query: 670 GYLAPEWLANLPITSKSDVYSYGMVL 695
GYL+PE L P + D+++ G++L
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-23
Identities = 55/232 (23%), Positives = 98/232 (42%), Gaps = 43/232 (18%)
Query: 490 QFSYKELQRSTKGFKDK------LGAGGFGAVYRGV-LANRTVVAVK-----QLEGIEQG 537
+ + K +D+ LG+G G V VA++ +
Sbjct: 120 DLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAR 179
Query: 538 EK----QFRMEVATISSTHHLNLVRLVG-FSSEGKHRLLVYEFMKNGSLDNFLFANE--- 589
E E+ + +H ++++ F +E + +V E M+ G L + + N+
Sbjct: 180 EADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYY--IVLELMEGGELFDKVVGNKRLK 237
Query: 590 EGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL---DENYNAKVSDF 646
E + KL +Q + YLHE I+H D+KPEN+LL +E+ K++DF
Sbjct: 238 EATCKLYFYQ--------MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 286
Query: 647 GLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL---PITSKSDVYSYGMVL 695
G +K++ + ++ GT YLAPE L ++ D +S G++L
Sbjct: 287 GHSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 36/172 (20%), Positives = 68/172 (39%), Gaps = 17/172 (9%)
Query: 538 EKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY---EFMKNGSLDNFLFANEEGSGK 594
I + VG ++ +Y + + +L +++ N S +
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM--NRRCSLE 159
Query: 595 LLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654
+I + A + +LH + ++H D+KP NI + KV DFGL ++
Sbjct: 160 DREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 216
Query: 655 KDHRHRTL---------TSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLE 697
+ L T GT+ Y++PE + + K D++S G++L E
Sbjct: 217 DEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLE--GIEQGEKQFRMEVATISSTHHLNLVRL 559
FK KLG+G FG V+ ++ +K + + +Q E+ + S H N++++
Sbjct: 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
+ + +V E + G L + + + L + + Y H +
Sbjct: 86 FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA-ELMKQMMNALAYFHSQH 144
Query: 620 RDCIVHCDIKPENILL---DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEW 676
+VH D+KPENIL + K+ DFGLA+L + T+ GT Y+APE
Sbjct: 145 ---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE----HSTNAAGTALYMAPEV 197
Query: 677 LANLPITSKSDVYSYGMVLLEIVSGRRNF 705
+T K D++S G+V+ +++G F
Sbjct: 198 F-KRDVTFKCDIWSAGVVMYFLLTGCLPF 225
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 57/211 (27%), Positives = 103/211 (48%), Gaps = 28/211 (13%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVK-----QLEGIEQGEKQFRMEVATISSTHHLNLVRLV 560
LG G FG V G VAVK ++ ++ K R E+ + H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR-EIQNLKLFRHPHIIKLY 77
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSR--FN--IALGTARGITYLH 616
S +V E++ G L +++ + G++ ++R F ++ + Y H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKH----GRVEEMEARRLFQQILS-----AVDYCH 128
Query: 617 EECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEW 676
R +VH D+KPEN+LLD + NAK++DFGL+ +++ + TS G+ Y APE
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR---TSC-GSPNYAAPEV 181
Query: 677 LANLPIT-SKSDVYSYGMVLLEIVSGRRNFE 706
++ + D++S G++L ++ G F+
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 46/214 (21%), Positives = 78/214 (36%), Gaps = 19/214 (8%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVK-----QLEGIEQGEKQ-FRMEVATISSTHHLN 555
+ +G G F V R + AVK + + + E + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 556 LVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYL 615
+V L+ S +V+EFM L + + + + + Y
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS-HYMRQILEALRYC 146
Query: 616 HEECRDCIVHCDIKPENILL---DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYL 672
H+ I+H D+KP +LL + + K+ FG+A + GT ++
Sbjct: 147 HDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV---GTPHFM 200
Query: 673 APEWLANLPITSKSDVYSYGMVLLEIV-SGRRNF 705
APE + P DV+ G V+L I+ SG F
Sbjct: 201 APEVVKREPYGKPVDVWGCG-VILFILLSGCLPF 233
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 38/220 (17%)
Query: 494 KELQRSTKGFKDK------LGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVA 546
++L R++ F D +G G + R + A AVK I++ ++ E+
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI---IDKSKRDPTEEIE 67
Query: 547 TI-SSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFN-- 603
+ H N++ L +GK+ +V E MK G L + + Q F+
Sbjct: 68 ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR-----------QKFFSER 116
Query: 604 ----IALGTARGITYLHEECRDCIVHCDIKPENILL-DENYNA---KVSDFGLAKLINPK 655
+ + + YLH + +VH D+KP NIL DE+ N ++ DFG AK + +
Sbjct: 117 EASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173
Query: 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVL 695
+ L + T ++APE L + D++S G++L
Sbjct: 174 NG---LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 17/205 (8%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVKQLEG---IEQGEKQFRMEVATISSTHHLNLVRLVGF 562
+G G F V + VA+K ++ ++ EV + +H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 563 SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC 622
K L+ E+ G + ++L A+ G++ ++R + + Y H +
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAH----GRMKEKEAR-SKFRQIVSAVQYCH---QKR 134
Query: 623 IVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPI 682
IVH D+K EN+LLD + N K++DFG + G Y APE
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD---AFC-GAPPYAAPELFQGKKY 190
Query: 683 T-SKSDVYSYGMVLLEIVSGRRNFE 706
+ DV+S G++L +VSG F+
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFD 215
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 33/212 (15%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVK-----QLEGIEQGE--KQFRMEVATISSTHHL 554
++LG+G F V + + A K + + +G + EV+ + H
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 555 NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTAR---- 610
N++ L +L+ E + G L +FL E + + A +
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE---------EATEFLKQILN 125
Query: 611 GITYLHEECRDCIVHCDIKPENILL----DENYNAKVSDFGLAKLINPKDHRHRTLTSVR 666
G+ YLH I H D+KPENI+L K+ DFGLA I+ + ++
Sbjct: 126 GVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN----EFKNIF 178
Query: 667 GTRGYLAPEWLANLPITSKSDVYSYGMVLLEI 698
GT ++APE + P+ ++D++S G V+ I
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIG-VITYI 209
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 59/230 (25%), Positives = 88/230 (38%), Gaps = 35/230 (15%)
Query: 484 ASGAPVQFSYKELQRSTKGFKDK------LGAGGFGAVYRGV-LANRTVVAVK-----QL 531
G + + + ++ F D LG G F V R V A K +L
Sbjct: 8 TGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL 67
Query: 532 EGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANE-- 589
+ ++ E H N+VRL E LV++ + G L + A E
Sbjct: 68 SARD--FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY 125
Query: 590 -EGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL---DENYNAKVSD 645
E Q I Y H IVH ++KPEN+LL + K++D
Sbjct: 126 SEADASHCIQQ--------ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLAD 174
Query: 646 FGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVL 695
FGLA +N + GT GYL+PE L P + D+++ G++L
Sbjct: 175 FGLAIEVNDSE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 6e-23
Identities = 54/207 (26%), Positives = 84/207 (40%), Gaps = 34/207 (16%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLE---GIEQGEKQFRMEVATISSTHHLNLVR 558
LG G FG V + + AVK + + EV + H N+++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 559 LVGFSSEGKHRLLVYEFMKNGSL-------DNFLFANEEGSGKLLNWQSRFNIALGTARG 611
L + +V E G L F +E + +++ + G
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKRF---SEHDAARIIK-----QVF----SG 133
Query: 612 ITYLHEECRDCIVHCDIKPENILL---DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGT 668
ITY+H+ IVH D+KPENILL +++ + K+ DFGL+ + GT
Sbjct: 134 ITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT----KMKDRIGT 186
Query: 669 RGYLAPEWLANLPITSKSDVYSYGMVL 695
Y+APE L K DV+S G++L
Sbjct: 187 AYYIAPEVLRG-TYDEKCDVWSAGVIL 212
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-23
Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 43/226 (19%)
Query: 497 QRSTKGFKDK------LGAGGFGAVYRGV-LANRTVVAVKQL---------EGIEQGEKQ 540
+ K F K +G G V R V A AVK + E +E+ +
Sbjct: 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREA 145
Query: 541 FRMEVATISS-THHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFA----NEEGSGKL 595
R E + H +++ L+ LV++ M+ G L ++L +E+ + +
Sbjct: 146 TRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI 205
Query: 596 LNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655
+ ++ +++LH IVH D+KPENILLD+N ++SDFG + + P
Sbjct: 206 M-----RSLL----EAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253
Query: 656 DHRHRTLTSVRGTRGYLAPEWLANLPITS------KSDVYSYGMVL 695
+ L + GT GYLAPE L + + D+++ G++L
Sbjct: 254 E----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 55/242 (22%), Positives = 100/242 (41%), Gaps = 44/242 (18%)
Query: 507 LGAGGFGAVYRG------------VLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHL 554
+G G FG V + + V ++ + E+ + H
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNV-------FKELQIMQGLEHP 75
Query: 555 NLVRLVG-FSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIA-LGTARG 611
LV L F E + +V + + G L + + + + I L A
Sbjct: 76 FLVNLWYSFQDEED--MFMVVDLLLGGDL----RYHLQQNVHFKEETVKLFICELVMA-- 127
Query: 612 ITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGY 671
+ YL + I+H D+KP+NILLDE+ + ++DF +A ++ + +T++ GT+ Y
Sbjct: 128 LDYLQN--QR-IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET----QITTMAGTKPY 180
Query: 672 LAPEWLANLPIT--SKS-DVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN 728
+APE ++ S + D +S G+ E++ GRR + + T+ K+ FE
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE----IVHTFETTV 236
Query: 729 VK 730
V
Sbjct: 237 VT 238
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQ--LEGIEQGEKQFRMEVATISSTHHLNLVRLVG 561
+K+G G FG V++G+ + VVA+K LE E + + E+ +S + + G
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 562 FSSEGKHRL-LVYEFMKNGSLDNFLFAN--EEGSGKLLNWQSRFNIAL---GTARGITYL 615
S +L ++ E++ GS + L +E IA +G+ YL
Sbjct: 88 -SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ-----------IATILREILKGLDYL 135
Query: 616 HEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPE 675
H E +H DIK N+LL E+ K++DFG+A + + T GT ++APE
Sbjct: 136 HSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV---GTPFWMAPE 189
Query: 676 WLANLPITSKSDVYSYGMVLLEIVSG 701
+ SK+D++S G+ +E+ G
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARG 215
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 56/225 (24%), Positives = 87/225 (38%), Gaps = 29/225 (12%)
Query: 484 ASGAPVQFSYKELQRSTKGFKDK------LGAGGFGAVYRGV-LANRTVVAVKQLEGIEQ 536
A + Y + D LG G VYR + A+K L+
Sbjct: 32 PGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK-KTV 90
Query: 537 GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANE---EGSG 593
+K R E+ + H N+++L LV E + G L + + E
Sbjct: 91 DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDA 150
Query: 594 KLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL---DENYNAKVSDFGLAK 650
Q + YLHE IVH D+KPEN+L + K++DFGL+K
Sbjct: 151 ADAVKQ--------ILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSK 199
Query: 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVL 695
++ + + +V GT GY APE L + D++S G++
Sbjct: 200 IVEHQV----LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 32/228 (14%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVKQLE-------GIEQGEKQFRMEVATISSTHHL--NL 556
LG+GGFG+VY G+ +++ VA+K +E G + MEV + +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 557 VRLVGFSSEGKHRLLVYEFMKN-GSLDNFLFAN---EEGSGKLLNWQSRFNIALGTARGI 612
+RL+ + +L+ E + L +F+ +E + WQ +
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ--------VLEAV 162
Query: 613 TYLHEECRDCIVHCDIKPENILLDENY-NAKVSDFGLAKLINPKDHRHRTLTSVRGTRGY 671
+ H ++H DIK ENIL+D N K+ DFG L KD T GTR Y
Sbjct: 163 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL--LKD---TVYTDFDGTRVY 214
Query: 672 LAPEWLANLPIT-SKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSL 718
PEW+ + V+S G++L ++V G FE +E R +
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF 262
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 48/205 (23%), Positives = 95/205 (46%), Gaps = 19/205 (9%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQ-FRMEVATISSTHHLNLVRLVGF 562
+LG G FG VY+ + A K +E + E + + +E+ +++ H +V+L+G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 563 SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC 622
++ EF G++D + E L Q + + + +LH +
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQV-VCRQMLEALNFLHSKR--- 137
Query: 623 IVHCDIKPENILLDENYNAKVSDFGL-AKLINPKDHRHRTLTSVRGTRGYLAPEWLANLP 681
I+H D+K N+L+ + +++DFG+ AK + R + + GT ++APE +
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD---SFI-GTPYWMAPEVVMCET 193
Query: 682 IT-----SKSDVYSYGMVLLEIVSG 701
+ K+D++S G+ L+E+
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-22
Identities = 51/204 (25%), Positives = 84/204 (41%), Gaps = 26/204 (12%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLE--GIEQGEKQ-FRMEVATISSTHHLNLVR 558
++LG G F V R V + A + + + Q E H N+VR
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 559 LVGFSSEGKHRLLVYEFMKNGSLDNFLFA----NEEGSGKLLNWQSRFNIALGTARGITY 614
L SE H L+++ + G L + A +E + + I + +
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ-----QIL----EAVLH 125
Query: 615 LHEECRDCIVHCDIKPENILL---DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGY 671
H+ +VH ++KPEN+LL + K++DFGLA + + GT GY
Sbjct: 126 CHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA---WFGFAGTPGY 179
Query: 672 LAPEWLANLPITSKSDVYSYGMVL 695
L+PE L P D+++ G++L
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 50/204 (24%), Positives = 86/204 (42%), Gaps = 32/204 (15%)
Query: 504 KDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATISS-THHLNLVRLVG 561
LG G F + V + AVK + ++ E + E+ + H N+V+L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIIS--KRMEANTQKEITALKLCEGHPNIVKLHE 73
Query: 562 FSSEGKHRLLVYEFMKNGSL-------DNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
+ H LV E + G L +F +E + ++ + +++
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHF---SETEASYIMR-----KLV----SAVSH 121
Query: 615 LHEECRDCIVHCDIKPENILL---DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGY 671
+H+ +VH D+KPEN+L ++N K+ DFG A+L P + L + T Y
Sbjct: 122 MHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP---LKTPCFTLHY 175
Query: 672 LAPEWLANLPITSKSDVYSYGMVL 695
APE L D++S G++L
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVIL 199
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 3e-22
Identities = 41/205 (20%), Positives = 69/205 (33%), Gaps = 16/205 (7%)
Query: 508 GAGGFGAVYRGV-LANRTVVAVKQ--LEGIEQGEKQF-RMEVATISSTHHLNLVRLVGFS 563
G V V V++ LE F + E+ +H N+V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 564 SEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCI 623
+V FM GS + + +N + I G + + Y+H
Sbjct: 96 IADNELWVVTSFMAYGSAKDLI---CTHFMDGMNELAIAYILQGVLKALDYIHHMGY--- 149
Query: 624 VHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVR----GTRGYLAPEWLAN 679
VH +K +IL+ + +S + R R + +L+PE L
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209
Query: 680 LPI--TSKSDVYSYGMVLLEIVSGR 702
+KSD+YS G+ E+ +G
Sbjct: 210 NLQGYDAKSDIYSVGITACELANGH 234
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-22
Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 28/210 (13%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRL--VGFS 563
+G+G FG + +VAVK +E ++ + E+ S H N+VR V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEV-IL 86
Query: 564 SEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFN----IALGTARGITYLHEEC 619
+ H ++ E+ G L + G+ ++RF ++ G++Y H
Sbjct: 87 TP-THLAIIMEYASGGELYERICNA----GRFSEDEARFFFQQLLS-----GVSYCH--- 133
Query: 620 RDCIVHCDIKPENILLDENY--NAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWL 677
I H D+K EN LLD + K+ DFG +K ++V GT Y+APE L
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STV-GTPAYIAPEVL 189
Query: 678 ANLPIT-SKSDVYSYGMVLLEIVSGRRNFE 706
+DV+S G+ L ++ G FE
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 37/213 (17%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVK-----QLEGIEQGEK----QFRMEVATISSTH 552
LG+G G V VA+K + E E+ + +
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 553 HLNLVRLVG-FSSEGKHRLLVYEFMKNGSLDNFLFANE---EGSGKLLNWQSRFNIALGT 608
H ++++ F +E + +V E M+ G L + + N+ E + KL +Q
Sbjct: 74 HPCIIKIKNFFDAEDYY--IVLELMEGGELFDKVVGNKRLKEATCKLYFYQ--------M 123
Query: 609 ARGITYLHEECRDCIVHCDIKPENILL---DENYNAKVSDFGLAKLINPKDHRHRTLTSV 665
+ YLHE I+H D+KPEN+LL +E+ K++DFG +K++ + ++
Sbjct: 124 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTL 176
Query: 666 RGTRGYLAPEWLANL---PITSKSDVYSYGMVL 695
GT YLAPE L ++ D +S G++L
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 8e-22
Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 28/211 (13%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVK-----QLEGIEQGEKQFRMEVATISSTHHLNLVRLV 560
LG G FG V G VAVK ++ ++ K R E+ + H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR-EIQNLKLFRHPHIIKLY 82
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSR--FN--IALGTARGITYLH 616
S +V E++ G L +++ N G+L +SR F ++ G+ Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKN----GRLDEKESRRLFQQILS-----GVDYCH 133
Query: 617 EECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEW 676
R +VH D+KPEN+LLD + NAK++DFGL+ +++ + TS G+ Y APE
Sbjct: 134 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR---TSC-GSPNYAAPEV 186
Query: 677 LANLP-ITSKSDVYSYGMVLLEIVSGRRNFE 706
++ + D++S G++L ++ G F+
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 1e-21
Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 37/218 (16%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQ-FRMEVATISSTHHLNLVRLV 560
++LG G FG V+R A A K + + +K+ R E+ T+S H LV L
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 220
Query: 561 GFSSEGKHRLLVYEFMKNGSL------DNFLFANEEGSGKLLNWQSRFNIALGTAR---- 610
+ +++YEFM G L ++ + +E A+ R
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE--------------AVEYMRQVCK 266
Query: 611 GITYLHEECRDCIVHCDIKPENILL--DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGT 668
G+ ++HE VH D+KPENI+ + K+ DFGL ++PK ++ GT
Sbjct: 267 GLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ----SVKVTTGT 319
Query: 669 RGYLAPEWLANLPITSKSDVYSYGMVLLEI-VSGRRNF 705
+ APE P+ +D++S G VL I +SG F
Sbjct: 320 AEFAAPEVAEGKPVGYYTDMWSVG-VLSYILLSGLSPF 356
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 29/211 (13%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVK-----QLEGIEQGEKQFRMEVATISSTHHLNLVRLV 560
LG G FG V + VA+K L+ + + R E++ + H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER-EISYLKLLRHPHIIKLY 75
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSR--FN--IALGTARGITYLH 616
+ ++V E+ G L +++ ++ + R F I I Y H
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYIVEK----KRMTEDEGRRFFQQIIC-----AIEYCH 125
Query: 617 EECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEW 676
R IVH D+KPEN+LLD+N N K++DFGL+ ++ + TS G+ Y APE
Sbjct: 126 ---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK---TSC-GSPNYAAPEV 178
Query: 677 LANLPIT-SKSDVYSYGMVLLEIVSGRRNFE 706
+ + DV+S G+VL ++ GR F+
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQ--LEGIEQGEKQFRMEVATISSTHHLNLVRLVG 561
+ +G+G V + VA+K+ LE + + E+ +S HH N+V
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 562 FSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIAL---GTARGITYLHE 617
S K L LV + + GS+ + + IA G+ YLH+
Sbjct: 81 -SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139
Query: 618 ECRDCIVHCDIKPENILLDENYNAKVSDFG----LAKLINPKDHRHRTLTSVRGTRGYLA 673
+H D+K NILL E+ + +++DFG LA + ++ R T V GT ++A
Sbjct: 140 NG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK-TFV-GTPCWMA 194
Query: 674 PEWLANL-PITSKSDVYSYGMVLLEIVSGR 702
PE + + K+D++S+G+ +E+ +G
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 22/210 (10%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATISST-HHLNLVR---- 558
+ +G G +G VY+G + + A+K ++ E++ + E+ + HH N+
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 559 -LVGFSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLH 616
+ +L LV EF GS+ + + L + I RG+++LH
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAY-ICREILRGLSHLH 146
Query: 617 EECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEW 676
+ ++H DIK +N+LL EN K+ DFG++ ++ R T GT ++APE
Sbjct: 147 QHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI---GTPYWMAPEV 200
Query: 677 LANLPIT-----SKSDVYSYGMVLLEIVSG 701
+A KSD++S G+ +E+ G
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 34/216 (15%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVK-----QLEGIEQGEKQFRMEVATISSTHHLNL 556
++ +G G +G V V R A K +E +++ F+ E+ + S H N+
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR----FKQEIEIMKSLDHPNI 68
Query: 557 VRLVGFSSEGKHRLLVYEFMKNGSLDNFLFA----NEEGSGKLLNWQSRFNIALGTARGI 612
+RL + LV E G L + E + ++ L +
Sbjct: 69 IRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI------MKDVLS---AV 119
Query: 613 TYLHEECRDCIVHCDIKPENILL---DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR 669
Y H+ + H D+KPEN L + K+ DFGLA P + + GT
Sbjct: 120 AYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK----MMRTKVGTP 172
Query: 670 GYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNF 705
Y++P+ L + D +S G+++ ++ G F
Sbjct: 173 YYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPF 207
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 62/230 (26%), Positives = 93/230 (40%), Gaps = 34/230 (14%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVKQLE-------GIEQGEKQFRMEVATI----SSTHHL 554
LG GGFG V+ G L +R VA+K + +EVA + + H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 555 NLVRLVGFSSEGKHRLLVYEFMKNGS-LDNFLFAN---EEGSGKLLNWQSRFNIALGTAR 610
++RL+ + + +LV E L +++ EG + Q
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQ--------VVA 150
Query: 611 GITYLHEECRDCIVHCDIKPENILLD-ENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR 669
I + H +VH DIK ENIL+D AK+ DFG L+ H GTR
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL----HDEPYTDFD-GTR 202
Query: 670 GYLAPEWLANLPIT-SKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSL 718
Y PEW++ + V+S G++L ++V G FE QE +
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHF 252
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 52/230 (22%), Positives = 91/230 (39%), Gaps = 46/230 (20%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEV-----------ATISSTH 552
KLG G F V+ + N T VA+K + G + + E+ S
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 553 HLNLVRLVGF----SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIAL-- 606
++++L+ G H ++V+E + +L + E +
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYE---------HRGIPLIYVK 134
Query: 607 GTAR----GITYLHEECRDCIVHCDIKPENILLDE------NYNAKVSDFGLAKLINPKD 656
++ G+ Y+H C I+H DIKPEN+L++ K++D G A
Sbjct: 135 QISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA------C 186
Query: 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFE 706
T+ TR Y +PE L P +D++S ++ E+++G FE
Sbjct: 187 WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 57/235 (24%), Positives = 92/235 (39%), Gaps = 51/235 (21%)
Query: 504 KDKLGAGGFGAVYRGV-LANRTVVAVKQLE---------------------GIEQGEKQF 541
KD++G G +G V + T A+K L +
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 542 RM------EVATISSTHHLNLVRL--VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSG 593
E+A + H N+V+L V H +V+E + G +
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----M-EVPTLK 132
Query: 594 KLLNWQSRF---NIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650
L Q+RF ++ G I YLH I+H DIKP N+L+ E+ + K++DFG++
Sbjct: 133 PLSEDQARFYFQDLIKG----IEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANLPIT---SKSDVYSYGMVLLEIVSGR 702
D L++ GT ++APE L+ DV++ G+ L V G+
Sbjct: 186 EFKGSDA---LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 48/234 (20%), Positives = 83/234 (35%), Gaps = 45/234 (19%)
Query: 485 SGAPVQFSYKELQRSTKGFKDK-------LGAGGFGAVYRGV-LANRTVVAVKQLEGIEQ 536
+ ++ ++ + D LG G G V A+K L
Sbjct: 8 HSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD--- 64
Query: 537 GEKQFRMEVATI-SSTHHLNLVRLVGF----SSEGKHRLLVYEFMKNGSL-------DNF 584
+ R EV ++ ++V ++ + L++ E M+ G L +
Sbjct: 65 -SPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQ 123
Query: 585 LFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL---DENYNA 641
F E + I I +LH I H D+KPEN+L +++
Sbjct: 124 AFTEREAA----------EIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVL 170
Query: 642 KVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVL 695
K++DFG AK L + T Y+APE L D++S G+++
Sbjct: 171 KLTDFGFAKETTQN-----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 8e-21
Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 30/222 (13%)
Query: 507 LGAGGFGAVYRG-VLANRTVVAVKQLE--------GIE--QGEKQFRMEVATISSTHHLN 555
+G GGFG VY + A+K L+ G E+ ++ +S+
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM---LSLVSTGDCPF 253
Query: 556 LVRLVGFSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
+V + ++ +L + + M G L L G RF A G+ +
Sbjct: 254 IVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAA-EIILGLEH 307
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAP 674
+H +V+ D+KP NILLDE+ + ++SD GLA + K + SV GT GY+AP
Sbjct: 308 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV-GTHGYMAP 359
Query: 675 EWLA-NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKK 715
E L + S +D +S G +L +++ G F + ++ +
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 401
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 8e-21
Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 17/215 (7%)
Query: 507 LGAGGFGAVYRG-VLANRTVVAVKQL--EGIEQ--GEKQFRMEVATISSTHHLNLVRLVG 561
LG GGFG V V A + A K+L + I++ GE E + + +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA- 250
Query: 562 FSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620
++ E K L LV M G L G ++ F A G+ LH E
Sbjct: 251 YAYETKDALCLVLTLMNGGDL--KFHIYHMGQAGFPEARAVFYAA-EICCGLEDLHRER- 306
Query: 621 DCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL 680
IV+ D+KPENILLD++ + ++SD GLA + V GT GY+APE + N
Sbjct: 307 --IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRV-GTVGYMAPEVVKNE 360
Query: 681 PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKK 715
T D ++ G +L E+++G+ F+ ++ +++
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 395
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 9e-21
Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 14/215 (6%)
Query: 507 LGAGGFGAVYRG-VLANRTVVAVKQL--EGIEQ--GEKQFRMEVATISSTHHLNLVRLVG 561
LG GGFG V+ + A + A K+L + +++ G + +E ++ H +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251
Query: 562 FSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620
++ E K L LV M G + ++ +E + ++ F A G+ +LH+
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA-QIVSGLEHLHQRN- 309
Query: 621 DCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL 680
I++ D+KPEN+LLD++ N ++SD GLA + K + +T GT G++APE L
Sbjct: 310 --IIYRDLKPENVLLDDDGNVRISDLGLAVEL--KAGQTKTKGYA-GTPGFMAPELLLGE 364
Query: 681 PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKK 715
D ++ G+ L E+++ R F E K
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK 399
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 57/212 (26%), Positives = 82/212 (38%), Gaps = 38/212 (17%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATI-SSTHHLNLVRLV 560
LG G G V + + A+K L+ + R EV ++ ++VR+V
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIV 121
Query: 561 GF----SSEGKHRLLVYEFMKNGSL-------DNFLFANEEGSGKLLNWQSRFNIALGTA 609
+ K L+V E + G L + F E S I
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS----------EIMKSIG 171
Query: 610 RGITYLHEECRDCIVHCDIKPENILL---DENYNAKVSDFGLAKLINPKDHRHRTLTSVR 666
I YLH I H D+KPEN+L N K++DFG AK H +LT+
Sbjct: 172 EAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS----HNSLTTPC 224
Query: 667 GTRGYLAPEWLANLPITSKSDVYSYGMVLLEI 698
T Y+APE L D++S G V++ I
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLG-VIMYI 255
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 61/260 (23%), Positives = 99/260 (38%), Gaps = 43/260 (16%)
Query: 504 KDKLGAGGFGAVYRGV-LANRTVVAVKQLE-GIEQGEKQFRMEVATISS-THHLNLVRLV 560
+D LG G V + L AVK +E + EV + H N++ L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 561 GFSSEGKHRLLVYEFMKNGSL-------DNFLFANEEGSGKLLNWQSRFNIALGTARGIT 613
F E LV+E M+ GS+ +F NE + ++ ++A +
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRRHF---NELEASVVVQ-----DVA----SALD 125
Query: 614 YLHEECRDCIVHCDIKPENILL---DENYNAKVSDFGLAKLINP----KDHRHRTLTSVR 666
+LH + I H D+KPENIL ++ K+ DF L I L +
Sbjct: 126 FLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 667 GTRGYLAPEWLANLPITSKS-----DVYSYGMVLLEIV-SGRRNFEVSQETNRKKFSLWA 720
G+ Y+APE + + D++S G V+L I+ SG F ++ W
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLG-VILYILLSGYPPFVGRCGSD----CGWD 237
Query: 721 YEEFEKGNVKGIVDKSLAGE 740
E + + G+
Sbjct: 238 RGEACPACQNMLFESIQEGK 257
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 32/211 (15%)
Query: 505 DKLGAGGFGAVYRGVLANRT---VVAVKQ--LEGIEQGEKQ--FRMEVATISSTHHLNLV 557
K+G G +G V++ NR +VA+K+ + K+ R E+ + H NLV
Sbjct: 9 GKIGEGSYGVVFKCR--NRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLV 65
Query: 558 RLVG-FSSEGKHRL-LVYEFMKN---GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGI 612
L+ F + + L LV+E+ + LD + E K + WQ T + +
Sbjct: 66 NLLEVFRRKRR--LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ--------TLQAV 115
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYL 672
+ H + +H D+KPENIL+ ++ K+ DFG A+L+ TR Y
Sbjct: 116 NFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS---DYYDDEVATRWYR 169
Query: 673 APEWLANLPITSKS-DVYSYGMVLLEIVSGR 702
+PE L DV++ G V E++SG
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 56/205 (27%), Positives = 86/205 (41%), Gaps = 23/205 (11%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQ--LEGIEQGE--KQFRMEVATISSTHHLNLVRL 559
++G G FGAVY + N VVA+K+ G + E + EV + H N ++
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
G LV E+ + D E L + + G +G+ YLH
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLL----EVHKKPLQEVEIAA-VTHGALQGLAYLHSHN 174
Query: 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN 679
++H D+K NILL E K+ DFG A ++ P S GT ++APE +
Sbjct: 175 ---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFVGTPYWMAPEVILA 224
Query: 680 L---PITSKSDVYSYGMVLLEIVSG 701
+ K DV+S G+ +E+
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAER 249
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 61/241 (25%), Positives = 99/241 (41%), Gaps = 58/241 (24%)
Query: 485 SGAPVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQF--R 542
+G + +Y + +G G FG V++ L VA+K+ + Q +K+F R
Sbjct: 34 TGEQREIAYTNCK--------VIGNGSFGVVFQAKLVESDEVAIKK---VLQ-DKRFKNR 81
Query: 543 MEVATISSTHHLNLVRLVGF-----SSEGKHRL-LVYEFM-------------KNGSLDN 583
E+ + H N+V L F + + L LV E++ ++
Sbjct: 82 -ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPM 140
Query: 584 FLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNA-K 642
L KL +Q R + Y+H I H DIKP+N+LLD K
Sbjct: 141 LLI-------KLYMYQ--------LLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLK 182
Query: 643 VSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPI-TSKSDVYSYGMVLLEIVSG 701
+ DFG AK++ S +R Y APE + T+ D++S G V+ E++ G
Sbjct: 183 LIDFGSAKILIAG----EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238
Query: 702 R 702
+
Sbjct: 239 Q 239
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 8e-18
Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 28/209 (13%)
Query: 505 DKLGAGGFGAVYRGVLANRT---VVAVKQ--LEGIEQGEKQ--FRMEVATISSTHHLNLV 557
+G G +G V + N+ +VA+K+ ++ K+ R E+ + H NLV
Sbjct: 31 GLVGEGSYGMVMKCR--NKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHENLV 87
Query: 558 RLVGFSSEGKHRLLVYEFMKN---GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
L+ + K LV+EF+ + L+ F + + +Q GI +
Sbjct: 88 NLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ--------IINGIGF 139
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAP 674
H I+H DIKPENIL+ ++ K+ DFG A+ + TR Y AP
Sbjct: 140 CH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG---EVYDDEVATRWYRAP 193
Query: 675 EWLANLPITSKS-DVYSYGMVLLEIVSGR 702
E L K+ DV++ G ++ E+ G
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 9e-18
Identities = 62/258 (24%), Positives = 106/258 (41%), Gaps = 46/258 (17%)
Query: 467 NSPKFVSLSAQYALLEYASGAPVQFSYKELQRSTKGFK-------DKLGAGGFGAVYRG- 518
N+ S Q ++ E+ + A F K S + LG G FG V
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 519 -----------VLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK 567
+L + VV +KQ+E E + + + LV+L +
Sbjct: 62 HKESGNHYAMKILDKQKVVKLKQIEHT-------LNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 568 HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRF---NIALGTARGITYLHEECRDCIV 624
+ +V E++ G + F++ G+ +RF I L YLH ++
Sbjct: 115 NLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLT----FEYLHSLD---LI 163
Query: 625 HCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITS 684
+ D+KPEN+L+D+ +V+DFG AK + RT T + GT LAPE + +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWT-LCGTPEALAPEIILSKGYNK 217
Query: 685 KSDVYSYGMVLLEIVSGR 702
D ++ G+++ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAGY 235
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-17
Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 27/221 (12%)
Query: 495 ELQRSTKGFK--DKLGAGGFGAVYRGV-LANRTVVAVKQ--LEGIEQGEKQFRM----EV 545
+++ K ++ D LG G F VY+ +VA+K+ L + + E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 546 ATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN---GSLDNFLFANEEGSGKLLNWQSRF 602
+ H N++ L+ + LV++FM+ + + K
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM--- 120
Query: 603 NIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTL 662
T +G+ YLH+ I+H D+KP N+LLDEN K++DFGLAK + R
Sbjct: 121 -----TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN---RAY 169
Query: 663 TSVRGTRGYLAPEWLANLPITSKS-DVYSYGMVLLEIVSGR 702
T TR Y APE L + D+++ G +L E++
Sbjct: 170 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 50/217 (23%), Positives = 89/217 (41%), Gaps = 42/217 (19%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATIS--------STHHLN 555
+G G FG V + VA+K + ++ +Q E+ + +T ++
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNV- 161
Query: 556 LVRLVGFSSEGKHRLLV--------YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALG 607
+ ++ + H + YE +K F S L+ A
Sbjct: 162 -IHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGF-------SLPLVR-----KFAHS 208
Query: 608 TARGITYLHEECRDCIVHCDIKPENILLDENYNA--KVSDFGLAKLINPKDHRHRTLTSV 665
+ + LH+ R I+HCD+KPENILL + + KV DFG + + H+ + +
Sbjct: 209 ILQCLDALHK-NR--IIHCDLKPENILLKQQGRSGIKVIDFGSSC------YEHQRVYTY 259
Query: 666 RGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGR 702
+R Y APE + D++S G +L E+++G
Sbjct: 260 IQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 507 LGAGGFGAVY--RGVLANRTVVAVKQL---EGIEQGE-KQFRMEVATISSTHHLNLVRLV 560
+G G FG V + A++ V A+K L E +++ E FR E + + + L
Sbjct: 82 IGRGAFGEVAVVKLKNADK-VFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 561 G-FSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIA-LGTARGITYLHE 617
F + L LV ++ G L L + +L +RF +A + A I +H+
Sbjct: 141 YAFQDDNN--LYLVMDYYVGGDLLTLL---SKFEDRLPEEMARFYLAEMVIA--IDSVHQ 193
Query: 618 ECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWL 677
VH DIKP+NIL+D N + +++DFG +D ++ +V GT Y++PE L
Sbjct: 194 LH---YVHRDIKPDNILMDMNGHIRLADFGSCLK-LMEDGTVQSSVAV-GTPDYISPEIL 248
Query: 678 ANLPITSKS-----DVYSYGMVLLEIVSGR 702
+ D +S G+ + E++ G
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 37/210 (17%)
Query: 507 LGAGGFGAVYRGVLA----NRTVVAVKQL--EGIEQGEKQF---RMEVATISSTHHLNLV 557
LG G FG V+ L N A+K L E + + KQ E +S H ++
Sbjct: 14 LGTGSFGRVH---LIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFII 69
Query: 558 RLVG-FSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRF---NIALGTARGI 612
R+ G F + + ++ ++++ G L F+ S + N ++F + L +
Sbjct: 70 RMWGTFQDAQQ--IFMIMDYIEGGEL----FSLLRKSQRFPNPVAKFYAAEVCLA----L 119
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYL 672
YLH +D I++ D+KPENILLD+N + K++DFG AK + T T + GT Y+
Sbjct: 120 EYLHS--KD-IIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYT-LCGTPDYI 170
Query: 673 APEWLANLPITSKSDVYSYGMVLLEIVSGR 702
APE ++ P D +S+G+++ E+++G
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 36/226 (15%)
Query: 498 RSTKGFK--DKLGAGGFGAVYRGV-LANRTVVAVKQ--LEGIEQGEKQFRM----EVAT- 547
+T ++ ++G G +G VY+ + VA+K + G + EVA
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 548 --ISSTHHLNLVRL----VGFSSEGKHRL-LVYEFMKN---GSLDNF-LFANEEGSGKLL 596
+ + H N+VRL ++ + ++ LV+E + LD + K L
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 597 NWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656
Q RG+ +LH +CIVH D+KPENIL+ K++DFGLA++ +
Sbjct: 126 MRQ--------FLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSY-- 172
Query: 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGR 702
LT V T Y APE L + D++S G + E+ +
Sbjct: 173 --QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 6e-17
Identities = 41/130 (31%), Positives = 58/130 (44%), Gaps = 14/130 (10%)
Query: 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL 635
K+ S A E+ L + + A+G+ +L R CI H D+ NILL
Sbjct: 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCI-HRDLAARNILL 226
Query: 636 DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYL-----APEWLANLPITSKSDVYS 690
E K+ DFGLA+ I VR L APE + + T +SDV+S
Sbjct: 227 SEKNVVKICDFGLARDIYKDP------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 280
Query: 691 YGMVLLEIVS 700
+G++L EI S
Sbjct: 281 FGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 38/166 (22%), Positives = 60/166 (36%), Gaps = 22/166 (13%)
Query: 503 FKDKLGAGGFGAVYRGVL------ANRTVVAVKQL-EGIEQGE-KQFRMEVATISS-THH 553
LG G FG V A VAVK L EG E + E+ + HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 554 LNLVRLVGFSSEGKHRLLV-YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGI 612
LN+V L+G ++ L+V EF K G+L +L R +G
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL------------RSKRNEFVPYKTKGA 133
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658
+ + + D+K + + ++ S F K ++ +
Sbjct: 134 RFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 29/212 (13%)
Query: 507 LGAGGFGAVYRGVLA----NRTVVAVKQL---EGIEQGE-KQFRMEVATISSTHHLNLVR 558
+G G F V + V A+K + + +++GE FR E + + + +
Sbjct: 69 IGRGAFSEVA---VVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 559 LVGFSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHE 617
L F+ + ++ L LV E+ G L L + ++ +RF +A I +H
Sbjct: 126 LH-FAFQDENYLYLVMEYYVGGDL-LTLLSKFGE--RIPAEMARFYLA-EIVMAIDSVHR 180
Query: 618 ECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWL 677
VH DIKP+NILLD + +++DFG + D R+L +V GT YL+PE L
Sbjct: 181 LG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRA-DGTVRSLVAV-GTPDYLSPEIL 235
Query: 678 ANLPITSKSDVY-------SYGMVLLEIVSGR 702
+ + Y + G+ E+ G+
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 50/218 (22%), Positives = 84/218 (38%), Gaps = 42/218 (19%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLN-------- 555
+G G FG V + + VA+K ++ + Q ++EV + +N
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLL---ELMNKHDTEMKY 116
Query: 556 -LVRLVGFSSEGKHRLLV--------YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIAL 606
+V L H LV Y+ ++N + S L A
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGV-------SLNLTR-----KFAQ 164
Query: 607 GTARGITYLHEECRDCIVHCDIKPENILLDENYNA--KVSDFGLAKLINPKDHRHRTLTS 664
+ +L I+HCD+KPENILL + K+ DFG + + +
Sbjct: 165 QMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC------QLGQRIYQ 217
Query: 665 VRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGR 702
+R Y +PE L +P D++S G +L+E+ +G
Sbjct: 218 YIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 40/215 (18%)
Query: 507 LGAGGFGAVY--RGVLANRTVVAVKQL---EGIEQGE-KQFRMEVATISSTHHLNLVRLV 560
+G G FG V R + V A+K L E I++ + F E ++ + +V+L
Sbjct: 77 IGRGAFGEVQLVRHKSTRK-VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 561 GFSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTAR--------G 611
++ + L +V E+M G G L+N S +++ AR
Sbjct: 136 -YAFQDDRYLYMVMEYM-PG-------------GDLVNLMSNYDVPEKWARFYTAEVVLA 180
Query: 612 ITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGY 671
+ +H +H D+KP+N+LLD++ + K++DFG +N + R T+V GT Y
Sbjct: 181 LDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCDTAV-GTPDY 235
Query: 672 LAPEWLANLPITSK----SDVYSYGMVLLEIVSGR 702
++PE L + D +S G+ L E++ G
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 66/231 (28%), Positives = 104/231 (45%), Gaps = 43/231 (18%)
Query: 488 PVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEK-QFRMEV 545
P + SY + + +G G FG VY+ L + +VA+K+ + Q ++ + R E+
Sbjct: 51 PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKK---VLQDKRFKNR-EL 98
Query: 546 ATISSTHHLNLVRLVGF---SSEGKHRL---LVYEFMK---NGSLDNFLFANEEGSG--- 593
+ H N+VRL F S E K + LV +++ ++ A +
Sbjct: 99 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 158
Query: 594 KLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNA-KVSDFGLAKLI 652
KL +Q R + Y+H I H DIKP+N+LLD + K+ DFG AK +
Sbjct: 159 KLYMYQ--------LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPI-TSKSDVYSYGMVLLEIVSGR 702
+ S +R Y APE + TS DV+S G VL E++ G+
Sbjct: 208 VRGE----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 33/211 (15%)
Query: 505 DKLGAGGFGAVYRGVLANRT--VVAVKQ--LEGIEQGEKQF-----RMEVATISSTHHLN 555
+K+G G +G VY+ N A+K+ LE ++G R E++ + H N
Sbjct: 8 EKIGEGTYGVVYKAQ--NNYGETFALKKIRLEKEDEG---IPSTTIR-EISILKELKHSN 61
Query: 556 LVRLVGFSSEGKHRLLVYEFMKN---GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGI 612
+V+L K +LV+E + LD E + K Q GI
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ--------LLNGI 113
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYL 672
Y H ++H D+KP+N+L++ K++DFGLA+ R T T Y
Sbjct: 114 AYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---RKYTHEIVTLWYR 167
Query: 673 APEWLANLPITSKS-DVYSYGMVLLEIVSGR 702
AP+ L S + D++S G + E+V+G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 49/185 (26%), Positives = 76/185 (41%), Gaps = 36/185 (19%)
Query: 506 KLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATISSTHH-LNLVRLVGFS 563
K+G G FG + G L VA+K LE ++ Q +E + ++ F
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 564 SEGKHRLLVYEFMKNG-SLDNFLFANEEGSGKLLNWQSR-------FNIALGTARGITYL 615
GK+ +V E + G SL++ L + R IA+ + Y+
Sbjct: 75 PCGKYNAMVLELL--GPSLED-----------LFDLCDRTFSLKTVLMIAIQLISRMEYV 121
Query: 616 HEECRDCIVHCDIKPENILLDENYNAKVS-----DFGLAKL-INPKDHRH---RTLTSVR 666
H ++ I + D+KPEN L+ N DF LAK I+P+ +H R S+
Sbjct: 122 HS--KNLI-YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLT 178
Query: 667 GTRGY 671
GT Y
Sbjct: 179 GTARY 183
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 3e-16
Identities = 56/227 (24%), Positives = 100/227 (44%), Gaps = 40/227 (17%)
Query: 498 RSTKGFK--DKLGAGGFGAVYRGVLANRT--VVAVKQ--LEGIEQG-------EKQFRME 544
R+ + ++ ++G G +G V++ VA+K+ ++ E+G E
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 545 VATISSTHHLNLVRL----VGFSSEGKHRL-LVYEFMKN---GSLDNF-LFANEEGSGKL 595
+ + H N+VRL ++ + +L LV+E + LD + K
Sbjct: 68 ---LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 124
Query: 596 LNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655
+ +Q RG+ +LH +VH D+KP+NIL+ + K++DFGLA++ +
Sbjct: 125 MMFQ--------LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF- 172
Query: 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGR 702
LTSV T Y APE L + D++S G + E+ +
Sbjct: 173 ---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 25/208 (12%), Positives = 50/208 (24%), Gaps = 47/208 (22%)
Query: 505 DKLGAGGFGAVYRGV--LANRTVVAVKQLE---GIEQGEKQ-FRMEVATISSTHHLNLVR 558
G ++ + +R V A+ ++ + Q +S + R
Sbjct: 37 IFHGGVPPLQFWQALDTALDRQV-ALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 559 LVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618
++ L+V E+++ GSL + + A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA---DTS----PSPVGAIRAMQSLAAAADAAH-- 146
Query: 619 CRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLA 678
R + P + VS G L +
Sbjct: 147 -RAGVALSIDHPSRVR--------VSIDGDVVL---------------AYPATMPDA--- 179
Query: 679 NLPITSKSDVYSYGMVLLEIVSGRRNFE 706
+ D+ G L ++ R
Sbjct: 180 ----NPQDDIRGIGASLYALLVNRWPLP 203
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 33/211 (15%)
Query: 505 DKLGAGGFGAVYRGVLANRT--VVAVKQ--LEGIEQGEKQF-----RMEVATISSTHHLN 555
+K+G G +G VY+ + +VA+K+ L+ ++G R E++ + HH N
Sbjct: 27 EKVGEGTYGVVYKAK--DSQGRIVALKRIRLDAEDEG---IPSTAIR-EISLLKELHHPN 80
Query: 556 LVRLVGFSSEGKHRLLVYEFMKN---GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGI 612
+V L+ + LV+EFM+ LD ++ K+ +Q RG+
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ--------LLRGV 132
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYL 672
+ H + I+H D+KP+N+L++ + K++DFGLA+ R+ T T Y
Sbjct: 133 AHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV---RSYTHEVVTLWYR 186
Query: 673 APEWLANLPITSKS-DVYSYGMVLLEIVSGR 702
AP+ L S S D++S G + E+++G+
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 78.3 bits (194), Expect = 5e-16
Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 30/211 (14%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQ--LEGIEQGEKQF-----RMEVATISSTHHLNL 556
+K+G G +G V++ +VA+K+ L+ ++G R E+ + H N+
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG---VPSSALR-EICLLKELKHKNI 63
Query: 557 VRLVGFSSEGKHRLLVYEFMKN---GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGIT 613
VRL K LV+EF D+ + K +Q +G+
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ--------LLKGLG 115
Query: 614 YLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLA 673
+ H ++H D+KP+N+L++ N K+++FGLA+ R ++ T Y
Sbjct: 116 FCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV---RCYSAEVVTLWYRP 169
Query: 674 PEWLANLPITSKS-DVYSYGMVLLEIVSGRR 703
P+ L + S S D++S G + E+ + R
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 6e-16
Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 34/218 (15%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQ--LEGIEQGEKQFRM----EVATISSTHHLNLV 557
K+G G FG V++ VA+K+ +E ++G F + E+ + H N+V
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLLKHENVV 79
Query: 558 RL----VGFSSEGKHRL----LVYEFMKN---GSLDNFLFANEEGSGKLLNWQSRFNIAL 606
L +S LV++F ++ G L N L K +
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM------- 132
Query: 607 GTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN-PKDHRHRTLTSV 665
G+ Y+H R+ I+H D+K N+L+ + K++DFGLA+ + K+ + T+
Sbjct: 133 -LLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 666 RGTRGYLAPEWLANLPITSKS-DVYSYGMVLLEIVSGR 702
T Y PE L D++ G ++ E+ +
Sbjct: 189 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 8e-16
Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 38/216 (17%)
Query: 506 KLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVA---TISSTHHLNLVRLVG 561
K+G+G FG +Y G +A VA+K E ++ Q +E + + +
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGI--PTIRW 72
Query: 562 FSSEGKHRLLVYEFMKNG-SLDNFLFANEEGSGKLLNWQSR-------FNIALGTARGIT 613
+EG + ++V E + G SL++ L N+ SR +A I
Sbjct: 73 CGAEGDYNVMVMELL--GPSLED-----------LFNFCSRKFSLKTVLLLADQMISRIE 119
Query: 614 YLHEECRDCIVHCDIKPENILLDENYNAK---VSDFGLAKL-INPKDHRH---RTLTSVR 666
Y+H + +H D+KP+N L+ + DFGLAK + + H+H R ++
Sbjct: 120 YIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176
Query: 667 GTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGR 702
GT Y + + + + D+ S G VL+ G
Sbjct: 177 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 9e-16
Identities = 51/225 (22%), Positives = 89/225 (39%), Gaps = 51/225 (22%)
Query: 505 DKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFR----MEVATISSTHHLNLVRL 559
G G FG V G VA+K+ + Q + +FR + ++ HH N+V+L
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKK---VIQ-DPRFRNRELQIMQDLAVLHHPNIVQL 84
Query: 560 VGF----SSEGKHRL---LVYEFM-------------KNGSLDNFLFANEEGSGKLLNWQ 599
+ + + +V E++ + + L K+ +Q
Sbjct: 85 QSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILI-------KVFLFQ 137
Query: 600 SRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD-ENYNAKVSDFGLAKLINPKDHR 658
R I LH + + H DIKP N+L++ + K+ DFG AK ++P
Sbjct: 138 --------LIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP---- 184
Query: 659 HRTLTSVRGTRGYLAPEWLANLPI-TSKSDVYSYGMVLLEIVSGR 702
+ +R Y APE + T+ D++S G + E++ G
Sbjct: 185 SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 48/185 (25%), Positives = 74/185 (40%), Gaps = 36/185 (19%)
Query: 506 KLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLV-RLVGFS 563
++G G FG ++ G L N VA+K E Q R E T + + F
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 564 SEGKHRLLVYEFMKNG-SLDNFLFANEEGSGKLLNWQSR-------FNIALGTARGITYL 615
EG H +LV + + G SL++ LL+ R A + +
Sbjct: 76 QEGLHNVLVIDLL--GPSLED-----------LLDLCGRKFSVKTVAMAAKQMLARVQSI 122
Query: 616 HEECRDCIVHCDIKPENILLDENYNAK-----VSDFGLAKL-INPKDHRH---RTLTSVR 666
HE+ +V+ DIKP+N L+ + V DFG+ K +P +H R ++
Sbjct: 123 HEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 179
Query: 667 GTRGY 671
GT Y
Sbjct: 180 GTARY 184
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 610 RGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR 669
GI +LH I+H D+KP NI++ + K+ DFGLA+ +T TR
Sbjct: 138 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM----MTPYVVTR 190
Query: 670 GYLAPEWLANLPITSKSDVYSYGMVLLEIVSGR 702
Y APE + + D++S G ++ E++ G
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-15
Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 32/226 (14%)
Query: 507 LGAGGFGAVY--RGVLANRT--VVAVKQL--EGIEQGEKQF---RME---VATISSTHHL 554
LG G +G V+ R + + T + A+K L I Q K R E + I
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR--QSP 119
Query: 555 NLVRLVG-FSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIA-LGTARG 611
LV L F +E K L L+ +++ G L F + + + + + + A
Sbjct: 120 FLVTLHYAFQTETK--LHLILDYINGGEL----FTHLSQRERFTEHEVQIYVGEIVLA-- 171
Query: 612 ITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGY 671
+ +LH+ I++ DIK ENILLD N + ++DFGL+K D R GT Y
Sbjct: 172 LEHLHK--LG-IIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFC-GTIEY 226
Query: 672 LAPEWLANLPI-TSKS-DVYSYGMVLLEIVSGRRNFEVSQETNRKK 715
+AP+ + K+ D +S G+++ E+++G F V E N +
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA 272
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 41/215 (19%)
Query: 505 DKLGAGGFGAVYRG-VLANRTVVAVKQLEGIEQGEKQFRM------------EVATISST 551
DKLG G + VY+G +VA+K++ R+ EV+ +
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEI----------RLEHEEGAPCTAIREVSLLKDL 57
Query: 552 HHLNLVRLVGFSSEGKHRLLVYEFMKN---GSLDNFLFANEEGSGKLLNWQSRFNIALGT 608
H N+V L K LV+E++ LD+ + KL +Q
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ--------L 109
Query: 609 ARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGT 668
RG+ Y H R ++H D+KP+N+L++E K++DFGLA+ + +T + T
Sbjct: 110 LRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT---KTYDNEVVT 163
Query: 669 RGYLAPEWLANLPITSKS-DVYSYGMVLLEIVSGR 702
Y P+ L S D++ G + E+ +GR
Sbjct: 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 5e-15
Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 507 LGAGGFGAVY--RGVLANRT--VVAVKQLEG---IEQGEKQFRMEVATISSTHHLNLVRL 559
LG G FG V+ + + + + A+K L+ + + +ME + +H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 560 V-GFSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIA-LGTARGITYLH 616
F +EGK L L+ +F++ G L F +F +A L A + +LH
Sbjct: 92 HYAFQTEGK--LYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALA--LDHLH 143
Query: 617 EECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEW 676
I++ D+KPENILLDE + K++DFGL+K + + + GT Y+APE
Sbjct: 144 SLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC---GTVEYMAPEV 197
Query: 677 LANLPITSKSDVYSYGMVLLEIVSGR 702
+ T +D +S+G+++ E+++G
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 61/210 (29%), Positives = 89/210 (42%), Gaps = 33/210 (15%)
Query: 507 LGAGGFGAVYRGVLA----NRTVVAVKQL--EGIEQGEKQFRMEVATI-------SSTHH 553
LG G FG V L A+K L E I + EVA ++ H
Sbjct: 156 LGKGTFGKVI---LVKEKATGRYYAMKILKKEVIVA-----KDEVAHTLTENRVLQNSRH 207
Query: 554 LNLVRLVGFSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGI 612
L L +S + RL V E+ G L F + ++RF A +
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGA-EIVSAL 261
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYL 672
YLH E +V+ D+K EN++LD++ + K++DFGL K +T GT YL
Sbjct: 262 DYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC---GTPEYL 316
Query: 673 APEWLANLPITSKSDVYSYGMVLLEIVSGR 702
APE L + D + G+V+ E++ GR
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 45/218 (20%)
Query: 507 LGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRM--EVATISSTHHLNLVRLVG-F 562
+G G +G V N+ VA+K++ E R E+ + H N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 563 SSEGKHRL----LVYEFM--------KNGSLDN-----FLFANEEGSGKLLNWQSRFNIA 605
+ ++ +V + M K L N FL+ ++L
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY-------QIL--------- 138
Query: 606 LGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSV 665
RG+ Y+H ++H D+KP N+LL+ + K+ DFGLA++ +P LT
Sbjct: 139 ----RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 666 RGTRGYLAPEWLANLPITSKS-DVYSYGMVLLEIVSGR 702
TR Y APE + N +KS D++S G +L E++S R
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 38/216 (17%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQ--LEGIEQGEKQF-----RMEVATISSTHHLNL 556
+KLG G + VY+G+ VA+K+ L+ E+G R E++ + H N+
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEG---TPSTAIR-EISLMKELKHENI 65
Query: 557 VRLVGFSSEGKHRLLVYEF--------MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGT 608
VRL LV+EF M + ++ N E K WQ
Sbjct: 66 VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ--------L 117
Query: 609 ARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN-PKDHRHRTLTSVRG 667
+G+ + H + I+H D+KP+N+L+++ K+ DFGLA+ P T +S
Sbjct: 118 LQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP----VNTFSSEVV 170
Query: 668 TRGYLAPEWLANLPITSKS-DVYSYGMVLLEIVSGR 702
T Y AP+ L S S D++S G +L E+++G+
Sbjct: 171 TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 48/234 (20%), Positives = 84/234 (35%), Gaps = 60/234 (25%)
Query: 505 DKLGAGGFGAVYRGV--LANRTVVAVKQLEGIEQGEKQFRMEVATIS--------STHHL 554
LG G FG V + ++ VA+K + + + + R+E+ + +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 555 NLVRLVGFSSEGKHRLLV--------YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIAL 606
V + + + H + +EF+K + + + ++A
Sbjct: 85 --VLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPY-------PLPHVR-----HMAY 130
Query: 607 GTARGITYLHEECRDCIVHCDIKPENILLDENYNA-------------------KVSDFG 647
+ +LHE + + H D+KPENIL + +V+DFG
Sbjct: 131 QLCHALRFLHE-NQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 648 LAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSG 701
A H T++ TR Y PE + L DV+S G +L E G
Sbjct: 188 SAT------FDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 43/164 (26%), Positives = 61/164 (37%), Gaps = 33/164 (20%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVAT-ISSTHHLNLVRLV 560
LG G G V + + A+K L+ + R EV ++ ++VR+V
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIV 77
Query: 561 GF----SSEGKHRLLVYEFMKNGSL-------DNFLFANEEGSGKLLNWQSRFNIALGTA 609
+ K L+V E + G L + F E S I
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS----------EIMKSIG 127
Query: 610 RGITYLHEECRDCIVHCDIKPENILL---DENYNAKVSDFGLAK 650
I YLH I H D+KPEN+L N K++DFG AK
Sbjct: 128 EAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 26/208 (12%)
Query: 507 LGAGGFGAVY--RGVLANRT--VVAVKQL--EGIEQGEKQF---RMEVATISSTHHLNLV 557
LG GG+G V+ R V T + A+K L I + K + E + H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 558 RLV-GFSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIA-LGTARGITY 614
L+ F + GK L L+ E++ G L F E G + + F +A + A + +
Sbjct: 85 DLIYAFQTGGK--LYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAEISMA--LGH 136
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAP 674
LH++ I++ D+KPENI+L+ + K++DFGL K T GT Y+AP
Sbjct: 137 LHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC---GTIEYMAP 190
Query: 675 EWLANLPITSKSDVYSYGMVLLEIVSGR 702
E L D +S G ++ ++++G
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 34/218 (15%)
Query: 505 DKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRM------------EVATISSTH 552
+ +G +GAV GV + VA+K++ + + E+ ++ H
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 553 HLNLVRLVG-FSSEGKHRL----LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNI--A 605
H N++ L F + + LV E M+ L + + ++ +
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRI---VISPQHIQYFMYHI 143
Query: 606 LGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSV 665
L G+ LHE +VH D+ P NILL +N + + DF LA+ + T
Sbjct: 144 L---LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADAN----KTHY 193
Query: 666 RGTRGYLAPEWLANLPITSKS-DVYSYGMVLLEIVSGR 702
R Y APE + +K D++S G V+ E+ + +
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 53/223 (23%), Positives = 91/223 (40%), Gaps = 39/223 (17%)
Query: 504 KDKLGAGGFGAVYRGVLANRT---VVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLV 560
K+G G +G VY+ + A+KQ+EG R E+A + H N++ L
Sbjct: 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-EIALLRELKHPNVISLQ 84
Query: 561 G-FSSEGKHRL-LVYEFM-----------KNGSLDNFLFANEEGSGKLLNWQSRFNIALG 607
F S ++ L++++ + + G K L +Q
Sbjct: 85 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ-------- 136
Query: 608 TARGITYLHEECRDCIVHCDIKPENILLDENYNA----KVSDFGLAKLINPKDHRHRTLT 663
GI YLH + ++H D+KP NIL+ K++D G A+L N + L
Sbjct: 137 ILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP---LKPLA 190
Query: 664 SVRG---TRGYLAPEWLANLPITSKS-DVYSYGMVLLEIVSGR 702
+ T Y APE L +K+ D+++ G + E+++
Sbjct: 191 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 3e-14
Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 38/216 (17%)
Query: 506 KLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVA---TISSTHHLNLVRLVG 561
K+G+G FG +Y G + VA+K E ++ Q E + + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGI--PNVRW 70
Query: 562 FSSEGKHRLLVYEFMKNG-SLDNFLFANEEGSGKLLNWQSR-------FNIALGTARGIT 613
F EG + +LV + + G SL++ L N+ SR +A +
Sbjct: 71 FGVEGDYNVLVMDLL--GPSLED-----------LFNFCSRKLSLKTVLMLADQMINRVE 117
Query: 614 YLHEECRDCIVHCDIKPENILLDENYNAK---VSDFGLAKL-INPKDHRH---RTLTSVR 666
++H + +H DIKP+N L+ A + DFGLAK + H+H R ++
Sbjct: 118 FVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
Query: 667 GTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGR 702
GT Y + + + + D+ S G VL+ + G
Sbjct: 175 GTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 48/208 (23%), Positives = 93/208 (44%), Gaps = 27/208 (12%)
Query: 506 KLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATISS-THHLNLVRL--VG 561
KLG G + V+ + + N V VK L+ +++ +K R E+ + + N++ L +
Sbjct: 43 KLGRGKYSEVFEAINITNNEKVVVKILKPVKK-KKIKR-EIKILENLRGGPNIITLADIV 100
Query: 562 FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNI--ALGTARGITYLHEEC 619
+ LV+E + N L ++ RF + L + + Y H
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEIL---KALDYCHSMG 150
Query: 620 RDCIVHCDIKPENILLD-ENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLA 678
I+H D+KP N+++D E+ ++ D+GLA+ +P + +R + PE L
Sbjct: 151 ---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG----QEYNVRVASRYFKGPELLV 203
Query: 679 NLPITSKS-DVYSYGMVLLEIVSGRRNF 705
+ + S D++S G +L ++ + F
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 4e-14
Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 610 RGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR 669
GI +LH I+H D+KP NI++ + K+ DFGLA+ +T TR
Sbjct: 175 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM----MTPYVVTR 227
Query: 670 GYLAPEWLANLPITSKSDVYSYGMVLLEIVSGR 702
Y APE + + D++S G ++ E+V +
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 6e-14
Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 37/216 (17%)
Query: 507 LGAGGFGAVYRGVLA----NRTVVAVKQL--EGIEQGEKQFRMEVA-TIS-------STH 552
LG G FG V+ LA A+K L + + +V T+ +
Sbjct: 25 LGKGSFGKVF---LAEFKKTNQFFAIKALKKDVVLM-----DDDVECTMVEKRVLSLAWE 76
Query: 553 HLNLVRLVG-FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARG 611
H L + F ++ V E++ G L + + K ++ F A G
Sbjct: 77 HPFLTHMFCTFQTKENL-FFVMEYLNGGDL----MYHIQSCHKFDLSRATFYAA-EIILG 130
Query: 612 ITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL-INPKDHRHRTLTSVRGTRG 670
+ +LH + IV+ D+K +NILLD++ + K++DFG+ K + + GT
Sbjct: 131 LQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA----KTNTFCGTPD 183
Query: 671 YLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFE 706
Y+APE L D +S+G++L E++ G+ F
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH 219
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 50/209 (23%), Positives = 96/209 (45%), Gaps = 30/209 (14%)
Query: 506 KLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQ----FRMEVATISSTHHLNLVRLV 560
+G+G +G+V + + VA+K+L Q E +R E+ + H N++ L+
Sbjct: 31 HVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLL 89
Query: 561 G-FSSEGKHRL-----LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
F+ R LV FM L + + ++ + +G+ Y
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK------FSEEKIQY-LVYQMLKGLKY 141
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAP 674
+H +VH D+KP N+ ++E+ K+ DFGLA+ + +T TR Y AP
Sbjct: 142 IHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADA------EMTGYVVTRWYRAP 192
Query: 675 EWLANLPITSKS-DVYSYGMVLLEIVSGR 702
E + + +++ D++S G ++ E+++G+
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 57/267 (21%), Positives = 88/267 (32%), Gaps = 82/267 (30%)
Query: 506 KLGAGGFGAVYRGVLA----NRTVVAVKQLEGIEQGEKQFRME------VATISSTH--H 553
KLG G F V+ L+ + VA+K ++ E + E V
Sbjct: 44 KLGWGHFSTVW---LSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNR 100
Query: 554 LNLVRLVG-F---SSEGKHRLLVYEFMKNG-SLDNFLFANEEGSGKLLNWQSRFNIALGT 608
+V+L+ F G H +V+E + G L ++ + + L I
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSN---YQGLPLPCVKKIIQQV 155
Query: 609 ARGITYLHEECRDCIVHCDIKPENILL--------------------------------- 635
+G+ YLH +CR I+H DIKPENILL
Sbjct: 156 LQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 636 ----------------DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN 679
E K++D G A TR Y + E L
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNAC---WVHKHFTEDIQ---TRQYRSLEVLIG 267
Query: 680 LPITSKSDVYSYGMVLLEIVSGRRNFE 706
+ +D++S + E+ +G FE
Sbjct: 268 SGYNTPADIWSTACMAFELATGDYLFE 294
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 63/209 (30%), Positives = 92/209 (44%), Gaps = 32/209 (15%)
Query: 507 LGAGGFGAVYRGVLA----NRTVVAVKQL--EGIEQGEKQFRMEVA-TISSTHHLNLVR- 558
LG G FG V L A+K L E I + EVA T++ + L R
Sbjct: 13 LGKGTFGKVI---LVREKATGRYYAMKILRKEVIIA-----KDEVAHTVTESRVLQNTRH 64
Query: 559 --LVG--FSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGIT 613
L ++ + RL V E+ G L F + ++RF A +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGA-EIVSALE 119
Query: 614 YLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLA 673
YLH RD +V+ DIK EN++LD++ + K++DFGL K +T GT YLA
Sbjct: 120 YLHS--RD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---GTPEYLA 173
Query: 674 PEWLANLPITSKSDVYSYGMVLLEIVSGR 702
PE L + D + G+V+ E++ GR
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 58/249 (23%), Positives = 91/249 (36%), Gaps = 52/249 (20%)
Query: 481 LEYASGAPVQFSYKELQ--RSTKGFK--DKLGAGGFGAVYRGV-LANRTVVAVKQ--LEG 533
LE + P S S ++ KLG G +G VY+ + VA+K+ LE
Sbjct: 12 LEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH 71
Query: 534 IEQGEKQF-----RMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM---------KNG 579
E+G R EV+ + H N++ L L++E+ KN
Sbjct: 72 EEEG---VPGTAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNP 127
Query: 580 SLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY 639
+ K +Q G+ + H +H D+KP+N+LL +
Sbjct: 128 DVS-------MRVIKSFLYQ--------LINGVNFCH---SRRCLHRDLKPQNLLLSVSD 169
Query: 640 NA-----KVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKS-DVYSYGM 693
+ K+ DFGLA+ R T T Y PE L S S D++S
Sbjct: 170 ASETPVLKIGDFGLARAFGIPI---RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIAC 226
Query: 694 VLLEIVSGR 702
+ E++
Sbjct: 227 IWAEMLMKT 235
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 29/94 (30%), Positives = 54/94 (57%), Gaps = 10/94 (10%)
Query: 610 RGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR 669
+G+ Y+H I+H D+KP N+ ++E+ K+ DFGLA+ + +T TR
Sbjct: 139 KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS------EMTGYVVTR 189
Query: 670 GYLAPEWLANLPITSKS-DVYSYGMVLLEIVSGR 702
Y APE + N +++ D++S G ++ E+++G+
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 30/216 (13%)
Query: 506 KLGAGGFGAVYRGV-LANRTVVAVKQL--EGIEQGEKQFRMEVATISSTHHLNLVRLVG- 561
LG GG G V+ V VA+K++ + + R E+ I H N+V++
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVFEI 76
Query: 562 FSSEGKHRL-------------LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGT 608
G +V E+M+ L N L G LL +R
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL-----EQGPLLEEHARL-FMYQL 129
Query: 609 ARGITYLHEECRDCIVHCDIKPENILLD-ENYNAKVSDFGLAKLINPKDHRHRTLTSVRG 667
RG+ Y+H ++H D+KP N+ ++ E+ K+ DFGLA++++P L+
Sbjct: 130 LRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 668 TRGYLAPEWLANLPITSKS-DVYSYGMVLLEIVSGR 702
T+ Y +P L + +K+ D+++ G + E+++G+
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 72.4 bits (177), Expect = 3e-13
Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 37/216 (17%)
Query: 507 LGAGGFGAVYRGVLA----NRTVVAVKQL--EGIEQGEKQFRMEVATI--------SSTH 552
LG G FG V L+ + AVK L + + Q +V
Sbjct: 349 LGKGSFGKVM---LSERKGTDELYAVKILKKDVVIQ-----DDDVECTMVEKRVLALPGK 400
Query: 553 HLNLVRLVG-FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARG 611
L +L F + + V E++ G L + + G+ + F A A G
Sbjct: 401 PPFLTQLHSCFQTMDRL-YFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYAA-EIAIG 454
Query: 612 ITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL-INPKDHRHRTLTSVRGTRG 670
+ +L + I++ D+K +N++LD + K++DFG+ K I T T GT
Sbjct: 455 LFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFC-GTPD 507
Query: 671 YLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFE 706
Y+APE +A P D +++G++L E+++G+ FE
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 54/243 (22%), Positives = 90/243 (37%), Gaps = 74/243 (30%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLN-------- 555
K+G G FG V + N+ AVK + I++ + ++E + +
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILK---KIQNDDINNNN 97
Query: 556 LVRLVG-FSSEGKHR--------LL---VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFN 603
+V+ G F + L +YE + + + F + +
Sbjct: 98 IVKYHGKF----MYYDHMCLIFEPLGPSLYEIITRNNYNGF-------HIEDIK-----L 141
Query: 604 IALGTARGITYLHEECRDCIVHCDIKPENILLDENYNA---------------------- 641
+ + + YL + + H D+KPENILLD+ Y
Sbjct: 142 YCIEILKALNYLRK-MS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198
Query: 642 ---KVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEI 698
K+ DFG A + S+ TR Y APE + NL SD++S+G VL E+
Sbjct: 199 TGIKLIDFGCAT------FKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252
Query: 699 VSG 701
+G
Sbjct: 253 YTG 255
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 56/238 (23%), Positives = 90/238 (37%), Gaps = 68/238 (28%)
Query: 505 DKLGAGGFGAVYRGV--LANRTVVAVKQLEGIEQGEKQFRMEVATIS--------STHHL 554
D LG G FG V + A VAVK ++ +++ + R E+ + ST
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 555 NLVRLVG-FSSEGKHR--------LL---VYEFMKNGSLDNFLFANEEGSGKLLNWQSRF 602
V+++ F +H LL Y+F+K F +
Sbjct: 80 --VQMLEWF----EHHGHICIVFELLGLSTYDFIKENGFLPF-------RLDHIR----- 121
Query: 603 NIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNA-------------------KV 643
+A + + +LH + + H D+KPENIL ++ KV
Sbjct: 122 KMAYQICKSVNFLHS-NK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 644 SDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSG 701
DFG A + +++ TR Y APE + L + DV+S G +L+E G
Sbjct: 179 VDFGSAT------YDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 4e-13
Identities = 65/215 (30%), Positives = 89/215 (41%), Gaps = 43/215 (20%)
Query: 507 LGAGGFGAVYRGVLA----NRTVVAVKQL--EGIEQGEKQFRMEVA-TIS-------STH 552
+G G FG V LA AVK L + I + + E +S +
Sbjct: 46 IGKGSFGKVL---LARHKAEEVFYAVKVLQKKAILK-----KKEEKHIMSERNVLLKNVK 97
Query: 553 HLNLVRLVG-FSSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRF---NIALG 607
H LV L F + K L V +++ G L F + + L ++RF IA
Sbjct: 98 HPFLVGLHFSFQTADK--LYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAEIASA 151
Query: 608 TARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRG 667
+ YLH IV+ D+KPENILLD + ++DFGL K + T G
Sbjct: 152 ----LGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC---G 201
Query: 668 TRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGR 702
T YLAPE L P D + G VL E++ G
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 31/94 (32%), Positives = 53/94 (56%), Gaps = 10/94 (10%)
Query: 610 RGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR 669
RG+ Y+H I+H D+KP N+ ++E+ K+ DFGLA+ +T TR
Sbjct: 143 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTAD------EMTGYVATR 193
Query: 670 GYLAPEWLANLPITSKS-DVYSYGMVLLEIVSGR 702
Y APE + N +++ D++S G ++ E+++GR
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 5e-13
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 507 LGAGGFGAVYRGVLA----NRTVVAVKQL--EGIEQGEKQFRMEVA-TIS-------STH 552
LG G FG V LA + AVK L + I Q +V T++ + +
Sbjct: 31 LGKGSFGKVM---LARVKETGDLYAVKVLKKDVILQ-----DDDVECTMTEKRILSLARN 82
Query: 553 HLNLVRLVG-FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARG 611
H L +L F + + V EF+ G L + + S + ++RF A
Sbjct: 83 HPFLTQLFCCFQTPDRL-FFVMEFVNGGDL----MFHIQKSRRFDEARARFYAA-EIISA 136
Query: 612 ITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL-INPKDHRHRTLTSVRGTRG 670
+ +LH++ I++ D+K +N+LLD + K++DFG+ K I T T GT
Sbjct: 137 LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV---TTATFC-GTPD 189
Query: 671 YLAPEWLANLPITSKSDVYSYGMVLLEIVSGR 702
Y+APE L + D ++ G++L E++ G
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 52/229 (22%), Positives = 90/229 (39%), Gaps = 52/229 (22%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRM--EVATISSTHHLNLVRL 559
K LG G +G V +VA+K++E ++ R E+ + H N++ +
Sbjct: 15 LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITI 74
Query: 560 VG-FSSEGKHRL----LVYEFM--------KNGSLDN-----FLFANEEGSGKLLNWQSR 601
+ ++ E M L + F++ + L
Sbjct: 75 FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY-------QTL----- 122
Query: 602 FNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRT 661
R + LH ++H D+KP N+L++ N + KV DFGLA++I+ +
Sbjct: 123 --------RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 662 LTSVRG-------TRGYLAPEWLANLPITSKS-DVYSYGMVLLEIVSGR 702
T + TR Y APE + S++ DV+S G +L E+ R
Sbjct: 172 PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 8e-13
Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 37/216 (17%)
Query: 507 LGAGGFGAVYRGVLA----NRTVVAVKQL--EGIEQGEKQFRMEVA-TIS-------STH 552
LG G FG V L+ + AVK L + + Q +V T+
Sbjct: 28 LGKGSFGKVM---LSERKGTDELYAVKILKKDVVIQ-----DDDVECTMVEKRVLALPGK 79
Query: 553 HLNLVRLVG-FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARG 611
L +L F + + V E++ G L + + G+ + F A A G
Sbjct: 80 PPFLTQLHSCFQTMDRL-YFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYAA-EIAIG 133
Query: 612 ITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL-INPKDHRHRTLTSVRGTRG 670
+ +L + I++ D+K +N++LD + K++DFG+ K I T T GT
Sbjct: 134 LFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFC-GTPD 186
Query: 671 YLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFE 706
Y+APE +A P D +++G++L E+++G+ FE
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 47/239 (19%), Positives = 90/239 (37%), Gaps = 53/239 (22%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQF--RMEVATISSTHHLNLVRL-- 559
LG G FG V + + A+K+ + Q + ++ R E+ + H+N+++L
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKK---VLQ-DPRYKNR-ELDIMKVLDHVNIIKLVD 67
Query: 560 ------------------VGFSSEGKHRLLVYEFMKNGSLDNFLFAN------EEGSGKL 595
+ + + + + N + K+
Sbjct: 68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKV 127
Query: 596 LNWQSRFNIALG----------TARGITYLHEECRDCIVHCDIKPENILLD-ENYNAKVS 644
L R ++ R + ++H I H DIKP+N+L++ ++ K+
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLC 184
Query: 645 DFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPI-TSKSDVYSYGMVLLEIVSGR 702
DFG AK + P + + +R Y APE + T D++S G V E++ G+
Sbjct: 185 DFGSAKKLIPSE----PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 43/215 (20%)
Query: 507 LGAGGFGAVYRGVLA----NRTVVAVKQL--EGIEQGEKQFRMEVATI--------SSTH 552
+G G + V L + A+K + E + ++ + +++
Sbjct: 17 IGRGSYAKVL---LVRLKKTDRIYAMKVVKKELVND-----DEDIDWVQTEKHVFEQASN 68
Query: 553 HLNLVRLVG-FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRF---NIALGT 608
H LV L F +E + V E++ G L + KL +RF I+L
Sbjct: 69 HPFLVGLHSCFQTESRL-FFVIEYVNGGDL--MFHMQRQR--KLPEEHARFYSAEISLA- 122
Query: 609 ARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL-INPKDHRHRTLTSVRG 667
+ YLHE I++ D+K +N+LLD + K++D+G+ K + P D T T G
Sbjct: 123 ---LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFC-G 172
Query: 668 TRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGR 702
T Y+APE L D ++ G+++ E+++GR
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 38/195 (19%), Positives = 68/195 (34%), Gaps = 38/195 (19%)
Query: 506 KLGAGGFGAVYRGV---------LANRTVVAVKQLE---GIEQGEKQFRMEVA------- 546
G +Y + ++K L+ G E+ F A
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 547 --TISSTHHLNLVRLVGF-SSEGKHRLLVYEFMKNG-SLDNFLFANEEGSGKLLNWQSRF 602
+ ST L + +GF + K+R LV + G SL + L + +L+ +S
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSAL---DVSPKHVLSERSVL 162
Query: 603 NIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKV--SDFGLAKL-INPKDH-- 657
+A + +LHE VH ++ ENI +D ++V + +G A H
Sbjct: 163 QVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA 219
Query: 658 -RHRTLTSVRGTRGY 671
+ + G +
Sbjct: 220 YVEGSRSPHEGDLEF 234
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 53/215 (24%), Positives = 94/215 (43%), Gaps = 43/215 (20%)
Query: 507 LGAGGFGAVYRGVLA----NRTVVAVKQL--EGIEQGEKQFRMEVATI--------SSTH 552
+G G + V L + A++ + E + ++ + +++
Sbjct: 60 IGRGSYAKVL---LVRLKKTDRIYAMRVVKKELVND-----DEDIDWVQTEKHVFEQASN 111
Query: 553 HLNLVRLVG-FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRF---NIALGT 608
H LV L F +E + V E++ G L + KL +RF I+L
Sbjct: 112 HPFLVGLHSCFQTESRL-FFVIEYVNGGDL--MFHMQRQR--KLPEEHARFYSAEISLA- 165
Query: 609 ARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL-INPKDHRHRTLTSVRG 667
+ YLHE I++ D+K +N+LLD + K++D+G+ K + P D T T G
Sbjct: 166 ---LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFC-G 215
Query: 668 TRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGR 702
T Y+APE L D ++ G+++ E+++GR
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 36/202 (17%), Positives = 64/202 (31%), Gaps = 52/202 (25%)
Query: 506 KLGAGGFGAVYRGVLANRTVVAVKQLEGIEQG---------EKQFRMEVA---TISSTHH 553
+G GGFG +Y + + V ++ E +F A I
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 554 LNLVRLVGF----------SSEGKHRLLVYEFMKNG-SLDNFLFANEEGSGKLLNWQSR- 601
++ +G + +R ++ + G L K+ ++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQ-----------KIYEANAKR 148
Query: 602 ------FNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKV--SDFGLAKL-I 652
++L + Y+HE VH DIK N+LL+ +V D+GLA
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYC 205
Query: 653 NPKDHRH---RTLTSVRGTRGY 671
H+ GT +
Sbjct: 206 PEGVHKAYAADPKRCHDGTIEF 227
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 37/199 (18%), Positives = 61/199 (30%), Gaps = 49/199 (24%)
Query: 506 KLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEV---------ATISSTHHLN 555
K+G+GGFG +Y A ++ Q E+ I
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 556 LVRLVGF----------SSEGKHRLLVYEFMKNG-SLDNFLFANEEGSGKLLNWQSRFN- 603
+ +G +R +V E + G L K+ F
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQ-----------KISGQNGTFKK 150
Query: 604 -----IALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKV--SDFGLAKL-INPK 655
+ + + Y+HE VH DIK N+LL +V +D+GL+
Sbjct: 151 STVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207
Query: 656 DHRH---RTLTSVRGTRGY 671
+H+ GT +
Sbjct: 208 NHKQYQENPRKGHNGTIEF 226
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 4e-11
Identities = 52/257 (20%), Positives = 89/257 (34%), Gaps = 68/257 (26%)
Query: 504 KDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQ----FRMEVATISSTHHLNLVR 558
K +G G +G VY VA+K++ + + R E+ ++ ++R
Sbjct: 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDYIIR 89
Query: 559 LVG-FSSEGKHRL----LVYEFM---------KNGSLDN-----FLFANEEGSGKLLNWQ 599
L + + +V E L L+ LL
Sbjct: 90 LYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY-------NLL--- 139
Query: 600 SRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRH 659
G ++HE I+H D+KP N LL+++ + KV DFGLA+ IN + +
Sbjct: 140 ----------LGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186
Query: 660 RTLTSVRG-------------------TRGYLAPEWLANLPITSKS-DVYSYGMVLLEIV 699
TR Y APE + +KS D++S G + E++
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246
Query: 700 SGRRNFEVSQETNRKKF 716
+ ++ F
Sbjct: 247 NMLQSHINDPTNRFPLF 263
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 8e-11
Identities = 42/252 (16%), Positives = 77/252 (30%), Gaps = 40/252 (15%)
Query: 28 SSFADISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGSTPV 87
+ S +L A QS + F++ Q N + + V +W + T
Sbjct: 6 GLSHEGSHPQTLHA---AQSLELSSFRFTM---QSDCN----LVLFDSDVRVWASN-TAG 54
Query: 88 DSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLNVTSA-SLDDSGNLVLLKNGGVSAWSSF 146
+ L S G L +++ I W S T+ L + + G + +S
Sbjct: 55 ATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGTSN 114
Query: 147 DNPTDTIVPSQN--------------FTSDKTLRSGYYSFTLLKSGNLSLKWNDSVVYFN 192
+ + ++L+ Y ++ NL L D V+
Sbjct: 115 KGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVW-- 172
Query: 193 QGLNSAINSTVNSNLTSPILRLQPVGILSISDVSLNSAAIIAYSSDYAEGSDILRFLSLG 252
++ T LQP G + + + A+ + + G L
Sbjct: 173 -------STNTAGKGTGCRAVLQPNGRMDVLTN--QNIAVWTSGNSRSAGR---YVFVLQ 220
Query: 253 SDGNLRIFSSAR 264
D NL I+ A
Sbjct: 221 PDRNLAIYGGAL 232
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 46.1 bits (108), Expect = 2e-05
Identities = 23/145 (15%), Positives = 41/145 (28%), Gaps = 30/145 (20%)
Query: 59 FIQRSPNSFIPAITYSGGVPIWTAGSTPVDSSAFFQLHSSGTLRLISGSGAIIWDSNTQR 118
+ A + S + + L L +W +NT
Sbjct: 120 VANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAG 178
Query: 119 LNVTS-ASLDDSGNLVLLKNGGVSAWSSFDNPTDTIVPSQNFTSDKTLRSGYYSFTLLKS 177
A L +G + +L N ++ W+S ++ + G Y F L
Sbjct: 179 KGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSA----------------GRYVFVLQPD 222
Query: 178 GNLSLKWNDSVVYFNQGLNSAINST 202
NL +Y A+ +T
Sbjct: 223 RNL-------AIY-----GGALWTT 235
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 33/112 (29%), Positives = 49/112 (43%), Gaps = 22/112 (19%)
Query: 610 RGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRG-- 667
+ I YLH ++H D+KP NILL+ + KV+DFGL++ +
Sbjct: 120 KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 668 ----------------TRGYLAPEWLANLPITSKS-DVYSYGMVLLEIVSGR 702
TR Y APE L +K D++S G +L EI+ G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 51/255 (20%), Positives = 96/255 (37%), Gaps = 64/255 (25%)
Query: 504 KDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQ----FRMEVATISSTHHLNLVR 558
+ +G G +G V + VVA+K++ + + R E+A ++ +H ++V+
Sbjct: 58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHVVK 116
Query: 559 LV----GFSSEGKHRL-LVYEFM---------KNGSLDNFLFANEEGSGKLLNWQSRFNI 604
++ E L +V E L K L +
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHI-------KTLLYN----- 164
Query: 605 ALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTS 664
G+ Y+H I+H D+KP N L++++ + KV DFGLA+ ++ ++ + L
Sbjct: 165 ---LLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218
Query: 665 VRG------------------------TRGYLAPEWLANLPITSKS-DVYSYGMVLLEIV 699
TR Y APE + +++ DV+S G + E++
Sbjct: 219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278
Query: 700 SGRRNFEVSQETNRK 714
V+ +R
Sbjct: 279 -NMIKENVAYHADRG 292
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 8e-10
Identities = 36/214 (16%), Positives = 63/214 (29%), Gaps = 50/214 (23%)
Query: 488 PVQFSYKELQRSTKGFKD--KLGAGGFGAVYRGVLANRTVVAVKQL----EGIEQGEKQF 541
PV FS+ T+ + K+G G FG V++ + A+ T VA+K + + G Q
Sbjct: 10 PVPFSH---CLPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQK 65
Query: 542 RME--------------VATISSTHHLNLVRLVGF----SSEGKHRLLVYEFM--KNGSL 581
E ++ + L S L ++ GS
Sbjct: 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125
Query: 582 DNFLFAN------------------EEGSGKLLNWQSRFNIALGTARGITYLHEECRDCI 623
++ E+ KL + + +I + R
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--F 183
Query: 624 VHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657
H D+ N+LL + K+ K
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSC 217
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 1e-08
Identities = 21/110 (19%), Positives = 39/110 (35%), Gaps = 5/110 (4%)
Query: 39 LSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGSTPVDSSAFFQLHSS 98
S L+ + Q N + Y +W +G+ S ++ +
Sbjct: 5 NSGHQLDTGGSLAEGGYLFII-QNDCNLVL----YDNNRAVWASGTNGKASGCVLKMQND 59
Query: 99 GTLRLISGSGAIIWDSNTQRLNVTSASLDDSGNLVLLKNGGVSAWSSFDN 148
G L + SGS AI + ++ L N+V+ N + W++ N
Sbjct: 60 GNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTN 109
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 7e-08
Identities = 27/113 (23%), Positives = 46/113 (40%), Gaps = 15/113 (13%)
Query: 150 TDTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWNDSVVYFNQGLNSAINSTVNSNLTS 209
+D + + +L G Y F + NL L N+ V+ S N +
Sbjct: 1 SDRLNSGHQLDTGGSLAEGGYLFIIQNDCNLVLYDNNRAVW---------ASGTNGKASG 51
Query: 210 PILRLQPVGILSISDVSLNSAAIIAYSSDYAEGSDILRFLSLGSDGNLRIFSS 262
+L++Q G L I S AI A +++ G+ +L L D N+ I+ +
Sbjct: 52 CVLKMQNDGNLVIYS---GSRAIWASNTNRQNGN---YYLILQRDRNVVIYDN 98
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 39.9 bits (93), Expect = 4e-04
Identities = 11/48 (22%), Positives = 20/48 (41%)
Query: 73 YSGGVPIWTAGSTPVDSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLN 120
YSG IW + + + + + L + + S IW ++T N
Sbjct: 65 YSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 55.8 bits (133), Expect = 1e-08
Identities = 43/274 (15%), Positives = 72/274 (26%), Gaps = 45/274 (16%)
Query: 33 ISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGS-------- 84
+ +LSA Q SPN F L Q N I G +W A
Sbjct: 17 LPAYQTLSA---GQYLLSPNQRFKLLL-QGDGNLVI----QDNGATVWVANEQQPFSSTI 68
Query: 85 TPVDSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLNVTSAS------LDDSGNLVLLKNG 138
+ A + L S +W ++ L D GN+VL+ +
Sbjct: 69 PLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVDSL 128
Query: 139 GVSAWSS------FDNPTDTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWNDSVVYFN 192
+ + + + P +G GNL + +N
Sbjct: 129 ALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQGDGNLVAYGPNGAATWN 188
Query: 193 QGLNSAINSTVNSNLTSPILRLQPVGILSISDVSLNSAAIIAYSSDYAEGSDILRFLSLG 252
G Q G L + A++ +S S +LR L
Sbjct: 189 AGTQGKGAVR---------AVFQGDGNLVVYG---AGNAVLWHSHTGGHASAVLR---LQ 233
Query: 253 SDGNLRIFSSAR--GSGTKTRRWAAVADQCEVFG 284
++G++ I + +
Sbjct: 234 ANGSIAILDEKPVWARFGFQPTYRHIRKINPDQK 267
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 52.7 bits (125), Expect = 1e-07
Identities = 26/133 (19%), Positives = 39/133 (29%), Gaps = 7/133 (5%)
Query: 40 SASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGSTPVDSSAFFQLHSSG 99
S L Q L F Q N G W AG T + G
Sbjct: 151 PGSELVQGVVYGAGASKLVF-QGDGNLVA---YGPNGAATWNAG-TQGKGAVRAVFQGDG 205
Query: 100 TLRLISGSGAIIWDSNTQRLNVTSASLDDSGNLVLLKNGGVSAWSSFDNPTDTIVPSQNF 159
L + A++W S+T L +G++ +L V W+ F +
Sbjct: 206 NLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDEKPV--WARFGFQPTYRHIRKIN 263
Query: 160 TSDKTLRSGYYSF 172
K + + F
Sbjct: 264 PDQKPIDIWTWHF 276
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 44.7 bits (104), Expect = 6e-05
Identities = 23/167 (13%), Positives = 40/167 (23%), Gaps = 17/167 (10%)
Query: 22 VSLNFISSFADISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWT 81
++ N + D + L + +
Sbjct: 97 LTDNSTFTSNDQWNRTHLVLQDDGNIVLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELV 156
Query: 82 AGSTPVDSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLNVTSASLDDSGNLVLLKNGGVS 141
G ++ G L +GA W++ TQ A GNLV+ G
Sbjct: 157 QGVVYGAGASKLVFQGDGNLVAYGPNGAATWNAGTQGKGAVRAVFQGDGNLVVYGAGNAV 216
Query: 142 AWSSFDNPTDTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWNDSV 188
W S T L +G++++ V
Sbjct: 217 LWHS-----------------HTGGHASAVLRLQANGSIAILDEKPV 246
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 3e-08
Identities = 19/122 (15%), Positives = 36/122 (29%), Gaps = 9/122 (7%)
Query: 25 NFISSFADISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGS 84
N I S + + + + Q N + Y PIW +
Sbjct: 2 NIIFSKQPDDNHPQILHATESLEILFGTHVYRFIM-QTDCN----LVLYDNNNPIWATNT 56
Query: 85 TPVDSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLNV-TSASLDDSGNLVLLKNGGVSAW 143
+ + L G L +I+ +W S L N+V+ + + W
Sbjct: 57 GGLGNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGD---ALW 113
Query: 144 SS 145
++
Sbjct: 114 AT 115
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 4e-08
Identities = 28/128 (21%), Positives = 47/128 (36%), Gaps = 19/128 (14%)
Query: 24 LNFISSFADISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAG 83
+N +SS + G SL ++ L Q N + Y G P+W +
Sbjct: 1 VNSLSSPNSLFTGHSLE----------VGPSYRLIM-QGDCNFVL----YDSGKPVWASN 45
Query: 84 STPVDSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLNVTS-ASLDDSGNLVLLKNGGVSA 142
+ + S LH++G L + S +IW + T L N+V+ G
Sbjct: 46 TGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIY---GPVV 102
Query: 143 WSSFDNPT 150
W++ P
Sbjct: 103 WATGSGPA 110
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 4e-08
Identities = 25/108 (23%), Positives = 37/108 (34%), Gaps = 9/108 (8%)
Query: 39 LSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGSTPVDSSAFFQLHSS 98
S L+ N + Q N + Y PIW + +D + S
Sbjct: 5 YSGETLSPGEFLNNGRYVFIM-QEDCNLVL----YDVDKPIWATNTGGLDRRCHLSMQSD 59
Query: 99 GTLRLISGSGAIIWDSNTQRLNVTS-ASLDDSGNLVLLKNGGVSAWSS 145
G L + S IW SNT N L N+V+ G + W++
Sbjct: 60 GNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIY---GTARWAT 104
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 2e-04
Identities = 23/119 (19%), Positives = 43/119 (36%), Gaps = 15/119 (12%)
Query: 151 DTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWNDSVVYFNQGLNSAINSTVNSNLTSP 210
+ + + + + L +G Y F + + NL L D ++
Sbjct: 2 NILYSGETLSPGEFLNNGRYVFIMQEDCNLVLYDVDKPIWATNTGGLDRRCH-------- 53
Query: 211 ILRLQPVGILSISDVSLNSAAIIAYSSDYAEGSDILRFLSLGSDGNLRIFSSAR-GSGT 268
L +Q G L + + I A ++ G+ L D N+ I+ +AR +GT
Sbjct: 54 -LSMQSDGNLVVYSP--RNNPIWASNTGGENGN---YVCVLQKDRNVVIYGTARWATGT 106
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-07
Identities = 24/123 (19%), Positives = 40/123 (32%), Gaps = 15/123 (12%)
Query: 151 DTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWNDSVVYFNQGLNSAINSTVNSNLTSP 210
+ ++ Q +D +L++G Y+ T+ NL N ++ +
Sbjct: 3 NVLLSGQTLHADHSLQAGAYTLTIQNKCNLVKYQNGRQIWASNTDRRGSGCR-------- 54
Query: 211 ILRLQPVGILSISDVSLNSAAIIAYSSDYAEGSDILRFLSLGSDGNLRIFSSAR-GSGTK 269
L L G L I D N+ + + G L L DG I+ G
Sbjct: 55 -LTLLSDGNLVIYDH--NNNDVWGSACWGDNGKYALV---LQKDGRFVIYGPVLWSLGPN 108
Query: 270 TRR 272
R
Sbjct: 109 GCR 111
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 7e-07
Identities = 25/111 (22%), Positives = 36/111 (32%), Gaps = 14/111 (12%)
Query: 36 GSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGSTPVDSSAFFQL 95
G +L A + S + T ++ Q N Y G IW + + S L
Sbjct: 8 GQTLHA---DHSLQAGAYTLTI---QNKCNLVK----YQNGRQIWASNTDRRGSGCRLTL 57
Query: 96 HSSGTLRLISGSGAIIWDSNTQRLNVTS-ASLDDSGNLVLLKNGGVSAWSS 145
S G L + + +W S N L G V+ G WS
Sbjct: 58 LSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIY---GPVLWSL 105
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 5e-06
Identities = 20/111 (18%), Positives = 34/111 (30%), Gaps = 15/111 (13%)
Query: 36 GSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGSTPVDSSAFFQL 95
G L + + N + Q N + Y G W + + F +L
Sbjct: 12 GQVLYG---DGRLTAKNHQLVM---QGDCNLVL----YGGK-YGWQSNTHGNGEHCFLRL 60
Query: 96 HSSGTLRLISGSGAIIWDSNTQRLNVTSA-SLDDSGNLVLLKNGGVSAWSS 145
+ G L + IW S + L D G V+ G + + +
Sbjct: 61 NHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIY---GPAIFET 108
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 3e-05
Identities = 22/121 (18%), Positives = 38/121 (31%), Gaps = 16/121 (13%)
Query: 149 PTDTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWNDSVVYFNQGLNSAINSTVNSNLT 208
+ + Q D L + + + NL L + + + + +
Sbjct: 5 TNNLLFSGQVLYGDGRLTAKNHQLVMQGDCNLVL-YGGKYGWQSNTHGNGEHCF------ 57
Query: 209 SPILRLQPVGILSISDVSLNSAAIIAYSSDYAEGSDILRFLSLGSDGNLRIFSSAR-GSG 267
LRL G L I D + I + S +G L L DG I+ A +
Sbjct: 58 ---LRLNHKGELIIKDD--DFKTIWSSRSSSKQGE---YVLILQDDGFGVIYGPAIFETS 109
Query: 268 T 268
+
Sbjct: 110 S 110
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 6e-06
Identities = 49/347 (14%), Positives = 98/347 (28%), Gaps = 104/347 (29%)
Query: 462 YWCCRNSPK-----FV--SLSAQYALLEYASGAPVQFSYKELQRSTKGF---KDKLGAGG 511
+W + + FV L Y L +P++ ++ T+ + +D+L
Sbjct: 68 FWTLLSKQEEMVQKFVEEVLRINYKFLM----SPIKTEQRQPSMMTRMYIEQRDRL---- 119
Query: 512 FGAVYRG--VLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHR 569
Y V A V ++ + Q + R N++ + G GK
Sbjct: 120 ----YNDNQVFAKYNVSRLQPYLKLRQALLELR---------PAKNVL-IDGVLGSGKT- 164
Query: 570 LLVYEFMKNGSLDNFL--------FANEEGSGKLL------------NWQSRFNIALGTA 609
+ + + + + N +L NW SR + +
Sbjct: 165 WVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIK 224
Query: 610 RGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTL-TSVRGT 668
I + E R + + ++L V + AK N + + L T T
Sbjct: 225 LRIHSIQAELRRLLKSKPYENCLLVLLN-----VQN---AKAWNAFNLSCKILLT----T 272
Query: 669 RGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAY------- 721
R +T + + L+ S E + +
Sbjct: 273 R---------FKQVTDFLSAATTTHISLDHHSM--TLT-PDEV-KSLLLKYLDCRPQDLP 319
Query: 722 EEFEKGNVKGIVDKSLAGE-------------DVDIEQVMRAIQVSF 755
E N + + S+ E V+ +++ I+ S
Sbjct: 320 REVLTTNPRRL---SIIAESIRDGLATWDNWKHVNCDKLTTIIESSL 363
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 2e-05
Identities = 41/324 (12%), Positives = 93/324 (28%), Gaps = 112/324 (34%)
Query: 489 VQFSYKE-LQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVAT 547
Q+ YK+ L F D + + +L+ ++++ I
Sbjct: 14 HQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSK------EEIDHI------------- 54
Query: 548 ISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALG 607
I S ++ + ++ K +V +F++ N+ + L
Sbjct: 55 IMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINY------------KF-------LM 95
Query: 608 TARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN-----PKDH--RHR 660
+ + E R P ++ Y + +L N K + R +
Sbjct: 96 SP-----IKTEQRQ--------PS--MMTRMYIEQRD-----RLYNDNQVFAKYNVSRLQ 135
Query: 661 TLTSVRGTRGYLAPEWLANLPITSKSDVYSYGM------VL-LEIVSGRRNFEVSQETNR 713
+R + L L +V G+ + L++ +++V + +
Sbjct: 136 PYLKLR--------QALLEL--RPAKNVLIDGVLGSGKTWVALDVC---LSYKVQCKMDF 182
Query: 714 KKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQ------VSFWCIQEQPSQRPM 767
K F W N+ E V+ +Q W + S
Sbjct: 183 KIF--WL-------NL---------KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIK 224
Query: 768 MGKVVQMLEGITE-IEKPPAPKAL 790
+ ++ + + ++ P L
Sbjct: 225 L-RIHSIQAELRRLLKSKPYENCL 247
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 9e-06
Identities = 23/118 (19%), Positives = 38/118 (32%), Gaps = 12/118 (10%)
Query: 149 PTDTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWNDSVVYFNQGLNSAINSTVNSNLT 208
+ + SQ + L + YS + NL V+ N S +
Sbjct: 5 VRNVLFSSQVMYDNAQLATRDYSLVMRDDCNL-------VLTKGSKTNIVWESGTSGRGQ 57
Query: 209 SPILRLQPVGILSISDVSLNSAAIIAYSSDYAEGSDILRFLSLGSDGNLRIFSSARGS 266
+RL G L I+D + ++ EG L L +G ++ A S
Sbjct: 58 HCFMRLGHSGELDITDD--RLNTVFVSNTVGQEGD---YVLILQINGQAVVYGPAVWS 110
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 7e-05
Identities = 17/73 (23%), Positives = 29/73 (39%), Gaps = 4/73 (5%)
Query: 74 SGGVPIWTAGSTPVDSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLNVTSA-SLDDSGNL 132
S +W +G++ F +L SG L + ++ SNT L +G
Sbjct: 42 SKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQA 101
Query: 133 VLLKNGGVSAWSS 145
V+ G + WS+
Sbjct: 102 VVY---GPAVWST 111
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 3e-05
Identities = 26/122 (21%), Positives = 43/122 (35%), Gaps = 14/122 (11%)
Query: 151 DTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWNDSVVYFNQGLNSAINSTVNSNLTSP 210
+ + + + ++L Y F + + NL V+Y + A N T
Sbjct: 2 NLLTNGEGLYAGQSLDVEPYHFIMQEDCNL-------VLYDHSTSVWASN-TGILGKKGC 53
Query: 211 ILRLQPVGILSISDVSLNSAAIIAYSSDYAEGSDILRFLSLGSDGNLRIFSSARGSGTKT 270
LQ G + D ++S G+ L L DGN+ I+ S S T T
Sbjct: 54 KAVLQSDGNFVVYDAEGR----SLWASHSVRGNGNYV-LVLQEDGNVVIYGSDIWS-TGT 107
Query: 271 RR 272
+
Sbjct: 108 YK 109
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 9e-05
Identities = 26/108 (24%), Positives = 37/108 (34%), Gaps = 19/108 (17%)
Query: 81 TAGSTPVDSSAFFQLHSSGTLRLISGSGAIIWDSNTQRL--NVTSASLDDSGNLVLLKNG 138
AG + F + L L S ++ W SNT L A L GN V+
Sbjct: 11 YAGQSLDVEPYHFIMQEDCNLVLYDHSTSV-WASNTGILGKKGCKAVLQSDGNFVVYDAE 69
Query: 139 GVSAWSSFDNPTDTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWND 186
G S W+S +G Y L + GN+ + +D
Sbjct: 70 GRSLWASHSVR----------------GNGNYVLVLQEDGNVVIYGSD 101
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 5e-05
Identities = 15/69 (21%), Positives = 26/69 (37%), Gaps = 4/69 (5%)
Query: 78 PIWTAGSTPVDSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLNVT-SASLDDSGNLVLLK 136
W + + L G L + +G G+ +W S Q + +A + G LV+
Sbjct: 38 GNWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVF- 96
Query: 137 NGGVSAWSS 145
G S +
Sbjct: 97 --GPSVFKI 103
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 39.5 bits (92), Expect = 5e-04
Identities = 22/123 (17%), Positives = 43/123 (34%), Gaps = 18/123 (14%)
Query: 150 TDTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWNDSVVYFNQGLNSAINSTVNSNLTS 209
T+ ++ Q ++ L++G + + NL V+Y N S +N
Sbjct: 3 TNYLLSGQTLDTEGHLKNGDFDLVMQDDCNL-------VLY-----NGNWQSNTANNGRD 50
Query: 210 PILRLQPVGILSISDVSLNSAAIIAYSSDYAEGSDILRFLSLGSDGNLRIFSSAR-GSGT 268
L L G L I + + + + + +G+ + DG L +F +
Sbjct: 51 CKLTLTDYGELVIKNG--DGSTVWKSGAQSVKGNYAAV---VHPDGRLVVFGPSVFKIDP 105
Query: 269 KTR 271
R
Sbjct: 106 WVR 108
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 40.2 bits (94), Expect = 3e-04
Identities = 23/119 (19%), Positives = 38/119 (31%), Gaps = 13/119 (10%)
Query: 152 TIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWNDSVVYFNQGLNSAINSTVNSNLTSPI 211
++ +D L +F + NL V+Y G ++T
Sbjct: 4 VLLTGDVIHTDNQLSYESAAFVMQGDCNL-------VLYNEAGGFQ--SNTHGRG-VDCT 53
Query: 212 LRLQPVGILSISDVSLNSAAIIAYSSDYAEGSDILRFLSLGSDGNLRIFSSARGSGTKT 270
LRL G L I + N+ + +LG D ++ I+ A S T
Sbjct: 54 LRLNNRGQLEIHSANSNTP--VWVYPRSVNTVRGNYAATLGPDQHVTIYGPAIWS-TPA 109
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 852 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.98 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.81 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.8 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.8 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.77 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.72 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.67 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.65 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.65 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.58 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.58 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.57 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.56 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.46 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.31 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.29 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.26 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.22 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.21 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.09 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.08 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.06 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.04 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.97 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.82 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.44 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.42 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.27 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.24 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.15 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.1 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.84 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.78 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.66 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.64 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.46 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.32 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.18 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.11 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.08 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.04 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.03 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.98 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.96 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.19 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.88 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.89 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 93.67 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.33 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 86.98 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 86.77 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 81.65 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 81.15 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.18 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=450.17 Aligned_cols=268 Identities=25% Similarity=0.383 Sum_probs=217.0
Q ss_pred cCHHHHHHhcccccccccccccceEEEEEEC------CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeee
Q 003059 491 FSYKELQRSTKGFKDKLGAGGFGAVYRGVLA------NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGF 562 (852)
Q Consensus 491 ~~~~el~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~ 562 (852)
..+.||..++++|.++||+|+||.||+|.+. +++.||||+++.. ....++|.+|+.++++++|||||+++|+
T Consensus 18 ~~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 97 (308)
T 4gt4_A 18 AKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGV 97 (308)
T ss_dssp -CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence 4455677778899999999999999999863 4678999999733 3345789999999999999999999999
Q ss_pred eccCceeeEEEeecCCCCHHHHhhhccc-----------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCC
Q 003059 563 SSEGKHRLLVYEFMKNGSLDNFLFANEE-----------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPE 631 (852)
Q Consensus 563 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~ 631 (852)
|.+.+..+||||||++|+|.++|..... .....++|..+++|+.|||+||+|||+ ++||||||||+
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~ 174 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATR 174 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCcccc
Confidence 9999999999999999999999975432 113469999999999999999999999 89999999999
Q ss_pred ceEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCcccccccc
Q 003059 632 NILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQE 710 (852)
Q Consensus 632 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~ 710 (852)
||||++++.+||+|||+++.+...+. ........||++|||||++.+..++.++|||||||+||||+| |+.||.....
T Consensus 175 NILl~~~~~~Ki~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~ 253 (308)
T 4gt4_A 175 NVLVYDKLNVKISDLGLFREVYAADY-YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 253 (308)
T ss_dssp GEEECGGGCEEECCSCCBCGGGGGGC-BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH
T ss_pred ceEECCCCCEEECCcccceeccCCCc-eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999987643221 122345679999999999999999999999999999999998 8999975432
Q ss_pred ccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 711 TNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 711 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
.+ ....+..+... +.+......+.+++.+||+.||.+||+|.||++.|+...
T Consensus 254 ~~-------~~~~i~~~~~~----------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 254 QD-------VVEMIRNRQVL----------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HH-------HHHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HH-------HHHHHHcCCCC----------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 11 11222222211 111122345778899999999999999999999998754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-52 Score=444.60 Aligned_cols=265 Identities=27% Similarity=0.440 Sum_probs=213.2
Q ss_pred HHHhcccccccccccccceEEEEEEC------CCcEEEEEEecCc-ccchHHHHHHHHHhhcccccceeeeeeeeccCce
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLA------NRTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKH 568 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 568 (852)
|.+..+.+.++||+|+||.||+|++. +++.||||+++.. ....++|.+|+++|++++|||||+++|+|.+++.
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 44556778899999999999999864 4678999999843 3456789999999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHhhhcc--------cCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCc
Q 003059 569 RLLVYEFMKNGSLDNFLFANE--------EGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYN 640 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~--------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 640 (852)
.+||||||++|+|.++|.... ......++|..+++|+.||++||+|||+ ++||||||||+||||++++.
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCc
Confidence 999999999999999997642 1234579999999999999999999999 89999999999999999999
Q ss_pred eEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHH
Q 003059 641 AKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLW 719 (852)
Q Consensus 641 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 719 (852)
+||+|||+++.....+. ........||++|||||++.+..++.++|||||||+||||+| |+.||......+
T Consensus 167 ~Ki~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~------- 238 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------- 238 (299)
T ss_dssp EEECCCSCHHHHTGGGC-EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------
T ss_pred EEECCcccceecCCCCc-eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 99999999987654221 122233568999999999999999999999999999999999 899997543211
Q ss_pred HHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 720 AYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 720 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
....+..+.... .+......+.+++.+||+.||++|||+++|++.|+++.+.
T Consensus 239 ~~~~i~~~~~~~----------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 239 VIECITQGRVLQ----------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHHHHHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCC----------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 112222222111 1111224567889999999999999999999999987653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=447.16 Aligned_cols=264 Identities=27% Similarity=0.424 Sum_probs=206.8
Q ss_pred HHhcccccccccccccceEEEEEEC------CCcEEEEEEecC-cccchHHHHHHHHHhhcccccceeeeeeeeccCcee
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLA------NRTVVAVKQLEG-IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHR 569 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 569 (852)
....+.+.++||+|+||.||+|++. +++.||||+++. .....++|.+|+++|++++|||||+++|+|.+.+..
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3445667889999999999999864 478899999984 344567899999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhhcccC----------CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC
Q 003059 570 LLVYEFMKNGSLDNFLFANEEG----------SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY 639 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~ 639 (852)
+||||||++|+|.++|...... ...+++|.++++|+.|||+||+|||+ ++||||||||+||||++++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCC
Confidence 9999999999999999764321 23469999999999999999999998 8999999999999999999
Q ss_pred ceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHH
Q 003059 640 NAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSL 718 (852)
Q Consensus 640 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~ 718 (852)
.+||+|||+++.+...+. ........||+.|||||++.+..++.++|||||||+||||+| |+.||.......
T Consensus 196 ~~Ki~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~------ 268 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE------ 268 (329)
T ss_dssp EEEECCCC-----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH------
T ss_pred cEEEcccccceeccCCCc-ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH------
Confidence 999999999997654322 223345679999999999999999999999999999999999 899997543211
Q ss_pred HHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 719 WAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 719 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
....+..+... +.+......+.+++.+||+.||++||||.||++.|+.+.+.
T Consensus 269 -~~~~i~~g~~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 269 -AIDCITQGREL----------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp -HHHHHHHTCCC----------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -HHHHHHcCCCC----------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 11222222111 11111224567889999999999999999999999988654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-51 Score=436.40 Aligned_cols=263 Identities=27% Similarity=0.460 Sum_probs=203.9
Q ss_pred HHHHhcccccccccccccceEEEEEECCCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeE
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLL 571 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 571 (852)
||....+.+.++||+|+||+||+|++.+ .||||+++.. ....++|.+|++++++++|||||+++|+|.+ +..+|
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 4555667788999999999999998754 5999998732 3345679999999999999999999999865 56899
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
|||||++|+|.++|... ...++|..+++|+.|||+||+|||+ ++||||||||+||||++++.+||+|||+|+.
T Consensus 109 VmEy~~gGsL~~~l~~~----~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQ----ETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATV 181 (307)
T ss_dssp EEECCSSCBHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred EEEcCCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCcee
Confidence 99999999999999643 2359999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhc---CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLAN---LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN 728 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (852)
...... ........||+.|||||++.+ .+++.++|||||||+||||+||+.||....... ........+.
T Consensus 182 ~~~~~~-~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~ 254 (307)
T 3omv_A 182 KSRWSG-SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGY 254 (307)
T ss_dssp -------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTC
T ss_pred cccCCc-ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCC
Confidence 653221 223345679999999999974 468999999999999999999999997543211 1111111111
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
..+.+. ..+......+.+++.+||+.||++||||.||++.|+.++.
T Consensus 255 ----~~p~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 255 ----ASPDLS--KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp ----CCCCST--TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred ----CCCCcc--cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 111111 1111223456788899999999999999999999987754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=432.94 Aligned_cols=271 Identities=22% Similarity=0.288 Sum_probs=206.8
Q ss_pred cccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCc----eeeEEEee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK----HRLLVYEF 575 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lV~e~ 575 (852)
++.+.++||+|+||.||+|++ .++.||||+++........++.|+..+.+++|||||+++|+|.+.+ ..+|||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 466788999999999999998 5788999999855544445567777888999999999999998654 67999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhcccc-----CCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC-----RDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
|++|+|.++|.. ..++|+.+++++.|+++||+|||+.. .++||||||||+||||+.++++||+|||+++
T Consensus 83 ~~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 83 HEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCCcHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999999964 34899999999999999999999741 3489999999999999999999999999998
Q ss_pred ccCCCCCcc-eeeeeecCCCCCCChhhhhcC------CCCCCccchhhhHHHHHHHhCCccccccccccchh--------
Q 003059 651 LINPKDHRH-RTLTSVRGTRGYLAPEWLANL------PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKK-------- 715 (852)
Q Consensus 651 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~------~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~-------- 715 (852)
......... .......||+.|||||++.+. .++.++|||||||+||||+||+.||..........
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 765432221 122346799999999999764 36779999999999999999998875432211100
Q ss_pred hHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 716 FSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 716 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
......... ....+++.+.....+.+....+.+++.+||+.||++||||.||++.|+++.+.
T Consensus 237 ~~~~~~~~~----~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 237 SVEEMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CHHHHHHHH----TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHHHHH----hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 001111111 11222233322223345667788999999999999999999999999987653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=434.40 Aligned_cols=248 Identities=23% Similarity=0.353 Sum_probs=198.2
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
+|.+.++||+|+||.||+|+. .+++.||||++.... ...+.|.+|+++|++++|||||++++++.+++..||||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 578889999999999999996 458999999997432 3346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
|++|+|.++|.... ...+++..++.++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 105 CEGGDLFKRINAQK---GVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CTTCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCcHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 99999999996543 3457889999999999999999999 89999999999999999999999999999876421
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
........||+.|||||++.+..++.++|||||||+||||++|+.||....... ....+..+....
T Consensus 179 ---~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~~~---- 244 (350)
T 4b9d_A 179 ---VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-------LVLKIISGSFPP---- 244 (350)
T ss_dssp ---HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCCCC----
T ss_pred ---cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHcCCCCC----
Confidence 112334679999999999999999999999999999999999999997543211 111122221111
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.+......+.+++.+||+.||++|||++|+++
T Consensus 245 ------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 ------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111235678889999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=430.76 Aligned_cols=267 Identities=26% Similarity=0.361 Sum_probs=214.1
Q ss_pred HHHHHhcccccccccccccceEEEEEECC------CcEEEEEEecCc--ccchHHHHHHHHHhhcccc-cceeeeeeeec
Q 003059 494 KELQRSTKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQLEGI--EQGEKQFRMEVATISSTHH-LNLVRLVGFSS 564 (852)
Q Consensus 494 ~el~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h-~niv~l~g~~~ 564 (852)
.||....+.+.++||+|+||.||+|.+.+ ++.||||++... ....++|.+|+++|.+++| ||||+++|+|.
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 36777888999999999999999998643 368999999743 2345679999999999965 89999999997
Q ss_pred cC-ceeeEEEeecCCCCHHHHhhhccc-----------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCc
Q 003059 565 EG-KHRLLVYEFMKNGSLDNFLFANEE-----------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPEN 632 (852)
Q Consensus 565 ~~-~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 632 (852)
+. +..+||||||++|+|.++|..... .....++|..++.++.|||+||+|||+ ++||||||||+|
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~N 215 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARN 215 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccc
Confidence 64 578999999999999999976432 123468999999999999999999999 899999999999
Q ss_pred eEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccc
Q 003059 633 ILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQET 711 (852)
Q Consensus 633 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~ 711 (852)
|||++++.+||+|||+|+.+...... .......||+.|||||++.+..++.++|||||||+||||+| |+.||......
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred eeeCCCCCEEECcchhhhhcccCCCc-eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999977543322 23345679999999999999999999999999999999998 99999754321
Q ss_pred cchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 712 NRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 712 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
. .....+.++.... . +......+.+++.+||+.||.+|||+.||++.|+.+.+
T Consensus 295 ~------~~~~~i~~g~~~~-----~-----p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 295 E------EFCRRLKEGTRMR-----A-----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp H------HHHHHHHHTCCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H------HHHHHHHcCCCCC-----C-----CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 1 1112222221111 1 11122356788899999999999999999999988764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=420.40 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=204.1
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecC-cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEG-IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
..|.+.++||+|+||.||+|+.. +++.||||++.. .....+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 35777889999999999999975 589999999973 3344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++|+|.+++.. ..+++..+..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+++.+....
T Consensus 154 ~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 154 EGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp TTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 99999999953 248999999999999999999999 899999999999999999999999999998775422
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
.......||+.|||||++.+..|+.++|||||||++|||++|+.||....... ....+.... .+.
T Consensus 225 ---~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~~-----~~~ 289 (346)
T 4fih_A 225 ---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDNL-----PPR 289 (346)
T ss_dssp ---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSS-----CCC
T ss_pred ---CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHcCC-----CCC
Confidence 22345789999999999999999999999999999999999999997543211 111111111 111
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+. ........+.+++.+||+.||++|||++|+++
T Consensus 290 ~~---~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 290 LK---NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CS---CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC---ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 11111235678889999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=407.45 Aligned_cols=243 Identities=25% Similarity=0.421 Sum_probs=194.1
Q ss_pred cccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeecc----CceeeEEE
Q 003059 502 GFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSE----GKHRLLVY 573 (852)
Q Consensus 502 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~ 573 (852)
.|.++||+|+||.||+|... +++.||+|++... ....+.|.+|++++++++|||||++++++.+ ++..||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56778999999999999975 5789999999633 2334679999999999999999999998864 45689999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCC--cccCCCCCCceEeC-CCCceEEeeccccc
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC--IVHCDIKPENILLD-ENYNAKVSDFGLAK 650 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NILl~-~~~~~kl~DFGla~ 650 (852)
|||++|+|.++|... ..+++..+..++.||+.||+|||+ ++ ||||||||+||||+ .++.+||+|||+|+
T Consensus 109 Ey~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 999999999999643 358999999999999999999998 55 99999999999998 48999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcc
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (852)
.... .......||+.|||||++.+ +++.++|||||||+||||+||+.||....... .....+..+...
T Consensus 181 ~~~~-----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~------~~~~~i~~~~~~ 248 (290)
T 3fpq_A 181 LKRA-----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKP 248 (290)
T ss_dssp GCCT-----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCC
T ss_pred eCCC-----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH------HHHHHHHcCCCC
Confidence 6432 12345689999999998865 69999999999999999999999996432211 111222222111
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 731 GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..+++ .. ...+.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~~-----~~----~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 249 ASFDK-----VA----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGGG-----CC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCc-----cC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111 11 124677889999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=416.73 Aligned_cols=253 Identities=21% Similarity=0.241 Sum_probs=200.5
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
.+.+.++||+|+||.||+|+.. +++.||||+++.... +.+|+.++++++|||||++++++.+++..|||||||++
T Consensus 59 ~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred heEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 3556778999999999999964 589999999974322 35799999999999999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC-ceEEeecccccccCCCCC
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY-NAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~~~~ 657 (852)
|+|.++|... ..+++..+..++.||+.||+|||+ ++||||||||+||||+.++ ++||+|||+|+.+.....
T Consensus 135 g~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 135 GSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999643 358999999999999999999998 8999999999999999987 699999999998754322
Q ss_pred cce--eeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 658 RHR--TLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 658 ~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
... ......||+.|||||++.+..++.++|||||||++|||++|+.||......... ..+...... . .
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-------~~i~~~~~~-~--~ 276 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC-------LKIASEPPP-I--R 276 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH-------HHHHHSCCG-G--G
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH-------HHHHcCCCC-c--h
Confidence 211 123357999999999999999999999999999999999999999754332211 111111110 0 0
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
.+ +......+.+++.+||+.||.+|||+.||++.|....
T Consensus 277 ~~-----~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 277 EI-----PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp GS-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hc-----CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 01 1112235667888999999999999999998886544
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=421.29 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=204.1
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecC-cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEG-IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
..|.+.++||+|+||.||+|... +++.||||++.. .....+.+.+|+.+|++++|||||++++++.+++..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 35778899999999999999974 589999999973 3344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++|+|.+++.. ..+++..+..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+++.+....
T Consensus 231 ~gG~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 231 EGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp TTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCcHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 99999999953 248999999999999999999999 899999999999999999999999999998775422
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
.......||+.|||||++.+..|+.++|||||||++|||++|+.||....... ....+.... .+.
T Consensus 302 ---~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~~-----~~~ 366 (423)
T 4fie_A 302 ---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDNL-----PPR 366 (423)
T ss_dssp ---CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSC-----CCC
T ss_pred ---ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHcCC-----CCC
Confidence 22345679999999999999999999999999999999999999997543211 111111111 111
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+.. .......+.+++.+||+.||++|||+.|+++
T Consensus 367 ~~~---~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 367 LKN---LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CSC---TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred Ccc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 0111235677888999999999999999876
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=408.69 Aligned_cols=246 Identities=24% Similarity=0.326 Sum_probs=204.3
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.|.+.++||+|+||.||+|+. .+++.||||++... ....+.+.+|+++|++++|||||++++++.+++..|||||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 488899999999999999996 45889999999732 3345679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++|+|.++|... ..+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+.+..
T Consensus 113 y~~gG~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 113 YAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred cCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999643 348999999999999999999999 8999999999999999999999999999998754
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
... ........||+.|||||++.+..++.++|||||||++|||++|+.||....... ....+..+..
T Consensus 185 ~~~-~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~~~----- 251 (311)
T 4aw0_A 185 ESK-QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-------IFAKIIKLEY----- 251 (311)
T ss_dssp TTT-CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCC-----
T ss_pred CCC-cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCC-----
Confidence 322 223445789999999999999999999999999999999999999997543211 1112222211
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVV 772 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~ 772 (852)
.+.. .. ...+.+++.+||+.||++|||++|+.
T Consensus 252 -~~p~-~~----s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 -DFPE-KF----FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -CCCT-TC----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -CCCc-cc----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1111 12 23567889999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=396.11 Aligned_cols=244 Identities=23% Similarity=0.356 Sum_probs=188.4
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
..|.+.++||+|+||.||+|.. .+++.||||++... ....+.+.+|++++++++|||||++++++.+.+..||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 4688899999999999999996 46899999999632 233467999999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+ +|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+||||++++++||+|||+|+...
T Consensus 93 Ey~-~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-----DKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp ECC-CEEHHHHHHHS-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred eCC-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 999 68999999653 358999999999999999999999 899999999999999999999999999998764
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcCCC-CCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPI-TSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI 732 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (852)
.. .......||+.|||||++.+..+ +.++|||||||++|||++|+.||...... . .......+..
T Consensus 164 ~~----~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~----~~~~i~~~~~--- 229 (275)
T 3hyh_A 164 DG----NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---V----LFKNISNGVY--- 229 (275)
T ss_dssp ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHHHHHTCC---
T ss_pred CC----CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---H----HHHHHHcCCC---
Confidence 32 22345679999999999998876 57999999999999999999999754321 1 1112222211
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.+.. .. ...+.+++.+||+.||++|||++|+++
T Consensus 230 ---~~p~-~~----s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 ---TLPK-FL----SPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ---CCCT-TS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CCCC-CC----CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0111 11 234678889999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=403.44 Aligned_cols=246 Identities=24% Similarity=0.311 Sum_probs=193.4
Q ss_pred hcccccccccccccceEEEEEEC----CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA----NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLL 571 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 571 (852)
..|.+.++||+|+||.||+|+.. .++.||||+++.. .....++.+|+++|++++|||||++++++.+++..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 35888999999999999999852 4678999999743 2234578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
||||+++|+|.++|... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.
T Consensus 104 vmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EECCCTTCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEcCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 99999999999999653 358999999999999999999999 8999999999999999999999999999986
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
..... .......||+.|||||++.+..++.++|||||||++|||++|+.||....... ....+.....
T Consensus 176 ~~~~~---~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~-- 243 (304)
T 3ubd_A 176 SIDHE---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-------TMTMILKAKL-- 243 (304)
T ss_dssp --------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC--
T ss_pred ccCCC---ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-------HHHHHHcCCC--
Confidence 54321 22345679999999999999999999999999999999999999997543211 1111112111
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMM-----GKVVQ 773 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~-----~ev~~ 773 (852)
.+.. .. ...+.+++.+||+.||++||++ +|+++
T Consensus 244 ----~~p~-~~----s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 ----GMPQ-FL----SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ----CCCT-TS----CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ----CCCC-cC----CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 0111 11 2356788899999999999984 56653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=393.54 Aligned_cols=250 Identities=20% Similarity=0.319 Sum_probs=185.6
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecC--cccchHHHHHHHHHhhcccccceeeeeeeeccCc---------
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEG--IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK--------- 567 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~--------- 567 (852)
.|.+.+.||+|+||.||+|+.. +++.||||+++. .....+.+.+|+++|++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 4677899999999999999964 688999999873 2334467899999999999999999999886543
Q ss_pred ---eeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEe
Q 003059 568 ---HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVS 644 (852)
Q Consensus 568 ---~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 644 (852)
..||||||+++|+|.+++..... .....+..++.++.||++||+|||+ ++||||||||+||||+.++.+||+
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEc
Confidence 46999999999999999965432 3345677788999999999999999 899999999999999999999999
Q ss_pred ecccccccCCCCCcc---------eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchh
Q 003059 645 DFGLAKLINPKDHRH---------RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKK 715 (852)
Q Consensus 645 DFGla~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~ 715 (852)
|||+|+.+....... .......||+.|||||.+.+..++.++|||||||++|||++ ||......
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~---- 233 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER---- 233 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH----
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH----
Confidence 999998775432211 11234579999999999999999999999999999999996 77532110
Q ss_pred hHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 716 FSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 716 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
. ............ +...+....+.+++.+||+.||++|||+.|+++
T Consensus 234 ~--~~~~~~~~~~~p----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 V--RTLTDVRNLKFP----------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp H--HHHHHHHTTCCC----------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H--HHHHHHhcCCCC----------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 011111111110 011122234567889999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=376.24 Aligned_cols=277 Identities=36% Similarity=0.623 Sum_probs=235.0
Q ss_pred cccccccccccccceEEEEEECCCcEEEEEEecC-cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEG-IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
.|.+.+.||+|+||.||+|.+.+++.||||++.. .....+++.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 40 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 119 (321)
T 2qkw_B 40 NFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMEN 119 (321)
T ss_dssp CCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTT
T ss_pred ccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCC
Confidence 4556788999999999999988899999999874 344567899999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
|+|.+++..... ....+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 120 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 194 (321)
T 2qkw_B 120 GNLKRHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ- 194 (321)
T ss_dssp CBTGGGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC-
T ss_pred CcHHHHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecccccccccccc-
Confidence 999999965432 23468999999999999999999999 8999999999999999999999999999986543211
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccC
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (852)
........||+.|+|||.+.+..++.++||||||+++|||++|+.||.............|.......+.+...+++.+.
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (321)
T 2qkw_B 195 THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA 274 (321)
T ss_dssp CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCT
T ss_pred cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhc
Confidence 11223455899999999999999999999999999999999999999876655555566666666666667777776665
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCC
Q 003059 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIE 782 (852)
Q Consensus 739 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~ 782 (852)
. ....+....+.+++.+|++.||++||++.+|++.|+.+.+..
T Consensus 275 ~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 275 D-KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp T-CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred c-ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 4 566788888999999999999999999999999999876543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=387.23 Aligned_cols=262 Identities=21% Similarity=0.317 Sum_probs=198.1
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeecc------Ccee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSE------GKHR 569 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------~~~~ 569 (852)
.|.+.++||+|+||.||+|.. .+++.||||+++... ...+.+.+|+++|++++|||||++++++.. .+..
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 578889999999999999996 468999999997432 234568899999999999999999998753 4678
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
|||||||+ |+|.+++... ..+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||++
T Consensus 135 ~ivmE~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEeCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeeccee
Confidence 99999995 6899999543 459999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCC-cceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhC
Q 003059 650 KLINPKDH-RHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG 727 (852)
Q Consensus 650 ~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (852)
+.+..... .........||+.|||||++.+. .++.++||||+||++|||++|+.||......+..... .......
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I---~~~~g~p 282 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI---MMVLGTP 282 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH---HHHHCCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH---HHhcCCC
Confidence 87643211 12233456899999999998875 5689999999999999999999999765432211111 0000000
Q ss_pred -----------CcccccccccCCCCCCHHH-----HHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 728 -----------NVKGIVDKSLAGEDVDIEQ-----VMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 728 -----------~~~~~~d~~l~~~~~~~~~-----~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.....+.......+.+.+. ...+.+++.+||+.||.+|||+.|+++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000111111122222 135678999999999999999999876
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=376.17 Aligned_cols=290 Identities=45% Similarity=0.743 Sum_probs=238.3
Q ss_pred CCCcccCHHHHHHhcccc--cccccccccceEEEEEECCCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeee
Q 003059 486 GAPVQFSYKELQRSTKGF--KDKLGAGGFGAVYRGVLANRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVG 561 (852)
Q Consensus 486 ~~~~~~~~~el~~~~~~~--~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g 561 (852)
+....|++.++.....+| .+.||+|+||.||+|...+++.||||++... ......+.+|++++.+++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 455678888888765554 6789999999999999888999999999743 233457899999999999999999999
Q ss_pred eeccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCce
Q 003059 562 FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNA 641 (852)
Q Consensus 562 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 641 (852)
++.+.+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+.+..+|+||||||+|||++.++.+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 99999999999999999999999975432 34569999999999999999999999333399999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCcccccccc--ccchhhHHH
Q 003059 642 KVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQE--TNRKKFSLW 719 (852)
Q Consensus 642 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~--~~~~~l~~~ 719 (852)
||+|||+++...... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||+.... ........|
T Consensus 174 kl~Dfg~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (326)
T 3uim_A 174 VVGDFGLAKLMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251 (326)
T ss_dssp EECCCSSCEECCSSS--SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred EeccCccccccCccc--ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence 999999998765422 2233445699999999999999999999999999999999999999974421 222334444
Q ss_pred HHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 720 AYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 720 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
............+.+..+.. ....+....+.+++.+|++.||.+||++.+|++.|++..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 252 VKGLLKEKKLEALVDVDLQG-NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp HTTTTSSCCSTTSSCTTCTT-SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHHHhhchhhhhhcChhhcc-ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 44444455556666666654 567788889999999999999999999999999998754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=376.90 Aligned_cols=198 Identities=24% Similarity=0.377 Sum_probs=168.3
Q ss_pred hcccccccccccccceEEEEEEC----CCcEEEEEEecCcccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA----NRTVVAVKQLEGIEQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 573 (852)
..|.+.++||+|+||.||+|+.+ .++.||||++.... ...++.+|+++|.++ +|||||++++++.+.++.||||
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 46888999999999999999853 46789999987433 345688999999988 6999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCC-CceEEeeccccccc
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDEN-YNAKVSDFGLAKLI 652 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFGla~~~ 652 (852)
||+++|+|.+++. .+++..+..++.||+.||+|||+ ++|+||||||+||||+.+ +.+||+|||+|+..
T Consensus 100 E~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 100 PYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp ECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 9999999999982 38899999999999999999999 899999999999999876 89999999999865
Q ss_pred CCCCCc-------------------------ceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCcccc
Q 003059 653 NPKDHR-------------------------HRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFE 706 (852)
Q Consensus 653 ~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~ 706 (852)
...... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 432110 1112345799999999999876 58999999999999999999999995
Q ss_pred cc
Q 003059 707 VS 708 (852)
Q Consensus 707 ~~ 708 (852)
..
T Consensus 249 ~~ 250 (361)
T 4f9c_A 249 KA 250 (361)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=370.52 Aligned_cols=275 Identities=26% Similarity=0.358 Sum_probs=210.3
Q ss_pred HhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCc----eeeEEE
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK----HRLLVY 573 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lV~ 573 (852)
...|.+.++||+|+||.||+|... ++.||||++.........++.|+.++.+++||||+++++++.+.. ..++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 356778899999999999999876 688999999866666667788999999999999999999988744 469999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhcccc-------CCCcccCCCCCCceEeCCCCceEEeec
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC-------RDCIVHCDIKPENILLDENYNAKVSDF 646 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------~~~ivH~Dlkp~NILl~~~~~~kl~DF 646 (852)
||+++|+|.+++.. ..+++..++.++.||++||+|||+.. ..+|+||||||+|||++.++.+||+||
T Consensus 102 e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 102 AFHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp ECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred ecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 99999999999954 24899999999999999999999820 119999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCChhhhhcC-----CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHH-
Q 003059 647 GLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL-----PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA- 720 (852)
Q Consensus 647 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~- 720 (852)
|+++........ .......||+.|+|||.+.+. .++.++||||||+++|||++|+.||..........+....
T Consensus 176 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 176 GLALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp TTCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CcccccccccCc-cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 999876543221 122335689999999999863 4556889999999999999999999765433222111110
Q ss_pred ----HHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 721 ----YEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 721 ----~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
..............+.+............+.+++.+||+.||++|||+.+|++.|+++.+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 000000000111111111111223455668899999999999999999999999998765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=389.93 Aligned_cols=249 Identities=23% Similarity=0.375 Sum_probs=203.9
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc-ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
.|.+.++||+|+||.||+|... +++.||+|++... ....+.+.+|+++|+.++|||||++++++.+.+..|||||||+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 5788899999999999999964 5889999998743 3345678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCC--CceEEeecccccccCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDEN--YNAKVSDFGLAKLINPK 655 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~--~~~kl~DFGla~~~~~~ 655 (852)
+|+|.++|... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 238 gg~L~~~i~~~----~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 238 GGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCBHHHHHTCT----TSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred CCcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 99999999533 2358999999999999999999999 899999999999999854 89999999999987542
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
.......||+.|||||++.+..++.++|||||||++|||++|+.||....... ....+...... ..+.
T Consensus 311 ----~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-------~~~~i~~~~~~-~~~~ 378 (573)
T 3uto_A 311 ----QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-------TLRNVKSCDWN-MDDS 378 (573)
T ss_dssp ----SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHTTCCC-CCSG
T ss_pred ----CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHhCCCC-CCcc
Confidence 23455689999999999999999999999999999999999999997543221 11111111110 0011
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
... .. ...+.+++.+||+.||.+||++.|+++
T Consensus 379 ~~~--~~----s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 379 AFS--GI----SEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GGT--TS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccc--CC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 11 235678889999999999999999987
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=366.08 Aligned_cols=266 Identities=28% Similarity=0.463 Sum_probs=201.7
Q ss_pred HHHhcccccccccccccceEEEEEECCCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
+....|.+.++||+|+||.||+|.. .++.||||++.... ...+++.+|++++++++||||+++++++.+.+..++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 4455778889999999999999987 57789999987433 2345789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCC--cccCCCCCCceEeCCCCceEEeeccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC--IVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
|||+++++|.+++..... ...+++..++.++.||++||+|||+ .+ |+||||||+|||++.++.+||+|||+++
T Consensus 113 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp EECCTTCBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred EecCCCCcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 999999999999965321 2358999999999999999999998 77 9999999999999999999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcc
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (852)
..... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ..........
T Consensus 188 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~-------~~~~~~~~~~ 257 (309)
T 3p86_A 188 LKAST---FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV-------VAAVGFKCKR 257 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH-------HHHHHHSCCC
T ss_pred ccccc---ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhcCCC
Confidence 64332 1123346799999999999999999999999999999999999999975432111 0111100000
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCCCCCC
Q 003059 731 GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPPA 786 (852)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~~~~~ 786 (852)
. ..+......+.+++.+||+.||.+||++.+|++.|+.+.+...|++
T Consensus 258 ----~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~ 304 (309)
T 3p86_A 258 ----L-----EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304 (309)
T ss_dssp ----C-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred ----C-----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence 0 1111122356788899999999999999999999999876555443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=389.00 Aligned_cols=246 Identities=24% Similarity=0.309 Sum_probs=194.9
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHH---HHHHHhhcccccceeeeeeeeccCceeeE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFR---MEVATISSTHHLNLVRLVGFSSEGKHRLL 571 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~---~E~~~l~~l~h~niv~l~g~~~~~~~~~l 571 (852)
.|.+.+.||+|+||.||+|+.. +++.||||++... ......+. .++.+++.++|||||++++++.+.+..||
T Consensus 190 df~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lyl 269 (689)
T 3v5w_A 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 269 (689)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred HeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEE
Confidence 3677889999999999999965 5899999999632 22223333 34667778899999999999999999999
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
||||++||+|.++|... ..+++..+..++.||+.||+|||+ ++||||||||+||||+.+|.+||+|||+|+.
T Consensus 270 VmEy~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 270 ILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EECCCCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999653 348999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcc
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (852)
+... ......||+.|||||++.. ..++.++|||||||+||||++|+.||......+...+ .........
T Consensus 342 ~~~~-----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i----~~~i~~~~~- 411 (689)
T 3v5w_A 342 FSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTMAV- 411 (689)
T ss_dssp CSSC-----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH----HHHHHHCCC-
T ss_pred cCCC-----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HHhhcCCCC-
Confidence 6532 1234679999999999964 5799999999999999999999999975433221111 111111110
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003059 731 GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPM-----MGKVVQ 773 (852)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt-----~~ev~~ 773 (852)
.+.. .. ...+.+++.+||+.||.+|++ ++||.+
T Consensus 412 -----~~p~-~~----S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 -----ELPD-SF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -----CCCT-TS----CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -----CCCc-cC----CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 0111 11 235678889999999999998 577764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=367.83 Aligned_cols=263 Identities=28% Similarity=0.448 Sum_probs=211.3
Q ss_pred HHHHhcccccccccccccceEEEEEEC----CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCce
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLA----NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKH 568 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 568 (852)
++...+|.+.+.||+|+||.||+|.+. .+..||||++... ....+.|.+|++++.+++||||+++++++.+++.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 455667888899999999999999974 4557999999843 3345679999999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.++||||+++++|.+++... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 197 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTH----DGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGL 197 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred cEEEeeCCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCc
Confidence 99999999999999999543 2358999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhC
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKG 727 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (852)
++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+
T Consensus 198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~~~~ 270 (325)
T 3kul_A 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-------VISSVEEG 270 (325)
T ss_dssp CEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTT
T ss_pred ccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHcC
Confidence 9987654333333444557889999999999999999999999999999999 999996543211 11111111
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 728 NVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 728 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
... +.+......+.+++.+||+.||.+||++.+|++.|+.+.+.
T Consensus 271 ~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 271 YRL----------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCC----------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 000 11112234677889999999999999999999999988654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=352.06 Aligned_cols=282 Identities=40% Similarity=0.636 Sum_probs=227.4
Q ss_pred CCcccCHHHHHHhccccc--------ccccccccceEEEEEECCCcEEEEEEecCc-----ccchHHHHHHHHHhhcccc
Q 003059 487 APVQFSYKELQRSTKGFK--------DKLGAGGFGAVYRGVLANRTVVAVKQLEGI-----EQGEKQFRMEVATISSTHH 553 (852)
Q Consensus 487 ~~~~~~~~el~~~~~~~~--------~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~-----~~~~~~f~~E~~~l~~l~h 553 (852)
....|++.++.+.+.+|. ++||+|+||.||+|.. +++.||||++... ....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 456799999999998886 4599999999999987 5678999998632 2335678999999999999
Q ss_pred cceeeeeeeeccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCce
Q 003059 554 LNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENI 633 (852)
Q Consensus 554 ~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI 633 (852)
|||+++++++.+.+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+ .+|+||||||+||
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Ni 164 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANI 164 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHE
Confidence 9999999999999999999999999999999965432 3568999999999999999999999 8999999999999
Q ss_pred EeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccc
Q 003059 634 LLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNR 713 (852)
Q Consensus 634 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~ 713 (852)
|++.++.+||+|||+++....... ........|++.|+|||.+.+ .++.++||||||+++|||++|+.||........
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 242 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQ-TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSS-CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred EEcCCCcEEEeecccccccccccc-cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence 999999999999999987654221 122234568999999998865 588999999999999999999999976543221
Q ss_pred hhhHHHHHHH-HhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 714 KKFSLWAYEE-FEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 714 ~~l~~~~~~~-~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
+..+.... .....+...+++.+. ..+......+.+++.+|++.||.+||++.+|++.|+++.+
T Consensus 243 --~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 243 --LLDIKEEIEDEEKTIEDYIDKKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp --TTHHHHHHHTTSCCHHHHSCSSCS--CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred --HHHHHHHhhhhhhhhhhhcccccc--ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 11111111 112233444555443 3456667788899999999999999999999999998753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=374.37 Aligned_cols=262 Identities=30% Similarity=0.472 Sum_probs=198.9
Q ss_pred HHHHhcccccccccccccceEEEEEEC----CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCce
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLA----NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKH 568 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 568 (852)
++....+.+.+.||+|+||.||+|.+. ++..||||+++.. ....++|.+|+.++++++||||+++++++.+.+.
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence 445567888899999999999999864 4678999999743 3345679999999999999999999999999999
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.++||||+++++|.+++... ...+++..++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 193 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGL 193 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred eEEEEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcc
Confidence 99999999999999999643 3458999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhC
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKG 727 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (852)
++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+
T Consensus 194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-------~~~~i~~~ 266 (373)
T 2qol_A 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-------VIKAVDEG 266 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-------HHHHHHTT
T ss_pred ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC
Confidence 9876543222222233446788999999999999999999999999999998 999996543211 11111111
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 728 NVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 728 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
. . . +.+......+.+++.+|++.||.+||++.+|++.|+.+..
T Consensus 267 ~----~---~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 267 Y----R---L---PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp E----E---C---CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C----C---C---CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 0 0 0 1111223467788999999999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=352.54 Aligned_cols=261 Identities=25% Similarity=0.430 Sum_probs=214.4
Q ss_pred HHHhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
+....|.+.+.||+|+||.||++...++..||+|++.......+++.+|++++.+++||||+++++++.+.+..++||||
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 44567888899999999999999999888999999987666778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+++++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 85 ISNGCLLNYLRSH----GKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp CTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred cCCCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999999654 2358999999999999999999999 89999999999999999999999999999876542
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
. ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||+...... .......+. ....
T Consensus 158 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~--~~~~ 226 (268)
T 3sxs_A 158 Q--YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-------VVLKVSQGH--RLYR 226 (268)
T ss_dssp C--EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTTC--CCCC
T ss_pred h--hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-------HHHHHHcCC--CCCC
Confidence 1 122233456778999999999999999999999999999999 999997543221 111111111 0000
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCC
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIE 782 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~ 782 (852)
+......+.+++.+|++.||.+||++.++++.|+.+.+..
T Consensus 227 --------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 227 --------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp --------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred --------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 1111235678889999999999999999999999987643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=363.53 Aligned_cols=269 Identities=22% Similarity=0.349 Sum_probs=205.6
Q ss_pred HHHHhcccccccccccccceEEEEEE-----CCCcEEEEEEecCc-ccchHHHHHHHHHhhcccccceeeeeeeeccC--
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVL-----ANRTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLVGFSSEG-- 566 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-- 566 (852)
++....|.+.++||+|+||.||++.+ .+++.||||++... ....+.+.+|++++.+++||||+++++++...
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 34556788899999999999999984 35789999999843 34456799999999999999999999998653
Q ss_pred ceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeec
Q 003059 567 KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDF 646 (852)
Q Consensus 567 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 646 (852)
...++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Df 158 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDF 158 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred CceEEEEEeCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccC
Confidence 46899999999999999996542 358999999999999999999998 89999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCcccccccccc---------chhhH
Q 003059 647 GLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETN---------RKKFS 717 (852)
Q Consensus 647 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~---------~~~l~ 717 (852)
|+++................++..|+|||.+.+..++.++||||||+++|||++|..|+....... .....
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence 999876543322223333457778999999999999999999999999999999999986542110 00001
Q ss_pred HHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 718 LWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 718 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
............ . +.+......+.+++.+||+.||.+||++.||++.|+.+.+
T Consensus 239 ~~~~~~~~~~~~-------~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 239 FHLIELLKNNGR-------L---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHHHHTTCC-------C---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhccCc-------C---CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 111111111110 0 1111223467788999999999999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=353.73 Aligned_cols=257 Identities=28% Similarity=0.476 Sum_probs=211.9
Q ss_pred HhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
...|.+.++||+|+||.||+|...+++.||+|++.......+++.+|++++.+++||||+++++++.+.+..++||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 45677889999999999999999888999999999777777889999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
+++|.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~~~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 159 (269)
T 4hcu_A 89 HGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-- 159 (269)
T ss_dssp TCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH--
T ss_pred CCcHHHHHHhc----CcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccc--
Confidence 99999999643 3358999999999999999999998 89999999999999999999999999999866431
Q ss_pred cceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 658 RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
.........+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+. ..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-------~~~~~~~~~-----~~- 226 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTGF-----RL- 226 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTC-----CC-
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhcCc-----cC-
Confidence 1112223446778999999999999999999999999999999 999997543211 111111110 00
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
..+......+.+++.+|++.||.+||++.++++.|+++.+
T Consensus 227 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 227 ----YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 0111112356788889999999999999999999998764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=356.98 Aligned_cols=261 Identities=26% Similarity=0.401 Sum_probs=207.8
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecC-cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEG-IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
..+.+.++||+|+||.||++... +++.||+|++.. .....+.|.+|++++.+++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 46777889999999999999975 588999998863 3445678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 90 ~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 90 KGGTLRGIIKSM----DSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp TTCBHHHHHHHC----CTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred CCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999653 3458999999999999999999999 899999999999999999999999999998764322
Q ss_pred Ccce-----------eeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHh
Q 003059 657 HRHR-----------TLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFE 725 (852)
Q Consensus 657 ~~~~-----------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 725 (852)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|..|+............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~-------- 234 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL-------- 234 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB--------
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh--------
Confidence 1110 111456999999999999999999999999999999999999998654322111000
Q ss_pred hCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 726 KGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
......+..... .....+.+++.+|++.||++||++.++++.|+.+...
T Consensus 235 --~~~~~~~~~~~~-----~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 235 --NVRGFLDRYCPP-----NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp --CHHHHHHHTCCT-----TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --hhhccccccCCC-----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 000011111100 1112466788899999999999999999999988643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=379.44 Aligned_cols=262 Identities=26% Similarity=0.436 Sum_probs=213.4
Q ss_pred HHHHhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
++....+.+.++||+|+||.||+|.+.++..||||+++......++|.+|+.++++++||||+++++++. .+..++|||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 4555677888999999999999999988899999999876667789999999999999999999999987 567899999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++|+|.+++.... ...+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 263 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CCTTCBHHHHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred ecCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 999999999996432 2357889999999999999999999 8999999999999999999999999999987643
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
.. ........++..|+|||.+....++.++||||||+++|||++ |+.||....... ....+..+..
T Consensus 337 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~---- 403 (454)
T 1qcf_A 337 NE--YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALERGYR---- 403 (454)
T ss_dssp HH--HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHHHTCC----
T ss_pred Cc--eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC----
Confidence 11 111123346788999999999999999999999999999999 999997543211 1111111110
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCC
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIE 782 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~ 782 (852)
+ +.+......+.+++.+||+.||++||++.+|++.|+.+....
T Consensus 404 ---~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 404 ---M---PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp ---C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred ---C---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 0 111112345678889999999999999999999999986543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=366.80 Aligned_cols=263 Identities=26% Similarity=0.392 Sum_probs=210.3
Q ss_pred HHhcccccccccccccceEEEEEEC--------CCcEEEEEEecCcc--cchHHHHHHHHHhhcc-cccceeeeeeeecc
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLA--------NRTVVAVKQLEGIE--QGEKQFRMEVATISST-HHLNLVRLVGFSSE 565 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~--~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~ 565 (852)
....|.+.+.||+|+||.||+|... ++..||||+++... ...+++.+|+++++++ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3456778899999999999999852 34679999997432 3446789999999999 89999999999999
Q ss_pred CceeeEEEeecCCCCHHHHhhhccc-----------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceE
Q 003059 566 GKHRLLVYEFMKNGSLDNFLFANEE-----------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENIL 634 (852)
Q Consensus 566 ~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIL 634 (852)
.+..++||||+++|+|.+++..... .....+++..++.++.||++||+|||+ ++|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEE
Confidence 9999999999999999999976432 112458999999999999999999999 89999999999999
Q ss_pred eCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccc
Q 003059 635 LDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNR 713 (852)
Q Consensus 635 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~ 713 (852)
|+.++.+||+|||+++........ .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.......
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~- 313 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 313 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTT-CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-
T ss_pred ECCCCCEEEccccCCcccCcccce-ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-
Confidence 999999999999999876543221 11223457789999999999999999999999999999999 999997543221
Q ss_pred hhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 714 KKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 714 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
+ ...+..+... ..+......+.+++.+||+.||.+||++.||++.|+.+..
T Consensus 314 --~----~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 314 --L----FKLLKEGHRM----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp --H----HHHHHTTCCC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --H----HHHHhcCCCC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1 1111111110 1111223457788899999999999999999999998764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=381.20 Aligned_cols=261 Identities=28% Similarity=0.421 Sum_probs=214.7
Q ss_pred HHHHhcccccccccccccceEEEEEECC-CcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
++....+.+.++||+|+||.||+|.+.. +..||||+++......++|.+|+.++++++||||++++++|.+.+..+|||
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 4556678888999999999999999865 789999999876667788999999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+++|+|.+++.... ...+++..++.++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 296 E~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 296 EFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp ECCTTCBHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EccCCCCHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 9999999999996542 3458999999999999999999999 899999999999999999999999999998764
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcccc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI 732 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (852)
... ........+++.|+|||.+....++.++||||||+++|||++ |+.||....... ....+..+..
T Consensus 370 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~--- 437 (495)
T 1opk_A 370 GDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYR--- 437 (495)
T ss_dssp TCC--EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHHHHHTTCC---
T ss_pred CCc--eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC---
Confidence 321 112223446788999999999999999999999999999999 999997543221 1111111110
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
+ ..+......+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 438 ----~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 438 ----M---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp ----C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred ----C---CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 0 1111222456788899999999999999999999998754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=352.74 Aligned_cols=248 Identities=21% Similarity=0.335 Sum_probs=203.1
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecC-cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEG-IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
..|.+.++||+|+||.||+|.. .+++.||||++.. .....+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 99 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence 4678889999999999999985 5688999999873 3445667899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 100 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp TTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999542 48899999999999999999999 899999999999999999999999999998765432
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .......... .
T Consensus 171 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~~~------~ 235 (297)
T 3fxz_A 171 S---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTP------E 235 (297)
T ss_dssp C---CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCSC------C
T ss_pred c---ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCC------C
Confidence 2 23345799999999999999999999999999999999999999975432111 0111111100 0
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+ ..+......+.+++.+||+.||++||++.|+++
T Consensus 236 ~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 236 L---QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp C---SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C---CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 111122235678889999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=375.89 Aligned_cols=264 Identities=30% Similarity=0.443 Sum_probs=209.8
Q ss_pred HHHHhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
++....+.+.++||+|+||.||+|.+.++..||||+++......++|.+|++++++++||||+++++++.+ +..++|||
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 34556778889999999999999999888889999998665667889999999999999999999999977 67899999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++|+|.+++.... ...+++..++.++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++....
T Consensus 259 ~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 259 YMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CCTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred hhcCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 999999999996432 2458999999999999999999999 8999999999999999999999999999987643
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
.. ........++..|+|||.+....++.++||||||+++|||++ |+.||....... ....+..+..
T Consensus 333 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~---- 399 (452)
T 1fmk_A 333 NE--YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYR---- 399 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC----
T ss_pred Cc--eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC----
Confidence 21 112233457889999999999999999999999999999999 999997543211 1111121110
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCCCC
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKP 784 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~~~ 784 (852)
+ +.+......+.+++.+||+.||++||++.+|++.|+.+.....+
T Consensus 400 ---~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 400 ---M---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp ---C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred ---C---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 0 11112234567888999999999999999999999998765443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=354.85 Aligned_cols=267 Identities=22% Similarity=0.307 Sum_probs=200.2
Q ss_pred HHhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhc--ccccceeeeeeeecc----Cceee
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISS--THHLNLVRLVGFSSE----GKHRL 570 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~--l~h~niv~l~g~~~~----~~~~~ 570 (852)
....|.+.++||+|+||.||+|.. +++.||||++... ....+..|.+++.. ++||||+++++++.+ ....+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 345778889999999999999988 6788999999743 33455556666555 899999999998654 45689
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhcccc-----CCCcccCCCCCCceEeCCCCceEEee
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC-----RDCIVHCDIKPENILLDENYNAKVSD 645 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dlkp~NILl~~~~~~kl~D 645 (852)
+||||+++|+|.+++. ...+++..+++++.||+.||+|||... .++|+||||||+|||++.++.+||+|
T Consensus 83 lv~e~~~~g~L~~~l~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHT------TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EehhhccCCCHHHHHh------hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEee
Confidence 9999999999999994 235899999999999999999999210 18999999999999999999999999
Q ss_pred cccccccCCCCCcce-eeeeecCCCCCCChhhhhcC------CCCCCccchhhhHHHHHHHhC----------Ccccccc
Q 003059 646 FGLAKLINPKDHRHR-TLTSVRGTRGYLAPEWLANL------PITSKSDVYSYGMVLLEIVSG----------RRNFEVS 708 (852)
Q Consensus 646 FGla~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~------~~s~ksDv~s~Gvvl~elltG----------~~p~~~~ 708 (852)
||+++.......... ......||+.|+|||.+.+. .++.++||||||+++|||++| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 999986644322211 12234799999999999876 445799999999999999999 7787544
Q ss_pred ccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 709 QETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 709 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
....... .... ..... ....+.+.....+......+.+++.+||+.||.+|||+.+|++.|+++
T Consensus 237 ~~~~~~~-~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDPSF-EDMR-KVVCV----DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSCCH-HHHH-HHHTT----SCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcch-hhhh-HHHhc----cCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 3222111 1111 11111 011111111112234567788999999999999999999999999865
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=352.21 Aligned_cols=260 Identities=23% Similarity=0.378 Sum_probs=210.7
Q ss_pred HHHHhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
++....|.+.++||+|+||.||++...++..||+|++.......+++.+|++++.+++||||+++++++.+.+..++|||
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 34556788889999999999999999998899999999776677889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++++|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 100 YMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCTTCBHHHHHHCG----GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred ccCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999643 2358999999999999999999999 8999999999999999999999999999987643
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
. .........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+.
T Consensus 173 ~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~----- 238 (283)
T 3gen_A 173 D--EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQGL----- 238 (283)
T ss_dssp H--HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTTC-----
T ss_pred c--ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH-------HHHHHhccc-----
Confidence 1 1111223346778999999999999999999999999999998 999997543211 111111110
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
.... +......+.+++.+|++.+|.+||++.++++.|+++.+
T Consensus 239 ~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 239 RLYR-----PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CCCC-----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC-----CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 0000 11112356788899999999999999999999988754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=353.36 Aligned_cols=258 Identities=21% Similarity=0.311 Sum_probs=207.5
Q ss_pred ccCHHHHHHhcc------------cccccccccccceEEEEEEC-CCcEEEEEEecC-cccchHHHHHHHHHhhcccccc
Q 003059 490 QFSYKELQRSTK------------GFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEG-IEQGEKQFRMEVATISSTHHLN 555 (852)
Q Consensus 490 ~~~~~el~~~~~------------~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~-~~~~~~~f~~E~~~l~~l~h~n 555 (852)
.++++++..++. .+.++||+|+||.||+|... +++.||||++.. .....+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 467777766653 34568999999999999976 689999999973 3445677899999999999999
Q ss_pred eeeeeeeeccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEe
Q 003059 556 LVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL 635 (852)
Q Consensus 556 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl 635 (852)
|+++++++...+..++||||+++++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||+
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll 174 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILL 174 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEE
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEE
Confidence 99999999999999999999999999999842 358999999999999999999999 899999999999999
Q ss_pred CCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchh
Q 003059 636 DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKK 715 (852)
Q Consensus 636 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~ 715 (852)
+.++.+||+|||+++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~--- 248 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVP---KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--- 248 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---
T ss_pred CCCCcEEEeeeeeeeecccCcc---ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---
Confidence 9999999999999987654211 2234579999999999999999999999999999999999999997543211
Q ss_pred hHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 716 FSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 716 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
....+..... +.+.. .......+.+++.+|++.||++||++.++++.
T Consensus 249 ----~~~~~~~~~~-----~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 249 ----AMKRLRDSPP-----PKLKN---SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp ----HHHHHHHSSC-----CCCTT---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----HHHHHhcCCC-----CCcCc---cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111111 11110 11112346778889999999999999999863
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=354.04 Aligned_cols=252 Identities=26% Similarity=0.388 Sum_probs=199.3
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
..|.+.++||+|+||.||+|... +++.||||++... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 35778899999999999999975 6889999998632 23346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+++++|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 87 ~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 87 CSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred CCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 9999999998532 358999999999999999999998 89999999999999999999999999999865422
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCC-CCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPI-TSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
. .........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......... . ......... ..
T Consensus 159 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~-----~~~~~~~~~--~~ 229 (323)
T 3tki_A 159 N-RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-Y-----SDWKEKKTY--LN 229 (323)
T ss_dssp T-EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-H-----HHHHTTCTT--ST
T ss_pred C-cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-H-----HHHhccccc--CC
Confidence 1 1122334679999999999988775 77899999999999999999999755432111 1 111111000 00
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
........+.+++.+||+.||.+||++.|+++.
T Consensus 230 -------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 -------PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 001112355688899999999999999999764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=369.83 Aligned_cols=260 Identities=27% Similarity=0.398 Sum_probs=207.6
Q ss_pred HHHhcccccccccccccceEEEEEEC-CCcEEEEEEecCcc--cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
+....+.+.++||+|+||.||+|.+. +++.||||.+.... ...++|.+|++++++++||||+++++++.+.+..++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 44556778899999999999999986 68899999987432 2345788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++|+|.+++... +..+++..++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 191 ~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTE----GARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 9999999999999643 2358899999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
..... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+..
T Consensus 264 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~-- 333 (377)
T 3cbl_A 264 ADGVY-AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------TREFVEKGGR-- 333 (377)
T ss_dssp TTSEE-ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-------HHHHHHTTCC--
T ss_pred CCCce-eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC--
Confidence 32110 000111234678999999999999999999999999999998 999997543211 1111111110
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
+ +.+......+.+++.+||+.||++||++.+|++.|+.+.+
T Consensus 334 -----~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 334 -----L---PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp -----C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----C---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 0 1111122356778899999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=343.54 Aligned_cols=264 Identities=26% Similarity=0.371 Sum_probs=205.6
Q ss_pred HHhcccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeE
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLL 571 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 571 (852)
...+|.+.++||+|+||.||++... +++.||+|.+... ....+.|.+|+.++.+++||||+++++++.+++..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 3456888899999999999999964 5889999998532 2234678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
||||+++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 89 v~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKA 160 (294)
T ss_dssp EEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred EEeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence 99999999999999643 358999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
..... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ...... ......
T Consensus 161 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~-~~~~~~ 231 (294)
T 4eqm_A 161 LSETS--LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHI-QDSVPN 231 (294)
T ss_dssp C---------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHH-SSCCCC
T ss_pred ccccc--ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHh-hccCCC
Confidence 64321 122334569999999999999999999999999999999999999997543211 011111 111111
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcCccCCC
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP-MMGKVVQMLEGITEIEK 783 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-t~~ev~~~L~~~~~~~~ 783 (852)
.... .. ......+.+++.+|++.||.+|| +++++.+.|+.+.....
T Consensus 232 ~~~~-~~-----~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 232 VTTD-VR-----KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp HHHH-SC-----TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred cchh-cc-----cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 1000 00 11123567888999999999998 99999999998765443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=349.84 Aligned_cols=267 Identities=16% Similarity=0.199 Sum_probs=209.8
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCcccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEEEeec
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
..|.+.+.||+|+||.||+|.. .+++.||||.+.... ..+++.+|+++++++ +||||+++++++.+++..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 3577789999999999999996 568899999987432 345689999999999 9999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCc-----eEEeecccccc
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYN-----AKVSDFGLAKL 651 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----~kl~DFGla~~ 651 (852)
+++|.+++... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||+++.
T Consensus 88 -~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 88 -GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp -CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred -CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99999999653 3468999999999999999999999 89999999999999999887 99999999987
Q ss_pred cCCCCCcce----eeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhC
Q 003059 652 INPKDHRHR----TLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG 727 (852)
Q Consensus 652 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (852)
+........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 643322111 1235679999999999999999999999999999999999999998654322211111111110000
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCCCCC
Q 003059 728 NVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPP 785 (852)
Q Consensus 728 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~~~~ 785 (852)
. .+.... .. ..+.+++.+|++.||.+||++.+|++.|+++.+.....
T Consensus 240 ~----~~~~~~--~~-----p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~ 286 (330)
T 2izr_A 240 P----IEVLCE--NF-----PEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYM 286 (330)
T ss_dssp C----HHHHTT--TC-----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred C----HHHHhc--cC-----hHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 0 000000 01 16778888999999999999999999999876544433
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=348.20 Aligned_cols=264 Identities=28% Similarity=0.407 Sum_probs=217.0
Q ss_pred CHHHHHHhcccccccccccccceEEEEEECC-CcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceee
Q 003059 492 SYKELQRSTKGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRL 570 (852)
Q Consensus 492 ~~~el~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 570 (852)
...++....+.+.++||+|+||.||+|.... +..||+|.+.......+++.+|++++++++||||+++++++.+.+..+
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 3445667788889999999999999999764 788999999877667788999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+||||+++++|.+++.... ...+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++.
T Consensus 86 ~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp EEEECCTTEEHHHHHHHCC---TTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred EEEEcCCCCcHHHHHHhcc---cCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccce
Confidence 9999999999999996543 3458999999999999999999999 799999999999999999999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCc
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
..... .........+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ ........
T Consensus 160 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~-------~~~~~~~~- 229 (288)
T 3kfa_A 160 LMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLEKDY- 229 (288)
T ss_dssp TSCSS--SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-------HHHHHTTC-
T ss_pred eccCC--ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHhccC-
Confidence 76542 2223334557889999999999999999999999999999999 9999975432211 11111110
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 730 KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
.. ..+......+.+++.+|++.||.+||++.+|++.|+.+..
T Consensus 230 ----~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 230 ----RM-----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp ----CC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CC-----CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 00 1111122457788889999999999999999999987653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=355.03 Aligned_cols=259 Identities=23% Similarity=0.384 Sum_probs=202.0
Q ss_pred HHHhcccccccccccccceEEEEEEC-CCc----EEEEEEecC--cccchHHHHHHHHHhhcccccceeeeeeeeccCce
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLA-NRT----VVAVKQLEG--IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKH 568 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 568 (852)
+....|.+.++||+|+||.||+|.+. +++ .||+|.+.. .....++|.+|+.++++++||||++++++|.+..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 34456788899999999999999964 333 468888863 2345678999999999999999999999998764
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.++|+||+++|+|.+++... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 163 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHS----TTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred eEEEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcc
Confidence 78999999999999999754 2358999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhC
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKG 727 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (852)
++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ ......+
T Consensus 164 a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~~~~~~~ 235 (327)
T 3poz_A 164 AKLLGAEEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKG 235 (327)
T ss_dssp HHHHTTTCC--------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHHTT
T ss_pred eeEccCCcc-cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH-------HHHHHcC
Confidence 987754322 122234557889999999999999999999999999999999 9999975433211 1111111
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 728 NVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 728 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
.. . ..+......+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 236 ~~-------~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 236 ER-------L---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CC-------C---CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CC-------C---CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 10 0 1112223467788999999999999999999999988754
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=340.94 Aligned_cols=222 Identities=20% Similarity=0.226 Sum_probs=177.8
Q ss_pred hccccccccCCCCccccCCCCCccccCCCceEEEEEecCCCCeeEEEEE-eCCeeEEeeCC-CCCCC-----CceEEEee
Q 003059 25 NFISSFADISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITY-SGGVPIWTAGS-TPVDS-----SAFFQLHS 97 (852)
Q Consensus 25 ~~~~~~~~~~~~~~l~~~~~~~~l~S~~g~f~lgf~~~~~~~~~~~i~~-~~~~~vW~an~-~p~~~-----~~~l~~~~ 97 (852)
.++++.|+|++|++|++++ +|+|++|.|+||||.+ +++|+ | +.+ +||+||| .|+.. +++|+|+.
T Consensus 9 ~~~~~~~~l~~g~~l~~~~---~l~S~~g~F~lgf~~~--~~~~l---y~~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~ 79 (276)
T 3m7h_A 9 FNGVGTSVLPAYQTLSAGQ---YLLSPNQRFKLLLQGD--GNLVI---QDNGA-TVWVANEQQPFSSTIPLRNKKAPLAF 79 (276)
T ss_dssp CCCTTSSEECTTEEBCTTC---EEECTTSSEEEEECTT--SCEEE---EETTE-EEEECSTTSTTEEEEECCCTTCCSEE
T ss_pred eccccCCEecCCCEecCCC---EEEcCCCcEEEEEECC--CCeEE---ECCCC-eEEECCCCCCcCCcccccceEEEEeC
Confidence 3567789999999999987 9999999999999943 35666 6 555 9999998 68843 78999999
Q ss_pred CccEEE--EcCCCceEeeccCCC------CceeEEEEcCCccEEEecCCCccccccCCCCCCcccCCCc----cccCcc-
Q 003059 98 SGTLRL--ISGSGAIIWDSNTQR------LNVTSASLDDSGNLVLLKNGGVSAWSSFDNPTDTIVPSQN----FTSDKT- 164 (852)
Q Consensus 98 ~g~l~l--~~~~~~~vWst~~~~------~~~~~~~l~d~GNlvl~~~~~~~lWQSFD~PTDtlLpg~k----l~~~~~- 164 (852)
|||||| .|++|.+||+|+++. ..+..|+|+|+|||||+| +.+|||| ||||||||||| |..+.+
T Consensus 80 ~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~~~lWqS--~ptdtlLpg~~~~~~l~~g~~L 155 (276)
T 3m7h_A 80 YVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--SLALWNG--TPAIPLVPGAIDSLLLAPGSEL 155 (276)
T ss_dssp EESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--EEEEEES--CTTSCCCCSCTTCEEECSSEEE
T ss_pred CCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--CceeeCc--ccccccccccccccccccCccc
Confidence 999999 788899999999765 345689999999999998 7899999 99999999999 544443
Q ss_pred -----ccccceEEEeecCCceeeeecCceeeeccCcccccccccccccccceeeeccCcceeeeeccCCcceEEEeeccc
Q 003059 165 -----LRSGYYSFTLLKSGNLSLKWNDSVVYFNQGLNSAINSTVNSNLTSPILRLQPVGILSISDVSLNSAAIIAYSSDY 239 (852)
Q Consensus 165 -----l~sG~~sl~~~~~g~~~~~~~~~~~yw~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (852)
+++|.|++.++++|+++++++++.+||++++++.. ...+.++.+|.+.+++... ....++...
T Consensus 156 ~S~~dps~G~fsl~l~~dGnlvLy~~~~~~yW~Sgt~~~~---------~~~l~l~~dGnLvl~d~~~---~~vWsS~t~ 223 (276)
T 3m7h_A 156 VQGVVYGAGASKLVFQGDGNLVAYGPNGAATWNAGTQGKG---------AVRAVFQGDGNLVVYGAGN---AVLWHSHTG 223 (276)
T ss_dssp CTTCEEEETTEEEEECTTSCEEEECTTSSEEEECCCTTTT---------CCEEEECTTSCEEEECTTS---CEEEECSCT
T ss_pred ccCCCCCCceEEEeecCCceEEEEeCCCeEEEECCCCCCc---------cEEEEEcCCCeEEEEeCCC---cEEEEecCC
Confidence 45599999999999988887778999999987531 1356788888888876533 122333222
Q ss_pred CCCcceEEEEEEccCCcEEEEEccCCCCcceeeehhhh
Q 003059 240 AEGSDILRFLSLGSDGNLRIFSSARGSGTKTRRWAAVA 277 (852)
Q Consensus 240 ~~~~~~~~r~~l~~dG~l~~~~w~~~~~~w~~~~~~p~ 277 (852)
. . ..+|++|+.||+|++|.| ...|..+|.+|+
T Consensus 224 ~-~--~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~ 255 (276)
T 3m7h_A 224 G-H--ASAVLRLQANGSIAILDE---KPVWARFGFQPT 255 (276)
T ss_dssp T-C--TTCEEEECTTSCEEEEEE---EEEEESSSCCTT
T ss_pred C-C--CCEEEEEcCCccEEEEcC---CCeEEccCccCC
Confidence 2 1 237999999999999999 357888887764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=353.13 Aligned_cols=246 Identities=22% Similarity=0.340 Sum_probs=201.5
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
..|.+.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 94 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME 94 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence 3577889999999999999997 578999999997432 334668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++++|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 95 YASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred CCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999654 248899999999999999999999 8999999999999999999999999999987643
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCC-CCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPIT-SKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
.. ......||+.|+|||.+.+..+. .++|||||||++|||++|+.||....... .......+..
T Consensus 167 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~~---- 231 (328)
T 3fe3_A 167 GG----KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE-------LRERVLRGKY---- 231 (328)
T ss_dssp SC----GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC----
T ss_pred CC----ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC----
Confidence 22 22345699999999999988875 79999999999999999999997543211 1111111111
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
..+......+.+++.+|++.||.+|||++|+++.
T Consensus 232 -------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 -------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0111122356678889999999999999999863
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=368.60 Aligned_cols=254 Identities=29% Similarity=0.402 Sum_probs=205.7
Q ss_pred HHHhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCc-eeeEEEe
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK-HRLLVYE 574 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~e 574 (852)
+....+.+.++||+|+||.||+|.+. ++.||||+++... ..+.|.+|+.++++++||||+++++++.+.. ..++|||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 34456777889999999999999986 6789999998543 5678999999999999999999999987665 7899999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++|+|.+++.... ...+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 268 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp CCTTCBHHHHHHHHC---TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred ecCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 999999999997542 2347899999999999999999999 8999999999999999999999999999985432
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||........ ...+..+..
T Consensus 342 ~------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~-------~~~i~~~~~---- 404 (450)
T 1k9a_A 342 T------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRVEKGYK---- 404 (450)
T ss_dssp -----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH-------HHHHHTTCC----
T ss_pred c------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCC----
Confidence 1 122357889999999999999999999999999999998 9999975432211 111122111
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
+ ..+......+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 405 ---~---~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 405 ---M---DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp ---C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---C---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 0 1111123456788889999999999999999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=343.28 Aligned_cols=270 Identities=22% Similarity=0.285 Sum_probs=210.6
Q ss_pred hcccccccccccccceEEEEEECC-CcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCc--eeeEEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK--HRLLVY 573 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV~ 573 (852)
..|.+.++||+|+||.||+|.... ++.||||++... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 467788999999999999999754 889999999743 234577889999999999999999999987655 779999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEe----CCCCceEEeecccc
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL----DENYNAKVSDFGLA 649 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~DFGla 649 (852)
||+++++|.+++..... ...+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 89 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp ECCTTCBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred eCCCCCCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999975432 2348999999999999999999999 899999999999999 88889999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCChhhhh--------cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHH
Q 003059 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLA--------NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAY 721 (852)
Q Consensus 650 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 721 (852)
+...... ......||+.|+|||.+. +..++.++||||||+++|||++|+.||.......... ....
T Consensus 164 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~ 237 (319)
T 4euu_A 164 RELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--EVMY 237 (319)
T ss_dssp EECCTTC----CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH--HHHH
T ss_pred eecCCCC----ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH--HHHH
Confidence 8765432 223456999999999986 5788999999999999999999999997543322111 1111
Q ss_pred HHHhhC---Cccccc---------c-cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 722 EEFEKG---NVKGIV---------D-KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 722 ~~~~~~---~~~~~~---------d-~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
...... ....+. . ...............+.+++.+||+.||++||+++|+++...+..
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 111111 111000 0 011111344556667889999999999999999999999887543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=362.66 Aligned_cols=268 Identities=27% Similarity=0.388 Sum_probs=214.5
Q ss_pred HHHHhcccccccccccccceEEEEEEC--------CCcEEEEEEecCc--ccchHHHHHHHHHhhcc-cccceeeeeeee
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLA--------NRTVVAVKQLEGI--EQGEKQFRMEVATISST-HHLNLVRLVGFS 563 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l-~h~niv~l~g~~ 563 (852)
++....+.+.++||+|+||.||+|... .+..||||++... ....+++.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 556678888999999999999999852 2357999999743 23346789999999999 999999999999
Q ss_pred ccCceeeEEEeecCCCCHHHHhhhccc-----------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCc
Q 003059 564 SEGKHRLLVYEFMKNGSLDNFLFANEE-----------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPEN 632 (852)
Q Consensus 564 ~~~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 632 (852)
.+.+..++||||+++|+|.+++..... .....+++..++.++.||+.||+|||+ .+|+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcce
Confidence 999999999999999999999976532 112469999999999999999999999 899999999999
Q ss_pred eEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccc
Q 003059 633 ILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQET 711 (852)
Q Consensus 633 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~ 711 (852)
|||+.++.+||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTT-CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred EEEcCCCcEEEcccCccccccccccc-ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999876543221 12233457889999999999999999999999999999999 99999754321
Q ss_pred cchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCCC
Q 003059 712 NRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEK 783 (852)
Q Consensus 712 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~~ 783 (852)
. ....+..+.... .+......+.+++.+||+.||.+||++.+|++.|+.+.....
T Consensus 301 ~-------~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 301 E-------LFKLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp H-------HHHHHHTTCCCC----------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred H-------HHHHHHcCCCCC----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 1 111122211111 111122357788899999999999999999999999876543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=357.35 Aligned_cols=283 Identities=16% Similarity=0.218 Sum_probs=213.1
Q ss_pred HHHhcccccccccccccceEEEEEECC------CcEEEEEEecCccc------------chHHHHHHHHHhhccccccee
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQLEGIEQ------------GEKQFRMEVATISSTHHLNLV 557 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~------------~~~~f~~E~~~l~~l~h~niv 557 (852)
+....|.+.++||+|+||.||+|.+.. ++.||||++..... ....+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 444578889999999999999999754 47899999874321 112344566677888999999
Q ss_pred eeeeeeccC----ceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCce
Q 003059 558 RLVGFSSEG----KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENI 633 (852)
Q Consensus 558 ~l~g~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI 633 (852)
++++++.+. ...+|||||+ +++|.+++... ...+++..++.++.||+.||+|||+ .+|+||||||+||
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Ni 183 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN----AKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNL 183 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGE
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHE
Confidence 999998764 4689999999 99999999653 3459999999999999999999999 8999999999999
Q ss_pred EeC--CCCceEEeecccccccCCCCCc----ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccc
Q 003059 634 LLD--ENYNAKVSDFGLAKLINPKDHR----HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEV 707 (852)
Q Consensus 634 Ll~--~~~~~kl~DFGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~ 707 (852)
||+ .++.+||+|||+++.+...... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999 8999999999999876432111 1111335599999999999999999999999999999999999999985
Q ss_pred cccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCCCCCCC
Q 003059 708 SQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPPAP 787 (852)
Q Consensus 708 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~~~~~~ 787 (852)
..... .......... ...+..++++.+.....+ ..+.+++.+|++.+|.+||++.+|++.|+.+.+.......
T Consensus 264 ~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~~~----~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~ 336 (364)
T 3op5_A 264 NLKDP--KYVRDSKIRY-RENIASLMDKCFPAANAP----GEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDD 336 (364)
T ss_dssp GTTCH--HHHHHHHHHH-HHCHHHHHHHHSCTTCCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCC
T ss_pred cccCH--HHHHHHHHHh-hhhHHHHHHHhcccccCH----HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcC
Confidence 43221 1111111111 123344444444321222 3566778889999999999999999999988766555554
Q ss_pred CccccC
Q 003059 788 KALTEG 793 (852)
Q Consensus 788 ~~~~~~ 793 (852)
....+.
T Consensus 337 ~~~dw~ 342 (364)
T 3op5_A 337 GKLDLS 342 (364)
T ss_dssp CCCCC-
T ss_pred CccceE
Confidence 444444
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=349.51 Aligned_cols=284 Identities=21% Similarity=0.302 Sum_probs=208.4
Q ss_pred CCCcccCHHHHHHhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeecc
Q 003059 486 GAPVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSE 565 (852)
Q Consensus 486 ~~~~~~~~~el~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~ 565 (852)
+....+...+.....|.+.++||+|+||.||+|... ++.||||++..........+.|+.....++||||+++++++.+
T Consensus 24 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 24 GSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp CSSSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CCCCCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 334445566677788999999999999999999886 7889999987443333233334444444599999999999887
Q ss_pred C----ceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhcccc-----CCCcccCCCCCCceEeC
Q 003059 566 G----KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC-----RDCIVHCDIKPENILLD 636 (852)
Q Consensus 566 ~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dlkp~NILl~ 636 (852)
. ...++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.. ..+|+||||||+|||++
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence 7 688999999999999999953 24899999999999999999999821 12899999999999999
Q ss_pred CCCceEEeecccccccCCCCCcce-eeeeecCCCCCCChhhhhcCCCCCC------ccchhhhHHHHHHHhC--------
Q 003059 637 ENYNAKVSDFGLAKLINPKDHRHR-TLTSVRGTRGYLAPEWLANLPITSK------SDVYSYGMVLLEIVSG-------- 701 (852)
Q Consensus 637 ~~~~~kl~DFGla~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k------sDv~s~Gvvl~elltG-------- 701 (852)
.++.+||+|||+++.+........ ......||+.|+|||.+.+.....+ +||||||+++|||++|
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 999999999999987644322111 1123569999999999988777765 9999999999999999
Q ss_pred --CccccccccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 702 --RRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 702 --~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
+.||.......... . ......... ...+.........+....+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus 257 ~~~~p~~~~~~~~~~~-~-~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 257 EYQLPYHDLVPSDPSY-E-DMREIVCIK----KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp CCCCTTTTTSCSSCCH-H-HHHHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccccHhhhcCCCCch-h-hhHHHHhhh----ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 55654332221111 0 011111111 111111111112355677889999999999999999999999999887
Q ss_pred cCC
Q 003059 780 EIE 782 (852)
Q Consensus 780 ~~~ 782 (852)
+..
T Consensus 331 ~~~ 333 (337)
T 3mdy_A 331 ESQ 333 (337)
T ss_dssp HTT
T ss_pred hhc
Confidence 543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=362.22 Aligned_cols=267 Identities=27% Similarity=0.387 Sum_probs=210.0
Q ss_pred HHHHHhcccccccccccccceEEEEEE------CCCcEEEEEEecCcc--cchHHHHHHHHHhhcc-cccceeeeeeeec
Q 003059 494 KELQRSTKGFKDKLGAGGFGAVYRGVL------ANRTVVAVKQLEGIE--QGEKQFRMEVATISST-HHLNLVRLVGFSS 564 (852)
Q Consensus 494 ~el~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~--~~~~~f~~E~~~l~~l-~h~niv~l~g~~~ 564 (852)
.++....|.+.++||+|+||.||+|.+ .+++.||||++.... ...+.+.+|++++.++ +||||+++++++.
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 345567788899999999999999974 235789999997432 3346799999999999 8999999999988
Q ss_pred cCc-eeeEEEeecCCCCHHHHhhhcccC----------------------------------------------------
Q 003059 565 EGK-HRLLVYEFMKNGSLDNFLFANEEG---------------------------------------------------- 591 (852)
Q Consensus 565 ~~~-~~~lV~e~~~~gsL~~~l~~~~~~---------------------------------------------------- 591 (852)
+.+ ..++||||+++|+|.+++......
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 755 589999999999999999764321
Q ss_pred ---------CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcceee
Q 003059 592 ---------SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTL 662 (852)
Q Consensus 592 ---------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 662 (852)
....+++..++.++.||++||+|||+ .+|+||||||+||||+.++.+||+|||+++....... ....
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 252 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRK 252 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-CEEC
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-chhc
Confidence 01238999999999999999999999 8999999999999999999999999999987644322 2233
Q ss_pred eeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcccccccccCCCC
Q 003059 663 TSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGED 741 (852)
Q Consensus 663 ~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 741 (852)
....||+.|+|||.+.+..++.++||||||+++|||++ |+.||........ .......+....
T Consensus 253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~~~~~~---------- 316 (359)
T 3vhe_A 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMR---------- 316 (359)
T ss_dssp --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHHTCCCC----------
T ss_pred cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHHHHcCCCCC----------
Confidence 45668999999999999999999999999999999998 9999975432211 111111111111
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 742 VDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 742 ~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
.+......+.+++.+|++.||.+||++.||++.|+++.+
T Consensus 317 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 317 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 111112356788889999999999999999999988754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=379.62 Aligned_cols=264 Identities=30% Similarity=0.440 Sum_probs=214.0
Q ss_pred HHHHhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
++....+.+.++||+|+||.||+|.+.++..||||+++......++|.+|+++|++++|+||+++++++.+ +..+||||
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 45566788889999999999999999888889999998666667889999999999999999999999977 67899999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++|+|.++|.... ...+++..++.|+.||++||+|||+ ++|+||||||+||||++++.+||+|||+++....
T Consensus 342 ~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 342 YMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CCTTEEHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred hhcCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 999999999996432 2458899999999999999999999 8999999999999999999999999999987643
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
. .........++..|+|||.+....++.++||||||++||||++ |+.||....... ....+..+..
T Consensus 416 ~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~---- 482 (535)
T 2h8h_A 416 N--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYR---- 482 (535)
T ss_dssp H--HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-------HHHHHHTTCC----
T ss_pred C--ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC----
Confidence 1 1111123446788999999999999999999999999999999 999997543211 1111221110
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCCCC
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKP 784 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~~~ 784 (852)
+ ..+......+.+++.+||+.||++||++.+|++.|+.+.....+
T Consensus 483 ---~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 483 ---M---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp ---C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred ---C---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 0 11112234567888999999999999999999999988654433
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=343.68 Aligned_cols=257 Identities=28% Similarity=0.466 Sum_probs=211.2
Q ss_pred HhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
...|.+.+.||+|+||.||++...+++.||+|++.......+++.+|++++.+++||||+++++++.+.+..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 35677889999999999999999888899999998766667889999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
+++|.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-- 157 (267)
T 3t9t_A 87 HGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-- 157 (267)
T ss_dssp TCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH--
T ss_pred CCcHHHHHhhC----cccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccc--
Confidence 99999999653 2358899999999999999999999 89999999999999999999999999999866431
Q ss_pred cceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 658 RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
.........++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+.. ..
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~i~~~~~-----~~ 225 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTGFR-----LY 225 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTCC-----CC
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH-------HHHHHhcCCc-----CC
Confidence 1111123446778999999999999999999999999999999 899997543211 1111111110 00
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
.+......+.+++.+|++.||.+||++.++++.|+++.+
T Consensus 226 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 226 -----KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 011112356788899999999999999999999998764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=347.42 Aligned_cols=257 Identities=27% Similarity=0.435 Sum_probs=198.9
Q ss_pred HhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
...+.+.+.||+|+||.||++... ++.||||++... ...+.|.+|++++++++||||+++++++.+ ..++||||++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 346777899999999999999885 678999999743 345679999999999999999999999874 4899999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCc-eEEeecccccccCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYN-AKVSDFGLAKLINPKD 656 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~-~kl~DFGla~~~~~~~ 656 (852)
+++|.+++..... ...+++..++.++.|+++||+|||+...++|+||||||+|||++.++. +||+|||++.....
T Consensus 83 ~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~-- 158 (307)
T 2eva_A 83 GGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-- 158 (307)
T ss_dssp TCBHHHHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCHHHHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc--
Confidence 9999999965432 335788999999999999999999865568999999999999998886 79999999976532
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... . . .....+.....
T Consensus 159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~--~-~~~~~~~~~~~---- 225 (307)
T 2eva_A 159 ----HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--I--M-WAVHNGTRPPL---- 225 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--H--H-HHHHTTCCCCC----
T ss_pred ----ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--H--H-HHHhcCCCCCc----
Confidence 123346899999999999999999999999999999999999999754322110 0 1 11111111111
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
. ......+.+++.+|++.||.+||++.+|++.|+.+...
T Consensus 226 ~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 226 I------KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp B------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred c------cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 1 11123567788899999999999999999999987653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=363.06 Aligned_cols=265 Identities=31% Similarity=0.412 Sum_probs=209.7
Q ss_pred HHHHhcccccccccccccceEEEEEEC------CCcEEEEEEecC--cccchHHHHHHHHHhhcccccceeeeeeeeccC
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLA------NRTVVAVKQLEG--IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEG 566 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~ 566 (852)
++....+.+.++||+|+||.||+|.+. +++.||||++.. ......++.+|+.++++++||||+++++++.+.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 445567888999999999999999953 456899999974 334456789999999999999999999999999
Q ss_pred ceeeEEEeecCCCCHHHHhhhccc--CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC---ce
Q 003059 567 KHRLLVYEFMKNGSLDNFLFANEE--GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY---NA 641 (852)
Q Consensus 567 ~~~~lV~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~ 641 (852)
...++||||+++|+|.+++..... .....+++..++.++.||++||+|||+ ++|+||||||+||||+.++ .+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceE
Confidence 999999999999999999976432 123468999999999999999999999 8999999999999999555 59
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHH
Q 003059 642 KVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWA 720 (852)
Q Consensus 642 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 720 (852)
||+|||+++....... ........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....... .
T Consensus 224 kL~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-------~ 295 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------V 295 (367)
T ss_dssp EECCCHHHHHHHHHSS-CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------H
T ss_pred EECCCccccccccccc-cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence 9999999985432111 112233557899999999999999999999999999999998 999997543211 1
Q ss_pred HHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 721 YEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 721 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
......+... ..+......+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 296 ~~~i~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 296 LEFVTSGGRM----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCCC----------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 1111111110 0111122356788899999999999999999999987754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=355.79 Aligned_cols=264 Identities=27% Similarity=0.417 Sum_probs=210.4
Q ss_pred HHHhcccccccccccccceEEEEEEC------CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCc
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLA------NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK 567 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~ 567 (852)
+....|.+.+.||+|+||.||+|... +++.||||++... ....+.|.+|++++++++||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34556778899999999999999974 3478999999743 233567999999999999999999999999999
Q ss_pred eeeEEEeecCCCCHHHHhhhcccC-------------------CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCC
Q 003059 568 HRLLVYEFMKNGSLDNFLFANEEG-------------------SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDI 628 (852)
Q Consensus 568 ~~~lV~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl 628 (852)
..++||||+++++|.+++...... ....+++..++.++.||++||+|||+ ++|+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCC
Confidence 999999999999999999764211 12568999999999999999999999 89999999
Q ss_pred CCCceEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccc
Q 003059 629 KPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEV 707 (852)
Q Consensus 629 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~ 707 (852)
||+|||++.++.+||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCcc-ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 99999999999999999999987643211 122234567899999999999999999999999999999999 9999975
Q ss_pred cccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 708 SQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 708 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
..... .......+.... .+......+.+++.+||+.||.+||++.+|++.|+++.+
T Consensus 280 ~~~~~-------~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 280 MAHEE-------VIYYVRDGNILA----------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp SCHHH-------HHHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CChHH-------HHHHHhCCCcCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 43211 111222221111 111112356788899999999999999999999998865
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=345.69 Aligned_cols=260 Identities=30% Similarity=0.466 Sum_probs=210.6
Q ss_pred HHHHhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
++....|.+.+.||+|+||.||+|...+++.||||.+.......+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 87 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence 34456788899999999999999999888899999998666667889999999999999999999999874 56899999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++++|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 88 ~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 88 YMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CCTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 999999999995432 2358999999999999999999999 8999999999999999999999999999987653
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
.. ........++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+.
T Consensus 162 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~----- 227 (279)
T 1qpc_A 162 NE--YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-------VIQNLERGY----- 227 (279)
T ss_dssp SC--EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTC-----
T ss_pred cc--cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH-------HHHHHhccc-----
Confidence 21 112223456788999999998899999999999999999999 999997543211 111111111
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
... .+......+.+++.+|++.||++||++.++++.|+++..
T Consensus 228 ~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 228 RMV-----RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp CCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC-----CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 000 011112456788889999999999999999999998754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=350.68 Aligned_cols=264 Identities=27% Similarity=0.399 Sum_probs=210.9
Q ss_pred HHHhcccccccccccccceEEEEEE------CCCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCc
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVL------ANRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK 567 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~ 567 (852)
+....|.+.+.||+|+||.||++.. .+++.||||++... ....+++.+|++++++++||||+++++++.+.+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 3456778889999999999999985 23578999999743 234467899999999999999999999999999
Q ss_pred eeeEEEeecCCCCHHHHhhhcccC-------------------CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCC
Q 003059 568 HRLLVYEFMKNGSLDNFLFANEEG-------------------SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDI 628 (852)
Q Consensus 568 ~~~lV~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl 628 (852)
..++||||+++++|.+++...... ....+++..++.++.||++||+|||+ .+|+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCccccc
Confidence 999999999999999999764321 12358999999999999999999999 89999999
Q ss_pred CCCceEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccc
Q 003059 629 KPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEV 707 (852)
Q Consensus 629 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~ 707 (852)
||+|||++.++.+||+|||+++....... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDS-YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSC-EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred chheEEEcCCCCEEEcccccccccccccc-ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987654321 112233457888999999999999999999999999999999 9999975
Q ss_pred cccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 708 SQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 708 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
...... ......+... ..+......+.+++.+|++.||.+||++.+|++.|+++..
T Consensus 256 ~~~~~~-------~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 256 IPPERL-------FNLLKTGHRM----------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp CCGGGH-------HHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHH-------HHHhhcCCcC----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 443211 1111111110 1111122457788899999999999999999999988754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=340.75 Aligned_cols=271 Identities=18% Similarity=0.238 Sum_probs=213.0
Q ss_pred HHhcccccccccccccceEEEEEE-CCCcEEEEEEecCcccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEEEe
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e 574 (852)
....|.+.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+.++.++ +|+|++++++++.+....++|||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 345678889999999999999996 568899999986432 345688999999999 89999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCc-----eEEeecccc
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYN-----AKVSDFGLA 649 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----~kl~DFGla 649 (852)
|+ +++|.+++... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||++
T Consensus 87 ~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 87 LL-GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp CC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ec-CCCHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 99 99999999653 2358999999999999999999998 89999999999999987776 999999999
Q ss_pred cccCCCCCcc----eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHh
Q 003059 650 KLINPKDHRH----RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFE 725 (852)
Q Consensus 650 ~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 725 (852)
+......... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 8765432211 123446699999999999999999999999999999999999999986543322221111111111
Q ss_pred hCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCCCCCC
Q 003059 726 KGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPPA 786 (852)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~~~~~ 786 (852)
........ + . ....+.+++.+|++.||.+||++.+|++.|+++.+......
T Consensus 239 ~~~~~~~~-~-----~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~ 289 (298)
T 1csn_A 239 STPLRELC-A-----G----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 289 (298)
T ss_dssp HSCHHHHT-T-----T----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred CccHHHHH-h-----h----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCC
Confidence 11111110 0 1 12356788889999999999999999999998876544433
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=345.21 Aligned_cols=272 Identities=22% Similarity=0.308 Sum_probs=211.4
Q ss_pred cCHHHHHHhcccccccccccccceEEEEEE-----CCCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeee
Q 003059 491 FSYKELQRSTKGFKDKLGAGGFGAVYRGVL-----ANRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFS 563 (852)
Q Consensus 491 ~~~~el~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~ 563 (852)
+...++....+.+.++||+|+||.||++.+ .+++.||||++... ....+.+.+|++++.+++||||+++++++
T Consensus 13 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (302)
T 4e5w_A 13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGIC 92 (302)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence 444455566788889999999999999984 35789999999733 33457899999999999999999999999
Q ss_pred ccC--ceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCce
Q 003059 564 SEG--KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNA 641 (852)
Q Consensus 564 ~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 641 (852)
.+. ...++||||+++++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+
T Consensus 93 ~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~ 165 (302)
T 4e5w_A 93 TEDGGNGIKLIMEFLPSGSLKEYLPKN----KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQV 165 (302)
T ss_dssp EC---CCEEEEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEE
T ss_pred ecCCCceEEEEEEeCCCCcHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCE
Confidence 876 6789999999999999999543 2358999999999999999999999 899999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccc--------cc
Q 003059 642 KVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQET--------NR 713 (852)
Q Consensus 642 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~--------~~ 713 (852)
||+|||+++................+|..|+|||.+.+..++.++||||||+++|||++|+.|+...... ..
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 245 (302)
T 4e5w_A 166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG 245 (302)
T ss_dssp EECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCG
T ss_pred EECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccc
Confidence 9999999988765433323334456888899999999999999999999999999999999987533110 00
Q ss_pred hhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 714 KKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 714 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
.............+... ..+......+.+++.+|++.||.+||++.++++.|+.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 246 QMTVTRLVNTLKEGKRL----------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp GGHHHHHHHHHHTTCCC----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHhccCCC----------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 00000111111111100 111122346778899999999999999999999998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=355.85 Aligned_cols=267 Identities=24% Similarity=0.308 Sum_probs=209.2
Q ss_pred HhcccccccccccccceEEEEEE-----CCCcEEEEEEecCc-ccchHHHHHHHHHhhcccccceeeeeeeec--cCcee
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVL-----ANRTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLVGFSS--EGKHR 569 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~--~~~~~ 569 (852)
...|.+.++||+|+||.||++.+ .+++.||||++... ....+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35678889999999999999984 35789999999743 344567999999999999999999999876 55678
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
++||||+++++|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred EEEEeecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccc
Confidence 99999999999999996532 358999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccch--------hhHHHHH
Q 003059 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRK--------KFSLWAY 721 (852)
Q Consensus 650 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~--------~l~~~~~ 721 (852)
+................+|..|+|||.+.+..++.++||||||+++|||++|+.||......... .......
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 88755433323334456888899999999999999999999999999999999998654321100 0000001
Q ss_pred HHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 722 EEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 722 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
.....+ ... ..+......+.+++.+|++.||.+||++.+|++.|+.+...
T Consensus 255 ~~~~~~---------~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 255 ELLEEG---------QRL-PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHHHTT---------CCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred HHhhcc---------cCC-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 111111 100 11222234577888999999999999999999999988543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=341.16 Aligned_cols=250 Identities=29% Similarity=0.414 Sum_probs=192.8
Q ss_pred HhcccccccccccccceEEEEEECCCcEEEEEEecCcc-----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIE-----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
...|.+.++||+|+||.||+|... ++.||||++.... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 346778899999999999999975 7889999987332 2346789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCC---cccCCCCCCceEeCC--------CCce
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC---IVHCDIKPENILLDE--------NYNA 641 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~---ivH~Dlkp~NILl~~--------~~~~ 641 (852)
|||+++++|.+++. ...+++..++.++.|+++||+|||+ .+ |+||||||+|||++. ++.+
T Consensus 85 ~e~~~~~~L~~~~~------~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 85 MEFARGGPLNRVLS------GKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp EECCTTEEHHHHHT------SSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred EEcCCCCCHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcce
Confidence 99999999999984 3358999999999999999999999 56 999999999999986 7789
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHH
Q 003059 642 KVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAY 721 (852)
Q Consensus 642 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 721 (852)
||+|||+++..... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ .
T Consensus 156 kl~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~ 223 (271)
T 3dtc_A 156 KITDFGLAREWHRT-----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-------A 223 (271)
T ss_dssp EECCCCC------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH-------H
T ss_pred EEccCCcccccccc-----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------H
Confidence 99999999865432 12245689999999999999999999999999999999999999975432110 1
Q ss_pred HHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 722 EEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 722 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
.......... ..+......+.+++.+|++.||.+||++.|+++.|+.+
T Consensus 224 ~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 224 YGVAMNKLAL---------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHHTSCCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HhhhcCCCCC---------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1111111110 11111224577888999999999999999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=344.15 Aligned_cols=259 Identities=25% Similarity=0.373 Sum_probs=196.7
Q ss_pred HHHHhcccccccccccccceEEEEEECC----CcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCce
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLAN----RTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKH 568 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 568 (852)
++....|.+.+.||+|+||.||+|.... +..||+|.+... ....+.+.+|+.++++++||||+++++++. ++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 3455678889999999999999998643 457999998743 334567899999999999999999999985 467
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.++||||+++++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred cEEEEecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccc
Confidence 89999999999999999643 2358999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhC
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKG 727 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (852)
++...... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ ...+..+
T Consensus 163 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~-------~~~i~~~ 233 (281)
T 1mp8_A 163 SRYMEDST--YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-------IGRIENG 233 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHHTT
T ss_pred ccccCccc--ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH-------HHHHHcC
Confidence 98764321 112233457789999999999999999999999999999996 9999975433211 1111111
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 728 NVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 728 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
... ..+......+.+++.+|++.||.+||++.+|++.|+.+.+
T Consensus 234 ~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 234 ERL----------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 110 1111122456788899999999999999999999988754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.18 Aligned_cols=261 Identities=22% Similarity=0.326 Sum_probs=194.6
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCce----e
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKH----R 569 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~----~ 569 (852)
..|.+.++||+|+||.||++.. .+++.||||++.... .....+.+|++++.+++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 4678889999999999999996 568899999997432 223578899999999999999999999876553 4
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
++||||+++++|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 92 ~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred EEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 9999999999999999643 348999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCc
Q 003059 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 650 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
+................||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~ 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPI 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCC
Confidence 876543332233344668999999999999999999999999999999999999997543211 11111111110
Q ss_pred cc-ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHH-HHHhcCccCC
Q 003059 730 KG-IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVV-QMLEGITEIE 782 (852)
Q Consensus 730 ~~-~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~-~~L~~~~~~~ 782 (852)
.. .... .....+.+++.+||+.||++||+..+++ +.+..+....
T Consensus 238 ~~~~~~~---------~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 283 (311)
T 3ork_A 238 PPSARHE---------GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGE 283 (311)
T ss_dssp CHHHHST---------TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTC
T ss_pred CcccccC---------CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCC
Confidence 00 0000 0123567888999999999999766654 5555554433
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=353.25 Aligned_cols=271 Identities=22% Similarity=0.297 Sum_probs=207.2
Q ss_pred ccccccccccccceEEEEEEC-----CCcEEEEEEecCcc--cchHHHHHHHHHhhcccccceeeeeeeecc--CceeeE
Q 003059 501 KGFKDKLGAGGFGAVYRGVLA-----NRTVVAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRLVGFSSE--GKHRLL 571 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l 571 (852)
+.+.++||+|+||.||++.+. +++.||||++.... ...+.+.+|++++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 378899999999999998753 57899999998432 345678999999999999999999999987 467899
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
||||+++++|.+++... .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 113 v~e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EECCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 99999999999999532 38999999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
...............++..|+|||.+.+..++.++||||||+++|||++|+.||.......... ..+.........+..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL-IGIAQGQMTVLRLTE 262 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-HCSCCHHHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhh-hcccccchhHHHHHH
Confidence 7654333333445568889999999999999999999999999999999999997542210000 000000000000111
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCC
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIE 782 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~ 782 (852)
.+...... ..+......+.+++.+||+.||.+||++.++++.|+.+.+..
T Consensus 263 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 263 LLERGERL-PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhcccCC-CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 11111110 112222346778889999999999999999999999886543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=344.12 Aligned_cols=246 Identities=20% Similarity=0.299 Sum_probs=204.8
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
..|.+.+.||+|+||.||++... +++.||+|.+.........+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 46778899999999999999975 57899999998666666778999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC--CCceEEeecccccccCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE--NYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~kl~DFGla~~~~~~ 655 (852)
+++|.+++... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 85 g~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 85 GLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 99999999532 2358999999999999999999999 89999999999999987 789999999999877542
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+.....
T Consensus 158 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~------ 220 (321)
T 1tki_A 158 ----DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEY------ 220 (321)
T ss_dssp ----CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCC------
T ss_pred ----CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-------HHHHHHcCCC------
Confidence 23345679999999999999889999999999999999999999997543211 1111111111
Q ss_pred ccCCCCCCHH----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 736 SLAGEDVDIE----QVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 736 ~l~~~~~~~~----~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..+.+ ....+.+++.+|++.||.+|||+.|+++
T Consensus 221 -----~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 221 -----TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -----CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111 1235678899999999999999999997
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.56 Aligned_cols=268 Identities=27% Similarity=0.466 Sum_probs=199.1
Q ss_pred ccCHHHHHHhcccccccccccccceEEEEEECCCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccC
Q 003059 490 QFSYKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEG 566 (852)
Q Consensus 490 ~~~~~el~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~ 566 (852)
.+...||....|.+.++||+|+||.||+|...+ .||||++.... ...+.|.+|++++++++||||+++++++ ..
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 344557778889999999999999999998644 49999997332 3346789999999999999999999966 45
Q ss_pred ceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeec
Q 003059 567 KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDF 646 (852)
Q Consensus 567 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 646 (852)
...++||||+++++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Df 164 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDF 164 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCC
T ss_pred CccEEEEEecCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccc
Confidence 5789999999999999999543 3458999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCChhhhh---cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHH
Q 003059 647 GLAKLINPKDHRHRTLTSVRGTRGYLAPEWLA---NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEE 723 (852)
Q Consensus 647 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 723 (852)
|+++....... ........||+.|+|||.+. +..++.++||||||+++|||++|+.||....... . ....
T Consensus 165 g~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~----~~~~ 237 (289)
T 3og7_A 165 GLATEKSRWSG-SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--Q----IIEM 237 (289)
T ss_dssp C-------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--H----HHHH
T ss_pred eeccccccccc-cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--H----HHHH
Confidence 99986543211 12234456999999999986 6678889999999999999999999997543221 1 1112
Q ss_pred HhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 724 FEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 724 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
...+.....+... .......+.+++.+|++.||.+||++.+|++.|+++.+
T Consensus 238 ~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 238 VGRGSLSPDLSKV------RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHTSCCCCTTSS------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hcccccCcchhhc------cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 2222221111111 11122467788889999999999999999999998754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=361.70 Aligned_cols=264 Identities=19% Similarity=0.271 Sum_probs=206.1
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCcccchHHHHHHHHHhhcccc-cceeeeeeeeccCceeeEEEeec
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVATISSTHH-LNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
..|.+.++||+|+||.||+|.. .+++.||||++.... ...++..|++++..++| +++..+..++.+.+..+|||||+
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 4677889999999999999996 568899999876432 23468899999999977 55666666777888999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEe---CCCCceEEeecccccccC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL---DENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFGla~~~~ 653 (852)
+++|.+++... ...+++..++.|+.||+.||+|||+ ++|+||||||+|||| +.++.+||+|||+++.+.
T Consensus 86 -g~sL~~ll~~~----~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 86 -GPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp -CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred -CCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99999999643 2359999999999999999999999 899999999999999 689999999999998765
Q ss_pred CCCCcc----eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCc
Q 003059 654 PKDHRH----RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 654 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
...... .......||+.|+|||.+.+..++.++|||||||+||||++|+.||....................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~---- 233 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV---- 233 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH----
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc----
Confidence 432211 112356799999999999999999999999999999999999999986544332222211111111
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 730 KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
...+.....+ . ...+.+++..||+.+|++||++.+|+++|+.+...
T Consensus 234 ~~~~~~l~~~--~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 234 ATSIEALCRG--Y----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp HSCHHHHHTT--S----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cccHHHHhcC--C----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 1111111111 1 23577888999999999999999999999887543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=339.81 Aligned_cols=262 Identities=22% Similarity=0.297 Sum_probs=200.2
Q ss_pred HhcccccccccccccceEEEEEECCCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
...|.+.++||+|+||.||+|...+++.||+|++.... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 35678889999999999999999889999999997332 224678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++ +|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 100 FMEK-DLKKVLDEN----KTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp CCSE-EHHHHHHTC----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred CCCC-CHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 9974 888888543 3358999999999999999999999 8999999999999999999999999999987643
Q ss_pred CCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccc-
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI- 732 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~- 732 (852)
.. .......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+... ..............
T Consensus 172 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 172 PV---RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP---KIFSILGTPNPREWP 245 (311)
T ss_dssp CC---C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHH---HHHHHHCCCCTTTSG
T ss_pred Cc---ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHHCCCChHHhh
Confidence 21 22334568999999999876 568999999999999999999999997654332211 11111110000000
Q ss_pred --------cccccCC-CCCCHH-----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 733 --------VDKSLAG-EDVDIE-----QVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 733 --------~d~~l~~-~~~~~~-----~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.+..... ...+.. ....+.+++.+|++.||.+|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000 001111 1235678999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=351.07 Aligned_cols=262 Identities=29% Similarity=0.468 Sum_probs=201.9
Q ss_pred HHHHhcccccccccccccceEEEEEECC-----CcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCc
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLAN-----RTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK 567 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~ 567 (852)
++....+.+.+.||+|+||.||+|.... +..||||.+... .....++.+|+.++++++||||+++++++.+.+
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 4445567778899999999999998643 246999999743 234457899999999999999999999999999
Q ss_pred eeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecc
Q 003059 568 HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFG 647 (852)
Q Consensus 568 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 647 (852)
..++||||+++++|.+++... ...+++..++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg 192 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFG 192 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred CcEEEEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCC
Confidence 999999999999999999643 2458999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhh
Q 003059 648 LAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEK 726 (852)
Q Consensus 648 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (852)
+++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+..
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~~~~~~ 265 (333)
T 1mqb_A 193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMKAIND 265 (333)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHT
T ss_pred cchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHC
Confidence 99876543222222233456789999999999999999999999999999999 999996443211 1111111
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 727 GNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
+.. . +.+......+.+++.+||+.||.+||++.+|++.|+++..
T Consensus 266 ~~~-------~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 266 GFR-------L---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp TCC-------C---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCc-------C---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 110 0 1111223456788899999999999999999999988764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=343.95 Aligned_cols=252 Identities=22% Similarity=0.263 Sum_probs=197.4
Q ss_pred ccCHHHHHHhcccccccccccccceEEEEEEC-CCcEEEEEEecCcc---cchHHHHHHHHHhhcc-cccceeeeeeeec
Q 003059 490 QFSYKELQRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---QGEKQFRMEVATISST-HHLNLVRLVGFSS 564 (852)
Q Consensus 490 ~~~~~el~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l-~h~niv~l~g~~~ 564 (852)
+....++....|.+.++||+|+||+||+|... +++.||||++.... ....++..|+..+.++ +||||+++++++.
T Consensus 48 p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~ 127 (311)
T 3p1a_A 48 PSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE 127 (311)
T ss_dssp TTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence 34455677788999999999999999999976 68999999986432 2233455666666555 8999999999999
Q ss_pred cCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEe
Q 003059 565 EGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVS 644 (852)
Q Consensus 565 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 644 (852)
+++..++||||+ +++|.+++... ...+++..++.++.||+.||+|||+ .+|+||||||+||||+.++.+||+
T Consensus 128 ~~~~~~lv~e~~-~~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~ 199 (311)
T 3p1a_A 128 EGGILYLQTELC-GPSLQQHCEAW----GASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLG 199 (311)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEEC
T ss_pred eCCEEEEEEecc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEc
Confidence 999999999999 77999988654 2459999999999999999999999 899999999999999999999999
Q ss_pred ecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHH
Q 003059 645 DFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEF 724 (852)
Q Consensus 645 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 724 (852)
|||+++..... .......||+.|+|||++.+ .++.++||||||+++|||++|..|+..... +..+
T Consensus 200 DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~ 264 (311)
T 3p1a_A 200 DFGLLVELGTA----GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQL 264 (311)
T ss_dssp CCTTCEECC----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHH
T ss_pred cceeeeecccC----CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHH
Confidence 99999876432 12234568999999999876 789999999999999999999776643211 1112
Q ss_pred hhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 725 EKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 725 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..+.....+.. .....+.+++.+|++.||++||++.|+++
T Consensus 265 ~~~~~~~~~~~---------~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 265 RQGYLPPEFTA---------GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp TTTCCCHHHHT---------TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hccCCCccccc---------CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 22111111111 11245778899999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=348.98 Aligned_cols=266 Identities=27% Similarity=0.415 Sum_probs=211.5
Q ss_pred HHHHhcccccccccccccceEEEEEE------CCCcEEEEEEecCcc--cchHHHHHHHHHhhcc-cccceeeeeeeecc
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVL------ANRTVVAVKQLEGIE--QGEKQFRMEVATISST-HHLNLVRLVGFSSE 565 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~--~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~ 565 (852)
++....|.+.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|++++.++ +||||+++++++.+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 34456788889999999999999985 346789999997433 3456789999999999 99999999999999
Q ss_pred CceeeEEEeecCCCCHHHHhhhccc-------------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCc
Q 003059 566 GKHRLLVYEFMKNGSLDNFLFANEE-------------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPEN 632 (852)
Q Consensus 566 ~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 632 (852)
.+..++||||+++|+|.+++..... .....+++..++.++.||++||+|||+ .+|+||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccce
Confidence 9999999999999999999976432 112358999999999999999999999 899999999999
Q ss_pred eEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccc
Q 003059 633 ILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQET 711 (852)
Q Consensus 633 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~ 711 (852)
||++.++.+||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred EEEcCCCCEEEccccccccccccccc-eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 99999999999999999876543221 22233457889999999999999999999999999999999 99999754322
Q ss_pred cchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 712 NRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 712 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
.. ......... ... .+......+.+++.+|++.||.+||++.+|++.|+++..
T Consensus 255 ~~------~~~~~~~~~-----~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 255 SK------FYKMIKEGF-----RML-----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp HH------HHHHHHHTC-----CCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hH------HHHHhccCC-----CCC-----CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 11 111111110 000 011122456788899999999999999999999987654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=353.89 Aligned_cols=267 Identities=26% Similarity=0.357 Sum_probs=209.4
Q ss_pred HHHHhcccccccccccccceEEEEEE------CCCcEEEEEEecCc--ccchHHHHHHHHHhhcc-cccceeeeeeeecc
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVL------ANRTVVAVKQLEGI--EQGEKQFRMEVATISST-HHLNLVRLVGFSSE 565 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~ 565 (852)
++....|.+.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++.++ +||||+++++++.+
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 44566788889999999999999996 24568999999732 33457899999999999 89999999999999
Q ss_pred CceeeEEEeecCCCCHHHHhhhcccC------------------CccccchhHHHHHHHhhHhhhhhhccccCCCcccCC
Q 003059 566 GKHRLLVYEFMKNGSLDNFLFANEEG------------------SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCD 627 (852)
Q Consensus 566 ~~~~~lV~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~D 627 (852)
.+..++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+ .+|+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCC
Confidence 99999999999999999999754321 11348999999999999999999999 8999999
Q ss_pred CCCCceEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCcccc
Q 003059 628 IKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFE 706 (852)
Q Consensus 628 lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~ 706 (852)
|||+|||++.++.+||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCcc-ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 999999999999999999999987643322 122334567889999999999999999999999999999998 999997
Q ss_pred ccccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 707 VSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 707 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
....... .......+. . . ..+......+.+++.+||+.||.+||++.+|++.|+.+.+.
T Consensus 277 ~~~~~~~------~~~~~~~~~-~----~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 277 GIPVDAN------FYKLIQNGF-K----M-----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TCCCSHH------HHHHHHTTC-C----C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cCCcHHH------HHHHHhcCC-C----C-----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 5432211 111111110 0 0 11111234567788999999999999999999999987653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=346.51 Aligned_cols=246 Identities=24% Similarity=0.269 Sum_probs=201.1
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
..|.+.+.||+|+||.||++... +++.||+|+++.. ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 35677899999999999999975 5889999999732 334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 85 E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 85 EYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999999643 358899999999999999999999 899999999999999999999999999998643
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+.....
T Consensus 157 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~---- 222 (337)
T 1o6l_A 157 SDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEI---- 222 (337)
T ss_dssp CTT---CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC----
T ss_pred cCC---CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC----
Confidence 221 12344679999999999999999999999999999999999999997543211 1111111111
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP-----MMGKVVQ 773 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~ev~~ 773 (852)
.+ +......+.+++.+|++.||.+|| ++.||++
T Consensus 223 --~~-----p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 --RF-----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CC-----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CC-----CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 01 111123567788899999999999 8998875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=338.89 Aligned_cols=260 Identities=23% Similarity=0.314 Sum_probs=196.5
Q ss_pred cccccccccccccceEEEEEECCCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
.|.+.++||+|+||.||+|...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence 467789999999999999999889999999997332 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++ +|.+++... ...+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 83 DQ-DLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp SE-EHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred CC-CHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 75 999988643 2358899999999999999999999 899999999999999999999999999998764321
Q ss_pred CcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC------c
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN------V 729 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~ 729 (852)
.......+|+.|+|||.+.+. .++.++||||||+++|||++|+.||........ + ........... .
T Consensus 155 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~-~~~~~~~~~~~~~~~~~~ 228 (288)
T 1ob3_A 155 ---RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--L-MRIFRILGTPNSKNWPNV 228 (288)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H-HHHHHHHCCCCTTTSTTG
T ss_pred ---cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHHHHCCCChhhchhh
Confidence 122345689999999999764 589999999999999999999999975432211 1 11111111000 0
Q ss_pred cc--ccccccCC-CCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 730 KG--IVDKSLAG-EDV-----DIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 730 ~~--~~d~~l~~-~~~-----~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.. ..++.... .+. .......+.+++.+|++.||.+||++.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 00111000 000 0011235678899999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=337.28 Aligned_cols=252 Identities=21% Similarity=0.340 Sum_probs=202.1
Q ss_pred HhcccccccccccccceEEEEEECCCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccC--ceeeEE
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEG--KHRLLV 572 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV 572 (852)
...|.+.++||+|+||.||+|+.. ++.||||++.... ...++|.+|+.++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 456778899999999999999985 7789999997432 3346799999999999999999999999877 788999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCC--cccCCCCCCceEeCCCCceEEeeccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC--IVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
|||+++|+|.+++.... ...+++..++.++.||++||+|||+ .+ |+||||||+|||++.++.++|.|||++.
T Consensus 88 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp EECCTTCBHHHHHHSCS---SCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred ecccCCCcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEecccee
Confidence 99999999999996432 3368999999999999999999998 67 9999999999999999999999998876
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhcCCCCC---CccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhC
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANLPITS---KSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG 727 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (852)
.... ....||+.|+|||.+.+...+. ++||||||+++|||++|+.||........ . ......
T Consensus 162 ~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~-~~~~~~ 226 (271)
T 3kmu_A 162 SFQS--------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------G-MKVALE 226 (271)
T ss_dssp TTSC--------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------H-HHHHHS
T ss_pred eecc--------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------H-HHHHhc
Confidence 5332 1235789999999998765554 79999999999999999999975432110 1 111111
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 728 NVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 728 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
.. .+.+ +......+.+++..|++.||.+||++.++++.|+.+.+
T Consensus 227 ~~----~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 227 GL----RPTI-----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CC----CCCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CC----CCCC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11 1111 11122356788889999999999999999999988754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=349.58 Aligned_cols=256 Identities=25% Similarity=0.368 Sum_probs=201.0
Q ss_pred hcccccccccccccceEEEEEECC-Cc----EEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLAN-RT----VVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLL 571 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~----~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 571 (852)
..|.+.+.||+|+||.||+|.... ++ .|++|.+... ......+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 457778899999999999999643 33 3888887632 334467889999999999999999999986 567899
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
||||+++|+|.+++... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 92 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH----RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEECCTTCBSHHHHHSS----GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEeCCCCCHHHHHHHc----cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 99999999999999643 3468999999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcc
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (852)
...... ........++..|+|||.+.+..++.++||||||+++|||++ |+.||........ ......+...
T Consensus 165 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~~~ 236 (325)
T 3kex_A 165 LPPDDK-QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV-------PDLLEKGERL 236 (325)
T ss_dssp SCCCTT-CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH-------HHHHHTTCBC
T ss_pred cCcccc-cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH-------HHHHHcCCCC
Confidence 754322 223345668889999999999999999999999999999999 9999975432211 1111111111
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 731 GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
.. .. .....+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 237 ~~-~~---------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 237 AQ-PQ---------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp CC-CT---------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CC-CC---------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00 00 011235678888999999999999999999988754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=337.81 Aligned_cols=253 Identities=28% Similarity=0.479 Sum_probs=200.4
Q ss_pred HHhcccccccccccccceEEEEEE-CCCcEEEEEEecCccc--------chHHHHHHHHHhhcccccceeeeeeeeccCc
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQ--------GEKQFRMEVATISSTHHLNLVRLVGFSSEGK 567 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~ 567 (852)
....|.+.+.||+|+||.||+|.. .+++.||+|++..... ..+.+.+|++++.+++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 345678889999999999999997 4688999999863221 1167899999999999999999999997765
Q ss_pred eeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCC--cccCCCCCCceEeCCCCc-----
Q 003059 568 HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC--IVHCDIKPENILLDENYN----- 640 (852)
Q Consensus 568 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NILl~~~~~----- 640 (852)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+ .+ |+||||||+|||++.++.
T Consensus 97 --~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~ 167 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDK----AHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVC 167 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred --eEEEEecCCCCHHHHHhcc----cCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCcee
Confidence 6999999999999988643 3468999999999999999999998 77 999999999999988776
Q ss_pred eEEeecccccccCCCCCcceeeeeecCCCCCCChhhhh--cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHH
Q 003059 641 AKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLA--NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSL 718 (852)
Q Consensus 641 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~ 718 (852)
+||+|||+++.... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||..........
T Consensus 168 ~kl~Dfg~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--- 238 (287)
T 4f0f_A 168 AKVADFGLSQQSVH------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF--- 238 (287)
T ss_dssp EEECCCTTCBCCSS------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH---
T ss_pred EEeCCCCccccccc------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH---
Confidence 99999999985432 234467999999999984 4567889999999999999999999997543322111
Q ss_pred HHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 719 WAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 719 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
........... .+ +......+.+++.+|++.||.+||++.+|++.|+++
T Consensus 239 --~~~~~~~~~~~----~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 239 --INMIREEGLRP----TI-----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp --HHHHHHSCCCC----CC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred --HHHHhccCCCC----CC-----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11111111111 11 111224577888899999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=350.39 Aligned_cols=252 Identities=24% Similarity=0.282 Sum_probs=193.6
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
.+|.+.++||+|+||.||++... +++.||||++.......+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 46888899999999999999975 68899999998666666789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCc--eEEeecccccccCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYN--AKVSDFGLAKLINPK 655 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~kl~DFGla~~~~~~ 655 (852)
+|+|.+++... ..+++..++.++.||+.||+|||+ ++|+||||||+||||+.++. +||+|||+++.....
T Consensus 100 ~~~L~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 100 GGELYERICNA-----GRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp SCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 99999999643 248999999999999999999998 89999999999999987765 999999999754221
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCC-ccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSK-SDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k-sDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
.......||+.|+|||.+.+..++.+ +||||||+++|||++|+.||......... .... ........
T Consensus 172 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~-~~~~~~~~----- 239 (361)
T 3uc3_A 172 ----SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTI-QRILSVKY----- 239 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHH-HHHHTTCC-----
T ss_pred ----CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHH-HHHhcCCC-----
Confidence 22234569999999999998887665 89999999999999999999754332211 1111 11111100
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.+ +........+.+++.+||+.||.+|||+.|+++.
T Consensus 240 -~~---~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 -SI---PDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -CC---CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -CC---CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00 0001112356788999999999999999999863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=346.28 Aligned_cols=251 Identities=19% Similarity=0.294 Sum_probs=196.4
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecC--cccchHHHHHHHHHhhcccccceeeeeeeeccCc--------
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEG--IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK-------- 567 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-------- 567 (852)
..|.+.+.||+|+||.||+|+.. +++.||||++.. .....+.+.+|++++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 45778899999999999999976 688999999873 3334578999999999999999999999885543
Q ss_pred -------------------------------------------------eeeEEEeecCCCCHHHHhhhcccCCccccch
Q 003059 568 -------------------------------------------------HRLLVYEFMKNGSLDNFLFANEEGSGKLLNW 598 (852)
Q Consensus 568 -------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~ 598 (852)
..++||||+++++|.+++..... .....+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~ 163 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--LEDREH 163 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS--GGGSCH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC--ccchhh
Confidence 37999999999999999976432 345677
Q ss_pred hHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcc---------eeeeeecCCC
Q 003059 599 QSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRH---------RTLTSVRGTR 669 (852)
Q Consensus 599 ~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~---------~~~~~~~gt~ 669 (852)
..++.++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++......... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 7889999999999999998 899999999999999999999999999998775432111 1123356999
Q ss_pred CCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHH
Q 003059 670 GYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMR 749 (852)
Q Consensus 670 ~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 749 (852)
.|+|||.+.+..++.++||||||+++|||++|..|+..... ........... .........
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~---------~~~~~~~~~~~----------~~~~~~~~~ 301 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR---------IITDVRNLKFP----------LLFTQKYPQ 301 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH---------HHHHHHTTCCC----------HHHHHHCHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH---------HHHHhhccCCC----------cccccCChh
Confidence 99999999999999999999999999999999877532110 01111111000 011122345
Q ss_pred HHHHHHhccccCCCCCCCHHHHHH
Q 003059 750 AIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 750 ~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+.+++.+|++.||.+||++.|+++
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCCCCcCCCHHHHhh
Confidence 678899999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.51 Aligned_cols=251 Identities=23% Similarity=0.332 Sum_probs=202.1
Q ss_pred HhcccccccccccccceEEEEEEC-CCcEEEEEEecCcc-------cchHHHHHHHHHhhcccccceeeeeeeeccCcee
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE-------QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHR 569 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 569 (852)
...|.+.+.||+|+||.||++... +++.||+|.+.... ...+++.+|+.++.+++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 346888899999999999999975 58899999987322 1356799999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC----ceEEee
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY----NAKVSD 645 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~D 645 (852)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|
T Consensus 90 ~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEEECCCSCBHHHHHTT-----SSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEcCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 999999999999999953 2358999999999999999999998 8999999999999999887 899999
Q ss_pred cccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHh
Q 003059 646 FGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFE 725 (852)
Q Consensus 646 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 725 (852)
||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ......
T Consensus 162 fg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~~~ 230 (326)
T 2y0a_A 162 FGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVS 230 (326)
T ss_dssp CTTCEECCTTS----CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHH
T ss_pred CCCCeECCCCC----ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-------HHHHHH
Confidence 99998765322 2234569999999999999999999999999999999999999996543211 011111
Q ss_pred hCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 726 KGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
..... ....... .....+.+++.+|++.||.+||++.++++.
T Consensus 231 ~~~~~-~~~~~~~------~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 231 AVNYE-FEDEYFS------NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HTCCC-CCHHHHT------TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hcCCC-cCccccc------cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11000 0000000 012356788899999999999999999873
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=374.25 Aligned_cols=249 Identities=25% Similarity=0.372 Sum_probs=197.5
Q ss_pred cccccccceEEEEEEC---CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCC
Q 003059 506 KLGAGGFGAVYRGVLA---NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGS 580 (852)
Q Consensus 506 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 580 (852)
+||+|+||.||+|.+. ++..||||+++.. ....++|.+|++++++++||||++++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999864 4567999999843 3356789999999999999999999999976 56899999999999
Q ss_pred HHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcce
Q 003059 581 LDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHR 660 (852)
Q Consensus 581 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 660 (852)
|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.+........
T Consensus 422 L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 494 (613)
T 2ozo_A 422 LHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494 (613)
T ss_dssp HHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred HHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence 99999643 3458999999999999999999999 8999999999999999999999999999987654322222
Q ss_pred eeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcccccccccCC
Q 003059 661 TLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAG 739 (852)
Q Consensus 661 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (852)
......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ ....+..+...
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~--------- 558 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRM--------- 558 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-------HHHHHHTTCCC---------
T ss_pred eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCC---------
Confidence 2233446789999999999999999999999999999998 999997543321 11122222111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 740 EDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 740 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
..+......+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 559 -~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 559 -ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp -CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111122346778889999999999999999999998764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=345.04 Aligned_cols=245 Identities=23% Similarity=0.337 Sum_probs=201.3
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCccc-------chHHHHHHHHHhhcccccceeeeeeeeccCceee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQ-------GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRL 570 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 570 (852)
..|.+.+.||+|+||.||++... +++.||+|.+..... ..+.+.+|+.++.+++||||+++++++.+....+
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 45778899999999999999975 588999999974321 2467999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC----ceEEeec
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY----NAKVSDF 646 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~DF 646 (852)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+||
T Consensus 92 lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 92 LILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEECCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999542 358999999999999999999999 8999999999999998877 7999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhh
Q 003059 647 GLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEK 726 (852)
Q Consensus 647 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (852)
|+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+..
T Consensus 164 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-------~~~~i~~ 232 (361)
T 2yab_A 164 GLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANITA 232 (361)
T ss_dssp SSCEECCTTC----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHT
T ss_pred CCceEcCCCC----ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHh
Confidence 9998765421 2234569999999999999999999999999999999999999997543211 1111111
Q ss_pred CCcccccccccCCCCCCHH----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 727 GNVKGIVDKSLAGEDVDIE----QVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~----~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
... ..+.+ ....+.+++.+|++.||.+||++.|+++
T Consensus 233 ~~~-----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 233 VSY-----------DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp TCC-----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCC-----------CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 110 11111 1235678889999999999999999885
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=346.50 Aligned_cols=264 Identities=28% Similarity=0.403 Sum_probs=195.7
Q ss_pred HHhcccccccccccccceEEEEEECCC----cEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCcee
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLANR----TVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHR 569 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 569 (852)
....|.+.+.||+|+||.||+|..... ..||||++... ....+++.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 345678889999999999999986543 27999999742 34457899999999999999999999999877655
Q ss_pred ------eEEEeecCCCCHHHHhhhcccC-CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceE
Q 003059 570 ------LLVYEFMKNGSLDNFLFANEEG-SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAK 642 (852)
Q Consensus 570 ------~lV~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 642 (852)
++||||+++++|.+++...... ....+++..++.++.||++||+|||+ .+|+||||||+|||+++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEE
Confidence 9999999999999999654321 22358999999999999999999999 8999999999999999999999
Q ss_pred EeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHH
Q 003059 643 VSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAY 721 (852)
Q Consensus 643 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 721 (852)
|+|||+++....... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ .
T Consensus 178 l~Dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-------~ 249 (323)
T 3qup_A 178 VADFGLSRKIYSGDY-YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-------Y 249 (323)
T ss_dssp ECCCCC------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------H
T ss_pred Eeecccccccccccc-ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH-------H
Confidence 999999987644221 122233457889999999999999999999999999999999 9999975443211 1
Q ss_pred HHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 722 EEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 722 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
.....+... ..+......+.+++.+|++.||++||++.++++.|+++..-
T Consensus 250 ~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 250 NYLIGGNRL----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp HHHHTTCCC----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHhcCCCC----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111111100 11112224577889999999999999999999999988653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=345.65 Aligned_cols=253 Identities=25% Similarity=0.401 Sum_probs=201.5
Q ss_pred HHHHhcccccccccccccceEEEEEECC-C-------cEEEEEEecC-cccchHHHHHHHHHhhcccccceeeeeeeecc
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLAN-R-------TVVAVKQLEG-IEQGEKQFRMEVATISSTHHLNLVRLVGFSSE 565 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~~-~-------~~vavK~l~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~ 565 (852)
++....|.+.+.||+|+||.||+|.... + ..||+|++.. .....+.+.+|++++++++||||+++++++.+
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 3445678889999999999999998543 2 5799999974 33455779999999999999999999999999
Q ss_pred CceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCc-----
Q 003059 566 GKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYN----- 640 (852)
Q Consensus 566 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~----- 640 (852)
.+..++||||+++++|.+++... ...+++..++.++.||++||+|||+ ++|+||||||+|||++.++.
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~ 156 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKN----KNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGN 156 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTB
T ss_pred CCCCEEEEECCCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccc
Confidence 99999999999999999999654 2348899999999999999999999 89999999999999998887
Q ss_pred ---eEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCc-cccccccccchh
Q 003059 641 ---AKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRR-NFEVSQETNRKK 715 (852)
Q Consensus 641 ---~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~-p~~~~~~~~~~~ 715 (852)
+||+|||++...... ....+++.|+|||.+.+ ..++.++||||||+++|||++|.. ||........
T Consensus 157 ~~~~kl~Dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-- 227 (289)
T 4fvq_A 157 PPFIKLSDPGISITVLPK-------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-- 227 (289)
T ss_dssp CCEEEECCCCSCTTTSCH-------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--
T ss_pred cceeeeccCcccccccCc-------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH--
Confidence 999999998755321 23457899999999987 678999999999999999999654 4433221100
Q ss_pred hHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 716 FSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 716 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
....... ..+.... ...+.+++.+||+.||.+||++.++++.|+++..
T Consensus 228 -----~~~~~~~---~~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 228 -----LQFYEDR---HQLPAPK---------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp -----HHHHHTT---CCCCCCS---------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred -----HHHhhcc---CCCCCCC---------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 0011100 0001111 1245678888999999999999999999998865
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=346.62 Aligned_cols=280 Identities=21% Similarity=0.305 Sum_probs=214.7
Q ss_pred CCcccCHHHHHHhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhc--ccccceeeeeeeec
Q 003059 487 APVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISS--THHLNLVRLVGFSS 564 (852)
Q Consensus 487 ~~~~~~~~el~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~--l~h~niv~l~g~~~ 564 (852)
....+...+.....|.+.+.||+|+||.||+|.. +++.||||++... ....+.+|++++.. ++||||+++++++.
T Consensus 30 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 30 SGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CCCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 3455666777888999999999999999999998 4788999999743 34567788888876 79999999999998
Q ss_pred cCc----eeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhcccc-----CCCcccCCCCCCceEe
Q 003059 565 EGK----HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC-----RDCIVHCDIKPENILL 635 (852)
Q Consensus 565 ~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dlkp~NILl 635 (852)
... ..++||||+++|+|.+++.. ..+++..++.++.|++.||+|||... ..+|+||||||+||||
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll 180 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 180 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE
Confidence 776 78999999999999999953 24899999999999999999999210 1799999999999999
Q ss_pred CCCCceEEeecccccccCCCCCcce-eeeeecCCCCCCChhhhhcCC------CCCCccchhhhHHHHHHHhC-------
Q 003059 636 DENYNAKVSDFGLAKLINPKDHRHR-TLTSVRGTRGYLAPEWLANLP------ITSKSDVYSYGMVLLEIVSG------- 701 (852)
Q Consensus 636 ~~~~~~kl~DFGla~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~------~s~ksDv~s~Gvvl~elltG------- 701 (852)
+.++.+||+|||+++.......... ......||+.|+|||.+.+.. ++.++||||||+++|||++|
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 9999999999999987654322111 223456899999999998763 33689999999999999999
Q ss_pred ---CccccccccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 702 ---RRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 702 ---~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
+.||......... ... ........ ...+.+.......+....+.+++.+||+.||.+||++.+|++.|+.+
T Consensus 261 ~~~~~p~~~~~~~~~~-~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 261 EDYQLPYYDLVPSDPS-VEE-MRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCCCCTTTTTSCSSCC-HHH-HHHHHTTS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccCccccCcCccc-HHH-HHHHHHHH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 6777544322111 111 11111111 11121111112335667788999999999999999999999999988
Q ss_pred ccC
Q 003059 779 TEI 781 (852)
Q Consensus 779 ~~~ 781 (852)
.+.
T Consensus 335 ~~~ 337 (342)
T 1b6c_B 335 SQQ 337 (342)
T ss_dssp HHT
T ss_pred HHH
Confidence 653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=346.37 Aligned_cols=255 Identities=21% Similarity=0.296 Sum_probs=203.5
Q ss_pred HHhcccccccccccccceEEEEEEC-CCcEEEEEEecCc------ccchHHHHHHHHHhhcccccceeeeeeeeccCcee
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI------EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHR 569 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~------~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 569 (852)
....|.+.+.||+|+||.||++... +++.||||++... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4557889999999999999999964 5889999998622 12457799999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCc---eEEeec
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYN---AKVSDF 646 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~DF 646 (852)
++||||+++++|.+++..... ....+++..+..++.||++||+|||+ ++|+||||||+|||++.++. +||+||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEeCCCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecC
Confidence 999999999999988865432 23458999999999999999999999 89999999999999987655 999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhh
Q 003059 647 GLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEK 726 (852)
Q Consensus 647 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (852)
|+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .......
T Consensus 178 g~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~i~~ 246 (351)
T 3c0i_A 178 GVAIQLGESG---LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER--------LFEGIIK 246 (351)
T ss_dssp TTCEECCTTS---CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH--------HHHHHHH
T ss_pred cceeEecCCC---eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH--------HHHHHHc
Confidence 9998765422 1233456999999999999999999999999999999999999999753210 1111111
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 727 GNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+..... ..... .....+.+++.+||+.||.+||++.++++
T Consensus 247 ~~~~~~-~~~~~------~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 247 GKYKMN-PRQWS------HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp TCCCCC-HHHHT------TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCC-ccccc------cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111000 00000 01235678889999999999999999985
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.41 Aligned_cols=257 Identities=25% Similarity=0.363 Sum_probs=206.0
Q ss_pred hcccccc-cccccccceEEEEEEC---CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 499 STKGFKD-KLGAGGFGAVYRGVLA---NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 499 ~~~~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
..+.+.+ .||+|+||.||+|.+. ++..||||++... ....+++.+|++++.+++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4455555 8999999999999853 5778999999853 33457789999999999999999999999 55678999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++++|.+++... ...+++..++.++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 88 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEeCCCCCHHHHHHhC----CccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 9999999999999533 3458999999999999999999999 89999999999999999999999999999877
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
..............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~i~~~~~~- 232 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRM- 232 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCCC-
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHhcCCcC-
Confidence 543322222233456889999999998899999999999999999998 999997543211 11111111110
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
..+......+.+++.+|++.||.+||++.+|++.|+.+..
T Consensus 233 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 233 ---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp ---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111223467788899999999999999999999998754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=346.55 Aligned_cols=274 Identities=22% Similarity=0.316 Sum_probs=197.1
Q ss_pred HhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeee-----ccCceeeEE
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFS-----SEGKHRLLV 572 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~-----~~~~~~~lV 572 (852)
...|.+.++||+|+||.||+|+. +++.||||++..........+.|+..+..++|+||+++++.+ ......++|
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 90 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV 90 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence 34677889999999999999987 578899999974433333334455556678999999999844 234467899
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhcccc------CCCcccCCCCCCceEeCCCCceEEeec
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC------RDCIVHCDIKPENILLDENYNAKVSDF 646 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~ivH~Dlkp~NILl~~~~~~kl~DF 646 (852)
|||+++|+|.+++... ..++..++.++.||++||+|||+.. ..+|+||||||+||||+.++.+||+||
T Consensus 91 ~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 91 MEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp ECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EecCCCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 9999999999999543 3588999999999999999999821 119999999999999999999999999
Q ss_pred ccccccCCCCC-----cceeeeeecCCCCCCChhhhhc-------CCCCCCccchhhhHHHHHHHhCCccccccccccc-
Q 003059 647 GLAKLINPKDH-----RHRTLTSVRGTRGYLAPEWLAN-------LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNR- 713 (852)
Q Consensus 647 Gla~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~- 713 (852)
|+++.+..... .........||+.|+|||.+.+ ..++.++||||||+++|||++|..||........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 99987653211 1112223469999999999986 4566789999999999999999877643221111
Q ss_pred -hhhH---------HHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 714 -KKFS---------LWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 714 -~~l~---------~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
..+. ...............+.... .........+.+++.+||+.||++|||+.||++.|+++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW---KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC---CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHhhhcccCCCchHHHHHhhhcccccCCCCCccc---ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 0000 00001111111111111111 12233555788999999999999999999999999987643
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=348.36 Aligned_cols=257 Identities=23% Similarity=0.378 Sum_probs=198.4
Q ss_pred HhcccccccccccccceEEEEEEC-CCc----EEEEEEecC--cccchHHHHHHHHHhhcccccceeeeeeeeccCceee
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRT----VVAVKQLEG--IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRL 570 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 570 (852)
...|.+.++||+|+||.||+|... +++ .|++|.+.. .....+++.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 456778899999999999999964 333 468887763 3445678999999999999999999999998765 78
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+|+||+++|+|.+++... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 93 ~v~~~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEECCCSSCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred EEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 999999999999999654 2358899999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCc
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......... .....+..
T Consensus 166 ~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-------~~~~~~~~ 237 (327)
T 3lzb_A 166 LLGAEEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKGER 237 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------HHHHTTCC
T ss_pred EccCccc-cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-------HHHHcCCC
Confidence 7643221 122233457889999999999999999999999999999999 99999765432211 11111110
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 730 KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
. +.+......+.+++.+||+.||.+||++.|+++.|+.+..
T Consensus 238 -------~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 238 -------L---PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -------C---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred -------C---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 0 1111122356788899999999999999999999998764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=353.01 Aligned_cols=267 Identities=26% Similarity=0.390 Sum_probs=209.9
Q ss_pred HHHHHhcccccccccccccceEEEEEECC------CcEEEEEEecCcc--cchHHHHHHHHHhhcc-cccceeeeeeeec
Q 003059 494 KELQRSTKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQLEGIE--QGEKQFRMEVATISST-HHLNLVRLVGFSS 564 (852)
Q Consensus 494 ~el~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~--~~~~~f~~E~~~l~~l-~h~niv~l~g~~~ 564 (852)
.++....+.+.+.||+|+||.||+|.... ...||+|.+.... ...+.+.+|+.++.++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34556677888999999999999999643 2479999997432 3456789999999999 8999999999999
Q ss_pred cCceeeEEEeecCCCCHHHHhhhcccC---------CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEe
Q 003059 565 EGKHRLLVYEFMKNGSLDNFLFANEEG---------SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL 635 (852)
Q Consensus 565 ~~~~~~lV~e~~~~gsL~~~l~~~~~~---------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl 635 (852)
+.+..++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+ .+|+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEE
Confidence 999999999999999999999754210 12357899999999999999999999 899999999999999
Q ss_pred CCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccch
Q 003059 636 DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRK 714 (852)
Q Consensus 636 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~ 714 (852)
+.++.+||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~- 275 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSN-YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK- 275 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTT-SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-
T ss_pred CCCCeEEECccccccccccccc-eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-
Confidence 9999999999999986643221 122234557889999999999999999999999999999998 9999975432211
Q ss_pred hhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 715 KFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
+ ......+. ... .+......+.+++.+|++.||.+||++.+|++.|+++..
T Consensus 276 -~----~~~~~~~~-----~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 276 -F----YKLVKDGY-----QMA-----QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp -H----HHHHHHTC-----CCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -H----HHHHhcCC-----CCC-----CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 1 11111110 000 011112356778889999999999999999999987643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=350.01 Aligned_cols=249 Identities=23% Similarity=0.293 Sum_probs=197.2
Q ss_pred HHHhcccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcc-cccceeeeeeeeccCcee
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHR 569 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 569 (852)
+....|.+.++||+|+||.||++... +++.||||++... ....+.+..|..++.++ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 44557888899999999999999975 5889999999742 23445678899999988 799999999999999999
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||++
T Consensus 100 ~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a 171 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMC 171 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccce
Confidence 9999999999999999653 348999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCc
Q 003059 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 650 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+..+..
T Consensus 172 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~~ 241 (353)
T 3txo_A 172 KEGICN---GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEV 241 (353)
T ss_dssp BCSCC------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC
T ss_pred eecccC---CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCC
Confidence 864321 123345679999999999999999999999999999999999999997543211 1111111111
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 003059 730 KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMM------GKVVQ 773 (852)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~------~ev~~ 773 (852)
..+......+.+++.+|++.||.+||++ .+|++
T Consensus 242 -----------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 -----------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1111122356778889999999999998 66664
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=349.16 Aligned_cols=248 Identities=19% Similarity=0.292 Sum_probs=195.9
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 572 (852)
..+.+.++||+|+||.||+++.. +++.||+|+++.. ....+.+..|..++.++ +||||+++++++.+.+..++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 45778899999999999999975 4788999999743 22335688999999887 899999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++|+|..++... ..+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++..
T Consensus 132 ~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEcCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999653 348999999999999999999999 89999999999999999999999999999863
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccc--hhhHHHHHHHHhhCCcc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNR--KKFSLWAYEEFEKGNVK 730 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~ 730 (852)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ................
T Consensus 204 ~~~~---~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~- 279 (396)
T 4dc2_A 204 LRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI- 279 (396)
T ss_dssp CCTT---CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-
T ss_pred ccCC---CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-
Confidence 3221 223456799999999999999999999999999999999999999965422111 1111112222222111
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 003059 731 GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMM 768 (852)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~ 768 (852)
..+......+.+++.+||+.||.+||++
T Consensus 280 ----------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 ----------RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ----------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1111122356788899999999999996
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=347.69 Aligned_cols=266 Identities=26% Similarity=0.399 Sum_probs=211.0
Q ss_pred HHHHhcccccccccccccceEEEEEEC--------CCcEEEEEEecCcc--cchHHHHHHHHHhhcc-cccceeeeeeee
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLA--------NRTVVAVKQLEGIE--QGEKQFRMEVATISST-HHLNLVRLVGFS 563 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~--~~~~~f~~E~~~l~~l-~h~niv~l~g~~ 563 (852)
++....|.+.+.||+|+||.||+|... +++.||||++.... ...+++.+|++++.++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 455678888999999999999999863 46789999997432 3456789999999999 899999999999
Q ss_pred ccCceeeEEEeecCCCCHHHHhhhcccC-----------CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCc
Q 003059 564 SEGKHRLLVYEFMKNGSLDNFLFANEEG-----------SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPEN 632 (852)
Q Consensus 564 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 632 (852)
.+.+..++||||+++++|.+++...... ....+++..++.++.||++||+|||+ .+|+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccce
Confidence 9999999999999999999999754321 12358999999999999999999999 899999999999
Q ss_pred eEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccc
Q 003059 633 ILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQET 711 (852)
Q Consensus 633 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~ 711 (852)
||++.++.+||+|||+++....... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSS-EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred EEEcCCCCEEEcccccccccccccc-ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 9999999999999999987654321 112233457889999999999999999999999999999999 99999754321
Q ss_pred cchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 712 NRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 712 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
. ....+..+... ..+......+.+++.+|++.||.+||++.+|++.|+++...
T Consensus 267 ~-------~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 267 E-------LFKLLKEGHRM----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp H-------HHHHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H-------HHHHHhcCCCC----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1 11111111110 01111223567888899999999999999999999988654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=344.73 Aligned_cols=253 Identities=24% Similarity=0.345 Sum_probs=202.7
Q ss_pred HHHhcccccccccccccceEEEEEEC-CCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceeeE
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLL 571 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 571 (852)
.....|.+.++||+|+||.||++... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34567888999999999999999975 58899999997432 234678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC---ceEEeeccc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY---NAKVSDFGL 648 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~DFGl 648 (852)
||||+++|+|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++ .+||+|||+
T Consensus 106 v~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EECCCCSCBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 99999999999999543 358999999999999999999999 8999999999999998654 599999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN 728 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (852)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+..+.
T Consensus 178 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-------~~~~i~~~~ 246 (362)
T 2bdw_A 178 AIEVNDSE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIKAGA 246 (362)
T ss_dssp CBCCTTCC----SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTC
T ss_pred ceEecCCc----ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCC
Confidence 98765322 2234569999999999999999999999999999999999999997543211 111122211
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
... ..+.. ......+.+++.+||+.||.+||++.++++.
T Consensus 247 ~~~-~~~~~------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 247 YDY-PSPEW------DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CCC-CTTGG------GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCC-Ccccc------cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 110 00000 0112356788899999999999999998853
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=345.33 Aligned_cols=244 Identities=25% Similarity=0.348 Sum_probs=198.8
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
..|.+.+.||+|+||.||+|.. .+++.||||++... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 3577889999999999999996 56889999998632 233467899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+ +|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||++....
T Consensus 89 E~~-~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp CCC-CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred ECC-CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 999 78999998653 348999999999999999999999 799999999999999999999999999998764
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcCCC-CCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPI-TSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI 732 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (852)
... ......||+.|+|||.+.+..+ ++++||||||+++|||++|+.||+....... ...
T Consensus 160 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~ 219 (336)
T 3h4j_B 160 DGN----FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKK 219 (336)
T ss_dssp TSB----TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCC
T ss_pred CCc----ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHH
Confidence 322 2234569999999999988776 6899999999999999999999975432110 000
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+..... ..+......+.+++.+|++.||.+|||++|+++
T Consensus 220 i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 220 VNSCVY--VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCSSCC--CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred HHcCCC--CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 100000 111112235678899999999999999999985
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=351.25 Aligned_cols=268 Identities=22% Similarity=0.343 Sum_probs=207.8
Q ss_pred HHHhcccccccccccccceEEEEEE-----CCCcEEEEEEecCc-ccchHHHHHHHHHhhcccccceeeeeeeeccCc--
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVL-----ANRTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK-- 567 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-- 567 (852)
+....+.+.++||+|+||.||++.+ .+++.||||++... ....+.+.+|++++++++||||+++++++...+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 3455678889999999999999984 35889999999743 344568999999999999999999999987654
Q ss_pred eeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecc
Q 003059 568 HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFG 647 (852)
Q Consensus 568 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 647 (852)
..++||||+++++|.+++... ...+++..++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHS----TTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred ceEEEEECCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCc
Confidence 789999999999999999654 2358999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCcccccccccc--------c-hhhHH
Q 003059 648 LAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETN--------R-KKFSL 718 (852)
Q Consensus 648 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~--------~-~~l~~ 718 (852)
+++................++..|+|||.+.+..++.++||||||+++|||++|+.|+....... . .....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence 99877543322222233457788999999999889999999999999999999999986431110 0 00000
Q ss_pred HHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 719 WAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 719 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
........+.. . +.+......+.+++.+||+.||.+||++.+|++.|+.+.+
T Consensus 271 ~~~~~~~~~~~-------~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 271 HLIELLKNNGR-------L---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHHHTTCC-------C---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhhcCCC-------C---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111111100 0 1111223457788899999999999999999999988754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=339.11 Aligned_cols=256 Identities=26% Similarity=0.397 Sum_probs=203.1
Q ss_pred Hhcccccc-cccccccceEEEEEE---CCCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceee
Q 003059 498 RSTKGFKD-KLGAGGFGAVYRGVL---ANRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRL 570 (852)
Q Consensus 498 ~~~~~~~~-~lG~G~fg~Vy~~~~---~~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 570 (852)
...|.+.+ .||+|+||.||+|.+ ..++.||||++.... ...+++.+|++++++++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 34666777 899999999999964 236789999997432 2356799999999999999999999999 567789
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+||||+++++|.+++... ..+++..++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 94 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEECCTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEeCCCCCHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 999999999999999653 348899999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCc
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
................+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~ 238 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGER 238 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC
Confidence 77554333223334456789999999999889999999999999999999 999997543211 1111111111
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 730 KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
. ..+......+.+++.+|++.||.+||++.+|++.|+++.
T Consensus 239 ~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 239 M----------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp C----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred C----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 111122345778889999999999999999999998764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=336.37 Aligned_cols=247 Identities=24% Similarity=0.329 Sum_probs=193.1
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCccc---------------------------chHHHHHHHHHhhc
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQ---------------------------GEKQFRMEVATISS 550 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------------------------~~~~f~~E~~~l~~ 550 (852)
..|.+.+.||+|+||.||+|... +++.||||++..... ..+++.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 46778899999999999999964 588999999863321 13568899999999
Q ss_pred ccccceeeeeeeecc--CceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCC
Q 003059 551 THHLNLVRLVGFSSE--GKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDI 628 (852)
Q Consensus 551 l~h~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl 628 (852)
++||||+++++++.+ .+..++||||+++++|.+++. ...+++..++.++.||++||+|||+ .+|+||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dl 163 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT------LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDI 163 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC------SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCC
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCC
Confidence 999999999999886 568899999999999988652 3468999999999999999999999 89999999
Q ss_pred CCCceEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCC---CCCCccchhhhHHHHHHHhCCccc
Q 003059 629 KPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLP---ITSKSDVYSYGMVLLEIVSGRRNF 705 (852)
Q Consensus 629 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDv~s~Gvvl~elltG~~p~ 705 (852)
||+|||++.++.+||+|||+++...... .......||+.|+|||.+.+.. .+.++||||||+++|||++|+.||
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 240 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSD---ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSS---CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CHHHEEECCCCCEEEecCCCcccccccc---ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 9999999999999999999998765321 2234467999999999997765 377899999999999999999999
Q ss_pred cccccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 706 EVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 706 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
...... . ............ +........+.+++.+|++.||++||++.|+++
T Consensus 241 ~~~~~~------~-~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 241 MDERIM------C-LHSKIKSQALEF---------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CCSSHH------H-HHHHHHHCCCCC---------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccHH------H-HHHHHhcccCCC---------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 753211 0 111111111100 000111235678889999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=374.46 Aligned_cols=249 Identities=25% Similarity=0.393 Sum_probs=196.4
Q ss_pred ccccccccceEEEEEEC---CCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 505 DKLGAGGFGAVYRGVLA---NRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
++||+|+||.||+|.+. .++.||||+++... ...++|.+|++++.+++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 45789999997432 235789999999999999999999999964 568899999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
|+|.+++... ..+++..++.|+.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.+......
T Consensus 454 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 454 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 9999999643 358999999999999999999999 89999999999999999999999999999987654333
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccccccc
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSL 737 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (852)
........+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... ....+..+...
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~------- 591 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERM------- 591 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCC-------
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC-------
Confidence 233344557889999999999999999999999999999998 999997543221 11122222111
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 738 AGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 738 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
..+......+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 592 ---~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 592 ---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111122345778889999999999999999999998653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=350.10 Aligned_cols=258 Identities=27% Similarity=0.408 Sum_probs=193.2
Q ss_pred cccccccccccccceEEEEEEC--CC--cEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeecc-CceeeEE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA--NR--TVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSE-GKHRLLV 572 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~--~~--~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV 572 (852)
.+.+.+.||+|+||.||+|.+. ++ ..||||.+... ....++|.+|+.++++++||||+++++++.+ ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4556789999999999999863 22 46899998732 3345789999999999999999999998754 5688999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++|+|.+++... ...+++..++.++.||++||+|||+ .+|+||||||+||||+.++.+||+|||+++..
T Consensus 170 ~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EECCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EECCCCCCHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccc
Confidence 9999999999999543 3458899999999999999999999 89999999999999999999999999999866
Q ss_pred CCCCCc-ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcc
Q 003059 653 NPKDHR-HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730 (852)
Q Consensus 653 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (852)
...... ........+++.|+|||.+.+..++.++||||||+++|||++ |..||......+.. .....+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~-------~~~~~~~~- 314 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT-------VYLLQGRR- 314 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH-------HHHHTTCC-
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH-------HHHHcCCC-
Confidence 432211 112234557889999999999999999999999999999999 67788654332111 11111110
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 731 GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
.. .+......+.+++.+||+.||++||++.+|++.|+.+...
T Consensus 315 -~~--------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 315 -LL--------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp -CC--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -CC--------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 00 0111123567888899999999999999999999987653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=339.45 Aligned_cols=243 Identities=25% Similarity=0.320 Sum_probs=200.1
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
..|.+.+.||+|+||.||++... +++.||+|+++.. ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 35777899999999999999975 6889999999732 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 86 DYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp CCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999653 348899999999999999999998 899999999999999999999999999998754
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+.....
T Consensus 158 ~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~~---- 220 (318)
T 1fot_A 158 DV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-------TYEKILNAEL---- 220 (318)
T ss_dssp SC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHCCC----
T ss_pred Cc------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC----
Confidence 31 234579999999999999999999999999999999999999997543211 1111111111
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP-----MMGKVVQ 773 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~ev~~ 773 (852)
..+......+.+++.+|++.||.+|| ++++|++
T Consensus 221 -------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 -------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 01111123567788899999999999 8888874
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=340.36 Aligned_cols=264 Identities=22% Similarity=0.324 Sum_probs=189.3
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
.|.+.++||+|+||.||+|... +++.||+|++... ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence 5667889999999999999864 5889999998732 334467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhccc-CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 577 KNGSLDNFLFANEE-GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 577 ~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+ ++|.+++..... .....+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 7 699999865432 123458999999999999999999999 89999999999999999999999999999876432
Q ss_pred CCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhC---Cccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG---NVKG 731 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~ 731 (852)
. .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......... .......... ....
T Consensus 162 ~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 162 V---NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL---KLIFDIMGTPNESLWPS 235 (317)
T ss_dssp C---CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCTTTCGG
T ss_pred c---ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCChhHhhh
Confidence 1 122345689999999999764 6899999999999999999999999755432111 1111111000 0000
Q ss_pred c-----cccccCC-CCCCH----------HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 732 I-----VDKSLAG-EDVDI----------EQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 732 ~-----~d~~l~~-~~~~~----------~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
. ..+.+.. ..... .....+.+++.+|++.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 0000000 00000 11235778999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=345.06 Aligned_cols=257 Identities=16% Similarity=0.176 Sum_probs=205.3
Q ss_pred HHHhcccccccccccccceEEEEE------ECCCcEEEEEEecCcccchHHHHHHHHHhhccc---ccceeeeeeeeccC
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGV------LANRTVVAVKQLEGIEQGEKQFRMEVATISSTH---HLNLVRLVGFSSEG 566 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~------~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~ 566 (852)
+....|.+.++||+|+||.||+|. ...++.||||++... ...++..|++++.+++ |+||+++++++...
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 344567788899999999999994 456788999999743 3457788888887776 99999999999999
Q ss_pred ceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC---------
Q 003059 567 KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE--------- 637 (852)
Q Consensus 567 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~--------- 637 (852)
+..+|||||+++|+|.+++..........+++..++.++.||++||+|||+ .+|+||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccc
Confidence 999999999999999999976544345679999999999999999999999 89999999999999998
Q ss_pred --CCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchh
Q 003059 638 --NYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKK 715 (852)
Q Consensus 638 --~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~ 715 (852)
++.+||+|||+++.+.... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFP-KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSC-TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred cccCCEEEeeCchhhhhhccC-CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 8999999999997654221 2234455679999999999999999999999999999999999999996432211
Q ss_pred hHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCC-CCHHHHHHHHhcCcc
Q 003059 716 FSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQR-PMMGKVVQMLEGITE 780 (852)
Q Consensus 716 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~R-Pt~~ev~~~L~~~~~ 780 (852)
..+...+.. ....+ .+.+++..|++.+|.+| |+++++.+.|++...
T Consensus 293 ---------------~~~~~~~~~-~~~~~---~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 293 ---------------CKPEGLFRR-LPHLD---MWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp ---------------EEECSCCTT-CSSHH---HHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred ---------------eeechhccc-cCcHH---HHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 011122222 12233 34456667999999988 678888888887654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=351.38 Aligned_cols=251 Identities=22% Similarity=0.326 Sum_probs=201.1
Q ss_pred HhcccccccccccccceEEEEEE-CCCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
...|.+.++||+|+||.||++.. .+++.+|+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 45688899999999999999986 468899999987433 23467899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeC---CCCceEEeeccccc
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD---ENYNAKVSDFGLAK 650 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~DFGla~ 650 (852)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++ +++.+||+|||+++
T Consensus 90 E~~~gg~L~~~i~~~-----~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 90 DLVTGGELFEDIVAR-----EYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp CCCBCCBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999654 348999999999999999999999 8999999999999998 56789999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcc
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (852)
...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+..+...
T Consensus 162 ~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~ 231 (444)
T 3soa_A 162 EVEGEQ---QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-------LYQQIKAGAYD 231 (444)
T ss_dssp CCCTTC---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCCC
T ss_pred EecCCC---ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-------HHHHHHhCCCC
Confidence 765422 22234679999999999999999999999999999999999999996543211 11122222111
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 731 GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
...+... .....+.+++.+|++.||.+||++.|+++
T Consensus 232 -~~~~~~~------~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 232 -FPSPEWD------TVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -CCTTTTT------TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -CCccccc------cCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1111111 11235668888999999999999999987
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=342.51 Aligned_cols=271 Identities=17% Similarity=0.201 Sum_probs=201.0
Q ss_pred HHHHHhcccccccccccccceEEEEEEC----CCcEEEEEEecCccc------------chHHHHHHHHHhhccccccee
Q 003059 494 KELQRSTKGFKDKLGAGGFGAVYRGVLA----NRTVVAVKQLEGIEQ------------GEKQFRMEVATISSTHHLNLV 557 (852)
Q Consensus 494 ~el~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~------------~~~~f~~E~~~l~~l~h~niv 557 (852)
.++....|.+.+.||+|+||.||+|... .+..||||++..... ....+.+|+..+..++||||+
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~ 111 (345)
T 2v62_A 32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP 111 (345)
T ss_dssp ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence 3455667888999999999999999975 567899999874321 123467888999999999999
Q ss_pred eeeeeecc----CceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCce
Q 003059 558 RLVGFSSE----GKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENI 633 (852)
Q Consensus 558 ~l~g~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI 633 (852)
++++++.+ ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+||
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NI 182 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANL 182 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGE
T ss_pred eeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHE
Confidence 99999887 77899999999 999999996432 68999999999999999999999 8999999999999
Q ss_pred EeCCCC--ceEEeecccccccCCCCCc----ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccc
Q 003059 634 LLDENY--NAKVSDFGLAKLINPKDHR----HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEV 707 (852)
Q Consensus 634 Ll~~~~--~~kl~DFGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~ 707 (852)
|++.++ .+||+|||+++.+...... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 183 ll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 183 LLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp EEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999887 9999999999876432111 1111345699999999999999999999999999999999999999964
Q ss_pred cccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 708 SQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 708 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
....... .......... .....+...... ......+.+++.+|++.||.+||++.+|++.|+.+..
T Consensus 263 ~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 263 NLKDPVA--VQTAKTNLLD-ELPQSVLKWAPS----GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp GTTCHHH--HHHHHHHHHH-TTTHHHHHHSCT----TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred cccccHH--HHHHHHhhcc-cccHHHHhhccc----cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 3221111 1111111111 111111111110 0112356778889999999999999999999987643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=347.58 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=200.8
Q ss_pred HhcccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
...|.+.+.||+|+||.||++... +++.||+|++... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 356778899999999999999965 4789999998632 23456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++.+
T Consensus 94 ~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp ECCCTTEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 9999999999999643 358999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhc---CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLAN---LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+. .......
T Consensus 166 ~~~----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~----~~~~~~~- 236 (384)
T 4fr4_A 166 PRE----TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV----HTFETTV- 236 (384)
T ss_dssp CTT----CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH----HHHHHCC-
T ss_pred cCC----CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH----HHHhhcc-
Confidence 432 22345679999999999964 45899999999999999999999999754332221111 1111110
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 003059 730 KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPM-MGKVVQ 773 (852)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt-~~ev~~ 773 (852)
. ..+......+.+++.+||+.||.+||+ +.+|.+
T Consensus 237 -------~---~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 -------V---TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -------C---CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -------c---CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0 111112245778889999999999998 666664
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=350.08 Aligned_cols=271 Identities=22% Similarity=0.283 Sum_probs=211.3
Q ss_pred hcccccccccccccceEEEEEECC-CcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCc--eeeEEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK--HRLLVY 573 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV~ 573 (852)
..|.+.++||+|+||.||+|.... ++.||||++... ....+.+.+|++++++++||||+++++++.+.. ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 467788999999999999999754 889999999743 234577889999999999999999999987655 779999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEe----CCCCceEEeecccc
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL----DENYNAKVSDFGLA 649 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~DFGla 649 (852)
||+++|+|.+++..... ...+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 89 e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp CCCTTEEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred ecCCCCCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 99999999999965432 2348999999999999999999999 899999999999999 88888999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCChhhhhc--------CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHH
Q 003059 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLAN--------LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAY 721 (852)
Q Consensus 650 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 721 (852)
+...... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......... ....
T Consensus 164 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~--~~~~ 237 (396)
T 4eut_A 164 RELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--EVMY 237 (396)
T ss_dssp EECCCGG----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH--HHHH
T ss_pred eEccCCC----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH--HHHH
Confidence 8764421 2234569999999999875 567789999999999999999999997543322111 1111
Q ss_pred HHHhhCCccccc--------------ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 722 EEFEKGNVKGIV--------------DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 722 ~~~~~~~~~~~~--------------d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
.. ..+.....+ ...-............+.+++.+|++.||++||++.++++.++.+...
T Consensus 238 ~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 238 KI-ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HH-HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HH-hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 11 111111100 000111133455666788999999999999999999999999887543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=337.39 Aligned_cols=265 Identities=20% Similarity=0.318 Sum_probs=198.6
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
..|.+.+.||+|+||.||+|.. .+++.||||++... .....++.+|+.++++++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4678889999999999999996 46889999998732 233467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+++++|.+++..... ....+++..++.++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 112 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp ECCCSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred ecCCCCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999964322 24468999999999999999999999 899999999999999999999999999998664
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ . .............
T Consensus 188 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~-~~~~~~~~~~~~~- 258 (310)
T 2wqm_A 188 SKT---TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----S-LCKKIEQCDYPPL- 258 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH----H-HHHHHHTTCSCCC-
T ss_pred CCC---ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH----H-HHHHhhcccCCCC-
Confidence 321 122345689999999999999999999999999999999999999964322110 1 1111111111111
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCCCC
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKP 784 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~~~ 784 (852)
.. ......+.+++.+|++.||.+||++.+|++.|+++.+...+
T Consensus 259 ----~~----~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 259 ----PS----DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp ----CT----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred ----cc----cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 00 11123567788899999999999999999999998765443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=336.29 Aligned_cols=265 Identities=24% Similarity=0.303 Sum_probs=197.8
Q ss_pred HHHHhcccccccccccccceEEEEEE-CCCcEEEEEEecCcc------cchHHHHHHHHHhhccc---ccceeeeeeeec
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE------QGEKQFRMEVATISSTH---HLNLVRLVGFSS 564 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~------~~~~~f~~E~~~l~~l~---h~niv~l~g~~~ 564 (852)
++...+|.+.++||+|+||.||+|.. .+++.||||++.... .....+.+|++++++++ ||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 45567888999999999999999995 568899999987321 22356778888887775 999999999987
Q ss_pred cCc-----eeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC
Q 003059 565 EGK-----HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY 639 (852)
Q Consensus 565 ~~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~ 639 (852)
... ..++||||+. ++|.+++.... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~ 157 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAP---PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGG 157 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCC---TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTS
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCC
Confidence 654 5799999996 69999996543 2348999999999999999999999 8999999999999999999
Q ss_pred ceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHH
Q 003059 640 NAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLW 719 (852)
Q Consensus 640 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 719 (852)
.+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ..
T Consensus 158 ~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~ 230 (308)
T 3g33_A 158 TVKLADFGLARIYSYQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL---GK 230 (308)
T ss_dssp CEEECSCSCTTTSTTCC----CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH---HH
T ss_pred CEEEeeCccccccCCCc----ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HH
Confidence 99999999998764322 223457899999999999999999999999999999999999999754332111 11
Q ss_pred HHHHHhhCCcccc------cccccC-CCCCCHH-----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 720 AYEEFEKGNVKGI------VDKSLA-GEDVDIE-----QVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 720 ~~~~~~~~~~~~~------~d~~l~-~~~~~~~-----~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
............. ...... ....... ....+.+++.+|++.||++|||+.|+++
T Consensus 231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 231 IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1111110000000 000000 0011111 1245678899999999999999999886
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=347.70 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=193.0
Q ss_pred HhcccccccccccccceEEEEEECCCcEEEEEEecCcc---cchHHHHHHHHHhhcccc--cceeeeeeeeccCceeeEE
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIE---QGEKQFRMEVATISSTHH--LNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV 572 (852)
...|.+.++||+|+||.||++...+++.||||++.... ...+.+.+|++++.+++| +||+++++++.+.+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 34677889999999999999998889999999987332 234678999999999976 9999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|| +.+++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||||+ ++.+||+|||+++..
T Consensus 88 ~e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EC-CCSEEHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred Ee-CCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 99 5688999999653 358899999999999999999999 8999999999999997 678999999999876
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhc-----------CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHH
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLAN-----------LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAY 721 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 721 (852)
..... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........ ..
T Consensus 158 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~ 230 (343)
T 3dbq_A 158 QPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------KL 230 (343)
T ss_dssp -------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH------HH
T ss_pred Ccccc-cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH------HH
Confidence 54221 112334679999999999975 6788999999999999999999999964322100 00
Q ss_pred HHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 722 EEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 722 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.. ++++.... ..+......+.+++.+||+.||.+||++.|+++.
T Consensus 231 ~~--------~~~~~~~~-~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 231 HA--------IIDPNHEI-EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HH--------HHCTTSCC-CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH--------HhcCCccc-CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 11 11111100 1111112356788889999999999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=336.56 Aligned_cols=258 Identities=27% Similarity=0.403 Sum_probs=200.1
Q ss_pred cccccccccccccceEEEEEECC----CcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeec-cCceeeEE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLAN----RTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSS-EGKHRLLV 572 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lV 572 (852)
+|.+.++||+|+||.||+|...+ ...||+|.+... ....+.+.+|++++++++||||+++++++. .++..++|
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 105 (298)
T 3f66_A 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 105 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence 56778999999999999998643 236899998743 234567899999999999999999999864 55688999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++++|.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 106 LPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EECCTTCBHHHHHHCT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EeCCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccc
Confidence 9999999999999643 3458899999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCc-ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcc
Q 003059 653 NPKDHR-HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730 (852)
Q Consensus 653 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (852)
...... ........+|+.|+|||.+.+..++.++||||||+++|||++ |..||......... .....+..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~-------~~~~~~~~- 250 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT-------VYLLQGRR- 250 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH-------HHHHTTCC-
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH-------HHHhcCCC-
Confidence 432211 122334567889999999999999999999999999999999 55666543322110 11111110
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 731 GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
.. .+......+.+++.+|++.||.+||++.++++.|+++...
T Consensus 251 ~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 251 LL---------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp CC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CC---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 00 0111123577888999999999999999999999987653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=334.37 Aligned_cols=258 Identities=20% Similarity=0.247 Sum_probs=196.9
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCccc----chHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQ----GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
..|.+.+.||+|+||.||++... +++.||+|++..... ..+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 46888899999999999999975 688999999974322 2367889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+++++|.+++... ..+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 114 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 114 RLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp ECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999643 348999999999999999999999 899999999999999999999999999998664
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCc-ccc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNV-KGI 732 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-~~~ 732 (852)
... ........|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ........... ...
T Consensus 186 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~ 256 (309)
T 2h34_A 186 DEK--LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIPRPST 256 (309)
T ss_dssp -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCCCGGG
T ss_pred ccc--cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCCCccc
Confidence 321 12233456899999999999999999999999999999999999999754321 01111111100 001
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcCccCC
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP-MMGKVVQMLEGITEIE 782 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-t~~ev~~~L~~~~~~~ 782 (852)
..+. ....+.+++.+|++.||++|| +++++++.|+...+..
T Consensus 257 ~~~~---------~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 257 VRPG---------IPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp TSTT---------CCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred cCCC---------CCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 1111 112466788899999999999 9999999999876544
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=343.49 Aligned_cols=249 Identities=21% Similarity=0.287 Sum_probs=192.6
Q ss_pred HHHhcccccccccccccceEEEEEE----CCCcEEEEEEecCcc-----cchHHHHHHHHHhhcccccceeeeeeeeccC
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVL----ANRTVVAVKQLEGIE-----QGEKQFRMEVATISSTHHLNLVRLVGFSSEG 566 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~ 566 (852)
+....|.+.+.||+|+||.||++.. .+++.||+|+++... .....+.+|++++++++||||+++++++.+.
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 3456788899999999999999997 468899999997432 2345678999999999999999999999999
Q ss_pred ceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeec
Q 003059 567 KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDF 646 (852)
Q Consensus 567 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 646 (852)
+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+||
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Df 165 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDF 165 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeC
Confidence 9999999999999999999643 348889999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhh
Q 003059 647 GLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEK 726 (852)
Q Consensus 647 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (852)
|+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+..
T Consensus 166 g~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i~~ 235 (327)
T 3a62_A 166 GLCKESIHDG---TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-------TIDKILK 235 (327)
T ss_dssp SCC-------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHH
T ss_pred CcccccccCC---ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHh
Confidence 9997543211 12234568999999999999999999999999999999999999997543211 1111111
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003059 727 GNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP-----MMGKVVQ 773 (852)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~ev~~ 773 (852)
... ..+......+.+++.+|++.||.+|| ++.++++
T Consensus 236 ~~~-----------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 236 CKL-----------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp TCC-----------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CCC-----------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 110 01111224567888899999999999 6777765
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=333.65 Aligned_cols=267 Identities=19% Similarity=0.249 Sum_probs=205.5
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeee-ccCceeeEEEeec
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFS-SEGKHRLLVYEFM 576 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lV~e~~ 576 (852)
..|.+.+.||+|+||.||+|.. .+++.||||++.... ...++.+|++++.+++|++++..+.++ .+....++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence 4678889999999999999996 568899999876332 234688999999999988877776655 6677889999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEe---CCCCceEEeecccccccC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL---DENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFGla~~~~ 653 (852)
+++|.+++... ...+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++...
T Consensus 88 -~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 88 -GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp -CCBHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred -CCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 99999999643 2358999999999999999999999 899999999999999 789999999999998765
Q ss_pred CCCCcc----eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCc
Q 003059 654 PKDHRH----RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 654 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 432211 1223467999999999999999999999999999999999999999865433322221111111111110
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCCCC
Q 003059 730 KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKP 784 (852)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~~~ 784 (852)
.. +.. .. ...+.+++.+|++.||++||++.+|++.|+++.+....
T Consensus 240 ~~-~~~-----~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 240 EV-LCK-----GY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HH-HTT-----TS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hh-hhc-----cC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 00 000 11 13577888899999999999999999999988764443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=332.70 Aligned_cols=253 Identities=20% Similarity=0.378 Sum_probs=206.1
Q ss_pred HHHHHhcccccccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeecc-------
Q 003059 494 KELQRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSE------- 565 (852)
Q Consensus 494 ~el~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------- 565 (852)
.+.....|.+.+.||+|+||.||+|... +++.||+|++.... +.+.+|++++.+++||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 3455667888999999999999999975 68899999997433 467899999999999999999998754
Q ss_pred ---------CceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeC
Q 003059 566 ---------GKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD 636 (852)
Q Consensus 566 ---------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~ 636 (852)
....++||||+++++|.+++.... ...+++..++.++.||+.||.|||+ .+|+||||||+|||++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLV 156 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEc
Confidence 456899999999999999996542 3468999999999999999999999 8999999999999999
Q ss_pred CCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhh
Q 003059 637 ENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKF 716 (852)
Q Consensus 637 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l 716 (852)
+++.+||+|||+++...... ......|++.|+|||.+.+..++.++||||||+++|||++|..|+.....
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~------ 226 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDG----KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK------ 226 (284)
T ss_dssp ETTEEEECCCTTCEESSCCS----CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH------
T ss_pred CCCCEEECcchhheeccccc----cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH------
Confidence 99999999999998765422 12334689999999999999999999999999999999999998742210
Q ss_pred HHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 717 SLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 717 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
......... +.. ..+ ..+.+++.+|++.||.+||++.|+++.|+.+...
T Consensus 227 ---~~~~~~~~~--------~~~-~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 227 ---FFTDLRDGI--------ISD-IFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp ---HHHHHHTTC--------CCT-TSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred ---HHHHhhccc--------ccc-cCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 111111111 111 112 2456788899999999999999999999887653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=359.05 Aligned_cols=254 Identities=22% Similarity=0.240 Sum_probs=198.9
Q ss_pred HhcccccccccccccceEEEEEECC-CcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
...+.+.++||+|+||.||+|.... ++.||+|++... ......+.+|+.++..++||||++++++|.+.+..+||
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence 3456677899999999999999765 789999999732 22234589999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++|+|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++..
T Consensus 153 ~Ey~~gg~L~~~l~~~----~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 225 (437)
T ss_dssp ECCCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence 9999999999999642 2358999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhh-----cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhC
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLA-----NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG 727 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (852)
.... ........||+.|+|||++. ...++.++|||||||++|||++|+.||........ ...+...
T Consensus 226 ~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-------~~~i~~~ 296 (437)
T 4aw2_A 226 MEDG--TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-------YGKIMNH 296 (437)
T ss_dssp CTTS--CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTH
T ss_pred ccCC--CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH-------HHhhhhc
Confidence 5422 22233467999999999997 56789999999999999999999999975432211 1111100
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHH
Q 003059 728 NVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQ--RPMMGKVVQ 773 (852)
Q Consensus 728 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~--RPt~~ev~~ 773 (852)
...-.+..... .. ...+.+++.+|+..+|++ ||+++||++
T Consensus 297 ~~~~~~p~~~~--~~----s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 297 KERFQFPTQVT--DV----SENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHCCCCSSCC--CS----CHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred cccccCCcccc--cC----CHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 00000011100 11 234567778888888887 999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=331.68 Aligned_cols=270 Identities=19% Similarity=0.243 Sum_probs=208.5
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeee-ccCceeeEEEeec
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFS-SEGKHRLLVYEFM 576 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lV~e~~ 576 (852)
..|.+.+.||+|+||.||+|.. .+++.||||++.... ..+++.+|+.++.+++|++++..+.++ .+....++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 3577789999999999999996 578999999987433 335689999999999988877666655 5677889999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEe---CCCCceEEeecccccccC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL---DENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFGla~~~~ 653 (852)
+++|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||+ ++++.+||+|||+++...
T Consensus 88 -~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 88 -GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp -CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred -CCCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99999999643 2358999999999999999999999 899999999999999 588999999999998765
Q ss_pred CCCCcc----eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCc
Q 003059 654 PKDHRH----RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 654 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 432211 1123457999999999999999999999999999999999999999865433222211111111111110
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCCCCCCC
Q 003059 730 KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPPAP 787 (852)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~~~~~~ 787 (852)
.. +.+ .. ...+.+++.+|++.||.+||++.+|++.|+.+......+..
T Consensus 240 ~~-~~~-----~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~ 287 (296)
T 3uzp_A 240 EV-LCK-----GY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 287 (296)
T ss_dssp HH-HTT-----TS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSS
T ss_pred HH-HHh-----hC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccc
Confidence 00 001 11 13577888999999999999999999999988765544433
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=343.08 Aligned_cols=265 Identities=25% Similarity=0.380 Sum_probs=209.5
Q ss_pred HHHHhcccccccccccccceEEEEEEC------CCcEEEEEEecCcc--cchHHHHHHHHHhhcccccceeeeeeeeccC
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLA------NRTVVAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRLVGFSSEG 566 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~ 566 (852)
++....|.+.+.||+|+||.||+|... .++.||||.+.... ....++.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 445567888999999999999999864 36789999997432 3345789999999999999999999999999
Q ss_pred ceeeEEEeecCCCCHHHHhhhccc-----CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCce
Q 003059 567 KHRLLVYEFMKNGSLDNFLFANEE-----GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNA 641 (852)
Q Consensus 567 ~~~~lV~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 641 (852)
+..++||||+++++|.+++..... .....+++..+++++.||+.||+|||+ ++|+||||||+|||++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeE
Confidence 999999999999999999965321 112457899999999999999999999 899999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHH
Q 003059 642 KVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWA 720 (852)
Q Consensus 642 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 720 (852)
||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... .
T Consensus 178 kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~ 249 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------V 249 (322)
T ss_dssp EECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-------H
T ss_pred EECcCccccccccccc-cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH-------H
Confidence 9999999986543211 111123346889999999999999999999999999999999 899997543211 1
Q ss_pred HHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 721 YEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 721 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
......+.... .+......+.+++.+|++.||.+||++.++++.|+++.+
T Consensus 250 ~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 250 LRFVMEGGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHcCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11111211111 111122356778889999999999999999999988754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=334.10 Aligned_cols=256 Identities=26% Similarity=0.370 Sum_probs=201.4
Q ss_pred HhcccccccccccccceEEEEEECC----CcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeE
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLAN----RTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLL 571 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 571 (852)
...|.+.+.||+|+||.||+|...+ +..||+|.+... ....+.+.+|+.++++++||||+++++++.++ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 4567788999999999999998643 346999998743 33457799999999999999999999998754 5689
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
||||+++++|.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 90 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 99999999999999653 2358899999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcc
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (852)
...... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ ......+...
T Consensus 163 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~-------~~~~~~~~~~ 233 (281)
T 3cc6_A 163 IEDEDY--YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV-------IGVLEKGDRL 233 (281)
T ss_dssp C-----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH-------HHHHHHTCCC
T ss_pred cccccc--cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH-------HHHHhcCCCC
Confidence 643211 12233457889999999999999999999999999999998 9999975432211 1111111100
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 731 GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
+.+......+.+++.+|++.||.+||++.++++.|+.+..
T Consensus 234 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 234 ----------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 0011112356788889999999999999999999988754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=343.52 Aligned_cols=266 Identities=27% Similarity=0.391 Sum_probs=209.6
Q ss_pred HHHHhcccccccccccccceEEEEEE------CCCcEEEEEEecCcc--cchHHHHHHHHHhhcc-cccceeeeeeeecc
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVL------ANRTVVAVKQLEGIE--QGEKQFRMEVATISST-HHLNLVRLVGFSSE 565 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~--~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~ 565 (852)
++....|.+.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|++++.++ +||||+++++++.+
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence 44566788899999999999999984 346789999997432 3346789999999999 79999999999877
Q ss_pred Cc-eeeEEEeecCCCCHHHHhhhcccC-----------CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCce
Q 003059 566 GK-HRLLVYEFMKNGSLDNFLFANEEG-----------SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENI 633 (852)
Q Consensus 566 ~~-~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI 633 (852)
.+ ..++||||+++++|.+++...... ....+++..++.++.||++||.|||+ .+|+||||||+||
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Ni 179 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNI 179 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceE
Confidence 54 589999999999999999754321 02238899999999999999999999 8999999999999
Q ss_pred EeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCcccccccccc
Q 003059 634 LLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETN 712 (852)
Q Consensus 634 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~ 712 (852)
|++.++.+||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 258 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred EECCCCCEEECCCccccccccCcc-ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence 999999999999999987654322 122334567899999999999999999999999999999998 999997543221
Q ss_pred chhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 713 RKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 713 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
. .......+.... . +......+.+++.+|++.||.+||++.+|++.|+.+.+
T Consensus 259 ~------~~~~~~~~~~~~-----~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 259 E------FCRRLKEGTRMR-----A-----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp H------HHHHHHHTCCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H------HHHHhccCccCC-----C-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1 111111111110 1 11112356788889999999999999999999988754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=345.44 Aligned_cols=271 Identities=15% Similarity=0.157 Sum_probs=207.4
Q ss_pred HhcccccccccccccceEEEEEECC---------CcEEEEEEecCcccchHHHHHHHHHhhcccccceee----------
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLAN---------RTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVR---------- 558 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~---------- 558 (852)
...|.+.+.||+|+||.||+|.... ++.||||.+... +.+.+|++++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 4578888999999999999999763 788999998743 46889999999999999998
Q ss_pred -----eeeeecc-CceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCc
Q 003059 559 -----LVGFSSE-GKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPEN 632 (852)
Q Consensus 559 -----l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 632 (852)
+++++.. ++..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+ .+|+||||||+|
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~N 189 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAEN 189 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGG
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHH
Confidence 5666665 67889999999 999999997542 3469999999999999999999999 899999999999
Q ss_pred eEeCCCC--ceEEeecccccccCCCCCc----ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCcccc
Q 003059 633 ILLDENY--NAKVSDFGLAKLINPKDHR----HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFE 706 (852)
Q Consensus 633 ILl~~~~--~~kl~DFGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~ 706 (852)
||++.++ .+||+|||+++.+...... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 9999999999876432111 111133468999999999999999999999999999999999999997
Q ss_pred ccccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCCCCCC
Q 003059 707 VSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPPA 786 (852)
Q Consensus 707 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~~~~~ 786 (852)
........ +.. ...... .....+.+........ ...+.+++.+|++.||.+||++.+|++.|+++.+......
T Consensus 270 ~~~~~~~~-~~~-~~~~~~-~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 342 (352)
T 2jii_A 270 NCLPNTED-IMK-QKQKFV-DKPGPFVGPCGHWIRP----SETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSP 342 (352)
T ss_dssp GGTTCHHH-HHH-HHHHHH-HSCCCEECTTSCEECC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCT
T ss_pred cCCcCHHH-HHH-HHHhcc-CChhhhhhhccccCCC----cHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCc
Confidence 65322111 111 111111 1111222211110011 2456778888999999999999999999998876544433
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=343.91 Aligned_cols=251 Identities=23% Similarity=0.354 Sum_probs=202.4
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc-ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
..|.+.++||+|+||.||+|... +++.||+|.+... ......+.+|++++.+++||||+++++++.+....++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 46788899999999999999975 5889999998743 334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC--CCceEEeecccccccCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE--NYNAKVSDFGLAKLINP 654 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~kl~DFGla~~~~~ 654 (852)
++|+|.+++... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++....
T Consensus 131 ~gg~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 131 SGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999998543 2358999999999999999999999 89999999999999974 57899999999987754
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........... .+
T Consensus 204 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------~~~~i~~~~~~--~~ 270 (387)
T 1kob_A 204 DE----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCDWE--FD 270 (387)
T ss_dssp TS----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHHCCCC--CC
T ss_pred Cc----ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC--CC
Confidence 22 2344579999999999999999999999999999999999999997543211 01111111110 01
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
... .......+.+++.+||+.||.+||++.|+++.
T Consensus 271 ~~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 271 EDA-----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp SST-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 100 01112356788999999999999999999863
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=340.25 Aligned_cols=248 Identities=20% Similarity=0.282 Sum_probs=196.3
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCcc----cchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE----QGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 572 (852)
..|.+.+.||+|+||.||++... +++.||+|++.... ...+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 35777889999999999999975 58899999997432 2345678899999887 899999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++..
T Consensus 89 ~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999999643 348999999999999999999999 89999999999999999999999999999864
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccch--hhHHHHHHHHhhCCcc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRK--KFSLWAYEEFEKGNVK 730 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~ 730 (852)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ...............
T Consensus 161 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~- 236 (345)
T 3a8x_A 161 LRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI- 236 (345)
T ss_dssp CCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-
T ss_pred cCCC---CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-
Confidence 3221 1234467999999999999999999999999999999999999999753221110 111111222222111
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 003059 731 GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMM 768 (852)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~ 768 (852)
..+......+.+++.+||+.||.+||++
T Consensus 237 ----------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 ----------RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ----------CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 0111122356788889999999999996
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=345.27 Aligned_cols=206 Identities=28% Similarity=0.374 Sum_probs=180.3
Q ss_pred cCHHHHHHhcccccccccccccceEEEEEE-CCCcEEEEEEecCcccchHHHHHHHHHhhccc-----ccceeeeeeeec
Q 003059 491 FSYKELQRSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVATISSTH-----HLNLVRLVGFSS 564 (852)
Q Consensus 491 ~~~~el~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~-----h~niv~l~g~~~ 564 (852)
+...++....|.+.++||+|+||.||+|.. .+++.||||++.........+..|++++.+++ ||||+++++++.
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 344455567888899999999999999997 46889999999866666677889999999886 999999999999
Q ss_pred cCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC-------
Q 003059 565 EGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE------- 637 (852)
Q Consensus 565 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~------- 637 (852)
..+..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+ .+|+||||||+||||+.
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNN---YNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEE
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccc
Confidence 999999999999 999999997543 2358899999999999999999998 89999999999999975
Q ss_pred ------------------CCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHH
Q 003059 638 ------------------NYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIV 699 (852)
Q Consensus 638 ------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ell 699 (852)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||+
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCCC------CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 889999999999865432 23456899999999999999999999999999999999
Q ss_pred hCCccccccc
Q 003059 700 SGRRNFEVSQ 709 (852)
Q Consensus 700 tG~~p~~~~~ 709 (852)
+|+.||....
T Consensus 254 ~g~~pf~~~~ 263 (360)
T 3llt_A 254 TGSLLFRTHE 263 (360)
T ss_dssp HSSCSCCCSS
T ss_pred HCCCCCCCCc
Confidence 9999997543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=352.24 Aligned_cols=252 Identities=20% Similarity=0.269 Sum_probs=199.6
Q ss_pred HhcccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
...|.+.++||+|+||.||++... +++.||+|++... ....+.+.+|+.++..++||||+++++++.+.+..|+|
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 147 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 345677889999999999999975 4789999998632 23345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++|+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++..
T Consensus 148 ~E~~~gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 148 MEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218 (410)
T ss_dssp ECCCTTEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence 9999999999998532 38899999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCC----CCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLP----ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN 728 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (852)
.... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||........ ...+....
T Consensus 219 ~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-------~~~i~~~~ 289 (410)
T 3v8s_A 219 NKEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-------YSKIMNHK 289 (410)
T ss_dssp CTTS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTHH
T ss_pred ccCC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH-------HHHHHhcc
Confidence 5421 12233567999999999998765 78999999999999999999999975432111 11111100
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 003059 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQ--RPMMGKVVQM 774 (852)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~--RPt~~ev~~~ 774 (852)
. .+ .... .......+.+++.+|++.+|.+ ||+++||++.
T Consensus 290 ~-~~---~~p~---~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 290 N-SL---TFPD---DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp H-HC---CCCT---TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred c-cc---cCCC---cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0 00 0000 0011235667788899999988 9999999863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=333.28 Aligned_cols=252 Identities=29% Similarity=0.390 Sum_probs=197.4
Q ss_pred HhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccC-ceeeEEEeec
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEG-KHRLLVYEFM 576 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV~e~~ 576 (852)
...|.+.+.||+|+||.||++... ++.||||.++... ..+.+.+|++++.+++||||+++++++.+. +..++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 456788899999999999999875 7789999997433 456799999999999999999999987554 5789999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 98 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 98 AKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 170 (278)
T ss_dssp TTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence 9999999996432 2347899999999999999999999 89999999999999999999999999999865321
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ ......+. ..
T Consensus 171 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-------~~~~~~~~-----~~ 233 (278)
T 1byg_A 171 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRVEKGY-----KM 233 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-------HHHHTTTC-----CC
T ss_pred -----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHhcCC-----CC
Confidence 123457889999999999999999999999999999998 9999975432211 11111111 00
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
..+......+.+++.+|++.||.+||++.++++.|+.+..
T Consensus 234 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 234 -----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 1111122456778889999999999999999999998754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=340.62 Aligned_cols=249 Identities=24% Similarity=0.347 Sum_probs=177.7
Q ss_pred ccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhccc-ccceeeeeeeeccCceeeEEEeecCCCCHH
Q 003059 505 DKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISSTH-HLNLVRLVGFSSEGKHRLLVYEFMKNGSLD 582 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 582 (852)
+.||+|+||.||++... +++.||||++.. .....+.+|+.++.+++ ||||+++++++.+....++||||+++|+|.
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 94 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEG--GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEECh--hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence 67999999999999975 588999999973 24567889999999997 999999999999999999999999999999
Q ss_pred HHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC---ceEEeecccccccCCCCCcc
Q 003059 583 NFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY---NAKVSDFGLAKLINPKDHRH 659 (852)
Q Consensus 583 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~DFGla~~~~~~~~~~ 659 (852)
+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++......
T Consensus 95 ~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--- 163 (325)
T 3kn6_A 95 ERIKKK-----KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--- 163 (325)
T ss_dssp HHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC---
Confidence 999653 358999999999999999999998 8999999999999997665 89999999998664321
Q ss_pred eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCC
Q 003059 660 RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAG 739 (852)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (852)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||..................+..+... ...
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~ 237 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEG 237 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCS
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCc
Confidence 22344568999999999999999999999999999999999999997653321111111112222221110 000
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 740 EDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 740 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.........+.+++.+|++.||.+||++.++++
T Consensus 238 -~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 238 -EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp -HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred -ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 000011245778899999999999999999874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=340.88 Aligned_cols=249 Identities=24% Similarity=0.339 Sum_probs=186.4
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
..|.+.++||+|+||.||+|... +++.||||++.... ..+.+.+|++++.+++||||+++++++.+.+..++||||++
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 45778889999999999999976 47889999998443 34678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC---CCceEEeecccccccCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE---NYNAKVSDFGLAKLINP 654 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFGla~~~~~ 654 (852)
+++|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++....
T Consensus 132 ~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 132 GGELFDRIVEK-----GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp SCBHHHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999999543 348999999999999999999999 89999999999999975 89999999999987643
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .....+...... ...
T Consensus 204 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~~~~~-~~~ 272 (349)
T 2w4o_A 204 Q----VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILNCEYY-FIS 272 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHTTCCC-CCT
T ss_pred c----cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHhCCCc-cCC
Confidence 2 12234568999999999999999999999999999999999999996443211 111112211110 111
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+.. .+....+.+++.+|++.||++||++.++++
T Consensus 273 ~~~------~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 273 PWW------DEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTT------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred chh------hhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 112235678899999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=346.59 Aligned_cols=262 Identities=25% Similarity=0.325 Sum_probs=188.5
Q ss_pred HHHhcccccccccccccceEEEEEEC-CCcEEEEEEec-CcccchHHHHHHHHHhhccc-ccceeeeeeee--------c
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLE-GIEQGEKQFRMEVATISSTH-HLNLVRLVGFS--------S 564 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~-~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~--------~ 564 (852)
+...+|.+.++||+|+||.||++... +++.||||++. ......+.+.+|+.++.++. ||||+++++++ .
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 34457888899999999999999964 68899999886 33344567899999999996 99999999998 3
Q ss_pred cCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCC--cccCCCCCCceEeCCCCceE
Q 003059 565 EGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC--IVHCDIKPENILLDENYNAK 642 (852)
Q Consensus 565 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NILl~~~~~~k 642 (852)
.....++||||+. |+|.+++..... ...+++..++.++.||+.||+|||+ .+ |+||||||+||||+.++.+|
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEE
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEE
Confidence 4556899999995 799999865322 3459999999999999999999998 67 99999999999999999999
Q ss_pred EeecccccccCCCCCcc---------eeeeeecCCCCCCChhhh---hcCCCCCCccchhhhHHHHHHHhCCcccccccc
Q 003059 643 VSDFGLAKLINPKDHRH---------RTLTSVRGTRGYLAPEWL---ANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQE 710 (852)
Q Consensus 643 l~DFGla~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~---~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~ 710 (852)
|+|||+++......... .......||+.|+|||.+ .+..++.++||||||+++|||++|+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 99999998765432211 111234589999999998 566788999999999999999999999964322
Q ss_pred ccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCCC
Q 003059 711 TNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEK 783 (852)
Q Consensus 711 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~~ 783 (852)
.. ....... . .........+.+++.+||+.||.+||++.|+++.|+.+.....
T Consensus 259 ~~-----------~~~~~~~----~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 259 LR-----------IVNGKYS----I-----PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp ------------------CC----C-----CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred HH-----------hhcCccc----C-----CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 10 0000000 0 0000111235678888999999999999999999998875433
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=344.81 Aligned_cols=248 Identities=23% Similarity=0.309 Sum_probs=200.2
Q ss_pred HHHhcccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcc-cccceeeeeeeeccCcee
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHR 569 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 569 (852)
+....|.+.+.||+|+||.||+|... +++.||||+++.. ....+.+..|..++.++ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34456778899999999999999975 5889999999743 33456678899999877 999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||++
T Consensus 94 ~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 9999999999999999643 348899999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCc
Q 003059 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 650 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+....
T Consensus 166 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~- 234 (345)
T 1xjd_A 166 KENMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDN- 234 (345)
T ss_dssp BCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCC-
T ss_pred hhcccCC---CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHhCC-
Confidence 8643221 12345679999999999999999999999999999999999999997543211 111111111
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 003059 730 KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMG-KVV 772 (852)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~-ev~ 772 (852)
... +......+.+++.+|++.||.+||++. +|+
T Consensus 235 -----~~~-----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 -----PFY-----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -----CCC-----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -----CCC-----CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 011 111123567888999999999999997 665
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=341.13 Aligned_cols=241 Identities=25% Similarity=0.322 Sum_probs=199.4
Q ss_pred HhcccccccccccccceEEEEEE-CCCcEEEEEEecCccc---------chHHHHHHHHHhhcccccceeeeeeeeccCc
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQ---------GEKQFRMEVATISSTHHLNLVRLVGFSSEGK 567 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~ 567 (852)
...|.+.+.||+|+||.||+|.. .+++.||||++..... ..+.+.+|++++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 45688889999999999999995 4688999999974321 3346788999999999999999999999999
Q ss_pred eeeEEEeecCCC-CHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeec
Q 003059 568 HRLLVYEFMKNG-SLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDF 646 (852)
Q Consensus 568 ~~~lV~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 646 (852)
..++||||+.+| +|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH-----PRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCC
T ss_pred EEEEEEEeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeec
Confidence 999999999777 999999643 348999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCChhhhhcCCC-CCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHh
Q 003059 647 GLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPI-TSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFE 725 (852)
Q Consensus 647 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 725 (852)
|+++...... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......
T Consensus 175 g~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------- 236 (335)
T 3dls_A 175 GSAAYLERGK----LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------------- 236 (335)
T ss_dssp TTCEECCTTC----CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------
T ss_pred ccceECCCCC----ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------
Confidence 9998765432 2234679999999999988876 78999999999999999999999642211
Q ss_pred hCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 726 KGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
....... +......+.+++.+|++.||++||++.++++.
T Consensus 237 -------~~~~~~~---~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -------VEAAIHP---PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -------TTTCCCC---SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -------HhhccCC---CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111100 00112356788889999999999999999874
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=343.45 Aligned_cols=249 Identities=23% Similarity=0.330 Sum_probs=195.3
Q ss_pred cccccccccceEEEEEE-CCCcEEEEEEecCcc-cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCCH
Q 003059 504 KDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE-QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSL 581 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 581 (852)
.+.||+|+||.||+|.. .+++.||+|++.... ...+++.+|++++.+++||||+++++++.+.+..+|||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 46799999999999996 458899999998433 4567899999999999999999999999999999999999999999
Q ss_pred HHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEe--CCCCceEEeecccccccCCCCCcc
Q 003059 582 DNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL--DENYNAKVSDFGLAKLINPKDHRH 659 (852)
Q Consensus 582 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl--~~~~~~kl~DFGla~~~~~~~~~~ 659 (852)
.+++... ...+++..++.++.||++||+|||+ .+|+||||||+|||+ +.++.+||+|||+++......
T Consensus 174 ~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--- 243 (373)
T 2x4f_A 174 FDRIIDE----SYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--- 243 (373)
T ss_dssp HHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---
Confidence 9998643 2358899999999999999999999 899999999999999 677899999999998765432
Q ss_pred eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCC
Q 003059 660 RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAG 739 (852)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (852)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+...... .......
T Consensus 244 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~~~~i~~~~~~-~~~~~~~- 313 (373)
T 2x4f_A 244 -KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-------TLNNILACRWD-LEDEEFQ- 313 (373)
T ss_dssp -BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCCC-SCSGGGT-
T ss_pred -ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhccCC-CChhhhc-
Confidence 1233469999999999999999999999999999999999999997543221 01111111110 0011110
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 003059 740 EDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ--MLEG 777 (852)
Q Consensus 740 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~--~L~~ 777 (852)
.....+.+++.+|++.||.+||++.|+++ .+..
T Consensus 314 -----~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 314 -----DISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp -----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred -----cCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 11245678899999999999999999987 4443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=348.28 Aligned_cols=205 Identities=20% Similarity=0.214 Sum_probs=175.0
Q ss_pred hccccccccccc--ccceEEEEEEC-CCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 499 STKGFKDKLGAG--GFGAVYRGVLA-NRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 499 ~~~~~~~~lG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
..|.+.++||+| +||.||++... +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 467888999999 99999999975 68899999997432 3346688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++|+|.+++.... ...+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||.+...
T Consensus 105 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHF---MDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EECCTTCBHHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEccCCCCHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999996542 2358999999999999999999999 89999999999999999999999999998654
Q ss_pred CCCCCc----ceeeeeecCCCCCCChhhhhc--CCCCCCccchhhhHHHHHHHhCCccccccc
Q 003059 653 NPKDHR----HRTLTSVRGTRGYLAPEWLAN--LPITSKSDVYSYGMVLLEIVSGRRNFEVSQ 709 (852)
Q Consensus 653 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~s~Gvvl~elltG~~p~~~~~ 709 (852)
...... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 221111 011122468899999999987 678999999999999999999999997543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=333.25 Aligned_cols=261 Identities=20% Similarity=0.267 Sum_probs=195.8
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
.|.+.++||+|+||.||+|... +++.||||++.... .....+.+|+.++++++||||+++++++.+++..++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 4677899999999999999975 58899999997332 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+++ +|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~-~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 83 CDQ-DLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CSE-EHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred CCC-CHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 975 566655432 2458999999999999999999999 89999999999999999999999999999876432
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCC-CCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCc-----
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLP-ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNV----- 729 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~----- 729 (852)
. .......||+.|+|||.+.+.. ++.++||||||+++|||++|..||....... ...............
T Consensus 155 ~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 155 V---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp C---SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTT
T ss_pred c---ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhhhh
Confidence 1 2223456899999999998765 7999999999999999999988864322111 111111111110000
Q ss_pred -cccccc--------ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 730 -KGIVDK--------SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 730 -~~~~d~--------~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
....+. ..............+.+++.+|++.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000000 00000011122345678889999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=328.31 Aligned_cols=251 Identities=24% Similarity=0.346 Sum_probs=195.8
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
..|.+.++||+|+||.||++... +++.||+|++... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46888999999999999999974 5789999998743 33457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEe---CCCCceEEeeccccccc
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL---DENYNAKVSDFGLAKLI 652 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFGla~~~ 652 (852)
+++++|.+++..... ....+++..++.++.||++||+|||+ .+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 102 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 102 CEGGELLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CSCCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred CCCCcHHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999965422 13568999999999999999999999 899999999999999 45688999999999866
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI 732 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (852)
... .......||+.|+|||.+. ..++.++||||||+++|||++|+.||........ ...........
T Consensus 178 ~~~----~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~-------~~~~~~~~~~~- 244 (285)
T 3is5_A 178 KSD----EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV-------QQKATYKEPNY- 244 (285)
T ss_dssp -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCCC-
T ss_pred CCc----ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH-------HhhhccCCccc-
Confidence 432 1234456899999999986 5689999999999999999999999975432111 01111110000
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
....... ...+.+++.+|++.||.+||++.||++
T Consensus 245 ---~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 ---AVECRPL----TPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ---CC--CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ---ccccCcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000011 235667888999999999999999985
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=342.42 Aligned_cols=243 Identities=21% Similarity=0.236 Sum_probs=200.8
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
..|.+.+.||+|+||.||++... +++.||+|++... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 46777889999999999999975 5889999999632 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 121 e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999999653 248899999999999999999998 899999999999999999999999999998764
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
.. .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+..+...
T Consensus 193 ~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~~--- 256 (350)
T 1rdq_E 193 GR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGKVR--- 256 (350)
T ss_dssp SC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC---
T ss_pred CC------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-------HHHHHHcCCCC---
Confidence 32 233568999999999999999999999999999999999999997543211 11222222110
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPM-----MGKVVQ 773 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt-----~~ev~~ 773 (852)
.+......+.+++.+|++.||.+||+ +++|++
T Consensus 257 --------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 --------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11112235678889999999999998 788775
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=342.56 Aligned_cols=249 Identities=22% Similarity=0.294 Sum_probs=200.1
Q ss_pred HHHhcccccccccccccceEEEEEECC-CcEEEEEEecCc----ccchHHHHHHHHHhhcc-cccceeeeeeeeccCcee
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGI----EQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHR 569 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 569 (852)
+....|.+.+.||+|+||.||++.... ++.||||++... ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 344567888999999999999999764 788999999742 23456788999999988 899999999999999999
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
|+||||+++|+|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||++
T Consensus 97 ~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a 168 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMC 168 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence 9999999999999999643 248899999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCc
Q 003059 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 650 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+.....
T Consensus 169 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~~ 238 (353)
T 2i0e_A 169 KENIWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-------LFQSIMEHNV 238 (353)
T ss_dssp BCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC
T ss_pred cccccCC---cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH-------HHHHHHhCCC
Confidence 8643221 22345679999999999999999999999999999999999999997543211 1111111111
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003059 730 KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPM-----MGKVVQ 773 (852)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt-----~~ev~~ 773 (852)
..+......+.+++.+|++.||.+||+ +++|++
T Consensus 239 -----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 -----------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -----------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 011112245678889999999999996 466654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=338.60 Aligned_cols=265 Identities=27% Similarity=0.403 Sum_probs=198.6
Q ss_pred HHHHhcccccccccccccceEEEEEEC----CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCc
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLA----NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK 567 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~ 567 (852)
.+....|.+.+.||+|+||.||+|... .++.||+|++... ....+.+.+|+.++.+++||||+++++++.+..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 344566778889999999999999854 3458999998733 233467899999999999999999999988755
Q ss_pred -----eeeEEEeecCCCCHHHHhhhccc-CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCce
Q 003059 568 -----HRLLVYEFMKNGSLDNFLFANEE-GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNA 641 (852)
Q Consensus 568 -----~~~lV~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 641 (852)
..++||||+++++|.+++..... .....+++..++.++.||++||.|||+ .+|+||||||+|||++.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcE
Confidence 35999999999999999964332 234579999999999999999999998 899999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHH
Q 003059 642 KVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWA 720 (852)
Q Consensus 642 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 720 (852)
||+|||+++....... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 187 kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------- 258 (313)
T 3brb_A 187 CVADFGLSKKIYSGDY-YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM------- 258 (313)
T ss_dssp EECSCSCC-----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-------
T ss_pred EEeecCcceecccccc-cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-------
Confidence 9999999987643221 122233457889999999999999999999999999999999 8899975432211
Q ss_pred HHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 721 YEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 721 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
......+... ..+......+.+++.+|++.||.+||++.+|++.|+.+.+
T Consensus 259 ~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 259 YDYLLHGHRL----------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp HHHHHTTCCC----------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCCC----------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111111110 1111122457788899999999999999999999988754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=334.83 Aligned_cols=258 Identities=26% Similarity=0.359 Sum_probs=200.5
Q ss_pred cccccccccccccceEEEEEECC----CcEEEEEEecCcc--cchHHHHHHHHHhhcccccceeeeeeeeccCcee-eEE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLAN----RTVVAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHR-LLV 572 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~-~lV 572 (852)
.+...++||+|+||.||+|...+ +..||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 34456899999999999998532 2379999997433 3456789999999999999999999999876655 999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+.+++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 102 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP----QRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp ECCCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred EecccCCCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 9999999999999642 3468899999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCC-cceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccc-cccccccchhhHHHHHHHHhhCCcc
Q 003059 653 NPKDH-RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNF-EVSQETNRKKFSLWAYEEFEKGNVK 730 (852)
Q Consensus 653 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~-~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (852)
..... .........+++.|+|||.+.+..++.++||||||+++|||++|..|+ ....... + ..........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~----~~~~~~~~~~ 247 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---L----THFLAQGRRL 247 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---H----HHHHHTTCCC
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---H----HHHhhcCCCC
Confidence 43211 111223355788999999999999999999999999999999966554 3322211 1 1111111100
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 731 GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
..+......+.+++.+|++.||.+||++.++++.|+++.+.
T Consensus 248 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 248 ----------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11111123577888999999999999999999999987654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=339.24 Aligned_cols=261 Identities=28% Similarity=0.429 Sum_probs=204.3
Q ss_pred HhcccccccccccccceEEEEEEC-CCcE--EEEEEecC--cccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeE
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTV--VAVKQLEG--IEQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLL 571 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~--vavK~l~~--~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 571 (852)
...|.+.+.||+|+||.||+|... ++.. |++|.+.. .....+.+.+|++++.++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 356788899999999999999964 4554 49998873 234456789999999999 99999999999999999999
Q ss_pred EEeecCCCCHHHHhhhccc-----------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCc
Q 003059 572 VYEFMKNGSLDNFLFANEE-----------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYN 640 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 640 (852)
||||+++++|.+++..... .....+++..++.++.||++||+|||+ .+|+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCe
Confidence 9999999999999975431 223468999999999999999999999 89999999999999999999
Q ss_pred eEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHH
Q 003059 641 AKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLW 719 (852)
Q Consensus 641 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 719 (852)
+||+|||+++.... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 181 ~kL~Dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------- 249 (327)
T 1fvr_A 181 AKIADFGLSRGQEV----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------- 249 (327)
T ss_dssp EEECCTTCEESSCE----ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------
T ss_pred EEEcccCcCccccc----cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-------
Confidence 99999999974321 111233457889999999999899999999999999999998 999997543211
Q ss_pred HHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCC
Q 003059 720 AYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIE 782 (852)
Q Consensus 720 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~ 782 (852)
....+..+. .. ..+......+.+++.+|++.||.+||++.++++.|+.+.+..
T Consensus 250 ~~~~~~~~~-----~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 250 LYEKLPQGY-----RL-----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp HHHHGGGTC-----CC-----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHhhcCC-----CC-----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 111111110 00 111112245678889999999999999999999999876544
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=329.89 Aligned_cols=246 Identities=24% Similarity=0.365 Sum_probs=180.1
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.|.+.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (278)
T 3cok_A 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE 91 (278)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence 577788999999999999996 56889999999632 2234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++++|.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 92 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 92 MCHNGEMNRYLKNR----VKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp CCTTEEHHHHHHTC----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred cCCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999643 3468999999999999999999999 8999999999999999999999999999987643
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ ...+..
T Consensus 165 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------------~~~~~~ 226 (278)
T 3cok_A 165 PHE---KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---------------LNKVVL 226 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCS
T ss_pred CCC---cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---------------HHHHhh
Confidence 211 12235689999999999998999999999999999999999999975432110 000110
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
... ..+......+.+++.+|++.||.+||++.++++
T Consensus 227 ~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 227 ADY---EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SCC---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccc---CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 000 111112235678899999999999999999876
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=339.05 Aligned_cols=265 Identities=23% Similarity=0.321 Sum_probs=203.6
Q ss_pred HHhcccccccccccccceEEEEEE-CCCcEEEEEEec-CcccchHHHHHHHHHhhcccccceeeeeeeec----cCceee
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLE-GIEQGEKQFRMEVATISSTHHLNLVRLVGFSS----EGKHRL 570 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~-~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~----~~~~~~ 570 (852)
....|.+.+.||+|+||.||++.. .+++.||||++. ......+.+.+|++++++++||||+++++++. .....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 345788899999999999999996 568899999986 33445677899999999999999999999986 345889
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+||||+++++|.+++..... ....+++..++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 107 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEeCCCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 99999999999999975322 24568999999999999999999999 899999999999999999999999999987
Q ss_pred ccCCCCCcc------eeeeeecCCCCCCChhhhhcCC---CCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHH
Q 003059 651 LINPKDHRH------RTLTSVRGTRGYLAPEWLANLP---ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAY 721 (852)
Q Consensus 651 ~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~---~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~ 721 (852)
......... .......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||.......... .
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~---- 257 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV-A---- 257 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH-H----
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh-h----
Confidence 643210000 0011235799999999987554 6899999999999999999999996432111110 0
Q ss_pred HHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 722 EEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 722 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
..... .. .. +........+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 258 ~~~~~-~~------~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 258 LAVQN-QL------SI---PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HHHHC-C--------C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred HHhhc-cC------CC---CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 00010 00 00 1111122457788899999999999999999999998754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=348.47 Aligned_cols=250 Identities=22% Similarity=0.329 Sum_probs=193.2
Q ss_pred hcccccccccccccceEEEEEECCCcEEEEEEecCc---ccchHHHHHHHHHhhccc--ccceeeeeeeeccCceeeEEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGI---EQGEKQFRMEVATISSTH--HLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lV~ 573 (852)
..|.+.++||+|+||.||++...+++.||||++... ....+.+.+|+.++.+++ ||||+++++++...+..+|||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 457888999999999999999888999999998633 234467899999999996 599999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
| +.+++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||||+ ++.+||+|||+++.+.
T Consensus 136 E-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp E-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred e-cCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 9 5688999999653 257888999999999999999998 8999999999999995 5899999999998764
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhc-----------CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHH
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLAN-----------LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYE 722 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 722 (852)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...
T Consensus 206 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~------~~~ 278 (390)
T 2zmd_A 206 PDTT-SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------KLH 278 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHH
T ss_pred CCCc-cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH------HHH
Confidence 3211 112234569999999999975 3688999999999999999999999964321100 011
Q ss_pred HHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 723 EFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 723 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.. ++..... ..+......+.+++.+||+.||.+||++.||++.
T Consensus 279 ~~--------~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 279 AI--------IDPNHEI-EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HH--------HCTTSCC-CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH--------hCccccC-CCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11 1111100 0111112356788889999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=348.35 Aligned_cols=278 Identities=22% Similarity=0.283 Sum_probs=212.1
Q ss_pred hccCCCcccCHHHHHHhcccccccccccccceEEEEEE-CCCcEEEEEEecCcccchHHHHHHHHHhhccc--------c
Q 003059 483 YASGAPVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVATISSTH--------H 553 (852)
Q Consensus 483 ~~~~~~~~~~~~el~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~--------h 553 (852)
+..+....+...++....|.+.++||+|+||.||+|.. .+++.||||++.......+.+.+|++++++++ |
T Consensus 21 ~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~ 100 (397)
T 1wak_A 21 YCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNR 100 (397)
T ss_dssp -CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGG
T ss_pred CCCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCc
Confidence 33444556667777778899999999999999999986 45889999999866666678899999999986 8
Q ss_pred cceeeeeeeec----cCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCC-CcccCCC
Q 003059 554 LNLVRLVGFSS----EGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD-CIVHCDI 628 (852)
Q Consensus 554 ~niv~l~g~~~----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dl 628 (852)
+||+++++++. +....++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+ + +|+||||
T Consensus 101 ~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDi 173 (397)
T 1wak_A 101 EMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDI 173 (397)
T ss_dssp GGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCC
T ss_pred ceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCC
Confidence 88999999987 667899999999 667777775432 2458999999999999999999998 7 8999999
Q ss_pred CCCceEeCCCC-------------------------------------------------ceEEeecccccccCCCCCcc
Q 003059 629 KPENILLDENY-------------------------------------------------NAKVSDFGLAKLINPKDHRH 659 (852)
Q Consensus 629 kp~NILl~~~~-------------------------------------------------~~kl~DFGla~~~~~~~~~~ 659 (852)
||+||||+.++ .+||+|||+++.....
T Consensus 174 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---- 249 (397)
T 1wak_A 174 KPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---- 249 (397)
T ss_dssp SGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----
T ss_pred CHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----
Confidence 99999999775 7999999999876432
Q ss_pred eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchh---hHHHHHHHHh--------hCC
Q 003059 660 RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKK---FSLWAYEEFE--------KGN 728 (852)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~---l~~~~~~~~~--------~~~ 728 (852)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... .......... .+.
T Consensus 250 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 327 (397)
T 1wak_A 250 --FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGK 327 (397)
T ss_dssp --SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCT
T ss_pred --CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccc
Confidence 233468999999999999999999999999999999999999997654322111 0000111000 000
Q ss_pred cc-ccccc------------------ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 729 VK-GIVDK------------------SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 729 ~~-~~~d~------------------~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.. ..... .......+.+....+.+++.+||+.||++|||+.||++
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 328 YSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp TGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 00000 00001234556677889999999999999999999985
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=327.35 Aligned_cols=244 Identities=22% Similarity=0.349 Sum_probs=200.3
Q ss_pred hcccccccccccccceEEEEEECC-CcEEEEEEecC-cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEG-IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
..|.+.++||+|+||.||+|.... +..||+|++.. .....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 467888999999999999999754 67899999874 3445678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEe---CCCCceEEeecccccccC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL---DENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFGla~~~~ 653 (852)
++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||++....
T Consensus 89 ~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 89 TGGELFERVVHK-----RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999998653 348999999999999999999999 899999999999999 888999999999998765
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
... ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||....... .......+..
T Consensus 161 ~~~----~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~---- 224 (277)
T 3f3z_A 161 PGK----MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-------VMLKIREGTF---- 224 (277)
T ss_dssp TTS----CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC----
T ss_pred Ccc----chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCC----
Confidence 422 22345699999999998764 8999999999999999999999997543211 1111111111
Q ss_pred ccccCCCCCCHH----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 734 DKSLAGEDVDIE----QVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 734 d~~l~~~~~~~~----~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..+.. ....+.+++.+|++.||.+||++.++++
T Consensus 225 -------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 225 -------TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -------CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111 1245678889999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=334.84 Aligned_cols=260 Identities=25% Similarity=0.328 Sum_probs=197.7
Q ss_pred HHhcccccccccccccceEEEEEEC--CC--cEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCce
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLA--NR--TVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKH 568 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~--~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 568 (852)
....|.+.++||+|+||.||+|.+. ++ ..||||+++.. ....+++.+|++++.+++||||+++++++.+..
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 3457888899999999999999853 23 36899988732 234577899999999999999999999998765
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.++||||+++++|.+++... ...+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~ 167 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGL 167 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred ceeeEecccCCCHHHHHHhc----cCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccc
Confidence 88999999999999999654 2358899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhC
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKG 727 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (852)
++................++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~ 240 (291)
T 1u46_A 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-------ILHKIDKE 240 (291)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTS
T ss_pred cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH-------HHHHHHcc
Confidence 9887554333233344567889999999999889999999999999999999 999997543211 11111111
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 728 NVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 728 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
... . ..+......+.+++.+|++.||.+||++.++++.|+++..
T Consensus 241 ~~~------~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 241 GER------L---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCC------C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCC------C---CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 100 0 1111123457788899999999999999999999988754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=335.55 Aligned_cols=256 Identities=23% Similarity=0.306 Sum_probs=194.3
Q ss_pred hccccc-ccccccccceEEEEEE-CCCcEEEEEEecCc-ccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEEEe
Q 003059 499 STKGFK-DKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI-EQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 499 ~~~~~~-~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e 574 (852)
..|.+. +.||+|+||.||++.. .+++.||||++... ....+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 355663 6799999999999995 46889999999743 34467889999999885 79999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCc---eEEeecccccc
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYN---AKVSDFGLAKL 651 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~DFGla~~ 651 (852)
|+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||+++.
T Consensus 92 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 92 KMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp CCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred cCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 99999999999653 348899999999999999999999 89999999999999998776 99999999986
Q ss_pred cCCCCCc----ceeeeeecCCCCCCChhhhhc-----CCCCCCccchhhhHHHHHHHhCCccccccccccchh-------
Q 003059 652 INPKDHR----HRTLTSVRGTRGYLAPEWLAN-----LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKK------- 715 (852)
Q Consensus 652 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~------- 715 (852)
....... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 5432111 111223459999999999975 568899999999999999999999997653322100
Q ss_pred -hHHHHHHHHhhCCcccccccccCCCCCCHH----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 716 -FSLWAYEEFEKGNVKGIVDKSLAGEDVDIE----QVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 716 -l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~----~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
...........+.. ..+.. ....+.+++.+|++.||.+||++.|+++
T Consensus 244 ~~~~~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQNMLFESIQEGKY-----------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHHCCC-----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHhccCc-----------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 00011111111111 11111 1235778899999999999999999987
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=342.16 Aligned_cols=266 Identities=31% Similarity=0.416 Sum_probs=206.2
Q ss_pred HHHHHhcccccccccccccceEEEEEE------CCCcEEEEEEecC--cccchHHHHHHHHHhhcccccceeeeeeeecc
Q 003059 494 KELQRSTKGFKDKLGAGGFGAVYRGVL------ANRTVVAVKQLEG--IEQGEKQFRMEVATISSTHHLNLVRLVGFSSE 565 (852)
Q Consensus 494 ~el~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~ 565 (852)
.++....|.+.+.||+|+||.||+|.+ .+++.||||++.. ......++.+|+.++++++||||+++++++.+
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 355667888999999999999999984 2467899999973 33445678999999999999999999999999
Q ss_pred CceeeEEEeecCCCCHHHHhhhcccC--CccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC---CCc
Q 003059 566 GKHRLLVYEFMKNGSLDNFLFANEEG--SGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE---NYN 640 (852)
Q Consensus 566 ~~~~~lV~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~---~~~ 640 (852)
....++||||+++++|.+++...... ....+++..++.++.||+.||.|||+ .+|+||||||+|||++. +..
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCC
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcce
Confidence 99999999999999999999765321 22458999999999999999999999 89999999999999984 456
Q ss_pred eEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHH
Q 003059 641 AKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLW 719 (852)
Q Consensus 641 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~ 719 (852)
+||+|||+++....... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 182 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------- 253 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------- 253 (327)
T ss_dssp EEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------
T ss_pred EEECccccccccccccc-cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH-------
Confidence 99999999986533211 112233457889999999999999999999999999999998 999997543211
Q ss_pred HHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 720 AYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 720 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
.......+... ..+......+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 254 ~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 254 VLEFVTSGGRM----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCC----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 11111111110 0111122356788899999999999999999999987754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=331.25 Aligned_cols=250 Identities=22% Similarity=0.327 Sum_probs=202.1
Q ss_pred HhcccccccccccccceEEEEEEC-CCcEEEEEEecCccc-------chHHHHHHHHHhhcccccceeeeeeeeccCcee
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQ-------GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHR 569 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 569 (852)
...|.+.+.||+|+||.||++... +++.||+|.+..... ..+++.+|+.++.+++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456888999999999999999975 588999999873221 356799999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC----ceEEee
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY----NAKVSD 645 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~D 645 (852)
++||||+++++|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 9999999999999999643 358999999999999999999999 8999999999999999888 799999
Q ss_pred cccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHh
Q 003059 646 FGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFE 725 (852)
Q Consensus 646 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 725 (852)
||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+.
T Consensus 163 fg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~i~ 231 (321)
T 2a2a_A 163 FGLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANIT 231 (321)
T ss_dssp CTTCEECCTTC----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHH
T ss_pred CccceecCccc----cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHH
Confidence 99998765422 2234568999999999999999999999999999999999999997543211 011111
Q ss_pred hCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 726 KGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..... .++... ......+.+++.+|++.||.+||++.|+++
T Consensus 232 ~~~~~--~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 232 SVSYD--FDEEFF-----SHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp TTCCC--CCHHHH-----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred hcccc--cChhhh-----cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11000 000000 001235678899999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=326.86 Aligned_cols=245 Identities=27% Similarity=0.384 Sum_probs=197.1
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
..|.+.+.||+|+||.||+|... +++.||+|++... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 35777889999999999999865 4678999998632 233567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+++++|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 89 e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 89 EYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred ecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999643 348899999999999999999998 899999999999999999999999999986543
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... .........
T Consensus 161 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~----- 223 (279)
T 3fdn_A 161 SS-----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVE----- 223 (279)
T ss_dssp ------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTC-----
T ss_pred cc-----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-------HHHHHHhCC-----
Confidence 21 2234568999999999999999999999999999999999999997543211 111111110
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
... +......+.+++.+|++.||.+||++.||++.
T Consensus 224 -~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 -FTF-----PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -CCC-----CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -CCC-----CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 001 11112356678889999999999999999963
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=352.68 Aligned_cols=245 Identities=25% Similarity=0.399 Sum_probs=201.2
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
..|.+.+.||+|+||.||+|... +++.||||++.... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46778899999999999999975 68899999997322 23467899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+++|+|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 96 E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 96 EYVSGGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp ECCSSEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999543 358999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcCCC-CCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPI-TSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI 732 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (852)
... ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||+...... ....+..+..
T Consensus 168 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~--- 233 (476)
T 2y94_A 168 DGE----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-------LFKKICDGIF--- 233 (476)
T ss_dssp TTC----CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH-------HHHHHHTTCC---
T ss_pred ccc----cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCc---
Confidence 422 2234569999999999988765 689999999999999999999997543211 1111221111
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
. .+......+.+++.+|++.||.+|||+.+|++
T Consensus 234 -----~---~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 -----Y---TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -----C---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----C---CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 0 01111235678889999999999999999996
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=341.46 Aligned_cols=203 Identities=28% Similarity=0.379 Sum_probs=175.9
Q ss_pred HHHHhcccccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeE
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLL 571 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 571 (852)
++....|.+.++||+|+||.||++... +++.||+|++... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 445567888899999999999999975 5889999998743 3345678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
||||+++++|.+++... ..+++..+..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||++..
T Consensus 109 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp EECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred EEECCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 99999999999999653 2488999999999999999999982 2799999999999999999999999999975
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccc
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQ 709 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~ 709 (852)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 182 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 182 LID-----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp HHH-----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred ccc-----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 422 12234578999999999999999999999999999999999999997543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.38 Aligned_cols=269 Identities=22% Similarity=0.299 Sum_probs=198.2
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCccc---chHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQ---GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
.|.+.++||+|+||.||+|... +++.||||++..... ..+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 5777899999999999999975 488999999864332 246688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 84 CDHTVLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CSEEHHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred CCCchHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999988533 348999999999999999999999 89999999999999999999999999999876532
Q ss_pred CCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHH--------HHHHhh
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA--------YEEFEK 726 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~ 726 (852)
. .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+........ ...+..
T Consensus 156 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 156 S---DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred c---cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 1 12234568999999999976 57899999999999999999999999765433221111000 000000
Q ss_pred CCcccccccccCCCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcCc
Q 003059 727 GNVKGIVDKSLAGEDVDI-----EQVMRAIQVSFWCIQEQPSQRPMMGKVVQ--MLEGIT 779 (852)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~-----~~~~~~~~l~~~cl~~dp~~RPt~~ev~~--~L~~~~ 779 (852)
.................. .....+.+++.+|++.||.+|||++|+++ .++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 000000000000000011 11234678999999999999999999985 344443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=354.52 Aligned_cols=247 Identities=23% Similarity=0.264 Sum_probs=191.2
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecC----cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEG----IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~----~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
..|.+.++||+|+||.||++... +++.||||++.. .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 45777899999999999999964 588999999973 2334466789999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+++|+|.+++... ..+++..+..++.||+.||+|||++ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 228 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 228 EYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp CCCSSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred eeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999643 3589999999999999999999962 689999999999999999999999999998643
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..........
T Consensus 301 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~---- 366 (446)
T 4ejn_A 301 KD---GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEEI---- 366 (446)
T ss_dssp C--------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC----
T ss_pred CC---CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHHhCCC----
Confidence 22 122345679999999999999999999999999999999999999997543211 1111111110
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP-----MMGKVVQ 773 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~ev~~ 773 (852)
..+......+.+++.+||+.||.+|| ++.|+++
T Consensus 367 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 -------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 01111123567888999999999999 9999985
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=346.25 Aligned_cols=253 Identities=21% Similarity=0.219 Sum_probs=197.9
Q ss_pred HhcccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
...+.+.+.||+|+||.||++... +++.||||++... ....+.+.+|..++.+++||||+++++++.+.+..|||
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 139 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 345667789999999999999975 6899999999742 22334588999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++|+|.+++... +..+++..+..++.||+.||+|||+ .+|+||||||+||||+.++++||+|||+++..
T Consensus 140 mE~~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~ 212 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKL 212 (412)
T ss_dssp ECCCCSCBHHHHHHHH----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EcCCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheec
Confidence 9999999999999643 2358999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhh-------cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHh
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLA-------NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFE 725 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 725 (852)
.... ........||+.|+|||++. ...++.++|||||||++|||++|+.||........ ...+.
T Consensus 213 ~~~~--~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-------~~~i~ 283 (412)
T 2vd5_A 213 RADG--TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET-------YGKIV 283 (412)
T ss_dssp CTTS--CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHH
T ss_pred cCCC--ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH-------HHHHH
Confidence 5422 12223457999999999997 35689999999999999999999999975432111 11111
Q ss_pred hCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCC---CCHHHHHH
Q 003059 726 KGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQR---PMMGKVVQ 773 (852)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~R---Pt~~ev~~ 773 (852)
... .....+.. .......+.+++.+|++ +|.+| |+++||++
T Consensus 284 ~~~-~~~~~p~~-----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 284 HYK-EHLSLPLV-----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp THH-HHCCCC---------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred hcc-cCcCCCcc-----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 000 00000100 01112356788889999 99988 68888875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.05 Aligned_cols=263 Identities=22% Similarity=0.328 Sum_probs=206.9
Q ss_pred CCcccCHHHHHHhccccc-ccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcc-cccceeeee
Q 003059 487 APVQFSYKELQRSTKGFK-DKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISST-HHLNLVRLV 560 (852)
Q Consensus 487 ~~~~~~~~el~~~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~ 560 (852)
....|...+.....|.+. ++||+|+||.||+|... +++.||+|++... .....++.+|+.++.++ +||||++++
T Consensus 16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 445677777778888887 78999999999999975 5889999998743 23457889999999999 569999999
Q ss_pred eeeccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC---
Q 003059 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE--- 637 (852)
Q Consensus 561 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~--- 637 (852)
+++.+.+..++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~ 169 (327)
T 3lm5_A 96 EVYENTSEIILILEYAAGGEIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYP 169 (327)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTT
T ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCC
Confidence 99999999999999999999999985432 3568999999999999999999999 89999999999999998
Q ss_pred CCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhH
Q 003059 638 NYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFS 717 (852)
Q Consensus 638 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~ 717 (852)
++.+||+|||+++..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 170 ~~~~kL~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---- 241 (327)
T 3lm5_A 170 LGDIKIVDFGMSRKIGHA----CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET---- 241 (327)
T ss_dssp BCCEEECCGGGCEEC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----
T ss_pred CCcEEEeeCccccccCCc----cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH----
Confidence 789999999999876432 122345799999999999999999999999999999999999999975432111
Q ss_pred HHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 718 LWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 718 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.......... ..... .......+.+++.+|++.||.+||+++++++
T Consensus 242 ---~~~i~~~~~~-~~~~~------~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 242 ---YLNISQVNVD-YSEET------FSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp ---HHHHHHTCCC-CCTTT------TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---HHHHHhcccc-cCchh------hcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 1111111100 00000 1112235678889999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=343.58 Aligned_cols=245 Identities=27% Similarity=0.300 Sum_probs=189.4
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCcc----cchHHHHHHHHH-hhcccccceeeeeeeeccCceeeEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE----QGEKQFRMEVAT-ISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~f~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
..|.+.+.||+|+||.||+++.. +++.||||++.... .....+..|..+ ++.++||||+++++++.+.+..|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 46778899999999999999975 47889999997432 233456677776 5778999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++..
T Consensus 118 ~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999643 347888999999999999999998 89999999999999999999999999999864
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI 732 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (852)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+......
T Consensus 190 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~~~-- 257 (373)
T 2r5t_A 190 IEHN---STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-------MYDNILNKPLQ-- 257 (373)
T ss_dssp BCCC---CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-------HHHHHHHSCCC--
T ss_pred ccCC---CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHhcccC--
Confidence 3211 12345679999999999999999999999999999999999999997543211 11111111110
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVV 772 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~ 772 (852)
+ +......+.+++.+|++.||.+||++.+.+
T Consensus 258 ----~-----~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 258 ----L-----KPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp ----C-----CSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred ----C-----CCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 1 111123567788899999999999986433
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=324.97 Aligned_cols=256 Identities=21% Similarity=0.347 Sum_probs=202.2
Q ss_pred HhcccccccccccccceEEEEEEC-CCcEEEEEEecCcc-------cchHHHHHHHHHhhcccccceeeeeeeeccCcee
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE-------QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHR 569 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 569 (852)
...|.+.+.||+|+||.||++... +++.||+|.+.... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 456888999999999999999976 58899999986322 1357899999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC----ceEEee
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY----NAKVSD 645 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~D 645 (852)
++||||+++++|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++ .+||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEeecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEe
Confidence 9999999999999999643 358999999999999999999999 8999999999999998877 899999
Q ss_pred cccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHh
Q 003059 646 FGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFE 725 (852)
Q Consensus 646 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 725 (852)
||++....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ......
T Consensus 156 fg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~ 224 (283)
T 3bhy_A 156 FGIAHKIEAGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-------TLTNIS 224 (283)
T ss_dssp CTTCEECC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHH
T ss_pred cccceeccCCC----cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-------HHHHhH
Confidence 99998764321 2234568999999999999999999999999999999999999997543211 111111
Q ss_pred hCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcCc
Q 003059 726 KGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ--MLEGIT 779 (852)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~--~L~~~~ 779 (852)
..... ...... ......+.+++.+|++.||.+||++.++++ .++.+.
T Consensus 225 ~~~~~-~~~~~~------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 225 AVNYD-FDEEYF------SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp TTCCC-CCHHHH------TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred hcccC-Ccchhc------ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 11000 000000 011235678899999999999999999996 455543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=338.85 Aligned_cols=264 Identities=22% Similarity=0.275 Sum_probs=199.8
Q ss_pred HhcccccccccccccceEEEEEEC-CCcEEEEEEecCc------ccchHHHHHHHHHhhcccccceeeeeeeeccCceee
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI------EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRL 570 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~------~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 570 (852)
...|.+.++||+|+||.||+|... +++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 457888999999999999999974 5788999998632 344578999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhhcccC-----------------------------------CccccchhHHHHHHHhhHhhhhhh
Q 003059 571 LVYEFMKNGSLDNFLFANEEG-----------------------------------SGKLLNWQSRFNIALGTARGITYL 615 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~ia~~L~yL 615 (852)
+||||+++|+|.+++...... ....+++..++.++.||+.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999998521110 122356778889999999999999
Q ss_pred ccccCCCcccCCCCCCceEeCCCC--ceEEeecccccccCCCCC-cceeeeeecCCCCCCChhhhhc--CCCCCCccchh
Q 003059 616 HEECRDCIVHCDIKPENILLDENY--NAKVSDFGLAKLINPKDH-RHRTLTSVRGTRGYLAPEWLAN--LPITSKSDVYS 690 (852)
Q Consensus 616 H~~~~~~ivH~Dlkp~NILl~~~~--~~kl~DFGla~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~s 690 (852)
|+ .+|+||||||+|||++.++ .+||+|||+++.+..... .........||+.|+|||.+.+ ..++.++||||
T Consensus 185 H~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 185 HN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 99 8999999999999998776 899999999986543211 1122345679999999999975 67899999999
Q ss_pred hhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 003059 691 YGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGK 770 (852)
Q Consensus 691 ~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~e 770 (852)
||+++|||++|+.||........ .......... ...+.. ......+.+++.+|++.||.+||++.+
T Consensus 262 lG~il~el~~g~~pf~~~~~~~~-------~~~~~~~~~~-~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~ 327 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDADT-------ISQVLNKKLC-FENPNY------NVLSPLARDLLSNLLNRNVDERFDAMR 327 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCC-TTSGGG------GGSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred HHHHHHHHHHCCCCCCCCChHHH-------HHHHHhcccc-cCCccc------ccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 99999999999999975432211 1111111100 000000 011235678889999999999999999
Q ss_pred HHH--HHhcC
Q 003059 771 VVQ--MLEGI 778 (852)
Q Consensus 771 v~~--~L~~~ 778 (852)
+++ .+++.
T Consensus 328 ~l~hp~~~~~ 337 (345)
T 3hko_A 328 ALQHPWISQF 337 (345)
T ss_dssp HHHSHHHHTT
T ss_pred HhcChhhccC
Confidence 986 44444
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=325.28 Aligned_cols=245 Identities=25% Similarity=0.420 Sum_probs=194.6
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeecc----CceeeE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSE----GKHRLL 571 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~----~~~~~l 571 (852)
.+.+.++||+|+||.||+|... ++..||+|.+... ....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4567788999999999999964 5778999998733 2345678999999999999999999998764 457899
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCC--cccCCCCCCceEeC-CCCceEEeeccc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC--IVHCDIKPENILLD-ENYNAKVSDFGL 648 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NILl~-~~~~~kl~DFGl 648 (852)
||||+++++|.+++... ..+++..++.++.||+.||+|||+ .+ |+||||||+|||++ +++.+||+|||+
T Consensus 107 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 99999999999999643 348899999999999999999998 66 99999999999997 889999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN 728 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (852)
+...... ......|++.|+|||.+.+ .++.++||||||+++|||++|+.||........ .......+.
T Consensus 179 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~ 246 (290)
T 1t4h_A 179 ATLKRAS-----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGV 246 (290)
T ss_dssp GGGCCTT-----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTC
T ss_pred ccccccc-----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH------HHHHHhccC
Confidence 9765432 2234568999999998874 589999999999999999999999975332111 111122211
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.....+.. ....+.+++.+||+.||.+||++.+|++
T Consensus 247 ~~~~~~~~---------~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 247 KPASFDKV---------AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCGGGGGC---------CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CccccCCC---------CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11111111 1135778889999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=355.84 Aligned_cols=252 Identities=25% Similarity=0.301 Sum_probs=203.2
Q ss_pred HhcccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
...+.+.+.||+|+||.||++... +++.||||++... ......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 345677789999999999999975 6899999999632 33456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++..
T Consensus 263 mEy~~gg~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp ECCCCSCBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 99999999999996432 3358999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI 732 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (852)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ..........
T Consensus 337 ~~~~----~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~---~i~~~i~~~~---- 405 (576)
T 2acx_A 337 PEGQ----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE---EVERLVKEVP---- 405 (576)
T ss_dssp CTTC----CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH---HHHHHHHHCC----
T ss_pred ccCc----cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH---HHHHHhhccc----
Confidence 5321 2344579999999999999999999999999999999999999997653321111 0111111110
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP-----MMGKVVQ 773 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~ev~~ 773 (852)
.. .+......+.+++.+|++.||.+|| ++.||++
T Consensus 406 --~~-----~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 --EE-----YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --CC-----CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --cc-----CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 00 1111123567888899999999999 6788875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=337.69 Aligned_cols=245 Identities=26% Similarity=0.346 Sum_probs=196.5
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
..|...+.||+|+||.||+|.. .+++.||||++.... ...+++.+|++++++++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4567788999999999999996 568999999997332 22357889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||++ |+|.+++... ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 134 e~~~-g~l~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp ECCS-EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred ecCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 9997 6888888543 2458999999999999999999999 899999999999999999999999999998654
Q ss_pred CCCCcceeeeeecCCCCCCChhhhh---cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLA---NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (852)
.. ....||+.|+|||.+. ...++.++||||||+++|||++|+.||....... ... .......
T Consensus 206 ~~-------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~~-~~~~~~~- 270 (348)
T 1u5q_A 206 PA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALY-HIAQNES- 270 (348)
T ss_dssp SB-------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHH-HHHHSCC-
T ss_pred CC-------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHH-HHHhcCC-
Confidence 31 2356899999999985 5678999999999999999999999996543211 011 1111111
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 731 GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
+.+..... ...+.+++.+||+.||.+||++.++++.
T Consensus 271 ----~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 271 ----PALQSGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ----CCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----CCCCCCCC----CHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11111111 2346678889999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=341.70 Aligned_cols=253 Identities=22% Similarity=0.254 Sum_probs=198.8
Q ss_pred hcccccccccccccceEEEEEE----CCCcEEEEEEecCc-----ccchHHHHHHHHHhhcc-cccceeeeeeeeccCce
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL----ANRTVVAVKQLEGI-----EQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKH 568 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~-----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~ 568 (852)
..|.+.++||+|+||.||++.. .+++.||||+++.. ....+.+.+|++++.++ +||||+++++++.+.+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 4677889999999999999997 36889999998732 23345678899999999 69999999999999999
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.++||||+++++|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+||||+.++.+||+|||+
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred EEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999643 348899999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhc--CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhh
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLAN--LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEK 726 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (852)
++..... .........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......... ..... ....
T Consensus 206 a~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~-~~~~ 280 (355)
T 1vzo_A 206 SKEFVAD--ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISR-RILK 280 (355)
T ss_dssp EEECCGG--GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHH-HHHH
T ss_pred CeecccC--CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHH-HHhc
Confidence 9865432 1122234569999999999986 34789999999999999999999999754322211 11111 1111
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 003059 727 GNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP-----MMGKVVQML 775 (852)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~ev~~~L 775 (852)
. .+ ..+.+....+.+++.+||+.||.+|| ++.++++..
T Consensus 281 ~------~~-----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 281 S------EP-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp C------CC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred c------CC-----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0 00 11111223567888999999999999 899988643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=337.63 Aligned_cols=266 Identities=22% Similarity=0.325 Sum_probs=194.8
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCccc--chHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQ--GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
+|.+.++||+|+||.||+|... +++.||||++..... ....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence 5677889999999999999975 688999999873322 2234668999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
+ ++|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~- 153 (324)
T 3mtl_A 83 D-KDLKQYLDDC----GNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIP- 153 (324)
T ss_dssp S-EEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred c-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCC-
Confidence 7 5999988653 3458999999999999999999998 89999999999999999999999999999865422
Q ss_pred CcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhC---Ccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG---NVKGI 732 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~ 732 (852)
........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+... ......... .....
T Consensus 154 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~ 228 (324)
T 3mtl_A 154 --TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLH---FIFRILGTPTEETWPGI 228 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCTTTSTTG
T ss_pred --ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCChHhchhh
Confidence 122334568999999999876 568999999999999999999999997654322111 111111100 00000
Q ss_pred ccc------ccCCC-CCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcCc
Q 003059 733 VDK------SLAGE-DVD-----IEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ--MLEGIT 779 (852)
Q Consensus 733 ~d~------~l~~~-~~~-----~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~--~L~~~~ 779 (852)
... ..... ... ......+.+++.+|++.||.+|||++|+++ .+.++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 000 00000 000 011235678899999999999999999986 444443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=324.38 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=200.1
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
..|.+.++||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 45778899999999999999975 58899999997433 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCc---eEEeecccccc
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYN---AKVSDFGLAKL 651 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~DFGla~~ 651 (852)
|+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||++..
T Consensus 86 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 86 LVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred cCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999988643 348999999999999999999999 89999999999999987665 99999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .......+...
T Consensus 158 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~- 225 (284)
T 3kk8_A 158 VNDSE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIKAGAYD- 225 (284)
T ss_dssp CCSSC----BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC-
T ss_pred cccCc----cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-------HHHHHHhcccc-
Confidence 64322 2234568999999999999999999999999999999999999996543211 11111111111
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
...+... .....+.+++.+|++.||.+||++.|+++
T Consensus 226 ~~~~~~~------~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 226 YPSPEWD------TVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CCTTTTT------TSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCchhhc------ccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0011100 11234678888999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=350.21 Aligned_cols=261 Identities=22% Similarity=0.267 Sum_probs=191.6
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccC------ce
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEG------KH 568 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~ 568 (852)
.+|.+.++||+|+||.||+|... +++.||||++... ....+++.+|+.+++.++||||+++++++... ..
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 35777889999999999999864 5889999999743 23456788999999999999999999998654 46
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.||||||+++ +|.+.+. ..+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+
T Consensus 142 ~~lv~E~~~~-~l~~~~~-------~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 142 VYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred EEEEEeCCCC-CHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 7999999976 4666662 238899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHH--------
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA-------- 720 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~-------- 720 (852)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+........
T Consensus 211 a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 211 ARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286 (464)
T ss_dssp C-----C----CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eeecCCC----cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9876432 2234567999999999999999999999999999999999999999765432211100000
Q ss_pred -------HHHHhhCC-------cccccccccCCCCCC--HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 721 -------YEEFEKGN-------VKGIVDKSLAGEDVD--IEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 721 -------~~~~~~~~-------~~~~~d~~l~~~~~~--~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.....+.. ....+...+...... ......+.+++.+||+.||++|||++|+++.
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 000000000000000 1113467899999999999999999999863
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=330.72 Aligned_cols=255 Identities=19% Similarity=0.305 Sum_probs=201.1
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeec--cCceeeEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSS--EGKHRLLV 572 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lV 572 (852)
..|.+.+.||+|+||.||++... +++.||+|.+... ....+.+.+|++++++++||||+++++++. .....++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 35777899999999999999975 6889999999743 234567899999999999999999999874 46789999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCC-----cccCCCCCCceEeCCCCceEEeecc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC-----IVHCDIKPENILLDENYNAKVSDFG 647 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-----ivH~Dlkp~NILl~~~~~~kl~DFG 647 (852)
|||+++++|.+++..... ....+++..++.++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||
T Consensus 86 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999975432 23458999999999999999999998 56 9999999999999999999999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhC
Q 003059 648 LAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG 727 (852)
Q Consensus 648 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (852)
+++...... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+..+
T Consensus 162 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~i~~~ 231 (279)
T 2w5a_A 162 LARILNHDT---SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREG 231 (279)
T ss_dssp HHHHC---C---HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHT
T ss_pred hheeecccc---ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH-------HHHHHhhc
Confidence 998764321 11223468999999999999999999999999999999999999997543211 11122222
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003059 728 NVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEG 777 (852)
Q Consensus 728 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~ 777 (852)
.... + +......+.+++.+|++.||.+||++.||++.+..
T Consensus 232 ~~~~-----~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 232 KFRR-----I-----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CCCC-----C-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cccc-----C-----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 2111 1 11122456788899999999999999999987644
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=325.00 Aligned_cols=251 Identities=26% Similarity=0.390 Sum_probs=200.4
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
..|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 46778899999999999999975 6889999998732 33457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+++++|.+++.. ...+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 87 ~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 87 CSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 999999999853 2358899999999999999999999 89999999999999999999999999999865322
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCC-CCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPI-TSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
. .........|++.|+|||.+.+..+ +.++||||||+++|||++|+.||........ .+ ..+...... ..
T Consensus 159 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~-----~~~~~~~~~--~~ 229 (276)
T 2yex_A 159 N-RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EY-----SDWKEKKTY--LN 229 (276)
T ss_dssp T-EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HH-----HHHHTTCTT--ST
T ss_pred c-chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HH-----HHhhhcccc--cC
Confidence 1 1112234568999999999987765 7789999999999999999999976543211 11 111111100 00
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
........+.+++.+|++.||.+||++.++++
T Consensus 230 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 -------PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00111235667889999999999999999876
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=349.45 Aligned_cols=242 Identities=17% Similarity=0.151 Sum_probs=188.0
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecC----cccchHHHHHHH---HHhhcccccceeeee-------eee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEG----IEQGEKQFRMEV---ATISSTHHLNLVRLV-------GFS 563 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~----~~~~~~~f~~E~---~~l~~l~h~niv~l~-------g~~ 563 (852)
..|.+.+.||+|+||.||+|.. .+++.||||++.. .....+.+.+|+ +++++++||||++++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 4566788999999999999995 5689999999862 233457789999 556666899999998 555
Q ss_pred ccCc-----------------eeeEEEeecCCCCHHHHhhhcccC--CccccchhHHHHHHHhhHhhhhhhccccCCCcc
Q 003059 564 SEGK-----------------HRLLVYEFMKNGSLDNFLFANEEG--SGKLLNWQSRFNIALGTARGITYLHEECRDCIV 624 (852)
Q Consensus 564 ~~~~-----------------~~~lV~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv 624 (852)
.+.+ ..+|||||+ +|+|.+++...... ....+++..++.|+.||++||+|||+ .+|+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iv 228 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLV 228 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCee
Confidence 4443 378999999 68999999754321 12456678999999999999999999 8999
Q ss_pred cCCCCCCceEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcC-----------CCCCCccchhhhH
Q 003059 625 HCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL-----------PITSKSDVYSYGM 693 (852)
Q Consensus 625 H~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDv~s~Gv 693 (852)
||||||+||||+.++.+||+|||+++.... ......| +.|+|||.+.+. .++.++|||||||
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 999999999999999999999999985322 3344567 999999999887 8999999999999
Q ss_pred HHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 694 VLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 694 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
++|||++|+.||........ ...+.. ... ..+ ..+.+++.+||+.||.+||++.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~---------------~~~~~~-~~~--~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG---------------SEWIFR-SCK--NIP----QPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CC---------------SGGGGS-SCC--CCC----HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccc---------------hhhhhh-hcc--CCC----HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999964432111 111111 111 111 35677888999999999999999985
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=336.62 Aligned_cols=261 Identities=20% Similarity=0.287 Sum_probs=190.5
Q ss_pred HhcccccccccccccceEEEEEEC-CCcEEEEEEecCccc---chHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQ---GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
...|.+.++||+|+||.||+|... +++.||||++..... ..+.+.+|++++++++||||+++++++.+++..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 346788899999999999999854 688999999973322 2356789999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEe-----CCCCceEEeeccc
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL-----DENYNAKVSDFGL 648 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl-----~~~~~~kl~DFGl 648 (852)
||++ ++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+
T Consensus 113 e~~~-~~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp ECCS-EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred ecCC-CCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9997 59999996543 48899999999999999999999 899999999999999 4556699999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhC
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG 727 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (852)
++..... ........||+.|+|||.+.+. .++.++|||||||++|||++|+.||......... .. ........
T Consensus 184 a~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~-~~~~~~~~ 257 (329)
T 3gbz_A 184 ARAFGIP---IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL--FK-IFEVLGLP 257 (329)
T ss_dssp HHHHC--------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HH-HHHHHCCC
T ss_pred ccccCCc---ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH--HH-HHHHhCCC
Confidence 9876432 1223445689999999999875 4899999999999999999999999754332111 11 11110000
Q ss_pred C---ccccc-----ccccCC-CCCCHH------HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 728 N---VKGIV-----DKSLAG-EDVDIE------QVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 728 ~---~~~~~-----d~~l~~-~~~~~~------~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
. ..... ...... .....+ ....+.+++.+|++.||.+|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0 00000 000000 001111 1245678999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=327.16 Aligned_cols=248 Identities=25% Similarity=0.327 Sum_probs=202.3
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
..|.+.+.||+|+||.||+|... +++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46778899999999999999975 5788999998632 233567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+++++|.+++... ..+++..++.++.||++||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 94 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 94 EFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999999653 248899999999999999999998 899999999999999999999999999987654
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... .........
T Consensus 166 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~----- 228 (284)
T 2vgo_A 166 SL-----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-------THRRIVNVD----- 228 (284)
T ss_dssp SS-----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTC-----
T ss_pred cc-----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-------HHHHHhccc-----
Confidence 32 1234568999999999999999999999999999999999999997543211 111111111
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ--MLEG 777 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~--~L~~ 777 (852)
..+ +......+.+++.+|++.||.+||++.++++ .++.
T Consensus 229 -~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 229 -LKF-----PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp -CCC-----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred -cCC-----CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 011 1111235678889999999999999999986 4443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=331.25 Aligned_cols=262 Identities=24% Similarity=0.367 Sum_probs=196.4
Q ss_pred cccccccccccccceEEEEEECC-CcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
.|.+.+.||+|+||.||++.... ++.||||++.... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 105 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF 105 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence 57778899999999999999754 8899999986332 2345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 106 ~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 106 VDHTILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp CSEEHHHHHHHST-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred CCcchHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999887432 348999999999999999999999 89999999999999999999999999999865432
Q ss_pred CCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHH--------HHHHHhh
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLW--------AYEEFEK 726 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~ 726 (852)
. .......|++.|+|||.+.+. .++.++||||||+++|||++|+.||.............. ....+..
T Consensus 178 ~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 178 G---EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred c---cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 1 223345689999999999875 789999999999999999999999976543221110000 0000111
Q ss_pred CC-cccccccccCCCCCCHH-----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 727 GN-VKGIVDKSLAGEDVDIE-----QVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 727 ~~-~~~~~d~~l~~~~~~~~-----~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.. ......+.+.. ..+.. ....+.+++.+||+.||.+||++.|+++
T Consensus 255 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 255 NPVFAGVRLPEIKE-REPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CGGGTTCCCCCCSS-CCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccccCccccc-cchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 10 11111111111 11111 1346788999999999999999999885
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=332.03 Aligned_cols=268 Identities=19% Similarity=0.330 Sum_probs=185.9
Q ss_pred HHHHhcccccccccccccceEEEEEE-CCCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeE
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLL 571 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 571 (852)
.+....|.+.+.||+|+||.||+|.. .+++.||||++... ....+++.+|+.++.+++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 34456788889999999999999985 46789999998732 3345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhhcc---cCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 572 VYEFMKNGSLDNFLFANE---EGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
||||+++++|.+++.... ......+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 999999999999996421 1123468999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCc--ceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHh
Q 003059 649 AKLINPKDHR--HRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFE 725 (852)
Q Consensus 649 a~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 725 (852)
+......... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......... ... .
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~-~ 240 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLT-L 240 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHH-H
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH------HHH-h
Confidence 9876432211 112234568999999999876 56899999999999999999999999765332111 011 1
Q ss_pred hCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 726 KGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
......... ..............+.+++.+|++.||.+||++.++++
T Consensus 241 ~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 241 QNDPPSLET-GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TSSCCCTTC------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCCCcccc-ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111111000 00000000111235677888999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=341.11 Aligned_cols=246 Identities=24% Similarity=0.280 Sum_probs=186.5
Q ss_pred ccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhh-cccccceeeeeeeecc----CceeeEEEeecCC
Q 003059 505 DKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATIS-STHHLNLVRLVGFSSE----GKHRLLVYEFMKN 578 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~-~l~h~niv~l~g~~~~----~~~~~lV~e~~~~ 578 (852)
+.||+|+||.||++... +++.||||++.. ...+.+|++++. ..+||||+++++++.. ....+|||||+++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g 143 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence 68999999999999975 588999999863 245778888874 4589999999998765 6688999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC---CCceEEeecccccccCCC
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE---NYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFGla~~~~~~ 655 (852)
|+|.+++.... ...+++..+..++.||+.||+|||+ .+|+||||||+||||+. ++.+||+|||+++.....
T Consensus 144 g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~ 217 (400)
T 1nxk_A 144 GELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217 (400)
T ss_dssp EEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred CcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence 99999996532 3458999999999999999999999 89999999999999997 789999999999865432
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ....+..+... ...+
T Consensus 218 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---~~~~i~~~~~~-~~~~ 289 (400)
T 1nxk_A 218 ----NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQYE-FPNP 289 (400)
T ss_dssp -------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS---HHHHHHHTCCC-CCTT
T ss_pred ----CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH---HHHHHHcCccc-CCCc
Confidence 223456789999999999999999999999999999999999999975433211000 00111111110 0000
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.. ......+.+++.+||+.||.+||++.||++.
T Consensus 290 ~~------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 290 EW------SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TT------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cc------ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 1112356788999999999999999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=330.12 Aligned_cols=247 Identities=25% Similarity=0.358 Sum_probs=201.6
Q ss_pred HhcccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
...|.+.+.||+|+||.||++... +++.||+|.+... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 456778899999999999999975 4788999998633 23346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++++|.+++... ..+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 94 LELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EECCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 9999999999988543 358999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI 732 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (852)
..... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ..........
T Consensus 166 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~--- 232 (294)
T 2rku_A 166 EYDGE---RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-------TYLRIKKNEY--- 232 (294)
T ss_dssp CSTTC---CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCC---
T ss_pred ccCcc---ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhhccC---
Confidence 43221 2234568999999999999999999999999999999999999997543211 1111111110
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.+ +......+.+++.+|++.||.+||++.++++
T Consensus 233 ---~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 ---SI-----PKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ---CC-----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---CC-----ccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 01 1111235667888999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=333.47 Aligned_cols=247 Identities=25% Similarity=0.367 Sum_probs=201.6
Q ss_pred HhcccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
...|.+.+.||+|+||.||++... +++.||+|++... ....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 346778899999999999999975 4788999998633 23456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++++|.+++... ..+++..++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 120 ~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp ECCCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 9999999999988643 358999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI 732 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (852)
..... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ..........
T Consensus 192 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~--- 258 (335)
T 2owb_A 192 EYDGE---RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-------TYLRIKKNEY--- 258 (335)
T ss_dssp CSTTC---CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCC---
T ss_pred ccCcc---cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-------HHHHHhcCCC---
Confidence 43221 2234568999999999999999999999999999999999999997543211 1111111111
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.+.. .. ...+.+++.+|++.||.+||++.|+++
T Consensus 259 ---~~~~-~~----~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 ---SIPK-HI----NPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ---CCCT-TS----CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---CCCc-cC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111 11 234667888999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=343.97 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=190.0
Q ss_pred HHHHhcccccccccccccceEEEEEEC-CCcEEEEEEecCcc---------cchHHHHHHHHHhhcccccceeeeeeeec
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---------QGEKQFRMEVATISSTHHLNLVRLVGFSS 564 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---------~~~~~f~~E~~~l~~l~h~niv~l~g~~~ 564 (852)
+.....|.+.++||+|+||.||+|... +++.||||++.... .....+.+|++++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 344567888999999999999999964 47899999986322 12235889999999999999999999985
Q ss_pred cCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC---ce
Q 003059 565 EGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY---NA 641 (852)
Q Consensus 565 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~ 641 (852)
. +..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~ 281 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLI 281 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCE
T ss_pred c-CceEEEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceE
Confidence 4 4579999999999999988543 358999999999999999999998 8999999999999997544 59
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCChhhhhc---CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHH
Q 003059 642 KVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN---LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSL 718 (852)
Q Consensus 642 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~ 718 (852)
||+|||+++..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ +
T Consensus 282 kl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~-- 353 (419)
T 3i6u_A 282 KITDFGHSKILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--L-- 353 (419)
T ss_dssp EECCSSTTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--H--
T ss_pred EEeecccceecCCC----ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--H--
Confidence 99999999876432 22345679999999999853 5678899999999999999999999975432211 1
Q ss_pred HHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 719 WAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 719 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
......+.... ...... .....+.+++.+|++.||.+||++.|+++
T Consensus 354 --~~~i~~~~~~~-~~~~~~------~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 354 --KDQITSGKYNF-IPEVWA------EVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp --HHHHHTTCCCC-CHHHHT------TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --HHHHhcCCCCC-Cchhhc------ccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 01111111100 000000 11245778899999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=330.54 Aligned_cols=254 Identities=19% Similarity=0.292 Sum_probs=185.5
Q ss_pred HHHhcccccccccccccceEEEEEE-CCCcEEEEEEecCccc--c-hHHHHHHHHHhhcccccceeeeeeeeccCceeeE
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQ--G-EKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLL 571 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~-~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 571 (852)
+....|.+.++||+|+||.||++.. .+++.||||++..... . .+.+..+...++.++||||+++++++.+++..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 3445778889999999999999996 4688999999974322 2 2334455556888899999999999999999999
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCC-CcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD-CIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
||||++ |+|.+++..... ....+++..++.++.|++.||+|||+ + +|+||||||+|||++.++.+||+|||+++
T Consensus 84 v~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp EEECCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred EEehhc-cchHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 999997 589888754322 24569999999999999999999998 6 89999999999999999999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhh----hcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhh
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWL----ANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEK 726 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (852)
..... .......||+.|+|||.+ .+..++.++||||||+++|||++|+.||........ .......
T Consensus 159 ~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~ 228 (290)
T 3fme_A 159 YLVDD----VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ------QLKQVVE 228 (290)
T ss_dssp ---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH------HHHHHHH
T ss_pred ccccc----ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH------HHHHHhc
Confidence 76432 122334689999999996 566789999999999999999999999974322111 0111111
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 727 GNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..... ... ......+.+++.+|++.||++||++.|+++
T Consensus 229 ~~~~~-----~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 229 EPSPQ-----LPA----DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp SCCCC-----CCT----TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCC-----ccc----ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11111 111 111235678888999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=334.46 Aligned_cols=262 Identities=24% Similarity=0.384 Sum_probs=199.1
Q ss_pred HHHHhcccccccccccccceEEEEEECCCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeE
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLL 571 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 571 (852)
++....|.+.+.||+|+||.||+|...+ .||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 4445677888999999999999998765 3999998732 2334568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
||||+++++|.+++... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||+++.
T Consensus 107 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDA----KIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp ECBCCCSEEHHHHTTSS----CCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred EeecccCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 99999999999999543 3468999999999999999999999 8999999999999998 67999999999876
Q ss_pred cCCCCC--cceeeeeecCCCCCCChhhhhc---------CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHH
Q 003059 652 INPKDH--RHRTLTSVRGTRGYLAPEWLAN---------LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA 720 (852)
Q Consensus 652 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~---------~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 720 (852)
...... .........|++.|+|||.+.. ..++.++||||||+++|||++|+.||....... .
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~ 251 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-------I 251 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-------H
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------H
Confidence 532111 1112233458899999999874 457889999999999999999999997543211 1
Q ss_pred HHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCC
Q 003059 721 YEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIE 782 (852)
Q Consensus 721 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~ 782 (852)
......+.........+ ...+.+++.+|++.||.+||++.+|+++|+.+.+..
T Consensus 252 ~~~~~~~~~~~~~~~~~---------~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 252 IWQMGTGMKPNLSQIGM---------GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HHHHHTTCCCCCCCSSC---------CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred HHHhccCCCCCCCcCCC---------CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 11112221111111111 124667888899999999999999999999987643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=342.16 Aligned_cols=204 Identities=29% Similarity=0.427 Sum_probs=162.5
Q ss_pred HHHhcccccccccccccceEEEEEE-CCCcEEEEEEecCc---ccchHHHHHHHHHhhccc-ccceeeeeeeeccCc--e
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI---EQGEKQFRMEVATISSTH-HLNLVRLVGFSSEGK--H 568 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~--~ 568 (852)
.....|.+.++||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++.++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3456788899999999999999996 45889999998633 334466789999999997 999999999987543 7
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.|+||||++ ++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEecccC-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 899999997 689998853 358899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCC------------------CcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccc
Q 003059 649 AKLINPKD------------------HRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQ 709 (852)
Q Consensus 649 a~~~~~~~------------------~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~ 709 (852)
++.+.... ..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 98653211 11122344679999999999986 678999999999999999999999997654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=334.57 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=197.0
Q ss_pred HhcccccccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEEEee
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
...|.+.+.||+|+||.||++... +++.||||++..... .+.+|++++.++ +||||+++++++.+++..++||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 346788899999999999999975 588999999975432 346788888888 799999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCC----CceEEeecccccc
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDEN----YNAKVSDFGLAKL 651 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~----~~~kl~DFGla~~ 651 (852)
+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+.++ +.+||+|||+++.
T Consensus 98 ~~gg~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 98 MKGGELLDKILRQ-----KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCSCBHHHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred CCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999643 358999999999999999999999 899999999999998543 3599999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ....+..+....
T Consensus 170 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~----~~~~i~~~~~~~ 242 (342)
T 2qr7_A 170 LRAEN---GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE----ILARIGSGKFSL 242 (342)
T ss_dssp CBCTT---CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHH----HHHHHHHCCCCC
T ss_pred CcCCC---CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHH----HHHHHccCCccc
Confidence 64322 12234568999999999988888999999999999999999999997543222111 112222221110
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
... ........+.+++.+|++.||++||++.++++
T Consensus 243 -~~~------~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 243 -SGG------YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp -CST------TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -Ccc------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 00111235667888999999999999999985
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=331.79 Aligned_cols=268 Identities=19% Similarity=0.235 Sum_probs=198.3
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeecc--------C
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSE--------G 566 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--------~ 566 (852)
..|.+.++||+|+||.||+|.. .+++.||||++... ......+.+|++++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 4678889999999999999997 56889999998632 2234578899999999999999999999876 4
Q ss_pred ceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeec
Q 003059 567 KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDF 646 (852)
Q Consensus 567 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 646 (852)
+..++||||+++ +|.+.+... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccCC-CHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 578999999975 777777533 2358999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCC-cceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHH
Q 003059 647 GLAKLINPKDH-RHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEF 724 (852)
Q Consensus 647 Gla~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 724 (852)
|+++.+..... .........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...................
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99987653221 1222344568999999999876 458999999999999999999999997654322111110000000
Q ss_pred hhCCccc-----cccc--ccCCCCCCH-HHH------HHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 725 EKGNVKG-----IVDK--SLAGEDVDI-EQV------MRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 725 ~~~~~~~-----~~d~--~l~~~~~~~-~~~------~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
....... ..+. ......... +.+ ..+.+++.+|++.||.+||++.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000000 0000 000101111 111 246789999999999999999999863
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=348.69 Aligned_cols=249 Identities=22% Similarity=0.298 Sum_probs=199.1
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
..+.+.+.||+|+||.||++... +++.||+|++... ......+..|+.++.+++||||+++++++.+.+..|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 34566788999999999999975 5899999999732 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+++|+|.+++..... ....+++..++.++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++.+.
T Consensus 265 E~~~gg~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp CCCTTCBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeccCCCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999965432 23468999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... . .........
T Consensus 341 ~~~~---~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~--~-~~~~i~~~~----- 409 (543)
T 3c4z_A 341 AGQT---KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--E-LKQRVLEQA----- 409 (543)
T ss_dssp TTCC---CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHH--H-HHHHHHHCC-----
T ss_pred CCCc---ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHH--H-HHHHHhhcc-----
Confidence 4221 1234579999999999999999999999999999999999999997643211110 1 111111111
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMM 768 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~ 768 (852)
. ..+......+.+++.+|++.||.+||++
T Consensus 410 ---~---~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 410 ---V---TYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp ---C---CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ---c---CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 0 1111122356678889999999999976
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=326.23 Aligned_cols=247 Identities=24% Similarity=0.375 Sum_probs=201.7
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
..|.+.++||+|+||.||+|... +++.||||++... ....+.+.+|+.++.+++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 35677889999999999999864 5889999999733 34457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+++++|.+++.. ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 102 ~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 102 LGGGSALDLLEP------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999842 358999999999999999999999 89999999999999999999999999999876432
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
. .......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... .......... +
T Consensus 173 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~-----~ 237 (303)
T 3a7i_A 173 Q---IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-------VLFLIPKNNP-----P 237 (303)
T ss_dssp B---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCC-----C
T ss_pred c---cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-------HHHHhhcCCC-----C
Confidence 1 12234568999999999999999999999999999999999999997543211 0111111111 1
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.+.. .. ...+.+++..|++.||.+||++.+|++.
T Consensus 238 ~~~~-~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 238 TLEG-NY----SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCCS-SC----CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CCcc-cc----CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1111 11 2346788889999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=335.55 Aligned_cols=266 Identities=22% Similarity=0.291 Sum_probs=205.7
Q ss_pred HHHHhcccccccccccccceEEEEEE--CCCcEEEEEEecCcccchHHHHHHHHHhhcccccc------eeeeeeeeccC
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVL--ANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLN------LVRLVGFSSEG 566 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~n------iv~l~g~~~~~ 566 (852)
++...+|.+.++||+|+||.||++.. .+++.||||+++......+.+.+|++++..++|++ ++++++++.+.
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 34456788899999999999999986 36889999999866666678899999999998775 99999999999
Q ss_pred ceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC---------
Q 003059 567 KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE--------- 637 (852)
Q Consensus 567 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~--------- 637 (852)
+..++||||+ +++|.+++.... ...+++..+..++.||++||+|||+ ++|+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred CcEEEEEcCC-CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCC
Confidence 9999999999 899999996543 2458899999999999999999999 89999999999999987
Q ss_pred ----------CCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccc
Q 003059 638 ----------NYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEV 707 (852)
Q Consensus 638 ----------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~ 707 (852)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccCCCceEeeCcccccCccc------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 678999999999865432 2235689999999999999999999999999999999999999975
Q ss_pred cccccchhhHHHHHH-----HHhhCCcccc---------------------cccccCCCCCCHHHHHHHHHHHHhccccC
Q 003059 708 SQETNRKKFSLWAYE-----EFEKGNVKGI---------------------VDKSLAGEDVDIEQVMRAIQVSFWCIQEQ 761 (852)
Q Consensus 708 ~~~~~~~~l~~~~~~-----~~~~~~~~~~---------------------~d~~l~~~~~~~~~~~~~~~l~~~cl~~d 761 (852)
............... .......... ..+..............+.+++.+|++.|
T Consensus 237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 316 (339)
T 1z57_A 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD 316 (339)
T ss_dssp SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence 533221111000000 0000000000 00000000122344567889999999999
Q ss_pred CCCCCCHHHHHH
Q 003059 762 PSQRPMMGKVVQ 773 (852)
Q Consensus 762 p~~RPt~~ev~~ 773 (852)
|.+||++.||++
T Consensus 317 P~~Rpt~~ell~ 328 (339)
T 1z57_A 317 PAKRITLREALK 328 (339)
T ss_dssp TTTSCCHHHHTT
T ss_pred cccccCHHHHhc
Confidence 999999999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=326.33 Aligned_cols=245 Identities=22% Similarity=0.329 Sum_probs=196.6
Q ss_pred HhcccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEE
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 572 (852)
...|.+.+.||+|+||.||+|... +++.||+|++... .....++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 456788899999999999999975 6889999998742 33456788999999999 999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCC--------------
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDEN-------------- 638 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-------------- 638 (852)
|||+++++|.+++..... ....+++..++.++.||++||+|||+ .+|+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EECCTTCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC----------------
T ss_pred EEecCCCcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999965432 12458999999999999999999999 899999999999999844
Q ss_pred -----CceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCcccccccccc
Q 003059 639 -----YNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETN 712 (852)
Q Consensus 639 -----~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~ 712 (852)
..+||+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|||++|..++.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ-- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--
T ss_pred ccCCceEEEEcccccccccCCcc-------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--
Confidence 479999999998765421 23489999999999876 566899999999999999999987643211
Q ss_pred chhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 713 RKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 713 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
......+.... +. ......+.+++.+|++.||.+||++.++++
T Consensus 237 --------~~~~~~~~~~~-----~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 --------WHEIRQGRLPR-----IP-----QVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp --------HHHHHTTCCCC-----CS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------HHHHHcCCCCC-----CC-----cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 11222222111 11 111235678888999999999999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=328.53 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=194.4
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCcccchHHHHHHHHHhhcc-cccceeeeeeeecc------Cceee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVATISST-HHLNLVRLVGFSSE------GKHRL 570 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~------~~~~~ 570 (852)
..|.+.+.||+|+||.||+|.. .+++.||||++.......+++.+|+.++.++ +||||+++++++.. .+..+
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~ 103 (326)
T 2x7f_A 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 103 (326)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence 4567788999999999999997 4688999999986666678899999999999 89999999999876 56889
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+||||+++++|.+++.... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.
T Consensus 104 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 104 LVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp EEEECCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred EEEEcCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 9999999999999996542 3468899999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhh-----cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHh
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLA-----NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFE 725 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 725 (852)
...... .......|++.|+|||.+. +..++.++||||||+++|||++|+.||........ .....
T Consensus 178 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~ 247 (326)
T 2x7f_A 178 QLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-------LFLIP 247 (326)
T ss_dssp ----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHH
T ss_pred ecCcCc---cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-------HHHhh
Confidence 654321 1223456899999999987 56789999999999999999999999965432110 11111
Q ss_pred hCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 726 KGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.......... .. ...+.+++.+||+.||.+||++.++++
T Consensus 248 ~~~~~~~~~~-----~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 248 RNPAPRLKSK-----KW----SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HSCCCCCSCS-----CS----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCccccCCcc-----cc----CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111111111 11 235677888999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=341.56 Aligned_cols=200 Identities=23% Similarity=0.310 Sum_probs=174.3
Q ss_pred HHhcccccccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhcc------cccceeeeeeeeccCcee
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISST------HHLNLVRLVGFSSEGKHR 569 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l------~h~niv~l~g~~~~~~~~ 569 (852)
...+|.+.++||+|+||.||+|... +++.||||++........++.+|+.++..+ +|+||+++++++...+..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 3446788899999999999999865 488999999987666667788899888877 567999999999999999
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCc--eEEeecc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYN--AKVSDFG 647 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~kl~DFG 647 (852)
++||||+. ++|.+++.... ...+++..++.++.||+.||+|||+ .+|+||||||+||||+.++. +||+|||
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK---FQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEeccC-CCHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999995 69999996543 2348999999999999999999999 79999999999999999987 9999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccc
Q 003059 648 LAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQ 709 (852)
Q Consensus 648 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~ 709 (852)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 248 ~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 248 SSCYEHQR------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TCEETTCC------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cceecCCc------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99765432 223568999999999999999999999999999999999999997654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=339.41 Aligned_cols=266 Identities=23% Similarity=0.265 Sum_probs=194.0
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeecc------CceeeEE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSE------GKHRLLV 572 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------~~~~~lV 572 (852)
.|.+.+.||+|+||.||+|... +++.||||++.... ..+.+|++++++++||||+++++++.. ....++|
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 5677889999999999999975 58899999986432 234579999999999999999998843 2246799
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCC-CceEEeecccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDEN-YNAKVSDFGLAKL 651 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~DFGla~~ 651 (852)
|||+++ +|.+++..... ....+++..+..++.||++||+|||+ .+|+||||||+||||+.+ +.+||+|||+++.
T Consensus 132 ~e~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EECCCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred hhcccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 999975 66666643211 24568999999999999999999998 899999999999999955 6789999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHH-------HH
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAY-------EE 723 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~-------~~ 723 (852)
+..... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+..... ..
T Consensus 207 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 207 LVRGEP----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CCTTCC----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHH
T ss_pred cccCCC----ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHH
Confidence 643221 2335689999999999765 78999999999999999999999997653221 1111110 00
Q ss_pred Hh--hCCcccccccccCCCC----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcCc
Q 003059 724 FE--KGNVKGIVDKSLAGED----VDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ--MLEGIT 779 (852)
Q Consensus 724 ~~--~~~~~~~~d~~l~~~~----~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~--~L~~~~ 779 (852)
+. .....+...+.+.... ........+.+++.+||+.||.+||++.|+++ .++++.
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 00 0011111111111000 00111246788999999999999999999985 444443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=330.91 Aligned_cols=251 Identities=25% Similarity=0.373 Sum_probs=200.0
Q ss_pred HHhcccccccccccccceEEEEEEC-CCcEEEEEEecCccc---------chHHHHHHHHHhhcc-cccceeeeeeeecc
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQ---------GEKQFRMEVATISST-HHLNLVRLVGFSSE 565 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~f~~E~~~l~~l-~h~niv~l~g~~~~ 565 (852)
....|.+.+.||+|+||.||+|... +++.||||++..... ..+.+.+|+.++.++ +||||+++++++..
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 3456788899999999999999985 689999999873321 135678999999999 79999999999999
Q ss_pred CceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEee
Q 003059 566 GKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSD 645 (852)
Q Consensus 566 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 645 (852)
.+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEe
Confidence 99999999999999999999643 358999999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeeecCCCCCCChhhhhcC------CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHH
Q 003059 646 FGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL------PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLW 719 (852)
Q Consensus 646 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 719 (852)
||++..+.... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||.......
T Consensus 244 fG~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~------- 312 (365)
T 2y7j_A 244 FGFSCHLEPGE----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL------- 312 (365)
T ss_dssp CTTCEECCTTC----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------
T ss_pred cCcccccCCCc----ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH-------
Confidence 99998765432 22346799999999998643 57889999999999999999999996532211
Q ss_pred HHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 720 AYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 720 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.......+.... ..+... .....+.+++.+|++.||.+||++.++++
T Consensus 313 ~~~~i~~~~~~~-~~~~~~------~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 313 MLRMIMEGQYQF-SSPEWD------DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHHHTCCCC-CHHHHS------SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhCCCCC-CCcccc------cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111111100 000000 01235678889999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=322.85 Aligned_cols=247 Identities=23% Similarity=0.370 Sum_probs=193.3
Q ss_pred HhcccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
...|.+.+.||+|+||.||+|... +++.||||.+... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 346778899999999999999975 6889999998632 23456789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++++|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999999653 248899999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCC-CCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPI-TSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
.... ......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||....... .......+..
T Consensus 162 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~-- 228 (276)
T 2h6d_A 162 SDGE----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-------LFKKIRGGVF-- 228 (276)
T ss_dssp CC-----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC--
T ss_pred CCCc----ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-------HHHHhhcCcc--
Confidence 4321 2234568999999999987765 689999999999999999999997542211 1111111110
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.+ +......+.+++.+|++.||.+||++.+|++.
T Consensus 229 ----~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 ----YI-----PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----CC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----cC-----chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01 11112346778899999999999999999873
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.91 Aligned_cols=250 Identities=20% Similarity=0.331 Sum_probs=195.5
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecC-cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEG-IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
..|.+.+.||+|+||.||+|... +++.||+|.+.. .....+.+.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 46778899999999999999975 488999999873 3445678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++++|.+++... ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 99 ~~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 169 (302)
T 2j7t_A 99 PGGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK-- 169 (302)
T ss_dssp TTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--
T ss_pred CCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccc--
Confidence 999999998643 2358999999999999999999999 8999999999999999999999999998764321
Q ss_pred CcceeeeeecCCCCCCChhhhh-----cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLA-----NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
.........|++.|+|||.+. ...++.++||||||+++|||++|+.||....... ............
T Consensus 170 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~ 241 (302)
T 2j7t_A 170 -TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-------VLLKIAKSDPPT 241 (302)
T ss_dssp -HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCCCC
T ss_pred -cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-------HHHHHhccCCcc
Confidence 011123356899999999984 6678999999999999999999999997543211 011111111111
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.. .+......+.+++.+|++.||.+||++.++++
T Consensus 242 ~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 LL--------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CS--------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cC--------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 10 11111235678889999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=326.29 Aligned_cols=246 Identities=25% Similarity=0.353 Sum_probs=192.7
Q ss_pred ccccccccceEEEEEE-CCCcEEEEEEecCc-ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCCCHH
Q 003059 505 DKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLD 582 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 582 (852)
..||+|+||.||+|.. .+++.||||.+... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 4899999999999996 45789999999743 344577999999999999999999999999999999999999999999
Q ss_pred HHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC-CCceEEeecccccccCCCCCccee
Q 003059 583 NFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE-NYNAKVSDFGLAKLINPKDHRHRT 661 (852)
Q Consensus 583 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~ 661 (852)
+++..... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++...... ..
T Consensus 108 ~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~---~~ 179 (295)
T 2clq_A 108 ALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN---PC 179 (295)
T ss_dssp HHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------
T ss_pred HHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC---Cc
Confidence 99965422 3356788899999999999999999 89999999999999987 8999999999998764321 12
Q ss_pred eeeecCCCCCCChhhhhcCC--CCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCC
Q 003059 662 LTSVRGTRGYLAPEWLANLP--ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAG 739 (852)
Q Consensus 662 ~~~~~gt~~y~aPE~~~~~~--~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 739 (852)
.....|++.|+|||.+.+.. ++.++||||||+++|||++|+.||......... .. ...... ..+.+
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~--~~~~~~-----~~~~~-- 247 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA---MF--KVGMFK-----VHPEI-- 247 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH---HH--HHHHHC-----CCCCC--
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH---HH--hhcccc-----ccccc--
Confidence 23456899999999997653 789999999999999999999999643321110 00 000000 01111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 740 EDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 740 ~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+......+.+++.+|++.||++||++.++++
T Consensus 248 ---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 248 ---PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ---CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ---cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1112235677889999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=327.67 Aligned_cols=253 Identities=22% Similarity=0.327 Sum_probs=197.7
Q ss_pred HHHHhcccccccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
+.....|.+.+.||+|+||.||+|... +++.||+|.+.... ..+++.+|+.++.+++||||+++++++.+.+..++||
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 344567788899999999999999975 48899999997533 4567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+++++|.+++... ...+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 104 e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 104 EYCGAGSVSDIIRLR----NKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp ECCTTEEHHHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred ecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 999999999999632 3458999999999999999999999 899999999999999999999999999998654
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ ...........
T Consensus 177 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~-- 244 (314)
T 3com_A 177 DTM---AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA-------IFMIPTNPPPT-- 244 (314)
T ss_dssp TTB---SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHSCCCC--
T ss_pred hhc---cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHhcCCCcc--
Confidence 321 122345689999999999999999999999999999999999999975432110 01111111100
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
. ..+......+.+++.+|++.||.+||++.++++
T Consensus 245 ---~---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 245 ---F---RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---C---SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---c---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0 001111245678889999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=341.14 Aligned_cols=251 Identities=10% Similarity=0.036 Sum_probs=178.5
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCcc----cchHHHHHHHHHhhcc--cccceeeee-------eeecc
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE----QGEKQFRMEVATISST--HHLNLVRLV-------GFSSE 565 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l--~h~niv~l~-------g~~~~ 565 (852)
.|.+.++||+|+||.||+|... +++.||||++.... ...+.+.+|++++..+ +||||++++ +++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 4667889999999999999965 68899999998533 3345677885555444 699988855 33322
Q ss_pred C-----------------ceeeEEEeecCCCCHHHHhhhcccCCccccchhHH------HHHHHhhHhhhhhhccccCCC
Q 003059 566 G-----------------KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSR------FNIALGTARGITYLHEECRDC 622 (852)
Q Consensus 566 ~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~~~ 622 (852)
. ...+|||||++ |+|.+++.... ..+.+..+ +.++.||++||+|||+ ++
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ 214 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANLQS---KG 214 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHHHH---CC
Confidence 2 34799999998 89999997542 23456666 7888999999999998 89
Q ss_pred cccCCCCCCceEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhc--CCCCCCccchhhhHHHHHHHh
Q 003059 623 IVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN--LPITSKSDVYSYGMVLLEIVS 700 (852)
Q Consensus 623 ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~s~Gvvl~ellt 700 (852)
|+||||||+||||+.++.+||+|||+++.... ......+|+.|+|||.+.+ ..++.++|||||||++|||++
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 99999999999999999999999999986532 1224567799999999987 679999999999999999999
Q ss_pred CCccccccccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 701 GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 701 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
|+.||........... ............... +........+.+++.+||+.||++||++.++++
T Consensus 289 g~~Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSW--------KRPSLRVPGTDSLAF-GSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SSCSTTBCCTTCTTCC--------CBCCTTSCCCCSCCC-TTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCCcCcccccch--------hhhhhhhccccccch-hhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999976532211100 000000000001100 000122345678888999999999999999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=345.03 Aligned_cols=194 Identities=25% Similarity=0.384 Sum_probs=152.4
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeecc-----Ccee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSE-----GKHR 569 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-----~~~~ 569 (852)
..|.+.++||+|+||.||+|... +++.||||++... ....+++.+|+++|++++||||+++++++.. ....
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 46788899999999999999864 6889999998743 2334678899999999999999999999843 3578
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
|+||||+ +++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||++
T Consensus 133 ~lv~e~~-~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEECCC-SEEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecc-ccchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccc
Confidence 9999998 57999988532 358999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCc------------------------ceeeeeecCCCCCCChhhh-hcCCCCCCccchhhhHHHHHHHhC
Q 003059 650 KLINPKDHR------------------------HRTLTSVRGTRGYLAPEWL-ANLPITSKSDVYSYGMVLLEIVSG 701 (852)
Q Consensus 650 ~~~~~~~~~------------------------~~~~~~~~gt~~y~aPE~~-~~~~~s~ksDv~s~Gvvl~elltG 701 (852)
+........ ........||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 876432111 1123456789999999986 466799999999999999999993
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=324.41 Aligned_cols=254 Identities=25% Similarity=0.400 Sum_probs=201.7
Q ss_pred HhcccccccccccccceEEEEEEC-CCcEEEEEEecCc-ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
...|.+.+.||+|+||.||++... +++.||+|.+... ....+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 457888899999999999999975 6889999999743 23456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEe---CCCCceEEeeccccccc
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL---DENYNAKVSDFGLAKLI 652 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFGla~~~ 652 (852)
+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 88 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 88 VSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred CCCccHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 9999999998643 348899999999999999999999 899999999999999 78899999999999764
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI 732 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (852)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+.++... .
T Consensus 160 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~~-~ 226 (304)
T 2jam_A 160 QNG-----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-------LFEKIKEGYYE-F 226 (304)
T ss_dssp CCB-----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHCCCC-C
T ss_pred CCC-----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCC-C
Confidence 321 1223468999999999999999999999999999999999999997543211 11122222110 0
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcC
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ--MLEGI 778 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~--~L~~~ 778 (852)
..+ ........+.+++.+|++.||.+||++.++++ .+++.
T Consensus 227 ~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 227 ESP------FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp CTT------TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred Ccc------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 000 01111245678889999999999999999986 44443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=360.00 Aligned_cols=250 Identities=22% Similarity=0.293 Sum_probs=201.5
Q ss_pred HHHHhcccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcc-cccceeeeeeeeccCce
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKH 568 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~ 568 (852)
.+....|.+.++||+|+||.||+|... +++.||||+++.. ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 344456778899999999999999965 5788999999732 33456788899999987 79999999999999999
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.||||||+++|+|.+++... ..+++..++.++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGl 488 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGM 488 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTT
T ss_pred EEEEEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecce
Confidence 99999999999999999654 248999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN 728 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (852)
++...... .......||+.|+|||++.+..++.++|||||||+||||++|+.||....... ....+....
T Consensus 489 a~~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~ 558 (674)
T 3pfq_A 489 CKENIWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-------LFQSIMEHN 558 (674)
T ss_dssp CEECCCTT---CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHSSC
T ss_pred eeccccCC---cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH-------HHHHHHhCC
Confidence 98643221 22345679999999999999999999999999999999999999997543211 111222111
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 003059 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMM-----GKVVQ 773 (852)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~-----~ev~~ 773 (852)
+ ..+......+.+++.+||+.||.+||++ +||++
T Consensus 559 --------~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 559 --------V---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp --------C---CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred --------C---CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1 1111223457788899999999999998 66653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=332.27 Aligned_cols=263 Identities=24% Similarity=0.307 Sum_probs=196.0
Q ss_pred HhcccccccccccccceEEEEEEC-CCcEEEEEEecCccc------chHHHHHHHHHhhcccccceeeeeeeeccCceee
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQ------GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRL 570 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 570 (852)
...|.+.+.||+|+||.||+|... +++.||||++..... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 346778899999999999999964 588999999873221 1346889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+||||+++ +|.+++... ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 89 lv~e~~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEECCSE-EHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEcCCC-CHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 99999976 898888543 3458899999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCc
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
...... .......||+.|+|||.+.+. .++.++||||||+++|||++|..||........ +. ...........
T Consensus 161 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~~-~i~~~~~~~~~ 234 (346)
T 1ua2_A 161 SFGSPN---RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LT-RIFETLGTPTE 234 (346)
T ss_dssp TTTSCC---CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH-HHHHHHCCCCT
T ss_pred eccCCc---ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HH-HHHHHcCCCCh
Confidence 764321 122345689999999999764 588999999999999999999999975432211 11 11111111000
Q ss_pred cc------ccccccC--CCCCCHH-----HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 730 KG------IVDKSLA--GEDVDIE-----QVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 730 ~~------~~d~~l~--~~~~~~~-----~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.. ..+.... ....+.. ....+.+++.+|++.||.+|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 0000000 0011111 12467889999999999999999999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=324.98 Aligned_cols=264 Identities=23% Similarity=0.314 Sum_probs=189.9
Q ss_pred hcccccccccccccceEEEEEECC-CcEEEEEEecCc-ccchHHHHHHHHHhhcccccceeeeeeeec------------
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLVGFSS------------ 564 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~------------ 564 (852)
.+|.+.+.||+|+||.||+|.... ++.||+|++... ....+++.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 467778899999999999999764 889999998743 344577899999999999999999999873
Q ss_pred --cCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeC-CCCce
Q 003059 565 --EGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD-ENYNA 641 (852)
Q Consensus 565 --~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~ 641 (852)
+....++||||++ |+|.+++.. ..+++..++.++.||++||+|||+ .+|+||||||+|||++ +++.+
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEE
T ss_pred ccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeE
Confidence 4468899999997 699999842 358899999999999999999999 8999999999999997 57799
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHH-
Q 003059 642 KVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLW- 719 (852)
Q Consensus 642 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~- 719 (852)
||+|||+++................++..|+|||.+.+ ..++.++||||||+++|||++|+.||..............
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999876432222222334567999999998875 6789999999999999999999999976542211100000
Q ss_pred -------HHHHHhhCCcccccccccCCCCCCHH-----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 720 -------AYEEFEKGNVKGIVDKSLAGEDVDIE-----QVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 720 -------~~~~~~~~~~~~~~d~~l~~~~~~~~-----~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
....... .+...+.........+.. ....+.+++.+|++.||.+||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHT-TSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhh-cCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0000000 000000000110011111 1245778999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=361.72 Aligned_cols=259 Identities=25% Similarity=0.380 Sum_probs=203.9
Q ss_pred HHHHhcccccccccccccceEEEEEECC----CcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCce
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLAN----RTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKH 568 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 568 (852)
++....+.+.+.||+|+||.||+|.+.. +..||||++... ....+.|.+|+.++++++||||+++++++.+ +.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cc
Confidence 4455678889999999999999998642 467999998743 2334679999999999999999999999854 56
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.++||||+++|+|.+++... ...+++..++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVR----KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHT----TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred eEEEEEcCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCC
Confidence 89999999999999999643 2358999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhC
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKG 727 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (852)
++...... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+
T Consensus 538 a~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-------~~~~i~~~ 608 (656)
T 2j0j_A 538 SRYMEDST--YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENG 608 (656)
T ss_dssp CCSCCC------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHHT
T ss_pred CeecCCCc--ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHcC
Confidence 98764322 122233457889999999999999999999999999999997 999997543211 11111111
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 728 NVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 728 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
... ..+......+.+++.+||+.||.+||++.+|++.|+.+.+
T Consensus 609 ~~~----------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 609 ERL----------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC----------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 111 0111122456788899999999999999999999988753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=342.49 Aligned_cols=251 Identities=25% Similarity=0.332 Sum_probs=200.7
Q ss_pred HHhcccccccccccccceEEEEEEC-CCcEEEEEEecC---cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEG---IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
....|.+.++||+|+||.||++... +++.||||++.. .......+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4467889999999999999999975 688999999863 233457889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeC---CCCceEEeecccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD---ENYNAKVSDFGLA 649 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~DFGla 649 (852)
|||+++++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||++
T Consensus 100 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 9999999999998654 348999999999999999999999 8999999999999995 5567999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCc
Q 003059 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 650 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
+..... .......||+.|+|||++.+ .++.++|||||||++|||++|+.||....... ....+..+..
T Consensus 172 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~ 239 (486)
T 3mwu_A 172 TCFQQN----TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVETGKY 239 (486)
T ss_dssp TTBCCC--------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCC
T ss_pred eECCCC----CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC
Confidence 876432 22344579999999999876 58999999999999999999999997543211 1111222211
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 730 KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.... +.. ......+.+++.+||+.||.+|||+.++++.
T Consensus 240 ~~~~-~~~------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 240 AFDL-PQW------RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CSCS-GGG------GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCC-ccc------CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1100 000 0112356788899999999999999999873
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=334.00 Aligned_cols=265 Identities=22% Similarity=0.302 Sum_probs=201.5
Q ss_pred HHHhcccccccccccccceEEEEEE-CCCcEEEEEEecCcccchHHHHHHHHHhhccc-----------ccceeeeeeee
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVATISSTH-----------HLNLVRLVGFS 563 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~-----------h~niv~l~g~~ 563 (852)
+....|.+.++||+|+||.||+|.. .+++.||||++.......+.+.+|++++.+++ |+||+++++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 3456788899999999999999996 56889999999866666678899999999886 89999999998
Q ss_pred ccCc----eeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCC-CcccCCCCCCceEeC--
Q 003059 564 SEGK----HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD-CIVHCDIKPENILLD-- 636 (852)
Q Consensus 564 ~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dlkp~NILl~-- 636 (852)
...+ ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+ + +|+||||||+||||+
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEE
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhh---ccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEecc
Confidence 7654 789999999 999999996543 2348899999999999999999998 7 899999999999994
Q ss_pred ----CCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCcccccccccc
Q 003059 637 ----ENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETN 712 (852)
Q Consensus 637 ----~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~ 712 (852)
..+.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 242 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred CCCcCcceEEEcccccccccCCC------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence 4458999999999876432 233468999999999999999999999999999999999999997543211
Q ss_pred ch---hhHHHHHHHHh--------hCCcc-------cccccc------------cCCCCCCHHHHHHHHHHHHhccccCC
Q 003059 713 RK---KFSLWAYEEFE--------KGNVK-------GIVDKS------------LAGEDVDIEQVMRAIQVSFWCIQEQP 762 (852)
Q Consensus 713 ~~---~l~~~~~~~~~--------~~~~~-------~~~d~~------------l~~~~~~~~~~~~~~~l~~~cl~~dp 762 (852)
.. ........... ..... ...... ......+......+.+++.+||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred cCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence 10 00000000000 00000 000000 00012345566778899999999999
Q ss_pred CCCCCHHHHHH
Q 003059 763 SQRPMMGKVVQ 773 (852)
Q Consensus 763 ~~RPt~~ev~~ 773 (852)
.+||+++||++
T Consensus 323 ~~Rpt~~ell~ 333 (373)
T 1q8y_A 323 RKRADAGGLVN 333 (373)
T ss_dssp TTCBCHHHHHT
T ss_pred cccCCHHHHhh
Confidence 99999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=337.52 Aligned_cols=205 Identities=25% Similarity=0.362 Sum_probs=155.8
Q ss_pred cccc-cccccccccceEEEEEEC---CCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeee--ccCceeeEEE
Q 003059 500 TKGF-KDKLGAGGFGAVYRGVLA---NRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFS--SEGKHRLLVY 573 (852)
Q Consensus 500 ~~~~-~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~--~~~~~~~lV~ 573 (852)
.|.+ .++||+|+||.||+|... +++.||||++.... ....+.+|++++++++||||+++++++ ......++||
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 3444 458999999999999965 47789999997443 335788999999999999999999998 4577899999
Q ss_pred eecCCCCHHHHhhhccc----CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEe----CCCCceEEee
Q 003059 574 EFMKNGSLDNFLFANEE----GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL----DENYNAKVSD 645 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~D 645 (852)
||++ ++|.+++..... .....+++..++.++.||+.||+|||+ .+|+||||||+|||| +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9996 588888753321 112358999999999999999999999 899999999999999 7789999999
Q ss_pred cccccccCCCCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccc
Q 003059 646 FGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQ 709 (852)
Q Consensus 646 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~ 709 (852)
||+++................||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 99998765432222333456799999999999874 58999999999999999999999997543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=326.59 Aligned_cols=256 Identities=19% Similarity=0.293 Sum_probs=196.6
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCcccchHHHHHHHHHhhccc-ccceeeeeeeecc--CceeeEEEe
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVATISSTH-HLNLVRLVGFSSE--GKHRLLVYE 574 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~lV~e 574 (852)
..|.+.++||+|+||.||+|.. .+++.||||++.. ...+.+.+|++++.+++ ||||+++++++.+ ....++|||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc--cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 4677889999999999999986 5688999999973 33567999999999997 9999999999987 668899999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC-ceEEeecccccccC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY-NAKVSDFGLAKLIN 653 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~~~~ 653 (852)
|+++++|.+++. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++...
T Consensus 114 ~~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 114 HVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp CCCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred ccCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 999999999883 27888999999999999999998 8999999999999999776 89999999998765
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHH--------HHH
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAY--------EEF 724 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~ 724 (852)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ .+..... ...
T Consensus 183 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 183 PGQ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp TTC----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHH
T ss_pred CCC----ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhhHH
Confidence 432 2234568999999999987 6789999999999999999999999954322111 1110000 000
Q ss_pred hhCCc------ccc--------cccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 725 EKGNV------KGI--------VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 725 ~~~~~------~~~--------~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..... .++ ....... .........+.+++.+|++.||.+|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHS-ENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCT-TTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhccccccchhhhhhhccccchhhhccc-cccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 000 0000000 011112346778899999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=338.88 Aligned_cols=199 Identities=26% Similarity=0.375 Sum_probs=164.8
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccC-----cee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEG-----KHR 569 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~ 569 (852)
..|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 36788899999999999999964 5788999999743 23346788999999999999999999998766 578
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
|+||||++ ++|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+||||+.++.+||+|||++
T Consensus 106 ~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEECCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 99999996 6999999532 358999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCc-------------------ceeeeeecCCCCCCChhhh-hcCCCCCCccchhhhHHHHHHHhCCcccc
Q 003059 650 KLINPKDHR-------------------HRTLTSVRGTRGYLAPEWL-ANLPITSKSDVYSYGMVLLEIVSGRRNFE 706 (852)
Q Consensus 650 ~~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~-~~~~~s~ksDv~s~Gvvl~elltG~~p~~ 706 (852)
+........ ........||+.|+|||.+ ....++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 876542211 0123556799999999986 56679999999999999999998655553
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=322.52 Aligned_cols=250 Identities=25% Similarity=0.335 Sum_probs=196.2
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc-----ccchHHHHHHHHHhhcccccceeeeeeee--ccCceee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI-----EQGEKQFRMEVATISSTHHLNLVRLVGFS--SEGKHRL 570 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~f~~E~~~l~~l~h~niv~l~g~~--~~~~~~~ 570 (852)
..|.+.+.||+|+||.||++... +++.||+|++... ....+.+.+|++++++++||||+++++++ .+....+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 46788899999999999999964 5789999999733 23457899999999999999999999998 4556889
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+||||++++ |.+++.... ...+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 85 lv~e~~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEECCSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEehhccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccc
Confidence 999999876 777775432 3468999999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhcCCC--CCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANLPI--TSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN 728 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (852)
....... ........|++.|+|||.+.+... +.++||||||+++|||++|+.||....... ....+..+.
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~i~~~~ 229 (305)
T 2wtk_C 158 ALHPFAA-DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK-------LFENIGKGS 229 (305)
T ss_dssp ECCTTCS-SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHCC
T ss_pred ccCcccc-ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH-------HHHHHhcCC
Confidence 7654222 223344568999999999986543 779999999999999999999997543211 111122211
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
. .+ +......+.+++.+|++.||.+||++.++++.
T Consensus 230 ~------~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 Y------AI-----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp C------CC-----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred C------CC-----CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 01 11112356678889999999999999999963
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=345.42 Aligned_cols=251 Identities=26% Similarity=0.334 Sum_probs=203.1
Q ss_pred HHHhcccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceee
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRL 570 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 570 (852)
+....|.+.++||+|+||.||++... +++.||||++... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34567888999999999999999975 6889999998632 334677999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEe---CCCCceEEeecc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL---DENYNAKVSDFG 647 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kl~DFG 647 (852)
+||||+++++|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|||
T Consensus 103 lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 174 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFG 174 (484)
T ss_dssp EEECCCCSCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred EEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence 999999999999999643 358999999999999999999999 899999999999999 567899999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhC
Q 003059 648 LAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG 727 (852)
Q Consensus 648 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (852)
+++...... ......||+.|+|||.+.+ .++.++|||||||++|||++|+.||....... ....+..+
T Consensus 175 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~ 242 (484)
T 3nyv_A 175 LSTHFEASK----KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-------ILKKVEKG 242 (484)
T ss_dssp HHHHBCCCC----SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHC
T ss_pred eeEEccccc----ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcC
Confidence 998765432 2234569999999999876 68999999999999999999999997543211 11122222
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 728 NVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 728 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
...... +.. ......+.+++.+|++.||.+|||+.|+++
T Consensus 243 ~~~~~~-~~~------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 243 KYTFEL-PQW------KKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CCCCCS-GGG------GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCC-ccc------ccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 111000 000 111235678889999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=341.93 Aligned_cols=249 Identities=26% Similarity=0.356 Sum_probs=196.1
Q ss_pred HhcccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
...|.+.++||+|+||.||+|... ++..||+|++... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 446888899999999999999975 5789999998743 334577899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCC---CceEEeeccccc
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDEN---YNAKVSDFGLAK 650 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~DFGla~ 650 (852)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.. +.+||+|||+++
T Consensus 116 e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 116 ECYKGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 999999999988643 348899999999999999999999 899999999999999764 459999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcc
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (852)
..... .......||+.|+|||++. ..++.++|||||||++|||++|+.||....... ....+..+...
T Consensus 188 ~~~~~----~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~ 255 (494)
T 3lij_A 188 VFENQ----KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-------ILRKVEKGKYT 255 (494)
T ss_dssp ECBTT----BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC
T ss_pred ECCCC----ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC
Confidence 76432 2234456999999999986 468999999999999999999999997543211 11112221111
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 731 GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
...+... . ....+.+++.+||+.||.+|||+.++++
T Consensus 256 -~~~~~~~--~----~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 256 -FDSPEWK--N----VSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp -CCSGGGT--T----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CCchhcc--c----CCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0011111 1 1235668889999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=344.16 Aligned_cols=249 Identities=26% Similarity=0.348 Sum_probs=197.6
Q ss_pred HhcccccccccccccceEEEEEEC-CCcEEEEEEecCcc--------------cchHHHHHHHHHhhcccccceeeeeee
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE--------------QGEKQFRMEVATISSTHHLNLVRLVGF 562 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------------~~~~~f~~E~~~l~~l~h~niv~l~g~ 562 (852)
...|.+.++||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 346788899999999999999975 57899999987432 234678999999999999999999999
Q ss_pred eccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC---
Q 003059 563 SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY--- 639 (852)
Q Consensus 563 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~--- 639 (852)
+.+....++||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCS
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCc
Confidence 99999999999999999999999653 348999999999999999999999 8999999999999998776
Q ss_pred ceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHH
Q 003059 640 NAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLW 719 (852)
Q Consensus 640 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 719 (852)
.+||+|||+++...... ......||+.|+|||.+. ..++.++|||||||++|||++|+.||.......
T Consensus 187 ~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------- 254 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY----KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD------- 254 (504)
T ss_dssp SEEECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------
T ss_pred cEEEEECCCCEEcCCCC----ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-------
Confidence 69999999998765421 233456999999999987 468999999999999999999999997543211
Q ss_pred HHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 720 AYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 720 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
....+..+....... ... . ....+.+++.+|++.||.+|||+.|+++
T Consensus 255 ~~~~i~~~~~~~~~~-~~~--~----~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 255 IIKKVEKGKYYFDFN-DWK--N----ISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHHHCCCCCCHH-HHT--T----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHcCCCCCCcc-ccC--C----CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111122211110000 000 0 1235778889999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=331.05 Aligned_cols=260 Identities=22% Similarity=0.261 Sum_probs=188.4
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCc------e
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK------H 568 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~ 568 (852)
..|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++++++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 35777889999999999999864 5889999999743 233467889999999999999999999987654 7
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.++||||++ ++|.+++. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 105 ~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 105 VYIVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEECCS-EEHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEcCC-CCHHHHHh-------hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeec
Confidence 899999997 47888873 238899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhH-----------
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFS----------- 717 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~----------- 717 (852)
++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||............
T Consensus 174 a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 174 ARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 249 (371)
T ss_dssp --------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHH
T ss_pred ccccccc----cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9865431 1233457899999999999999999999999999999999999999764322110000
Q ss_pred -----HHHHHHHhhC------CcccccccccCCCCC--CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 718 -----LWAYEEFEKG------NVKGIVDKSLAGEDV--DIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 718 -----~~~~~~~~~~------~~~~~~d~~l~~~~~--~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.......... .....+......... .......+.+++.+||+.||.+|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0000000000 000000000000000 1112456789999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=333.61 Aligned_cols=261 Identities=23% Similarity=0.319 Sum_probs=193.0
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCc------e
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGK------H 568 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~ 568 (852)
..|.+.+.||+|+||.||+|.. .+++.||||++.... ...+++.+|++++++++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 3577788999999999999997 468899999996332 23467889999999999999999999987653 4
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.++||||+ +++|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 105 ~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 69999999 8899999853 348899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhC
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG 727 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (852)
++..... .....+|+.|+|||.+.+ ..++.++|||||||+++||++|+.||......+.... . .... ..
T Consensus 175 a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~--i-~~~~-g~ 244 (367)
T 1cm8_A 175 ARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE--I-MKVT-GT 244 (367)
T ss_dssp CEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--H-HHHH-CC
T ss_pred ccccccc------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--H-HHhc-CC
Confidence 9875431 234568999999999987 6899999999999999999999999976543211100 0 0000 00
Q ss_pred Ccccc------------cc--cccCCCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcCc
Q 003059 728 NVKGI------------VD--KSLAGED---VDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ--MLEGIT 779 (852)
Q Consensus 728 ~~~~~------------~d--~~l~~~~---~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~--~L~~~~ 779 (852)
...+. +. +...... ........+.+++.+|++.||.+|||+.++++ .++.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 00000 00 0000000 00111235678889999999999999999987 455443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=324.58 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=195.0
Q ss_pred HHHhcccccccccccccceEEEEEEC-CCcEEEEEEecCcc---------cchHHHHHHHHHhhcccccceeeeeeeecc
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---------QGEKQFRMEVATISSTHHLNLVRLVGFSSE 565 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~ 565 (852)
.....|.+.+.||+|+||.||+|... +++.||||.+.... .....+.+|++++++++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 34567889999999999999999975 57899999986322 123458899999999999999999999876
Q ss_pred CceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCc---eE
Q 003059 566 GKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYN---AK 642 (852)
Q Consensus 566 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~k 642 (852)
+. .++||||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +|
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEE
T ss_pred Cc-eEEEEecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEE
Confidence 55 89999999999999998543 358899999999999999999998 89999999999999987665 99
Q ss_pred EeecccccccCCCCCcceeeeeecCCCCCCChhhhh---cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHH
Q 003059 643 VSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLA---NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLW 719 (852)
Q Consensus 643 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 719 (852)
|+|||+++..... .......||+.|+|||.+. ...++.++||||||+++|||++|+.||........ +.
T Consensus 158 l~Dfg~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~-- 229 (322)
T 2ycf_A 158 ITDFGHSKILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LK-- 229 (322)
T ss_dssp ECCCTTCEECCCC----HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HH--
T ss_pred EccCccceecccc----cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HH--
Confidence 9999999876432 1123356899999999974 46789999999999999999999999975432211 11
Q ss_pred HHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 720 AYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 720 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.....+.... ...... .....+.+++.+|++.||.+||++.++++
T Consensus 230 --~~~~~~~~~~-~~~~~~------~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 230 --DQITSGKYNF-IPEVWA------EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --HHHHHTCCCC-CHHHHT------TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --HHHHhCcccc-Cchhhh------hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1111111100 000000 11245778899999999999999999985
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=331.54 Aligned_cols=262 Identities=22% Similarity=0.307 Sum_probs=198.2
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCcc--cchHHHHHHHHHhhcccccceeeeeeeeccC-----ceee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRLVGFSSEG-----KHRL 570 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~ 570 (852)
.+|.+.+.||+|+||.||+|... +++.||||++.... ...+.+.+|++++.+++||||+++++++... ...+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 36788899999999999999964 57889999997432 3346789999999999999999999998654 4789
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+||||++ ++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 107 iv~e~~~-~~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 107 IVQDLME-TDLYKLLKT------QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEECCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEcccC-cCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 9999997 599998853 248999999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCc
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
................||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+..... .........
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~~~~ 253 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---LGILGSPSQ 253 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH---HHHHCSCCH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH---HHHhCCCCH
Confidence 76543222222344579999999998764 45899999999999999999999999765433211110 000000000
Q ss_pred -----------ccccccccCCCCCCHH-----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 730 -----------KGIVDKSLAGEDVDIE-----QVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 730 -----------~~~~d~~l~~~~~~~~-----~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.............+.. ....+.+++.+|++.||.+|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000011111 1235778999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=333.04 Aligned_cols=256 Identities=21% Similarity=0.313 Sum_probs=180.4
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccC------ce
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEG------KH 568 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~ 568 (852)
..|.+.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+++++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 4677788999999999999985 45889999999743 23346788999999999999999999998654 56
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.++|+||+ +++|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 109 ~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred EEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 79999999 7899998843 358999999999999999999998 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhC
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG 727 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (852)
++.... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.... ........
T Consensus 179 a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~---i~~~~g~p 249 (367)
T 2fst_X 179 ARHTAD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL---ILRLVGTP 249 (367)
T ss_dssp ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSC
T ss_pred cccccc------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCC
Confidence 986532 2344578999999999987 6789999999999999999999999976543221110 00000000
Q ss_pred -----------CcccccccccCCCCCCHHH-----HHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 728 -----------NVKGIVDKSLAGEDVDIEQ-----VMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 728 -----------~~~~~~d~~l~~~~~~~~~-----~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.....+............. ...+.+++.+||+.||.+|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0000011000001111111 235678999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=332.88 Aligned_cols=261 Identities=23% Similarity=0.261 Sum_probs=190.3
Q ss_pred HhcccccccccccccceEEEEEECCCcEEEEEEecCccc------------chHHHHHHHHHhhcccccceeeeeeeec-
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQ------------GEKQFRMEVATISSTHHLNLVRLVGFSS- 564 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~------------~~~~f~~E~~~l~~l~h~niv~l~g~~~- 564 (852)
...|.+.+.||+|+||.||+|...+++.||||++..... ..+.+.+|++++++++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 356777899999999999999988899999999863211 1267899999999999999999999984
Q ss_pred ----cCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCc
Q 003059 565 ----EGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYN 640 (852)
Q Consensus 565 ----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 640 (852)
.....++||||++ |+|.+++... ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.
T Consensus 101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~ 172 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMR-TDLAQVIHDQ----RIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNND 172 (362)
T ss_dssp CCTTTCCEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCC
T ss_pred ccCCCcceEEEEEccCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCCCC
Confidence 3447899999997 6888888633 3468999999999999999999999 89999999999999999999
Q ss_pred eEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHH
Q 003059 641 AKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLW 719 (852)
Q Consensus 641 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~ 719 (852)
+||+|||+++..... .......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......... .
T Consensus 173 ~kl~Dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~ 245 (362)
T 3pg1_A 173 ITICDFNLAREDTAD----ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN---K 245 (362)
T ss_dssp EEECCTTC-------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---H
T ss_pred EEEEecCcccccccc----cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH---H
Confidence 999999999854332 22234568999999999877 678999999999999999999999997643221110 0
Q ss_pred HHHHHhhCC-----------cccccccccCCC-CCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 720 AYEEFEKGN-----------VKGIVDKSLAGE-DVDI-----EQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 720 ~~~~~~~~~-----------~~~~~d~~l~~~-~~~~-----~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
......... ....+...+... .... .....+.+++.+|++.||.+|||+.|+++
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 000000000 000111111100 0001 11235778899999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=328.71 Aligned_cols=202 Identities=25% Similarity=0.346 Sum_probs=172.6
Q ss_pred HHhcccccccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhccc-cc-----ceeeeeeeeccCcee
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISSTH-HL-----NLVRLVGFSSEGKHR 569 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~-h~-----niv~l~g~~~~~~~~ 569 (852)
....|.+.++||+|+||.||+|... +++.||||++........++..|+.++..++ |+ +|+++++++...+..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 3457788899999999999999965 5789999999866555677888999988875 44 499999999999999
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeC--CCCceEEeecc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD--ENYNAKVSDFG 647 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kl~DFG 647 (852)
++||||++ ++|.+++.... ...+++..+..++.||+.||.|||.. ..+|+||||||+||||+ .++.+||+|||
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTN---FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEecCC-CCHHHHHhhcC---cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 99999996 59999996543 23589999999999999999999952 26899999999999994 57889999999
Q ss_pred cccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccc
Q 003059 648 LAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQ 709 (852)
Q Consensus 648 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~ 709 (852)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 207 ~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 207 SSCQLGQR------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TCEETTCC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cceecccc------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99876432 234568999999999999999999999999999999999999997653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=332.63 Aligned_cols=262 Identities=21% Similarity=0.271 Sum_probs=193.5
Q ss_pred HHhcccccccccccccceEEEEEE-CCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeecc----------
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSE---------- 565 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~---------- 565 (852)
...+|.+.+.||+|+||.||+|.. .+++.||||++..... ...+|++++++++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 345678889999999999999986 5689999999874322 23479999999999999999999843
Q ss_pred ----------------------------CceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhcc
Q 003059 566 ----------------------------GKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHE 617 (852)
Q Consensus 566 ----------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~ 617 (852)
....++||||++ ++|.+.+..... ....+++..+..++.||++||+|||+
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp ----------------------------CCEEEEEECCCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 335889999997 588888764322 24568999999999999999999998
Q ss_pred ccCCCcccCCCCCCceEeC-CCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHH
Q 003059 618 ECRDCIVHCDIKPENILLD-ENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVL 695 (852)
Q Consensus 618 ~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl 695 (852)
.+|+||||||+|||++ .++.+||+|||+++.+.... ......+|+.|+|||.+.+. .++.++|||||||++
T Consensus 160 ---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 160 ---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE----PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp ---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS----CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred ---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC----CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 8999999999999998 68999999999998764432 22345689999999998875 489999999999999
Q ss_pred HHHHhCCccccccccccchhhHHHHHHHHhh----------CCcccccccccCCCC----CCHHHHHHHHHHHHhccccC
Q 003059 696 LEIVSGRRNFEVSQETNRKKFSLWAYEEFEK----------GNVKGIVDKSLAGED----VDIEQVMRAIQVSFWCIQEQ 761 (852)
Q Consensus 696 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----------~~~~~~~d~~l~~~~----~~~~~~~~~~~l~~~cl~~d 761 (852)
|||++|+.||......+. +.... ..... ....+..-+.+.... .+......+.+++.+||+.|
T Consensus 233 ~ell~g~~pf~~~~~~~~--~~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQ--LVRII-QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHSSCSSCCSSHHHH--HHHHH-HHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHhCCCCCCCCChHHH--HHHHH-HHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 999999999976533221 11110 00000 000010001110000 01112235778899999999
Q ss_pred CCCCCCHHHHHH
Q 003059 762 PSQRPMMGKVVQ 773 (852)
Q Consensus 762 p~~RPt~~ev~~ 773 (852)
|.+|||+.|+++
T Consensus 310 P~~R~t~~e~l~ 321 (383)
T 3eb0_A 310 PDLRINPYEAMA 321 (383)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhhCCCHHHHhc
Confidence 999999999984
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=323.72 Aligned_cols=261 Identities=22% Similarity=0.292 Sum_probs=196.7
Q ss_pred hcccccccccccccceEEEEEE--CCCcEEEEEEecCcc---cchHHHHHHHHHhhcc---cccceeeeeeeec-----c
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL--ANRTVVAVKQLEGIE---QGEKQFRMEVATISST---HHLNLVRLVGFSS-----E 565 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l---~h~niv~l~g~~~-----~ 565 (852)
..|.+.+.||+|+||.||+|.. .+++.||+|++.... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 4577889999999999999997 467899999987322 2234677888887766 8999999999987 5
Q ss_pred CceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEee
Q 003059 566 GKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSD 645 (852)
Q Consensus 566 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 645 (852)
....++||||++ |+|.+++.... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred CceEEEEEecCC-CCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEec
Confidence 678899999997 69999996543 2348999999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHh
Q 003059 646 FGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFE 725 (852)
Q Consensus 646 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 725 (852)
||+++..... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ .........
T Consensus 164 fg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~ 236 (326)
T 1blx_A 164 FGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIG 236 (326)
T ss_dssp CCSCCCCCGG----GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHC
T ss_pred CcccccccCC----CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcC
Confidence 9999865421 122345689999999999999999999999999999999999999975533211 111111110
Q ss_pred hCCccccc------ccccCC---C---CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 726 KGNVKGIV------DKSLAG---E---DVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 726 ~~~~~~~~------d~~l~~---~---~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
........ ...... . .........+.+++.+|++.||.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000 000000 0 000111235678889999999999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=318.59 Aligned_cols=253 Identities=25% Similarity=0.358 Sum_probs=191.4
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeecc------------
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSE------------ 565 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------------ 565 (852)
..|.+.+.||+|+||.||+|... +++.||||++.......+.+.+|++++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 46778899999999999999964 68899999997655566789999999999999999999998754
Q ss_pred -CceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEe
Q 003059 566 -GKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVS 644 (852)
Q Consensus 566 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 644 (852)
.+..++||||+++++|.+++... ...+++..++.++.||++||+|||+ .+|+||||||+|||++.++.+||+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSE----NLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHS----CGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred cCCceEEEEecCCCCCHHHhhhcc----ccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEe
Confidence 45789999999999999999643 3357888999999999999999999 899999999999999999999999
Q ss_pred ecccccccCCCCC-----------cceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCcccccccccc
Q 003059 645 DFGLAKLINPKDH-----------RHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETN 712 (852)
Q Consensus 645 DFGla~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~ 712 (852)
|||+++....... .........|++.|+|||.+.+. .++.++||||||+++|||++ ||......
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~- 234 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER- 234 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH-
Confidence 9999987643211 01122345689999999999865 78999999999999999998 44321110
Q ss_pred chhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 713 RKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 713 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
. .....+.... ..+.+ ..+......+.+++.+|++.||.+||++.++++.
T Consensus 235 -~----~~~~~~~~~~--~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 235 -V----NILKKLRSVS--IEFPP-----DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp -H----HHHHHHHSTT--CCCCT-----TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -H----HHHHhccccc--cccCc-----cccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 0 0111111110 00111 1122233456788899999999999999999873
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=327.60 Aligned_cols=267 Identities=20% Similarity=0.211 Sum_probs=187.1
Q ss_pred HHHhcccccccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCc-------
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK------- 567 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------- 567 (852)
.....|.+.++||+|+||.||+|... +++.||||++.........+.+|++.+..++||||+++++++...+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 34456788899999999999999974 5889999999765555667788999999999999999999986533
Q ss_pred eeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhc--cccCCCcccCCCCCCceEeCC-CCceEEe
Q 003059 568 HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLH--EECRDCIVHCDIKPENILLDE-NYNAKVS 644 (852)
Q Consensus 568 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~ivH~Dlkp~NILl~~-~~~~kl~ 644 (852)
..++||||+++ +|.+.+.... .....+++..+..++.|++.||.||| + .+|+||||||+||||+. ++.+||+
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 100 YLNVVMEYVPD-TLHRCCRNYY-RRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp EEEEEEECCSC-BHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred eEEEEeecccc-cHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEe
Confidence 37899999976 5555443221 12456889999999999999999999 6 89999999999999997 8999999
Q ss_pred ecccccccCCCCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHH--
Q 003059 645 DFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAY-- 721 (852)
Q Consensus 645 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~-- 721 (852)
|||+++...... ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||........ +.....
T Consensus 175 Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~~~~~~ 248 (360)
T 3e3p_A 175 DFGSAKKLSPSE----PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ--LHEIVRVL 248 (360)
T ss_dssp CCTTCBCCCTTS----CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHH
T ss_pred eCCCceecCCCC----CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH--HHHHHHHc
Confidence 999998765422 12345689999999998765 489999999999999999999999976533211 111100
Q ss_pred --------HHHhhCC-cccccccc-cC----CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 722 --------EEFEKGN-VKGIVDKS-LA----GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 722 --------~~~~~~~-~~~~~d~~-l~----~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
....... .....+.. .. -..........+.+++.+||+.||.+|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000 00000000 00 00011113456788999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=330.07 Aligned_cols=254 Identities=20% Similarity=0.295 Sum_probs=192.0
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCcee-----
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHR----- 569 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~----- 569 (852)
.+|.+.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 35677889999999999999964 58899999997432 2346788999999999999999999999877654
Q ss_pred -eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 570 -LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 570 -~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
++||||+. ++|.+++ ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 122 ~~lv~e~~~-~~l~~~~-------~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIM-------GMEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CEEEEECCC-EEHHHHT-------TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred EEEEEcccc-ccHHHHh-------hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 6888887 2348999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhC
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG 727 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (852)
++.... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.. ... ... ...
T Consensus 191 a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~i-~~~-~~~ 260 (371)
T 4exu_A 191 ARHADA------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL--TQI-LKV-TGV 260 (371)
T ss_dssp C--------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHH-HHH-HCC
T ss_pred cccccc------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHH-HHH-hCC
Confidence 986532 2234568999999999987 68899999999999999999999999754322110 000 000 000
Q ss_pred Cccc------------ccccccCCCCCCHH-----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 728 NVKG------------IVDKSLAGEDVDIE-----QVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 728 ~~~~------------~~d~~l~~~~~~~~-----~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
...+ .............. ....+.+++.+|++.||.+||++.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 261 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0000 00000000011111 1246778899999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=331.52 Aligned_cols=270 Identities=20% Similarity=0.277 Sum_probs=204.8
Q ss_pred cCHHHHHHhcccccccccccccceEEEEEEC-C-CcEEEEEEecCcccchHHHHHHHHHhhcccccc------eeeeeee
Q 003059 491 FSYKELQRSTKGFKDKLGAGGFGAVYRGVLA-N-RTVVAVKQLEGIEQGEKQFRMEVATISSTHHLN------LVRLVGF 562 (852)
Q Consensus 491 ~~~~el~~~~~~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~n------iv~l~g~ 562 (852)
....+.....|.+.++||+|+||.||++... + ++.||+|++.......+.+.+|+.++++++|++ ++.++++
T Consensus 11 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDW 90 (355)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred cccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence 3344555678889999999999999999964 3 478999999866666778899999999998877 9999999
Q ss_pred eccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEe-------
Q 003059 563 SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILL------- 635 (852)
Q Consensus 563 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl------- 635 (852)
+...+..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+ .+|+||||||+|||+
T Consensus 91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 91 FNFHGHMCIAFELL-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEE
T ss_pred eeeCCeEEEEEecc-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccc
Confidence 99999999999999 677777775432 2458999999999999999999998 899999999999999
Q ss_pred ------------CCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCc
Q 003059 636 ------------DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRR 703 (852)
Q Consensus 636 ------------~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~ 703 (852)
+.++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 237 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEH------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETTSC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccccccCCCcEEEeecCcccccccc------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCC
Confidence 67889999999999865432 233568999999999999999999999999999999999999
Q ss_pred cccccccccchhhHHHHH-----HHHhhCCcccc-cc--------------------cccCCCCCCHHHHHHHHHHHHhc
Q 003059 704 NFEVSQETNRKKFSLWAY-----EEFEKGNVKGI-VD--------------------KSLAGEDVDIEQVMRAIQVSFWC 757 (852)
Q Consensus 704 p~~~~~~~~~~~l~~~~~-----~~~~~~~~~~~-~d--------------------~~l~~~~~~~~~~~~~~~l~~~c 757 (852)
||................ ........... .. +..............+.+++.+|
T Consensus 238 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 317 (355)
T 2eu9_A 238 LFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRM 317 (355)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHH
Confidence 997543321111000000 00000000000 00 00000011223345678999999
Q ss_pred cccCCCCCCCHHHHHH
Q 003059 758 IQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 758 l~~dp~~RPt~~ev~~ 773 (852)
|+.||.+|||+.|+++
T Consensus 318 L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 318 LEFDPAQRITLAEALL 333 (355)
T ss_dssp TCSSTTTSCCHHHHTT
T ss_pred hcCChhhCcCHHHHhc
Confidence 9999999999999984
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=316.67 Aligned_cols=249 Identities=25% Similarity=0.317 Sum_probs=199.2
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCcc----------cchHHHHHHHHHhhccc-ccceeeeeeeeccC
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE----------QGEKQFRMEVATISSTH-HLNLVRLVGFSSEG 566 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----------~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~ 566 (852)
..|.+.+.||+|+||.||+|... +++.||||++.... ...+.+.+|++++.+++ ||||+++++++.+.
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (298)
T 1phk_A 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 96 (298)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence 46777889999999999999975 57899999997332 12356789999999996 99999999999999
Q ss_pred ceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeec
Q 003059 567 KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDF 646 (852)
Q Consensus 567 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 646 (852)
+..++||||+++++|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 97 ~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 97 TFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred CeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecc
Confidence 9999999999999999999643 358999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCChhhhh------cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHH
Q 003059 647 GLAKLINPKDHRHRTLTSVRGTRGYLAPEWLA------NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA 720 (852)
Q Consensus 647 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 720 (852)
|++....... ......+++.|+|||.+. ...++.++||||||+++|||++|+.||....... .
T Consensus 169 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~ 237 (298)
T 1phk_A 169 GFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------M 237 (298)
T ss_dssp TTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------H
T ss_pred cchhhcCCCc----ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-------H
Confidence 9998765422 223456899999999985 4568899999999999999999999996543211 1
Q ss_pred HHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 721 YEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 721 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
......+.... ..+ ........+.+++.+|++.||.+||++.++++
T Consensus 238 ~~~~~~~~~~~-~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 238 LRMIMSGNYQF-GSP------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHTCCCC-CTT------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHhcCCccc-Ccc------cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11111111110 000 00112345778889999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=315.84 Aligned_cols=253 Identities=25% Similarity=0.332 Sum_probs=201.7
Q ss_pred HHHHHhcccccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCcee
Q 003059 494 KELQRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHR 569 (852)
Q Consensus 494 ~el~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 569 (852)
.+....+|.+.++||+|+||.||++... +++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 3455678999999999999999999975 6889999998632 23457889999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCC---CceEEeec
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDEN---YNAKVSDF 646 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~DF 646 (852)
++||||+++++|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.+ +.+||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Df 168 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDF 168 (287)
T ss_dssp EEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred EEEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEecc
Confidence 9999999999999998643 248899999999999999999999 899999999999999754 46999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhh
Q 003059 647 GLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEK 726 (852)
Q Consensus 647 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (852)
|++....... ......+++.|+|||.+.+ .++.++||||||+++|||++|+.||....... ....+..
T Consensus 169 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~ 236 (287)
T 2wei_A 169 GLSTCFQQNT----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVET 236 (287)
T ss_dssp TGGGTBCCCS----SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHH
T ss_pred CcceeecCCC----ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHc
Confidence 9998764322 1223457889999999876 48999999999999999999999997543211 1112222
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 727 GNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+...... +... . ....+.+++.+|++.||.+||++.++++
T Consensus 237 ~~~~~~~-~~~~--~----~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 237 GKYAFDL-PQWR--T----ISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCCCCCS-GGGT--T----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCc-hhhh--h----cCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 2111000 0000 1 1235678889999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=323.92 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=193.4
Q ss_pred HHHHhcccccccccccccceEEEEEECCCcEEEEEEecCc---ccchHHHHHHHHHhhccc--ccceeeeeeeeccCcee
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGI---EQGEKQFRMEVATISSTH--HLNLVRLVGFSSEGKHR 569 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~--h~niv~l~g~~~~~~~~ 569 (852)
++....|.+.+.||+|+||.||++...+++.||||++... ....+.+.+|++++.+++ |+||+++++++.+.+..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 3445678888999999999999999888999999999633 234467899999999997 49999999999999999
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
++||| +.+++|.+++... ..+++..++.++.||++||.|||+ .+|+||||||+|||+++ +.+||+|||++
T Consensus 104 ~lv~e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~ 173 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIA 173 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred EEEEe-cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeecccc
Confidence 99999 5688999999653 358899999999999999999999 89999999999999964 89999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCChhhhhc-----------CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHH
Q 003059 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLAN-----------LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSL 718 (852)
Q Consensus 650 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~ 718 (852)
+....... ........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||........
T Consensus 174 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~----- 247 (313)
T 3cek_A 174 NQMQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----- 247 (313)
T ss_dssp CC---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----
T ss_pred ccccCccc-cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH-----
Confidence 87643221 112234568999999999875 4688899999999999999999999964322110
Q ss_pred HHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 719 WAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 719 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
........... ... +......+.+++.+||+.||.+||++.|+++.
T Consensus 248 -~~~~~~~~~~~----~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 248 -KLHAIIDPNHE----IEF-----PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp -HHHHHHCTTSC----CCC-----CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHHHHHhcccc----cCC-----cccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 01111111100 001 11112356778889999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=326.06 Aligned_cols=256 Identities=26% Similarity=0.370 Sum_probs=177.1
Q ss_pred HhcccccccccccccceEEEEEEC-CCcEEEEEEecCcc--cchHHHHHHHH-HhhcccccceeeeeeeeccCceeeEEE
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE--QGEKQFRMEVA-TISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~f~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
...|.+.+.||+|+||.||+|... +++.||||++.... ....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 345677889999999999999974 68899999997432 33345666666 677889999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCC-CcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD-CIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
||+++ +|.+++..........+++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99975 88888754322234568999999999999999999998 6 8999999999999999999999999999866
Q ss_pred CCCCCcceeeeeecCCCCCCChhhh----hcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWL----ANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN 728 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (852)
... .......||+.|+|||.+ .+..++.++||||||+++|||++|+.||........ .. ...
T Consensus 177 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------~~-~~~ 242 (327)
T 3aln_A 177 VDS----IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---------QL-TQV 242 (327)
T ss_dssp ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------------CCC
T ss_pred ccc----cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---------HH-HHH
Confidence 432 122334689999999998 466789999999999999999999999975321100 00 000
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
... ..+.+.. .........+.+++.+||+.||.+||++.+|++
T Consensus 243 ~~~-~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 243 VKG-DPPQLSN-SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCS-CCCCCCC-CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hcC-CCCCCCC-cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000 0011110 001112245778889999999999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=336.91 Aligned_cols=266 Identities=22% Similarity=0.255 Sum_probs=193.9
Q ss_pred hcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCc------eeeEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK------HRLLV 572 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~~~lV 572 (852)
.+|.+.++||+|+||.||+|....+..||+|++..... ...+|++++++++||||+++++++...+ ..++|
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc---hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 46778899999999999999987777799998864322 2347999999999999999999985433 47899
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeC-CCCceEEeecccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD-ENYNAKVSDFGLAKL 651 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~DFGla~~ 651 (852)
|||++++.+........ ....+++..+..++.||++||+|||+ .+|+||||||+||||+ .++.+||+|||+++.
T Consensus 117 ~e~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 117 LEYVPETVYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EECCSEEHHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eeccCccHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99998754443332111 23468999999999999999999999 8999999999999999 799999999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHH-------HH
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAY-------EE 723 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~-------~~ 723 (852)
...... .....+|+.|+|||.+.+. .++.++|||||||++|||++|+.||......+. +..... ..
T Consensus 192 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 192 LIAGEP----NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIKVLGTPSREQ 265 (394)
T ss_dssp CCTTCC----CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHH
T ss_pred ccCCCC----CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHH
Confidence 643221 2345689999999999765 589999999999999999999999976543211 111100 00
Q ss_pred HhhCCcccccccccCC-CCCCHH------HHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcCc
Q 003059 724 FEKGNVKGIVDKSLAG-EDVDIE------QVMRAIQVSFWCIQEQPSQRPMMGKVVQM--LEGIT 779 (852)
Q Consensus 724 ~~~~~~~~~~d~~l~~-~~~~~~------~~~~~~~l~~~cl~~dp~~RPt~~ev~~~--L~~~~ 779 (852)
+.... .......+.. ...+.. ....+.+++.+||+.||.+||++.|+++. ++++.
T Consensus 266 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 266 IKTMN-PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHHC-GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HHhhC-hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 00000 0000000000 011111 22467889999999999999999999863 55544
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=326.57 Aligned_cols=262 Identities=20% Similarity=0.287 Sum_probs=201.4
Q ss_pred HhcccccccccccccceEEEEEECCCcEEEEEEecCcccc----h--------------HHHHHHHHHhhcccccceeee
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQG----E--------------KQFRMEVATISSTHHLNLVRL 559 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~----~--------------~~f~~E~~~l~~l~h~niv~l 559 (852)
...|.+.+.||+|+||.||+|.. +++.||||++...... . +.+.+|++++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 34677889999999999999999 8899999998732211 1 789999999999999999999
Q ss_pred eeeeccCceeeEEEeecCCCCHHHHhhhc---ccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeC
Q 003059 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFAN---EEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD 636 (852)
Q Consensus 560 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~ 636 (852)
++++.+.+..++||||+++++|.+++... .......+++..++.++.||+.||.|||+ ..+|+||||||+|||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD 186 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence 99999999999999999999999983211 11124579999999999999999999996 26899999999999999
Q ss_pred CCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcC-CCCC-CccchhhhHHHHHHHhCCccccccccccch
Q 003059 637 ENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL-PITS-KSDVYSYGMVLLEIVSGRRNFEVSQETNRK 714 (852)
Q Consensus 637 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-ksDv~s~Gvvl~elltG~~p~~~~~~~~~~ 714 (852)
.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||.......
T Consensus 187 ~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-- 259 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-- 259 (348)
T ss_dssp TTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--
T ss_pred CCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--
Confidence 9999999999999875432 33445689999999999877 6666 9999999999999999999997543311
Q ss_pred hhHHHHHHHHhhCCcccccc------cccCC--CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 715 KFSLWAYEEFEKGNVKGIVD------KSLAG--EDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 715 ~l~~~~~~~~~~~~~~~~~d------~~l~~--~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
. ....+..+......+ +.... ..........+.+++.+|++.||.+||++.|+++
T Consensus 260 ~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 E----LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp H----HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred H----HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 111122211110000 00000 0000112245678899999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=325.26 Aligned_cols=262 Identities=21% Similarity=0.312 Sum_probs=194.9
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccC-----ceee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEG-----KHRL 570 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~ 570 (852)
..|.+.+.||+|+||.||+|... +++.||||++... ......+.+|++++++++||||+++++++... ...+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 35777889999999999999975 5889999999733 23346788999999999999999999987654 6789
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+||||+. ++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 91 lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 91 IIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 9999996 699998853 358999999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCcce-------eeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHH
Q 003059 651 LINPKDHRHR-------TLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYE 722 (852)
Q Consensus 651 ~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 722 (852)
.......... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~ 237 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL---LIFG 237 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHH
Confidence 7653221111 1223468999999998765 678999999999999999999999997653221110 0000
Q ss_pred HHhhCC------------cccccccccCCCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 723 EFEKGN------------VKGIVDKSLAGEDVDI-----EQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 723 ~~~~~~------------~~~~~d~~l~~~~~~~-----~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
...... ..+.+........... .....+.+++.+|++.||.+||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000 0000000000000111 11235678899999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=334.41 Aligned_cols=253 Identities=25% Similarity=0.310 Sum_probs=185.7
Q ss_pred cccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEEEeecCCCC
Q 003059 502 GFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLVYEFMKNGS 580 (852)
Q Consensus 502 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gs 580 (852)
...+.||+|+||+||.+...+++.||||++... ..+.+.+|++++.++ +||||+++++++.+++..++||||+. |+
T Consensus 18 ~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gs 94 (434)
T 2rio_A 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LN 94 (434)
T ss_dssp EEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EE
T ss_pred eccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CC
Confidence 345789999999998777778899999998743 245678999999876 89999999999999999999999995 69
Q ss_pred HHHHhhhcccCCc--cccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCC-------------CceEEee
Q 003059 581 LDNFLFANEEGSG--KLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDEN-------------YNAKVSD 645 (852)
Q Consensus 581 L~~~l~~~~~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~-------------~~~kl~D 645 (852)
|.+++........ ....+..++.++.||+.||+|||+ .+|+||||||+||||+.+ +.+||+|
T Consensus 95 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp HHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 9999975432111 122455678899999999999998 899999999999999754 4899999
Q ss_pred cccccccCCCCCcc-eeeeeecCCCCCCChhhhhc-------CCCCCCccchhhhHHHHHHHh-CCccccccccccchhh
Q 003059 646 FGLAKLINPKDHRH-RTLTSVRGTRGYLAPEWLAN-------LPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKF 716 (852)
Q Consensus 646 FGla~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l 716 (852)
||+++......... .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---- 247 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE---- 247 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH----
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH----
Confidence 99998775432211 12234579999999999976 678999999999999999999 999996432211
Q ss_pred HHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 717 SLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 717 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.....+... .+.+ ...........+.+++.+|++.||.+||++.+|++
T Consensus 248 -----~~i~~~~~~---~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 -----SNIIRGIFS---LDEM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -----HHHHHTCCC---CCCC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----HHHhcCCCC---cccc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 011111100 0001 11223444567889999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=326.28 Aligned_cols=253 Identities=20% Similarity=0.290 Sum_probs=191.4
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCce------
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKH------ 568 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~------ 568 (852)
.+|.+.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+.++++++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 35777889999999999999974 58899999997432 234678899999999999999999999987654
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.++||||++ ++|.+++. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred EEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 68888772 248999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhC
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG 727 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (852)
++.... ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. +.. ........
T Consensus 173 ~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~-i~~~~~~~ 243 (353)
T 3coi_A 173 ARHADA------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQ-ILKVTGVP 243 (353)
T ss_dssp TTC--------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH--HHH-HHHHHCBC
T ss_pred ccCCCC------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCC
Confidence 986532 1234568999999999987 6789999999999999999999999976532211 000 00000000
Q ss_pred ------------------CcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 728 ------------------NVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 728 ------------------~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.+.......+. .........+.+++.+|++.||.+||++.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFT--QLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CHHHHTTCSCHHHHHHHHTSCBCSSCCTT--TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CHHHHHHHhhHHHHHHHHhCcCCCCccHH--HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000000 011122346778889999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=328.32 Aligned_cols=243 Identities=28% Similarity=0.448 Sum_probs=196.9
Q ss_pred HHHHHhcccccccccccccceEEEEEE-CCCcEEEEEEecCccc-------chHHHHHHHHHhhccc--ccceeeeeeee
Q 003059 494 KELQRSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQ-------GEKQFRMEVATISSTH--HLNLVRLVGFS 563 (852)
Q Consensus 494 ~el~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-------~~~~f~~E~~~l~~l~--h~niv~l~g~~ 563 (852)
.+.....|.+.+.||+|+||.||+|.. .+++.||||++..... ..+.+.+|+.++.+++ |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 344556788899999999999999986 4688999999974321 2356788999999996 59999999999
Q ss_pred ccCceeeEEEeecCC-CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeC-CCCce
Q 003059 564 SEGKHRLLVYEFMKN-GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD-ENYNA 641 (852)
Q Consensus 564 ~~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~ 641 (852)
.+.+..++||||+.+ ++|.+++... ..+++..++.++.||++||+|||+ .+|+||||||+|||++ +++.+
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEE
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCE
Confidence 999999999999976 8999999653 358899999999999999999998 8999999999999999 78999
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCC-CCCccchhhhHHHHHHHhCCccccccccccchhhHHHH
Q 003059 642 KVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPI-TSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA 720 (852)
Q Consensus 642 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 720 (852)
||+|||+++..... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.....
T Consensus 190 kL~Dfg~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---------- 254 (320)
T 3a99_A 190 KLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------- 254 (320)
T ss_dssp EECCCTTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------
T ss_pred EEeeCccccccccc-----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----------
Confidence 99999999876532 1234568999999999987765 6789999999999999999999964321
Q ss_pred HHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 721 YEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 721 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
...... .... .. ...+.+++.+||+.||.+||++.+|++
T Consensus 255 ---~~~~~~--~~~~-----~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 ---IIRGQV--FFRQ-----RV----SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ---HHHCCC--CCSS-----CC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---hhcccc--cccc-----cC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011100 0011 11 235678889999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=322.32 Aligned_cols=245 Identities=27% Similarity=0.389 Sum_probs=189.2
Q ss_pred HHHHHHhcccccccccccccceEEEEEE-CCCcEEEEEEecCccc-------chHHHHHHHHHhhcc----cccceeeee
Q 003059 493 YKELQRSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQ-------GEKQFRMEVATISST----HHLNLVRLV 560 (852)
Q Consensus 493 ~~el~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-------~~~~f~~E~~~l~~l----~h~niv~l~ 560 (852)
..+.....|.+.+.||+|+||.||+|.. .+++.||||++..... ....+.+|+.++.++ +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3456667899999999999999999986 4688999999974321 234466799999888 899999999
Q ss_pred eeeccCceeeEEEee-cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeC-CC
Q 003059 561 GFSSEGKHRLLVYEF-MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD-EN 638 (852)
Q Consensus 561 g~~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~-~~ 638 (852)
+++.+.+..++|||| +++++|.+++... ..+++..++.++.||++||+|||+ .+|+||||||+|||++ .+
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRR 176 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCC
Confidence 999999999999999 7899999999653 248999999999999999999999 7999999999999999 89
Q ss_pred CceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCC-CCccchhhhHHHHHHHhCCccccccccccchhhH
Q 003059 639 YNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPIT-SKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFS 717 (852)
Q Consensus 639 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~ 717 (852)
+.+||+|||+++...... .....|+..|+|||.+.+..+. .++||||||+++|||++|+.||.....
T Consensus 177 ~~~kl~dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------- 244 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDEP-----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------- 244 (312)
T ss_dssp TEEEECCCSSCEECCSSC-----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------
T ss_pred CeEEEEEcchhhhcccCc-----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-------
Confidence 999999999998765421 2345689999999999877664 589999999999999999999964311
Q ss_pred HHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 718 LWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 718 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
..... . ..+......+.+++.+|++.||++||++.|+++.
T Consensus 245 ------~~~~~--------~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 ------ILEAE--------L---HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ------HHHTC--------C---CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------Hhhhc--------c---CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01110 0 0011112356788899999999999999999873
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=331.53 Aligned_cols=249 Identities=25% Similarity=0.318 Sum_probs=184.3
Q ss_pred cccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEEEeecCC
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
.+.+.+.||+|+||+||.....+++.||||++.... ...+.+|+++++++ +||||+++++++.+....+|||||++
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~- 101 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA- 101 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence 466678999999999766556678899999997432 23467899999999 89999999999999999999999996
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC-----CCceEEeecccccccC
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE-----NYNAKVSDFGLAKLIN 653 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~DFGla~~~~ 653 (852)
|+|.+++.... ..+.+..++.++.||++||+|||+ .+|+||||||+||||+. ...+||+|||+++...
T Consensus 102 g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 102 ATLQEYVEQKD----FAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp EEHHHHHHSSS----CCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CCHHHHHHhcC----CCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 69999996542 234455677899999999999999 89999999999999953 3468899999998765
Q ss_pred CCCCcceeeeeecCCCCCCChhhhh---cCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLA---NLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
.............||+.|+|||.+. ...++.++|||||||++|||++ |+.||....... . ........
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~-~~~~~~~~ 246 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------A-NILLGACS 246 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------H-HHHTTCCC
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------H-HHHhccCC
Confidence 4322223334567999999999997 4567889999999999999999 999995432110 0 00110000
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 730 KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
. ... .........+.+++.+|++.||.+||++.+|++
T Consensus 247 ~----~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 247 L----DCL---HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp C----TTS---CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c----ccc---CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 000 112223345678999999999999999999984
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=317.15 Aligned_cols=249 Identities=20% Similarity=0.303 Sum_probs=175.1
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCccc--ch-HHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQ--GE-KQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~-~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
..|.+.+.||+|+||.||+|... +++.||||++..... .. +.+..+..+++.++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 35677889999999999999975 688999999974322 22 334455566888899999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCC-CcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD-CIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
|+ ++.+..++... ...+++..++.++.||++||.|||+ . +|+||||||+|||++.++.+||+|||++....
T Consensus 105 ~~-~~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 105 LM-GTCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CC-SEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred cc-CCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 99 55555554322 2458899999999999999999998 4 89999999999999999999999999997654
Q ss_pred CCCCcceeeeeecCCCCCCChhhhh-----cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLA-----NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN 728 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (852)
... ......+++.|+|||.+. ...++.++||||||+++|||++|+.||........ .........
T Consensus 177 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~~ 246 (318)
T 2dyl_A 177 DDK----AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE------VLTKVLQEE 246 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH------HHHHHHHSC
T ss_pred CCc----cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH------HHHHHhccC
Confidence 321 223456899999999994 55788999999999999999999999975322110 111111111
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
. +.+.. .......+.+++.+||+.||.+||++.+|++
T Consensus 247 ~-----~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 P-----PLLPG---HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp C-----CCCCS---SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C-----CCCCc---cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1 11110 0011235667888999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=320.85 Aligned_cols=251 Identities=20% Similarity=0.247 Sum_probs=169.4
Q ss_pred hcccccc-cccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeecc----CceeeEE
Q 003059 499 STKGFKD-KLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSE----GKHRLLV 572 (852)
Q Consensus 499 ~~~~~~~-~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV 572 (852)
..|.+.+ .||+|+||.||+|... +++.||||++.......+ .....+..++||||+++++++.. +...++|
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 104 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLLII 104 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence 3566644 6999999999999976 588999999975432222 22233566799999999999875 4568999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC---CCceEEeecccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE---NYNAKVSDFGLA 649 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFGla 649 (852)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||++
T Consensus 105 ~e~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 105 MECMEGGELFSRIQERG---DQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EeccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 99999999999997542 3469999999999999999999999 89999999999999976 455999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCc
Q 003059 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 650 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
+..... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||........... .........
T Consensus 179 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~- 249 (336)
T 3fhr_A 179 KETTQN-----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MKRRIRLGQ- 249 (336)
T ss_dssp EEC---------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred eecccc-----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HHHhhhccc-
Confidence 865431 22345689999999999888899999999999999999999999965432211000 000000000
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 730 KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.....+ ........+.+++.+|++.||.+||++.|+++
T Consensus 250 ~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 250 YGFPNP------EWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -CCCTT------TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccCch------hhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000 00112345678889999999999999999997
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=305.95 Aligned_cols=235 Identities=11% Similarity=0.094 Sum_probs=185.1
Q ss_pred ccCHHH-HHHhcccccccccccccceEEEEEECC-CcEEEEEEecCccc----chHHHHHHHHHhhcccccceeeeeeee
Q 003059 490 QFSYKE-LQRSTKGFKDKLGAGGFGAVYRGVLAN-RTVVAVKQLEGIEQ----GEKQFRMEVATISSTHHLNLVRLVGFS 563 (852)
Q Consensus 490 ~~~~~e-l~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~f~~E~~~l~~l~h~niv~l~g~~ 563 (852)
.+...+ +...+|.+.+.||+|+||.||+|.... ++.||||++..... ..+.|.+|+.++.+++||||+++++++
T Consensus 21 ~~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 100 (286)
T 3uqc_A 21 QLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV 100 (286)
T ss_dssp CCCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE
Confidence 344444 556778899999999999999999754 88999999984432 236789999999999999999999999
Q ss_pred ccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEE
Q 003059 564 SEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKV 643 (852)
Q Consensus 564 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl 643 (852)
.+.+..|+||||+++++|.+++... .....+.+++.||+.||+|||+ ++|+||||||+||||+.++.+||
T Consensus 101 ~~~~~~~lv~e~~~g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl 170 (286)
T 3uqc_A 101 HTRAGGLVVAEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVL 170 (286)
T ss_dssp EETTEEEEEEECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEE
T ss_pred EECCcEEEEEEecCCCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEE
Confidence 9999999999999999999999421 2445678899999999999999 89999999999999999999999
Q ss_pred eecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHH
Q 003059 644 SDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEE 723 (852)
Q Consensus 644 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 723 (852)
++++ |++ .++.++||||||+++|||++|+.||..........
T Consensus 171 ~~~~-----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-------- 212 (286)
T 3uqc_A 171 AYPA-----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-------- 212 (286)
T ss_dssp CSCC-----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE--------
T ss_pred Eecc-----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH--------
Confidence 8543 333 36889999999999999999999997643321000
Q ss_pred HhhCCcccccccccCCCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 724 FEKGNVKGIVDKSLAGEDVDI-----EQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 724 ~~~~~~~~~~d~~l~~~~~~~-----~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
.....+.+..... .....+.+++.+||+.||.+| |+.|+++.|+.+...
T Consensus 213 --------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 213 --------PAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp --------ECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred --------HHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 0000000001111 112356788999999999999 999999999987643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=348.06 Aligned_cols=242 Identities=23% Similarity=0.298 Sum_probs=193.8
Q ss_pred HHHHHhcccccccccccccceEEEEEEC--CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCce-
Q 003059 494 KELQRSTKGFKDKLGAGGFGAVYRGVLA--NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKH- 568 (852)
Q Consensus 494 ~el~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~- 568 (852)
.++....|.+.++||+|+||.||++.+. +++.||||++... ......+.+|++++.+++||||+++++++.+.+.
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 3444567888999999999999999975 5889999998633 2344678999999999999999999999987665
Q ss_pred ----eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEe
Q 003059 569 ----RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVS 644 (852)
Q Consensus 569 ----~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~ 644 (852)
.||||||+++++|.+++. ..+++..++.++.||++||.|||+ ++|+||||||+||||+.+ .+||+
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~-------~~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~ 223 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLI 223 (681)
T ss_dssp SCEEEEEEEECCCCEECC-----------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEEC
T ss_pred CCceeEEEEEeCCCCcHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEE
Confidence 699999999999998773 258999999999999999999999 899999999999999986 99999
Q ss_pred ecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHH
Q 003059 645 DFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEF 724 (852)
Q Consensus 645 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 724 (852)
|||+++..... ....||+.|+|||.+.+.. +.++||||||+++|||++|..||.......
T Consensus 224 DFG~a~~~~~~-------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------ 283 (681)
T 2pzi_A 224 DLGAVSRINSF-------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG------------ 283 (681)
T ss_dssp CCTTCEETTCC-------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS------------
T ss_pred ecccchhcccC-------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc------------
Confidence 99999876432 3456999999999998765 889999999999999999999886421110
Q ss_pred hhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCC-HHHHHHHHhcC
Q 003059 725 EKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPM-MGKVVQMLEGI 778 (852)
Q Consensus 725 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt-~~ev~~~L~~~ 778 (852)
+............+.+++.+|++.||.+||+ ++++.+.|.++
T Consensus 284 ------------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 284 ------------LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ------------CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ------------ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0000111122345778999999999999995 56666666654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=338.97 Aligned_cols=263 Identities=25% Similarity=0.331 Sum_probs=195.1
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeecc------Ccee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSE------GKHR 569 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------~~~~ 569 (852)
..|.+.++||+|+||.||+|.. .+++.||||++... ....+.+.+|++++.+++||||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 5788999999999999999986 45889999998743 3345678999999999999999999998765 6788
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCc---eEEeec
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYN---AKVSDF 646 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kl~DF 646 (852)
++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 999999999999999975432 3458999999999999999999999 89999999999999997665 999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccc--hhhHHHHHHH-
Q 003059 647 GLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNR--KKFSLWAYEE- 723 (852)
Q Consensus 647 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~--~~l~~~~~~~- 723 (852)
|+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ..........
T Consensus 169 G~a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 169 GYAKELDQGE----LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244 (676)
T ss_dssp CCCCBTTSCC----CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred cccccccccc----ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence 9998765422 22345789999999999999999999999999999999999999964321100 0000000000
Q ss_pred HhhCCccccc--ccccC-CCCCCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 003059 724 FEKGNVKGIV--DKSLA-GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGK 770 (852)
Q Consensus 724 ~~~~~~~~~~--d~~l~-~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~e 770 (852)
.........+ ...+. ...........+.+++.+|++.||++||++.+
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 0000000000 00100 01123334567788999999999999999977
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-34 Score=319.64 Aligned_cols=240 Identities=17% Similarity=0.122 Sum_probs=176.6
Q ss_pred ccccccccccccceEEEEEE-CCCcEEEEEEecCc----ccchHHHHHHHHHhhcccc-ccee---------------ee
Q 003059 501 KGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI----EQGEKQFRMEVATISSTHH-LNLV---------------RL 559 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h-~niv---------------~l 559 (852)
+.+.+.||+|+||.||+|.. .+++.||||++... ....+.|++|+.++..++| +|.. .+
T Consensus 80 ~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 159 (413)
T 3dzo_A 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 159 (413)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred EEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence 44567899999999999995 46889999998722 2235789999999999987 2211 11
Q ss_pred ------eeeecc-----CceeeEEEeecCCCCHHHHhhhcc--cCCccccchhHHHHHHHhhHhhhhhhccccCCCcccC
Q 003059 560 ------VGFSSE-----GKHRLLVYEFMKNGSLDNFLFANE--EGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHC 626 (852)
Q Consensus 560 ------~g~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~ 626 (852)
..++.. ....+++|+++ +++|.+++.... ......+++..++.++.||++||+|||+ ++|+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHr 235 (413)
T 3dzo_A 160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHT 235 (413)
T ss_dssp CC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECS
T ss_pred CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccC
Confidence 111111 12456777765 789999884211 1234568899999999999999999998 899999
Q ss_pred CCCCCceEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhh----------hcCCCCCCccchhhhHHHH
Q 003059 627 DIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWL----------ANLPITSKSDVYSYGMVLL 696 (852)
Q Consensus 627 Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~ksDv~s~Gvvl~ 696 (852)
||||+||||+.++.+||+|||+++.... ......| +.|+|||.+ ....++.++|||||||++|
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGA------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTE------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCC------ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999886432 2344567 999999999 5556888999999999999
Q ss_pred HHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 697 EIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 697 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
||++|+.||........ ...++... . ..+ ..+.+++.+||+.||++||++.++++
T Consensus 309 elltg~~Pf~~~~~~~~---------------~~~~~~~~-~--~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGG---------------SEWIFRSC-K--NIP----QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGSC---------------SGGGGSSC-C--CCC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhhh---------------HHHHHhhc-c--cCC----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999975432211 11111110 1 122 45778888999999999999877753
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.8e-32 Score=294.09 Aligned_cols=224 Identities=22% Similarity=0.266 Sum_probs=175.1
Q ss_pred cccc-ccccccccceEEEEEE-CCCcEEEEEEecCcccchHHHHHHHHHh-hcccccceeeeeeeecc----CceeeEEE
Q 003059 501 KGFK-DKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVATI-SSTHHLNLVRLVGFSSE----GKHRLLVY 573 (852)
Q Consensus 501 ~~~~-~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~f~~E~~~l-~~l~h~niv~l~g~~~~----~~~~~lV~ 573 (852)
|.+. +.||+|+||.||++.. .+++.||+|+++. ...+.+|++++ +.++||||+++++++.. ....++||
T Consensus 19 y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 94 (299)
T 3m2w_A 19 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 94 (299)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred hhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEE
Confidence 4444 6799999999999996 4688999999864 34677888888 55699999999999876 67889999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC---CCceEEeeccccc
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE---NYNAKVSDFGLAK 650 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFGla~ 650 (852)
||+++++|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 95 e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 95 ECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp CCCCSCBHHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eecCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 9999999999997543 3468999999999999999999999 89999999999999998 7899999999987
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcc
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (852)
.... ..++.++||||||+++|||++|+.||........ ......
T Consensus 169 ~~~~-------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~ 212 (299)
T 3m2w_A 169 ETTG-------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKT 212 (299)
T ss_dssp ECTT-------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCC
T ss_pred cccc-------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHH
Confidence 5431 3467899999999999999999999965432110 000000
Q ss_pred cccccccCCCCCCHH----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 731 GIVDKSLAGEDVDIE----QVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 731 ~~~d~~l~~~~~~~~----~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.+..... ..+.. ....+.+++.+|++.||.+||++.|+++
T Consensus 213 ~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 213 RIRMGQY---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SSCTTCC---SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhccc---cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1110000 11111 1345778899999999999999999986
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-32 Score=281.56 Aligned_cols=206 Identities=17% Similarity=0.231 Sum_probs=158.8
Q ss_pred ccccccCCCCccccCCCCCccccCCCceEEEEEecCCCCeeEEEEEeCCeeEEeeCCCCCCCCceEEEeeCccEEEEcCC
Q 003059 28 SSFADISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGSTPVDSSAFFQLHSSGTLRLISGS 107 (852)
Q Consensus 28 ~~~~~~~~~~~l~~~~~~~~l~S~~g~f~lgf~~~~~~~~~~~i~~~~~~~vW~an~~p~~~~~~l~~~~~g~l~l~~~~ 107 (852)
++.|+|++|++|.+++ +| ++|.|+||||.+++ +. +|..+++||+|||+.. .++.|+|+.||||||+|.+
T Consensus 6 ~~~~~i~~g~~L~~g~---~l--~~g~f~l~f~~~gn----l~-ly~~~~~vW~an~~~~-~~~~l~l~~dGnLvl~d~~ 74 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQ---SL--ELSSFRFTMQSDCN----LV-LFDSDVRVWASNTAGA-TGCRAVLQSDGLLVILTAQ 74 (236)
T ss_dssp CSSSSSCSCSCCCTTC---EE--CSTTEEEEECTTSC----EE-EEESSSEEECCCCCSC-SCCBCCBCSSSCBCCBCTT
T ss_pred eccceeCCCCEECCCC---EE--EcCCEEEEECCCCc----EE-EEECCEEEEECCCCCC-CCeEEEEcCCCcEEEEcCC
Confidence 4669999999999998 77 59999999985543 22 3556899999998433 7789999999999999999
Q ss_pred CceEeeccCCCC-ceeEEEEcCCccEEEecCCCccccccCCCCCCc----------ccCCC-------ccccCccccccc
Q 003059 108 GAIIWDSNTQRL-NVTSASLDDSGNLVLLKNGGVSAWSSFDNPTDT----------IVPSQ-------NFTSDKTLRSGY 169 (852)
Q Consensus 108 ~~~vWst~~~~~-~~~~~~l~d~GNlvl~~~~~~~lWQSFD~PTDt----------lLpg~-------kl~~~~~l~sG~ 169 (852)
|.+||+|++... ....|+|+|+|||||++. ++|||||||||| |+||| .|..+.++++|.
T Consensus 75 ~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~---~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s~~d~s~G~ 151 (236)
T 1dlp_A 75 NTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP---GLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSP 151 (236)
T ss_dssp TCCSCCCCCCCCSSCCEEEECSSSCEEEECS---EEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECSSCCCBCSS
T ss_pred CcEEEeCCccccCCcEEEEEeCCCCEEEecC---CEEECCCCCCcccccCCccceEEecCCcCCCccceEEcCcEeecCc
Confidence 999999997643 335799999999999964 899999999855 58898 555667788899
Q ss_pred eEEEeecCCceeeeecCceeeeccCcccccccccccccccceeeeccCcceeeeeccCCcceEEEeecccCCCcceEEEE
Q 003059 170 YSFTLLKSGNLSLKWNDSVVYFNQGLNSAINSTVNSNLTSPILRLQPVGILSISDVSLNSAAIIAYSSDYAEGSDILRFL 249 (852)
Q Consensus 170 ~sl~~~~~g~~~~~~~~~~~yw~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~ 249 (852)
|+|.++++|+++++ ++..+||++++|+.. +...++++.+|.+.+++.+ ....++++.... ...+|+
T Consensus 152 ~~l~l~~dG~LvL~-~~~~~~W~s~~~~~~--------~~~~~~L~~~Gnl~ly~~~---~~~vw~s~~~~~--~~~~rl 217 (236)
T 1dlp_A 152 YRLSMETDCNLVLF-DRDDRVWSTNTAGKG--------TGCRAVLQPNGRMDVLTNQ---NIAVWTSGNSRS--AGRYVF 217 (236)
T ss_dssp CEEEEETTTEEEEE-BTTBCCSCCCCCSSC--------SSCEEEEETTTEEEEEETT---TEEEEECCCCCS--SSCCEE
T ss_pred EEEEECCCCcEEEE-cCCEeEEeCCCcCCC--------CceEEEECCCCcEEEEeCC---CcEEEEeCCCCC--CCCEEE
Confidence 99999999987765 445799999987432 2345778888877777532 123333332222 135789
Q ss_pred EEccCCcEEEEE
Q 003059 250 SLGSDGNLRIFS 261 (852)
Q Consensus 250 ~l~~dG~l~~~~ 261 (852)
+|++||++++|.
T Consensus 218 ~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 218 VLQPDRNLAIYG 229 (236)
T ss_dssp EECSSSCEEEEC
T ss_pred EEcCCCcEEEeC
Confidence 999999999995
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=5.2e-33 Score=304.97 Aligned_cols=242 Identities=13% Similarity=0.085 Sum_probs=179.8
Q ss_pred HHhcccccccccccccceEEEEEECCCcEEEEEEecCcc---------cchHHHHHHHHHhhccc---------ccceee
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIE---------QGEKQFRMEVATISSTH---------HLNLVR 558 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---------~~~~~f~~E~~~l~~l~---------h~niv~ 558 (852)
....|.+.++||+|+||.||+|+. +++.||||++.... ...+.+.+|+.++++++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 345678889999999999999998 67899999997332 22377899999998886 555555
Q ss_pred e-----------------eeeecc-------------CceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhh
Q 003059 559 L-----------------VGFSSE-------------GKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGT 608 (852)
Q Consensus 559 l-----------------~g~~~~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i 608 (852)
+ ++++.+ .+..+|||||+++|++.+.+.. ..+++..++.++.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQL 170 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHH
Confidence 5 444443 6789999999999977666632 358899999999999
Q ss_pred Hhhhhhhc-cccCCCcccCCCCCCceEeCCCC--------------------ceEEeecccccccCCCCCcceeeeeecC
Q 003059 609 ARGITYLH-EECRDCIVHCDIKPENILLDENY--------------------NAKVSDFGLAKLINPKDHRHRTLTSVRG 667 (852)
Q Consensus 609 a~~L~yLH-~~~~~~ivH~Dlkp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~~g 667 (852)
+.||+||| + .+|+||||||+||||+.++ .+||+|||+++.... ....|
T Consensus 171 ~~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--------~~~~g 239 (336)
T 2vuw_A 171 TASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--------GIVVF 239 (336)
T ss_dssp HHHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------TEEEC
T ss_pred HHHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------CcEEE
Confidence 99999999 7 7999999999999999887 899999999987643 13479
Q ss_pred CCCCCChhhhhcCCCCCCccchhhhHH-HHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHH
Q 003059 668 TRGYLAPEWLANLPITSKSDVYSYGMV-LLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQ 746 (852)
Q Consensus 668 t~~y~aPE~~~~~~~s~ksDv~s~Gvv-l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 746 (852)
|+.|+|||.+.+.. +.++|||||+++ .+++++|..||..... . ......+... ...............
T Consensus 240 t~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~-----~-~~~~~~~~~~----~~~~~~~~~~~~~~~ 308 (336)
T 2vuw_A 240 CDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW-----L-HYLTDKMLKQ----MTFKTKCNTPAMKQI 308 (336)
T ss_dssp CCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH-----H-HHHHHHHHHT----CCCSSCCCSHHHHHH
T ss_pred eecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh-----h-hHHHHhhhhh----hccCcccchhhhhhc
Confidence 99999999998766 889999998777 7889999999853110 0 0011111100 000000000112234
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHH
Q 003059 747 VMRAIQVSFWCIQEQPSQRPMMGKVV 772 (852)
Q Consensus 747 ~~~~~~l~~~cl~~dp~~RPt~~ev~ 772 (852)
...+.+++.+||+.| |++|++
T Consensus 309 s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 309 KRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHGGGSS-----SHHHHH
T ss_pred CHHHHHHHHHHhccC-----CHHHHH
Confidence 467889999999966 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-28 Score=283.67 Aligned_cols=186 Identities=16% Similarity=0.118 Sum_probs=131.3
Q ss_pred ccccccccceEEEEE-ECCCcEEEEEEecCc-----------ccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeE
Q 003059 505 DKLGAGGFGAVYRGV-LANRTVVAVKQLEGI-----------EQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLL 571 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~-----------~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 571 (852)
..++.|++|.+..+. .--|+.++||.+... ....++|.+|+++|+++ .|+||+++++++.+++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 457777777777654 334677999998632 12235799999999999 79999999999999999999
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
||||++|++|.++|.... +++.. +|+.||+.||+|||+ ++||||||||+||||++++++||+|||+|+.
T Consensus 320 VMEyv~G~~L~d~i~~~~-----~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~ 388 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGE-----EIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVT 388 (569)
T ss_dssp EEECCCSEEHHHHHHTTC-----CCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred EEecCCCCcHHHHHHhCC-----CCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCee
Confidence 999999999999996432 35443 589999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccc
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNF 705 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~ 705 (852)
..... .......||+.|||||.+.+ .+..++|+|++|++++++.++..++
T Consensus 389 ~~~~~---~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 389 TPQDC---SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp CC------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCCC---ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 65321 22344679999999999976 4677899999999999998876654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4e-25 Score=256.56 Aligned_cols=184 Identities=16% Similarity=0.199 Sum_probs=144.4
Q ss_pred cccccccccceEEEEEECCCcEEEEEEecCccc---------chHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 504 KDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQ---------GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.+.||+|+||.||++.. .++.+++|+...... ..+++.+|++++++++||||+++..++...+..+||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 46899999999999954 456788887642211 13458999999999999999976666667778899999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++++|.+++.. ++.++.|++++|+|||+ ++|+||||||+|||++. ++||+|||+++....
T Consensus 420 ~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 420 YINGKLAKDVIED-------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp CCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred CCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 9999999999953 45799999999999998 89999999999999999 999999999998754
Q ss_pred CCCcce----eeeeecCCCCCCChhhhhc--CCCCCCccchhhhHHHHHHHhCCcccc
Q 003059 655 KDHRHR----TLTSVRGTRGYLAPEWLAN--LPITSKSDVYSYGMVLLEIVSGRRNFE 706 (852)
Q Consensus 655 ~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~s~Gvvl~elltG~~p~~ 706 (852)
...... ......||+.|||||++.. ..|+...|+|+..+-.++.+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 211110 1134679999999999986 567888999999999999888887763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=8.3e-22 Score=209.62 Aligned_cols=143 Identities=14% Similarity=0.077 Sum_probs=116.7
Q ss_pred ccccccccccccceEEEEEECCCcEEEEEEecCcc-------------------cchHHHHHHHHHhhcccccceeeeee
Q 003059 501 KGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIE-------------------QGEKQFRMEVATISSTHHLNLVRLVG 561 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-------------------~~~~~f~~E~~~l~~l~h~niv~l~g 561 (852)
+.+.+.||+|+||.||+|...+++.||||.++... .....+.+|++++++++ | +++.+
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~ 168 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK 168 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred EEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence 34568999999999999999779999999996321 12456889999999999 4 66666
Q ss_pred eeccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCce
Q 003059 562 FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNA 641 (852)
Q Consensus 562 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 641 (852)
++. .+..++||||+++++|.+ +. ......++.|+++||.|||+ .+|+||||||+|||++ ++.+
T Consensus 169 ~~~-~~~~~lvmE~~~g~~L~~-l~-----------~~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~v 231 (282)
T 1zar_A 169 VYA-WEGNAVLMELIDAKELYR-VR-----------VENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGI 231 (282)
T ss_dssp EEE-EETTEEEEECCCCEEGGG-CC-----------CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEE
T ss_pred EEe-ccceEEEEEecCCCcHHH-cc-----------hhhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcE
Confidence 543 356799999999999988 41 12345799999999999998 8999999999999999 9999
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCChhhhhc
Q 003059 642 KVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN 679 (852)
Q Consensus 642 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 679 (852)
||+|||+++.. ..++|||++..
T Consensus 232 kl~DFG~a~~~----------------~~~~a~e~l~r 253 (282)
T 1zar_A 232 WIIDFPQSVEV----------------GEEGWREILER 253 (282)
T ss_dssp EECCCTTCEET----------------TSTTHHHHHHH
T ss_pred EEEECCCCeEC----------------CCCCHHHHHHH
Confidence 99999999743 35789998853
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=9.5e-20 Score=163.56 Aligned_cols=109 Identities=21% Similarity=0.409 Sum_probs=92.1
Q ss_pred ccccCCCCccccCCCCCccccCCCceEEEEEecCCCCeeEEEEEeCCeeEEeeCCCCCCCCceEEEeeCccEEEEcCCCc
Q 003059 30 FADISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGSTPVDSSAFFQLHSSGTLRLISGSGA 109 (852)
Q Consensus 30 ~~~~~~~~~l~~~~~~~~l~S~~g~f~lgf~~~~~~~~~~~i~~~~~~~vW~an~~p~~~~~~l~~~~~g~l~l~~~~~~ 109 (852)
.|+|.+|+.|.+++ +|+ ++|.|+|+|+.+++ | |+|..+++||+||+.....++.|+|.+||||||+|.++.
T Consensus 1 ~d~l~~g~~L~~g~---~l~-~~~~~~l~~~~dGn----l-vl~~~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~~ 71 (110)
T 3a0c_A 1 VNSLSSPNSLFTGH---SLE-VGPSYRLIMQGDCN----F-VLYDSGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNR 71 (110)
T ss_dssp CCEEETTCEECTTC---EEE-ETTTEEEEECTTSC----E-EEEETTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCC
T ss_pred CCEeCCCCEECCCC---EEE-ECCCEEEEEcCCCc----E-EEEECCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCCc
Confidence 37899999999998 899 99999999986654 3 456678999999985334568999999999999999999
Q ss_pred eEeeccCCCCc-eeEEEEcCCccEEEecCCCccccccCCCCC
Q 003059 110 IIWDSNTQRLN-VTSASLDDSGNLVLLKNGGVSAWSSFDNPT 150 (852)
Q Consensus 110 ~vWst~~~~~~-~~~~~l~d~GNlvl~~~~~~~lWQSFD~PT 150 (852)
+||+|++.... ...++|+|+|||||++. .+||||+||.
T Consensus 72 ~~W~S~t~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~ 110 (110)
T 3a0c_A 72 VIWQTKTNGKEDHYVLVLQQDRNVVIYGP---VVWATGSGPA 110 (110)
T ss_dssp EEEECCCCCSSSCCEEEECTTSCEEEECS---EEEECSCCC-
T ss_pred EEEecCCCCCCCCEEEEEeCCccEEEECC---CEecCCCcCC
Confidence 99999976543 34799999999999975 7999999983
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.80 E-value=1.4e-19 Score=164.49 Aligned_cols=108 Identities=18% Similarity=0.301 Sum_probs=92.5
Q ss_pred ccccccCCCCccccCCCCCccc--cCCCceEEEEEecCCCCeeEEEEEeCCeeEEeeCCCCCCCCceEEEeeCccEEEEc
Q 003059 28 SSFADISLGSSLSASNLNQSWP--SPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGSTPVDSSAFFQLHSSGTLRLIS 105 (852)
Q Consensus 28 ~~~~~~~~~~~l~~~~~~~~l~--S~~g~f~lgf~~~~~~~~~~~i~~~~~~~vW~an~~p~~~~~~l~~~~~g~l~l~~ 105 (852)
++.++|.+|++|.+|+ +|+ |++|.|+|+|+.+++ + +||..+++||+||+.....++.|+|.+||||||+|
T Consensus 6 ~~~~~l~~g~~L~~g~---~l~~~S~~g~~~L~~~~dgn--l---vly~~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d 77 (119)
T 1b2p_A 6 SKQPDDNHPQILHATE---SLEILFGTHVYRFIMQTDCN--L---VLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVIT 77 (119)
T ss_dssp CSCSSSCCCCEEETTC---EEEEEETTEEEEEEECTTSC--E---EEEETTEEEEECCCTTSCSSCEEEECTTSCEEEEC
T ss_pred ecCcccCCCCEEcCCC---EEEEeCCCCCEEEEEecCCC--E---EEEECCEEEEeCCCccCCCceEEEEccCCEEEEEe
Confidence 5679999999999999 899 999999999997654 2 46877999999998544557899999999999999
Q ss_pred CCCceEeeccCCCC-ceeEEEEcCCccEEEecCCCccccccC
Q 003059 106 GSGAIIWDSNTQRL-NVTSASLDDSGNLVLLKNGGVSAWSSF 146 (852)
Q Consensus 106 ~~~~~vWst~~~~~-~~~~~~l~d~GNlvl~~~~~~~lWQSF 146 (852)
.++.+||+|++... +...++|+|+|||||++ .++|||=
T Consensus 78 ~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~---~~~W~Sg 116 (119)
T 1b2p_A 78 NENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWATQ 116 (119)
T ss_dssp TTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEECC
T ss_pred CCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC---ccEeCCC
Confidence 99999999997643 34579999999999998 3899983
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.8e-19 Score=159.90 Aligned_cols=103 Identities=19% Similarity=0.339 Sum_probs=87.9
Q ss_pred ccccCCCCccccCCCCCccccCCCceEEEEEecCCCCeeEEEEEeCCeeEEeeCC-CCCCCCceEEEeeCccEEEEcCCC
Q 003059 30 FADISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGS-TPVDSSAFFQLHSSGTLRLISGSG 108 (852)
Q Consensus 30 ~~~~~~~~~l~~~~~~~~l~S~~g~f~lgf~~~~~~~~~~~i~~~~~~~vW~an~-~p~~~~~~l~~~~~g~l~l~~~~~ 108 (852)
+|+|.+||.|.+|+ +|+| |.|.|.|+.+++ |.+ |...++||+||+ .|...++.|.|+.||||||+|.++
T Consensus 1 kn~L~~g~~L~~g~---~L~s--g~y~l~~q~DgN----Lvl-y~~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~ 70 (105)
T 4h3o_A 1 RNILDNNEGLYAGQ---SLDV--EPYHFIMQDDCN----LVL-YDHSTSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSG 70 (105)
T ss_dssp CCEECTTEEECTTC---EEEE--TTEEEEECTTSC----EEE-EETTEEEEECCCCCTTCCSCEEEECTTSCEEEECTTC
T ss_pred CCCcCCCCEEcCCC---EEEE--CCEEEEECCCCe----EEE-EECCEEEEEecCCCCCCccEEEEEeCCccEEEECCCc
Confidence 47899999999998 8887 889999986554 444 457899999998 577778899999999999999999
Q ss_pred ceEeeccCCCCc-eeEEEEcCCccEEEecCCCcccccc
Q 003059 109 AIIWDSNTQRLN-VTSASLDDSGNLVLLKNGGVSAWSS 145 (852)
Q Consensus 109 ~~vWst~~~~~~-~~~~~l~d~GNlvl~~~~~~~lWQS 145 (852)
.+||+|++.... ...|+|+|+|||||++. .+|||
T Consensus 71 ~~vWss~t~~~~~~~~l~L~ddGNlVly~~---~~W~S 105 (105)
T 4h3o_A 71 RSLWASHSTRGSGNYILILQDDGNVIIYGS---DIWST 105 (105)
T ss_dssp CEEEECCCCCCSSCEEEEECTTSCEEEEES---EEEEC
T ss_pred EEEEEecCCCCCCCEEEEEeCCCeEEEECC---cEecC
Confidence 999999986543 45799999999999964 69998
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.2e-18 Score=157.81 Aligned_cols=109 Identities=20% Similarity=0.328 Sum_probs=90.4
Q ss_pred ccccCCCCccccCCCCCccccCCCceEEEEEecCCCCeeEEEEEeCCeeEEeeCCCCCCCCceEEEeeCccEEEEcCCCc
Q 003059 30 FADISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGSTPVDSSAFFQLHSSGTLRLISGSGA 109 (852)
Q Consensus 30 ~~~~~~~~~l~~~~~~~~l~S~~g~f~lgf~~~~~~~~~~~i~~~~~~~vW~an~~p~~~~~~l~~~~~g~l~l~~~~~~ 109 (852)
.|+|.+||+|.+++ +|+ +|.|+|+|+.+++ +.| |..+++||+||+.....++.|.|.++|||||+|.++.
T Consensus 2 ~dtl~~gq~L~~g~---~L~--~g~~~L~~~~dgn--lvl---y~~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~ 71 (115)
T 2dpf_A 2 DNVLLSGQTLHADH---SLQ--AGAYTLTIQNKCN--LVK---YQNGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNN 71 (115)
T ss_dssp CCEEETTCEEETTE---EEE--ETTEEEEECTTSC--EEE---EETTEEEEECSCTTSCSSCEEEECTTSCEEEECTTCC
T ss_pred CCEeCCCCEECCCC---EEE--CCCEEEEEcCCCc--EEE---EeCCEEEEeCCCCCCCCceEEEECCCCcEEEECCCce
Confidence 47999999999988 787 8999999975543 332 5578999999984224578999999999999998899
Q ss_pred eEeeccCCCC-ceeEEEEcCCccEEEecCCCccccccCCCCCC
Q 003059 110 IIWDSNTQRL-NVTSASLDDSGNLVLLKNGGVSAWSSFDNPTD 151 (852)
Q Consensus 110 ~vWst~~~~~-~~~~~~l~d~GNlvl~~~~~~~lWQSFD~PTD 151 (852)
+||+|+.... +...++|+|+|||||++. ++||||.++..
T Consensus 72 ~vW~S~~~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~~ 111 (115)
T 2dpf_A 72 DVWGSACWGDNGKYALVLQKDGRFVIYGP---VLWSLGPNGCR 111 (115)
T ss_dssp EEEECCCCCSSSCCEEEECTTSCEEEECS---EEECSSTTCBC
T ss_pred EEEEcCCCCCCCCEEEEEeCCCeEEEECC---CEEECCCCCCc
Confidence 9999997643 345799999999999964 89999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.8e-18 Score=156.13 Aligned_cols=109 Identities=21% Similarity=0.409 Sum_probs=91.3
Q ss_pred ccccCCCCccccCCCCCccccCCCceEEEEEecCCCCeeEEEEEeCCeeEEeeCCCCCCCCceEEEeeCccEEEEcCCCc
Q 003059 30 FADISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGSTPVDSSAFFQLHSSGTLRLISGSGA 109 (852)
Q Consensus 30 ~~~~~~~~~l~~~~~~~~l~S~~g~f~lgf~~~~~~~~~~~i~~~~~~~vW~an~~p~~~~~~l~~~~~g~l~l~~~~~~ 109 (852)
.|+|.+||+|.+++ +| ++|.|+|+|+.+++ | ++|..+++||+||+.....++.|+|.++|||||+| ++.
T Consensus 1 tdtl~~gq~L~~g~---~L--~~~~~~L~~~~dgn----l-vl~~~~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~~ 69 (112)
T 1xd5_A 1 SDRLNSGHQLDTGG---SL--AEGGYLFIIQNDCN----L-VLYDNNRAVWASGTNGKASGCVLKMQNDGNLVIYS-GSR 69 (112)
T ss_dssp CCEEETTEEECTTC---EE--EETTEEEEECTTSC----E-EEEETTEEEEECCCTTSCSSEEEEECTTSCEEEEE-TTE
T ss_pred CCCCCCCCEECCCC---EE--eCCCEEEEEcCCCc----E-EEEECCEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CCE
Confidence 47899999999998 77 58999999987655 2 24656899999998533456899999999999999 888
Q ss_pred eEeeccCCCCc-eeEEEEcCCccEEEecCCCccccccCCCC
Q 003059 110 IIWDSNTQRLN-VTSASLDDSGNLVLLKNGGVSAWSSFDNP 149 (852)
Q Consensus 110 ~vWst~~~~~~-~~~~~l~d~GNlvl~~~~~~~lWQSFD~P 149 (852)
+||+|++.... ...++|+++|||||++..+.++||||++.
T Consensus 70 ~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 70 AIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNV 110 (112)
T ss_dssp EEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCC
T ss_pred EEEECCccCCCCCEEEEEeCCCcEEEECCCCceEEECCCcc
Confidence 99999975433 35799999999999987788999999985
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=5.2e-18 Score=178.01 Aligned_cols=135 Identities=16% Similarity=0.130 Sum_probs=106.8
Q ss_pred ccccccccccccceEEEEEE-CCCcE--EEEEEecCcccc-------------------------hHHHHHHHHHhhccc
Q 003059 501 KGFKDKLGAGGFGAVYRGVL-ANRTV--VAVKQLEGIEQG-------------------------EKQFRMEVATISSTH 552 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~-~~~~~--vavK~l~~~~~~-------------------------~~~f~~E~~~l~~l~ 552 (852)
+.+.+.||+|+||.||+|.. .+++. ||||+++..... ...+.+|+.++.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45678999999999999997 67888 999987532111 136789999999999
Q ss_pred ccce--eeeeeeeccCceeeEEEeecCC-C----CHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhc-cccCCCcc
Q 003059 553 HLNL--VRLVGFSSEGKHRLLVYEFMKN-G----SLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLH-EECRDCIV 624 (852)
Q Consensus 553 h~ni--v~l~g~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~iv 624 (852)
|+++ ..++++ ...+|||||+.+ | +|.+++.. .++..+..++.|++.+|.||| + .+|+
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~---~giv 193 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQE---AELV 193 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHT---SCEE
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHH---CCEE
Confidence 8864 444443 367899999942 4 67665421 235567889999999999999 7 8999
Q ss_pred cCCCCCCceEeCCCCceEEeeccccccc
Q 003059 625 HCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 625 H~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
||||||+|||+++ .++|+|||++...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999765
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.6e-17 Score=148.76 Aligned_cols=104 Identities=22% Similarity=0.379 Sum_probs=86.4
Q ss_pred cccCCCCccccCCCCCccccCCCceEEEEEecCCCCeeEEEEEeCCeeEEeeCCCCCCCCceEEEeeCccEEEEcCCCce
Q 003059 31 ADISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGSTPVDSSAFFQLHSSGTLRLISGSGAI 110 (852)
Q Consensus 31 ~~~~~~~~l~~~~~~~~l~S~~g~f~lgf~~~~~~~~~~~i~~~~~~~vW~an~~p~~~~~~l~~~~~g~l~l~~~~~~~ 110 (852)
+||.+||.|.+|+ .|+ +|.|+|.|+.+++ ++| |..+++||++|+...+.++.|.|.+||||||+|.++.+
T Consensus 2 ntL~~gq~L~~g~---~L~--~g~~~L~~q~dGn--Lvl---y~~~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~ 71 (109)
T 3dzw_A 2 NILYSGETLSPGE---FLN--NGRYVFIMQEDCN--LVL---YDVDKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNP 71 (109)
T ss_dssp CEEETTEEECTTC---EEE--ETTEEEEECTTSC--EEE---EETTEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCE
T ss_pred CCcCCCCEeCCCC---EEE--CCCEEEEEcCCCc--EEE---EeCCEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCE
Confidence 6899999999988 775 8999999976554 433 76689999999843345689999999999999999999
Q ss_pred EeeccCCCCce-eEEEEcCCccEEEecCCCccccccCC
Q 003059 111 IWDSNTQRLNV-TSASLDDSGNLVLLKNGGVSAWSSFD 147 (852)
Q Consensus 111 vWst~~~~~~~-~~~~l~d~GNlvl~~~~~~~lWQSFD 147 (852)
||++++..... .+|+|+|+|||||++. .+|||=.
T Consensus 72 ~W~S~t~~~~~~~~~~L~ddGNlvly~~---~~W~s~t 106 (109)
T 3dzw_A 72 IWASNTGGENGNYVCVLQKDRNVVIYGT---ARWATGT 106 (109)
T ss_dssp EEECCCCCSSSCEEEEECTTSCEEEEES---CCCCCCC
T ss_pred EEECCCCCCCCCEEEEEeCCCEEEEECC---CEEeCCC
Confidence 99999865443 5799999999999984 8999853
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.3e-16 Score=142.83 Aligned_cols=106 Identities=16% Similarity=0.219 Sum_probs=85.1
Q ss_pred ccccccccCCCCccccCCCCCccccCCCceEEEEEecCCCCeeEEEEEeCCeeEEeeCCCCCCCCceEEEeeCccEEEEc
Q 003059 26 FISSFADISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGSTPVDSSAFFQLHSSGTLRLIS 105 (852)
Q Consensus 26 ~~~~~~~~~~~~~l~~~~~~~~l~S~~g~f~lgf~~~~~~~~~~~i~~~~~~~vW~an~~p~~~~~~l~~~~~g~l~l~~ 105 (852)
...+.|+|.+||.|..++ +|+| |.|.|-|..+++ |.+ |.. .+||++|+.....++.|.|.+||||||+|
T Consensus 2 ~~~~~dtL~~gq~L~~g~---~L~s--g~~~L~~q~dGn----Lvl-~~~-~~vW~snt~~~~~~~~l~l~~dGNLvl~d 70 (110)
T 3r0e_B 2 IPFTNNLLFSGQVLYGDG---RLTA--KNHQLVMQGDCN----LVL-YGG-KYGWQSNTHGNGEHCFLRLNHKGELIIKD 70 (110)
T ss_dssp CCCBTTEEETTCEEETTE---EEEC--SSCEEEECTTSC----EEE-ECS-SSCEECCCTTSSSSCEEEECTTSCEEEEC
T ss_pred CccccCEECCCCEecCCC---EEEe--CCEEEEEcCCCe----EEE-ECC-eEEEECCCcCCCcCEEEEEeCCCcEEEEe
Confidence 456889999999999998 8887 569997654333 433 544 69999998543456799999999999999
Q ss_pred CCCceEeeccCCCCc-eeEEEEcCCccEEEecCCCcccccc
Q 003059 106 GSGAIIWDSNTQRLN-VTSASLDDSGNLVLLKNGGVSAWSS 145 (852)
Q Consensus 106 ~~~~~vWst~~~~~~-~~~~~l~d~GNlvl~~~~~~~lWQS 145 (852)
.++.+||++++.... ..+|+|+|+|||||++ ..+|+|
T Consensus 71 ~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~---~~~W~t 108 (110)
T 3r0e_B 71 DDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG---PAIFET 108 (110)
T ss_dssp TTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred CCCCEEEEcCCcCCCCCEEEEEcCCccEEEec---CCEecC
Confidence 999999999986433 3579999999999998 488987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.65 E-value=4.1e-16 Score=140.40 Aligned_cols=108 Identities=17% Similarity=0.219 Sum_probs=88.1
Q ss_pred ccccccccCCCCccccCCCCCccccCCCceEEEEEecCCCCeeEEEEEe-CCeeEEeeCCCCCCCCceEEEeeCccEEEE
Q 003059 26 FISSFADISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYS-GGVPIWTAGSTPVDSSAFFQLHSSGTLRLI 104 (852)
Q Consensus 26 ~~~~~~~~~~~~~l~~~~~~~~l~S~~g~f~lgf~~~~~~~~~~~i~~~-~~~~vW~an~~p~~~~~~l~~~~~g~l~l~ 104 (852)
...+.|+|.+||.|.+++ .|. +|.|.|-|+.+++ |.++.. ..++||++|+.....++.|.|.++|||||+
T Consensus 2 ~~~~~~tL~~gq~L~~g~---~L~--~g~~~L~~q~dGN----LvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~ 72 (113)
T 3mez_B 2 IPRVRNVLFSSQVMYDNA---QLA--TRDYSLVMRDDCN----LVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDIT 72 (113)
T ss_dssp CCCCSSEEETTCEEETTC---EEE--ETTEEEEECTTSC----EEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEE
T ss_pred CcccCCEeCCCCEECCCC---EeE--cCCEEEEEcCCCE----EEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEE
Confidence 356789999999999998 776 5899999975544 555444 479999999843345689999999999999
Q ss_pred cCCCceEeeccCCCCc-eeEEEEcCCccEEEecCCCcccccc
Q 003059 105 SGSGAIIWDSNTQRLN-VTSASLDDSGNLVLLKNGGVSAWSS 145 (852)
Q Consensus 105 ~~~~~~vWst~~~~~~-~~~~~l~d~GNlvl~~~~~~~lWQS 145 (852)
|.++.+||++++.... ..+|+|+|+|||||++ ..+|+|
T Consensus 73 d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---~~~W~s 111 (113)
T 3mez_B 73 DDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG---PAVWST 111 (113)
T ss_dssp CTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred CCCCCEEEECCCcCCCCCEEEEEcCCceEEEec---CCEecC
Confidence 9999999999986433 3589999999999997 689987
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.65 E-value=3.9e-16 Score=140.68 Aligned_cols=92 Identities=22% Similarity=0.372 Sum_probs=79.3
Q ss_pred CCceEEEeeCccEEEEcCCCceEeeccCCCCc-eeEEEEcCCccEEEecCCCccccccCCCCCCcccCCCccccCccccc
Q 003059 89 SSAFFQLHSSGTLRLISGSGAIIWDSNTQRLN-VTSASLDDSGNLVLLKNGGVSAWSSFDNPTDTIVPSQNFTSDKTLRS 167 (852)
Q Consensus 89 ~~~~l~~~~~g~l~l~~~~~~~vWst~~~~~~-~~~~~l~d~GNlvl~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~l~s 167 (852)
....|.|..||||+|++. +++||++++.... ...|+|+|+|||||+| ++.++||||++|. +
T Consensus 19 ~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~~~~W~S~~~~~----------------~ 80 (112)
T 1xd5_A 19 GGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GSRAIWASNTNRQ----------------N 80 (112)
T ss_dssp TTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TTEEEEECCCCCS----------------C
T ss_pred CCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CCEEEEECCccCC----------------C
Confidence 457899999999999987 7899999976433 4689999999999999 7889999998774 4
Q ss_pred cceEEEeecCCceeeeecCceeeeccCcccc
Q 003059 168 GYYSFTLLKSGNLSLKWNDSVVYFNQGLNSA 198 (852)
Q Consensus 168 G~~sl~~~~~g~~~~~~~~~~~yw~~g~~~~ 198 (852)
|.|++.++++|+++++.+...+||++++|+|
T Consensus 81 g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 81 GNYYLILQRDRNVVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp CCCEEEECTTSCEEEECTTSCEEEECCCCCC
T ss_pred CCEEEEEeCCCcEEEECCCCceEEECCCccC
Confidence 7899999999999988777789999998764
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=5.4e-16 Score=138.99 Aligned_cols=89 Identities=24% Similarity=0.365 Sum_probs=75.6
Q ss_pred CCCceEEEeeCccEEEEcCCCceEeeccCCCCc-eeEEEEcCCccEEEecCCCccccccCCCCCCcccCCCccccCcccc
Q 003059 88 DSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLN-VTSASLDDSGNLVLLKNGGVSAWSSFDNPTDTIVPSQNFTSDKTLR 166 (852)
Q Consensus 88 ~~~~~l~~~~~g~l~l~~~~~~~vWst~~~~~~-~~~~~l~d~GNlvl~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~l~ 166 (852)
+....|.|..||||||+| .+++||++++.... ...++|+|+|||||+|.++.++||||..|.
T Consensus 19 ~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~~~~W~S~t~~~---------------- 81 (110)
T 3a0c_A 19 GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTKTNGK---------------- 81 (110)
T ss_dssp TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCCCS----------------
T ss_pred CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCCcEEEecCCCCC----------------
Confidence 446789999999999998 58999999976443 357999999999999988899999997664
Q ss_pred ccceEEEeecCCceeeeecCceeeeccCcc
Q 003059 167 SGYYSFTLLKSGNLSLKWNDSVVYFNQGLN 196 (852)
Q Consensus 167 sG~~sl~~~~~g~~~~~~~~~~~yw~~g~~ 196 (852)
+|.|++.++++|+++++.. .||+++++
T Consensus 82 ~g~~~l~l~~dGnlvl~~~---~~W~S~~~ 108 (110)
T 3a0c_A 82 EDHYVLVLQQDRNVVIYGP---VVWATGSG 108 (110)
T ss_dssp SSCCEEEECTTSCEEEECS---EEEECSCC
T ss_pred CCCEEEEEeCCccEEEECC---CEecCCCc
Confidence 4889999999999888653 79999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1e-15 Score=166.96 Aligned_cols=138 Identities=10% Similarity=0.014 Sum_probs=97.1
Q ss_pred ccccccccccccceEEEEEECCCcEEEEEEecCccc---------------chHHHHHHHHHhhcccccceeeeeeeecc
Q 003059 501 KGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQ---------------GEKQFRMEVATISSTHHLNLVRLVGFSSE 565 (852)
Q Consensus 501 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---------------~~~~f~~E~~~l~~l~h~niv~l~g~~~~ 565 (852)
|.+..+||+|+||.||+|...+|+.||||+++.... .......++++.+...|+|+.+++.....
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 677889999999999999998999999998752110 01122223333333334444443322111
Q ss_pred ------CceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC
Q 003059 566 ------GKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY 639 (852)
Q Consensus 566 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~ 639 (852)
....+|||||++++.|.++.. ......++.||+.+|.|||+ .+||||||||.||||++++
T Consensus 177 vp~p~~~~~~~LVME~i~G~~L~~l~~-----------~~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 177 VPEPIAQSRHTIVMSLVDALPMRQVSS-----------VPDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp CCCEEEEETTEEEEECCSCEEGGGCCC-----------CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEE
T ss_pred CCeeeeccCceEEEEecCCccHhhhcc-----------cHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCC
Confidence 123379999999988865431 12345688999999999998 8999999999999998877
Q ss_pred ----------ceEEeeccccccc
Q 003059 640 ----------NAKVSDFGLAKLI 652 (852)
Q Consensus 640 ----------~~kl~DFGla~~~ 652 (852)
.+.|+||+-+...
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEET
T ss_pred CcccccccccceEEEEeCCcccC
Confidence 3899999987654
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.58 E-value=5.1e-15 Score=134.38 Aligned_cols=85 Identities=25% Similarity=0.339 Sum_probs=73.3
Q ss_pred ceEEEeeCccEEEEcCCCceEeeccCCCCc-eeEEEEcCCccEEEecCCCccccccCCCCCCcccCCCccccCccccccc
Q 003059 91 AFFQLHSSGTLRLISGSGAIIWDSNTQRLN-VTSASLDDSGNLVLLKNGGVSAWSSFDNPTDTIVPSQNFTSDKTLRSGY 169 (852)
Q Consensus 91 ~~l~~~~~g~l~l~~~~~~~vWst~~~~~~-~~~~~l~d~GNlvl~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~l~sG~ 169 (852)
..|.|..||||+|++. +++||++++.... ...++|+|+|||||+|.++.++||||++|. +|.
T Consensus 32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~~~lW~S~~~~~----------------~g~ 94 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVAGK----------------AGH 94 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECSCCCC----------------SSC
T ss_pred EEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCCCcEEEcCCCCCC----------------CCC
Confidence 5688889999999987 8999999976443 358999999999999988999999997764 488
Q ss_pred eEEEeecCCceeeeecCceeeeccCc
Q 003059 170 YSFTLLKSGNLSLKWNDSVVYFNQGL 195 (852)
Q Consensus 170 ~sl~~~~~g~~~~~~~~~~~yw~~g~ 195 (852)
|++.++++|+++++. .+||++|+
T Consensus 95 ~~l~l~~~Gnlvl~~---~~~W~Sg~ 117 (119)
T 1b2p_A 95 YVLVLQPDRNVVIYG---DALWATQT 117 (119)
T ss_dssp EEEEECTTSCEEEEE---SEEEECCC
T ss_pred EEEEEECCCcEEEEC---ccEeCCCC
Confidence 999999999988876 38999985
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.57 E-value=3.4e-15 Score=133.34 Aligned_cols=107 Identities=21% Similarity=0.376 Sum_probs=85.1
Q ss_pred cccccCCCCccccCCCCCccccCCCceEEEEEecCCCCeeEEEEEeCCeeEEeeCCCCCCCCceEEEeeCccEEEEcCCC
Q 003059 29 SFADISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGSTPVDSSAFFQLHSSGTLRLISGSG 108 (852)
Q Consensus 29 ~~~~~~~~~~l~~~~~~~~l~S~~g~f~lgf~~~~~~~~~~~i~~~~~~~vW~an~~p~~~~~~l~~~~~g~l~l~~~~~ 108 (852)
+.|||.+||.|.+++ +| .+|.|.|.|+.+++ ..+ |. .+|.+|+.....++.|+|.+||||||+|.++
T Consensus 2 ~~dtL~~gq~L~~g~---~L--~~g~~~L~~q~dGN--Lvl---~~---~~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~ 68 (109)
T 3r0e_A 2 GTNYLLSGQTLDTEG---HL--KNGDFDLVMQDDCN--LVL---YN---GNWQSNTANNGRDCKLTLTDYGELVIKNGDG 68 (109)
T ss_dssp CCSEEETTCEECTTC---EE--EETTEEEEECTTSC--EEE---ET---TTEECCCTTSCSSCEEEECTTSCEEEECTTS
T ss_pred ccCCcCCCCCcCCCC---Ee--ECCCEEEEEecCCe--EEE---Ee---CeEEcCCCCCCCcEEEEEcCCCeEEEEeCCC
Confidence 679999999999998 67 57999999965544 222 42 2799997433457899999999999999999
Q ss_pred ceEeeccCCCCc-eeEEEEcCCccEEEecCCCccccccCCCCCCcccCC
Q 003059 109 AIIWDSNTQRLN-VTSASLDDSGNLVLLKNGGVSAWSSFDNPTDTIVPS 156 (852)
Q Consensus 109 ~~vWst~~~~~~-~~~~~l~d~GNlvl~~~~~~~lWQSFD~PTDtlLpg 156 (852)
.+||++++.... ..+|+|+|+|||||++ ..+|+| .|.+||
T Consensus 69 ~~vWss~t~~~~~~~~~~L~~dGNlvly~---~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 69 STVWKSGAQSVKGNYAAVVHPDGRLVVFG---PSVFKI-----DPWVRG 109 (109)
T ss_dssp CEEEECCCCCSSSCCEEEEETTTEEEEEC---SEEEEE-----CTTSCC
T ss_pred CEEEcCCCcCCCcCEEEEEcCCCeEEEEe---cCEECC-----CCccCC
Confidence 999999976433 4579999999999997 689998 555543
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=9.9e-15 Score=132.05 Aligned_cols=88 Identities=26% Similarity=0.391 Sum_probs=74.8
Q ss_pred CceEEEeeCccEEEEcCCCceEeeccCCCCc-eeEEEEcCCccEEEecCCCccccccCCCCCCcccCCCccccCcccccc
Q 003059 90 SAFFQLHSSGTLRLISGSGAIIWDSNTQRLN-VTSASLDDSGNLVLLKNGGVSAWSSFDNPTDTIVPSQNFTSDKTLRSG 168 (852)
Q Consensus 90 ~~~l~~~~~g~l~l~~~~~~~vWst~~~~~~-~~~~~l~d~GNlvl~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~l~sG 168 (852)
...|.|..||||+|++ .+++||++++.... ...++|+++|||||+|.++.++||||++|. +|
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~~~----------------~g 83 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACWGD----------------NG 83 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCCCS----------------SS
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCCceEEEEcCCCCC----------------CC
Confidence 4668888999999998 58899999976443 357999999999999988899999999964 47
Q ss_pred ceEEEeecCCceeeeecCceeeeccCccc
Q 003059 169 YYSFTLLKSGNLSLKWNDSVVYFNQGLNS 197 (852)
Q Consensus 169 ~~sl~~~~~g~~~~~~~~~~~yw~~g~~~ 197 (852)
.|++.++++|+++++. . +||++++|.
T Consensus 84 ~~~l~l~~dGnlvl~~-~--~~W~S~~~~ 109 (115)
T 2dpf_A 84 KYALVLQKDGRFVIYG-P--VLWSLGPNG 109 (115)
T ss_dssp CCEEEECTTSCEEEEC-S--EEECSSTTC
T ss_pred CEEEEEeCCCeEEEEC-C--CEEECCCCC
Confidence 8999999999988873 3 899999884
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.46 E-value=9.6e-14 Score=124.36 Aligned_cols=102 Identities=12% Similarity=0.215 Sum_probs=80.1
Q ss_pred ccccCCCCccccCCCCCccccCCCceEEEEEecCCCCeeEEEEEeCCeeEEeeCCCCCCCCceEEEeeCccEEEEcCCCc
Q 003059 30 FADISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGSTPVDSSAFFQLHSSGTLRLISGSGA 109 (852)
Q Consensus 30 ~~~~~~~~~l~~~~~~~~l~S~~g~f~lgf~~~~~~~~~~~i~~~~~~~vW~an~~p~~~~~~l~~~~~g~l~l~~~~~~ 109 (852)
+|+|.+||.|.+|+ .| .+|.|.|.|+.+++ + .+ |.... ||.+|+.....++.|.|.++|||||+|.++.
T Consensus 2 ~~~l~~gq~L~~g~---~L--~~g~~~L~~q~dGn--L--vl-~~~~~-vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~ 70 (111)
T 3mez_A 2 NNVLLTGDVIHTDN---QL--SYESAAFVMQGDCN--L--VL-YNEAG-GFQSNTHGRGVDCTLRLNNRGQLEIHSANSN 70 (111)
T ss_dssp TTEEETTCEECTTC---EE--EETTEEEEECTTSC--E--EE-ECSSC-CEECCCTTSCSSCEEEECTTSCEEEECSSCS
T ss_pred cCEeCCCCEeCCCC---EE--ecCCEEEEEccCCe--E--EE-ECCCC-EEECCcccCCcCEEEEEcCCCcEEEEeCCCC
Confidence 57899999999998 67 47999999965443 3 33 64445 9999974224468999999999999998876
Q ss_pred -eEeeccCCC---CceeEEEEcCCccEEEecCCCcccccc
Q 003059 110 -IIWDSNTQR---LNVTSASLDDSGNLVLLKNGGVSAWSS 145 (852)
Q Consensus 110 -~vWst~~~~---~~~~~~~l~d~GNlvl~~~~~~~lWQS 145 (852)
+||+|++.. ....+++|+|+|||||++ ..+|+|
T Consensus 71 ~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---~~~W~s 107 (111)
T 3mez_A 71 TPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---PAIWST 107 (111)
T ss_dssp SCSEEESSSCCCCSSCCEEEECTTSCEEEEC---SEEEEC
T ss_pred EEEEEeccccCCCCcCEEEEECCCCeEEEec---cCEEcc
Confidence 599999632 234579999999999997 688987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.31 E-value=6.1e-12 Score=113.05 Aligned_cols=88 Identities=18% Similarity=0.215 Sum_probs=72.0
Q ss_pred CCceEEEeeCccEEEEcC-CCceEeeccCCCCc-eeEEEEcCCccEEEecCCCccccccCCCCCCcccCCCccccCcccc
Q 003059 89 SSAFFQLHSSGTLRLISG-SGAIIWDSNTQRLN-VTSASLDDSGNLVLLKNGGVSAWSSFDNPTDTIVPSQNFTSDKTLR 166 (852)
Q Consensus 89 ~~~~l~~~~~g~l~l~~~-~~~~vWst~~~~~~-~~~~~l~d~GNlvl~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~l~ 166 (852)
....|.+..||||||++. .+.+||++++.... ...++|+++|||||+|.++.++|||-.+-.
T Consensus 24 g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~~~iW~S~t~~~---------------- 87 (113)
T 3mez_B 24 RDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQ---------------- 87 (113)
T ss_dssp TTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECSCCCS----------------
T ss_pred CCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCCCEEEECCCcCC----------------
Confidence 457899999999999998 48999999986433 457999999999999988899999854210
Q ss_pred ccceEEEeecCCceeeeecCceeeeccCc
Q 003059 167 SGYYSFTLLKSGNLSLKWNDSVVYFNQGL 195 (852)
Q Consensus 167 sG~~sl~~~~~g~~~~~~~~~~~yw~~g~ 195 (852)
.|.|.+.++.+|++++|. .+.|.+++
T Consensus 88 ~~~~~~~L~~dGnlvly~---~~~W~s~~ 113 (113)
T 3mez_B 88 EGDYVLILQINGQAVVYG---PAVWSTAA 113 (113)
T ss_dssp SSCCEEEECTTSCEEEEC---SEEEESCC
T ss_pred CCCEEEEEcCCceEEEec---CCEecCCC
Confidence 256889999999999985 57898863
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.29 E-value=8.3e-12 Score=111.71 Aligned_cols=87 Identities=20% Similarity=0.246 Sum_probs=69.8
Q ss_pred CceEEEeeCccEEEEcCCCceEeeccCCCCc-eeEEEEcCCccEEEecCCCc-cccccCCCCCCcccCCCccccCccccc
Q 003059 90 SAFFQLHSSGTLRLISGSGAIIWDSNTQRLN-VTSASLDDSGNLVLLKNGGV-SAWSSFDNPTDTIVPSQNFTSDKTLRS 167 (852)
Q Consensus 90 ~~~l~~~~~g~l~l~~~~~~~vWst~~~~~~-~~~~~l~d~GNlvl~~~~~~-~lWQSFD~PTDtlLpg~kl~~~~~l~s 167 (852)
...|.+..||||||++.++ +|++++.... ...++|+++|||||++.++. ++|||..+ + .-..
T Consensus 21 ~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~-~-------------~~~~ 84 (111)
T 3mez_A 21 SAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS-V-------------NTVR 84 (111)
T ss_dssp TEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESSS-C-------------CCCS
T ss_pred CEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEeccc-c-------------CCCC
Confidence 5679999999999998876 9999986543 35899999999999998765 59999742 0 0113
Q ss_pred cceEEEeecCCceeeeecCceeeeccCc
Q 003059 168 GYYSFTLLKSGNLSLKWNDSVVYFNQGL 195 (852)
Q Consensus 168 G~~sl~~~~~g~~~~~~~~~~~yw~~g~ 195 (852)
|.|.+.++.||++++|- .++|.+++
T Consensus 85 ~~~~l~Lq~dGNlvly~---~~~W~s~t 109 (111)
T 3mez_A 85 GNYAATLGPDQHVTIYG---PAIWSTPA 109 (111)
T ss_dssp SCCEEEECTTSCEEEEC---SEEEECCC
T ss_pred cCEEEEECCCCeEEEec---cCEEccCC
Confidence 68999999999999985 67998874
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=1.5e-11 Score=109.76 Aligned_cols=86 Identities=24% Similarity=0.362 Sum_probs=70.5
Q ss_pred CceEEEeeCccEEEEcCCCceEeeccCCCCc-eeEEEEcCCccEEEecCCCccccccCCCCCCcccCCCccccCcccccc
Q 003059 90 SAFFQLHSSGTLRLISGSGAIIWDSNTQRLN-VTSASLDDSGNLVLLKNGGVSAWSSFDNPTDTIVPSQNFTSDKTLRSG 168 (852)
Q Consensus 90 ~~~l~~~~~g~l~l~~~~~~~vWst~~~~~~-~~~~~l~d~GNlvl~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~l~sG 168 (852)
...|.|..||||||++. +.+||++++.... ...++|+++|||||+|.++.++|||..... .+
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~~~----------------~~ 82 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGGE----------------NG 82 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCEEEECCCCCS----------------SS
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCEEEECCCCCC----------------CC
Confidence 46788999999999987 7899999986543 357999999999999988899999965321 25
Q ss_pred ceEEEeecCCceeeeecCceeeeccCc
Q 003059 169 YYSFTLLKSGNLSLKWNDSVVYFNQGL 195 (852)
Q Consensus 169 ~~sl~~~~~g~~~~~~~~~~~yw~~g~ 195 (852)
.|.+.++.+|++++|-. +.|.+++
T Consensus 83 ~~~~~L~ddGNlvly~~---~~W~s~t 106 (109)
T 3dzw_A 83 NYVCVLQKDRNVVIYGT---ARWATGT 106 (109)
T ss_dssp CEEEEECTTSCEEEEES---CCCCCCC
T ss_pred CEEEEEeCCCEEEEECC---CEEeCCC
Confidence 68899999999999853 7898874
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.22 E-value=3.3e-11 Score=107.65 Aligned_cols=84 Identities=21% Similarity=0.309 Sum_probs=68.6
Q ss_pred CceEEEeeCccEEEEcCCCceEeeccCCCCc-eeEEEEcCCccEEEecCCCccccccCCCCCCcccCCCccccCcccccc
Q 003059 90 SAFFQLHSSGTLRLISGSGAIIWDSNTQRLN-VTSASLDDSGNLVLLKNGGVSAWSSFDNPTDTIVPSQNFTSDKTLRSG 168 (852)
Q Consensus 90 ~~~l~~~~~g~l~l~~~~~~~vWst~~~~~~-~~~~~l~d~GNlvl~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~l~sG 168 (852)
+..|.+..||||||++. .++|++++.... ...++|+|+|||||+|.++.++|||-.+- ..|
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~~----------------~~~ 86 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSSS----------------KQG 86 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTTCCEEEECCCCC----------------SSS
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCCCEEEEcCCcC----------------CCC
Confidence 46788999999999976 589999986543 35799999999999998889999996531 125
Q ss_pred ceEEEeecCCceeeeecCceeeeccC
Q 003059 169 YYSFTLLKSGNLSLKWNDSVVYFNQG 194 (852)
Q Consensus 169 ~~sl~~~~~g~~~~~~~~~~~yw~~g 194 (852)
.|.+.++.+|++++|- .+.|.++
T Consensus 87 ~~~~~L~~dGNlvly~---~~~W~t~ 109 (110)
T 3r0e_B 87 EYVLILQDDGFGVIYG---PAIFETS 109 (110)
T ss_dssp CCEEEECTTSCEEEEC---SEEEESC
T ss_pred CEEEEEcCCccEEEec---CCEecCC
Confidence 6889999999999985 3789876
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=3.3e-11 Score=126.03 Aligned_cols=111 Identities=16% Similarity=0.370 Sum_probs=83.5
Q ss_pred ccccccCCCCc----cccCCCCCccccCCCceEEEEEec---CCCCeeEEEEE-eCCeeEEeeCCCCCCCCceEEEeeCc
Q 003059 28 SSFADISLGSS----LSASNLNQSWPSPNSTFSLSFIQR---SPNSFIPAITY-SGGVPIWTAGSTPVDSSAFFQLHSSG 99 (852)
Q Consensus 28 ~~~~~~~~~~~----l~~~~~~~~l~S~~g~f~lgf~~~---~~~~~~~~i~~-~~~~~vW~an~~p~~~~~~l~~~~~g 99 (852)
...||+.||+. |..++ .|+|+ ..++.|+|.. ..+.+++ | ...+++|.+++...+. ..|.+..+|
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~---~L~S~-~dps~G~fsl~l~~dGnlvL---y~~~~~~yW~Sgt~~~~~-~~l~l~~dG 205 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGS---ELVQG-VVYGAGASKLVFQGDGNLVA---YGPNGAATWNAGTQGKGA-VRAVFQGDG 205 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSE---EECTT-CEEEETTEEEEECTTSCEEE---ECTTSSEEEECCCTTTTC-CEEEECTTS
T ss_pred ccccccccccccccccccCc---ccccC-CCCCCceEEEeecCCceEEE---EeCCCeEEEECCCCCCcc-EEEEEcCCC
Confidence 35688889988 77766 67654 3455554432 2334444 5 3458999999732232 789999999
Q ss_pred cEEEEcCCCceEeeccCCCCceeEEEEcCCccEEEecCCCccccccCCC
Q 003059 100 TLRLISGSGAIIWDSNTQRLNVTSASLDDSGNLVLLKNGGVSAWSSFDN 148 (852)
Q Consensus 100 ~l~l~~~~~~~vWst~~~~~~~~~~~l~d~GNlvl~~~~~~~lWQSFD~ 148 (852)
||+++|.++.++|++++......+|+|+++|||||++. ..+||||||
T Consensus 206 nLvl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~--~~~Wqsf~~ 252 (276)
T 3m7h_A 206 NLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE--KPVWARFGF 252 (276)
T ss_dssp CEEEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE--EEEEESSSC
T ss_pred eEEEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC--CCeEEccCc
Confidence 99999998899999997655557899999999999986 689999997
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=4.2e-11 Score=125.52 Aligned_cols=140 Identities=14% Similarity=0.033 Sum_probs=110.0
Q ss_pred cccccccccccccceEEEEEECCCcEEEEEEecCcc-cchHHHHHHHHHhhccc-ccceeeeeeeeccCceeeEEEeecC
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIE-QGEKQFRMEVATISSTH-HLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
.+.+...++.|+.+.||+.... ++.+++|+..... .....+.+|+++++.+. |..+.++++++.+.+..|+||||++
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 93 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred cceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecC
Confidence 3556677888889999999754 5779999987421 33456899999999884 6788899999998889999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccc---------------------------------------
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE--------------------------------------- 618 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~--------------------------------------- 618 (852)
|.+|.+.+. +......++.+++++|+.||+.
T Consensus 94 G~~l~~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 94 GVLCSEEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp SEEHHHHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred CeehhhccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 999987631 1223346788999999999971
Q ss_pred -----------------cCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 619 -----------------CRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 619 -----------------~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
.+..++|+|+++.|||++++..+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 11458999999999999876667799999775
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.09 E-value=4e-10 Score=115.79 Aligned_cols=145 Identities=21% Similarity=0.261 Sum_probs=95.8
Q ss_pred eEEEeeCccEEEEcCCCceEeeccCCCCceeEEEEcCCccEEEecCCCccccccCCCCCCcccCCCccccCccccccceE
Q 003059 92 FFQLHSSGTLRLISGSGAIIWDSNTQRLNVTSASLDDSGNLVLLKNGGVSAWSSFDNPTDTIVPSQNFTSDKTLRSGYYS 171 (852)
Q Consensus 92 ~l~~~~~g~l~l~~~~~~~vWst~~~~~~~~~~~l~d~GNlvl~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~l~sG~~s 171 (852)
.|.|..+|||+|++. +++||.+|+.......++|+++|||||+|.++.++|+|+++.. +|.|.
T Consensus 29 ~l~f~~~gnl~ly~~-~~~vW~an~~~~~~~~l~l~~dGnLvl~d~~~~~vW~s~~~~~----------------~~~~~ 91 (236)
T 1dlp_A 29 RFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTKGS----------------IGNYV 91 (236)
T ss_dssp EEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCCCCC----------------SSCCE
T ss_pred EEEECCCCcEEEEEC-CEEEEECCCCCCCCeEEEEcCCCcEEEEcCCCcEEEeCCcccc----------------CCcEE
Confidence 455667899999986 7899999976555557999999999999999999999997521 36788
Q ss_pred EEeecCCceeeeecCceeeeccCccccc---------ccccc----------------cccccceeeeccCcceeeeecc
Q 003059 172 FTLLKSGNLSLKWNDSVVYFNQGLNSAI---------NSTVN----------------SNLTSPILRLQPVGILSISDVS 226 (852)
Q Consensus 172 l~~~~~g~~~~~~~~~~~yw~~g~~~~~---------~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~ 226 (852)
+.++.+|+++++.. ++|.+..+..- ..... .......+.++++|.+.+++..
T Consensus 92 ~~l~d~Gnlvl~~~---~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s~~d~s~G~~~l~l~~dG~LvL~~~~ 168 (236)
T 1dlp_A 92 LVLQPDRTVTIYGP---GLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRD 168 (236)
T ss_dssp EEECSSSCEEEECS---EEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBTT
T ss_pred EEEeCCCCEEEecC---CEEECCCCCCcccccCCccceEEecCCcCCCccceEEcCcEeecCcEEEEECCCCcEEEEcCC
Confidence 99999999999732 79988644210 00000 0012334566777755554321
Q ss_pred CCcceEEEeecccCCCcceEEEEEEccCCcEEEEEc
Q 003059 227 LNSAAIIAYSSDYAEGSDILRFLSLGSDGNLRIFSS 262 (852)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~r~~l~~dG~l~~~~w 262 (852)
. .++.+... +.....+++|+.+|++.+|..
T Consensus 169 ~-----~~W~s~~~-~~~~~~~~~L~~~Gnl~ly~~ 198 (236)
T 1dlp_A 169 D-----RVWSTNTA-GKGTGCRAVLQPNGRMDVLTN 198 (236)
T ss_dssp B-----CCSCCCCC-SSCSSCEEEEETTTEEEEEET
T ss_pred E-----eEEeCCCc-CCCCceEEEECCCCcEEEEeC
Confidence 1 11222111 111235678999999998863
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.08 E-value=2.7e-10 Score=101.44 Aligned_cols=85 Identities=24% Similarity=0.313 Sum_probs=68.5
Q ss_pred CCceEEEeeCccEEEEcCCCceEeeccCCCCc-eeEEEEcCCccEEEecCCCccccccCCCCCCcccCCCccccCccccc
Q 003059 89 SSAFFQLHSSGTLRLISGSGAIIWDSNTQRLN-VTSASLDDSGNLVLLKNGGVSAWSSFDNPTDTIVPSQNFTSDKTLRS 167 (852)
Q Consensus 89 ~~~~l~~~~~g~l~l~~~~~~~vWst~~~~~~-~~~~~l~d~GNlvl~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~l~s 167 (852)
....|.+..||||||+++ +|+|++.... ...++|+++|||||+|.++.++|+|-..- ..
T Consensus 21 g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~~~vWss~t~~----------------~~ 80 (109)
T 3r0e_A 21 GDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQS----------------VK 80 (109)
T ss_dssp TTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECCCCC----------------SS
T ss_pred CCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCCCCEEEcCCCcC----------------CC
Confidence 356789999999999974 7999987543 35799999999999998889999763211 12
Q ss_pred cceEEEeecCCceeeeecCceeeeccCcc
Q 003059 168 GYYSFTLLKSGNLSLKWNDSVVYFNQGLN 196 (852)
Q Consensus 168 G~~sl~~~~~g~~~~~~~~~~~yw~~g~~ 196 (852)
+.|.+.++.+|++++|- .+.|++++|
T Consensus 81 ~~~~~~L~~dGNlvly~---~~~W~s~t~ 106 (109)
T 3r0e_A 81 GNYAAVVHPDGRLVVFG---PSVFKIDPW 106 (109)
T ss_dssp SCCEEEEETTTEEEEEC---SEEEEECTT
T ss_pred cCEEEEEcCCCeEEEEe---cCEECCCCc
Confidence 56889999999999984 578999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.06 E-value=2.1e-10 Score=119.79 Aligned_cols=129 Identities=18% Similarity=0.081 Sum_probs=96.1
Q ss_pred cccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccc--eeeeeeeeccCceeeEEEeecCCCCHHHHh
Q 003059 508 GAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLN--LVRLVGFSSEGKHRLLVYEFMKNGSLDNFL 585 (852)
Q Consensus 508 G~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 585 (852)
+.|..+.||++...+++.+++|..... ....+..|+++++.+++.+ +.+++++...++..++||||++|.+|. .
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~ 104 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S 104 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c
Confidence 455569999998777778999997643 3356889999999886544 556888888888899999999998874 2
Q ss_pred hhcccCCccccchhHHHHHHHhhHhhhhhhcccc----------------------------------------------
Q 003059 586 FANEEGSGKLLNWQSRFNIALGTARGITYLHEEC---------------------------------------------- 619 (852)
Q Consensus 586 ~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------------------- 619 (852)
. . . ....++.++++.|..||+..
T Consensus 105 ~-~-------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 105 S-H-------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp S-C-------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred C-c-------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 1 0 0 11245666667777776521
Q ss_pred ---------CCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 620 ---------RDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 620 ---------~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
+..++|+|++|.|||++++..++|+||+.+..
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999998763
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.04 E-value=6.6e-10 Score=98.17 Aligned_cols=83 Identities=28% Similarity=0.407 Sum_probs=65.3
Q ss_pred ceEEEeeCccEEEEcCCCceEeeccCCCC--ceeEEEEcCCccEEEecCCCccccccCCCCCCcccCCCccccCcccccc
Q 003059 91 AFFQLHSSGTLRLISGSGAIIWDSNTQRL--NVTSASLDDSGNLVLLKNGGVSAWSSFDNPTDTIVPSQNFTSDKTLRSG 168 (852)
Q Consensus 91 ~~l~~~~~g~l~l~~~~~~~vWst~~~~~--~~~~~~l~d~GNlvl~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~l~sG 168 (852)
-.|.+..||||||++ .+++||++++... ....++|+++|||||+|.++.++|+|-... .++
T Consensus 21 y~l~~q~DgNLvly~-~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss~t~~----------------~~~ 83 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYD-HSTSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASHSTR----------------GSG 83 (105)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEECCCCC----------------CSS
T ss_pred EEEEECCCCeEEEEE-CCEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEecCCC----------------CCC
Confidence 457888999999997 4689999997643 335799999999999999999999884321 136
Q ss_pred ceEEEeecCCceeeeecCceeeecc
Q 003059 169 YYSFTLLKSGNLSLKWNDSVVYFNQ 193 (852)
Q Consensus 169 ~~sl~~~~~g~~~~~~~~~~~yw~~ 193 (852)
.|.+.++.+|++++|- ...|.+
T Consensus 84 ~~~l~L~ddGNlVly~---~~~W~S 105 (105)
T 4h3o_A 84 NYILILQDDGNVIIYG---SDIWST 105 (105)
T ss_dssp CEEEEECTTSCEEEEE---SEEEEC
T ss_pred CEEEEEeCCCeEEEEC---CcEecC
Confidence 7889999999999983 246653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.97 E-value=1.3e-09 Score=119.87 Aligned_cols=141 Identities=14% Similarity=0.170 Sum_probs=106.0
Q ss_pred cccccccccceEEEEEECCCcEEEEEEec--Ccc--cchHHHHHHHHHhhccc--ccceeeeeeeeccC---ceeeEEEe
Q 003059 504 KDKLGAGGFGAVYRGVLANRTVVAVKQLE--GIE--QGEKQFRMEVATISSTH--HLNLVRLVGFSSEG---KHRLLVYE 574 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~--~~~--~~~~~f~~E~~~l~~l~--h~niv~l~g~~~~~---~~~~lV~e 574 (852)
.+.|+.|.++.||+....+ ..+++|+.. ... .....+.+|+.+++.++ +..+.++++++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 3579999999999998765 467788765 322 23457889999999887 45688899988776 45899999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhcccc-----------------------------------
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC----------------------------------- 619 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----------------------------------- 619 (852)
|++|..+.+.. ...++...+..++.++++.|+.||...
T Consensus 122 ~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 122 FVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp CCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred ecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 99998774422 123667788889999999999999721
Q ss_pred --------------------CCCcccCCCCCCceEeCCCCc--eEEeeccccccc
Q 003059 620 --------------------RDCIVHCDIKPENILLDENYN--AKVSDFGLAKLI 652 (852)
Q Consensus 620 --------------------~~~ivH~Dlkp~NILl~~~~~--~kl~DFGla~~~ 652 (852)
+..++|+|+++.|||++.++. +.|.||+.+..-
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 256999999999999997753 689999988743
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.82 E-value=9.5e-10 Score=117.88 Aligned_cols=183 Identities=20% Similarity=0.231 Sum_probs=119.8
Q ss_pred ccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhccc-ccc--eeeeeeeeccCc---eeeEEEeecCC
Q 003059 505 DKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTH-HLN--LVRLVGFSSEGK---HRLLVYEFMKN 578 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~-h~n--iv~l~g~~~~~~---~~~lV~e~~~~ 578 (852)
+.++.|....||+.. ..+++|+.... .....+.+|++++..+. +.. +.+++......+ ..|+|||+++|
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 458999999999863 45888886532 34567899999998873 332 445555544433 45899999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccc----------------------------------------
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE---------------------------------------- 618 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------------------------------------- 618 (852)
.+|.+... ..++..++..++.++++.|+.||..
T Consensus 101 ~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 101 VPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp EECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred eECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 88865432 1245556666777777777777641
Q ss_pred ---------------cCCCcccCCCCCCceEeCC--CCceEEeecccccccCCCCCcceeeeeecCCCCC---CChhhhh
Q 003059 619 ---------------CRDCIVHCDIKPENILLDE--NYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGY---LAPEWLA 678 (852)
Q Consensus 619 ---------------~~~~ivH~Dlkp~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y---~aPE~~~ 678 (852)
....++|+|+++.||++++ ...+.|+||+.+..-.+..+.. ....+ ..|+...
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~-------~~~~~~~~~~~~~~~ 246 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI-------SLMEDDEEYGMEFVS 246 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH-------TTCCTTTSCCHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH-------HHHhhccccCHHHHH
Confidence 1235899999999999998 5668899999887543311110 00111 2333221
Q ss_pred c-----CCC---------CCCccchhhhHHHHHHHhCCcccc
Q 003059 679 N-----LPI---------TSKSDVYSYGMVLLEIVSGRRNFE 706 (852)
Q Consensus 679 ~-----~~~---------s~ksDv~s~Gvvl~elltG~~p~~ 706 (852)
. ... ....+.|+++.++|++.+|+.+|-
T Consensus 247 ~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 247 KILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1 011 112588999999999999998874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=2.3e-06 Score=91.39 Aligned_cols=135 Identities=18% Similarity=0.188 Sum_probs=89.2
Q ss_pred ccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhccccc---ceeeeeeeec-cCceeeEEEeecCCCC
Q 003059 505 DKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHL---NLVRLVGFSS-EGKHRLLVYEFMKNGS 580 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~---niv~l~g~~~-~~~~~~lV~e~~~~gs 580 (852)
+.++.|....||+. +..+++|+-.. ......+..|+++|..+.+. .+.+++.++. ..+..++||||++|..
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 45788888899987 45578887532 23456789999999998653 3566677664 4567789999999988
Q ss_pred HHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccc------------------------------------------
Q 003059 581 LDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE------------------------------------------ 618 (852)
Q Consensus 581 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------------ 618 (852)
|.+.... .++...+..++.++++.|+.||+.
T Consensus 100 l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 100 LGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred Cchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 8663211 112222333333333333333321
Q ss_pred ---------------cCCCcccCCCCCCceEeCC---CCc-eEEeecccccc
Q 003059 619 ---------------CRDCIVHCDIKPENILLDE---NYN-AKVSDFGLAKL 651 (852)
Q Consensus 619 ---------------~~~~ivH~Dlkp~NILl~~---~~~-~kl~DFGla~~ 651 (852)
.+..++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2246799999999999987 455 48999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=3.5e-06 Score=88.16 Aligned_cols=136 Identities=18% Similarity=0.147 Sum_probs=93.3
Q ss_pred ccccccccc-eEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhccc-ccceeeeeeeeccCceeeEEEeecCCCCH
Q 003059 505 DKLGAGGFG-AVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISSTH-HLNLVRLVGFSSEGKHRLLVYEFMKNGSL 581 (852)
Q Consensus 505 ~~lG~G~fg-~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL 581 (852)
+.+..|..+ .||+.... +++.+++|+-... ...++..|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 345556655 58987754 4567888886532 3456888999988774 44577889999999999999999999887
Q ss_pred HHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccc-------------------------------------------
Q 003059 582 DNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE------------------------------------------- 618 (852)
Q Consensus 582 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------------- 618 (852)
.+..... ......+..++++.|+.||..
T Consensus 108 ~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 108 FQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred cccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 7654211 111223334444444444421
Q ss_pred ------------cCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 619 ------------CRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 619 ------------~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
.+..++|+|+++.|||+++++.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012379999999999999887788999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=5.7e-06 Score=90.37 Aligned_cols=78 Identities=6% Similarity=0.049 Sum_probs=56.9
Q ss_pred ccc-cccccceEEEEEEC-------CCcEEEEEEecCcc----cchHHHHHHHHHhhcccc---cceeeeeeeeccC---
Q 003059 505 DKL-GAGGFGAVYRGVLA-------NRTVVAVKQLEGIE----QGEKQFRMEVATISSTHH---LNLVRLVGFSSEG--- 566 (852)
Q Consensus 505 ~~l-G~G~fg~Vy~~~~~-------~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h---~niv~l~g~~~~~--- 566 (852)
+.| +.|....+|+.... +++.+++|+..... .....+..|+.+++.+.. ..+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 88889999998764 25678888765332 123568889999988853 3577788887665
Q ss_pred ceeeEEEeecCCCCHH
Q 003059 567 KHRLLVYEFMKNGSLD 582 (852)
Q Consensus 567 ~~~~lV~e~~~~gsL~ 582 (852)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 4678999999987764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.84 E-value=5.1e-05 Score=82.00 Aligned_cols=141 Identities=18% Similarity=0.250 Sum_probs=81.8
Q ss_pred cccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhccccc--ceeeeee------eeccCceeeEEEeecC
Q 003059 506 KLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHL--NLVRLVG------FSSEGKHRLLVYEFMK 577 (852)
Q Consensus 506 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~--niv~l~g------~~~~~~~~~lV~e~~~ 577 (852)
.|+.|..+.||+....+++ +++|+.... ..++..|+.++..+... .+.+++. +....+..++||||++
T Consensus 39 ~l~gG~~n~~~~v~~~~~~-~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~ 114 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSGA-VCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE 114 (346)
T ss_dssp ECC----CEEEEEEETTEE-EEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred eccccccCcEEEEEeCCCC-EEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence 4666778999999876654 889988752 23445566666555321 2344443 1124567899999999
Q ss_pred CCCHH--------------HHhhhcccCC---------ccccchhHHH-------------------------------H
Q 003059 578 NGSLD--------------NFLFANEEGS---------GKLLNWQSRF-------------------------------N 603 (852)
Q Consensus 578 ~gsL~--------------~~l~~~~~~~---------~~~l~~~~~~-------------------------------~ 603 (852)
|..+. ..++...... ...-.|...+ .
T Consensus 115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (346)
T 2q83_A 115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG 194 (346)
T ss_dssp CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence 86542 1122111100 0111232210 1
Q ss_pred HHHhhHhhhhhhcc----------ccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 604 IALGTARGITYLHE----------ECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 604 i~~~ia~~L~yLH~----------~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+...+..++.+|++ ..+..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11123345666653 134789999999999999888899999999775
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.78 E-value=3.3e-05 Score=85.68 Aligned_cols=73 Identities=14% Similarity=0.114 Sum_probs=49.0
Q ss_pred ccccccccceEEEEEEC-CCcEEEEEEecCcc--------cchHHHHHHHHHhhcccc--c-ceeeeeeeeccCceeeEE
Q 003059 505 DKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE--------QGEKQFRMEVATISSTHH--L-NLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~f~~E~~~l~~l~h--~-niv~l~g~~~~~~~~~lV 572 (852)
+.||.|.++.||++... +++.++||...... .....+..|.+++..+.. + .+.+++.+. .+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEEE
Confidence 57999999999999754 46789999764211 123456788888887742 3 344566543 3456899
Q ss_pred EeecCCC
Q 003059 573 YEFMKNG 579 (852)
Q Consensus 573 ~e~~~~g 579 (852)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00011 Score=77.60 Aligned_cols=74 Identities=22% Similarity=0.219 Sum_probs=55.5
Q ss_pred cccccccccceEEEEEECCCcEEEEEEecCc-ccchHHHHHHHHHhhcccc---cceeeeeeeeccCceeeEEEeecCCC
Q 003059 504 KDKLGAGGFGAVYRGVLANRTVVAVKQLEGI-EQGEKQFRMEVATISSTHH---LNLVRLVGFSSEGKHRLLVYEFMKNG 579 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h---~niv~l~g~~~~~~~~~lV~e~~~~g 579 (852)
.+.+|.|..+.||+.++.+|+.|+||+-... ......|..|+..|+.|.. --+.+++++. ..++||||++++
T Consensus 20 v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~ 95 (288)
T 3f7w_A 20 VAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDER 95 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCC
T ss_pred EEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeeccc
Confidence 4679999999999999999999999987633 3334568899999887742 2345556543 347899999876
Q ss_pred CH
Q 003059 580 SL 581 (852)
Q Consensus 580 sL 581 (852)
..
T Consensus 96 ~~ 97 (288)
T 3f7w_A 96 PP 97 (288)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00014 Score=77.43 Aligned_cols=139 Identities=19% Similarity=0.199 Sum_probs=91.4
Q ss_pred ccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhccc---ccceeeeeeeeccCceeeEEEeecCCCCH
Q 003059 505 DKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTH---HLNLVRLVGFSSEGKHRLLVYEFMKNGSL 581 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~e~~~~gsL 581 (852)
+.|+.|....+|+.... ++.+++|+.... ....|..|++.|+.|. ...+.++++++...+..++||||+++..+
T Consensus 42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-VQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECCSSSSEEEEEESS-SCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EEeCCccceeeeEEEEC-CCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 46999999999998764 566888887632 3567889999998884 35688899988888899999999998865
Q ss_pred HH-----------Hhhhccc--CCc---------------cccchhHHH---HHHH----------------hhHhhh-h
Q 003059 582 DN-----------FLFANEE--GSG---------------KLLNWQSRF---NIAL----------------GTARGI-T 613 (852)
Q Consensus 582 ~~-----------~l~~~~~--~~~---------------~~l~~~~~~---~i~~----------------~ia~~L-~ 613 (852)
.. .|+.... .-+ -.-+|...+ ++.. .+.+.+ .
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 21 1222111 000 012454322 1111 111111 2
Q ss_pred hhcc-ccCCCcccCCCCCCceEeCCCCceEEeecc
Q 003059 614 YLHE-ECRDCIVHCDIKPENILLDENYNAKVSDFG 647 (852)
Q Consensus 614 yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~DFG 647 (852)
.|.. ..+..++|+|+.+.||+++.++ +.|.||.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3321 1246799999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00031 Score=78.40 Aligned_cols=71 Identities=13% Similarity=0.151 Sum_probs=45.6
Q ss_pred ccccccccceEEEEEECCCcEEEEEEecC-------c-c--cchHHHHHHHHHhhc-ccccceeeeeeeeccCceeeEEE
Q 003059 505 DKLGAGGFGAVYRGVLANRTVVAVKQLEG-------I-E--QGEKQFRMEVATISS-THHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~-------~-~--~~~~~f~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
+.||.|....||++.. +++.++||.... . . .....++.|+..+.. ..+..+.+++.+. .+..++||
T Consensus 40 ~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv~ 116 (420)
T 2pyw_A 40 KEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIGM 116 (420)
T ss_dssp EECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEEE
T ss_pred EEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEEE
Confidence 5689999999999964 456799994321 0 1 122345555544332 2335677777765 46779999
Q ss_pred eec-CC
Q 003059 574 EFM-KN 578 (852)
Q Consensus 574 e~~-~~ 578 (852)
||+ ++
T Consensus 117 e~l~~g 122 (420)
T 2pyw_A 117 RYLEPP 122 (420)
T ss_dssp CCCCTT
T ss_pred eecCCc
Confidence 999 76
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.32 E-value=0.001 Score=71.23 Aligned_cols=143 Identities=13% Similarity=0.044 Sum_probs=82.9
Q ss_pred cccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccc--eeeeeee-----eccCceeeEEEeecCC
Q 003059 506 KLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLN--LVRLVGF-----SSEGKHRLLVYEFMKN 578 (852)
Q Consensus 506 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~g~-----~~~~~~~~lV~e~~~~ 578 (852)
.|+ |....||+....+++.+++|..........++..|..++..+.... +++++.. ....+..++||||++|
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence 466 7788999987777777999998743334567778888887775322 4445443 1124466889999987
Q ss_pred CCHH-----HH---------hhhccc----CCccccchhHH----H------------------HHHHhhHhhhhhhcc-
Q 003059 579 GSLD-----NF---------LFANEE----GSGKLLNWQSR----F------------------NIALGTARGITYLHE- 617 (852)
Q Consensus 579 gsL~-----~~---------l~~~~~----~~~~~l~~~~~----~------------------~i~~~ia~~L~yLH~- 617 (852)
..+. .+ ++.... .....+++... . ..+..++..++-+..
T Consensus 112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 191 (328)
T 1zyl_A 112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 191 (328)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 5432 11 111110 00111222211 0 111111112221111
Q ss_pred ccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 618 ECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 618 ~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
..+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1235689999999999999 4 899999987754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0005 Score=76.75 Aligned_cols=72 Identities=15% Similarity=0.167 Sum_probs=50.5
Q ss_pred ccccccccceEEEEEECC--------CcEEEEEEecCcccchHHHHHHHHHhhcccccce-eeeeeeeccCceeeEEEee
Q 003059 505 DKLGAGGFGAVYRGVLAN--------RTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNL-VRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~ 575 (852)
+.|+.|....+|+....+ ++.+++|+.... .....+..|..++..+...++ .++++.+.+ .+|+||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 468888889999998753 467889987432 122556689999888854444 567776653 289999
Q ss_pred cCCCCH
Q 003059 576 MKNGSL 581 (852)
Q Consensus 576 ~~~gsL 581 (852)
+++.+|
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 986444
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.00082 Score=71.19 Aligned_cols=71 Identities=7% Similarity=0.037 Sum_probs=45.3
Q ss_pred cccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccce-eeeeeeeccCceeeEEEeec-CCCCH
Q 003059 504 KDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNL-VRLVGFSSEGKHRLLVYEFM-KNGSL 581 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~-~~gsL 581 (852)
.+.|+.|....+|+. +.+++|+.............|+.++..+...++ .++++++. +.-++|+||+ ++.+|
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCccC
Confidence 467889999999998 448888876432222234668888877753333 45665543 3457899999 66554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0015 Score=71.34 Aligned_cols=143 Identities=17% Similarity=0.151 Sum_probs=84.7
Q ss_pred ccccccccceEEEEEECC--------CcEEEEEEecCcccchHHHHHHHHHhhcccccc-eeeeeeeeccCceeeEEEee
Q 003059 505 DKLGAGGFGAVYRGVLAN--------RTVVAVKQLEGIEQGEKQFRMEVATISSTHHLN-LVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~e~ 575 (852)
+.|..|....+|+....+ ++.+++|+..........+.+|..+++.+...+ ..++++++.++ +||||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEE
Confidence 467788889999988642 467888886433334556778999988875322 35677776652 89999
Q ss_pred cCCCCHHHH-----------------hhhcccCCcccc--chhHHHHHHHhhHhh-------------------hhhhcc
Q 003059 576 MKNGSLDNF-----------------LFANEEGSGKLL--NWQSRFNIALGTARG-------------------ITYLHE 617 (852)
Q Consensus 576 ~~~gsL~~~-----------------l~~~~~~~~~~l--~~~~~~~i~~~ia~~-------------------L~yLH~ 617 (852)
++|..|..- |+.......+.. -|.++.++..++... +..|.+
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 998665311 111111111112 245555555444221 222221
Q ss_pred -----ccCCCcccCCCCCCceEeCCC----CceEEeecccccc
Q 003059 618 -----ECRDCIVHCDIKPENILLDEN----YNAKVSDFGLAKL 651 (852)
Q Consensus 618 -----~~~~~ivH~Dlkp~NILl~~~----~~~kl~DFGla~~ 651 (852)
..+..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 123569999999999999876 7899999998763
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.04 E-value=0.003 Score=67.78 Aligned_cols=144 Identities=14% Similarity=0.027 Sum_probs=75.1
Q ss_pred ccccccccce-EEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccc--cceeeeeeeeccCceeeEEEeecCCCCH
Q 003059 505 DKLGAGGFGA-VYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHH--LNLVRLVGFSSEGKHRLLVYEFMKNGSL 581 (852)
Q Consensus 505 ~~lG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~e~~~~gsL 581 (852)
+.|+.|+... +|+....+++.+++|...... ..++..|+.++..+.. -.+.+++.+..+.+ ++|||++.+..+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l 99 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF 99 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence 3465555444 677765445667777654322 1345567777766643 23566777655444 789999987777
Q ss_pred HHHhhhccc---------------------CCccccchhHHH-------HH-------------HHhhHhhhhhhc---c
Q 003059 582 DNFLFANEE---------------------GSGKLLNWQSRF-------NI-------------ALGTARGITYLH---E 617 (852)
Q Consensus 582 ~~~l~~~~~---------------------~~~~~l~~~~~~-------~i-------------~~~ia~~L~yLH---~ 617 (852)
.+++..... .....++..... .+ ...+...++.|. .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 655432110 000011110000 00 001111122221 1
Q ss_pred ccCCCcccCCCCCCceEeCCC----CceEEeeccccccc
Q 003059 618 ECRDCIVHCDIKPENILLDEN----YNAKVSDFGLAKLI 652 (852)
Q Consensus 618 ~~~~~ivH~Dlkp~NILl~~~----~~~kl~DFGla~~~ 652 (852)
..+..++|||+.+.|||++.+ +.+.|+||+.+..-
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 123679999999999999875 68999999988754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0012 Score=74.23 Aligned_cols=73 Identities=11% Similarity=0.014 Sum_probs=47.9
Q ss_pred ccccccccceEEEEEECC-CcEEEEEEecCcccchHHHHHHHHHhhcccccce-eeeeeeeccCceeeEEEeecCCCCH
Q 003059 505 DKLGAGGFGAVYRGVLAN-RTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNL-VRLVGFSSEGKHRLLVYEFMKNGSL 581 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~~~gsL 581 (852)
+.|+.|-...+|+....+ ++.+++|+........-+...|..++..|...++ .++++.+.. .+||||+++..|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 468888889999998865 4678888775322211123688888888865444 567777642 259999987554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.98 E-value=0.00095 Score=72.97 Aligned_cols=73 Identities=12% Similarity=0.050 Sum_probs=45.0
Q ss_pred ccccccccceEEEEEECC---------CcEEEEEEecCcccchHHHHHHHHHhhcccccc-eeeeeeeeccCceeeEEEe
Q 003059 505 DKLGAGGFGAVYRGVLAN---------RTVVAVKQLEGIEQGEKQFRMEVATISSTHHLN-LVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~e 574 (852)
+.|+.|....+|+....+ ++.+++|+.........+...|.+++..+...+ +.++++... -++|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEEE
Confidence 467888888999998754 257888887533222223467888888775444 346665542 368999
Q ss_pred ecCCCCH
Q 003059 575 FMKNGSL 581 (852)
Q Consensus 575 ~~~~gsL 581 (852)
|++|..+
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987544
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0035 Score=66.83 Aligned_cols=144 Identities=11% Similarity=0.113 Sum_probs=80.3
Q ss_pred ccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccc--eeeeeee------eccCceeeEEEeec
Q 003059 505 DKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLN--LVRLVGF------SSEGKHRLLVYEFM 576 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~g~------~~~~~~~~lV~e~~ 576 (852)
+.|+.|....+|+....++ .+++|..... ....++..|+.++..+...+ +.+++.. ....+..++|++|+
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 3577788889999987766 4778887642 22345667888877764323 3334422 11235678999999
Q ss_pred CCCCHHH--------------HhhhcccC---C----ccccchhHHHHHH------------HhhHhhhhhhcc----cc
Q 003059 577 KNGSLDN--------------FLFANEEG---S----GKLLNWQSRFNIA------------LGTARGITYLHE----EC 619 (852)
Q Consensus 577 ~~gsL~~--------------~l~~~~~~---~----~~~l~~~~~~~i~------------~~ia~~L~yLH~----~~ 619 (852)
+|..+.. .++..... . .....|...+.-. ..+.+.++++++ ..
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 8865421 11211000 0 0111233211110 012233344432 12
Q ss_pred CCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 620 ~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+..++|+|+++.|||++++..+.|+||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3579999999999999987666899998765
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.19 E-value=0.011 Score=63.74 Aligned_cols=68 Identities=13% Similarity=0.214 Sum_probs=43.5
Q ss_pred cccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccc---cceeeeeee------eccCceeeEEEeecCC
Q 003059 508 GAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHH---LNLVRLVGF------SSEGKHRLLVYEFMKN 578 (852)
Q Consensus 508 G~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h---~niv~l~g~------~~~~~~~~lV~e~~~~ 578 (852)
|.|....||+....++ .+++|+...... ..|+.++..|.. +.+.+++.. ....+..++||+|++|
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 4444689999987777 789998764331 345555555532 224455432 2335678999999998
Q ss_pred CCH
Q 003059 579 GSL 581 (852)
Q Consensus 579 gsL 581 (852)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.89 E-value=0.11 Score=57.35 Aligned_cols=73 Identities=10% Similarity=0.079 Sum_probs=48.5
Q ss_pred ccccccccceEEEEEECC--------CcEEEEEEecCcccchHHHHHHHHHhhcccccc-eeeeeeeeccCceeeEEEee
Q 003059 505 DKLGAGGFGAVYRGVLAN--------RTVVAVKQLEGIEQGEKQFRMEVATISSTHHLN-LVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~e~ 575 (852)
+.|..|-...+|+....+ ++.+++|+........-+..+|..+++.+...+ ..++++.+. -++||||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEE
Confidence 467778888999998763 567888886532222223467888888775333 345565443 2789999
Q ss_pred cCCCCH
Q 003059 576 MKNGSL 581 (852)
Q Consensus 576 ~~~gsL 581 (852)
++|..|
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998664
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=93.67 E-value=0.26 Score=48.41 Aligned_cols=102 Identities=10% Similarity=0.031 Sum_probs=65.4
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
.-||.+.|... +.+|++++++.++.|.++.|.-+-.. ..-..+=+.|..|+|..+|.+.+.+ ..+.
T Consensus 32 ~vSL~eIL~~~----~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------- 97 (229)
T 2yle_A 32 ALSLEEILRLY----NQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD------- 97 (229)
T ss_dssp EEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred cccHHHHHHHc----CCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc-------
Confidence 34788888654 56899999999999999998776210 1111333457999999999988764 1110
Q ss_pred cceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCC
Q 003059 658 RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGR 702 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~ 702 (852)
.....+.|||... ...+.+.=|||||+++|.-+-=.
T Consensus 98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp -----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 1122466887653 34467788999999999988633
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.33 E-value=0.15 Score=55.98 Aligned_cols=30 Identities=30% Similarity=0.427 Sum_probs=25.3
Q ss_pred CcccCCCCCCceEe------CCCCceEEeecccccc
Q 003059 622 CIVHCDIKPENILL------DENYNAKVSDFGLAKL 651 (852)
Q Consensus 622 ~ivH~Dlkp~NILl------~~~~~~kl~DFGla~~ 651 (852)
.++|+|+.+.|||+ +++..++++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567799999998764
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=86.98 E-value=28 Score=35.23 Aligned_cols=68 Identities=15% Similarity=0.206 Sum_probs=43.9
Q ss_pred EEEEEe-CCeeEEeeCC-C---C----CCCCceEEEeeCccEEEEcCCCceEeeccCCC-CceeEEEEcCCccEEEec
Q 003059 69 PAITYS-GGVPIWTAGS-T---P----VDSSAFFQLHSSGTLRLISGSGAIIWDSNTQR-LNVTSASLDDSGNLVLLK 136 (852)
Q Consensus 69 ~~i~~~-~~~~vW~an~-~---p----~~~~~~l~~~~~g~l~l~~~~~~~vWst~~~~-~~~~~~~l~d~GNlvl~~ 136 (852)
+.+|=. .+.++|.... . + +..++.+-++.++.+..+|.+|..+|...... .....++.+.+||+++-+
T Consensus 17 v~~~d~~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~~ 94 (276)
T 3no2_A 17 IAIINKDTKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVAW 94 (276)
T ss_dssp EEEEETTTTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEEE
T ss_pred EEEEECCCCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEEe
Confidence 334443 6778888764 2 1 12345555566667777888999999987642 234457777888887764
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=86.77 E-value=0.5 Score=38.46 Aligned_cols=37 Identities=30% Similarity=0.518 Sum_probs=30.5
Q ss_pred ccccChhhHHhhhccCCcEEEEEeccCCccceEeccCC
Q 003059 359 VFFVGISACRLNCLVTGSCVASTSLSDGTGLCYLKTPD 396 (852)
Q Consensus 359 ~~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~C~~~~~~ 396 (852)
...+++++|+..|+.+=.|.||.|+.. ...|+++.+.
T Consensus 27 ~~~~sl~~Cq~aC~a~~~C~aFTyN~~-s~~CflKs~~ 63 (82)
T 2ll3_A 27 KRASSLSECRARCQAEKECSHYTYNVK-SGLCYPKRGK 63 (82)
T ss_dssp EECSSHHHHHHHHHHCTTEEEEEEETT-TTEEEEEESS
T ss_pred ccCCCHHHHHHHhhccCCCCeEEeccC-CCceEcccCC
Confidence 345789999999999999999999733 3579999763
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=81.65 E-value=4.2 Score=39.83 Aligned_cols=118 Identities=10% Similarity=0.138 Sum_probs=80.0
Q ss_pred ccccceeeeeeeeccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCC
Q 003059 551 THHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKP 630 (852)
Q Consensus 551 l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp 630 (852)
..||+++.. .+-.+.+...+.|+.-+. ...|-. -+.++...+++++.+|+....+++. -+|--|+|
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f~~------ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P 107 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDN--HTPFDN------IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAP 107 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTT--SEEGGG------GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcc--cCCHHH------HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEec
Confidence 368888866 455555666666665432 222221 2347788899999999999877775 47888999
Q ss_pred CceEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccc
Q 003059 631 ENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEV 707 (852)
Q Consensus 631 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~ 707 (852)
+||+++.++.+++.-.|+-..+.+.. +.+|- =.-.+=+++..+++++..|+.
T Consensus 108 ~NL~f~~~~~p~i~~RGik~~l~P~~---------------~~ee~----------fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 108 DELFFTRDGLPIAKTRGLQNVVDPLP---------------VSEAE----------FLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp GGEEECTTSCEEESCCEETTTBSCCC---------------CCHHH----------HHHHHHHHHHHHHCTTCCHHH
T ss_pred ceEEEcCCCCEEEEEccCccCCCCCC---------------CCHHH----------HHHHHHHHHHHHHcCCCCHHH
Confidence 99999999999998888755443211 01221 123466788889999988863
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=81.15 E-value=6 Score=40.38 Aligned_cols=14 Identities=7% Similarity=0.128 Sum_probs=9.1
Q ss_pred EEEeecCCceeeee
Q 003059 171 SFTLLKSGNLSLKW 184 (852)
Q Consensus 171 sl~~~~~g~~~~~~ 184 (852)
.++++++|.++..+
T Consensus 246 ~~~~~~~g~~~W~~ 259 (276)
T 3no2_A 246 LVEIDSEGKVVWQL 259 (276)
T ss_dssp EEEECTTSBEEEEE
T ss_pred EEEECCCCCEEEEe
Confidence 56677777776543
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.18 E-value=0.25 Score=55.29 Aligned_cols=60 Identities=8% Similarity=0.059 Sum_probs=19.1
Q ss_pred cccccccccccceEEEEEECC-CcEEEE------EEecCc---ccchHHHHHHHHHhhcccccceeeeeeeec
Q 003059 502 GFKDKLGAGGFGAVYRGVLAN-RTVVAV------KQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSS 564 (852)
Q Consensus 502 ~~~~~lG~G~fg~Vy~~~~~~-~~~vav------K~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~ 564 (852)
.+.++|| ||.||+|.+.. ..+||| |..... .+....|.+|..++..++|+|+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 5667887 99999999865 367888 766532 223346888999999999999999988743
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 852 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-69 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-61 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-58 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-57 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-47 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-20 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 4e-11 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 3e-08 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 1e-10 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 6e-07 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 5e-10 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 3e-07 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 1e-06 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 8e-10 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 2e-07 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 1e-07 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 6e-07 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 4e-05 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 2e-06 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 2e-05 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 3e-69
Identities = 73/292 (25%), Positives = 137/292 (46%), Gaps = 29/292 (9%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQL---EGIEQGEKQFRMEVATISST 551
E+ ++G+G FG VY+G VAVK L Q + F+ EV + T
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 552 HHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARG 611
H+N++ +G+S+ +V ++ + SL + L E +IA TA+G
Sbjct: 62 RHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQG 116
Query: 612 ITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGY 671
+ YLH + I+H D+K NI L E+ K+ DFGLA + + H+ + G+ +
Sbjct: 117 MDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILW 172
Query: 672 LAPEWL---ANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN 728
+APE + P + +SDVY++G+VL E+++G+ + NR +G
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS--NINNRD----QIIFMVGRGY 226
Query: 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780
+ + K + ++++M C++++ +RP+ +++ +E +
Sbjct: 227 LSPDLSKVRSNCPKAMKRLMA------ECLKKKRDERPLFPQILASIELLAR 272
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (573), Expect = 1e-67
Identities = 64/300 (21%), Positives = 121/300 (40%), Gaps = 27/300 (9%)
Query: 503 FKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGF 562
++ +G G FG V+RG VAVK E+ E+ H N++ +
Sbjct: 7 LQESIGKGRFGEVWRGKWRGE-EVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 563 SSEG----KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618
++ LV ++ ++GSL ++L + + + +AL TA G+ +LH E
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLHME 119
Query: 619 CRDC-----IVHCDIKPENILLDENYNAKVSDFGLAKLINP-KDHRHRTLTSVRGTRGYL 672
I H D+K +NIL+ +N ++D GLA + D GT+ Y+
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 673 APEWL------ANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSL----WAYE 722
APE L + ++D+Y+ G+V EI + ++ + L + E
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 723 EFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIE 782
E K + + ++ E + ++ C + R ++ + L +++ E
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (555), Expect = 2e-65
Identities = 79/284 (27%), Positives = 126/284 (44%), Gaps = 25/284 (8%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHL 554
E+ R T ++LGAG FG V+ G T VAVK L+ F E + H
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 555 NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
LVRL ++ ++ E+M+NGSL +FL G L ++A A G+ +
Sbjct: 69 RLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAF 124
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAP 674
+ E +H D++ NIL+ + + K++DFGLA+LI ++ R + + AP
Sbjct: 125 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR--EGAKFPIKWTAP 179
Query: 675 EWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734
E + T KSDV+S+G++L EIV+ R + E + +G
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIP----------YPGMTNPEVIQNLERGYRM 229
Query: 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778
++ Q+MR C +E+P RP + +LE
Sbjct: 230 VRPDNCPEELYQLMR------LCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 3e-64
Identities = 68/280 (24%), Positives = 121/280 (43%), Gaps = 29/280 (10%)
Query: 503 FKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGF 562
F ++G+G FG V+ G N+ VA+K + E+ F E + H LV+L G
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 563 SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC 622
E LV+EFM++G L ++L L ++ + L G + C
Sbjct: 69 CLEQAPICLVFEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEG---MAYLEEAC 121
Query: 623 IVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPI 682
++H D+ N L+ EN KVSDFG+ + + + T + + +PE +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS--TGTKFPVKWASPEVFSFSRY 179
Query: 683 TSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDV 742
+SKSDV+S+G+++ E+ S + +E + +V+ G +
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIP------------------YENRSNSEVVEDISTGFRL 221
Query: 743 DIEQVM--RAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780
++ Q+ C +E+P RP ++++ L I E
Sbjct: 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 7e-63
Identities = 58/278 (20%), Positives = 111/278 (39%), Gaps = 29/278 (10%)
Query: 503 FKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGF 562
F +LG G FG V G + VA+K ++ E +F E + + H LV+L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 563 SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC 622
++ + ++ E+M NG L N+L Q + + YL
Sbjct: 68 CTKQRPIFIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLE---SKQ 120
Query: 623 IVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPI 682
+H D+ N L+++ KVSDFGL++ + D + + + + PE L
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL--DDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 683 TSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDV 742
+SKSD++++G+++ EI S + +E+ + G +
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMP------------------YERFTNSETAEHIAQGLRL 220
Query: 743 DIEQVM--RAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778
+ + + + C E+ +RP ++ + +
Sbjct: 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 209 bits (534), Expect = 3e-62
Identities = 77/320 (24%), Positives = 134/320 (41%), Gaps = 48/320 (15%)
Query: 491 FSYKELQRSTKGF-----------KDKLGAGGFGAVYRGVLA----NRTVVAVKQL--EG 533
F++++ + + F + +GAG FG V G L VA+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 534 IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSG 593
E+ + F E + + H N++ L G ++ +++ EFM+NGSLD+FL N+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND---- 122
Query: 594 KLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653
+ G A G+ YL VH D+ NIL++ N KVSDFGL++ +
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 654 PKDHRHRTLTSV--RGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQET 711
+++ + + APE + TS SDV+SYG+V+ E++S
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP------ 233
Query: 712 NRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDI--EQVMRAIQVSFWCIQEQPSQRPMMG 769
+ + +++ + + Q+ C Q+ + RP G
Sbjct: 234 ------------YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281
Query: 770 KVVQMLEGITEIEKPPAPKA 789
++V L+ + I P + KA
Sbjct: 282 QIVNTLDKM--IRNPNSLKA 299
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 7e-62
Identities = 79/293 (26%), Positives = 123/293 (41%), Gaps = 29/293 (9%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHL 554
E+ R + + KLG G FG V+ G T VA+K L+ + F E + H
Sbjct: 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 72
Query: 555 NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
LV+L SE +V E+M GSL +FL GK L ++A A G+ Y
Sbjct: 73 KLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAY 128
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAP 674
+ R VH D++ NIL+ EN KV+DFGLA+LI ++ R + + AP
Sbjct: 129 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR--QGAKFPIKWTAP 183
Query: 675 EWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734
E T KSDV+S+G++L E+ + R + + ++D
Sbjct: 184 EAALYGRFTIKSDVWSFGILLTELTTKGRVP------------------YPGMVNREVLD 225
Query: 735 KSLAGEDVDIEQVM--RAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPP 785
+ G + + C +++P +RP + LE +P
Sbjct: 226 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 3e-61
Identities = 74/279 (26%), Positives = 117/279 (41%), Gaps = 35/279 (12%)
Query: 503 FKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGF 562
+G G FG V G V AVK ++ + + F E + ++ H NLV+L+G
Sbjct: 11 LLQTIGKGEFGDVMLGDYRGNKV-AVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGV 68
Query: 563 SSEGKHRL-LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD 621
E K L +V E+M GSL ++L + +L +L + YL
Sbjct: 69 IVEEKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN-- 123
Query: 622 CIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLP 681
VH D+ N+L+ E+ AKVSDFGL K + T + + + APE L
Sbjct: 124 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS------TQDTGKLPVKWTAPEALREKK 176
Query: 682 ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGED 741
++KSDV+S+G++L EI S R + + +K +V + G
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVP------------------YPRIPLKDVVPRVEKGYK 218
Query: 742 VDIEQVM--RAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778
+D +V C + RP ++ + LE I
Sbjct: 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 207 bits (527), Expect = 4e-61
Identities = 72/320 (22%), Positives = 127/320 (39%), Gaps = 51/320 (15%)
Query: 490 QFSYKELQRSTKGFKDKLGAGGFGAVYRGVLANR------TVVAVKQL--EGIEQGEKQF 541
+ E R+ + +G G FG V++ T+VAVK L E + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 542 RMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEE----------- 590
+ E A ++ + N+V+L+G + GK L++E+M G L+ FL +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 591 --------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAK 642
L+ + IA A G+ YL E VH D+ N L+ EN K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180
Query: 643 VSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGR 702
++DFGL++ I D+ + ++ PE + T++SDV++YG+VL EI S
Sbjct: 181 IADFGLSRNIYSADYYKAD-GNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 703 RNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQ--VMRAIQVSFWCIQE 760
+ + ++ G + + + + C +
Sbjct: 240 LQP------------------YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSK 281
Query: 761 QPSQRPMMGKVVQMLEGITE 780
P+ RP + ++L+ + E
Sbjct: 282 LPADRPSFCSIHRILQRMCE 301
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (519), Expect = 3e-60
Identities = 79/306 (25%), Positives = 136/306 (44%), Gaps = 34/306 (11%)
Query: 488 PVQFSYK--ELQRSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRME 544
P +Y E++R+ K KLG G +G VY GV VAVK L+ ++F E
Sbjct: 4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 63
Query: 545 VATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNI 604
A + H NLV+L+G + ++ EFM G+L ++L E + + ++ +
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR---ECNRQEVSAVVLLYM 120
Query: 605 ALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTS 664
A + + YL ++ +H D+ N L+ EN+ KV+DFGL++L+ +
Sbjct: 121 ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAG 175
Query: 665 VRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEF 724
+ + APE LA + KSDV+++G++L EI + + Y
Sbjct: 176 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP---------------YPGI 220
Query: 725 EKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI------ 778
+ V +++K E + + ++ C Q PS RP ++ Q E +
Sbjct: 221 DLSQVYELLEKDYRMERPE-GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 279
Query: 779 -TEIEK 783
E+EK
Sbjct: 280 SDEVEK 285
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 6e-60
Identities = 69/291 (23%), Positives = 122/291 (41%), Gaps = 34/291 (11%)
Query: 496 LQRSTKGFKD-KLGAGGFGAVYRGVLANR---TVVAVKQL-EGIEQGE-KQFRMEVATIS 549
L+R D +LG G FG+V +GV R VA+K L +G E+ + ++ E +
Sbjct: 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMH 64
Query: 550 STHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTA 609
+ +VRL+G + + +LV E G L FL G + + + + +
Sbjct: 65 QLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV----GKREEIPVSNVAELLHQVS 119
Query: 610 RGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR 669
G+ YL E+ VH D+ N+LL + AK+SDFGL+K + D + ++ +
Sbjct: 120 MGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 670 GYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNV 729
+ APE + +S+SDV+SYG+ + E +S + ++K
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP------------------YKKMKG 218
Query: 730 KGIVDKSLAGEDVDIEQVM--RAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778
++ G+ ++ + C + RP V Q +
Sbjct: 219 PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 2e-59
Identities = 70/286 (24%), Positives = 112/286 (39%), Gaps = 35/286 (12%)
Query: 503 FKDKLGAGGFGAVYRGVLAN----RTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNL 556
F + +G G FG VY G L + + AVK L I QF E + H N+
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 557 VRLVGFSSEGK-HRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYL 615
+ L+G + L+V +MK+G L NF+ + L A+G +
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKG---M 143
Query: 616 HEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD-HRHRTLTSVRGTRGYLAP 674
VH D+ N +LDE + KV+DFGLA+ + K+ T + ++A
Sbjct: 144 KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 675 EWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734
E L T+KSDV+S+G++L E+++ + N I
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP------------------YPDVNTFDITV 245
Query: 735 KSLAGEDVDIEQVM--RAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778
L G + + +V C + RP ++V + I
Sbjct: 246 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 4e-59
Identities = 78/335 (23%), Positives = 135/335 (40%), Gaps = 52/335 (15%)
Query: 490 QFSYKELQRSTKGFKDKLGAGGFGAVYRGVLAN---RTVVAVKQL--EGIEQGEKQFRME 544
+ +++ F+D +G G FG V + + R A+K++ + + F E
Sbjct: 6 VLDWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGE 60
Query: 545 VATISS-THHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFL-----------FANEEGS 592
+ + HH N++ L+G + L E+ +G+L +FL FA +
Sbjct: 61 LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 120
Query: 593 GKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652
L+ Q + A ARG+ YL ++ +H D+ NIL+ ENY AK++DFGL++
Sbjct: 121 ASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQ 177
Query: 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETN 712
+ T R ++A E L T+ SDV+SYG++L EIVS
Sbjct: 178 EV----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP------- 226
Query: 713 RKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVM--RAIQVSFWCIQEQPSQRPMMGK 770
+ + +K G ++ + C +E+P +RP +
Sbjct: 227 -----------YCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 275
Query: 771 VVQMLEGITEIEKPPAPKALTEGSVGGTSVNMSSS 805
++ L + E K L E T + S
Sbjct: 276 ILVSLNRMLEERKTYVNTTLYEKF---TYAGIDCS 307
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 2e-58
Identities = 79/305 (25%), Positives = 135/305 (44%), Gaps = 32/305 (10%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRT-----VVAVKQL--EGIEQGEKQFRMEVAT 547
E+ S + +GAG FG VY+G+L + VA+K L E+ F E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 548 ISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALG 607
+ H N++RL G S+ K +++ E+M+NG+LD FL + + + G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRG 118
Query: 608 TARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRG 667
A G+ YL VH D+ NIL++ N KVSDFGL++++ T + +
Sbjct: 119 IAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 668 TRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG 727
+ APE ++ TS SDV+S+G+V+ E+++ Y E
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP---------------YWELSNH 220
Query: 728 NVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPPAP 787
V ++ ++ Q+ C Q++ ++RP +V +L+ + I P +
Sbjct: 221 EVMKAINDGFRLPT-PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL--IRAPDSL 277
Query: 788 KALTE 792
K L +
Sbjct: 278 KTLAD 282
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 4e-58
Identities = 79/316 (25%), Positives = 125/316 (39%), Gaps = 44/316 (13%)
Query: 488 PVQFSYK---ELQRSTKGFKDKLGAGGFGAVYRGVLA------NRTVVAVKQL--EGIEQ 536
P Q Y E R+ F LGAG FG V VAVK L
Sbjct: 9 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 68
Query: 537 GEKQFRMEVATISS-THHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANE------ 589
+ E+ +S +H+N+V L+G + G L++ E+ G L NFL
Sbjct: 69 EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 590 -------EGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAK 642
E L+ + + + A+G+ +L + +H D+ NILL K
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITK 185
Query: 643 VSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGR 702
+ DFGLA+ I D + + R ++APE + N T +SDV+SYG+ L E+ S
Sbjct: 186 ICDFGLARDI-KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244
Query: 703 RNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQP 762
+ + +F K +G S ++ +M+ C P
Sbjct: 245 SSPYPGMPVD---------SKFYKMIKEGFRMLSPEHAPAEMYDIMK------TCWDADP 289
Query: 763 SQRPMMGKVVQMLEGI 778
+RP ++VQ++E
Sbjct: 290 LKRPTFKQIVQLIEKQ 305
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 8e-58
Identities = 70/288 (24%), Positives = 118/288 (40%), Gaps = 32/288 (11%)
Query: 496 LQRSTKGFKDK-LGAGGFGAVYRGVLANR---TVVAVKQLE---GIEQGEKQFRMEVATI 548
L R +DK LG+G FG V +G + VAVK L+ + + E +
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 549 SSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGT 608
+ +VR++G E + +LV E + G L+ +L N + + ++ +
Sbjct: 63 QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQV 116
Query: 609 ARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGT 668
+ G+ YL E VH D+ N+LL + AK+SDFGL+K + ++ ++ T +
Sbjct: 117 SMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
Query: 669 RGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN 728
+ APE + +SKSDV+S+G+++ E S + + E
Sbjct: 174 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP----------YRGMKGSEVTAML 223
Query: 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776
KG AG ++ +M C RP V L
Sbjct: 224 EKGERMGCPAGCPREMYDLMN------LCWTYDVENRPGFAAVELRLR 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 5e-57
Identities = 63/269 (23%), Positives = 110/269 (40%), Gaps = 17/269 (6%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQL--EGIEQGEKQFRMEVATISSTHHLNLVRL 559
+LGAG G V++ + V+A K + E Q E+ + + +V
Sbjct: 10 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 69
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
G + E M GSLD L + Q +++ +G+TYL E+
Sbjct: 70 YGAFYSDGEISICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN 679
+ I+H D+KP NIL++ K+ DFG++ + S GTR Y++PE L
Sbjct: 125 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-----DSMANSFVGTRSYMSPERLQG 177
Query: 680 LPITSKSDVYSYGMVLLEIVSGRRNFEV--SQETNRKKFSLWAYEEFEKGNVKGIVDKSL 737
+ +SD++S G+ L+E+ GR ++E + E + L
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 738 AGEDVDIEQVMRAIQVSFWCIQEQPSQRP 766
+ +D M ++ + + E P + P
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLP 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 1e-55
Identities = 75/326 (23%), Positives = 117/326 (35%), Gaps = 51/326 (15%)
Query: 482 EYASGAPVQFSYK---ELQRSTKGFKDKLGAGGFGAVYRGVL------ANRTVVAVKQL- 531
EY ++ Y E R F LG+G FG V VAVK L
Sbjct: 17 EYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK 76
Query: 532 -EGIEQGEKQFRMEVATISS-THHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFAN- 588
+ + E+ ++ H N+V L+G + L++E+ G L N+L +
Sbjct: 77 EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 136
Query: 589 -----------------EEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPE 631
EE +L ++ A A+G+ +L + VH D+
Sbjct: 137 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193
Query: 632 NILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSY 691
N+L+ K+ DFGLA+ I + + R ++APE L T KSDV+SY
Sbjct: 194 NVLVTHGKVVKICDFGLARDIMSDS-NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 252
Query: 692 GMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRA 750
G++L EI S G + + F K G +I +M+
Sbjct: 253 GILLWEIFSLGVNPYP----------GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQ- 301
Query: 751 IQVSFWCIQEQPSQRPMMGKVVQMLE 776
C +RP + L
Sbjct: 302 -----SCWAFDSRKRPSFPNLTSFLG 322
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-55
Identities = 71/315 (22%), Positives = 129/315 (40%), Gaps = 38/315 (12%)
Query: 482 EYASGAPVQFSYK-ELQRSTKGFKDKLGAGGFGAVYRGVLANR------TVVAVKQL--E 532
EY S A V + E+ R +LG G FG VY GV T VA+K +
Sbjct: 2 EYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA 61
Query: 533 GIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGS 592
+ +F E + + + ++VRL+G S+G+ L++ E M G L ++L +
Sbjct: 62 ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAM 121
Query: 593 GKL-----LNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFG 647
+ +A A G+ YL+ VH D+ N ++ E++ K+ DFG
Sbjct: 122 ANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFG 178
Query: 648 LAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEV 707
+ + I D+ + +++PE L + T+ SDV+S+G+VL EI +
Sbjct: 179 MTRDIYETDYYRKG-GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-- 235
Query: 708 SQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVM--RAIQVSFWCIQEQPSQR 765
++ + + ++ + G +D ++ C Q P R
Sbjct: 236 ----------------YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMR 279
Query: 766 PMMGKVVQMLEGITE 780
P +++ ++ E
Sbjct: 280 PSFLEIISSIKEEME 294
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 1e-54
Identities = 61/280 (21%), Positives = 111/280 (39%), Gaps = 36/280 (12%)
Query: 503 FKDKLGAGGFGAVYRGVL-ANRTVVAVKQL---EGIEQGEKQFRMEVATISSTHHLNLVR 558
F ++G G F VY+G+ VA +L + + ++F+ E + H N+VR
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 559 LVGF----SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
K +LV E M +G+L +L K++ + + +G+ +
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQF 127
Query: 615 LHEECRDCIVHCDIKPENILL-DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLA 673
LH I+H D+K +NI + + K+ D GLA L +V GT ++A
Sbjct: 128 LHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-----FAKAVIGTPEFMA 181
Query: 674 PEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733
PE DVY++GM +LE+ + + Q Y G
Sbjct: 182 PEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPASF 234
Query: 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773
DK ++++++ CI++ +R + ++
Sbjct: 235 DKVA---IPEVKEIIE------GCIRQNKDERYSIKDLLN 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 7e-54
Identities = 50/279 (17%), Positives = 108/279 (38%), Gaps = 29/279 (10%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQL---EGIEQGEKQFRMEVATISSTHHLNLVR 558
+G G +G + ++ ++ K+L E ++ EV + H N+VR
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 67
Query: 559 L--VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLH 616
+V E+ + G L + + + + L+ + + + H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECH 126
Query: 617 E--ECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAP 674
+ ++H D+KP N+ LD N K+ DFGLA+++N + GT Y++P
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF---AKAFVGTPYYMSP 183
Query: 675 EWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734
E + + KSD++S G +L E+ + F + +E +G
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----------KELAGKIREGKFR 232
Query: 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773
+ ++ +++ + + RP + ++++
Sbjct: 233 RIPYRYSDELNEIIT------RMLNLKDYHRPSVEEILE 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-53
Identities = 69/275 (25%), Positives = 109/275 (39%), Gaps = 28/275 (10%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQL--EGIEQGEKQFRMEVATISSTHHLNLVRL 559
LG G +G V V VAVK + + + + E+ +H N+V+
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 68
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
G EG + L E+ G L + + + + G+ YLH
Sbjct: 69 YGHRREGNIQYLFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN 679
I H DIKPEN+LLDE N K+SDFGLA + ++R R L + GT Y+APE L
Sbjct: 124 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRY-NNRERLLNKMCGTLPYVAPELLKR 179
Query: 680 LPI-TSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738
DV+S G+VL +++G ++ ++ +E+ K
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---------QEYSDWKEKKTYLNPWK 230
Query: 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773
D ++ + E PS R + + +
Sbjct: 231 KIDSAPLALLH------KILVENPSARITIPDIKK 259
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 4e-53
Identities = 68/283 (24%), Positives = 104/283 (36%), Gaps = 33/283 (11%)
Query: 503 FKDKLGAGGFGAVYRGVL----ANRTVVAVKQLE----GIEQGEKQFRMEVATISSTHHL 554
+KLG G FG V RG VAVK L+ + F EV + S H
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 555 NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
NL+RL G ++ V E GSL + L ++ + A+ A G+ Y
Sbjct: 72 NLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGY 126
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAP 674
L + +H D+ N+LL K+ DFGL + + D + + + AP
Sbjct: 127 LESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 675 EWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733
E L + SD + +G+ L E+ + G+ + L + K + +G
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI----------GLNGSQILHKIDKEGER 233
Query: 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776
DI VM C +P RP + L
Sbjct: 234 LPRPEDCPQDIYNVMV------QCWAHKPEDRPTFVALRDFLL 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (468), Expect = 8e-53
Identities = 60/277 (21%), Positives = 104/277 (37%), Gaps = 41/277 (14%)
Query: 506 KLGAGGFGAVYRGV-LANRTVVAVKQL----EGIEQGEKQFRMEVATISSTHHLNLVRLV 560
++G G FGAVY + N VVA+K++ + + + EV + H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620
G LV E+ + D K L + G +G+ YLH
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSHN- 135
Query: 621 DCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL 680
++H D+K NILL E K+ DFG A ++ P S GT ++APE + +
Sbjct: 136 --MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFVGTPYWMAPEVILAM 186
Query: 681 ---PITSKSDVYSYGMVLLEIVSGRRNF-EVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736
K DV+S G+ +E+ + ++ + + + G+
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW------- 239
Query: 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773
+ C+Q+ P RP +++
Sbjct: 240 ----SEYFRNFVD------SCLQKIPQDRPTSEVLLK 266
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 1e-52
Identities = 66/297 (22%), Positives = 118/297 (39%), Gaps = 36/297 (12%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANR----TVVAVKQLEGI--EQGEKQFRMEVATI 548
E+QR +G G FG V++G+ + VA+K + + ++F E T+
Sbjct: 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 62
Query: 549 SSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGT 608
H ++V+L+G +E ++ E G L +FL + L+ S A
Sbjct: 63 RQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYS----LDLASLILYAYQL 117
Query: 609 ARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGT 668
+ + YL + VH DI N+L+ N K+ DFGL++ + + + +
Sbjct: 118 STALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA--SKGKLP 172
Query: 669 RGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN 728
++APE + TS SDV+ +G+ + EI+ F+
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP------------------FQGVK 214
Query: 729 VKGIVDKSLAGEDVDIEQVM--RAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEK 783
++ + GE + + + C PS+RP ++ L I E EK
Sbjct: 215 NNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-52
Identities = 59/293 (20%), Positives = 115/293 (39%), Gaps = 37/293 (12%)
Query: 493 YKELQRSTKG-----FKDKLGAGGFGAVYRGV-LANRTVVAVKQLE-GIEQGEKQFRMEV 545
Y+ + R +LG G FG VY+ + A K ++ E+ + + +E+
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 546 ATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIA 605
++S H N+V+L+ + ++ EF G++D + E + L +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE----RPLTESQIQVVC 116
Query: 606 LGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSV 665
T + YLH+ I+H D+K NIL + + K++DFG++ R S
Sbjct: 117 KQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR---DSF 170
Query: 666 RGTRGYLAPEWLA-----NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA 720
GT ++APE + + P K+DV+S G+ L+E+ + + A
Sbjct: 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH--HELNPMRVLLKIA 228
Query: 721 YEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773
E + + ++ C+++ R +++Q
Sbjct: 229 KSEPPTLAQPSRWSS-------NFKDFLK------KCLEKNVDARWTTSQLLQ 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 6e-52
Identities = 72/308 (23%), Positives = 123/308 (39%), Gaps = 46/308 (14%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGVL--------ANRTVVAVKQL--EGIEQGEKQFRME 544
EL R LG G FG V T VAVK L + E+ E
Sbjct: 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68
Query: 545 VATISS-THHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFL-----------FANEEGS 592
+ + H N++ L+G ++ ++ E+ G+L +L +
Sbjct: 69 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 593 GKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652
+ L+ + + A ARG+ YL + +H D+ N+L+ E+ K++DFGLA+ I
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETN 712
+ D+ +T R ++APE L + T +SDV+S+G++L EI + +
Sbjct: 186 HHIDYYKKTTN-GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP------- 237
Query: 713 RKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVM--RAIQVSFWCIQEQPSQRPMMGK 770
+ V+ + G +D + C PSQRP +
Sbjct: 238 -----------YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQ 286
Query: 771 VVQMLEGI 778
+V+ L+ I
Sbjct: 287 LVEDLDRI 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 2e-51
Identities = 76/307 (24%), Positives = 120/307 (39%), Gaps = 40/307 (13%)
Query: 495 ELQRSTKGFKDKLGAGGFGAVYRGV------LANRTVVAVKQL--EGIEQGEKQFRMEVA 546
E R LG G FG V A VAVK L + E+
Sbjct: 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 68
Query: 547 TISST-HHLNLVRLVG-FSSEGKHRLLVYEFMKNGSLDNFLF-----------ANEEGSG 593
+ HHLN+V L+G + G +++ EF K G+L +L A E+
Sbjct: 69 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 594 KLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653
L + + A+G+ +L +H D+ NILL E K+ DFGLA+ I
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIY 185
Query: 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNR 713
R R ++APE + + T +SDV+S+G++L EI S + + +
Sbjct: 186 KDPDYVRK-GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244
Query: 714 KKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773
++G D + ++ Q M C +PSQRP ++V+
Sbjct: 245 -----EFCRRLKEGTRMRAPDYT----TPEMYQTML------DCWHGEPSQRPTFSELVE 289
Query: 774 MLEGITE 780
L + +
Sbjct: 290 HLGNLLQ 296
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 3e-51
Identities = 59/283 (20%), Positives = 116/283 (40%), Gaps = 32/283 (11%)
Query: 503 FKDKLGAGGFGAVYRGVLAN-----RTVVAVKQL--EGIEQGEKQFRMEVATISSTHHLN 555
LG+G FG VY+G+ + VA+K+L + K+ E ++S + +
Sbjct: 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 72
Query: 556 LVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYL 615
+ RL+G +L + + M G L +++ + + Q N + A+G+ YL
Sbjct: 73 VCRLLGICLTSTVQL-ITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYL 127
Query: 616 HEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPE 675
+ +VH D+ N+L+ + K++DFGLAKL+ ++ + + ++A E
Sbjct: 128 EDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMALE 183
Query: 676 WLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735
+ + T +SDV+SYG+ + E+++ + E KG
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKP----------YDGIPASEISSILEKGERLP 233
Query: 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778
+D+ +M C RP +++ +
Sbjct: 234 QPPICTIDVYMIMV------KCWMIDADSRPKFRELIIEFSKM 270
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-50
Identities = 67/277 (24%), Positives = 110/277 (39%), Gaps = 38/277 (13%)
Query: 503 FKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLV 557
LG G FG VY ++ ++A+K L E Q R EV S H N++
Sbjct: 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 69
Query: 558 RLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHE 617
RL G+ + L+ E+ G++ L + Q A ++Y H
Sbjct: 70 RLYGYFHDATRVYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHS 124
Query: 618 ECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWL 677
+ ++H DIKPEN+LL K++DFG + T++ GT YL PE +
Sbjct: 125 KR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-----SSRRTTLCGTLDYLPPEMI 176
Query: 678 ANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSL 737
K D++S G++ E + G+ FE + + +
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-------------------TYQETYKRIS 217
Query: 738 AGEDVDIEQVMR-AIQVSFWCIQEQPSQRPMMGKVVQ 773
E + V A + ++ PSQRPM+ +V++
Sbjct: 218 RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-48
Identities = 48/204 (23%), Positives = 97/204 (47%), Gaps = 14/204 (6%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQ-FRMEVATISSTHHLNLVRLVGF 562
+K+G G G VY + +A VA++Q+ +Q +K+ E+ + + N+V +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 563 SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC 622
G +V E++ GSL + + ++ + + + +LH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHSNQ--- 136
Query: 623 IVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPI 682
++H DIK +NILL + + K++DFG I P+ + +++ GT ++APE +
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRKAY 193
Query: 683 TSKSDVYSYGMVLLEIVSGRRNFE 706
K D++S G++ +E++ G +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYL 217
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 8e-48
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 14/209 (6%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLE----GIEQGEKQFRMEVATISSTHHLNLV 557
F LG G F V LA A+K LE E E +S H V
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 558 RLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHE 617
+L + + + KNG L ++ G +RF A ++ L
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTA----EIVSALEY 123
Query: 618 ECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWL 677
I+H D+KPENILL+E+ + +++DFG AK+++P+ + R S GT Y++PE L
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NSFVGTAQYVSPELL 182
Query: 678 ANLPITSKSDVYSYGMVLLEIVSGRRNFE 706
SD+++ G ++ ++V+G F
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFR 211
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 168 bits (427), Expect = 9e-47
Identities = 68/327 (20%), Positives = 122/327 (37%), Gaps = 32/327 (9%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQL-EGIEQGEKQFRMEVATISSTHHLNLVRLV 560
++LG G FG V+R A A K + E ++ R E+ T+S H LV L
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 89
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620
+ +++YEFM G L + ++ +G+ ++HE
Sbjct: 90 DAFEDDNEMVMIYEFMSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHEN-- 143
Query: 621 DCIVHCDIKPENILL--DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLA 678
VH D+KPENI+ + K+ DFGL ++PK GT + APE
Sbjct: 144 -NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK----VTTGTAEFAAPEVAE 198
Query: 679 NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738
P+ +D++S G++ ++SG F + + + + D + +
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-------TLRNVKSCDWN-MDDSAFS 250
Query: 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPPAPKALTEGSVGGT 798
G D + +R + P+ R + + ++ +T P + T
Sbjct: 251 GISEDGKDFIR------KLLLADPNTRMTIHQALEH-PWLTPGNAPGRDSQIPSSRY--T 301
Query: 799 SVNMSSSTSALSTFAASAPAPSSSSST 825
+ S T + P S+ +
Sbjct: 302 KIRDSIKTKYDAWPEPLPPLGRISNYS 328
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (407), Expect = 1e-44
Identities = 52/283 (18%), Positives = 105/283 (37%), Gaps = 28/283 (9%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVG 561
K+G+G FG +Y G +A VA+K ++ Q +E + +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMMQGGVGIPTIR 69
Query: 562 FS-SEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620
+ +EG + ++V E + D F F + + ++ +A I Y+H +
Sbjct: 70 WCGAEGDYNVMVMELLGPSLEDLFNF-----CSRKFSLKTVLLLADQMISRIEYIHSKN- 123
Query: 621 DCIVHCDIKPENIL---LDENYNAKVSDFGLAKLINP----KDHRHRTLTSVRGTRGYLA 673
+H D+KP+N L + + DFGLAK + +R ++ GT Y +
Sbjct: 124 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 674 PEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733
+ + + D+ S G VL+ G ++ + + YE + + +
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK----RQKYERISEKKMSTPI 237
Query: 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776
+ G + + +C + +P + Q+
Sbjct: 238 EVLCKGYPSEFATYLN------FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 159 bits (404), Expect = 2e-44
Identities = 51/285 (17%), Positives = 99/285 (34%), Gaps = 30/285 (10%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATISS-THHLNLVRLV 560
++G G FG ++ G L N VA+K Q R E T + +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-RRSDAPQLRDEYRTYKLLAGCTGIPNVY 67
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620
F EG H +LV + + D + G+ + ++ A + +HE+
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLL-----DLCGRKFSVKTVAMAAKQMLARVQSIHEKS- 121
Query: 621 DCIVHCDIKPENILLDENYN-----AKVSDFGLAKLINP----KDHRHRTLTSVRGTRGY 671
+V+ DIKP+N L+ + V DFG+ K + +R ++ GT Y
Sbjct: 122 --LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 672 LAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731
++ + + D+ + G V + + G ++ + + YE +
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT----NKQKYERIGEKKQST 235
Query: 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776
+ + AG + + M + P + +
Sbjct: 236 PLRELCAGFPEEFYKYMH------YARNLAFDATPDYDYLQGLFS 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (402), Expect = 7e-44
Identities = 73/294 (24%), Positives = 122/294 (41%), Gaps = 34/294 (11%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQL--EGIEQGEKQFRMEVATISSTHHLNLVRL 559
F+D LG G F V + +VA+K + + +E E E+A + H N+V L
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL 72
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
G H L+ + + G L + + + + + YLH+
Sbjct: 73 DDIYESGGHLYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLHD-- 125
Query: 620 RDCIVHCDIKPENILL---DENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEW 676
IVH D+KPEN+L DE+ +SDFGL+K+ +P L++ GT GY+APE
Sbjct: 126 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP----GSVLSTACGTPGYVAPEV 180
Query: 677 LANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736
LA P + D +S G++ ++ G F + + L A EF+ I D
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD-- 238
Query: 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM--LEGITEIEKPPAPK 788
+ +R +++ P +R + +Q + G T ++K
Sbjct: 239 ------SAKDFIR------HLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQS 280
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 159 bits (402), Expect = 2e-43
Identities = 69/340 (20%), Positives = 135/340 (39%), Gaps = 42/340 (12%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLE-GIEQGEKQFRMEVATISSTHHLNLVRLV 560
++LG+G FG V+R V A V K + + + E++ ++ HH L+ L
Sbjct: 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 92
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620
+ +L+ EF+ G L + + A ++ N G+ ++HE
Sbjct: 93 DAFEDKYEMVLILEFLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEH-- 146
Query: 621 DCIVHCDIKPENILLD--ENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLA 678
IVH DIKPENI+ + + + K+ DFGLA +NP + T T + APE +
Sbjct: 147 -SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT----TATAEFAAPEIVD 201
Query: 679 NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738
P+ +D+++ G++ ++SG F + + ++ + + + + +
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCDWE-FDEDAFS 253
Query: 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM--LEGITEIEKPPAPKALTEGSVG 796
+ + ++ +Q++P +R + ++ L+G P
Sbjct: 254 SVSPEAKDFIK------NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIP--------- 298
Query: 797 GTSVNMSSSTSALSTFAASAPAPSSSSSTHTGVSALASDR 836
S + + A PAP + S+L R
Sbjct: 299 --SSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHR 336
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 155 bits (393), Expect = 4e-43
Identities = 64/289 (22%), Positives = 115/289 (39%), Gaps = 44/289 (15%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQL----------EGIEQGEKQFRMEVATISST 551
K+ LG G V R + AVK + E +++ + EV +
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 552 H-HLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTAR 610
H N+++L LV++ MK G L ++L L+ + I
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLE 121
Query: 611 GITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRG 670
I LH+ IVH D+KPENILLD++ N K++DFG + ++P + L V GT
Sbjct: 122 VICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE----KLREVCGTPS 174
Query: 671 YLAPEWLA------NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEF 724
YLAPE + + + D++S G+++ +++G F ++ + + +F
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234
Query: 725 EKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773
D ++ ++ + QP +R + +
Sbjct: 235 GSPEWDDYSD--------TVKDLVS------RFLVVQPQKRYTAEEALA 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 154 bits (390), Expect = 1e-42
Identities = 58/273 (21%), Positives = 104/273 (38%), Gaps = 31/273 (11%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQL----EGIEQGEKQFRMEVATISSTHHLNLV 557
+ LG GG V+ L VAVK L +FR E ++ +H +V
Sbjct: 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70
Query: 558 RLVGF----SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGIT 613
+ + G +V E++ +L + + + + + + +
Sbjct: 71 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALN 125
Query: 614 YLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLA 673
+ H+ I+H D+KP NI++ KV DFG+A+ I + +V GT YL+
Sbjct: 126 FSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 674 PEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733
PE + ++SDVYS G VL E+++G F + + +G+
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL- 241
Query: 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP 766
D++ V+ + + P R
Sbjct: 242 -------SADLDAVVL------KALAKNPENRY 261
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-42
Identities = 49/274 (17%), Positives = 111/274 (40%), Gaps = 28/274 (10%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVG 561
+ LG G FG V+R V +++ K ++ + + E++ ++ H N++ L
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 562 FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD 621
+ ++++EF+ + + + LN + + + +LH
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHSH--- 121
Query: 622 CIVHCDIKPENILLD--ENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN 679
I H DI+PENI+ + K+ +FG A+ + P D+ + Y APE +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF----RLLFTAPEYYAPEVHQH 177
Query: 680 LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAG 739
+++ +D++S G ++ ++SG F ETN++ E+ +++
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFL--AETNQQIIENIMNAEYT------FDEEAFKE 229
Query: 740 EDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773
++ + + ++ R + +Q
Sbjct: 230 ISIEAMDFVD------RLLVKERKSRMTASEALQ 257
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-41
Identities = 60/298 (20%), Positives = 118/298 (39%), Gaps = 27/298 (9%)
Query: 496 LQRSTKGFK--DKLGAGGFGAVYRG--VLANRTVVAVKQL------EGIEQGEKQFRMEV 545
L R+ + ++ ++G G +G V++ + VA+K++ EG+ + +
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 546 ATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDN-FLFANEEGSGKLLNWQSRFNI 604
+ + H N+VRL + + + +D ++ + ++ ++
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 605 ALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTS 664
RG+ +LH +VH D+KP+NIL+ + K++DFGLA++ + + TS
Sbjct: 122 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL----TS 174
Query: 665 VRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNF----EVSQETNRKKFSLWA 720
V T Y APE L + D++S G + E+ + F +V Q
Sbjct: 175 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234
Query: 721 YEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSF-----WCIQEQPSQRPMMGKVVQ 773
EE +V + IE+ + I C+ P++R +
Sbjct: 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 152 bits (385), Expect = 4e-41
Identities = 62/292 (21%), Positives = 108/292 (36%), Gaps = 42/292 (14%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLE----GIEQGEKQFRMEVATIS---STHHL 554
+G GGFG VY + A+K L+ ++QGE E +S +
Sbjct: 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 67
Query: 555 NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
+V + + + M G L L + + + A G+ +
Sbjct: 68 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEH 122
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAP 674
+H +V+ D+KP NILLDE+ + ++SD GLA D + + GT GY+AP
Sbjct: 123 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYMAP 174
Query: 675 EWLA-NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733
E L + S +D +S G +L +++ G F Q + K + +
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR--QHKTKDKHEIDRMTLTMAVELPDSF 232
Query: 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIEKPP 785
L ++ +Q ++R G E+++ P
Sbjct: 233 SPEL-------RSLLE------GLLQRDVNRRLGCLG-----RGAQEVKESP 266
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 8e-41
Identities = 65/283 (22%), Positives = 108/283 (38%), Gaps = 48/283 (16%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQL-------EGIEQGEKQFRMEVATIS--STH 552
LG+GGFG+VY G+ +++ VA+K + G + MEV + S+
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 553 HLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGI 612
++RL+ + +L+ E + L + + +
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAV 123
Query: 613 TYLHEECRDCIVHCDIKPENILLDEN-YNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGY 671
+ H ++H DIK ENIL+D N K+ DFG L+ + T GTR Y
Sbjct: 124 RHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-----TDFDGTRVY 175
Query: 672 LAPEWLANLPITSKS-DVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730
PEW+ +S V+S G++L ++V G FE +E R +
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR----------- 224
Query: 731 GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773
+ V E + WC+ +PS RP ++
Sbjct: 225 ---------QRVSSE----CQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 149 bits (378), Expect = 1e-40
Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 19/209 (9%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLE----GIEQGEKQFRMEVATISSTHHLNLV 557
LG G FG V+ N A+K L+ + + E +S H ++
Sbjct: 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 67
Query: 558 RLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHE 617
R+ G + + ++ ++++ G L + L + A L
Sbjct: 68 RMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--------QRFPNPVAKFYAAEVCLALEY 119
Query: 618 ECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWL 677
I++ D+KPENILLD+N + K++DFG AK + ++ GT Y+APE +
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV------PDVTYTLCGTPDYIAPEVV 173
Query: 678 ANLPITSKSDVYSYGMVLLEIVSGRRNFE 706
+ P D +S+G+++ E+++G F
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFY 202
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-40
Identities = 50/210 (23%), Positives = 89/210 (42%), Gaps = 17/210 (8%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLE----GIEQGEKQFRMEVATISST-HHLNL 556
LG G FG V+ A+K L+ ++ + +E +S H L
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 557 VRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLH 616
+ ++ V E++ G L + + + + A G+ +LH
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-----FDLSRATFYAAEIILGLQFLH 120
Query: 617 EECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEW 676
+ IV+ D+K +NILLD++ + K++DFG+ K D + + GT Y+APE
Sbjct: 121 SKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NTFCGTPDYIAPEI 174
Query: 677 LANLPITSKSDVYSYGMVLLEIVSGRRNFE 706
L D +S+G++L E++ G+ F
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFH 204
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-40
Identities = 53/271 (19%), Positives = 102/271 (37%), Gaps = 31/271 (11%)
Query: 504 KDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVG- 561
LG G G V + + A+K L+ + ++ + ++ ++VR+V
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELH---WRASQCPHIVRIVDV 73
Query: 562 ---FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618
+ K L+V E + G L + + ++ + + I I YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 619 CRDCIVHCDIKPENILLDENYN---AKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPE 675
I H D+KPEN+L K++DFG AK + + T Y+APE
Sbjct: 131 N---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT----TPCYTPYYVAPE 183
Query: 676 WLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735
L D++S G+++ ++ G F + S G + +
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPF---YSNHGLAISPGMKTRIRMGQYE-FPNP 239
Query: 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP 766
+ +++ ++R ++ +P+QR
Sbjct: 240 EWSEVSEEVKMLIR------NLLKTEPTQRM 264
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 4e-40
Identities = 55/279 (19%), Positives = 108/279 (38%), Gaps = 22/279 (7%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGE--KQFRMEVATISSTHHLNLVRLVG 561
+G G +G V N+ VA+K++ E ++ E+ + H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 562 FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD 621
+ ++ + L+ + + L+ RG+ Y+H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLY--KLLKTQHLSNDHICYFLYQILRGLKYIHSAN-- 129
Query: 622 CIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN-L 680
++H D+KP N+LL+ + K+ DFGLA++ +P LT TR Y APE + N
Sbjct: 130 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 188
Query: 681 PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGE 740
T D++S G +L E++S R F ++ L + ++ I++
Sbjct: 189 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 248
Query: 741 DVDIEQVMR-------------AIQVSFWCIQEQPSQRP 766
+ + + A+ + + P +R
Sbjct: 249 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 287
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-39
Identities = 62/288 (21%), Positives = 108/288 (37%), Gaps = 29/288 (10%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQL------EGIEQGEKQFRMEVATISSTHHLNLV 557
D LG G F VY+ +VA+K++ E + + E+ + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 558 RLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHE 617
L+ + LV++FM+ + + +L L T +G+ YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII-----KDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 618 ECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWL 677
I+H D+KP N+LLDEN K++DFGLAK +R T TR Y APE L
Sbjct: 119 HW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF---GSPNRAYTHQVVTRWYRAPELL 172
Query: 678 ANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETN-----RKKFSLWAYEEFEKGNVKG 731
D+++ G +L E++ + + + E++
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 732 IVDKSLAGEDVDIEQVMRAIQVSF-----WCIQEQPSQRPMMGKVVQM 774
+ + + + A P R + ++M
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 3e-38
Identities = 60/302 (19%), Positives = 115/302 (38%), Gaps = 39/302 (12%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQL---EGIEQGEKQFRMEVATISSTHHLNLVRLV 560
+K+G G +G VY+ VVA+K++ E E++ + +H N+V+L+
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620
LV+EF+ + L F+ A+ + + +G+ + H
Sbjct: 68 DVIHTENKLYLVFEFL-HQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFCHSHR- 122
Query: 621 DCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL 680
++H D+KP+N+L++ K++DFGLA+ + T T Y APE L
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILLGC 177
Query: 681 P-ITSKSDVYSYGMVLLEIVSGRRNFE-----------------VSQETNRKKFSLWAYE 722
++ D++S G + E+V+ R F + S+ Y+
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 723 EFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIE 782
+ K + D D ++ + P++R + ++
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLS------QMLHYDPNKRISAKAALAH-PFFQDVT 290
Query: 783 KP 784
KP
Sbjct: 291 KP 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 140 bits (354), Expect = 9e-38
Identities = 54/284 (19%), Positives = 107/284 (37%), Gaps = 26/284 (9%)
Query: 505 DKLGAGGFGAVYRGVLANRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVG 561
+K+G G +G VY+ A+K++ E E++ + H N+V+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 562 FSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRD 621
K +LV+E + L + + L GI Y H+
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDRR-- 120
Query: 622 CIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL- 680
++H D+KP+N+L++ K++DFGLA+ ++ T Y AP+ L
Sbjct: 121 -VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV---TLWYRAPDVLMGSK 176
Query: 681 PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGE 740
++ D++S G + E+V+G F E ++ N + +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 741 DVDIEQVMR-----------AIQVSFWCIQEQPSQRPMMGKVVQ 773
+ + + + I + ++ P+QR + ++
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-37
Identities = 54/283 (19%), Positives = 104/283 (36%), Gaps = 38/283 (13%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQL-------EGIEQGEKQFRMEVATISSTHHL 554
++LG+G F V + + A K + + EV+ + H
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 555 NLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
N++ L +L+ E + G L +FL + L + G
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNG--- 125
Query: 615 LHEECRDCIVHCDIKPENILLDEN----YNAKVSDFGLAKLINPKDHRHRTLTSVRGTRG 670
++ I H D+KPENI+L + K+ DFGLA I+ + ++ GT
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN----EFKNIFGTPE 181
Query: 671 YLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730
++APE + P+ ++D++S G++ ++SG F + N +
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSAVNYE 234
Query: 731 GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773
D+ + + +R + + P +R + +Q
Sbjct: 235 -FEDEYFSNTSALAKDFIR------RLLVKDPKKRMTIQDSLQ 270
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 3e-37
Identities = 63/302 (20%), Positives = 109/302 (36%), Gaps = 46/302 (15%)
Query: 488 PVQFSYKELQRSTKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVA 546
P + SY + + +G G FG VY+ L + +VA+K+ + Q ++ E+
Sbjct: 17 PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKK---VLQDKRFKNRELQ 65
Query: 547 TISSTHHLNLVRLVGF------SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQS 600
+ H N+VRL F + + LV +++ + + L
Sbjct: 66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK--QTLPVIY 123
Query: 601 RFNIALGTARGITYLHEECRDCIVHCDIKPENILLD-ENYNAKVSDFGLAKLINPKDHRH 659
R + Y+H I H DIKP+N+LLD + K+ DFG AK + +
Sbjct: 124 VKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 660 RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETN------- 712
+ + TS DV+S G VL E++ G+ F +
Sbjct: 181 ---SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237
Query: 713 --------RKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQ 764
+ + Y EF+ +K + E AI + ++ P+
Sbjct: 238 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPE----AIALCSRLLEYTPTA 293
Query: 765 RP 766
R
Sbjct: 294 RL 295
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-36
Identities = 63/324 (19%), Positives = 122/324 (37%), Gaps = 36/324 (11%)
Query: 491 FSYKELQRSTKGFKD------KLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGE---KQ 540
F +E+ ++ + +G+G +GAV V VA+K+L Q E K+
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 541 FRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQS 600
E+ + H N++ L+ + + +F KL
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKL-GEDR 122
Query: 601 RFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHR 660
+ +G+ Y+H +H D+KP N+ ++E+ K+ DFGLA+ + +
Sbjct: 123 IQFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLARQADSE----- 174
Query: 661 TLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETN------- 712
+T TR Y APE + N + T D++S G ++ E+++G+ F+ S +
Sbjct: 175 -MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233
Query: 713 -RKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMR-----AIQVSFWCIQEQPSQRP 766
+ + K + E D ++ A+ + + QR
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293
Query: 767 MMGKVVQM--LEGITEIEKPPAPK 788
G+ + E + + E P +
Sbjct: 294 TAGEALAHPYFESLHDTEDEPQVQ 317
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 4e-35
Identities = 52/209 (24%), Positives = 78/209 (37%), Gaps = 16/209 (7%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLE----GIEQGEKQFRMEVATISSTHHLNLV 557
+ LG G FG V A A+K L + E + +T H L
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 558 RLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHE 617
L V E+ G L L + A ++ L
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHLSRE--------RVFTEERARFYGAEIVSALEY 120
Query: 618 ECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWL 677
+V+ DIK EN++LD++ + K++DFGL K T+ + GT YLAPE L
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFCGTPEYLAPEVL 177
Query: 678 ANLPITSKSDVYSYGMVLLEIVSGRRNFE 706
+ D + G+V+ E++ GR F
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 7e-35
Identities = 50/290 (17%), Positives = 101/290 (34%), Gaps = 36/290 (12%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQL---EGIEQGEKQFRMEVATISSTHHLNLVRLV 560
K+G G FG V++ VA+K++ E E+ + H N+V L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 561 GFSSEGKHR--------LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGI 612
LV++F ++ + + + R L +
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL---SEIKRVMQML-----L 127
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP-KDHRHRTLTSVRGTRGY 671
L+ R+ I+H D+K N+L+ + K++DFGLA+ + K+ + T+ T Y
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 672 LAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730
PE L D++ G ++ E+ + + + E ++
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247
Query: 731 GIVDKSLAGEDVDIEQVMRAIQVSFW--------------CIQEQPSQRP 766
+ + L + ++ R ++ + P+QR
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-34
Identities = 51/286 (17%), Positives = 104/286 (36%), Gaps = 28/286 (9%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQL---EGIEQGEKQFRMEVATISSTHHLNLVRLV 560
+K+G G +G V++ +VA+K++ + E E+ + H N+VRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 561 GFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECR 620
K LV+EF F N + + + L
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCN--------GDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 621 DCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANL 680
++H D+KP+N+L++ N K+++FGLA+ R ++ T Y P+ L
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV---RCYSAEVVTLWYRPPDVLFGA 176
Query: 681 PI-TSKSDVYSYGMVLLEIVSGRR-------NFEVSQETNRKKFSLWAYEEFEKGNVKGI 732
+ ++ D++S G + E+ + R + + R + + +
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 733 VDKSLAGEDVDIEQVMRAIQVSF-----WCIQEQPSQRPMMGKVVQ 773
+ + V+ + + ++ P QR + +Q
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (324), Expect = 4e-33
Identities = 45/207 (21%), Positives = 82/207 (39%), Gaps = 19/207 (9%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQLE----GIEQGEKQFRMEVATISSTHHLNLVRL 559
LG G FG V + A+K L+ + + E + + + LV+L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 560 VGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC 619
+ + +V E++ G + + L + A YLH
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 620 RDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN 679
+++ D+KPEN+L+D+ +V+DFG AK ++ GT LAPE + +
Sbjct: 162 ---LIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWTLCGTPEALAPEIILS 212
Query: 680 LPITSKSDVYSYGMVLLEIVSGRRNFE 706
D ++ G+++ E+ +G F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFF 239
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 122 bits (307), Expect = 4e-31
Identities = 45/209 (21%), Positives = 89/209 (42%), Gaps = 23/209 (11%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATISS-THHLNLVRLV 560
KLG G + V+ + + N V VK L+ ++ +K+ + E+ + + N++ L
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLA 96
Query: 561 GFSSEGKHRL--LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEE 618
+ R LV+E + N L ++ RF + + Y H
Sbjct: 97 DIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRF-YMYEILKALDYCHSM 148
Query: 619 CRDCIVHCDIKPENILLD-ENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPE-W 676
I+H D+KP N+++D E+ ++ D+GLA+ +P + + +R + PE
Sbjct: 149 ---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV----ASRYFKGPELL 201
Query: 677 LANLPITSKSDVYSYGMVLLEIVSGRRNF 705
+ D++S G +L ++ + F
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPF 230
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (300), Expect = 5e-30
Identities = 48/211 (22%), Positives = 81/211 (38%), Gaps = 25/211 (11%)
Query: 505 DKLGAGGFGAVYRGV-LANRTVVAVKQL---EGIEQGEKQFRMEVATISSTHHLNLVRLV 560
+G+G G V VA+K+L + K+ E+ + +H N++ L+
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 561 GF------SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITY 614
E + LV E M + + + GI +
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--------DHERMSYLLYQMLCGIKH 134
Query: 615 LHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAP 674
LH I+H D+KP NI++ + K+ DFGLA+ +T TR Y AP
Sbjct: 135 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMTPYVVTRYYRAP 187
Query: 675 EWLANLPITSKSDVYSYGMVLLEIVSGRRNF 705
E + + D++S G ++ E+V + F
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILF 218
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 8e-30
Identities = 48/222 (21%), Positives = 82/222 (36%), Gaps = 22/222 (9%)
Query: 503 FKDKLGAGGFGAVYRGVLA----NRTVVAVKQL-----EGIEQGEKQFRMEVATISS-TH 552
LG G +G V+ + A+K L + + R E +
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 553 HLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGI 612
LV L L+ +++ G L L + + + +
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--------ERFTEHEVQIYVGEIV 139
Query: 613 TYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYL 672
L + I++ DIK ENILLD N + ++DFGL+K + GT Y+
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER--AYDFCGTIEYM 197
Query: 673 APEWL--ANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETN 712
AP+ + + D +S G+++ E+++G F V E N
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (297), Expect = 2e-29
Identities = 48/217 (22%), Positives = 87/217 (40%), Gaps = 16/217 (7%)
Query: 503 FKDKLGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVG 561
KLG G F V+ + N T VA+K + G + + E+ + + + +
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 562 FSSEGKHRLL-VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFN----------IALGTAR 610
+ +LL + + + G L + + I+
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 611 GITYLHEECRDCIVHCDIKPENILLD-ENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTR 669
G+ Y+H C I+H DIKPEN+L++ + + +A L N + T+ TR
Sbjct: 137 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-TNSIQTR 193
Query: 670 GYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFE 706
Y +PE L P +D++S ++ E+++G FE
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 7e-28
Identities = 53/228 (23%), Positives = 96/228 (42%), Gaps = 21/228 (9%)
Query: 490 QFSYKELQRSTKGFKDK------LGAGGFGAVYRGV-LANRTVVAVKQLEGIEQGE---K 539
F +EL ++ ++ +G+G +G+V VAVK+L Q K
Sbjct: 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62
Query: 540 QFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQ 599
+ E+ + H N++ L+ + + + L N KL +
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 122
Query: 600 SRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRH 659
+F + RG+ Y+H H D+KP N+ ++E+ K+ DFGLA+ + + +
Sbjct: 123 VQF-LIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 178
Query: 660 RTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFE 706
TR Y APE + N + D++S G ++ E+++GR F
Sbjct: 179 VA------TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 88.3 bits (218), Expect = 1e-20
Identities = 34/204 (16%), Positives = 63/204 (30%), Gaps = 29/204 (14%)
Query: 505 DKLGAGGFGAVYRGVLANRTVVAVKQLE-----------GIEQGEKQFRMEVATISSTHH 553
+G G AV+ VK + + G+ F + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 554 LNLVRLVGFSSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGIT 613
L +L G VY + N L + A E ++ N + +
Sbjct: 66 RALQKLQGL-----AVPKVYAWEGNAVLMELIDAKELYRVRVENPDE---VLDMILEEVA 117
Query: 614 YLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLA 673
+ IVH D+ N+L+ E + DF + + + R VR Y +
Sbjct: 118 KFY---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS 173
Query: 674 PEWLANLPITSKSDVYSYGMVLLE 697
+ ++ D+ S +L+
Sbjct: 174 RTY------RTEKDINSAIDRILQ 191
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 58.7 bits (141), Expect = 4e-11
Identities = 21/113 (18%), Positives = 40/113 (35%), Gaps = 5/113 (4%)
Query: 39 LSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGSTPVDSSAFFQLHSS 98
S L+ + Q N + Y +W +G+ S ++ +
Sbjct: 5 NSGHQLDTGGSLAEGGYLFII-QNDCNLVL----YDNNRAVWASGTNGKASGCVLKMQND 59
Query: 99 GTLRLISGSGAIIWDSNTQRLNVTSASLDDSGNLVLLKNGGVSAWSSFDNPTD 151
G L + SGS AI + ++ L N+V+ N + W++ N +
Sbjct: 60 GNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 50.2 bits (119), Expect = 3e-08
Identities = 23/113 (20%), Positives = 40/113 (35%), Gaps = 15/113 (13%)
Query: 150 TDTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWNDSVVYFNQGLNSAINSTVNSNLTS 209
+D + + +L G Y F + NL L N+ V+ S N +
Sbjct: 1 SDRLNSGHQLDTGGSLAEGGYLFIIQNDCNLVLYDNNRAVW---------ASGTNGKASG 51
Query: 210 PILRLQPVGILSISDVSLNSAAIIAYSSDYAEGSDILRFLSLGSDGNLRIFSS 262
+L++Q G L I A + + +L L D N+ I+ +
Sbjct: 52 CVLKMQNDGNLVIYSG------SRAIWASNTNRQNGNYYLILQRDRNVVIYDN 98
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 57.3 bits (138), Expect = 1e-10
Identities = 22/134 (16%), Positives = 40/134 (29%), Gaps = 17/134 (12%)
Query: 137 NGGVSAWSSFDNPTDTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWNDSVVYFNQGLN 196
N + + DN + +++ + Y F + NL L N++ ++
Sbjct: 1 NNIIFSKQPDDNHPQILHATESLEILFG--THVYRFIMQTDCNLVLYDNNNPIW------ 52
Query: 197 SAINSTVNSNLTSPILRLQPVGILSISDVSLNSAAIIAYSSDYAEGSDILRFLSLGSDGN 256
+ LQP G+L + G L L D N
Sbjct: 53 ---ATNTGGLGNGCRAVLQPDGVLVVITNENV-----TVWQSPVAGKAGHYVLVLQPDRN 104
Query: 257 LRIFSSAR-GSGTK 269
+ I+ A + T
Sbjct: 105 VVIYGDALWATQTV 118
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 46.9 bits (111), Expect = 6e-07
Identities = 15/77 (19%), Positives = 26/77 (33%), Gaps = 4/77 (5%)
Query: 73 YSGGVPIWTAGSTPVDSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLNVTS-ASLDDSGN 131
Y PIW + + + L G L +I+ +W S L N
Sbjct: 45 YDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRN 104
Query: 132 LVLLKNGGVSAWSSFDN 148
+V+ G + W++
Sbjct: 105 VVIY---GDALWATQTV 118
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 55.7 bits (134), Expect = 5e-10
Identities = 26/134 (19%), Positives = 45/134 (33%), Gaps = 18/134 (13%)
Query: 130 GNLVLLKNGGVSAWSSFDNPTDTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWNDSVV 189
G++V+ NG +S+ N Q + ++L+ Y ++ NL L D V
Sbjct: 1 GSVVVANNGNSILYSTQGNDN----HPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRV 56
Query: 190 YFNQGLNSAINSTVNSNLTSPILRLQPVGILSISDVSLNSAAIIAYSSDYAEGSDILRFL 249
+ LQP G + + + A+ + + G
Sbjct: 57 WSTNTAGKGTGCR---------AVLQPNGRMDVLTN--QNIAVWTSGNSRSAGR---YVF 102
Query: 250 SLGSDGNLRIFSSA 263
L D NL I+ A
Sbjct: 103 VLQPDRNLAIYGGA 116
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 47.6 bits (113), Expect = 3e-07
Identities = 11/74 (14%), Positives = 26/74 (35%), Gaps = 4/74 (5%)
Query: 73 YSGGVPIWTAGSTPVDSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLN-VTSASLDDSGN 131
+ +W+ + + L +G + +++ +W S R L N
Sbjct: 50 FDRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRN 109
Query: 132 LVLLKNGGVSAWSS 145
L + G + W++
Sbjct: 110 LAIY---GGALWTT 120
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 46.1 bits (109), Expect = 1e-06
Identities = 18/107 (16%), Positives = 38/107 (35%), Gaps = 18/107 (16%)
Query: 78 PIWTAGST-PVDSSAF-FQLHSSGTLRLISGSGAIIWDSNTQRLNVTSASLDDSGNLVLL 135
T +T + S + + + L L + + + A L +G + +L
Sbjct: 22 HPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQPNGRMDVL 81
Query: 136 KNGGVSAWSSFDNPTDTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSL 182
N ++ W+S ++ + +G Y F L NL++
Sbjct: 82 TNQNIAVWTSGNSRS----------------AGRYVFVLQPDRNLAI 112
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 54.6 bits (131), Expect = 8e-10
Identities = 24/121 (19%), Positives = 46/121 (38%), Gaps = 15/121 (12%)
Query: 151 DTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWNDSVVYFNQGLNSAINSTVNSNLTSP 210
+ + + ++ + L G + F + + NL L D ++ + S
Sbjct: 2 NILYSGETLSTGEFLNYGSFVFIMQEDCNLVLYDVDKPIW---------ATNTGGLSRSC 52
Query: 211 ILRLQPVGILSISDVSLNSAAIIAYSSDYAEGSDILRFLSLGSDGNLRIFSSAR-GSGTK 269
L +Q G L V N + ++S+ G + L D N+ I+ + R +GT
Sbjct: 53 FLSMQTDGNL----VVYNPSNKPIWASNTG-GQNGNYVCILQKDRNVVIYGTDRWATGTH 107
Query: 270 T 270
T
Sbjct: 108 T 108
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 48.1 bits (114), Expect = 2e-07
Identities = 20/77 (25%), Positives = 31/77 (40%), Gaps = 4/77 (5%)
Query: 73 YSGGVPIWTAGSTPVDSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLNVTS-ASLDDSGN 131
Y PIW + + S F + + G L + + S IW SNT N L N
Sbjct: 34 YDVDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRN 93
Query: 132 LVLLKNGGVSAWSSFDN 148
+V+ G W++ +
Sbjct: 94 VVIY---GTDRWATGTH 107
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 48.8 bits (116), Expect = 1e-07
Identities = 23/113 (20%), Positives = 36/113 (31%), Gaps = 15/113 (13%)
Query: 36 GSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGS-TPVDSSAFFQ 94
G L A QS + Q N + Y +W + +
Sbjct: 7 GEGLYA---GQSLDV--EPYHFIM-QEDCNLVL----YDHSTSVWASNTGILGKKGCKAV 56
Query: 95 LHSSGTLRLISGSGAIIWDSNTQR-LNVTSASLDDSGNLVLLKNGGVSAWSSF 146
L S G + G +W S++ R L + GN+V+ G WS+
Sbjct: 57 LQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIY---GSDIWSTG 106
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 46.5 bits (110), Expect = 6e-07
Identities = 23/120 (19%), Positives = 43/120 (35%), Gaps = 14/120 (11%)
Query: 151 DTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWNDSVVYFNQGLNSAINSTVNSNLTSP 210
+ + + + ++L Y F + + NL L + + V+ ++T
Sbjct: 2 NLLTNGEGLYAGQSLDVEPYHFIMQEDCNLVLYDHSTSVW--------ASNTGILGKKGC 53
Query: 211 ILRLQPVGILSISDVSLNSAAIIAYSSDYAEGSDILRFLSLGSDGNLRIFSSAR-GSGTK 269
LQ G + D ++S G+ L L DGN+ I+ S +GT
Sbjct: 54 KAVLQSDGNFVVYDAEGR----SLWASHSVRGNGNYV-LVLQEDGNVVIYGSDIWSTGTY 108
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 41.5 bits (97), Expect = 4e-05
Identities = 24/108 (22%), Positives = 36/108 (33%), Gaps = 19/108 (17%)
Query: 81 TAGSTPVDSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLNV--TSASLDDSGNLVLLKNG 138
AG + F + L ++ +W SNT L A L GN V+
Sbjct: 11 YAGQSLDVEPYHFIMQEDCNL-VLYDHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAE 69
Query: 139 GVSAWSSFDNPTDTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWND 186
G S W+S +G Y L + GN+ + +D
Sbjct: 70 GRSLWASHSVRG----------------NGNYVLVLQEDGNVVIYGSD 101
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 44.9 bits (106), Expect = 2e-06
Identities = 23/127 (18%), Positives = 47/127 (37%), Gaps = 17/127 (13%)
Query: 146 FDNPTDTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWNDSVVYFNQGLNSAINSTVNS 205
F + P Q + ++L + FT+ NL V++ + + + ++ +
Sbjct: 5 FGLSHEGSHP-QTLHAAQSLELSSFRFTMQSDCNL-------VLFDS---DVRVWASNTA 53
Query: 206 NLTSPILRLQPVGILSISDVSLNSAAIIAYSSDYAEGSDILRFLSLGSDGNLRIFSSAR- 264
T LQ G+L I + + + + G+ +L L D + I+
Sbjct: 54 GATGCRAVLQSDGLLVILTA--QNTIRWSSGTKGSIGNYVLV---LQPDRTVTIYGPGLW 108
Query: 265 GSGTKTR 271
SGT +
Sbjct: 109 DSGTSNK 115
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 42.6 bits (100), Expect = 2e-05
Identities = 23/106 (21%), Positives = 31/106 (29%), Gaps = 17/106 (16%)
Query: 81 TAGSTPVDSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLNVTSASLDDSGNLVLLKNGGV 140
A + SS F + S L L + W SNT A L G LV+L
Sbjct: 18 HAAQSLELSSFRFTMQSDCNLVLFDSDVRV-WASNTAGATGCRAVLQSDGLLVILTAQNT 76
Query: 141 SAWSSFDNPTDTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWND 186
WSS + G Y L +++
Sbjct: 77 IRWSSGTKGS----------------IGNYVLVLQPDRTVTIYGPG 106
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 852 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.81 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.79 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.78 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.6 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.58 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.55 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.33 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.14 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.12 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.06 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.04 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.84 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.21 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.69 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.24 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.14 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.57 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.32 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=417.14 Aligned_cols=255 Identities=28% Similarity=0.475 Sum_probs=201.2
Q ss_pred cccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCC
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNG 579 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 579 (852)
.+.+.++||+|+||.||+|.+.+++.||||+++......++|.+|++++++++|||||+++|+|.+.+..++||||+++|
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g 85 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 85 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCC
Confidence 46778899999999999999988889999999877777789999999999999999999999999999999999999999
Q ss_pred CHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcc
Q 003059 580 SLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRH 659 (852)
Q Consensus 580 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 659 (852)
+|.+++... ...+++..++.++.|||+||+|||+ ++|+||||||+||||++++.+||+|||+++...... .
T Consensus 86 ~L~~~l~~~----~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~--~ 156 (263)
T d1sm2a_ 86 CLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--Y 156 (263)
T ss_dssp BHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred cHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCC--c
Confidence 999998643 3468999999999999999999999 899999999999999999999999999998765422 1
Q ss_pred eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhC-CccccccccccchhhHHHHHHHHhhCCcccccccccC
Q 003059 660 RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSG-RRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738 (852)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (852)
.......||+.|+|||.+.+..++.++|||||||++|||+|+ ++||...... . ....+..+.. ..
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~---~----~~~~i~~~~~--~~----- 222 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---E----VVEDISTGFR--LY----- 222 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH---H----HHHHHHHTCC--CC-----
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH---H----HHHHHHhcCC--CC-----
Confidence 223345689999999999999999999999999999999995 5555432211 1 1111121110 00
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 739 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
.+.....++.+++.+||+.||++||+|+||++.|+++++
T Consensus 223 ---~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 223 ---KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 111112356788999999999999999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.3e-49 Score=416.32 Aligned_cols=263 Identities=28% Similarity=0.389 Sum_probs=216.2
Q ss_pred HHHHHhcccccccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 494 KELQRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 494 ~el~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
.||....+.+.++||+|+||+||+|.+. +++.||||+++......++|.+|+++|++++|||||+++|+|.+++..++|
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 3566778888999999999999999975 488999999987667778899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++|+|.+++.... ...+++..++.++.||++||+|||+ ++|+||||||+||||++++.+||+|||+++..
T Consensus 92 ~E~~~~g~l~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EECCTTCBHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred eecccCcchHHHhhhcc---ccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeec
Confidence 99999999999996543 3568999999999999999999999 89999999999999999999999999999976
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI 732 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (852)
... .........|++.|+|||++.+..++.++|||||||++|||++|..|+....... . ....+..+..
T Consensus 166 ~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~--~----~~~~i~~~~~--- 234 (287)
T d1opja_ 166 TGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--Q----VYELLEKDYR--- 234 (287)
T ss_dssp CSS--SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H----HHHHHHTTCC---
T ss_pred CCC--CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH--H----HHHHHhcCCC---
Confidence 542 2233344568999999999999999999999999999999999777664322111 1 1111111110
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
. ..+......+.+++.+||+.||++|||++||++.|+.+..
T Consensus 235 --~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 235 --M-----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp --C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred --C-----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0 1111122457788999999999999999999999987754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=414.79 Aligned_cols=258 Identities=29% Similarity=0.447 Sum_probs=209.3
Q ss_pred HHHHhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
||....+.+.++||+|+||.||+|.+++++.||||+++......++|.+|++++++++|||||+++|++.+ +..++|||
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 35556788899999999999999999988999999998766677889999999999999999999998865 56799999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++|+|.+++.... ...++|..+++|+.||++||+|||+ ++|+||||||+||||++++.+||+|||+++.+..
T Consensus 88 y~~~g~L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 88 YMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp CCTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred eCCCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccC
Confidence 999999999885432 3358999999999999999999999 8999999999999999999999999999998754
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccc-cccccccchhhHHHHHHHHhhCCccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNF-EVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~-~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
. .........||+.|+|||.+.+..++.++|||||||++|||+||..|+ ...... . ....+..+.
T Consensus 162 ~--~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~---~----~~~~i~~~~----- 227 (272)
T d1qpca_ 162 N--EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---E----VIQNLERGY----- 227 (272)
T ss_dssp S--CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---H----HHHHHHTTC-----
T ss_pred C--ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH---H----HHHHHHhcC-----
Confidence 2 222233456899999999999999999999999999999999966554 322211 0 111122111
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
.... +......+.+++.+||+.||++||||.+|++.|+..
T Consensus 228 ~~~~-----p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 228 RMVR-----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CCCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC-----cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 1111 111123567888999999999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=409.66 Aligned_cols=263 Identities=26% Similarity=0.453 Sum_probs=203.1
Q ss_pred HHHHhcccccccccccccceEEEEEECCCcEEEEEEecC---cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeE
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEG---IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLL 571 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 571 (852)
||....+.+.++||+|+||+||+|++++ .||||+++. .....++|++|++++++++|||||+++|++.+ +..+|
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 3445677888999999999999998653 599999873 23445789999999999999999999999865 56899
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
||||+++|+|.++|... ...+++..++.++.||++||+|||+ ++||||||||+||||+.++.+||+|||+++.
T Consensus 81 v~Ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHII----ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153 (276)
T ss_dssp EEECCCEEEHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred EEecCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceee
Confidence 99999999999999643 2358999999999999999999998 8999999999999999999999999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhc---CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLAN---LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN 728 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (852)
...... ........||+.|||||++.+ ..++.++|||||||++|||+||+.||........ .......+.
T Consensus 154 ~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------~~~~~~~~~ 226 (276)
T d1uwha_ 154 KSRWSG-SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGY 226 (276)
T ss_dssp -------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHHTS
T ss_pred ccccCC-cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH------HHHHHhcCC
Confidence 653221 223345679999999999964 3588999999999999999999999975432211 111122221
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
....+... +......+.+++.+||+.||.+|||++||++.|+.+.+
T Consensus 227 ~~p~~~~~------~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 227 LSPDLSKV------RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CCCCGGGS------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcchhc------cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11111111 11112456788899999999999999999999998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-48 Score=414.82 Aligned_cols=259 Identities=29% Similarity=0.456 Sum_probs=198.0
Q ss_pred HhcccccccccccccceEEEEEECC----CcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeE
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLAN----RTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLL 571 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 571 (852)
...+.+.++||+|+||+||+|.+.. ...||||++... ....++|.+|+++|++++|||||+++|+|.+++..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 4456677899999999999999743 236899998733 3345679999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
||||+++|+|.+++... ...++|..++.++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++.
T Consensus 105 v~Ey~~~g~L~~~~~~~----~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp EEECCTTEEHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEecCCCcceeeeccc----cCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceE
Confidence 99999999999988643 3358999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCcce--eeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCC
Q 003059 652 INPKDHRHR--TLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGN 728 (852)
Q Consensus 652 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (852)
+........ ......||+.|||||.+.+..++.++|||||||++|||+| |+.||....... ....+..+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~-------~~~~i~~~~ 250 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-------VINAIEQDY 250 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTC
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC
Confidence 754322211 1223457999999999999999999999999999999998 899997543211 111111111
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
.+ +.+.+....+.+++.+||+.||.+||++.||++.|+++.+
T Consensus 251 -------~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 251 -------RL---PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp -------CC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -------CC---CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 01 1122233457788999999999999999999999988754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=400.38 Aligned_cols=253 Identities=23% Similarity=0.383 Sum_probs=212.2
Q ss_pred cccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCCC
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKNG 579 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 579 (852)
.+.|.++||+|+||+||+|++++++.||||+++......++|.+|++++++++||||++++|+|.+.+..++||||+++|
T Consensus 5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g 84 (258)
T d1k2pa_ 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 84 (258)
T ss_dssp CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTE
T ss_pred HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCC
Confidence 45688999999999999999998999999999977777889999999999999999999999999999999999999999
Q ss_pred CHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCcc
Q 003059 580 SLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHRH 659 (852)
Q Consensus 580 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 659 (852)
+|.+++... ...+++..+++++.||++||+|||+ ++|+||||||+||||++++.+||+|||+++.......
T Consensus 85 ~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-- 155 (258)
T d1k2pa_ 85 CLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-- 155 (258)
T ss_dssp EHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC--
T ss_pred cHHHhhhcc----ccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCc--
Confidence 999998544 3458899999999999999999998 8999999999999999999999999999987654322
Q ss_pred eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcccccccccC
Q 003059 660 RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSLA 738 (852)
Q Consensus 660 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 738 (852)
.......||+.|+|||.+.+..++.++||||||+++|||+| |+.||+...... ....+.++.. .
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-------~~~~i~~~~~--~------ 220 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQGLR--L------ 220 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTTCC--C------
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-------HHHHHHhCCC--C------
Confidence 22334568999999999999999999999999999999998 899997554321 1112222111 0
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 739 GEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 739 ~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
..+......+.+++.+||+.||++|||+++|++.|.++
T Consensus 221 --~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 221 --YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp --CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred --CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 11111224677889999999999999999999998654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-48 Score=409.46 Aligned_cols=261 Identities=28% Similarity=0.425 Sum_probs=200.2
Q ss_pred HHhcccccccccccccceEEEEEECCC-----cEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCcee
Q 003059 497 QRSTKGFKDKLGAGGFGAVYRGVLANR-----TVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHR 569 (852)
Q Consensus 497 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~-----~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 569 (852)
....+.+.+.||+|+||.||+|.+++. ..||||++... .....+|.+|++++++++|||||+++|++.+.+..
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 334566778999999999999997542 47999999733 33446799999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
++||||+.+++|.+++... ...++|..+++++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||++
T Consensus 85 ~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla 157 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLS 157 (283)
T ss_dssp EEEEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEEEEecccCcchhhhhcc----cccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchh
Confidence 9999999999999988644 3469999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCc
Q 003059 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 650 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
+.+..............||+.|+|||++.+..++.++|||||||++|||++|..|+...... .. ....+.++..
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~----~~~~i~~~~~ 231 (283)
T d1mqba_ 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HE----VMKAINDGFR 231 (283)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HH----HHHHHHTTCC
T ss_pred hcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HH----HHHHHhccCC
Confidence 98755433333344566899999999999999999999999999999999976665432211 11 1112222111
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 730 KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
. +.+......+.+++.+||+.||++||+|.||+++|+.+.+
T Consensus 232 -----~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 232 -----L-----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp -----C-----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----C-----CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 0 1112223467789999999999999999999999988765
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=406.29 Aligned_cols=262 Identities=29% Similarity=0.407 Sum_probs=206.7
Q ss_pred HHHhcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
|....+.+.++||+|+||.||+|++++++.||||+++......++|.+|+.++++++|||||+++|+|.+ +..++||||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 3445788899999999999999999988899999998777777899999999999999999999999865 567999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+++|+|..++.... ...++|..++.++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++.....
T Consensus 93 ~~~g~l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 93 MSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred cCCCchhhhhhhcc---cccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 99999999986543 3359999999999999999999999 89999999999999999999999999999876542
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
. ........||+.|+|||++....++.++||||||+++|||++|..|+...... .. ....+..+.. .
T Consensus 167 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~----~~~~i~~~~~-----~ 233 (285)
T d1fmka3 167 E--YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--RE----VLDQVERGYR-----M 233 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HH----HHHHHHTTCC-----C
T ss_pred C--ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HH----HHHHHHhcCC-----C
Confidence 2 22334467899999999999999999999999999999999976665432211 11 1111111110 0
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCC
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIE 782 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~ 782 (852)
+.+......+.+++.+||+.||++||++.+|+++|+......
T Consensus 234 -----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 234 -----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -----CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 111122245778899999999999999999999999865433
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=405.31 Aligned_cols=254 Identities=26% Similarity=0.365 Sum_probs=204.5
Q ss_pred cccccc-cccccccceEEEEEEC---CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 500 TKGFKD-KLGAGGFGAVYRGVLA---NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 500 ~~~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
.+.+.+ +||+|+||.||+|.++ ++..||||+++.. ....++|.+|+++|++++|||||+++|+|.+ +..+|||
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm 87 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 87 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence 344556 5999999999999864 3557999999733 3345789999999999999999999999865 4689999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+++|+|.+++... ...+++..++.++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++.+.
T Consensus 88 E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp ECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EeCCCCcHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 999999999998543 3468999999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcccc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI 732 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (852)
.............||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+ ....+..+....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-------~~~~i~~~~~~~- 232 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRME- 232 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCCCC-
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC-
Confidence 54333333344568999999999999999999999999999999998 999997543221 112222222111
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
.+......+.+++.+||+.||++||++.+|++.|+..
T Consensus 233 ---------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 233 ---------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp ---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111224567889999999999999999999998764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=402.35 Aligned_cols=248 Identities=25% Similarity=0.397 Sum_probs=198.7
Q ss_pred ccccccccceEEEEEECC---CcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 505 DKLGAGGFGAVYRGVLAN---RTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
++||+|+||.||+|.+++ ++.||||+++.. ....++|.+|+++|++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998643 468999999732 2234679999999999999999999999965 467899999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCCc
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDHR 658 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 658 (852)
|+|.+++... ..+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.+......
T Consensus 92 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 9999999643 358999999999999999999998 89999999999999999999999999999987654444
Q ss_pred ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccccccccc
Q 003059 659 HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSL 737 (852)
Q Consensus 659 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (852)
........||++|+|||.+.+..++.++|||||||++|||+| |+.||....... ....+..+...
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-------~~~~i~~~~~~------- 229 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERM------- 229 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCC-------
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-------HHHHHHcCCCC-------
Confidence 344445679999999999999999999999999999999998 899997543211 11222222111
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 738 AGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 738 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
+.+......+.+++.+||+.||++||++++|+++|+..
T Consensus 230 ---~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 230 ---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 11111224567888999999999999999999988753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-47 Score=397.75 Aligned_cols=250 Identities=26% Similarity=0.367 Sum_probs=199.2
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
.|.+.++||+|+||.||+|+.. +++.||||++... ....+++.+|++++++++|||||++++++.+++..||||||+
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 85 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence 4778899999999999999974 5889999998733 234467999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
++|+|.++|.. ...+++..+..++.||++||+|||+ ++|+||||||+||||++++.+||+|||+++.+....
T Consensus 86 ~gg~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 86 SGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp TTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCcHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999953 2358999999999999999999998 899999999999999999999999999998764322
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCC-CCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPI-TSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
.........||+.|||||++.+..+ +.++|||||||++|||++|+.||.......... ...........
T Consensus 158 -~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~------~~~~~~~~~~~--- 227 (271)
T d1nvra_ 158 -RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTYLN--- 227 (271)
T ss_dssp -EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH------HHHHTTCTTST---
T ss_pred -ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH------HHHhcCCCCCC---
Confidence 1222345679999999999998876 578999999999999999999997544322110 11111111000
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
........+.+++.+||+.||++|||++|+++
T Consensus 228 ------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 ------PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00011235567888999999999999999865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=399.15 Aligned_cols=247 Identities=21% Similarity=0.335 Sum_probs=202.9
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecC-cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEG-IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
.|.+.++||+|+||.||+|.. .+++.||||++.. .....+.+.+|++++++++|||||++++++.+.+..||||||++
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 588889999999999999996 4689999999873 33455779999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
+|+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+||||+.++++||+|||+++.+....
T Consensus 101 gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~- 170 (293)
T d1yhwa1 101 GGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (293)
T ss_dssp TCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred CCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence 9999998753 248999999999999999999999 899999999999999999999999999998775422
Q ss_pred cceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccccc
Q 003059 658 RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKSL 737 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 737 (852)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......... .+
T Consensus 171 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~~~~~~~~------~~ 236 (293)
T d1yhwa1 171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTP------EL 236 (293)
T ss_dssp --CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCSC------CC
T ss_pred --ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH------HHHHHhCCCC------CC
Confidence 223456799999999999999999999999999999999999999975432111 1111111110 00
Q ss_pred CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 738 AGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 738 ~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..+......+.+++.+||+.||.+|||+.|+++
T Consensus 237 ---~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 ---QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp ---SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111245678889999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=393.24 Aligned_cols=243 Identities=27% Similarity=0.394 Sum_probs=202.0
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecC----cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEG----IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~----~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.|.+.+.||+|+||.||+|+.. +++.||+|++.. .....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 4778899999999999999975 588999999863 23345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++|+|.+++... ..+++..+..++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 87 y~~~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 87 YAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp CCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred ecCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999643 348999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..........
T Consensus 159 ~-----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~----- 221 (263)
T d2j4za1 159 S-----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVEF----- 221 (263)
T ss_dssp C-----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCC-----
T ss_pred C-----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC-----
Confidence 2 2244679999999999999999999999999999999999999997543211 1111121111
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.+. ......+.+++.+||+.||.+|||++|+++
T Consensus 222 -~~p-----~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 -TFP-----DFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCC-----ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 111 111235667888999999999999999985
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-47 Score=408.82 Aligned_cols=262 Identities=27% Similarity=0.388 Sum_probs=206.5
Q ss_pred HHHHhcccccccccccccceEEEEEECC------CcEEEEEEecC--cccchHHHHHHHHHhhcc-cccceeeeeeeecc
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLAN------RTVVAVKQLEG--IEQGEKQFRMEVATISST-HHLNLVRLVGFSSE 565 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~--~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~ 565 (852)
|+....+.+.++||+|+||+||+|+... ...||||++.. .......|.+|+.++.++ +|||||++++++.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 4555678889999999999999998643 23699999863 334456799999999998 89999999999999
Q ss_pred CceeeEEEeecCCCCHHHHhhhccc------------------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCC
Q 003059 566 GKHRLLVYEFMKNGSLDNFLFANEE------------------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCD 627 (852)
Q Consensus 566 ~~~~~lV~e~~~~gsL~~~l~~~~~------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~D 627 (852)
.+..+|||||+++|+|.++|..... .....+++..++.++.||++||+|||+ ++|||||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecc
Confidence 9999999999999999999975432 112468999999999999999999999 8999999
Q ss_pred CCCCceEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCcccc
Q 003059 628 IKPENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFE 706 (852)
Q Consensus 628 lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~ 706 (852)
|||+|||++.++.+||+|||+++....... ........||+.|||||.+.+..++.++|||||||++|||+| |+.||.
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CchhccccccCCeEEEeeccccccccCCCc-eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 999999999999999999999987654322 223334668999999999999999999999999999999998 899997
Q ss_pred ccccccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003059 707 VSQETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLE 776 (852)
Q Consensus 707 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~ 776 (852)
...... .+ ......+. . + +.+......+.+++.+||+.||++|||++||++.|.
T Consensus 269 ~~~~~~--~~----~~~~~~~~-----~--~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVDA--NF----YKLIQNGF-----K--M---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCCSH--HH----HHHHHTTC-----C--C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHH--HH----HHHHhcCC-----C--C---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 543221 11 11111111 0 0 111112245778899999999999999999999984
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=388.29 Aligned_cols=243 Identities=25% Similarity=0.422 Sum_probs=193.6
Q ss_pred cccccccccccceEEEEEEC-CCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeecc----CceeeEEE
Q 003059 502 GFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSE----GKHRLLVY 573 (852)
Q Consensus 502 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~ 573 (852)
.|.++||+|+||+||+|... +++.||+|++... ....+.|.+|+++|++++|||||++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56778999999999999975 5789999998733 2334678999999999999999999999854 45689999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCC--cccCCCCCCceEeC-CCCceEEeeccccc
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDC--IVHCDIKPENILLD-ENYNAKVSDFGLAK 650 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NILl~-~~~~~kl~DFGla~ 650 (852)
||+++|+|.+++... ..+++..++.++.||++||+|||+ ++ |+||||||+||||+ +++.+||+|||+++
T Consensus 92 E~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 999999999999643 358999999999999999999998 55 99999999999996 58999999999998
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcc
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (852)
..... ......||+.|||||.+.+ +++.++|||||||++|||++|+.||....... .....+..+...
T Consensus 164 ~~~~~-----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~------~~~~~i~~~~~~ 231 (270)
T d1t4ha_ 164 LKRAS-----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKP 231 (270)
T ss_dssp GCCTT-----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCC
T ss_pred eccCC-----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH------HHHHHHHcCCCC
Confidence 65431 2245679999999999875 69999999999999999999999996432211 011222222111
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 731 GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..+++ .. ...+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~-----~~----~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 ASFDK-----VA----IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGGG-----CC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCc-----cC----CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11111 11 124678889999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-47 Score=396.65 Aligned_cols=253 Identities=19% Similarity=0.319 Sum_probs=191.3
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeecc--CceeeEEE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSE--GKHRLLVY 573 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~ 573 (852)
.|.+.+.||+|+||.||+|+.. +++.||||.+.... ...+.+.+|++++++++|||||++++++.+ .+..||||
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm 84 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence 5778899999999999999964 58899999997432 234668899999999999999999998865 45689999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhcccc--CCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC--RDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
||+++|+|.+++..... ....+++..++.++.||+.||+|||+.. ..+||||||||+||||+.++.+||+|||+++.
T Consensus 85 Ey~~~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 85 EYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp ECCTTEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred ecCCCCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999965432 2456999999999999999999999832 13499999999999999999999999999998
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+..+....
T Consensus 164 ~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-------~~~~i~~~~~~~ 233 (269)
T d2java1 164 LNHDT---SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFRR 233 (269)
T ss_dssp C--------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCCCC
T ss_pred cccCC---CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCCCC
Confidence 75422 22345679999999999999999999999999999999999999997543211 112222222211
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+ .. .. ...+.+++.+||+.||.+|||+.|+++
T Consensus 234 ~-----~~-~~----s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 I-----PY-RY----SDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp C-----CT-TS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C-----Cc-cc----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1 11 11 235678889999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=404.72 Aligned_cols=202 Identities=27% Similarity=0.375 Sum_probs=176.6
Q ss_pred HHHhcccccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
|....|.+.++||+|+||+||+|... +++.||+|+++.. ....+++.+|+.+|++++|||||+++++|.+.++.+||
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34456778899999999999999964 6899999998733 33456789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++|+|.+++.+.. .+++..+..++.||++||.|||+. ++|+||||||+||||++++++||+|||+|+.+
T Consensus 83 mEy~~gg~L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEcCCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 99999999999996542 489999999999999999999972 47999999999999999999999999999865
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQ 709 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~ 709 (852)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 156 ~~-----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 156 ID-----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp HH-----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred CC-----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 32 12234679999999999999999999999999999999999999997543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=396.67 Aligned_cols=249 Identities=22% Similarity=0.318 Sum_probs=201.2
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecC-cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEG-IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
.|.+.++||+|+||.||+|... +++.||||+++. .....+.|.+|+++|++++|||||++++++.+.+..+|||||++
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 4677889999999999999974 588999999973 44556789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
+|+|.+++... ...+++..+..++.||++||.|||+ ++|+||||||+||||+.++++||+|||+++.....
T Consensus 93 ~g~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-- 163 (288)
T d2jfla1 93 GGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-- 163 (288)
T ss_dssp TEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--
T ss_pred CCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCC--
Confidence 99999998643 2359999999999999999999999 89999999999999999999999999999754321
Q ss_pred cceeeeeecCCCCCCChhhhh-----cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccc
Q 003059 658 RHRTLTSVRGTRGYLAPEWLA-----NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGI 732 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 732 (852)
........||+.|+|||++. ...++.++|||||||++|||++|+.||........ ......+....
T Consensus 164 -~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-------~~~i~~~~~~~- 234 (288)
T d2jfla1 164 -IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-------LLKIAKSEPPT- 234 (288)
T ss_dssp -HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-------HHHHHHSCCCC-
T ss_pred -cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-------HHHHHcCCCCC-
Confidence 11223467999999999984 45688999999999999999999999975433211 11111111111
Q ss_pred cccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 733 VDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 733 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
+ ..+......+.+++.+||+.||.+|||+.|+++
T Consensus 235 ----~---~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 ----L---AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ----C---SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----C---CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 111112245678889999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=398.89 Aligned_cols=273 Identities=22% Similarity=0.288 Sum_probs=206.7
Q ss_pred hcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCc----eeeEEEe
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGK----HRLLVYE 574 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lV~e 574 (852)
.++.+.++||+|+||.||+|++ +++.||||+++........++.|+..+.+++|||||+++++|.+.+ ..++|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 3566788999999999999997 5678999999755444444556777777899999999999997654 6799999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhcccc-----CCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC-----RDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
|+++|+|.++|... .++|..+++++.|++.||+|||+.. .++||||||||+||||++++.+||+|||++
T Consensus 82 y~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp CCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cccCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999999643 4899999999999999999999742 368999999999999999999999999999
Q ss_pred cccCCCCCcc-eeeeeecCCCCCCChhhhhcCC------CCCCccchhhhHHHHHHHhCCccccccccccchh-------
Q 003059 650 KLINPKDHRH-RTLTSVRGTRGYLAPEWLANLP------ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKK------- 715 (852)
Q Consensus 650 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~------~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~------- 715 (852)
+......... .......||+.|+|||++.+.. ++.++|||||||+||||+||..||..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 8775432222 2234567999999999987653 5678999999999999999998875432211100
Q ss_pred -hHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCC
Q 003059 716 -FSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIE 782 (852)
Q Consensus 716 -l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~ 782 (852)
......... ....+++.+.....+.+....+.+++.+||+.||++|||+.||++.|+++.+..
T Consensus 236 ~~~~~~~~~~----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 236 PSVEEMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CCHHHHHHHH----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHH----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 011111111 111222222222223455667889999999999999999999999999886543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=388.63 Aligned_cols=251 Identities=29% Similarity=0.391 Sum_probs=197.1
Q ss_pred hcccccccccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeecc-CceeeEEEeecC
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSE-GKHRLLVYEFMK 577 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~e~~~ 577 (852)
..+.+.++||+|+||.||+|.+. ++.||||+++.. ...++|.+|++++++++||||++++|+|.+ .+..++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 45678899999999999999985 678999999753 345779999999999999999999999865 456899999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKDH 657 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 657 (852)
+|+|.++|.... ...++|..+++|+.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~--- 155 (262)
T d1byga_ 85 KGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--- 155 (262)
T ss_dssp TEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCC---
Confidence 999999997543 3358999999999999999999998 8999999999999999999999999999986543
Q ss_pred cceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 658 RHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 658 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
......++..|+|||++.+..+++++||||||+++|||+| |+.||......+ +. ..+..+.. +.
T Consensus 156 ---~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~----~~i~~~~~-----~~ 220 (262)
T d1byga_ 156 ---TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEKGYK-----MD 220 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH----HHHTTTCC-----CC
T ss_pred ---CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcCCC-----CC
Confidence 2233468899999999999999999999999999999998 688876543221 11 11111111 11
Q ss_pred cCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 737 LAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 737 l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
.+......+.+++.+||+.||.+|||+.+|+++|+.++.
T Consensus 221 -----~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 221 -----APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 111122456788999999999999999999999988753
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.8e-46 Score=397.28 Aligned_cols=262 Identities=27% Similarity=0.407 Sum_probs=208.9
Q ss_pred HhcccccccccccccceEEEEEEC------CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCcee
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA------NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHR 569 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 569 (852)
+..+.+.++||+|+||.||+|++. +++.||||+++.. ....++|.+|++++++++||||++++++|.+.+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 445778899999999999999864 3578999999743 23356799999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhhccc-------------------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCC
Q 003059 570 LLVYEFMKNGSLDNFLFANEE-------------------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKP 630 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp 630 (852)
++||||+++|+|.++|..... .....+++..++.|+.|++.||+|||+ ++||||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcc
Confidence 999999999999999965321 123458999999999999999999998 8999999999
Q ss_pred CceEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCC-ccccccc
Q 003059 631 ENILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGR-RNFEVSQ 709 (852)
Q Consensus 631 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~-~p~~~~~ 709 (852)
+||||+.++.+||+|||+++.+..... ........|++.|+|||.+.+..++.++|||||||++|||++|. .||....
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEECCCCcEEEccchhheeccCCcc-ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999987654321 22334466889999999999999999999999999999999986 5676443
Q ss_pred cccchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 710 ETNRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 710 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
..+ ....+.++..... +.....++.+++.+||+.+|.+||||.||+++|+++.+
T Consensus 248 ~~e-------~~~~v~~~~~~~~----------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 248 HEE-------VIYYVRDGNILAC----------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp HHH-------HHHHHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHH-------HHHHHHcCCCCCC----------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 221 1122222222111 11112357788999999999999999999999998864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=391.73 Aligned_cols=247 Identities=23% Similarity=0.320 Sum_probs=200.3
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 5788899999999999999974 6889999998632 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||||++++.+||+|||+++.+..
T Consensus 89 y~~gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 89 YAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred ccCCCCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999998644 358999999999999999999999 8999999999999999999999999999997754
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..........
T Consensus 161 ~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~----- 227 (288)
T d1uu3a_ 161 ESK-QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-------IFQKIIKLEY----- 227 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHTTCC-----
T ss_pred CCc-ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-------HHHHHHcCCC-----
Confidence 221 122344679999999999999999999999999999999999999997543211 1112222111
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.+.. .. ...+.+++.+||+.||.+|||++|+++
T Consensus 228 -~~p~-~~----s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 -DFPE-KF----FPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -CCCT-TC----CHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -CCCc-cC----CHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 0111 11 235678899999999999999998743
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8e-45 Score=389.20 Aligned_cols=250 Identities=27% Similarity=0.415 Sum_probs=188.0
Q ss_pred HhcccccccccccccceEEEEEEC-CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 498 RSTKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 498 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
+..|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+++|++++|||||++++++.+++..|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 356888999999999999999975 5889999998733 2334668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeC---CCCceEEeecccccc
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD---ENYNAKVSDFGLAKL 651 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~DFGla~~ 651 (852)
|+++|+|.++|... ..+++..+..++.||+.||+|||+ ++|+||||||+|||+. +++.+||+|||+++.
T Consensus 88 ~~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 88 LVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCSCBHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred ccCCCcHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 99999999999643 359999999999999999999999 8999999999999994 578999999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ...........
T Consensus 160 ~~~~----~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~~- 227 (307)
T d1a06a_ 160 EDPG----SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-------LFEQILKAEYE- 227 (307)
T ss_dssp -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHTTCCC-
T ss_pred ccCC----CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHhccCCC-
Confidence 6432 22344679999999999999999999999999999999999999997543211 11111111111
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
... +........+.+++.+||+.||.+|||++|+++
T Consensus 228 -~~~-----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 228 -FDS-----PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp -CCT-----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCC-----ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 000 011111235678889999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=388.56 Aligned_cols=258 Identities=25% Similarity=0.377 Sum_probs=197.6
Q ss_pred HHHhcccccccccccccceEEEEEECC----CcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccCcee
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLAN----RTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHR 569 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 569 (852)
|.+..|.+.+.||+|+||.||+|++.. +..||||+++.. ....+.|.+|++++++++|||||+++|++.+ +..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeE
Confidence 445678889999999999999998643 357899998733 3345679999999999999999999999964 678
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
++||||+++|+|.+++... ...+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 83 ~iv~E~~~~g~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp EEEEECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred EEEEEeccCCcHHhhhhcc----CCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhh
Confidence 9999999999999988643 3458999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCC
Q 003059 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGN 728 (852)
Q Consensus 650 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 728 (852)
+.+.... ........||+.|+|||.+.+..++.++|||||||++|||++ |+.||....... ....+..+.
T Consensus 156 ~~~~~~~--~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-------~~~~i~~~~ 226 (273)
T d1mp8a_ 156 RYMEDST--YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGE 226 (273)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTC
T ss_pred eeccCCc--ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC
Confidence 8765322 222344568999999999999999999999999999999998 899997654321 111222221
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 729 VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 729 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
... .+......+.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 227 ~~~----------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 227 RLP----------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp CCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC----------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111 111122457788899999999999999999999987754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=388.55 Aligned_cols=256 Identities=25% Similarity=0.327 Sum_probs=196.3
Q ss_pred hcccccccccccccceEEEEEECC----CcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLAN----RTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRL 570 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 570 (852)
..+++.++||+|+||.||+|++.. ...||||++... ....++|.+|++++++++|||||+++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 457788999999999999998632 247899998632 3334689999999999999999999999976 4678
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+||||+++|+|.+++... ...+++..+++++.||++||.|||+ ++|+||||||+||||+.++.+||+|||+++
T Consensus 87 lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeeeecCcchhhhhhcc----cCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhh
Confidence 999999999999988654 3359999999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCc
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
.+..............|+..|+|||.+.+..++.++||||||+++|||+| |+.||....... . ...+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~----~~~i~~~~~ 232 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---I----LHKIDKEGE 232 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H----HHHHHTSCC
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---H----HHHHHhCCC
Confidence 87654444344445668899999999999999999999999999999998 899997543221 1 111111111
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 003059 730 KGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGI 778 (852)
Q Consensus 730 ~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~ 778 (852)
.. + .+......+.+++.+||+.||++|||+.+|++.|++.
T Consensus 233 ~~---~------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 233 RL---P------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CC---C------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---C------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 00 0 1111123567889999999999999999999999764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.8e-45 Score=389.40 Aligned_cols=244 Identities=25% Similarity=0.322 Sum_probs=197.7
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
..|...++||+|+||.||+|+. .+++.||||++.... ...+++.+|+++|++++|||||++++++.+.+..||||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3577788999999999999996 468899999987432 23356889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
|||++|+|..++... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 95 E~~~~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp ECCSEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccC
Confidence 999999998776433 358999999999999999999999 899999999999999999999999999998654
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhc---CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLAN---LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (852)
. .....||+.|||||++.+ ..++.++|||||||++|||++|+.||....... .......+...
T Consensus 167 ~-------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-------~~~~i~~~~~~ 232 (309)
T d1u5ra_ 167 P-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNESP 232 (309)
T ss_dssp S-------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCCC
T ss_pred C-------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCCC
Confidence 3 133569999999999864 468999999999999999999999997543211 11111111111
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 731 GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..... .. ...+.+++.+||+.||.+|||++|+++
T Consensus 233 ~~~~~-----~~----s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 233 ALQSG-----HW----SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCSCT-----TS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCC-----CC----CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11111 11 235678888999999999999999976
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=388.47 Aligned_cols=259 Identities=26% Similarity=0.376 Sum_probs=204.0
Q ss_pred cccccccccccccceEEEEEECCC----cEEEEEEecC--cccchHHHHHHHHHhhcccccceeeeeeeecc-CceeeEE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLANR----TVVAVKQLEG--IEQGEKQFRMEVATISSTHHLNLVRLVGFSSE-GKHRLLV 572 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV 572 (852)
+.+|.++||+|+||+||+|++.++ ..||||+++. .....++|.+|++++++++||||++++|++.+ ++..++|
T Consensus 28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 456678999999999999997442 3689999973 33345779999999999999999999999865 5688999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
|||+++|+|.+++... ...+++..+++++.|+++||.|||+ ++|+||||||+||||++++.+||+|||+++..
T Consensus 108 ~E~~~~g~l~~~~~~~----~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 180 (311)
T ss_dssp EECCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred EEEeecCchhhhhccc----cccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhc
Confidence 9999999999998643 3457888999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCcc-eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 653 NPKDHRH-RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 653 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
....... .......||+.|+|||.+....++.++||||||+++|||+||+.||....... .. ...+..+...
T Consensus 181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~----~~~i~~g~~~- 253 (311)
T d1r0pa_ 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DI----TVYLLQGRRL- 253 (311)
T ss_dssp TTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------C----HHHHHTTCCC-
T ss_pred cccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HH----HHHHHcCCCC-
Confidence 5432221 12233568999999999999999999999999999999999888875432111 11 1111121110
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccC
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEI 781 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~ 781 (852)
.. +......+.+++.+||+.||++||+|.||++.|+++...
T Consensus 254 -~~--------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 254 -LQ--------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp -CC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -CC--------cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 00 111123567889999999999999999999999988653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=391.33 Aligned_cols=254 Identities=23% Similarity=0.383 Sum_probs=200.5
Q ss_pred cccccccccccccceEEEEEECC-Cc----EEEEEEecC--cccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLAN-RT----VVAVKQLEG--IEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~-~~----~vavK~l~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 572 (852)
.|.+.++||+|+||+||+|.+.. ++ .||+|+++. .....++|.+|++++++++|||||+++|+|.++ ..+++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence 47778999999999999998643 33 689999863 344567899999999999999999999999875 56788
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
+||+.+|+|.+++... ...+++..+++++.||++||+|||+ ++||||||||+||||+.++.+||+|||+++..
T Consensus 89 ~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EECCTTCBHHHHHHHT----SSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEeccCCccccccccc----ccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 9999999999988654 3468999999999999999999999 89999999999999999999999999999987
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccccchhhHHHHHHHHhhCCccc
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETNRKKFSLWAYEEFEKGNVKG 731 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 731 (852)
..... ........||+.|+|||.+.+..++.++|||||||++|||+| |+.||+...... + ...+..+..
T Consensus 162 ~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~----~~~i~~~~~-- 231 (317)
T d1xkka_ 162 GAEEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I----SSILEKGER-- 231 (317)
T ss_dssp TTTCC---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---H----HHHHHHTCC--
T ss_pred ccccc-cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---H----HHHHHcCCC--
Confidence 54322 222344568999999999999999999999999999999998 789987543321 1 111111110
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 732 IVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 732 ~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
+ +.+......+.+++.+||+.||.+|||+.||++.|+.+.
T Consensus 232 -----~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 232 -----L---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp -----C---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----C---CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 1 111122245678899999999999999999999988764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.9e-44 Score=388.54 Aligned_cols=250 Identities=23% Similarity=0.365 Sum_probs=203.6
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCc-ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
.|.+.++||+|+||.||+|+. .+++.||||++... ....+.+.+|+.+|++++|||||++++++.+++..||||||++
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 688899999999999999996 46899999999743 3345678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeC--CCCceEEeecccccccCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD--ENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kl~DFGla~~~~~~ 655 (852)
+|+|.+++... ...+++..+..++.||+.||+|||+ ++||||||||+||||+ .++.+||+|||+++.+...
T Consensus 107 gg~L~~~l~~~----~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 107 GGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp SCBHHHHHTCT----TSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 99999999533 3359999999999999999999999 8999999999999995 4688999999999887542
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
.......||+.|||||++.+..++.++|||||||++|||++|+.||....... ....+...... ....
T Consensus 180 ----~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~-~~~~ 247 (350)
T d1koaa2 180 ----QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-------TLRNVKSCDWN-MDDS 247 (350)
T ss_dssp ----SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC-SCCG
T ss_pred ----cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC-CCcc
Confidence 23345679999999999999999999999999999999999999997543211 11111111110 0000
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.. ......+.+++.+||+.||.+|||++|+++.
T Consensus 248 ~~------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 248 AF------SGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GG------GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cc------cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0112356788899999999999999999873
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-45 Score=389.53 Aligned_cols=266 Identities=26% Similarity=0.361 Sum_probs=199.9
Q ss_pred HHHHhcccccccccccccceEEEEEEC------CCcEEEEEEecCc--ccchHHHHHHHHHhhcc-cccceeeeeeeecc
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLA------NRTVVAVKQLEGI--EQGEKQFRMEVATISST-HHLNLVRLVGFSSE 565 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~ 565 (852)
||.+..|.+.++||+|+||.||+|.+. +++.||||+++.. ....+++..|++++.++ +|+||+.+++++.+
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence 455667889999999999999999853 2468999999732 33456788888888777 78999999998766
Q ss_pred C-ceeeEEEeecCCCCHHHHhhhccc-----------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCce
Q 003059 566 G-KHRLLVYEFMKNGSLDNFLFANEE-----------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENI 633 (852)
Q Consensus 566 ~-~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI 633 (852)
. ...++||||+++|+|.++|..... .....+++..++.++.||++||+|||+ ++||||||||+||
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NI 165 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNI 165 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGE
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccce
Confidence 4 568999999999999999975432 123468999999999999999999999 8999999999999
Q ss_pred EeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCC-cccccccccc
Q 003059 634 LLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGR-RNFEVSQETN 712 (852)
Q Consensus 634 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~-~p~~~~~~~~ 712 (852)
||++++.+||+|||+++........ .......||+.|+|||.+.+..++.++|||||||++|||++|. .||.......
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp EECGGGCEEECC------CCSCTTS-CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred eECCCCcEEEccCcchhhccccccc-cccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999876543222 2233467999999999999999999999999999999999975 5776433211
Q ss_pred chhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 713 RKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 713 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
.....+.++.... . +......+.+++.+||+.||.+|||+.||++.|+++.+
T Consensus 245 ------~~~~~~~~~~~~~-----~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 245 ------EFCRRLKEGTRMR-----A-----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp ------HHHHHHHHTCCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HHHHHHhcCCCCC-----C-----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1111222221111 1 11112356788999999999999999999999988754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=378.73 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=201.9
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCc-------ccchHHHHHHHHHhhcccccceeeeeeeeccCceee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI-------EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRL 570 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-------~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 570 (852)
..|.+.++||+|+||.||+|.. .+++.||||+++.. ....+.|++|+++|++++|||||++++++.+.+..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4688899999999999999997 46889999998632 123567999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC----ceEEeec
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY----NAKVSDF 646 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~DF 646 (852)
|||||+++|+|.++|... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++ .+||+||
T Consensus 90 iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecch
Confidence 999999999999999653 359999999999999999999999 8999999999999998776 4999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhh
Q 003059 647 GLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEK 726 (852)
Q Consensus 647 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (852)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+..
T Consensus 162 G~a~~~~~~~----~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~ 230 (293)
T d1jksa_ 162 GLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSA 230 (293)
T ss_dssp TTCEECTTSC----BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHT
T ss_pred hhhhhcCCCc----cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-------HHHHHHh
Confidence 9998765322 2344578999999999999999999999999999999999999997543211 1111111
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 727 GNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.... ...+.. ......+.+++.+||+.||.+|||++|+++
T Consensus 231 ~~~~-~~~~~~------~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 231 VNYE-FEDEYF------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp TCCC-CCHHHH------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCC-CCchhc------CCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1110 000000 011235678899999999999999999976
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=388.89 Aligned_cols=265 Identities=28% Similarity=0.422 Sum_probs=211.1
Q ss_pred HHHHhcccccccccccccceEEEEEE------CCCcEEEEEEecCc--ccchHHHHHHHHHhhcc-cccceeeeeeeecc
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVL------ANRTVVAVKQLEGI--EQGEKQFRMEVATISST-HHLNLVRLVGFSSE 565 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~ 565 (852)
|+....+.+.++||+|+||.||+|++ ..++.||||+++.. .....+|.+|+.+++++ +|||||+++|+|.+
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 56677888999999999999999985 24578999999743 33455789999999999 69999999999999
Q ss_pred CceeeEEEeecCCCCHHHHhhhccc-------------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCc
Q 003059 566 GKHRLLVYEFMKNGSLDNFLFANEE-------------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPEN 632 (852)
Q Consensus 566 ~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 632 (852)
....++||||+++|+|.++|..... .....+++..+++++.||++||+|||+ ++||||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccc
Confidence 9999999999999999999976432 123468999999999999999999999 899999999999
Q ss_pred eEeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCccccccccc
Q 003059 633 ILLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQET 711 (852)
Q Consensus 633 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~ 711 (852)
||++.++.+||+|||+++....... ........||+.|+|||.+.+..++.++|||||||++|||+| |++||......
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred ccccccCcccccccchheeccCCCc-ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999997754322 233345678999999999999999999999999999999999 45555433221
Q ss_pred cchhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 003059 712 NRKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGIT 779 (852)
Q Consensus 712 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~ 779 (852)
. .+ ......+. .. ..+......+.+++.+||+.||++|||+.+|+++|+++.
T Consensus 255 ~--~~----~~~i~~~~-----~~-----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 255 S--KF----YKMIKEGF-----RM-----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp H--HH----HHHHHHTC-----CC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H--HH----HHHHhcCC-----CC-----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 1 11 11111111 00 111112245778899999999999999999999998754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-44 Score=385.90 Aligned_cols=260 Identities=27% Similarity=0.417 Sum_probs=203.4
Q ss_pred hcccccccccccccceEEEEEECC-Cc--EEEEEEecC--cccchHHHHHHHHHhhcc-cccceeeeeeeeccCceeeEE
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLAN-RT--VVAVKQLEG--IEQGEKQFRMEVATISST-HHLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~--~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 572 (852)
..+.+.++||+|+||.||+|++.+ +. .||||++.. .....++|.+|+++|.++ +|||||+++|+|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 346678899999999999999754 33 578888763 334556899999999998 799999999999999999999
Q ss_pred EeecCCCCHHHHhhhcc-----------cCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCce
Q 003059 573 YEFMKNGSLDNFLFANE-----------EGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNA 641 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 641 (852)
|||+++|+|.++|+... ......+++..+++++.||++||.|||+ ++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 99999999999997542 1234679999999999999999999999 899999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCC-ccccccccccchhhHHHH
Q 003059 642 KVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGR-RNFEVSQETNRKKFSLWA 720 (852)
Q Consensus 642 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~ 720 (852)
||+|||+++..... .......||..|+|||.+.+..++.++|||||||++|||++|. .||....... .
T Consensus 167 kl~DfG~a~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-------~ 235 (309)
T d1fvra_ 167 KIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------L 235 (309)
T ss_dssp EECCTTCEESSCEE----CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------H
T ss_pred EEcccccccccccc----ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH-------H
Confidence 99999999865321 1223456899999999999999999999999999999999976 4665432211 1
Q ss_pred HHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCC
Q 003059 721 YEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIE 782 (852)
Q Consensus 721 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~ 782 (852)
...+.++.. . ..+......+.+++.+||+.||++||+|.||++.|+++.+..
T Consensus 236 ~~~i~~~~~-----~-----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 236 YEKLPQGYR-----L-----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp HHHGGGTCC-----C-----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHHhcCC-----C-----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 111222110 1 111122346778889999999999999999999999887543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-43 Score=386.65 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=203.8
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCc-ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecC
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI-EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 577 (852)
.|++.++||+|+||.||+|.. .+++.||||++... ....+.+++|+++|++++|||||++++++.+++..||||||++
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 588889999999999999996 46899999998743 3345678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeC--CCCceEEeecccccccCCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD--ENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kl~DFGla~~~~~~ 655 (852)
+|+|.+++... ...+++..++.|+.||+.||+|||+ ++|+||||||+||||+ .++.+||+|||+++.+...
T Consensus 110 gg~L~~~~~~~----~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 110 GGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CChHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99999887532 3459999999999999999999998 8999999999999998 6789999999999987542
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDK 735 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 735 (852)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+...... ...
T Consensus 183 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~~~--~~~ 249 (352)
T d1koba_ 183 ----EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCDWE--FDE 249 (352)
T ss_dssp ----SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-------HHHHHHHCCCC--CCS
T ss_pred ----CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC--CCc
Confidence 23455679999999999999999999999999999999999999997543221 11111211111 000
Q ss_pred ccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 736 SLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 736 ~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.. .......+.+++.+||+.||.+|||+.|+++
T Consensus 250 ~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 250 DA-----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp ST-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cc-----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0111235678899999999999999999976
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=386.66 Aligned_cols=265 Identities=25% Similarity=0.369 Sum_probs=210.7
Q ss_pred HHHHhcccccccccccccceEEEEEEC------CCcEEEEEEecCc--ccchHHHHHHHHHhhcccccceeeeeeeeccC
Q 003059 495 ELQRSTKGFKDKLGAGGFGAVYRGVLA------NRTVVAVKQLEGI--EQGEKQFRMEVATISSTHHLNLVRLVGFSSEG 566 (852)
Q Consensus 495 el~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~ 566 (852)
||....+.+.++||+|+||+||+|.+. +++.||||+++.. ......|.+|++++++++|||||+++|+|..+
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 455567788899999999999999863 2578999999743 23345689999999999999999999999999
Q ss_pred ceeeEEEeecCCCCHHHHhhhccc-----CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCce
Q 003059 567 KHRLLVYEFMKNGSLDNFLFANEE-----GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNA 641 (852)
Q Consensus 567 ~~~~lV~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 641 (852)
+..++||||+++|+|.+++..... .....+++..+.+++.|+++||.|||+ ++|+||||||+||||++++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceE
Confidence 999999999999999999975321 123457899999999999999999999 899999999999999999999
Q ss_pred EEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCC-ccccccccccchhhHHHH
Q 003059 642 KVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGR-RNFEVSQETNRKKFSLWA 720 (852)
Q Consensus 642 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~ 720 (852)
||+|||+++.+..... ........||+.|+|||.+.+..++.++||||||+++|||+||. .||....... .
T Consensus 173 Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~-------~ 244 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------V 244 (308)
T ss_dssp EECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-------H
T ss_pred EEeecccceeccCCcc-eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence 9999999987643211 12223346899999999999999999999999999999999985 6675432211 1
Q ss_pred HHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 721 YEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 721 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
...+.++..... +......+.+++.+||+.+|.+||||.+|+++|++..+
T Consensus 245 ~~~i~~~~~~~~----------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 245 LRFVMEGGLLDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHhCCCCCC----------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 112222221111 11112457888999999999999999999999987754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=386.33 Aligned_cols=264 Identities=27% Similarity=0.381 Sum_probs=206.6
Q ss_pred HHHhcccccccccccccceEEEEEECC--------CcEEEEEEecCcc--cchHHHHHHHHHhhcc-cccceeeeeeeec
Q 003059 496 LQRSTKGFKDKLGAGGFGAVYRGVLAN--------RTVVAVKQLEGIE--QGEKQFRMEVATISST-HHLNLVRLVGFSS 564 (852)
Q Consensus 496 l~~~~~~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~--~~~~~f~~E~~~l~~l-~h~niv~l~g~~~ 564 (852)
|....+.+.++||+|+||.||+|+... +..||||+++... ....++.+|+..+.++ +|||||+++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 445678888999999999999998532 2479999997433 3457788999999888 8999999999999
Q ss_pred cCceeeEEEeecCCCCHHHHhhhccc-----------CCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCce
Q 003059 565 EGKHRLLVYEFMKNGSLDNFLFANEE-----------GSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENI 633 (852)
Q Consensus 565 ~~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI 633 (852)
+++..++||||+++|+|.++|..... .....+++..++.++.||+.||+|||+ .+||||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccce
Confidence 99999999999999999999975432 123568999999999999999999999 8999999999999
Q ss_pred EeCCCCceEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHh-CCcccccccccc
Q 003059 634 LLDENYNAKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVS-GRRNFEVSQETN 712 (852)
Q Consensus 634 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~ellt-G~~p~~~~~~~~ 712 (852)
|++.++.+||+|||+++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~ 245 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTT-CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred eecCCCCeEeccchhhccccccccc-cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence 9999999999999999876543222 22334568999999999999999999999999999999998 788886443211
Q ss_pred chhhHHHHHHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 713 RKKFSLWAYEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 713 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
....+..+.... . +......+.+++.+||+.||.+|||+.||++.|+++.+
T Consensus 246 -------~~~~i~~~~~~~-----~-----p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 246 -------LFKLLKEGHRMD-----K-----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -------HHHHHHTTCCCC-----C-----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------HHHHHHcCCCCC-----C-----CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 122222221111 1 11112357789999999999999999999999998754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.5e-44 Score=376.53 Aligned_cols=258 Identities=22% Similarity=0.332 Sum_probs=198.0
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCcc----cchHHHHHHHHHhhcccccceeeeeeeeccCc----ee
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE----QGEKQFRMEVATISSTHHLNLVRLVGFSSEGK----HR 569 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~----~~ 569 (852)
.+|.+.+.||+|+||.||+|+. .+++.||||+++... ...+.|.+|++++++++||||+++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 3578889999999999999996 468999999997332 23457899999999999999999999987543 47
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
||||||+++++|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+||||+.++..+|+|||.+
T Consensus 87 ~lvmE~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEECCCCCEehhhhccc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhh
Confidence 9999999999999988644 358999999999999999999998 89999999999999999999999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCc
Q 003059 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 650 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
+................||+.|+|||.+.+..++.++|||||||++|||+||+.||....... ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~~~~~~~ 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPI 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHHHhcCCC
Confidence 876544333344456779999999999999999999999999999999999999997543211 11111221111
Q ss_pred c-cccccccCCCCCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcCc
Q 003059 730 K-GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP-MMGKVVQMLEGIT 779 (852)
Q Consensus 730 ~-~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-t~~ev~~~L~~~~ 779 (852)
. ....+ .. ...+.+++.+|++.||.+|| +++++++.|.++.
T Consensus 233 ~~~~~~~-----~~----s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 PPSARHE-----GL----SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CGGGTSS-----SC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCchhcc-----CC----CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1 01111 11 23567788899999999999 8999998887653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-43 Score=378.70 Aligned_cols=242 Identities=25% Similarity=0.324 Sum_probs=200.1
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.|++.++||+|+||.||+|+. .+++.||||+++.. ....+.+.+|+.++++++|||||++++++.+.+..|+|||
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 377889999999999999997 45899999998632 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++|+|..++.... .+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 85 ~~~gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 85 YIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred ecCCccccccccccc-----cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 999999999886543 47888889999999999999998 8999999999999999999999999999987643
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+..
T Consensus 157 ~------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-------~~~~i~~~~~----- 218 (316)
T d1fota_ 157 V------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-------TYEKILNAEL----- 218 (316)
T ss_dssp C------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHCCC-----
T ss_pred c------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH-------HHHHHHcCCC-----
Confidence 2 234679999999999999999999999999999999999999997543211 1111111111
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP-----MMGKVVQ 773 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~ev~~ 773 (852)
.. +......+.+++.+|++.||.+|| +++++++
T Consensus 219 -~~-----p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 -RF-----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -CC-----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CC-----CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 01 111123466788899999999996 8899876
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-43 Score=379.41 Aligned_cols=245 Identities=24% Similarity=0.277 Sum_probs=201.7
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.|.+.+.||+|+||.||+|+. .+++.||||+++.. ....+.+.+|+.+|++++||||+++++++.+.+..|+|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence 477889999999999999996 56899999999732 3345778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+++|+|.+++.... .+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 86 y~~gg~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 86 YANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp CCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred ccCCCchhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999996543 48889999999999999999999 8999999999999999999999999999987643
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+..
T Consensus 158 ~~---~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-------~~~~i~~~~~----- 222 (337)
T d1o6la_ 158 DG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEI----- 222 (337)
T ss_dssp TT---CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC-----
T ss_pred CC---cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-------HHHHHhcCCC-----
Confidence 22 22345679999999999999999999999999999999999999997654211 1111222111
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPM-----MGKVVQ 773 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt-----~~ev~~ 773 (852)
.+.. .. ...+.+++.+||+.||.+||+ ++|+++
T Consensus 223 -~~p~-~~----s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 -RFPR-TL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CCCT-TS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCc-cC----CHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1111 12 234678889999999999995 777765
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-43 Score=376.25 Aligned_cols=245 Identities=20% Similarity=0.300 Sum_probs=203.8
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeecCC
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFMKN 578 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 578 (852)
+|.+.++||+|+||+||+|... +++.||||.++........+.+|+++|++++|||||++++++.+++..||||||+++
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g 85 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence 5788899999999999999975 688999999986666667789999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC--CCceEEeecccccccCCCC
Q 003059 579 GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE--NYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 579 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~kl~DFGla~~~~~~~ 656 (852)
|+|.++|... +..+++.++..++.||+.||+|||+ .+|+||||||+|||++. ...+||+|||+++.....
T Consensus 86 g~L~~~i~~~----~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 86 LDIFERINTS----AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred CcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 9999999543 2358999999999999999999998 89999999999999985 458999999999876432
Q ss_pred CcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccccc
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVDKS 736 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 736 (852)
.......+|+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+.....
T Consensus 158 ---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-------~~~~i~~~~~------- 220 (321)
T d1tkia_ 158 ---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEY------- 220 (321)
T ss_dssp ---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCC-------
T ss_pred ---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC-------
Confidence 23445679999999999999999999999999999999999999997543211 1111111111
Q ss_pred cCCCCCCHH----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 737 LAGEDVDIE----QVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 737 l~~~~~~~~----~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..+.+ ....+.+++.+|++.||.+|||+.|+++
T Consensus 221 ----~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 221 ----TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ----CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111 1234678899999999999999999987
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.6e-42 Score=364.04 Aligned_cols=249 Identities=25% Similarity=0.319 Sum_probs=200.5
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCccc----------chHHHHHHHHHhhccc-ccceeeeeeeeccC
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQ----------GEKQFRMEVATISSTH-HLNLVRLVGFSSEG 566 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----------~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~ 566 (852)
..|.+.++||+|+||+||+|+. .+++.||||++..... ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 3577889999999999999996 5689999999863321 1245889999999997 99999999999999
Q ss_pred ceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeec
Q 003059 567 KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDF 646 (852)
Q Consensus 567 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 646 (852)
+..||||||+++|+|.++|... ..+++..++.++.||++||+|||+ ++|+||||||+||||+.++.+||+||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred cceEEEEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccc
Confidence 9999999999999999999643 358999999999999999999998 89999999999999999999999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCChhhhhc------CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHH
Q 003059 647 GLAKLINPKDHRHRTLTSVRGTRGYLAPEWLAN------LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWA 720 (852)
Q Consensus 647 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~ 720 (852)
|+++.+.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... .
T Consensus 155 G~a~~~~~~~----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-------~ 223 (277)
T d1phka_ 155 GFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------M 223 (277)
T ss_dssp TTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------H
T ss_pred hheeEccCCC----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-------H
Confidence 9998875422 2244679999999999863 346889999999999999999999997553221 1
Q ss_pred HHHHhhCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 721 YEEFEKGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 721 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
......+... ... +........+.+++.+||+.||.+||++.||++
T Consensus 224 ~~~i~~~~~~-~~~------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 224 LRMIMSGNYQ-FGS------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHHHTCCC-CCT------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHhCCCC-CCC------cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1222222211 000 011112245778899999999999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-42 Score=377.29 Aligned_cols=242 Identities=21% Similarity=0.237 Sum_probs=200.8
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEe
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYE 574 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 574 (852)
.|.+.++||+|+||.||+|+.. +++.||||++... ....+.+.+|+++|++++|||||++++++.+....++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 5788899999999999999974 6899999998632 2344678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 654 (852)
|+.+|+|..++.... .+++..+..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++.+..
T Consensus 122 ~~~~g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp CCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cccccchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 999999999996543 48999999999999999999998 8999999999999999999999999999997643
Q ss_pred CCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcccccc
Q 003059 655 KDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIVD 734 (852)
Q Consensus 655 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 734 (852)
. .....||+.|||||++.+..++.++|||||||++|||++|+.||....... ....+..+...
T Consensus 194 ~------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-------~~~~i~~~~~~---- 256 (350)
T d1rdqe_ 194 R------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGKVR---- 256 (350)
T ss_dssp C------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC----
T ss_pred c------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH-------HHHHHhcCCCC----
Confidence 2 234579999999999999999999999999999999999999997543211 11111211110
Q ss_pred cccCCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003059 735 KSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRP-----MMGKVVQ 773 (852)
Q Consensus 735 ~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RP-----t~~ev~~ 773 (852)
.+......+.+++.+||+.||.+|+ +++++++
T Consensus 257 -------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 -------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 0111123567888899999999994 8999886
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.7e-42 Score=379.83 Aligned_cols=246 Identities=24% Similarity=0.302 Sum_probs=193.9
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHH---HHHHhhcccccceeeeeeeeccCceeeE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRM---EVATISSTHHLNLVRLVGFSSEGKHRLL 571 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~---E~~~l~~l~h~niv~l~g~~~~~~~~~l 571 (852)
.|.+.+.||+|+||.||+|+.. +++.||||++... ......+.+ |+.+++.++|||||++++++.+.+..|+
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence 4677889999999999999975 5899999998632 222333444 4677788889999999999999999999
Q ss_pred EEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 572 VYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 572 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
||||+++|+|.++|... ..+++..+..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+++.
T Consensus 85 vmE~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EECCCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEecCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999654 347889999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcc
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (852)
+... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+ .... ..
T Consensus 157 ~~~~-----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----~~~~----~~ 223 (364)
T d1omwa3 157 FSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMT----LT 223 (364)
T ss_dssp CSSS-----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH----HHHS----SS
T ss_pred cCCC-----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhc----cc
Confidence 6542 1234579999999999975 5689999999999999999999999976433221110 0000 00
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003059 731 GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPM-----MGKVVQ 773 (852)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt-----~~ev~~ 773 (852)
. ...+.. .. ...+.+++.+||+.||.+||+ ++|+++
T Consensus 224 ~--~~~~~~-~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 224 M--AVELPD-SF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp C--CCCCCS-SS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred C--CCCCCC-CC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0 000100 11 234678889999999999999 577764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-42 Score=370.39 Aligned_cols=245 Identities=23% Similarity=0.316 Sum_probs=198.7
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCc----ccchHHHHHHHHHhh-cccccceeeeeeeeccCceeeEEE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGI----EQGEKQFRMEVATIS-STHHLNLVRLVGFSSEGKHRLLVY 573 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~f~~E~~~l~-~l~h~niv~l~g~~~~~~~~~lV~ 573 (852)
.|.+.++||+|+||+||+|+.. +++.||||+++.. ....+.+..|..++. .++|||||++++++.+++..||||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 4778899999999999999974 5899999999632 333456777777765 689999999999999999999999
Q ss_pred eecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccC
Q 003059 574 EFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLIN 653 (852)
Q Consensus 574 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 653 (852)
||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||+++++++||+|||+++...
T Consensus 83 Ey~~~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp ECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred eecCCCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcc
Confidence 9999999999996543 47889999999999999999999 899999999999999999999999999998664
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV 733 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 733 (852)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+..
T Consensus 155 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~---- 220 (320)
T d1xjda_ 155 LGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNP---- 220 (320)
T ss_dssp CTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC----
T ss_pred ccc---ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCC----
Confidence 322 22344679999999999999999999999999999999999999997543221 1112221111
Q ss_pred ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 003059 734 DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMG-KVVQ 773 (852)
Q Consensus 734 d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~-ev~~ 773 (852)
.... .. ...+.+++.+||+.||.+||++. ++++
T Consensus 221 --~~p~-~~----s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 --FYPR-WL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CCCT-TS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCCc-cC----CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1111 11 23467888999999999999995 6754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-42 Score=366.08 Aligned_cols=256 Identities=23% Similarity=0.292 Sum_probs=193.0
Q ss_pred cccccccccceEEEEEE-CCCcEEEEEEecCccc------chHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 504 KDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQ------GEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 504 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
.++||+|+||+||+|.. .+++.||||+++.... ..+.+.+|++++++++|||||++++++.+++..+|||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 36899999999999996 4589999999863221 1356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
.++++..++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~~~~~~~-----~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred cchHHhhhhhc-----ccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 88877666532 3458899999999999999999999 899999999999999999999999999998765422
Q ss_pred CcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCccccc--
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVKGIV-- 733 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-- 733 (852)
.......||+.|+|||.+... .++.++|||||||++|||++|+.||......+... . ..............
T Consensus 155 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~--~-i~~~~~~~~~~~~~~~ 228 (299)
T d1ua2a_ 155 ---RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT--R-IFETLGTPTEEQWPDM 228 (299)
T ss_dssp ---CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--H-HHHHHCCCCTTTSSST
T ss_pred ---ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHH--H-HHHhcCCCChhhccch
Confidence 122345689999999998754 57999999999999999999999997554322111 0 11111000000000
Q ss_pred ----c-cccCC-CCCCHHH-----HHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 734 ----D-KSLAG-EDVDIEQ-----VMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 734 ----d-~~l~~-~~~~~~~-----~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
. ..... ...+... ...+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0 00000 0111111 245788999999999999999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-42 Score=372.63 Aligned_cols=248 Identities=23% Similarity=0.261 Sum_probs=194.7
Q ss_pred cccccc-cccccccceEEEEEE-CCCcEEEEEEecCcccchHHHHHHHHHhhcc-cccceeeeeeeecc----CceeeEE
Q 003059 500 TKGFKD-KLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVATISST-HHLNLVRLVGFSSE----GKHRLLV 572 (852)
Q Consensus 500 ~~~~~~-~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~lV 572 (852)
.|.+.+ .||+|+||.||+|.. .+++.||||+++. ...+.+|++++.++ +|||||++++++.+ +...|||
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv 87 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 87 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence 466654 599999999999996 5688999999864 34678899987655 89999999998864 5678999
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC---CCceEEeecccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE---NYNAKVSDFGLA 649 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~DFGla 649 (852)
||||++|+|.++|.... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||++
T Consensus 88 mEy~~gg~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 88 MECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EECCCSEEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EECCCCCcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccccccee
Confidence 99999999999996432 3469999999999999999999998 89999999999999985 567999999999
Q ss_pred cccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCc
Q 003059 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNV 729 (852)
Q Consensus 650 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 729 (852)
+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.......... .+.
T Consensus 162 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~-------~~~---- 226 (335)
T d2ozaa1 162 KETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------GMK---- 226 (335)
T ss_dssp EECCCCC----CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred eeccCCC----ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH-------HHH----
Confidence 8765432 2344679999999999999999999999999999999999999997543221100 000
Q ss_pred ccccccccCCCCCC--HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 730 KGIVDKSLAGEDVD--IEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 730 ~~~~d~~l~~~~~~--~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
..+......- +.+ ......+.+++.+||+.||.+|||+.|+++
T Consensus 227 ~~i~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 227 TRIRMGQYEF-PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -CCCSCSSSC-CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhcCCCCC-CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0011011100 111 122346788999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=363.96 Aligned_cols=266 Identities=23% Similarity=0.313 Sum_probs=198.7
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
.|.+.++||+|+||.||+|+. .+++.||||+++.. ....+++.+|++++++++|||||++++++.++++.|+||||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~ 82 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence 466778999999999999996 56899999999633 23457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+.+ ++.+++.... ...+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~-~~~~~~~~~~---~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 83 LHQ-DLKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CSE-EHHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred cCC-chhhhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCC
Confidence 965 4555553322 3459999999999999999999999 89999999999999999999999999999876532
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCC-CCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhh---CCccc
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLP-ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEK---GNVKG 731 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~ 731 (852)
. .......||+.|+|||.+.... .+.++|||||||++|||++|+.||......+.. .. ....... .....
T Consensus 156 ~---~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~--~~-i~~~~~~~~~~~~~~ 229 (298)
T d1gz8a_ 156 V---RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL--FR-IFRTLGTPDEVVWPG 229 (298)
T ss_dssp S---BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HH-HHHHHCCCCTTTSTT
T ss_pred c---ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHH--HH-HHHhcCCCchhhccc
Confidence 2 2233457999999999987665 578999999999999999999999754322111 00 0110000 00000
Q ss_pred ---ccc--ccc-CCCCCCHHH-----HHHHHHHHHhccccCCCCCCCHHHHHHH--HhcC
Q 003059 732 ---IVD--KSL-AGEDVDIEQ-----VMRAIQVSFWCIQEQPSQRPMMGKVVQM--LEGI 778 (852)
Q Consensus 732 ---~~d--~~l-~~~~~~~~~-----~~~~~~l~~~cl~~dp~~RPt~~ev~~~--L~~~ 778 (852)
..+ ... .....+... ...+.+++.+|++.||.+|||+.|+++. |+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 000 000 000111111 1456788999999999999999999873 5444
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=365.02 Aligned_cols=238 Identities=27% Similarity=0.452 Sum_probs=193.4
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCcc-------cchHHHHHHHHHhhccc--ccceeeeeeeeccCce
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE-------QGEKQFRMEVATISSTH--HLNLVRLVGFSSEGKH 568 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-------~~~~~f~~E~~~l~~l~--h~niv~l~g~~~~~~~ 568 (852)
.+|.+.+.||+|+||.||+|+. .+++.||||++.... ....++.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 4688889999999999999996 468999999986321 11245778999999986 8999999999999999
Q ss_pred eeEEEeecCC-CCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC-CCceEEeec
Q 003059 569 RLLVYEFMKN-GSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE-NYNAKVSDF 646 (852)
Q Consensus 569 ~~lV~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~DF 646 (852)
.++||||+.+ +++.+++... ..+++..+..++.||++||+|||+ ++|+||||||+|||++. ++.+||+||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEEEeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECcc
Confidence 9999999976 6788887543 358999999999999999999999 89999999999999985 579999999
Q ss_pred ccccccCCCCCcceeeeeecCCCCCCChhhhhcCCC-CCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHh
Q 003059 647 GLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPI-TSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFE 725 (852)
Q Consensus 647 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 725 (852)
|+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ..
T Consensus 156 G~a~~~~~~-----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------i~ 217 (273)
T d1xwsa_ 156 GSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------II 217 (273)
T ss_dssp TTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HH
T ss_pred ccceecccc-----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------------Hh
Confidence 999875432 2344679999999999988765 5678999999999999999999974321 11
Q ss_pred hCCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 726 KGNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 726 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.+.. .+.+ ..+ ..+.+++.+||+.||++|||++|+++
T Consensus 218 ~~~~--~~~~-----~~s----~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 218 RGQV--FFRQ-----RVS----SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HCCC--CCSS-----CCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hccc--CCCC-----CCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1111 0111 122 35678889999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.7e-41 Score=359.51 Aligned_cols=260 Identities=23% Similarity=0.302 Sum_probs=196.5
Q ss_pred cccccccccccccceEEEEEECCCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEeec
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
+|.+.++||+|+||+||+|+..+++.||||++... ....+.+.+|+.+|++++||||+++++++.+.+..++++||+
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence 56778999999999999999999999999999743 233578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCCC
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPKD 656 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 656 (852)
.++.+..+... ...+++..+..++.||+.||+|||+ .+||||||||+||||+.++.+||+|||++.......
T Consensus 83 ~~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 83 DQDLKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp SEEHHHHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred hhhhHHHHHhh-----cCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 88776666532 3459999999999999999999998 899999999999999999999999999998765422
Q ss_pred CcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCC------c
Q 003059 657 HRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGN------V 729 (852)
Q Consensus 657 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~ 729 (852)
.......+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+. +.. ......... .
T Consensus 155 ---~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~-i~~~~~~~~~~~~~~~ 228 (286)
T d1ob3a_ 155 ---RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMR-IFRILGTPNSKNWPNV 228 (286)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHCCCCTTTSTTG
T ss_pred ---cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--HHH-HHHhhCCCChhhccch
Confidence 122344689999999998754 568999999999999999999999975432211 110 011000000 0
Q ss_pred cccc--cccc-CCCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 730 KGIV--DKSL-AGEDVD-----IEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 730 ~~~~--d~~l-~~~~~~-----~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.... +... .....+ ......+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0000 000000 111235678899999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-41 Score=360.94 Aligned_cols=266 Identities=22% Similarity=0.288 Sum_probs=195.7
Q ss_pred hcccccccccccccceEEEEEEC-C-CcEEEEEEecCc---ccchHHHHHHHHHhhcc---cccceeeeeeeec-----c
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-N-RTVVAVKQLEGI---EQGEKQFRMEVATISST---HHLNLVRLVGFSS-----E 565 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~l~~~---~~~~~~f~~E~~~l~~l---~h~niv~l~g~~~-----~ 565 (852)
..|.+.++||+|+||+||+|... + ++.||||+++.. ......+.+|+++++.+ +||||++++++|. .
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 46778899999999999999963 3 678999998632 22334577888877766 7999999999885 3
Q ss_pred CceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEee
Q 003059 566 GKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSD 645 (852)
Q Consensus 566 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D 645 (852)
....+++|||++++.+....... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred CceEEEEEEeccCCchhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecc
Confidence 45789999999887776554322 3468899999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHh
Q 003059 646 FGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFE 725 (852)
Q Consensus 646 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 725 (852)
||+++.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .. ......
T Consensus 160 fg~~~~~~~----~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~--~~-i~~~~~ 232 (305)
T d1blxa_ 160 FGLARIYSF----QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL--GK-ILDVIG 232 (305)
T ss_dssp CCSCCCCCG----GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HH-HHHHHC
T ss_pred hhhhhhhcc----cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHH--HH-HHHhhC
Confidence 999886532 22334567999999999999999999999999999999999999999765432211 11 001100
Q ss_pred hCCcc----------cccccccCC--CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcC
Q 003059 726 KGNVK----------GIVDKSLAG--EDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM--LEGI 778 (852)
Q Consensus 726 ~~~~~----------~~~d~~l~~--~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~--L~~~ 778 (852)
..... ......... ..........+.+++.+||+.||++|||+.|+++. |+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 00000 000000000 00001112346678899999999999999999863 4444
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.2e-40 Score=349.58 Aligned_cols=265 Identities=19% Similarity=0.250 Sum_probs=205.8
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhcccc-cceeeeeeeeccCceeeEEEeec
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISSTHH-LNLVRLVGFSSEGKHRLLVYEFM 576 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~e~~ 576 (852)
..|.+.++||+|+||.||+|+.. +++.||||++... ....++++|+++++.++| +|++.+++++.++...++||||+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc-cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 46788899999999999999964 5889999988643 234567889999999965 89999999999999999999999
Q ss_pred CCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCC-----CCceEEeecccccc
Q 003059 577 KNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDE-----NYNAKVSDFGLAKL 651 (852)
Q Consensus 577 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~DFGla~~ 651 (852)
+++|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||||+. ++.+||+|||+++.
T Consensus 84 -~~~l~~~~~~~----~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 84 -GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp -CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred -CCCHHHHHHhh----ccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 78999988543 3458999999999999999999999 89999999999999974 57899999999987
Q ss_pred cCCCCCcc----eeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhC
Q 003059 652 INPKDHRH----RTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG 727 (852)
Q Consensus 652 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 727 (852)
+....... .......||+.|||||.+.+..++.++|||||||++|||++|+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 65322111 12334679999999999999999999999999999999999999997654332221111111111111
Q ss_pred CcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCccCC
Q 003059 728 NVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITEIE 782 (852)
Q Consensus 728 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~~~ 782 (852)
...++ .. ..+ ..+.+++..|+..+|++||+++.+.+.|+++.+..
T Consensus 236 ~~~~l----~~--~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 236 PLREL----CA--GFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp CHHHH----TT--TSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ChHHh----cC--CCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 11111 11 112 24566777799999999999999999988765433
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.8e-40 Score=350.04 Aligned_cols=262 Identities=19% Similarity=0.245 Sum_probs=196.5
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCcccchHHHHHHHHHhhcccccceee-eeeeeccCceeeEEEeecC
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVR-LVGFSSEGKHRLLVYEFMK 577 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~-l~g~~~~~~~~~lV~e~~~ 577 (852)
+|.+.++||+|+||.||+|.. .+++.||||++.... ..+++..|++++++++|+|++. +.++..+++..++||||+
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~- 85 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 85 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence 578889999999999999996 458899999887432 3456889999999998776555 555667788999999999
Q ss_pred CCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeC---CCCceEEeecccccccCC
Q 003059 578 NGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLD---ENYNAKVSDFGLAKLINP 654 (852)
Q Consensus 578 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kl~DFGla~~~~~ 654 (852)
+++|.+.+... ...+++..++.++.|++.||+|||+ ++||||||||+|||++ .+..+||+|||+++.+..
T Consensus 86 ~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 86 GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred CCchhhhhhhc----cCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 56776666433 3458999999999999999999999 8999999999999985 456799999999997754
Q ss_pred CCCc----ceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCcc
Q 003059 655 KDHR----HRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNVK 730 (852)
Q Consensus 655 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 730 (852)
.... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.........................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 3221 122345679999999999999999999999999999999999999997654332221111111111111111
Q ss_pred cccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcc
Q 003059 731 GIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQMLEGITE 780 (852)
Q Consensus 731 ~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~L~~~~~ 780 (852)
.. .+ .. ...+.+++..|++.+|.+||++.++.+.|+.+..
T Consensus 239 ~~-~~-----~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 239 VL-CK-----GY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HH-TT-----TS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred Hh-cc-----CC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 11 00 11 1346678888999999999999999998887643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-40 Score=354.01 Aligned_cols=268 Identities=18% Similarity=0.203 Sum_probs=194.1
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCc---ccchHHHHHHHHHhhcccccceeeeeeeecc--------C
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGI---EQGEKQFRMEVATISSTHHLNLVRLVGFSSE--------G 566 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--------~ 566 (852)
.+|.+.++||+|+||+||+|+. .+++.||||++... .....++.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 5778889999999999999997 46899999998632 3345678999999999999999999998754 3
Q ss_pred ceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeec
Q 003059 567 KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDF 646 (852)
Q Consensus 567 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DF 646 (852)
+..++||||+.++.+..+... ...++...+..++.||++||.|||+ .+|+||||||+||||+.++.+||+||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~-----~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccCCCccchhhhc-----ccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeec
Confidence 468999999988776655422 3457888899999999999999998 89999999999999999999999999
Q ss_pred ccccccCCCCCcc-eeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHH
Q 003059 647 GLAKLINPKDHRH-RTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEF 724 (852)
Q Consensus 647 Gla~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 724 (852)
|+++......... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...................
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9998765422111 122235699999999999765 68999999999999999999999997543322111110000000
Q ss_pred hhCCcccccc-------cccCCCCCCHHH-------HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 725 EKGNVKGIVD-------KSLAGEDVDIEQ-------VMRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 725 ~~~~~~~~~d-------~~l~~~~~~~~~-------~~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.......... ............ ...+++++.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000000000 001111111211 1245688999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-40 Score=357.84 Aligned_cols=263 Identities=21% Similarity=0.299 Sum_probs=194.3
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCcc--cchHHHHHHHHHhhcccccceeeeeeeeccCc----eeeEE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE--QGEKQFRMEVATISSTHHLNLVRLVGFSSEGK----HRLLV 572 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lV 572 (852)
+|.+.++||+|+||+||+|+. .+++.||||++.... ...+++.+|+++|++++||||+++++++.... ..+++
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 577889999999999999986 578999999997432 33467889999999999999999999986543 33555
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLI 652 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~ 652 (852)
++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+++..
T Consensus 89 ~~~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 89 VTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeecCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 667779999999953 248999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCcceeeeeecCCCCCCChhhhh-cCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhCCc--
Q 003059 653 NPKDHRHRTLTSVRGTRGYLAPEWLA-NLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKGNV-- 729 (852)
Q Consensus 653 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-- 729 (852)
..............||+.|+|||.+. ...++.++||||+||++|||++|+.||......+........ ......
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI---LGSPSQED 236 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH---HCSCCHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhh---ccCCChhh
Confidence 54333222334567999999999985 456789999999999999999999999765432211111000 000000
Q ss_pred ---------ccccccccCCCCCCHHHH-----HHHHHHHHhccccCCCCCCCHHHHHHH
Q 003059 730 ---------KGIVDKSLAGEDVDIEQV-----MRAIQVSFWCIQEQPSQRPMMGKVVQM 774 (852)
Q Consensus 730 ---------~~~~d~~l~~~~~~~~~~-----~~~~~l~~~cl~~dp~~RPt~~ev~~~ 774 (852)
.............+.... .++.+++.+|++.||.+|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000001111111 257789999999999999999999863
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=356.64 Aligned_cols=267 Identities=23% Similarity=0.245 Sum_probs=193.0
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCcccchHHHHHHHHHhhcccccceeeeeeeecc------CceeeEE
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLVGFSSE------GKHRLLV 572 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------~~~~~lV 572 (852)
+|+..++||+|+||+||+|+.. +++.||||++..... .+.+|+++|++++||||+++++++.. ..+.+||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 5667789999999999999975 589999999974432 33579999999999999999998853 3357899
Q ss_pred EeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC-ceEEeecccccc
Q 003059 573 YEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY-NAKVSDFGLAKL 651 (852)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~~ 651 (852)
|||++++.+..+..... ....+++..+..++.||+.||+|||+ ++|+||||||+||||+.++ .+||+|||+++.
T Consensus 98 ~Ey~~~~~~~~l~~~~~--~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EECCSEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EeccCCccHHHHHhhhh--ccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhh
Confidence 99998764444332211 24569999999999999999999998 8999999999999999775 899999999987
Q ss_pred cCCCCCcceeeeeecCCCCCCChhhhhc-CCCCCCccchhhhHHHHHHHhCCccccccccccchhhHHH--------HHH
Q 003059 652 INPKDHRHRTLTSVRGTRGYLAPEWLAN-LPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLW--------AYE 722 (852)
Q Consensus 652 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~--------~~~ 722 (852)
..... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....... .+.
T Consensus 173 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 173 LVRGE----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CCTTS----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ccCCc----ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence 65432 2234579999999998875 4789999999999999999999999975543221110000 000
Q ss_pred HHhhCCcccccccccCCC----CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcCc
Q 003059 723 EFEKGNVKGIVDKSLAGE----DVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ--MLEGIT 779 (852)
Q Consensus 723 ~~~~~~~~~~~d~~l~~~----~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~--~L~~~~ 779 (852)
..... .....-+..... .........+.+++.+||+.||++|||+.|+++ .++++.
T Consensus 249 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 249 EMNPN-YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HHCC----CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhccc-hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 00000 000000000000 000111235678889999999999999999986 355554
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-39 Score=350.00 Aligned_cols=263 Identities=24% Similarity=0.320 Sum_probs=191.6
Q ss_pred hcccccccccccccceEEEEEEC-CCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCc------e
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGK------H 568 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~ 568 (852)
.+|.+.++||+|+||+||+|... +++.||||+++... ...+.+.+|+++|++++|||||+++++|...+ +
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 46777889999999999999964 58999999997432 23457889999999999999999999987654 5
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.++||||+ +.+|..++.. ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 98 ~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccc
Confidence 79999999 6678777642 349999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHH-----H
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAY-----E 722 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~-----~ 722 (852)
++..... .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||................ .
T Consensus 168 a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 168 ARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241 (346)
T ss_dssp CEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred eeccCCc------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHH
Confidence 9876432 2446799999999998764 56899999999999999999999997653221110000000 0
Q ss_pred HHhhCC----------cccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcCc
Q 003059 723 EFEKGN----------VKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQM--LEGIT 779 (852)
Q Consensus 723 ~~~~~~----------~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~~--L~~~~ 779 (852)
...... ........+.. ........+.+++.+||+.||.+|||++|+++. |+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDFAS--ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGG--TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHhhhcchhhhhhhccCCcccccchHH--hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 000000 00000000000 000111345688899999999999999999973 66554
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-39 Score=342.62 Aligned_cols=261 Identities=19% Similarity=0.250 Sum_probs=198.2
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeeccCceeeEEEee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 575 (852)
+|++.++||+|+||+||+|+. .+++.||||+++... ....++.+|+.+++.++||||+++++++.+....++|+|+
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 577789999999999999996 568899999986332 3357889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccccccCCC
Q 003059 576 MKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAKLINPK 655 (852)
Q Consensus 576 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 655 (852)
+.+++|..++... ..+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||.++.....
T Consensus 83 ~~~~~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 83 CDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CSEEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ccccccccccccc-----cccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999988877533 457899999999999999999999 89999999999999999999999999999876543
Q ss_pred CCcceeeeeecCCCCCCChhhhhcCC-CCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhhC---Cc--
Q 003059 656 DHRHRTLTSVRGTRGYLAPEWLANLP-ITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEKG---NV-- 729 (852)
Q Consensus 656 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~-- 729 (852)
.. ......++..|+|||.+.... ++.++|||||||++|||++|+.||......... ........... ..
T Consensus 155 ~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 155 VR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp CS---CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCCTTTCTT
T ss_pred Cc---cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH--HHHHHhhcCCCChhhhhh
Confidence 22 223345788899999987665 689999999999999999999997433221111 11111110000 00
Q ss_pred -cccc--------ccccCCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 730 -KGIV--------DKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 730 -~~~~--------d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.... ................+.+++.+|++.||.+|||++||++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0000000111112235678889999999999999999976
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-39 Score=347.58 Aligned_cols=251 Identities=22% Similarity=0.246 Sum_probs=197.2
Q ss_pred hcccccccccccccceEEEEEEC----CCcEEEEEEecCc-----ccchHHHHHHHHHhhcccc-cceeeeeeeeccCce
Q 003059 499 STKGFKDKLGAGGFGAVYRGVLA----NRTVVAVKQLEGI-----EQGEKQFRMEVATISSTHH-LNLVRLVGFSSEGKH 568 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~-----~~~~~~f~~E~~~l~~l~h-~niv~l~g~~~~~~~ 568 (852)
..|.+.++||+|+||+||+|... +++.||||+++.. ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 34888999999999999999852 4789999998632 2334678899999999976 899999999999999
Q ss_pred eeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccc
Q 003059 569 RLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGL 648 (852)
Q Consensus 569 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGl 648 (852)
.++||||+.+|+|.+++.... .+....+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eeeeeecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccc
Confidence 999999999999999996543 36778888999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCcceeeeeecCCCCCCChhhhhcC--CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHHHHHhh
Q 003059 649 AKLINPKDHRHRTLTSVRGTRGYLAPEWLANL--PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAYEEFEK 726 (852)
Q Consensus 649 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 726 (852)
++.+.... ........|++.|+|||.+.+. .++.++|||||||+||||++|+.||........... .......
T Consensus 176 a~~~~~~~--~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~---i~~~~~~ 250 (322)
T d1vzoa_ 176 SKEFVADE--TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE---ISRRILK 250 (322)
T ss_dssp EEECCGGG--GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH---HHHHHHH
T ss_pred hhhhcccc--cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhccc
Confidence 98764321 2223346799999999999765 468899999999999999999999976543322111 1111111
Q ss_pred CCcccccccccCCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003059 727 GNVKGIVDKSLAGEDVDIEQVMRAIQVSFWCIQEQPSQRPM-----MGKVVQ 773 (852)
Q Consensus 727 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt-----~~ev~~ 773 (852)
. .. ..+......+.+++.+||+.||.+||+ ++|+++
T Consensus 251 ~--------~~---~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 251 S--------EP---PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp C--------CC---CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred C--------CC---CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1 00 111122346777888999999999995 788875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.3e-38 Score=342.38 Aligned_cols=258 Identities=19% Similarity=0.302 Sum_probs=193.9
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCcccchHHHHHHHHHhhccc-ccceeeeeeeecc--CceeeEEEe
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVATISSTH-HLNLVRLVGFSSE--GKHRLLVYE 574 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~lV~e 574 (852)
..|.+.++||+|+||+||+|+. .+++.||||+++.. ..+++.+|+++|.+++ ||||+++++++.. ....++|||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 3688889999999999999997 56899999999743 3567899999999995 9999999999864 457899999
Q ss_pred ecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCC-ceEEeecccccccC
Q 003059 575 FMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENY-NAKVSDFGLAKLIN 653 (852)
Q Consensus 575 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~DFGla~~~~ 653 (852)
|+++++|..+. +.+++..+..++.||+.||+|||+ ++|+||||||+||||+.++ .+||+|||+++...
T Consensus 113 ~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 113 HVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp CCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred ecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceecc
Confidence 99999987654 248899999999999999999999 8999999999999998654 69999999998765
Q ss_pred CCCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHH-------HHHHHHh
Q 003059 654 PKDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSL-------WAYEEFE 725 (852)
Q Consensus 654 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~-------~~~~~~~ 725 (852)
... ......+|+.|+|||.+.+. .++.++||||+||+++||++|+.||............. .......
T Consensus 182 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 182 PGQ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp TTC----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred CCC----cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence 432 22345689999999998765 47999999999999999999999996543221110000 0000000
Q ss_pred hCCc--cccccccc-----------CCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 726 KGNV--KGIVDKSL-----------AGEDVDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 726 ~~~~--~~~~d~~l-----------~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.... .......+ ............+.+++.+||+.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00000000 000011111235678899999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-37 Score=340.09 Aligned_cols=259 Identities=22% Similarity=0.252 Sum_probs=185.6
Q ss_pred cccccccccccccceEEEEEEC-CCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeecc------Ccee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVLA-NRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSE------GKHR 569 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------~~~~ 569 (852)
+|.+.++||+|+||+||+|... +++.||||++.... ...+++.+|+.++++++|||||++++++.. ..+.
T Consensus 18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~ 97 (355)
T d2b1pa1 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97 (355)
T ss_dssp TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence 4777889999999999999975 58999999997432 234568899999999999999999999864 4688
Q ss_pred eEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeecccc
Q 003059 570 LLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLA 649 (852)
Q Consensus 570 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla 649 (852)
|+||||+.++.+ +.+. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||++
T Consensus 98 ~iv~Ey~~~~l~-~~~~-------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 98 YLVMELMDANLC-QVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEECCSEEHH-HHHT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEEEeccchHHH-Hhhh-------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhh
Confidence 999999976544 4442 247899999999999999999999 89999999999999999999999999998
Q ss_pred cccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccchhhHH----------H
Q 003059 650 KLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSL----------W 719 (852)
Q Consensus 650 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~----------~ 719 (852)
+..... .......+|+.|+|||++.+..+++++||||+||+++||++|+.||............. |
T Consensus 167 ~~~~~~----~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 167 RTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hccccc----cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 866432 23345678999999999999999999999999999999999999997543211100000 0
Q ss_pred -----HHHHHhhCCc-------ccccccccCCCC--CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003059 720 -----AYEEFEKGNV-------KGIVDKSLAGED--VDIEQVMRAIQVSFWCIQEQPSQRPMMGKVVQ 773 (852)
Q Consensus 720 -----~~~~~~~~~~-------~~~~d~~l~~~~--~~~~~~~~~~~l~~~cl~~dp~~RPt~~ev~~ 773 (852)
.......... ............ ........+.+++.+|++.||++|||++||++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000000 001111111100 11223456788999999999999999999985
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-38 Score=342.82 Aligned_cols=264 Identities=21% Similarity=0.291 Sum_probs=192.5
Q ss_pred cccccccccccccceEEEEEE-CCCcEEEEEEecCcc---cchHHHHHHHHHhhcccccceeeeeeeecc-----Cceee
Q 003059 500 TKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIE---QGEKQFRMEVATISSTHHLNLVRLVGFSSE-----GKHRL 570 (852)
Q Consensus 500 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~ 570 (852)
+|.+.++||+|+||+||+|.. .+++.||||++.... ...+++.+|+++|++++|||||++++++.. ....+
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 577889999999999999996 568999999997432 234568899999999999999999998863 33457
Q ss_pred EEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 571 LVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 571 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
+|++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||++.
T Consensus 99 ~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp EEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhc
Confidence 77888889999999843 348999999999999999999999 899999999999999999999999999997
Q ss_pred ccCCCCCcceeeeeecCCCCCCChhhhhcC-CCCCCccchhhhHHHHHHHhCCccccccccccchhhHHHHH----HHHh
Q 003059 651 LINPKDHRHRTLTSVRGTRGYLAPEWLANL-PITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRKKFSLWAY----EEFE 725 (852)
Q Consensus 651 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~----~~~~ 725 (852)
.... ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||................ ....
T Consensus 170 ~~~~------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 170 HTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp CCTG------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccCc------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 5432 22345688899999987765 46899999999999999999999997543221111000000 0000
Q ss_pred hCC----cccccccccCCCCCCHH-----HHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcC
Q 003059 726 KGN----VKGIVDKSLAGEDVDIE-----QVMRAIQVSFWCIQEQPSQRPMMGKVVQ--MLEGI 778 (852)
Q Consensus 726 ~~~----~~~~~d~~l~~~~~~~~-----~~~~~~~l~~~cl~~dp~~RPt~~ev~~--~L~~~ 778 (852)
... ................. ....+.+++.+||+.||.+|||++|+++ .+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 000 00000000000011111 1134678899999999999999999987 45544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-34 Score=316.88 Aligned_cols=265 Identities=21% Similarity=0.253 Sum_probs=190.5
Q ss_pred hcccccccccccccceEEEEEE-CCCcEEEEEEecCcccchHHHHHHHHHhhccc-----------ccceeeeeeeeccC
Q 003059 499 STKGFKDKLGAGGFGAVYRGVL-ANRTVVAVKQLEGIEQGEKQFRMEVATISSTH-----------HLNLVRLVGFSSEG 566 (852)
Q Consensus 499 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~-----------h~niv~l~g~~~~~ 566 (852)
.+|.+.++||+|+||+||+|+. .+++.||||+++......+.+.+|+.++++++ |+||+++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4688999999999999999996 56899999999866555677889999988875 57899999987653
Q ss_pred --ceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCc----
Q 003059 567 --KHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYN---- 640 (852)
Q Consensus 567 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~---- 640 (852)
...+++++++..+......... .....+++..+..++.||+.||+|||+. .+|+||||||+||||+.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTE
T ss_pred cccceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCccccc
Confidence 4566777776555433332221 1245688889999999999999999973 68999999999999986653
Q ss_pred --eEEeecccccccCCCCCcceeeeeecCCCCCCChhhhhcCCCCCCccchhhhHHHHHHHhCCccccccccccch----
Q 003059 641 --AKVSDFGLAKLINPKDHRHRTLTSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLEIVSGRRNFEVSQETNRK---- 714 (852)
Q Consensus 641 --~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~s~Gvvl~elltG~~p~~~~~~~~~~---- 714 (852)
+||+|||.+..... ......||+.|+|||.+....++.++||||+||+++||++|+.||.........
T Consensus 169 ~~~kl~dfg~s~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEECCCTTCEETTB------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ceeeEeeccccccccc------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 99999999986532 223456999999999999999999999999999999999999999754321111
Q ss_pred hhHHHHHH-------HHhhCC-cccccc-----ccc-------------CCCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 003059 715 KFSLWAYE-------EFEKGN-VKGIVD-----KSL-------------AGEDVDIEQVMRAIQVSFWCIQEQPSQRPMM 768 (852)
Q Consensus 715 ~l~~~~~~-------~~~~~~-~~~~~d-----~~l-------------~~~~~~~~~~~~~~~l~~~cl~~dp~~RPt~ 768 (852)
.+...... ...... .....+ ..+ ............+.+++.+|++.||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 01100000 000000 000000 000 0112334556678899999999999999999
Q ss_pred HHHHH
Q 003059 769 GKVVQ 773 (852)
Q Consensus 769 ~ev~~ 773 (852)
+|+++
T Consensus 323 ~e~L~ 327 (362)
T d1q8ya_ 323 GGLVN 327 (362)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=3e-22 Score=198.00 Aligned_cols=163 Identities=15% Similarity=0.161 Sum_probs=121.2
Q ss_pred cccccccccccceEEEEEECCCcEEEEEEecCccc-------------------chHHHHHHHHHhhcccccceeeeeee
Q 003059 502 GFKDKLGAGGFGAVYRGVLANRTVVAVKQLEGIEQ-------------------GEKQFRMEVATISSTHHLNLVRLVGF 562 (852)
Q Consensus 502 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-------------------~~~~f~~E~~~l~~l~h~niv~l~g~ 562 (852)
.+.++||+|+||.||+|...+++.||||+++.... .......|+..+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45789999999999999998999999998752110 01234568889999999999998876
Q ss_pred eccCceeeEEEeecCCCCHHHHhhhcccCCccccchhHHHHHHHhhHhhhhhhccccCCCcccCCCCCCceEeCCCCceE
Q 003059 563 SSEGKHRLLVYEFMKNGSLDNFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEECRDCIVHCDIKPENILLDENYNAK 642 (852)
Q Consensus 563 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 642 (852)
.. .++||||+++..+.+ ++......++.|++++|+|||+ .+|+||||||+|||++++ .++
T Consensus 83 ~~----~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp ET----TEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEE
T ss_pred cC----CEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEE
Confidence 43 379999998755432 4455667899999999999998 899999999999999965 489
Q ss_pred EeecccccccCCCCCcceeeeeecCCCCCCCh------hhhhcCCCCCCccchhhhHHHH
Q 003059 643 VSDFGLAKLINPKDHRHRTLTSVRGTRGYLAP------EWLANLPITSKSDVYSYGMVLL 696 (852)
Q Consensus 643 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~s~ksDv~s~Gvvl~ 696 (852)
|+|||+|+........ .|... |. -.+.++.++|+||..--++
T Consensus 143 liDFG~a~~~~~~~~~-----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 143 IIDFPQSVEVGEEGWR-----------EILERDVRNIITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp ECCCTTCEETTSTTHH-----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred EEECCCcccCCCCCcH-----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHHh
Confidence 9999999865432110 01111 11 1356788999999765443
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.81 E-value=4.1e-20 Score=164.47 Aligned_cols=111 Identities=21% Similarity=0.416 Sum_probs=93.0
Q ss_pred ccccCCCCccccCCCCCccccCCCceEEEEEecCCCCeeEEEEEeCCeeEEeeCCCCCCCCceEEEeeCccEEEEcCCCc
Q 003059 30 FADISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGSTPVDSSAFFQLHSSGTLRLISGSGA 109 (852)
Q Consensus 30 ~~~~~~~~~l~~~~~~~~l~S~~g~f~lgf~~~~~~~~~~~i~~~~~~~vW~an~~p~~~~~~l~~~~~g~l~l~~~~~~ 109 (852)
.|+|.+||.|.+|+ .|+ +|.|.|.|+.+++ |.| |...++||.||+.+....+.|.|+.||||+|+|. +.
T Consensus 1 tDtL~~gq~L~~g~---~l~--~g~~~l~~q~DGN----Lvl-y~~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~-~~ 69 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGG---SLA--EGGYLFIIQNDCN----LVL-YDNNRAVWASGTNGKASGCVLKMQNDGNLVIYSG-SR 69 (112)
T ss_dssp CCEEETTEEECTTC---EEE--ETTEEEEECTTSC----EEE-EETTEEEEECCCTTSCSSEEEEECTTSCEEEEET-TE
T ss_pred CCEecCCCEecCCC---EEE--ECCEEEEEcCCCC----EEE-EcCCcEEEEccCccCCCCcEEEEeccccEEEEec-CC
Confidence 48999999999999 776 5999999986655 444 4578999999986556678899999999999986 56
Q ss_pred eEeeccCCCC-ceeEEEEcCCccEEEecCCCccccccCCCCCC
Q 003059 110 IIWDSNTQRL-NVTSASLDDSGNLVLLKNGGVSAWSSFDNPTD 151 (852)
Q Consensus 110 ~vWst~~~~~-~~~~~~l~d~GNlvl~~~~~~~lWQSFD~PTD 151 (852)
.+|++++... +..+|+|+|+|||||++.++.++|||+.+|++
T Consensus 70 ~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 70 AIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp EEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred eEEEEeeccCCCceEEEEcCCCCEEEECCCCcEEecCCCccCC
Confidence 7787776544 44589999999999999999999999999975
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.79 E-value=2.2e-19 Score=158.07 Aligned_cols=106 Identities=21% Similarity=0.337 Sum_probs=89.2
Q ss_pred ccccCCCCccccCCCCCccccCCCceEEEEEecCCCCeeEEEEEeCCeeEEeeCCCCCCCCceEEEeeCccEEEEcCCCc
Q 003059 30 FADISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGSTPVDSSAFFQLHSSGTLRLISGSGA 109 (852)
Q Consensus 30 ~~~~~~~~~l~~~~~~~~l~S~~g~f~lgf~~~~~~~~~~~i~~~~~~~vW~an~~p~~~~~~l~~~~~g~l~l~~~~~~ 109 (852)
.|+|.+|++|.+|+ .|. +|.|.|.|+.+++ |.|+ ...++||.||+.+....+.|.+..+|||+|+|++|.
T Consensus 1 ~~~L~~g~~L~~G~---~l~--ng~~~l~~q~DGN----Lvly-~~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~ 70 (108)
T d1jpca_ 1 DNILYSGETLSTGE---FLN--YGSFVFIMQEDCN----LVLY-DVDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNK 70 (108)
T ss_dssp CCEEETTEEECTTC---EEE--ETTEEEEECTTSC----EEEE-ETTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCC
T ss_pred CCCccCCCEecCCC---EEE--cCCEEEEECCCCe----EEEE-eCCceeeEeCCCCCCCccEEEEeccceEEEECCCcc
Confidence 37889999999998 674 7999999987765 5554 578899999986556677899999999999999999
Q ss_pred eEeeccCCCCce-eEEEEcCCccEEEecCCCccccccCCC
Q 003059 110 IIWDSNTQRLNV-TSASLDDSGNLVLLKNGGVSAWSSFDN 148 (852)
Q Consensus 110 ~vWst~~~~~~~-~~~~l~d~GNlvl~~~~~~~lWQSFD~ 148 (852)
+||+|++..... .+|+|+|+|||||++. .+||||+|
T Consensus 71 ~vWsS~t~~~~~~~~l~L~ddGNlVly~~---~~W~S~t~ 107 (108)
T d1jpca_ 71 PIWASNTGGQNGNYVCILQKDRNVVIYGT---DRWATGTH 107 (108)
T ss_dssp EEEECCCCCSCSCEEEEECTTSCEEEEEC---CCCCCCCC
T ss_pred ceEEccccCCCCcEEEEEcCCCCEEEeCC---CcccCCCC
Confidence 999999765444 4689999999999964 58999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.78 E-value=3.5e-19 Score=156.75 Aligned_cols=106 Identities=18% Similarity=0.322 Sum_probs=89.3
Q ss_pred ccccCCCCccccCCCCCccccCCCceEEEEEecCCCCeeEEEEEeCCeeEEeeCC-CCCCCCceEEEeeCccEEEEcCCC
Q 003059 30 FADISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGS-TPVDSSAFFQLHSSGTLRLISGSG 108 (852)
Q Consensus 30 ~~~~~~~~~l~~~~~~~~l~S~~g~f~lgf~~~~~~~~~~~i~~~~~~~vW~an~-~p~~~~~~l~~~~~g~l~l~~~~~ 108 (852)
+|+|.+|+.|.+|+ .|. +|.|.|+|+.+++ |.+ |...++||+||+ .|...++.|.|+.||||||+|.+|
T Consensus 1 ~~~L~~g~~L~~g~---~l~--~g~~~l~~q~dgn----Lvl-~~~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g 70 (109)
T d1kj1a_ 1 RNLLTNGEGLYAGQ---SLD--VEPYHFIMQEDCN----LVL-YDHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEG 70 (109)
T ss_dssp CCEEETTCEEETTC---EEE--ETTEEEEECTTSC----EEE-EETTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSS
T ss_pred CCCccCCCEEeCCC---EEE--eCCEEEEecCCCe----EEE-EeCCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCC
Confidence 47899999999998 675 5899999986544 433 567899999998 577778899999999999999999
Q ss_pred ceEeeccCCC-CceeEEEEcCCccEEEecCCCccccccCCC
Q 003059 109 AIIWDSNTQR-LNVTSASLDDSGNLVLLKNGGVSAWSSFDN 148 (852)
Q Consensus 109 ~~vWst~~~~-~~~~~~~l~d~GNlvl~~~~~~~lWQSFD~ 148 (852)
.+||+|+++. .+..+|+|+|+|||||++. .+|||+.|
T Consensus 71 ~~vW~s~t~~~~~~~~l~L~ddGNlvly~~---~~W~S~t~ 108 (109)
T d1kj1a_ 71 RSLWASHSVRGNGNYVLVLQEDGNVVIYGS---DIWSTGTY 108 (109)
T ss_dssp CEEEECCCCCCSSCCEEEECTTSCEEEECC---EEEECCCC
T ss_pred cEEEEEeeECCCCCEEEEEeCCCcEEEECC---CEecCCCc
Confidence 9999999764 3445799999999999964 59999875
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.60 E-value=6.6e-16 Score=137.81 Aligned_cols=103 Identities=21% Similarity=0.350 Sum_probs=83.0
Q ss_pred EEE---eCCeeEEeeCC-CCCC-CCceEEEeeCccEEEEcCCCceEeeccCCCCc-eeEEEEcCCccEEEecCCCccccc
Q 003059 71 ITY---SGGVPIWTAGS-TPVD-SSAFFQLHSSGTLRLISGSGAIIWDSNTQRLN-VTSASLDDSGNLVLLKNGGVSAWS 144 (852)
Q Consensus 71 i~~---~~~~~vW~an~-~p~~-~~~~l~~~~~g~l~l~~~~~~~vWst~~~~~~-~~~~~l~d~GNlvl~~~~~~~lWQ 144 (852)
||| ++.+++|++|+ .++. ..-.|.|..||||||++. +.+||++++...+ ...|+|+++|||||+|.++.++||
T Consensus 12 il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW~ 90 (120)
T d1dlpa2 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWT 90 (120)
T ss_dssp ECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEEE
T ss_pred EEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCCCCEEEE
Confidence 556 56789999997 6774 455899999999999985 6789999977544 458999999999999999999999
Q ss_pred cCCCCCCcccCCCccccCccccccceEEEeecCCceeeeecCceeeecc
Q 003059 145 SFDNPTDTIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWNDSVVYFNQ 193 (852)
Q Consensus 145 SFD~PTDtlLpg~kl~~~~~l~sG~~sl~~~~~g~~~~~~~~~~~yw~~ 193 (852)
||.... .|.|.+.+++||++++| +.++|.+
T Consensus 91 S~t~~~----------------~~~~~l~Lq~DGnlvlY---~~~~W~t 120 (120)
T d1dlpa2 91 SGNSRS----------------AGRYVFVLQPDRNLAIY---GGALWTT 120 (120)
T ss_dssp CCCCCS----------------SSCCEEEECSSSCEEEE---CCCCCBC
T ss_pred eCCCCC----------------CCcEEEEECCCCcEEEe---CCCcccC
Confidence 996322 37889999999999998 2356653
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.58 E-value=5.3e-16 Score=136.90 Aligned_cols=103 Identities=25% Similarity=0.316 Sum_probs=84.6
Q ss_pred eCCeeEEeeCC-CCC-CCCceEEEeeCccEEEEcCCCceEeeccCCCCceeEEEEcCCccEEEecCCCccccccCCCCCC
Q 003059 74 SGGVPIWTAGS-TPV-DSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLNVTSASLDDSGNLVLLKNGGVSAWSSFDNPTD 151 (852)
Q Consensus 74 ~~~~~vW~an~-~p~-~~~~~l~~~~~g~l~l~~~~~~~vWst~~~~~~~~~~~l~d~GNlvl~~~~~~~lWQSFD~PTD 151 (852)
...+..|..+. .++ .....|.|..||||||++ ++.++|++++.+..+..+.|+|+|||||+|.++.++|||+....
T Consensus 9 ~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~~~~vWsS~t~~~- 86 (115)
T d1dlpa1 9 HEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTKGS- 86 (115)
T ss_dssp SSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCCCCC-
T ss_pred CCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCCCceEEEEeccCCEEEEccCCCEEEEcCCCCC-
Confidence 34555677775 455 455689999999999998 57889999988777788999999999999999999999986532
Q ss_pred cccCCCccccCccccccceEEEeecCCceeeeecCceeeeccCcc
Q 003059 152 TIVPSQNFTSDKTLRSGYYSFTLLKSGNLSLKWNDSVVYFNQGLN 196 (852)
Q Consensus 152 tlLpg~kl~~~~~l~sG~~sl~~~~~g~~~~~~~~~~~yw~~g~~ 196 (852)
.|.|.+.+++||++++| +.++|.+|+.
T Consensus 87 ---------------~g~y~l~Lq~DGNlvlY---~~~~Wssgt~ 113 (115)
T d1dlpa1 87 ---------------IGNYVLVLQPDRTVTIY---GPGLWDSGTS 113 (115)
T ss_dssp ---------------SSCCEEEECSSSCEEEE---CSEEEECSCC
T ss_pred ---------------CCCEEEEECCCCcEEEe---CCCeecCCCC
Confidence 48899999999999988 3479998753
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.55 E-value=5.6e-15 Score=131.22 Aligned_cols=102 Identities=16% Similarity=0.277 Sum_probs=81.2
Q ss_pred cccCCCCccccCCCCCccccCCCceEEEEEecCCCCeeEEEEEeCCeeEEeeCCCCCCCCceEEEeeCccEEEEcCCCce
Q 003059 31 ADISLGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGSTPVDSSAFFQLHSSGTLRLISGSGAI 110 (852)
Q Consensus 31 ~~~~~~~~l~~~~~~~~l~S~~g~f~lgf~~~~~~~~~~~i~~~~~~~vW~an~~p~~~~~~l~~~~~g~l~l~~~~~~~ 110 (852)
++|.++|+| ...+..|.|.|.|+.+++ |.+ |...++||.+|+........|.|..||||+|.|.+|.+
T Consensus 15 ~~l~~~q~l-------~~~~~~~~y~l~mQ~DGN----LVL-y~~~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~ 82 (119)
T d1b2pa_ 15 QILHATESL-------EILFGTHVYRFIMQTDCN----LVL-YDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVT 82 (119)
T ss_dssp CEEETTCEE-------EEEETTEEEEEEECTTSC----EEE-EETTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCE
T ss_pred CEEeCCCeE-------EEecCCceEEEEECCCCc----EEE-EECCeEEEEecCCCCCcceEEEEEeCCCEEEECCCCcE
Confidence 455555555 346779999999987666 433 56788999999854455688999999999999999999
Q ss_pred EeeccCCCCce-eEEEEcCCccEEEecCCCccccccCC
Q 003059 111 IWDSNTQRLNV-TSASLDDSGNLVLLKNGGVSAWSSFD 147 (852)
Q Consensus 111 vWst~~~~~~~-~~~~l~d~GNlvl~~~~~~~lWQSFD 147 (852)
||++++..... .+++|+|||||||++ ..+|||..
T Consensus 83 vWsS~t~~~~~~~~l~Lq~DGNlvlYg---~~~W~S~T 117 (119)
T d1b2pa_ 83 VWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWATQT 117 (119)
T ss_dssp EEECSCCCCSSCEEEEECTTSCEEEEE---SEEEECCC
T ss_pred EEECCCcCCCCceEEEEcCCCCEEEEC---CCEeccCC
Confidence 99999765443 469999999999995 47999965
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.33 E-value=3e-13 Score=118.97 Aligned_cols=88 Identities=17% Similarity=0.315 Sum_probs=70.1
Q ss_pred CCCceEEEEEecCCCCeeEEEEEeCCeeEEeeCCCCCCCCceEEEeeCccEEEEcCCCceEeeccCCCCce-eEEEEcCC
Q 003059 51 PNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGSTPVDSSAFFQLHSSGTLRLISGSGAIIWDSNTQRLNV-TSASLDDS 129 (852)
Q Consensus 51 ~~g~f~lgf~~~~~~~~~~~i~~~~~~~vW~an~~p~~~~~~l~~~~~g~l~l~~~~~~~vWst~~~~~~~-~~~~l~d~ 129 (852)
.+|.|.|.|+.+++ |.+ |..+.+||.+|... ...+.+.|.++|||||+|.++.+||++++..... ..++|++|
T Consensus 24 ~~g~~~l~~q~DGN----LvL-~~~~~~vW~s~t~~-~~~~~l~l~~dGNLvl~d~~~~~vWsS~t~~~~g~y~l~Lq~D 97 (115)
T d1dlpa1 24 ELSSFRFTMQSDCN----LVL-FDSDVRVWASNTAG-ATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPD 97 (115)
T ss_dssp CSTTEEEEECTTSC----EEE-EESSSEEECCCCCS-CSCCBCCBCSSSCBCCBCTTTCCSCCCCCCCCSSCCEEEECSS
T ss_pred EcCCEEEEECCCCe----EEE-EcCCeeEEEcccCC-CCceEEEEeccCCEEEEccCCCEEEEcCCCCCCCCEEEEECCC
Confidence 35779999986666 555 44678899999632 3467899999999999999999999999765433 46999999
Q ss_pred ccEEEecCCCccccccCC
Q 003059 130 GNLVLLKNGGVSAWSSFD 147 (852)
Q Consensus 130 GNlvl~~~~~~~lWQSFD 147 (852)
|||||++ ..+|+|-.
T Consensus 98 GNlvlY~---~~~Wssgt 112 (115)
T d1dlpa1 98 RTVTIYG---PGLWDSGT 112 (115)
T ss_dssp SCEEEEC---SEEEECSC
T ss_pred CcEEEeC---CCeecCCC
Confidence 9999995 47898854
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.14 E-value=8.6e-11 Score=104.13 Aligned_cols=98 Identities=16% Similarity=0.325 Sum_probs=73.7
Q ss_pred CCCccccCCCCCccccCCCceEEEEEecCCCCeeEEEEEeCCeeEEeeCCCCCCCCceEEEeeCccEEEEcCCCceEeec
Q 003059 35 LGSSLSASNLNQSWPSPNSTFSLSFIQRSPNSFIPAITYSGGVPIWTAGSTPVDSSAFFQLHSSGTLRLISGSGAIIWDS 114 (852)
Q Consensus 35 ~~~~l~~~~~~~~l~S~~g~f~lgf~~~~~~~~~~~i~~~~~~~vW~an~~p~~~~~~l~~~~~g~l~l~~~~~~~vWst 114 (852)
+.+.|..++ .| ..|.|.|.|...++ |.| |..+.+||.++.........+.|..+|||||+|.++.+||++
T Consensus 22 ~~~~l~~~q---~l--~~g~y~L~~q~DGN----LvL-~~~~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW~S 91 (120)
T d1dlpa2 22 HPQTLHATQ---SL--QLSPYRLSMETDCN----LVL-FDRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTS 91 (120)
T ss_dssp CCCEECSSC---CC--BCSSCEEEEETTTE----EEE-EBTTBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEEEC
T ss_pred cccEEcCCC---ee--EcCCEEEEEcCCCc----EEE-ecCCcEEEEEccccCCCcEEEEEeCCeeEEEEcCCCCEEEEe
Confidence 445565555 33 25779998875554 444 456788999986433556789999999999999999999999
Q ss_pred cCCCC-ceeEEEEcCCccEEEecCCCcccccc
Q 003059 115 NTQRL-NVTSASLDDSGNLVLLKNGGVSAWSS 145 (852)
Q Consensus 115 ~~~~~-~~~~~~l~d~GNlvl~~~~~~~lWQS 145 (852)
++... ...+++|++||||||++ ..+|.|
T Consensus 92 ~t~~~~~~~~l~Lq~DGnlvlY~---~~~W~t 120 (120)
T d1dlpa2 92 GNSRSAGRYVFVLQPDRNLAIYG---GALWTT 120 (120)
T ss_dssp CCCCSSSCCEEEECSSSCEEEEC---CCCCBC
T ss_pred CCCCCCCcEEEEECCCCcEEEeC---CCcccC
Confidence 97654 34479999999999994 468875
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.12 E-value=1e-10 Score=103.21 Aligned_cols=84 Identities=25% Similarity=0.351 Sum_probs=68.3
Q ss_pred eEEEeeCccEEEEcCCCceEeeccCCCCc-eeEEEEcCCccEEEecCCCccccccCCCCCCcccCCCccccCccccccce
Q 003059 92 FFQLHSSGTLRLISGSGAIIWDSNTQRLN-VTSASLDDSGNLVLLKNGGVSAWSSFDNPTDTIVPSQNFTSDKTLRSGYY 170 (852)
Q Consensus 92 ~l~~~~~g~l~l~~~~~~~vWst~~~~~~-~~~~~l~d~GNlvl~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~l~sG~~ 170 (852)
.|.+..||||||++. +.+||++++.+.. ...+.|+++|||||+|.++.++|+|.-. -..|.|
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~vWsS~t~----------------~~~~~~ 95 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVA----------------GKAGHY 95 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECSCC----------------CCSSCE
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCCCcEEEECCCc----------------CCCCce
Confidence 477889999999975 5789999986543 4689999999999999999999987531 012678
Q ss_pred EEEeecCCceeeeecCceeeeccCc
Q 003059 171 SFTLLKSGNLSLKWNDSVVYFNQGL 195 (852)
Q Consensus 171 sl~~~~~g~~~~~~~~~~~yw~~g~ 195 (852)
.+.++.||++++|- .++|.+++
T Consensus 96 ~l~Lq~DGNlvlYg---~~~W~S~T 117 (119)
T d1b2pa_ 96 VLVLQPDRNVVIYG---DALWATQT 117 (119)
T ss_dssp EEEECTTSCEEEEE---SEEEECCC
T ss_pred EEEEcCCCCEEEEC---CCEeccCC
Confidence 89999999999983 46898874
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.06 E-value=1.9e-10 Score=100.12 Aligned_cols=85 Identities=26% Similarity=0.356 Sum_probs=67.9
Q ss_pred ceEEEeeCccEEEEcCCCceEeeccCCCCc-eeEEEEcCCccEEEecCCCccccccCCCCCCcccCCCccccCccccccc
Q 003059 91 AFFQLHSSGTLRLISGSGAIIWDSNTQRLN-VTSASLDDSGNLVLLKNGGVSAWSSFDNPTDTIVPSQNFTSDKTLRSGY 169 (852)
Q Consensus 91 ~~l~~~~~g~l~l~~~~~~~vWst~~~~~~-~~~~~l~d~GNlvl~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~l~sG~ 169 (852)
-.|.+..||||||++ .+.+||++++.+.+ ...++|+++|||||++.++.++|+|- | .-..+.
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS~---t-------------~~~~~~ 83 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWASN---T-------------GGQNGN 83 (108)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECC---C-------------CCSCSC
T ss_pred EEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCCccceEEcc---c-------------cCCCCc
Confidence 457888999999997 56899999987654 35799999999999999999999872 1 112367
Q ss_pred eEEEeecCCceeeeecCceeeeccCc
Q 003059 170 YSFTLLKSGNLSLKWNDSVVYFNQGL 195 (852)
Q Consensus 170 ~sl~~~~~g~~~~~~~~~~~yw~~g~ 195 (852)
|.+.++.+|++++|- .+.|.++.
T Consensus 84 ~~l~L~ddGNlVly~---~~~W~S~t 106 (108)
T d1jpca_ 84 YVCILQKDRNVVIYG---TDRWATGT 106 (108)
T ss_dssp EEEEECTTSCEEEEE---CCCCCCCC
T ss_pred EEEEEcCCCCEEEeC---CCcccCCC
Confidence 889999999999983 34787763
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.04 E-value=3.4e-10 Score=98.49 Aligned_cols=85 Identities=27% Similarity=0.427 Sum_probs=67.7
Q ss_pred ceEEEeeCccEEEEcCCCceEeeccCCCC--ceeEEEEcCCccEEEecCCCccccccCCCCCCcccCCCccccCcccccc
Q 003059 91 AFFQLHSSGTLRLISGSGAIIWDSNTQRL--NVTSASLDDSGNLVLLKNGGVSAWSSFDNPTDTIVPSQNFTSDKTLRSG 168 (852)
Q Consensus 91 ~~l~~~~~g~l~l~~~~~~~vWst~~~~~--~~~~~~l~d~GNlvl~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~l~sG 168 (852)
-.|.|..||||||++ .+.+||++++... ....+.|+++|||||++.++.++|+|-.. -..|
T Consensus 21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s~t~----------------~~~~ 83 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSV----------------RGNG 83 (109)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEECCCC----------------CCSS
T ss_pred EEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEEeeE----------------CCCC
Confidence 457788999999996 5689999997643 34579999999999999999999998321 1136
Q ss_pred ceEEEeecCCceeeeecCceeeeccCc
Q 003059 169 YYSFTLLKSGNLSLKWNDSVVYFNQGL 195 (852)
Q Consensus 169 ~~sl~~~~~g~~~~~~~~~~~yw~~g~ 195 (852)
.|.+.++.+|++++|- ...|.+++
T Consensus 84 ~~~l~L~ddGNlvly~---~~~W~S~t 107 (109)
T d1kj1a_ 84 NYVLVLQEDGNVVIYG---SDIWSTGT 107 (109)
T ss_dssp CCEEEECTTSCEEEEC---CEEEECCC
T ss_pred CEEEEEeCCCcEEEEC---CCEecCCC
Confidence 7889999999999982 35888764
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.84 E-value=5.2e-09 Score=91.58 Aligned_cols=88 Identities=20% Similarity=0.363 Sum_probs=68.5
Q ss_pred ceEEEeeCccEEEEcCCCceEeeccCCC-CceeEEEEcCCccEEEecCCCccccccCCCCCCcccCCCccccCccccccc
Q 003059 91 AFFQLHSSGTLRLISGSGAIIWDSNTQR-LNVTSASLDDSGNLVLLKNGGVSAWSSFDNPTDTIVPSQNFTSDKTLRSGY 169 (852)
Q Consensus 91 ~~l~~~~~g~l~l~~~~~~~vWst~~~~-~~~~~~~l~d~GNlvl~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~l~sG~ 169 (852)
-.|.|..||||||++ .+.+||+++... ...+.++|+.+|||||++. +..+|.|=. .-.+|.
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~-~~~~w~s~t----------------~~~~~~ 82 (112)
T d1xd5a_ 21 YLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSG-SRAIWASNT----------------NRQNGN 82 (112)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEET-TEEEEECCC----------------CCSCCC
T ss_pred EEEEEcCCCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEec-CCeEEEEee----------------ccCCCc
Confidence 457888999999996 578999999764 3446799999999999996 456665521 112367
Q ss_pred eEEEeecCCceeeeecCceeeeccCcc
Q 003059 170 YSFTLLKSGNLSLKWNDSVVYFNQGLN 196 (852)
Q Consensus 170 ~sl~~~~~g~~~~~~~~~~~yw~~g~~ 196 (852)
|.+.++.+|++++|.....+.|.++..
T Consensus 83 ~~l~L~ddGNlvly~~~~~~~W~S~t~ 109 (112)
T d1xd5a_ 83 YYLILQRDRNVVIYDNSNNAIWATHTN 109 (112)
T ss_dssp CEEEECTTSCEEEECTTSCEEEECCCC
T ss_pred eEEEEcCCCCEEEECCCCcEEecCCCc
Confidence 889999999999998777889998743
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.21 E-value=2.2e-06 Score=86.64 Aligned_cols=136 Identities=15% Similarity=0.070 Sum_probs=88.6
Q ss_pred ccccccccceEEEEEECCCcEEEEEEecC-cccchHHHHHHHHHhhccc-ccceeeeeeeeccCceeeEEEeecCCCCHH
Q 003059 505 DKLGAGGFGAVYRGVLANRTVVAVKQLEG-IEQGEKQFRMEVATISSTH-HLNLVRLVGFSSEGKHRLLVYEFMKNGSLD 582 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~-~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 582 (852)
+..+.+....||+....+ +.+++|+... .......+.+|...+..+. +--+.+++++..+++..++||+++++..+.
T Consensus 20 ~~~~G~s~~~v~rv~~~~-~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~ 98 (263)
T d1j7la_ 20 KDTEGMSPAKVYKLVGEN-ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp ECSCCCSSSEEEEEECSS-CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred EcCCCCCCCcEEEEEeCC-CeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccc
Confidence 333334456899987544 4567787763 3334456788888887664 444677888888888999999999998876
Q ss_pred HHhhhcccCCccccchhHHHHHHHhhHhhhhhhcccc-------------------------------------------
Q 003059 583 NFLFANEEGSGKLLNWQSRFNIALGTARGITYLHEEC------------------------------------------- 619 (852)
Q Consensus 583 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------------- 619 (852)
+..... .....++.++++.|+.||+..
T Consensus 99 ~~~~~~----------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T d1j7la_ 99 EEYEDE----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp HHTTTC----------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHH
T ss_pred cccccc----------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHH
Confidence 543210 111122333333333333210
Q ss_pred -------------CCCcccCCCCCCceEeCCCCceEEeecccccc
Q 003059 620 -------------RDCIVHCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 620 -------------~~~ivH~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
...++|+|+.|.|||+++++.+.|.||+.+..
T Consensus 169 ~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999877778999997763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.69 E-value=3.4e-05 Score=77.16 Aligned_cols=75 Identities=19% Similarity=0.118 Sum_probs=54.3
Q ss_pred ccccccc-ceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhcccc--cceeeeeeeeccCceeeEEEeecCCCCHH
Q 003059 506 KLGAGGF-GAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHH--LNLVRLVGFSSEGKHRLLVYEFMKNGSLD 582 (852)
Q Consensus 506 ~lG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 582 (852)
.+..|.. +.||+...+++..+++|...... ..++..|+..++.+.. -.+.+++++..+.+..++|||++++.++.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 3444543 67899988888878889866332 3357778888876643 34567788888888999999999887653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.24 E-value=0.00048 Score=73.34 Aligned_cols=74 Identities=14% Similarity=0.099 Sum_probs=47.7
Q ss_pred ccccccccceEEEEEECC-CcEEEEEEecC--------cccchHHHHHHHHHhhccc---ccceeeeeeeeccCceeeEE
Q 003059 505 DKLGAGGFGAVYRGVLAN-RTVVAVKQLEG--------IEQGEKQFRMEVATISSTH---HLNLVRLVGFSSEGKHRLLV 572 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~--------~~~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV 572 (852)
+.||.|....||+....+ ++.++||.-.. ......+...|.+.|..+. ...+.+++.+. ....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence 468999999999998654 67788886431 1122334556777776552 23566676654 3456899
Q ss_pred EeecCCCC
Q 003059 573 YEFMKNGS 580 (852)
Q Consensus 573 ~e~~~~gs 580 (852)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.14 E-value=0.00061 Score=70.52 Aligned_cols=137 Identities=13% Similarity=0.043 Sum_probs=81.0
Q ss_pred ceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhccccccee--eeee-----eeccCceeeEEEeecCCCCHH---
Q 003059 513 GAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLV--RLVG-----FSSEGKHRLLVYEFMKNGSLD--- 582 (852)
Q Consensus 513 g~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv--~l~g-----~~~~~~~~~lV~e~~~~gsL~--- 582 (852)
-.||++..++|+.+++|.........+++..|...+..|....+. ..+. ....++..+.|+++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~ 115 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN 115 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence 479999999999999999876555677888999888877543322 1111 223456788999999764431
Q ss_pred --HH---------hhh----cccCCccccchh-------------------H---HHHHHHhhHhhhhh-hccccCCCcc
Q 003059 583 --NF---------LFA----NEEGSGKLLNWQ-------------------S---RFNIALGTARGITY-LHEECRDCIV 624 (852)
Q Consensus 583 --~~---------l~~----~~~~~~~~l~~~-------------------~---~~~i~~~ia~~L~y-LH~~~~~~iv 624 (852)
.+ ++. ........+++. . ....+.++...+.- +.+..+.++|
T Consensus 116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li 195 (325)
T d1zyla1 116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL 195 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence 11 011 000111111211 1 11122222222221 1222346799
Q ss_pred cCCCCCCceEeCCCCceEEeecccccc
Q 003059 625 HCDIKPENILLDENYNAKVSDFGLAKL 651 (852)
Q Consensus 625 H~Dlkp~NILl~~~~~~kl~DFGla~~ 651 (852)
|+|+.+.|||++++ ..+.||+-+..
T Consensus 196 HgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 196 HGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred cCCCCcccEEEeCC--ceEEechhccc
Confidence 99999999999754 45899997763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.57 E-value=0.0019 Score=68.68 Aligned_cols=72 Identities=15% Similarity=0.172 Sum_probs=50.1
Q ss_pred ccccccccceEEEEEECCC--------cEEEEEEecCcccchHHHHHHHHHhhcccccce-eeeeeeeccCceeeEEEee
Q 003059 505 DKLGAGGFGAVYRGVLANR--------TVVAVKQLEGIEQGEKQFRMEVATISSTHHLNL-VRLVGFSSEGKHRLLVYEF 575 (852)
Q Consensus 505 ~~lG~G~fg~Vy~~~~~~~--------~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~ 575 (852)
+.|+.|-.-.+|+....++ +.|.+++.-. ....-...+|..+++.+.-.++ .++++++.+ .+|+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 5688888899999986542 4566666553 3334456789999888854444 477887764 589999
Q ss_pred cCCCCH
Q 003059 576 MKNGSL 581 (852)
Q Consensus 576 ~~~gsL 581 (852)
+++..|
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.32 E-value=0.024 Score=57.58 Aligned_cols=143 Identities=8% Similarity=0.007 Sum_probs=74.0
Q ss_pred cccccccceEEEEEECCCcEEEEEEecCcccchHHHHHHHHHhhccccccee--eeee------eeccCceeeEEEeecC
Q 003059 506 KLGAGGFGAVYRGVLANRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLV--RLVG------FSSEGKHRLLVYEFMK 577 (852)
Q Consensus 506 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~f~~E~~~l~~l~h~niv--~l~g------~~~~~~~~~lV~e~~~ 577 (852)
.|..|---+.|+.+.++++ +++|+.+.. ...+++..|++++..+.+.++. ..+. +.........++.+..
T Consensus 25 ~i~~G~~N~ny~v~t~~g~-yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~ 102 (316)
T d2ppqa1 25 GIAEGVENSNFLLHTTKDP-LILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 102 (316)
T ss_dssp EECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred cCCCCcccCeEEEEECCCc-EEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeecc
Confidence 3556666788999887776 888988643 2334556677777766533321 1111 1122345566777766
Q ss_pred CCCHHH--------------Hhhhccc------CCcc----------------ccchhHHHHHHHhhHhhhhhhcc-ccC
Q 003059 578 NGSLDN--------------FLFANEE------GSGK----------------LLNWQSRFNIALGTARGITYLHE-ECR 620 (852)
Q Consensus 578 ~gsL~~--------------~l~~~~~------~~~~----------------~l~~~~~~~i~~~ia~~L~yLH~-~~~ 620 (852)
+..... .++.... .... ..........+..+...+...+. ..+
T Consensus 103 g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~ 182 (316)
T d2ppqa1 103 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 182 (316)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred cccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccccc
Confidence 543311 0000000 0000 00011111222222222222222 235
Q ss_pred CCcccCCCCCCceEeCCCCceEEeeccccc
Q 003059 621 DCIVHCDIKPENILLDENYNAKVSDFGLAK 650 (852)
Q Consensus 621 ~~ivH~Dlkp~NILl~~~~~~kl~DFGla~ 650 (852)
.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 689999999999999998878999999775
|